FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Alaniz, AJ
   Carvajal, MA
   Bacigalupo, A
   Cattan, PE
AF Alaniz, Alberto J.
   Carvajal, Mario A.
   Bacigalupo, Antonella
   Cattan, Pedro E.
TI Global spatial assessment of Aedes aegypti and Culex quinquefasciatus: a
   scenario of Zika virus exposure
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Arbovirus; exposure level; mosquito; spatial epidemiology; ZIKV risk
ID MOSQUITOS DIPTERA; CULICIDAE; VECTORS; DISEASE; PIPIENS; HEALTH;
   TRANSMISSION; RELEASE; BIOLOGY; MODELS
AB Zika virus (ZIKV) is an arbovirus transmitted mainly by Aedes aegypti mosquitoes. Recent scientific evidence on Culex quinquefasciatus has suggested its potential as a vector for ZIKV, which may change the current risk zones. We aimed to quantify the world population potentially exposed to ZIKV in a spatially explicit way, considering the primary vector (A. aegypti) and the potential vector (C. quinquefasciatus). Our model combined species distribution modelling of mosquito species with spatially explicit human population data to estimate ZIKV exposure risk. We estimated the potential global distribution of C. quinquefasciatus and estimated its potential interaction zones with A. aegypti. Then we evaluated the risk zones for ZIKV considering both vectors. Finally, we quantified and compared the people under risk associated with each vector by risk level, country and continent. We found that C. quinquefasciatus had a more temperate distribution until 42 degrees in both hemispheres, while the risk involving A. aegypti is concentrated mainly in tropical latitudes until 35 degrees in both hemispheres. Globally, 4.2 billion people are under risk associated with ZIKV. Around 2.6 billon people are under very high risk associated with C. quinquefasciatus and 1 billion people associated with A. aegypti. Several countries could be exposed to ZIKV, which emphasises the need to clarify the competence of C. quinquefasciatus as a potential vector as soon as possible. The models presented here represent a tool for risk management, public health planning, mosquito control and preventive actions, especially to focus efforts on the most affected areas.
C1 [Alaniz, Alberto J.; Carvajal, Mario A.] Ctr Estudios Ecol Espacial & Medio Ambiente Ecoge, Santiago, Chile.
   [Alaniz, Alberto J.; Bacigalupo, Antonella; Cattan, Pedro E.] Univ Chile, Lab Ecol, Dept Ciencias Biol Anim, Fac Ciencias Vet & Pecuarias, Santiago, Chile.
RP Alaniz, AJ (corresponding author), Ctr Estudios Ecol Espacial & Medio Ambiente Ecoge, Santiago, Chile.; Alaniz, AJ (corresponding author), Univ Chile, Lab Ecol, Dept Ciencias Biol Anim, Fac Ciencias Vet & Pecuarias, Santiago, Chile.
EM alberto.alaniz@ug.uchile.cl
RI CATTAN, PEDRO E/A-2780-2008; Bacigalupo, Antonella/Q-7189-2019; Alaniz,
   Alberto J./J-3104-2019
OI Bacigalupo, Antonella/0000-0003-1661-8916; 
FU CONICYT FONDECYTComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [1140650]
FX P.E.C and A.B thanks to CONICYT FONDECYT (grant number 1140650).
CR Alaniz AJ, 2018, J APPL ENTOMOL, V142, P513, DOI 10.1111/jen.12498
   Alaniz AJ, 2019, ENCY ENV HLTH, P1
   Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Alsan MM, 2011, INFECT DIS CLIN N AM, V25, P611, DOI 10.1016/j.idc.2011.05.004
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BARR AR, 1957, AM J TROP MED HYG, V6, P153, DOI 10.4269/ajtmh.1957.6.153
   Batallan GP, 2015, ACTA TROP, V146, P53, DOI 10.1016/j.actatropica.2015.03.009
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   BRADLEY C, 1985, MATH GAZ, V69, P12, DOI 10.2307/3616441
   Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   CIESIN (Center for International Earth Science Information Network-Columbia University), 2016, GRIDD POP WORLD VERS
   Ciota AT, 2012, J MED ENTOMOL, V49, P35, DOI 10.1603/ME11077
   Collucci C, 2016, BMJ-BRIT MED J, V355, P6716
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111
   Duchin JS, 2016, DISASTER MED PUBLIC, V10, P298, DOI 10.1017/dmp.2016.26
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Evans M, 2016, ELIFE, V6
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Foley DH, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-11
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Greenberg JA, 2012, J VECTOR ECOL, V37, P83, DOI 10.1111/j.1948-7134.2012.00203.x
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lashley Felissa R, 2004, Expert Rev Anti Infect Ther, V2, P299, DOI 10.1586/14787210.2.2.299
   Leal Walter S, 2016, F1000Res, V5, P2546
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Perez-Perez J, 2017, CES MEDICINA, V33, P175, DOI [10.1590/0074-02760170521, DOI 10.1590/0074-02760170521]
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049
   Rather IA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00830
   REISEN WK, 1991, J MED ENTOMOL, V28, P357, DOI 10.1093/jmedent/28.3.357
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Sands P, 2016, LANCET, V388, P2443, DOI 10.1016/S0140-6736(16)30594-3
   Shaw WR, 2015, CURR OPIN INSECT SCI, V10, P142, DOI 10.1016/j.cois.2015.05.001
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.80
   Sumner T, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005470
   Thornton JH, 2016, J VECTOR ECOL, V41, P265, DOI 10.1111/jvec.12221
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Velasquez-Serra GC, 2016, AM J EPIDEMIOLOGY IN, V4, P78
   Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 59
TC 2
Z9 2
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR UNSP e52
DI 10.1017/S0950268818003102
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HG9OV
UT WOS:000455339100051
PM 30474578
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Adanns, LE
   Martin, SW
   Lindsey, NP
   Lehman, JA
   Rivera, A
   Kolsin, J
   Landry, K
   Staples, JE
   Sharp, TM
   Paz-Bailey, G
   Fischer, M
AF Adanns, Laura E.
   Martin, Stacey W.
   Lindsey, Nicole P.
   Lehman, Jennifer A.
   Rivera, Aidsa
   Kolsin, Jonathan
   Landry, Kimberly
   Staples, J. Erin
   Sharp, Tyler M.
   Paz-Bailey, Gabriela
   Fischer, Marc
TI Epidemiology of Dengue, Chikungunya, and Zika Virus Disease in US States
   and Territories, 2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DISTRICT-OF-COLUMBIA; TEXAS-MEXICO BORDER; UNITED-STATES; PUERTO-RICO;
   NOVEMBER 1; FEVER; TRAVELERS; TRANSMISSION; OUTBREAK; AMERICA
AB Dengue, chikungunya, and Zika viruses, primarily transmitted by Aedes species mosquitoes, have caused large outbreaks in the Americas, leading to travel-associated cases and local mosquito-borne transmission in the United States. We describe the epidemiology of dengue, chikungunya, and noncongenital Zika virus disease cases reported from U.S. states and territories in 2017, including 971 dengue cases, 195 chikungunya cases, and 1,118 Zika virus disease cases. Cases of all three diseases reported from the territories were reported as resulting from local mosquito-borne transmission. Cases reported from the states were primarily among travelers, with only seven locally acquired mosquito-transmitted Zika virus disease cases reported from Texas (n = 5) and Florida (n = 2). In the territories, most dengue cases (n = 508, 98%) were reported from American Samoa, whereas the majority of chikungunya (n = 39, 100%) and Zika virus disease (n = 620, 93%) cases were reported from Puerto Rico. Temporally, the highest number of Zika virus disease cases occurred at the beginning of the year, followed by a sharp decline, mirroring decreasing case numbers across the Americas following large outbreaks in 2015 and 2016. Dengue and chikungunya cases followed a more seasonal pattern, with higher case numbers from July through September. Travelers to the United States and residents of areas with active virus transmission should be informed of both the ongoing risk from dengue, chikungunya, and Zika virus disease and personal protective measures to lower their risk of mosquito bites and to help prevent the spread of these diseases.
C1 [Adanns, Laura E.; Rivera, Aidsa; Sharp, Tyler M.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR USA.
   [Martin, Stacey W.; Lindsey, Nicole P.; Lehman, Jennifer A.; Kolsin, Jonathan; Landry, Kimberly; Staples, J. Erin; Fischer, Marc] Ctr Dis Control & Prevent, Arboviral Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
RP Martin, SW (corresponding author), Ctr Dis Control & Prevent, Arboviral Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM ipb2@cdc.gov; zmt0@cdc.gov; frd3@cdc.gov; zjg3@cdc.gov; erj2@cdc.gov;
   jonathan.kolsin@dshs.texas.gov; nrn8@cdc.gov; auvl@cdc.gov;
   iyp4@cdc.gov; gmb5@cdc.gov; mxf2@cdc.gov
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], 2015, DENG VIR INF 2015 CA
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Centers for Disease Control and Prevention, 2018, SURV CAS DEF CURR HI
   Centers for Disease Control and Prevention, ZIK VIR DIS ZIK VIR
   Centers for Disease Control and Prevention, 2018, CHIK VIR US
   Centers for Disease Control and Prevention Arboviral Diseases, 2015, NEUR NONN 2015 CAS D
   Cotter CJ, 2018, MMWR-MORBID MORTAL W, V67, P1319, DOI 10.15585/mmwr.mm6747a5
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Feldstein LR, 2017, EMERG INFECT DIS, V23, P673, DOI 10.3201/eid2304.161562
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Hsu CH, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007084
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Kumar A, 2017, J TROP PEDIATRICS, V63, P43, DOI 10.1093/tropej/fmw051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, AM J TROP MED HYG, V98, P192, DOI 10.4269/ajtmh.17-0668
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Monaghan AJ, 2018, CLIMATIC CHANGE, V146, P487, DOI 10.1007/s10584-016-1679-0
   Pan American Health Organization, 2017, DENG FEV AM NUMB REP
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rigau-Perez Jose G., 1994, Morbidity and Mortality Weekly Report, V43, P7
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004625
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wilder-Smith A., 2018, J TRAVEL MED, V25, P1, DOI DOI 10.1093/JTM/TAY057
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 45
TC 2
Z9 2
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 4
BP 884
EP 890
DI 10.4269/ajtmh.19-0309
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JB4JA
UT WOS:000488520700029
PM 31436154
DA 2020-07-08
ER

PT J
AU Ficenec, SC
   Schieffelin, JS
   Emmett, SD
AF Ficenec, Samuel C.
   Schieffelin, John S.
   Emmett, Susan D.
TI A Review of Hearing Loss Associated with Zika, Ebola, and Lassa Fever
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Review
ID VIRUS DISEASE SURVIVORS; MENTAL-HEALTH; HEMORRHAGIC-FEVER; SIERRA-LEONE;
   SEQUELAE; INFECTION; IMPAIRMENT; DEAFNESS; INFANTS; ADULTS
AB The neglected tropical diseases Zika, Ebola, and Lassa fever (LF) have all been noted to cause some degree of hearing loss (HL). Hearing loss is a chronic disability that can lead to a variety of detrimental effects, including speech and language delays in children, decreased economic productivity in adults, and accelerated cognitive decline in older adults. The objective of this review is to summarize what is known regarding HL secondary to these viruses. Literature for this review was gathered using the PubMed database. Articles were excluded if there were no data of the respective viruses, postinfectious complications, or conditions related to survivorship. A total of 50 articles were included in this review. Fourteen articles discussing Zika virus and subsequent complications were included. Across these studies, 56 (21.2%) of 264 Zika-infected individuals were found to have HL. Twenty-one articles discussing Ebola virus and subsequent complications were included, with 190 (5.7%) of 3,350 Ebola survivors found to have HL. Fifteen additional articles discussing LF and subsequent complications were included. Of 926 individuals with LF, 79 (8.5%) were found to have HL. These results demonstrate a relationship between HL and infection. The true prevalence is likely underestimated, however, because of lack of standardization of reporting and measurement. Future studies of viral sequelae would benefit from including audiometric evaluation. This information is critical to understanding pathophysiology, preventing future cases of this disability, and improving quality of life after survival of infection.
C1 [Ficenec, Samuel C.; Schieffelin, John S.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Emmett, Susan D.] Duke Univ, Sch Med, Dept Head & Neck Surg & Commun Sci, DUMC Box 3805, Durham, NC 27710 USA.
   [Emmett, Susan D.] Duke Global Hlth Inst, Durham, NC USA.
   [Emmett, Susan D.] Duke Univ, Ctr Hlth Policy & Inequal Res, Durham, NC USA.
RP Emmett, SD (corresponding author), Duke Univ, Sch Med, Dept Head & Neck Surg & Commun Sci, DUMC Box 3805, Durham, NC 27710 USA.
EM sficenec@tulane.edu; jschieff@tulane.edu; susan.emmett@duke.edu
FU NIH Research Training Grant - NIH Fogarty International Center [D43
   TW009340]; NINDSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS); NIMHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH); NHBLI
FX This project was supported by NIH Research Training Grant #D43 TW009340
   funded by the NIH Fogarty International Center, NINDS, NIMH, and NHBLI
   and serves as background for the World Health Organization World Report
   on Hearing.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Arlinger S, 2003, INT J AUDIOL, V42, pS17
   Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001
   Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308
   BYL FM, 1984, LARYNGOSCOPE, V94, P647
   Calle-Giraldo JP, 2019, PEDIATR INFECT DIS J, V38, P1
   Cashman KA, 2018, MBIO, V9, DOI [10.1128/mBio.01896-18, 10.1128/mbio.01896-18]
   Cashman KA, 2017, HUM VACC IMMUNOTHER, V13, P2902, DOI 10.1080/21645515.2017.1356500
   Choi MJ, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy131
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   CUMMINS D, 1990, JAMA-J AM MED ASSOC, V264, P2093
   DAVIS JM, 1986, J SPEECH HEAR DISORD, V51, P53, DOI 10.1044/jshd.5101.53
   de Laval F, 2018, J CLIN VIROL, V109, P57, DOI 10.1016/j.jcv.2018.09.015
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de St Maurice A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy239
   Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3
   Fallah MP, 2016, LANCET GLOB HEALTH, V4, pE678, DOI 10.1016/S2214-109X(16)30147-4
   FRAME JD, 1989, REV INFECT DIS, V11, pS783
   Franca TLB, 2018, INT J ENV RES PUB HE, V15, pE1990
   Grahn A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw198
   GRUNDY DJ, 1980, LANCET, V2, P649
   Guevara Jade Gieseke, 2018, J Med Case Rep, V12, P161, DOI 10.1186/s13256-018-1679-y
   Gunther S, 2001, J INFECT DIS, V184, P345, DOI 10.1086/322033
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hereth-Hebert E, 2017, AM J OPHTHALMOL, V175, P114, DOI 10.1016/j.ajo.2016.12.005
   HIRABAYASHI Y, 1988, J INFECT DIS, V158, P872, DOI 10.1093/infdis/158.4.872
   Hotez P, 2006, ADV EXP MED BIOL, V582, P23
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000230
   Howlett PJ, 2018, EMERG INFECT DIS, V24, P1412, DOI 10.3201/eid2408.171367
   Ibekwe TS, 2011, EUR ARCH OTO-RHINO-L, V268, P197, DOI 10.1007/s00405-010-1370-4
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   JAFFE BF, 1978, OTOLARYNG CLIN N AM, V11, P63
   Jagadesh S, 2018, CLIN INFECT DIS, V66, P131, DOI 10.1093/cid/cix705
   Kelly JD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007185
   Kelly JD, 2019, CLIN INFECT DIS, V68, P1388, DOI 10.1093/cid/ciy677
   Kvam MH, 2007, J DEAF STUD DEAF EDU, V12, P1, DOI 10.1093/deafed/enl015
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MC, 2016, BRAZ J OTORHINOLAR, V16, P30126
   Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42
   Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868
   Lin FR, 2011, J GERONTOL A-BIOL, V66, P1131, DOI 10.1093/gerona/glr115
   Macher AM, 2006, EMERG INFECT DIS, V12, P835, DOI 10.3201/eid1205.050052
   Mackenzie I, 2009, ANN TROP MED PARASIT, V103, P565, DOI 10.1179/000349809X12459740922372
   Martins Odailza Rosa, 2017, Audiol., Commun. Res., V22, pe1850, DOI 10.1590/2317-6431-2017-1850
   Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2
   MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445
   MERTENS PE, 1973, AM J TROP MED HYG, V22, P780, DOI 10.4269/ajtmh.1973.22.780
   Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162
   MONSON MH, 1987, AM J TROP MED HYG, V36, P408, DOI 10.4269/ajtmh.1987.36.408
   Nanyonga M, 2016, CLIN INFECT DIS, V62, P125, DOI 10.1093/cid/civ795
   Okokhere P, 2018, LANCET INFECT DIS, V18, P684, DOI 10.1016/S1473-3099(18)30121-X
   Okokhere Peter O, 2009, J Med Case Rep, V3, P36, DOI 10.1186/1752-1947-3-36
   Overholt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206595
   Parra Viviane M., 2003, Rev. Bras. Otorrinolaringol., V69, P283, DOI 10.1590/S0034-72992003000200022
   PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897
   Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453
   Racicot K, 2017, TRENDS MOL MED, V23, P778, DOI 10.1016/j.molmed.2017.07.004
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   RYBAK LP, 1990, JAMA-J AM MED ASSOC, V264, P2119, DOI 10.1001/jama.264.16.2119
   Santos VS, 2017, AM J TROP MED HYG, V97, P151, DOI 10.4269/ajtmh.16-1021
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shantha JG, 2017, OPHTHALMOLOGY, V124, P170, DOI 10.1016/j.ophtha.2016.10.011
   Shin HY, 2017, KOREAN J FAM MED, V38, P57, DOI 10.4082/kjfm.2017.38.2.57
   Sneller MC, 2019, NEW ENGL J MED, V380, P924, DOI 10.1056/NEJMoa1805435
   Spengler JR, 2017, CURR OPIN VIROL, V25, P90, DOI 10.1016/j.coviro.2017.07.028
   Tambs K, 2004, PSYCHOSOM MED, V66, P776, DOI 10.1097/01.psy.0000133328.03596.fb
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   VAN DISHOECK H A, 1957, Ann Otol Rhinol Laryngol, V66, P963
   Ventura CV, 2018, OSLI RETINA, V49, pE93, DOI 10.3928/23258160-20180907-14
   Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3
   Vianna RAO, 2019, J TROP PEDIATRICS, V19, P1
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   WHITE HA, 1972, T ROY SOC TROP MED H, V66, P390, DOI 10.1016/0035-9203(72)90269-6
   WILSON HW, 2018, BIOMED RES INT, V2018, P1, DOI DOI 10.1155/2018/
   Wing K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209655
   Wiwanitkit V, 2017, BRAZ J OTORHINOLAR, V83, P239, DOI 10.1016/j.bjorl.2016.08.007
   World Health Organization, 2008, GUIN LIF EB HAS NEW
   Yeh S, 2018, OCUL IMMUNOL INFLAMM, V26, P1128, DOI 10.1080/09273948.2018.1484493
   Younan P, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006932
   Yun NE, 2016, J VIROL, V90, P2920, DOI 10.1128/JVI.02948-15
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 89
TC 2
Z9 2
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 3
BP 484
EP 490
DI 10.4269/ajtmh.18-0934
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JB4IJ
UT WOS:000488518900006
PM 31333155
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Nascimento, EJM
   Bonaparte, MI
   Luo, P
   Vincent, TS
   Hu, B
   George, JK
   Anez, G
   Noriega, F
   Zheng, LY
   Huleatt, JW
AF Nascimento, Eduardo J. M.
   Bonaparte, Matthew I.
   Luo, Ping
   Vincent, Timothy S.
   Hu, Branda
   George, James K.
   Anez, German
   Noriega, Fernando
   Zheng, Lingyi
   Huleatt, James W.
TI Use of a Blockade-of-Binding ELISA and Microneutralization Assay to
   Evaluate Zika Virus Serostatus in Dengue-Endemic Areas
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID COMPETITIVE ELISA; INFECTION; DISEASE; ANTIBODIES; RESPONSES; OUTBREAK;
   STATES
AB Zika virus (ZIKV) serological diagnostics are compromised in areas where dengue viruses (DENV) co-circulate because of their high levels of protein sequence homology. Here, we describe the characterization of a Zika blockade-of-binding ELISA (Zika BOB) and a Zika microneutralization assay (Zika MN) for the detection of ZIKV nonstructural protein 1 (NS1)-specific antibodies and ZIKV neutralizing antibodies, respectively. Zika BOB and Zika MN cutoffs were established as 10 and 100 endpoint titers, respectively, using samples collected pre- and post-virologically confirmed ZIKV infection from subjects living in DENV-endemic areas. Specificity of the assays was equally high, whereas sensitivity of Zika BOB was lower than that of Zika MN, especially in samples collected > 6 months post-infection. Immunosurveillance analysis, using combined results from both Zika BOB and Zika MN, carried out also in DENV endemic regions in Colombia, Honduras, Mexico, and Puerto Rico before (2013-2014) and after (2017-2018) ZIKV introduction in the Americas suggests unapparent ZIKV seroprevalence rates ranged from 25% to 80% over the specified period of time in the regions investigated.
C1 [Nascimento, Eduardo J. M.; Bonaparte, Matthew I.; Luo, Ping; Vincent, Timothy S.; Hu, Branda; George, James K.; Zheng, Lingyi; Huleatt, James W.] Sanofi Pasteur, Global Clin Immunol, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [Anez, German; Noriega, Fernando] Sanofi Pasteur, Global Clin Sci, Swiftwater, PA USA.
   [Anez, German; Noriega, Fernando] Sanofi Pasteur, Clin Sci, Swiftwater, PA USA.
RP Huleatt, JW (corresponding author), Sanofi Pasteur, Global Clin Immunol, 1 Discovery Dr, Swiftwater, PA 18370 USA.
EM ejmnascimento@gmail.com; matthew.bonaparte@sanofi.com;
   ping.luo@sanofi.com; tsvincent5@gmail.com; hubranda@gmail.com;
   james.george@sanofi.com; german.anez@sanofi.com;
   fernando.noriega@sanofi.com; lingyi.zheng@sanofi.com;
   james.huleatt@sanofi.com
RI Anez, German/B-3643-2008
OI Anez, German/0000-0001-5361-3001
FU Sanofi Pasteur; Department of Health and Human Services; Office of the
   Assistant Secretary for Preparedness and Response; Biomedical Advanced
   Research and Development Authority [HHSO1002016000039C]
FX Sanofi Pasteur partially funded this study. This project has been also
   funded with Federal funds from the Department of Health and Human
   Services; Office of the Assistant Secretary for Preparedness and
   Response; Biomedical Advanced Research and Development Authority, under
   Contract No. HHSO1002016000039C for Zika NS1 BOB ELISA development and
   evaluation of its performance.
CR AFSHAR A, 1987, J CLIN MICROBIOL, V25, P1705, DOI 10.1128/JCM.25.9.1705-1710.1987
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Boaz M., 2014, Trials in Vaccinology, V3, P127, DOI 10.1016/j.trivac.2014.07.002
   Brooks T, 2017, EMERG INFECT DIS, V23, P1360, DOI 10.3201/eid2308.161944
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chen YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152639
   Cruz-Pacheco G, 2014, B MATH BIOL, V76, P2073, DOI 10.1007/s11538-014-9999-6
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins Sean, 2016, F1000Res, V5, P275
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guideline IHT, 2005, ICH HARMONISED TRIPA
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lelli D, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-81
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Nascimento EJM, 2018, J VIROL METHODS, V257, P48, DOI 10.1016/j.jviromet.2018.03.007
   PAHO, 2015, DENG INC AM 2014
   PAHO, 2017, REG ZIK EP UPD AM AU
   PAHO WHO, 2018, EP AL DENG
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Pierson-Perry JF, 2012, PROTOCOLS DETERMINAT
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Schuster I, 2016, ANTIVIR RES, V134, P161, DOI 10.1016/j.antiviral.2016.09.004
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Taketa-Graham M, 2010, AM J TROP MED HYG, V82, P501, DOI 10.4269/ajtmh.2010.09-0297
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Yang M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0650-z
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 42
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 3
BP 708
EP 715
DI 10.4269/ajtmh.19-0270
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JB4IJ
UT WOS:000488518900040
PM 31392955
OA Other Gold, Green Published
DA 2020-07-08
ER

PT S
AU Xu, D
   Li, C
   Qin, CF
   Xu, ZH
AF Xu, Dan
   Li, Cui
   Qin, Cheng-Feng
   Xu, Zhiheng
BE Enquist, L
   DiMaio, D
   Demody, T
TI Update on the Animal Models and Underlying Mechanisms for ZIKV-Induced
   Microcephaly
SO ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019
SE Annual Review of Virology
LA English
DT Article; Book Chapter
DE Zika virus; microcephaly; mouse model; neuropathogenesis; mechanism
ID VIRUS-INFECTION; NEURAL PROGENITORS; GLIAL-CELLS; MOUSE MODEL;
   STEM-CELLS; SEXUAL TRANSMISSION; CEREBRAL ORGANOIDS; ONCOLYTIC ACTIVITY;
   HUMAN BRAIN; AXL
AB The circulation of Zika virus (ZIKV) in nearly 80 countries and territories poses a significant global threat to public health. ZIKV is causally linked to severe developmental defects in the brain, recognized as congenital Zika syndrome (CZS), which includes microcephaly and other serious congenital neurological complications. Since the World Health Organization declared the ZIKV outbreak a public health emergency of international concern, remarkable progress has been made in the generation of different ZIKV infection animal models to gain insight into cellular targets and pathogenesis and to explore the associated underlying mechanisms. Here we focus on summarizing our current understanding of the effects of ZIKV on mammalian brain development in different developmental stages and discuss the potential underlying mechanisms of ZIKV-induced CZS, as well as future perspectives.
C1 [Xu, Dan] Fuzhou Univ, Inst Life Sci, Coll Biol Sci & Engn, Fuzhou 350108, Fujian, Peoples R China.
   [Li, Cui; Xu, Zhiheng] Chinese Acad Sci, State Key Lab Mol Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100069, Peoples R China.
RP Xu, D (corresponding author), Fuzhou Univ, Inst Life Sci, Coll Biol Sci & Engn, Fuzhou 350108, Fujian, Peoples R China.
EM xu200828@163.com; qincf@bmi.ac.cn; zhxu@genetics.ac.cn
OI Li, Cui/0000-0001-9777-9628
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Azar SR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110661
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BROWN AM, 1981, LAB INVEST, V45, P278
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang YF, 2019, GENOM PROTEOM BIOINF
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058156
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Cheshier SH, 2009, NEUROSURGERY, V65, P237, DOI 10.1227/01.NEU.0000349921.14519.2A
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de Sousa JR, 2018, AM J PATHOL, V188, P2644, DOI [10.1016/j.ajpath.2018.07.009, 10.1016/j.ajpat]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong SP, 2018, VIROL SIN, V33, P125, DOI 10.1007/s12250-018-0007-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0042-1
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Lubin JA, 2018, NEUROSURGERY, V82, pE113, DOI 10.1093/neuros/nyy047
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39
   Malmlov A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007071
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McDonell LM, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-22
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013
   Pena LJ, 2018, J GEN VIROL, V99, P1529, DOI 10.1099/jgv.0.001153
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pierson TC, 2013, FIELDS VIROLOGY, P746
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3339/fnhum.2016.00566
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Schaub B, 2017, ULTRASOUND OBST GYN, V49, P658, DOI 10.1002/uog.17210
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Winkler CW, 2018, IMMUNOLOGY, V153, P443, DOI 10.1111/imm.12883
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006848
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhang HJ, 2019, MOL NEUROBIOL, V56, P4072, DOI 10.1007/s12035-018-1358-4
   Zhang NN, 2019, J VIROL, V93, DOI [10.1128/JVI.01982-18, 10.1128/jvi.01982-18]
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304
NR 147
TC 1
Z9 1
U1 1
U2 2
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2327-056X
EI 2327-0578
J9 ANNU REV VIROL
PY 2019
VL 6
BP 459
EP 479
DI 10.1146/annurev-virology-092818-015740
PG 21
WC Virology
SC Virology
GA BN9CS
UT WOS:000488796700022
PM 31206355
DA 2020-07-08
ER

PT S
AU Dudley, DM
   Aliota, MT
   Mohr, EL
   Newman, CM
   Golos, TG
   Friedrich, TC
   O'Connor, DH
AF Dudley, Dawn M.
   Aliota, Matthew T.
   Mohr, Emma L.
   Newman, Christina M.
   Golos, Thaddeus G.
   Friedrich, Thomas C.
   O'Connor, David H.
BE Enquist, L
   DiMaio, D
   Demody, T
TI Using Macaques to Address Critical Questions in Zika Virus Research
SO ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019
SE Annual Review of Virology
LA English
DT Article; Book Chapter
DE ZIKV; macaque; arbovirus; flavivirus; Zika virus; pregnant; congenital
   Zika syndrome
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; PREGNANCY OUTCOMES;
   CROSS-REACTIVITY; VACCINE REFUSAL; VIRAL DYNAMICS; INFECTION; RHESUS;
   RESPONSES; IMMUNOGENICITY
AB Zika virus (ZIKV) and nonhuman primates have been inextricably linked since the virus was first discovered in a sentinel rhesus macaque in Uganda in 1947. Soon after ZIKV was epidemiologically associated with birth defects in Brazil late in 2015, researchers capitalized on the fact that rhesus macaques are commonly used to model viral immunity and pathogenesis, quickly establishing macaque models for ZIKV infection. Within months, the susceptibility of pregnant macaques to experimental ZIKV challenge and ZIKV-associated abnormalities in fetuses was confirmed. This review discusses key unanswered questions in ZIKV immunity and in the pathogenesis of the congenital Zika virus syndrome. We focus on those questions that can be best addressed in pregnant nonhuman primates and lessons learned from developing macaque models for ZIKV amid an active epidemic.
C1 [Dudley, Dawn M.; Newman, Christina M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA.
   [Aliota, Matthew T.] Univ Minnesota Twin Cities, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53792 USA.
   [Golos, Thaddeus G.; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.
   [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Dudley, DM (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA.
EM dmdudley@wisc.edu; mtaliota@umn.edu; emohr2@wisc.edu; ccondon2@wisc.edu;
   golos@primate.wisc.edu; tfriedri@wisc.edu; dhoconno@wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI132563, R01 AI132519, R21 AI136014,
   R21 AI129308, P01 AI132132, R56 AI132563, R01 AI116382, R01 AI138647];
   NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R21 HD091163]
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aiello AE, 2017, GEROSCIENCE, V39, P261, DOI 10.1007/s11357-017-9983-9
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Alves MP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110593
   Andersen K., 2009, 10 WORST GREATESTHIT
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Baqui AH, 2018, LANCET GLOB HEALTH, V6, pE1297, DOI 10.1016/S2214-109X(18)30385-1
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bauman MD, 2018, EXP NEUROL, V299, P252, DOI 10.1016/j.expneurol.2017.07.021
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cent. Dis. Control Prev, 2018, CONG ZIK SYNDR OTH B
   Chang SWC, 2013, P NATL ACAD SCI USA, V110, P10387, DOI 10.1073/pnas.1301213110
   Charles AS, 2016, PLOS CURR, V2016, P8
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Converse AK, 2014, ALCOHOL CLIN EXP RES, V38, P2934, DOI 10.1111/acer.12575
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   da Silva S, 2018, VIRUSES, V10, P89
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550
   Guevara Jade Gieseke, 2018, J Med Case Rep, V12, P161, DOI 10.1186/s13256-018-1679-y
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Larson HJ, 2019, HUM VACC IMMUNOTHER, V15, P625, DOI 10.1080/21645515.2018.1522468
   Leask J, 2009, NEW ENGL J MED, V361, P723
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leonova GN, 2011, PROCEDIA VACCINOL, V4, DOI 10.1016/j.provac.2011.07.012
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Lo JO, 2018, REPROD SCI, V25, P64, DOI 10.1177/1933719117699704
   Ludwig KD, 2018, MAGN RESON MED, V6, pe1297
   Macdonald JA, 2019, J MAGN RESON IMAGING, V49, P534, DOI 10.1002/jmri.26206
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marin M, 2013, MMWR-MORBID MORTAL W, V62, P574
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379
   Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nelson CS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94002
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pereira L, 2011, J INFECT DIS, V203, P1510, DOI 10.1093/infdis/jir126
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pulla P., 2018, HINDU           1127
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Russell W.M.S., 1959, PRINCIPLES HUMANE EX
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Schneider ML, 1997, CHILD DEV, V68, P747, DOI 10.2307/1132030
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Silver RM, 2018, BEST PRACT RES CL OB, V49, P89, DOI 10.1016/j.bpobgyn.2018.03.004
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organ, 2014, WHO TECH REP SER, V980
   World Health Organ, 2013, WHO TECH REP SER, V978
   World Health Organ, 2018, MAT NEWB CHILD AD HL
   Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 149
TC 1
Z9 1
U1 0
U2 0
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2327-056X
EI 2327-0578
J9 ANNU REV VIROL
PY 2019
VL 6
BP 481
EP 500
DI 10.1146/annurev-virology-092818-015732
PG 20
WC Virology
SC Virology
GA BN9CS
UT WOS:000488796700023
PM 31180813
OA Bronze
DA 2020-07-08
ER

PT J
AU Bayona-Pacheco, B
   Acosta-Reyes, J
   Navarro, E
   San-Juan, H
   Bula, J
   Baquero, H
AF Bayona-Pacheco, Brayan
   Acosta-Reyes, Jorge
   Navarro, Edgar
   San-Juan, Homero
   Bula, Johan
   Baquero, Hernando
TI Seroprevalence of Zika virus among blood donors before the epidemic in
   Barranquilla, Colombia, 2015-2016
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE Zika virus; seroprevalence; pre-epidemic dates; pregnant women
ID UNITED-STATES; DENGUE VIRUS; PERSISTENCE; INFECTION; INFANTS;
   ANTIBODIES; SYMPTOMS; BIRTH; IGG
AB The first cases of Zika virus infection in Colombia were reported and confirmed in October 2015. The objective of the study was estimate the seroprevalence of ZIKV infection during the preepidemic phase in Barranquilla, Colombia, and demonstrate the presence of virus before the Colombian Ministry of Health confirmed the first case. We conducted a descriptive study of the seroprevalence of Zika virus in 390 samples obtained from a blood bank located in Barranquilla, Colombia - a city endemic for dengue, and with a recent history of a Chikungunya disease epidemic. The serum pools were tested using Euroimmun ZIKV ELISA kit. Seroprevalence of Zika virus IgG were: May 2015: 0%, June and July 2015: 2.62% (95% CI = 0.28-12.13) and August 2015: 5.35% (95% CI = 1.74-16.74). This brings to our attention the need for extending the surveillance period of this virus in order to adequately assess its teratogenic effects.
C1 [Bayona-Pacheco, Brayan; San-Juan, Homero; Baquero, Hernando] Univ Norte, Div Ciencias Salud, Dept Med, Area Metropolitana Barranquilla, Km 5,Via Puerto Colombia, Barranquilla, Colombia.
   [Acosta-Reyes, Jorge; Navarro, Edgar] Univ Norte, Div Ciencias Salud, Dept Salud Publ, Area Metropolitana Barranquilla, Km 5,Via Puerto Colombia, Barranquilla, Colombia.
   [Bula, Johan] Banco Nacl Sangre, Carrera,50 80-192, Barranquilla, Atlantico, Colombia.
RP Bayona-Pacheco, B (corresponding author), Univ Norte, Div Ciencias Salud, Dept Med, Area Metropolitana Barranquilla, Km 5,Via Puerto Colombia, Barranquilla, Colombia.
EM bbayona@uninorte.edu.co
RI Acosta-Reyes, Jorge/D-1906-2011
OI Acosta-Reyes, Jorge/0000-0003-4303-3243; Baquero,
   Hernando/0000-0002-1284-7853
CR [Anonymous], 2017, EP TOOLS EPITOOLS E
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Contreras CE, 1999, AM J TROP MED HYG, V60, P948, DOI 10.4269/ajtmh.1999.60.948
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   LEON-MAYORGA Y, 2017, ATENCION FAMILIAR, V24, P131
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MINISTRY OF HEALTH COLOMBIA, 2015, 0043 MIN HLTH COL
   NATIONAL INSTITUTE OF HEALTH COLOMBIA, 2015, WEEKL EP B SE, V40
   NATIONAL INSTITUTE OF HEALTH COLOMBIA, 2016, WEEKL EP B SE, V11
   NATIONAL INSTITUTE OF HEALTH COLOMBIA, 2017, WEEKL EP B SE, V14
   Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Veguilla V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150428
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WILLIAMS BG, 2010, ARXIV10074903, P1
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P1099, DOI 10.1016/j.apjtm.2016.10.004
   WORLD HEALTH ORGANIZATION, 2016, ZIK VIR DIS
   WORLD HEALTH ORGANIZATION, 2015, ZIKA VIRUS INFECT BR
   Yamashiro T, 2004, AM J TROP MED HYG, V71, P138, DOI 10.4269/ajtmh.2004.71.138
NR 37
TC 1
Z9 1
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2019
VL 91
IS 3
AR UNSP e20180860
DI 10.1590/0001-3765201920180860
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JA7JX
UT WOS:000488020100001
PM 31553367
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Salgueiro, P
   Restrepo-Zabaleta, J
   Costa, M
   Galardo, AKR
   Pinto, J
   Gaborit, P
   Guidez, A
   Martins, AJ
   Dusfour, I
AF Salgueiro, Patricia
   Restrepo-Zabaleta, Johana
   Costa, Monique
   Ribeiro Galardo, Allan Kardec
   Pinto, Joao
   Gaborit, Pascal
   Guidez, Amandine
   Martins, Ademir Jesus
   Dusfour, Isabelle
TI Liaisons dangereuses: cross-border gene flow and dispersal of
   insecticide resistance-associated genes in the mosquito Aedes aegypti
   from Brazil and French Guiana
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Aedes aegypti; Brazil; French Guiana; insecticide resistance; population
   genetics; vector control
ID RE-IMPLEMENTATION; COMPUTER-PROGRAM; VECTOR; POPULATIONS; SOFTWARE;
   DENGUE; DIFFERENTIATION; EQUILIBRIUM; CULICIDAE; DYNAMICS
AB BACKGROUND In recent years, South America has suffered the burden of continuous high impact outbreaks of dengue, chikungunya and Zika. Aedes aegypti is the main mosquito vector of these arboviruses and its control is the only solution to reduce transmission.
   OBJECTIVES In order to improve vector control it is essential to study mosquito population genetics in order to better estimate the population structures and the geneflow among them.
   METHODS We have analysed microsatellites and knockdown resistance (kdr) mutations from a trans-border region in Amazonia between the state of Amapa (Brazil) and French Guiana (overseas territory of France), to provide further knowledge on these issues. These two countries have followed distinct vector control policies since last century. For population genetic analyses we evaluated variability in 13 well-established microsatellites loci in Ae. aegypti from French Guiana (Saint Georges and Cayenne) and Brazil (Oiapoque and Macapa). The occurrence and frequency of kdr mutations in these same populations were accessed by TaqMan genotype assays for the sites 1016 (Val/Ile) and 1534 (Phe/Cys).
   FINDINGS We have detected high levels of gene flow between the closest cross-border samples of Saint-Georges and Oiapoque. These results suggest one common origin of re-colonisation for the populations of French Guiana and Oiapoque in Brazil, and a different source for Macapit, more similar to the other northern Brazilian populations. Genotyping of the kdr mutations revealed distinct patterns for Cayenne and Macapa associated with their different insecticide use history, and an admixture zone between these two patterns in Saint Georges and Oiapoque, in accordance with population genetic results.
   MAIN CONCLUSIONS The present study highlights the need for regional-local vector surveillance and transnational collaboration between neighboring countries to assess the impact of implemented vector control strategies, promote timely actions and develop preparedness plans.
C1 [Salgueiro, Patricia; Pinto, Joao] Univ Nova Lisboa, Global Hlth & Trop Med Ctr, Inst Higiene & Med Trop, Lisbon, Portugal.
   [Restrepo-Zabaleta, Johana; Gaborit, Pascal; Guidez, Amandine; Dusfour, Isabelle] Inst Pasteur Guyane, Vectopole Amazonien Emile Abonnenc, Vector Control & Adaptat Unit, Cayenne, France.
   [Costa, Monique; Martins, Ademir Jesus] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, Brazil.
   [Ribeiro Galardo, Allan Kardec] Inst Pesquisas Cient & Tecnol Estado Amapa, Amapa, Brazil.
   [Dusfour, Isabelle] Inst Natl Rech Sci, Ctr Armand Frappier Sante Biotechnol, Laval, PQ, Canada.
RP Dusfour, I (corresponding author), Inst Pasteur Guyane, Vectopole Amazonien Emile Abonnenc, Vector Control & Adaptat Unit, Cayenne, France.; Dusfour, I (corresponding author), Inst Natl Rech Sci, Ctr Armand Frappier Sante Biotechnol, Laval, PQ, Canada.
EM isabelle.dusfour@pasteur.fr
RI Martins, Ademir J./B-4117-2009; Pinto, Joao/C-2208-2012; Salgueiro,
   Patricia/B-6410-2012
OI Pinto, Joao/0000-0001-8572-7708; Salgueiro,
   Patricia/0000-0001-8628-3651; Dusfour, Isabelle/0000-0002-5265-8432;
   Martins, Ademir/0000-0001-5739-1215
FU Project SPREAD through the FIOCRUZ - PASTEUR Program; Investissement
   d'Avenir (Agence Nationale de la Recherche)French National Research
   Agency (ANR) [CEBA: ANR-10-LABEX-25-01]; INCT-EM [465678/2014-9];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [UO1 AI115595]; FAPERJCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/110.168/2014, E-26/201.836/2017]; Fundacao para a Ciencia
   e Tecnologia (FCT)Portuguese Foundation for Science and Technology
   [SFRH/BPD/72532/2010]
FX This work was funded by the Project SPREAD through the FIOCRUZ - PASTEUR
   Program 2013 and the Investissement d'Avenir (grant of the Agence
   Nationale de la Recherche - CEBA: ANR-10-LABEX-25-01), INCT-EM (grant no
   465678/2014-9), NIH (grant no UO1 AI115595), FAPERJ (grants no
   E-26/110.168/2014 and E-26/201.836/2017). PS has been supported by the
   Post-doc fellowship SFRH/BPD/72532/2010 from Fundacao para a Ciencia e
   Tecnologia (FCT).
CR Adde A, 2017, J MED ENTOMOL, V54, P597, DOI 10.1093/jme/tjx031
   Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323
   BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63
   Belkhir K, 1996, GENETIX 4 05 LOGICIE
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brito LP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2410819
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campos M, 2012, ECOL EVOL, V2, P2794, DOI 10.1002/ece3.392
   Costa Mauricio, 2017, THESIS
   Day JF, 2016, INSECTS, V7, DOI 10.3390/insects7040065
   Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Epelboin Y, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170398
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Failloux AB, 2002, MED VET ENTOMOL, V16, P456, DOI 10.1046/j.1365-2915.2002.00398.x
   Gloria-Soria A, 2016, MED VET ENTOMOL, V30, P235, DOI 10.1111/mve.12153
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x
   Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167
   Pritchard JK, 2000, GENETICS, V155, P945
   Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Sherpa S, 2018, GENOME BIOL EVOL, V10, P56, DOI 10.1093/gbe/evx267
   SLATKIN M, 1995, GENETICS, V139, P457
   SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Steffler LM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1814-9
   Valle D, 2019, MEM I O CRUZ, V114
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
NR 39
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR UNSP e190120
DI 10.1590/0074-02760190120
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JA7JC
UT WOS:000488017600001
PM 31553370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kuna, A
   Gajewski, M
   Biernat, B
AF Kuna, Anna
   Gajewski, Michal
   Biernat, Beata
TI Selected arboviral diseases imported to Poland - current state of
   knowledge and perspectives for research
SO ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
LA English
DT Review
DE arboviruses; Chikungunya; Dengue; West Nile Fever; Zika Virus Infection;
   communicable diseases; imported
ID WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS; AEDES-ALBOPICTUS; POLISH TRAVELERS;
   WILD BIRDS; DENGUE; ANTIBODIES; TRANSMISSION; INFECTION; DIAGNOSIS
AB Introduction. Arthropod-borne viruses are important causes of human morbidity worldwide. However, the available literatur and the epidemiological data concerning the importation to Poland of globally emerging arboviral infections, such as DENY, CHIKV, WNV, or ZIKV, are scarce. Only few seroepidemiologic studies concerning WNV in animals or humans in Poland have been published.
   Objective. The aim of this review paper is to summarize and present the current state of knowledge and the perspectives for research concerning the importation and the risk posed by the introduction to Poland of the four above-mentioned arboviral diseases.
   Current state of knowledge. Climate change may facilitate the northward expansion of both the vectors for diseases previously unseen in Europe, as well as of the viruses themselves, resulting in autochthonous cases of diseases previously exclusively imported. Little is known about the importation of arboviral diseases to Poland because of the frequently asymptomatic or self-limiting course of the disease, lack of epidemiologic studies or effective disease reporting, as well as inadequate access to diagnostic methods.
   Conclusions. Further epidemiologic studies in Polish travellers are necessary in order to prevent importation or introduction of the above-mentioned viruses, and to act against potential problems related to blood transfusion or organ transplantation from infected donors.
C1 [Kuna, Anna] Inst Maritime & Trop Med, Dept Trop & Parasit Dis, Gdynia, Poland.
   [Kuna, Anna; Biernat, Beata] Med Univ Gdansk, Fac Hlth Sci, Gdansk, Poland.
   [Gajewski, Michal] Prov Hosp, Outpatient Clin Hepatol, Szczecin, Poland.
   [Biernat, Beata] Inst Maritime & Trop Med, Dept Trop Parasitol, Gdynia, Poland.
RP Gajewski, M (corresponding author), Voivodship Hosp, Outpatient Clin Hepatol, Szczecin, Poland.
EM mgajewski@gumed.edu.pl
RI Biernat, Beata/AAP-9866-2020
OI Biernat, Beata/0000-0003-4938-3113
FU Medical University of Gdansk, PolandMedical University Gdansk
   [02-0136/07]
FX The authors gratefully acknowledge the funding of his study by statutory
   Research Grant No. 02-0136/07 from the Medical University of Gdansk,
   Poland.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bazanow B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020087
   Becker N, 2017, PARASITOL RES, V116, P847, DOI 10.1007/s00436-016-5356-z
   Biernat B, 2015, INT MARIT HEALTH, V66, P72, DOI 10.5603/IMH.2015.0018
   Bockova E, 2013, ACTA PARASITOL, V58, P603, DOI 10.2478/s11686-013-0158-2
   Burki T, 2018, LANCET, V392, P1000, DOI 10.1016/S0140-6736(18)32286-4
   Burt F, 2014, LANCET INFECT DIS, V14, P789, DOI 10.1016/S1473-3099(14)70869-2
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Czupryna P, 2014, PRZEGL EPIDEMIOL, V68, P109
   Czupryna P, 2018, EPIDEMIOL INFECT, V146, P1663, DOI [10.1017/S0950268818002005, 10.1017/s0950268818002005]
   Czupryna Piotr, 2014, Przegl Epidemiol, V68, P17
   ECDC, 2017, AED AEG CURR KNOWN D
   ECDC, 2013, W NIL VIR RISK ASS T
   Ganczak M., 2016, PRZEGL EPIDEMIOL, V70, P93
   Ganczak Maria, 2016, Przegl Epidemiol, V70, P1
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   Goljan J, 2010, INT MARIT HEALTH, V61, P36
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hermanowska-Szpakowicz Teresa, 2006, Przegl Epidemiol, V60, P93
   Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111
   Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0
   Jablonska J, 2016, CENT EUR J IMMUNOL, V41, P383, DOI 10.5114/ceji.2016.65137
   Juricova Z, 1998, AVIAN DIS, V42, P182, DOI 10.2307/1592593
   Knap Jozef Piotr, 2010, Pol Merkur Lekarski, V28, P331
   Knap Jozef Piotr, 2003, Przegl Epidemiol, V57, P399
   Kondrusik Maciej, 2007, Przegl Epidemiol, V61, P409
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Kubica-Biernat B, 2007, ARTHROPODS ENV PATHO, P61
   Kubica-Biernat Beata, 1999, European Mosquito Bulletin, V5, P1
   Kubica-Biernat Beata, 2009, Wiadomosci Parazytologiczne, V55, P259
   Kuna A, 2016, J VECTOR DIS, V53, P234
   Kuna A, 2016, INT MARIT HEALTH, V67, P179, DOI 10.5603/IMH.2016.0033
   Kuna A, 2016, INT MARIT HEALTH, V67, P38, DOI 10.5603/IMH.2016.0008
   Kuna A, 2015, INT MARIT HEALTH, V66, P233, DOI 10.5603/IMH.2015.0044
   Kwasniewski W, 2016, WIAD LEK 2, V69, P560
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Moniuszko-Malinowska Anna, 2016, Przegl Epidemiol, V70, P7
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Niczyporuk JS, 2011, POL J VET SCI, V14, P573, DOI 10.2478/v10181-011-0085-9
   Niczyporuk JS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/234181
   Niczyporuk JS, 2011, ACTA VET HUNG, V59, P405, DOI 10.1556/AVet.2011.023
   Olszynska-Krowicka Maria, 2011, Przegl Epidemiol, V65, P571
   Pancer Katarzyna, 2014, Przegl Epidemiol, V68, P651
   Paradowska-Stankiewicz Iwona, 2017, Przegl Epidemiol, V71, P493
   Plusa Tadeusz, 2016, Pol Merkur Lekarski, V40, P149
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rudolf I, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.31.20867
   Sadkowska-Todys M., 2017, Przeglad Epidemiologiczny, V71, P295
   Sadkowska-Todys Mlgorzata, 2018, Przegl Epidemiol, V72, P129
   Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211
   Sebesta O, 2012, EUROSURVEILLANCE, V17, P6
   Stefanoff P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040677
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wegner Elzbieta, 2008, Fragmenta Faunistica (Warsaw), V51, P15
   Weitzel T, 2015, PARASITOL RES, V114, P289, DOI 10.1007/s00436-014-4193-1
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 62
TC 1
Z9 1
U1 0
U2 2
PU INST AGRICULTURAL MEDICINE
PI LUBLIN
PA JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND
SN 1232-1966
EI 1898-2263
J9 ANN AGR ENV MED
JI Ann. Agr. Env. Med.
PY 2019
VL 26
IS 3
BP 385
EP 391
DI 10.26444/aaem/102471
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA JA1BJ
UT WOS:000487551700001
PM 31559790
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rodrigues, RRN
   Grisotti, M
AF Nogueira Rodrigues, Raphaela Rezende
   Grisotti, Marcia
TI Communicating on Zika: prevention recommendations in contexts of
   uncertainties
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Article
DE Zika virus; Public policies; Epidemics; Prevention and control;
   Reproductive rights
ID VIRUS; ABORTION; SEMEN
AB The Zika virus epidemic, which was treated as a national and international public health emergency during a specific period, gave rise to unusual measures, which claims for a more detailed analysis, especially the recommendations given by the Brazilian Ministry of Health in the website "Combate Aedes". In this work, we analyze those recommendations employing the Collective Mindsets Analysis method. The recommendations targeted at health professionals and general public fail due to not clarifying the characteristics of the most vulnerable population, compromising its applicability. The recommendations also fail to make clear who is responsible for many recommended actions, leaving to the public the responsibility of decision making. Without a proper attention for the reality of the affected public, there is a risk of making public policies ineffective.
C1 [Nogueira Rodrigues, Raphaela Rezende] Fac Pato Branco, Rua Benjamin Borges dos Santos 1100, BR-85503350 Pato Branco, PR, Brazil.
   [Grisotti, Marcia] Univ Fed Santa Catarina, Dept Sociol & Ciencia Polit, Florianopolis, SC, Brazil.
RP Rodrigues, RRN (corresponding author), Fac Pato Branco, Rua Benjamin Borges dos Santos 1100, BR-85503350 Pato Branco, PR, Brazil.
EM raphaela.rnogueira@gmail.com; marcia.grisotti@ufsc.br
OI Grisotti, Marcia/0000-0003-0389-7100; R N Rodrigues,
   Raphaela/0000-0002-7685-4155
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Brasil. Instituto Brasileiro de Geografia e Estatistica-IBGE, 2014, EST GEN AN RES CENS
   Brasil. Ministerio da Saude, 2016, COMB AED US REP AMB
   Brasil. Ministerio da Saude, 2016, COMB AED CONF COM OR
   Brasil. Ministerio da Saude, 2016, COMB AED CUID REC NA
   Brasil. Ministerio da Saude, 2015, VIR ZIK INF PUBL
   Brasil. Ministerio da Saude, 2016, REC GEST
   Brasil. Ministerio da Saude, 2016, AT SAUD
   Brasil. Ministerio da Saude. Combate Aedes, 2016, DENG CHIK ZIK
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Feldmann H, 2018, NEW ENGL J MED, V378, P1440, DOI 10.1056/NEJMe1803212
   Freiedman SM, 1999, COMMUNICATIN UNCERTA
   Freitas PSS, 2018, ARCH HLTH INVEST, V7, P12
   Fundacao Oswaldo Cruz-Fiocruz, 2008, CONH COMP MOSQ AED A
   Funtowicz S, 1997, HIST CIENC SAUDE-MAN, V4, P219
   Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Lerner K, 2000, REV ECO POS, V14, P33
   Löwy Ilana, 2016, Physis, V26, P11, DOI 10.1590/S0103-73312016000100002
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Ministerio da Saude Brasil, 2016, DIR EST PREC CRIANC
   Ministerio da Saude (Brazil), 2016, OR INT VIG AT SAUD A
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Pohlmann Markus, 2014, Rev. Sociol. Polit., V22, P7, DOI 10.1590/1678-987314225202
   Popper K., 1982, CONJECTURAS REFUTACO
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Toppenberg-Pekcic D, 2018, HEALTH COMMUN, V34, P437
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura M, 2016, DIREITO PRAX, V7, P622, DOI 10.12957/dep.2016.25168
NR 32
TC 0
Z9 0
U1 0
U2 0
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PY 2019
VL 23
AR UNSP e190140
DI 10.1590/Interface.190140
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IZ8FI
UT WOS:000487338800118
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Liang, YF
   Greenhalgh, D
AF Liang, Yanfeng
   Greenhalgh, David
TI Estimation of the expected number of cases of microcephaly in Brazil as
   a result of Zika
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE Zika virus; microcephaly; dengue; Aedes aegypti; parameter estimation;
   least square estimation; ordinary differential equations; partial
   differential equations
ID SEXUAL TRANSMISSION; DENGUE; VIRUS; RISK; INFECTION; OUTBREAK; R-0
AB In this paper we have adapted a delayed dengue model to Zika. By assuming that the epidemic starts by a single infected individual entering a disease-free population at some initial time to we have used the least squares parameter estimation technique in R to estimate the initial time to using observed Zika data from Brazil as well as the transmission probabilities of Zika in Brazil between humans and mosquitoes and vice-versa. Different values of Aedes aegypti (A. aegypti) biting rate are used throughout the paper.
   We have estimated the value of the basic reproduction number for Zika in Brazil and calculated the expected number of cases of microcephaly in newborns as a result of women infected with Zika during pregnancy. We started off with a non-age-structured model then introduced age-structure into the model.
   However in reality seasonality, in particular temperature and rainfall, have a great impact on the population size of A. aegypti. Hence we repeat both the non-age-structured and age-structured analyses introducing seasonality into the A. aegypti birth function to model the effect of these environmental factors.
C1 [Liang, Yanfeng; Greenhalgh, David] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
RP Liang, YF (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland.
EM yanfeng.liang@hotmail.com
FU EPSRC under the EPSRC Global Challenges Research Fund Institutional
   Award 2016Engineering & Physical Sciences Research Council (EPSRC)
   [EP/P511055/1]; University of Strathclyde under the EPSRC Global
   Challenges Research Fund Institutional Award 2016 [EP/P511055/1];
   British Council, Malaysia from the Dengue Tech Challenge [DTC 16022];
   Science Without Borders Program, Brazil (CNPq) [30098/2014-7];
   Leverhulme Trust from a Leverhulme Research Fellowship [RF-2015-88]
FX The authors are grateful to the EPSRC and the University of Strathclyde
   for support for this work under the EPSRC Global Challenges Research
   Fund Institutional Award 2016 (EPSRC grant reference number
   EP/P511055/1) and the British Council, Malaysia for funding from the
   Dengue Tech Challenge (Application Reference DTC 16022). DG is grateful
   to the Science Without Borders Program, Brazil, for a Special Visiting
   Fellowship (CNPq grant 30098/2014-7), with Professor E. Massad,
   Department of Legal Medicine, University of Sao Paulo, Sao Paulo,
   Brazil, and to the Leverhulme Trust for support from a Leverhulme
   Research Fellowship (RF-2015-88).
CR Adamu G., 2017, Journal of Applied Sciences & Environmental Management, V21, P615, DOI 10.4314/jasem.v21i4.1
   Agusto FB, 2015, J BIOL SYST, V23, P597, DOI 10.1142/S0218339015500308
   Amaku M, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0069-2
   Amaku M, 2016, B MATH BIOL, V78, P970, DOI 10.1007/s11538-016-0170-4
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Aranda DF, 2019, MATH COMPUT SIMULAT, V163, P1, DOI 10.1016/j.matcom.2019.02.009
   Barnett AG, 2012, R J, V4, P5
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, SURV CONTR AED AEG A
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chowell G, 2013, MATH BIOSCI ENG, V10, P1455, DOI 10.3934/mbe.2013.10.1455
   Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Ding CX, 2016, CHIN CONTR CONF, P2642, DOI 10.1109/ChiCC.2016.7553763
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FOCKS DA, 2006, MULTICOUNTRY STUDY A
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goswami NK, 2018, J PHYS CONF SER, V1000, DOI 10.1088/1742-6596/1000/1/012114
   Haynes B., 2016, HLTH NEWS
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Koutou O, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1671-2
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mahatoa B., 2018, INT J APPL ENG RES, V13, P12296
   Maier SB, 2017, MATH BIOSCI, V294, P15, DOI 10.1016/j.mbs.2017.09.004
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mpeshe Saul C., 2017, INT J ADV APPL MATH, V4, P14
   Ndairou F, 2018, MATH METHOD APPL SCI, V41, P8929, DOI 10.1002/mma.4702
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Oluyo T. O., 2016, IOSR J MATH, V12, P21
   Pan American Health Organization World Heath Organization, 2017, ZIK EP REP
   Rodrigues H. S., 2014, P 14 CMMSE C COST BA, P1084
   Rodrigues HS, 2016, MATH METHOD APPL SCI, V39, P4671, DOI 10.1002/mma.3319
   Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235
   Supriatna A. K., 2009, Dengue Bulletin, V33, P21
   Tang B, 2019, MATH BIOSCI ENG, V16, P5092, DOI 10.3934/mbe.2019256
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   United Nation, 2015, WORLD POP PROSP 2015
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P698, DOI 10.1016/j.apjtm.2016.05.014
   Zamani M, 2017, IRAN J PUBLIC HEALTH, V46, P1305
NR 49
TC 0
Z9 0
U1 2
U2 5
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 6
BP 8217
EP 8242
DI 10.3934/mbe.2019416
PG 26
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA IZ8CY
UT WOS:000487331700108
PM 31698665
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Sampaio, GD
   Brites, C
   Drexler, JF
   Moreira-Soto, A
   Miranda, F
   Netto, EM
AF Sampaio, Gilmara de Souza
   Brites, Carlos
   Drexler, Jan Felix
   Moreira-Soto, Andres
   Miranda, Fernanda
   Netto, Eduardo Martins
TI Expansion of Zika virus circulation from Africa to the Americas,
   1947-2018: a literature review
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Review
DE Zika Virus; Flavivirus; Epidemiology; Epidemics; Congenital
   Abnormalities; Review Literature as Topic
ID YELLOW-FEVER; SEROLOGICAL SURVEY; ARBOVIRUS INFECTIONS; CHIKUNGUNYA
   VIRUSES; BORNE TRANSMISSION; AEDES-ALBOPICTUS; DENGUE; ANTIBODIES;
   NIGERIA; EPIDEMIC
AB Objective: to describe the temporal and geographical expansion of Zika virus (ZIKV) circulation in countries and territories, from the time it was first isolated until 2018. Methods: This was a non-systematic literature review covering the period from 1947 to 2018 using the MEDLINE database and World Health Organization estimates. Results: Since its isolation in 1947, ZIKV circulation spread through Africa, Asia and the Pacific before reaching the Americas in 2013, causing serious clinical manifestations; the highest seroprevalence rates were recorded in Yap (74%) and in Brazil (63%); genetic mutations, absence of immunity and high vector susceptibility may have influenced ZIKV transmissibility and help to explain the magnitude of its expansion. Conclusion: The spread of ZIKV circulation in the Americas was the most extensive recorded thus far, possibly as a result of population and geographical characteristics of the sites where the virus circulated.
C1 [Sampaio, Gilmara de Souza; Brites, Carlos; Miranda, Fernanda; Netto, Eduardo Martins] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Drexler, Jan Felix; Moreira-Soto, Andres] Charite Univ Med Berlin, Inst Virol, Berlim, Germany.
RP Sampaio, GD (corresponding author), Univ Fed Bahia, Hosp Univ Edgard Santos, Lab Pesquisa Infectol, Rua Joao Botas 157b, BR-40110160 Salvador, BA, Brazil.
EM gilmara.s.sampaio@hotmail.com
RI Netto, Eduardo/D-1432-2013
OI Netto, Eduardo/0000-0003-1691-6761; Moreira-Soto,
   Andres/0000-0002-9224-5157
FU Brazilian Hospital Services Company (EBSERH)
FX We thank the Brazilian Hospital Services Company (EBSERH), for its
   support in the development of this study.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Aubry F, 2018, BIORXIV, P1, DOI [10.1101/ 342741, DOI 10.1101/342741, 10.1101/342741]
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   da Nobrega MEB, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000200016
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Campos TDL, 2018, INT J GENOMICS, V2018, P1
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   CHIPPAUX.C, 1966, B WORLD HEALTH ORGAN, V34, P105
   Chippaux-Hyppolite C, 1965, Bull Soc Pathol Exot Filiales, V58, P812
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Codrington J, 2018, PLOS CURR, V10
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516, DOI 10.4269/ajtmh.1975.24.516
   Fokam E B, 2010, East Afr Med J, V87, P262
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   GONZALEZ JP, 1979, B SOC PATHOL EXOT, V72, P416
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P787
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   LOURENCO M, 2018, PLOS CURR, V10, DOI DOI 10.3390/V10060327
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude (BR), 2017, 57 MIN SAUD BRAS
   Ministerio da Saude (BR), 2018, B EPIDEMIOL, V49
   Ministerio da Saude (BR), 2018, B EPIDEMIOL, V49, P1
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OMER AHS, 1981, J TROP MED HYG, V84, P63
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization, 2016, ZIK EP UPD 22 SEPT 2
   Pan American Health Organization, 2016, ZIK SUSP CONF CAS RE
   Pan American Health Organization, 2015, IMPL PUBL HLTH AM
   Pan American Health Organization, 2015, EP AL INCR MICR NE B
   Pan American Health Organization, 2016, ZIKA EP UPD 29 DEC 2
   Pan American Health Organization/World Health Organization, 2017, ZIK SUSP CONF CAS RE
   PELLISSIER AIME, 1954, BULL SOC PATHOL EXOT, V47, P223
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   PINTO MR, 1967, B WORLD HEALTH ORGAN, V37, P101
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REAGAN RL, 1953, TEX REP BIOL MED, V11, P347
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Ritchie SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105846
   ROBIN Y, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P833
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodier GR, 1996, T ROY SOC TROP MED H, V90, P237, DOI 10.1016/S0035-9203(96)90228-X
   Rodrigues LC, 2017, LANCET, V390, P824, DOI 10.1016/S0140-6736(17)31478-2
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Ryan SJ, 2017, EMERG INFECT DIS, V23, P1926, DOI 10.3201/eid2311.171140
   SALAUN JJ, 1967, B WORLD HEALTH ORGAN, V37, P343
   Sanchez-Carbonel Jose, 2018, BMC Res Notes, V11, P175, DOI 10.1186/s13104-018-3290-0
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Sun JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43527
   Fantinato FFST, 2016, EPIDEMIOL SERV SAUDE, V25, P683, DOI [10.5123/S1679-49742016000400002, 10.5123/s1679-49742016000400002]
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 157
TC 1
Z9 1
U1 0
U2 2
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2019
VL 28
IS 2
AR UNSP e2018411
DI 10.5123/S1679-49742019000200022
PG 23
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IY7XJ
UT WOS:000486608200012
PM 31460659
OA DOAJ Gold
DA 2020-07-08
ER

PT S
AU Garg, N
   Kumar, P
   Gadhave, K
   Giri, R
AF Garg, Neha
   Kumar, Prateek
   Gadhave, Kundlik
   Giri, Rajanish
BE Uversky, VN
TI The dark proteome of cancer: Intrinsic disorderedness and functionality
   of HIF-1 alpha along with its interacting proteins
SO DANCING PROTEIN CLOUDS: INTRINSICALLY DISORDERED PROTEINS IN HEALTH AND
   DISEASE, PT A
SE Progress in Molecular Biology and Translational Science
LA English
DT Review; Book Chapter
ID CREB-BINDING-PROTEIN; ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE
   FACTOR; LINEAGE LEUKEMIA PROTEIN; STRUCTURAL BASIS; KIX DOMAIN;
   TRANSACTIVATION DOMAIN; UNSTRUCTURED PROTEINS; FACTOR 1-ALPHA; ZIKA
   VIRUS
AB The dark side of protein is the region (s) where molecular conformation is unknown. Intrinsically disordered proteins (IDPs) and intrinsically disordered protein regions (IDPRs) are the dark matter of biology due to inability to visualize them using standard structure elucidation technique such as X-ray crystallography due to lack in diffraction signal. IDPs are the functionally important class of proteins with entire protein or its parts lack ordered three-dimensional structure. Computational studies have predicted that nearly one-third of the human proteome is disordered, which gives the enormous flexibility and functional diversity to proteins. The conserved residues and elements in disordered proteins are critical for function and might be parts of peptide motifs or protein-protein interaction interfaces. For example, regions of proteins that are involved in disorder-based molecular recognition are known as molecular recognition features (MoRFs). Generally, MoRFs could undergo disorder to order transition or vice versa at interaction with specific partners. Hypoxia inducible factor 1 alpha (HIF-1 alpha) is a master transcriptional regulator involved in response to hypoxia, which is associated with many pathological conditions. Importantly, HIF-1a regulates various steps of cancer progression such as cell survival, tumor cell invasion, and metastasis. In this chapter, we have extensively analyzed the molecular recognition features and their relationship with disordered regions and associated structural islands of HIF-1 alpha. We had also analyzed the disorderness and MoRFs of HIF-1 alpha primary interaction partners that are enriched in IDPRs and MoRFs giving their role in protein-protein interaction and cancer regulation.
C1 [Garg, Neha; Kumar, Prateek; Gadhave, Kundlik; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.
RP Giri, R (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.
EM rajanishgiri@iitmandi.ac.in
RI Garg, Neha/AAG-5180-2020; Giri, Rajanish/Q-6530-2018
OI Garg, Neha/0000-0003-2227-8292; Giri, Rajanish/0000-0002-2046-836X;
   Gadhave, Kundlik/0000-0003-4530-4772; Kumar, Prateek/0000-0001-7392-5045
CR Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548
   Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425
   Bergantino F, 2015, BBA-PROTEINS PROTEOM, V1854, P410, DOI 10.1016/j.bbapap.2015.01.005
   Berlow RB, 2018, J MOL BIOL, V430, P2309, DOI 10.1016/j.jmb.2018.04.003
   Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100
   Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103
   Chowdhury R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12673
   Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002
   Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518
   Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805
   Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25
   Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200
   Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4
   Erez N, 2003, CANCER RES, V63, P8777
   Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899
   Fukuchi S, 2014, NUCLEIC ACIDS RES, V42, pD320, DOI 10.1093/nar/gkt1010
   Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110
   Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200
   Hakimi AA, 2015, MODERN PATHOL, V28, P845, DOI 10.1038/modpathol.2015.6
   Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199
   Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x
   Huang F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S4
   Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5
   Iyer LM, 2001, GENOME BIOL, V2
   Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744
   Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10
   Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788
   Kim I, 2018, CELL BIOL INT, V42, P303, DOI 10.1002/cbin.10895
   Kim YK, 2013, ACTA CRYSTALLOGR D, V69, P1587, DOI 10.1107/S0907444913011220
   Kirilyuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048243
   Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lewis MD, 2004, ONCOGENE, V23, P2315, DOI 10.1038/sj.onc.1207384
   Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718
   Liu N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20489
   Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f
   Malaney P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02035
   Malhis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141603
   Malhis N, 2015, BIOINFORMATICS, V31, P1738, DOI 10.1093/bioinformatics/btv060
   Mao K, 2017, ONCOL LETT, V13, P893, DOI 10.3892/ol.2016.5492
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440
   Minervini G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006478
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947
   Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o
   Peng ZL, 2015, CELL MOL LIFE SCI, V72, P137, DOI 10.1007/s00018-014-1661-9
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Sciorra VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040053
   Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Shieh JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099242
   Sigalov A. B., 2011, SELF NONSELF, V2, P55, DOI DOI 10.4161/SELF.2.1.14790
   Singh A, 2018, RSC ADV, V8, P27293, DOI 10.1039/c8ra04760j
   Singh A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23969-0
   Stauffer ME, 2002, J BIOMOL NMR, V23, P57, DOI 10.1023/A:1015346504499
   Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Takagi Y, 1996, J BIOL CHEM, V271, P25562, DOI 10.1074/jbc.271.41.25562
   Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032
   Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480
   Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924
   Uversky VN, 2017, MOL BIOSYST, V13, P56, DOI 10.1039/c6mb00657d
   Uversky VN, 2016, GENES GENOM, V38, P577, DOI 10.1007/s13258-015-0384-0
   Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r
   Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261
   Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7
   van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m
   Van Molle I, 2012, CHEM BIOL, V19, P1300, DOI 10.1016/j.chembiol.2012.08.015
   Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920
   Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883
   Xue B, 2013, BBA-PROTEINS PROTEOM, V1834, P725, DOI 10.1016/j.bbapap.2013.01.012
   Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145
   Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002
   Zhang J, 2017, ONCOTARGET, V8, P74623, DOI 10.18632/oncotarget.20284
   Zhang XL, 2014, J PHYS CHEM B, V118, P2009, DOI 10.1021/jp409778e
   Zhong H, 1999, CANCER RES, V59, P5830
   Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038
NR 96
TC 5
Z9 5
U1 1
U2 1
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1877-1173
BN 978-0-12-816851-6
J9 PROG MOL BIOL TRANSL
JI Prog. Molec. Biol. Transl. Sci.
PY 2019
VL 166
BP 371
EP 403
DI 10.1016/bs.pmbts.2019.05.006
PG 33
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BN6SQ
UT WOS:000486242200011
PM 31521236
DA 2020-07-08
ER

PT J
AU de Sousa, JR
   Azevedo, RDD
   Quaresma, JAS
   Vasconcelos, PFD
AF de Sousa, Jorge Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Simoes Quaresma, Juarez Antonio
   da Costa Vasconcelos, Pedro Fernando
TI Cell Death And Zika Virus: An Integrated Network Of The Mechanisms Of
   Cell Injury
SO INFECTION AND DRUG RESISTANCE
LA English
DT Article
DE ZIKV; microcephaly; neuroinflammatory response; cell death
ID INFECTION
AB Zika virus (ZIKV) is an arbovirus that is transmitted by Aedes mosquitos. Its prototype was isolated in 1947 from serum of a sentinel Rhesus monkey (Macaca mulatta) in the Zika forest of Uganda. As a member of the genus Flavivirus, family Flaviviridae, ZIKV is enveloped and icosahedral and possesses a single-stranded, positive-sense RNA genome of approximately 10.7 kb. Epidemiologically, infection by ZIKV has become a global health concern in recent years because of the occurrence of epidemics, its speed of dissemination, routes of transmission, and the sequelae it can cause especially in newborns. At the neural level, there are still many gaps in our understanding of the mechanisms that induce ZIKV infection-associated microcephaly. However, some studies already demonstrated that underlying cell death is determinant to induce the congenital malformation. In this report, we reviewed the various mechanisms of cell injury involved in the immunopathogenesis of ZIKV infection and discussed its relationship with the death of neuronal and glial cells development and microcephaly.
C1 [de Sousa, Jorge Rodrigues; da Silva Azevedo, Raimunda do Socorro; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Dept Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
   [de Sousa, Jorge Rodrigues; Simoes Quaresma, Juarez Antonio] Univ Fed Para, Nucleo Med Trop Belem, Belem, Para, Brazil.
   [Simoes Quaresma, Juarez Antonio] Inst Evandro Chagas, Dept Patol, Ananindeua, Para, Brazil.
   [Simoes Quaresma, Juarez Antonio; da Costa Vasconcelos, Pedro Fernando] Univ Estado Para, Belem, Para, Brazil.
RP Vasconcelos, PFD (corresponding author), Evandro Chagas Inst, Rodovia BR-316,Km 07 S-N, BR-67030000 Ananindeua, Brazil.
EM pedrovasconcelos@iec.gov.br
RI QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012; Azevedo,
   Raimunda/T-4656-2019; Quaresma, Juarez AS/M-4190-2014; Vasconcelos,
   Pedro/AAH-3142-2019
OI QUARESMA, JUAREZ ANTONIO SIMOES/0000-0002-6267-9966; Azevedo,
   Raimunda/0000-0003-1932-9976; Quaresma, Juarez AS/0000-0002-6267-9966; 
FU Ministry of Science, Technology and Innovation/National Council for
   Scientific and Technological Development CNPQ/Brazil [303999/2016-0,
   439971/2016-0, 440405/2016-5]; CAPES (Zika Fast-track)CAPES
FX This work was supported by the Ministry of Science, Technology and
   Innovation/National Council for Scientific and Technological Development
   CNPQ/Brazil (grant numbers: 303999/2016-0, 439971/2016-0, and
   440405/2016-5), and CAPES (Zika Fast-track).
CR Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017
   de Sousa JR, 2018, CYTOKINE, V111, P255, DOI 10.1016/j.cyto.2018.08.008
   de Sousa JR, 2018, AM J PATHOL, V9440, P30153
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Screaton G, 2017, SCIENCE, V358, P863, DOI 10.1126/science.aaq1297
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 23
TC 0
Z9 0
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2019
VL 12
BP 2917
EP 2920
DI 10.2147/IDR.S209213
PG 4
WC Infectious Diseases; Pharmacology & Pharmacy
SC Infectious Diseases; Pharmacology & Pharmacy
GA IX7XH
UT WOS:000485897900004
PM 31571944
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liang, B
   Guida, JP
   Do Nascimento, MLC
   Mysorekar, IU
AF Liang, Brooke
   Guida, Jose Paulo
   Costa Do Nascimento, Maria Laura
   Mysorekar, Indira U.
TI Host and viral mechanisms of congenital Zika syndrome
SO VIRULENCE
LA English
DT Review
DE Placenta; trophoblast; hydroxychloroquine; autophagy; type I interferon;
   interferon lambda
ID VIRUS-INFECTION; VERTICAL TRANSMISSION; MOUSE MODEL; FETAL; PREGNANCY;
   BRAZIL; BRAIN; PATHOLOGY; FETUSES; CELLS
AB In 2015-2016, in the Americas, and especially in northeast Brazil, a significant number of cases of microcephaly and other congenital brain abnormalities were linked with an outbreak of Zika virus (ZIKV) infection in pregnant women. While maternal symptoms of ZIKV are generally mild and self-limiting, clinical presentation in fetuses and newborns infected is extensive and includes microcephaly, decreased cortical development, atrophy and hypoplasia of the cerebellum and cerebellar vermis, arthrogryposis, and polyhydramnios. The term congenital ZIKV syndrome (CZS) was introduced to describe the range of findings associated with maternal-fetal ZIKV transmission. ZIKV is primarily transmitted by Aedes aegypti mosquitoes, however non-vector-dependent routes are also possible. Mechanisms of maternal-fetal transmission remain unknown, and the trans-placental route has been extensively studied in animal models and in human samples. The aim of this review was to summarize recent studies that helped to elucidate the mechanism of CZS in animal models and observational studies. There are still challenges in the diagnosis and prevention of CZS in humans, due to the large gap that remains in translating ZIKV research to clinical practice. Translational research linking governments, local health workers, scientists and industry is fundamental to improve care for mothers and children.
C1 [Liang, Brooke; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet Gynecol, St Louis, MO 63110 USA.
   [Guida, Jose Paulo; Costa Do Nascimento, Maria Laura] Univ Estadual Campinas, Sch Med Sci, Dept Obstet Gynecol, Campinas, SP, Brazil.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Ctr Reprod Hlth Sci, St Louis, MO 63110 USA.
RP Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet Gynecol, St Louis, MO 63110 USA.; Do Nascimento, MLC (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet Gynecol, Campinas, SP, Brazil.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Ctr Reprod Hlth Sci, St Louis, MO 63110 USA.
EM imysorekar@wustl.edu
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [409605/2016-6]; Howard Hughes Medical InstituteHoward Hughes Medical
   Institute; National Institutes of Health (US)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01HD091218]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico [409605/2016-6]; Howard Hughes Medical
   Institute [Medical Research Fellowship Program]; National Institutes of
   Health (US) [R01HD091218]
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   [Anonymous], 2015, FACT SHEET AB LAT AM
   [Anonymous], 2015, MON CAS MICR BRAS
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bermas BL, 2019, J RHEUMATOL, V46, P1, DOI 10.3899/jrheum.181046
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao B, 2018, FUTURE MICROBIOL, V13, P137, DOI 10.2217/fmb-2017-0213
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86654
   Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446
   Chakhtoura N, 2018, CURR OPIN OBSTET GYN, V30, P116, DOI 10.1097/GCO.0000000000000440
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Costedoat-Chalumeau N, 2003, ARTHRITIS RHEUM, V48, P3207, DOI 10.1002/art.11304
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Faye-Petersen OM, 2006, HDB PLACENTAL PATHOL
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Health BMo, 2016, PROT VIG RESP OC MIC
   Heerema-McKenney A, 2018, APMIS, V126, P570, DOI 10.1111/apm.12847
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Ke PY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123940
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lecuit M, 2018, NAT MICROBIOL, V3, P966, DOI 10.1038/s41564-018-0233-4
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McNeil CJ, 2017, J TROP PEDIATRICS, V63, P242, DOI 10.1093/tropej/fmw080
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Motta Mario, 2005, J Perinatol, V25, P86, DOI 10.1038/sj.jp.7211208
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Novak CM, 2019, BRAIN BEHAV IMMUN, V75, P129, DOI 10.1016/j.bbi.2018.09.025
   Proenca-Modena JL, 2018, MICROBES INFECT, V20, P661, DOI 10.1016/j.micinf.2018.02.008
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Robinson N, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1985
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Setia H, 2019, SEMIN CELL DEV BIOL
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sperber K, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-9
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
   World Health Organization, 2016, CONS CAUS LINK ZIK N
   World Health Organization, 2016, EM COMM ZIK VIR OBS
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00402
   Zorrilla CD, 2018, P R HEALTH SCI J, V37, pS66
NR 100
TC 2
Z9 2
U1 3
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2150-5594
EI 2150-5608
J9 VIRULENCE
JI Virulence
PD JAN 1
PY 2019
VL 10
IS 1
BP 768
EP 775
DI 10.1080/21505594.2019.1656503
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IY5YU
UT WOS:000486471500001
PM 31451049
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, P
   Chakraborty, P
   He, DH
   Mergia, A
AF Singh, P.
   Chakraborty, P.
   He, D-H
   Mergia, A.
TI Extract prepared from the leaves of Ocimum basilicum inhibits the entry
   of Zika virus
SO ACTA VIROLOGICA
LA English
DT Article
DE Zika virus; basil extract; antiviral
ID CONSTITUENTS; GROWTH; SCREEN; OILS
AB The recent Zika virus (ZIKV) outbreaks and rapid spread in tropical Latin America since introduction to Brazil in 2014, and now appearing cases in the USA, are alarming. World Health Organization (WHO) has considered transmission of ZIKV, a serious public health problem because of the increasing number of outbreaks. There are currently no drugs approved for the treatment of ZIKV infection. Discovery of safe and effective drugs are hampered by the risk in treating pregnant woman and toxicity to the fetus. Sweet basil, known as Ocimum basilicum in the scientific community, is a very well-known medicinal herb. Numerous studies have documented its beneficial activity against a great variety of human pathogens ranging from bacteria and virus to fungus and protozoans. Although, basil extracts and oils have been tested successfully against other viruses, its application to tackle ZIKV infection has not been exploited at all. In this study, we report for the first time that highly diluted ethanol extracts prepared from basil leaves can effectively inhibit ZIKV replication in Vero E6 cells with a half maximal inhibitory concentration (IC50) value of 1:134. The diluted extract as well as the amount of ethanol that goes into its preparation have been found to be completely non-toxic to the above mentioned cell line. The extract seems to inhibit the virus at the step of attachment and entry into the host cell. The specific inhibition of ZIKV observed using the basil leaf extract suggests a new alternative mode of treatment against flavivirus.
C1 [Singh, P.; Chakraborty, P.; He, D-H; Mergia, A.] Univ Florida, Dept Infect Dis & Immunol, 1945 SW 16th Ave, Gainesville, FL 32611 USA.
RP Mergia, A (corresponding author), Univ Florida, Dept Infect Dis & Immunol, 1945 SW 16th Ave, Gainesville, FL 32611 USA.
EM mergiaa@ufl.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI39126]
FX The work is supported from indirect cost returns from a previous grant
   from the National Institutes of Health (AI39126) to Ayalew Mergia.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chiang LC, 2005, CLIN EXP PHARMACOL P, V32, P811, DOI 10.1111/j.1440-1681.2005.04270.x
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Gavanji S, 2015, J ACUTE MED, V5, P62, DOI 10.1016/j.jacme.2015.07.001
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   KHALIL A, 2013, BIOTECHNOLOGY, V12, P61, DOI DOI 10.3923/biotech.2013.61.64
   Marwat SK, 2011, ASIAN J CHEM, V23, P3773
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey Abhay Kumar, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P682
   Roy A, 2013, ANTIVIR RES, V100, P346, DOI 10.1016/j.antiviral.2013.09.003
   Suppakul P, 2003, J AGR FOOD CHEM, V51, P3197, DOI 10.1021/jf021038t
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 16
TC 0
Z9 0
U1 0
U2 0
PU AEPRESS SRO
PI BRATISLAVA
PA BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA
SN 0001-723X
EI 1336-2305
J9 ACTA VIROL
JI Acta Virol.
PY 2019
VL 63
IS 3
BP 316
EP 321
DI 10.4149/av_2019_307
PG 6
WC Virology
SC Virology
GA IW7PV
UT WOS:000485187300010
PM 31507198
DA 2020-07-08
ER

PT J
AU Melo, VAD
   Silva, JRS
   La Corte, R
AF Dantas Melo, Vladimir Antonio
   Santos Silva, Jose Rodrigo
   La Corte, Roseli
TI Personal protective measures of pregnant women against Zika virus
   infection
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Pregnant Women; Zika Virus Infection, prevention & control; Arbovirus
   Infections, prevention & control; Insect Repellents; Mosquito Nets
   utilization; Socioeconomic Factors
ID AEDES-AEGYPTI CONTROL; BRAZIL; REPELLENTS; SAFETY
AB OBJECTIVE: To evaluate the adherence of pregnant women to personal protective measures against mosquito bites, recommended by the Ministry of Health, and to investigate the factors associated with the non-adoption of these measures.
   METHODS: We interviewed 177 pregnant women between November 2016 and February 2017 in the 10 basic health units of the municipality of Propria, state of Sergipe, two located in the rural area and eight in the urban area, during prenatal appointments, to raise information about the use of preventive measures against the vector transmission of Zika virus. Data were analyzed using descriptive statistical methods, chi-square test or Fisher's exact test, and the odds ratio was calculated. The independent variables were grouped by the analysis of principal components, and the dependents (the use of repellent, mosquito nets, garments, screens and insecticides) were analyzed using the logistic regression method.
   RESULTS: Among the measures recommended by the Ministry of Health, mosquito nets were the most used by pregnant women living in rural areas and with low education level, while the repellents were more used by women in the urban area and with higher education level. Women in a vulnerable socio-economic situation presented a risk 2.4 times higher for not using screens in their homes, 1.9 times higher for not changing clothes and 2.5 times higher for not using repellent than pregnant women in better economic conditions.
   CONCLUSIONS: The socioeconomic status of pregnant women, especially among the less privileged, influenced the use of protective measures against Zika virus, from the purchase of repellent, clothing, insecticides to other resources in the municipality of Propria, SE.
C1 [Dantas Melo, Vladimir Antonio; Santos Silva, Jose Rodrigo; La Corte, Roseli] Univ Fed Sergipe, Programa Posgrad Biol Parasitaria, Sao Cristovao, SE, Brazil.
   [Santos Silva, Jose Rodrigo] Univ Fed Sergipe, Dept Estat & Ciencias Atuariais, Ctr Ciencias Exatas & Tecnol, Sao Cristovao, SE, Brazil.
   [La Corte, Roseli] Univ Fed Sergipe, Dept Morfol, Ctr Ciencias Biol & Saude, Sao Cristovao, SE, Brazil.
RP La Corte, R (corresponding author), Ave Marechal Rondon S-N, BR-49100000 Sao Cristovao, SE, Brazil.
EM rlacorte@ufs.br
RI Santos, Roseli LC/F-1735-2015; Silva, Jose Rodrigo S/A-2784-2016
OI Santos Silva, Jose Rodrigo/0000-0002-1918-7122
CR Alvarenga D, 2017, JORNAL GLOBO    0201
   Avelino-Silva VI, 2018, EINSTEIN-SAO PAULO, V16, DOI [10.1590/S1679-45082018ED4325, 10.1590/s1679-45082018ed4325]
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1516
   Cremonese C, 2012, CAD SAUDE PUBLICA, V28, P1263, DOI 10.1590/S0102-311X2012000700005
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Diel C, 2003, REV SAUDE PUBL, V37, P83, DOI 10.1590/s0034-89102003000100013
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Garcia Guilherme D, 2017, THESIS
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ POP MUN BRAS
   Kerr WE, 2009, EM EXTENSAO, V8, P152
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Ministerio da Saude (BR), 2016, ZIK ZER ESTR RESP VI
   Ministerio da Saude (BR) Secretaria de Atencao a Saude., 2015, PROT AT SAUD PROT AT
   Ministerio da Saude (BR) Secretaria Executiva, 2015, DAT INF SAUD TABNET
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Rodriguez SD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew117
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Paumgartten FJR, 2016, VIGIL SANIT DEBATE, V4, P97, DOI 10.3395/2317-269x.00736
   Secretaria de Estado da Saude de Sergipe, 2016, VIG ENT AED AEG 2016
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Stefani Germana Pimentel, 2009, Rev. paul. pediatr., V27, P81, DOI 10.1590/S0103-05822009000100013
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   World Health Organization, 2016, REV VECT ZIK AED
NR 36
TC 0
Z9 0
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2019
VL 53
AR 72
DI 10.11606/0518-8787.2019053001146
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IV4SR
UT WOS:000484263300001
PM 31483008
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Medeiros, DBA
   Vasconcelos, PFC
AF Medeiros, Daniele B. A.
   Vasconcelos, Pedro Fernando C.
TI Is the brazilian diverse environment is a crib for the emergence and
   maintenance of exotic arboviruses?
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE arboviruses; new introduction; zika; chikungunya
ID ZIKA VIRUS; DENGUE; CHIKUNGUNYA; EPIDEMIC
AB We review the potential of Amazon forest as a source for circulation and maintenance of native arboviruses as well its capacity to host exotic arboviruses introduced in Brazil during their process of adapting to the Amazon environment. After a brief introduction about arboviruses isolated in Amazon region and description of the main arboviruses pathogenic to humans, we highlight the history of the last two exotic viruses introduced in Brazil - Chikungunya virus (CHIKV) and Zika virus (ZIKV) - and their consequences to the public health. Finally, we discuss and hypothesize what will happen with them after the outbreak. We look to the past to predict the future.
C1 [Medeiros, Daniele B. A.; Vasconcelos, Pedro Fernando C.] SVS Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Inst Evandro Chagas, Rodovia BR 316,Km 07 S-N, BR-67030000 Ananindeua, PA, Brazil.
RP Medeiros, DBA (corresponding author), SVS Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Inst Evandro Chagas, Rodovia BR 316,Km 07 S-N, BR-67030000 Ananindeua, PA, Brazil.
EM danielemedeiros@iec.gov.br
RI Vasconcelos, Pedro/AAH-3142-2019
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [306581/2016-7, 303999/2016-0]
FX In memory of Amelia P. A. Travassos da Rosa and all the restless
   dedication and knowledge passed to our generation of arbovirologist from
   Evandro Chagas Institute. A Special thanks to Flavia Barreto dos Santos
   for scientific support. We are grateful to Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq processes 306581/2016-7
   and 303999/2016-0) for financial support.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   DARWISH M, 1895, WHO TECH REP SER, V719, P1
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P124
   Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532
   Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   MAGALHAES T, 2017, PLOS NEGLECT TROP D, V26, P1
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NAVECA FG, 2019, PLOS NEGLECT TROP D, V3, P7065
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   TADEU L, 2003, DENGUE B, V27, P25
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   TRAVASSOS DA ROSA APA, 1992, CIENCIA CULTURA PUBL, V44, P158
   Travassos-da-Rosa A.P.D.A, 2016, REV PAN AMAZONICA SA, V7, P61, DOI DOI 10.5123/S2176-62232016000500007
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   VASCONCELOS PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   White SL, 2019, TRANSPLANT DIRECT, V5, DOI 10.1097/TXD.0000000000000852
NR 34
TC 1
Z9 1
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2019
VL 91
SU 3
AR UNSP e20190407
DI 10.1590/0001-3765201920190407
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IU8GA
UT WOS:000483818800005
PM 31460596
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Musso, D
   Nhan, TX
   de Pina, JJ
   Marchi, J
   Texier, G
AF Musso, Didier
   Nhan, Tu-Xuan
   de Pina, Jean-Jacques
   Marchi, Joffrey
   Texier, Gaetan
TI The Use of Simple Laboratory Parameters in the Differential Diagnosis of
   Acute-Phase Zika and Dengue Viruses
SO INTERVIROLOGY
LA English
DT Article
DE Zika; Dengue; Arbovirus; Differential diagnosis; Laboratory parameters
AB Background: Differential diagnosis between acute-phase Zika and dengue is challenging because of a similar clinical presentation and the lack of available molecular diagnosis tools in most of endemic areas. Objectives: Our study aimed to evaluate the use of simple laboratory parameters to differentiate these infections. Methods: We retrospectively compared simple hematology and biochemistry values in 81 and 341 patients with confirmed Zika and dengue, respectively, collected from June 2013 to March 2014 during the French Polynesia outbreaks. Results: Thrombocytopenia, neutropenia, leukopenia, lymphopenia, and elevated aspartate aminotransaminases were significantly more frequent in dengue than in Zika (p < 0.001). Platelets <100 x 10(9)/L, neutrophils <0.5 x 10(9)/L, lymphocytes <0.5 x 10(9)/L, and aspartate aminotransaminases >100 IU/mL were found in dengue but not in Zika. The positive predictive value of the association of leukocytes <4 x 10(9)/L + lymphocytes <1 x 10(9)/L + aspartate aminotransaminases >40 IU/mL for the diagnosis of dengue was 90%, with an accuracy of 82.4%. Conclusion: For the differential diagnosis between acute-phase Zika and dengue, there is no specific standard laboratory pattern. We identified cutoff values and a combination of laboratory parameters that are a strong argument against Zika and in favor of dengue. (C) 2019 S. Karger AG, Basel
C1 [Musso, Didier; Nhan, Tu-Xuan; de Pina, Jean-Jacques] Inst Louis Malarde, POB 30, F-98713 Papeete, French Polynesi, France.
   [Musso, Didier; Texier, Gaetan] Aix Marseille Univ, AP HM, UMR VITROME, IRD,SSA,IHU Mediterranee Infect, Marseille, France.
   [Marchi, Joffrey; Texier, Gaetan] Ctr Epidemiol & Sante Publ Armees, Marseille, France.
RP Musso, D (corresponding author), Inst Louis Malarde, POB 30, F-98713 Papeete, French Polynesi, France.
EM dmusso12345@gmail.com
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Ho HJ, 2017, EMERG INFECT DIS, V23, P2085, DOI 10.3201/eid2312.171224
   Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004
   R Development Core Team, 2018, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   'Thein TL, 2014, AM J TROP MED HYG, V90, P984, DOI 10.4269/ajtmh.14-0004
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   World Health Organization, 2009, DENGUE GUIDELINES FO
NR 29
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2019
VL 62
IS 2
BP 51
EP 56
DI 10.1159/000499567
PG 6
WC Virology
SC Virology
GA IU8UL
UT WOS:000483857100001
PM 31307046
DA 2020-07-08
ER

PT J
AU Kim, KS
AF Kim, Kwang-Sun
TI Current Challenges in the Development of Vaccines and Drugs Against
   Emerging Vector-borne Diseases
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Biological vector; Vector-Borne Disease (VBD); outbreaks; vaccine;
   clinical trial; drug
ID VIRUS-LIKE PARTICLES; CHIKUNGUNYA VIRUS; CLIMATE-CHANGE; SCRUB TYPHUS;
   PLASMODIUM-FALCIPARUM; AEDES-ALBOPICTUS; DOUBLE-BLIND; MALARIA; DENGUE;
   TICK
AB Vectors are living organisms that transmit infectious diseases from an infected animal to humans or another animal. Biological vectors such as mosquitoes, ticks, and sand flies carry pathogens that multiply within their bodies prior to delivery to a new host. The increased prevalence of Vector-Borne Diseases (VBDs) such as Aedes-borne dengue, Chikungunya (CHIKV), Zika (ZIKV), malaria, Tick-Borne Disease (TBD), and scrub typhus has a huge impact on the health of both humans and livestock worldwide. In particular, zoonotic diseases transmitted by mosquitoes and ticks place a considerable burden on public health. Vaccines, drugs, and vector control methods have been developed to prevent and treat VBDs and have prevented millions of deaths. However, development of such strategies is falling behind the rapid emergence of VBDs. Therefore, a comprehensive approach to fighting VBDs must be considered immediately. In this review, I focus on the challenges posed by emerging outbreaks of VBDs and discuss available drugs and vaccines designed to overcome this burden. Research into promising drugs needs to be upgraded and fast-tracked, and novel drugs or vaccines being tested in in vitro and in vivo models need to be moved into human clinical trials. Active preventive tactics, as well as new and upgraded diagnostics, surveillance, treatments, and vaccination strategies, need to be monitored constantly if we are to manage VBDs of medical importance.
C1 [Kim, Kwang-Sun] Pusan Natl Univ, Dept Chem, Busan 46241, South Korea.
   [Kim, Kwang-Sun] Pusan Natl Univ, Chem Inst Funct Mat, Busan 46241, South Korea.
RP Kim, KS (corresponding author), Pusan Natl Univ, Dept Chem, Busan 46241, South Korea.; Kim, KS (corresponding author), Pusan Natl Univ, Chem Inst Funct Mat, Busan 46241, South Korea.
EM kwangsun.kim@pusan.ac.kr
RI Kim, Kwang-sun/AAB-6478-2020
OI Kim, Kwang-sun/0000-0003-3703-5461
FU Basic Science Research Programs through the National Research Foundation
   of Korea (NRF) [NRF-2018R1D1A1B07040941]
FX This work supported by the Basic Science Research Programs through the
   National Research Foundation of Korea (NRF) (NRF-2018R1D1A1B07040941).
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ahola T, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0050-0
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   [Anonymous], 2016, WORLD MALARIA REPORT
   [Anonymous], 2014, GLOBAL BRIEF VECTOR
   Apandi Y, 2010, SE ASIAN J TROP MED, V41, P1374
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bonell A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005838
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Brand SPC, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0481
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Caminade C, 2019, ANN NY ACAD SCI, V1436, P157, DOI 10.1111/nyas.13950
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carpenter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027987
   Chakraborty S, 2017, INDIAN J DERMATOL, V62, P478, DOI 10.4103/ijd.IJD_388_17
   Chretien JP, 2007, JAMA-J AM MED ASSOC, V297, P2278, DOI 10.1001/jama.297.20.2278
   Coelho CH, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0035-3
   Cui Liwang, 2009, V470, P263, DOI 10.1007/978-1-59745-204-5_18
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Delang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31819
   Dhangadamajhi Gunanidhi, 2010, Malar Res Treat, V2010, P973094, DOI 10.4061/2010/973094
   Diehl MC, 2013, HUM VACC IMMUNOTHER, V9, P2246, DOI 10.4161/hv.24702
   Domingos A, 2013, REV SOC BRAS MED TRO, V46, P265, DOI 10.1590/0037-8682-0014-2012
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Fang YR, 2012, INTERNAL MED, V51, P2313, DOI 10.2169/internalmedicine.51.7816
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8
   Fitzpatrick C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005785
   Fusco D.N., 2014, J BIOANALY BIOMED
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006
   Ha NY, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003585
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Hoffman SL, 2015, VACCINE, V33, pD13, DOI 10.1016/j.vaccine.2015.07.091
   Isah MB, 2014, PARASITOL RES, V113, P801, DOI 10.1007/s00436-014-3804-1
   Jeong YJ, 2007, RADIOGRAPHICS, V27, P161, DOI 10.1148/rg.271065074
   Kaur P, 2013, DRUG DISCOV TODAY, V18, P969, DOI 10.1016/j.drudis.2013.05.002
   Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kumar NP, 2011, MEM I OSWALDO CRUZ, V106, P912, DOI 10.1590/S0074-02762011000800003
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Larsen CP, 2015, VACCINE, V33, P7075, DOI 10.1016/j.vaccine.2015.09.052
   Lee MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178493
   Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Metz SW, 2013, VACCINE, V31, P6092, DOI 10.1016/j.vaccine.2013.09.045
   Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124
   Mulwa F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006746
   National Institute of Allergy and Infectious Diseases National Institutes of Health Clinical Center, 2013, CHIK VIR VACC TRIAL
   Negev M, 2015, INT J ENV RES PUB HE, V12, P6745, DOI 10.3390/ijerph120606745
   Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015
   Ouattara A, 2015, CLIN INFECT DIS, V60, P930, DOI 10.1093/cid/ciu954
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Peter John Victor, 2015, World J Crit Care Med, V4, P244, DOI 10.5492/wjccm.v4.i3.244
   Price RN, 2000, EXPERT OPIN INV DRUG, V9, P1815, DOI 10.1517/13543784.9.8.1815
   Rajapakse S, 2011, TROP DOCT, V41, P1, DOI 10.1258/td.2010.100311
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rianthavorn P, 2010, INT J INFECT DIS, V14, pE161, DOI 10.1016/j.ijid.2010.01.001
   Robin S, 2010, EUR J PEDIATR, V169, P67, DOI 10.1007/s00431-009-0986-0
   Schwameis M, 2016, HUM VACC IMMUNOTHER, V12, P716, DOI 10.1080/21645515.2015.1101197
   Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shanks GD, 2017, LANCET INFECT DIS, V17, P1223, DOI 10.1016/S1473-3099(17)30475-9
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Smit R, 2016, EXPERT REV VACCINES, V15, P5, DOI 10.1586/14760584.2016.1111142
   Srikanth P, 2010, INDIAN J MED MICROBI, V28, P299, DOI 10.4103/0255-0857.71812
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Tavassoli M, 2012, PARASITOL RES, V111, P1779, DOI 10.1007/s00436-012-3023-6
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Valbuena G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00170
   Vasantha-Srinivasan P, 2017, ECOTOX ENVIRON SAFE, V139, P439, DOI 10.1016/j.ecoenv.2017.01.026
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vora Neil, 2008, Medscape J Med, V10, P238
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573
   White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5
   Xiao JP, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0131-z
   Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006062
   Zent O, 2005, EXPERT REV VACCINES, V4, P747, DOI 10.1586/14760584.4.5.747
   Zhang X, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-194, 10.1186/1743-422X-10-174]
NR 97
TC 3
Z9 3
U1 6
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2019
VL 26
IS 16
BP 2974
EP 2986
DI 10.2174/0929867325666181105121146
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA IU1KS
UT WOS:000483335800014
PM 30394204
DA 2020-07-08
ER

PT J
AU Oeser, C
   Aarons, E
   Heath, PT
   Johnson, K
   Khalil, A
   Knight, M
   Lynn, RM
   Morgan, D
   Pebody, R
AF Oeser, C.
   Aarons, E.
   Heath, P. T.
   Johnson, K.
   Khalil, A.
   Knight, M.
   Lynn, R. M.
   Morgan, D.
   Pebody, R.
TI Surveillance of congenital Zika syndrome in England and Wales: methods
   and results of laboratory, obstetric and paediatric surveillance
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Arboviruses; Congenital (intrauterine) infection; Infectious disease
   control; Surveillance; Surveillance system
AB The spread of the Zika virus (ZIKV) in the Americas led to large outbreaks across the region and most of the Southern hemisphere. Of greatest concern were complications following acute infection during pregnancy. At the beginning of the outbreak, the risk to unborn babies and their clinical presentation was unclear. This report describes the methods and results of the UK surveillance response to assess the risk of ZIKV to children born to returning travellers. Established surveillance systems operating within the UK - the paediatric and obstetric surveillance units for rare diseases, and national laboratory monitoring - enabled rapid assessment of this emerging public health threat. A combined total of 11 women experiencing adverse pregnancy outcomes after possible ZIKV exposure were reported by the three surveillance systems; five miscarriages, two intrauterine deaths and four children with clinical presentations potentially associated with ZIKV infection. Sixteen women were diagnosed with ZIKV during pregnancy in the UK. Amongst the offspring of these women, there was unequivocal laboratory evidence of infection in only one child. In the UK, the number and risk of congenital ZIKV infection for travellers returning from ZIKV-affected countries is very small.
C1 [Oeser, C.; Lynn, R. M.; Morgan, D.; Pebody, R.] Publ Hlth England, Natl Infect Serv, London, England.
   [Aarons, E.] Publ Hlth England, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
   [Heath, P. T.] St Georges Univ London, Inst Infect & Immun, London, England.
   [Johnson, K.] Leeds Teaching Hosp NHS Trust, Neonatal Serv, Leeds, W Yorkshire, England.
   [Khalil, A.] St Georges Univ London, Obstet & Maternal Fetal Med, London, England.
   [Knight, M.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.
RP Oeser, C (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.
EM Clarissa_oeser@yahoo.com
RI Khall, Asma/AAC-1459-2020
OI Khall, Asma/0000-0003-2802-7670
CR [Anonymous], 2016, MBRRACE UK PERINATAL
   Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014
   DeSilva M, 2017, VACCINE, V35, P6472, DOI 10.1016/j.vaccine.2017.01.044
   Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x
   Petridou C, 2019, TRAVEL MED INFECT DI, V29, P21, DOI 10.1016/j.tmaid.2019.03.001
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 6
TC 0
Z9 0
U1 1
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR PII S0950268819001535
DI 10.1017/S0950268819001535
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IU7LW
UT WOS:000483766400001
PM 31481135
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT S
AU Christian, KM
   Song, HJ
   Ming, GL
AF Christian, Kimberly M.
   Song, Hongjun
   Ming, Guo-li
BE Roska, B
   Zoghbi, HY
TI Pathophysiology and Mechanisms of Zika Virus Infection in the Nervous
   System
SO ANNUAL REVIEW OF NEUROSCIENCE, VOL 42
SE Annual Review of Neuroscience
LA English
DT Review; Book Chapter
DE microcephaly; Zika; neurodevelopment
ID NEURAL STEM-CELLS; CEREBRAL ORGANOIDS; DRUG CANDIDATES; MOUSE MODEL;
   PROTEIN; AXL; CONTRIBUTES; PROGENITORS; INHIBITORS; INDUCTION
AB In 2015, public awareness of Zika virus (ZIKV) rose in response to alarming statistics of infants with microcephaly being born to women who were infected with the virus during pregnancy, triggering global concern over these potentially devastating consequences. Although we have discovered a great deal about the genome and pathogenesis of this reemergent flavivirus since this recent outbreak, we still have much more to learn, including the nature of the virus-host interactions and mechanisms that determine its tropism and pathogenicity in the nervous system, which are in turn shaped by the continual evolution of the virus. Inevitably, we will find out more about the potential long-term effects of ZIKV exposure on the nervous system from ongoing longitudinal studies. Integrating clinical and epidemiological data with a wider range of animal and human cell culture models will be critical to understanding the pathogenetic mechanisms and developing more specific antiviral compounds and vaccines.
C1 [Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Dev & Cell Biol, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Inst Epigenet, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.
RP Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Dev & Cell Biol, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.
EM gming@pennmedicine.upenn.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI131130]; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [U19 MH106434, R21
   MH118037]; NINDS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R35 NS097370, R37 NS047344]
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bido-Medina R, 2018, ANN CLIN TRANSL NEUR, V5, P752, DOI 10.1002/acn3.575
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gopinath S, 2018, NAT MICROBIOL, V3, P611, DOI 10.1038/s41564-018-0138-2
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McFadden MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020095
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris JH, 2014, NAT PROTOC, V9, P2539, DOI 10.1038/nprot.2014.164
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Martinez ARM, 2018, MUSCLE NERVE, V57, pE100, DOI 10.1002/mus.25958
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Ruggiero E, 2018, NUCLEIC ACIDS RES, V46, P3270, DOI 10.1093/nar/gky187
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarukhanyan E, 2018, ACS OMEGA, V3, P5281, DOI 10.1021/acsomega.8b00223
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song G, 2018, MOL CELL PROTEOMICS, V17, P349, DOI 10.1074/mcp.RA117.000310
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taracena ML, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006498
   Teng Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00327
   Thackray LB, 2018, CELL REP, V22, P3440, DOI 10.1016/j.celrep.2018.03.001
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Volpi VG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28257-5
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu S, 2017, ANTIVIR RES, V145, P70, DOI 10.1016/j.antiviral.2017.07.012
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 117
TC 0
Z9 0
U1 2
U2 4
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0147-006X
EI 1545-4126
BN 978-0-8243-2442-1
J9 ANNU REV NEUROSCI
JI Annu. Rev. Neurosci.
PY 2019
VL 42
BP 249
EP 269
DI 10.1146/annurev-neuro-080317-062231
PG 21
WC Neurosciences
SC Neurosciences & Neurology
GA BN5IR
UT WOS:000483393600013
PM 31283901
DA 2020-07-08
ER

PT J
AU Zarante, I
   Hurtado-Villa, P
   Walani, SR
   Kancherla, V
   Camelo, JL
   Giugliani, R
   Groisman, B
   Howson, CP
   Duran, P
AF Zarante, Ignacio
   Hurtado-Villa, Paula
   Walani, Salimah R.
   Kancherla, Vijaya
   Lopez Camelo, Jorge
   Giugliani, Roberto
   Groisman, Boris
   Howson, Christopher P.
   Duran, Pablo
CA 8th Int Conference Birth Defects
TI A consensus statement on birth defects surveillance, prevention, and
   care in Latin America and the Caribbean
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Congenital abnormalities; epidemiology; medical care; neonatal
   screening; prenatal diagnosis; primary prevention; surveillance; Latin
   America; West Indies
AB Birth defects contribute up to 21% of the mortality in those under 5 years of age in Latin America and the Caribbean (LAC), and that burden has been compounded by the Zika virus epidemic. In 2001, the March of Dimes launched a series of biennial assemblies called the International Conference on Birth Defects and Disabilities in the Developing World (ICBD). The latest ICBD, in 2017, convened in Bogota, Colombia, and was attended by over 300 professionals, policymakers, and donors. The conference attendees, a majority of whom were from LAC, supported a call to action in the form of a consensus statement. The consensus statement lists key actions for maximizing birth defects surveillance, prevention, and care in LAC: 1) improving surveillance; 2) reducing risks for birth defects; 3) fortifying staple foods; 4) preventing and treating infections associated with birth defects; 5) implementing newborn screening; 6) providing care and services for people with birth defects and disabilities; 7) involving governments, civil society, and international agencies; and 8) advancing research for birth defects. Implementation and scale-up of evidence-based interventions using multisectoral and multidisciplinary collaborative approaches were endorsed. LAC countries can leverage technology and social media to advance and advocate for approaches identified in the consensus statement. The consensus statement can be used as a guide by both governments and nongovernmental agencies to take immediate steps for improving the quality of life of those living with birth defects and associated disabilities in the LAC countries.
C1 [Zarante, Ignacio] Pontificia Univ Javeriana, Sch Med, Inst Human Genet, Bogota, Colombia.
   [Hurtado-Villa, Paula] Pontificia Univ Javeriana, Fac Hlth Sci, Basic Hlth Sci Dept, Cali, Colombia.
   [Walani, Salimah R.] March Dimes, Arlington, VA 22202 USA.
   [Kancherla, Vijaya] Emory Univ, Ctr Spina Bifida Prevent, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Lopez Camelo, Jorge] Ctr Med Educ & Clin Res CEMIC CONICET, Latin Amer Collaborat Study Congenital Malformat, Buenos Aires, DF, Argentina.
   [Giugliani, Roberto] Univ Fed Rio Grande do Sul, Med Genet Serv, Hosp Clin Porto Alegre, Dept Genet, Porto Alegre, RS, Brazil.
   [Groisman, Boris] Natl Network Congenital Anomalies Argentina, Natl Ctr Med Genet, Natl Adm Labs & Hlth Inst, Buenos Aires, DF, Argentina.
   [Howson, Christopher P.] Howson & Partners Global Hlth, Santa Fe, NM USA.
   [Duran, Pablo] World Hlth Org, Pan Amer Hlth Org, Latin Amer Ctr Perinatol Womens & Reprod Hlth, Montevideo, Uruguay.
RP Walani, SR (corresponding author), March Dimes, Arlington, VA 22202 USA.
EM swalani@marchofdimes.org
RI Zarante, Ignacio/L-6467-2017; Hurtado-Villa, Paula/O-2543-2014
OI Zarante, Ignacio/0000-0002-0729-6866; Hurtado-Villa,
   Paula/0000-0003-3822-7780
FU World Health OrganizationWorld Health Organization [001]
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   [Anonymous], 2017, 8 INT C BIRTH DEF DI
   Gili JA, 2016, BIRTH DEFECTS RES A, V106, P257, DOI 10.1002/bdra.23481
   Bautista LE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5566-7
   Botto LD, 2018, ANN NY ACAD SCI, V1414, P126, DOI 10.1111/nyas.13600
   Campana H, 2010, J ULTRAS MED, V29, P203, DOI 10.7863/jum.2010.29.2.203
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   Darmstadt GL, 2016, JAMA PEDIATR, V170, P790, DOI 10.1001/jamapediatrics.2016.0388
   Every Woman Every Child, GLOB STRAT WOM CHILD
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Howson CP, 2018, MOL GENET METAB, V124, P177, DOI 10.1016/j.ymgme.2018.04.009
   International Telecommunication Union, ICT FACTS FIGURES 20
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8
   Martorell R, 2017, FOOD NUTR BULL, V38, P384, DOI 10.1177/0379572117707890
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Nading A, 2018, MED ANTHROPOL, P1
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Rittler M, 2004, BIRTH DEFECTS RES A, V70, P939, DOI 10.1002/bdra.20089
   Rosenthal J, 2014, PUBLIC HEALTH NUTR, V17, P537, DOI 10.1017/S1368980013000256
   Trindade IEK, 2006, CLEFT PALATE-CRAN J, V43, P722, DOI 10.1597/05-124
   United Nations, SUST DEV GOAL 3 ENS
   United Nations Development Programme, SOC IMP ASS ZIK VIR
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Woodhouse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091292
NR 24
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR UNSP e2
DI 10.26633/RPSP.2019.2
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IU2MW
UT WOS:000483415500001
PM 31093226
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Strottmann, DM
   Zanluca, C
   Mosimann, ALP
   Koishi, AC
   Auwerter, NC
   Faoro, H
   Cataneo, AHD
   Kuczera, D
   Wowk, PF
   Bordignon, J
   dos Santos, CND
AF Strottmann, Daisy Maria
   Zanluca, Camila
   Pamplona Mosimann, Ana Luiza
   Koishi, Andrea C.
   Auwerter, Nathalia Cavalheiro
   Faoro, Helisson
   Depieri Cataneo, Allan Henrique
   Kuczera, Diogo
   Wowk, Pryscilla Fanini
   Bordignon, Juliano
   Duarte dos Santos, Claudia Nunes
TI Genetic and biological characterisation of Zika virus isolates from
   different Brazilian regions
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; Flavivirus; molecular markers; biological characterisation
ID MEMBRANE TOPOLOGY; INFECTION
AB BACKGROUND Zika virus (ZIKV) infections reported in recent epidemics have been linked to clinical complications that had never been associated with ZIKV before. Adaptive mutations could have contributed to the successful emergence of ZIKV as a global health threat to a nonimmune population. However, the causal relationships between the ZIKV genetic determinants, the pathogenesis and the rapid spread in Latin America and in the Caribbean remain widely unknown.
   OBJECTIVES The aim of this study was to characterise three ZIKV isolates obtained from patient samples during the 2015/2016 Brazilian epidemics.
   METHODS The ZIKV genomes of these strains were completely sequenced and in vitro infection kinetics experiments were carried out in cell lines and human primary cells.
   FINDINGS Eight nonsynonymous substitutions throughout the viral genome of the three Brazilian isolates were identified. Infection kinetics experiments were carried out with mammalian cell lines A549, Huh7.5, Vero E6 and human monocyte-derived dendritic cells (mdDCs) and insect cells (Aag2, C6/36 and AP61) and suggest that some of these mutations might be associated with distinct viral fitness. The clinical isolates also presented differences in their infectivity rates when compared to the well-established ZIKV strains (MR766 and PE243), especially in their abilities to infect mammalian cells.
   MAIN CONCLUSIONS Genomic analysis of three recent ZIKV isolates revealed some nonsynonymous substitutions, which could have an impact on the viral fitness in mammalian and insect cells.
C1 [Strottmann, Daisy Maria; Zanluca, Camila; Pamplona Mosimann, Ana Luiza; Koishi, Andrea C.; Auwerter, Nathalia Cavalheiro; Depieri Cataneo, Allan Henrique; Kuczera, Diogo; Wowk, Pryscilla Fanini; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz Fiocruz, Lab Virol Mol, Inst Carlos Chagas, Curitiba, Parana, Brazil.
   [Faoro, Helisson] Fundacao Oswaldo Cruz Fiocruz, Lab Regulacao Expressao Genica, Inst Carlos Chagas, Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Virol Mol, Inst Carlos Chagas, Curitiba, Parana, Brazil.
EM claudia.dossantos@fiocruz.br
RI Wowk, Pryscilla Fanini/AAR-7230-2020; Wowk, Pryscilla/AAA-3281-2019;
   Mosimann, Ana Luiza Pamplona/AAB-4714-2019; Cataneo,
   Allan/AAB-7997-2020; Faoro, Helisson/F-7163-2012; Bordignon,
   Juliano/Z-6268-2019
OI Mosimann, Ana Luiza Pamplona/0000-0002-3504-5562; Faoro,
   Helisson/0000-0002-0146-8639; Bordignon, Juliano/0000-0002-1965-6152;
   Wowk, Pryscilla/0000-0002-8976-2647; Zanluca, Camila/0000-0001-7350-9105
FU FIOCRUZ; BNDES; CNPqNational Council for Scientific and Technological
   Development (CNPq) [439968/2016-0]; CAPESCAPES [88887.116626/201601,
   88887.130200/2017-01]; Fundacao AraucariaFundacao Araucaria [CP 04/2016]
FX FIOCRUZ, BNDES, CNPq (439968/2016-0), CAPES (88887.116626/201601 and
   88887.130200/2017-01), Fundacao Araucaria (CP 04/2016).; CNDS and JB
   have a CNPq fellowship.
CR Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   [Anonymous], 2017, ZIK MAC ELISA
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Shrivastava S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34147-7
   Tajima S, 2007, J GEN VIROL, V88, P2214, DOI 10.1099/vir.0.82661-0
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zanluca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110620
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 30
TC 1
Z9 1
U1 1
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR UNSP e190150
DI 10.1590/0074-02760190150
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IS2YU
UT WOS:000482021100001
PM 31432892
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vieira, DS
   Zambenedetti, MR
   Requiao, L
   Borghetti, IA
   Luna, LKD
   dos Santos, AD
   Taborda, RLM
   Pereira, DB
   Krieger, MA
   Salcedo, JMV
   Rampazzo, RDP
AF Vieira, Deusilene Souza
   Zambenedetti, Miriam Ribas
   Requiao, Luciana
   Borghetti, Ivo Alberto
   de Souza Luna, Luciano Kleber
   dos Santos, Alcione de Oliveira
   Mesquite Taborda, Roger Lafontaine
   Pereira, Dhelio Batista
   Krieger, Marco Aurelio
   Villalobos Salcedo, Juan Miguel
   Pontello Rampazzo, Rita de Cassia
TI Epidemiological profile of Zika, Dengue and Chikungunya virus infections
   identified by medical and molecular evaluations in Rondonia, Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Zika; Chikungunya; Dengue; One-step real-time RT-PCR; Diagnostic;
   Arboviruses
ID OUTBREAK
AB Several arboviruses have emerged and/or re-emerged in North. Central and South-American countries. Viruses from some regions of Africa and Asia, such as the Zika and Chikungunya virus have been introduced in new continents causing major public health problems. The aim of this study was to investigate the presence of RNA from Zika, Dengue and Chikungunya viruses in symptomatic patients from Rondonia. where the epidemiological profile is still little known, by one-step real-time RT-PCR. The main clinical signs and symtoms were fever (51.2%), headache (78%), chills (6.1%), pruritus (12.2%), exanthema (20.1%). arthralgia (35.3%). myalgia (26.8%) and retro-orbital pain (19.5%). Serum from 164 symptomatic patients were collected and tested for RNA of Zika, Dengue types 1 to 4 and Chikungunya viruses, in addition to antibodies against Dengue NS1 antigen. Direct microscopy for Malaria was also performed. Only ZIKV RNA was detected in 4.3% of the patients, and in the remaining 95.7% of the patients RNA for Zika, Dengue and Chikungunya viruses were not detected. This finding is intriguing as the region has been endemic for Dengue for a long time and more recently for Chikungunya virus as well. The results indicated that medical and molecular parameters obtained were suitable to describe the first report of symptomatic Zika infections in this region. Furthermore, the low rate of detection, compared to clinical signs and symptoms as the solely diagnosis criteria, suggests that molecular assays for detection of viruses or other pathogens that cause similar symptoms should be used and the corresponding diseases could be included in the compulsory notification list.
C1 [Vieira, Deusilene Souza; dos Santos, Alcione de Oliveira; Villalobos Salcedo, Juan Miguel] Fundacao Oswaldo Cruz Rondonia, Porto Velho, Rondonia, Brazil.
   [Vieira, Deusilene Souza] Univ Fed Rondonia, Programa Posgrad Biol Expt, Porto Velho, Rondonia, Brazil.
   [Vieira, Deusilene Souza; dos Santos, Alcione de Oliveira; Mesquite Taborda, Roger Lafontaine; Pereira, Dhelio Batista; Villalobos Salcedo, Juan Miguel] Ctr Pesquisa Med Trop, Porto Velho, Rondonia, Brazil.
   [Zambenedetti, Miriam Ribas; Requiao, Luciana; Borghetti, Ivo Alberto; de Souza Luna, Luciano Kleber; Krieger, Marco Aurelio; Pontello Rampazzo, Rita de Cassia] Inst Biol Mol Parana, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
   [Borghetti, Ivo Alberto] Univ Fed Parana, Dept Engn Bioprocessos & Biotecnol, Curitiba, Parana, Brazil.
   [Krieger, Marco Aurelio] Inst Carlos Chagas, Curitiba, Parana, Brazil.
RP Rampazzo, RDP (corresponding author), Inst Biol Mol Parana, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
EM rcprampazzo@gmail.com
RI Rampazzo, Rita/AAA-4590-2020; Krieger, Marco/AAE-8611-2020; de Souza
   Luna, Luciano Kleber/AAG-6418-2019; de Souza Luna, Luciano
   Kleber/L-1213-2013; Pereira, Dhelio/F-9312-2017
OI Rampazzo, Rita/0000-0002-8367-999X; de Souza Luna, Luciano
   Kleber/0000-0002-3552-5507; de Souza Luna, Luciano
   Kleber/0000-0002-3552-5507; Pereira, Dhelio/0000-0002-7761-5498
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Laporta GZ, 2012, CAD SAUDE PUBLICA, V28, P229, DOI 10.1590/S0102-311X2012000200003
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Proenca-Modena JL, 2018, MICROBES INFECT, V20, P661, DOI 10.1016/j.micinf.2018.02.008
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Vieira DS, 2007, REV SOC BRAS MED TRO, V40, P268, DOI 10.1590/S0037-86822007000300003
   Vieira DS, 2008, VIRUS REV RES, V13, P1
   W.H.O, CHIK
   WHO, 2018, WORLD MAL REP 2018
   WHO, DENG CONTR EP
   World Health Organization, EM ARCH ZIK VIR CLAS
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 0
Z9 0
U1 1
U2 3
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2019
VL 61
AR UNSP e40
DI 10.1590/S1678-9946201961040
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IS3BI
UT WOS:000482027800001
PM 31432989
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, RAS
   de Oliveira, EF
   Fernandes, AIV
   Brito, CAA
   Marques, ETA
   Tenorio, MC
   Gil, LHGV
AF Oliveira, Renato A. S.
   de Oliveira-Filho, Edmilson F.
   Fernandes, Ana I., V
   Brito, Carlos A. A.
   Marques, Ernesto T. A.
   Tenorio, Marli C.
   Gil, Laura H. G., V
TI Previous dengue or Zika virus exposure can drive to infection
   enhancement or neutralisation of other flaviviruses
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE ADE; flavivirus; dengue; Zika
ID ANTIBODY-DEPENDENT ENHANCEMENT; PERNAMBUCO; FEVER; STATE
AB BACKGROUND Dengue virus (DENV) has circulated in Brazil for over 30 years. During this time, one serotype has cyclically replaced the other, until recently, when all four distinct serotypes began to circulate together. Persistent circulation of DENV for long time periods makes sequential infections throughout a person's life possible. After primary DENV infection, life-long immunity is developed for the infecting serotype. Since DENV and Zika virus (ZIKV) arc antigenically similar, the possibility of cross-reactions has attracted attention and has been demonstrated in vitro.
   OBJECTIVE The aim of this study was to investigate whether immune-sera from DENV and ZIKV infected patients would cross-react in vitro with other Flaviviridae family members.
   METHODS Cross reaction of the studied samples with yellow fever virus (YFV), West Nile virus (WNV), Rocio virus (ROCV), Saint Louis virus (SLEV) and Ilheus virus (ILHV) has been investigated by plaque reduction neutralisation test (PRNT) and the antibody-dependent enhancement (ADE) by flow-cytometry.
   FINDINGS Antibodies against ZIKV and DENV virus cross-reacted with other flaviviruses either neutralising or enhancing the infection. Thus, viral entrance into FcRFc gamma RII-expressing cells were influenced by the cross-reactive antibodies. ZIKV or DENV immune sera enhanced cellular infection by WNV, ILHV, ROCV and SLEV. Finally, DENV immune sera presented higher neutralising activity for YFV and SLEV. While ZIKV immune sera neutralised WNV, ILHV and ROCV with high frequencies of positivity.
   MAIN CONCLUSIONS The co-circulation of those viruses in the same area represents a risk for the development of severe infections if they spread throughout the country. Successive flavivirus infections may have an impact on disease pathogenesis, as well as on the development of safe vaccine strategies.
C1 [Oliveira, Renato A. S.; de Oliveira-Filho, Edmilson F.; Marques, Ernesto T. A.; Tenorio, Marli C.; Gil, Laura H. G., V] Inst Aggeu Magalhaes, Dept Virol, Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Oliveira, Renato A. S.] Univ Fed Paraiba, Dept Fisiol & Patol, Joao Pessoa, Paraiba, Brazil.
   [de Oliveira-Filho, Edmilson F.] Charite Univ Med Berlin, Berlin, Germany.
   [Fernandes, Ana I., V] Univ Fed Paraiba, Hosp Univ Lauro Wanderley, Serv Doencas Infecciosas & Parasitarias, Joao Pessoa, Paraiba, Brazil.
   [Fernandes, Ana I., V] Univ Fed Paraiba, Escola Tecn Saude, Grp Estudos & Pesquisas Imunol Humana, Joao Pessoa, Paraiba, Brazil.
   [Brito, Carlos A. A.] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Oliveira, RAS (corresponding author), Inst Aggeu Magalhaes, Dept Virol, Fundacao Oswaldo Cruz, Recife, PE, Brazil.; Oliveira, RAS (corresponding author), Univ Fed Paraiba, Dept Fisiol & Patol, Joao Pessoa, Paraiba, Brazil.
EM renaoliveira1977@gmail.com
RI Oliveira, Renato/AAN-9879-2020; Marques, Ernesto T. A/L-4967-2013;
   Oliveira, Renato/AAN-9394-2020
OI Oliveira, Renato/0000-0002-4044-0794; Marques, Ernesto T.
   A/0000-0003-3826-9358; 
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (Facepe) [BFP-0117-2.11/13, APQ 1380-5.05/15]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [DCR-0003-5.05/16]
FX To Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (Facepe) (grant BFP-0117-2.11/13), for granting RASO a visiting research
   fellowship and EFO-F (grant APQ 1380-5.05/15) and CNPq
   (DCR-0003-5.05/16), and to Louisa F. Ludwig-Begall, for the careful
   English proofreading of this manuscript.
CR Amarilla AA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199071
   Andrade P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08845-3
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   de Oliveira EF, 2018, TRANSBOUND EMERG DIS, V65, P1094, DOI 10.1111/tbed.12829
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kum DB, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0092-2
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Santos JJS, 2014, AN ACAD BRAS CIENC, V86, P1749, DOI 10.1590/0001-3765201420130332
NR 23
TC 5
Z9 5
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR UNSP e190098
DI 10.1590/0074-02760190098
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IR8UC
UT WOS:000481716000001
PM 31411310
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nolen, LD
   Lirow, E
   Gee, JE
   Elrod, MG
   Kolton, CB
   Liu, L
   Bower, WA
   Person, MK
   Marfel, M
   Blaney, DD
AF Nolen, Leisha D.
   Lirow, Eric
   Gee, Jay E.
   Elrod, Mindy G.
   Kolton, Cari B.
   Liu, Lindy
   Bower, William A.
   Person, Marissa K.
   Marfel, Maria
   Blaney, David D.
TI Differentiating New from Newly Detected: Melioidosis in Yap, Federated
   States of Micronesia
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID BURKHOLDERIA-PSEUDOMALLEI; DIVERSE MICROBES; DIAGNOSIS; RECOVERY
AB Melioidosis is a bacterial infection caused by exposure to water or soil that contains Burkholderia pseudomallei (Bp). Burkholderia pseudomallei is endemic to many tropical and subtropical areas of the world. In 2013, the first case of melioidosis was recognized in Yap, the Federated States of Micronesia. Six additional cases were identified in the subsequent 3 years. An investigation was initiated to understand the epidemiology of melioidosis in Yap. Serum from family and community members of the identified cases were tested for antibodies to Bp. Archived serum from a 2007 Zika serosurvey were also tested for antibodies to Bp. Sequencing of bacterial isolates was performed to understand bacterial phylogeny. Soil and water were tested for the presence of Bp in the environment by culture and PCR. None of the affected patients had a history of travel to melioidosis-endemic countries. Two of the 34 (5.8%) samples from the field investigation and 67 (11.7%) of the historical samples demonstrated serologic evidence of prior Bp exposure. No Bp were detected from 30 soil or water samples. Genotype analysis showed highly related Bp isolates that were unique to Yap. Melioidosis is likely to be endemic to Yap; however, it has only recently been recognized by the clinical community in country. Further investigation is needed to understand the local sites that harbor Bp and represent the highest risk to the community.
C1 [Nolen, Leisha D.; Gee, Jay E.; Elrod, Mindy G.; Kolton, Cari B.; Liu, Lindy; Bower, William A.; Blaney, David D.] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Nolen, Leisha D.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA USA.
   [Lirow, Eric; Marfel, Maria] Yap Mem Hosp, FSM Dept Hlth & Social Affairs, Yap, Micronesia.
   [Person, Marissa K.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
RP Nolen, LD (corresponding author), 1600 Clifton Rd NE, Atlanta, GA 30320 USA.
EM xdf8@cdc.gov; elirow@fsmhealth.fm; xzg4@cdc.gov; wzg0@cdc.gov;
   fts3@cdc.gov; fuz3@cdc.gov; wab4@cdc.gov; wnu6@cdc.gov;
   mmarfel@fsmhealth.fm; znr5@cdc.gov
OI Gee, Jay/0000-0003-4308-1659
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX The Centers for Disease Control and Prevention baseline funding
   supported this work.
CR ALEXANDER AD, 1970, APPL MICROBIOL, V20, P825, DOI 10.1128/AEM.20.5.825-833.1970
   Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x
   Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06
   Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005
   Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900
   Doker TJ, 2015, CLIN INFECT DIS, V60, P243, DOI 10.1093/cid/ciu764
   Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003
   Inglis Timothy J.J., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P1, DOI 10.1590/S0036-46652006000100001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2015.8, 10.1038/NMICROBIOL.2015.8]
   Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105
   Mull B, 2012, J MICROBIOL METH, V91, P429, DOI 10.1016/j.mimet.2012.10.001
   Smith CM, 2009, APPL ENVIRON MICROB, V75, P5284, DOI 10.1128/AEM.00456-09
   United States Department of Agriculture Soil Conservation Service, 1983, SOIL SURV ISL YAP FE
   Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699
NR 15
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 2
BP 323
EP 327
DI 10.4269/ajtmh.19-0253
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA IO1DQ
UT WOS:000479121100010
PM 31264560
DA 2020-07-08
ER

PT J
AU Amrun, SN
   Yee, WX
   Abu Bakar, F
   Lee, B
   Kam, YW
   Lum, FM
   Tan, JJL
   Lim, VWX
   Watthanaworawit, W
   Ling, C
   Nosten, F
   Renia, L
   Leo, YS
   Ng, LFP
AF Amrun, Siti Naqiah
   Yee, Wearn-Xin
   Abu Bakar, Farhana
   Lee, Bernett
   Kam, Yiu-Wing
   Lum, Fok-Moon
   Tan, Jeslin J. L.
   Lim, Vanessa W. X.
   Watthanaworawit, Wanitda
   Ling, Clare
   Nosten, Francois
   Renia, Laurent
   Leo, Yee-Sin
   Ng, Lisa F. P.
TI Novel differential linear B-cell epitopes to identify Zika and dengue
   virus infections in patients
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Article
DE flavivirus; epitopes; patients; diagnostic
ID CHIKUNGUNYA VIRUS; OUTBREAK; SPECIFICITY; ANTIBODIES; SINGAPORE;
   DIAGNOSIS; ASSAY
AB Objectives Recent Zika virus (ZIKV) outbreaks challenged existing laboratory diagnostic standards, especially for serology-based methods. Because of the genetic and structural similarity of ZIKV with other flaviviruses, this results in cross-reactive antibodies, which confounds serological interpretations. Methods Plasma from Singapore ZIKV patients was screened longitudinally for antibody responses and neutralising capacities against ZIKV. Samples from healthy controls, ZIKV patients and DENV patients were further assessed using ZIKV and DENV peptides of precursor membrane (prM), envelope (E) or non-structural 1 (NS1) viral proteins in a peptide-based ELISA for epitope identification. Identified epitopes were re-validated and diagnostically evaluated using sera of patients with DENV, bacteria or unknown infections from Thailand. Results Long-lasting ZIKV-neutralising antibodies were elicited during ZIKV infection. Thirteen potential linear B-cell epitopes were identified, and of these, four common flavivirus, three ZIKV-specific and one DENV-specific differential epitopes had more than 50% sensitivity and specificity. Notably, ZIKV-specific peptide 26 on domain I/II of E protein (amino acid residues 271-288) presented 80% sensitivity and 85.7% specificity. Importantly, the differential epitopes also showed significance in differentiating non-flavivirus patient samples. Conclusion Linear B-cell epitope candidates to differentiate between ZIKV and DENV infections were identified, providing the first step towards the design of a much-needed serology-based assay.
C1 [Amrun, Siti Naqiah; Yee, Wearn-Xin; Abu Bakar, Farhana; Lee, Bernett; Kam, Yiu-Wing; Lum, Fok-Moon; Tan, Jeslin J. L.; Renia, Laurent; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
   [Lim, Vanessa W. X.; Leo, Yee-Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Watthanaworawit, Wanitda; Ling, Clare; Nosten, Francois] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.
   [Nosten, Francois] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
   [Leo, Yee-Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
RP Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Nosten, Francois/AAC-5509-2019
OI Nosten, Francois/0000-0002-7951-0745
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund, Agency for
   Science, Technology and Research (A*STAR), Singapore [15/1/82/27/001];
   BMRC IAF grant [311006]; BMRC transition funds [H16/99/b0/011]
FX This work was supported by core research grants provided to the
   Singapore Immunology Network (SIgN) by the Biomedical Research Council
   (BMRC) and also partially supported by the BMRC A*STAR-led Zika Virus
   Consortium Fund [project number: 15/1/82/27/001], Agency for Science,
   Technology and Research (A*STAR), Singapore. SIgN Immunomonitoring and
   Flow Cytometry platforms are supported by BMRC IAF 311006 grant and BMRC
   transition funds #H16/99/b0/011.
CR Ang LW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006163
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kam YW, 2019, J INFECT DIS, V220, P203, DOI 10.1093/infdis/jiz092
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Lee HJ, 2018, BIOCHEM BIOPH RES CO, V505, P1010, DOI 10.1016/j.bbrc.2018.10.024
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Magalhaes T, 2017, SCI TRANSL MED, V9
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Mohns MS, 2018, PLOS NEGLECT TROP D, V12
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Ng LC, 2015, AM J TROP MED HYG, V92, P1150, DOI 10.4269/ajtmh.14-0588
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rajarethinam J, 2018, AM J TROP MED HYG, V99, P204, DOI 10.4269/ajtmh.17-0819
   Ramanathan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155900
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0
   Suwandono A, 2006, T ROY SOC TROP MED H, V100, P855, DOI 10.1016/j.trstmh.2005.11.010
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 55
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PY 2019
VL 8
IS 7
AR e1066
DI 10.1002/cti2.1066
PG 15
WC Immunology
SC Immunology
GA IM0DB
UT WOS:000477654300005
PM 31372218
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Candelo, E
   Caicedo, G
   Rosso, F
   Ballesteros, A
   Orrego, J
   Escobar, L
   Lapunzina, P
   Nevado, J
   Pachajoa, H
AF Candelo, Estephania
   Caicedo, Gabriela
   Rosso, Fernando
   Ballesteros, Adriana
   Orrego, Jaime
   Escobar, Luis
   Lapunzina, Pablo
   Nevado, Julian
   Pachajoa, Harry
TI First report case with negative genetic study (array CGH, exome
   sequencing) in patients with vertical transmission of Zika virus
   infection and associated brain abnormalities
SO APPLICATION OF CLINICAL GENETICS
LA English
DT Article
DE Colombia; microcephaly; whole exome sequencing; Zika virus infection;
   vertical transmission; brain abnormalities
ID FETAL; OUTCOMES; BRAZIL
AB Introduction: Zika virus (ZIKV) is a little-known emerging mosquito-borne flavivirus. The perinatal ZIKV infection was associated with birth defects during the Brazilian outbreak. There was an increased risk of intrauterine transmission of the virus and a marked increase in the number of newborns with microcephaly. We report on two such cases.
   Case Report: The first case was a 25-year-old pregnant woman from Colombia who became acutely ill with general symptoms during the tenth week of gestation, followed by severe generalized itching and maculopapular rash for approximately five days. This case was reported during the epidemic stage of the ZIKV infection in Colombia. At 23.3 gestational weeks, ultrasonography showed abnormal intracranial anatomy with cerebral ventriculomegaly, microcephaly, and parenchymal calcification. Given the grave prognosis, the patient elected to terminate the pregnancy at 25 gestational weeks. The second case was a 24-year-old pregnant woman who became acutely ill during the 17th week of gestation, which corresponded with the ZIKV epidemic in Colombia. At 30.5 gestational weeks, ultrasonography showed isolated fetal cerebral ventriculomegaly. We detected ZIKV in the amniotic fluid; however, the virus was not detected in the urine or serum of the mother or fetus. Tests for dengue virus, chikungunya virus, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus, HIV, hepatitis B and C, and parvovirus B19 were all negative. Different samples obtained from the placenta, amniotic liquid, and cerebrospinal fluid were positive for viral isolation of ZIKV RNA using TaqMan RT-PCR. Additionally, the parents and fetuses were tested for genetic diseases using whole exome sequencing and array CGH to rule out possible genetic syndromes that produce these congenital abnormalities.
   Conclusion: These were the first cases in Colombia to show early vertical transmission of ZIKV and the first cases associated with congenital cerebral abnormalities in which molecular, infectious, and genomic tests were performed.
C1 [Candelo, Estephania; Caicedo, Gabriela; Pachajoa, Harry] Univ Icesi, Ctr Res Congenital Anomalies & Rare Dis CIACER, Dept Basic Med Sci, Cali, Colombia.
   [Candelo, Estephania] UCL, MSc Biomat & Tissues Engn & Genet Human Dis, London, England.
   [Rosso, Fernando] Fdn Valle Lili, Infectol Dept, Cali, Colombia.
   [Ballesteros, Adriana; Orrego, Jaime] Fdn Valle Lili, Neonatal Dept, Cali, Colombia.
   [Escobar, Luis] Fdn Valle Lili, Pathol Dept, Cali, Colombia.
   [Lapunzina, Pablo; Nevado, Julian] Hosp Univ La Paz, IdiPAZ, Inst Genet Med & Mol INGEMM, Madrid 28046, Spain.
   [Lapunzina, Pablo; Nevado, Julian] ISCIII, CIBER Enfermedades Raras CIBERER, Madrid, Spain.
   [Pachajoa, Harry] Fdn Valle Lili, Genet Dept, Cali, Colombia.
RP Pachajoa, H (corresponding author), Univ ICESI, Ctr Invest Anomalias Congenitas & Enfermedades Ra, Calle 18 122-135, Cali, Colombia.
EM hmpachajoa@icesi.edu.co
RI ; Lapunzina, Pablo/L-7075-2014
OI escobar, luis alberto/0000-0001-5898-5736; Lapunzina,
   Pablo/0000-0002-6324-4825
CR Blanco-Kelly F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172363
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Candelo E, 2018, BIOMOMTUR, V38
   Chu V, 2017, OPEN FORUM INFECT S1, pS696, DOI [10.1093/ofid/ofx163.1867, DOI 10.1093/OFID/OFX163.1867]
   De Kumar B, 2015, GENOME RES, V25, P1229, DOI 10.1101/gr.184978.114
   FARRELL TA, 1994, RADIOLOGY, V193, P409, DOI 10.1148/radiology.193.2.7972754
   Fellner Chris, 2016, P T, V41, P242
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scala C, 2017, ULTRASOUND OBST GYN, V49, P450, DOI 10.1002/uog.15943
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   2015, RELEVE EPIDEMIOL HEB, V90, P609
NR 30
TC 0
Z9 0
U1 3
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-704X
J9 APPL CLIN GENET
JI Appl. Clin. Genet.
PY 2019
VL 12
BP 141
EP 150
DI 10.2147/TACG.S190661
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA IN6QQ
UT WOS:000478806100001
PM 31440073
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barrera, R
   Felix, G
   Acevedo, V
   Amador, M
   Rodriguez, D
   Rivera, L
   Gonzalez, O
   Nazario, N
   Ortiz, M
   Munoz-Jordan, JL
   Waterman, SH
   Hemme, RR
AF Barrera, Roberto
   Felix, Gilberto
   Acevedo, Veronica
   Amador, Manuel
   Rodriguez, Damaris
   Rivera, Luis
   Gonzalez, Orlando
   Nazario, Nicole
   Ortiz, Marianyoly
   Munoz-Jordan, Jorge L.
   Waterman, Stephen H.
   Hemme, Ryan R.
TI Impacts of Hurricanes Irma and Maria on Aedes aegypti Populations,
   Aquatic Habitats, and Mosquito Infections with Dengue, Chikungunya, and
   Zika Viruses in Puerto Rico
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID WEST NILE VIRUS; SURVEILLANCE; DISEASE; INCREASE; VECTORS
AB Puerto Rico was severely impacted by Hurricanes Irma and Maria in September 2017. The island has been endemic for dengue viruses (DENV) and recently suffered epidemics of chikungunya (CHIKV 2014) and Zika (ZIKV 2016) viruses. Although severe storms tend to increase the number of vector and nuisance mosquitoes, we do not know how they influence Aedes aegypti populations and arboviral transmission. We compared the abundance of female Ae. aegypti in autocidal gravid ovitraps (AGO traps), container habitats, and presence of RNA of DENV, CHIKV, and ZIKV in this vector before and after the hurricanes in Caguas city and in four communities in southern Puerto Rico. Two of these communities were under vector control using mass AGO trapping and the other two nearby communities were not. We also investigated mosquito species composition and relative abundance (females/trap) using Biogents traps (BG-2 traps) in 59 sites in metropolitan San Juan city after the hurricanes. Mosquitoes sharply increased 5 weeks after Hurricane Maria. Ensuing abundance of Ae. aegypti was higher in Caguas and in one of the southern communities without vector control. Aedes aegypti did not significantly change in the two areas with vector control. The most abundant mosquitoes among the 26 species identified in San Juan were Culex (Melanoconion) spp., Culex quinquefasciatus, Culex nigripalpus, and Ae. aegypti. No arboviruses were detected in Ae. aegypti following the hurricanes, in contrast with observations from the previous year, so that the potential for Aedes-borne arboviral outbreaks following the storms in 2017 was low.
C1 [Barrera, Roberto; Felix, Gilberto; Acevedo, Veronica; Amador, Manuel; Rodriguez, Damaris; Rivera, Luis; Gonzalez, Orlando; Waterman, Stephen H.; Hemme, Ryan R.] Ctr Dis Control & Prevent, Entomol & Ecol Team, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Nazario, Nicole; Ortiz, Marianyoly] Puerto Rico Sci Trust, Vector Control Unit Puerto Rico, San Juan, PR USA.
   [Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Dengue Branch, Mol Diagnost Lab, San Juan, PR USA.
RP Barrera, R (corresponding author), Ctr Dis Control & Prevent, Entomol & Ecol Team, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
EM rbarrera@cdc.gov; ckn5@cdc.gov; gra3@cdc.gov; maa4@cdc.gov;
   mzn9@cdc.gov; hkd5@cdc.gov; fai2@cdc.gov; nnazario@prvectorcontrol.org;
   mortiz@prvectorcontrol.org; ckq2@cdc.gov; shw2@cdc.gov; wma0@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   Vector Control Unit of Puerto RicoIndian Council of Medical Research
   (ICMR)
FX Financial support was provided by the Centers for Disease Control and
   Prevention and the Vector Control Unit of Puerto Rico.
CR Barrera R, 2019, MED VET ENTOMOL, V33, P68, DOI 10.1111/mve.12338
   Barrera R, 2010, J MED ENTOMOL, V47, P1185, DOI 10.1603/ME10038
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Breidenbaugh MS, 2008, J AM MOSQUITO CONTR, V24, P327, DOI 10.2987/5731.1
   Brown JS, 1997, J ENVIRON HEALTH, V60, P8
   Caillouet KA, 2008, J VECTOR ECOL, V33, P166, DOI 10.3376/1081-1710(2008)33[166:COASPB]2.0.CO;2
   Caillouet KA, 2008, EMERG INFECT DIS, V14, P804, DOI 10.3201/eid1405.071066
   Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P240
   Foppa IM, 2007, J AM MOSQUITO CONTR, V23, P229, DOI 10.2987/8756-971X(2007)23[229:MFAASI]2.0.CO;2
   Harris JW, 2014, ENVIRON HEALTH INSIG, V8, P29, DOI [10.4137/EHI.S16001, 10.4137/EHi.s16001]
   Harrison BA, 2009, J AM MOSQUITO CONTR, V25, P265, DOI 10.2987/08-5754.1
   Hashizume M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-98
   Lehman JA, 2007, EMERG INFECT DIS, V13, P1273, DOI 10.3201/eid1308.061570
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Morrow MG, 2010, REV PANAM SALUD PUBL, V28, P19, DOI 10.1590/S1020-49892010000700003
   Nasci RS, 1998, EMERG INFECT DIS, V4, P333, DOI 10.3201/eid0402.980227
   Organizacio n Panamericana de la Salud, 1999, REV PANAM SALUD PUBL, V6, P440
   PAHO, 2018, ZIK CUM CAS
   Pasch RJ, 2018, HURRICANE MARIA 16 3
   Pradutkanchana Jintana, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P175
   (PRDH) Puerto Rico Department of Health, 2018, WEEKL REP ARB DIS
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Simpson JE, 2006, J AM MOSQUITO CONTR, V22, P457, DOI 10.2987/8756-971X(2006)22[457:EMASRT]2.0.CO;2
   Smith J, 2009, J AM MOSQUITO CONTR, V25, P38, DOI 10.2987/08-5782.1
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
NR 28
TC 1
Z9 1
U1 2
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 6
BP 1413
EP 1420
DI 10.4269/ajtmh.19-0015
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA IK6DA
UT WOS:000476674600018
PM 30963992
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mehta, N
   Perrais, B
   Martin, K
   Kumar, A
   Hobman, TC
   Cabalfin-Chua, MN
   Donaldo, ME
   Painaga, MSS
   Gaite, JY
   Tran, V
   Kain, KC
   Hawkes, MT
   Yanow, SK
AF Mehta, Ninad
   Perrais, Bastien
   Martin, Kimberly
   Kumar, Anil
   Hobman, Tom C.
   Noreen Cabalfin-Chua, Mary
   Emerson Donaldo, Manuel
   Siose Painaga, Maria Salome
   Yared Gaite, James
   Tran, Vanessa
   Kain, Kevin C.
   Hawkes, Michael T.
   Yanow, Stephanie K.
TI A Direct from Blood/Plasma Reverse Transcription-Polymerase Chain
   Reaction for Dengue Virus Detection in Point-of-Care Settings
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RNA EXTRACTION; PCR; QUANTIFICATION; INFECTION; ASSAY
AB Infection with dengue virus (DENV) is widespread across tropical regions and can result in severe disease. Early diagnosis is important both for patient management and to differentiate infections that present with similar symptoms, such as malaria, chikungunya, and Zika. Rapid diagnostic tests that are used presently for point-of-care detection of DENV antigens lack the sensitivity of molecular diagnostics that detect viral RNA. However, no molecular diagnostic test for DENV is available for use in field settings. In this study, we developed and validated a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of DENV adapted for use in field settings. Reverse transcription-polymerase chain reaction was performed directly from plasma samples without RNAextraction. The assay detected all four serotypes of DENV spiked into blood or plasma. Our RT-PCR does not cross-react with pathogens that cause symptoms that overlap with dengue infection. The test performed equally well in a conventional laboratory qPCR instrument and a small, low-cost portable instrument that can be used in a field setting. The lower limit of detection for the assay was 1 x 10(4) genome copy equivalents/mL in blood. Finally, we validated our test using 126 archived patient samples. The sensitivity of our RT-PCR was 76.7% (95% CI: 65.8-87.9%) on the conventional instrument, and 78.3% (95% CI: 65.8-87.9%) on the field instrument, when compared with the RealStar Dengue RT-PCR Kit 2.0. The molecular test described here is user-friendly, low-cost, and can be used in regions with limited laboratory capabilities.
C1 [Mehta, Ninad; Perrais, Bastien; Martin, Kimberly; Hawkes, Michael T.; Yanow, Stephanie K.] Univ Alberta, Sch Publ Hlth, Katz Grp Ctr 6-032B, Edmonton, AB T6G 2E1, Canada.
   [Kumar, Anil; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.
   [Hobman, Tom C.; Yanow, Stephanie K.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Noreen Cabalfin-Chua, Mary] Chong Hua Hosp, Sect Pediat Infect Dis, Dept Pediat, Cebu, Philippines.
   [Emerson Donaldo, Manuel] Cebu Inst Med, Cebu, Philippines.
   [Siose Painaga, Maria Salome; Yared Gaite, James] Lebumfacil Santa Ana Med Ctr, Cebu, Philippines.
   [Tran, Vanessa; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Trop Dis Unit, Toronto, ON, Canada.
   [Hawkes, Michael T.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada.
   [Hawkes, Michael T.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
   [Hawkes, Michael T.] Stollery Sci Lab, Edmonton, AB, Canada.
RP Yanow, SK (corresponding author), Univ Alberta, Sch Publ Hlth, Katz Grp Ctr 6-032B, Edmonton, AB T6G 2E1, Canada.
EM ntmehta@ualberta.ca; bastienperrais1@gmail.com; sharplin@ualberta.ca;
   anilkuma@ualberta.ca; thobman@ualberta.ca; mncchuamd@gmail.com;
   sambagii2000@icloud.com; sakepp@yahoo.com; jamesyaredgaite@yahoo.com;
   vanessa.tran@utoronto.ca; kevin.kain@uhn.ca; mthawkes@ualberta.ca;
   yanow@ualberta.ca
RI , Michael/AAP-3049-2020
OI Kumar, Anil/0000-0002-6179-4516
FU IC-IMPACTS, Canada [NCEICIMP CRPBCI 24000]; Canadian Institutes of
   Health Research (CIHR) FoundationCanadian Institutes of Health Research
   (CIHR) [FDN-148439]; Canada Research Chair programCanada Research
   Chairs; Tesari Foundation [MRA-102]
FX This research was supported by funds from IC-IMPACTS (NCEICIMP CRPBCI
   24000), Canada, Canadian Institutes of Health Research (CIHR) Foundation
   grant FDN-148439 [KCK], Canada Research Chair program [KCK], and the
   Tesari Foundation. We are thankful for Plasmodium falciparum 3D7,
   MRA-102, deposited by D. J. Carucci, obtained through the MR4 as part of
   the BEI Resources Repository, NIAID, NIH. We also thank Eileen Reklow
   for excellent technical support and the Alberta Public Health
   Laboratories (ProvLab) for providing the Plasmodium vivax clinical
   sample.
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Alejandria MM, 2015, BMJ CLIN EVID, V2015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Dans AL, 2018, J CLIN EPIDEMIOL, V95, P137, DOI 10.1016/j.jclinepi.2017.11.019
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Dhochak N, 2019, INDIAN J PEDIATR, V86, P287, DOI 10.1007/s12098-018-2794-x
   Go YY, 2016, J CLIN MICROBIOL, V54, P1528, DOI 10.1128/JCM.00225-16
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Higuera A, 2019, ACTA TROP, V190, P99, DOI 10.1016/j.actatropica.2018.11.010
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Lee JS, 2018, VACCINE, V36, P2346, DOI 10.1016/j.vaccine.2018.03.002
   MALEWICZ B, 1979, J CLIN MICROBIOL, V9, P609
   Monleau M, 2009, J CLIN MICROBIOL, V47, P1107, DOI 10.1128/JCM.02255-08
   Najioullah F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-164
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pang JX, 2017, J CLIN MICROBIOL, V55, P3339, DOI 10.1128/JCM.00707-17
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Shan XY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1088-4
   Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760
   Taylor BJ, 2017, AM J TROP MED HYG, V97, P533, DOI 10.4269/ajtmh.17-0039
   Taylor BJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-179
   Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461
   Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2
   Trajman A, 2008, SCAND J CLIN LAB INV, V68, P77, DOI 10.1080/00365510701666031
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Tsai JJ, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01865-17, 10.1128/JCM.01865-17]
   Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000
   Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81
   Wong H B, 1981, Ann Acad Med Singapore, V10, P91
   Zhang H, 2014, INT J INFECT DIS, V26, P57, DOI 10.1016/j.ijid.2014.02.002
   Zhong JF, 2007, J VIROL METHODS, V144, P98, DOI 10.1016/j.jviromet.2007.04.006
NR 36
TC 1
Z9 1
U1 2
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 6
BP 1534
EP 1540
DI 10.4269/ajtmh.19-0138
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA IK6DA
UT WOS:000476674600035
PM 30994095
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Roma, JHF
   Alves, RC
   da Silva, VS
   Ferreira, MJ
   de Araujo, C
   Pavoni, JHC
AF Francisco Roma, Jose Henrique
   Alves, Rachel Cruz
   da Silva, Vanessa Siano
   Ferreira, Marcio Jose
   de Araujo, Claudineia
   Chavez Pavoni, Juliana Helena
TI Descriptive study of suspected congenital Zika syndrome cases during the
   2015-2016 epidemic in Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Congenital Zika Syndrome; Epidemiology; Microcephaly; Mato Grosso; Zika
   virus
ID VIRUS; INFECTION
AB Introduction: Clinical and epidemiological data on suspected congenital Zika syndrome (CZS) cases from southern Mato Grosso (MT) in Brazil during the Zika virus (ZIKV) outbreak in 2015-2016 were evaluated. Methods: This is a descriptive case series study of newborns whose mothers were suspected cases of ZIKV infections during their pregnancies. The medical records of all the suspected CZS cases (mothers and newborns) treated by the specialized ambulatory service from June 2015 to August 2016 were analyzed. Results: Twenty suspected CZS cases were included in these analyses. They were categorized into four groups based on the clinical and laboratory findings: confirmed cases (n=1), highly probable cases (n=13), moderately probable cases (n=5), and somewhat probable cases (n=1). The mothers tested negative for STORCH (syphilis, toxoplasmosis, other infections, rubella, cytomegalovirus infection, and herpes simplex) and other important congenital infections; however, specific ZIKV tests were not performed during the study period. Microcephaly was observed in the majority of these newborns, and all the patients showed altered cranial computed tomography image findings. Extracranial abnormalities such as arthrogryposis, and otological and ophthalmological manifestations were also observed. Conclusions: Although ZIKV was not confirmed to cause the congenital malformations, this study demonstrated that the clinical and epidemiological findings associated with a STORCH exclusion strengthened the CZS diagnosis. The suspected cases in MT occurred simultaneously with the first CZS cases reported in Brazil, suggesting ZIKV circulation in the study region during the same period.
C1 [Francisco Roma, Jose Henrique; Alves, Rachel Cruz; da Silva, Vanessa Siano; Ferreira, Marcio Jose; de Araujo, Claudineia; Chavez Pavoni, Juliana Helena] Univ Fed Mato Grosso, Curso Grad Med, Inst Ciencias Exatas & Nat, Rondonopolis, MT, Brazil.
   [Francisco Roma, Jose Henrique] Univ Estadual Campinas, Programa Posgrad Clin Med, Fac Ciencias Med, Campinas, SP, Brazil.
RP Pavoni, JHC (corresponding author), Univ Fed Mato Grosso, Curso Grad Med, Inst Ciencias Exatas & Nat, Rondonopolis, MT, Brazil.
EM julianachavez@yahoo.com.br
RI ; Chavez-Pavoni, Juliana Helena/N-1165-2018
OI Alves, Rachel/0000-0002-5258-0292; Chavez-Pavoni, Juliana
   Helena/0000-0003-2568-9601
CR Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   [Anonymous], 2016, WHO
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito CAA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3313-4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2017, MON INT ALT CRES DES
   Ministerio da Saude, 2015, CONF ZIK VIR BRAS
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude (MS), 2015, SECR VIG SAUD SIT EP
   Ministerio da Saude Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, MSPHERE, V3
   Ribeiro Bruno Niemeyer de Freitas, 2017, Radiol Bras, V50, P314, DOI 10.1590/0100-3984.2017.0098
   Secretaria de Saude de Mato Grosso, 2016, MON CAS MICR MAT GRO
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 0
Z9 0
U1 1
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20190105
DI 10.1590/0037-8682-0105-2019
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IL1PF
UT WOS:000477072400001
PM 31340371
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Martelli, CMT
   de Albuquerque, MDPM
   de Souza, WV
   Brandao, SP
AF Turchi Martelli, Celina Maria
   Pessoa Militao de Albuquerque, Maria de Fatima
   de Souza, Wayner Vieira
   Brandao Filho, Sinval Pinto
TI Zika virus infection three years after the microcephaly outbreak: A
   meeting report
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 [Turchi Martelli, Celina Maria; Pessoa Militao de Albuquerque, Maria de Fatima; de Souza, Wayner Vieira; Brandao Filho, Sinval Pinto] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Consorcio Int ZikaPlan, Grp Pesquisa Epidemia Microcefalia MERG, Recife, PE, Brazil.
RP Brandao, SP (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Consorcio Int ZikaPlan, Grp Pesquisa Epidemia Microcefalia MERG, Recife, PE, Brazil.
EM sinval@cpqam.fiocruz.br
RI Brandao-Filho, Sinval Pinto/AAP-4792-2020
OI Brandao-Filho, Sinval Pinto/0000-0003-3768-2810; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   ZikaPLAN, 2016, ZIK PREP LAT AM NETW
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20190203
DI 10.1590/0037-8682-0203-2019
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IL1PS
UT WOS:000477073800001
PM 31340378
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI Modelling an optimum vaccination strategy against ZIKA virus for
   outbreak use
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Control strategies; mathematical models; vaccines; Zika virus
AB We present a model to optimise a vaccination campaign aiming to prevent or to curb a Zika virus outbreak. We show that the optimum vaccination strategy to reduce the number of cases by a mass vaccination campaign should start when the Aedes mosquitoes' density reaches the threshold of 1.5 mosquitoes per humans, the moment the reproduction number crosses one. The maximum time it is advisable to wait for the introduction of a vaccination campaign is when the first ZIKV case is identified, although this would not be as effective to minimise the number of infections as when the mosquitoes' density crosses the critical threshold. This suboptimum strategy, however, would still curb the outbreak. In both cases, the catch up strategy should aim to vaccinate at least 25% of the target population during a concentrated effort of 1 month immediately after identifying the threshold. This is the time taken to accumulate the herd immunity threshold of 56.5%. These calculations were done based on theoretical assumptions that vaccine implementation would be feasible within a very short time frame.
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] LIM01 HCFMUSP, Sao Paulo, Brazil.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Germany G Dept Publ Hlth & Clin, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Umea Univ, Med Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), LIM01 HCFMUSP, Sao Paulo, Brazil.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@dim.fm.usp.br
RI Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
FU project ZikaPLAN - European Union's Horizon 2020 research and innovation
   programme [734584]; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP);  [LIM01-HFMUSP]
FX This work was supported by the project ZikaPLAN, funded by the European
   Union's Horizon 2020 research and innovation programme under Grant
   Agreement No. 734584, by LIM01-HFMUSP, CNPq and FAPESP.
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   [Anonymous], 2018, PHARM J, V300, DOI [10.1211/PJ.2018.20204340, DOI 10.1211/PJ.2018.20204340]
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Chernick MR, 2008, BOOTSTRAP METHODS GU
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2018, EPIDEMIOL INFECT, V146, P1219, DOI [10.1017/S0950268818001334, 10.1017/s0950268818001334]
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pan American Health Organization (PAHO)/ World Health Organization (WHO), 2016, ZIK EP UPD
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   WHO, 2018, VACC PIP TRACK
   WHO, 2018, ZIK VACC DEV TECHN R
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
NR 31
TC 2
Z9 2
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR UNSP e196
DI 10.1017/S0950268819000712
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IJ4ZI
UT WOS:000475912200127
PM 31364534
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mercado-Reyes, M
   Acosta-Reyes, J
   Navarro-Lechuga, E
   Corchuelo, S
   Rico, A
   Parra, E
   Tolosa, N
   Pardo, L
   Gonzalez, M
   Martin-Rodriguez-Hernandez, J
   Karime-Osorio, L
   Ospina-Martinez, M
   Rodriguez-Perea, H
   Del Rio-Pertuz, G
   Viasus, D
AF Mercado-Reyes, Marcela
   Acosta-Reyes, Jorge
   Navarro-Lechuga, Edgar
   Corchuelo, Sherill
   Rico, Angelica
   Parra, Edgar
   Tolosa, Natalia
   Pardo, Lissethe
   Gonzalez, Maritza
   Martin-Rodriguez-Hernandez, Jorge
   Karime-Osorio, Luz
   Ospina-Martinez, Martha
   Rodriguez-Perea, Helena
   Del Rio-Pertuz, Gaspar
   Viasus, Diego
TI Dengue, chikungunya and zika virus coinfection: results of the national
   surveillance during the zika epidemic in Colombia
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Coinfection; chikungunya; dengue; mortality; zika
AB Our objective was to determine the frequency of zika (ZIKV), chikungunya (CHIKV) and dengue (DENV) virus coinfection and describe the mortality cases that occurred during the epidemiologic surveillance of the ZIKV epidemic in Colombia. We analysed all cases of suspected ZIKV infection that were reported to the National Institute of Health (October 2015-December 2016). DENV, CHIKV and ZIKV RNA were detected in serum or tissue samples using polymerase chain reaction assay. Medical records of the fatal cases were reviewed. We identified that 23 871 samples were processed. The frequency of viral agents was 439 (1.84%) for DENV, 257 (1.07%) for CHIKV and 10118 (42.38%) for ZIKV. Thirty-four (0.14%) cases of coinfection were identified. The CHIKV-ZIKV coinfection was present in 28 cases (82.3%), DENV-CHIKV in three (8.8%) and DENV-ZIKV in three (8.8%). Seven (20.6%) coinfection cases were fatal (two DENV-CHIKV cases and five CHIKV-ZIKV cases). Two cases were foetal deaths and the others were related to neurological syndrome and sepsis. In conclusion, the frequency of arbovirus coinfection during epidemic of ZIKV was low, and CHIKV-ZIKV coinfection was the most common. Mortality was high among coinfection patients. The role of each virus in the mortality cases of coinfection warrants further studies.
C1 [Mercado-Reyes, Marcela; Rodriguez-Perea, Helena] Natl Inst Hlth, Dept Res Publ Hlth, Bogota, Colombia.
   [Acosta-Reyes, Jorge; Navarro-Lechuga, Edgar] Univ Norte, Hlth Sci Div, Dept Publ Hlth, Barranquilla, Colombia.
   [Corchuelo, Sherill; Rico, Angelica; Parra, Edgar; Pardo, Lissethe; Karime-Osorio, Luz] Natl Inst Hlth, Dept Network Publ Hlth, Bogota, Colombia.
   [Tolosa, Natalia; Gonzalez, Maritza] Natl Inst Hlth, Dept Publ Hlth Surveillance, Bogota, Colombia.
   [Martin-Rodriguez-Hernandez, Jorge] Javeriana Univ, Inst Publ Hlth, Bogota, Colombia.
   [Ospina-Martinez, Martha] Natl Inst Hlth, Bogota, Colombia.
   [Del Rio-Pertuz, Gaspar; Viasus, Diego] Univ Norte, Hlth Sci Div, Dept Med, Barranquilla, Colombia.
   [Del Rio-Pertuz, Gaspar; Viasus, Diego] Hosp Univ Norte, Barranquilla, Colombia.
RP Viasus, D (corresponding author), Univ Norte, Hlth Sci Div, Dept Med, Barranquilla, Colombia.; Viasus, D (corresponding author), Hosp Univ Norte, Barranquilla, Colombia.
EM dviasus@uninorte.edu.co
RI Acosta-Reyes, Jorge/D-1906-2011
OI Acosta-Reyes, Jorge/0000-0003-4303-3243; CORCHUELO CHAVARRO, SHERYLL
   YOHANA/0000-0003-2950-9102
NR 0
TC 6
Z9 6
U1 1
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR UNSP e77
DI 10.1017/S095026881800359X
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IJ4ZI
UT WOS:000475912200008
PM 30869010
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Schuler-Faccini, L
   Sanseverino, MTV
   Abeche, AM
   Vianna, FSL
   Fraga, LR
   Rocha, AG
   da Silva, AA
   de Souza, PRA
   Hilgert, AH
   Barbosa, CP
   Kauppinem, CG
   Martins, DF
   Santos, DS
   Colpes, GH
   Ecco, G
   da Silva, HMFS
   Penteado, LP
   dos Santos, T
AF Schuler-Faccini, Lavinia
   Vieira Sanseverino, Maria Teresa
   Abeche, Alberto Mantovani
   Luiz Vianna, Fernanda Sales
   Fraga, Lucas Rosa
   Rocha, Anastacia Guimaraes
   da Silva, Andre Anjos
   Assis de Souza, Paulo Ricardo
   Hilgert, Artur Hartmann
   Barbosa, Camila Pocharski
   Kauppinem, Caroline Grasso
   Martins, Daniela Fernandes
   Santos, Daniela Silva
   Colpes, Gabriel Henrique
   Ecco, Gabriela
   Flores Soares da Silva, Helena Margot
   Penteado, Louise Piva
   dos Santos, Tatiane
TI From abortion-inducing medications to Zika Virus Syndrome: 27 years
   experience of the First Teratogen Information Service in Latin America
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Article
DE Teratogens; pregnancy; zika; thalidomide; misoprostol; rubella
ID THALIDOMIDE EMBRYOPATHY; TERATOLOGY INFORMATION; BIRTH-DEFECTS;
   PREGNANCY; BRAZIL; MISOPROSTOL; EXPOSURE; HEALTH; SPECTRUM; SAFETY
AB In 1990, the first Teratogen Information Service in Brazil (SIAT) was implemented in the Medical Genetics Service at Hospital de Clinicas de Porto Alegre. SIAT is a free-to-use information service both to health professionals and the general population, especially to women who are pregnant or planning pregnancy. The main objective of this paper is to present the activities of SIAT in its initial years (1990-2006), compared to those in the last decade (2007-2017). In addition we review the scientific contribution of SIAT in the field of human teratogenesis. Since 1990, SIAT received 10,533 calls. Use of medications were the main reason for concern, accounting for 74% of all questions, followed by other chemical exposures (occupational, cosmetics, environmental), and maternal infectious diseases. Among its main contributions to scientific knowledge was the collaboration for the identification of two new human teratogens: misoprostol in the 1990s and Zika virus in 2015/16. In conclusion, SIAT is still evolving, as is the Medical Genetics Service that hosts it. Through its 27 years of existence more than 300 undergraduate and graduate students have rotated at SIAT. Presently, SIAT is expanding the research to experimental teratogenesis and to investigation of molecular mechanisms of teratogens.
C1 [Schuler-Faccini, Lavinia; Vieira Sanseverino, Maria Teresa; Abeche, Alberto Mantovani; Luiz Vianna, Fernanda Sales; Fraga, Lucas Rosa; Rocha, Anastacia Guimaraes; da Silva, Andre Anjos; Assis de Souza, Paulo Ricardo; Hilgert, Artur Hartmann; Barbosa, Camila Pocharski; Kauppinem, Caroline Grasso; Martins, Daniela Fernandes; Santos, Daniela Silva; Colpes, Gabriel Henrique; Ecco, Gabriela; Flores Soares da Silva, Helena Margot; Penteado, Louise Piva; dos Santos, Tatiane] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Sistema Nacl Informacao Agentes Teratogen SIAT, Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, Caixa Postal 15053, BR-91501970 Porto Alegre, RS, Brazil.
EM lschuler@hcpa.edu.br
RI SCHULER-FACCINI, LAVINIA/C-8309-2013; Fraga, Lucas/L-1538-2015
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; 
FU PROREXT-UFRGS (Pro-Reitoria de Extensao da Universidade Federal do Rio
   Grande do Sul); FIPE-HCPA (Fundo de Incentivo a Pesquisa do Hospital de
   Clinicas de Porto Alegre)
FX We wish to thank to prof. Anthony Fensom for the critical review and
   helpful comments on this manuscript. We thank PROREXT-UFRGS
   (Pro-Reitoria de Extensao da Universidade Federal do Rio Grande do Sul)
   for the scholarships for the students, and FIPE-HCPA (Fundo de Incentivo
   a Pesquisa do Hospital de Clinicas de Porto Alegre) for financial
   support.
CR Campbell SC, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0076-7
   Chambers C, 2011, AM J MED GENET C, V157C, P195, DOI 10.1002/ajmg.c.30303
   Costa SH, 1998, INT J GYNECOL OBSTET, V63, pS131, DOI 10.1016/S0020-7292(98)00195-7
   Dathe K, 2018, EUR J CLIN PHARMACOL, V74, P171, DOI 10.1007/s00228-017-2351-y
   De Santis M, 2008, STUD NONLINEAR DYN E, V11
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Einarson A, 2001, AM J PSYCHIAT, V158, P1728, DOI 10.1176/appi.ajp.158.10.1728
   Fitzpatrick Roberta Bronson, 2008, Medical Reference Services Quarterly, V27, P73, DOI [10.1300/J115v27n01_05, 10.1080/02763860802080168]
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcias GD, 2004, GENET MOL BIOL, V27, P147, DOI 10.1590/S1415-47572004000200003
   Gendron MP, 2009, EUR J CLIN PHARMACOL, V65, P523, DOI 10.1007/s00228-008-0611-6
   Han JY, 2005, BIRTH DEFECTS RES A, V73, P245, DOI 10.1002/bdra.20132
   Hancock RL, 2010, J EVAL CLIN PRACT, V16, P957, DOI 10.1111/j.1365-2753.2009.01238.x
   Hohmann-Marriott BE, 2017, AUST NZ J OBSTET GYN, V48, P257
   Kennedy D, 2013, AUST NZ J OBSTET GYN, V53, P544, DOI 10.1111/ajo.12129
   Kowalski TW, 2017, REPROD TOXICOL, V70, P133, DOI 10.1016/j.reprotox.2017.01.012
   Kowalski TW, 2015, BIRTH DEFECTS RES A, V103, P794, DOI 10.1002/bdra.23376
   Kularatne SAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090198
   Leite JCL, 2001, REV SAUDE PUBL, V35, P136, DOI 10.1590/S0034-89102001000200006
   Vianna FSL, 2017, EUR J MED GENET, V60, P12, DOI 10.1016/j.ejmg.2016.09.015
   Vianna FSL, 2015, REPROD TOXICOL, V53, P63, DOI 10.1016/j.reprotox.2015.03.007
   Vianna FSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021735
   Mazzu-Nascimento T, 2017, GENET MOL BIOL, V40, P387, DOI [10.1590/1678-4685-GMB-2016-0179, 10.1590/1678-4685-gmb-2016-0179]
   Ministerio da Saude, 2008, BRAS LIVR RUB CAMP N
   Ministerio da Saude, 2017, SINASC SIST INF NASC
   Minussi L, 2008, REPROD TOXICOL, V25, P120, DOI 10.1016/j.reprotox.2007.09.002
   Momino W, 2012, GENET MOL BIOL, V35, P960, DOI 10.1590/S1415-47572012000600011
   Momino Wakana, 2003, Community Genet, V6, P77, DOI 10.1159/000073002
   Moretti ME, 2003, J ALLERGY CLIN IMMUN, V111, P479, DOI 10.1067/mai.2003.130
   Oliveira LM, 2002, REV SAUDE PUBL, V36, P81, DOI 10.1590/S0034-89102002000100013
   Pastuszak AL, 1998, NEW ENGL J MED, V338, P1881, DOI 10.1056/NEJM199806253382604
   Sanseverino MTV, 2001, MANUAL TERATOGENESE
   Schuler L, 1999, REPROD TOXICOL, V13, P147, DOI 10.1016/S0890-6238(98)00072-0
   SCHULER L, 1992, LANCET, V339, P437, DOI 10.1016/0140-6736(92)90131-L
   SCHULER L, 1993, REV BRAS GENET, V16, P1085
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 1997, MOTHERISK LETT, V1, P1
   Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schüler-Faccini Lavínia, 2002, Ciênc. saúde coletiva, V7, P65, DOI 10.1590/S1413-81232002000100006
   Vargas FR, 2000, AM J MED GENET, V95, P302, DOI 10.1002/1096-8628(20001211)95:4<302::AID-AJMG2>3.0.CO;2-B
   Vianna FSL, 2013, CLIN DYSMORPHOL, V22, P59, DOI 10.1097/MCD.0b013e32835ffc58
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 44
TC 0
Z9 0
U1 1
U2 2
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PY 2019
VL 42
IS 1
SU S
BP 297
EP 304
DI 10.1590/1678-4685-GMB-2018-0111
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA II9DV
UT WOS:000475496600014
PM 30985857
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sever, B
   Altintop, MD
   Ozdemir, A
   Tabanca, N
   Estep, AS
   Becnel, JJ
   Bloomquist, JR
AF Sever, Belgin
   Altintop, Mehlika Dilek
   Ozdemir, Ahmet
   Tabanca, Nurhayat
   Estep, Alden S.
   Becnel, James J.
   Bloomquist, Jeffrey R.
TI Biological evaluation of a series of benzothiazole derivatives as
   mosquitocidal agents
SO OPEN CHEMISTRY
LA English
DT Article
DE mosquito control; Aedes aegypti; benzothiazole; piperidine; docking
   studies
ID STEROL CARRIER PROTEIN-2; AEDES-AEGYPTI; RESISTANCE; MECHANISMS;
   PESTICIDES; MUTATIONS
AB Aedes aegypti is associated with the transmission of numerous human and animal diseases, such as yellow fever, dengue fever, chikungunya, and more recently Zika virus. Emerging insecticide resistance has created a need to develop new mosquitocidal agents for effective control operations. A series of benzothiazole-piperidine derivatives (1-24) were investigated for their larvicidal and adulticidal effects on Ae. aegypti. It was observed that compounds 2, 4, 6, 7, 8, 11 and 13 showed notable larvicidal activity. Furthermore, compounds 6 and 10 showed promising adulticidal activity. Based on the mosquitocidal properties of these compounds, docking studies were also carried out in the active site of the AeSCP2 enzyme to explore any insights into further in vitro enzyme studies. Docking results indicated that all these active compounds showed reasonable interactions with critical residues in the active site of this enzyme. This outcome suggested that these compounds might show their larvicidal and adulticidal effects via the inhibition of AeSCP2. According to in vitro and in silico studies, compounds 2, 4, 6, 7, 8, 10, 11 and 13 stand out as candidates for further studies.
C1 [Sever, Belgin; Altintop, Mehlika Dilek; Ozdemir, Ahmet] Anadolu Univ, Dept Pharmaceut Chem, Fac Pharm, TR-26470 Eskisehir, Turkey.
   [Tabanca, Nurhayat] USDA ARS, Subtrop Hort Res Stn, 13601 Old Cutler Rd, Miami, FL 33158 USA.
   [Tabanca, Nurhayat; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematot, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   [Estep, Alden S.] Navy Entomol Ctr Excellence, Res & Dev Dept, 1700 SW 23rd Dr, Gainesville, FL 32608 USA.
   [Estep, Alden S.; Becnel, James J.] USDA ARS, Ctr Med Agr & Vet Entomol, 1700 SW 23rd Dr, Gainesville, FL 32608 USA.
RP Altintop, MD (corresponding author), Anadolu Univ, Dept Pharmaceut Chem, Fac Pharm, TR-26470 Eskisehir, Turkey.
EM mdaltintop@anadolu.edu.tr
RI Sever, Belgin/V-8319-2017
OI Sever, Belgin/0000-0003-4847-9711
FU Deployed War-Fighter Protection Research Program; U.S. Department of
   Defense through the Armed Forces Pest Management BoardUnited States
   Department of Defense
FX This study was partly funded by the Deployed War-Fighter Protection
   Research Program via grants from the U.S. Department of Defense through
   the Armed Forces Pest Management Board (to JJB and to JRB). We thank
   Miss Jessica Louton (USDA-ARS, CMAVE, Gainesville, FL) for mosquito
   bioassays. Mention of trade names or commercial products in this
   publication is solely for the purpose of providing specific information
   and does not imply recommendation or endorsement by the U.S. Department
   of Agriculture or the U.S. Department of Defense. USDA is an equal
   opportunity provider and employer.
CR Agarwal S, 2017, LETT ORG CHEM, V14, P729, DOI 10.2174/1570178614666170707160654
   Altintop MD, 2013, LETT DRUG DES DISCOV, V10, P453
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chakraborty G, 2012, PROTEINS, V80, P2476, DOI 10.1002/prot.24146
   Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577
   da Silva JBP, 2015, EUR J MED CHEM, V100, P162, DOI 10.1016/j.ejmech.2015.04.061
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Dyer DH, 2009, MOL CELL BIOCHEM, V326, P67, DOI 10.1007/s11010-008-0007-z
   Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Keri RS, 2015, EUR J MED CHEM, V89, P207, DOI 10.1016/j.ejmech.2014.10.059
   Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200
   Kumar RB, 2010, PHARMACOGN RES, V2, P247, DOI 10.4103/0974-8490.69126
   Li T, 2009, J MED ENTOMOL, V46, P1430, DOI 10.1603/033.046.0626
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Ma HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18186
   Mao MZ, 2017, PHOSPHORUS SULFUR, V192, P42, DOI 10.1080/10426507.2016.1224876
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v
   Rouf A, 2015, EUR J MED CHEM, V97, P911, DOI 10.1016/j.ejmech.2014.10.058
   RUBIRALTA M, 1991, PIPERIDINE STRUCTURE
   Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840
   Senthil Raja P, 2011, RES BIOSCIENTIA, V2, P1
   Sharma PC, 2013, J ENZYM INHIB MED CH, V28, P240, DOI 10.3109/14756366.2012.720572
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Singarapu KK, 2016, BIOCHEMISTRY-US, V55, P4919, DOI 10.1021/acs.biochem.6b00322
   Smith LB, 2018, PEST MANAG SCI, V74, P737, DOI 10.1002/ps.4771
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Van den Driessche G, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0202-6
   Vardanyan R., 2017, PIPERIDINE BASED DRU
   Venugopala KN, 2013, EUR J MED CHEM, V65, P295, DOI 10.1016/j.ejmech.2013.04.061
   WHO Regional Office for the Eastern Mediterranean Integrated vector management, 2017, STRATEGIC FRAMEWORK
NR 35
TC 1
Z9 1
U1 0
U2 0
PU SCIENDO
PI WARSAW
PA DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND
SN 2391-5420
J9 OPEN CHEM
JI Open Chem.
PD JAN
PY 2019
VL 17
IS 1
BP 288
EP 294
DI 10.1515/chem-2019-0027
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA IJ3EN
UT WOS:000475786600001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dalvi, APR
   Braga, JU
AF Dalvi, A. P. R.
   Braga, J. U.
TI Spatial diffusion of the 2015-2016 Zika, dengue and chikungunya
   epidemics in Rio de Janeiro Municipality, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Chikungunya virus; dengue virus; spatio temporal analysis; Zika virus
ID NEAREST-NEIGHBOR ANALYSIS; VIRUS; SPREAD; RISK
AB Different countries, especially Brazil, that have faced recurrent dengue epidemics for decades and chikungunya epidemics since 2014, have had to restructure their health services to combat a triple epidemic of arboviruses - Zika, dengue and Chikungunya - transmitted by the same vector, mainly Aedes aegypti, in 2015-2016. Several efforts have been made to better understand these three arboviruses. Spatial analysis plays an important role in the knowledge of disease dynamics. The knowledge of the patterns of spatial diffusion of these three arboviruses during an epidemic can contribute to the planning of surveillance actions and control of these diseases. This study aimed to identify the spatial diffusion processes of these viruses in the context of the triple epidemic in 2015-2016 in Rio de Janeiro, Brazil. Two study designs were used: cross-sectional and ecological. Sequential Kernel maps, nearest-neighbour ratios calculated cumulatively over time, Moran global autocorrelation correlograms, and local autocorrelation changes over time were used to identify spatial diffusion patterns. The results suggested an expansion diffusion pattern for the three arboviruses during 2015-2016 in Rio de Janeiro. These findings can be considered for more effective control measures and for new studies on the dynamics of these three arboviruses.
C1 [Dalvi, A. P. R.; Braga, J. U.] Esco Natl Saude PubE Sergio Arouca, Fundacao Oswa Cruz, Rio De Janeiro, Brazil.
   [Braga, J. U.] Univ Estado Rio de Janeiro, Lnstituto Med Social, Rio De Janeiro, Brazil.
RP Braga, JU (corresponding author), Esco Natl Saude PubE Sergio Arouca, Fundacao Oswa Cruz, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Escola Nacional de Saude Publica Sergio Arouca of
   Fundacao Oswaldo Cruz
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. APRD was
   supported by a doctoral fellowship from the Escola Nacional de Saude
   Publica Sergio Arouca of Fundacao Oswaldo Cruz.
CR [Anonymous], 2017, B EP MON CAS DENG FE
   [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Anselin L, 2016, GEODA 1 8 14 USERS G
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Bailey T.C., 1995, INTERACTIVE SPATIAL, P413
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CLIFF AD, 1989, PROG HUM GEOG, V13, P315, DOI 10.1177/030913258901300301
   Cliff AD, 1981, SPATIAL DIFFUSION HI, P248
   Cohen J, 1999, J QUANT CRIMINOL, V15, P451, DOI 10.1023/A:1007596225550
   Cromley EK, 2012, GIS PUBLIC HLTH, P503
   Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005
   Fletcher-Lartey SM, 2016, PARASITOLOGY, V143, P401, DOI 10.1017/S0031182015001869
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 CAR PO
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lam NSN, 1996, GEOGR ANAL, V28, P93
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lee J, 2014, INT J APPL GEOSPAT R, V5, P1, DOI 10.4018/ijagr.2014010101
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio da Saude do Brasil, 2014, PREP RESP INTR VIR C, P100
   Morato DG, 2015, MEM I OSWALDO CRUZ, V110, P528, DOI 10.1590/0074-0276140388
   Murthy S, 2013, CRIT CARE CLIN, V29, P485, DOI 10.1016/j.ccc.2013.03.005
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   Programa das Nacoes Unidas para o desenvolvimento Instituto de Pesquisa Economica Aplicada Fundacao Joao Pinheiro, 2014, ATL DES HUM NAS REG, P120
   QGIS Development Team, 2009, QGIS GEOGR INF SYST
   Report S, 2017, ZIK VIR MICR GUILL B
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossbacher L. A., 1986, Geografiska Annaler, A, V68, P101
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Saint-Julien T, 2007, MODELS SPATIAL ANAL, P127, DOI DOI 10.1002/9780470612255.CH5
   Melo MSS, 2010, REV SOC BRAS MED TRO, V43, P139, DOI 10.1590/S0037-86822010000200007
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7
NR 42
TC 0
Z9 0
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR PII S0950268819001250
DI 10.1017/S0950268819001250
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IH5TG
UT WOS:000474555800001
PM 31364556
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wichit, S
   Hamel, R
   Yainoy, S
   Gumpangseth, N
   Panich, S
   Phuadraksa, T
   Saetear, P
   Monteil, A
   Vargas, RM
   Misse, D
AF Wichit, Sineewanlaya
   Hamel, Rodolphe
   Yainoy, Sakda
   Gumpangseth, Nuttamonpat
   Panich, Suchawadee
   Phuadraksa, Thanawat
   Saetear, Phoonthawee
   Monteil, Arnaud
   Vargas, Ronald Morales
   Misse, Dorothee
TI INTERFERON-INDUCIBLE PROTEIN (IFI) 16 REGULATES CHIKUNGUNYA AND ZIKA
   VIRUS INFECTION IN HUMAN SKIN FIBROBLASTS
SO EXCLI JOURNAL
LA English
DT Article
DE Chikungunya virus; Zika virus; IFI16; human skin fibroblasts; antiviral
ID DNA; INFLAMMASOME; REPLICATION; SENSOR; MECHANISMS; SALIVA; ACTS
AB Chikungunya virus (CHIKV), a re-emerging infectious arbovirus, causes Chikungunya fever that is characterized by fever, skin rash, joint pain, arthralgia and occasionally death. Despite it has been described for 66 years already, neither potential vaccine nor a specific drug is available yet. During CHIKV infection, interferon type I signaling pathway is stimulated and releases hundreds of interferon stimulated genes (ISGs). Our previous study reported that IFI16, a member of ISGs, is up-regulated during CHIKV virus infection and the suppression of the gene resulted in increased virus replication. Furthermore, our group also found that inflammasome activation can inhibit CHIKV infection in human foreskin cells (HFF1). Concomitantly, it has been reported that IFI16 activates the inflammasome to suppress virus infection. Therefore, we have hypothesized that IFI16 could be involved in CHIKV infection. In this study, we confirmed the expression level of IFI16 by Western blotting analysis and found that IFI16 was up-regulated following CHIKV infection in both HFF1 and human embryonic kidney cells. We next investigated its antiviral activity and found that forced expression of IFI16 completely restricted CHIKV infection while endogenous silencing of the gene markedly increased virus replication. Furthermore, we have discovered that IFI16 inhibited CHIKV replication, at least, in cell-to-cell transmission as well as the diffusion step. Interestingly, IFI16 also exerted its antiviral activity against Zika virus (ZIKV) infection, the global threat reemerging virus can cause microcephaly in humans. Taken together, this study provides the first evidence of an antivirus activity of IFI16 during in vitro arbovirus infection, thus expanding its antiviral spectrum that paves the way to further development of antiviral drugs and vaccines.
C1 [Wichit, Sineewanlaya; Yainoy, Sakda; Gumpangseth, Nuttamonpat; Panich, Suchawadee; Phuadraksa, Thanawat] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Salaya 73170, Nakhon Pathom, Thailand.
   [Hamel, Rodolphe; Misse, Dorothee] Univ Montpellier, CNRS, IRD, Lab MIVEGEC, F-34000 Montpellier, France.
   [Hamel, Rodolphe] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10400, Thailand.
   [Saetear, Phoonthawee] Mahidol Univ, Fac Sci, Dept Chem, Bangkok 10400, Thailand.
   [Saetear, Phoonthawee] Mahidol Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok 10400, Thailand.
   [Monteil, Arnaud] Univ Montpellier, INSERM, CNRS, Plateforme Vectorol, BioCampus, F-34094 Montpellier, France.
   [Vargas, Ronald Morales] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok 10400, Thailand.
RP Wichit, S (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Salaya 73170, Nakhon Pathom, Thailand.
EM sineewanlaya.wic@mahidol.ac.th
RI Hamel, Rodolphe/AAG-1714-2020; Monteil, Arnaud/G-3113-2012
OI Hamel, Rodolphe/0000-0001-8603-7039; Monteil, Arnaud/0000-0003-1632-7318
FU Thailand Research Fund (TRF)Thailand Research Fund (TRF) [MRG6280009]
FX This work was funded by Thailand Research Fund (TRF) (grant no.
   MRG6280009).
CR Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479
   Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031
   Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025
   Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2019, CLIN INFECT DIS, V68, P1435
   Huang YJS, 2019, CURR OPIN VIROL, V34, P104, DOI 10.1016/j.coviro.2019.01.001
   Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110
   Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014
   Johnson Karen E, 2018, PLoS Pathog, V14, pe1007113, DOI 10.1371/journal.ppat.1007113
   Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Li T, 2013, CELL HOST MICROBE, V14, P591, DOI 10.1016/j.chom.2013.10.007
   Lo Cigno I, 2015, J VIROL, V89, P7506, DOI 10.1128/JVI.00013-15
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   Merkl PE, 2019, MBIO, V10, DOI 10.1128/mBio.02621-18
   Merkl PE, 2018, J VIROL, V92, DOI 10.1128/JVI.00057-18
   Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112
   Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110
   Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109
   Pisano G, 2017, J VIROL, V14, P221
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147
   Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wichit S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071695
   Wichit S, 2017, INFECT GENET EVOL, V55, P68, DOI 10.1016/j.meegid.2017.08.032
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Wichit S, 2016, CURR OPIN VIROL, V21, P139, DOI 10.1016/j.coviro.2016.10.001
NR 29
TC 1
Z9 1
U1 1
U2 5
PU EXCLI JOURNAL MANAGING OFFICE
PI DORTMUND
PA LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI
   JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY
SN 1611-2156
J9 EXCLI J
JI EXCLI J.
PY 2019
VL 18
BP 467
EP 476
DI 10.17179/excli2019-1271
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA IH6MT
UT WOS:000474611400003
PM 31423125
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lin, HH
   Yang, SP
   Tsai, MJ
   Lin, GC
   Wu, HC
   Wu, SC
AF Lin, Hsiao-Han
   Yang, Shao-Ping
   Tsai, Meng-Ju
   Lin, Guan-Cheng
   Wu, Han-Chung
   Wu, Suh-Chin
TI Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E
   Antigen for Prime-Boost Immunization
SO THERANOSTICS
LA English
DT Article
DE flagellin-domain III fusion; dengue and Zika viruses; neutralizing
   antibodies; cross-reactive antibodies; prime-boost vaccines
ID ANTIBODY-DEPENDENT ENHANCEMENT; CROSS-NEUTRALIZING ANTIBODIES; ENVELOPE
   PROTEIN; TETRAVALENT VACCINE; IMMUNE-RESPONSE; INFECTION; REPLICATION;
   DISEASE; INNATE; IMMUNOGENICITY
AB The viral E proteins of dengue virus (DENV) and Zika virus (ZIKV) are the major viral proteins involved in receptor binding and fusion, and for the induction of protective antibodies against viral infections. DIII of the E proteins is an independent domain and stretches out on the virion surface that can elicit type-specific neutralizing antibodies. For recombinant DIII vaccine development, prime-boost immunizations can provide an advantage of eliciting more type-specific neutralizing antibodies by recalling DIII antigens after DIII booster to improve protection.
   Methods: The DIII of the E genes of DENV and ZIKV were fused with bacterial fliC gene for the expression of flagellin-DIII (FliC-DIII) fusion proteins. Prime-boost immunization strategies by the second-dose booster of four DENV serotype or ZIKV FliC-DIII fusion proteins were used to investigate the induction of neutralizing antibodies and protection against viral infections. Cross-reactive non-neutralizing antibodies in each group of antisera were also examined using in vitro antibody-dependent enhancement (ADE) assay. A series of glycan-masking E antigens were finally constructed for prime-boost immunizations to abolish the elicitation of cross-reactive non-neutralizing antibodies for ADE activity.
   Results: We showed that inclusion of a bivalent live-attenuated vaccine with a FliC-DIII booster is superior in eliciting neutralization titers and protection in vivo against all four-serotype DENVs. We also demonstrated that recombinant adenovirus vectors encoding four-serotype DENV prMEs with a FliC-DIII prime-boost scheme is capable of eliciting good antibody responses. In contract, recombinant adenovirus vector of ZIKV prME gene priming, followed by ZIKV FliC-DIII booster did not improve vaccine efficacy. The glycan-masking mutation on the ZIKV E protein ij loop (E-248NHT), but not on DENV2 E protein ij loop (E-242NHT), resulted in abolishing the elicitation of cross-reactive antibodies for DENV and ZIKV infection enhancements.
   Conclusions: Our findings can provide useful information for designing novel immunogens and vaccination strategies in an attempt to develop a safe and efficacious DENV or ZIKV vaccine.
C1 [Lin, Hsiao-Han; Yang, Shao-Ping; Tsai, Meng-Ju; Lin, Guan-Cheng; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.
   [Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan.
   [Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan.
RP Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.; Wu, SC (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan.
EM scwu@mx.nthu.edu.tw
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST108-2321-B-007-001, MOST108-2321-B-002-006]
FX We thank CJ Lai from the US NIH to provide the infectious cDNA plasmids
   of LAV containing the full-length cDNA copies of 3' noncoding region
   deletion vaccine strain DENV4.30, and DENV2/4.30 containing the prM and
   E genes of the DENV2 NGC strain. This work was supported by Ministry of
   Science and Technology, Taiwan (MOST108-2321-B-007-001,
   MOST108-2321-B-002-006). The funders had no role in the study design,
   data collection and analysis, decision to publish, or manuscript
   preparation.
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HW, 2013, ARCH VIROL, V158, P1523, DOI 10.1007/s00705-013-1639-1
   Chen SP, 2007, DNA CELL BIOL, V26, P361, DOI 10.1089/dna.2006.0547
   Chiang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30648
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gil L, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.24
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Hajam IA, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.172
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036
   Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Lai CH, 2015, VACCINE, V33, P4321, DOI 10.1016/j.vaccine.2015.03.082
   Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu G, 2015, CLIN VACCINE IMMUNOL, V22, P516, DOI 10.1128/CVI.00770-14
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Lu Y, 2013, BIOTECHNOL BIOENG, V110, P2073, DOI 10.1002/bit.24903
   McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613
   Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simmons M, 2001, AM J TROP MED HYG, V65, P159, DOI 10.4269/ajtmh.2001.65.159
   Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Valdes I, 2011, CLIN VACCINE IMMUNOL, V18, P455, DOI 10.1128/CVI.00382-10
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 66
TC 0
Z9 0
U1 0
U2 0
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2019
VL 9
IS 16
BP 4811
EP 4826
DI 10.7150/thno.35919
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA II0LR
UT WOS:000474897700015
PM 31367259
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Silva, YRD
   Arrais, BB
   Santos, MD
   Barata, MFO
   Falcao, IV
AF de Oliveira Silva, Yone Regina
   Arrais, Barbara Botelho
   Santos, Marilia de Arruda
   Oliveira Barata, Mayara Francelle
   Falcao, Ilka Veras
TI The frevo step improving the rehabilitation of children with Congenital
   Zika Virus Syndrome
SO CADERNOS BRASILEIROS DE TERAPIA OCUPACIONAL-BRAZILIAN JOURNAL OF
   OCCUPATIONAL THERAPY
LA English
DT Article
DE Occupational Therapy; Microcephaly; Rehabilitation
AB Introduction: Occupational therapy understands that the context is constituted by elements that permeate the life of the client exerting influence on their occupational performance. Objective: To present a cultural context activity as a resource in the rehabilitation of children with Congenital Zika Virus Syndrome (SCZV). Method: Report of experience during the occupational therapy stage, in rehabilitation service for children with SCZV in Recife/PE. Through information in the medical records, field diary and supervision meetings, the possible therapeutic strategies used were analyzed and a carnival cultural activity was proposed, valuing the context for the rehabilitation. The outpatient clinic was decorated in advance, requesting that the children come dressed on the day of the activity, when they were stimulated and photographed in different functional postures, with benefits highlighted by the team. Results: The relaxed cultural activity facilitated orientations, clarification of doubts and benefits of social participation. It was observed that the family members interacted, comparing the development, advances in the rehabilitation and experiences of care in the home, besides exchange of personal contacts and photos of the children in the social networks. The activity enabled contacts between children and new look beyond the problems of SCZV and its most evident clinical sign is microcephaly. It was emphasized by the relatives that the diagnosis is not an impediment to participation, as expressed in the statements "my son is in the carnival" and "she can also". Conclusion: Including a cultural activity has brought gains to the clientele. The environment, fantasies and photographs facilitated the interaction and understanding of therapeutic orientations, del Using intervention only in development and favoring social belonging. It is ratified that adopting elements of the cultural context is an important resource for the occupational therapist.
C1 [de Oliveira Silva, Yone Regina] Assoc Pais & Amigos Excepcionais, Estr Arraial 4744, BR-52070230 Recife, PE, Brazil.
   [Arrais, Barbara Botelho] HAM, Recife, PE, Brazil.
   [Santos, Marilia de Arruda] Ctr Reabilitacao HIDROFISIO, Recife, PE, Brazil.
   [Oliveira Barata, Mayara Francelle] Univ Pernambuco UPE, HUOC, Recife, PE, Brazil.
   [Falcao, Ilka Veras] Univ Fed Pernambuco UFPE, Recife, PE, Brazil.
RP Silva, YRD (corresponding author), Assoc Pais & Amigos Excepcionais, Estr Arraial 4744, BR-52070230 Recife, PE, Brazil.
EM yone.oliveira04@gmail.com
OI de Arruda dos Santos, Marilia/0000-0003-3380-3478
CR ALCANTARA G. S., 2011, MONOGRAFIA
   American Occupational Therapy Association-AOTA, 2015, REV TERAPIA OCUPACIO, V26, P1
   [Anonymous], 2015, PROTOCOLO VIGILANCIA
   BRITO C. M. D., 2013, CADERNOS TERAPIA OCU, V21, P459, DOI DOI 10.4322/CTO.2013.047
   Chacon Miguel Cláudio Moriel, 2011, Rev. bras. educ. espec., V17, P441, DOI 10.1590/S1413-65382011000300007
   Falkenbach AP, 2008, CIENC SAUDE COLETIVA, V13, P2065, DOI 10.1590/S1413-81232008000900011
   Guerra Camilla de Sena, 2015, Texto contexto - enferm., V24, P459, DOI 10.1590/0104-07072015000992014
   HALL Stuart, 2011, IDENTIDADE CULTURAL
   Kondo T, 2004, AM J OCCUP THER, V58, P174, DOI 10.5014/ajot.58.2.174
   MAGALHAES S. S., 2014, SEM INT 2014
   Medeiros Carolina Silva de, 2012, Rev. bras. educ. espec., V18, P283, DOI 10.1590/S1413-65382012000200008
   Oliveira IG, 2015, REV SPAGESP, V16, P102
   ORGANIZACAO MUNDIAL DA SAUDE-OMS, 2016, AP PSIC MULH GRAV FA
   Henriques CMP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000100001, 10.5123/s1679-49742016000100001]
   Piccinini Cesar Augusto, 2009, Estud. psicol. (Campinas), V26, P373, DOI 10.1590/S0103-166X2009000300010
   Pintanel Aline Campelo, 2013, Rev. Gaúcha Enferm., V34, P86, DOI 10.1590/S1983-14472013000200011
   Townsend E., 2013, CADERNOS TERAPIA OCU, V21, P215, DOI [10.4322%2Fcto.2013.025, DOI 10.4322/CTO.2013.025]
   VILLELA S., 2016, MAES BEBES COM MICRO
NR 18
TC 0
Z9 0
U1 0
U2 0
PU CUBA EDITORA
PI SAO CARLOS
PA CUBA EDITORA, SAO CARLOS, 00000, BRAZIL
SN 2526-8910
J9 CAD BRAS TER OCUP
JI Cad. Bras. Ter. Ocup.
PY 2019
VL 27
IS 2
BP 448
EP 453
DI 10.4322/2526-8910.ctoRE1265
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IF6VM
UT WOS:000473218200021
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Soares, ENL
   Santos, MAB
   de Macedo, LO
   Santos, CVB
   Agra, MCR
   Alves, LC
   Ramos, RAN
   de Carvalho, GA
AF Lopes Soares, Efraim Naftali
   Bezerra Santos, Marcos Antonio
   de Macedo, Lucia Oliveira
   Brito Santos, Cleber Vinicius
   Ribeiro Agra, Maria Claudia
   Alves, Leucio Camara
   Nascimento Ramos, Rafael Antonio
   de Carvalho, Gilcia Aparecida
TI Spatial distribution of Aedes aegypti (Diptera: Culicidae) in vulnerable
   areas for the transmission of arboviruses
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Culicids; Ovitrap; Dengue; Chikungunya; Zika
AB Introduction: Areas at risk of transmission of arboviruses have been monitored using ovitraps. This study aimed to evaluate the spatial distribution of Aedes aegypti in vulnerable areas for the transmission of arboviruses and assess the influence of climatic conditions on the infestation of these culicids. Methods: Ovitraps were installed in Agrestina, Pernambuco, Northeastern Brazil. Results: Overall, 44,936 eggs were collected, and the indexes of infestation varied. Relative humidity was significantly associated with the infestations. Conclusions: Using ovitraps, entomologic indexes and analysis of climatic factors might be good strategies for monitoring vulnerable areas for the transmission of arboviruses.
C1 [Lopes Soares, Efraim Naftali] Univ Fed Rural Pernambuco, Programa Posgrad Stricto Sensu Ciencia Anim Trop, Recife, PE, Brazil.
   [Lopes Soares, Efraim Naftali] Secretaria Estadual Saude, Gerencia Reg Saude 4, Recife, PE, Brazil.
   [de Macedo, Lucia Oliveira; Brito Santos, Cleber Vinicius; de Carvalho, Gilcia Aparecida] Univ Fed Rural Pernambuco, Unidade Acad Garanhuns, Garanhuns, PE, Brazil.
   [Brito Santos, Cleber Vinicius] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
   [Ribeiro Agra, Maria Claudia] Secretaria Municipal Saude Caruaru, Gerencia Vigilancia Saude, Caruaru, PE, Brazil.
   [Alves, Leucio Camara] Univ Fed Rural Pernambuco, Dept Med Vet, Recife, PE, Brazil.
RP de Carvalho, GA (corresponding author), Univ Fed Rural Pernambuco, Unidade Acad Garanhuns, Garanhuns, PE, Brazil.
EM rafaelanramos10@yahoo.com.br; gilcia.acarvalho@yahoo.com
OI Bezerra-Santos, Marcos Antonio/0000-0003-0575-6758; Carvalho,
   Gilcia/0000-0003-2197-9759; Oliveira de Macedo,
   Lucia/0000-0002-3655-4414
FU Secretaria Municipal de Saude de Agrestina; IV Gerencia Regional de
   Saude; Secretaria Estadual de Saude
FX This article is based on the Master of Science dissertation
   (Postgraduate Program in Tropical Animal Science) of the first author,
   developed at the Federal Rural University of Pernambuco. The authors
   would like to thank the Secretaria Municipal de Saude de Agrestina, IV
   Gerencia Regional de Saude and Secretaria Estadual de Saude for
   supporting this study.
CR Alecrim JS, 2016, J HEALTH SCI, V18, P286
   AYRES M, 2000, BIOESTAT 2 0 APLICAC
   Bezerra J.M.T., 2017, REV PESQ SAUDE, V8, P102
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, P1
   Gonzalez M, 2005, MANUELLE THER, V9, P1
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Muller EPL, 2010, REV BRAS ENFERM, V63, P978, DOI 10.1590/S0034-71672010000600017
   Ministerio da Saude, 2018, B EPIDEMIOL, V49, P1
   Ministerio da Saude (MS). Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, DIR NAC PREV CONTR A
   Ministerio da Saude (MS). Secretaria de Vigilancia em Saude. Diretoria Tecnica de Gestao, 2005, DIAGN RAP NOS MUN A
   R Core Team, 2017, R LANG ENV STAT COMP
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Vasconcelos PFC, 2014, REV PAN AMAZ SAUDE, V6, P9
NR 15
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20180341
DI 10.1590/0037-8682-0341-2018
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IG4VV
UT WOS:000473802600001
PM 31271613
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Greenberg, J
   Capurro, G
   Dube, E
   Driedger, SM
AF Greenberg, Josh
   Capurro, Gabriela
   Dube, Eve
   Driedger, S. Michelle
TI Measles, Mickey, and the Media: Anti-Vaxxers and Health Risk Narratives
   during the 2015 Disneyland Outbreak
SO CANADIAN JOURNAL OF COMMUNICATION
LA English
DT Article
DE Health communication; Risk; Discourse Analysis; Narrative
AB Background Outbreaks of disease are common fodder for political debate and public discourse. In the past decade alone, health officials have faced a steady stream of serious public health threats, from H1N1 to Ebola and Zika, as well as large outbreaks of measles and other highly contagious illnesses. These incidents command intense media attention and focus public conversation around questions of risk and responsibility.
   Analysis This article examines major frames in Canadian news coverage of the Disneyland measles outbreak in 2015 to show how public health events are translated into social problems that magnify moral and political concerns. It discusses how parents who reject or express worries about vaccination were portrayed, and traces which solutions were presented to address the problem of vaccine preventable illness.
   Conclusion and implications Media coverage focused heavily on "anti-vaxzers" as central characters in the outbreak story. The coverage conformed largely to an established biomedical narrative, in which medical and health experts set the definitional parameters around the outbreak causes and consequences, and the preventive measures that should be taken to prevent future occurrences.
C1 [Greenberg, Josh; Capurro, Gabriela] Carleton Univ, Sch Journalism & Commun, Ottawa, ON, Canada.
   [Greenberg, Josh] Carleton Univ, Commun & Media Studies, Ottawa, ON, Canada.
   [Dube, Eve] Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada.
   [Driedger, S. Michelle] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.
RP Greenberg, J (corresponding author), Carleton Univ, Sch Journalism & Commun, Ottawa, ON, Canada.
EM berg@carleton.ca; GabrielaCapurro@cmail.carleton.ca;
   Eve.Dube@inspq.qc.ca; michelle.driedger@umanitoba.ca
OI Capurro, Gabriela/0000-0002-2211-6229
FU Canadian Immunization Research Network (CIRN)
FX The authors wish to thank the Canadian Immunization Research Network
   (CIRN), which funded the wider study on which this article is based.
CR Altheide DL, 1997, SOCIOL QUART, V38, P647, DOI 10.1111/j.1533-8525.1997.tb00758.x
   [Anonymous], 2014, VANCOUVER SUN, pB8
   [Anonymous], 2015, NATL POST, pA4
   [Anonymous], 2015, WINNIPEG FREE PRESS, pA6
   [Anonymous], 2015, VANCOUVER SUN, pB6
   [Anonymous], 2015, WINNIPEG FREE PRESS, pA5
   [Anonymous], 2015, NATL POST, pA8
   [Anonymous], 2014, OTTAWA CITIZEN, pC4
   Ashby M, 2015, OTTAWA CITIZEN, pC4
   Belluz Julia, 2015, VOX             0219
   Belluz Julia, 2015, VOX             0302
   Belluz Julia, 2015, VOX             0421
   Benford RD, 2000, ANNU REV SOCIOL, V26, P611, DOI 10.1146/annurev.soc.26.1.611
   Best J, 2001, SOCIOL QUART, V42, P1
   BEST J, 1995, IMAGES ISSUES TYPIFY
   Bors Matt, 2015, MEDIUM
   Brean Joseph, 2015, VANCOUVER SUN, pA8
   Briggs Charles, 2016, MAKING HLTH PUBLIC N
   Chadwick A., 2013, HYBRID MEDIA SYSTEM
   Clarke K, 2015, TORONTO STAR
   Cohen S., 2002, FOLK DEVILS MORAL PA
   Cowart Leigh, 2015, MEDIUM
   Dube E, 2016, CANADA COMMUNICABLE, V42
   Fisher Max., 2015, VOX             0202
   Fowler R., 1991, LANGUAGE NEWS DISCOU
   Fraser H, 2004, QUALITATIVE SOCIAL W, V3, P179, DOI DOI 10.1177/1473325004043383
   Fulford R., 1999, TRIUMPH NARRATIVE ST
   Gee JP, 2004, INTRO DISCOURSE ANAL
   Gerlach Neil, 2014, REFRACTORY J ENTERTA
   Gillespie Colin, 2015, WINNIPEG FREE PRESS, pD4
   Greenberg J, 2017, PLOS CURRENTS
   Gusfield Joseph, 1981, CULTURE PUBLIC PROBL
   Kitsuse John I., 2001, CONSTRUCTING SOCIAL
   Kliff Sarah, 2015, VOX             0131
   Kulik Dina, 2015, HUFFINGTON POST
   Kurchak Sarah, 2015, MEDIUM
   Lee Jon D, 2014, EPIDEMIC RUMOURS STO
   Levi-Strauss C., 1955, J AM FOLKLORE, V68, P428, DOI DOI 10.2307/536768
   Lindsay B, 2015, VANCOUVER SUN, pA7
   LOSEKE DR, 2003, THINKING SOCIAL PROB
   Lye Harriet Alida, 2015, HUFFINGTON POST
   Menon Vinay, 2015, TORONTO STAR, pE5
   Olsheski Naomi, 2015, HUFFINGTON POST
   Payne Elizabeth, 2015, OTTAWA CITIZEN, pC2
   Picazo Alheli, 2015, OTTAWA CITIZEN, pC4
   Porter C., 2015, TORONTO STAR, pA10
   Potter A, 2015, NATL POST, pA11
   Schneidereit P, 2015, HALIFAX CHRONIC 0128, pA11
   Southey Tabatha, 2015, GLOBE MAIL, pF3
   Spears T, 2015, OTTAWA CITIZEN, pA6
   Ubelacker S, 2015, GLOBE MAIL, pL7
   Wald P, 2008, CONTAGIOUS CULTURES
   Weeks C, 2015, GLOBE MAIL, pA19
   Zoratti J, 2015, WINNIPEG FREE PRESS, pB1
NR 54
TC 0
Z9 0
U1 0
U2 2
PU CANADIAN JOURNAL COMMUNICATION
PI VANCOUVER
PA C/O SIMON FRASER UNIV, 515 WEST HASTINGS ST, VANCOUVER, BC V6B 5K3,
   CANADA
SN 0705-3657
EI 1499-6642
J9 CAN J COMMUN
JI Can. J. Commun.
PY 2019
VL 44
IS 2
BP 175
EP 189
DI 10.22230/cjc.2019v44n2a3346
PG 15
WC Communication
SC Communication
GA IF5TD
UT WOS:000473144200020
OA Other Gold
DA 2020-07-08
ER

PT J
AU Mitchell, SSD
AF Mitchell, Scott S. D.
TI Population Control, Deadly Vaccines, and Mutant Mosquitoes: The
   Construction and Circulation of Zika Virus Conspiracy Theories Online
SO CANADIAN JOURNAL OF COMMUNICATION
LA English
DT Article
DE Conspiracy theories; Frame analysis; Social network analysis; Zika;
   Twitter
ID SOCIAL MEDIA; RETROSPECTIVE ANALYSIS; PEOPLE TALK; EBOLA; TWITTER;
   REPRESENTATIONS; INFORMATION; SCIENCE; HEALTH; MISINFORMATION
AB Background Disease outbreaks are often accompanied by sensationalist news media coverage, social media panic, and a barrage of conspiracy theories and misinformation. The Zika virus outbreak of 2015-2016 followed this pattern.
   Analysis Drawing on frame analysis, this article examines the construction and circulation of a conspiracy theory concerning the 2015-2016 Zika outbreak, analyzing the flow of misinformation across online platforms including "conspiracy" websites, online discussion threads, and Twitter.
   Conclusion and implications Conspiracy theories produced and shared on social and digital media platforms have the power to discursively construct contagious diseases such as Zika, which may fuel misguided public perceptions and impact health policy.
C1 [Mitchell, Scott S. D.] Carleton Univ, Sch Journalism & Commun, Ottawa, ON, Canada.
RP Mitchell, SSD (corresponding author), Carleton Univ, Sch Journalism & Commun, Ottawa, ON, Canada.
EM scott.dobson.mitchell@gmail.com
CR Anderson J, 2017, FUTURE TRUTH MISINFO
   Annenberg Public Policy Center, 2016, ZIKA FEBR 12 16 2016
   [Anonymous], 2017, LEAD SOC NETW WORLDW
   [Anonymous], 2016, GENETICALLY MODIFIED
   Attwell K, 2017, J BIOETHIC INQ, V14, P65, DOI 10.1007/s11673-016-9756-7
   Bateman Tiffany, 2016, CBC NEWS
   Bernish Claire, 2016, ANTIMEDIA       0128
   Bhattacharya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112235
   Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166
   Boyd AD, 2009, J TOXICOL ENV HEAL A, V72, P1096, DOI 10.1080/15287390903084629
   Bozdag E, 2016, ETHICS INF TECHNOL, V17, P249, DOI 10.1007/s10676-015-9380-y
   Bricker BJ, 2013, COMMUN STUD, V64, P218, DOI 10.1080/10510974.2012.749294
   Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258
   Carson James, 2019, TELEGRAPH
   Ceccarelli L, 2011, RHETOR PUBLIC AFF, V14, P195, DOI 10.1353/rap.2010.0222
   Centers for Disease Control and Prevention, 2014, CDC TEL CDC UPD 1 EB
   Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249
   CNBC.com, 2016, CNN COM
   Cook J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175799
   Corner A, 2012, CLIMATIC CHANGE, V114, P463, DOI 10.1007/s10584-012-0424-6
   Daudin Guillaume, 2018, PHYS            1215
   Davison P, 2012, SOCIAL MEDIA READER
   Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113
   DiResta R., 2018, WIRED
   Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P2568, DOI 10.1093/jac/dku165
   Erlanger Steven, 2017, NY TIMES
   Faasse K, 2016, VACCINE, V34, P5808, DOI 10.1016/j.vaccine.2016.09.029
   Fitzpatrick M, 2009, BRIT J GEN PRACT, V59, P457, DOI 10.3399/bjgp09X421094
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Gallie W. B, 1956, PHILOS HIST UNDERSTA, V56, P157
   Gerlach Neil, 2014, REFRACTORY J ENTERTA
   Gesser-Edelsburg A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209505
   Girginova K, 2016, COMMUN SPORT, V4, P243, DOI 10.1177/2167479515576101
   GOERTZEL T, 1994, POLIT PSYCHOL, V15, P731, DOI 10.2307/3791630
   Goertzel T, 2010, EMBO REP, V11, P493, DOI 10.1038/embor.2010.84
   Greenberg Josh, 2017, PLOS ONE
   Grennell Amanda, 2018, PBS NEWS HOUR
   Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147905
   Gruzd A, 2011, AM BEHAV SCI, V55, P1294, DOI 10.1177/0002764211409378
   Gruzd Anatoliy, 2016, NETLYTIC SOFTWARE AU
   Heldman AB, 2013, PUBLIC HEALTH REV, V35, DOI 10.1007/BF03391698
   Himelboim I, 2013, COMMUN METHODS MEAS, V7, P195, DOI 10.1080/19312458.2013.813922
   Howell L, 2013, DIGITAL WILDFIRES HY
   Huang YLL, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P969, DOI 10.1145/2675133.2675202
   Ironstone-Catterall P, 2011, ROUT STUD CONTEMP LI, V4, P81
   Joffe H, 2002, SOC SCI MED, V54, P955, DOI 10.1016/S0277-9536(01)00068-5
   Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453
   Kasperson J., 2003, SOCIAL AMPLIFICATION, P13, DOI DOI 10.1017/CBO9780511550461
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Korda H, 2013, HEALTH PROMOT PRACT, V14, P15, DOI 10.1177/1524839911405850
   Leach M., 2010, EPIDEMICS SCI GOVERN, P1, DOI 10.4324/
   Levin S, 2019, GUARDIAN
   Levin S., 2018, GUARDIAN
   Lynas Mark, 2016, GUARDIAN
   Ma JX, 2017, LIBR INFORM SCI RES, V39, P303, DOI 10.1016/j.lisr.2017.11.005
   Magnus D, 2008, AGNOTOLOGY MAKING UN, P250
   Marwick A, 2017, MEDIA MANIPULATION D
   Meylakhs P, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3338
   Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863
   Nagpal SJS, 2015, TRAVEL MED INFECT DI, V13, P338, DOI 10.1016/j.tmaid.2015.05.002
   Neiger BL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2775
   Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017
   ORESKES N, 2008, AGNOTOLOGY MAKING UN, P55
   Pan American Health Organization; World Health Organization, 2018, ZIK CAS CONG SYNDR A
   Pariser E., 2011, FILTER BUBBLE NEW PE
   Peter C, 2016, SCI COMMUN, V38, P3, DOI 10.1177/1075547015613523
   Procter R, 2013, INT J SOC RES METHOD, V16, P197, DOI 10.1080/13645579.2013.774172
   Reddit, 2016, REDD
   ROBERTSON DG, 2016, UFOS CONSPIRACY THEO
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P100, DOI 10.1016/j.tmaid.2014.11.004
   Roozenbeek J, 2019, J RISK RES, V22, P570, DOI 10.1080/13669877.2018.1443491
   Ryan C, 2001, J BROADCAST ELECTRON, V45, P175, DOI 10.1207/s15506878jobem4501_11
   Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004
   Schipani Vanessa, 2016, HUFFINGTON POST
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Simis MJ, 2016, PUBLIC UNDERST SCI, V25, P400, DOI 10.1177/0963662516629749
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Specter M, 2016, NEW YORKER
   SteelFisher GK, 2015, NEW ENGL J MED, V373, P789, DOI 10.1056/NEJMp1506290
   Sumiala J, 2016, MEDIA COMMUN, V4, P97, DOI 10.17645/mac.v4i4.593
   Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x
   Svalastog AL, 2015, CROAT MED J, V56, P321, DOI 10.3325/cmj.2015.56.321
   The Anti-Media, 2016, US
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Uldam J, 2013, INT J COMMUN-US, V7, P1185
   Uscinski Joseph E., 2017, OXFORD RES ENCY CLIM, DOI [10.1093/acrefore/9780190228620.001.0001/acrefore-9780190228620-e-328, DOI 10.1093/ACREFORE/9780190228620.001.0001/ACREFORE-9780190228620-E-328]
   Wagner-Egger P, 2011, PUBLIC UNDERST SCI, V20, P461, DOI 10.1177/0963662510393605
   Wald P, 2008, CONTAGIOUS CULTURES
   Washer P, 2004, SOC SCI MED, V59, P2561, DOI 10.1016/j.socscimed.2004.03.038
   Waterson J., 2018, GUARDIAN
   Wilcox Christie, 2016, DISCOVER
   World Health Organization, 2016, ZIK SIT REP
   Yang JZ, 2018, J RISK RES, V21, P834, DOI 10.1080/13669877.2016.1247378
   York G., 2014, GLOBE MAIL
NR 94
TC 0
Z9 0
U1 1
U2 3
PU CANADIAN JOURNAL COMMUNICATION
PI VANCOUVER
PA C/O SIMON FRASER UNIV, 515 WEST HASTINGS ST, VANCOUVER, BC V6B 5K3,
   CANADA
SN 0705-3657
EI 1499-6642
J9 CAN J COMMUN
JI Can. J. Commun.
PY 2019
VL 44
IS 2
BP 211
EP 237
DI 10.22230/cjc.2019v44n2a3329
PG 27
WC Communication
SC Communication
GA IF5TD
UT WOS:000473144200022
OA Other Gold
DA 2020-07-08
ER

PT J
AU Faizan, MI
   Naqvi, A
   Hassan, MI
   Abdullah, M
   Tazeen, A
   Shafat, Z
   Hisamuddin, M
   Alam, A
   Ali, S
   Ali, S
   Farooqui, A
   Hamza, A
   Parveen, N
   Deeba, F
   Ahmed, A
   Parveen, S
AF Faizan, Md Imam
   Naqvi, Abu Turab
   Hassan, Md Imtaiyaz
   Abdullah, Mohd
   Tazeen, Ayesha
   Shafat, Zoya
   Hisamuddin, Malik
   Alam, Aftab
   Ali, Shahnawaz
   Ali, Sher
   Farooqui, Anam
   Hamza, Abu
   Parveen, Nazish
   Deeba, Farah
   Ahmed, Anwar
   Parveen, Shama
TI Structure Based Identification of Potential Inhibitors of NS3 Protein of
   Zika Virus
SO LETTERS IN DRUG DESIGN & DISCOVERY
LA English
DT Article
DE Zika virus; NS3 protein; inhibitors; antiviral drugs; molecular docking;
   structure based drug design and discovery
ID SMALL-MOLECULE INHIBITORS; YELLOW-FEVER VIRUS; DENGUE VIRUS; NS2B-NS3
   PROTEASE; HELICASE ACTIVITY; SERINE-PROTEASE; DRUG DISCOVERY; IN-VITRO;
   REPLICATION; ACTIVATION
AB Background: The re-emerging Zika virus has posed a serious threat to human health due to its association with the neurological disorders. The NS3 protein of Zika virus plays a pivotal role in the genome replication and thus may prove to be a critical target for the drug designing studies.
   Objective: The present study was conceptualized to analyze the crystal structure of NS3 protein of Zika virus followed by the identification of it's potential inhibitors.
   Methods: Crystal structure of the NS3 protein was evaluated in detail. Docking of the NS3 protein was done with 130 different ligands including dengue virus inhibitors and their similar compounds along with some approved drugs. The drug likeliness properties were checked for non drug compounds.
   Results: Structural analysis of the NS3 protein revealed three important sites namely ATP- and RNA-binding sites as well as a central cavity. The selected ten ligands (ZINC05487635, ZiNC0092398, ZINC13345444, 4-methoxyphenyl 4-chloro-3-nitrobenzoate, Luteolin, Ivermectin, Suramin, Dasatinib, Panduratin A, and ARDP0009) showed a higher binding affinity for the NS3 protein and good drug likeliness properties.
   Conclusion: These inhibitors could possibly act as potential lead molecules for future drug designing studies. Our present computational data is envisaged to be useful for gathering experimental evidences towards the development of potential therapeutic molecules against this arthropod mediated pathogen.
C1 [Faizan, Md Imam; Naqvi, Abu Turab; Hassan, Md Imtaiyaz; Abdullah, Mohd; Tazeen, Ayesha; Shafat, Zoya; Hisamuddin, Malik; Alam, Aftab; Ali, Shahnawaz; Ali, Sher; Farooqui, Anam; Hamza, Abu; Parveen, Nazish; Deeba, Farah; Parveen, Shama] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
   [Abdullah, Mohd; Hisamuddin, Malik] Jaipur Natl Univ, Sch Life & Basic Sci, Jaipur, Rajasthan, India.
   [Ahmed, Anwar] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh, Saudi Arabia.
   [Ahmed, Anwar] Kind Saud Univ, Coll Sci, Ctr Excellence Biotechnol Res, Dept Biochem, Riyadh, Saudi Arabia.
RP Parveen, S (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM shamp25@yahoo.com
RI HASSAN, Imtaiyaz/G-7072-2017; Ali, Shahnawaz/K-5884-2015
OI HASSAN, Imtaiyaz/0000-0002-3663-4940; Ali, Shahnawaz/0000-0002-7601-4762
FU University Grants Commission, Government of IndiaUniversity Grants
   Commission, India; J.C. Bose National Fellowship from DST-SERB, New
   Delhi, India; University Grants CommissionUniversity Grants Commission,
   India; Council of Scientific and Industrial Research, Government of
   IndiaCouncil of Scientific & Industrial Research (CSIR) - India; King
   Saud University, Deanship of Scientific Research, College of Science
   Research CentreDeanship of Scientific Research at King Saud University
FX Md. Imam Faizan is supported by a research fellowship of the University
   Grants Commission, Government of India. Sher Ali acknowledges the award
   of a J.C. Bose National Fellowship from DST-SERB, New Delhi, India. Work
   in our laboratory is supported by grants from the University Grants
   Commission and Council of Scientific and Industrial Research, Government
   of India. This study was supported by King Saud University, Deanship of
   Scientific Research, College of Science Research Centre.
CR Abdullah M., 2016, INDIAN J HLTH SCI CA, V3, P78
   Ahsan MJ, 2011, BIOORG MED CHEM LETT, V21, P7246, DOI 10.1016/j.bmcl.2011.10.057
   Alam A., 2018, SILICO APPROACH SUST, P217, DOI 10.1007/978-981-13-0347-0_13
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002
   Badshah SL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010007
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064
   Berman H. M., 2006, INT TABLES CRYSTALLO, VF, P675, DOI DOI 10.1107/97809553602060000722
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blake JF, 2003, BIOTECHNIQUES, P16
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Campbell WC, 2012, IVERMECTIN ABAMECTIN
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chiow KH, 2016, ASIAN PAC J TROP MED, V9, P1, DOI 10.1016/j.apjtm.2015.12.002
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Delano W.L., 2002, PYMOL MOL GRAPHICS S
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071
   Gratacap MP, 2009, BLOOD, V114, P1884, DOI 10.1182/blood-2009-02-205328
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Klages J, 2007, ANALYST, V132, P693, DOI 10.1039/b709658p
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   LIU S, 1991, J UROLOGY, V145, P389, DOI 10.1016/S0022-5347(17)38350-7
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Narayana KR, 2001, INDIAN J PHARM, V33, P2
   Sanchez I, 2000, PHYTOTHER RES, V14, P89, DOI 10.1002/(SICI)1099-1573(200003)14:2&lt;89::AID-PTR569&gt;3.0.CO;2-C
   Sanseau P., 2011, COMPUTATIONAL METHOD
   Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tjioe KC, 2016, NUTR CANCER, V68, P838, DOI 10.1080/01635581.2016.1180411
   Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889
   Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   World Health Organization, ZIK VIR MICR GUILL B
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 60
TC 0
Z9 0
U1 1
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1808
EI 1875-628X
J9 LETT DRUG DES DISCOV
JI Lett. Drug Des. Discov.
PY 2019
VL 16
IS 7
BP 761
EP 774
DI 10.2174/1570180815666180821105012
PG 14
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA IF5CZ
UT WOS:000473100200005
DA 2020-07-08
ER

PT J
AU Tong, DF
   Cai, YL
   Wang, BX
   Wang, WM
AF Tong, Dongfu
   Cai, Yongli
   Wang, Bingxian
   Wang, Weiming
TI Bifurcation structure of nonconstant positive steady states for a
   diffusive predator-prey model
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE turing instability; nonconstant positive steady states; global
   bifurcation; neumann boundary condition
ID TRANSMISSION DYNAMICS; TURING PATTERNS; SPATIOTEMPORAL COMPLEXITY;
   EPIDEMIC MODEL; ZIKA VIRUS; SYSTEM; STABILITY
AB In this paper, we make a detailed descriptions for the local and global bifurcation structure of nonconstant positive steady states of a modified Holling-Tanner predator-prey system under homogeneous Neumann boundary condition. We first give the stability of constant steady state solution to the model, and show that the system exhibits Turing instability. Second, we establish the local structure of the steady states bifurcating from double eigenvalues by the techniques of space decomposition and implicit function theorem. It is shown that under certain conditions, the local bifurcation can be extended to the global bifurcation.
C1 [Tong, Dongfu; Cai, Yongli; Wang, Bingxian; Wang, Weiming] Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
RP Wang, WM (corresponding author), Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
EM weimingwang2003@163.com
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [11601179, 61672013, 61772017]; Huaian Key Laboratory for
   Infectious Diseases Control and Prevention, Huaian, Jiangsu Province,
   China [HAP201704]
FX This research was supported by the National Science Foundation of China
   (11601179, 61672013 and 61772017) and Huaian Key Laboratory for
   Infectious Diseases Control and Prevention (HAP201704), Huaian, Jiangsu
   Province, China.
CR Alonso D, 2002, ECOLOGY, V83, P28
   BRITTON NF, 2003, ESSENTIAL MATH BIOL
   Cai YL, 2019, APPL MATH LETT, V92, P190, DOI 10.1016/j.aml.2019.01.015
   Cai YL, 2019, NONLINEAR ANAL-REAL, V46, P178, DOI 10.1016/j.nonrwa.2018.09.006
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Cai YL, 2018, INT J BIFURCAT CHAOS, V28, DOI 10.1142/S0218127418501407
   Cai YL, 2016, NONLINEAR ANAL-REAL, V30, P99, DOI 10.1016/j.nonrwa.2015.12.002
   Cai YL, 2014, MATH BIOSCI ENG, V11, P1247, DOI 10.3934/mbe.2014.11.1247
   Cao X, 2016, INT J BIFURCAT CHAOS, V26, DOI 10.1142/S0218127416501674
   Chertock A, 2012, KINET RELAT MOD, V5, P51, DOI 10.3934/krm.2012.5.51
   HSU SB, 1995, SIAM J APPL MATH, V55, P763, DOI 10.1137/S0036139993253201
   Jang J., 2004, J DYN DIFFER EQU, V2, P297
   Jiang J, 2016, INT J BIFURCAT CHAOS, V26, DOI 10.1142/S0218127416501170
   Kuniya T, 2018, NONLINEAR ANAL-REAL, V43, P262, DOI 10.1016/j.nonrwa.2018.03.001
   Kuto K, 2004, J DIFFER EQUATIONS, V197, P293, DOI 10.1016/j.jde.2003.10.016
   Kuto K, 2004, J DIFFER EQUATIONS, V197, P315, DOI 10.1016/j.jde.2003.08.003
   Li SB, 2015, J DIFFER EQUATIONS, V259, P1990, DOI 10.1016/j.jde.2015.03.017
   Lou Y, 1996, J DIFFER EQUATIONS, V131, P79, DOI 10.1006/jdeq.1996.0157
   Medvinsky AB, 2002, SIAM REV, V44, P311, DOI 10.1137/S0036144502404442
   Murray J. D., 2003, MATH BIOL
   Neuhauser C., 2001, NOT AM MATH SOC, V48, P1304
   Ni WM, 2005, T AM MATH SOC, V357, P3953, DOI 10.1090/S0002-9947-05-04010-9
   NISHIURA Y, 1982, SIAM J MATH ANAL, V13, P555, DOI 10.1137/0513037
   OKUBO A, 2001, DIFFUSION ECOLOGICAL
   Pang PYH, 2003, P ROY SOC EDINB A, V133, P919, DOI 10.1017/S0308210500002742
   Peng R, 2009, J DIFFER EQUATIONS, V247, P866, DOI 10.1016/j.jde.2009.03.008
   Rabinowitz P. H., 1971, J FUNCT ANAL, V7, P487, DOI [10.1016/0022-1236(71)90030-9, DOI 10.1016/0022-1236(71)90030-9, 10.1016/0022-1236(71)90030-9.]
   SEGEL LA, 1972, J THEOR BIOL, V37, P545, DOI 10.1016/0022-5193(72)90090-2
   Shi HB, 2015, IMA J APPL MATH, V80, P1534, DOI 10.1093/imamat/hxv006
   Shi HB, 2010, NONLINEAR ANAL-REAL, V11, P3711, DOI 10.1016/j.nonrwa.2010.02.001
   Song YL, 2017, SIAM J APPL DYN SYST, V16, P2030, DOI 10.1137/16M1097560
   Song YL, 2017, STUD APPL MATH, V139, P371, DOI 10.1111/sapm.12165
   TAKAGI I, 1986, J DIFFER EQUATIONS, V61, P208, DOI 10.1016/0022-0396(86)90119-1
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Wang JL, 2019, APPL MATH COMPUT, V347, P78, DOI 10.1016/j.amc.2018.11.012
   Wang Y, 2008, ECOL MODEL, V217, P139, DOI 10.1016/j.ecolmodel.2008.06.007
   Wu SH, 2019, NONLINEAR ANAL-REAL, V48, P12, DOI 10.1016/j.nonrwa.2019.01.004
   Yi FQ, 2009, J DIFFER EQUATIONS, V246, P1944, DOI 10.1016/j.jde.2008.10.024
   Zeng XZ, 2007, J MATH ANAL APPL, V332, P989, DOI 10.1016/j.jmaa.2006.10.075
   Zhang HS, 2019, APPL MATH COMPUT, V356, P328, DOI 10.1016/j.amc.2019.03.034
NR 40
TC 0
Z9 0
U1 0
U2 0
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 5
BP 3988
EP 4006
DI 10.3934/mbe.2019197
PG 19
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA IF1YA
UT WOS:000472872700015
PM 31499646
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Huang, MG
   Tang, MX
   Yu, JS
   Zheng, B
AF Huang, Mugen
   Tang, Moxun
   Yu, Jianshe
   Zheng, Bo
TI The impact of mating competitiveness and incomplete cytoplasmic
   incompatibility on Wolbachia-driven mosquito population suppression
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE mosquito-born diseases; Wolbachia; cytoplasmic incompatibility; mosquito
   population suppression; delay differential equation
ID INFECTION DYNAMICS; AEDES-ALBOPICTUS; BLOCKS DENGUE; ESTABLISHMENT;
   INVASION; SPREAD; FEVER
AB To control mosquito-borne diseases such as dengue, malaria, and Zika, Wolbachia-infected male mosquitoes have been released in open areas to suppress wild mosquito population driven by cytoplasmic incompatibility (CI). In this work, we initiate a preliminary assessment on how the CI intensity xi, and the mating competitiveness mu of released males relative to wild males, impact the suppression efficacy by a delay differential equation model. Our analysis identifies a threshold CI intensity xi(0) is an element of (0, 1) as an increasing function of the natural reproduction rate of the wild mosquitoes, and a threshold value r* for the ratio r(t) between the numbers of released males and wild males. The population suppression fails when xi <= xi(0), and succeeds when xi > xi(0) and r(t) >= r*. Our analyses indicate that xi plays a more important role than mu in the population suppression. For instance, a slight decrease of xi from 1 to 0.92 is more devastating than halving mu from 1 to 0.5. In our estimation of the optimal starting date for infected male release to target a more than 95% wild population reduction during the peak season of dengue in Guangzhou, we find that the optimal date is almost independent of mu but is sensitive to xi. If CI is complete, then starting about two months ahead can be an optimal option for less financial and labor costs. A slight reduction in the CI intensity requires a considerably earlier starting date.
C1 [Huang, Mugen] Guangdong Univ Finance & Econ, Sch Stat & Math, Guangzhou 510320, Guangdong, Peoples R China.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
   [Yu, Jianshe; Zheng, Bo] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
   Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
RP Tang, MX (corresponding author), Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
EM tangm@msu.edu
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11471085, 11631005]; Program for Changjiang
   Scholars and Innovative Research Team in UniversityProgram for
   Changjiang Scholars & Innovative Research Team in University (PCSIRT)
   [IRT_16R16]; Natural Science Foundation of Guangdong ProvinceNational
   Natural Science Foundation of Guangdong Province [2017A030310597];
   Guangdong University of Finance & Economics Big Data and Educational
   Statistics Application Laboratory [2017WSYS001]
FX This work was supported by National Natural Science Foundation of China
   (11471085, 11631005), Program for Changjiang Scholars and Innovative
   Research Team in University (IRT_16R16), Natural Science Foundation of
   Guangdong Province (2017A030310597), and Guangdong University of Finance
   & Economics Big Data and Educational Statistics Application
   Laboratory(2017WSYS001).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Freedman H. I., 1987, DETERMINISTIC MATH M
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hu LC, 2019, J DIFFER EQUATIONS, V266, P4377, DOI 10.1016/j.jde.2018.09.035
   Hu LC, 2019, J THEOR BIOL, V462, P247, DOI 10.1016/j.jtbi.2018.11.009
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang M., 2019, J APPL ANAL COMPUT, V9, P1
   Huang MG, 2018, J THEOR BIOL, V440, P1, DOI 10.1016/j.jtbi.2017.12.012
   Huang MG, 2016, SCI CHINA MATH, V59, P1249, DOI 10.1007/s11425-016-5149-y
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Lee Shae-Jinn, 1994, Chinese Journal of Entomology, V14, P13
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Lin HL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004919
   Liu Fusheng, 1992, Acta Scientiarum Naturalium Universitatis Sunyatseni, V31, P84
   Liu Fusheng, 1990, Acta Scientiarum Naturalium Universitatis Sunyatseni, V29, P118
   LIU ZW, 1985, ACTA ENTOMOL SINICA, V28, P274
   Smith H, 2011, INTRO DELAY DIFFEREN
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Wang X, 2016, J THEOR BIOL, V411, P27, DOI 10.1016/j.jtbi.2016.09.015
   Wang YG, 2017, J ECON ENTOMOL, V110, P239, DOI 10.1093/jee/tow254
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yu JS, 2018, SIAM J APPL MATH, V78, P3168, DOI 10.1137/18M1204917
   Zhang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130156
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zhang Ling-Yao, 2009, Jishengchong Yu Yixue Kunchong Xuebao, V16, P219, DOI 10.3969/j.issn.1005-0507.2009.04.006
   Zhang XH, 2016, B MATH BIOL, V78, P1968, DOI 10.1007/s11538-016-0208-7
   Zheng B, 2019, J THEOR BIOL, V472, P95, DOI 10.1016/j.jtbi.2019.04.010
   Zheng B, 2018, ECOL MODEL, V387, P38, DOI 10.1016/j.ecolmodel.2018.09.004
   Zheng B, 2018, J BIOL DYNAM, V12, P596, DOI 10.1080/17513758.2018.1499969
   Zheng B, 2018, MATH BIOSCI ENG, V15, P523, DOI 10.3934/mbe.2018024
   Zheng B, 2018, J MATH BIOL, V76, P235, DOI 10.1007/s00285-017-1142-5
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
   Zhong Z, 1988, ZHONGSHAN YI KE DA X, V9, P35
NR 36
TC 2
Z9 2
U1 0
U2 2
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 5
BP 4741
EP 4757
DI 10.3934/mbe.2019238
PG 17
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA IF1YA
UT WOS:000472872700055
PM 31499687
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tang, B
   Zhou, WK
   Xiao, YN
   Wu, JH
AF Tang, Biao
   Zhou, Weike
   Xiao, Yanni
   Wu, Jianhong
TI Implication of sexual transmission of Zika on dengue and Zika outbreaks
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE Zika; Dengue; coinfection; sexual transmission; antibody dependent
   enhancement; cascade effect
ID ANTIBODY-DEPENDENT ENHANCEMENT; DISEASE TRANSMISSION; VIRUS-INFECTION;
   DYNAMICS; MODEL; PATHOGENESIS; UNCERTAINTY; SENSITIVITY; SEROTYPES;
   PATTERN
AB Dengue and Zika viruses belong to the same Flavivirus family and usually cocirculate within the same area. Both the viruses can be transmitted by a common mosquito species Aedes aegypti. However, non-vector-borne transmission of Zika virus, such as sexual transmission and vertical transmission, has been reported in recent studies. In this study, we develop a dengue-Zika coinfection model with a particular focus on the impact of Zika sexual transmission to the transmission dynamics of both dengue and Zika. Our sensitivity analysis shows that Zika sexual transmission has a significant influence on the Zika basic reproduction number. Consequently, Zika sexual transmission can lead Zika to be endemic within an area where vector-borne transmission only cannot. Theoretically, we prove that the disease-free equilibrium for dengue only model is always globally stable if the dengue basic reproduction number is less than 1. However, our cascade analysis and numerical simulations show that increasing the sexual transmission coefficient of Zika can also result in the persistence of dengue even though the dengue basic reproduction number is less than 1, due to the cocirculation of dengue and Zika and the antibody-dependent enhancement of Zika infection for dengue infection. Our numerical analyses also show that the endemic levels of Zika increase as the Zika sexual transmission probability increases.
C1 [Tang, Biao; Wu, Jianhong] York Univ, LIAM, Toronto, ON M3J 1P3, Canada.
   [Zhou, Weike; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Shaanxi, Peoples R China.
RP Xiao, YN (corresponding author), Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Shaanxi, Peoples R China.
EM yxiao@mail.xjtu.edu.cn
OI Tang, Biao/0000-0002-0418-5773
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [11631012, 11571273]; Canada Research Chair
   ProgramCanada Research Chairs [230720]; Natural Sciences and Engineering
   Research Council of CanadaNatural Sciences and Engineering Research
   Council of Canada [105588-2011]
FX This project was supported by the National Natural Science Foundation of
   China (NSFC, 11631012, 11571273(YX)), and by the Canada Research Chair
   Program (230720 (JW)), the Natural Sciences and Engineering Research
   Council of Canada (105588-2011 (JW)).
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Charles A. S., 2016, PLOS CURR, V8
   Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V2015, P381
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gao DZ, 2016, J MATH ANAL APPL, V442, P171, DOI 10.1016/j.jmaa.2016.04.039
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Kautner I, 1997, J PEDIATR-US, V131, P516, DOI 10.1016/S0022-3476(97)70054-4
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pradeep BGSA, 2015, ELECTRON J DIFFER EQ
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Saad-Roy CM, 2018, J MATH BIOL, V77, P1917, DOI 10.1007/s00285-018-1230-1
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Sasmal SK, 2018, B MATH BIOL, V80, P3038, DOI 10.1007/s11538-018-0510-7
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   Tang SY, 2012, J THEOR BIOL, V295, P47, DOI 10.1016/j.jtbi.2011.10.035
   Terefe YA, 2018, THEOR BIOSCI, V137, P209, DOI 10.1007/s12064-018-0272-7
   Tewa JJ, 2009, CHAOS SOLITON FRACT, V39, P936, DOI 10.1016/j.chaos.2007.01.069
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Wei HM, 2008, J MATH ANAL APPL, V342, P895, DOI 10.1016/j.jmaa.2007.12.058
   World Health Organization (WHO), ZIK SIT REP
   Xiao YN, 2013, MATH BIOSCI ENG, V10, P445, DOI 10.3934/mbe.2013.10.445
NR 54
TC 2
Z9 2
U1 1
U2 3
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 5
BP 5092
EP 5113
DI 10.3934/mbe.2019256
PG 22
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA IF1YA
UT WOS:000472872700073
PM 31499705
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Biazar, J
   Goldoust, F
AF Biazar, Jafar
   Goldoust, Fereshteh
TI An Algorithm for Systems of Nonlinear Ordinary Differential Equations
   Based on Legendre Wavelets
SO PUNJAB UNIVERSITY JOURNAL OF MATHEMATICS
LA English
DT Article
DE Legendre wavelet method; Nonlinear differential equation; Moving least
   squares method
ID ZIKA VIRUS; SERIES
AB In the present paper, we study Legendre Wavelet Method (LWM) and apply an algorithm based on this approach to solve systems of nonlinear differential equations. Differential equations of any degree can be expanded as a series in Legendre polynomials. So depending on the kind of problem, derivative or integral operational matrices appear, after simplification the nonlinear ordinary system changed to an algebraic system which includes the coefficients. In this step the suggested algorithm is approximated the system of coefficients by using an iterative method. For comparison, this equation is solved by Moving Least Squares Method (MLSM) and properties of LWM and MLSM approaches are expressed. These two approaches are applied to solve an equation that shows effect and transferring a kind of virus to a set of statistical society. Numerical results and figures of applying LWM and MLSM are shown finally.
C1 [Biazar, Jafar; Goldoust, Fereshteh] Univ Guilan, Fac Math Sci, Dept Appl Math, Rasht, Iran.
RP Biazar, J (corresponding author), Univ Guilan, Fac Math Sci, Dept Appl Math, Rasht, Iran.
EM biazar@guilan.ac.ir; fereshtegoldoust@yahoo.com
CR Anwar MA, 2019, PUNJAB UNIV J MATH, V51, P115
   Atluri SN, 1998, COMPUT MECH, V22, P117, DOI 10.1007/s004660050346
   Belinha J., 2014, MESHLESS METHODS BIO
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   CHANG RY, 1983, J OPTIMIZ THEORY APP, V39, P299, DOI 10.1007/BF00934535
   CHEN CF, 1975, J FRANKLIN I, V300, P265, DOI 10.1016/0016-0032(75)90199-4
   Chen MQ, 1996, INT J NUMER METH ENG, V39, P2921
   CHOU JH, 1987, INT J CONTROL, V45, P269, DOI 10.1080/00207178708933727
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebrahimnejad M, 2014, ENG ANAL BOUND ELEM, V46, P10, DOI 10.1016/j.enganabound.2014.04.023
   Faisshuuer G. E., 2007, MESHLESS APPROXIMATI
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gu JS, 1996, INT J SYST SCI, V27, P623
   HWANG C, 1982, COMPUT ELECTR ENG, V9, P123, DOI 10.1016/0045-7906(82)90018-0
   Jackson, 1941, FOURIER SERIES ORTHO
   Jafar B., 2013, AM J APPL MATH STAT, V1, P83
   LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.1090/S0025-5718-1981-0616367-1
   Levin D, 1998, MATH COMPUT, V67, P1517, DOI 10.1090/S0025-5718-98-00974-0
   Liu NS, 2010, NUMER METH PART D E, V26, P81, DOI 10.1002/num.20417
   Matinfar M, 2018, COMPUT APPL MATH, V37, P5857, DOI 10.1007/s40314-018-0667-6
   Mohammadi F, 2011, INT J SYST SCI, V42, P579, DOI 10.1080/00207721003658194
   Nouri K, 2019, PUNJAB UNIV J MATH, V51, P47
   Parsian H., 2005, ACTA MATH ACAD PAEDA, V21
   Razzaghi M, 2000, MATH COMPUT SIMULAT, V53, P185, DOI 10.1016/S0378-4754(00)00170-1
   Saleem S, 2019, PUNJAB UNIV J MATH, V51, P89
   Shepard D., 1968, P 1968 23 ACM NAT C, P517, DOI DOI 10.1145/800186.810616
   Ur-Rehman A, 2019, PUNJAB UNIV J MATH, V51, P1
   Waswas A. M., 2011, LINEAR NONLINEAR INT
   Wendland H., 2005, SCOTTERED DATA APPRO
   Zuppa C, 2003, APPL NUMER MATH, V47, P575, DOI 10.1016/S0168-9274(03)00091-6
NR 30
TC 0
Z9 0
U1 1
U2 1
PU UNIV PUNJAB, DEPT MATHEMATICS
PI LAHORE
PA NEW CAMPUS, LAHORE, 54590, PAKISTAN
EI 1016-2526
J9 PUNJAB UNIV J MATH
JI Punjab Univ. J. Math.
PY 2019
VL 51
IS 6
BP 65
EP 80
PG 16
WC Mathematics
SC Mathematics
GA ID8VH
UT WOS:000471965000005
DA 2020-07-08
ER

PT J
AU Kelly-Cirino, CD
   Nkengasong, J
   Kettler, H
   Tongio, I
   Gay-Andrieu, F
   Escadafal, C
   Piot, P
   Peeling, RW
   Gadde, R
   Boehme, C
AF Kelly-Cirino, Cassandra D.
   Nkengasong, John
   Kettler, Hannah
   Tongio, Isabelle
   Gay-Andrieu, Francoise
   Escadafal, Camille
   Piot, Peter
   Peeling, Rosanna W.
   Gadde, Renuka
   Boehme, Catharina
TI Importance of diagnostics in epidemic and pandemic preparedness
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID EBOLA-VIRUS DISEASE; OUTBREAK; LESSONS; FEVER
AB Diagnostics are fundamental for successful outbreak containment. In this supplement, 'Diagnostic preparedness for WHO Blueprint pathogens', we describe specific diagnostic challenges presented by selected priority pathogens most likely to cause future epidemics. Some challenges to diagnostic preparedness are common to all outbreak situations, as highlighted by recent outbreaks of Ebola, Zika and yellow fever. In this article, we review these overarching challenges and explore potential solutions. Challenges include fragmented and unreliable funding pathways, limited access to specimens and reagents, inadequate diagnostic testing capacity at both national and community levels of healthcare and lack of incentives for companies to develop and manufacture diagnostics for priority pathogens during non-outbreak periods. Addressing these challenges in an efficient and effective way will require multiple stakeholders-public and private-coordinated in implementing a holistic approach to diagnostics preparedness. All require strengthening of healthcare system diagnostic capacity ( including surveillance and education of healthcare workers), establishment of sustainable financing and market strategies and integration of diagnostics with existing mechanisms. Identifying overlaps in diagnostic development needs across different priority pathogens would allow more timely and cost-effective use of resources than a pathogen by pathogen approach; target product profiles for diagnostics should be refined accordingly. We recommend the establishment of a global forum to bring together representatives from all key stakeholders required for the response to develop a coordinated implementation plan. In addition, we should explore if and how existing mechanisms to address challenges to the vaccines sector, such as Coalition for Epidemic Preparedness Innovations and Gavi, could be expanded to cover diagnostics.
C1 [Kelly-Cirino, Cassandra D.; Escadafal, Camille; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland.
   [Nkengasong, John] Africa Centres Dis Control & Prevent, Addis Ababa, Ethiopia.
   [Kettler, Hannah] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Tongio, Isabelle; Gay-Andrieu, Francoise] BioMerieux, Marcy Letoile, France.
   [Piot, Peter; Peeling, Rosanna W.] London Sch Hyg & Trop Med, London, England.
   [Gadde, Renuka] BD, Franklin Lakes, NJ USA.
RP Boehme, C (corresponding author), Fdn Innovat New Diagnost, Geneva, Switzerland.
EM Catharina.Boehme@finddx.org
OI Kelly-Cirino, Cassandra/0000-0002-4526-8487
FU Foundation for Innovative New Diagnostics (FIND)
FX Medical writing assistance and editorial support, under the direction of
   the authors, was provided by Rachel Wright, PhD, funded by Foundation
   for Innovative New Diagnostics (FIND), according to Good Publication
   Practice guidelines.
CR Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   [Anonymous], 2017, GAVI EFFECTIVE FIT P
   [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P437
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Berkley S, 2018, SCIENCE, V359, P1075, DOI 10.1126/science.aat4714
   Butler D, 2018, NATURE, V558, P172, DOI 10.1038/d41586-018-05389-2
   Centers for Disease Control and Prevention, 2016, COST EB EP
   Centers for Disease Control and Prevention (CDC), 2014, NIP VIR NIV
   Centers for Disease Control and Prevention (CDC), 2017, SEV AC RESP SYNDR
   Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109
   Dhillon RS, 2018, LANCET, V391, P2499, DOI 10.1016/S0140-6736(18)31315-1
   Emperador DM, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001112
   FIND, 2018, DIAGN EP PREP OUTBR
   Fitchett JRA, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020703
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gebreyes WA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003257
   Ginocchio CC, 2011, CLIN INFECT DIS, V52, pS312, DOI 10.1093/cid/cir046
   Hamblion EL, 2018, INT J INFECT DIS, V66, P65, DOI 10.1016/j.ijid.2017.11.007
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Infectious Disease Research Institute (IDRI), 2018, LEISHM DIAGN
   Kelly-Cirino C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001105
   Kennedy SB, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i3.509
   Kumar S, 2012, CLIN MICROBIOL REV, V25, P344, DOI 10.1128/CMR.05016-11
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Maxmen A, 2017, NATURE, V549, P15, DOI 10.1038/nature.2017.22545
   Mazzola LT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001114
   Mazzola LT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001116
   Mazzola LT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001118
   Nkengasong JN, 2018, LANCET, V391, P2395, DOI 10.1016/S0140-6736(18)31326-6
   Nkengasong JN, 2018, LANCET, V391, P1873, DOI 10.1016/S0140-6736(18)30308-8
   Nyenswah T, 2015, MMWR-MORBID MORTAL W, V64, P500
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Sayed S, 2018, LANCET, V391, P1939, DOI 10.1016/S0140-6736(18)30459-8
   US Food and Drug Administration (FDA), 2018, EM US AUTH 2014 EB V
   WHO, 2017, RIFT VALL FEV FACT S
   WHO, 2016, ZIK VIR FACT SHEET
   WHO, 2013, CRIM CONG HAEM FEV F
   WHO, 2018, EB VIR DIS FACT SHEE
   Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]
   World Health Organisation, 2018, LASS FEV NIG
   World Health Organization, 2018, MERS COV DIS OUTBREA
   World Health Organization, 2018, 12 WHO
   World Health Organization, 2017, MARB VIR DIS UG KEN
   World Health Organization, 2018, MIDDL E RESP SYNDR C
   World Health Organization, 2018, NIP VIR DIS OUTBR NE
   World Health Organization, 2017, MARB VIR DIS FACT SH
   World Health Organization, 2004, NIP VIR BANGL
   World Health Organization, 2017, LASS FEV FACT SHEET
   World Health Organization, 2018, WHO R D BLUEPR LIST
   World Health Organization, 2018, PAND INFL PREP PIP F
   World Health Organization, 2018, EB ADD DOC PUBL REP
NR 52
TC 1
Z9 1
U1 4
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD JAN
PY 2019
VL 4
SU 2
AR UNSP e001179
DI 10.1136/bmjgh-2018-001179
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6VX
UT WOS:000471820000007
PM 30815287
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT S
AU Pradana, MS
   Amiroch, S
AF Pradana, Mohammad Syaiful
   Amiroch, Siti
BE Tasman, H
   Handari, BD
   Seno, H
TI Protein Sequence Analysis of The Zika Virus and The Dengue Virus Using
   Smith Waterman Algorithm
SO PROCEEDINGS OF THE SYMPOSIUM ON BIOMATHEMATICS (SYMOMATH) 2018
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Symposium on BioMathematics (SYMOMATH)
CY AUG 31-SEP 02, 2018
CL Depok, INDONESIA
SP Univ Indonesia, Dept Math, Indonesian Biomathemat Soc, Indonesia Re, Univ Gunadarma, BPJS Kesehatan, AIA
AB Zika virus that became a hot issue in the media recent years behind is very interesting to study, especially the Zika virus has similar to infection to Dengue fever. The virus that is infect to humans through mosquito bites by Aedes genus, Especially Aedes aegypti is identical mosquito that spread Dengue, yellow fever and chikungunya. In Brazil, an increase syndrome Zika virus infection in the community have observed by local health authorities, and also in northeast Brazil an increase of microcephaly condition in babies born. In addition, the Zika virus sporadic infection has reported by approximately 13 Americas countries that show very rapid expansion, and also Indonesia, the euphoria discussed increasingly after the positive patient infected by Zika virus has discovered in Jambi on January 2016. Moving on from this, the authors wanted to know how the sequences protein Zika virus when compared with the Dengue virus, the percentage of identical sequence and also the calculation of local alignment its using the Smith Waterman algorithm. In addition it will also be known genetic mutations that occur in Zika virus from its origin until Zika virus into Indonesia and phylogenetic tree spread of the virus to get to Jambi. So the researcher construct sequence alignment tools by using graphical user interface in MATLAB program based on Smith Waterman algorithm, and also a link in the system with the browser as an option for online data retrieval. From the result of sequence alignment by MATLAB and BLAST, that the identical values of sequence using MATLAB is higher than BLAST values. Likewise, the duration of computation that MATLAB computation is more effective than BLAST computation.
C1 [Pradana, Mohammad Syaiful; Amiroch, Siti] Univ Islam Darul Ulum, Fac Math & Nat Sci, Dept Math, Lamongan, Indonesia.
RP Pradana, MS (corresponding author), Univ Islam Darul Ulum, Fac Math & Nat Sci, Dept Math, Lamongan, Indonesia.
EM syaifulp@unisda.ac.id; Siti.Amiroch@unisda.ac.id
RI Pradana, Mohammad Syaiful/AAC-1511-2020
OI Pradana, Mohammad Syaiful/0000-0001-6280-2752
FU Directorate of Research and Community Service, Directorate General of
   Strengthening Research and Development at the Ministry of Research,
   Technology and Higher Education [120/SP2H/LT/DRPM/IV/2017]
FX This paper is an output of the research of beginner lecturers in 2017
   funded by the Directorate of Research and Community Service, Directorate
   General of Strengthening Research and Development at the Ministry of
   Research, Technology and Higher Education Number:
   120/SP2H/LT/DRPM/IV/2017, on April 3rd 2017.
CR Cristianini N., 2006, INTRO COMPUTATIONAL
   Pradana M. S., 2018, INT J COMPUT SCI APP, V4, P15
   Shen S, 2008, BIOL MED PHYS BIOMED, P1
NR 3
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1814-1
J9 AIP CONF PROC
PY 2019
VL 2084
AR 020011
DI 10.1063/1.5094275
PG 5
WC Mathematical & Computational Biology; Physics, Applied
SC Mathematical & Computational Biology; Physics
GA BM9SS
UT WOS:000471594700011
DA 2020-07-08
ER

PT J
AU Alonso-Palomares, LA
   Moreno-Garcia, M
   Lanz-Mendoza, H
   Salazar, MI
AF Alonso-Palomares, Luis A.
   Moreno-Garcia, Miguel
   Lanz-Mendoza, Humberto
   Isabel Salazar, Ma
TI Molecular Basis for Arbovirus Transmission by Aedes aegypti Mosquitoes
SO INTERVIROLOGY
LA English
DT Review
DE Arbovirus; Aedes aegypti; Mosquitoes; Transmission; Determinants
ID NATURAL VERTICAL TRANSMISSION; IN-FIELD POPULATIONS; DENGUE VIRUS;
   VECTOR COMPETENCE; ANTIMICROBIAL PEPTIDES; CHIKUNGUNYA; INFECTION;
   UPDATE; TEMPERATURE; WOLBACHIA
AB Mosquitoes are considered the most important vectors for the transmission of pathogens to humans. Aedes aegypti is a unique species, not only by its highly anthropophilic and peridomestic habits but also because it can transmit an important variety of pathogenic viruses. Examples are dengue, yellow fever, chikungunya, Zika, and Mayaro viruses. After ingesting viremic blood, a wide range of mechanisms are activated in the mosquito to counteract viral infection. Nevertheless, these arboviruses possess strategies to overcome barriers in the mosquito and eventually reach the salivary glands to continue the transmission cycle. However, the infection and eventual transmission of arbovirus depends on multiple factors. The current review focuses in detail on the anatomic, physiological, and molecular characteristics of the mosquito A. aegypti that participate in response to a viral infection. In the past decades, the awareness of the importance of this mosquito as a disease vector and its impact on human health was largely recognized. We need to improve our comprehension of molecular mechanisms that determine the outcome of successful virus replication or control of infection for each arbovirus in the vector; this could lead to the design of effective control strategies in the future. (C) 2019 S. Karger AG, Basel
C1 [Alonso-Palomares, Luis A.; Isabel Salazar, Ma] IPN, ENCB, Unidad Profes Lazaro Cardenas, Lab Virol & Inmunovirol,Dept Microbiol, Mexico City, DF, Mexico.
   [Alonso-Palomares, Luis A.; Lanz-Mendoza, Humberto] INSP, CISEI, Cuernavaca, Morelos, Mexico.
   [Moreno-Garcia, Miguel] CERECOVE, SS, Ctr Reg Control Vectores, Panchimalco, Mexico.
RP Salazar, MI (corresponding author), IPN, ENCB, Dept Microbiol, Lab Virol & Inmunovirol, Mexico City, DF, Mexico.
EM isalazarsan@yahoo.com
OI MORENO-GARCIA, MIGUEL/0000-0001-6733-9007
CR Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x
   Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Anglero-Rodriguez YI, 2017, ELIFE, V6, P6
   Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762
   Araujo HCR, 2008, MICRON, V39, P184, DOI 10.1016/j.micron.2007.01.003
   Balenghien T, VET RES
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Baron OL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.4101
   Behura SK, 2014, FUNCT INTEGR GENOMIC, V14, P581, DOI 10.1007/s10142-014-0376-1
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chepkorir E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-435
   Choi YJ, 2012, INSECT BIOCHEM MOLEC, V42, P729, DOI 10.1016/j.ibmb.2012.06.005
   Chompoosri J, PARASIT VECTORS
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   da Costa CF, PLOS NEGL TROP DIS
   Dalziel BD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004455
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Dimmock N.J., 2007, INTRO MODERN VIROLOG
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Etebari K, MSPHERE
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gaburro J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0069-2
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Jupatanakul Natapong, 2017, PLOS NEGLECT TROP D, V11, P1
   Klitting R, 2016, INFECT GENET EVOL, V45, P332, DOI 10.1016/j.meegid.2016.09.017
   Krzemien J, 2010, INT J DEV BIOL, V54, P1117, DOI 10.1387/ijdb.093053jk
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Lee M, 2017, J GEN VIROL, V98, P1892, DOI 10.1099/jgv.0.000832
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   Liu T, 2018, DEV COMP IMMUNOL, V83, P34, DOI 10.1016/j.dci.2017.12.025
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Marinho MC, 2019, ORAL DIS, V25, P588, DOI 10.1111/odi.12996
   McElroy KL, 2008, VECTOR-BORNE ZOONOT, V8, P675, DOI 10.1089/vbz.2007.0269
   Mourya DT, 1998, INDIAN J MED RES, V107, P10
   Mukherjee S, BMC MICROBIOL
   Myles KM, 2004, J MED ENTOMOL, V41, P95, DOI 10.1603/0022-2585-41.1.95
   Ocampo CB, PLOS ONE
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Olson KE, CURR OPIN VIROL
   Padilha KP, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180290
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Parikh G., 2011, ENTOMOLOGY COMMONS, P12164
   PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Reyes-del Valle J, 2014, CURR TROP MED REP, V1, P36, DOI DOI 10.1007/s40475-013-0002-7
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204
   Ruckert Claudia, 2014, VirusDisease, V25, P249, DOI 10.1007/s13337-014-0217-9
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Salazar M. I., 2010, REV BIOMED, V21, P121
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shrinet J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060314
   Shrinet J, 2017, BIOCHEM BIOPH RES CO, V492, P617, DOI 10.1016/j.bbrc.2017.01.162
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Smith DR, 2012, INSECT MOL BIOL, V21, P1, DOI 10.1111/j.1365-2583.2011.01098.x
   Taracena ML, PLOS NEGL TROP DIS
   Terradas G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2589-3
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Varjak M, MSPHERE
   Walker T., 2014, PARASITE VECTOR, V7, P1
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Xue L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006666
   Zhang GM, 2014, INSECT BIOCHEM MOLEC, V53, P81, DOI 10.1016/j.ibmb.2014.08.003
   Zhang RD, 2017, FRONT CELL INFECT MI, V7, DOI [10.3382/fcimb.2017.00022, 10.3389/fcimb.2017.00022]
NR 99
TC 1
Z9 1
U1 1
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2019
VL 61
IS 6
BP 255
EP 264
DI 10.1159/000499128
PG 10
WC Virology
SC Virology
GA IC3JQ
UT WOS:000470856800001
PM 31082816
OA Bronze
DA 2020-07-08
ER

PT J
AU Simo, FBN
   Yousseu, FBS
   Mbarga, AE
   Bigna, JJ
   Melong, A
   Ntoude, A
   Kamgang, B
   Bouyne, R
   Fewou, PM
   Demanou, M
AF Simo, Fredy Brice Nemg
   Yousseu, Francine Berlange Sado
   Mbarga, Armel Evouna
   Bigna, Jean Joel
   Melong, Armel
   Ntoude, Anicet
   Kamgang, Basile
   Bouyne, Raphael
   Fewou, Paul Moundipa
   Demanou, Maurice
TI Investigation of an Outbreak of Dengue Virus Serotype 1 in a Rural Area
   of Kribi, South Cameroon: A Cross-Sectional Study
SO INTERVIROLOGY
LA English
DT Article
DE Dengue virus; RT-PCR; ELISA; South Cameroon
ID CHIKUNGUNYA; INFECTIONS
AB Background: On May 2017, a case of dengue serotype 1 was detected and confirmed through routine surveillance in a traveler returning from Kribi, a seaside town of Southern Cameroon. This study aimed at confirming the circulation of dengue virus (DENV) in Southern Cameroon. Methods: A cross sectional study was carried out in Londji near Kribi from June 21-25, 2017, by a joint team of Centre Pasteur of Cameroon and the Department of Diseases, Epidemics and Pandemics Control. Blood samples of consented participants were collected and tested for anti-D ENV IgM using an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA), and for the detection of Zika, dengue, or chikungunya viruses using Trioplex real-time reverse transcription- polymerase chain reaction (RT-PCR). DENV RNA-posi-tive samples were serotyped using an end-point nested RT-PCR. Results: Ninety-one participants were enrolled, 50.55% (46/91) of them males. The mean age of the population was 30.71 years (+/- 18.89). In total, 14.28% (13/91) of the participants had DENV infection (3 anti-DENV IgM positive and 10 DENV serotype 1 RT-PCR positive). Conclusion: The detection of DENV serotype 1 in an autochthonous population during this survey is a confirmation that the seaside city of Kribi is a risk area for contracting dengue infection in Cameroon. (C) 2019 S. Karger AG, Basel
C1 [Simo, Fredy Brice Nemg; Yousseu, Francine Berlange Sado; Demanou, Maurice] Ctr Pasteur Cameroon, Dept Virol, Natl Reference Lab Chikungunya & Dengue, Yaounde, Cameroon.
   [Simo, Fredy Brice Nemg; Fewou, Paul Moundipa] Univ Yaounde I, Dept Biochem, Fac Sci, Yaounde, Cameroon.
   [Mbarga, Armel Evouna; Melong, Armel] Minist Publ Hlth, Cameroon Field Epidemiol Training Program, Yaounde, Cameroon.
   [Bigna, Jean Joel] Univ Paris Sud, Sch Publ Hlth, Fac Med, Paris, France.
   [Ntoude, Anicet] Delegat Reg Sante Publ Sud Cameroun, Ebolowa, Cameroon.
   [Kamgang, Basile] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Yaounde, Cameroon.
   [Bouyne, Raphael] Ctr Med Social Ambassade France, Yaounde, Cameroon.
RP Demanou, M (corresponding author), Ctr Pasteur Cameroon, Charge Rech, POB 1274, Yaounde, Cameroon.
EM demanou@pasteur-yaounde.org
OI Kamgang, Basile/0000-0002-8883-4557
FU Centre Pasteur of Cameroon (CPC); Cameroon Field Epidemiology Training
   Program (CAFETP)
FX This study was funded both by Centre Pasteur of Cameroon (CPC) and the
   Cameroon Field Epidemiology Training Program (CAFETP).
CR Abreu C, 2016, J CLIN VIROL, V79, P77, DOI 10.1016/j.jcv.2016.04.011
   Beckett CG, 2005, AM J TROP MED HYG, V72, P777, DOI 10.4269/ajtmh.2005.72.777
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950
   Farnon E., 2007, Morbidity and Mortality Weekly Report, V56, P276
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Kajeguka DC, 2017, TROP MED INT HEALTH, V22, P583, DOI 10.1111/tmi.12863
   Konongoi L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0641-0
   Krippner R, 2002, J TRAVEL MED, V9, P273, DOI 10.2310/7060.2002.24119
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   Malik Amal, 2011, J Infect Public Health, V4, P1, DOI 10.1016/j.jiph.2010.08.001
   Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371
   Ndip LM, 2004, EMERG INFECT DIS, V10, P432, DOI 10.3201/eid1003.020713
   Ngoi CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167508
   NIH, CDC TRIOPL REAL TIM
   Rafique I, 2017, ASIAN PAC J TROP MED, V10, P1002, DOI 10.1016/j.apjtm.2017.09.013
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   WHO, LAB DIAGN DIAGN TEST
   Wichmann O, 2017, VACCINE, V35, P5535, DOI 10.1016/j.vaccine.2017.08.066
   World Health Organization, DENG SEV DENG
NR 23
TC 2
Z9 2
U1 1
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2019
VL 61
IS 6
BP 265
EP 271
DI 10.1159/000499465
PG 7
WC Virology
SC Virology
GA IC3JQ
UT WOS:000470856800002
PM 31048588
DA 2020-07-08
ER

PT J
AU Peniche, T
   Duarte, JL
   Amaral, FAS
   Sarquis, IR
   Sarquis, RSFR
   Cruz, RAS
   Oliveira, AEMFM
   Ferreira, RMA
   Rocha, L
   Tietbohl, LAC
   Florentino, AC
   Carvalho, JCT
   Souto, RNP
   Fernandes, CP
AF Peniche, Taires
   Duarte, Jonatas L.
   Amaral, Frankli A. S.
   Sarquis, Icaro R.
   Sarquis, Rosangela S. F. R.
   Cruz, Rodrigo A. S.
   Oliveira, Anna E. M. F. M.
   Ferreira, Ricardo M. A.
   Rocha, Leandro
   Tietbohl, Luis A. C.
   Florentino, Alexandro C.
   Carvalho, Jose C. T.
   Souto, Raimundo N. P.
   Fernandes, Caio P.
TI Hyptis suaveolens (L.) Poit. Essential Oil: A Raw Material for a
   Larvicidal Nano-emulsion
SO LATIN AMERICAN JOURNAL OF PHARMACY
LA English
DT Article
DE chikungunya; dengue; nanodispersion; third-instar larvae; zika
ID INDIGENOUS PLANT-EXTRACTS; AEDES-AEGYPTI L.; CHEMICAL-COMPOSITION;
   BOTANICAL INSECTICIDES; CULEX-QUINQUEFASCIATUS; SILVER NANOPARTICLES;
   MEDICINAL-PLANTS; BRAZILIAN PLANTS; GREEN SYNTHESIS; ZIKA VIRUS
AB This study aimed to generate an oil in water nano-emulsion using the essential oil extracted from the leaves of Hyptis suaveolens and evaluate its larvicidal potential against Aedes aegypti larvae. The nano-emulsion was prepared by a titration low energy method, being constituted by H. suaveolens essential oil, polysorbate 80 and deionized water. The bioassay was performed with third-instar larvae. Gas chromatography analysis revealed that 1,8-cineole was the major compound, corresponding to 2634% of the relative composition. Low mean droplet size, which remained around 150 nm was observed even after seven days of storage. The estimated LC50 and LC90 values after 24 h were, 202.66 and 339.618 ppm, respectively. The present study provides valuable information concerning nanobiotechnology of larvicidal agents from plant origin and opens perspectives for the viable preparation of these novel systems through low energy/non-heating methods with great potential to be used in integrative practices of vector control.
C1 [Peniche, Taires; Ferreira, Ricardo M. A.; Souto, Raimundo N. P.] Univ Fed Amapa, Curso Ciencias Biol, Lab Artropodes, Campus Univ Marco Zero Equador, BR-68902280 Macapa, AP, Brazil.
   [Duarte, Jonatas L.; Amaral, Frankli A. S.; Sarquis, Icaro R.; Cruz, Rodrigo A. S.; Oliveira, Anna E. M. F. M.; Fernandes, Caio P.] Univ Fed Amapa, Curso Farm, Lab Nanobiotecnol Fitofarmaceut, Campus Univ Marco Zero Equador, BR-68902280 Macapa, AP, Brazil.
   [Sarquis, Rosangela S. F. R.; Carvalho, Jose C. T.] Univ Fed Amapa, Curso Farm, Lab Pesquisa Farmacos, Campus Univ Marco Zero Equador, BR-68902280 Macapa, AP, Brazil.
   [Rocha, Leandro; Tietbohl, Luis A. C.] Univ Fed Fluminense, LTPN, Dept & Tecnol Farntaceut, Fac Farm, Rua Mario Viana 523, BR-24241000 Niteroi, RJ, Brazil.
   [Florentino, Alexandro C.] Univ Fed Amapa, Curso Farm, Lab Absorcao Atom & Bioprospecao, Rodovia Juscelino Kubitschek Km 02, BR-68903419 Macapa, AP, Brazil.
RP Fernandes, CP (corresponding author), Univ Fed Amapa, Curso Farm, Lab Nanobiotecnol Fitofarmaceut, Campus Univ Marco Zero Equador, BR-68902280 Macapa, AP, Brazil.
EM caio_pfernandes@yahoo.com.br
RI Duarte, Jonatas/M-4442-2017; Oliveira, Anna/AAN-6694-2020; Cruz,
   Rodrigo/B-3224-2013; Rocha, Leandro M./N-4088-2013; Fernandes, Caio
   Pinho/A-1542-2015
OI Duarte, Jonatas/0000-0002-7276-3686; Oliveira, Anna/0000-0001-9337-4519;
   Cruz, Rodrigo/0000-0003-1728-4145; Fernandes, Caio
   Pinho/0000-0002-6538-7360
FU FAPEAP (Prodetec Araguari-Process) [250.203.035/2013]
FX Authors would like to thank FAPEAP (Prodetec Araguari-Process No
   250.203.035/2013) for the financial support and PROPESPG/UNI-FAP
   (PROPUBLIC and PAPESQ).
CR Abagli AZ, 2012, J AM MOSQUITO CONTR, V28, P15, DOI 10.2987/11-6181.1
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amusan A. A. S., 2006, TANZANIA J HLTH RES, V7, P174
   Anjali CH, 2012, PEST MANAG SCI, V68, P158, DOI 10.1002/ps.2233
   Azevedo NR, 2001, PHYTOCHEMISTRY, V57, P733, DOI 10.1016/S0031-9422(01)00128-5
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bouchemal K, 2004, INT J PHARM, V280, P241, DOI 10.1016/j.ijpharm.2004.05.016
   Bruxel F, 2012, QUIM NOVA, V35, P1827, DOI 10.1590/S0100-40422012000900023
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Conti B, 2012, PARASITOL RES, V110, P2013, DOI 10.1007/s00436-011-2730-8
   de Mendonca FAC, 2005, FITOTERAPIA, V76, P629, DOI 10.1016/j.fitote.2005.06.013
   de Oliveira JL, 2014, BIOTECHNOL ADV, V32, P1550, DOI 10.1016/j.biotechadv.2014.10.010
   Dias CN, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/490765
   Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.2010, 10.1016/j.bjp.2015.02.010]
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Freitas FP, 2010, CHEM BIODIVERS, V7, P2801, DOI 10.1002/cbdv.200900260
   Ghosh V, 2013, ASIAN J CHEM, V25, pS321
   Gobbo-Neto L, 2007, QUIM NOVA, V30, P374, DOI 10.1590/S0100-40422007000200026
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Joy B, 2008, J ESSENT OIL BEAR PL, V11, P384, DOI 10.1080/0972060X.2008.10643644
   Kovendan K., 2014, Journal of Entomological and Acarological Research, V46, P90, DOI 10.4081/jear.2014.1747
   Kovendan K, 2012, PARASITOL RES, V110, P2105, DOI 10.1007/s00436-011-2736-2
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McClements DJ, 2012, SOFT MATTER, V8, P1719, DOI 10.1039/c2sm06903b
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Muthukumaran U, 2015, PARASITOL RES, V114, P4385, DOI 10.1007/s00436-015-4677-7
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oliveira AEMFM, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-016-0234-5
   Oliveira AEMFM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145835
   Ostertag F, 2012, J COLLOID INTERF SCI, V388, P95, DOI 10.1016/j.jcis.2012.07.089
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Peerzada N, 1997, MOLECULES, V2, P165, DOI 10.3390/21100165
   Moreira ACP, 2010, BRAZ J MICROBIOL, V41, P28, DOI 10.1590/S1517-83822010000100006
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   Rios Tesch Nurby, 2015, Revista Peruana de Biologia, V22, P103
   Rodrigues EDR, 2014, REV BRAS FARMACOGN, V24, P699, DOI 10.1016/j.bjp.2014.10.013
   Seo SM, 2012, J AGR FOOD CHEM, V60, P5909, DOI 10.1021/jf301296d
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004
   Soonwera M, 2015, PARASITOL RES, V114, P4531, DOI 10.1007/s00436-015-4699-1
   Suganya G, 2014, PARASITOL RES, V113, P875, DOI 10.1007/s00436-013-3718-3
   Sugumar S, 2014, B ENTOMOL RES, V104, P393, DOI 10.1017/S0007485313000710
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Tennyson Samuel, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1842
   Tietbohl LAC, 2014, REV BRAS FARMACOGN, V24, P316, DOI 10.1016/j.bjp.2014.07.009
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Wang LJ, 2007, J COLLOID INTERF SCI, V314, P230, DOI 10.1016/j.jcis.2007.04.079
   WHO, 2012, HDB INT VECT MAN, P66
   WHO, 2015, NEGL TROP DIS VECT E
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Yadav R, 2014, J ARTHROPOD-BORNE DI, V8, P174
NR 61
TC 0
Z9 0
U1 0
U2 1
PU COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
PI LA PLATA
PA DEPT CIENTIFICO, CALLE 5 NO 966, LA PLATA, 00000, ARGENTINA
SN 0326-2383
J9 LAT AM J PHARM
JI Lat. Am. J. Pharm.
PY 2019
VL 38
IS 5
BP 938
EP 944
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IB2FO
UT WOS:000470085300014
DA 2020-07-08
ER

PT J
AU Lockrow, J
   Tully, H
   Saneto, RP
AF Lockrow, Jason
   Tully, Hannah
   Saneto, Russell P.
TI Epileptic spasms as the presenting seizure type in a patient with a new
   "O" of TORCH, congenital Zika virus infection
SO EPILEPSY & BEHAVIOR CASE REPORTS
LA English
DT Article
ID INFANTILE SPASMS; CHILDREN
AB Congenital TORCH infections are a significant cause of epileptic spasms, an infantile epileptic encephalopathy, through disruptions to several pathways in neurodevelopment. Congenital Zika virus has a similar neurotropism to other TORCH agents, and leads to microcephaly, severe neurodevelopmental impairment, and high rates of early onset seizures. Here we report a child with confirmed congenital Zika virus who developed extensor epileptic spasms and hypsarrhythmia associated with a loss of early developmental milestones. Early treatment led to resolution of epileptic spasms and improved developmental trajectory, though the child continues to have ongoing focal seizures and prominent developmental impairment. Congenital Zika virus infection requires close monitoring as early identification of epileptic spasms is likely important in long term developmental outcome. (C) 2018 The Authors. Published by Elsevier Inc.
C1 [Lockrow, Jason] Univ Washington, Div Pediat Neurol, Seattle, WA 98195 USA.
   Seattle Childrens Hosp, Seattle, WA USA.
RP Lockrow, J (corresponding author), Univ Washington, Div Pediat Neurol, Seattle, WA 98195 USA.
EM jason.lockrow@seartlechildrens.org
OI Saneto, Russell/0000-0002-7250-2347
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alves LV, 2018, J CHILD NEUROL, V33, P664, DOI 10.1177/0883073818780105
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Jackson MC, 2017, EPILEPSIA, V58, P1575, DOI 10.1111/epi.13836
   Kang JW, 2013, BRAIN DEV-JPN, V35, P816, DOI 10.1016/j.braindev.2013.06.013
   Kwak M, 2018, PEDIATR NEUROL, V83, P14, DOI 10.1016/j.pediatrneurol.2018.03.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mytinger JR, 2015, EPILEPSY RES, V116, P93, DOI 10.1016/j.eplepsyres.2015.07.008
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Osborne JP, 2010, EPILEPSIA, V51, P2168, DOI 10.1111/j.1528-1167.2010.02695.x
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 12
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2213-3232
J9 EPILEPSY BEHAV CASE
JI Epilepsy Behav. Case Rep.
PY 2019
VL 11
BP 1
EP 3
DI 10.1016/j.ebcr.2018.09.002
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA HY0EQ
UT WOS:000467784000001
PM 30456170
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, IF
   Alencar, PNB
   de Andrade, MDC
   Silva, PGD
   Carvalho, EDF
   Araujo, LS
   Cavalcante, MPM
   Sousa, FB
AF Carvalho, Isabella Fernandes
   Barbosa Alencar, Phillipe Nogueira
   Carvalho de Andrade, Maria Denise
   de Barros Silva, Paulo Goberlanio
   Fernandes Carvalho, Ellaine Doris
   Araujo, Lavina Sousa
   Monteiro Cavalcante, Michelly Pedrosa
   Sousa, Fabricio Bitu
TI Clinical and x-ray oral evaluation in patients with congenital Zika
   Virus
SO JOURNAL OF APPLIED ORAL SCIENCE
LA English
DT Article
DE Zika virus; Microcephaly; Tooth eruption
AB Objective: The aim of this study was to investigate possible malformations in the soft, bone and/or dental tissues in patients with congenital Zika Virus (ZIKV) by clinical and x-ray evaluation. Methodology: Thirty children born with ZIKV and 30 children born without ZIKV (control group) were included in the study. Patients were evaluated over 24 consecutive months according to the variables: sex, age, cleft palates, soft tissue lesions, alveolar ridge hyperplasia, short labial and lingual frenums, inadequate posture of the lingual and perioral muscles at rest, micrognathia, narrow palatine vaults, changes in the teeth shape and/or number, sequence eruption, spasms, seizures and eruption delay were evaluated. Chi-square test, Student's t-test and nominal logistic regression were used (p<0.05). Results: Among the 30 babies examined, the mean age of the first dental eruption was 10.8 +/- 3.8 with almost two-thirds of the children (n=18, 60%) experiencing eruptions of their first tooth after 9 months of age, nine children (30%) had inadequate lingual posture at rest, more than half of the children (n=18, 60%) had short labial or lingual frenums. ZIKV babies showed a high prevalence of clef palate (p<0.001), inadequate lingual posture at rest (p=0.004), micrognathia (p=0.002), changes in the shape and/or number of teeth (p=0.006), alteration in sequence of dental eruption (p<0.001) and muscles spasms (p=0.002). The delay eruption was associated with inadequate lingual posture at rest (p=0.047), micrognathia (p=0.002) and changes in the shape and/or number of teeth (p=0.021). The delayed eruption (p=0.006) and narrow palatine vaults (p=0.008) were independently associated with ZIKV. Moreover, female patients showed the most narrow palatine vaults (p=0.010). Conclusions: The children with ZIKV showed a greater tendency to have delayed eruption of the first deciduous tooth, inadequate lingual posture and short labial and lingual frenums.
C1 [Carvalho, Isabella Fernandes; Barbosa Alencar, Phillipe Nogueira; Carvalho de Andrade, Maria Denise; de Barros Silva, Paulo Goberlanio; Fernandes Carvalho, Ellaine Doris; Araujo, Lavina Sousa; Monteiro Cavalcante, Michelly Pedrosa; Sousa, Fabricio Bitu] Ctr Univ Christus, Dept Odontol, Fortaleza, Ceara, Brazil.
RP Silva, PGD (corresponding author), Ctr Univ Christus, Fac Odontol, Rua Adolfo Gurgel 133, BR-60160230 Fortaleza, Ceara, Brazil.
EM paulo_goberlanio@yahoo.com.br
RI Carvalho, Isabella/AAQ-3441-2020; Barros Silva, Paulo
   Goberlanio/H-7300-2015
OI FERNANDES CARVALHO DE ANDRADE, MARIA DENISE/0000-0003-1890-4721;
   FERNANDES CARVALHO, ELLAINE DORIS/0000-0001-6466-4429; Barros Silva,
   Paulo Goberlanio/0000-0002-1513-9027; Araujo,
   Lavina/0000-0002-3162-5295; Alencar, Phillipe/0000-0002-0026-3359
CR Aguirre AL, 1988, ODONTOL MOD, V15, P34
   BRANDAO CF, 2004, JBP REV IBERO AM ODO, V7, P528
   Brasil. Governo do Estado do Ceara. Secretaria da Saude, 2017, B EP SINDR CONG ASS
   Brasil. Ministerio da Saude, 2016, SECR VIG SAUD PROT V
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Cobourne MT, 2006, J EXP ZOOL PART B, V306B, P251, DOI 10.1002/jez.b.21084
   Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X
   Aguiar YPC, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.16
   Dougherty Nancy J, 2009, Dent Clin North Am, V53, P329, DOI 10.1016/j.cden.2008.12.001
   Health Centre for Oral Health Strategy, 2014, EARL CHILDH OR HLTH
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lautrou Alain, 2002, Orthod Fr, V73, P5
   Madan K, 2015, J MED RADIOL PATHOL, V1, P21
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Nejaim Y, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20150065
   Rodrigues dos Santos Maria Teresa Botti, 2003, J Dent Child (Chic), V70, P40
   Santa Maria C, 2017, GLOB PEDIAT HLTH, V4
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Suda Naoto, 2017, Clin Calcium, V27, P1357, DOI CliCa171013571362
   Tamburus JR, 1977, REV FAC FARM ODONTOL, V14, P23
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Valente TV, 2008, REV BRAS ODONTOL, V65, P159
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 1
Z9 1
U1 1
U2 2
PU UNIV SAO PAULO FAC ODONTOLOGIA BAURU
PI BAURU-SP
PA AL DR OCTAVIO PINHEIRO BRISOLLA, 9-75, BAURU-SP, 17012-901, BRAZIL
SN 1678-7757
EI 1678-7765
J9 J APPL ORAL SCI
JI J. Appl. Oral Sci.
PY 2019
VL 27
AR UNSP e20180276
DI 10.1590/1678-7757-2018-0276
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA HZ3TK
UT WOS:000468771000001
PM 31116278
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jorente, MJV
   Nakano, N
   Padua, MC
   Silva, AR
AF Vicentini Jorente, Maria Jose
   Nakano, Natalia
   Padua, Mariana Cantisani
   Silva, Anahi Rocha
TI Collaborative e-Health Environments: The enhanced role of health agents
SO TRANSINFORMACAO
LA English
DT Article
DE Collaborative environments; E-Health; Health communication;
   Microcephaly; Web 2.0; Virus Zika
ID INFORMATICS; EHEALTH
AB The literature has discussed the importance of the impact of Information and Communication Technology on health promotion, health education and applications to promote change in health behaviors, denominated e-Health promotion. The objective of this article is to describe Web 2.0 properties that should converge to a peer-to-peer collaboration platform, with the mediation of a health agent. This Web 2.0 system should provide a space where people may, not only receive information, but also exchange ideas and experiences about how to deal with the conditions resulting from the diseases caused by Zika virus, such as microcephaly. Microcephaly is a rare neurological condition in which the child's head and brain are significantly smaller than those of others at the same age and sex and may cause a number of genetic or environmental problems. The risk of a Zika epidemic is real, it mainly affects people in poor countries, and especially Brazil that has the social responsibility to face the challenge of supporting hundreds of families of children born with microcephaly. E-Health projects are often focused only on health service managers, practitioners and research partners. These projects are not of open access and, in Brazil, there is no public platform that serves non-specialized citizens. We suggest a design that includes the health worker, family and stakeholders as content creators, able to act peer-to-peer and bottom-up, which may be useful for developing countries with similar health contexts.
C1 [Vicentini Jorente, Maria Jose; Nakano, Natalia; Padua, Mariana Cantisani; Silva, Anahi Rocha] Univ Estadual Paulista, Dept Ciencia Informacao, Programa Posgrad Ciencia Informacao, Curso Bibliotecon & Arquivol, Av Hygino Muzzi Filho 737, BR-17525900 Marilia, SP, Brazil.
RP Padua, MC (corresponding author), Univ Estadual Paulista, Dept Ciencia Informacao, Programa Posgrad Ciencia Informacao, Curso Bibliotecon & Arquivol, Av Hygino Muzzi Filho 737, BR-17525900 Marilia, SP, Brazil.
EM mariana.cantisani@gmail.com
RI Padua, Mariana P/C-3934-2015
OI Padua, Mariana P/0000-0003-1245-3608; Nakano,
   Natalia/0000-0002-3217-2515; Jorente, Maria Jose
   Vicentini/0000-0002-0492-0918
CR Brender J, 2000, INT J MED INFORM, V58, P257, DOI 10.1016/S1386-5056(00)00092-7
   Chou W. Y., 2013, AM J PUBLIC HEALTH, V103, P9
   Cunningham S, 2014, EHEALTH CARE QUALITY, P15
   ENG T, 2001, EHEALTH LANDSCAPE TE
   Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e20
   Gibson J. J., 1986, ECOLOGICAL APPROACH
   Hendriks J. M., 2015, EUROPEAN J CARDIOVAS, V15, P200
   Kaplan B, 2001, INT J MED INFORM, V64, P15, DOI 10.1016/S1386-5056(01)00183-6
   Knott VE, 2014, EUR J CANCER CARE, V23, P713, DOI 10.1111/ecc.12268
   Leadbeater C., 2010, LEARNING EXTREMES
   Ministerio da Saude. Departamento de Monitoramento e Avaliacao do SUS, 2016, POL NAC INF INF SAUD
   Morris L., 2002, J INNOVATION HLTH IN, V10, P85
   Mukherjee A, 2007, INT J PHARM HEALTHC, V1, P349, DOI 10.1108/17506120710840170
   O'Reilly T., 2005, CIPEDYA, V5
   Saez Vacas F., 2007, WEB 2 0, P96
   Showell C, 2012, STUD HEALTH TECHNOL, V180, P881, DOI 10.3233/978-1-61499-101-4-881
   Sinha R. K., 2012, INT J BIOSCIENCES TE, V5, P76
   Skinner HA, 2006, HEALTH PROMOT PRACT, V7, P406, DOI 10.1177/1524839905278889
   P GRAPHICS INTERFACE, P179
NR 19
TC 0
Z9 0
U1 0
U2 2
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 0103-3786
J9 TRANSINFORMACAO
JI Transinformacao
PY 2019
VL 31
AR UNSP e170059
DI 10.1590/2318-0889201931e170059
PG 9
WC Information Science & Library Science
SC Information Science & Library Science
GA HY9ST
UT WOS:000468482300001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Auerbach, Y
   Isseroff, R
   Clayton, N
   Hulyalkar, M
   Todt, A
   Ricotta, V
   Rafailovich, M
AF Auerbach, Yehoshua
   Isseroff, Rebecca
   Clayton, Nicholas
   Hulyalkar, Miguel
   Todt, Andrew
   Ricotta, Vincent
   Rafailovich, Miriam
TI Reusable Surface Molecular Imprint Biosensors Aided by Naturally
   Occurring Surface Roughness Indices for Point-of-Care Diagnostics
SO MRS ADVANCES
LA English
DT Article
AB We have shown that molecular imprinting (MI) technology can be used to produce sensitive, robust, cost-effective biosensing systems with a real-time electrochemical readout that can be utilized for point of care diagnostics. Real time detection of biomarkers is essential when rapid, critical decisions need to be made, such as in situations where public health is threatened. Our biosensor has high sensitivity compared to standard methods like ELISA, and results are obtained within minutes, using inexpensive, accessible potentiometric readout technology. These biosensors utilize surface molecular imprinting of a self-assembling monolayer of hydroxy-terminated alkanethiol chains which form a crystalline 'lock-and-key' structure around a target analyte, allowing the sensors to detect and differentiate between bio-macromolecules of similar size and shape with high selectivity and sensitivity. The sensors are extremely versatile and able to detect a diverse range of molecules of varied chemical composition and structure. To fully exploit the sensors' advantages, especially in remote, economically disadvantaged areas, it is important to quantify their durability and reusability. Biosensor chips were created to test the viability of hemoglobin detection and to evaluate the potential for sensor reusability when washed after detection testing. The successful readsorption of hemoglobin even after washing, accompanied by cyclic voltammetry data indicating the preservation of the SAM, indicate that these biosensors are reusable, significantly augmenting the device's value. Potential applications include the analysis of complex chemical and biological processes such as stem cell differentiation and on-the-spot detection of diseases such as Zika.
C1 [Auerbach, Yehoshua; Isseroff, Rebecca] Lawrence High Sch, Cedarhurst, NY 11516 USA.
   [Clayton, Nicholas; Ricotta, Vincent; Rafailovich, Miriam] SUNY Stony Brook, Stony Brook, NY 11794 USA.
   [Hulyalkar, Miguel] South Side High Sch, Rockville Ctr, NY USA.
   [Todt, Andrew] Lake Oswego High Sch, Lake Oswego, OR USA.
RP Auerbach, Y (corresponding author), Lawrence High Sch, Cedarhurst, NY 11516 USA.
FU Morin Foundation; National Science Foundation Project Inspire
FX The authors would like to thank the Morin Foundation and the National
   Science Foundation Project Inspire for their generous support of this
   research.
CR BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Mathur A., 2013, PLOS ONE, V8
   Wang YT, 2008, BIOSENS BIOELECTRON, V24, P162, DOI 10.1016/j.bios.2008.04.010
   Wang YT, 2010, SENSOR ACTUAT B-CHEM, V146, P381, DOI 10.1016/j.snb.2010.02.032
   Yu YJ, 2016, ANALYST, V141, P5607, DOI 10.1039/c6an01157h
   Yu YJ, 2016, ANALYST, V141, P4424, DOI 10.1039/c6an00375c
NR 6
TC 0
Z9 0
U1 1
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 2059-8521
J9 MRS ADV
JI MRS Adv.
PY 2019
VL 4
IS 22
BP 1299
EP 1308
DI 10.1557/adv.2019.138
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA HX5OM
UT WOS:000467451400006
DA 2020-07-08
ER

PT J
AU Abu-rish, EY
   Elayeh, ER
   Albsoul-Younes, AM
AF Abu-rish, Eman Y.
   Elayeh, Eman R.
   Albsoul-Younes, Abla M.
TI The Role of the Middle East in ZIKA Virus Circulation: Implications of a
   Cross-Sectional Study in Jordan
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DISEASE; PREVENTION; INFECTION; KNOWLEDGE
AB ZIKA virus (ZIKAV) outbreak in Latin America was associated with international concerns of ZIKAV circulation. The lack of vaccine and Food and Drug Administration (FDA)-approved drugs against this virus rendered prevention as the single most effective method to control its spread. Hence, this study aimed to assess Jordanian population knowledge, attitude, and practices toward ZIKAV and its prevention. An anonymous questionnaire was administered to adults in Amman, Jordan. The overall knowledge of participants was poor (mean knowledge score of 13.7/32). Between 75% and 86% of the respondents did not know the highest risk group of ZIKAV infection, its complications, and the major routes of transmission. About 40% of the population did not know that ZIKAV is sexually transmitted. Only 40% of the population believed that prevention measures are effective. Female gender, working in the medical field, having children, and the source of medical information were associated with significantly higher level of knowledge (R-2 = 0.143, P-value < 0.0001). Being pregnant, however, was not associated with a significantly high knowledge score. Physician recommendations and government's role were the most important predictors of practices toward ZIKAV prevention. Of the 14 returnees from outbreak areas, only six were tested for ZIKAV on coming back and only three continued the use of prevention measures for a sufficient time. Therefore, formulation of a national health policy, preparedness plans against any potential transmission, and organization of educational campaigns to meet the population's health educational needs are required. Special emphasis should be placed on pregnant women and travelers to/returnees from ZIKAV-affected areas.
C1 [Abu-rish, Eman Y.; Elayeh, Eman R.; Albsoul-Younes, Abla M.] Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman 11942, Jordan.
RP Abu-rish, EY (corresponding author), Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman 11942, Jordan.
EM e.aburish@ju.edu.jo; e.elayeh@ju.edu.jo; ablabsoul@ju.edu.jo
RI Abu-rish, Eman Y./G-2006-2016
OI Abu-rish, Eman Y./0000-0003-4274-9354
FU Deanship of Academic Research (DAR) at the University of Jordan
FX The Deanship of Academic Research (DAR) at the University of Jordan.
CR Abu-rish EY, 2016, FAM PRACT, V33, P690, DOI 10.1093/fampra/cmw086
   Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Al Rifai R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007703
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Brissett DI, 2018, AM J TROP MED HYG, V99, P211, DOI 10.4269/ajtmh.18-0014
   CDC, 2018, ZIK VIR
   Centers for disease control and prevention (CDC), 2018, WORLD MAP AR ZIK RIS
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Connor P, 2016, MIDDLE E MIGRANT POP
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Howells ME, 2018, ANN HUM BIOL, V45, P229, DOI 10.1080/03014460.2018.1465594
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Kanani K, 2017, J AM MOSQUITO CONTR, V33, P134, DOI 10.2987/17-6641.1
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   McCulloch K, 2017, AM J INFECT CONTROL, V45, pS148
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Nimer NA, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/8679174
   Pan American Health Organization (PAHO), 2016, GUID SURV ZIK VIR DI
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Silva GS, 2018, J CRIT CARE, V46, P106, DOI 10.1016/j.jcrc.2018.03.030
   Sweileh WM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5690-4
   Tridane A, 2016, TRAVEL MED INFECT DI, V14, P277, DOI 10.1016/j.tmaid.2016.03.003
   WHO, 2017, ZIK VIR SIT REP
   World Health Organization (WHO), 2009, PRINC INF DIS TRANSM
NR 30
TC 2
Z9 2
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 4
BP 974
EP 980
DI 10.4269/ajtmh.18-0715
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HW9UV
UT WOS:000467037100035
PM 30675847
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Prata-Barbos, A
   Martins, AM
   Guastavino, AB
   da Cunha, AJLA
AF Prata-Barbos, Arnaldo
   Martins, Arlos Melo
   Guastavino, Andreia Bittencourt
   Ledo Alves da Cunha, Antonio Jose
TI Effects of Zika infection on growth
SO JORNAL DE PEDIATRIA
LA English
DT Review
DE Zika virus infection; Growth; Microcephaly
ID CHILDREN; INFANTS
AB Objectives: To present the currently available evidence of the effects of congenital Zika virus infection on infant growth, to discuss possible intervening factors, and to describe preliminary data on this growth in a cohort of exposed children.
   Source of data: Non-systematic review in PubMed, BVS, CAPES, Scopus, Web of Science, Cochrane and Google Scholar databases in the last 5 years, using the terms infection/disease by Zika virus and growth/nutrition/nutritional status/infant nutrition and nutritional needs. Additionally, the anthropometric data of the first 2.5 years of a cohort of children exposed to the Zika virus during pregnancy were reviewed.
   Synthesis of data: Both intrauterine growth restriction and low birth weight were reported in series of cases of children with congenital Zika syndrome. The postnatal growth deficit of these children appears to be directly proportional to the degree of neurological impairment. The etiology is multifactorial, and nutritional and non-nutritional factors are probably involved. The data from the present cohort show that the head circumference evolution depends on this measurement at birth and that weight-height growth has a trend toward lower weight and length in children with congenital microcephaly and normocephalic at birth who develop some neurological abnormality.
   Conclusions: The few existing data suggest that, in children with congenital Zika, the greater the degree of neurological impairment, the greater the impact on growth, whether or not associated with microcephaly at birth. (C) 2018 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [Prata-Barbos, Arnaldo] Inst DOr Pesquisa & Ensino IDOR, Rio De Janeiro, RJ, Brazil.
   [Martins, Arlos Melo; Guastavino, Andreia Bittencourt] Univ Fed Rio de Janeiro, Maternidade Escola, Rio de Janeiro, RJ, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Rio de Janeiro, RJ, Brazil.
   [Prata-Barbos, Arnaldo; Martins, Arlos Melo; Guastavino, Andreia Bittencourt; Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
RP Prata-Barbos, A (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Rio De Janeiro, RJ, Brazil.
EM arnatdo.prata@idor.org
RI Barbosa, Arnaldo Prata/B-2212-2009
OI Barbosa, Arnaldo Prata/0000-0002-4726-9782
CR de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Brasil. Ministerio da Saude, 2017, OR INT VIG AT SAUD A
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2015, B EPIDEMIOLOGICO, V46
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Onis M., 2006, WHO CHILD GROWTH STA
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Le Roy C, 2017, NEUROLOGIA, DOI [10.1016/j.nrl.2017.11.005, DOI 10.1016/J.NRL.2017.11.005]
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Romano C, 2017, J PEDIATR GASTR NUTR, V65, P242, DOI 10.1097/MPG.0000000000001646
   Sanchez-Lastres J, 2003, ACTA PAEDIATR, V92, P747, DOI 10.1080/08035250310002623
   Santa Rita Ticiane Henriques, 2017, BMC Res Notes, V10, P457, DOI 10.1186/s13104-017-2796-1
   Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249
   Valentine GC, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.005
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Verrotti A, 2011, EPILEPSY RES, V95, P189, DOI 10.1016/j.eplepsyres.2011.05.014
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   Yacubian EM, 2014, TRATAMENTO MEDICAMEN
   2016, EUR J PAEDIATR NEURO, V20, P810, DOI DOI 10.1016/J.EJPN.2016.05.019
   2016, CELL STEM CELL, V18, P587, DOI DOI 10.1016/J.STEM.2016.02.016
   2015, NUTRIENTS, V7, P9400, DOI DOI 10.3390/NU7115469
   2008, INT J HEMATOL, V88, P495, DOI DOI 10.1007/S12185-008-0191-3
   2018, CHILD NERV SYST, V34, P73, DOI DOI 10.1007/S00381-017-3634-4
   2015, PHYS MED REH CLIN N, V26, P39, DOI DOI 10.1016/J.PMR.2014.09.001
   2016, DEV MED CHILD NEUROL, V58, P936, DOI DOI 10.1111/DMCN.13108
   2017, J AAPOS, V21, P295, DOI DOI 10.1016/J.JAAPOS.2017.04.003
   2013, AM J HUM BIOL, V25, P58, DOI DOI 10.1002/AJHB.22341
   2016, JAMA OPHTHALMOL, V134, P912, DOI DOI 10.1001/JAMAOPHTHALMOL.2016.1784
   2016, LANCET INFECT DIS, V16, P1356, DOI DOI 10.1016/S1473-3099(16)30318-8
   2019, ARCH DIS CHILD, V104, P199, DOI DOI 10.1136/ARCHDISCHILD-2018-314782
   2015, INDIAN J PEDIATR, V82, P140, DOI DOI 10.1007/S12098-014-1543-Z
   2016, SCIENCE, V352, P816, DOI DOI 10.1126/SCIENCE.AAF6116
   2016, DEV MED CHILD NEUROL, V58, P893, DOI DOI 10.1111/DMCN.13134
   2017, LANCET, V390, P861, DOI DOI 10.1016/S0140-6736(17)31368-5
   1995, ARCH PEDIAT ADOLESC, V149, P658
   2018, EMERG INFECT DIS, V24, P1850, DOI DOI 10.3201/EID2410.172079
NR 42
TC 5
Z9 5
U1 0
U2 3
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PY 2019
VL 95
SU 1
BP S30
EP S41
DI 10.1016/j.jped.2018.10.016
PG 12
WC Pediatrics
SC Pediatrics
GA HU4QV
UT WOS:000465261900005
PM 30593788
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, Y
   Huang, M
   Peng, L
AF Li, Yong
   Huang, Meng
   Peng, Li
TI A multi-group model for estimating the transmission rate of hand, foot
   and mouth disease in mainland China
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE HFMD; multi-group model; basic reproduction number; parameter
   estimation; sensitivity analyses
ID SEIR EPIDEMIC MODEL; CONTAMINATED ENVIRONMENTS; HFMD INFECTIONS;
   SEASONAL HFMD; ZIKA VIRUS; DYNAMICS; STABILITY; ENTEROVIRUS-71
AB In order to access the influence of different age groups on the spread of hand, foot and mouth disease (HFMD), we established the multi-group model with migration following the epidemiology of HFMD. The basic reproduction number of the HFMD epidemic model was calculated by the next generation operator method. According to China's national surveillance data on HFMD, we fitted the model parameters and estimated the transmission rates among different age groups. Besides, we carried out sensitivity analysis for the basic reproduction number to find some valuable regulatory measures. Our findings showed that the children under three years of age were indeed at high risk and adult group who had more contacts with children had a crucial influence on the spread of HFMD.
C1 [Li, Yong; Huang, Meng; Peng, Li] Yangtze Univ, Sch Informat & Math, Jingzhou 434023, Peoples R China.
   [Li, Yong] Yangtze Univ, Inst Appl Math, Jingzhou 434023, Peoples R China.
RP Li, Y (corresponding author), Yangtze Univ, Sch Informat & Math, Jingzhou 434023, Peoples R China.; Li, Y (corresponding author), Yangtze Univ, Inst Appl Math, Jingzhou 434023, Peoples R China.
EM yongli@yangtzeu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11471133, 11547006]; Chongqing Postdoctoral Science
   Foundation [Xm2017139]; Scientific Research Project of Hubei Provincial
   Department of Education [B2017039]
FX We would like to thank anonymous reviewers for very helpful suggestions
   which improved greatly this manuscript. The work is supported by
   National Natural Science Foundation of China (Nos. 11471133 and
   11547006), Chongqing Postdoctoral Science Foundation Special Funded
   Project (No. Xm2017139) and Scientific Research Project of Hubei
   Provincial Department of Education (No. B2017039).
CR [Anonymous], 2018, NOTIFIABLE INFECT DI
   [Anonymous], 2017, HAND FOOT MOUTH DIS
   Cai YL, 2019, APPL MATH LETT, V92, P190, DOI 10.1016/j.aml.2019.01.015
   Cai YL, 2019, NONLINEAR ANAL-REAL, V46, P178, DOI 10.1016/j.nonrwa.2018.09.006
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Feng ZL, 2005, J DIFFER EQUATIONS, V218, P292, DOI 10.1016/j.jde.2004.10.009
   Gao SJ, 2008, NONLINEAR ANAL-REAL, V9, P599, DOI 10.1016/j.nonrwa.2006.12.004
   Guo H., 2006, CANADIAN APPL MATH Q, V14, P259
   Hamaguchi T, 2008, EMERG INFECT DIS, V14, P828, DOI 10.3201/eid1405.071121
   Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3
   HUANG WZ, 1992, SIAM J APPL MATH, V52, P835, DOI 10.1137/0152047
   Koide C, 1996, MATH COMPUT MODEL, V23, P67, DOI 10.1016/0895-7177(96)00004-0
   Korobeinikov A, 2009, B MATH BIOL, V71, P75, DOI 10.1007/s11538-008-9352-z
   LAJMANOVICH A, 1976, Mathematical Biosciences, V28, P221, DOI 10.1016/0025-5564(76)90125-5
   Li GH, 2005, CHAOS SOLITON FRACT, V25, P1177, DOI 10.1016/j.chaos.2004.11.062
   Li Y, 2016, APPL MATH COMPUT, V276, P61, DOI 10.1016/j.amc.2015.11.090
   Li Y, 2014, INT J ENV RES PUB HE, V11, P3108, DOI 10.3390/ijerph110303108
   Liang H, 2010, ANN APPL STAT, V4, P460, DOI 10.1214/09-AOAS290
   Ljubin-Sternak S, 2011, EUROSURVEILLANCE, V16, P9
   Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003
   Ma YJ, 2013, MATH BIOSCI ENG, V10, P1159, DOI 10.3934/mbe.2013.10.1159
   Mao QY, 2016, EXPERT REV VACCINES, V15, P599, DOI 10.1586/14760584.2016.1138862
   Mathes EF, 2013, PEDIATRICS, V132, pE149, DOI 10.1542/peds.2012-3175
   Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y
   Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10
   Moles CG, 2004, APPL SOFT COMPUT, V5, P35, DOI 10.1016/j.asoc.2004.03.011
   Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180
   Samanta GP, 2015, COMPUT APPL MATH, V34, P1131, DOI 10.1007/s40314-014-0170-7
   Samsuzzoha M, 2013, APPL MATH MODEL, V37, P903, DOI 10.1016/j.apm.2012.03.029
   Thieme H.R., 2003, MATH POPULATION BIOL
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang JY, 2016, BIOSYSTEMS, V140, P1, DOI 10.1016/j.biosystems.2015.12.001
   Wang JY, 2016, APPL MATH COMPUT, V274, P615, DOI 10.1016/j.amc.2015.11.035
   Wang WM, 2018, J FRANKLIN I, V355, P7226, DOI 10.1016/j.jfranklin.2018.07.014
   Wang X, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.30
   Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443
   Yang B, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1925-z
   Yang JY, 2013, J APPL MATHE COMPUT, V41, P99, DOI 10.1007/s12190-012-0597-1
   Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7
   Yin XG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-251
   Zhu Y., 2014, ABSTR APPL ANAL, V2014, P16
NR 41
TC 1
Z9 2
U1 1
U2 4
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 4
BP 2305
EP 2321
DI 10.3934/mbe.2019115
PG 17
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA HU7BG
UT WOS:000465435500033
PM 31137214
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Sanchez, F
   Barboza, LA
   Vasquez, P
AF Sanchez, Fabio
   Barboza, Luis A.
   Vasquez, Paola
TI Parameter estimates of the 2016-2017 Zika outbreak in Costa Rica: An
   Approximate Bayesian Computation (ABC) approach
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE Zika virus; basic reproductive number; Approximate Bayesian Computation;
   public health; transmission dynamics; epidemic models; vector-borne
   diseases
ID DENGUE TRANSMISSION; VIRUS-INFECTION; DISEASE; MODELS; DISPERSAL;
   DYNAMICS; AEGYPTI; NUMBER
AB In Costa Rica, the first known cases of Zika were reported in 2016. We looked at the 2016-2017 Zika outbreak and explored the transmission dynamics using weekly reported data. A nonlinear differential equation single-outbreak model with sexual transmission, as well as host availability for vector-feeding was used to estimate key parameters, fit the data and compute the basic reproductive number, R-0, distribution. Furthermore, a sensitivity and elasticity analysis was computed based on the R-0 parameters.
C1 [Sanchez, Fabio; Barboza, Luis A.] Univ Costa Rica, CIMPA Escuela Matemat, San Jose, Costa Rica.
   [Vasquez, Paola] Univ Costa Rica, Escuela Salud Publ, San Jose, Costa Rica.
RP Sanchez, F (corresponding author), Univ Costa Rica, CIMPA Escuela Matemat, San Jose, Costa Rica.
EM fabio.sanchez@ucr.ac.cr
RI Chinchilla, Luis A. Barboza/V-4414-2019
OI Chinchilla, Luis A. Barboza/0000-0002-7009-5207
CR Aguilera A. I., 2018, ESTUDIO URBANIZACION
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Althaus CL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003871
   Arriola L., 2009, MATH STAT ESTIMATION
   Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Basu S., 2013, PLOS MED, V10
   Besnard M., 2013, EURO SURVEILL, V13
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brauer F., 2012, COMPUTATIONAL MODELI
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006
   Cruz G., 2019, J BIOL SYST, V27
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eisenberg JNS, 2002, ENVIRON HEALTH PERSP, V110, P783, DOI 10.1289/ehp.02110783
   Esteva L, 1999, J MATH BIOL, V38, P220, DOI 10.1007/s002850050147
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Ferdousi T., 2019, BIORXIV
   Gao D., 2016, SCI REP, V6
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman L. A., 2009, CAMBIO CLIMATICO CAU
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Holland J.H., 1992, ADAPTATION NATURAL A
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Instituto Costarricense de Investigaci on y Ense nanzaen Nutricion y Salud, 2017, INF VIG ARB BAS LAB
   Instituto Costarricense de Investigacion y Ense nanzaen Nutrici on y Salud, 2018, INF VIG ARB BAS LAB
   Instituto Costarricense de Investigacion y Ense nanzaen Nutricion y Salud, 2016, INF VIG ARB BAS LAB
   Instituto Nacional de Estadistica y Censos, 2018, EN NAC US TIEMP 2017
   Jabot F, 2013, METHODS ECOL EVOL, V4, P684, DOI 10.1111/2041-210X.12050
   Juarbe D., 2018, INT J ENV RES PUB HE, V15, P2
   KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1
   Lee S, 2015, J THEOR BIOL, V374, P152, DOI 10.1016/j.jtbi.2015.03.005
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Lock JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27957-2
   Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Mena N, 2011, REV PANAM SALUD PUBL, V29, P234, DOI 10.1590/S1020-49892011000400004
   Ministerio de Salud, 2010, LIN NAC CONTR DENG
   Ministerio de Salud, 2016, LIN NAC AB INT MUJ E
   Morice A., 2010, SALUD PUBLICA COSTA, P197
   Murillo D., 2014, BIOL LETT, V1, P249, DOI DOI 10.1080/23737867.2014.11414484
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mustafa M S, 2018, Med J Armed Forces India, V74, P61, DOI 10.1016/j.mjafi.2016.08.010
   Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186
   Olawoyin O, 2018, INFECT DIS MODEL, V3, P331, DOI 10.1016/j.idm.2018.11.003
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pan American Health Organization; World Health Organization, 2018, ZIK CAS CONG SYNDR A
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pritchard J. K., 1998, MOL BIOL EVOL, P1791
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sanchez A., 2017, TROP MED INT HEALTH, V23, P92
   Sanchez F, 2006, CONTEMP MATH, V410, P311
   Sanchez F, 2012, BIOMAT 2011: INTERNATIONAL SYMPOSIUM ON MATHEMATICAL AND COMPUTATIONAL BIOLOGY, P191
   Sanchez F, 2018, RIC MAT, V67, P163, DOI 10.1007/s11587-018-0362-3
   SCHOOF HF, 1967, B WORLD HEALTH ORGAN, V36, P600
   Scrucca L, 2013, J STAT SOFTW, V53, P1
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Sisson S. A., 2019, HDB APPROXIMATE BAYE
   Solano J., 2000, REGIONES SUBREGIONES
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Troyo A., 2007, THESIS
   van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002
   WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   2013, MATH BIOSCI ENG, V10, P1455, DOI DOI 10.3934/MBE.2013.10.1455
NR 82
TC 0
Z9 0
U1 1
U2 5
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 4
BP 2738
EP 2755
DI 10.3934/mbe.2019136
PG 18
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA HU7BG
UT WOS:000465435500054
PM 31137235
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Yamamoto, N
   Lee, H
   Nishiura, H
AF Yamamoto, Nao
   Lee, Hyojung
   Nishiura, Hiroshi
TI Exploring the mechanisms behind the country-specific time of Zika virus
   importation
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE effective distance; network; prediction; pandemic; probabilistic models;
   global spread
ID TRANSMISSION; EPIDEMIOLOGY; OUTBREAK; NUMBER; SOUTH
AB The international spread of Zika virus (ZIKV) began in Brazil in 2015. To estimate the risk of observing imported ZIKV cases, we calculated effective distance, typically an excellent predictor of arrival time, from airline network data. However, we eventually concluded that, for ZIKV, effective distance alone is not an adequate predictor of arrival time, which we partly attributed to the difficulty of diagnosing and ascertaining ZIKV infections. Herein, we explored the mechanisms behind the observed time delay of ZIKV importation by country, statistically decomposing the delay into two parts: the actual time to importation from Brazil and the reporting delay. The latter was modeled as a function of the gross domestic product (GDP) and other variables that influence underlying diagnostic capacity in a given country. We showed that a high GDP per capita is a good predictor of short reporting delay. ZIKV infection is generally mild and, without substantial laboratory capacity, cases can be underestimated. This study successfully demonstrates this phenomenon and emphasizes the importance of accounting for reporting delays as part of the data generating process for estimating time to importation.
C1 [Yamamoto, Nao; Lee, Hyojung; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
   [Yamamoto, Nao; Lee, Hyojung; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Saitama, Japan.
RP Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.
EM nishiurah@med.hokudai.ac.jp
FU Japan Agency for Medical Research and DevelopmentJapan Agency for
   Medical Research and Development (AMED) [JP18fk0108050]; Japan Society
   for the Promotion of Science KAKENHIMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [18H06385, 16KT0130, 17H04701, 17H05808, 18H04895]; Health and Labour
   Sciences Research GrantMinistry of Health, Labour and Welfare, Japan
   [H28-AIDS-General-001]; Inamori Foundation; Telecommunication
   Advancement Foundation; Japan Science and Technology Agency (JST) CREST
   program [JPMJCR1413]; Japan Society for the Promotion of Science,
   Program for Advancing Strategic International Networks to Accelerate the
   Circulation of Talented ResearchersMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of Science
FX HN received funding support from the Japan Agency for Medical Research
   and Development (JP18fk0108050); Japan Society for the Promotion of
   Science KAKENHI (Grant Numbers 16KT0130, 17H04701, 17H05808 and
   18H04895); Health and Labour Sciences Research Grant
   (H28-AIDS-General-001); the Inamori Foundation; the Telecommunication
   Advancement Foundation; and the Japan Science and Technology Agency
   (JST) CREST program (JPMJCR1413). HL received financial support from the
   Japan Society for the Promotion of Science, Program for Advancing
   Strategic International Networks to Accelerate the Circulation of
   Talented Researchers; and the Japan Society for the Promotion of Science
   KAKENHI (Grant number 18H06385). The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. We also thank Ashley Hazel, PhD, from
   Edanz Group (www.edanzediting.com/ac) for editing a draft of this
   manuscript.
CR Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Benelli G., 2016, PARASITOL RES, V115
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Central Intelligence Agency, WORLD FACTB 2017
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Keegan LT, 2017, J INFECT DIS, V216, pS884, DOI 10.1093/infdis/jix437
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Malone R. W., 2016, PLOS NEGLECTED TROP, V10, P1
   Marshall J. M., 2018, SCI REP, V8, P1
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Nah K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1675-z
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   Organization W.H, GLOB HLTH OBS DAT RE
   Otsuki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163418
   Patokallio J., 2016, OPENFLIGHTS DATA
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sun KY, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1185-5
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   World Health Organization, 2017, SIT REPORTZIKA VIR M
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 42
TC 1
Z9 1
U1 0
U2 1
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PY 2019
VL 16
IS 5
BP 3272
EP 3284
DI 10.3934/mbe.2019163
PG 13
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA HU7CB
UT WOS:000465437600005
PM 31499613
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mitchell, PK
   Mier-y-Teran-Romero, L
   Biggerstaff, BJ
   Delorey, MJ
   Aubry, M
   Cao-Lormeau, VM
   Lozier, MJ
   Cauchemez, S
   Johansson, MA
AF Mitchell, Patrick K.
   Mier-y-Teran-Romero, Luis
   Biggerstaff, Brad J.
   Delorey, Mark J.
   Aubry, Maite
   Cao-Lormeau, Van-Mai
   Lozier, Matthew J.
   Cauchemez, Simon
   Johansson, Michael A.
TI Reassessing Serosurvey-Based Estimates of the Symptomatic Proportion of
   Zika Virus Infections
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Markov chain; serological tests; signs and symptoms; Zika virus; Zika
   virus infection
ID EXPOSURE; OUTBREAK; UPDATE; STATES
AB Since the 2007 Zika epidemic in the Micronesian state of Yap, it has been apparent that not all people infected with Zika virus (ZIKV) experience symptoms. However, the proportion of infections that result in symptoms remains unclear. Existing estimates have varied in their interpretation of symptoms due to other causes and the case definition used, and they have assumed perfect test sensitivity and specificity. Using a Bayesian model and data from ZIKV serosurveys in Yap (2007), French Polynesia (2013-2014), and Puerto Rico (2016), we found that assuming perfect sensitivity and specificity generally led to lower estimates of the symptomatic proportion. Incorporating reasonable assumptions for assay sensitivity and specificity, we estimated that 27% (95% credible interval (CrI): 15, 37) (Yap), 44% (95% CrI: 26, 66) (French Polynesia), and 50% (95% CrI: 34, 92) (Puerto Rico) of infections were symptomatic, with variation due to differences in study populations, study designs, and case definitions. The proportion of ZIKV infections causing symptoms is critical for surveillance system design and impact assessment. Here, we accounted for key uncertainties in existing seroprevalence data and found that estimates for the symptomatic proportion ranged from 27% to 50%, suggesting that while the majority of infections are asymptomatic or mildly symptomatic, symptomatic infections might be more common than previously estimated.
C1 [Mitchell, Patrick K.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Mitchell, Patrick K.] Pennsylvania Dept Hlth, Harrisburg, PA USA.
   [Mier-y-Teran-Romero, Luis; Lozier, Matthew J.; Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Biggerstaff, Brad J.; Delorey, Mark J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Aubry, Maite; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, Simon] CNRS, URA 3012, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA USA.
RP Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 1324 Calle Canada, San Juan, PR 00920 USA.
EM mjohansson@cdc.gov
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Johansson,
   Michael/0000-0002-5090-7722; Aubry, Maite/0000-0002-9913-5794
FU European Union's Horizon 2020 Programme through ZIKAlliance [734548];
   Laboratory of Excellence Integrative Biology of Emerging Infectious
   Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious Disease
   Agent Study of the National Institute of General Medical Sciences; AXA
   Research Fund; Contrat de Projet Etat-Pays [convention 7331/MSS/DSP du
   31/08/12 modifiee]; French Government's Investissement d'Avenir
   Programme (Labex Integrative Biology of Emerging Infectious Diseases)
   [ANR-10-LABX-62-IBEID]; Models of Infectious Disease Agent Study program
   [1U54GM088558]
FX S.C. acknowledges support from the European Union's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Laboratory of
   Excellence Integrative Biology of Emerging Infectious Diseases program
   (grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent
   Study of the National Institute of General Medical Sciences, and the AXA
   Research Fund. The serosurvey conducted in French Polynesia was
   partially funded by the Contrat de Projet Etat-Pays (convention
   7331/MSS/DSP du 31/08/12 modifiee) and the French Government's
   Investissement d'Avenir Programme (Labex Integrative Biology of Emerging
   Infectious Diseases, grant ANR-10-LABX-62-IBEID). M.A.J. received
   partial support from the Models of Infectious Disease Agent Study
   program (Cooperative Agreement 1U54GM088558).
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pan American Health Organization, 2016, TIM EM ZIK VIR AM AP
   Plummer M., 2016, RJAGS BAYESIAN GRAPH
   Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Team RC, 2016, R LANG ENV STAT COMP
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 26
TC 8
Z9 8
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD JAN
PY 2019
VL 188
IS 1
BP 206
EP 213
DI 10.1093/aje/kwy189
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HU6AB
UT WOS:000465359900024
PM 30165474
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Einspieler, C
   Utsch, F
   Brasil, P
   Aizawa, CYP
   Peyton, C
   Hasue, RH
   Genovesi, FF
   Damasceno, L
   Moreira, ME
   Adachi, K
   Marschik, PB
   Nielsen-Saines, K
   Bartl-Pokorny, KD
   Krieber-Tomantschger, I
   Krieber-Tomantschger, M
   Langmann, L
   Peharz, R
   Pokorny, FB
   Zhang, DJ
   Ramos, C
   Silva, D
   Reis, A
   Alves, E
   Passos, SA
   Velloso, R
   Dobaja, F
   Pansy, J
   Scheuchenegger, A
AF Einspieler, Christa
   Utsch, Fabiana
   Brasil, Patricia
   Aizawa, Carolina Y. Panvequio
   Peyton, Colleen
   Hasue, Renata Hydee
   Genovesi, Fernanda Francoso
   Damasceno, Luana
   Moreira, Maria Elisabeth
   Adachi, Kristina
   Marschik, Peter B.
   Nielsen-Saines, Karin
   Bartl-Pokorny, Katrin D.
   Krieber-Tomantschger, Iris
   Krieber-Tomantschger, Magdalena
   Langmann, Laura
   Peharz, Robert
   Pokorny, Florian B.
   Zhang, Dajie
   Ramos, Cinthia
   Silva, Diniz
   Reis, Alberto
   Alves, Elaine
   Passos, Sandra Alvarenga
   Velloso Filho, Roberto
   Dobaja, Felicitas
   Pansy, Jasmin
   Scheuchenegger, Anna
CA GM Zika Working Grp
TI Association of Infants Exposed to Prenatal Zika Virus Infection With
   Their Clinical, Neurologic, and Developmental Status Evaluated via the
   General Movement Assessment Tool
SO JAMA NETWORK OPEN
LA English
DT Article
ID CEREBRAL-PALSY; BIRTH
AB IMPORTANCE There is an urgent need to assess neurodevelopment in Zika virus (ZIKV)-exposed infants
   OBJECTIVES To perform general movement assessment (GMA) at 9 to 20 weeks' postterm age and to evaluate whether the findings are associated with neurodevelopmental outcomes at age 12 months in infants prenatally exposed to acute maternal illness with rash in Brazil during the ZIKV outbreak and in age-matched controls.
   DESIGN, SETTING, AND PARTICIPANTS In this cohort study, infants prenatally exposed to acute maternal illness with rash were recruited at medical institutions in Rio de Janeiro and Belo Horizonte, Brazil, from February 1, 2016, to April 30, 2017, while infants without any exposure to maternal illness originated from the Graz University Audiovisual Research Database for the Interdisciplinary Analysis of Neurodevelopment. Participants were 444 infants, including 76 infants without congenital microcephaly, 35 infants with microcephaly, and 333 neurotypical children matched for sex, gestational age at birth, and age at GMA.
   MAIN OUTCOMES AND MEASURES General movement assessment performed at 9 to 20 weeks' postterm age, with negative predictive value, positive predictive value, sensitivity, and specificity generated, as well as clinical, neurologic, and developmental status (Bayley Scales of Infant and Toddler Development, Third Edition [Bayley-III] scores) at age 12 months. Motor Optimality Scores were generated based on the overall quality of the motor repertoire. Adverse outcomes were defined as a Bayley-III score less than 2 SD in at least 1 domain, a score less than 1 SD in at least 2 domains, and/or atypical neurologic findings.
   RESULTS A total of 444 infants were enrolled, including 111 children prenatally exposed to a maternal illness with rash and 333 children without any prenatal exposure to maternal illness (57.7% male and mean [SD] age, 14 [2] weeks for both groups); 82.1%(46 of 56) of ZIKV-exposed infants without congenital microcephaly were healthy at age 12 months. Forty-four of 46 infants were correctly identified by GMA at 3 months, with a negative predictive value of 94%(95% CI, 85%-97%). Seven of 10 ZIKV-exposed children without microcephaly with adverse neurodevelopmental outcomes were identified by GMA. The GMA positive predictive value was 78% (95% CI, 46%-94%), sensitivity was 70%(95% CI, 35%-93%), specificity was 96%(95% CI, 85%-99%), and accuracy was 91%(95% CI, 80%-97%). Children with microcephaly had bilateral spastic cerebral palsy; none had normal movements. The Motor Optimality Score differentiated outcomes: the median Motor Optimality Score was 23 (interquartile range [IQR], 21-26) in children with normal development, 12 (IQR, 8-19) in children with adverse outcomes, and 5 (IQR, 5-6) in children with microcephaly, a significant difference (P=.001).
   CONCLUSIONS AND RELEVANCE This study suggests that although a large proportion of ZIKV-exposed infants without microcephaly develop normally, many do not. The GMA should be incorporated into routine infant assessments to enable early entry into targeted treatment programs.
C1 [Einspieler, Christa; Marschik, Peter B.; Bartl-Pokorny, Katrin D.; Krieber-Tomantschger, Iris; Krieber-Tomantschger, Magdalena; Langmann, Laura; Peharz, Robert; Pokorny, Florian B.; Zhang, Dajie] Med Univ Graz, Interdisciplinary Dev Neurosci iDN, Graz, Austria.
   [Utsch, Fabiana; Ramos, Cinthia; Silva, Diniz; Reis, Alberto; Alves, Elaine; Passos, Sandra Alvarenga; Velloso Filho, Roberto] Rede SARAH Hosp Reabil, Reabil Infantil, Belo Horizonte, MG, Brazil.
   [Brasil, Patricia; Damasceno, Luana] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Aizawa, Carolina Y. Panvequio; Hasue, Renata Hydee; Genovesi, Fernanda Francoso] Univ Sao Paulo, Fac Med, Dept Phys Therapy Commun Sci & Disorders & Occupa, Sao Paulo, Brazil.
   [Peyton, Colleen] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
   [Peyton, Colleen] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.
   [Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Dept Pediat, Rio De Janeiro, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Marschik, Peter B.] Univ Med Ctr Gottingen, Dept Child & Adolescent Psychiat & Psychotherapy, Interdisciplinary Dev Neurosci iDN, Gottingen, Germany.
   [Marschik, Peter B.] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders KIND, Stockholm, Sweden.
   [Dobaja, Felicitas; Pansy, Jasmin; Scheuchenegger, Anna] Med Univ Graz, Dept Pediat, Graz, Austria.
RP Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect,Marion Davies Childrens Clin, Room 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Marschik, Peter
   B/F-8195-2011
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Marschik, Peter
   B/0000-0001-8932-0980
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [AI129847-01]; Thrasher Foundation; Bill and Melinda
   Gates Foundation Grand Challenges ExplorationsGates Foundation [OPP
   1128871]
FX Drs Brasil, Moreira, and Nielsen-Saines were supported by grants AI28697
   and AI1259534-01 from the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (NIH), by grant
   AI129847-01 from the National Eye Institute of the NIH, and by the
   Thrasher Foundation. Dr Marschik was supported by the Bill and Melinda
   Gates Foundation Grand Challenges Explorations (grant OPP 1128871).
CR Adde L, 2016, EUR J PAEDIATR NEURO, V20, P918, DOI 10.1016/j.ejpn.2016.07.019
   Bayley N, 2006, BAYLEY SCALES INFANT
   Bosanquet M, 2013, DEV MED CHILD NEUROL, V55, P418, DOI 10.1111/dmcn.12140
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burger M, 2009, EUR J PAEDIATR NEURO, V13, P408, DOI 10.1016/j.ejpn.2008.09.004
   Cardoso Jr TF, ARCH DIS CHILD
   Crowle C, 2018, EARLY HUM DEV, V118, P42, DOI 10.1016/j.earlhumdev.2018.02.001
   Einspieler C, 2004, SERIES CLIN DEV MED
   Einspieler C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00406
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   Palchik AB, 2013, EARLY HUM DEV, V89, P229, DOI 10.1016/j.earlhumdev.2013.02.004
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricci E, 2018, PHYS OCCUP THER PEDI, V38, P269, DOI 10.1080/01942638.2017.1395380
   Soares-Marangoni DA, DEV NEUROREHABIL
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wu SS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00227
   2017, ARCH PATHOL LAB MED, V141, P26, DOI DOI 10.5858/ARPA.2016-0382-RA
   2018, CURR OPIN PEDIATR, V30, P105, DOI DOI 10.1097/MOP.0000000000000582
   2008, EMERG INFECT DIS, V14, P1232, DOI DOI 10.3201/EID1408.080287
   2011, DEV MED CHILD NEUROL, V53, P896, DOI DOI 10.1111/J.1469-8749.2011.04017.X
   2016, LANCET, V388, P891, DOI DOI 10.1016/S0140-6736(16)30902-3
   2008, DEV MED CHILD NEUROL, V50, P744, DOI DOI 10.1111/J.1469-8749.2008.03089.X
   2016, J PAEDIATR CHILD H, V52, P54, DOI DOI 10.1111/JPC.12995
   2018, MMWR-MORBID MORTAL W, V67, P858, DOI DOI 10.15585/MMWR.MM6731E1
   2016, EARLY HUM DEV, V100, P27, DOI DOI 10.1016/J.EARLHUMDEV.2016.03.010
   2015, EARLY HUM DEV, V91, P479, DOI DOI 10.1016/J.EARLHUMDEV.2015.05.007
NR 30
TC 12
Z9 12
U1 1
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JAN
PY 2019
VL 2
IS 1
AR e187235
DI 10.1001/jamanetworkopen.2018.7235
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA HU6WO
UT WOS:000465422700020
PM 30657537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tozetto-Mendoza, TR
   Avelino-Silva, VI
   Fonseca, S
   Claro, IM
   de Paula, AV
   Levin, AS
   Sabino, EC
   Mendes-Correa, MC
   Figueiredo, WM
   Felix, AC
   Souza, NCS
   Costa, AA
   Inenami, M
   da Silva, RMG
   Levi, JE
   Romano, CM
   Paranhos-BaccalA, G
   Segurado, AC
   Mayaud, P
AF Tozetto-Mendoza, Tania Regina
   Avelino-Silva, Vivian Iida
   Fonseca, Silvia
   Claro, Ingra Morales
   de Paula, Anderson Vicente
   Levin, Anna Sara
   Sabino, Ester Cerdeira
   Mendes-Correa, Maria Cassia
   Figueiredo, Walter Manso
   Felix, Alvina Clara
   Santiago Souza, Nathalia C.
   Costa, Angela Aparecida
   Inenami, Maria
   Gasparetto da Silva, Rosangela M.
   Levi, Jose Eduardo
   Romano, Camila Malta
   Paranhos-BaccalA, Glaucia
   Segurado, Aluisio Cotrim
   Mayaud, Philippe
TI Zika virus infection among symptomatic patients from two healthcare
   centers in Sao Paulo State, Brazil: prevalence, clinical
   characteristics, viral detection in body fluids and serodynamics
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Zika virus; Differential diagnosis; Kinetics; Body fluids; Polymerase
   chain reaction; Real-Time Polymerase Chain Reaction; Serology; Brazil
ID MALE SEXUAL TRANSMISSION; TIME RT-PCR; DENGUE; EPIDEMIC
AB Zika virus (ZIKV) clinical presentation and frequency/duration of shedding need further clarification. Symptomatic ZIKV-infected individuals identified in two hospitals in Sao Paulo State, Brazil, were investigated regarding clinical characteristics, shedding in body fluids, and serodynamics. Ninety-four of 235 symptomatic patients (Site A: 58%; Site B: 16%) had Real-Time PCR-confirmed ZIKV infection; fever, headache and gastrointestinal symptoms were less frequent, and rash was more frequent compared to ZIKV-negative patients. Real-Time PCR in serum had worse performance compared to plasma, while urine had the highest sensitivity. Shedding in genital fluids and saliva was rare. IgM positivity was the highest <14 days after the symptoms onset (86%), decreasing >28 days (24%); IgG positivity increased >14 days (96%) remaining positive in 94% of patients >28 days. ZIKV prevalence varied importantly in two neighboring cities during the same transmission season. Urine Real-Time PCR can improve diagnostic sensitivity; serum testing is less useful. Accurate serological tests are needed to improve diagnosis and surveillance.
C1 [Tozetto-Mendoza, Tania Regina; de Paula, Anderson Vicente; Levin, Anna Sara; Sabino, Ester Cerdeira; Mendes-Correa, Maria Cassia; Felix, Alvina Clara; Santiago Souza, Nathalia C.; Levi, Jose Eduardo; Romano, Camila Malta; Paranhos-BaccalA, Glaucia; Segurado, Aluisio Cotrim; Mayaud, Philippe] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil.
   [Avelino-Silva, Vivian Iida; Claro, Ingra Morales; Levin, Anna Sara; Sabino, Ester Cerdeira; Mendes-Correa, Maria Cassia; Segurado, Aluisio Cotrim] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil.
   [Fonseca, Silvia] Hosp Sao Francisco, Ribeirao Preto, SP, Brazil.
   [Figueiredo, Walter Manso; Costa, Angela Aparecida; Inenami, Maria; Gasparetto da Silva, Rosangela M.] Univ Sao Paulo, Fac Saude Publ, Serv Especial Saude Araraquara, Araraquara, SP, Brazil.
   [Paranhos-BaccalA, Glaucia] BioMerieux SA, Med Diagnost Discovery Dept MD3, Marcy Letoile, France.
   [Mayaud, Philippe] Fac Infect & Trop Dis, London Sch Hyg & Trop Med, London, England.
RP Avelino-Silva, VI (corresponding author), Univ Sao Paulo, Inst Med Trop Sao Paulo, Av Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM viviansilva87@gmail.com
RI Avelino-Silva, Vivian I/L-2640-2013; Sabino, Ester Cerdeira/F-7750-2010;
   Romano, Camila M/C-8185-2013; Levin, Anna S/C-8831-2012
OI Avelino-Silva, Vivian I/0000-0002-6660-3088; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Levin, Anna S/0000-0003-2427-8368
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance [734548]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES -Ministry of Education, Brazil)CAPES
   [CSF-PVE-S-88887.122640/2016-00, CSF-PVE-S-88881.068160/2014-01];
   bioMerieux Corporation
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement No 734548,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES
   -Ministry of Education, Brazil, grants No CSF-PVE-S-88887.122640/2016-00
   [VAS support] and CSF-PVE-S-88881.068160/2014-01 [ASL, ACS and PM
   support]) and bioMerieux Corporation. The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li Jiandong, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P329, DOI 10.3760/cma.j.issn.0254-6450.2016.03.007
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Vranjac Alexandre, 2016, DISTRIBUICAO CASOS C
   Vranjac Alexandre, 2016, DISTRIBUICAO CASOS D
   Vranjac Alexandre, 2016, DISTRIBUICAO CASOS Z
   WHO, WHO DIR GEN SUMM OUT
NR 40
TC 3
Z9 3
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2019
VL 61
AR UNSP e19
DI 10.1590/S1678-9946201961019
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS4BZ
UT WOS:000463808000002
PM 30970110
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Eren, A
   Baran, MF
AF Eren, A.
   Baran, M. F.
TI GREEN SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF SILVER
   NANOPARTICLES (AgNPs) FROM MAIZE (ZEA MAYS L.)
SO APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH
LA English
DT Article
DE antimicrobial activity; green AgNPs; Escherichia coli; Staphylococcus
   aureus; Candida albicans
ID AQUEOUS EXTRACT; FRUIT EXTRACT; ZIKA VIRUS; BIOSYNTHESIS; LEAVES;
   ANTIBACTERIAL; ANTIOXIDANT; TOXICITY; MALARIA
AB In recent years, the biosynthesis (green synthesis) of metal nanoparticles such as silver nanoparticles (AgNPs) have become one of the safest, most cost-effective and environmentally friendly approaches. In this study, AgNPs were synthesized using maize (Zea mays L.) leaves. For the characterization of synthesized AgNPs different techniques were used, such as X-ray diffraction spectroscopy (XRD), Ultraviolet visible (UV-Vis) spectroscopy, transmission electron microscopy (TEM), Energy dispersive X-ray spectroscopy (EDX), Fourier-transformed infrared spectroscopy (FT-IR) and Thermal gravimetric and Differential thermal analysis (TGA-DTA). The XRD results showed that AgNPs had a mean diameter of 12.63 nm and a crystal-like appearance. In addition, antimicrobial activities of synthesized AgNPs were evaluated using 3 different antibiotics against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus bacteria and Candida albicans yeast. Antifungal activity of AgNPs with antibiotics has been observed to be better than the antibiotics against Gram-positive and Gram-negative bacteria. The minimum inhibitory concentrations were found to be 0.084, 0.337 and 0.021 mg mL(-1) for Escherichia coli, Staphylococcus aureus, and Candida albicans, respectively. The results revealed that AgNPs synthesized from maize leaf extract have antibacterial activity against Gram-negative Escherichia coli, Gram-positive Staphylococcus aureus and antifungal activity against Candida albicans yeast, and that the produced AgNPs could be used in the production of biomedical products and in the pharmaceutical industry.
C1 [Eren, A.] Artuklu Univ, Kiziltepe Vocat Training High Sch, Dept Crops & Anim Prod, TR-47200 Mardin, Turkey.
   [Baran, M. F.] Artuklu Univ Mardin, Vocat Higher Sch Healthcare Studies, Med Lab Tech, TR-47200 Mardin, Turkey.
RP Eren, A (corresponding author), Artuklu Univ, Kiziltepe Vocat Training High Sch, Dept Crops & Anim Prod, TR-47200 Mardin, Turkey.
EM abdullaheren@artuklu.edu.tr; mfiratbaran@gmail.com
CR Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Banerjee P., 2014, BIORESOURCES BIOPROC, V1, P3, DOI [DOI 10.1186/S40643-014-0003-Y, 10.1186/s40643-014-0003-y]
   Baran M. F, 2017, THESIS
   Edison TJI, 2012, PROCESS BIOCHEM, V47, P1351, DOI 10.1016/j.procbio.2012.04.025
   Gunalan S, 2012, PROG NAT SCI-MATER, V22, P695, DOI 10.1016/j.pnsc.2012.11.015
   Gurmen S, 2008, METALURJI DERGISI, V150, P31
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Isaac RSR, 2013, J NANOTECHNOL, V2013, DOI 10.1155/2013/906592
   Jamdagni P., 2016, J KING SAUD U SCI
   Kagithoju S, 2015, 3 BIOTECH, V5, P709, DOI 10.1007/s13205-014-0272-3
   Kanipandian N, 2014, IND CROP PROD, V55, P1, DOI 10.1016/j.indcrop.2014.01.042
   Khan AU, 2018, J PHOTOCH PHOTOBIO B, V183, P367, DOI 10.1016/j.jphotobiol.2018.05.007
   Khan FA, 2016, J NANOMATER, V2016, P1, DOI 10.1155/2016/8026843
   Kotakadi VS, 2013, COLLOID SURFACE B, V105, P194, DOI 10.1016/j.colsurfb.2013.01.003
   Kreyling WG, 2006, J NANOPART RES, V8, P543, DOI 10.1007/s11051-005-9068-z
   Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001
   Majeed A, 2018, MATER TECHNOL, V33, P313, DOI 10.1080/10667857.2015.1108065
   Nabila MI, 2018, BIOCATAL AGRIC BIOTE, V15, P56, DOI 10.1016/j.bcab.2018.05.011
   Nadaroglu H, 2017, SPECTROCHIM ACTA A, V172, P2, DOI 10.1016/j.saa.2016.08.052
   Nartop P., 2016, PAMUKKALE U MUH BILI, V23, P759
   Phanjom P, 2012, INT J NANOSCI NANOTE, V3, P73
   Savithramma N., 2011, Journal of Biological Sciences, V11, P39, DOI 10.3923/jbs.2011.39.45
   Shah M, 2017, INT J RES MED SCI, V4, P2886
   Singh AK, 2017, J PHOTOCH PHOTOBIO B, V166, P202, DOI 10.1016/j.jphotobiol.2016.11.020
   Swamy MK, 2015, SPECTROCHIM ACTA A, V151, P939, DOI 10.1016/j.saa.2015.07.009
   Tippayawat P, 2016, PEERJ, V4, DOI 10.7717/peerj.2589
   Wang MM, 2017, RSC ADV, V7, P12144, DOI 10.1039/c6ra27706c
NR 28
TC 3
Z9 3
U1 2
U2 3
PU CORVINUS UNIV BUDAPEST
PI BUDAPEST
PA VILLANYI UT 29/43, BUDAPEST, H-1118, HUNGARY
SN 1589-1623
EI 1785-0037
J9 APPL ECOL ENV RES
JI Appl. Ecol. Environ. Res.
PY 2019
VL 17
IS 2
BP 4097
EP 4105
DI 10.15666/aeer/1702_40974105
PG 9
WC Ecology; Environmental Sciences
SC Environmental Sciences & Ecology
GA HR0PJ
UT WOS:000462830400173
OA Bronze
DA 2020-07-08
ER

PT J
AU Stenn, T
   Peck, KJ
   Pereira, GR
   Burkett-Cadena, ND
AF Stenn, Tanise
   Peck, Karlette J.
   Pereira, Glauber Rocha
   Burkett-Cadena, Nathan D.
TI Vertebrate Hosts of Aedes aegypti, Aedes albopictus, and Culex
   quinquefasciatus (Diptera: Culicidae) as Potential Vectors of Zika Virus
   in Florida
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito; Zika virus; bloodmeal analysis; vertebrate host
ID BLOOD-FEEDING PATTERNS; WEST-NILE-VIRUS; SPECIES IDENTIFICATION; PIPIENS
   COMPLEX; MOSQUITOS; TRANSMISSION; URBAN; INFECTION; OUTBREAK; BEHAVIOR
AB Zika virus (ZIKV), once considered an obscure pathogen, spread rapidly from 2014 to 2016 to become an internationally notifiable condition of major public health concern. The relative importance of various Culex and Aedes species mosquitoes (Diptera: Culicidae) in ZIKV transmission is a topic of debate. Quantifying host use is important in determining the vectorial capacity of a mosquito species for transmitting ZIKV in nature. In the United States, few data are available on host use of Aedes aegypti L. (Diptera: Culicidae) and Aedes albopictus (Skuse) (Diptera: Culicidae), confirmed and suspected vectors of ZIKV, respectively. Here, we report results of bloodmeal analysis to quantify host use of confirmed (Ae. aegypti) and suspected (Ae. albopictus and Culex quinquefasciatus Say (Diptera: Culicidae)) vectors of ZIKV in two Florida counties. At an auto salvage yard in Indian River County, Ae. aegypti, Ae. albopictus and Cx. quinquefasciatus fed mainly on humans, taking 90.2, 90.8, and 78.6% of bloodmeals from humans, respectively. At a residential area in Martin County, Ae. aegypti, Ae. albopictus took 61.5 and 66.7% of bloodmeals from humans, higher than Cx. quinquefasciatus (11.1%). Patterns of host use suggest that Ae. aegypti and Ae. albopictus are the most likely vectors of ZIKV in Florida and that Cx. quinquefasciatus would likely play a lesser role in ZIKV transmission in Florida. However, the relative importance of the three species in ZIKV transmission is likely location and population specific. Detailed studies quantifying other parameters of vectorial capacity, including vector competence, are needed in order to determine the actual role for each species in ZIKV transmission.
C1 [Stenn, Tanise; Burkett-Cadena, Nathan D.] Univ Florida, Florida Med Entomol Lab, IFAS, 200 9th St SE, Vero Beach, FL 32962 USA.
   [Peck, Karlette J.] Florida Dept Hlth Martin Cty, 3441 SE Willoughby Blvd, Stuart, FL 34994 USA.
   [Pereira, Glauber Rocha] Inst Oswaldo Cruz Fiocruz, Lab Mosquitos Transmissores Hematozoarios, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
RP Burkett-Cadena, ND (corresponding author), Univ Florida, Florida Med Entomol Lab, IFAS, 200 9th St SE, Vero Beach, FL 32962 USA.
EM nburkettcadena@ufl.edu
OI Burkett-Cadena, Nathan/0000-0001-6168-1637
FU Florida Department of Health [100006827]; BRACE funding from the Centers
   for Disease Control and Prevention (CDC);  [FIFAFLA-VME-005446]
FX We thank A. Majka and G. Lemire from Martin County Mosquito Control for
   field assistance in Martin County and E. Stenn for field assistance in
   Indian River County. Funding for this research was provided in part by
   the Florida Department of Health(100006827) and BRACE funding from the
   Centers for Disease Control and Prevention (CDC) and FIFAFLA-VME-005446.
CR Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Ayres C, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.86
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Bingham AM, 2014, AM J TROP MED HYG, V91, P685, DOI 10.4269/ajtmh.14-0081
   Blosser EM, 2016, ACTA TROP, V164, P352, DOI 10.1016/j.actatropica.2016.10.001
   Burkett-Cadena ND, 2016, J MED ENTOMOL, V53, P1449, DOI 10.1093/jme/tjw106
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3
   CHOW E, 1993, J AM MOSQUITO CONTR, V9, P196
   Darsie RF, 2003, TECH B FLA MOSQ CONT, V1, P1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   EDMAN JD, 1974, J MED ENTOMOL, V11, P95, DOI 10.1093/jmedent/11.1.95
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Florida Department of Health, 2017, MOSQ BORN DIS SURV
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Goodman H, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2779-7
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   HASS CA, 1993, BIOCHEM SYST ECOL, V21, P97, DOI 10.1016/0305-1978(93)90015-J
   Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008
   Janssen N, 2015, TROP MED INT HEALTH, V20, P1488, DOI 10.1111/tmi.12587
   Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78
   JUMALI, 1979, AM J TROP MED HYG, V28, P717
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226
   Kim H, 2017, J ASIA-PAC ENTOMOL, V20, P809, DOI 10.1016/j.aspen.2017.05.007
   Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Lee JCI, 2008, ELECTROPHORESIS, V29, P2413, DOI 10.1002/elps.200700711
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   LOURENCODEOLIVEIRA, 2017, PLOS NEGLECT TROP D, V11, DOI DOI 10.1371/JOURNAL.PNTD.0005511
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCLELLAND GAH, 1963, ANN TROP MED PARASIT, V57, P214, DOI 10.1080/00034983.1963.11686176
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Munoz J, 2011, J MED ENTOMOL, V48, P956, DOI 10.1603/ME11016
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Samuel PP, 2004, J MED ENTOMOL, V41, P442, DOI 10.1603/0022-2585-41.3.442
   Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339
   TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635
   TEMPELIS CH, 1970, AM J TROP MED HYG, V19, P335, DOI 10.4269/ajtmh.1970.19.335
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilson J. John, 2015, Academic Journal of Entomology, V8, P80
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 63
TC 6
Z9 6
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2019
VL 56
IS 1
BP 10
EP 17
DI 10.1093/jme/tjy148
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HS5JP
UT WOS:000463907900003
PM 30165498
DA 2020-07-08
ER

PT J
AU Lam-Phua, SG
   Yeo, HQ
   Lee, RML
   Chong, CS
   Png, AB
   Foo, SY
   Liew, C
   Ng, LC
   Tang, CS
   Rueda, LM
   Pecor, JE
   Harrison, BA
AF Lam-Phua, Sai-Gek
   Yeo, Huiqing
   Lee, Ruth Mee-Lian
   Chong, Chee-Seng
   Png, Ah-Bah
   Foo, Siew-Yoong
   Liew, Christina
   Ng, Lee-Ching
   Tang, Choon-Siang
   Rueda, Leopoldo M.
   Pecor, James E.
   Harrison, Bruce A.
TI Mosquitoes (Diptera: Culicidae) of Singapore: Updated Checklist and New
   Records
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes; Anopheles; Culex; taxonomy; Southeast Asia
ID JAPANESE ENCEPHALITIS-VIRUS; ANOPHELES-MACULATUS DIPTERA;
   AEDES-ALBOPICTUS SKUSE; PLASMODIUM-KNOWLESI; CYTOGENETIC EVIDENCE; ZIKA
   VIRUS; AEGYPTI L.; INFECTION; VECTOR; CLASSIFICATION
AB Prior to 1965, Singapore was part of the Malaya (now Malaysia) and was usually not mentioned when mosquito records were reported for Malaya. Consequently, many species that occurred in Singapore were not listed in the world mosquito catalog, and the available checklist for Singapore since 1986 is incomplete, with some imprecise species information. In updating this checklist, we examined and verified mosquito specimens collected from Singapore in various depositories, including a thorough review of past taxonomic literature. Here, we report a checklist of 182 mosquito species, 33 new distribution records, and a consolidated status list of vectors for Singapore. As Singapore is a travel hub and hosts one of the busiest container ports in the world, there is a risk of introducing mosquito species and their associated pathogens of human disease to the country. Hence, the distribution records are important to increase our knowledge on mosquito ecology as well as to understand the risk of newly introduced vectors and their associated pathogens.
C1 [Lam-Phua, Sai-Gek; Yeo, Huiqing; Lee, Ruth Mee-Lian; Chong, Chee-Seng; Png, Ah-Bah; Foo, Siew-Yoong; Liew, Christina; Ng, Lee-Ching] Natl Environm Agcy, Environm Hlth Inst, 11 Biopolis Way,06-05-08 Helios Block, Singapore 138667, Singapore.
   [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Tang, Choon-Siang] Natl Environm Agcy, Environm Publ Hlth Operat, 40 Scotts Rd,Environm Bldg, Singapore 138667, Singapore.
   [Rueda, Leopoldo M.; Pecor, James E.; Harrison, Bruce A.] Museum Support Ctr MRC534, Smithsonian Inst, Walter Reed Biosystemat Unit, Dept Entomol, 4210 Silver Hill Rd, Suitland, MD 20746 USA.
   [Rueda, Leopoldo M.] 204 Draymore Way, Cary, NC 27519 USA.
   [Harrison, Bruce A.] 661 Drumheller Rd, Clemmons, NC 27012 USA.
RP Chong, CS (corresponding author), Natl Environm Agcy, Environm Hlth Inst, 11 Biopolis Way,06-05-08 Helios Block, Singapore 138667, Singapore.
EM chong_chee_seng@nea.gov.sg
OI Chong, Chee-Seng/0000-0003-2993-1741
CR Ahmad Rohani, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P138
   Apiwathnasorn C., 1986, LIST MOSQUITO SPECIE
   BANERJEE K, 1977, INDIAN J MED RES, V65, P746
   Barr A. R, 1963, SINGAP MED J, V41, P184
   BARRAUD PJ, 1934, DIPTERA, V5
   Beier John C, 2002, Methods Mol Med, V72, P3
   Bram RA, 1967, CONTRIBUTIONS AM ENT, V2, P1
   Brug S. L., 1947, CHRON NAT, V103, P179
   Brunetti E., 1920, Records of the Indian Museum, V17
   Chan A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0569-4
   Chan K L, 1969, Singapore Med J, V10, P57
   Chan K.L., 1976, SMJ, V17, P124
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617
   Chavatte JM, 2017, CASE REP INFECT DIS, DOI 10.1155/2017/1972587
   Cheong W H, 1965, Med J Malaya, V20, P74
   Chung YK, 2002, TROP MED INT HEALTH, V7, P322, DOI 10.1046/j.1365-3156.2002.00873.x
   COATNEY GR, 1971, PRIMATE MALARIAS
   Colbourne M J, 1972, Southeast Asian J Trop Med Public Health, V3, P40
   Coleman RE, 2002, J MED ENTOMOL, V39, P556, DOI 10.1603/0022-2585-39.3.556
   COLLES DONALD H., 1965, J MED ENTOMOL, V2, P261, DOI 10.1093/jmedent/2.3.261
   COLLESS D. H., 1955, ANN TROP MED AND PARASITOL, V49, P311
   COLLESS D H, 1957, Ann Trop Med Parasitol, V51, P102
   COLLESS D. H., 1958, ANN TROP MED AND PARASITOL, V52, P468
   COLLESS D. H., 1959, ANN TROP MED AND PARASITOL, V53, P251
   COLLESS D. H., 1959, ANN TROP MED AND PARASITOL, V53, P259
   Colless D. H., 1957, Medical Journal of Malaya, V12, P464
   COLLESS D. H., 1962, PROC LINN SOC NEW SOUTH WALES, V87, P312
   COLLESS D H, 1957, Ann Trop Med Parasitol, V51, P87
   Colless D. H., 1956, Transactions of the Royal Entomological Society of London, V108, P37
   DANARAJ T J, 1958, Med J Malaya, V12, P605
   Delfinado M. D., 1967, CONTRIB AM ENTOMOL I, V1, P1
   EDWARDS F. W., 1928, BULL ENT RES, V18, P337, DOI 10.1017/S0007485300020265
   EDWARDS F. W., 1928, BULL ENT RES, V18, P267, DOI 10.1017/S0007485300019994
   EDWARDS F. W., 1926, BULL ENT RES, V17, P101, DOI 10.1017/S0007485300019143
   Edwards F. W., 1932, GEN INSECTORUM DIPTE, V194
   Eldridge BF, 2012, MED ENTOMOLOGY TXB P
   Faust C, 2015, ONE HEALTH, V1, P66, DOI 10.1016/j.onehlt.2015.10.001
   GATER B. A. R., 1933, BULL RAFFLES MUS, V8, P162
   GINGRICH JB, 1992, J MED ENTOMOL, V29, P436, DOI 10.1093/jmedent/29.3.436
   Goh K. T., 1983, SINGAP MED J, V9, P345
   GOULD DJ, 1974, AM J EPIDEMIOL, V100, P49, DOI 10.1093/oxfordjournals.aje.a112008
   GREEN CA, 1985, BIOL J LINN SOC, V24, P321, DOI 10.1111/j.1095-8312.1985.tb00378.x
   Harbach R. E., 2018, VALID SPECIES MOSQUI
   Harbach RE, 2007, ZOOTAXA, P591
   Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695
   Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x
   HARRISON B A, 1973, Mosquito Systematics, V5, P263
   HARRISON B A, 1990, Mosquito Systematics, V22, P196
   HARRISON B A, 1980, Contributions of the American Entomological Institute, V17, P1
   HARRISON B A, 1975, Contributions of the American Entomological Institute, V12, P1
   Heng Y-K, 2015, MANAGING GLOBAL RISK
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Huang Y.M., 1977, Contributions Am. ent. Inst., V14, P113
   HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1
   HUANG YM, 1971, P ENTOMOL SOC WASH, V73, P1
   Hutchings RSG, 2016, J MED ENTOMOL, V53, P1330, DOI 10.1093/jme/tjw101
   Institute of Medicine Board on Global Health, 2010, INF DIS MOV BORD WOR, P180
   James S. P., 1912, Paludism Simla, VNo. 5
   Jeffery J, 2010, TROP BIOMED, V27, P138
   Jeslyn WPS, 2011, VECTOR-BORNE ZOONOT, V11, P131, DOI 10.1089/vbz.2010.0024
   Kee C P, 1968, Singapore Med J, V9, P111
   KITTAYAPONG P, 1992, J MED ENTOMOL, V29, P379, DOI 10.1093/jmedent/29.3.379
   Knight K.L., 1977, CATALOG MOSQUITOES W
   KNIGHT KENNETH L., 1953, PACIFIC SCI, V7, P453
   Koh YL, 2006, EMERG INFECT DIS, V12, P525, DOI 10.3201/eid1203.051251
   LAIRD M, 1988, NATURAL HIST LARVAL
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lee D. J, 1987, U SYDNEY MON SER ENT
   Lee D. J, 1989, U SYDNEY MON SER ENT, V2
   Lee D. J, 1988, U SYDNEY MON SER ENT
   Lee RML, 2012, J AM MOSQUITO CONTR, V28, P248, DOI 10.2987/12-6239R.1
   LEE V H, 1983, Southeast Asian Journal of Tropical Medicine and Public Health, V14, P298
   Lee VJ, 2010, AM J TROP MED HYG, V82, P1024, DOI 10.4269/ajtmh.2010.09-0562
   Leicester G. F., 1908, Studies from the Institute for Medical Research Feder Malay States Singapore, Vvol. 3
   Lim S. J, 1997, VECTOR CONTROL RES D, V7, P1
   Linton YM, 2005, B ENTOMOL RES, V95, P329, DOI 10.1079/BER2005364
   MacDONALD W. W., 1957, STUD INST MED RES MALAYA, V28, P1
   MACDONALD W. W., 1958, Proc. Centenary & Bicentenary Congress of Biol., Singapore., P117
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MARTINI E., 1920, Sitzungsber. u. Abh. naturf. Ges. zu Rostock, V7, P203
   MATTINGLY P F, 1981, Contributions of the American Entomological Institute, V17, P1
   MATTINGLY P. F., 1970, Contributions of the American Entomological Institute, V5, P1
   Mattingly P.F., 1957, CULICINE MOSQUITOE 2
   Mattingly P. F., 1965, CULICINE MOSQUITOES
   Mattingly P. F., 1961, MOSQUITOES INDOMALAY
   MATTINGLY PF, 1959, CULICINE MOSQUITOE 4
   MATTINGLY PF, 1958, CULICINE MOSQUITOE 3
   MATTINGLY PF, 1957, CULICINE MOSQUITOE 1
   Mendonca-da-Silva I, 2017, PLOS NEGLECT TROP D, V11, P1
   Metereological Services Singapore, 2017, CLIM SING
   Muslim A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-219
   Ng LC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-305
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863
   OLSON JG, 1985, T ROY SOC TROP MED H, V79, P845, DOI 10.1016/0035-9203(85)90135-X
   Pang SC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2114-3
   PEYTON E L, 1972, Mosquito Systematics, V4, P16
   PEYTON E L, 1977, Contributions of the American Entomological Institute, V14, P1
   RAMALINGAM S, 1975, Ceylon Journal of Medical Science, V24, P1
   RAMALINGAM S, 1987, Tropical Biomedicine, V4, P55
   RATTANARITHIKUL R, 1986, Mosquito Systematics, V18, P246
   Rattanarithikul R, 1996, AM J TROP MED HYG, V54, P114, DOI 10.4269/ajtmh.1996.54.114
   Rattanarithikul Rampa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1
   Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1
   Rattanarithikul Rampa, 2010, Southeast Asian J Trop Med Public Health, V41 Suppl 1, P1
   Rattanarithikul Rampa, 2007, Southeast Asian J Trop Med Public Health, V38 Suppl 2, P1
   REID J A, 1970, Miscellaneous Publications of the Entomological Society of America, V7, P56
   REID J. A., 1950, BULL RAFFLES MUS, V21, P48
   REID JA, 1953, B ENTOMOL RES, V44, P5, DOI 10.1017/S0007485300022938
   REID JA, 1968, STUD I MED RES MALAY, V31, P1
   REINERT J F, 1976, Contributions of the American Entomological Institute, V13, P1
   REINERT J F, 1974, Contributions of the American Entomological Institute, V11, P1
   Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x
   Reinert John F., 2000, European Mosquito Bulletin, V6, P1
   REUBEN R, 1969, B ENTOMOL RES, V58, P643, DOI 10.1017/S0007485300057369
   Rodenwaldt E., 1925, Geneeskundig Tijdschrift voor Nederlandsch-Indie, V65, P173
   Rueda LM, 2005, P ENTOMOL SOC WASH, V107, P235
   Saeung A, 2008, PARASITOL RES, V102, P499, DOI 10.1007/s00436-007-0788-0
   Sirivanakarn S., 1976, Contributions Am ent Inst, V12, P1
   SIRIVANAKARN S, 1977, Contributions of the American Entomological Institute, V13, P1
   Sirivanakarn S., 1972, Contributions Am ent Inst, V8, P1
   Stone A., 1959, SYNOPTIC CATALOG MOS
   Taai K, 2015, ZOOL J LINN SOC-LOND, V174, P244, DOI 10.1111/zoj.12236
   Taai K, 2013, MEM I OSWALDO CRUZ, V108, P312, DOI 10.1590/S0074-02762013000300009
   Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Thavara U, 2009, SE ASIAN J TROP MED, V40, P951
   Theobald F. V., 1904, Entomologist, P12
   Theobald F. V., 1904, ENTOMOLOGIST, V37, P111
   Theobald F. V., 1904, ENTOMOLOGIST, V37, P236
   Theobald F. V., 1904, ENTOMOLOGIST, V37, P36
   Theobald F. V., 1904, ENTOMOLOGIST, V37, P77
   Theobald F. V., 1904, ENTOMOLOGIST, V37, P211
   Theobald F. V., 1904, ENTOMOLOGIST, V37, P163
   Theobald FV, 1901, MONOGRAPH CULICIDAE, VI-V
   Theobald FV, 1905, ANN MUSEI NATL HUNGA, V3, P61
   THEOBALD FV, 1903, MONOGRAPH CULICIDAE, V3
   Thurman E. H. B., 1959, Bull Univ Maryland agric exp Sta A-100, P1
   Townsend B. C, 1990, CATALOGUE TYPES BLOO
   Townson H, 2013, SYST ENTOMOL, V38, P180, DOI 10.1111/j.1365-3113.2012.00653.x
   Vythilingam I., 2005, Tropical Biomedicine, V22, P83
   VYTHILINGAM I, 1995, J AM MOSQUITO CONTR, V11, P94
   Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006
   Vythilingam I, 1997, J MED ENTOMOL, V34, P257, DOI 10.1093/jmedent/34.3.257
   Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26
   Walter Reed Biosystematics Unit, 2018, SYST CAT CUL
   Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001
   Ward Ronald A., 1992, Mosquito Systematics, V24, P177
   WHARTON R. H., 1962, BULL INST MED RES FED MALAYA, V11, P1
   WHARTON RH, 1961, SCIENCE, V134, P279, DOI 10.1126/science.134.3474.279
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Wilson AJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0085
   Yee A. T. K., 2011, Gardens' Bulletin (Singapore), V63, P205
   YINCOGGRAVE M, 1964, ANN TROP MED PARASIT, V58, P359, DOI 10.1080/00034983.1964.11686257
   Zavortink T. J., 1971, Contr Am ent Inst, V7, P1
   Zavortink T.J., 1968, CONTRIB AM ENTOMOL I, V3, P1
NR 156
TC 1
Z9 1
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2019
VL 56
IS 1
BP 103
EP 119
DI 10.1093/jme/tjy154
PG 17
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HS5JP
UT WOS:000463907900014
PM 30169704
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Lozano-Fuentes, S
   Kenney, JL
   Varnado, W
   Byrd, BD
   Burkhalter, KL
   Savage, HM
AF Lozano-Fuentes, Saul
   Kenney, Joan L.
   Varnado, Wendy
   Byrd, Brian D.
   Burkhalter, Kristen L.
   Savage, Harry M.
TI Susceptibility and Vectorial Capacity of American Aedes albopictus and
   Aedes aegypti (Diptera: Culicidae) to American Zika Virus Strains
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Zika virus; vector competence;
   vectorial capacity
ID BLOOD-FEEDING PATTERNS; REPORTED DISTRIBUTION; STEGOMYIA ALBOPICTUS;
   UNITED-STATES; MOSQUITOS; COMPETENCE; EPIDEMIC; OUTBREAK; ISLAND; FEVER
AB The rapid expansion of Zika virus (ZIKV), following the recent outbreaks of Chikungunya virus, overwhelmed the public health infrastructure in many countries and alarmed many in the scientific community. Aedes aegypti (L.) (Diptera: Culicidae) and Aedes albopictus (Skuse) (Diptera: Culicidae) have previously been incriminated as the vectors of these pathogens in addition to dengue virus. In our study, we challenged low generation Ae. aegypti (Chiapas, Mexico) and Ae. albopictus (North Carolina, Mississippi), with three strains of ZIKV, Puerto Rico (GenBank: KU501215), Honduras (GenBank: KX694534), and Miami (GenBank: MF988743). Following an oral challenge with 10(7.5) PFU/ml of the Puerto Rico strain, we observed high infection and dissemination rates in both species (95%). We report estimated transmission rates for both species (74 and 33%, for Ae. aegypti (L.) (Diptera: Culicidae) and Ae. albopictus (Skuse) (Diptera: Culicidae), respectively), and the presence of a probable salivary gland barrier in Ae. albopictus to Zika virus. Finally, we calculated vectorial capacity for both species and found that Ae. albopictus had a slightly lower vectorial capacity when compared with Ae. aegypti. Second Language Abstract: La rapida expansion del virus Zika, poco despues de las epidemias de chikungunya, rebaso la infraestructura de salud publica en muchos paises y sorprendio a muchos en la comunidad cientifica. Notablemente, Aedes aegypti y Aedes albopictus transmiten estos patogenos ademas del virus del dengue. En este estudio se expusieron con tres cepas americanas de virus Zika a grupos de Aedes aegypti y Aedes albopictus de generacion reciente. Encontramos altos porcentajes de infeccion y diseminacion en ambas especies (95%). Se reporta, la transmision viral en ambas especies (74 y 33%, para Aedes aegypti and Aedes albopictus, respectivamente) y una probable barrera a nivel de glandulas salivarias. Finalmente, calculamos la capacidad vectorial para ambas especies.
C1 [Lozano-Fuentes, Saul; Kenney, Joan L.; Burkhalter, Kristen L.; Savage, Harry M.] Ctr Dis Control & Prevent, Arbovirus Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Varnado, Wendy] Mississippi Dept Hlth, 570 East Woodrow Wilson Ave, Jackson, MS 39216 USA.
   [Byrd, Brian D.] Western Carolina Univ, Vector Borne Infect Dis Lab, 3971 Little Savannah Rd, Cullowhee, NC 28723 USA.
RP Lozano-Fuentes, S (corresponding author), Ctr Dis Control & Prevent, Arbovirus Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM nkq3@cdc.gov
RI Kenney, Joan L./AAE-7416-2019; Lozano-Fuentes, Saul/H-4324-2011
OI Lozano-Fuentes, Saul/0000-0003-1517-6853; Kenney,
   Joanie/0000-0002-6761-4272
FU Intramural CDC HHS [CC999999]
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   BLACK WC, 2004, BIOL DIS VECTORS, P187
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Burkhalter KL, 2017, EMERG INFECT DIS, V23, P680, DOI 10.3201/eid2304.161772
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cunze S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1853-2
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, P1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fine P.E.M., 1981, P77
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Huerta H, 2017, T ROY SOC TROP MED H, V111, P328, DOI 10.1093/trstmh/trx056
   Janssen CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130009
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kruschke J, 2014, DOING BAYESIAN DATA
   Kruschke J. K., 2011, DOING BAYESIAN DATA, P77
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEG TROP DIS, V6, P1
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lozano-Fuentes S, 2009, PLOS NEGLECT TROP D, V3, P10
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCLELLAND GA, 1971, NATURE, V232, P485, DOI 10.1038/232485a0
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Poole-Smith B. K, 2015, PLOS NEGLECT TROP D, V9, P1
   R Core Team, 2014, R LANG ENV STAT COMP
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1
   Sokal R. R., 1995, BIOMETRY PRINCIPLES
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 1961, TECHNICAL REPORT SER
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
NR 64
TC 2
Z9 2
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2019
VL 56
IS 1
BP 233
EP 240
DI 10.1093/jme/tjy114
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HS5JP
UT WOS:000463907900027
PM 30102327
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Richards, T
   Tucker, BJ
   Hassan, H
   Bron, GM
   Bartholomay, L
   Paskewitz, S
AF Richards, Thomas
   Tucker, Bradley J.
   Hassan, Hassan
   Bron, Gebbiena M.
   Bartholomay, Lyric
   Paskewitz, Susan
TI First Detection of Aedes albopictus (Diptera: Culicidae) and Expansion
   of Aedes japonicus japonicus in Wisconsin, United States
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE ovitrap; Asian tiger mosquito; first record
ID INTRODUCED MOSQUITO; STEGOMYIA AEGYPTI; INVASION; LARVAL; TIRES; TIGER
AB The 2015-2016 epidemic of Zika virus in the Americas raised concerns about the range of Aedes albopictus (Skuse) in the United States. In response, the University of Wisconsin Medical Entomology Laboratory coordinated with the Wisconsin Department of Health Services in 2016 to conduct Aedes spp. surveillance and set up an oviposition trap (ovitrap) network operated by local public health partners across southern and western Wisconsin. During 2016, 916 ovitrap events were processed, but only Aedes triseriatus Say (Diptera: Culicidae) and Aedes japonicus japonicus (Theobald) were detected. In 2017, a focused surveillance approach was employed to detect Ae. albopictus near sites with tires stored outdoors. Using this targeted approach, Ae. albopictus was detected from ovitraps in two out of seven counties surveyed during June, July, and August. This is the first record of Ae. albopictus in Wisconsin.
C1 [Richards, Thomas; Tucker, Bradley J.; Hassan, Hassan; Bron, Gebbiena M.; Paskewitz, Susan] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.
   [Bartholomay, Lyric] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Paskewitz, S (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.
EM smpaskew@wisc.edu
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   Wisconsin Department of Health Services under the Epidemiology and
   Laboratory Capacity (ELC) program;  [U01CK000505]
FX We would like to thank Diep Hoang Johnson, Megan Meller, Rebecca Osborn,
   and Christine Muganda of the Wisconsin Department of Health Services for
   facilitating contacts with public and environmental health staff in
   Wisconsin counties. We thank staff and interns from all participating
   counties for trap monitoring and the employees at the tire facilities
   for fruitful discussions and enabling access to their properties. We
   thank Scott Larson for help with map production. This work was supported
   by Cooperative Agreement Number U01CK000505, funded by the Centers for
   Disease Control and Prevention. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the Centers for Disease Control and Prevention or the
   Department of Health and Human Services. This work also received
   financial support from the Wisconsin Department of Health Services under
   the Epidemiology and Laboratory Capacity (ELC) program.
CR Alto BW, 2011, J MED ENTOMOL, V48, P232, DOI 10.1603/ME09252
   Andreadis TG, 2001, J MED ENTOMOL, V38, P774, DOI 10.1603/0022-2585-38.6.774
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, P11
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Dunphy BM, 2014, J AM MOSQUITO CONTR, V30, P119, DOI 10.2987/13-6388.1
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Grard G., 2014, PLOS NEGLECT TROP D, V8, P6
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P354
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hughes TH, 2008, J AM MOSQUITO CONTR, V24, P583, DOI 10.2987/5735.1
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238
   RIGHTOR JA, 1987, J AM MOSQUITO CONTR, V3, P657
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Swanson J, 2000, J MED ENTOMOL, V37, P454, DOI 10.1603/0022-2585(2000)037[0454:OAEOAA]2.0.CO;2
   Thomas M. C., 2017, PLOS NEGLECT TROP D, V11, P13
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Wright JA, 2015, J AM MOSQUITO CONTR, V31, P26, DOI 10.2987/14-6434R.1
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
NR 26
TC 1
Z9 1
U1 2
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2019
VL 56
IS 1
BP 291
EP 296
DI 10.1093/jme/tjy184
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HS5JP
UT WOS:000463907900037
PM 30321385
DA 2020-07-08
ER

PT J
AU Rekha, R
   Vaseeharan, B
   Vijayakumar, S
   Abinaya, M
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Al-anbr, MN
AF Rekha, Ravichandran
   Vaseeharan, Baskaralingam
   Vijayakumar, Sekar
   Abinaya, Muthukumar
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Al-anbr, Mohammed N.
TI Crustin-capped selenium nanowires against microbial pathogens and
   Japanese encephalitis mosquito vectors - Insights on their toxicity and
   internalization
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Biocompatibility; Culex quinquefasciatus; Culex tritaeniorhynchus;
   Integrated vector management; Mosquito control; Culicidae; Nanomaterial;
   Pesticide
ID ZNO NANOPARTICLES; GREEN SYNTHESIS; BOTANICAL INSECTICIDES; GOLD
   NANOPARTICLES; BETA-CARYOPHYLLENE; BINDING-PROTEIN; PLANT-EXTRACTS;
   AEDES-AEGYPTI; ESSENTIAL OIL; ANTIBACTERIAL
AB Herein, we reported a method to synthesize selenium nanowires (Cr-SeNWs) relying to purified cysteine-rich antimicrobial peptide crustin in presence of ascorbic acid. Cr-SeNWs were characterized by UV-vis, XRD, FTIR and Raman spectroscopy, as well as SEM, HR-TEM and EDAX. The UV-vis spectroscopy peak was noted at 350 nm. XRD showed the crystalline nature of Cr-SeNWs through diffraction peaks observed 2 theta at 12 degrees and 28 degrees corresponding to (020), and (241) lattice planes, respectively. HR-TEM results shed light on the size of Cr-SeNWs, ranging from 17 to 47 nm. Raman spectroscopy and EDAX analysis of Cr-SeNWS showed presence of 57% selenium element. Furthermore, Cr-SeNWs showed higher antimicrobial activity on Gram-positive bacteria (Staphylococcus aureus, Enterococcus faecalis) over Gram-negative ones (Pseudomonas aeruginosa, Escherichia colt). The zone of inhibition was larger on S. aureus (50 mu g/ml = 4.0 mm, 75 mu g/ml = 7.2 mm) and E. faecalis (50 mu g/ml = 3.1 mm, 75 mu g/ml = 5.1 mm), over P. aeruginosa (50 mu g/ml = 2.1 mm, 75 mu g/ml = 4.8 mm), E. colt (50 mu g/ml = 1.3 mm, 75 mu g/ml = 4.3 mm) bacteria. The antibiofilm activity of Cr-SeNWs was also investigated and biofilm reduction was observed at 75 mu g/ml. In addition, Cr-SeNWs were highly effective as larvicides against Zika virus and Japanese encephalitis mosquito vectors, i.e., Culex quinquefasciatus and Culex tritaeniorhynchus, with LC50 values of 4.15 and 4.85 mg/l, respectively. The nanowire toxicity and internalization was investigated through confocal laser scanning microscopy and histological studies. To investigate the potential of Cr-SeNWs for real-world applications, we also evaluated Cr-SeNWs in hemolytic assays, showing no cytotoxicity till 5 mg/ ml. Besides, higher antioxidant activity at the concentration at 100 mu g/ml was noted, if compared with purified crustin. The strong antioxidant potential of this nanomaterial can be helpful to boost the shelf-life potential of Cr-SeNWs-based pesticides and antimicrobials.
C1 [Rekha, Ravichandran; Vaseeharan, Baskaralingam; Vijayakumar, Sekar; Abinaya, Muthukumar] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Govt Coll Women, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.; Al-anbr, Mohammed N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI Khaled, Jamal/D-8188-2017; Alharbi, Naiyf S/B-9402-2019; /L-2836-2013;
   GOVINDARAJAN, MARIMUTHU/A-8070-2019; Sekar/A-8600-2018
OI /0000-0001-7018-5379; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931;
   Sekar/0000-0001-8211-069X; Muthukumar, Abinaya/0000-0002-9635-4852
FU Department of Biotechnology (DBT), New Delhi, IndiaDepartment of
   Biotechnology (DBT) India [BT/PR7903/AAquote/3/638/2013]; Deanship of
   Scientific Research at King Saud UniversityDeanship of Scientific
   Research at King Saud University [RG-1438- 091]
FX This work was supported by the Department of Biotechnology (DBT), New
   Delhi, India, under the Project grants code
   BT/PR7903/AAquote/3/638/2013. The authors extend their appreciation to
   the Deanship of Scientific Research at King Saud University for funding
   this work through Research Group No. RG-1438- 091.
CR Abdelouas A, 2000, CHEM MATER, V12, P1510, DOI 10.1021/cm990763p
   Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Al-Hazmi F, 2012, SUPERLATTICE MICROST, V52, P200, DOI 10.1016/j.spmi.2012.04.013
   Ali A., 2017, SCI REP, V7, P1
   Andersson DI, 2016, DRUG RESIST UPDATE, V26, P43, DOI 10.1016/j.drup.2016.04.002
   Anjugam M, 2018, MICROB PATHOGENESIS, V115, P31, DOI 10.1016/j.micpath.2017.12.003
   Avendano R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37155
   Bandow JE, 2009, CHEMBIOCHEM, V10, P2847, DOI 10.1002/cbic.200900628
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Barik TK, 2012, PARASITOL RES, V111, P1075, DOI 10.1007/s00436-012-2934-6
   Benelli G., 2015, ENVIRON SCI POLLUT R, V25, P10149
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Chung PY, 2017, J MICROBIOL IMMUNOL, V50, P405, DOI 10.1016/j.jmii.2016.12.005
   Das D, 2013, COLLOID SURFACE B, V111, P556, DOI 10.1016/j.colsurfb.2013.06.041
   Divya M, 2018, INT J BIOL MACROMOL, V114, P864, DOI 10.1016/j.ijbiomac.2018.03.159
   Divya M, 2018, J PHOTOCH PHOTOBIO B, V178, P211, DOI 10.1016/j.jphotobiol.2017.11.008
   Fallon AM, 2014, J MICROBIOL METH, V107, P119, DOI 10.1016/j.mimet.2014.09.011
   Fleming J, 2001, NUTR CANCER, V40, P42, DOI 10.1207/S15327914NC401_9
   Gao XY, 2003, J MATER CHEM, V13, P6, DOI 10.1039/b209399e
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774
   Hong WY, 2014, BIOMATERIALS, V35, P9573, DOI 10.1016/j.biomaterials.2014.08.027
   Hou S, 2013, ADV MATER, V25, P1547, DOI 10.1002/adma.201203185
   Huang P, 2011, CHEM-ASIAN J, V6, P1156, DOI 10.1002/asia.201000818
   Huang XQ, 2016, ACTA BIOMATER, V30, P397, DOI 10.1016/j.actbio.2015.10.041
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Isman MB, 2017, IND CROP PROD, V110, P10, DOI 10.1016/j.indcrop.2017.07.012
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Iswarya A, 2017, COLLOID SURFACE B, V158, P257, DOI 10.1016/j.colsurfb.2017.06.035
   Jayanthi S, 2017, J PHOTOCH PHOTOBIO B, V170, P208, DOI 10.1016/j.jphotobiol.2017.04.011
   Jayanthi S, 2017, FISH SHELLFISH IMMUN, V62, P227, DOI 10.1016/j.fsi.2017.01.019
   Kalishwaralal K, 2015, J TRACE ELEM MED BIO, V32, P135, DOI 10.1016/j.jtemb.2015.06.010
   Kamaraj C, 2017, J CLUST SCI, V28, P1667, DOI 10.1007/s10876-017-1180-6
   Karthika P, 2018, ACTA TROP, V183, P84, DOI 10.1016/j.actatropica.2018.04.006
   Kieliszek M, 2019, BIOL TRACE ELEM RES, V187, P328, DOI 10.1007/s12011-018-1390-2
   Kieliszek M, 2016, MOLECULES, V21, DOI 10.3390/molecules21050609
   Kieliszek M, 2016, J TRACE ELEM MED BIO, V35, P90, DOI 10.1016/j.jtemb.2016.01.014
   Kieliszek M, 2016, BIOL TRACE ELEM RES, V169, P387, DOI 10.1007/s12011-015-0415-3
   Kieliszek M, 2015, APPL MICROBIOL BIOT, V99, P5373, DOI 10.1007/s00253-015-6650-x
   Kieliszek M, 2013, NUTRITION, V29, P713, DOI 10.1016/j.nut.2012.11.012
   Kiruba Daniel S.C.G., 2011, J NANOSCI NANOTECHNO, V2, P103
   Lee S, 2009, CARBOHYD RES, V344, P1230, DOI 10.1016/j.carres.2009.04.014
   Li Q, 2006, CHEM COMMUN, P1006, DOI 10.1039/b515025f
   Li Y, 2010, ELECTROCHEM COMMUN, V12, P777, DOI 10.1016/j.elecom.2010.03.031
   Li YQ, 2014, ANGEW CHEM INT EDIT, V53, P5837, DOI 10.1002/anie.201310135
   Liu LL, 2013, NEW J CHEM, V37, P2179, DOI 10.1039/c3nj00135k
   Liu W, 2012, ACS NANO, V6, P6578, DOI 10.1021/nn202452c
   Liu XL, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.43
   Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oluwafemi OS, 2010, COLLOID SURFACE B, V79, P126, DOI 10.1016/j.colsurfb.2010.03.040
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10904, DOI 10.1007/s11356-018-1398-3
   Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS
   Ramya S, 2015, J TRACE ELEM MED BIO, V32, P30, DOI 10.1016/j.jtemb.2015.05.005
   Rao L, 2014, INT J NANOMED, V9, P4819, DOI 10.2147/IJN.S67871
   Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9
   Rekha R, 2018, MOL IMMUNOL, V101, P396, DOI 10.1016/j.molimm.2018.07.024
   Saxena M., 2013, RSC ADV, V12, P1
   Shah CP, 2010, MATER RES BULL, V45, P1213, DOI 10.1016/j.materresbull.2010.05.013
   Shen QL, 2013, ADV MATER, V25, P2368, DOI 10.1002/adma.201300082
   Sivakamavalli J, 2015, APPL BIOCHEM BIOTECH, V176, P1084, DOI 10.1007/s12010-015-1631-1
   Skalickova S, 2017, NUTRITION, V33, P83, DOI 10.1016/j.nut.2016.05.001
   Song RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42058
   Sruthy KS, 2017, FISH SHELLFISH IMMUN, V71, P83, DOI 10.1016/j.fsi.2017.09.071
   Stiefel P., 2015, BMC MICROBIOL, V36, P1
   Teimouri M, 2018, J CLEAN PROD, V184, P740, DOI 10.1016/j.jclepro.2018.02.268
   Thirunarayanan A, 2014, RSC ADV, V4, P41778, DOI 10.1039/c4ra04967e
   Torres SK, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1236-3
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPR0T.2014.05.003]
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Vijayakumar S, 2016, BIOMED PHARMACOTHER, V84, P1213, DOI 10.1016/j.biopha.2016.10.038
   Volohonsky G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006113
   Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013
   Wang J., 2013, NAT COMMUN, V444, P1
   WHO, 1996, PER MORT LIST AV INF, V96, P1
   Yu B, 2012, INORG CHEM, V51, P8956, DOI 10.1021/ic301050v
   Zhang B, 2006, NANOTECHNOLOGY, V17, P385, DOI 10.1088/0957-4484/17/2/007
   Zhang YF, 2010, LANGMUIR, V26, P17617, DOI 10.1021/la1033959
NR 91
TC 2
Z9 2
U1 2
U2 18
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2019
VL 51
BP 191
EP 203
DI 10.1016/j.jtemb.2018.10.017
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA HR4LZ
UT WOS:000463119100028
PM 30466931
DA 2020-07-08
ER

PT J
AU de Castro-Jorge, LA
   Siconelli, MJL
   Ribeiro, BD
   de Moraes, FM
   de Moraes, JB
   Agostinho, MR
   Klein, TM
   Floriano, VG
   da Fonseca, BAL
AF de Castro-Jorge, Luiza Antunes
   Lima Siconelli, Marcio Junio
   Ribeiro, Beatriz dos Santos
   de Moraes, Flavia Masson
   de Moraes, Jonathan Ballico
   Agostinho, Mayara Rovariz
   Klein, Taline Monteiro
   Floriano, Vitor Goncalves
   Lopes da Fonseca, Benedito Antonio
TI West Nile virus infections are here! Are we prepared to face another
   flavivirus epidemic?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE West Nile virus (WNV); Arbovirus; Outbreak; Surveillance
ID HUMANIZED MONOCLONAL-ANTIBODY; NEW-YORK; NEUTRALIZING ANTIBODIES;
   FUNCTIONAL OUTCOMES; ENCEPHALITIS; TRANSMISSION; VACCINE;
   ENCEPHALOMYELITIS; HORSES; BIRDS
AB Emerging arthropod-borne viruses (arboviruses), such as chikungunya and Zika viruses, are a major threat to public health in countries like Brazil where biodiversity is high and medical care is sometimes precarious. West Nile fever is a disease caused by the West Nile Virus (WNV), an RNA virus belonging to the Flaviviridae family. It is transmitted by infected mosquitoes to numerous animals like birds, reptiles and mammals, including human and non-human primates. In the last decade, the number of reported cases of WNV infection in humans and animals has increased in the Americas. Circulation of WNV in forests and rural areas in Brazil has been detected based on serological surveys and, in 2014, the first case of West Nile fever was confirmed in a patient from Piaui State. In 2018, the virus was isolated for the first time from a horse from a rural area in the state of Espirito Santo presenting with a neurological disorder; this raises the possibility that other cases of WNV encephalitis may have occurred without clinical recognition and without laboratory diagnosis by specific assays. The imminent WNV outbreak poses a challenge for Brazilian clinicians and researchers. In this review, we summarize the basic biological and ecological characteristics of this virus and the clinical presentation and treatment of febrile illnesses caused by WNV. We also discuss the epidemiological aspects, prophylaxis of WNV infections, and monitoring strategies that could be applied in the possibility of a WNV outbreak in Brazil.
C1 [de Castro-Jorge, Luiza Antunes; Lima Siconelli, Marcio Junio; Ribeiro, Beatriz dos Santos; de Moraes, Flavia Masson; de Moraes, Jonathan Ballico; Agostinho, Mayara Rovariz; Klein, Taline Monteiro; Floriano, Vitor Goncalves; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI de Castro Jorge, Luiza Antunes/D-3773-2009; Fonseca,
   Benedito/F-3252-2012
OI Moraes, Jonathan/0000-0002-0021-3714; Fonseca,
   Benedito/0000-0003-3159-5687; Lima Siconelli, Marcio
   Junio/0000-0001-5340-0962
CR Diaz LA, 2008, EMERG INFECT DIS, V14, P689, DOI 10.3201/eid1404.071257
   Agrawal AG, 2003, J INFECT DIS, V188, P1, DOI 10.1086/376871
   Alker A., 2015, BMJ CASE REP, V2015, P1
   [Anonymous], 2019, ALL SKETCH
   Araujo F., 2014, TRATADO ANIMAIS SELV, V2
   Assessoria de Comunicacao SESAPI, 2019, PORT SAUD SECR EST S
   Balasuriya U, 2015, AAEP VACC GUID, V1
   Beigel JH, 2010, ANTIMICROB AGENTS CH, V54, P2431, DOI 10.1128/AAC.01178-09
   BERNKOPF H, 1953, J INFECT DIS, V93, P207, DOI 10.1093/infdis/93.3.207
   Blau DM, 2013, EMERG INFECT DIS, V19, P1518, DOI 10.3201/eid1909.130365
   Bosch I, 2007, EMERG INFECT DIS, V13, P651, DOI 10.3201/eid1304.061383
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Coordenacao-Geral de Desenvolvimento da Epidemiologia em Servicos, 2016, COORD GER DES EP SER
   Bunning ML, 2002, EMERG INFECT DIS, V8, P380
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Callan RJ, 2004, VET CLIN N AM-FOOD A, V20, P327, DOI 10.1016/j.cvfa.2004.02.001
   Cannon AB, 2006, J VET INTERN MED, V20, P1219, DOI 10.1892/0891-6640(2006)20[1219:AEPAMA]2.0.CO;2
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Carboneras C, 2019, HDB BIRDS WORLD ALIV
   Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845
   Centers for Disease Control and Prevention (CDC), 2017, MOSQ SPEC WHICH W NI, P1999
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) D of V-BD (DVBD), 2018, SYMPT DIAGN AMP TREA
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Contigiani M.S, 2017, ARTHROPOD BORNE DIS, P73
   Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717
   D'Agostino JJ, 2004, JAVMA-J AM VET MED A, V224, P1640, DOI 10.2460/javma.2004.224.1640
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Diamond Michael S, 2005, Expert Rev Anti Infect Ther, V3, P931, DOI 10.1586/14787210.3.6.931
   Diaz LA, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00493
   El Garch H, 2008, VET IMMUNOL IMMUNOP, V123, P230, DOI 10.1016/j.vetimm.2008.02.002
   Emig M, 2004, CLIN INFECT DIS, V38, P289, DOI 10.1086/380458
   Ferguson DD, 2005, CLIN INFECT DIS, V41, P1204, DOI 10.1086/444506
   Fitzpatrick J., 2019, HDB BIRDS WORLD ALIV
   Flores EF, 2009, CIENC RURAL, V39, P604, DOI 10.1590/S0103-84782008005000070
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hawkes MA, 2018, NEUROCRIT CARE, V29, P47, DOI 10.1007/s12028-017-0500-x
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hayes EB, 2004, PEDIATRICS, V113, P1375, DOI 10.1542/peds.113.5.1375
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   International Society for Infectious Diseases, 2019, PROMEDMAIL
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200
   Jacobson ER, 2005, J WILDLIFE DIS, V41, P96, DOI 10.7589/0090-3558-41.1.96
   Joseph S, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.53
   Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945
   Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879
   Klenk K, 2004, EMERG INFECT DIS, V10, P2150, DOI 10.3201/eid1012.040264
   Klenk K, 2003, AM J TROP MED HYG, V69, P260, DOI 10.4269/ajtmh.2003.69.260
   Kokay Szabolcs, 2019, COMMON TERN STERNA H
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   KOSTYUKOV M A, 1985, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P49
   Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829
   LaDeau SL, 2011, ECOL APPL, V21, P1443, DOI 10.1890/09-1409.1
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lowe Nancy, 2004, RYNCHOPS NIGER
   Lustig Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02421
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Maharaj S, 2017, BMJ CASE REP
   Martins LC, 2018, MEM I O CRUZ, P1
   Mattar S, 2005, EMERG INFECT DIS, V11, P1497, DOI 10.3201/eid1109.050426
   Maximova OA, 2016, PLOS NEGLECT TROP D, V10, P1
   Ministerio da Saude, 2010, FEBR NIL OC GUIA V A
   Ministerio da Saude, 2017, GUIA VIG SAUD
   Ministerio da Saude, 2018, SECR VIG SAUD VIG NI
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2011, GUIA VIG CUL QUINQ A
   Mobley J., 2019, HDB BIRDS WORLD ALIV
   Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852
   Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293
   Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Ng T, 2003, Dev Biol (Basel), V114, P221
   OIE World Organisation for Animal Health, 2018, OIE TERR MAN 2018
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Ostlund EN, 2001, EMERG INFECT DIS, V7, P665
   Ostlund EN, 2000, VET CLIN N AM-EQUINE, V16, P427, DOI 10.1016/S0749-0739(17)30087-1
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Pepperell C, 2003, CAN MED ASSOC J, V168, P1399
   Pesko KN, 2012, INFECT GENET EVOL, V12, P181, DOI 10.1016/j.meegid.2011.11.014
   Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P1
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Rising J., 2019, HDB BIRDS WORLD ALIV
   Robinson RL, 2003, AM J MED, V115, P252, DOI 10.1016/S0002-9343(03)00291-2
   Saegerman C, 2016, TRANSBOUND EMERG DIS, V63, P184, DOI 10.1111/tbed.12243
   SBMT-Sociedade Brasileira de Medicina Tropical, 2017, NIL FEV PIAUI 285 IN
   SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194
   Sejvar James J, 2003, Ochsner J, V5, P6
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312
   Sejvar JJ, 2004, NEUROLOGY, V63, P206, DOI 10.1212/01.WNL.0000130361.62281.69
   Sejvar JJ, 2003, JAMA, V290
   Shimoni Z, 2001, EMERG INFECT DIS, V7, P759
   Silva JR, 2013, MEM I OSWALDO CRUZ, V108, P921, DOI 10.1590/0074-0276130052
   SILVASANCHEZ A, 2018, TRANSBOUND EMERG DIS, V1845, P1, DOI DOI 10.1007/978-1-4939-8709-2_1
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Smeraski CA, 2011, ANTIVIR RES, V91, P43, DOI 10.1016/j.antiviral.2011.04.011
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Snook CS, 2001, J AM VET MED ASSOC, V218, P1576, DOI 10.2460/javma.2001.218.1576
   Solomon T, 2003, CLIN INFECT DIS, V36, pE140, DOI 10.1086/374936
   Steinman A, 2003, EMERG INFECT DIS, V9, P887
   Summers-Smith D, 2019, HDB BIRDS WORLD ALIV
   TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579
   Trevejo RT, 2008, JAVMA-J AM VET MED A, V232, P1302, DOI 10.2460/javma.232.9.1302
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z
   van Gils J, 2019, HDB BIRDS WORLD ALIV
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Ward MP, 2006, VET MICROBIOL, V118, P255, DOI 10.1016/j.vetmic.2006.07.016
   Ward MP, 2005, PREV VET MED, V71, P253, DOI 10.1016/j.prevetmed.2005.07.008
   Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Winkelmann ER, 2016, F1000RES, V5, pF1000
   World Health Organization, 2017, W NIL VIR
   Zanoni F, 2018, EXP CLIN TRANSPLANT
   Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602
NR 126
TC 2
Z9 2
U1 3
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20190089
DI 10.1590/0037-8682-0089-2018
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HR6BV
UT WOS:000463233900001
PM 30942263
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Andersen, ML
   Winter, LMF
AF Andersen, Monica L.
   Winter, Lucile M. F.
TI Animal models in biological and biomedical research - experimental and
   ethical concerns
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE animal use; biology; ethics; research
ID CHIKUNGUNYA VIRUS-INFECTION; ZIKA VIRUS; HUMANIZED MICE;
   LEISHMANIA-MAJOR; NITRIC-OXIDE; EXPRESSION; DEFECTS; ANXIETY
AB Animal models have been used in experimental research to increase human knowledge and contribute to finding solutions to biological and biomedical questions. However, increased concern for the welfare of the animals used, and a growing awareness of the concept of animal rights, has brought a greater focus on the related ethical issues. In this review, we intend to give examples on how animals are used in the health research related to some major health problems in Brazil, as well as to stimulate discussion about the application of ethics in the use of animals in research and education, highlighting the role of National Council for the Control of Animal Experimentation Conselho Nacional de Controle de Experimentacao Animal - CONCEA) in these areas. In 2008, Brazil emerged into a new era of animal research regulation, with the promulgation of Law 11794, previously known as the Arouca Law, resulting in an increased focus, and rapid learning experience, on questions related to all aspects of animal experimentation. The law reinforces the idea that animal experiments must be based on ethical considerations and integrity-based assumptions, and provides a regulatory framework to achieve this. This review describes the health research involving animals and the current Brazilian framework for regulating laboratory animal science, and hopes to help to improve the awareness of the scientific community of these ethical and legal rules.
C1 [Andersen, Monica L.] Univ Fed Sao Paulo, UNIFESP, Dept Psicobiol, Rua Napoleao de Barros 925, BR-04024002 Sao Paulo, SP, Brazil.
   [Winter, Lucile M. F.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Rua Matao,Travessa 14, BR-05508090 Sao Paulo, SP, Brazil.
RP Andersen, ML (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Psicobiol, Rua Napoleao de Barros 925, BR-04024002 Sao Paulo, SP, Brazil.
EM ml.andersen12@gmail.com
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [305177/2013-3, 307587/2014-2]; Associacao Fundo de Incentivo a
   Pesquisa (AFIP)
FX The authors receive fellowships from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq): 305177/2013-3 (MLA) and
   307587/2014-2 (LMFW). The authors also thank Associacao Fundo de
   Incentivo a Pesquisa (AFIP).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009
   ANDERSEN ML, 2015, GUIA PRATICO LEGISLA
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CONCEA-CONSELHO NACIONAL DE CONTROLE DA EXPERIMENTACAO ANIMAL, 2015, NORM CONCEA PAR PROD
   Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418
   Dahlberg A, 2006, VIROLOGY, V353, P422, DOI 10.1016/j.virol.2006.05.034
   DASILVA MFL, 2014, ARGINASE LEISHMANIA, P103
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ernst W, 2016, COMP IMMUNOL MICROB, V49, P29, DOI 10.1016/j.cimid.2016.08.006
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FOUNDATION FOR BIOMEDICAL RESEARCH, 2016, CRIT ROL NONH PRIM M
   Garcia JV, 2016, CURR OPIN VIROL, V19, P56, DOI 10.1016/j.coviro.2016.06.010
   Greek R, 2013, INT J MED SCI, V10, P206, DOI 10.7150/ijms.5529
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   INSTITUTE OF MEDICINE AND NATIONAL RESEARCH COUNCIL, 1988, US LAB AN BIOM BEH R
   INSTITUTE OF MEDICINE AND NATIONAL RESEARCH COUNCIL, 1991, SCI MED AN
   Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   da Silva MFL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034022
   Laranjeira-Silva MF, 2015, J PINEAL RES, V59, P478, DOI 10.1111/jpi.12279
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   Micci L, 2016, CURR OPIN VIROL, V19, pIX, DOI 10.1016/j.coviro.2016.08.014
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   OPARIN AI, 1957, ORIGIN LIFE EARTH
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pires GN, 2016, NEUROSCI BIOBEHAV R, V68, P575, DOI 10.1016/j.neubiorev.2016.06.028
   Qadoumi M, 2002, INFECT IMMUN, V70, P4638, DOI 10.1128/IAI.70.8.4638-4642.2002
   Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P21
   RUSSEL WMS, 1959, PRINCIPLES HUMANE EX
   Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   TIMMERMANS S, 2003, SOC STUD SCI, V33, P32
   Tufik S, 2010, ANIMAL MODELS ETHICA
   van der Valk J, 1999, ATLA-ALTERN LAB ANIM, V27, P39, DOI 10.1177/026119299902700105
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wege AK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001741
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
NR 46
TC 17
Z9 17
U1 1
U2 10
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2019
VL 91
SU 1
AR UNSP e20170238
DI 10.1590/0001-3765201720170238
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ7CO
UT WOS:000462577300003
PM 28876358
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Spiliopoulos, D
   Panchal, M
   Economides, DL
AF Spiliopoulos, D.
   Panchal, M.
   Economides, D. L.
TI Surveillance of pregnant women with potential exposure to Zika virus
   following travel
SO GIORNALE DI CHIRURGIA
LA English
DT Article
DE Pregnancy; Zika virus (ZIKV); Microcephaly; Head circumference
ID INFECTION; INFANTS; RISK
AB Aim. To describe the experience of a single fetal medicine unit in evaluating pregnant women with potential exposure to Zika virus (ZIKV) following travel.
   Method. Between February 2016 and June 2017, a multidisciplinary team evaluated pregnant women by developing a local pathway based on Public Health England guidance. All pregnant women were offered serial fetal ultrasound scans (USS). If they presented with a history of clinical symptoms consistent with ZIKV infection during or within two weeks of travel or fetal USS was suggestive of microcephaly, reverse transcriptase polymerase chain reaction (RT PCR) and/or serology was used.
   Results. 69 women were referred. Eight patients reported symptoms consistent with ZIKV infection (11.6%) and six (8.7%) patients reported mosquito bites. Maternal exposure was mainly during the preconception period and the first trimester in 35 (50.8%) and 19 (27.5%) women, respectively. Prenatally, there was no evidence of microcephaly in any of the 69 referrals. Sixty-two live births and seven miscarriages were reported. One patient had serology confirming ZIKV infection during pregnancy. At birth, 57 babies had normal head circumference (HC) measurements, including the baby born to the Zika positive mother. Two babies had small HC measurements but were not infected and were small for gestational age.
   Conclusions. One case of maternal ZIKV infection was detected but without any fetal congenital abnormalities postnatally. The number of potentially infected patients referred to our unit is a demonstration of the concern regarding perinatal ZIKV infection in the pregnant population.
C1 [Spiliopoulos, D.; Panchal, M.; Economides, D. L.] Royal Free London NHS Fdn Trust, Fetal Med Unit, London, England.
RP Spiliopoulos, D (corresponding author), Royal Free London NHS Fdn Trust, Fetal Med Unit, London, England.
EM dimspiliop@yahoo.com
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR TRANSM
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Musso D, POTENTIAL ZIKA VIRUS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization, ZIK VIR INF ZIK FEV
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rao R, 2017, OBSTET GYNECOL, V129, P1098, DOI 10.1097/AOG.0000000000002049
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), 5 M EM COMM INT HLTH
NR 25
TC 0
Z9 0
U1 0
U2 0
PU CIC EDIZIONI INT
PI ROME
PA CORSO TRIESTE 42, ROME, 00198, ITALY
SN 0391-9005
EI 1971-145X
J9 G CHIR
JI G. Chir.
PD JAN-FEB
PY 2019
VL 40
IS 1
BP 58
EP 65
PG 8
WC Surgery
SC Surgery
GA HQ7BO
UT WOS:000462574600010
PM 30771801
DA 2020-07-08
ER

PT J
AU Ahmad, Z
   Poh, CL
AF Ahmad, Zuleeza
   Poh, Chit Laa
TI The Conserved Molecular Determinants of Virulence in Dengue Virus
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE dengue virus; virulence; vaccine; mutations; live attenuated vaccine
ID NONSTRUCTURAL PROTEIN 4A; YELLOW-FEVER VIRUS; MEMBRANE TOPOLOGY;
   RNA-SYNTHESIS; 3'-UNTRANSLATED REGION; SECONDARY STRUCTURE; ENVELOPE
   PROTEIN; VACCINE SAFETY; IMMUNOGENICITY; RECOMBINANT
AB Dengue virus belongs to the Flaviviridae family which also includes viruses such as the Zika, West Nile and yellow fever virus. Dengue virus generally causes mild disease, however, more severe forms of the dengue virus infection, dengue haemorrhagic fever (DHF) and dengue haemorrhagic fever with shock syndrome (DSS) can also occur, resulting in multiple organ failure and even death, especially in children. The only dengue vaccine available in the market, CYD-TDV offers limited coverage for vaccinees from 9-45 years of age and is only recommended for individuals with prior dengue exposure. A number of mutations that were shown to attenuate virulence of dengue virus in vitro and/or in vivo have been identified in the literature. The mutations which fall within the conserved regions of all four dengue serotypes are discussed. This review hopes to provide information leading to the construction of a live attenuated dengue vaccine that is suitable for all ages, irrespective of the infecting dengue serotype and prior dengue exposure.
C1 [Ahmad, Zuleeza; Poh, Chit Laa] Sunway Univ, Ctr Virus & Vaccine Res, Sch Sci & Technol, Subang Jaya 47500, Selangor, Malaysia.
RP Poh, CL (corresponding author), Sunway Univ, Ctr Virus & Vaccine Res, Sch Sci & Technol, Subang Jaya 47500, Selangor, Malaysia.
EM pohcl@sunway.edu.my
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Balas C, 2011, J INFECT DIS, V203, P103, DOI 10.1093/infdis/jiq022
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528
   BLOK J, 1985, J GEN VIROL, V66, P1323, DOI 10.1099/0022-1317-66-6-1323
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   Butrapet S, 2006, J VIROL METHODS, V131, P1, DOI 10.1016/j.jviromet.2005.06.019
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052
   Chawla T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065231
   Chotiwan N, 2014, VIROLOGY, V456, P238, DOI 10.1016/j.virol.2014.03.031
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Carmo AMD, 2017, J CLIN VIROL, V90, P7, DOI 10.1016/j.jcv.2017.03.001
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a030700
   Hanley KA, 2003, VIROLOGY, V312, P222, DOI 10.1016/S0042-6822(03)00197-1
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Kanesa-thasan N, 2001, VACCINE, V19, P3179, DOI 10.1016/S0264-410X(01)00020-2
   Kellman EM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060329
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7
   Kroeger MA, 2002, ARCH VIROL, V147, P1155, DOI 10.1007/s00705-002-0809-3
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Liu Lihui, 2010, Front Biol (Beijing), V5, P286
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McArthur MA, 2015, J INFECT DIS, V212, P681, DOI 10.1093/infdis/jiv086
   McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Ni HL, 2000, J VIROL, V74, P2903, DOI 10.1128/JVI.74.6.2903-2906.2000
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Proutski V, 1999, VIRUS RES, V64, P107, DOI 10.1016/S0168-1702(99)00079-9
   Pryor MJ, 2004, J GEN VIROL, V85, P3627, DOI 10.1099/vir.0.80283-0
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4
   Sanchez V, 2006, VACCINE, V24, P4914, DOI 10.1016/j.vaccine.2006.03.066
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Sirigulpanit W, 2007, J GEN VIROL, V88, P1748, DOI 10.1099/vir.0.82455-0
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Vannice KS, 2018, VACCINE, V36, P3411, DOI 10.1016/j.vaccine.2018.02.062
   Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053
   WANG E, 1995, J GEN VIROL, V76, P2749, DOI 10.1099/0022-1317-76-11-2749
   Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   WHO, REV SAGE REC US DENG
   Wichmann O, 2017, VACCINE, V35, P5535, DOI 10.1016/j.vaccine.2017.08.066
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Wu RH, 2017, J VIROL, V91, DOI [10.1128/JVI.01836-16, 10.1128/jvi.01836-16]
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 105
TC 0
Z9 0
U1 3
U2 3
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
J9 INT J MED SCI
JI Int. J. Med. Sci.
PY 2019
VL 16
IS 3
BP 355
EP 365
DI 10.7150/ijms.29938
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA HQ7TP
UT WOS:000462625700001
PM 30911269
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Sookaromdee, P
   Wiwanitkit, V
AF Sookaromdee, Pathum
   Wiwanitkit, Viroj
TI Antibodies to dengue, Zika, Campylobacter jejuni and gangliosides in
   Guillain-Barre syndrome
SO NEUROLOGY INDIA
LA English
DT Letter
ID VIRUS
C1 [Sookaromdee, Pathum] TWS Med Ctr, Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, Ilara Mokin, Nigeria.
RP Sookaromdee, P (corresponding author), TWS Med Ctr, Bangkok 022134567, Thailand.
EM pathumsook@gmail.com
CR Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Joob B, 2018, ARQ NEURO-PSIQUIAT, V76, P63, DOI 10.1590/0004-282X20170173
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD JAN-FEB
PY 2019
VL 67
IS 1
BP 335
EP 335
DI 10.4103/0028-3886.253641
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA HP1IA
UT WOS:000461419000075
PM 30860160
DA 2020-07-08
ER

PT J
AU Obtel, M
   Malik, MR
   Nguyen, TMN
   Buliva, E
   Elkhobby, A
   Salim, SA
   Ghosn, N
   Hemmati, P
   Thuan, V
   Mala, P
AF Obtel, Majdouline
   Malik, Mamunur Rahman
   Tran Minh Nhu Nguyen
   Buliva, Evans
   Elkhobby, Ahmed
   Salim, Salim A.
   Ghosn, Nada
   Hemmati, Payman
   Thuan, Vo
   Mala, Peter
TI Enhancing surveillance for early detection of Zika virus infection:
   strategies for the countries of Eastern Mediterranean Region
SO EASTERN MEDITERRANEAN HEALTH JOURNAL
LA English
DT Article
DE Zika virus infection; Eastern Mediterranean Region; syndromic
   surveillance; Aedes; event-based surveillance
ID SYNDROMIC SURVEILLANCE; SITUATION; OUTBREAK
AB Background: Zika virus infection (ZIKV) has caused major outbreaks in tropic and sub-tropic areas. No case from ZIKV has yet been reported in the countries of the Eastern Mediterranean Region (EMR) despite the presence of competent vector Aedes mosquitoes in many of these countries.
   Aims: This study addresses appropriate surveillance strategies for early detection of ZIKV infection, which is important for EMR countries with established Aedes populations, but with no known or documented autochthonous transmission of ZIKV.
   Methods: The WHO Regional Office for the Eastern Mediterranean developed a strategic framework for enhancing surveillance for ZIKV infection in EMR countries with established Aedes populations through a consultative process and review of available evidence.
   Results: The framework calls for enhancing surveillance for early detection of ZIKV infection using a combination of both syndromic and event-based surveillance approaches.
   Conclusions: Enhancing surveillance for ZIKAV would require no shift in the existing system. A number of considerations would be required to integrate this syndromic and event-based surveillance approaches within the existing system.
C1 [Obtel, Majdouline] Univ Mohammed 5, Lab Community Hlth Prevent Med & Hyg, Dept Publ Hlth, Fac Med & Pharm, Rabat, Morocco.
   [Obtel, Majdouline] Univ Mohammed 5, Lab Epidemiol Clin Res & Biostat, Dept Publ Hlth, Fac Med & Pharm, Rabat, Morocco.
   [Malik, Mamunur Rahman; Tran Minh Nhu Nguyen; Buliva, Evans; Thuan, Vo; Mala, Peter] WHO, Dept Hlth Emergency, Infect Hazard Management, Reg Off Eastern Mediterranean, Cairo, Egypt.
   [Elkhobby, Ahmed] Minist Publ Hlth & Populat, Epidem Control Directorate, Cairo, Egypt.
   [Salim, Salim A.] Fed Minist Hlth, Khartoum, Sudan.
   [Ghosn, Nada] Minist Publ Hlth, Epidemiol Surveillance Programme, Beirut, Lebanon.
   [Hemmati, Payman] Minist Hlth & Med Educ, Surveillance Dept, Iranian Ctr Dis Control, Tehran, Iran.
RP Malik, MR (corresponding author), WHO, Dept Hlth Emergency, Infect Hazard Management, Reg Off Eastern Mediterranean, Cairo, Egypt.
EM malikm@who.int
OI Vo, Thuan/0000-0002-8551-4240
FU World Health OrganizationWorld Health Organization [001]
CR [Anonymous], 2014, EARL DET ASS RESP AC
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buliva E, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00276
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, CLIN EV DIS
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Diop OM, 2017, J INFECT DIS, V216, pS299, DOI 10.1093/infdis/jix092
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuy C, 2013, PREV VET MED, V111, P220, DOI 10.1016/j.prevetmed.2013.06.005
   HENNING KJ, 2004, MORB MORTAL WKLY R S, V53, P7
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Kandel N, 2016, B WORLD HEALTH ORGAN, V94, P705, DOI 10.2471/BLT.16.171504
   Kirkwood Amy, 2007, J Public Health Manag Pract, V13, P194
   Kool JL, 2012, GLOB PUBLIC HEALTH, V7, P670, DOI 10.1080/17441692.2012.699536
   Lateef F, 2012, J ACUTE DIS, V1, P90, DOI 10.1016/S2221-6189(13)60022-0
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Minh NNT, 2016, E MEDITERR HEALTH J, V22, P350
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mostashari F, 2003, J URBAN HEALTH, V80, pI1, DOI 10.1093/jurban/jtg042
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   WHO, 2016, ZIK SIT REP NEUR SYN
   *WHO, 2008, GLOB BURD DIS 2004 U, P28
   World Health Organization, 2008, EARL WARN RESP OUTBR, P32
   World Health Organization, 2016, SURV ZIK VIR INF MIC
   World Health Organization, 2017, POT US POL SURV SYST
   World Health Organization, 2017, STRAT FRAM STRENGTH
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2017, WHO ZIK VIR COUNTR C
   World Health Organization, 2016, ENT SURV AED SPP CON
   Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18
NR 39
TC 1
Z9 1
U1 0
U2 0
PU WHO EASTERN MEDITERRANEAN REGIONAL OFFICE
PI NASR CITY, CAIRO
PA P. O. BOX 7608, NASR CITY, CAIRO, EGYPT
SN 1020-3397
EI 1687-1634
J9 E MEDITERR HEALTH J
JI East Mediterr. Health J.
PD JAN
PY 2019
VL 25
IS 1
BP 58
EP 65
DI 10.26719/emhj.18.011
PG 8
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA HP2BD
UT WOS:000461472100009
PM 30919926
OA Bronze
DA 2020-07-08
ER

PT J
AU Martins, RS
   Froes, MH
   Saad, LD
   Ignacio, SM
   Prado, WDA
   Figueiredo, EM
   de Souza, RP
   Nogueira, JS
   Maeda, AY
   Sate, HK
   de Paula, RC
   Katz, G
AF Martins, Renata Soares
   Froes, Michele Higa
   Saad, Leila del Castillo
   Ignacio Junior, Satiro Marcia
   Almeida Prado, Walkiria Delnero
   Figueiredo, Ernesto Machado
   de Souza, Renato Pereira
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   Sate, Helena Keico
   de Paula, Regiane Cardoso
   Katz, Gizelda
TI The role of pregnant women with rash in the Zika virus sentinel
   surveillance
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Pregnant women; Zika virus; Microcephaly
AB Introduction: The state of Sao Paulo has been monitoring cases of microcephaly and pregnant women presenting with acute rash, through CeVeSP. Methods: This was a descriptive study focusing on pregnant women with rash and the outcome of their pregnancy, based on the notifications through the CeVeSP. Results: During 2016, 2,209 cases of pregnant women with rash were reported and investigated. Of these, 36.6% were confirmed. Of the pregnant women who tested positive for ZIKV, 6.4% did not have a favorable outcome. Conclusions: Our results allowed the characterization of pregnant women exposed to ZIKV and the outcome of pregnancy.
C1 [Martins, Renata Soares; Froes, Michele Higa; Saad, Leila del Castillo; Ignacio Junior, Satiro Marcia; Almeida Prado, Walkiria Delnero; Figueiredo, Ernesto Machado; Sate, Helena Keico; de Paula, Regiane Cardoso; Katz, Gizelda] Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Sao Paulo, SP, Brazil.
   [de Souza, Renato Pereira; Nogueira, Juliana Silva; Maeda, Adriana Yurika] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
RP Martins, RS (corresponding author), Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Sao Paulo, SP, Brazil.
EM renatamartins47@gmail.com
OI Soares Martins, Renata/0000-0002-2568-7692; Pereira de Souza,
   Renato/0000-0003-1315-7085
CR Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2016, POP RES EST TCU SAO
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao a Saude, 2017, OR INT VIG AT SAUD A
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Regadas VC, 2018, REV ASSOC MED BRAS, V64, P11, DOI 10.1590/1806-9282.64.01.11
   Secretaria Estadual de Saude de Sao Paulo, 2017, DISTR CAS ZIK VIR NO
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e20180351
DI 10.1590/0037-8682-0351-2018
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HP8EG
UT WOS:000461921600001
PM 30892549
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Roy, P
   Dey, S
   Nandy, A
   Basak, SC
   Das, S
AF Roy, Proyasha
   Dey, Sumanta
   Nandy, Ashesh
   Basak, Subhash C.
   Das, Sukhen
TI Base Distribution in Dengue Nucleotide Sequences Differs Significantly
   from other Mosquito-Borne Human-Infecting Flavivirus Members
SO CURRENT COMPUTER-AIDED DRUG DESIGN
LA English
DT Article
DE Flaviviruses; 2D graphical representation; dengue; envelope gene; NS5
   gene; relative excess adenines; dengue evolution; codon usage bias;
   methyltransferase; vaccines
ID GRAPHICAL REPRESENTATION; ZIKA VIRUS; RNA; METHYLTRANSFERASE; DISEASE
AB Introduction: Among the mosquito-borne human-infecting flavivirus species that include Zika, West Nile, yellow fever, Japanese encephalitis and Dengue viruses, the Zika virus is found to be closest to Dengue virus, sharing the same Glade in the Flavivirus phylogenetic tree. We consider these five flaviviruses and on closer examination in our analyses, the nucleotide sequences of the Dengue viral genes (envelope and NS5) and genomes are seen to be quite widely different from the other four flaviviruses. We consider the extent of this distinction and determine the advantage and/or disadvantage such differences may confer upon the Dengue viral pathogenesis.
   Methods: We have primarily used a 2D graphical representation technique to show the differences in base distributions in these five flaviviruses and subsequently, obtained quantitative estimates of the differences. Similarity/dissimilarity between the viruses based on the genes were also determined which showed that the differences with the Dengue genes are more pronounced.
   Results: We found that the Dengue viruses compared to the other four flaviviruses spread rapidly worldwide and became endemic in various regions with small alterations in sequence composition relative to the host populations as revealed by codon usage biases and phylogenetic examination.
   Conclusion: We conclude that the Dengue genes are indeed more widely separated from the other aforementioned mosquito-borne human-infecting flaviviruses due to excess adenine component, a feature that is sparse in the literature. Such excesses have a bearing on drug and vaccine, especially peptide vaccine, development and should be considered appropriately.
C1 [Roy, Proyasha; Dey, Sumanta; Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700058, India.
   [Basak, Subhash C.] Univ Minnesota Duluth, Dept Chem & Biochem, Duluth Nat Resources Res Inst, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
   [Das, Sukhen] Jadavpur Univ, Dept Phys, Kolkata 700032, India.
RP Nandy, A (corresponding author), Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700058, India.
EM anandy43@yahoo.com
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P69
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   [Anonymous], 2016, MURR VALL ENC MVE FA
   Behura SK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-37
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Bradrick SS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02374
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   CDC. Centers for Disease Control and Prevention, FIN CUM MAPS DAT 199
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Diambra LA, 2017, PEERJ, V5, DOI 10.7717/peerj.3081
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gupta N, 2012, INDIAN J MED RES, V136, P373
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Nandy A, 2003, CHEM PHYS LETT, V368, P102, DOI 10.1016/S0009-2614(02)01830-4
   NANDY A, 1994, CURR SCI INDIA, V66, P309
   Nandy A, 2017, EXPLOR RES HYPOTHESI, V2, P43
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Ramakrishnan L, 2015, VIRAL IMMUNOL, V28, P76, DOI 10.1089/vim.2014.0093
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Raychaudhury C, 1999, J CHEM INF COMP SCI, V39, P243, DOI 10.1021/ci980077v
   Ryu WS, 2017, MOLECULAR VIROLOGY OF HUMAN PATHOGENIC VIRUSES, P165, DOI 10.1016/B978-0-12-800838-6.00012-6
   Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW
   Sessions OM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004044
   Soucheray S., 2017, SANOFI RESTRICTS DEN
   Spencer PS, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204006
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Villabona-Arenas CJ, 2013, INFECT GENET EVOL, V18, P202, DOI 10.1016/j.meegid.2013.05.012
   Wangikar P., 2016, J INFECT DIS PATHOL, V1, P108
   Weyer J, 2013, VECTOR-BORNE ZOONOT, V13, P330, DOI 10.1089/vbz.2012.1181
   WHO, DENGUE
   World Health Organization, 2017, UPD QUEST ANSW REL D
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 49
TC 0
Z9 0
U1 1
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4099
EI 1875-6697
J9 CURR COMPUT-AID DRUG
JI Curr. Comput.-Aided Drug Des.
PY 2019
VL 15
IS 1
BP 29
EP 44
DI 10.2174/1573409914666180731090005
PG 16
WC Chemistry, Medicinal; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Computer Science
GA HO4GW
UT WOS:000460881600004
PM 30062973
DA 2020-07-08
ER

PT J
AU Saraf, N
   Villegas, M
   Willenberg, BJ
   Seal, S
AF Saraf, Nileshi
   Villegas, Michael
   Willenberg, Bradley Jay
   Seal, Sudipta
TI Multiplex Viral Detection Platform Based on a Aptamers-Integrated
   Microfluidic Channel
SO ACS OMEGA
LA English
DT Article
ID ZIKA VIRUS; SENSITIVE DETECTION; GOLD NANOPARTICLES; TRANSMISSION;
   IMMOBILIZATION; CHEMISTRY; DIAGNOSIS; DNA
AB A polydimethylsiloxane-based microfluidic device has been developed for the multiplex detection of viral envelope proteins such as Zika and chikungunya on a single platform using aptamer-analyte interactions. The channel is integrated with microsized pillars that increase the surface area allowing more aptamers to attach to the incoming envelope protein molecules, thus increasing the overall sensitivity of the system. The working of the device depends on the formation of protein-mediated sandwich morphology that is obtained using an aptamer and aptamer-functionalized gold nano-particle (AuNP) pair. The colorimetric signal is obtained upon introduction of silver reagents into the channel, which are selectively deposited on the AuNP surface, providing a gray contrast in the testing zone. The microfluidic channel approach successfully detected clinically relevant concentrations of Zika and chikungunya envelope proteins in phosphine-buffered saline (1 pM) and calf blood (100 pM) with high specificity using gold-decorated aptamers integrated in a microfluidic channel.
C1 [Saraf, Nileshi; Seal, Sudipta] Univ Cent Florida, Adv Mat Proc & Anal Ctr, Dept Mat Sci & Engn, Orlando, FL 32827 USA.
   [Willenberg, Bradley Jay] Univ Cent Florida, Dept Internal Med, Coll Med, Orlando, FL 32827 USA.
   [Seal, Sudipta] Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32827 USA.
   [Villegas, Michael] Univ Florida, Gainesville, FL 32611 USA.
RP Seal, S (corresponding author), Univ Cent Florida, Adv Mat Proc & Anal Ctr, Dept Mat Sci & Engn, Orlando, FL 32827 USA.; Seal, S (corresponding author), Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32827 USA.
EM Sudipta.seal@ucf.edu
RI Seal, Sudipta/A-7698-2012
FU National Science FoundationNational Science Foundation (NSF) [REU EEC
   1560007]; Florida Department of Agriculture and Consumer Services
   (FDACS) [023593, 24236]; Bill & Melinda Gates Foundation Grand
   Challenges Explorations Grant [OPP1138590]
FX National Science Foundation, REU EEC 1560007, Florida Department of
   Agriculture and Consumer Services (FDACS #023593, #24236) and Bill &
   Melinda Gates Foundation Grand Challenges Explorations Grant, Investment
   ID OPP1138590.
CR Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408
   Crew E, 2013, ANALYST, V138, P4941, DOI 10.1039/c3an00683b
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Famulok M, 2014, CHEM BIOL, V21, P1055, DOI 10.1016/j.chembiol.2014.08.003
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Han YH, 2018, ANAL METHODS-UK, V10, P2436, DOI 10.1039/c8ay00386f
   Hoek I, 2010, LAB CHIP, V10, P2283, DOI 10.1039/c004769d
   Lake M., 2015, PROTOC EXCH, DOI DOI 10.1038/PRO-TEX.2015.069
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li D, 2010, ADV FUNCT MATER, V20, P1767, DOI 10.1002/adfm.201000188
   Liu R, 2014, APPL SPECTROSC REV, V49, P121, DOI 10.1080/05704928.2013.807817
   Mark D, 2010, NATO SCI PEACE SEC A, P305, DOI 10.1007/978-90-481-9029-4_17
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Niu SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109263
   Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP US AM JUN
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Ren XQ, 2001, J CHROMATOGR B, V762, P117, DOI 10.1016/S0378-4347(01)00327-9
   Saraf N, 2018, BIOSENS BIOELECTRON, V117, P40, DOI 10.1016/j.bios.2018.05.031
   Saraf N, 2017, RSC ADV, V7, P49133, DOI 10.1039/c7ra10272k
   Shen G, 2004, NUCLEIC ACIDS RES, V32, P5973, DOI 10.1093/nar/gkh932
   Soares J. W., 2010, EFFECT SURFACE MODIF
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612
   Souf S., 2016, BIOSCI HORIZ, V9, phzw010, DOI [10.1093/biohorizons/hzw010., DOI 10.1093/BIOHORIZONS/HZW010]
   Thatiparti TR, 2011, MACROMOL BIOSCI, V11, P1544, DOI 10.1002/mabi.201100159
   Thorslund S, 2005, ELECTROPHORESIS, V26, P4674, DOI 10.1002/elps.200500338
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Toh SY, 2015, BIOSENS BIOELECTRON, V64, P392, DOI 10.1016/j.bios.2014.09.026
   TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Weinert U., 2011, WIT T MODELL SIMUL, V51, P569
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Wu YX, 2016, METHODS, V106, P21, DOI 10.1016/j.ymeth.2016.04.020
   Yu Q, 2015, FOOD CONTROL, V54, P347, DOI 10.1016/j.foodcont.2015.02.019
   Zhuo ZJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102142
NR 49
TC 2
Z9 2
U1 3
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD JAN
PY 2019
VL 4
IS 1
BP 2234
EP 2240
DI 10.1021/acsomega.8b03277
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA HN5HN
UT WOS:000460214700244
PM 30729227
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gorchakov, R
   Berry, RM
   Patel, SM
   El Sahly, HM
   Ronca, SE
   Murray, KO
AF Gorchakov, Rodion
   Berry, Rebecca M.
   Patel, Shital M.
   El Sahly, Hana M.
   Ronca, Shannon E.
   Murray, Kristy O.
TI Optimizing PCR Detection of Zika Virus from Various Body Fluids
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID WEST-NILE-VIRUS; SEXUAL TRANSMISSION; BIRTH-DEFECTS; RNA; INFECTION;
   INFANTS; RHESUS; URINE
AB Current diagnostic protocols of acute Zika virus (ZIKV) infection focus on detection of viral RNA in serum or urine using reverse transcription quantitative polymerase chain reaction (RT-qPCR); however, detecting infection can be a challenge, given that 80% of people with acute ZIKV infection are asymptomatic, and the window to detect viremia in serum is short. The ability to extend that window is needed to detect ZIKV at later time points after infection, particularly in high-risk individuals such as pregnant women. We evaluated RNA extraction methods to optimize detection of ZIKV in various body fluids using RT-qPCR as a means of improving the analytical sensitivity of detection. We optimized methods for ZIKV RNA recovery from a number of body fluids by spiking with three varying concentrations of virus, then comparing recovery with that of spiked buffer control. RNA extraction protocols were adjusted as necessary for maximum RNA recovery. Adjustment of the elution step was essential for improved ZIKV RNA recovery from whole blood, saliva, vaginal secretions, and breast milk. Optimal recovery from urine samples required the addition of Urine Conditioning Buffer, and the use of RLT Plus buffer and RNeasy Mini Spin Columns was necessary for RNA extractions from semen samples. Optimized QIAamp MinElute Virus Spin Kit (QIAGEN, Valencia, CA) protocol followed by the singleplex ZIKV RT-qPCR assay provided a reliable method for detection of ZIKV RNA in a variety of biological samples. Improved diagnostics are crucial for timely detection and diagnosis, particularly during pregnancy when the consequences of ZIKV infection can greatly impact the developing fetus.
C1 [Gorchakov, Rodion; Berry, Rebecca M.; Ronca, Shannon E.; Murray, Kristy O.] Baylor Coll Med, Dept Pediat Trop Med, One Baylor Plaza,BCM320, Houston, TX 77030 USA.
   [Gorchakov, Rodion; Berry, Rebecca M.; Ronca, Shannon E.; Murray, Kristy O.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Patel, Shital M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [El Sahly, Hana M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
RP Murray, KO (corresponding author), Baylor Coll Med, Dept Pediat Trop Med, One Baylor Plaza,BCM320, Houston, TX 77030 USA.
EM rodion@bcm.edu; rberry@bcm.edu; shitalp@bcm.edu; hanae@bcm.edu;
   ronca@bcm.edu; kmurray@bcm.edu
FU National Institutes of Allergy and Infectious Diseases at the National
   Institutes of Health [HHSN272201500002C]; Elkins Foundation
FX The study was supported by the National Institutes of Allergy and
   Infectious Diseases at the National Institutes of Health contract
   HHSN272201500002C and the Elkins Foundation.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   CDC Zika, 2017, CAS US
   Christopher-Hennings J, 2006, J VIROL METHODS, V136, P248, DOI 10.1016/j.jviromet.2006.03.012
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deng MY, 2005, J VET DIAGN INVEST, V17, P574, DOI 10.1177/104063870501700609
   El Bali Latifa, 2014, J Biomol Tech, V25, P96, DOI 10.7171/jbt.14-2504-002
   El-Khoury V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19529
   Farrell Jr R.E, 2017, RNA METHODOLOGIES LA
   Fieni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076367
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Georgiadis AP, 2015, J UROLOGY, V193, P352, DOI 10.1016/j.juro.2014.07.107
   Gibney KB, 2011, J INFECT DIS, V203, P344, DOI 10.1093/infdis/jiq057
   Goodrich Robert J, 2013, Methods Mol Biol, V927, P385
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EURO SURVEILL, V21
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   QIAGEN, 2010, QIAAMP MINELUTE VIR
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
NR 37
TC 3
Z9 3
U1 1
U2 8
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 2
BP 427
EP 433
DI 10.4269/ajtmh.18-0755
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HN7YU
UT WOS:000460410600037
PM 30560770
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Monaghan, AJ
   Schmidt, CA
   Hayden, MH
   Smith, KA
   Reiskind, MH
   Cabell, R
   Ernst, KC
AF Monaghan, Andrew J.
   Schmidt, Christopher A.
   Hayden, Mary H.
   Smith, Kirk A.
   Reiskind, Michael H.
   Cabell, Ryan
   Ernst, Kacey C.
TI A Simple Model to Predict the Potential Abundance of Aedes aegypti
   Mosquitoes One Month in Advance
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID STEGOMYIA-AEGYPTI; UNITED-STATES; ALBOPICTUS; DIPTERA; TRANSMISSION;
   TEMPERATURE; IMPACT; VIRUS
AB The mosquito Aedes (Stegomyia) aegypti (L.) is the primary vector of dengue, chikungunya, and Zika viruses in the United States. Surveillance for adult Ae. aegypti is limited, hindering understanding of the mosquito's seasonal patterns and predictions of areas at elevated risk for autochthonous virus transmission. We developed a simple, intuitive empirical model that uses readily available temperature and humidity variables to predict environmental suitability for low, medium, or high potential abundance of adult Ae. aegypti in a given city 1 month in advance. Potential abundance was correctly predicted in 73% of months in arid Phoenix, AZ (over a 10-year period), and 63% of months in humid Miami, FL (over a 2-year period). The monthly model predictions can be updated daily, weekly, or monthly and thus may be applied to forecast suitable conditions for Ae. aegypti to inform vector-control activities and guide household-level actions to reduce mosquito habitat and human exposure.
C1 [Monaghan, Andrew J.] Univ Colorado, 597 POB 3000, Boulder, CO 80309 USA.
   [Schmidt, Christopher A.; Cabell, Ryan] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.
   [Hayden, Mary H.] Univ Colorado, Colorado Springs, CO 80907 USA.
   [Smith, Kirk A.] Maricopa Cty Environm Serv Vector Control Dept, Phoenix, AZ USA.
   [Reiskind, Michael H.] North Carolina State Univ, Dept Entomol, Raleigh, NC USA.
   [Ernst, Kacey C.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA.
RP Monaghan, AJ (corresponding author), Univ Colorado, 597 POB 3000, Boulder, CO 80309 USA.
EM andrew.monaghan@colorado.edu; casch@ucar.edu; mhayden@uccs.edu;
   ksmith@mail.maricopa.gov; mhreiski@ncsu.edu; rcabell@ucar.edu;
   kernst@email.arizona.edu
RI Reiskind, Michael Hay/I-5614-2012
OI Reiskind, Michael/0000-0001-7307-9416
FU NASANational Aeronautics & Space Administration (NASA) [NNX16A098G];
   National Science FoundationNational Science Foundation (NSF)
FX This work was funded by NASA Grant NNX16A098G. The National Center for
   Atmospheric Research is sponsored by the National Science Foundation.
CR Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Cosgrove BA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003118
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hayden MH, 2015, AM J TROP MED HYG, V93, P397, DOI 10.4269/ajtmh.15-0128
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Monaghan AJ, 2016, PLOS CURR, V8
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Sukumaran D, 2016, INDIAN J NAT PROD RE, V7, P207
   Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830
NR 18
TC 1
Z9 1
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 2
BP 434
EP 437
DI 10.4269/ajtmh.17-0860
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HN7YU
UT WOS:000460410600038
PM 30594264
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Connery, AK
   Berrios-Siervo, G
   Arroyave, P
   Bauer, D
   Hernandez, S
   Paniagua-Avila, A
   Bolanos, GA
   Bunge-Montes, S
   El Sahly, HM
   Calvimontes, M
   Olson, D
   Munoz, FM
   Asturias, EJ
AF Connery, Amy K.
   Berrios-Siervo, Gretchen
   Arroyave, Paola
   Bauer, Desiree
   Hernandez, Sara
   Paniagua-Avila, Alejandra
   Antonio Bolanos, Guillermo
   Bunge-Montes, Saskia
   El Sahly, Hana M.
   Calvimontes, Mirella
   Olson, Daniel
   Munoz, Flor M.
   Asturias, Edwin J.
TI Responding to the Zika Epidemic: Preparation of a Neurodevelopmental
   Testing Protocol to Evaluate Young Children in Rural Guatemala
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MIDDLE-INCOME COUNTRIES; VIRUS; GUIDELINES; LANGUAGE; CULTURE; GROWTH;
   TOOLS
AB The ongoing Zika virus (ZIKV) epidemic in Latin America presented a unique opportunity to develop a neurodevelopmental assessment protocol for children in a lower middle-income country. Although studies of neuro-development in young children have taken place in many diverse global settings, we are not aware of any study that has provided a high level of detail about how a measure was selected and then specifically translated and adapted in a low-resource setting. Here, we describe considerations in measurement selection and then the process of translation and adaptation to assess neurodevelopmental outcomes of infants and young children with postnatal exposure to ZIKV in rural Guatemala. We provide a framework to other research teams seeking to develop similar assessment models across the globe.
C1 [Connery, Amy K.; Berrios-Siervo, Gretchen; Olson, Daniel; Asturias, Edwin J.] Childrens Hosp Colorado, Aurora, CO 80045 USA.
   [Connery, Amy K.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA.
   [Berrios-Siervo, Gretchen; Olson, Daniel; Asturias, Edwin J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.
   [Berrios-Siervo, Gretchen] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA.
   [Arroyave, Paola; Bauer, Desiree; Hernandez, Sara; Paniagua-Avila, Alejandra; Antonio Bolanos, Guillermo; Bunge-Montes, Saskia; Calvimontes, Mirella] Fdn Salud Integral Guatemaltecos, Ctr Human Dev, Retalhuleu, Guatemala.
   [Bunge-Montes, Saskia; Olson, Daniel; Asturias, Edwin J.] Colorado Sch Publ Hlth, Ctr Global Hlth, Aurora, CO USA.
   [Bunge-Montes, Saskia; Olson, Daniel; Asturias, Edwin J.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA.
   [El Sahly, Hana M.; Munoz, Flor M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Munoz, Flor M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
RP Connery, AK (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.
EM amy.connery@childrenscolorado.org;
   gretchen.berrios-siervo@childrenscolorado.org; parroyave@ufm.edu;
   desibauerh@gmail.com; smhh93@gmail.com;
   alejandra.paniagua.fsigcu@gmail.com; guillermo.bolando.fsigcu@gmail.com;
   saskia.bunge@gmail.com; hana.elsahly@bcm.edu;
   mirellacalvimontes@yahoo.com; daniel.olson@childrenscolorado.org;
   florm@bcm.edu; edwin.asturias@childrenscolorado.org
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; VTEU
   [HHSN272201300015I, HHSN27200013-16-0057, C1D1.0058]
FX This work was supported by the National Institutes of Health (NIH),
   funding mechanism: VTEU Contract HHSN272201300015I, Task Order No.
   HHSN27200013-16-0057.C1D1.0058.
CR Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x
   American Educational Research Association (AERA) American Psychological Association (APA) & National Council for Measurement in Education (NCME), 2014, STAND ED PSYCH TEST
   Asturias EJ, 2015, ADV PEDIATR, V63, P357
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayley N, 2006, BAYLEY SCALES INFANT
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7
   Bornman J, 2010, J POLICY PRACT INTEL, V7, P111, DOI 10.1111/j.1741-1130.2010.00254.x
   Byrne BM, 2010, INT J TEST, V10, P107, DOI 10.1080/15305051003637306
   Cassepp-Borges V, 2010, INSTRUMENTACAO PSICO, P506
   Chen CY, 2017, INFANT YOUNG CHILD, V30, P111, DOI 10.1097/IYC.0000000000000089
   Cole TJ, 2012, ANN HUM BIOL, V39, P382, DOI 10.3109/03014460.2012.694475
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Erkut S, 2010, CHILD DEV PERSPECT, V4, P19, DOI 10.1111/j.1750-8606.2009.00111.x
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernald LC, 2017, TOOLKIT MEASURING EA
   Fischer VJ, 2014, J HEALTH POPUL NUTR, V32, P314
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   GEISINGER KF, 1994, PSYCHOL ASSESSMENT, V6, P304, DOI DOI 10.1037/1040-3590.6.4.304
   Gregoire J, 2018, INT J TEST, V18, P101, DOI 10.1080/15305058.2017.1398166
   Gudmundsson E, 2009, NORD PSYCHOL, V61, P29, DOI 10.1027/1901-2276.61.2.29
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1322
   Hambleton R.K., 2004, ADAPTING ED PSYCHOL, P3, DOI DOI 10.4324/9781410611758
   Hambleton R. K., 1985, ITEM RESPONSE THEORY
   Hambleton RK, 1999, J APPL TEST TECHNOL, V53, P1689
   Janus M, 2007, EARLY DEV INSTRUMENT
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Koura KG, 2013, J DEV BEHAV PEDIATR, V34, P486, DOI 10.1097/DBP.0b013e31829d211c
   Krach SK, 2017, SCHOOL PSYCHOL INT, V38, P3, DOI 10.1177/0143034316684672
   Macrine SL, 2015, INT J SCH ED PSYCHOL, V3, P256
   Mangin KS, 2017, CHILD DEV, V88, P282, DOI 10.1111/cdev.12585
   Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563
   McCarthy AM, 2012, INFANT BEHAV DEV, V35, P280, DOI 10.1016/j.infbeh.2011.12.003
   McCoy DC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002034
   Milfont TL, 2010, INT J PSYCHOL RES, V3, P111
   Mullen EM, 1995, MULLEN SCALES EARLY
   Newborg J, 2004, BATELLE DEV INVENTOR
   Olson D, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx049
   Panter-Brick C, 2018, CHILD DEV, V89, P1803, DOI 10.1111/cdev.12868
   Pena ED, 2007, CHILD DEV, V78, P1255, DOI 10.1111/j.1467-8624.2007.01064.x
   Pitt MB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3939
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552
   Sabanathan S, 2015, ARCH DIS CHILD, V100, P482, DOI 10.1136/archdischild-2014-308114
   Semrud-Clikeman M, 2016, SELECTING MEASURES N, V23, P761
   Sireci S. G., 2004, ADAPTING ED PSYCHOL, DOI [10.4324/9781410611758, DOI 10.4324/9781410611758]
   Snow C. E., 2008, EARLY CHILDHOOD ASSE
   Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111
   UN, 2001, ROAD MAP IMPL UN MIL
   Van de Vijver F., 2005, ADAPTING ED PSYCHOL, P51, DOI [10.4324/9781410611758, DOI 10.4324/9781410611758]
   Van de Vijver F. J. R., 2004, EUR REV APPL PSYCHOL, V54, P119, DOI [10.1016/j.erap.2003.12.004, DOI 10.1016/J.ERAP.2003.12.004]
   WHO, 2009, PROC TRANSL AD INSTR
   WHO, 2012, DEV DIFF EARL CHILDH
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 56
TC 4
Z9 4
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 2
BP 438
EP 444
DI 10.4269/ajtmh.18-0713
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HN7YU
UT WOS:000460410600039
PM 30594262
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rubio, E
   Alejo-Cancho, I
   Aylagas, C
   Camprubi, D
   Ferre, R
   Albarracin, MR
   Gonzalo, V
   Barrachina, J
   Alvarez-Martinez, MJ
   Valls, ME
   Mas, J
   Vila, J
   Losada, I
   Martinez, MJ
   Casals-Pascual, C
AF Rubio, Elisa
   Alejo-Cancho, Izaskun
   Aylagas, Cristian
   Camprubi, Daniel
   Ferre, Roser
   Rosa Albarracin, Ma
   Gonzalo, Veronica
   Barrachina, Josep
   Jose Alvarez-Martinez, Miriam
   Eugenia Valls, Maria
   Mas, Jordi
   Vila, Jordi
   Losada, Irene
   Martinez, Miguel J.
   Casals-Pascual, Climent
TI Diagnostic Value of Platelet and Leukocyte Counts in the Differential
   Diagnosis of Fever in the Returning Traveler
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID GEOSENTINEL SURVEILLANCE; PLASMODIUM-FALCIPARUM; ZIKA VIRUS; MALARIA;
   THROMBOCYTOPENIA; DISEASE; INFECTION; SPECTRUM; DIARRHEA; DENGUE
AB Malaria, arbovirus infection and travelers' diarrhea are among the most common etiologies of fever after a stay in the tropics. Because the initial symptoms of these diseases often overlap, the differential diagnostic remains a challenge. The aim of this study was to establish the effectiveness of platelet and leukocyte counts in the differential diagnosis of fever in the returning traveler. Between 2013 and 2016, patients with a clinical suspicion of malaria, who had thick blood smears performed were retrospectively included. The microbiological etiology of each episode was established based on molecular detection in the case of arbovirus infection, the detection of pathogens in stool samples for diarrhea and other gastrointestinal symptoms and the thick and thin blood smear results for malaria. A total of 1,218 episodes were included. Malaria, arbovirus infection, and diarrhea and other gastrointestinal symptoms caused 102 (8.4%), 68 (5.6%), and 72 (5.9%) episodes, respectively. The median platelet counts in malaria episodes were 89 x 10(9)/L and thrombocytopenia (< 150,000 x 10(9) platelets/L) yielded a 98% negative predictive value to predict malaria. The median leukocyte counts in arbovirus infection episodes were 3.19 x 10(9)/L and leucopenia (< 4 x 10(9) leukocytes/L) yielded a 97.9% negative predictive value to predict arbovirus infections. Platelet and leukocyte counts were not significantly altered in episodes caused by diarrhea and other gastrointestinal symptoms. Initial platelet and leukocyte counts might be useful for the clinical differential diagnosis of fever in the returning traveler. Although these results are insufficient to establish a diagnosis, they should be considered in the initial clinical assessment.
C1 [Rubio, Elisa; Alejo-Cancho, Izaskun; Aylagas, Cristian; Ferre, Roser; Rosa Albarracin, Ma; Gonzalo, Veronica; Barrachina, Josep; Jose Alvarez-Martinez, Miriam; Eugenia Valls, Maria; Mas, Jordi; Vila, Jordi; Martinez, Miguel J.; Casals-Pascual, Climent] Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.
   [Camprubi, Daniel; Losada, Irene] Hosp Clin Barcelona, Dept Trop Med & Int Hlth, Barcelona, Spain.
   [Camprubi, Daniel; Jose Alvarez-Martinez, Miriam; Vila, Jordi; Losada, Irene; Martinez, Miguel J.; Casals-Pascual, Climent] ISGlobal Barcelona Inst Global Hlth, Barcelona, Spain.
   [Rubio, Elisa; Alejo-Cancho, Izaskun; Aylagas, Cristian; Ferre, Roser; Rosa Albarracin, Ma; Gonzalo, Veronica; Barrachina, Josep; Jose Alvarez-Martinez, Miriam; Eugenia Valls, Maria; Mas, Jordi; Vila, Jordi; Martinez, Miguel J.; Casals-Pascual, Climent] Hosp Clin Barcelona, Dept Clin Microbiol, Villarroel 170, E-08036 Barcelona, Spain.
   [Camprubi, Daniel; Losada, Irene] Hosp Clin Barcelona, Dept Trop Med & Int Hlth, Barcelona, Spain.
RP Rubio, E (corresponding author), Hosp Clin Barcelona, Dept Clin Microbiol, Villarroel 170, E-08036 Barcelona, Spain.
EM elrubio@clinic.cat; alejo@clinic.cat; aylagas@clinic.cat;
   dcamprub@clinic.cat; mrferre@clinic.cat; ralbarra@clinic.cat;
   vgonzal1@clinic.cat; barrachina@clinic.cat; malvarez@clinic.cat;
   mevalls@clinic.cat; jmas@clinic.cat; jvila@clinic.cat;
   ilosada@clinic.cat; myoldi@clinic.cat; ccasals@clinic.cat
RI Losada, Irene/AAM-6222-2020; Casals-Pascual, Climent/N-7692-2018
OI Losada, Irene/0000-0002-5122-2039; Alvarez-Martinez, Miriam
   Jose/0000-0003-4157-0117; Camprubi, Daniel/0000-0003-4215-6030;
   Martinez, Miguel Julian/0000-0002-0682-1075; Casals-Pascual,
   Climent/0000-0002-0867-8954
CR Aranda KRS, 2004, J CLIN MICROBIOL, V42, P5849, DOI 10.1128/JCM.42.12.5849-5853.2004
   Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544
   Azmatullah A, 2015, J GLOB HEALTH, V5, P107, DOI 10.7189/jogh.05.020407
   Berens-Riha N, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-155
   Bottieau E, 2007, MEDICINE, V86, P18, DOI 10.1097/MD.0b013e3180305c48
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Grynberg P, 2007, CLIN MICROBIOL INFEC, V13, P1089, DOI 10.1111/j.1469-0691.2007.01815.x
   Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   KELTON JG, 1983, J CLIN INVEST, V71, P832, DOI 10.1172/JCI110836
   Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952
   Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308
   Kutsuna S, 2015, J INFECT CHEMOTHER, V21, P272, DOI 10.1016/j.jiac.2014.12.004
   Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x
   Lampah DA, 2015, J INFECT DIS, V211, P623, DOI 10.1093/infdis/jiu487
   Leal-Santos FA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-462
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Okhuysen PC, 2001, CLIN INFECT DIS, V33, P110, DOI 10.1086/320894
   Pistone T, 2014, TRAVEL MED INFECT DI, V12, P48, DOI 10.1016/j.tmaid.2013.08.006
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006
   Thachil J, 2017, BRIT J HAEMATOL, V177, P960, DOI 10.1111/bjh.14582
   Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072
   Zboromyrska Y, 2014, CLIN MICROBIOL INFEC, V20, pO753, DOI 10.1111/1469-0691.12621
NR 35
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 2
BP 470
EP 475
DI 10.4269/ajtmh.18-0736
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HN7YU
UT WOS:000460410600043
PM 30526735
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Pastorino, B
   Sengvilaipaseuth, O
   Chanthongthip, A
   Vongsouvath, M
   Souksakhone, C
   Mayxay, M
   Thirion, L
   Newton, PN
   de Lamballerie, X
   Dubot-Peres, A
AF Pastorino, Boris
   Sengvilaipaseuth, Onanong
   Chanthongthip, Anisone
   Vongsouvath, Manivanh
   Souksakhone, Chanthala
   Mayxay, Mayfong
   Thirion, Laurence
   Newton, Paul N.
   de lamballerie, Xavier
   Dubot-Peres, Audrey
TI Low Zika Virus Seroprevalence in Vientiane, Laos, 2003-2015
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Zika virus (ZIKV) has been presumed to be endemic in Southeast Asia (SEA), with a low rate of human infections. Although the first ZIKV evidence was obtained in the 1950s through serosurveys, the first laboratory-confirmed case was only detected in 2010 in Cambodia. The epidemiology of ZIKV in SEA remains uncertain because of the scarcity of available data. From 2016, subsequent to the large outbreaks in the Pacific and Latin America, several Asian countries started reporting increasing numbers of confirmed ZIKV patients, but no global epidemiological assessment is available to date. Here, with the aim of providing information on ZIKV circulation and population immunity, we conducted a seroprevalence study among blood donors in Vientiane, Laos. Sera from 359 asymptomatic consenting adult donors in 2003-2004 and 687 in 2015 were screened for anti-ZIKV IgG using NS1 ELISA assay (Euroimmun, Luebeck, Germany). Positive and equivocal samples were confirmed for anti-ZIKV-neutralizing antibodies by virus neutralization tests. Our findings suggest that ZIKV has been circulating in Vientiane over at least the last decade. Zika virus seroprevalence observed in the studied blood donors was low, 4.5% in 2003-2004 with an increase in 2015 to 9.9% (P = 0.002), possibly reflecting the increase of ZIKV incident cases reported over this period. We did not observe any significant difference in seroprevalence according to gender. With a low herd immunity in the Vientiane population, ZIKV represents a risk for future large-scale outbreaks. Implementation of a nationwide ZIKV surveillance network and epidemiological studies throughout the country is needed.
C1 [Pastorino, Boris; Thirion, Laurence; de lamballerie, Xavier; Dubot-Peres, Audrey] Aix Marseille Univ, UVE, IRD190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
   [Sengvilaipaseuth, Onanong; Chanthongthip, Anisone; Vongsouvath, Manivanh; Mayxay, Mayfong; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Microbiol Lab, Viangchan, Laos.
   [Souksakhone, Chanthala] Natl Blood Transfus Ctr, Lao Red Cross, Viangchan, Laos.
   [Mayxay, Mayfong] Univ Hlth Sci, Inst Res & Educ Dev, Viangchan, Laos.
   [Mayxay, Mayfong; Newton, Paul N.; Dubot-Peres, Audrey] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Churchill Hosp, Oxford, England.
RP Dubot-Peres, A (corresponding author), Fac Med, Unite Virus Emergents, 27 Bldg Jean Moulin, F-13005 Marseille, France.
EM audrey@tropmedres.ac
OI Newton, Paul/0000-0002-4608-6431; pastorino, boris/0000-0001-5233-5193
FU Wellcome Trust of Great BritainWellcome Trust; Institute of Research for
   Development; Aix-Marseille University; European Union's Horizon 2020
   Research and Innovation Programme EVAg [653316]; European Union's
   Horizon 2020 Research and Innovation Programme under ZIKAlliance grant
   [734548]
FX This study was funded by the Wellcome Trust of Great Britain, the
   Institute of Research for Development, and Aix-Marseille University, by
   the European Union's Horizon 2020 Research and Innovation Programme EVAg
   under grant agreement No. 653316 and by the European Union's Horizon
   2020 Research and Innovation Programme under ZIKAlliance grant agreement
   No. 734548.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5577
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 18
TC 7
Z9 7
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 3
BP 639
EP 642
DI 10.4269/ajtmh.18-0439
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HN8AQ
UT WOS:000460416400033
PM 30693859
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Borba, L
   Villordo, SM
   Marsico, FL
   Carballeda, JM
   Filomatori, CV
   Gebhard, LG
   Pallares, HM
   Lequime, S
   Lambrechts, L
   Vargas, IS
   Blair, CD
   Gamarnik, AV
AF de Borba, Luana
   Villordo, Sergio M.
   Marsico, Franco L.
   Carballeda, Juan M.
   Filomatori, Claudia V.
   Gebhard, Leopoldo G.
   Pallares, Horacio M.
   Lequime, Sebastian
   Lambrechts, Louis
   Vargas, Irma Sanchez
   Blair, Carol D.
   Gamarnik, Andrea V.
TI RNA Structure Duplication in the Dengue Virus 3 ' UTR: Redundancy or
   Host Specificity?
SO MBIO
LA English
DT Article
DE RNA virus; RNA virus evolution; RNA-RNA interactions; dengue virus;
   flavivirus; host adaptation; viral RNA structures
ID VACCINE CANDIDATE; 3'-UNTRANSLATED REGION; SECONDARY STRUCTURE;
   FLAVIVIRUS RNA; UNTRANSLATED REGION; 3'-NONCODING REGION; DIRECT
   REPEATS; VIRAL-RNA; REPLICATION; MOSQUITO
AB Flaviviruses include a diverse group of medically important viruses that cycle between mosquitoes and humans. During this natural process of switching hosts, each species imposes different selective forces on the viral population. Using dengue virus (DENV) as model, we found that paralogous RNA structures originating from duplications in the viral 3' untranslated region (UTR) are under different selective pressures in the two hosts. These RNA structures, known as dumbbells (DB1 and DB2), were originally proposed to be enhancers of viral replication. Analysis of viruses obtained from infected mosquitoes showed selection of mutations that mapped in DB2. Recombinant viruses carrying the identified variations confirmed that these mutations greatly increase viral replication in mosquito cells, with low or no impact in human cells. Use of viruses lacking each of the DB structures revealed opposite viral phenotypes. While deletion of DB1 reduced viral replication about 10-fold, viruses lacking DB2 displayed a great increase of fitness in mosquitoes, confirming a functional diversification of these similar RNA elements. Mechanistic analysis indicated that DB1 and DB2 differentially modulate viral genome cyclization and RNA replication. We found that a pseudoknot formed within DB2 competes with long-range RNA-RNA interactions that are necessary for minus-strand RNA synthesis. Our results support a model in which a functional diversification of duplicated RNA elements in the viral 3' UTR is driven by host-specific requirements. This study provides new ideas for understanding molecular aspects of the evolution of RNA viruses that naturally jump between different species.
   IMPORTANCE Flaviviruses constitute the most relevant group of arthropod-transmitted viruses, including important human pathogens such as the dengue, Zika, yellow fever, and West Nile viruses. The natural alternation of these viruses between vertebrate and invertebrate hosts shapes the viral genome population, which leads to selection of different viral variants with potential implications for epidemiological fitness and pathogenesis. However, the selective forces and mechanisms acting on the viral RNA during host adaptation are still largely unknown. Here, we found that two almost identical tandem RNA structures present at the viral 3' untranslated region are under different selective pressures in the two hosts. Mechanistic studies indicated that the two RNA elements, known as dumbbells, contain sequences that overlap essential RNA cyclization elements involved in viral RNA synthesis. The data support a model in which the duplicated RNA structures differentially evolved to accommodate distinct functions for viral replication in the two hosts.
C1 [de Borba, Luana; Villordo, Sergio M.; Marsico, Franco L.; Carballeda, Juan M.; Filomatori, Claudia V.; Gebhard, Leopoldo G.; Pallares, Horacio M.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.
   [Vargas, Irma Sanchez; Blair, Carol D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Lequime, Sebastian; Lambrechts, Louis] Inst Pasteur, Dept Genomes & Genet, Insect Virus Interact Grp, Paris, France.
   [Lequime, Sebastian; Lambrechts, Louis] CNRS, Evolutionary Genom Modeling & Hlth, Unite Mixte Rech 2000, Paris, France.
   [Lequime, Sebastian] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Clin & Epidemiol Virol, Leuven, Belgium.
RP Gamarnik, AV (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.
EM agamarnik@leloir.org.ar
RI FILOMATORI, Claudia/W-9924-2019; Lequime, Sebastian/E-9380-2011; Blair,
   Carol/D-1357-2019; Lambrechts, Louis/A-2057-2010
OI Lequime, Sebastian/0000-0002-3140-0651; Blair,
   Carol/0000-0002-2803-0354; Lambrechts, Louis/0000-0001-5958-2138
FU NIH (NIAID)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01.AI095175]; ANPCyT ArgentinaANPCyT
   [PICT-2014-2111, PICT-2015-2555, PICT-2017-1717]; CONICET
   fellowshipsConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET)
FX A.V.G., L.B., C.V.F., and L.G.G. are members of the Argentinean Council
   of Investigation (CONICET). F.L.M., J.M.C., and H.M.P. were granted
   CONICET fellowships. This work was supported by NIH (NIAID) R01.AI095175
   and ANPCyT Argentina PICT-2014-2111, -2015-2555, and -2017-1717 to
   A.V.G.
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Andrade CC, 2016, J EVOLUTION BIOL, V29, P2205, DOI 10.1111/jeb.12939
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brinton MA, 2015, VIRUS RES, V206, P1, DOI 10.1016/j.virusres.2015.06.010
   Bustos-Arriaga J, 2018, VACCINE, V36, P3460, DOI 10.1016/j.vaccine.2018.04.087
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen RB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003591
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   de Castro MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-3
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Fauquet C. M., 2005, VIRUS TAXONOMY CLASS
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Fontaine A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007187
   Fricke M, 2016, BIOINFORMATICS, V32, P2928, DOI 10.1093/bioinformatics/btw323
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friedrich S, 2018, J VIROL, V92, DOI 10.1128/JVI.01647-17
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687
   Gritsun DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092056
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0
   Groat-Carmona AM, 2012, VIROLOGY, V432, P511, DOI 10.1016/j.virol.2012.06.028
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11
   Iglesias NG, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P334, DOI 10.1079/9781845939649.0334
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   MANDL CW, 1991, BIOTECHNIQUES, V10, P484
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Markoff L, 2002, J VIROL, V76, P3318, DOI 10.1128/JVI.76.7.3318-3328.2002
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Olsthoorn RCL, 2001, RNA, V7, P1370
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Proutski V, 1999, VIRUS RES, V64, P107, DOI 10.1016/S0168-1702(99)00079-9
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Song BH, 2008, RNA, V14, P1791, DOI 10.1261/rna.993608
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Troyer JM, 2001, AM J TROP MED HYG, V65, P414, DOI 10.4269/ajtmh.2001.65.414
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2
   Whitehead SS, 2003, J VIROL, V77, P1653, DOI 10.1128/JVI.77.2.1653-1657.2003
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
NR 72
TC 10
Z9 10
U1 2
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2019
VL 10
IS 1
AR e02506-18
DI 10.1128/mBio.02506-18
PG 18
WC Microbiology
SC Microbiology
GA HN6RV
UT WOS:000460314300046
PM 30622191
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tauro, LB
   Cardoso, CW
   Souza, RL
   Nascimento, LCJ
   dos Santos, DR
   Campos, GS
   Sardi, S
   dos Reis, OB
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Tauro, Laura B.
   Cardoso, Cristiane W.
   Souza, Raquel L.
   Nascimento, Leile C. J.
   dos Santos, Daniela R.
   Campos, Gubio S.
   Sardi, Silvia
   dos Reis, Olivete B.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI A localized outbreak of Chikungunya virus in Salvador, Bahia, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Chikungunya virus; Alphavirus; Outbreak
ID ZIKA; INFECTION; DIAGNOSIS; STATE
AB A localized Chikungunya virus (CHIKV; East/Central/South African genotype) outbreak (50 cases, 70% laboratory-confirmed; attack rate: 5.3 confirmed cases/100 people) occurred in a Salvador, Brazil neighborhood, between Apr-Jun/2017. Highly clustered cases in space and time, mostly along a single street, highlight an increased risk of CHIKV transmission among pockets of susceptible populations. This finding underscores the need for ongoing local level surveillance for arboviral outbreaks.
C1 [Tauro, Laura B.; Souza, Raquel L.; Nascimento, Leile C. J.; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, FIOCRUZ, Salvador, BA, Brazil.
   [Tauro, Laura B.] Consejo Nacl Invest Cient & Tecn, Inst Biol Subtrop, Puerto Iguazu, Misiones, Argentina.
   [Cardoso, Cristiane W.; dos Santos, Daniela R.; dos Reis, Olivete B.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Campos, Gubio S.; Sardi, Silvia] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Reis, Mitermayer G.] Yale Univ, New Haven, CT USA.
   [Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, FIOCRUZ, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; sardi,
   silvia ines/P-9349-2016
OI Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060; sardi, silvia ines/0000-0002-2002-8436
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400830/2013-2, 440891/2016-7]; FAPESB [APP0044/2016, PET0022/2016];
   CAPESCAPES [88887.130746/2016-00]; UFBA; FIOCRUZ
FX CNPq (grants 400830/2013-2 and 440891/2016-7 to GSR; and scholarships to
   LBT, UK, MGR, and GSR), FAPESB (grants APP0044/2016, and PET0022/2016 to
   GSR), CAPES (grant 88887.130746/2016-00 to GSR), UFBA, FIOCRUZ.
CR [Anonymous], 2018, B EPIDEMIOLOGICO, V13, P1
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Cardoso C.W., 2017, PLOS NEGLECT TROP D, V11, P1
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Jacquez GM, 1996, STAT MED, V15, P1935, DOI 10.1002/(SICI)1097-0258(19960930)15:18<1935::AID-SIM406>3.0.CO;2-I
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003977
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 14
TC 1
Z9 1
U1 1
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR UNSP e180597
DI 10.1590/0074-02760180597
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HO1BE
UT WOS:000460639400001
PM 30843962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU El Sahly, HM
   Gorchakov, R
   Lai, LL
   Natrajan, MS
   Patel, SM
   Atmar, RL
   Keitel, WA
   Hoft, DF
   Barrett, J
   Bailey, J
   Edupuganti, S
   Raabe, V
   Wu, HM
   Fairley, J
   Rouphael, N
   Murray, KO
   Mulligan, MJ
AF El Sahly, Hana M.
   Gorchakov, Rodion
   Lai, Lilin
   Natrajan, Muktha S.
   Patel, Shital M.
   Atmar, Robert L.
   Keitel, Wendy A.
   Hoft, Daniel F.
   Barrett, Jill
   Bailey, Jason
   Edupuganti, Srilatha
   Raabe, Vanessa
   Wu, Henry M.
   Fairley, Jessica
   Rouphael, Nadine
   Murray, Kristy O.
   Mulligan, Mark J.
TI Clinical, Virologic, and Immunologic Characteristics of Zika Virus
   Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole
   Blood
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE Zika; diagnostics; serologic response; cell-mediated immune response;
   dengue
ID DENGUE; RESPONSES; TERRITORIES; SECONDARY; STATES; IGG
AB Background Clinical, virologic, and immunologic characteristics of Zika virus (ZIKV) infections in US patients are poorly defined.
   Methods US subjects with suspected ZIKV infection were enrolled. Clinical data and specimens were prospectively collected for ZIKV RNA detection and serologic and cellular assays. Confirmed ZIKV infection (cases) and ZIKV-negative (controls) subjects were compared. Dengue-experienced and dengue-naive cases were also compared.
   Results We enrolled 45 cases and 14 controls. Commonly reported symptoms among cases and controls were maculopapular rash (97.8% and 81.8%), fatigue (86.7% and 81.8%), and arthralgia (82.2% and 54.5%), respectively. The sensitivity (94%) and duration of infection detection (80% positivity at 65-79 days after disease onset) by polymerase chain reaction were highest in whole-blood specimens. ZIKV-neutralizing antibodies had a half-life of 105 days and were significantly higher in dengue virus-experienced cases than naive ones (P = .046). In intracellular cytokine staining assays, the ZIKV proteins targeted most often by peripheral blood mononuclear cells from cases were structural proteins C and E for CD4+ T cells and nonstructural proteins NS3, NS5, and NS4B for CD8+ T cells.
   Conclusions ZIKV RNA detection was more frequent and prolonged in whole-blood specimens. Immunoglobulin G (IgG) and neutralizing antibodies, but not IgM, were influenced by prior dengue infection. Robust cellular responses to E and nonstructural proteins have potential vaccine development implications.
C1 [El Sahly, Hana M.; Keitel, Wendy A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Gorchakov, Rodion; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Sect Pediat Trop Med, Ctr Human Immunobiol, Houston, TX 77030 USA.
   [Lai, Lilin; Natrajan, Muktha S.; Edupuganti, Srilatha; Raabe, Vanessa; Fairley, Jessica; Rouphael, Nadine] Emory Univ, Sch Med, Emory Vaccine Ctr, Hope Clin,Div Infect Dis,Dept Med, Decatur, GA 30033 USA.
   [Patel, Shital M.; Atmar, Robert L.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.
   [Hoft, Daniel F.] St Louis Univ, Dept Mol Microbiol & Immunol, Div Infect Dis Allergy & Immunol, St Louis, MO 63103 USA.
   [Hoft, Daniel F.] St Louis Univ, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63103 USA.
   [Barrett, Jill; Bailey, Jason] Emmes Corp, Rockville, MD USA.
   [Wu, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Decatur, GA 30033 USA.
   [Mulligan, Mark J.] NYU, Div Infect Dis & Microbiol, New York, NY USA.
   [Mulligan, Mark J.] NYU, NYU Langone Vaccine Ctr, New York, NY USA.
RP El Sahly, HM (corresponding author), One Baylor Plaza,BCM MS280, Houston, TX 77030 USA.
EM hanae@bcm.edu
RI Fairley, Jessica K/W-2777-2019; Mulligan, Mark/V-9275-2019; Raabe,
   Vanessa/AAP-9582-2020
OI Natrajan, Muktha/0000-0003-1854-0382; Lai, Lilin/0000-0002-9528-6990;
   Raabe, Vanessa/0000-0003-2579-1104
FU National Institutes of Allergy and Infectious Diseases at the National
   Institutes of Health [HHSN272201300015I, HHSN272201300018I,
   HHSN27220130021I, HHSN272201500002C]; Georgia Research Alliance;
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI074492]
FX The National Institutes of Allergy and Infectious Diseases at the
   National Institutes of Health provided contract funding for this project
   to the Vaccine and Treatment Evaluation Units at Baylor College of
   Medicine (HHSN272201300015I), Emory University (HHSN272201300018I), St.
   Louis University (HHSN27220130021I), and Emmes Corporation
   (HHSN272201500002C). Additional support was provided to M.J.M. by the
   Georgia Research Alliance and to V.R. by T32AI074492 from the National
   Institute of Allergy and Infectious Diseases.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIK MAC ELISA INSTR
   Changal KH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2053-6
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Grifoni A, J VIROL
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lustig Y, 2016, EURO SURVEILL, V21
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 35
TC 5
Z9 5
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD JAN
PY 2019
VL 6
IS 1
AR UNSP ofy352
DI 10.1093/ofid/ofy352
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HO1AF
UT WOS:000460636900024
PM 30697574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Van Dyne, EA
   Neaterour, P
   Rivera, A
   Bello-Pagan, M
   Adams, L
   Munoz-Jordan, J
   Baez, P
   Garcia, M
   Waterman, SH
   Reyes, N
   Richardson, LC
   Rivera-Garcia, B
   Sharp, TM
AF Van Dyne, Elizabeth A.
   Neaterour, Paige
   Rivera, Aidsa
   Bello-Pagan, Melissa
   Adams, Laura
   Munoz-Jordan, Jorge
   Baez, Priscilla
   Garcia, Myriam
   Waterman, Stephen H.
   Reyes, Nimia
   Richardson, Lisa C.
   Rivera-Garcia, Brenda
   Sharp, Tyler M.
TI Incidence and Outcome of Severe and Nonsevere Thrombocytopenia
   Associated With Zika Virus InfectionPuerto Rico, 2016
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE Zika; thrombocytopenia; immune thrombocytopenia; ITP; platelets
ID IMMUNE THROMBOCYTOPENIA; PUERTO-RICO; ADULTS; STANDARDIZATION; CHILDREN;
   PURPURA
AB Background Zika virus (ZIKV) infection has been associated with severe thrombocytopenia. We describe the incidence, clinical manifestations, and outcomes of patients with ZIKV infection and thrombocytopenia.
   Methods We reviewed medical records of patients with ZIKV infection and thrombocytopenia (platelet count <100 x10(9) cells/L) in Puerto Rico during 2016. Severe thrombocytopenia was defined by platelet count <20 x10(9)/L or a platelet count <50 x10(9)/L and treatment for immune thrombocytopenia (ITP).
   Results Of 37 878 patients with ZIKV infection, 47 (0.1%) had thrombocytopenia in the absence of an alternative etiology (1.4 cases/100 000 population), including 12 with severe thrombocytopenia. Most patients with thrombocytopenia were adult (77%) and male (53%). Platelet nadir occurred a median (range) of 6 (1-16) and 5 (0-34) days after symptom onset for patients with severe and nonsevere thrombocytopenia, respectively. Among patients with severe thrombocytopenia, all had bleeding, 33% were admitted to the intensive care unit, and 8% died; 50% were treated for ITP. Among 5 patients with severe thrombocytopenia who received intravenous immunoglobulin, the median platelet count increase (range) was 112 (65-202) x10(9)/L. In contrast, among 4 patients who received platelet transfusion, the median increase in platelet count (range) was 8.5 (-6 to 52) x10(9)/L.
   Conclusions Patients with severe thrombocytopenia and ZIKV infection experienced prominent acute morbidity. Consistent with recommended management, administration of ITP treatments to such patients may be more efficacious than platelet transfusion in resolving thrombocytopenia. Severe thrombocytopenia should be considered a rare outcome of ZIKV infection.
C1 [Van Dyne, Elizabeth A.; Richardson, Lisa C.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Van Dyne, Elizabeth A.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Van Dyne, Elizabeth A.; Adams, Laura; Waterman, Stephen H.; Sharp, Tyler M.] US PHS, Silver Spring, MD USA.
   [Neaterour, Paige; Rivera, Aidsa; Adams, Laura; Munoz-Jordan, Jorge; Waterman, Stephen H.; Sharp, Tyler M.] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR USA.
   [Bello-Pagan, Melissa; Baez, Priscilla; Garcia, Myriam; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Reyes, Nimia] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
RP Van Dyne, EA (corresponding author), 4770 Buford Hwy NE,Mailstop F-76, Atlanta, GA 30341 USA.
EM elizabeth.vandyne@ihs.gov
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Cooper N, 2006, BRIT J HAEMATOL, V133, P364, DOI 10.1111/j.1365-2141.2006.06024.x
   de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Hottz ED, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00121
   Joob B, 2014, PLATELETS, V25, P308, DOI 10.3109/09537104.2013.815342
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Koma T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20185-8
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Michel M, 2011, AM J HEMATOL, V86, P980, DOI 10.1002/ajh.22170
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Neaterour P, 2017, AM J TROP MED HYG, V97, P1085, DOI 10.4269/ajtmh.17-0250
   Neunert C, 2015, J THROMB HAEMOST, V13, P457, DOI 10.1111/jth.12813
   Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Puerto Rico Department of Health, WEEKL REP ARB DIS
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodeghiero F, 2013, BLOOD, V121, P2596, DOI 10.1182/blood-2012-07-442392
   Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schirmer PL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006416
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stasi R, 2009, HEMATOL ONCOL CLIN N, V23, P1275, DOI 10.1016/j.hoc.2009.08.009
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   US Census Bureau, 2017, PUERT RIC COMM POP T
   US Food and Drug Administration, CDC ZIK MAC ELISA
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zea-Vera AF, 2017, LUPUS, V26, P890, DOI 10.1177/0961203316671816
NR 39
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD JAN
PY 2019
VL 6
IS 1
AR UNSP ofy325
DI 10.1093/ofid/ofy325
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HO1AF
UT WOS:000460636900006
PM 30631791
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Diamond, MS
   Ledgerwood, JE
   Pierson, TC
AF Diamond, Michael S.
   Ledgerwood, Julie E.
   Pierson, Theodore C.
BE Klotman, ME
TI Zika Virus Vaccine Development: Progress in the Face of New Challenges
SO ANNUAL REVIEW OF MEDICINE, VOL 70
SE Annual Review of Medicine
LA English
DT Review; Book Chapter
DE Zika virus; ZIKV; dengue virus; flavivirus; vaccine; antibody;
   neutralization; antibody-dependent enhancement
ID ANTIBODY-DEPENDENT ENHANCEMENT; MALE SEXUAL TRANSMISSION; MESSENGER-RNA
   VACCINES; DENGUE VIRUS; DNA VACCINE; HEALTHY-ADULTS; NEUTRALIZING
   ANTIBODY; CROSS-REACTIVITY; STRUCTURAL BASIS; INFECTION
AB Zika virus (ZIKV) emerged at a global level when it spread to the Americas and began causing congenital malformations and microcephaly in 2015. A rapid response by academia, government, public health infrastructure, and industry has enabled the expedited development and testing of a suite of vaccine platforms aiming to control and eliminate ZIKV-induced disease. Analysis of key immunization and pathogenesis studies in multiple animal models, including during pregnancy, has begun to define immune correlates of protection. Nonetheless, the deployment of ZIKV vaccines, along with the confirmation of their safety and efficacy, still has major challenges, one of which is related to the waning of the epidemic. In this review, we discuss the measures that enabled rapid progress and highlight the path forward for successful deployment of ZIKV vaccines.
C1 [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
   [Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Immunol, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM mdiamond@wustl.edu; jumartin@niaid.nih.gov; piersontc@niaid.nih.gov
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI083019, R01 AI073755, R01 AI104972];
   NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01 HD091218]
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Asher J., 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2018, HUM VACC IMMUNOTHER, V20181, P5
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   KONISHI E, 1991, VIROLOGY, V185, P401, DOI 10.1016/0042-6822(91)90788-D
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 97
TC 19
Z9 19
U1 11
U2 21
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4219
BN 978-0-8243-0570-3
J9 ANNU REV MED
JI Annu. Rev. Med.
PY 2019
VL 70
BP 121
EP 135
DI 10.1146/annurev-med-040717-051127
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BM1LC
UT WOS:000460209700009
PM 30388054
DA 2020-07-08
ER

PT J
AU Batista, MN
   Braga, ACS
   Campos, GRF
   Souza, MM
   de Matos, RPA
   Lopes, TZ
   Candido, NM
   Lima, MLD
   Machado, FC
   de Andrade, STQ
   Bittar, C
   Nogueira, ML
   Carneiro, BM
   Mariutti, RB
   Arni, RK
   Calmon, MF
   Rahal, P
AF Batista, Mariana N.
   Braga, Ana Claudia S.
   Fernandes Campos, Guilherme Rodrigues
   Souza, Marcos Michel
   Adum de Matos, Renata Prandini
   Lopes, Tairine Zara
   Candido, Natalia Maria
   Duarte Lima, Maria Leticia
   Machado, Francielly Cristina
   Queiroz de Andrade, Stephane Tereza
   Bittar, Cintia
   Nogueira, Mauricio L.
   Carneiro, Bruno M.
   Mariutti, Ricardo B.
   Arni, Raghuvir Krishnaswamy
   Calmon, Marilia Freitas
   Rahal, Paula
TI Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika
   Virus
SO VIRUSES-BASEL
LA English
DT Article
DE ZIKV; berberin; emodin; Vero E6 cells
ID POLYGONUM-CUSPIDATUM; ALOE-EMODIN; ANTIVIRAL ACTIVITY; IN-VITRO; ORAL
   BIOAVAILABILITY; BERBERINE CHLORIDE; MAJOR COMPONENT; NANOPARTICLES;
   VIVO; PHARMACOKINETICS
AB Zika virus (ZIKV) has been associated with serious health conditions, and an intense search to discover different ways to prevent and treat ZIKV infection is underway. Berberine and emodin possess several pharmacological properties and have been shown to be particularly effective against the entry and replication of several viruses. We show that emodin and berberine trigger a virucidal effect on ZIKV. When the virus was exposed to 160 mu M of berberine, a reduction of 77.6% in the infectivity was observed; when emodin was used (40 mu M), this reduction was approximately 83.3%. Dynamic light scattering data showed that both compounds significantly reduce the hydrodynamic radius of virus particle in solution. We report here that berberine and emodin, two natural compounds, have strong virucidal effect in Zika virus.
C1 [Batista, Mariana N.; Braga, Ana Claudia S.; Fernandes Campos, Guilherme Rodrigues; Souza, Marcos Michel; Adum de Matos, Renata Prandini; Lopes, Tairine Zara; Candido, Natalia Maria; Duarte Lima, Maria Leticia; Machado, Francielly Cristina; Queiroz de Andrade, Stephane Tereza; Bittar, Cintia; Carneiro, Bruno M.; Calmon, Marilia Freitas; Rahal, Paula] Sao Paulo State Univ, UNESP, Lab Genom Studies, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Nogueira, Mauricio L.] FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Carneiro, Bruno M.] Univ Fed Mato Grosso, Inst Exact & Nat Sci, BR-78060900 Rondonopolis, MG, Brazil.
   [Mariutti, Ricardo B.; Arni, Raghuvir Krishnaswamy] Sao Paulo State Univ, UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Calmon, MF (corresponding author), Sao Paulo State Univ, UNESP, Lab Genom Studies, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM batista_m.n@hotmail.com; anabragga@gmail.com;
   guilhermecampos07@gmail.com; marcosmichel@gmail.com;
   renatapram@hotmail.com; tairinezlopes@gmail.com; naty_candido@ig.com.br;
   mle.lima94@gmail.com; francielly.cristinam@gmail.com; teph94@gmail.com;
   cibittar@gmail.com; mnogueira@famerp.br; brunocopo@yahoo.com.br;
   ricardomariutti@yahoo.com.br; arni@ibilce.unesp.br; macal131@gmail.com;
   rahalp@yahoo.com.br
RI de Matos, Renata Prandini Adum/O-6766-2019; Candido, Natalia
   M./H-5703-2013; Carneiro, Bruno/P-2415-2019; Nogueira, Mauricio
   L/B-7599-2012; Arni, Raghuvir K/B-2222-2013; Bittar, Cintia/A-5042-2015;
   Calmon, Marilia Freitas/H-3150-2012; Rahal, Paula/D-3871-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Arni, Raghuvir
   K/0000-0003-2460-1145; Bittar, Cintia/0000-0002-2048-4589; Calmon,
   Marilia Freitas/0000-0001-5203-0103; Carneiro,
   Bruno/0000-0002-2355-7907; Rahal, Paula/0000-0001-5693-6148; Rodrigues
   Fernandes Campos, Guilherme/0000-0003-1118-8486; Zara Lopes,
   Tairine/0000-0002-0336-4067
FU Sao Paulo Research Foundation (FAPESP), BrazilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2014/22198-0]
FX This research was funding by the Sao Paulo Research Foundation (FAPESP),
   Brazil Grant number 2014/22198-0.
CR Ahmed T, 2015, PHARMACOL REP, V67, P970, DOI 10.1016/j.pharep.2015.03.002
   Alam Z, 2015, ANTIVIR RES, V114, P86, DOI 10.1016/j.antiviral.2014.12.003
   Alves DS, 2004, BIOCHEM PHARMACOL, V68, P549, DOI 10.1016/j.bcp.2004.04.012
   Battu SK, 2010, AAPS PHARMSCITECH, V11, P1466, DOI 10.1208/s12249-010-9520-y
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chin LW, 2010, ARCH VIROL, V155, P1933, DOI 10.1007/s00705-010-0779-9
   da Cunha Antonio R, 2017, Biophys Rev, V9, P729, DOI 10.1007/s12551-017-0323-1
   Dang SS, 2009, WORLD J GASTROENTERO, V15, P5669, DOI 10.3748/wjg.15.5669
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong XX, 2016, PHYTOTHER RES, V30, P1207, DOI 10.1002/ptr.5631
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duan HG, 2009, DRUG DEVELOP RES, V70, P363, DOI 10.1002/ddr.20312
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freag MS, 2016, INT J NANOMED, V11, P4799, DOI 10.2147/IJN.S111736
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085
   Hsiang CY, 2008, BRIT J PHARMACOL, V155, P227, DOI 10.1038/bjp.2008.242
   Imenshahidi M, 2016, PHYTOTHER RES, V30, P1745, DOI 10.1002/ptr.5693
   Lee MH, 2011, J AGR FOOD CHEM, V59, P9135, DOI 10.1021/jf201577f
   Li L, 2016, MICROBIOL RES, V186, P139, DOI 10.1016/j.micres.2016.03.008
   Li SW, 2014, EUR J PHARMACOL, V738, P125, DOI 10.1016/j.ejphar.2014.05.028
   Lin CW, 2008, INT J ANTIMICROB AG, V32, P355, DOI 10.1016/j.ijantimicag.2008.04.018
   Liu HY, 2016, PHARM RES-DORDR, V33, P217, DOI 10.1007/s11095-015-1781-4
   Liu Z, 2015, J HUAZHONG U SCI-MED, V35, P916, DOI 10.1007/s11596-015-1528-9
   Liu Z, 2013, MOLECULES, V18, P11842, DOI 10.3390/molecules181011842
   Lu YC, 2006, J CHEM ENG DATA, V51, P642, DOI 10.1021/je0504360
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mischitelli M, 2016, CELL PHYSIOL BIOCHEM, V40, P91, DOI 10.1159/000452527
   Naqvi S, 2010, INDIAN J BIOCHEM BIO, V47, P161
   Pund S, 2014, PHYTOMEDICINE, V21, P307, DOI 10.1016/j.phymed.2013.09.013
   Rad SZK, 2017, IRAN J BASIC MED SCI, V20, P516, DOI 10.22038/IJBMS.2017.8676
   SATO F, 1994, EUR J BIOCHEM, V225, P125, DOI 10.1111/j.1432-1033.1994.00125.x
   Schwarz S, 2011, ANTIVIR RES, V90, P64, DOI 10.1016/j.antiviral.2011.02.008
   Shia CS, 2010, J PHARM SCI-US, V99, P2185, DOI 10.1002/jps.21978
   SYDISKIS RJ, 1991, ANTIMICROB AGENTS CH, V35, P2463, DOI 10.1128/AAC.35.12.2463
   Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683
   Tan XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077969
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wang B, 2015, J MATER CHEM B, V3, P3840, DOI 10.1039/c5tb00065c
   Wang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014449, 10.1371/journal.pone.0024498]
   Wang TC, 2012, INT J NANOMED, V7, P2325, DOI 10.2147/IJN.S31029
   Wu Y, 2011, CHIN J INTEGR MED, V17, P444, DOI 10.1007/s11655-011-0640-3
   Xiong HR, 2011, J ETHNOPHARMACOL, V133, P718, DOI 10.1016/j.jep.2010.10.059
   Xue M, 2013, INT J NANOMED, V8, P4677, DOI 10.2147/IJN.S51262
   Yang YC, 2003, J AGR FOOD CHEM, V51, P7629, DOI 10.1021/jf034727t
   Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330
   Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013
   Yiu CY, 2014, MOLECULES, V19, P1258, DOI 10.3390/molecules19011258
   Zhu JX, 2013, DRUG DEV IND PHARM, V39, P499, DOI 10.3109/03639045.2012.683875
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 55
TC 8
Z9 9
U1 7
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 49
DI 10.3390/v11010049
PG 10
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000048
PM 30641880
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bhaumik, SK
   Priyamvada, L
   Kauffman, RC
   Lai, L
   Natrajan, MS
   Cho, A
   Rouphael, N
   Suthar, MS
   Mulligan, MJ
   Wrammert, J
AF Bhaumik, Siddhartha K.
   Priyamvada, Lalita
   Kauffman, Robert C.
   Lai, Lilin
   Natrajan, Muktha S.
   Cho, Alice
   Rouphael, Nadine
   Suthar, Mehul S.
   Mulligan, Mark J.
   Wrammert, Jens
TI Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response
   in ZIKV-Infected Patient
SO VIRUSES-BASEL
LA English
DT Article
DE ZIKV; DENV; antibodies; plasmablast; B-cell; cross-reactivity
ID HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; VIRUS-INFECTION;
   CROSS-REACTIVITY; DISEASE; ENHANCEMENT; REPLICATION; BRAZIL
AB The re-emergence of Zika virus (ZIKV) in the western hemisphere has most significantly affected dengue virus (DENV) endemic regions. Due to the geographical overlap between these two closely related flaviviruses, numerous individuals who suffered ZIKV infection during recent outbreaks may have also previously been exposed to DENV. As such, the impact of pre-existing dengue immunity on immune responses to ZIKV has been an area of focused research and interest. To understand how B cell responses to a ZIKV infection may be modulated by prior dengue exposures, we compared and contrasted plasmablast repertoire and specificity between two ZIKV-infected individuals, one dengue-naive (ZK018) and the other dengue-experienced (ZK016). In addition to examining serological responses, we generated 59 patient plasmablast-derived monoclonal antibodies (mAbs) to define the heterogeneity of the early B cell response to ZIKV. Both donors experienced robust ZIKV-induced plasmablast expansions early after infection, with comparable mutational frequencies in their antibody variable genes. However, notable differences were observed in plasmablast clonality and functional reactivity. Plasmablasts from the dengue-experienced donor ZK016 included cells with shared clonal origin, while ZK018 mAbs were entirely clonally unrelated. Both at the mAb and plasma level, ZK016 antibodies displayed extensive cross-reactivity to DENV1-4, and preferentially neutralized DENV compared to ZIKV. In contrast, the neutralization activity of ZK018 mAbs was primarily directed towards ZIKV, and fewer mAbs from this donor were cross-reactive, with the cross-reactive phenotype largely limited to fusion loop-specific mAbs. ZK016 antibodies caused greater enhancement of DENV2 infection of FcR-expressing cells overall compared to ZK018, with a striking difference at the plasma level. Taken together, these data strongly suggest that the breadth and protective capacity of the initial antibody responses after ZIKV infection may depend on the dengue immune status of the individual. These findings have implications for vaccine design, given the likelihood that future epidemics will involve both dengue-experienced and naive populations.
C1 [Bhaumik, Siddhartha K.; Priyamvada, Lalita; Kauffman, Robert C.; Cho, Alice; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Bhaumik, Siddhartha K.; Priyamvada, Lalita; Kauffman, Robert C.; Cho, Alice; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Lai, Lilin; Natrajan, Muktha S.; Rouphael, Nadine; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30033 USA.
RP Wrammert, J (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.; Wrammert, J (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
EM siddharthabhaumik@gmail.com; odk7@cdc.gov; robert.kauffman@emory.edu;
   llai@emory.edu; muktha.natrajan@emory.edu; alice.hong.cho@emory.edu;
   nroupha@emory.edu; mehul.s.suthar@emory.edu;
   mark.mulligan@nyulangone.org; jwramme@emory.edu
RI Priyamvada, Lalita/J-6252-2019; Mulligan, Mark/V-9275-2019
OI Priyamvada, Lalita/0000-0002-0479-0164; Natrajan,
   Muktha/0000-0003-1854-0382; Lai, Lilin/0000-0002-9528-6990
FU Emory University School of Medicine; Emory Vaccine Center; Emory
   Department of Pediatrics; Georgia Research Alliance; National Institutes
   of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HHSN272201300018I,
   AI115651, U19AI090023, U19AI057266, 1U01AI115651]
FX This work was supported by the Emory University School of Medicine
   (M.J.M., M.S.S., J.W.); Emory Vaccine Center (M.J.M., M.S.S., J.W.);
   Emory Department of Pediatrics (M.S.S. and J.W.), Georgia Research
   Alliance (M.J.M. and M.S.S.); and the National Institutes of Health
   (NIH) through the following grants: contract HHSN272201300018I (Emory
   University VTEU), supplement to grant AI115651 (M.J.M.), U19AI090023
   (N.R.), U19AI057266 (J.W.) and 1U01AI115651 (J.W.).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kauffman RC, 2016, MBIO, V7, DOI [10.1128/mBio.02021-16, 10.1128/mbio.02021-16]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Moi ML, 2013, LANCET, V381, P1094, DOI 10.1016/S0140-6736(13)60754-0
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pauli NT, 2014, J EXP MED, V211, P2331, DOI 10.1084/jem.20141404
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shi Y, 2018, ADV EXP MED BIOL, V1062, P77, DOI 10.1007/978-981-10-8727-1_6
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 53
TC 5
Z9 5
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 19
DI 10.3390/v11010019
PG 17
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000019
PM 30597938
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU El Kalamouni, C
   Frumence, E
   Bos, S
   Turpin, J
   Nativel, B
   Harrabi, W
   Wilkinson, DA
   Meilhac, O
   Gadea, G
   Despres, P
   Krejbich-Trotot, P
   Viranaicken, W
AF El Kalamouni, Chaker
   Frumence, Etienne
   Bos, Sandra
   Turpin, Jonathan
   Nativel, Brice
   Harrabi, Wissal
   Wilkinson, David A.
   Meilhac, Olivier
   Gadea, Gilles
   Despres, Philippe
   Krejbich-Trotot, Pascale
   Viranaicken, Wildriss
TI Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus
SO VIRUSES-BASEL
LA English
DT Article
DE antiviral; heme-oxygenase 1; Zika virus; viral replication
ID DOWN-REGULATION; REPLICATION; INDUCTION; INFECTION; EXPRESSION;
   EPIDEMIC; CELLS
AB Heme oxygenase-1 (HO-1), a rate-limiting enzyme involved in the degradation of heme, is induced in response to a wide range of stress conditions. HO-1 exerts antiviral activity against a broad range of viruses, including the Hepatitis C virus, the human immunodeficiency virus, and the dengue virus by inhibiting viral growth. It has been reported that HO-1 displays antiviral activity against the Zika virus (ZIKV) but the mechanisms of viral inhibition remain largely unknown. Using a ZIKV RNA replicon with the Green Fluorescent Protein (GFP) as a reporter protein, we were able to show that HO-1 expression resulted in the inhibition of viral RNA replication. Conversely, we observed a decrease in HO-1 expression in cells replicating the ZIKV RNA replicon. The study of human cells infected with ZIKV showed that the HO-1 expression level was significantly lower once viral replication was established, thereby limiting the antiviral effect of HO-1. Our work highlights the capacity of ZIKV to thwart the anti-replicative activity of HO-1 in human cells. Therefore, the modulation of HO-1 as a novel therapeutic strategy against ZIKV infection may display limited effect.
C1 [El Kalamouni, Chaker; Frumence, Etienne; Bos, Sandra; Turpin, Jonathan; Harrabi, Wissal; Wilkinson, David A.; Gadea, Gilles; Despres, Philippe; Krejbich-Trotot, Pascale; Viranaicken, Wildriss] Univ Reunion, INSERM, UMR 1187, PIMIT,Plateforme CYROI,CNRS 9192,IRD,UMR 249, 2 Rue Maxime Riviere, F-97490 St Clotilde, France.
   [Nativel, Brice; Meilhac, Olivier] Univ Reunion, INSERM, UMR 1188, Diabete Atherothrombose Therapies Reunion Ocean I, F-97490 St Clotilde, France.
   [Meilhac, Olivier] CHU Reunion, F-97400 St Denis, Reunion, France.
RP Krejbich-Trotot, P; Viranaicken, W (corresponding author), Univ Reunion, INSERM, UMR 1187, PIMIT,Plateforme CYROI,CNRS 9192,IRD,UMR 249, 2 Rue Maxime Riviere, F-97490 St Clotilde, France.
EM chaker.el-kalamouni@univ-reunion.fr; etienne.frumence@univ-reunion.fr;
   sandrabos.lab@gmail.com; jonas97480@live.fr; brice.nativel@gmail.com;
   wissalharrabi500@yahoo.fr; dwilkin799@gmail.com;
   olivier.meilhac@inserm.fr; gilles.gadea@inserm.fr;
   philippe.despres@univ-reunion.fr; pascale.krejbich@univ-reunion.fr;
   wildriss.viranaicken@univ-reunion.fr
RI Gilles, Gadea/M-9966-2015; Meilhac, Olivier/N-4385-2017
OI Gilles, Gadea/0000-0001-6325-4866; Wilkinson, David/0000-0002-9986-6212;
   NATIVEL, Brice/0000-0003-3719-7903; El Kalamouni,
   Chaker/0000-0003-4673-6614; TURPIN, Jonathan/0000-0003-2667-345X;
   viranaicken, wildriss/0000-0002-0915-8635; BOS,
   Sandra/0000-0001-5036-0336; Krejbich Trotot, Pascale/0000-0001-7329-1716
FU Federation BioST from Reunion Island University; ZIKAlliance project
   (European Union-Horizon 2020 program) [735548]; ZIKAlert project
   (European Union-Region Reunion program) [SYNERGY: RE0001902]; Regional
   Council of Reunion Island (European Union-Region Reunion program)
   [SYNERGY: RE0012406]; Regional Council of Reunion Island [DIRED
   20131515]; La Reunion Island University - French ministry MEESR
FX This work was supported by the Federation BioST from Reunion Island
   University, the ZIKAlliance project (European Union-Horizon 2020 program
   under grant agreement no735548) and the ZIKAlert project (European
   Union-Region Reunion program under grant agreement no SYNERGY:
   RE0001902). E.F. holds a fellowship from the Regional Council of Reunion
   Island (European Union-Region Reunion program under grant agreement no
   SYNERGY: RE0012406). B.N. holds a fellowship (DIRED 20131515) from the
   Regional Council of Reunion Island. S.B. has a PhD degree scholarship
   from La Reunion Island University (Ecole Doctorale STS), funded by the
   French ministry MEESR.
CR Abdalla MY, 2004, J INFECT DIS, V190, P1109, DOI 10.1086/423488
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen WC, 2018, VIRULENCE, V9, P588, DOI 10.1080/21505594.2017.1421893
   Espinoza JA, 2017, J IMMUNOL, V199, P212, DOI 10.4049/jimmunol.1601414
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gill AJ, 2014, J CLIN INVEST, V124, P4459, DOI 10.1172/JCI72279
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Huang HX, 2017, VIROLOGY, V503, P1, DOI 10.1016/j.virol.2016.12.019
   Lee J, 2013, J GEN VIROL, V94, P1658, DOI 10.1099/vir.0.052142-0
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005
   Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Pae HO, 2007, EXP MOL MED, V39, P267, DOI 10.1038/emm.2007.30
   Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006
   Ramezani A, 2018, J CELL BIOCHEM, V119, P6366, DOI 10.1002/jcb.26897
   SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8
   Shi ZX, 2013, VIRUS RES, V173, P315, DOI 10.1016/j.virusres.2013.01.012
   Son Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/639541
   Tseng CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32176
   Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296
   Waza AA, 2018, INFLAMM RES, V67, P579, DOI 10.1007/s00011-018-1151-x
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Zhang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15575
   Zimmermann K, 2015, FREE RADICAL BIO MED, V88, P417, DOI 10.1016/j.freeradbiomed.2015.03.030
NR 31
TC 8
Z9 8
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 2
DI 10.3390/v11010002
PG 13
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000002
PM 30577437
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Henss, L
   Yue, C
   Kandler, J
   Faddy, HM
   Simmons, G
   Panning, M
   Lewis-Ximenez, LL
   Baylis, SA
   Schnierle, BS
AF Henss, Lisa
   Yue, Constanze
   Kandler, Joshua
   Faddy, Helen M.
   Simmons, Graham
   Panning, Marcus
   Lewis-Ximenez, Lia Laura
   Baylis, Sally A.
   Schnierle, Barbara S.
TI Establishment of an Alphavirus-Specific Neutralization Assay to
   Distinguish Infections with Different Members of the Semliki Forest
   Complex
SO VIRUSES-BASEL
LA English
DT Article
DE alphavirus; neutralization assay; lentiviral vector; pseudotyping
ID ROSS RIVER VIRUS; MAYARO-VIRUS; CHIKUNGUNYA; HISTORY; DISEASE;
   GLYCOPROTEINS; PATHOGENESIS; OUTBREAK
AB Background: Alphaviruses are transmitted by arthropod vectors and can be found worldwide. Alphaviruses of the Semliki Forest complex such as chikungunya virus (CHIKV), Mayaro virus (MAYV) or Ross River virus (RRV) cause acute febrile illness and long-lasting arthralgia in humans, which cannot be clinically discriminated from a dengue virus or Zika virus infection. Alphaviruses utilize a diverse array of mosquito vectors for transmission and spread. For instance, adaptation of CHIKV to transmission by Aedes albopictus has increased its spread and resulted in large outbreaks in the Indian Ocean islands. For many alphaviruses commercial diagnostic tests are not available or show cross-reactivity among alphaviruses. Climate change and globalization will increase the spread of alphaviruses and monitoring of infections is necessary and requires virus-specific methods. Method: We established an alphavirus neutralization assay in a 384-well format by using pseudotyped lentiviral vectors. Results: MAYV-specific reactivity could be discriminated from CHIKV reactivity. Human plasma from blood donors infected with RRV could be clearly identified and did not cross-react with other alphaviruses. Conclusion: This safe and easy to use multiplex assay allows the discrimination of alphavirus-specific reactivity within a single assay and has potential for epidemiological surveillance. It might also be useful for the development of a pan-alphavirus vaccine.
C1 [Henss, Lisa; Yue, Constanze; Kandler, Joshua; Baylis, Sally A.; Schnierle, Barbara S.] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Faddy, Helen M.] Australian Red Cross Blood Serv, Brisbane, Qld 4000, Australia.
   [Simmons, Graham] Vitalant Res Inst, San Francisco, CA 94118 USA.
   [Panning, Marcus] Univ Freiburg, Fac Med, Inst Virol, Med Ctr, D-79106 Freiburg, Germany.
   [Lewis-Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Schnierle, BS (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
EM Lisa.Henss@pei.de; Constanze.Yue@pei.de; jdkandler@gmail.com;
   hFaddy@redcrossblood.org.au; gsimmons@vitalant.org;
   marcus.panning@uniklinik-freiburg.de; lialewis.fiocruz@gmail.com;
   Sally.Baylis@pei.de; Barbara.Schnierle@pei.de
RI Schnierle, Barbara/AAG-8108-2019; Panning, Marcus/I-7889-2016
FU German Ministry of Health (BMG); NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI119056]
FX This research was funded by the German Ministry of Health (BMG) by a
   grant to S.A.B. and B.S.S and the NIH grant R01 AI119056 to G.S.
CR Adam A, 2016, VECTOR-BORNE ZOONOT, V16, P290, DOI 10.1089/vbz.2015.1897
   Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   ATKINS GJ, 1985, J GEN VIROL, V66, P395, DOI 10.1099/0022-1317-66-3-395
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Claflin SB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005070
   Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998
   Flies EJ, 2018, BIOSCIENCE, V68, P288, DOI 10.1093/biosci/biy011
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Jacups SP, 2008, VECTOR-BORNE ZOONOT, V8, P283, DOI 10.1089/vbz.2007.0152
   Kahl CA, 2005, MOL THER, V11, P470, DOI 10.1016/j.ymthe.2004.08.032
   Kahl CA, 2004, J VIROL, V78, P1421, DOI 10.1128/JVI.78.3.1421-1430.2004
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Kishishita N, 2013, J CLIN MICROBIOL, V51, P1389, DOI 10.1128/JCM.03109-12
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Liu X, 2017, MICROBES INFECT, V19, P496, DOI 10.1016/j.micinf.2017.07.001
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lum FM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20305-4
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Salvador B, 2009, VIROLOGY, V393, P33, DOI 10.1016/j.virol.2009.07.013
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09
   Siegert Sandra, 2005, AIDS Res Ther, V2, P7, DOI 10.1186/1742-6405-2-7
   Smith JL, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00003-18, 10.1128/msphere.00003-18]
   SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Theilacker C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-369
   Weber C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005318
   Weber C, 2014, J VIROL METHODS, V201, P7, DOI 10.1016/j.jviromet.2014.02.001
   World Health Organization (WHO), 2014, ANN EMERG MED, V64, P552, DOI DOI 10.1016/J.ANNEMERGMED.2014.08.002
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 39
TC 5
Z9 5
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 82
DI 10.3390/v11010082
PG 13
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000081
PM 30669393
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marin-Lopez, A
   Calvo-Pinilla, E
   Moreno, S
   Utrilla-Trigo, S
   Nogales, A
   Brun, A
   Fikrig, E
   Ortego, J
AF Marin-Lopez, Alejandro
   Calvo-Pinilla, Eva
   Moreno, Sandra
   Utrilla-Trigo, Sergio
   Nogales, Aitor
   Brun, Alejandro
   Fikrig, Erol
   Ortego, Javier
TI Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta
   Receptor
SO VIRUSES-BASEL
LA English
DT Review
DE arbovirus; IFNAR(-/-) mice model; interferon; pathology; vaccines
ID VALLEY FEVER VIRUS; HORSE SICKNESS VIRUS; WEST-NILE-VIRUS; EPIZOOTIC
   HEMORRHAGIC-DISEASE; MALE SEXUAL TRANSMISSION; WHITE-TAILED DEER;
   BLUETONGUE VIRUS; ZIKA VIRUS; IFNAR(-/-) MICE; MOUSE MODEL
AB Arboviruses are arthropod-borne viruses that exhibit worldwide distribution and are a constant threat, not only for public health but also for wildlife, domestic animals, and even plants. To study disease pathogenesis and to develop efficient and safe therapies, the use of an appropriate animal model is a critical concern. Adult mice with gene knockouts of the interferon / (IFN-/) receptor (IFNAR(-/-)) have been described as a model of arbovirus infections. Studies with the natural hosts of these viruses are limited by financial and ethical issues, and in some cases, the need to have facilities with a biosafety level 3 with sufficient space to accommodate large animals. Moreover, the number of animals in the experiments must provide results with statistical significance. Recent advances in animal models in the last decade among other gaps in knowledge have contributed to the better understanding of arbovirus infections. A tremendous advantage of the IFNAR(-/-) mouse model is the availability of a wide variety of reagents that can be used to study many aspects of the immune response to the virus. Although extrapolation of findings in mice to natural hosts must be done with care due to differences in the biology between mouse and humans, experimental infections of IFNAR(-/-) mice with several studied arboviruses closely mimics hallmarks of these viruses in their natural host. Therefore, IFNAR(-/-) mice are a good model to facilitate studies on arbovirus transmission, pathogenesis, virulence, and the protective efficacy of new vaccines. In this review article, the most important arboviruses that have been studied using the IFNAR(-/-) mouse model will be reviewed.
C1 [Marin-Lopez, Alejandro; Calvo-Pinilla, Eva; Moreno, Sandra; Utrilla-Trigo, Sergio; Nogales, Aitor; Brun, Alejandro; Ortego, Javier] INIA CISA, Ctr Anim Hlth Res, Madrid 28130, Spain.
   [Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
RP Ortego, J (corresponding author), INIA CISA, Ctr Anim Hlth Res, Madrid 28130, Spain.
EM alejandro.marinlopez@yale.edu; evacalvopinilla@gmail.com;
   moreno.sandra@inia.es; sergioutrilla@gmail.com;
   aitor_nogales@hotmail.com; brun@inia.es; erol.fikrig@yale.edu;
   ortego@inia.es
RI ortego, javier/K-6020-2014; Ortego, Javier/M-6810-2019; Brun,
   Alejandro/J-9808-2014
OI ortego, javier/0000-0002-4275-7277; Ortego, Javier/0000-0002-4275-7277;
   Brun, Alejandro/0000-0001-7865-538X; NOGALES, AITOR/0000-0002-2424-7900
FU Spanish MCIU [AGL2017-82570-R, AGL-2017-83226-R]; EU Horizon 2020
   Program (European Commission) [727393-PALE-Blu]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI127865, AI08992]
FX This manuscript was supported by the Spanish MCIU grants AGL2017-82570-R
   (to Javier Ortego) and AGL-2017-83226-R (to Alejandro Brun), the EU
   Horizon 2020 Program (European Commission Grant Agreement NO.
   727393-PALE-Blu (to Javier Ortego), and by NIH grants AI127865 and
   AI08992 (to Erol Fikrig).
CR Adams AP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001875
   Alberca B, 2014, VACCINE, V32, P3670, DOI 10.1016/j.vaccine.2014.04.036
   Aoki K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-105
   Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5
   Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0
   Bird BH, 2016, J INFECT DIS, V213, P703, DOI 10.1093/infdis/jiv538
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Borrego B, 2016, NANOMED-NANOTECHNOL, V12, P1185, DOI 10.1016/j.nano.2016.01.021
   Boshra H, 2011, VACCINE, V29, P4469, DOI 10.1016/j.vaccine.2011.04.043
   Boshra HY, 2017, ANTIVIR RES, V141, P107, DOI 10.1016/j.antiviral.2017.02.013
   Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001
   Boyd A, 2006, J GEN VIROL, V87, P2005, DOI 10.1099/vir.0.81767-0
   Buettner N, 2010, J GEN VIROL, V91, P220, DOI 10.1099/vir.0.015172-0
   Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516
   Calvo-Pinilla E, 2015, ANTIVIR RES, V116, P27, DOI 10.1016/j.antiviral.2015.01.009
   Calvo-Pinilla E, 2014, VIRUS RES, V180, P23, DOI 10.1016/j.virusres.2013.12.002
   Calvo-Pinilla E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034735
   Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027
   Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171
   Canakoglu N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003579
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Caporale M, 2014, J VIROL, V88, P10399, DOI 10.1128/JVI.01641-14
   Caporale M, 2011, J VIROL, V85, P11479, DOI 10.1128/JVI.05226-11
   Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chen CC, 2013, INT J ENV RES PUB HE, V10, P3052, DOI 10.3390/ijerph10073052
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Darpel KE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-40
   Darwish M A, 1979, J Egypt Public Health Assoc, V54, P1
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Davies F Glyn, 2006, Vet Ital, V42, P31
   de la Grandiere MA, 2014, VET MICROBIOL, V174, P322, DOI 10.1016/j.vetmic.2014.10.006
   de la Poza F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070197
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596
   Dondi E, 2003, J IMMUNOL, V170, P749, DOI 10.4049/jimmunol.170.2.749
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Eschbaumer M, 2012, VET MICROBIOL, V155, P417, DOI 10.1016/j.vetmic.2011.08.019
   Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712
   FILIPE AR, 1986, ACTA VIROL, V30, P337
   Franceschi V, 2011, VACCINE, V29, P3074, DOI 10.1016/j.vaccine.2011.01.075
   Frontera JA, 2016, NEW ENGL J MED, V375, P1581, DOI 10.1056/NEJMe1611840
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Garrison AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005908
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Goncalves D, 2012, SCI WORLD J, DOI 10.1100/2012/525947
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002
   Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515
   Hagmaier K, 2003, J VIROL, V77, P2747, DOI 10.1128/JVI.77.4.2747-2752.2003
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315
   Hermance ME, 2015, J VIROL, V89, P7852, DOI 10.1128/JVI.01056-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hinkula J, 2017, J VIROL, V91, DOI [10.1128/JVI.02076-16, 10.1128/jvi.02076-16]
   HOUSE JA, 1993, VET CLIN N AM-EQUINE, V9, P355, DOI 10.1016/S0749-0739(17)30402-9
   HOWERTH EW, 1988, AM J VET RES, V49, P1914
   Jaafar FM, 2014, VACCINE, V32, P4059, DOI 10.1016/j.vaccine.2014.05.056
   Jabbar TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060574
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kochs G, 2016, J VIROL, V90, P9330, DOI 10.1128/JVI.00744-16
   Kochs G, 2010, J VIROL, V84, P12344, DOI 10.1128/JVI.00931-10
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Kraatz F, 2015, J VIROL, V89, P1825, DOI 10.1128/JVI.02729-14
   Kraus J, 2004, ANN NEUROL, V56, P192, DOI 10.1002/ana.20161
   KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835
   Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978
   Lee AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02061
   Lee AJ, 2017, J EXP MED, V214, P1153, DOI 10.1084/jem.20160880
   Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571
   Legisa DM, 2015, VACCINE, V33, P2614, DOI 10.1016/j.vaccine.2015.03.067
   Li JP, 2015, APPL MICROBIOL BIOT, V99, P8643, DOI 10.1007/s00253-015-6697-8
   Lindqvist R, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070340
   Liu Y, 2014, J VIROL, V88, P1781, DOI 10.1128/JVI.02277-13
   Lopez-Gil E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002309
   Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018
   Lulla V, 2016, J VIROL, V90, P7405, DOI 10.1128/JVI.00548-16
   Ma GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034425
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003
   Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747
   MALHERBE H., 1963, S AFRICAN MED JOUR, V37, P547
   Marin-Lopez A, 2018, J VIROL, V92, DOI 10.1128/JVI.00938-18
   Marin-Lopez A, 2017, ANTIVIR RES, V142, P55, DOI 10.1016/j.antiviral.2017.03.010
   Marin-Lopez A, 2016, INT J BIOL SCI, V12, P1448, DOI 10.7150/ijbs.14967
   Marin-Lopez A, 2014, ANTIVIR RES, V110, P42, DOI 10.1016/j.antiviral.2014.07.008
   Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2
   Martin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143273
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021
   METTLER NE, 1962, J EXP MED, V116, P665, DOI 10.1084/jem.116.5.665
   MIMS CA, 1956, BRIT J EXP PATHOL, V37, P99
   Mohamed DKA, 2018, VET MICROBIOL, V219, P40, DOI 10.1016/j.vetmic.2018.04.007
   MONATH TP, 1983, LAB INVEST, V48, P399
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279
   O'Hara RS, 1998, ARCH VIROL, P259
   Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Pages N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083683
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Perez P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35724-6
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Saxton-Shaw KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128712
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schoneboom BA, 2000, J INTERF CYTOK RES, V20, P205, DOI 10.1089/107999000312621
   Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023
   Seymour RL, 2013, AM J TROP MED HYG, V88, P1170, DOI 10.4269/ajtmh.12-0674
   SHOPE RE, 1960, J EXP MED, V111, P155, DOI 10.1084/jem.111.2.155
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DR, 2010, VIROLOGY, V407, P256, DOI 10.1016/j.virol.2010.08.016
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   STAEHELI P, 1986, MOL CELL BIOL, V6, P4770, DOI 10.1128/MCB.6.12.4770
   Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004
   Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850
   Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609
   Tauscher K, 2017, ARCH VIROL, V162, P3119, DOI 10.1007/s00705-017-3475-1
   TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947
   Touret Y, 2006, PRESSE MED, V35, P1656, DOI 10.1016/S0755-4982(06)74874-6
   Umeshappa CS, 2010, VET MICROBIOL, V144, P310, DOI 10.1016/j.vetmic.2010.02.033
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van Zyl AR, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0370-5
   Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133
   Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002
   Wernike K, 2017, ADV VIRUS RES, V99, P39, DOI 10.1016/bs.aivir.2017.07.001
   Wernike K, 2017, SCI REP-UK, V7, DOI 10.1038/srep42500
   Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001
   Winkelmann ER, 2012, VACCINE, V30, P1465, DOI 10.1016/j.vaccine.2011.12.103
   Wong G, 2018, ZOOL RES, V39, P3, DOI 10.24272/j.issn.2095-8137.2017.052
   Worwa G, 2010, VET MICROBIOL, V144, P264, DOI 10.1016/j.vetmic.2010.01.011
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yilmaz H, 2014, VECTOR-BORNE ZOONOT, V14, P223, DOI 10.1089/vbz.2013.1451
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111
   Zivcec M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006628
   Zivcec M, 2013, J INFECT DIS, V207, P1909, DOI 10.1093/infdis/jit061
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 169
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 35
DI 10.3390/v11010035
PG 25
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000035
PM 30625992
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mavian, C
   Dulcey, M
   Munoz, O
   Salemi, M
   Vittor, AY
   Capua, I
AF Mavian, Carla
   Dulcey, Melissa
   Munoz, Olga
   Salemi, Marco
   Vittor, Amy Y.
   Capua, Ilaria
TI Islands as Hotspots for Emerging Mosquito-Borne Viruses: A One-Health
   Perspective
SO VIRUSES-BASEL
LA English
DT Review
DE One-Health; island; hotspot; Indian; Pacific; Caribbean; arbovirus;
   dengue; zika; chikungunya
ID ROSS RIVER VIRUS; WEST-NILE-VIRUS; DENGUE HEMORRHAGIC-FEVER; LA REUNION
   ISLAND; ST-LOUIS VIRUS; SEA-LEVEL RISE; CHIKUNGUNYA-VIRUS; ZIKA VIRUS;
   AEDES-AEGYPTI; PUERTO-RICO
AB During the past ten years, an increasing number of arbovirus outbreaks have affected tropical islands worldwide. We examined the available literature in peer-reviewed journals, from the second half of the 20th century until 2018, with the aim of gathering an overall picture of the emergence of arboviruses in these islands. In addition, we included information on environmental and social drivers specific to island setting that can facilitate the emergence of outbreaks. Within the context of the One Health approach, our review highlights how the emergence of arboviruses in tropical islands is linked to the complex interplay between their unique ecological settings and to the recent changes in local and global sociodemographic patterns. We also advocate for greater coordination between stakeholders in developing novel prevention and mitigation approaches for an intractable problem.
C1 [Mavian, Carla; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.
   [Mavian, Carla; Dulcey, Melissa; Munoz, Olga; Salemi, Marco; Vittor, Amy Y.; Capua, Ilaria] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Dulcey, Melissa; Munoz, Olga] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA.
   [Munoz, Olga; Capua, Ilaria] Univ Florida, Hlth Ctr Excellence 1, Gainesville, FL 32611 USA.
   [Vittor, Amy Y.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.
RP Mavian, C (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.; Mavian, C (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM cmavian@ufl.edu; dulceym@ufl.edu; omunoz@ufl.edu;
   salemi@pathology.ufl.edu; Amy.Vittor@medicine.ufl.edu; icapua@ufl.edu
FU  [734857]
FX This work was supported by funding provided by ZikAction: Preparedness,
   research and action network on maternal-paediatric axes of ZIKV
   infection in Latin America and the Caribbean, Grant Agreement Number
   734857.
CR A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029
   AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
   Abdulla Aishath Aroona, 2014, WHO South East Asia J Public Health, V3, P60, DOI 10.4103/2224-3151.206886
   ANDERSON CR, 1956, SCIENCE, V124, P224, DOI 10.1126/science.124.3214.224
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P688, DOI 10.4269/ajtmh.1957.6.688
   ANDERSON S. G., 1960, MED JOUR AUSTRALIAN II, V47, P410
   [Anonymous], 2001, HUMANCAYMAN ISL
   [Anonymous], HLTH OFF REINF MOSQ
   [Anonymous], 2002, JAPANESE ENCEPHALITI, V267
   Aponte J. Torres, 2008, Morbidity and Mortality Weekly Report, V57, P577
   Ashford DA, 2003, AM J TROP MED HYG, V69, P135, DOI 10.4269/ajtmh.2003.69.135
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Auguste AJ, 2009, VIROLOGY, V392, P123, DOI 10.1016/j.virol.2009.06.038
   Balenghien T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-78
   Bangert M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006796
   BARNES WJS, 1974, AM J TROP MED HYG, V23, P495, DOI 10.4269/ajtmh.1974.23.495
   BARRERA R, 1993, J AM MOSQUITO CONTR, V9, P189
   Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P203, DOI 10.1111/geb.12093
   Belle E A, 1966, West Indian Med J, V15, P217
   BELLE EA, 1980, AM J TROP MED HYG, V29, P667, DOI 10.4269/ajtmh.1980.29.667
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   BEREZIN VV, 1977, VOP VIRUSOL+, P62
   Berlioz-Arthaud A., 2004, LAB SURVEILLANCE DEN
   BOISIER P, 1994, ANN SOC BELG MED TR, V74, P217
   Bonifay T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx247
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   BRIGUGLIO L, 1995, WORLD DEV, V23, P1615, DOI 10.1016/0305-750X(95)00065-K
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CALISHER CH, 1981, B WORLD HEALTH ORGAN, V59, P619
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Catteau C, 2005, Med Trop (Mars), V65, P515
   Chaaithanya IK, 2012, EPIDEMIOL INFECT, V140, P1920, DOI 10.1017/S0950268811002500
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Choi J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3893-0
   Cloudsley-Thompson J.L., 1976, INSECTS AND HIST
   Coffey LL, 2006, EMERG INFECT DIS, V12, P1873
   Dellagi K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004840
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dimou M.S., 2017, P ASRDLF ERSA GR 201
   DOHERTY R. L., 1963, AUSTRALIAN J SCI, V26, P183
   Dolja VV, 2018, VIRUS RES, V244, P36, DOI 10.1016/j.virusres.2017.10.020
   Dorleans F, 2018, AM J TROP MED HYG, V98, P1819, DOI 10.4269/ajtmh.16-0719
   DOWNS WG, 1957, AM J TROP MED HYG, V6, P693, DOI 10.4269/ajtmh.1957.6.693
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Dupuis AP, 2005, AM J TROP MED HYG, V73, P474, DOI 10.4269/ajtmh.2005.73.474
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   EHRENKRANZ NJ, 1971, NEW ENGL J MED, V285, P1460, DOI 10.1056/NEJM197112232852606
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Ernst KC, 2015, HUM HEALT HANDB, V10, P489, DOI 10.3920/978-90-8686-806-3_28
   FAURAN P, 1978, B SOC PATHOL EXOT, V71, P400
   FAURAN P, 1984, AM J TROP MED HYG, V33, P1228, DOI 10.4269/ajtmh.1984.33.1228
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Florida Department of Health, 2017, REP DAT ARB SURV
   Florida Department of Health, 2018, REP DAT ARB SURV
   Florida Department of Health, 2016, REP DAT ARB SURV
   Fonzi E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003829
   Forde MS, 2017, REV PANAM SALUD PUBL, V41
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gautret P, 2010, EUROSURVEILLANCE, V15, P2
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grant C., US CARIBBEAN RELATIO
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler D J, 1983, MMWR CDC Surveill Summ, V32, p23SS
   GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gyawali N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02150
   Hanley KA, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P351, DOI 10.1016/B978-0-12-374153-0.00016-3
   Healy JM, 2016, MMWR-MORBID MORTAL W, V65, P1146, DOI 10.15585/mmwr.mm6541a4
   Hinojosa J., PUERTO RICAN EXODUS
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130
   Hunter J.A., 2002, NOTE RELATIVE SEA LE
   Issack MI, 2010, EMERG INFECT DIS, V16, P716, DOI 10.3201/eid1604.091582
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   JONKERS AH, 1967, AM J TROP MED HYG, V16, P74, DOI 10.4269/ajtmh.1967.16.74
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Journel I, 2017, MMWR-MORBID MORTAL W, V66, P172, DOI 10.15585/mmwr.mm6606a4
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KLES V, 1994, B SOC PATHOL EXOT, V87, P71
   Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kouri G, 1986, Bull Pan Am Health Organ, V20, P24
   KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krishnamoorthy K, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-32
   Kukreti H, 2008, INT J INFECT DIS, V12, P542, DOI 10.1016/j.ijid.2008.02.009
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Lai SJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006743
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   Langsjoen RM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005189
   Lau C, 2012, TRAVEL MED INFECT DI, V10, P129, DOI 10.1016/j.tmaid.2012.04.001
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Limonta D, 2012, INFECTION, V40, P689, DOI 10.1007/s15010-012-0260-7
   Loison J., 1974, J SOC OCEAN ANN, V42, P105, DOI [10.3406/jso.1974.2634, DOI 10.3406/JSO.1974.2634]
   Lustig Y, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.26.30563
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Martin B., 2005, DENGUE FEVER TYPE 1
   Matheus S, 2012, AM J TROP MED HYG, V86, P159, DOI 10.4269/ajtmh.2012.11-0475
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   MCCARTHY D. D., 1943, East African Medical Journal, V20, P293
   MCLEAN RG, 1979, J WILDLIFE DIS, V15, P327
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MILES JAR, 1964, AM J TROP MED HYG, V13, P327, DOI 10.4269/ajtmh.1964.13.327
   Mimura N.N.L., 2007, SMALL ISLANDS, V9
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Montagner FRG, 2018, BRAZ J BIOL, V78, P233, DOI 10.1590/1519-6984.04416
   Moody C.O., 1979, DENGUE CARIBBEAN, P1987
   Moore PR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.103
   MOREAU JP, 1973, AM J TROP MED HYG, V22, P237, DOI 10.4269/ajtmh.1973.22.237
   MORENS DM, 1986, AM J TROP MED HYG, V35, P197, DOI 10.4269/ajtmh.1986.35.197
   Mowatt L, 2014, INFECT DIS THER, V3, P63, DOI 10.1007/s40121-014-0043-9
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Muruganandam N, 2014, J VECTOR DIS, V51, P58
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Nemeth NM, 2010, J WILDLIFE DIS, V46, P659, DOI 10.7589/0090-3558-46.2.659
   Newell J., CLIMATE CHANGE MARSH
   Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782
   Padbidri V. S., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P794
   PAHO, TIM EM ZIK VIR AM
   PAHO, 1997, REP AED AEG CONTR
   PAHO WHO, NUMB REP CAS CHIK FE, V35
   PANON G, 1983, B SOC PATHOL EXOT, V76, P755
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Pastula DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005410
   Patel SS, 2006, NATURE, V440, P734, DOI 10.1038/440734a
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x
   Pelling M., 2001, ENV HAZARDS, V3, P49, DOI DOI 10.1016/S1464-2867(01)00018-3
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peterson L.R., 2015, INTERIM ASSESSMENT R
   Pfeffer M, 2010, EUROSURVEILLANCE, V15, P6
   Pierre V., 2005, JOURNEES VEILLE SANI
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ramasamy R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104977
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401
   Rawlinson T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002685
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Renault P, 2008, EMERG INFECT DIS, V14, P1327, DOI 10.3201/eid1408.080201
   Ritchie SA, 2001, EMERG INFECT DIS, V7, P900
   ROSEN L, 1981, AM J TROP MED HYG, V30, P1294, DOI 10.4269/ajtmh.1981.30.1294
   ROSEN L, 1967, JPN J MED SCI BIOL, VS 20, P67
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Sakkas H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040175
   Santillana M, 2017, CLIN INFECT DIS, V64, P42, DOI 10.1093/cid/ciw660
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019
   SCHWARZ TF, 1994, J MED VIROL, V44, P379, DOI 10.1002/jmv.1890440411
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sherpa S, 2018, GENOME BIOL EVOL, V10, P56, DOI 10.1093/gbe/evx267
   Shineberg D., 1967, THEY CAME SANDALWOOD, P1830
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Sissoko D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014141
   Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045
   SPENCE L, 1967, P SOC EXP BIOL MED, V125, P45, DOI 10.3181/00379727-125-32009
   SPENCE L, 1969, AM J TROP MED HYG, V18, P584, DOI 10.4269/ajtmh.1969.18.584
   SPENCE L., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P504, DOI 10.1016/0035-9203(62)90074-3
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   TESH RB, 1981, T ROY SOC TROP MED H, V75, P426, DOI 10.1016/0035-9203(81)90112-7
   TESH RB, 1975, AM J TROP MED HYG, V24, P664, DOI 10.4269/ajtmh.1975.24.664
   The World Bank, CLIM CHANG MALD
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Thompson NN, 2012, VECTOR-BORNE ZOONOT, V12, P969, DOI 10.1089/vbz.2012.0959
   Tisdell C., 2009, CHALLENGE EU ENLARGE
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tortosa P, 2012, INFECT GENET EVOL, V12, P1333, DOI 10.1016/j.meegid.2012.03.024
   TravelStateGov, ZIK VIR INF TRAV
   Trofa AF, 1997, JAMA-J AM MED ASSOC, V277, P1546, DOI 10.1001/jama.277.19.1546
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   United Nations Conference on Environment and Development (UNCED), 1992, EARTH SUMM AG 21
   van den Hurk AF, 2008, EMERG INFECT DIS, V14, P1736, DOI 10.3201/eid1411.071368
   van TONGEREN H, 1963, Acta Leiden, V32, P286
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasilenko V A, 1971, Vopr Virusol, V16, P682
   Vazeille M, 2018, MED VET ENTOMOL, V32, P251, DOI 10.1111/mve.12284
   VENTURA AK, 1976, J INFECT DIS, V134, P436, DOI 10.1093/infdis/134.5.436
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Wasem R.E., IMMIGR POLICY
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Webster-Kerr KR, 2016, W INDIAN MED J, V65, P243, DOI 10.7727/wimj.2016.488
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   White SK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006505
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   WHO, ZIK VIR COMPL 2016 P
   WHO, 2011, DENG OUTBR MALD
   WHO, HIST ZIK VIR
   WHO, 2014, NAT M STRENGTH DENG
   Widmar Nicole J Olynk, 2017, Prev Med Rep, V6, P162, DOI 10.1016/j.pmedr.2017.02.023
   WILBAR CL, 1947, AM J PUBLIC HEALTH, V37, P663
   Wiley James W., 1993, Bird Conservation International, V3, P319
   Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361
   World Bank, AIR TRANSP PASS CARR
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health organization, 1993, MON DENG DENG HAEM F
   Yang SH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2424-7
   Yoosuf AA, 2009, T ROY SOC TROP MED H, V103, P192, DOI 10.1016/j.trstmh.2008.09.006
   Young P.R., 2008, ORIGIN EVOLUTION VIR
   Zeller HG, 1998, B SOC PATHOL EXOT, V91, P56
   Zellweger RELM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005471
NR 228
TC 2
Z9 2
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 11
DI 10.3390/v11010011
PG 28
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000011
PM 30585228
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mlera, L
   Bloom, ME
AF Mlera, Luwanika
   Bloom, Marshall E.
TI Differential Zika Virus Infection of Testicular Cell Lines
SO VIRUSES-BASEL
LA English
DT Article
DE flavivirus; Zika virus; viral persistence; testicular cells; testes
ID SEXUAL TRANSMISSION; HUMAN NEUROBLASTOMA; BARRE-SYNDROME; GUILLAIN
AB Background: Zika virus is a mosquito-borne flavivirus responsible for recent outbreaks of epidemic proportions in Latin America. Sexual transmission of the virus has been reported in 13 countries and may be an important route of infection. Sexual transmission of ZIKV has mostly been male-to-female, and persistence of viral RNA in semen for up to 370 days has been recorded. The susceptibility to ZIKV of different testicular cell types merits investigation. Methods: We infected primary Sertoli cells, a primary testicular fibroblast Hs1.Tes, and 2 seminoma cell lines SEM-1 and TCam-2 cells with ZIKV Paraiba and the prototype ZIKV MR766 to evaluate their susceptibility and to look for viral persistence. A human neuroblastoma cell line SK-N-SH served as a control cell type. Results: Both virus strains were able to replicate in all cell lines tested, but ZIKV MR766 attained higher titers. Initiation of viral persistence by ZIKV Paraiba was observed in Sertoli, Hs1.Tes, SEM-1 and TCam-2 cells, but was of limited duration due to delayed cell death. ZIKV MR766 persisted only in Hs1.Tes and Sertoli cells, and persistence was also limited. In contrast, SK-N-SH cells were killed by both ZIKV MR766 and ZIKV Paraiba and persistence could not be established in these cells. Conclusions: ZIKV prototype strain MR766 and the clinically relevant Paraiba strain replicated in several testicular cell types. Persistence of ZIKV MR766 was only observed in Hs1.Tes and Sertoli cells, but the persistence did not last more than 3 or 4 passages, respectively. ZIKV Paraiba persisted in TCam-2, Hs1.Tes, Sertoli and SEM-1 cells for up to 5 passages, depending on cell type. TCam-2 cells appeared to clear persistent infection by ZIKV Paraiba.
C1 [Mlera, Luwanika; Bloom, Marshall E.] NIAID, Biol Vector Borne Viruses Sect, Lab Virol, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.
   [Mlera, Luwanika] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.
RP Bloom, ME (corresponding author), NIAID, Biol Vector Borne Viruses Sect, Lab Virol, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.
EM Luwanika.Mlera@gmail.com; mbloom@niaid.nih.gov
FU Division of Intramural Research program of the National Institute of
   Allergy and Infectious Diseases at the National Institutes of Health
FX This study was supported by the Division of Intramural Research program
   of the National Institute of Allergy and Infectious Diseases at the
   National Institutes of Health.
CR BIEDLER JL, 1973, CANCER RES, V33, P2643
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Russell SM, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.09.029
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
NR 29
TC 4
Z9 4
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 42
DI 10.3390/v11010042
PG 11
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000042
PM 30634400
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nazerai, L
   Christensen, JP
   Thomsen, AR
AF Nazerai, Loulieta
   Christensen, Jan Pravsgaard
   Thomsen, Allan Randrup
TI A "Furry-Tale' of Zika Virus Infection: What Have We Learned from Animal
   Models?
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; animal models; pathogenesis; immune responses; vaccines
ID DNA VACCINE; MOUSE MODEL; GUINEA-PIG; BRAIN; PROTECTION; LEADS; ADULT;
   IMMUNOGENICITY; TRANSMISSION; INOCULATION
AB The worldwide attention that the Zika virus (ZIKV) attracted, following its declaration as a Public Health Emergency of International concern by WHO in 2016, has led to a large collective effort by the international scientific community to understand its biology. Despite the mild symptoms caused by ZIKV in most infected people, the virus displays a number of worrying features, such as its ability to cause transplacental infection, fetal abnormalities and vector independent transmission through body fluids. In addition, the virus has been associated with the induction of Guillain-Barre syndrome in a number of infected individuals. With travelling, the virus has spread outside the original ZIKV endemic areas making it imperative to find ways to control it. Thus far, the large number of animal models developed to study ZIKV pathogenesis have proven to be valuable tools in understanding how the virus replicates and manifests itself in the host, its tissue tropism and the type of immune responses it induces. Still, vital questions, such as the molecular mechanisms of ZIKV persistence and the long-term consequences of ZIKV infection in the developing brain, remain unanswered. Here, we reviewed and discussed the major and most recent findings coming from animal studies and their implications for a ZIKV vaccine design.
C1 [Nazerai, Loulieta; Christensen, Jan Pravsgaard; Thomsen, Allan Randrup] Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark.
RP Thomsen, AR (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark.
EM julietanaze@sund.ku.dk; jpc@sund.ku.dk; athomsen@sund.ku.dk
RI Christensen, Jan/I-4782-2017
OI Christensen, Jan/0000-0002-4299-9479; Thomsen, Allan
   Randrup/0000-0002-2392-9803; Nazerai, Loulieta/0000-0002-1090-9029
FU Lundbeck Foundation - Lundbeck Foundation; Faculty of Health and Medical
   Sciences, University of Copenhagen, Denmark
FX This work was supported by the Lundbeck Foundation. L.N. was the
   recipient of a Ph.D scholarship partly funded by the Lundbeck Foundation
   and partly by the Faculty of Health and Medical Sciences, University of
   Copenhagen, Denmark.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aldhous P, 1999, NEW SCI, V162, P26
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 92
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 29
DI 10.3390/v11010029
PG 13
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000029
PM 30621317
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petrova, E
   Gracias, S
   Beauclair, G
   Tangy, F
   Jouvenet, N
AF Petrova, Evgeniya
   Gracias, Segolene
   Beauclair, Guillaume
   Tangy, Frederic
   Jouvenet, Nolwenn
TI Uncovering Flavivirus Host Dependency Factors through a Genome-Wide
   Gain-of-Function Screen
SO VIRUSES-BASEL
LA English
DT Article
DE Flavivirus; West Nile virus; Yellow fever virus; Zika virus;
   Host-pathogen interactions; Virus replication; Genome-wide
   gain-of-function screen; Oligosaccharyltransferase complex; Ribosomal
   proteins
ID ZIKA VIRUS; GLYCOSYLATION SITES; N-GLYCOSYLATION; DENGUE; RNA;
   PATHOGENESIS; REPLICATION; PROTEINS; IDENTIFICATION; REGION
AB Flaviviruses, such as dengue (DENV), West Nile (WNV), yellow fever (YFV) and Zika (ZIKV) viruses, are mosquito-borne pathogens that present a major risk to global public health. To identify host factors that promote flavivirus replication, we performed a genome-wide gain-of-function cDNA screen for human genes that enhance the replication of flavivirus reporter particles in human cells. The screen recovered seventeen potential host proteins that promote viral replication, including the previously known dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit (DDOST). Using silencing approaches, we validated the role of four candidates in YFV and WNV replication: ribosomal protein L19 (RPL19), ribosomal protein S3 (RPS3), DDOST and importin 9 (IPO9). Applying a panel of virological, biochemical and microscopic methods, we validated further the role of RPL19 and DDOST as host factors required for optimal replication of YFV, WNV and ZIKV. The genome-wide gain-of-function screen is thus a valid approach to advance our understanding of flavivirus replication.
C1 [Petrova, Evgeniya; Gracias, Segolene; Beauclair, Guillaume; Tangy, Frederic; Jouvenet, Nolwenn] Inst Pasteur, Dept Virol, Viral Genom & Vaccinat Unit, CNRS,UMR3569, F-75015 Paris, France.
RP Jouvenet, N (corresponding author), Inst Pasteur, Dept Virol, Viral Genom & Vaccinat Unit, CNRS,UMR3569, F-75015 Paris, France.
EM epetrova@jacobs-alumni.de; segolene.gracias@pasteur.fr;
   guillaume.beauclair@pasteur.fr; frederic.tangy@pasteur.fr;
   nolwenn.jouvenet@pasteur.fr
OI jouvenet, nolwenn/0000-0001-6103-6048; Tangy,
   Frederic/0000-0002-5937-5654; Beauclair, Guillaume/0000-0001-5323-5987;
   Petrova, Evgeniya/0000-0002-7060-1114
FU Marie Curie International Reintegration programEuropean Union (EU)
   [PCIG11-GA-2012-322060]; Agence Nationale pour la RechercheFrench
   National Research Agency (ANR) [ANR-12-JSV3-003-01,
   ANR-16-CE15-0025-01]; Ville de Paris EMERGENCE Program; Institut
   Pasteur; EMBO YIP program; Centre National de la Recherche Scientifique
   (CNRS)Centre National de la Recherche Scientifique (CNRS)
FX This research was funded by Marie Curie International Reintegration
   program (grant number PCIG11-GA-2012-322060), Agence Nationale pour la
   Recherche (grant numbers ANR-12-JSV3-003-01 and ANR-16-CE15-0025-01),
   Ville de Paris EMERGENCE Program, Centre National de la Recherche
   Scientifique (CNRS), Institut Pasteur and the EMBO YIP program.
CR Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Crocker SJ, 2007, AM J PATHOL, V171, P1762, DOI 10.2353/ajpath.2007.070179
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Khou C, 2017, INTERVIROLOGY, V60, P8, DOI 10.1159/000479966
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005
   Yang Eun-Jeong, 2011, Immune Netw, V11, P155, DOI 10.4110/in.2011.11.3.155
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao TS, 2016, VIRUS GENES, V52, P172, DOI 10.1007/s11262-015-1270-1
   Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014
NR 46
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 68
DI 10.3390/v11010068
PG 17
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000067
PM 30650657
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Willard, KA
   Elling, CL
   Stice, SL
   Brindley, MA
AF Willard, Katherine A.
   Elling, Christina L.
   Stice, Steven L.
   Brindley, Melinda A.
TI The Oxysterol 7-Ketocholesterol Reduces Zika Virus Titers in Vero Cells
   and Human Neurons
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; antiviral compounds; neural cells; viral replication
ID AUTOPHAGY; PHAGOCYTOSIS; INFECTION; OXIDATION; REQUIRES
AB Zika virus (ZIKV) is an emerging flavivirus responsible for a major epidemic in the Americas beginning in 2015. ZIKV associated with maternal infection can lead to neurological disorders in newborns, including microcephaly. Although there is an abundance of research examining the neurotropism of ZIKV, we still do not completely understand the mechanism by which ZIKV targets neural cells or how to limit neural cell infection. Recent research suggests that flaviviruses, including ZIKV, may hijack the cellular autophagy pathway to benefit their replication. Therefore, we hypothesized that ZIKV replication would be impacted when infected cells were treated with compounds that target the autophagy pathway. We screened a library of 94 compounds known to affect autophagy in both mammalian and insect cell lines. A subset of compounds that inhibited ZIKV replication without affecting cellular viability were tested for their ability to limit ZIKV replication in human neurons. From this second screen, we identified one compound, 7-ketocholesterol (7-KC), which inhibited ZIKV replication in neurons without significantly affecting neuron viability. Interestingly, 7-KC induces autophagy, which would be hypothesized to increase ZIKV replication, yet it decreased virus production. Time-of-addition experiments suggest 7-KC inhibits ZIKV replication late in the replication cycle. While 7-KC did not inhibit RNA replication, it decreased the number of particles in the supernatant and the relative infectivity of the released particles, suggesting it interferes with particle budding, release from the host cell, and particle integrity.
C1 [Willard, Katherine A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
   [Elling, Christina L.; Stice, Steven L.] Univ Georgia, Coll Agr & Environm Sci, Dept Anim & Dairy Sci, Regenerat Biosci Ctr, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis,Dept Populat Hlth, Athens, GA 30602 USA.
RP Brindley, MA (corresponding author), Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis,Dept Populat Hlth, Athens, GA 30602 USA.
EM katherine.willard@duke.edu; christina.elling@ucdenver.edu;
   sstice@uga.edu; mbrindle@uga.edu
OI Brindley, Melinda/0000-0002-4929-8085; Willard,
   Katherine/0000-0002-0044-2664
FU University of Georgia
FX Work was supported by laboratory start-up funds provided by the
   University of Georgia.
CR Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028
   Chang YP, 2010, J BIOL CHEM, V285, P28715, DOI 10.1074/jbc.M110.133355
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487
   Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004
   He CY, 2013, AM J PATHOL, V183, P626, DOI 10.1016/j.ajpath.2013.04.028
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Huang JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100985
   Kimmey JM, 2016, TRENDS MOL MED, V22, P1060, DOI 10.1016/j.molmed.2016.10.008
   Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15807
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lu SM, 2018, TRAFFIC, V19, P591, DOI 10.1111/tra.12576
   Lyons MA, 1999, INT J BIOCHEM CELL B, V31, P369, DOI 10.1016/S1357-2725(98)00123-X
   Magenau A, 2011, TRAFFIC, V12, P1730, DOI 10.1111/j.1600-0854.2011.01272.x
   Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002
   Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425
   Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Richards AL, 2013, J VIROL, V87, P9966, DOI 10.1128/JVI.00460-13
   Rodriguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Sager G, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100559
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150
   Shinkyo R, 2011, J BIOL CHEM, V286, P33021, DOI 10.1074/jbc.M111.282434
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x
   Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193
   Wang SF, 2013, BIOCHEM PHARMACOL, V86, P548, DOI 10.1016/j.bcp.2013.06.006
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00402
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 44
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 20
DI 10.3390/v11010020
PG 17
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000020
PM 30598036
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU White, SL
   Rawlinson, W
   Boan, P
   Sheppeard, V
   Wong, G
   Waller, K
   Opdam, H
   Kaldor, J
   Fink, M
   Verran, D
   Webster, A
   Wyburn, K
   Grayson, L
   Glanville, A
   Cross, N
   Irish, A
   Coates, T
   Griffin, A
   Snell, G
   Alexander, SI
   Campbell, S
   Chadban, S
   Macdonald, P
   Manley, P
   Mehakovic, E
   Ramachandran, V
   Mitchell, A
   Ison, M
AF White, Sarah L.
   Rawlinson, William
   Boan, Peter
   Sheppeard, Vicky
   Wong, Germaine
   Waller, Karen
   Opdam, Helen
   Kaldor, John
   Fink, Michael
   Verran, Deborah
   Webster, Angela
   Wyburn, Kate
   Grayson, Lindsay
   Glanville, Allan
   Cross, Nick
   Irish, Ashley
   Coates, Toby
   Griffin, Anthony
   Snell, Greg
   Alexander, Stephen I.
   Campbell, Scott
   Chadban, Steven
   Macdonald, Peter
   Manley, Paul
   Mehakovic, Eva
   Ramachandran, Vidya
   Mitchell, Alicia
   Ison, Michael
TI Infectious Disease Transmission in Solid Organ Transplantation: Donor
   Evaluation, Recipient Risk, and Outcomes of Transmission
SO TRANSPLANTATION DIRECT
LA English
DT Review
ID HEPATITIS-C VIRUS; WEST-NILE-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; CELL
   LYMPHOTROPIC VIRUS; PROGRAM ANNUAL-REPORT; STRONGYLOIDES-STERCORALIS
   INFECTION; ANTIBODY-POSITIVE DONORS; MYCOBACTERIUM-TUBERCULOSIS
   INFECTION; ORTHOTOPIC LIVER-TRANSPLANTATION; MULTIDRUG-RESISTANT
   TUBERCULOSIS
AB In 2016, the Transplantation Society of Australia and New Zealand, with the support of the Australian Government Organ and Tissue authority, commissioned a literature review on the topic of infectious disease transmission from deceased donors to recipients of solid organ transplants. The purpose of this review was to synthesize evidence on transmission risks, diagnostic test characteristics, and recipient management to inform best-practice clinical guidelines. The final review, presented as a special supplement in Transplantation Direct, collates case reports of transmission events and other peer-reviewed literature, and summarizes current (as of June 2017) international guidelines on donor screening and recipient management. Of particular interest at the time of writing was how to maximize utilization of donors at increased risk for transmission of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus, given the recent developments, including the availability of direct-acting antivirals for hepatitis C virus and improvements in donor screening technologies. The review also covers emerging risks associated with recent epidemics (eg, Zika virus) and the risk of transmission of nonendemic pathogens related to donor travel history or country of origin. Lastly, the implications for recipient consent of expanded utilization of donors at increased risk of blood-borne viral disease transmission are considered.
C1 [White, Sarah L.; Waller, Karen; Wyburn, Kate; Chadban, Steven] Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia.
   [Rawlinson, William; Ramachandran, Vidya] Prince Wales Hosp, Serol & Virol Div, NSW Hlth Pathol, Sydney, NSW, Australia.
   [Rawlinson, William] Univ New South Wales, Womens & Childrens Hlth & Biotechnol & Biomol Sci, Sch Med, Sydney, NSW, Australia.
   [Boan, Peter] Fiona Stanley Hosp, Dept Infect Dis, Perth, WA, Australia.
   [Boan, Peter] Fiona Stanley Hosp, Dept Microbiol, Perth, WA, Australia.
   [Boan, Peter] PathWest Lab Med, Perth, WA, Australia.
   [Sheppeard, Vicky] New South Wales Hlth, Communicable Dis Network Australia, Sydney, NSW, Australia.
   [Wong, Germaine; Webster, Angela] Westmead Hosp, Ctr Transplant & Renal Res, Sydney, NSW, Australia.
   [Wong, Germaine; Alexander, Stephen I.] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia.
   [Wong, Germaine; Webster, Angela] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   [Opdam, Helen; Fink, Michael; Grayson, Lindsay] Austin Hlth, Melbourne, Australia.
   [Opdam, Helen; Mehakovic, Eva] Australian Govt, Organ & Tissue Author, Canberra, ACT, Australia.
   [Kaldor, John] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.
   [Fink, Michael; Grayson, Lindsay] Univ Melbourne, Melbourne Med Sch, Dept Surg, Melbourne, Australia.
   [Verran, Deborah] Royal Prince Alfred Hosp, Transplantat Serv, Sydney, NSW, Australia.
   [Wyburn, Kate; Chadban, Steven] Royal Prince Alfred Hosp, Renal Med, Sydney, NSW, Australia.
   [Glanville, Allan; Mitchell, Alicia] St Vincents Hosp, Dept Thorac Med & Lung Transplantat, Sydney, NSW, Australia.
   [Cross, Nick] Christchurch Hosp, Canterbury Dist Hlth Board, Dept Nephrol, Christchurch, New Zealand.
   [Irish, Ashley] Fiona Stanley Hosp, Dept Nephrol, Perth, WA, Australia.
   [Irish, Ashley] Univ Western Australia, UWA Med Sch, Fac Hlth & Med Sci, Crawley, Australia.
   [Coates, Toby] Royal Adelaide Hosp, Renal & Transplantat, Adelaide, SA, Australia.
   [Coates, Toby] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia.
   [Griffin, Anthony] Princess Alexandra Hosp, Renal Transplantat, Woolloongabba, Qld, Australia.
   [Snell, Greg] Alfred Hlth, Lung Transplant, Melbourne, Vic, Australia.
   [Campbell, Scott] Univ Queensland, Princess Alexandra Hosp, Dept Renal Med, Woolloongabba, Qld, Australia.
   [Macdonald, Peter] St Vincents Hosp, Dept Cardiol, Sydney, NSW, Australia.
   [Macdonald, Peter] Univ New South Wales, St Vincents Hosp, Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.
   [Manley, Paul] Auckland City Hosp, Auckland Dist Hlth Board, Kidney Disorders, Auckland, New Zealand.
   [Mitchell, Alicia] Woolcock Inst Med Res, Sydney, NSW, Australia.
   [Mitchell, Alicia] Univ Technol, Sch Med & Mol Biosci, Sydney, NSW, Australia.
   [Ison, Michael] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA.
   [Ison, Michael] Northwestern Univ, Feinberg Sch Med, Div Organ Transplantat, Chicago, IL 60611 USA.
RP White, SL (corresponding author), Univ Sydney, Charles Perkins Ctr, Level 2 West 66, Camperdown, NSW 2006, Australia.
EM sarah.white@sydney.edu.au
RI Verran, Deborah/V-3954-2019; Macdonald, Peter/Q-3188-2019; Mitchell,
   Alicia/R-6479-2019; Irish, Ashley/H-5468-2019
OI Irish, Ashley/0000-0002-9577-3764; Mitchell, Alicia/0000-0002-9086-1589;
   Waller, Karen/0000-0002-0530-3292
FU Transplantation Society of Australia and New Zealand; Australian
   Government Organ and Tissue Authority
FX This literature review was funded by The Transplantation Society of
   Australia and New Zealand and the Australian Government Organ and Tissue
   Authority.
CR Abanyie FA, 2015, AM J TRANSPLANT, V15, P1369, DOI 10.1111/ajt.13137
   Abikhaled JA, 1997, AM SURGEON, V63, P1109
   Adamu B, 2014, COCHRANE DB SYST REV, V3
   Ahn J, 2008, LIVER TRANSPLANT, V14, P1603, DOI 10.1002/lt.21534
   Albano L, 2009, CLIN INFECT DIS, V48, P194, DOI 10.1086/595688
   Alfaiate D, 2015, ANTIVIR RES, V122, P112, DOI 10.1016/j.antiviral.2015.08.009
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Andreoni M, 2001, J INFECTION, V43, P195, DOI 10.1053/jinf.2001.0899
   [Anonymous], 2013, ORG DON TRANSPL RISK
   [Anonymous], ANN NOT DIS TABL
   [Anonymous], 2011, GUID MICR SAF HUM OR
   [Anonymous], 2017, 2017 ANZOD ANN REP
   [Anonymous], 2016, AUSTR VIG SURV FRAM
   [Anonymous], 2005, CONS MED TREATM PAT
   [Anonymous], 2012, COMM DIS CONTR MAN 2
   [Anonymous], 2014, GUID HTLV 1 SCREEN C
   [Anonymous], 2013, W NIL VIR SOL ORG TR
   [Anonymous], 2016, GUID PREV TRANSM INF
   [Anonymous], 2015, EP AL NEUR SYNDR CON
   [Anonymous], WORLD DRUG REPORT 20
   [Anonymous], 2016, CDI, V40, pE285
   [Anonymous], 2018, SUMMARY INFORM OVERS
   [Anonymous], 2013, SOHO V S GUID COMP A
   [Anonymous], 2014, UN DON RISK ASS INT
   [Anonymous], 2017, ZIK VIR INF WEEKL RE
   [Anonymous], 2017, POL 15 ID TRANSM DIS
   [Anonymous], MURR VALL ENC KUNJ V
   [Anonymous], 2017, HIV VIR HEP SEX TRAN
   [Anonymous], 2017, AIDS NZ
   [Anonymous], 2009, TT VIRUSES STILL ELU
   [Anonymous], 2017, POL 2 DEC DON ORG PR
   [Anonymous], 2011, NOTIFY EXPL VIG NOT
   Antinori S, 2008, LANCET INFECT DIS, V8, P191, DOI 10.1016/S1473-3099(08)70043-4
   Ariza-Heredia EJ, 2012, TRANSPL INFECT DIS, V14, P229, DOI 10.1111/j.1399-3062.2012.00742.x
   Atsukawa M, 2017, HEPATOL RES, V47, P1429, DOI 10.1111/hepr.12910
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   BABINET J, 1991, BRIT MED J, V303, P1515, DOI 10.1136/bmj.303.6816.1515
   Baddley JW, 2011, CLIN INFECT DIS, V52, pE94, DOI 10.1093/cid/ciq216
   Bahrami T, 2008, ANN THORAC SURG, V86, P1554, DOI 10.1016/j.athoracsur.2008.07.047
   Baleriola C, 2012, TRANSPL INFECT DIS, V14, P278, DOI 10.1111/j.1399-3062.2012.00734.x
   Baleriola C, 2016, FRONT TRANSPLANTOL
   Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bangham CRM, 2000, CURR OPIN IMMUNOL, V12, P397, DOI 10.1016/S0952-7915(00)00107-2
   Barker DE, 2000, J TRAUMA, V48, P201, DOI 10.1097/00005373-200002000-00001
   Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862
   Bart A, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.30.20544
   Beknazarova M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050517
   Bell JM, 2016, COMMUN DIS INTELL, V40, pE229
   Bellandi T, 2010, TRANSPL P, V42, P2187, DOI 10.1016/j.transproceed.2010.05.034
   Ben-Youssef R, 2005, TRANSPLANTATION, V80, P997, DOI 10.1097/01.tp.0000173825.12681.eb
   Benito N, 2015, CLIN MICROBIOL INFEC, V21, P651, DOI 10.1016/j.cmi.2015.03.010
   Berenguer M, 2008, AM J TRANSPLANT, V8, P679, DOI 10.1111/j.1600-6143.2007.02126.x
   Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002
   Bharat A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8419
   Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9
   Blanes M, 2002, TRANSPLANT P, V34, P61, DOI 10.1016/S0041-1345(01)02666-5
   Blydt-Hansen T, 2014, TRANSPLANTATION, V98, P365, DOI 10.1097/TP.0000000000000251
   Boedefeld RL, 2008, J HEART LUNG TRANSPL, V27, P1176, DOI 10.1016/j.healun.2008.07.009
   Borchi B, 2010, TRANSPL P, V42, P2267, DOI 10.1016/j.transproceed.2010.05.026
   Botterel F, 2002, J CLIN MICROBIOL, V40, P1648, DOI 10.1128/JCM.40.5.1648-1650.2002
   BOWEN PA, 1988, ANN INTERN MED, V108, P46, DOI 10.7326/0003-4819-108-1-46
   Bowring MG, 2017, AM J TRANSPLANT, V17, P519, DOI 10.1111/ajt.13976
   Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   BRINER V, 1989, SCHWEIZ MED WSCHR, V119, P1046
   Brugemann J, 2010, J HEART LUNG TRANSPL, V29, P1433, DOI 10.1016/j.healun.2010.08.002
   Butler T, 2015, NATL PRISON ENTRANTS
   Caballero F, 1998, TRANSPLANTATION, V65, P598, DOI 10.1097/00007890-199802270-00029
   Caballero F, 2012, TRANSPLANTATION, V93, pE11, DOI 10.1097/TP.0b013e31823f9093
   Cahlin C, 2001, TRANSPLANT P, V33, P2467, DOI 10.1016/S0041-1345(01)02050-4
   Campbell AL, 2006, TRANSPLANTATION, V81, P408, DOI 10.1097/01.tp.0000188183.49025.d5
   CARLSEN SE, 1990, AM J ROENTGENOL, V154, P495, DOI 10.2214/ajr.154.3.2106211
   Caruana SR, 2006, J TRAVEL MED, V13, P233, DOI 10.1111/j.1708-8305.2006.00045.x
   Castells L, 1999, TRANSPLANT P, V31, P2464, DOI 10.1016/S0041-1345(99)00419-4
   Centers for Disease Control and Prevention, 2015 SEX TRANSM DIS
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1021
   Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1697
   Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P333
   Centers for Disease Control (CDC), 1987, MMWR Morb Mortal Wkly Rep, V36, P306
   Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010
   Charlton M, 2015, GASTROENTEROLOGY, V148, P108, DOI 10.1053/j.gastro.2014.10.001
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen C, 2016, TRANSPLANTATION, V100, P678, DOI 10.1097/TP.0000000000000868
   Chiche L, 2003, TRANSPLANTATION, V75, P166, DOI 10.1097/00007890-200301150-00031
   Chiereghin A, 2017, TRANSPLANTATION, V101, P1935, DOI 10.1097/TP.0000000000001740
   Chin-Hong PV, 2011, AM J TRANSPLANT, V11, P672, DOI 10.1111/j.1600-6143.2011.03444.x
   Choe J, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13022
   Coilly A, 2016, J HEPATOL, V64, P226, DOI 10.1016/j.jhep.2015.09.002
   Coll E, 2013, TRANSPLANTATION, V96, P205, DOI 10.1097/TP.0b013e3182977adf
   Colson P, 2007, EMERG INFECT DIS, V13, P648, DOI 10.3201/eid1304.061387
   Coombs GW, 2016, COMMUN DIS INTELL, V40, pE236
   Coombs GW, 2016, COMMUN DIS INTELL, V40, pE244
   Coombs GW, 2013, COMMUN DIS INTELL, V37, pE210
   Cordova S P, 2000, Commun Dis Intell, V24, P368
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cortes NJ, 2006, AM J TRANSPLANT, V6, P2497, DOI 10.1111/j.1600-6143.2006.01461.x
   Costa AN, 2011, EUROSURVEILLANCE, V16, P2
   Costa AN, 2008, TRANSPLANTATION, V85, pS52, DOI 10.1097/TP.0b013e31816c2f05
   Coster LO, 2013, INFECT DIS CLIN N AM, V27, P395, DOI 10.1016/j.idc.2013.02.008
   CRAFA F, 1991, TRANSPLANT P, V23, P2664
   Cunningham AL, 2006, SEX TRANSM INFECT, V82, P164, DOI 10.1136/sti.2005.016899
   Cura CI, 2013, AM J TRANSPLANT, V13, P3253, DOI 10.1111/ajt.12487
   Dalton CB, 2015, COMMUN DIS INTELL, V39, pE361
   Darke S, 2017, ADDICTION, V112, P2191, DOI 10.1111/add.13897
   DATRY A, 1994, T ROY SOC TROP MED H, V88, P344, DOI 10.1016/0035-9203(94)90110-4
   De Feo TM, 2005, TRANSPL P, V37, P1238, DOI 10.1016/j.transproceed.2004.12.041
   De Silva S, 2002, EPIDEMIOL INFECT, V128, P439, DOI 10.1017/S0950268801006677
   Dedicoat M, 2004, J INFECT DIS, V190, P1068, DOI 10.1086/423326
   Delladetsima I, 2006, AM J KIDNEY DIS, V47, P309, DOI 10.1053/j.ajkd.2005.11.008
   Dhillon GS, 2009, TRANSPLANTATION, V88, P842, DOI 10.1097/TP.0b013e3181b4e1fd
   Dickson RC, 1997, GASTROENTEROLOGY, V113, P1668, DOI 10.1053/gast.1997.v113.pm9352871
   Dollard SC, 2011, CLIN VACCINE IMMUNOL, V18, P1895, DOI 10.1128/CVI.05228-11
   Douglas D D, 1997, Liver Transpl Surg, V3, P105, DOI 10.1002/lt.500030202
   Duan KI, 2010, AM J TRANSPLANT, V10, P416, DOI 10.1111/j.1600-6143.2009.02931.x
   Dubey J. P., 1988, TOXOPLASMOSIS ANIMAL
   Dummer JS, 2004, J HEART LUNG TRANSPL, V23, P1376, DOI 10.1016/j.healun.2003.09.028
   Durand C, 2017, AM J TRANSPLANT, V17
   Edathodu J, 2010, INT J TUBERC LUNG D, V14, P1493
   Einsiedel LJ, 2010, EMERG INFECT, V9, P109
   Einsiedel L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3366-5
   Einsiedel LJ, 2016, MED J AUSTRALIA, V205, P305, DOI 10.5694/mja16.00285
   ERICE A, 1991, REV INFECT DIS, V13, P537
   European Centre for Disease Prevention and Control, 2013, CARB PROD BACT EUR I
   European Centre for Disease Prevention and Control, 2014, ANN EP REP ANT RES H
   European Centre for Disease Prevention and Control (EDC), 2016, ZIK VIR SAF SUBST HU
   European Directorate for the Quality of Medicines and Healthcare of the Council of Europe, 2016, GUID QUAL SAF ORG TR
   Fabrizi F, 2002, J NEPHROL, V15, P605
   Farci P, 2012, SEMIN LIVER DIS, V32, P228, DOI 10.1055/s-0032-1323628
   Ferenci P, 2006, J HEPATOL, V44, P275, DOI 10.1016/j.jhep.2005.09.015
   Fernandez R, 2017, ANN THORAC SURG, V103, P670, DOI 10.1016/j.athoracsur.2016.09.026
   Fernandez-Sabe N, 2012, CLIN INFECT DIS, V54, P355, DOI 10.1093/cid/cir806
   Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005
   File E, 2003, TRANSPLANTATION, V76, P1096, DOI 10.1097/01.TP.0000088663.76640.C9
   Fischer L, 1999, CLIN TRANSPLANT, V13, P491, DOI 10.1034/j.1399-0012.1999.130609.x
   Fischer SA, 2013, AM J TRANSPLANT, V13, P9, DOI 10.1111/ajt.12094
   Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240
   FISHER D, 1993, MED J AUSTRALIA, V159, P88, DOI 10.5694/j.1326-5377.1993.tb137741.x
   Fishman JA, 2012, CLIN INFECT DIS, V55, P720, DOI 10.1093/cid/cis519
   Fitzsimmons GJ, 2010, COMMUN DIS INTELL, V34, P225
   Fitzsimmons GJ, 2009, COMMUN DIS INTELL, V33, P155
   Fong TL, 2002, TRANSPLANTATION, V73, P85, DOI 10.1097/00007890-200201150-00016
   Forns X, 2015, HEPATOLOGY, V61, P1485, DOI 10.1002/hep.27681
   Freeman RB, 1999, TRANSPLANTATION, V68, P1107, DOI 10.1097/00007890-199910270-00008
   Furukawa Y, 2000, J INFECT DIS, V182, P1343, DOI 10.1086/315897
   Fytili P, 2006, TRANSPLANTATION, V81, P808, DOI 10.1097/01.tp.0000198585.51562.57
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gane EJ, 2007, GASTROENTEROLOGY, V132, P931, DOI 10.1053/j.gastro.2007.01.005
   GANN PH, 1994, J INFECT DIS, V169, P1076, DOI 10.1093/infdis/169.5.1076
   Garzoni C, 2011, TRANSPLANTATION, V92, P1297, DOI 10.1097/TP.0b013e318236cd02
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   GIBEL LJ, 1987, J UROLOGY, V138, P1226, DOI 10.1016/S0022-5347(17)43558-0
   Giordano LFC, 2002, TRANSPL P, V34, P498, DOI 10.1016/S0041-1345(02)02607-6
   Gish R G, 1996, Liver Transpl Surg, V2, P161, DOI 10.1002/lt.500020213
   Goldberg DS, 2016, AM J TRANSPLANT, V16, P2836, DOI 10.1111/ajt.13971
   Goldberg DS, 2017, NEW ENGL J MED, V376, P2394, DOI 10.1056/NEJMc1705221
   Goldberg E, 2012, TRANSPL INFECT DIS, V14, P296, DOI 10.1111/j.1399-3062.2011.00697.x
   Gomez AJ, 2015, J CLIN MICROBIOL, V53, P2749, DOI 10.1128/JCM.00834-15
   Gordon EJ, 2017, TRANSPLANTATION, V101, P1167, DOI 10.1097/TP.0000000000001273
   Gordon FD, 2012, J CLIN GASTROENTEROL, V46, P700, DOI 10.1097/MCG.0b013e31825833be
   Gotuzzo E, 1999, AM J TROP MED HYG, V60, P146, DOI 10.4269/ajtmh.1999.60.146
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   GOUT O, 1990, NEW ENGL J MED, V322, P383, DOI 10.1056/NEJM199002083220607
   Gow PJ, 2001, QJM-MON J ASSOC PHYS, V94, P271, DOI 10.1093/qjmed/94.5.271
   Green M, 2015, TRANSPLANTATION, V99, P282, DOI 10.1097/TP.0000000000000584
   Grivas R, 2014, PATHOLOGY, V46, P644, DOI 10.1097/PAT.0000000000000164
   GROVE DI, 1980, BRIT MED J, V280, P598, DOI 10.1136/bmj.280.6214.598
   Ha J, 2017, J CLIN VIROL, V96, P60, DOI 10.1016/j.jcv.2017.09.010
   Hamilton KW, 2011, TRANSPLANTATION, V91, P1019, DOI 10.1097/TP.0b013e3182115b7b
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Hartwig MG, 2005, TRANSPLANTATION, V80, P320, DOI 10.1097/01.tp.0000165858.86067.a2
   Hayashi J, 1997, AM J TROP MED HYG, V56, P71, DOI 10.4269/ajtmh.1997.56.71
   Heidrich B, 2009, J VIRAL HEPATITIS, V16, P883, DOI 10.1111/j.1365-2893.2009.01144.x
   Heidrich B, 2013, CURR INFECT DIS REP, V15, P31, DOI 10.1007/s11908-012-0307-z
   Hermanns B, 2001, PATHOL RES PRACT, V197, P211, DOI 10.1078/0344-0338-00036
   Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5
   Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   HOLZER BR, 1985, TRANSPLANTATION, V39, P315, DOI 10.1097/00007890-198503000-00023
   Hommann M, 2002, TRANSPLANT P, V34, P2294, DOI 10.1016/S0041-1345(02)03241-4
   HORBER FF, 1993, TRANSPLANT INT, V6, P55, DOI 10.1111/j.1432-2277.1993.tb00747.x
   HOY WE, 1981, JAMA-J AM MED ASSOC, V246, P1937, DOI 10.1001/jama.246.17.1937
   HUANG CC, 1993, TRANSPLANT P, V25, P1474
   Huang RC, 2011, TRANSPLANTATION, V91, P146, DOI 10.1097/TP.0b013e3181ffb9bb
   Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9
   Humar A., 2011, Morbidity and Mortality Weekly Report, V60, P172
   Humar A, 2010, AM J TRANSPLANT, V10, P889, DOI 10.1111/j.1600-6143.2009.02992.x
   Huprikar S, 2015, AM J TRANSPLANT, V15, P1162, DOI 10.1111/ajt.13187
   Ijaz S, 2014, J INFECT DIS, V209, P1212, DOI 10.1093/infdis/jit652
   Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005
   Inojosa WO, 2012, INFECTION, V40, P557, DOI 10.1007/s15010-012-0263-4
   Institute of Environmental Science and Research Ltd, 2017, NOT DIS NZ ANN REP 2
   Ison MG, 2013, AM J TRANSPLANT, V13, P22, DOI 10.1111/ajt.12095
   Ison MG, 2011, AM J TRANSPLANT, V11, P1218, DOI 10.1111/j.1600-6143.2011.03597.x
   Ison MG, 2011, AM J TRANSPLANT, V11, P1123, DOI 10.1111/j.1600-6143.2011.03493.x
   Ison MG, 2009, AM J TRANSPLANT, V9, P1929, DOI 10.1111/j.1600-6143.2009.02700.x
   Issa NC, 2002, LIVER TRANSPLANT, V8, P977, DOI 10.1053/jlts.2002.0080977
   Ivanovski N, 2005, TRANSPLANT P, V37, P563, DOI 10.1016/j.transproceed.2004.12.139
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848
   Jensen TO, 2016, TRANSPL INFECT DIS, V18, P782, DOI 10.1111/tid.12580
   Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182
   JOHNSTON IDA, 1981, BRIT MED J, V282, P780, DOI 10.1136/bmj.282.6266.780
   Joseph P, 2002, J CLIN MICROBIOL, V40, P4499, DOI 10.1128/JCM.40.12.4499-4503.2002
   KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185
   Kanj SS, 1996, MEDICINE, V75, P142, DOI 10.1097/00005792-199605000-00004
   Kasprzyk T, 2007, TRANSPL P, V39, P2701, DOI 10.1016/j.transproceed.2007.09.021
   Kaul DR, 2010, AM J TRANSPLANT, V10, P207, DOI 10.1111/j.1600-6143.2009.02867.x
   Kaul DR, 2014, TRANSPLANTATION, V98, P666, DOI 10.1097/TP.0000000000000117
   Kawano N, 2006, TRANSPLANTATION, V82, P840, DOI 10.1097/01.tp.0000235186.30113.c7
   Keating MR, 1996, CHEST, V109, P1119, DOI 10.1378/chest.109.4.1119
   Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004
   Khuroo MS, 2016, J VIRAL HEPATITIS, V23, P68, DOI 10.1111/jvh.12445
   Khuroo MS, 2016, WORLD J GASTROENTERO, V22, P7030, DOI 10.3748/wjg.v22.i31.7030
   Kiberd BA, 2004, AM J TRANSPLANT, V4, P1296, DOI 10.1111/j.1600-6143.2004.00519.x
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kirwan PD, 2016, HIV UK2016 REPORT, P2016
   Klug GM, 2016, COMMUN DIS INTELL, V40, pE368
   Knope K, 2013, COMMUN DIS INTELL, V37, pE1
   Knope KE, 2016, COMMUN DIS INTELL, V40, pE401
   Knope KE, 2014, COMMUN DIS INTELL, V38, pE122
   Ko WJ, 1998, TRANSPLANT P, V30, P3667, DOI 10.1016/S0041-1345(98)01185-3
   Ko WJ, 2001, J HEART LUNG TRANSPL, V20, P865, DOI 10.1016/S1053-2498(01)00280-7
   Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d
   Kotton CN, 2016, TRANSPLANTATION, V100, P970, DOI 10.1097/TP.0000000000001179
   Kovacs Christopher S Jr, 2014, World J Transplant, V4, P43, DOI 10.5500/wjt.v4.i2.43
   KRAJDEN M, 1995, CLIN DIAGN VIROL, V3, P113, DOI 10.1016/0928-0197(94)00031-O
   Kucirka LM, 2015, AM J TRANSPLANT, V15, P3215, DOI 10.1111/ajt.13356
   Kucirka LM, 2011, AM J TRANSPLANT, V11, P1176, DOI 10.1111/j.1600-6143.2010.03329.x
   Kucirka LM, 2011, AM J TRANSPLANT, V11, P1188, DOI 10.1111/j.1600-6143.2011.03460.x
   Kucirka LM, 2011, ARCH SURG-CHICAGO, V146, P41, DOI 10.1001/archsurg.2010.303
   Kumar D, 2005, AM J TRANSPLANT, V5, P2031, DOI 10.1111/j.1600-6143.2005.00971.x
   Kumar D, 2013, AM J TRANSPLANT, V13, P2225, DOI 10.1111/ajt.12344
   Kumar D, 2010, AM J TRANSPLANT, V10, P18, DOI 10.1111/j.1600-6143.2009.02960.x
   Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921
   LAI PK, 1975, J HYG-CAMBRIDGE, V74, P329, DOI 10.1017/S0022172400046842
   LAMMERMEIER DE, 1990, ANN THORAC SURG, V50, P222, DOI 10.1016/0003-4975(90)90738-R
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lanini S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123706
   Lattes R, 2010, TRANSPL P, V42, P3354, DOI 10.1016/j.transproceed.2010.09.019
   Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9
   Le M, 2014, AM J TRANSPLANT, V14, P1199, DOI 10.1111/ajt.12670
   Le Page AK, 2010, TRANSPLANTATION, V90, P99, DOI 10.1097/TP.0b013e3181da1933
   Lebbe C, 2013, AM J TRANSPLANT, V13, P207, DOI 10.1111/j.1600-6143.2012.04290.x
   Lee AS, 2018, INFECT CONT HOSP EP, V39, P668, DOI 10.1017/ice.2018.29
   Lee J, 2003, J HEART LUNG TRANSPL, V22, P1168, DOI 10.1016/S1053-2498(02)01189-0
   Lempp FA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070172
   Leroy V, 2015, CLIN GASTROENTEROL H, V13, P1993, DOI 10.1016/j.cgh.2015.05.030
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Levitsky J, 2013, AM J TRANSPLANT, V13, P147, DOI 10.1111/ajt.12108
   Levitsky J, 2017, AM J TRANSPLANT
   Levitsky J, 2012, GASTROENTEROLOGY, V142, P1132, DOI 10.1053/j.gastro.2012.01.030
   Lewis James S Jr, 2002, Expert Rev Mol Diagn, V2, P616
   Lichtenstein GR, 2000, ANN INTERN MED, V132, P283, DOI 10.7326/0003-4819-132-4-200002150-00006
   LIU LX, 1993, INFECT DIS CLIN N AM, V7, P655
   Ljungman P, 2016, TRANSPLANT INFECT
   LopezNavidad A, 1997, TRANSPLANTATION, V64, P365
   Lumb R, 2014, COMMUN DIS INTELL, V38, pE369
   Lumbreras C, 2001, CLIN INFECT DIS, V33, P722, DOI 10.1086/322599
   Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905
   Luppi M, 2000, BLOOD, V96, P3279
   Luppi M, 2002, TRANSPLANTATION, V74, P131, DOI 10.1097/00007890-200207150-00023
   LUTWICK LI, 1983, CLIN NEPHROL, V19, P317
   Macesic N, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12739
   MACKENZIE JS, 1993, MED J AUSTRALIA, V158, P591, DOI 10.5694/j.1326-5377.1993.tb137623.x
   Madayag RM, 1997, TRANSPLANTATION, V64, P1781, DOI 10.1097/00007890-199712270-00027
   Magiorkinis E, 2013, TRANSPL INFECT DIS, V15, P393, DOI 10.1111/tid.12094
   Mahony AA, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0335-z
   Malone A, 2007, IRISH J MED SCI, V176, P233, DOI 10.1007/s11845-007-0048-4
   Marcelin AG, 2004, LIVER TRANSPLANT, V10, P295, DOI 10.1002/lt.20058
   Marek A, 2012, SEX TRANSM DIS, V39, P485, DOI 10.1097/OLQ.0b013e318249db35
   Marelli D, 2002, AM J TRANSPLANT, V2, P443, DOI 10.1034/j.1600-6143.2002.20508.x
   Mari JMPI, 2000, TRANSPL P, V32, P75
   Martin-Davila P, 2008, CLIN MICROBIOL REV, V21, P60, DOI 10.1128/CMR.00021-07
   Martina MN, 2011, TRANSPL INT, V24, pe6, DOI 10.1111/j.1432-2277.2010.01173.x
   Martins N, 2012, TRANSPL INFECT DIS, V14, P316, DOI 10.1111/j.1399-3062.2011.00701.x
   Marty FM, 2005, CLIN INFECT DIS, V41, pE5, DOI 10.1086/430827
   Marvin MR, 2009, TRANSPLANTATION, V87, P1180, DOI 10.1097/TP.0b013e31819ebf76
   MASON JC, 1987, TRANSPLANTATION, V44, P588, DOI 10.1097/00007890-198710000-00031
   Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x
   McPherson S, 2018, TRANSPLANTATION, V102, P15, DOI 10.1097/TP.0000000000001908
   Meylan PRA, 2007, TRANSPL INFECT DIS, V9, P55, DOI 10.1111/j.1399-3062.2006.00175.x
   Miller R, 2015, AM J TRANSPLANT, V15, P259, DOI 10.1111/ajt.12978
   MILLER RA, 1995, AM J RESP CRIT CARE, V152, P374, DOI 10.1164/ajrccm.152.1.7599848
   Minhas V, 2014, VIRUSES-BASEL, V6, P4178, DOI 10.3390/v6114178
   Mitchell AB, 2016, AM J RESP CRIT CARE, V194, P1458, DOI 10.1164/rccm.201606-1278CI
   Rueda MJM, 2013, GASTROENT HEPAT-BARC, V36, P546, DOI 10.1016/j.gastrohep.2013.03.003
   Moraleda G, 2006, AM J TRANSPLANT, V6, P438, DOI 10.1111/j.1600-6143.2005.01189.x
   Morelli MC, 2010, CLIN INFECT DIS, V51, pE34, DOI 10.1086/655146
   Morris MI, 2012, AM J TRANSPLANT, V12, P2288, DOI 10.1111/j.1600-6143.2012.04205.x
   Mortensen E, 2014, TRANSPL INFECT DIS, V16, P67, DOI 10.1111/tid.12171
   MOURAD G, 1985, NEPHRON, V41, P82, DOI 10.1159/000183552
   Mueller NJ, 2010, TRANSPL INFECT DIS, V12, P54, DOI 10.1111/j.1399-3062.2009.00463.x
   Mukhopadhyay P, 2012, Indian J Nephrol, V22, P133, DOI 10.4103/0971-4065.97135
   Mularoni A, 2015, AM J TRANSPLANT, V15, P2674, DOI 10.1111/ajt.13317
   Muller E, 2015, NEW ENGL J MED, V372, P613, DOI 10.1056/NEJMoa1408896
   Murray HW, 2012, AM J TROP MED HYG, V86, P434, DOI 10.4269/ajtmh.2012.11-0682
   Nakamura N, 2005, TRANSPL P, V37, P1779, DOI 10.1016/j.transproceed.2005.03.132
   Nakamura N, 1998, TRANSPLANT P, V30, P1324, DOI 10.1016/S0041-1345(98)00261-9
   Nakashima K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-43
   Nampoory MRN, 1999, TRANSPLANT P, V31, P3207, DOI 10.1016/S0041-1345(99)00691-0
   Natov S N, 2002, Transpl Infect Dis, V4, P117, DOI 10.1034/j.1399-3062.2002.t01-1-01002.x
   Nery JR, 2003, TRANSPLANTATION, V75, P1179, DOI 10.1097/01.TP.0000065283.98275.FE
   Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x
   Newall AT, 2008, VACCINE, V26, P2135, DOI 10.1016/j.vaccine.2008.01.051
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Northup PG, 2010, TRANSPL INT, V23, P1038, DOI 10.1111/j.1432-2277.2010.01092.x
   Noureddin Mazen, 2014, Curr Gastroenterol Rep, V16, P365, DOI 10.1007/s11894-013-0365-x
   NSW Health, 2017, NSW HIV STRAT 2016 2
   O'Callaghan G, 2009, GUIDELINE ASSESSING
   O'Connor P, 2016, NEW ZEAL MED J, V129, P44
   OOI BS, 1971, TRANSPLANTATION, V11, P428, DOI 10.1097/00007890-197104000-00018
   Orlando G, 2009, TRANSPL INFECT DIS, V11, P442, DOI 10.1111/j.1399-3062.2009.00412.x
   Owen SM, 2012, CURR OPIN HIV AIDS, V7, P125, DOI 10.1097/COH.0b013e3283506613
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Palau LA, 1997, AM J TROP MED HYG, V57, P413, DOI 10.4269/ajtmh.1997.57.413
   Pan American Health Organization/World Health Organization, 2017, ZIK EP UPD
   Park YJ, 2017, KOREAN J INTERN MED, V32, P750, DOI 10.3904/kjim.2015.124
   Parry J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6523
   Patel G, 2008, TRANSPL INFECT DIS, V10, P137, DOI 10.1111/j.1399-3062.2007.00256.x
   PEREIRA BJG, 1995, LANCET, V345, P484, DOI 10.1016/S0140-6736(95)90583-9
   PEREIRA BJG, 1994, KIDNEY INT, V46, P886, DOI 10.1038/ki.1994.346
   PEREIRA BJG, 1991, NEW ENGL J MED, V325, P454, DOI 10.1056/NEJM199108153250702
   Peters CJ, 1995, EXOTIC VIRAL INFECT
   PETERS TG, 1984, TRANSPLANTATION, V38, P514, DOI 10.1097/00007890-198411000-00015
   Pietrosi G, 2011, AM J TRANSPLANT, V11, P2715, DOI 10.1111/j.1600-6143.2011.03769.x
   Pilmore H, 2009, TRANSPLANTATION, V88, P762, DOI 10.1097/TP.0b013e3181b4749f
   Pilmore HL, 2012, TRANSPLANTATION, V94, P205, DOI 10.1097/TP.0b013e31824e3db4
   Pinazo MJ, 2011, TRANSPLANT REV-ORLAN, V25, P91, DOI 10.1016/j.trre.2010.12.002
   Pinney SP, 2005, J HEART LUNG TRANSPL, V24, P34, DOI 10.1016/j.healun.2003.09.036
   POLI F, 1989, TRANSPLANTATION, V47, P725
   Prieto M, 2001, LIVER TRANSPLANT, V7, P51, DOI 10.1053/jlts.2001.20786
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   PROCIV P, 1993, MED J AUSTRALIA, V158, P160, DOI 10.5694/j.1326-5377.1993.tb121693.x
   Pruett TL, 2017, TRANSPLANTATION, V101, P1670, DOI 10.1097/TP.0000000000001716
   Pungpapong S, 2015, HEPATOLOGY, V61, P1880, DOI 10.1002/hep.27770
   Quagliarello VJ, 1997, NEW ENGL J MED, V336, P708, DOI 10.1056/NEJM199703063361007
   Rabe IB, 2013, TRANSPLANTATION, V96, P463, DOI 10.1097/TP.0b013e31829b4142
   Rahmanian H, 2015, AUST NZ J PUBL HEAL, V39, P331, DOI 10.1111/1753-6405.12360
   Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014
   Reddy KR, 2017, HEPATOL RES, V47, P1340, DOI 10.1111/hepr.12899
   Reese PP, 2015, NEW ENGL J MED, V373, P303, DOI 10.1056/NEJMp1505074
   Regamey N, 1998, NEW ENGL J MED, V339, P1358, DOI 10.1056/NEJM199811053391903
   Renoult E, 1997, CLIN INFECT DIS, V24, P625, DOI 10.1093/clind/24.4.625
   Rhee C, 2011, TRANSPL INFECT DIS, V13, P312, DOI 10.1111/j.1399-3062.2010.00595.x
   Ridgeway AL, 1996, AM J RESP CRIT CARE, V153, P1166, DOI 10.1164/ajrccm.153.3.8630561
   Rizzetto M, 2012, SEMIN LIVER DIS, V32, P211, DOI 10.1055/s-0032-1323626
   Roberts T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119212
   Rodriguez-Hernandez MJ, 2009, AM J TRANSPLANT, V9, P2637, DOI 10.1111/j.1600-6143.2009.02828.x
   Rogers NM, 2008, TRANSPL INFECT DIS, V10, P71, DOI 10.1111/j.1399-3062.2007.00244.x
   Roseman DA, 2013, AM J TRANSPLANT, V13, P2483, DOI 10.1111/ajt.12390
   Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9
   Roxby AC, 2009, CLIN INFECT DIS, V49, P1411, DOI 10.1086/630201
   Ruiz I, 2006, AM J TRANSPLANT, V6, P178, DOI 10.1111/j.1600-6143.2005.01145.x
   Russell DB, 2001, J CLIN VIROL, V22, P305, DOI 10.1016/S1386-6532(01)00203-7
   Saberi B, 2018, LIVER TRANSPLANT, V24, P140, DOI 10.1002/lt.24838
   Salvador F, 2011, LIVER TRANSPLANT, V17, P1304, DOI 10.1002/lt.22346
   Sampaio MS, 2012, NEPHROL DIAL TRANSPL, V27, P2971, DOI 10.1093/ndt/gfr769
   SAMUEL D, 1988, LANCET, V1, P1221
   SATO Y, 1995, AM J TROP MED HYG, V53, P248, DOI 10.4269/ajtmh.1995.53.248
   Satoi S, 2001, TRANSPLANTATION, V72, P1108, DOI 10.1097/00007890-200109270-00022
   Saxena V, 2016, LIVER INT, V36, P807, DOI 10.1111/liv.13102
   Schlosser B, 2012, J HEPATOL, V56, P500, DOI 10.1016/j.jhep.2011.06.021
   Schulman LL, 1997, CHEST, V111, P1459, DOI 10.1378/chest.111.5.1459
   Schussler T, 2004, AM J TRANSPLANT, V4, P1375, DOI 10.1111/j.1600-6143.2004.00504.x
   Schwartz BS, 2013, AM J TRANSPLANT, V13, P280, DOI 10.1111/ajt.12120
   Schwartz BS, 2011, AM J TRANSPLANT, V11, P848, DOI 10.1111/j.1600-6143.2011.03436.x
   SCHWARZ A, 1987, TRANSPLANTATION, V44, P21, DOI 10.1097/00007890-198707000-00006
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Seale H, 2006, CLIN VACCINE IMMUNOL, V13, P1181, DOI 10.1128/CVI.00203-06
   Seem DL, 2013, PUBLIC HEALTH REP, V128, P247, DOI 10.1177/003335491312800403
   Selzner N, 2011, J HEPATOL, V55, P207, DOI 10.1016/j.jhep.2010.11.012
   Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832
   Setyapranata S, 2015, NEPHROLOGY, V20, P17, DOI 10.1111/nep.12423
   Shadur B, 2013, INTERN MED J, V43, P1081, DOI 10.1111/imj.12247
   Shaheen MA, 2015, WORLD J HEPATOL, V7, P616, DOI 10.4254/wjh.v7.i3.616
   Shames BD, 2002, AM J TRANSPLANT, V2, P658, DOI 10.1034/j.1600-6143.2002.20712.x
   Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12
   Shitrit ABG, 2006, ANN THORAC SURG, V81, P1851, DOI 10.1016/j.athoracsur.2005.12.026
   Shitrit D, 2004, THORAX, V59, P79
   Sho T, 2018, HEPATOL RES
   Shoham S, 2010, TRANSPL INFECT DIS, V12, P371, DOI 10.1111/j.1399-3062.2010.00498.x
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Simkins J, 2012, TRANSPL INFECT DIS, V14, P292, DOI 10.1111/j.1399-3062.2011.00674.x
   SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102
   Singh N, 2013, AM J TRANSPLANT, V13, P361, DOI 10.1111/ajt.12128
   Singh N, 2012, AM J TRANSPLANT, V12, P2414, DOI 10.1111/j.1600-6143.2012.04100.x
   Singh N, 2002, LIVER TRANSPLANT, V8, P975, DOI 10.1053/jlts.2002.0080975
   Singh N, 1998, CLIN INFECT DIS, V27, P1266, DOI 10.1086/514993
   SKOGBERG K, 1992, CLIN INFECT DIS, V14, P815, DOI 10.1093/clinids/14.4.815
   Soyama A, 2008, LIVER TRANSPLANT, V14, P647, DOI 10.1002/lt.21414
   Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018
   Stafford J, 2017, AUSTR DRUG TREND SER, V163
   Stafford J., 2015, AUSTR DRUG TREND SER, V127
   Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263
   Steinmann J, 2009, J HEART LUNG TRANSPL, V28, P857, DOI 10.1016/j.healun.2009.04.029
   Stewart DE, 2015, AM J TRANSPLANT, V15, P3123, DOI 10.1111/ajt.13528
   Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197
   Suarez-Benjumea A, 2015, TRANSPL P, V47, P2672, DOI 10.1016/j.transproceed.2015.09.047
   Subramonia S, 2009, WORLD J SURG, V33, P931, DOI 10.1007/s00268-009-9947-z
   Suda G, 2017, HEPATOL RES, V47, P1127, DOI 10.1111/hepr.12851
   Sullivan Sheena G, 2016, Commun Dis Intell Q Rep, V40, pE351
   Sun HY, 2009, CLIN INFECT DIS, V48, P1566, DOI 10.1086/598936
   Suryaprasad A, 2015, AM J TRANSPLANT, V15, P1827, DOI 10.1111/ajt.13283
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   TAN H W, 1991, SMJ Singapore Medical Journal, V32, P189
   Tan HH, 2011, CASE REP TRANSPLANT, V2011
   Tanabe K, 1998, TRANSPLANT P, V30, P3168, DOI 10.1016/S0041-1345(98)00980-4
   Tariciotti L, 2012, TRANSPL INFECT DIS, V14, P321, DOI 10.1111/j.1399-3062.2012.00745.x
   Terrault NA, 2012, LIVER TRANSPLANT, V18, P716, DOI 10.1002/lt.23411
   Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943
   The Institute of Environmental Science and Research Ltd, 2015, SEX TRANSM INF NZ AN
   The Kirby Institute, 2015, HIV VIR HEP SEX TRAN, P2052
   The Transplantation Society of Australia, 2016, CLIN GUID ORG TRANSP
   Theodoropoulos N, 2016, DONOR DERIVED INFECT
   Theodoropoulos N, 2015, TRANSPLANTATION, V99, P438, DOI 10.1097/TP.0000000000000323
   Thomas MC, 1998, INT J CLIN PRACT, V52, P520
   Tillmann HL, 2006, AM J TRANSPLANT, V6, P1980, DOI 10.1111/j.1600-6143.2006.01421.x
   Toms C, 2015, COMMUN DIS INTELL, V39, pE217
   Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6
   Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920
   Toro C, 2005, J MED VIROL, V76, P268, DOI 10.1002/jmv.20331
   Toro C, 2003, TRANSPLANTATION, V75, P102, DOI 10.1097/00007890-200301150-00019
   Trotter PB, 2017, TRANSPLANTATION, V101, P1679, DOI 10.1097/TP.0000000000001727
   TSE N, 1991, AM J HEMATOL, V38, P140, DOI 10.1002/ajh.2830380213
   TSURUMI H, 1992, AM J HEMATOL, V41, P292, DOI 10.1002/ajh.2830410414
   Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008
   Turbett SE, 2016, DIAGNOSTIC TESTING G
   TURIK MA, 1992, J HEART LUNG TRANSPL, V11, P781
   TZAKIS AG, 1990, TRANSPLANTATION, V49, P354, DOI 10.1097/00007890-199002000-00025
   van de Laar MJW, 1998, INT J EPIDEMIOL, V27, P127, DOI 10.1093/ije/27.1.127
   van Duin D, 2013, AM J TRANSPLANT, V13, P31, DOI 10.1111/ajt.12096
   van Hal SJ, 2017, J ANTIMICROB CHEMOTH, V72, P998, DOI 10.1093/jac/dkw539
   Vargas HE, 1999, GASTROENTEROLOGY, V117, P149, DOI 10.1016/S0016-5085(99)70561-5
   Verna EC, 2018, LIVER TRANSPLANT, V24, P12, DOI 10.1002/lt.24985
   Vijgen S, 2016, TRANSPLANTATION, V100, P134, DOI 10.1097/TP.0000000000000801
   Villa E, 2007, EURO SURVEILL, V12
   Volk ML, 2017, TRANSPLANTATION, V101, P1666, DOI 10.1097/TP.0000000000001673
   WACHS ME, 1995, TRANSPLANTATION, V59, P230
   Waller K, 2017, TRANSPLANTATION SOC
   WALPOLE IR, 1991, MED J AUSTRALIA, V154, P720, DOI 10.5694/j.1326-5377.1991.tb121307.x
   Watkins AC, 2012, TRANSPL INFECT DIS, V14, P311, DOI 10.1111/j.1399-3062.2011.00712.x
   Weile J, 2013, INT J MED MICROBIOL, V303, P449, DOI 10.1016/j.ijmm.2013.06.005
   Wendt JM, 2014, AM J TRANSPLANT, V14, P2633, DOI 10.1111/ajt.12898
   White SL, 2017, TRANSPLANTATION, V101, P1518, DOI 10.1097/TP.0000000000001718
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Winston DJ, 2014, TRANSPLANTATION, V97, P881, DOI 10.1097/TP.0000000000000024
   Winthrop KL, 2004, AM J TRANSPLANT, V4, P1529, DOI 10.1111/j.1600-6143.2004.00536.x
   WOLF JL, 1979, ANN INTERN MED, V91, P412, DOI 10.7326/0003-4819-91-3-412
   Wolfe C, 2017, AM J TRANSPLANT, V17, P365
   Wong CF, 2008, RESPIROLOGY, V13, P903, DOI 10.1111/j.1440-1843.2008.01360.x
   World Health Organization, LEISHM EP SIT
   Wright P, 2012, COMMUN DIS INTELL, V36, P70
   Wu TJ, 2008, TRANSPL P, V40, P2486, DOI 10.1016/j.transproceed.2008.07.039
   Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735
   Xiao N, 2010, HEPATIC MED-EVID RES, V2, P99
   Yango AF, 2014, TRANSPLANTATION, V97, P953, DOI 10.1097/01.TP.0000438621.81686.ab
   Yao F, 2007, AM J TRANSPLANT, V7, P2723, DOI 10.1111/j.1600-6143.2007.02012.x
   YENEN OS, 1994, NEPHROL DIAL TRANSPL, V9, P1805
   Young JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/ajt.13031
   ZANKE BW, 1989, TRANSPLANTATION, V48, P695
   Zoll J, 2015, J CLIN VIROL, V66, P6, DOI 10.1016/j.jcv.2015.02.010
NR 462
TC 9
Z9 10
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2373-8731
J9 TRANSPLANT DIRECT
JI Transplant. Direct.
PD JAN
PY 2019
VL 5
IS 1
AR e416
DI 10.1097/TXD.0000000000000852
PG 91
WC Transplantation
SC Transplantation
GA HL9KZ
UT WOS:000459063000005
PM 30656214
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khan, MA
   Ullah, S
   Farhan, M
AF Khan, Muhammad Altaf
   Ullah, Saif
   Farhan, Muhammad
TI The dynamics of Zika virus with Caputo fractional derivative
SO AIMS MATHEMATICS
LA English
DT Article
DE Zika virus model; stability analysis; generalized mean value theorem;
   Lyapunov function; Caputo derivative; numerical results
ID MODELS
AB In the present paper, we investigate a fractional model in Caputo sense to explore the dynamics of the Zika virus. The basic results of the fractional Zika model are presented. The local and global stability analysis of the proposed model is obtained when the basic reproduction reproduction number is less or greater than I. ID show the global stability of the fractional Zika model, we use the Lyapunov function theory in fractional environment. Further, we simulate the fractional Zika model to present the graphical results for different values of fractional order and model parameters.
C1 [Khan, Muhammad Altaf] City Univ Sci & Informat Technol, Dept Math, Peshawar, KP, Pakistan.
   [Ullah, Saif] Univ Peshawar, Dept Math, Peshawar, KP, Pakistan.
   [Farhan, Muhammad] Abdul Wali Khan Univ, Dept Math, Mardan, KP, Pakistan.
RP Khan, MA (corresponding author), City Univ Sci & Informat Technol, Dept Math, Peshawar, KP, Pakistan.
EM altafdir@gmail.com
RI Khan, Muhammad Altaf/K-2201-2013
OI Khan, Muhammad Altaf/0000-0002-4483-7879
CR Alkahtani BST, 2017, J NONLINEAR SCI APPL, V10, P3191, DOI 10.22436/jnsa.010.06.32
   Antosiewicz H. A., 1977, STUDIES ORDINARY DIF
   Atangana A, 2016, THERM SCI, V20, P763, DOI 10.2298/TSCI160111018A
   Bas E, 2018, CHAOS SOLITON FRACT, V116, P121, DOI 10.1016/j.chaos.2018.09.019
   Bas E, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1803-8
   Bas E, 2015, ACTA SCI-TECHNOL, V37, P251, DOI 10.4025/actascitechnol.v37i2.17273
   Bas E, 2013, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2013-300
   Bonyah E., 2016, ASIAN PACIFIC J TROP, V6, P637
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CAPUTO M, 2015, PROGR FRACT DIFFER A, V1, P1, DOI DOI 10.12785/PFDA/010201
   Delavari H, 2012, NONLINEAR DYNAM, V67, P2433, DOI 10.1007/s11071-011-0157-5
   Elsaka H., 2016, BIORXIV
   Khan MA, 2018, CHAOS SOLITON FRACT, V116, P227, DOI 10.1016/j.chaos.2018.09.039
   Kucharski A. J., 2016, PLOS NEGLECT TROP D, V10, P38588
   Lin W, 2007, J MATH ANAL APPL, V332, P709, DOI 10.1016/j.jmaa.2006.10.040
   Odibat ZM, 2007, APPL MATH COMPUT, V186, P286, DOI 10.1016/j.amc.2006.07.102
   Owolabi KM, 2018, CHAOS SOLITON FRACT, V111, P119, DOI 10.1016/j.chaos.2018.04.019
   Owolabi KM, 2017, CHAOS SOLITON FRACT, V103, P544, DOI 10.1016/j.chaos.2017.07.013
   Owolabi KM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3295-x
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Podlubny I., 1998, FRACTIONAL DIFFERENT, V198
   SAMKO S. G., 1993, FRACTIONAL INTEGRALS
   Ullah S, 2018, CHAOS SOLITON FRACT, V116, P63, DOI 10.1016/j.chaos.2018.09.001
   Ullah S, 2018, EUR PHYS J PLUS, V133, DOI 10.1140/epjp/i2018-12072-4
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vargas-De-Leon C, 2015, COMMUN NONLINEAR SCI, V24, P75, DOI 10.1016/j.cnsns.2014.12.013
   WHO, ZIK VIR
NR 28
TC 11
Z9 11
U1 2
U2 2
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
EI 2473-6988
J9 AIMS MATH
JI AIMS Math.
PY 2019
VL 4
IS 1
BP 134
EP 146
DI 10.3934/Math.2019.1.134
PG 13
WC Mathematics, Applied; Mathematics
SC Mathematics
GA HL9VQ
UT WOS:000459091100010
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wright, JK
   Castellani, L
   Lecce, C
   Khatib, A
   Bonta, M
   Boggild, AK
AF Wright, Julie Korol
   Castellani, Lucas
   Lecce, Christian
   Khatib, Aisha
   Bonta, Mark
   Boggild, Andrea K.
TI Zika Virus-Associated Aseptic Meningitis and Guillain-Barre Syndrome in
   a Traveler Returning from Latin America: a Case Report and Mini-Review
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Emerging infectious diseases; Flaviviruses; Guillain-Barre syndrome;
   Vector-borne infections; Zika virus
ID PUERTO-RICO; INFECTION; OUTBREAK; TRANSMISSION
AB ZIKV-associated Guillain-Barre syndrome presents with an accelerated clinical course compared to classic post-infectious Guillain-Barre syndrome. Clinicians should anticipate and screen patients with ZIKV infection for neurologic complications bearing in mind that these may manifest during the acute viremic phase or during early convalescence.
C1 [Wright, Julie Korol; Bonta, Mark; Boggild, Andrea K.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Castellani, Lucas] Northern Ontario Sch Med, Div Clin Sci, Dept Med, Sudbury, ON, Canada.
   [Lecce, Christian; Khatib, Aisha; Boggild, Andrea K.] Toronto Gen Hosp, Trop Dis Unit, 200 Elizabeth St,13EN-218, Toronto, ON, Canada.
   [Boggild, Andrea K.] Publ Hlth Ontario Labs, Toronto, ON, Canada.
RP Boggild, AK (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Boggild, AK (corresponding author), Toronto Gen Hosp, Trop Dis Unit, 200 Elizabeth St,13EN-218, Toronto, ON, Canada.; Boggild, AK (corresponding author), Publ Hlth Ontario Labs, Toronto, ON, Canada.
EM julie.wright@mail.utoronto.ca; lucas.castellani@mail.utoronto.ca;
   clecce@uwo.ca; khatib.aisha@gmail.com; mark.bonta@uhn.ca;
   andrea.boggild@utoronto.ca
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Huits R, 2018, TRAVEL MED INFECT DI
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mancera-Paez O, 2018, J NEUROL SCI, V395, P47, DOI 10.1016/j.jns.2018.09.028
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russo FB, 2017, CELL MICROBIOL, V31
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WHO, 2016, AMB AIR POLL GLOB AS, P1
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wilder-Smith A, 2018, J TRAVEL MED, V25, pe101
NR 40
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD JAN
PY 2019
VL 21
IS 1
AR 3
DI 10.1007/s11908-019-0661-1
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA HL5DX
UT WOS:000458747700001
PM 30767073
DA 2020-07-08
ER

PT J
AU Lynch, RM
   Mantus, G
   Encinales, L
   Pacheco, N
   Li, GZ
   Porras, A
   Mendoza, AR
   Peng, J
   Rengifo-Pardo, M
   Cruz, MM
   Harris, E
   Bethony, JM
   Simon, GL
   Chang, AY
AF Lynch, Rebecca M.
   Mantus, Grace
   Encinales, Liliana
   Pacheco, Nelly
   Li, Guangzhao
   Porras, Alexandra
   Mendoza, Alejandro R.
   Peng, Jin
   Rengifo-Pardo, Monica
   Cruz, Magelda Montoya
   Harris, Eva
   Bethony, Jeff M.
   Simon, Gary L.
   Chang, Aileen Y.
TI Augmented Zika and Dengue Neutralizing Antibodies Are Associated With
   Guillain-Barre Syndrome
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Guillain-Barre syndrome; neutralizing antibody; flavivirus; Zika; dengue
ID VIRUS-INFECTION; CUCUTA
AB The role of neutralizing antibodies in Zika-induced Guillain-Barre syndrome (GBS) has not yet been investigated. We conducted a case-control study using sera from the 2016 Zika epidemic in Colombia to determine the neutralizing antibody activity against Zika virus (ZIKV) and dengue virus serotype 2 (DENV2). We observed increased neutralizing antibody titers against DENV2 in ZIKV-infected individuals compared with uninfected controls and higher titers to both ZIKV and DENV2 in ZIKV-infected patients diagnosed with GBS compared with non-GBS ZIKV-infected controls. These data suggest that high neutralizing antibody titers to DENV and to ZIKV are associated with GBS during ZIKV infection.
C1 [Lynch, Rebecca M.; Mantus, Grace; Li, Guangzhao; Peng, Jin; Bethony, Jeff M.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
   [Encinales, Liliana; Pacheco, Nelly] Allied Res Soc LLC, Dept Med, Baranquilla, Colombia.
   [Porras, Alexandra; Mendoza, Alejandro R.] Univ El Bosque, Grp Med Comunitaria, Bogota, Colombia.
   [Rengifo-Pardo, Monica] George Washington Univ, Dept Dermatol, Washington, DC USA.
   [Cruz, Magelda Montoya; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Simon, Gary L.; Chang, Aileen Y.] George Washington Univ, Dept Med, Washington, DC USA.
RP Lynch, RM (corresponding author), George Washington Univ, 2300 Eye St NW, Washington, DC 20037 USA.
EM rmlynch@email.gwu.edu
OI Porras-Ramirez, Alexandra/0000-0002-0800-1388; Chang,
   Aileen/0000-0001-7410-9867; Rengifo Pardo, Monica/0000-0002-3518-6867
FU NIH National Center for Advancing Translational Sciences [UL1TR001876,
   KL2TR001877]; National Institute of Allergy and Infectious Diseases,
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01AI106695]
FX This work was supported by the NIH National Center for Advancing
   Translational Sciences (award numbers UL1TR001876 and KL2TR001877) and
   by the National Institute of Allergy and Infectious Diseases, NIH (grant
   number P01AI106695 to E. H.).
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Hahn AF, 1998, LANCET, V352, P635, DOI 10.1016/S0140-6736(97)12308-X
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
NR 14
TC 7
Z9 7
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JAN 1
PY 2019
VL 219
IS 1
BP 26
EP 30
DI 10.1093/infdis/jiy466
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HL3JK
UT WOS:000458610200006
PM 30113672
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Medina, FA
   Torres, G
   Acevedo, J
   Fonseca, S
   Casiano, L
   De Leon-Rodriguez, CM
   Santiago, GA
   Doyle, K
   Sharp, TM
   Alvarado, LI
   Paz-Bailey, G
   Munoz-Jordan, JL
AF Medina, Freddy A.
   Torres, Giselle
   Acevedo, Jenny
   Fonseca, Sharon
   Casiano, Leslie
   De Leon-Rodriguez, Carlos M.
   Santiago, Gilberto A.
   Doyle, Katherine
   Sharp, Tyler M.
   Alvarado, Luisa I.
   Paz-Bailey, Gabriela
   Munoz-Jordan, Jorge L.
TI Duration of the Presence of Infectious Zika Virus in Semen and Serum
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; sexual; transmission; pregnancy; semen; serum; infectious
ID MALE SEXUAL TRANSMISSION; RNA; OUTBREAK; SALIVA; STATES
AB Zika virus (ZIKV) has recently caused a large epidemic in the Americas that is associated with birth defects. Although ZIKV is primarily transmitted by Aedes mosquitoes, ZIKV RNA is detectable in blood and semen of infected individuals for weeks or months, during which sexual and other modes of transmission are possible. However, viral RNA is usually detectable longer than infectious virus is present. We determined the frequency of isolation of infectious virus from semen and serum samples prospectively obtained from a cohort of patients in Puerto Rico. We confirmed isolation of infectious virus on the basis of a tissue culture cytopathic effect, an increase in virus genome copy equivalents (GCE), and positive results of immunofluorescence analysis; virus in infected cells was quantitated by flow cytometry. These criteria confirmed the presence of infectious virus in semen specimens from 8 of 97 patients for up to 38 days after initial detection when virus loads are >1.4 x 10(6) genome copy equivalents/mL. Two serum isolates were obtained from 296 patients. These findings can help guide important prevention guidelines for persons that may potentially be infectious and transmit ZIKV sexually.
C1 [Medina, Freddy A.; Torres, Giselle; Acevedo, Jenny; Fonseca, Sharon; Casiano, Leslie; De Leon-Rodriguez, Carlos M.; Santiago, Gilberto A.; Doyle, Katherine; Sharp, Tyler M.; Paz-Bailey, Gabriela; Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Alvarado, Luisa I.] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp Consortium, Ponce, PR USA.
RP Munoz-Jordan, JL (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
EM ckq2@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX This work was supported by the Centers for Disease Control and
   Prevention.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Earley E. M., 1988, VERO CELLS ORIGIN PR, P26
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Medina FA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003468
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 48
TC 12
Z9 12
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JAN 1
PY 2019
VL 219
IS 1
BP 31
EP 40
DI 10.1093/infdis/jiy462
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HL3JK
UT WOS:000458610200007
PM 30059980
OA Bronze
DA 2020-07-08
ER

PT J
AU Cataneo, AHD
   Kuczera, D
   Mosimann, ALP
   Silva, EG
   Ferreira, AGA
   Marques, JT
   Wowk, PF
   dos Santos, CND
   Bordignon, J
AF Depieri Cataneo, Allan Henrique
   Kuczera, Diogo
   Pamplona Mosimann, Ana Luiza
   Silva, Emanuele Guimaraes
   Araujo Ferreira, Alvaro Gil
   Marques, Joao Trindade
   Wowk, Pryscilla Fanini
   Duarte dos Santos, Claudia Nunes
   Bordignon, Juliano
TI Detection and clearance of a mosquito densovirus contaminant from
   laboratory stocks of Zika virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE arixwirus isolation; contamination; C6/36 cultures; densovirus;
   vertebrate cells; Zika virus
ID AEDES-ALBOPICTUS; A549 CELLS; INFECTION; IDENTIFICATION; PATHOGENICITY;
   SEQUENCE; LINE
AB BACKGROUND The Zika virus (ZIKV) epidemics that affected South America in 2016 raised several research questions and prompted an increase in studies in the field. The transient and low viraemia observed in the course of ZIKV infection is a challenge for viral isolation from patient serum, which leads to many laboratories around the world sharing viral strains for their studies. C6/36 cells derived from Aedes albopictus larvae are commonly used for arbovirus isolation from clinical samples and for the preparation of viral stocks.
   OBJECTIVES Here, we report the contamination of two widely used ZIKV strains by Brevidensovirus, here designated as mosquito densovirus (MDV).
   METHODS Molecular and immunological techniques were used to analyse the MDV contamination of ZIKV stocks. Also, virus passages in mammalian cell line and infecting susceptible mice were used to MDV clearance from ZIKV stocks.
   FINDINGS MDV contamination was confirmed by molecular and immunological techniques and likely originated from C6/36 cultures commonly used to grow viral stocks. We applied two protocols that successfully eliminated MDV contamination from ZIKV stocks, and these protocols can be widely applied in the field. As MDV does not infect vertebrate cells, we performed serial passages of contaminated stocks using a mammalian cell line and infecting susceptible mice prior to re-isolating ZIKV from the animals' blood scrum. MDV elimination was confirmed with immunostaining, polymerase chain reaction (PCR), and analysis of the mosquitoes that were allowed to feed on the infected mice.
   MAIN CONCLUSIONS Since the putative impact of viral contaminants in ZIKV strains generally used for research purposes is unknown, researchers working in the field must be aware of potential contaminants and test viral stocks to certify sample purity.
C1 [Depieri Cataneo, Allan Henrique; Kuczera, Diogo; Pamplona Mosimann, Ana Luiza; Wowk, Pryscilla Fanini; Duarte dos Santos, Claudia Nunes; Bordignon, Juliano] Fundacao Oswaldo Cruz Fiocruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Silva, Emanuele Guimaraes; Araujo Ferreira, Alvaro Gil; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
RP Bordignon, J (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
EM juliano.bordignon@fiocruz.br
RI Wowk, Pryscilla/AAA-3281-2019; Mosimann, Ana Luiza
   Pamplona/AAB-4714-2019; Ferreira, Alvaro G A/O-3649-2015; Wowk,
   Pryscilla Fanini/AAR-7230-2020; Cataneo, Allan/AAB-7997-2020; Marques,
   Joao T/F-7683-2012; Santos, Claudia Duarte dos/P-4868-2019; Bordignon,
   Juliano/Z-6268-2019
OI Mosimann, Ana Luiza Pamplona/0000-0002-3504-5562; Marques, Joao
   T/0000-0002-3457-3320; Santos, Claudia Duarte dos/0000-0001-8707-6638;
   Bordignon, Juliano/0000-0002-1965-6152; Wowk,
   Pryscilla/0000-0002-8976-2647
FU Ministerio da Saude e Fundacao Araucaria (PPSUS/2013); Fundacao
   Araucaria/SESA-PR/CNPq/MS-Decit PPSUS/2015 [019/2017]
FX Ministerio da Saude e Fundacao Araucaria (PPSUS/2013), Fundacao
   Araucaria/SESA-PR/CNPq/MS-Decit PPSUS/2015 - (019/2017). JTM
   (305357/2014-0), CNDS (309432/2015-4) and JB (303306/2017-3) are CNPq
   fellows.
CR AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F
   Barreau C, 1996, J INVERTEBR PATHOL, V68, P299, DOI 10.1006/jipa.1996.0100
   Bergoin M, 2000, CONTRIB MICROBIOL, V4, P12
   Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X
   Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1
   DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FONG CKY, 1975, J CLIN MICROBIOL, V1, P219, DOI 10.1128/JCM.1.2.219-224.1975
   FONG CKY, 1992, J CLIN MICROBIOL, V30, P1611, DOI 10.1128/JCM.30.6.1611-1613.1992
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   HIRUMI H, 1976, IN VITRO CELL DEV B, V12, P83
   Horbach SPJM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186281
   JOUSSET FX, 1993, VIRUS RES, V29, P99, DOI 10.1016/0168-1702(93)90052-O
   LEBEDEVA OP, 1973, ACTA VIROL, V17, P253
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Olmo RP, 2018, NAT MICROBIOL, V3, P1385, DOI 10.1038/s41564-018-0268-6
   ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067
   Mosimann ALP, 2011, MEM I OSWALDO CRUZ, V106, P285, DOI 10.1590/S0074-02762011000300006
   Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037
   Sivaram A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-95
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Suchman EL, 2006, BIOL CONTROL, V39, P465, DOI 10.1016/j.biocontrol.2006.05.001
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wei W, 2006, AM J TROP MED HYG, V75, P1118, DOI 10.4269/ajtmh.2006.75.1118
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 2
Z9 2
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR UNSP e180432
DI 10.1590/0074-02760180432
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HL3KY
UT WOS:000458615100001
PM 30758394
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cole, P
   Bofill, X
   Dulsat, C
AF Cole, P.
   Bofill, X.
   Dulsat, C.
TI Animal models snapshot
SO DRUGS OF THE FUTURE
LA English
DT Article
DE Experimental models; Animal models
AB The development of new therapies can be greatly facilitated by the use of experimental models of disease, and the development of these models represents an active and exciting field of investigation. This article highlights a selection of newly created models described in the literature and at conferences for a variety of diseases and conditions such as several types of cancer, heart failure, diabetic complications, glaucoma, Crohn's and celiac disease, a variety of rare disorders, Zika and hepatitis B virus infections and some neurological, renal and respiratory disorders.
C1 [Cole, P.; Bofill, X.; Dulsat, C.] Clarivate Anatyt, Barcelona, Spain.
RP Dulsat, C (corresponding author), Clarivate Anatyt, Barcelona, Spain.
EM coia.dulsat@clarivate.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD JAN
PY 2019
VL 44
IS 1
BP 29
EP 38
DI 10.1358/dof.2019.44.1.2939527
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HL0JQ
UT WOS:000458381200004
DA 2020-07-08
ER

PT J
AU Patil, V
   Patil, SA
   Patil, R
   Bugarin, A
   Beaman, K
   Patil, SA
AF Patil, Vikrant
   Patil, Sidaappa A.
   Patil, Renukadevi
   Bugarin, Alejandro
   Beaman, Kenneth
   Patil, Shivaputra A.
TI Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and
   Anticancer Activities
SO MEDICINAL CHEMISTRY
LA English
DT Article
DE Anticancer; antiviral; colon; thienyl chalcone; aryl/heteroaryl;
   structure-activity relationship
ID CELL-CULTURE ASSAY; CANCER; CHALCONES; DERIVATIVES; INHIBITORS;
   DISCOVERY; INFECTION; ANALOGS; AGENTS; PANEL
AB Background: Search for new antiviral and anticancer agents are essential because of the emergence of drug resistance in recent years. In continuation of our efforts in identifying the new small molecule antiviral and anticancer agents, we identified chalcones as potent antiviral and anticancer agents.
   Objective: With the aim of identifying the broad acting antiviral and anticancer agents, we discovered substituted aryl/heteroaryl derived thienyl chalcones as antiviral and anticancer agents.
   Method: A focused set of thienyl chalcone derivaties II-VI was screened for selected viruses Hepatitis B virus (HBV), Herpes simplex virus 1 (HSV-1), Human cytomegalovirus (HCMV), Dengue virus 2 (DENV2), Influenza A (H1N1) virus, MERS coronavirus, Poliovirus 1 (PV 1), Rift Valley fever (RVF), Tacaribe virus (TCRV), Venezuelan equine encephalitis virus (VEE) and Zika virus (ZIKV) using the National Institute of Allergy and Infectious Diseases (NIAID)'s Division of Microbiology and Infectious Diseases (DMID) antiviral screening program. Additionally, a cyclopropylquinoline derivative IV has been screened for 60 human cancer cell lines using the Development Therapeutics Program (DTP) of NCI.
   Results: All thienyl chalcone derivatives II-VI displayed moderate to excellent antiviral activity towards several viruses tested. Compounds V and VI were turned out be active compounds towards human cytomegalovirus for both normal strain (AD169) as well as resistant isolate (GDGr K17). Particularly, cyano derivative V showed very high potency (EC50: <0.05 mu M) towards AD169 strain of HCMV compared to standard drug Ganciclovir (EC50: 0.12 mu M). Additionally, it showed moderate activity in the secondary assay (AD169; EC50: 2.30 mu M). The cyclopropylquinoline derivative IV displayed high potency towards Rift Valley fever virus (RVFV) and Tacaribe virus (TCRV) towards Rift Valley fever virus (RVFV). The cyclopropylquinoline derivative IV is nearly 28 times more potent in our initial in vitro visual assay (EC50: 0.39 mu g/ml) and nearly 17 times more potent in neutral red assay (EC50: 0.71 mu g/ml) compared to the standard drug Ribavirin (EC50: 11 mu g/ml; visual assay and EC50: 12 mu g/ml; neutral red assay). It is nearly 12 times more potent in our initial in vitro visual assay (EC50: >1 mu g/ml) and nearly 8 times more potent in neutral red assay (EC50: >1.3 mu g/ml) compared to the standard drug Ribavirin (EC50: 12 mu g/ml; visual assay and EC50: 9.9 mu g/ml; neutral red assay) towards Tacaribe virus (TCRV). Additionally, cyclopropylquinoline derivative IV has shown strong growth inhibitory activity towards three major cancers (colon, breast, and leukemia) cell lines and moderate growth inhibition shown towards other cancer cell lines screened.
   Conclusion: Compounds V and VI were demonstrated viral inhibition towards Human cytomegalovirus, whereas cyclopropylquinoline derivative IV towards Rift Valley fever virus and Tacaribe virus. Additionally, cyclopropylquinoline derivative IV has displayed very good cytotoxicity against colon, breast and leukemia cell lines in vitro.
C1 [Patil, Vikrant; Patil, Sidaappa A.] Jain Univ, Ctr Nano & Mat Sci, Jain Global Campus, Bangalore 562112, Karnataka, India.
   [Patil, Renukadevi; Patil, Shivaputra A.] Rosalind Franklin Univ Med & Sci, Pharmaceut Sci Dept, Coll Pharm, 3333 Green Bay Rd, N Chicago, IL 60064 USA.
   [Bugarin, Alejandro] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.
   [Beaman, Kenneth] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.
RP Patil, SA (corresponding author), Jain Univ, Ctr Nano & Mat Sci, Jain Global Campus, Bangalore 562112, Karnataka, India.; Patil, SA (corresponding author), Rosalind Franklin Univ Med & Sci, Pharmaceut Sci Dept, Coll Pharm, 3333 Green Bay Rd, N Chicago, IL 60064 USA.
EM p.siddappa@jainuniversity.ac.in; shivaputra.patil@rosalindfranklin.edu
FU DST-SERB, India [YSS/2015/ 000010]; DST-Nanomission, India [SR/NM/
   NS-20/2014]
FX Dr. Siddappa A. Patil thanks DST-SERB, India (YSS/2015/ 000010),
   DST-Nanomission, India (SR/NM/ NS-20/2014) for financial support.
   Rosalind Franklin University of Medicine and Science (Shivaputra A.
   Patil) utilized the nonclinical and pre-clinical services program
   offered by the National Institute of Allergy and Infectious Diseases
   (NIAID). We sincerely thank Dr. D. Smee (Utah State University) for
   Dengue virus 2 (DENV2), Influenza A (H1N1) virus, MERS coronavirus,
   Poliovirus 1 (PV 1), Rift Valley fever (RVF), Tacaribe virus (TCRV),
   Venezuelan equine encephalitis virus (VEE) and Zika virus (ZIKV); Dr. M.
   Prichard (University of Alabama, Birmingham) for Herpes simplex virus 1
   (HSV-1), Human cytomegalovirus (HCMV), and Dr. Brent Korba for Hepatitis
   B virus (HBV) anti-viral screening. The screening of
   cyclopropylquinoline derivative IV against 60 human cancer cell lines of
   NCI's developmental therapeutic program is gratefully acknowledged.
CR Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951
   BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203
   Chiaradia LD, 2008, BIOORG MED CHEM LETT, V18, P6227, DOI 10.1016/j.bmcl.2008.09.105
   Covell DG, 2007, MOL CANCER THER, V6, P2261, DOI 10.1158/1535-7163.MCT-06-0787
   Croom KF, 2003, DRUGS, V63, P513, DOI 10.2165/00003495-200363050-00005
   Dimmock JR, 1999, CURR MED CHEM, V6, P1125
   Dominguez JN, 2001, EUR J MED CHEM, V36, P555, DOI 10.1016/S0223-5234(01)01245-4
   Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401
   Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106
   Irwin KK, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew014
   KORBA BE, 1992, ANTIVIR RES, V19, P55, DOI 10.1016/0166-3542(92)90056-B
   KORBA BE, 1991, ANTIVIR RES, V15, P217, DOI 10.1016/0166-3542(91)90068-3
   Lee JM, 2014, CANCER LETT, V354, P348, DOI 10.1016/j.canlet.2014.08.041
   Lok ASF, 2000, J HEPATOL, V32, P89, DOI 10.1016/S0168-8278(00)80418-3
   Mai CW, 2014, EUR J MED CHEM, V77, P378, DOI 10.1016/j.ejmech.2014.03.002
   Maria K, 2008, MED CHEM, V4, P586, DOI 10.2174/157340608786242070
   Miranda CL, 2000, J AGR FOOD CHEM, V48, P3876, DOI 10.1021/jf0002995
   MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757
   Nowakowska Z, 2007, EUR J MED CHEM, V42, P125, DOI 10.1016/j.ejmech.2006.09.019
   Patil R, 2017, BIOORG MED CHEM LETT, V27, P1129, DOI 10.1016/j.bmcl.2017.01.089
   Patil SA, 2015, MED CHEM, V11, P400, DOI 10.2174/1573406410666140914162701
   Patil SA, 2012, BIOORG MED CHEM LETT, V22, P4458, DOI 10.1016/j.bmcl.2012.04.074
   Patil SA, 2017, MED CHEM, V13, P787, DOI 10.2174/1573406413666170330094822
   Patil V, 2016, CHEMISTRYSELECT, V1, P3647, DOI 10.1002/slct.201600703
   Prichard MN, 2013, ANTIMICROB AGENTS CH, V57, P3518, DOI 10.1128/AAC.00429-13
   Sharma A, 2010, BIOORGAN MED CHEM, V18, P4711, DOI 10.1016/j.bmc.2010.05.015
   Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001
   Smee DF, 2016, ANTIVIR RES, V131, P61, DOI 10.1016/j.antiviral.2016.04.003
   Wu JH, 2003, BIOORG MED CHEM LETT, V13, P1813, DOI 10.1016/S0960-894X(03)00197-5
   Wu JZ, 2011, J MED CHEM, V54, P8110, DOI 10.1021/jm200946h
NR 33
TC 0
Z9 0
U1 6
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4064
EI 1875-6638
J9 MED CHEM
JI Med. Chem.
PY 2019
VL 15
IS 2
BP 150
EP 161
DI 10.2174/1573406414666180524074648
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HL0UC
UT WOS:000458408600004
PM 29792154
DA 2020-07-08
ER

PT J
AU Asad, S
   Feitosa-Suntheimer, F
   Gold, A
   Londono-Renteria, B
   Colpitts, TM
AF Asad, Sultan
   Feitosa-Suntheimer, Fabiana
   Gold, Alexander
   Londono-Renteria, Berlin
   Colpitts, Tonya M.
TI Quantification of Antibody-dependent Enhancement of the Zika Virus in
   Primary Human Cells
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology and Infection; Issue 143; Zika virus; dengue virus;
   pre-immune serum; antibody-dependent enhancement; flaviviruses; viral
   RNA quantification
ID INFECTION
AB The recent emergence of the flavivirus Zika and neurological complications, such as Guillain-Barre syndrome and microcephaly in infants, has brought serious public safety concerns. Among the risk factors, antibody-dependent enhancement (ADE) poses the most significant threat, as the recent re-emergence of the Zika virus (ZIKV) is primarily in areas where the population has been exposed and is in a state of pre-immunity to other closely related flaviviruses, especially dengue virus (DENV). Here, we describe a protocol for quantifying the effect of human serum antibodies against DENV on ZIKV infection in primary human cells or cell lines.
C1 [Asad, Sultan; Feitosa-Suntheimer, Fabiana; Gold, Alexander; Colpitts, Tonya M.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA.
   [Asad, Sultan; Feitosa-Suntheimer, Fabiana; Gold, Alexander; Londono-Renteria, Berlin; Colpitts, Tonya M.] Boston Univ, Sch Med, Natl Emerging Infect Dis Laborator, Boston, MA 02215 USA.
   Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.
RP Colpitts, TM (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA.; Colpitts, TM (corresponding author), Boston Univ, Sch Med, Natl Emerging Infect Dis Laborator, Boston, MA 02215 USA.
EM tmcol@bu.edu
OI Asad, Sultan/0000-0001-8627-6080; Colpitts, Tonya/0000-0003-3915-1554
FU National Emerging Infectious Diseases Laboratories [1R21AI129881-01];
   Boston University School of Medicine
FX This work was generously supported by 1R21AI129881-01 (to T.M.C.),
   start-up funds from the National Emerging Infectious Diseases
   Laboratories, and the Boston University School of Medicine.
CR Charles A. S., 2016, PLOS CURRENTS, V8
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ganger MT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1949-5
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412
   MORENS DM, 1990, J GEN VIROL, V71, P2909, DOI 10.1099/0022-1317-71-12-2909
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Renn LA, 2015, JOVE-J VIS EXP, DOI 10.3791/52650
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
NR 21
TC 0
Z9 0
U1 0
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JAN
PY 2019
IS 143
AR e58691
DI 10.3791/58691
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK5NC
UT WOS:000458012000100
PM 30735189
DA 2020-07-08
ER

PT J
AU Huits, R
   Maniewski, U
   Van Den Bossche, D
   Lotgering, E
   Tsoumanis, A
   Cnops, L
   Jacobs, J
   Van Esbroeck, M
   Bottieau, E
AF Huits, Ralph
   Maniewski, Ula
   Van Den Bossche, Dorien
   Lotgering, Erica
   Tsoumanis, Achilleas
   Cnops, Lieselotte
   Jacobs, Jan
   Van Esbroeck, Marjan
   Bottieau, Emmanuel
TI A cross-sectional analysis of Zika virus infection in symptomatic and
   asymptomatic non-pregnant travellers: Experience of a European reference
   center during the outbreak in the Americas
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Outbreak; Returning traveller; Asymptomatic; ELISA;
   Likelihood ratio
ID LINKED IMMUNOSORBENT ASSAYS; DIAGNOSIS; STATES; IGM
AB Background: Zika virus (ZIKV) infection a concern to travellers because of potential sexual transmission and adverse pregnancy outcomes.
   Objective: To describe our experience in diagnosing ZIKV in travellers returning from endemic territories.
   Method: Travellers were evaluated for ZIKV at our clinic in a 12-month period during the outbreak, using ZIKV-specific RT-PCR and anti-ZIKV Immunoglobulin M/G ELISA when symptomatic, and ELISA only for asymptomatic travellers, preferably from 20 days after the last exposure. All positive ELISA results were subject to confirmation by Virus Neutralization Testing. We estimated post-test probabilities of ZIKV in asymptomatic travellers.
   Results: Of 462 travellers, 227 reported symptoms and 235 did not. Asymptomatic travellers had similar baseline characteristics, but were younger (median age 31 vs. 33 years, p = 0.01) and had reproductive concerns more often (75.8% vs. 24.2%). ZIKV infection was confirmed in 49 cases: 46/227 (20.3%) were symptomatic and 3/235 (1.3%) asymptomatic. Rash (positive likelihood ratio (LRP) 5.6) and conjunctivitis (LRP 10.8) predicted ZIKV infection. The post-test probability of a negative ELISA-result at 20-25 days was below 0.1%.
   Conclusion: ZIKV infection was frequent in symptomatic, but not in asymptomatic travellers. We consider negative ELISA results at 20-25 days after exposure a safe strategy to rule out ZIKV infection. Testing for ZIKV-specific antibodies within this timeframe could be particularly valuable in the management of returning travellers who wish to conceive.
C1 [Huits, Ralph; Maniewski, Ula; Van Den Bossche, Dorien; Lotgering, Erica; Tsoumanis, Achilleas; Cnops, Lieselotte; Jacobs, Jan; Van Esbroeck, Marjan; Bottieau, Emmanuel] Inst Trop Med Antwerp ITM, Antwerp, Belgium.
   [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.
RP Huits, R (corresponding author), Inst Trop Med, Kronenburgstr 43-3, B-2000 Antwerp, Belgium.
EM rhuits@itg.be; umaniewski@itg.be; dvandenbossche@itg.be;
   elotgering@gmail.com; atsoumanis@itg.be; lcnops@itg.be; jjacobs@itg.be;
   mvesbroeck@itg.be; ebottieau@itg.be
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468; Cnops, Lieselotte/0000-0003-0658-1291;
   Van Esbroeck, Marjan/0000-0002-7294-6319
FU European UnionEuropean Union (EU) [734584]
FX The Institute of Tropical Medicine is a member of the ZikaPLAN
   consortium that received funding from the European Union's Horizon 2020
   research and innovation programme under ZikaPLAN grant agreement No
   734584.
CR Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Charrel RN, 2016, TRAVEL MED INFECT DI, V14, P11, DOI 10.1016/j.tmaid.2016.01.006
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Diaz-Menendez M, 2018, ENFERM INFEC MICR CL, V36, P4, DOI 10.1016/j.eimc.2016.08.003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, COUNTR ACT LOC TRANS
   European Centre for Disease Control and Prevention (ECDC), 2016, RAP RISK ASS ZIK VIR, P1
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rodo C, 2017, TROP MED INT HEALTH, V22, P200
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Turmel P. A. Jean Marie, 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   World Health Organization, 2016, PREV SEX TRANSM ZIK, P1
NR 32
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2019
VL 27
BP 107
EP 114
DI 10.1016/j.tmaid.2018.08.007
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HK2GZ
UT WOS:000457729300019
PM 30205195
OA Bronze
DA 2020-07-08
ER

PT J
AU Khatib, A
   Showler, AJ
   Kain, D
   Melvin, R
   Lecce, C
   Boggild, AK
AF Khatib, Aisha
   Showler, Adrienne J.
   Kain, Dylan
   Melvin, Rochelle
   Lecce, Christian
   Boggild, Andrea K.
TI A diagnostic gap illuminated by a sexually-transmitted case of
   congenital Zika virus infection
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Congenital Zika virus; Pregnancy; Sexually-transmitted infection;
   Vector-borne disease; Zika virus
C1 [Khatib, Aisha; Showler, Adrienne J.; Kain, Dylan; Melvin, Rochelle; Lecce, Christian; Boggild, Andrea K.] Univ Hlth Network, Div Infect Dis, Trop Dis Unit, Toronto Gen Hosp, Toronto, ON, Canada.
   [Khatib, Aisha; Kain, Dylan; Boggild, Andrea K.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Showler, Adrienne J.] Georgetown Univ, Dept Infect Dis & Travel Med, Washington, DC USA.
   [Melvin, Rochelle] Univ Toronto, Fac Med, Toronto, ON, Canada.
   [Lecce, Christian] Ryerson Univ, Ryerson Yeates Sch Grad Studies, Toronto, ON, Canada.
   [Boggild, Andrea K.] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada.
RP Boggild, AK (corresponding author), Toronto Gen Hosp, Trop Dis Unit, 200 Elizabeth St,13EN-218, Toronto, ON M5G 2C4, Canada.
EM andrea.boggild@utoronto.ca
FU Molecular Diagnostics and Virology Research laboratories of Public
   Health Ontario Laboratories
FX We thank the Molecular Diagnostics and Virology Research laboratories of
   Public Health Ontario Laboratories for their support of extended Zika
   diagnostics.
CR Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Roberts CC, 2018, VACCINES, V70, P1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2019
VL 27
BP 117
EP 118
DI 10.1016/j.tmaid.2018.10.017
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HK2GZ
UT WOS:000457729300022
PM 30739645
OA Bronze
DA 2020-07-08
ER

PT J
AU De Pijper, CA
   Koen, G
   Schinkel, J
   Grobusch, MP
   Goorhuis, A
   Stijnis, C
AF De Pijper, Cornelis A.
   Koen, Gerrit
   Schinkel, Janke
   Grobusch, Martin P.
   Goorhuis, Abraham
   Stijnis, Cornelis
TI No detection of Zika virus infection in asymptomatic Dutch military
   personnel after deployment in high endemic areas (Belize, Curacao, Saint
   Martin) from December 2016 to December 2017
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Military personnel; Arboviruses; Asymptomatic infections;
   Dengue virus; Chikungunya virus
C1 [De Pijper, Cornelis A.; Grobusch, Martin P.; Goorhuis, Abraham; Stijnis, Cornelis] Univ Amsterdam, Ctr Trop Med & Travel Med, Amsterdam Infect & Immun, Amsterdam UMC,Div Internal Med,Dept Infect Dis, Meibergdreef 9, Amsterdam, Netherlands.
   [Koen, Gerrit; Schinkel, Janke] Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun, Div Lab Specialism,Dept Med Microbiol,Lab Clin Vi, Meibergdreef 9, Amsterdam, Netherlands.
RP De Pijper, CA (corresponding author), Univ Amsterdam, Amsterdam UMC, Ctr Trop Med & Travel Med, POB 22660, NL-1100 DD Amsterdam, Netherlands.
EM c.a.depijper@amc.uva.nl
FU Dutch Ministry of Defense
FX We like to thank all participants of the study and the Dutch Ministry of
   Defense for their support.
CR Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   European Centre for Disease Prevention and Control, 2017, ZIK TRANSM CAR
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Vouga M, 2018, LANCET, V392, P818, DOI 10.1016/S0140-6736(18)31827-0
NR 6
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2019
VL 27
BP 119
EP 120
DI 10.1016/j.tmaid.2018.09.009
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HK2GZ
UT WOS:000457729300023
PM 30243931
OA Other Gold
DA 2020-07-08
ER

PT J
AU Saxena, SK
   Kumar, S
   Sharma, R
   Maurya, VK
   Dandu, HR
   Bhatt, MLB
AF Saxena, Shailendra K.
   Kumar, Swatantra
   Sharma, Raman
   Maurya, Vimal K.
   Dandu, Himanshu R.
   Bhatt, Madan L. B.
TI Zika virus disease in India - Update October 2018
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Disease outbreaks; India; Travel; Transmission; Jaipur
C1 [Saxena, Shailendra K.; Kumar, Swatantra; Maurya, Vimal K.; Bhatt, Madan L. B.] King Georges Med Univ, Fac Med, Ctr Adv Res, Lucknow 226003, Uttar Pradesh, India.
   [Saxena, Shailendra K.] CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, India.
   [Sharma, Raman] Sawai Man Singh Med Coll, Dept Med, Jaipur 302004, Rajasthan, India.
   [Dandu, Himanshu R.] King Georges Med Univ, Dept Internal Med, Lucknow 226003, Uttar Pradesh, India.
RP Saxena, SK (corresponding author), KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India.
EM shailen@kgmcindia.edu
RI Brain, Molecular/X-4252-2019
OI Brain, Molecular/0000-0003-2856-4185
CR [Anonymous], 2016, LANCET GLOB HEALTH, V4, pE427, DOI 10.1016/S2214-109X(16)30109-7
   Government of India Ministry of Health and Family Welfare, 2018, HIGH LEV REV M ZIK V
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Mallhi TH, 2017, TRAVEL MED INFECT DI, V18, P75, DOI 10.1016/j.tmaid.2017.07.005
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   World Health Organization, ZIK VIR DIS
NR 6
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2019
VL 27
BP 121
EP 122
DI 10.1016/j.tmaid.2018.10.022
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HK2GZ
UT WOS:000457729300024
PM 30399445
DA 2020-07-08
ER

PT J
AU Machado-Duque, ME
   Machado-Alba, JE
   Rodriguez-Morales, AJ
AF Machado-Duque, Manuel E.
   Machado-Alba, Jorge E.
   Rodriguez-Morales, Alfonso J.
TI Are the 2014-2016 Zika and Chikungunya epidemics in Colombia associated
   with a higher use of antihistamines?
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Chikungunya; Antihistamines; Epidemics; Latin America
C1 [Machado-Duque, Manuel E.; Machado-Alba, Jorge E.] Univ Tecnol Pereira, Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika & Other Arbovir, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Fac Hlth Sci, Med Sch, Cochabamba, Bolivia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR Bandyopadhyay Debabrata, 2010, Indian J Dermatol, V55, P64, DOI 10.4103/0019-5154.60356
   Cunha BA, 2016, IDCases, V6, P29, DOI 10.1016/j.idcr.2016.09.003
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   He A, 2017, AM J CLIN DERMATOL, V18, P231, DOI 10.1007/s40257-016-0243-z
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2019
VL 27
BP 123
EP 124
DI 10.1016/j.tmaid.2018.10.001
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HK2GZ
UT WOS:000457729300025
PM 30291893
OA Bronze
DA 2020-07-08
ER

PT J
AU Caminade, C
   McIntyre, KM
   Jones, AE
AF Caminade, Cyril
   McIntyre, K. Marie
   Jones, Anne E.
TI Impact of recent and future climate change on vector-borne diseases
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Review
DE climate change; vector-borne disease; water-borne disease; public
   health; emerging disease
ID WEST-NILE-VIRUS; AUTOCHTHONOUS DENGUE-FEVER; MALARIA TRANSMISSION;
   CHIKUNGUNYA VIRUS; EL-NINO; AEDES-ALBOPICTUS; ZIKA VIRUS; GLOBAL
   DISTRIBUTION; IXODES-RICINUS; SPATIOTEMPORAL DISTRIBUTION
AB Climate change is one of the greatest threats to human health in the 21st century. Climate directly impacts health through climatic extremes, air quality, sea-level rise, and multifaceted influences on food production systems and water resources. Climate also affects infectious diseases, which have played a significant role in human history, impacting the rise and fall of civilizations and facilitating the conquest of new territories. Our review highlights significant regional changes in vector and pathogen distribution reported in temperate, peri-Arctic, Arctic, and tropical highland regions during recent decades, changes that have been anticipated by scientists worldwide. Further future changes are likely if we fail to mitigate and adapt to climate change. Many key factors affect the spread and severity of human diseases, including mobility of people, animals, and goods; control measures in place; availability of effective drugs; quality of public health services; human behavior; and political stability and conflicts. With drug and insecticide resistance on the rise, significant funding and research efforts must to be maintained to continue the battle against existing and emerging diseases, particularly those that are vector borne.
C1 [Caminade, Cyril; McIntyre, K. Marie] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England.
   [Caminade, Cyril; McIntyre, K. Marie] NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.
   [Jones, Anne E.] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England.
RP Caminade, C (corresponding author), Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Horn Off, LUCINDA Grp, Liverpool Sci Pk IC2 Bldg,146 Brownlow Hill, Liverpool L3 5RF, Merseyside, England.
EM Cyril.Caminade@liverpool.ac.uk
OI Caminade, Cyril/0000-0002-3846-7082; McIntyre, Kirsty
   Marie/0000-0003-1360-122X
FU National Institute for Health Research Health Protection Research Unit
   (NIHR HPRU) in Emerging and Zoonotic Infections at the University of
   Liverpool; Public Health England (PHE); Liverpool School of Tropical
   Medicine (LSTM)
FX This work was funded by the National Institute for Health Research
   Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic
   Infections at the University of Liverpool in partnership with Public
   Health England (PHE) and the Liverpool School of Tropical Medicine
   (LSTM). The views expressed are those of the authors and not necessarily
   those of the NHS, the NIHR, the Department of Health, and Public Health
   England. C.C. wrote the manuscript with significant inputs from A.E.J.
   and K.M.M.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Afrane YA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-405
   Alemu K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-223
   Alkishe AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189092
   Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020
   Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401
   Andriopoulos P, 2013, INT J INFECT DIS, V17, pE125, DOI 10.1016/j.ijid.2012.09.009
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Asante KP, 2011, LANCET INFECT DIS, V11, P727
   Ashley EA, 2018, LANCET, V391, P1608, DOI 10.1016/S0140-6736(18)30324-6
   Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Ballester J, 2016, ANN NY ACAD SCI, V1382, P8, DOI 10.1111/nyas.13129
   Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX
   Baylis M, 2017, REV SCI TECH OIE, V36, P467, DOI 10.20506/rst.36.2.2667
   Baylis M., 2012, SAGE HDB ENV CHANGE, V2
   Beguin A, 2011, GLOBAL ENVIRON CHANG, V21, P1209, DOI 10.1016/j.gloenvcha.2011.06.001
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2018, TRENDS PARASITOL, V34, P351, DOI 10.1016/j.pt.2018.01.002
   Berger J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19416-9
   Berry A, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.1.30100
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonovas S, 2012, J Prev Med Hyg, V53, P169
   Boyce R, 2016, J INFECT DIS, V214, P1403, DOI 10.1093/infdis/jiw363
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Caminade C, 2015, GEOSPATIAL HEALTH, V9, P301, DOI 10.4081/gh.2015.352
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284
   Chretien J.P., 2015, PLOS CURR, DOI [10.1371/currents.outbreaks.95fbc4a8fb4695e049baabfc2fc8289f, DOI 10.1371/CURRENTS.OUTBREAKS.95FBC4A8FB4695E049BAABFC2FC8289F]
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122
   Constantin de Magny Guillaume, 2009, Trans Am Clin Climatol Assoc, V120, P119
   Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4
   Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2
   Danielova V, 2010, VECTOR-BORNE ZOONOT, V10, P223, DOI 10.1089/vbz.2009.0020
   DEFRA, 2018, BLUET VIRUS BTV 4
   DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13
   Dhimal M, 2014, MALAR J S1, V13, P26
   Dhimal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129869
   Dhimal M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0540-4
   Dhimal M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-457
   Diamond J., 1997, GUNS GERMS STEEL FAT, V44
   Dobson A, 2015, TRENDS PARASITOL, V31, P181, DOI 10.1016/j.pt.2015.03.006
   DYE C, 1986, Parasitology Today, V2, P203
   ECDC, 2014, FACT SHEET LYM BORR
   Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079
   Epstein PR, 2001, J URBAN HEALTH, V78, P367, DOI 10.1093/jurban/78.2.367
   Ermert V, 2012, ENVIRON HEALTH PERSP, V120, P77, DOI 10.1289/ehp.1103681
   Estrada-Pena A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00064
   European Centre for Disease Prevention and Control (ECDC), 2009, 0905 ECDC
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126
   Gagnon AS, 2001, CLIM RES, V19, P35, DOI 10.3354/cr019035
   Gao HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043686
   Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gone T, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0483-9
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Government of Canada, 2018, SURV LYM DIS, V2018
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255
   Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7
   Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a
   Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473
   Haydock LAJ, 2016, VET PARASITOL, V228, P52, DOI 10.1016/j.vetpar.2016.05.033
   Hemingway J, 2017, SCIENCE, V358, P998, DOI 10.1126/science.aaj1644
   Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009
   Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Jin X, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.3
   KANEKO T, 1975, APPL MICROBIOL, V30, P251, DOI 10.1128/AEM.30.2.251-257.1975
   Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268
   Kibret S, 2017, ECOHEALTH, V14, P408, DOI 10.1007/s10393-015-1029-0
   Korenromp E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1461-9
   Korotkov Y, 2015, MED VET ENTOMOL, V29, P129, DOI 10.1111/mve.12101
   Kraemer M.U., 2015, ALBOPICTUS ELIFE, V4
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285
   Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008
   Kweka EJ, 2013, ACTA TROP, V128, P158, DOI 10.1016/j.actatropica.2013.06.006
   Lafferty KD, 2016, F1000RES, V5, pF1000
   Levy S, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP2095
   Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070
   Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5
   MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584
   Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932
   McCreesh N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0617-0
   McIntyre KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06948-9
   McMichael AJ, 2012, P NATL ACAD SCI USA, V109, P4730, DOI 10.1073/pnas.1120177109
   McPherson M, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/ehp57, 10.1289/EHP57]
   Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Mogi M, 2014, J MED ENTOMOL, V51, P572, DOI 10.1603/ME13178
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   NADIS, 2018, PAR FOR
   Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   OLLERENSHAW C. B., 1959, Veterinary Record, V71, P591
   Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12
   Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107
   Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286
   Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561
   Perkins T Alex, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc
   Petersen LR, 2001, EMERG INFECT DIS, V7, P611
   Pinault LL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-236
   Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554
   Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090
   Qadri F, 2017, NEW ENGL J MED, V377, P2005, DOI 10.1056/NEJMp1712099
   Quin D., 2013, WORKING GROUP 1 CONT
   Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4
   Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077
   Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rogers DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0562
   Rogers DJ, 2000, SCIENCE, V289, P1763
   Rose H, 2016, GLOBAL CHANGE BIOL, V22, P1271, DOI 10.1111/gcb.13132
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325
   Sorensen CJ, 2017, GEOHEALTH, V1, P298, DOI 10.1002/2017GH000104
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Stensgaard AS, 2016, GEOSPATIAL HEALTH, V11, P94, DOI 10.4081/gh.2016.406
   Stevenson J, 2012, EMERG INFECT DIS, V18, P1547, DOI 10.3201/eid1809.120283
   Suss J, 2008, J TRAVEL MED, V15, P39, DOI 10.1111/j.1708-8305.2007.00176.x
   Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2
   The malERA Refresh Consultative Panel on Combination Interventions and Modelling, 2017, PLOS MED, V14
   Thomas SJ, 2013, CURR OPIN INFECT DIS, V26, P429, DOI 10.1097/01.qco.0000433310.28771.cc
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tjaden NB, 2018, TRENDS PARASITOL, V34, P227, DOI 10.1016/j.pt.2017.11.006
   Tokarevich NK, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8448
   Tong MX, 2018, SOC SCI MED, V206, P60, DOI 10.1016/j.socscimed.2018.04.021
   Tonnang HEZ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-111
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991
   van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009
   Velasco E, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1915-8
   Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   Warszawski L, 2014, P NATL ACAD SCI USA, V111, P3228, DOI 10.1073/pnas.1312330110
   Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9
   Watts N, 2017, LANCET, V389, P1151, DOI 10.1016/S0140-6736(16)32124-9
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889
   WHO (World Health Organization), 2017, WORLD MALARIA REPORT
   Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208
   Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318
   Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188
   ZUKOWSKI SH, 1993, VET PARASITOL, V47, P51, DOI 10.1016/0304-4017(93)90175-M
NR 202
TC 19
Z9 19
U1 30
U2 94
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0077-8923
EI 1749-6632
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD JAN
PY 2019
VL 1436
IS 1
SI SI
BP 157
EP 173
DI 10.1111/nyas.13950
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HJ9TZ
UT WOS:000457543300009
PM 30120891
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Abernathy, E
   Mateo, R
   Majzoub, K
   van Buuren, N
   Bird, SW
   Carette, JE
   Kirkegaard, K
AF Abernathy, Emma
   Mateo, Roberto
   Majzoub, Karim
   van Buuren, Nick
   Bird, Sara W.
   Carette, Jan E.
   Kirkegaard, Karla
TI Differential and convergent utilization of autophagy components by
   positive-strand RNA viruses
SO PLOS BIOLOGY
LA English
DT Article
ID UNCONVENTIONAL SECRETION; ULK1 COMPLEX; EARLY STEPS; PROTEINS;
   REPLICATION; LC3; ATG9; INHIBITION; INFECTION; MACHINERY
AB Many viruses interface with the autophagy pathway, a highly conserved process for recycling cellular components. For three viral infections in which autophagy constituents are proviral (poliovirus, dengue, and Zika), we developed a panel of knockouts (KOs) of autophagy-related genes to test which components of the canonical pathway are utilized. We discovered that each virus uses a distinct set of initiation components; however, all three viruses utilize autophagy-related gene 9 (ATG9), a lipid scavenging protein, and LC3 (light-chain 3), which is involved in membrane curvature. These results show that viruses use noncanonical routes for membrane sculpting and LC3 recruitment. By measuring viral RNA abundance, we also found that poliovirus utilizes these autophagy components for intracellular growth, while dengue and Zika virus only use autophagy components for post-RNA replication processes. Comparing how RNA viruses manipulate the autophagy pathway reveals new noncanonical autophagy routes, explains the exacerbation of disease by starvation, and uncovers common targets for antiviral drugs.
C1 [Abernathy, Emma; Mateo, Roberto; van Buuren, Nick; Kirkegaard, Karla] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.
   [Abernathy, Emma; Mateo, Roberto; Majzoub, Karim; van Buuren, Nick; Bird, Sara W.; Carette, Jan E.; Kirkegaard, Karla] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Majzoub, Karim] Univ Strasbourg, INSERM, U1110, Inst Viral & Liver Dis, Strasbourg, France.
RP Kirkegaard, K (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Kirkegaard, K (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
EM karlak@stanford.edu
OI Carette, Jan/0000-0002-5187-8070; Majzoub, Karim/0000-0001-7345-6840
FU Jane Coffin Childs Postdoctoral Fellowship JCCfund.org; National
   Institutes of Allergy and Infectious DiseaseUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19-A109662]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R56-AI103500, DP2 AI104557]; Stanford Child Health Research Institute;
   Stanford University School of Medicine
FX Jane Coffin Childs Postdoctoral Fellowship JCCfund.org (to EA). The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. National
   Institutes of Allergy and Infectious Disease (grant number U19-A109662).
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. National
   Institutes of Health (grant number R56-AI103500). The funder had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. National Institutes of Health (grant
   number DP2 AI104557). (to JEC). The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. Stanford Child Health Research Institute (to KM). The funder
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. Stanford University School of
   Medicine. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109
   Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694
   Beale R, 2014, CELL HOST MICROBE, V15, P239, DOI 10.1016/j.chom.2014.01.006
   Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11
   Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111
   Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098
   Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098
   Cemma M, 2016, AUTOPHAGY, V12, P1440, DOI 10.1080/15548627.2016.1191724
   Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108
   Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249
   Crawford SE, 2012, P NATL ACAD SCI USA, V109, pE3405, DOI 10.1073/pnas.1216539109
   Delorme-Axford E, 2018, AUTOPHAGY, V14, P365, DOI 10.1080/15548627.2017.1401425
   Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154
   Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031
   Egger D, 2000, J VIROL, V74, P6570, DOI 10.1128/JVI.74.14.6570-6580.2000
   Farhan H, 2017, MOL BIOL CELL, V28, P1161, DOI 10.1091/mbc.E16-11-0762
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475
   Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200
   Ge L, 2014, ELIFE, V3, DOI 10.7554/eLife.04135
   Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608
   Grose C, 2016, AUTOPHAGY, V12, P1429, DOI 10.1080/15548627.2016.1203489
   Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114
   Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200
   Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200
   Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263
   Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x
   Koike S, 2016, METHODS MOL BIOL, V1387, P129, DOI 10.1007/978-1-4939-3292-4_7
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Liang CG, 2008, AUTOPHAGY, V4, P268, DOI 10.4161/auto.5210
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586
   Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089
   Martrus G, 2016, J VIROL, V90, P9018, DOI 10.1128/JVI.01448-16
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005
   Monastyrska I, 2013, AUTOPHAGY, V9, P164, DOI 10.4161/auto.22743
   Munz C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00269
   Nguyen N, 2017, J MOL BIOL, V429, P457, DOI 10.1016/j.jmb.2017.01.006
   Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455
   Noda T, 2010, SEMIN CELL DEV BIOL, V21, P671, DOI 10.1016/j.semcdb.2010.04.002
   Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004
   Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746
   Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007
   Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015
   PFISTER T, 1992, VIROLOGY, V188, P676, DOI 10.1016/0042-6822(92)90522-Q
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044
   RACANIELLO VR, 1981, SCIENCE, V214, P916, DOI 10.1126/science.6272391
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078
   Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013
   Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207
   Richards AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003046
   Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045
   Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014
   Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681
   Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80
   Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996
   Schwartz M, 2004, P NATL ACAD SCI USA, V101, P11263, DOI 10.1073/pnas.0404157101
   Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005
   Shvets E, 2011, AUTOPHAGY, V7, P683, DOI 10.4161/auto.7.7.15279
   Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014
   Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53
   Soreng K, 2018, EMBO REP, V19, DOI 10.15252/embr.201744837
   Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000
   Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200
   Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233
   Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07
   Tian SH, 2010, AUTOPHAGY, V6, P1032, DOI 10.4161/auto.6.8.13336
   Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831
   van Buuren N, 2018, ELIFE, V7, DOI 10.7554/eLife.32579
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79
   Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292
   Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061
   Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172
   Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021
   Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104
   Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
NR 108
TC 19
Z9 19
U1 3
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JAN
PY 2019
VL 17
IS 1
AR e2006926
DI 10.1371/journal.pbio.2006926
PG 28
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA HK0NH
UT WOS:000457596000008
PM 30608919
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vogels, CBF
   Ruckert, C
   Cavany, SM
   Perkins, TA
   Ebel, GD
   Grubaugh, ND
AF Vogels, Chantal B. F.
   Ruckert, Claudia
   Cavany, Sean M.
   Perkins, T. Alex
   Ebel, Gregory D.
   Grubaugh, Nathan D.
TI Arbovirus coinfection and co-transmission: A neglected public health
   concern?
SO PLOS BIOLOGY
LA English
DT Article
ID ZIKA VIRUS-INFECTION; CHIKUNGUNYA VIRUS; DENGUE VIRUS; AEDES-AEGYPTI;
   CO-CIRCULATION; CLINICAL PRESENTATION; CONCURRENT ISOLATION; DUAL
   INFECTION; TRANSMISSION; PATIENT
AB Epidemiological synergy between outbreaks of viruses transmitted by Aedes aegypti mosquitoes, such as chikungunya, dengue, and Zika viruses, has resulted in coinfection of humans with multiple viruses. Despite the potential impact on public health, we know only little about the occurrence and consequences of such coinfections. Here, we review the impact of coinfection on clinical disease in humans, discuss the possibility for co-transmission from mosquito to human, and describe a role for modeling transmission dynamics at various levels of co-transmission. Solving the mystery of virus coinfections will reveal whether they should be viewed as a serious concern for public health.
C1 [Vogels, Chantal B. F.; Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Ruckert, Claudia; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Cavany, Sean M.; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Cavany, Sean M.; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
RP Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
EM nathan.grubaugh@yale.edu
OI Cavany, Sean/0000-0002-2559-797X; Grubaugh, Nathan/0000-0003-2031-1933;
   Ruckert, Claudia/0000-0003-3732-6752; Perkins, Alex/0000-0002-7518-4014;
   Vogels, Chantal/0000-0003-0027-6480
FU NWO RubiconNetherlands Organization for Scientific Research (NWO)
   [019.181EN.004]; NIH NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI067380, 1P01AI098670];
   DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [D16AP00114]
FX CBFV is supported by NWO Rubicon 019.181EN.004, CR and GDE are supported
   by NIH NIAID AI067380, SMC and TAP are supported by NIH NIAID
   1P01AI098670, and TAP is supported by DARPA D16AP00114. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209
   Alizon S, 2013, EVOLUTION, V67, P921, DOI 10.1111/j.1558-5646.2012.01827.x
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Delgado FG, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090480
   do Rosario MS, 2018, INT J INFECT DIS, V75, P11, DOI 10.1016/j.ijid.2018.07.019
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Estofolete CF, 2019, J INFECT PUBLIC HEAL, V12, P178, DOI 10.1016/j.jiph.2018.09.007
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gandhi BS, INT J HLTH BIOMED RE, V3, P117, DOI [10.4049/jimmunol.0904181, DOI 10.4049/JIMMUNOL.0904181]
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grubaugh N. D., 2017, NATURE, V90, P4864
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gunasekaran P, 2012, INT J PHARM BIO SCI, V3, P374
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P972, DOI 10.4269/ajtmh.1969.18.972
   Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hollidge BS, 2011, VIRUSES-BASEL, V3, P629, DOI 10.3390/v3060629
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kalawat U, 2011, INDIAN J PATHOL MICR, V54, P844, DOI 10.4103/0377-4929.91518
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   MING CK, 1974, B WORLD HEALTH ORGAN, V51, P227
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohanty Indrani, 2013, J Family Med Prim Care, V2, P33, DOI 10.4103/2249-4863.109939
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Mourya DT, 2018, INDIAN J MED RES, V147, P88, DOI 10.4103/ijmr.IJMR_1142_17
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Myrielle Dupont- Rouzeyrol, 2015, EMERG INFECT DIS, V21, P381
   Nayar S K, 2007, Med J Malaysia, V62, P335
   Neeraja M, 2013, J CLIN DIAGN RES, V7, P457, DOI 10.7860/JCDR/2013/4786.2798
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Omarjee R, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.13.20753
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Prata-Barbosa A, 2018, INT J INFECT DIS, V72, P25, DOI 10.1016/j.ijid.2018.04.4320
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P443
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Ruiz Silva M, 2017, PLOS NEGLECT TROP D, V11
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Saswat T, 2019, J MED VIROL, V91, P163, DOI 10.1002/jmv.25307
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
   Singh J, 2018, TZU CHI MED J, V30, P158, DOI 10.4103/tcmj.tcmj_138_17
   Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671
   Supramaniam A, 2018, J GEN VIROL, V99, P953, DOI 10.1099/jgv.0.001024
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   van Tol S, 2016, ADV INSECT PHYSIOL, V51, P243, DOI 10.1016/bs.aiip.2016.04.006
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   White SK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006505
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zaidi MB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2942-1
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
NR 99
TC 17
Z9 17
U1 2
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JAN
PY 2019
VL 17
IS 1
AR e3000130
DI 10.1371/journal.pbio.3000130
PG 16
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA HK0NH
UT WOS:000457596000030
PM 30668574
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Achee, NL
   Grieco, JP
   Vatandoost, H
   Seixas, G
   Pinto, J
   Ching-Ng, L
   Martins, AJ
   Juntarajumnong, W
   Corbel, V
   Gouagna, C
   David, JP
   Logan, JG
   Orsborne, J
   Marois, E
   Devine, GJ
   Vontas, J
AF Achee, Nicole L.
   Grieco, John P.
   Vatandoost, Hassan
   Seixas, Goncalo
   Pinto, Joao
   Ching-Ng, Lee
   Martins, Ademir J.
   Juntarajumnong, Waraporn
   Corbel, Vincent
   Gouagna, Clement
   David, Jean-Philippe
   Logan, James G.
   Orsborne, James
   Marois, Eric
   Devine, Gregor J.
   Vontas, John
TI Alternative strategies for mosquito-borne arbovirus control
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID ALBOPICTUS DIPTERA-CULICIDAE; LARVICIDE BACILLUS-SPHAERICUS; STANDARD
   OPERATING PROCEDURES; VECTORS AEDES-AEGYPTI; GENE DRIVE; POPULATION
   SUPPRESSION; BIOLOGICAL-CONTROL; ADULT MOSQUITOS; DENGUE VECTOR; SUGAR
   BAITS
AB Background Mosquito-borne virusessuch as Zika, chikungunya, dengue fever, and yellow fever, among othersare of global importance. Although vaccine development for prevention of mosquito-borne arbovirus infections has been a focus, mitigation strategies continue to rely on vector control. However, vector control has failed to prevent recent epidemics and arrest expanding geographic distribution of key arboviruses, such as dengue. As a consequence, there has been increasing necessity to further optimize current strategies within integrated approaches and advance development of alternative, innovative strategies for the control of mosquito-borne arboviruses.
   Methods and findings This review, intended as a general overview, is one of a series being generated by the Worldwide Insecticide resistance Network (WIN). The alternative strategies discussed reflect those that are currently under evaluation for public health value by the World Health Organization (WHO) and represent strategies of focus by globally recognized public health stakeholders as potential insecticide resistance (IR)-mitigating strategies. Conditions where these alternative strategies could offer greatest public health value in consideration of mitigating IR will be dependent on the anticipated mechanism of action. Arguably, the most pressing need for endorsement of the strategies described here will be the epidemiological evidence of a public health impact.
   Conclusions As the burden of mosquito-borne arboviruses, predominately those transmitted by Aedes aegypti and A. albopictus, continues to grow at a global scale, new vector-control tools and integrated strategies will be required to meet public health demands. Decisions regarding implementation of alternative strategies will depend on key ecoepidemiological parameters that each is intended to optimally impact toward driving down arbovirus transmission.
   Author summary International public health workers are challenged by the burden of arthropod-borne viral diseases, to include mosquito-borne arboviruses transmitted by Aedes aegypti and A. albopictus due in part to lack of sustainable vector control and insecticide resistance (IR), as well as the inability to scale up and sustain existing interventions for prevention of urban epidemics. As a consequence, there has been increasing interest to advance the development of alternative methods. This review provides a general overview of alternative vector-control strategies under development for the control of arbovirus mosquito vectors and highlights how each could offer innovative public health value. Considerations to regulations, acceptance, and sustainability are also provided.
C1 [Achee, Nicole L.; Grieco, John P.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Vatandoost, Hassan] Tehran Univ Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.
   [Seixas, Goncalo; Pinto, Joao] Univ Nova Lisboa, IHMT, GHTM, Lisbon, Portugal.
   [Ching-Ng, Lee] NEA, EHI, Singapore, Singapore.
   [Martins, Ademir J.] Fundacao Oswaldo Cruz FIOCRUZ, IOC, Rio De Janeiro, Brazil.
   [Juntarajumnong, Waraporn] KU, Dept Entomol, Bangkok, Thailand.
   [Corbel, Vincent; Gouagna, Clement] Univ Montpellier, IRD, Malad Infect & Vecteurs, Ecol Genet Evolut & Controle, Montpellier, France.
   [David, Jean-Philippe] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine LECA, Domaine Univ St Martin dHeres, Grenoble, France.
   [Logan, James G.; Orsborne, James] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Logan, James G.] London Sch Hyg & Trop Med, ARCTEC, London, England.
   [Marois, Eric] Univ Strasbourg, CNRS UPR 9022, INSERM U963, Strasbourg, France.
   [Devine, Gregor J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Vontas, John] Fdn Res & Technol FORTH, IMBB, Iraklion, Greece.
   [Vontas, John] Agr Univ Athens, Pesticide Sci Lab, Athens, Greece.
RP Achee, NL (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA.
EM nachee@nd.edu
RI Seixas, Goncalo/F-9282-2014; Pinto, Joao/C-2208-2012; Martins, Ademir
   J./B-4117-2009; Devine, Gregor J/H-1141-2014; DAVID,
   jean-philippe/F-3077-2012
OI Seixas, Goncalo/0000-0001-5745-2153; Pinto, Joao/0000-0001-8572-7708;
   Devine, Gregor J/0000-0001-6312-0390; Vontas, John/0000-0002-8704-2574;
   DAVID, jean-philippe/0000-0002-3950-5909; Martins,
   Ademir/0000-0001-5739-1215
FU World Health Organization's Special Programme for Research and Training
   in Tropical Diseases; WIN network
FX The preparation of this review was funded by an award from the World
   Health Organization's Special Programme for Research and Training in
   Tropical Diseases (http://www.who.int/tdr/) to VC, JPD, and the WIN
   network. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Achee N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-300
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164
   Allan SA, 2011, J VECTOR ECOL, V36, P59, DOI 10.1111/j.1948-7134.2011.00141.x
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Beaghton A, 2017, GENETICS, V205, P1587, DOI 10.1534/genetics.116.197632
   Beaghton A, 2016, THEOR POPUL BIOL, V108, P51, DOI 10.1016/j.tpb.2015.11.005
   Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31
   Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Britch SC, 2016, J AM MOSQUITO CONTR, V32, P341, DOI 10.2987/16-6606.1
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Choi DB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004850
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Endersby-Harshman NM, 2017, J MED ENTOMOL, V54, P1649, DOI 10.1093/jme/tjx145
   Faulde M, 2016, PARASITOL RES, V115, P1573, DOI 10.1007/s00436-015-4892-2
   Federici Brian A., 2007, P25, DOI 10.1007/978-1-4020-5799-1_2
   Fiorenzano JM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040398
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945
   Garcia G, 2016, PYRETHROIDS RESISTAN
   Gorman K, 2016, PEST MANAG SCI, V72, P618, DOI 10.1002/ps.4151
   Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716
   GRIMSTAD PR, 1974, J MED ENTOMOL, V11, P331, DOI 10.1093/jmedent/11.3.331
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6
   Hill N, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-208
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Horstmann S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149738
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Kartzinel MA, 2016, J AM MOSQUITO CONTR, V32, P194, DOI 10.2987/16-6555.1
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Kline DL, 1999, J AM MOSQUITO CONTR, V15, P276
   Lea AO, 1965, MOSQUITO NEWS, V25
   Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Maciel-de Freitas R, 2016, ENTOMOL VISOVE
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406
   Massad E, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20473
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Most B, 2017, PARASITOL RES, V116, P677, DOI 10.1007/s00436-016-5333-6
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210
   Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x
   Naranjo DP, 2013, PARASITOL RES, V112, P1583, DOI 10.1007/s00436-013-3312-8
   National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI
   Ng L, 2017, ENTOMOLOGICAL NEWS B
   Norris EJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020124
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Paz-Soldan VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160386
   Paz-Soldan VA, 2015, AM J TROP MED HYG, V93, P1330, DOI 10.4269/ajtmh.15-0096
   Paz-Soldan VA, 2011, AM J TROP MED HYG, V84, P208, DOI 10.4269/ajtmh.2011.09-0615
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Poopathi S, 2010, J PHYSL PATHOPHYSIOL, V1, P22
   PROVERBS MD, 1969, ANNU REV ENTOMOL, V14, P81, DOI 10.1146/annurev.en.14.010169.000501
   Revay EE, 2014, PARASITOL RES, V113, P73, DOI 10.1007/s00436-013-3628-4
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Robert LL, 1997, J AM MOSQUITO CONTR, V13, P140
   Roberts D, 2016, EXCELLENT POWDER DDT
   Rodriguez-Perez MA, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P241
   SCHLEIN Y, 1990, MED VET ENTOMOL, V4, P283, DOI 10.1111/j.1365-2915.1990.tb00441.x
   Schlein Y, 2008, J MED ENTOMOL, V45, P384, DOI 10.1603/0022-2585(2008)45[384:AATMCU]2.0.CO;2
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Sirisopa P, 2014, KASETSART J NAT SCI
   Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x
   STAMM DD, 1962, AM J HYG, V76, P61, DOI 10.1093/oxfordjournals.aje.a120265
   Syafruddin D, 2014, AM J TROP MED HYG, V91, P1079, DOI 10.4269/ajtmh.13-0735
   Tsunoda T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-6
   Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Wagman JM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003726
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wesson D, 2012, INT J INFECT DIS, V16, pE473, DOI 10.1016/j.ijid.2012.05.687
   WHO, 2013, GUID EFF TEST SPAT R
   WHO, 2012, GLOB PLAN INS RES MA
   WHO, 2012, E MEDITERR HEALTH J, V18, P392
   WHO Malaria Policy Advisory Committee Meeting, 2015, WHO MAL POL ADV COMM
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, WHO PEST EV SCHEM
   World Health Organization, WHO PREQ
   World Health Organization, VECT CONTR ADV GROUP
   World Health Organization, 2017, MOSQ CONTR CAN IT ST
   World Health Organization-VCAG, 5 M VECT CONTR ADV G
   Xi ZY, 2005, APPL ENVIRON MICROB, V71, P3199, DOI 10.1128/AEM.71.6.3199-3204.2005
   Xue RD, 2003, J ECON ENTOMOL, V96, P1559, DOI 10.1603/0022-0493-96.5.1559
   Xue RD, 2008, J AM MOSQUITO CONTR, V24, P415, DOI 10.2987/5683.1
   Xue RD, 2006, J AM MOSQUITO CONTR, V22, P497, DOI 10.2987/8756-971X(2006)22[497:AOBABT]2.0.CO;2
   Yao TT, 2015, MED VET ENTOMOL, V29, P37, DOI 10.1111/mve.12088
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2
NR 114
TC 31
Z9 32
U1 7
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2019
VL 13
IS 1
AR e0006822
DI 10.1371/journal.pntd.0006822
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HJ7SX
UT WOS:000457398700008
PM 30605475
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU de Freitas, CS
   Higa, LM
   Sacramento, CQ
   Ferreira, AC
   Reis, PA
   Delvecchio, R
   Monteiro, FL
   Barbosa-Lima, G
   Westgarth, HJ
   Vieira, YR
   Mattos, M
   Rocha, N
   Hoelz, LVB
   Leme, RPP
   Bastos, MM
   Rodrigues, GOL
   Lopes, CEM
   Queiroz, CM
   Lima, CX
   Costa, VV
   Teixeira, MM
   Bozza, FA
   Bozza, PT
   Boechat, N
   Tanuri, A
   Souza, TML
AF de Freitas, Caroline S.
   Higa, Luiza M.
   Sacramento, Carolina Q.
   Ferreira, Andre C.
   Reis, Patricia A.
   Delvecchio, Rodrigo
   Monteiro, Fabio L.
   Barbosa-Lima, Giselle
   Westgarth, Harrison James
   Vieira, Yasmine Rangel
   Mattos, Mayara
   Rocha, Natasha
   Boas Hoelz, Lucas Villas
   Paes Leme, Rennan Papaleo
   Bastos, Monica M.
   Rodrigues, Gisele Olinto L.
   Lopes, Carla Elizabeth M.
   Queiroz-Junior, Celso Martins
   Lima, Cristiano X.
   Costa, Vivian V.
   Teixeira, Mauro M.
   Bozza, Fernando A.
   Bozza, Patricia T.
   Boechat, Nubia
   Tanuri, Amilcar
   Souza, Thiago Moreno L.
TI Yellow fever virus is susceptible to sofosbuvir both in vitro and in
   vivo
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; RIBAVIRIN; REPLICATION; INTERFERON; POLYMERASE; MODELS;
   DENGUE
AB Yellow fever virus (YFV) is a member of the Flaviviridae family. In Brazil, yellow fever (YF) cases have increased dramatically in sylvatic areas neighboring urban zones in the last few years. Because of the high lethality rates associated with infection and absence of any antiviral treatments, it is essential to identify therapeutic options to respond to YFV outbreaks. Repurposing of clinically approved drugs represents the fastest alternative to discover antivirals for public health emergencies. Other Flaviviruses, such as Zika (ZIKV) and dengue (DENV) viruses, are susceptible to sofosbuvir, a clinically approved drug against hepatitis C virus (HCV). Our data showed that sofosbuvir docks onto YFV RNA polymerase using conserved amino acid residues for nucleotide binding. This drug inhibited the replication of both vaccine and wild-type strains of YFV on human hepatoma cells, with EC50 values around 5 M. Sofosbuvir protected YFV-infected neonatal Swiss mice and adult type I interferon receptor knockout mice (A129(-/-)) from mortality and weight loss. Because of its safety profile in humans and significant antiviral effects in vitro and in mice, Sofosbuvir may represent a novel therapeutic option for the treatment of YF. Key-words: Yellow fever virus; Yellow fever, antiviral; sofosbuvir
   Author summary Yellow fever virus is transmitted by mosquitoes and its infection may be asymptomatic or lead to a wide clinical spectrum ranging from a mild febrile illness to a potentially lethal viral hemorrhagic fever characterized by liver damage. Although a yellow fever vaccine is available, low coverage allows 80,000-200,000 cases and 30,000-60,000 deaths annually worldwide. There are no specific therapy and treatment relies on supportive care, reinforcing an urgent need for antiviral repourposing. Here, we showed that sofosbuvir, clinically approved against hepatitis C, inhibits yellow fever virus replication in liver cell lines and animal models. In vitro, sofosbuvir inhibits viral RNA replication, decreases the number of infected cells and the production of infectious virus particles. These data is particularly relevante since the liver is the main target of yellow fever infection. Sofosbuvir also protected infected animals from mortality, weight loss and liver injury, especially prophylatically. Our pre-clinical results supports a second use of sofosbuvir against yellow fever.
C1 [de Freitas, Caroline S.; Sacramento, Carolina Q.; Ferreira, Andre C.; Reis, Patricia A.; Mattos, Mayara; Rocha, Natasha; Bozza, Fernando A.; Bozza, Patricia T.; Souza, Thiago Moreno L.] Fdn Oswaldo Cruz Fiocruz, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [de Freitas, Caroline S.; Sacramento, Carolina Q.; Ferreira, Andre C.; Vieira, Yasmine Rangel; Mattos, Mayara; Rocha, Natasha; Souza, Thiago Moreno L.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, RJ, Brazil.
   [Higa, Luiza M.; Delvecchio, Rodrigo; Monteiro, Fabio L.; Westgarth, Harrison James; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Lab Virol Mol, Rio de Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Bozza, Fernando A.; Souza, Thiago Moreno L.] Fiocruz MS, INI, Rio De Janeiro, RJ, Brazil.
   [Boas Hoelz, Lucas Villas; Paes Leme, Rennan Papaleo; Bastos, Monica M.; Boechat, Nubia] Fiocruz MS, Inst Tecnol Farm Farmanguinhos, Rio De Janeiro, RJ, Brazil.
   [Rodrigues, Gisele Olinto L.; Lopes, Carla Elizabeth M.; Costa, Vivian V.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Ctr Res & Dev Pharmaceut, Belo Horizonte, MG, Brazil.
   [Rodrigues, Gisele Olinto L.; Lopes, Carla Elizabeth M.; Costa, Vivian V.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Morphol, Res Grp Arboviral Dis, Belo Horizonte, MG, Brazil.
   [Queiroz-Junior, Celso Martins] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Morphol, Cardiac Lab, Belo Horizonte, MG, Brazil.
   [Lima, Cristiano X.] Univ Fed Minas Gerais, Dept Cirurgia, Fac Med, Belo Horizonte, MG, Brazil.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, Immunopharmacol Lab, Belo Horizonte, MG, Brazil.
RP Souza, TML (corresponding author), Fdn Oswaldo Cruz Fiocruz, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, INI, Rio De Janeiro, RJ, Brazil.
EM tmoreno@cdts.fiocruz.br
RI Teixeira, Mauro M/A-4587-2008; Boechat, Nubia/N-1406-2014;
   Queiroz-Junior, Celso/L-5438-2013; Boechat, Nubia/K-2520-2019; Costa,
   Vivian VVC/I-2499-2018; Souza, Thiago Moreno L./G-2900-2012; Higa,
   Luiza/W-2698-2019
OI Teixeira, Mauro M/0000-0002-6944-3008; Boechat,
   Nubia/0000-0003-0146-2218; Queiroz-Junior, Celso/0000-0002-7884-7709;
   Boechat, Nubia/0000-0003-0146-2218; Costa, Vivian
   VVC/0000-0002-0175-642X; Souza, Thiago Moreno L./0000-0003-2212-3899;
   Lima Monteiro, Fabio Luis/0000-0002-9107-6865; Bozza, Fernando
   Augusto/0000-0003-4878-0256; Bozza, Patricia/0000-0001-8349-9529
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/201.573/2014]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [306389/2014-2,
   425636/2016-0]; National Institute of Science and Technology in Dengue
   (INCT dengue) - Brazilian National Science Council (CNPq, Brazil); Minas
   Gerais Foundation for Science (FAPEMIG, Brazil); National Council for
   Scientific and Technological Development (CNPq), Ministry of Science,
   Technology, Information and Communications [465313/2014-0]; Ministry of
   Education/CAPESCAPES [465313/2014-0]; Research Foundation of the State
   of Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [465313/2014-0]; Oswaldo
   Cruz Foundation/FIOCRUZ; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior Brasil (CAPES)CAPES [001]
FX The financial support was provided by Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ -http://www.faperj.br/ - Grant Number
   E-26/201.573/2014) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq - http://cnpq.br/-Grant Numbers 306389/2014-2 and
   425636/2016-0). TMLS received the funds. This work has received
   financial support from the National Institute of Science and Technology
   in Dengue (INCT dengue), a scheme funded by the Brazilian National
   Science Council (CNPq, Brazil) and Minas Gerais Foundation for Science
   (FAPEMIG, Brazil). Funding was also provided by National Council for
   Scientific and Technological Development (CNPq), Ministry of Science,
   Technology, Information and Communications (no. 465313/2014-0); Ministry
   of Education/CAPES (no. 465313/2014-0); Research Foundation of the State
   of Rio de Janeiro/FAPERJ (no. 465313/2014-0) and Oswaldo Cruz
   Foundation/FIOCRUZ to National Institute for Science and Technology on
   Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for
   Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ,
   Brazil. This study was financed in part by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance
   Code 001. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amarela CF, 2017, 432017 INFORME
   [Anonymous], 2017, WILL YELL FEV STRIK
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Babusis D, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02587-17
   Barnett ED, 2018, CLIN INFECT DIS, V44, P850
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Bhatia HK, 2014, J PHARMACOL PHARMACO, V5, P278, DOI 10.4103/0976-500X.142464
   Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002
   Buckwold VE, 2003, ANTIMICROB AGENTS CH, V47, P2293, DOI 10.1128/AAC.47.7.2293-2298.2003
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Costa VV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001663
   de Santana F, 2014, B FEBRE CHIKUNGUNYA
   Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   FDA FaDA, COP RIB TABL 2015
   Ferreira AC, 2018, ANTIMICROB AGENTS CH
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gilead, PROD MON PR SOVALDI
   Gilead Sciences Canada I, 2015, PROD MON SOVALDI SOF
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Julander JG, 2007, ANTIVIR RES, V73, P140, DOI 10.1016/j.antiviral.2006.08.008
   Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010
   Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057
   Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009
   Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041
   Paulo F-FdMdUdS, 1 LIVER TRANSPLANT D
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Reed LJ, 1938, AM J HYG
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Smolders EJ, 2016, DRUG SAFETY, V39, P589, DOI 10.1007/s40264-016-0420-2
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Song ATW, 2018, HEPATOLOGY
   Souza TML, 2008, ANTIVIR RES, V77, P20, DOI 10.1016/j.antiviral.2007.08.011
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Villegoureix I., 2018, VILL I
   Xu HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06612-2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
NR 51
TC 11
Z9 11
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2019
VL 13
IS 1
AR e0007072
DI 10.1371/journal.pntd.0007072
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HJ7SX
UT WOS:000457398700038
PM 30699122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia, GD
   Sylvestre, G
   Aguiar, R
   da Costa, GB
   Martins, AJ
   Lima, JBP
   Petersen, MT
   Lourenco-de-Oliveira, R
   Shadbolt, MF
   Rasic, G
   Hoffmann, AA
   Villela, DAM
   Dias, FBS
   Dong, Y
   O'Neill, SL
   Moreira, LA
   Maciel-de-Freitas, R
AF Garcia, Gabriela de Azambuja
   Sylvestre, Gabriel
   Aguiar, Raquel
   da Costa, Guilherme Borges
   Martins, Ademir Jesus
   Pereira Lima, Jose Bento
   Petersen, Martha T.
   Lourenco-de-Oliveira, Ricardo
   Shadbolt, Marion F.
   Rasic, Gordana
   Hoffmann, Ary A.
   Villela, Daniel A. M.
   Dias, Fernando B. S.
   Dong, Yi
   O'Neill, Scott L.
   Moreira, Luciano A.
   Maciel-de-Freitas, Rafael
TI Matching the genetics of released and local Aedes aegypti populations is
   critical to assure Wolbachia invasion
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; DIPTERA-CULICIDAE; HARMONIC CONVERGENCE; DENGUE VECTOR;
   RESISTANCE; ESTABLISHMENT; INFECTION; FEMALES; STRAIN; TUNE
AB Background Traditional vector control approaches such as source reduction and insecticide spraying have limited effect on reducing Aedes aegypti population. The endosymbiont Wolbachia is pointed as a promising tool to mitigate arbovirus transmission and has been deployed worldwide. Models predict a rapid increase on the frequency of Wolbachia-positive Ae. aegypti mosquitoes in local settings, supported by cytoplasmic incompatibility (CI) and high maternal transmission rate associated with the wMelBr strain.
   Methodology/principle findings Wolbachia wMelBr strain was released for 20 consecutive weeks after receiving >87% approval of householders of the isolated community of Tubiacanga, Rio de Janeiro. wMelBr frequency plateued40% during weeks 7-19, peaked 65% but dropped as releases stopped. A high (97.56%) maternal transmission was observed. Doubling releases and deploying mosquitoes with large wing length and low laboratory mortality produced no detectable effects on invasion trend. By investigating the lab colony maintenance procedures backwardly, pyrethroid resistant genotypes in wMelBr decreased from 68% to 3.5% after 17 generations. Therefore, we initially released susceptible mosquitoes in a local population highly resistant to pyrethroids which, associated with the over use of insecticides by householders, ended jeopardizing Wolbachia invasion. A new strain (wMelRio) was produced after backcrossing wMelBr females with males from field to introduce mostly pyrethroid resistance alleles. The new strain increased mosquito survival but produced relevant negative effects on Ae. aegypti fecundity traits, reducing egg clutche size and egg hatch. Despite the cost on fitness, wMelRio successful established where wMelBr failed, revealing that matching the local population genetics, especially insecticide resistance background, is critical to achieve invasion.
   Conclusions/significance Local householders support was constantly high, reaching 90% backing on the second release (wMelRio strain). Notwithstanding the drought summer, the harsh temperature recorded (daily average above 30 degrees C) did not seem to affect the expression of maternal transmission of wMel on a Brazilian background. Wolbachia deployment should match the insecticide resistance profile of the wild population to achieve invasion. Considering pyrethroid-resistance is a widely distributed phenotype in natural Ae. aegypti populations, future Wolbachia deployments must pay special attention in maintaining insecticide resistance in lab colonies for releases.
   Author summary Traditional vector control methods have been showing limited success in managing arboviruses disease outbreaks in endemic areas. The endosymbiont bacterium Wolbachia was microinjected on the mosquito Aedes aegypti and later showed the ability to block dengue, chikungunya and Zika viruses' development on vector body. Nowadays, Wolbachia-infected Ae. aegypti has been deployed in twelve countries as an attempt to mitigate arboviruses transmission. Herein, we report the failure of Wolbachia releases on a suburban isolated district of Rio de Janeiro/Brazil. For the first time, we demonstrated that the insecticide resistance profile of released and wild mosquitoes is a critical feature for achieving Wolbachia invasion. Special consideration must be given to avoid releasing susceptible mosquitoes where native populations are resistant, since local householders might rely on domestic use of spraying insecticides (mostly pyrethroids) to protect themselves from mosquito bites.
C1 [Garcia, Gabriela de Azambuja; Sylvestre, Gabriel; Petersen, Martha T.; Lourenco-de-Oliveira, Ricardo; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Aguiar, Raquel] Fiocruz MS, Inst Oswaldo Cruz, Serv Jornalismo & Comunicacao, Rio De Janeiro, Brazil.
   [da Costa, Guilherme Borges] Fiocruz MS, World Mosquito Program, Rio De Janeiro, Brazil.
   [Martins, Ademir Jesus; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, Brazil.
   [Martins, Ademir Jesus; Pereira Lima, Jose Bento; Lourenco-de-Oliveira, Ricardo; Moreira, Luciano A.; Maciel-de-Freitas, Rafael] CNPq, INCT EM, Rio De Janeiro, Brazil.
   [Shadbolt, Marion F.; Rasic, Gordana; Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Bio21 Inst, Parkville, Vic, Australia.
   [Villela, Daniel A. M.] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Dias, Fernando B. S.] Fiocruz MS, Gabinete Presidencia, Rio De Janeiro, Brazil.
   [Dong, Yi; O'Neill, Scott L.] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
   [Moreira, Luciano A.] Fiocruz MS, Inst Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
RP Maciel-de-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.; Maciel-de-Freitas, R (corresponding author), CNPq, INCT EM, Rio De Janeiro, Brazil.
EM freitas@ioc.fiocruz.br
RI O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; Hoffmann,
   Ary/R-2972-2019; Martins, Ademir J./B-4117-2009; Rasic,
   Gordana/AAO-4360-2020; Villela, Daniel/AAG-6445-2019
OI O'Neill, Scott L/0000-0002-4131-3615; O'Neill,
   Scott/0000-0002-4131-3615; Hoffmann, Ary/0000-0001-9497-7645; Rasic,
   Gordana/0000-0002-3057-0093; Villela, Daniel/0000-0001-8371-2959;
   Martins, Ademir/0000-0001-5739-1215; Shadbolt,
   Marion/0000-0001-7505-5418
FU Bill and Melinda Gates Foundation through a grant as part the
   Vector-Based Transmission of Control: Discovery Research (VCTR) program
   of the Grand Challenges in Global Health initiative [OPP1153619]; CNPq -
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [422092/2017-7]; FAPERJ - Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa no Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [E_41/2013]
FX SLO: This work was supported by the Bill and Melinda Gates Foundation
   through a grant as part the Vector-Based Transmission of Control:
   Discovery Research (VCTR) program of the Grand Challenges in Global
   Health initiative [OPP1153619] managed by the Foundation for the
   National Institutes of Health. RMF: This work was supported by CNPq -
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (422092/2017-7), and FAPERJ - Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa no Estado do Rio de Janeiro (E_41/2013). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013
   Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brito LP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2410819
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354
   Cator LJ, 2011, ANIM BEHAV, V82, P627, DOI 10.1016/j.anbehav.2011.07.013
   Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330
   Endersby-Harshman NM, 2017, J MED ENTOMOL, V54, P1649, DOI 10.1093/jme/tjx145
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Garcia GD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160196
   Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Harbach R.E., 1980, TAXONOMISTS GLOSSARY
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0371
   Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379
   Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   McNaughton D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002794
   Gesto JSM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2695-x
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Montero M., 2006, HACER TRANSFORMAR ME
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   WHO, 1981, INSTR DET SUSC RES M, P1
   World Health Organization (WHO), 1998, WHOCDSCPCMAL9812
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58
NR 59
TC 21
Z9 21
U1 3
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2019
VL 13
IS 1
AR e0007023
DI 10.1371/journal.pntd.0007023
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HJ7SX
UT WOS:000457398700020
PM 30620733
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Masel, J
   McCracken, MK
   Gleeson, T
   Morrison, B
   Rutherford, G
   Imrie, A
   Jarman, RG
   Koren, M
   Pollett, S
AF Masel, Jennifer
   McCracken, Michael K.
   Gleeson, Todd
   Morrison, Brian
   Rutherford, George
   Imrie, Allison
   Jarman, Richard G.
   Koren, Michael
   Pollett, Simon
TI Does prior dengue virus exposure worsen clinical outcomes of Zika virus
   infection? A systematic review, pooled analysis and lessons learned
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; RESPONSES; PATHOGENESIS; IMMUNITY; LOAD
AB Zika virus (ZIKV) recently caused a pandemic complicated by Guillain-Barre syndrome (GBS) and birth defects. ZIKV is structurally similar to the dengue viruses (DENV) and in vitro studies suggest antibody dependent enhancement occurs in ZIKV infections preceded by DENV; however, the clinical significance of this remains unclear. We undertook a PRISMA-adherent systematic review of all current human and non-human primate (NHP) data to determine if prior infection with DENV, compared to DENV-naive hosts, is associated with a greater risk of ZIKV clinical complications or greater ZIKV peak viremia in vivo. We identified 1146 studies in MEDLINE, EMBASE and the grey literature, of which five studies were eligible. One human study indicated no increase in the risk of GBS in ZIKV infections with prior DENV exposure. Two additional human studies showed a small increase in ZIKV viremia in those with prior DENV exposure; however, this was not statistically significant nor was it associated with an increase in clinical severity or adverse pregnancy outcomes. While no meta-analysis was possible using human data, a pooled analysis of the two NHP studies leveraging extended data provided only weak evidence of a 0.39 log10 GE/mL rise in ZIKV viremia in DENV experienced rhesus macaques compared to those with no DENV exposure (p = 0.22). Using a customized quality grading criteria, we further show that no existing published human studies have offered high quality measurement of both acute ZIKV and antecedent DENV infections. In conclusion, limited human and NHP studies indicate a small and non-statistically significant increase in ZIKV viremia in DENV-experienced versus DENV-naive hosts; however, there is no evidence that even a possible small increase in ZIKV viremia would correlate with a change in ZIKV clinical phenotype. More data derived from larger sample sizes and improved sero-assays are needed to resolve this question, which has major relevance for clinical prognosis and vaccine design.
   Author summary Zika virus (ZIKV) is a mosquito borne virus that recently caused a large epidemic with some cases complicated by ascending paralysis (Guillain-Barre syndrome) and birth defects. One major concern is that such complications may be more common in those who have had previous infection with the closely related mosquito-borne dengue virus (DENV) which also circulates in the tropics. Here, we undertook a thorough, structured review of all human and high-order animal literature to synthesize the current evidence about whether ZIKV outcomes are worse in those with previous DENV exposure. We further undertook a pooled analysis across the two major non-human primate studies to improve statistical power. We summarize that, in humans and in non-human primates, prior DENV exposure may lead to a small increase in ZIKV viral load during infection. However, we do not show that any possible increase in ZIKV viral replication is associated with a higher rate of Zika complications or Zika clinical severity. We further graded the quality of these published literature and indicate that substantial improvements in the immunological measurement of ZIKV and DENV exposure in humans are needed to answer these and other pertinent questions about these two epidemic pathogens.
C1 [Masel, Jennifer; Gleeson, Todd; Koren, Michael] USUHS, Dept Med, Bethesda, MD USA.
   [McCracken, Michael K.; Morrison, Brian; Jarman, Richard G.; Koren, Michael; Pollett, Simon] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Rutherford, George] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.
   [Imrie, Allison] Univ Western Australia, Perth, WA, Australia.
   [Pollett, Simon] USUHS, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.
   [Pollett, Simon] Univ Sydney, Marie Bashir Inst Infect Dis, Camperdown, NSW, Australia.
RP Pollett, S (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.; Pollett, S (corresponding author), USUHS, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.; Pollett, S (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis, Camperdown, NSW, Australia.
EM spollett@med.usyd.edu.au
RI Imrie, Allison/AAH-2421-2019
OI McCracken, Michael/0000-0002-4035-5485
FU US Department of Defense Global Emerging Infections Surveillance and
   Response System (DoD-GEIS), a division of the Armed Forces Health
   Surveillance BranchUnited States Department of Defense [P0082_18_WR]
FX SP and RGJ were funded by the US Department of Defense Global Emerging
   Infections Surveillance and Response System (DoD-GEIS), a division of
   the Armed Forces Health Surveillance Branch (WORK UNIT NUMBER:
   P0082_18_WR). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pollett S, 2018, INFECT GENET EVOL, V62, P279, DOI 10.1016/j.meegid.2018.04.032
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Saenz C, 2016, LANCET GLOB HEALTH, V4, pE686, DOI 10.1016/S2214-109X(16)30222-4
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Siraj AS, 2017, ASSESSING POPULATION, V2, DOI DOI 10.1136/BMJGH-2017-00030929082009
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
NR 39
TC 5
Z9 5
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2019
VL 13
IS 1
AR e0007060
DI 10.1371/journal.pntd.0007060
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HJ7SX
UT WOS:000457398700033
PM 30682026
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mehta, R
   Soares, CN
   Medialdea-Carrera, R
   Ellul, M
   da Silva, MTT
   Rosala-Hallas, A
AF Mehta, R.
   Soares, C. N.
   Medialdea-Carrera, R.
   Ellul, M.
   da Silva, M. T. T.
   Rosala-Hallas, A.
TI The spectrum of neurological disease associated with Zika and
   chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series
   (vol 12, e0006212, 2018)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Correction
CR Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
NR 1
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2019
VL 13
IS 1
AR e0007166
DI 10.1371/journal.pntd.0007166
PG 1
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HJ7SX
UT WOS:000457398700070
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tancharoen, C
   Sukjee, W
   Thepparit, C
   Jaimipuk, T
   Auewarakul, P
   Thitithanyanont, A
   Sangma, C
AF Tancharoen, Chompoonuch
   Sukjee, Wannisa
   Thepparit, Chutima
   Jaimipuk, Thitigun
   Auewarakul, Prasert
   Thitithanyanont, Arunee
   Sangma, Chak
TI Electrochemical Biosensor Based on Surface Imprinting for Zika Virus
   Detection in Serum
SO ACS SENSORS
LA English
DT Article
DE Zika virus; surface imprinted polymers; biosensor; electrochemical
   sensor; cyclic voltammetry
ID MOLECULAR-DETECTION; SENSITIVE DETECTION; POLYMERS; SPREAD; SENSOR;
   ASSAY
AB Zika virus (ZIKV) is a flavivirus that was first identified in 1947. Initially, the virus was of little concern for health authorities given there were very few casualties among those suffering an infection. As such, only limited studies were performed on ZIKV. Recently, the viral infection has been linked to microcephaly in infants, which has prompted a dramatic increase in scientific interest in ZIKV research, including methods to allow for rapid virus identification. In this work we report the development of a new type of ZIKV electrochemical biosensor based on surface imprinted polymers and graphene oxide composites. The biosensor was used to detect ZIKV by measuring changes in the electrical signal with changing virus concentrations in buffer and serum using standard electrochemical techniques. The detection limit of our method is similar to the detection limit of the real-time quantitative reverse transcription PCR method.
C1 [Tancharoen, Chompoonuch; Sukjee, Wannisa; Sangma, Chak] Kasetsart Univ, Dept Chem, Fac Sci, Bangkok 10900, Thailand.
   [Thepparit, Chutima; Jaimipuk, Thitigun] Mahidol Univ, Inst Mol Biosci, Bangkok, Nakhon Pathom 73170, Thailand.
   [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok 10700, Thailand.
   [Thitithanyanont, Arunee] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok 10400, Thailand.
   [Sangma, Chak] Kasetsart Univ, Inst Adv Studies, Ctr Adv Studies Nanotechnol Chem Food & Agr Ind, Bangkok 10900, Thailand.
RP Sangma, C (corresponding author), Kasetsart Univ, Dept Chem, Fac Sci, Bangkok 10900, Thailand.; Sangma, C (corresponding author), Kasetsart Univ, Inst Adv Studies, Ctr Adv Studies Nanotechnol Chem Food & Agr Ind, Bangkok 10900, Thailand.
EM fscicsm@ku.ac.th
OI Thitithanyanont, Arunee/0000-0002-9756-4763
FU Thailand Research Fund (TRF), the Royal Golden Jubilee Ph.D. Program
   (RGJ) [PHD/0170/2556]
FX This work was supported by the Thailand Research Fund (TRF), the Royal
   Golden Jubilee Ph.D. Program (RGJ; Grant No. PHD/0170/2556). We thank
   Kasetsart University Research and Development Institute (KURDI) and the
   National Research University Project of Thailand (NRU). We also thank
   the Armed Forces Research Institute of Medical Sciences (AFRIMS) and the
   Department of Disease Control, Ministry of Public Health, Thailand, for
   providing the Zika viral isolates used in this study. Additionally, we
   thank the Department of Biochemistry, Faculty of Science, Kasetsart
   University, for providing the BSL-2 workspace. Finally, we thank Prof.
   Matthew Paul Gleeson for his help in editing and revising the
   manuscript.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Altintas Z, 2015, ANAL CHEM, V87, P6801, DOI 10.1021/acs.analchem.5b00989
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, MORBIDITY MORTALITY
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ghanbari K, 2018, SENSOR ACTUAT B-CHEM, V258, P1066, DOI 10.1016/j.snb.2017.11.145
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Liang CS, 2016, TALANTA, V160, P360, DOI 10.1016/j.talanta.2016.06.010
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Ma Y, 2017, TALANTA, V164, P121, DOI 10.1016/j.talanta.2016.11.043
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Navakul K, 2017, NANOMED-NANOTECHNOL, V13, P549, DOI 10.1016/j.nano.2016.08.009
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Sukjee W, 2017, J BIOMAT SCI-POLYM E, V28, P1786, DOI 10.1080/09205063.2017.1338503
   Sukjee W, 2017, CHEMISTRYOPEN, V6, P340, DOI 10.1002/open.201700037
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wangchareansak T, 2013, J MATER CHEM B, V1, P2190, DOI 10.1039/c3tb00027c
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
NR 32
TC 13
Z9 13
U1 12
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD JAN
PY 2019
VL 4
IS 1
BP 69
EP 75
DI 10.1021/acssensors.8b00885
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA HJ5FF
UT WOS:000457203200009
PM 30596236
DA 2020-07-08
ER

PT J
AU Zhang, QF
   Zeininger, L
   Sung, KJ
   Miller, EA
   Yoshinaga, K
   Sikes, HD
   Swager, TM
AF Zhang, Qifan
   Zeininger, Lukas
   Sung, Ki-Joo
   Miller, Eric A.
   Yoshinaga, Kosuke
   Sikes, Hadley D.
   Swager, Timothy M.
TI Emulsion Agglutination Assay for the Detection of Protein-Protein
   Interactions: An Optical Sensor for Zika Virus
SO ACS SENSORS
LA English
DT Article
DE carbohydrates; rcSso7d; emulsions; Zika virus; Janus particles; sensors
AB A new class of Janus emulsion agglutination assay is reported for the detection of interfacial protein protein interactions. Janus emulsion droplets are functionalized with a thermally stable, antigen binding protein rcSso7d variant (rcSso7d-ZNS1) for the detection of Zika NS1 protein. The emulsion droplets containing fluorescent dyes in their hydrocarbon and fluorocarbon phases intensify the intrinsic optical signal with the emission intensity ratio, which can be detected by a simple optical fiber. This assay provides an opportunity for the in-field detection of Zika virus and other pathogens with a stable, inexpensive, and convenient device.
C1 [Zhang, Qifan; Zeininger, Lukas; Yoshinaga, Kosuke; Swager, Timothy M.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Zhang, Qifan; Zeininger, Lukas; Yoshinaga, Kosuke; Swager, Timothy M.] MIT, Inst Soldier Nanotechnol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Sung, Ki-Joo; Miller, Eric A.; Sikes, Hadley D.] MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Swager, TM (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Swager, TM (corresponding author), MIT, Inst Soldier Nanotechnol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sikes, HD (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM sikes@mit.edu; tswager@mit.edu
RI Zeininger, Lukas/AAA-6418-2020
OI /0000-0002-6217-3922; Yoshinaga, Kosuke/0000-0002-3365-1155;
   /0000-0002-7096-138X
FU National Institutes of Health of General Medical Sciences [GM095843];
   MIT Tata Center for Technology and Design, Singapore's National Research
   Foundation via the Singapore-MIT Alliance for Research and Technology
   (AMR IRG); National Cancer InstituteUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P30CCA14051]; MIT's Deshpande Center for
   Technological Innovation; German Research Foundation (DFG)German
   Research Foundation (DFG) [ZE1121/1-1]; National Science
   FoundationNational Science Foundation (NSF) [1122374]; Funai Overseas
   Scholarship
FX T.M.S. is grateful for funding from National Institutes of Health of
   General Medical Sciences (Grant No. GM095843). H.D.S. acknowledges
   support from the MIT Tata Center for Technology and Design, Singapore's
   National Research Foundation via the Singapore-MIT Alliance for Research
   and Technology (AMR IRG), the National Cancer Institute (Grant No.
   P30CCA14051), and MIT's Deshpande Center for Technological Innovation.
   L.Z. acknowledges support from the German Research Foundation (DFG,
   Grant No. ZE1121/1-1). K.S. thanks the National Science Foundation for a
   graduate research fellowship (Grant No. 1122374). K.Y. thanks the
   support from the Funai Overseas Scholarship.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Miller EA, 2016, MOL SYST DES ENG, V1, P377, DOI [10.1039/c6me00032k, 10.1039/C6ME00032K]
   Miller EA, 2018, BIOSENS BIOELECTRON, V102, P456, DOI 10.1016/j.bios.2017.11.050
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nagelberg S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14673
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Traxlmayr MW, 2016, J BIOL CHEM, V291, P22496, DOI 10.1074/jbc.M116.741314
   Yoshinaga K, 2018, SYNLETT, V29, P2509, DOI 10.1055/s-0037-1610224
   Zarzar LD, 2017, P NATL ACAD SCI USA, V114, P3821, DOI 10.1073/pnas.1618807114
   Zarzar LD, 2015, NATURE, V518, P520, DOI 10.1038/nature14168
   Zhang QF, 2018, BIOORGAN MED CHEM, V26, P5307, DOI 10.1016/j.bmc.2018.04.020
   Zhang QF, 2017, ACS CENTRAL SCI, V3, P309, DOI 10.1021/acscentsci.7b00021
NR 15
TC 7
Z9 7
U1 9
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD JAN
PY 2019
VL 4
IS 1
BP 180
EP 184
DI 10.1021/acssensors.8b01202
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA HJ5FF
UT WOS:000457203200022
PM 30624045
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Vasireddi, M
   Crum, A
   May, H
   Katz, D
   Hilliard, J
AF Vasireddi, Mugdha
   Crum, Albert
   May, Harold
   Katz, David
   Hilliard, Julia
TI A novel antiviral inhibits Zika virus infection while increasing
   intracellular glutathione biosynthesis in distinct cell culture models.
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID OXIDATIVE STRESS; N-ACETYLCYSTEINE; SEXUAL TRANSMISSION; INDUCED DAMAGE;
   IN-VITRO; GSH; LINE; REPLICATION; EXPRESSION; APOPTOSIS
AB We investigated the effects of a specific free-form amino acids formulation on Zika virus replication in two different cell culture model systems, one representative of humans and the other of Old World primates from whom Zika virus was first isolated. Here we present data demonstrating that the formulation of the specific free-form amino acid (FFAAP), comprising cystine, glycine, and a glutamate source, along with a minute concentration of selenium inhibited Zika virus replication by up to 90% with an ED90 (effective dose at which 90% of a dose of Zika virus was inhibited) of 2.5 mM in human cells and 4 mM Vero cells. The ED90 concentration of precursors was innocuous for uninfected cells, but resulted in reduced Zika virus replication by up to 90% at 2-5 mM concentrations in nonhuman primate cells and at 1-3 mM concentration in human placental cells.
   Two important observations were forthcoming: 1) Zika virus production was decreased by up to 90% in Vero and JEG-3 cells treated with FFAAP (ED90 4.0 mM, and 2.5 mM, respectively) throughout 48-72 h of post infection (hpi) compared to untreated infected cells and 2) Zika virus requires intracellular glutathione for replication in human placental cells, while showing enhanced replication in Vero cells with no glutathione. Relative increases in intracellular glutathione biosynthesis followed FFAAP treatment but blocking intracellular biosynthesis of glutathione in human cells resulted in virus inhibition in human placental cells. The blockade of biosynthesis actually increased Zika virus replication in Vero cells. These findings identify an efficacious inhibitor, FFAAP, of Zika virus replication in both human and nonhuman primate cells, while providing novel insight into the different roles of intracellular glutathione in Zika virus replication.
C1 [Vasireddi, Mugdha; Katz, David; Hilliard, Julia] Georgia State Univ, Dept Biol, Viral Immunol Ctr, POB 4010, Atlanta, GA 30303 USA.
   [Crum, Albert] ProImmune Res Inst LLC, Rhinebeck, NY 12572 USA.
   [May, Harold] FAMILY Inc, Newton, MA 02467 USA.
RP Hilliard, J (corresponding author), Georgia State Univ, Dept Biol, Viral Immunol Ctr, POB 4010, Atlanta, GA 30303 USA.
EM jhilliard@gsu.edu
FU Georgia Research Alliance
FX Authors, Vasireddi and Hilliard contributed to this work as follows,
   Drs. Vasireddi and Hilliard conceived the experiments and MV executed
   these in the laboratory. Vasireddi and Hilliard analyzed data and
   established conclusions for additional experiments and Dr. Katz provided
   critical reviews, important contributions as the work progressed, and
   was invaluable during manuscript preparation. Dr. Hilliard drafted the
   manuscript, while Dr. Vasireddi took charge of statistical analyses and
   graphics. Drs. Crum and May provided critical discussions and insight
   into the mechanisms of the free -form amino acid precursors, which was
   quality assessed and provided. Dr. Crum originally conceived of the
   formulation of free -form amino acids, and is the president of the
   Prolmmune Company, LLC. The work performed here was suggested by Julia
   Hilliard and subsequently a collaboration was discussed and formed with
   the Drs. Crum and May, as well as Drs. Vasireddi and Katz. This work was
   supported by special project resources from the Viral Immunology Center
   and special interest funds from the endowment of the Georgia Research
   Alliance to whom the authors are greatly appreciative. The Viral
   Immunology Center also gratefully acknowledges the support of the
   Georgia Research Alliance for the facilities in which these studies were
   performed.
CR AALTO TK, 1993, PEDIATR RES, V34, P572, DOI 10.1203/00006450-199311000-00004
   Abdo H, 2010, FASEB J, V24, P1082, DOI 10.1096/fj.09-139519
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   [Anonymous], WKLY EPIDEMIOL REC, V91, P73
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Babu E, 2011, INVEST OPHTH VIS SCI, V52, P5749, DOI 10.1167/iovs.10-6825
   Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240
   Besnard M, 2014, EURO SURVEILL, V19
   Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   BUCKMAN TD, 1993, J NEUROCHEM, V60, P2046, DOI 10.1111/j.1471-4159.1993.tb03489.x
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cameron JC, 2010, PLANT PHYSIOL, V154, P1672, DOI 10.1104/pp.110.162990
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chardonnet S, 2015, J PROTEOME RES, V14, P59, DOI 10.1021/pr500625a
   Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011
   Crum A, 2011, United States Reissued Patent, Patent No. [USRE42645 (E), 42645]
   Crum A., 2015, PCT/. US, Patent No. [2015/054862, 2015054862]
   Crum A., 2007, US RE, Patent No. [39743E, 39743]
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   De Rosa SC, 2000, EUR J CLIN INVEST, V30, P915, DOI 10.1046/j.1365-2362.2000.00736.x
   DEBIEU D, 1987, CLIN CHIM ACTA, V170, P161, DOI 10.1016/0009-8981(87)90124-0
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer CD, 2018, ANIM REPROD SCI, V195, P38, DOI 10.1016/j.anireprosci.2018.05.003
   Fratemale A, 2008, ANTIVIR RES, V77, P120, DOI 10.1016/j.antiviral.2007.11.004
   Fraternale A, 2006, CURR MED CHEM, V13, P1749, DOI 10.2174/092986706777452542
   Fraternale A, 2014, MED MICROBIOL IMMUN, V203, P283, DOI 10.1007/s00430-014-0335-4
   Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001
   GARACI E, 1992, BIOCHEM BIOPH RES CO, V188, P1090, DOI 10.1016/0006-291X(92)91343-O
   Hoskins C, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-77
   LOPEZTORRES M, 1991, J COMP PHYSIOL B, V160, P655, DOI 10.1007/BF00571264
   Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   MUTOH H, 1990, GASTROENTEROLOGY, V98, P1452, DOI 10.1016/0016-5085(90)91075-H
   Nickodem C, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12995
   Palamara Anna Teresa, 2004, Antiviral Chemistry & Chemotherapy, V15, P83
   PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A
   PARKER J, 1992, BIOCHEM PHARMACOL, V43, P1053, DOI 10.1016/0006-2952(92)90612-M
   RAJU PA, 1994, AIDS RES HUM RETROV, V10, P961, DOI 10.1089/aid.1994.10.961
   ROBBINS CH, 1981, BIOCHEM BIOPH RES CO, V103, P103, DOI 10.1016/0006-291X(81)91666-1
   ROEDERER M, 1992, AIDS RES HUM RETROV, V8, P209, DOI 10.1089/aid.1992.8.209
   Sinha-Hikim I, 2011, EXP MOL PATHOL, V91, P419, DOI 10.1016/j.yexmp.2011.04.009
   VILAS NN, 1976, J NUTR, V106, P589
   Volk J, 2014, DENT MATER, V30, P215, DOI 10.1016/j.dental.2013.11.008
   YOUNES M, 1990, J APPL TOXICOL, V10, P319, DOI 10.1002/jat.2550100503
NR 51
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2019
VL 161
BP 46
EP 52
DI 10.1016/j.antiviral.2018.09.004
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HJ1CS
UT WOS:000456900100006
PM 30217651
DA 2020-07-08
ER

PT J
AU Diosa-Toro, M
   Troost, B
   van de Pol, D
   Heberle, AM
   Urcuqui-Inchima, S
   Thedieck, K
   Smit, JM
AF Diosa-Toro, Mayra
   Troost, Berit
   van de Pol, Denise
   Heberle, Alexander Martin
   Urcuqui-Inchima, Silvio
   Thedieck, Kathrin
   Smit, Jolanda M.
TI Tomatidine, a novel antiviral compound towards dengue virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Tomatidine; Dengue virus; Antiviral; Activating transcription factor 4
ID ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN; DOUBLE-BLIND;
   INFECTION; INHIBITOR; DISCOVERY
AB Dengue is the most common arboviral disease worldwide with 96 million symptomatic cases annually. Despite its major impact on global human health and huge economic burden there is no antiviral drug available to treat the disease. The first tetravalent dengue virus vaccine was licensed in 2015 for individuals aged 9 to 45, however, most cases are reported in infants and young children. This, together with the limited efficacy of the vaccine to dengue virus (DENV) serotype 2, stresses the need to continue the search for compounds with anti-viral activity to DENV. In this report, we describe tomatidine as a novel compound with potent antiviral properties towards all DENV serotypes and the related Zika virus. The strongest effect was observed for DENV-2 with an EC50 and EC90 value of 0.82 and 1.61 mu M, respectively, following infection of Huh7 cells at multiplicity of infection of 1. The selectivity index is 97.7. Time-of-drug-addition experiments revealed that tomatidine inhibits virus particle production when added pre, during and up to 12 h post-infection. Subsequent experiments show that tomatidine predominantly acts at a step after virus-cell binding and membrane fusion but prior to the secretion of progeny virions. Tomatidine was found to control the expression of the cellular protein activating transcription factor 4 (ATF4), yet, this protein is not solely responsible for the observed antiviral effect. Here, we propose tomatidine as a candidate for the treatment of dengue given its potent antiviral activity.
C1 [Diosa-Toro, Mayra; Troost, Berit; van de Pol, Denise; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, NL-9713 AV Groningen, Netherlands.
   [Diosa-Toro, Mayra; Urcuqui-Inchima, Silvio] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Calle 70 52-21, Medellin, Colombia.
   [Heberle, Alexander Martin; Thedieck, Kathrin] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Sect Syst Med Metab & Signaling, NL-9713 AV Groningen, Netherlands.
   [Thedieck, Kathrin] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Dept Neurosci, D-26129 Oldenburg, Germany.
   [Diosa-Toro, Mayra] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
RP Smit, JM (corresponding author), POB 30-001,EB889700, Groningen, Netherlands.
EM jolanda.smit@umcg.nl
RI Diosa-Toro, Mayra/C-5826-2016; Toro, Mayra Diosa/N-5567-2019
OI Diosa-Toro, Mayra/0000-0002-6693-3474; Toro, Mayra
   Diosa/0000-0002-6693-3474; Heberle, Alexander/0000-0001-6414-8707;
   Thedieck, Kathrin/0000-0002-9069-2930
FU Colciencias ColombiaDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [528-2011]; University Medical Center Groningen;
   Universidad de Antioquia, UdeA; Federal Ministry of Education and
   Research (BMBF) e:Med project GlioPATH [01ZX1402B]; Federal Ministry of
   Education and Research (BMBF) e:Med project MAPTor-NET [031A426B];
   Stichting TSC Fonds; German Research FoundationGerman Research
   Foundation (DFG) [TH 1358/3-1]; MESI-STRAT project from the European
   Union's Horizon 2020 research and innovation programme [754688];
   Rosaling Franklin Fellowship of the University of Groningen; German
   Tuberous Sclerosis Foundation
FX MDT was supported by Colciencias Colombia (call 528-2011) and the
   University Medical Center Groningen. SUI was supported by the
   Universidad de Antioquia, UdeA. KT is supported by the Federal Ministry
   of Education and Research (BMBF) e:Med projects GlioPATH (01ZX1402B) and
   MAPTor-NET (031A426B), the Stichting TSC Fonds (calls 2015 and 2017),
   the German Research Foundation (TH 1358/3-1) and the MESI-STRAT project,
   which has received funding from the European Union's Horizon 2020
   research and innovation programme under grant agreement No. 754688. KT
   is recipient of a Rosaling Franklin Fellowship of the University of
   Groningen and of the Research Award 2017 of the German Tuberous
   Sclerosis Foundation. AMH, BT and JMS were supported by the University
   Medical Center Groningen. The funders had no participation in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The University Medical Center Groningen
   has filed a patent application related to this research. Inventors on
   this application are MDT, BT, and JMS. The authors acknowledge Richard
   Kuhn (Purdue University), Gorben Pijlman (Wageningen University) and
   Tonya Colpitts (University of South Carolina) for sharing cell lines and
   Martijn van Hemert (Leiden University Medical Center) and Claire Huang
   (CDC) for sharing viral strains.
CR Bailly B., 2016, SCI REP, V6, P1
   Beesetti H, 2016, EXPERT OPIN INV DRUG, V25, P1059, DOI 10.1080/13543784.2016.1201063
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bier E., 2013, United States of America US, Patent No. 20130203793
   Blankemeyer JT, 1997, FOOD CHEM TOXICOL, V35, P639, DOI 10.1016/S0278-6915(97)00038-0
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Cheng YB, 2016, BIOORG MED CHEM LETT, V26, P2344, DOI 10.1016/j.bmcl.2016.03.029
   Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241
   Ebert SM, 2015, J BIOL CHEM, V290, P25497, DOI 10.1074/jbc.M115.681445
   Frabasile S., 2017, SCI REP, V7, P1
   Fraser JE, 2016, ANTIVIR RES, V130, P1, DOI 10.1016/j.antiviral.2016.03.006
   Friedman M, 2003, FOOD CHEM TOXICOL, V41, P61, DOI 10.1016/S0278-6915(02)00205-3
   Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c
   Fujiwara Y, 2012, J AGR FOOD CHEM, V60, P2472, DOI 10.1021/jf204197r
   Gomez-Calderon C, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1562-1
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   JAIN DC, 1990, NATL ACAD SCI LETT, V13, P41
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Mitchell G, 2011, ANTIMICROB AGENTS CH, V55, P1937, DOI 10.1128/AAC.01468-10
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   Pu JY, 2017, J MED VIROL, V89, P571, DOI 10.1002/jmv.24571
   Richter MKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098785
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   THORNE HV, 1985, ANTIVIR RES, V5, P335, DOI 10.1016/0166-3542(85)90003-8
   Tricou V., 2010, PLOS NEGLECTED TROP, V4
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203
   World Health Organization, 2009, SPEC PROGR RES TRAIN, V147
   Yan KH, 2013, CHEM-BIOL INTERACT, V203, P580, DOI 10.1016/j.cbi.2013.03.016
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 43
TC 3
Z9 3
U1 2
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2019
VL 161
BP 90
EP 99
DI 10.1016/j.antiviral.2018.11.011
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HJ1CS
UT WOS:000456900100011
PM 30468746
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tohma, D
   Tajima, S
   Kato, F
   Sato, H
   Kakisaka, M
   Hishiki, T
   Kataoka, M
   Takeyama, H
   Lim, CK
   Aida, Y
   Saijo, M
AF Tohma, Daiki
   Tajima, Shigeru
   Kato, Fumihiro
   Sato, Hirotaka
   Kakisaka, Michinori
   Hishiki, Takayuki
   Kataoka, Michiyo
   Takeyama, Haruko
   Lim, Chang-Kweng
   Aida, Yoko
   Saijo, Masayuki
TI An estrogen antagonist, cyclofenil, has anti-dengue-virus activity
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID PROTEIN NS1; RECEPTOR; TYPE-1; REPLICATION; INFECTIONS; DISCOVERY;
   REVEALS; HSP70
AB Dengue virus (DENV) infections are a major cause of morbidity and mortality in tropical and subtropical areas. Several compounds that act against DENV have been studied in clinical trials to date; however, there have been no compounds identified that are effective in reducing the severity of the clinical manifestations. To explore anti-DENV drugs, we examined small molecules that interact with DENV NS1 and inhibit DENV replication. Cyclofenil, which is a selective estrogen receptor modulator (SERM) and has been used clinically as an ovulation-inducing drug, showed an inhibitory effect on DENV replication in mammalian cells but not in mosquito cells. Other SERMs also inhibited DENV replication in mammalian cells, but cyclofenil showed the weakest cytotoxicity among these SERMs. Cyclofenil also inhibited the replication of Zika virus. A time-of-addition assay suggested that cyclofenil may interfere with two stages of the DENV life cycle: the translation-RNA synthesis and assembly-maturation stages. However, the level of intracellular infectious particles decreased more drastically after treatment with cyclofenil than the viral RNA level did, indicating that the assembly-maturation stage might be the main target of cyclofenil. In electron microscopy analysis, many aggregated particles were detected in DENV-infected cells in the presence of cyclofenil, supporting the possibility that cyclofenil impedes the process of assembly and maturation of DENV.
C1 [Tohma, Daiki; Tajima, Shigeru; Kato, Fumihiro; Lim, Chang-Kweng; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Tohma, Daiki; Takeyama, Haruko] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsucho, Tokyo 1628480, Japan.
   [Sato, Hirotaka; Aida, Yoko] RIKEN, Nano Med Engn Lab, Cluster Pioneering Res, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
   [Sato, Hirotaka; Kakisaka, Michinori; Aida, Yoko] RIKEN, Virus Infect Dis Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
   [Hishiki, Takayuki] Kanagawa Prefectural Inst Publ Hlth, Dept Microbiol, 1-3-1 Shimomachiya, Chigasaki, Kanagawa 2530087, Japan.
   [Kataoka, Michiyo] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
RP Tajima, S (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
EM stajima@nih.go.jp
OI Sato, Hirotaka/0000-0002-8321-9731; Shigeru, Tajima/0000-0002-1981-9062;
   Saijo, Masayuki/0000-0001-5458-7298
FU Research Program on Emerging and Re-emerging Infectious Diseases of the
   Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108035]; RIKEN Program
   for Drug Discovery and Medical Technology Platforms
FX We thank Dr. Yasumitsu Kondoh and Dr. Hiroyuki Osada, RIKEN Center for
   Sustainable Resource Science, for performing the chemical array
   screening, and Dr. T. Saito for supplying compounds from the RIKEN
   NPDepo chemical library. This research was supported by the Research
   Program on Emerging and Re-emerging Infectious Diseases of the Japan
   Agency for Medical Research and Development (AMED) under Grant Number
   JP18fk0108035, and by a RIKEN Program for Drug Discovery and Medical
   Technology Platforms.
CR Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006
   Dhamad AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160312
   Drecktrah D, 1998, J CELL SCI, V111, P951
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058
   Halstead SB, 1997, EPIDEMIOLOGY DENGUE
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004
   Kurane Ichiro, 1997, P273
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach B.D., 2013, FLAVIVIRIDAE
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Murakami Y, 2013, MICROBES INFECT, V15, P45, DOI 10.1016/j.micinf.2012.10.003
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Nakayama E, 2016, VIRUS GENES
   Nazareth T, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.00, 10.1371/journal.pntd.0003395]
   Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306
   Quintana VM, 2016, ANTIVIR RES, V134, P26, DOI 10.1016/j.antiviral.2016.08.018
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tajima S, 2006, VIRUS RES, V116, P38, DOI 10.1016/j.virusres.2005.08.015
   Tajima S, 2008, VIRUS GENES, V36, P323, DOI 10.1007/s11262-008-0211-7
   Tian YS, 2018, CHEM PHARM BULL, V66, P191, DOI 10.1248/cpb.c17-00794
   Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200
   WHO, 2017, GACVS STAT DENGV
NR 32
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JAN
PY 2019
VL 164
IS 1
BP 225
EP 234
DI 10.1007/s00705-018-4079-0
PG 10
WC Virology
SC Virology
GA HI8EO
UT WOS:000456688300022
PM 30357482
DA 2020-07-08
ER

PT J
AU Riccio, F
   Talapatra, SK
   Oxenford, S
   Angell, R
   Mazzon, M
   Kozielski, F
AF Riccio, Federica
   Talapatra, Sandeep K.
   Oxenford, Sally
   Angell, Richard
   Mazzon, Michela
   Kozielski, Frank
TI Development and validation of RdRp Screen, a crystallization screen for
   viral RNA-dependent RNA polymerises
SO BIOLOGY OPEN
LA English
DT Article
DE Dengue virus; Crystallization screen; RNA-dependent RNA polymerase;
   Flavivirus; Antiviral drug discovery
ID CRYSTAL-STRUCTURE; VIRUS; NS5; SOFOSBUVIR/VELPATASVIR; TARGET; DOMAIN
AB Members of the Flaviviridae family constitute a severe risk to human health. Whilst effective drugs have been developed against the hepacivirus HCV, no antiviral therapy is currently available for any other viruses, induding the flaviviruses dengue (DENV), West Nile and Zika viruses. The RNA-dependent RNA polymerase (RdRp) is responsible for viral replication and represents an excellent therapeutic target with no homologue found in mammals. The identification of compounds targeting the RdRp of other flaviviruses is an active area of research. One of the main factors hampering further developments in the field is the difficulty in obtaining high-quality crystal information that could aid a structure-based drug discovery approach. To address this, we have developed a convenient and economical 96-well screening platform. We validated the screen by successfully obtaining crystals of both native DENV serotype 2 and 3 RdRps under several conditions included in the screen. In addition, we have obtained crystal structures of RdRp3 in complex with a previously identified fragment using both soaking and co-crystallization techniques. This work will streamline and accelerate the generation of crystal structures of viral RdRps and provide the community with a valuable tool to aid the development of structure-based antiviral design.
C1 [Riccio, Federica; Talapatra, Sandeep K.; Kozielski, Frank] UCL Sch Pharm, Dept Pharmaceut & Biol Chem, 29-39 Brunswick Sq, London WC1N 1AX, England.
   [Oxenford, Sally; Angell, Richard] UCL Sch Pharm, Translat Res Off, 29-39 Brunswick Sq, London WC1N 1AX, England.
   [Mazzon, Michela] UCL MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.
   [Talapatra, Sandeep K.] AstraZeneca, Discovery Biol, Discovery Sci, IMED Biotech Unit, Alderley Pk, Macclesfield, Cheshire, England.
RP Talapatra, SK; Kozielski, F (corresponding author), UCL Sch Pharm, Dept Pharmaceut & Biol Chem, 29-39 Brunswick Sq, London WC1N 1AX, England.; Talapatra, SK (corresponding author), AstraZeneca, Discovery Biol, Discovery Sci, IMED Biotech Unit, Alderley Pk, Macclesfield, Cheshire, England.
EM s.talapatra@ucl.ac.uk; f.kozielski@ucl.ac.uk
OI Angell, Richard/0000-0002-6125-8270; Riccio,
   Federica/0000-0001-5577-2583
FU PharmAlliance
FX We are grateful to PharmAlliance for financial support.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonaventura A, 2016, WORLD J HEPATOL, V8, P785, DOI 10.4254/wjh.v8.i19.785
   De Clercq E, 2006, BRIT J PHARMACOL, V147, P1, DOI 10.1038/sj.bjp.0706446
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fields B. N., 2007, FIELDS VIROLOGY
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Rajapakse Senaka, 2011, J Emerg Trauma Shock, V4, P120, DOI 10.4103/0974-2700.76835
   Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Schr?dinger L., 2015, PYMOL MOL GRAPH SYST
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Younossi ZM, 2016, J HEPATOL, V65, P33, DOI 10.1016/j.jhep.2016.02.042
NR 34
TC 0
Z9 1
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 2046-6390
J9 BIOL OPEN
JI Biol. Open
PD JAN
PY 2019
VL 8
IS 1
AR UNSP bio037663
DI 10.1242/bio.037663
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HJ7VT
UT WOS:000457406100011
PM 30602529
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Anderson, T
   Humphreys, G
AF Anderson, Tatum
   Humphreys, Gary
TI Zika: the continuing threat
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 7
Z9 7
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JAN
PY 2019
VL 97
IS 1
BP 6
EP 7
DI 10.2471/BLT.19.020119
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HJ6WB
UT WOS:000457332700010
PM 30618459
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Simonin, Y
   Erkilic, N
   Damodar, K
   Cle, M
   Desmetz, C
   Bollore, K
   Taleb, M
   Torriano, S
   Barthelemy, J
   Dubois, G
   Lajoix, AD
   Foulongne, V
   Tuaillon, E
   Van de Perre, P
   Kalatzis, V
   Salinas, S
AF Simonin, Yannick
   Erkilic, Nejla
   Damodar, Krishna
   Cle, Marion
   Desmetz, Caroline
   Bollore, Karine
   Taleb, Mehdi
   Torriano, Simona
   Barthelemy, Jonathan
   Dubois, Gregor
   Lajoix, Anne Dominique
   Foulongne, Vincent
   Tuaillon, Edouard
   Van de Perre, Philippe
   Kalatzis, Vasiliki
   Salinas, Sara
TI Zika virus induces strong inflammatory responses and impairs homeostasis
   and function of the human retinal pigment epithelium
SO EBIOMEDICINE
LA English
DT Article
ID HUMAN CYTOMEGALOVIRUS; EBOLA-VIRUS; INFECTION; CELLS; REPLICATION;
   HEALTH; TRANSMISSION; EXPRESSION; SIGNATURES; BRAZIL
AB Background: Zika virus (ZIKV) has recently re-emerged as a pathogenic agent with epidemic capacities as was well illustrated in South America. Because of the extent of this health crisis, a number of more serious symptoms have become associated with ZIKV infection than what was initially described. In particular, neuronal and ocular disorders have been characterized, both in infants and in adults. Notably, the macula and the retina can be strongly affected by ZIKV, possibly by a direct effect of the virus. This is supported by the detection of replicative and infectious virus in lachrimal fluid in human patients and mouse models.
   Methods: Here, we used an innovative, state-of-the-art iPSC-derived human retinal pigment epithelium (RPE) model to study ZIKV retinal impairment.
   Findings: We showed that the human RPE is highly susceptible to ZIKV infection and that a ZIKV African strain was more virulent and led to a more potent epithelium disruption and stronger anti-viral response than an Asian strain, suggesting lineage differences. Moreover, ZIKV infection led to impaired membrane dynamics involved in endocytosis, organelle biogenesis and potentially secretion, key mechanisms of RPE homeostasis and function.
   Interpretation: Taken together, our results suggest that ZIKV has a highly efficient ocular tropism, which creates a strong inflammatory environment that could have acute or chronic adverse effects.
   Fund: This work was funded by Retina France, REACTing and La Region Languedoc-Roussillon. (c) 2018 The Authors. Published by Elsevier B.V.
C1 [Simonin, Yannick; Cle, Marion; Bollore, Karine; Taleb, Mehdi; Barthelemy, Jonathan; Salinas, Sara] Univ Montpellier, Etab Francais Sang, INSERM, Pathogenesis & Control Chron Infect, Montpellier, France.
   [Erkilic, Nejla; Damodar, Krishna; Torriano, Simona; Dubois, Gregor; Kalatzis, Vasiliki] Univ Montpellier, INSERM, Inst Neurosci Montpellier, Montpellier, France.
   [Desmetz, Caroline; Lajoix, Anne Dominique] Univ Montpellier, BioCommun CardioMetab, Montpellier, France.
   [Foulongne, Vincent; Tuaillon, Edouard; Van de Perre, Philippe] Univ Montpellier, INSERM, Pathogenesis & Control Chron Infect, Etab Francais Sang,CHU Montpellier, Montpellier, France.
RP Salinas, S (corresponding author), Univ Montpellier, Etab Francais Sang, INSERM, Pathogenesis & Control Chron Infect, Montpellier, France.; Kalatzis, V (corresponding author), Univ Montpellier, INSERM, Inst Neurosci Montpellier, Montpellier, France.
EM vasiliki.kalatzis@inserm.fr; sara.salinas@inserm.fr
RI Kalatzis, Vasiliki/F-6170-2019; Salinas, Sara/O-1150-2019; Desmetz,
   Caroline/N-4892-2016; Van de Perre, Philippe/B-9692-2008
OI Kalatzis, Vasiliki/0000-0002-9626-8807; Salinas,
   Sara/0000-0003-4492-2093; Desmetz, Caroline/0000-0002-8530-6011; Van de
   Perre, Philippe/0000-0002-3912-0427; simonin,
   yannick/0000-0002-3475-1369
FU Retina France; La Region Languedoc-RoussillonRegion Occitanie; REACTing
FX This work was funded by Retina France, REACTing and La Region
   Languedoc-Roussillon.
CR Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391
   Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Blenkinsop TA, 2015, INVEST OPHTH VIS SCI, V56, P7085, DOI 10.1167/iovs.14-16246
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bodaghi B, 1999, J IMMUNOL, V162, P957
   Boiko E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141754
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cinatl J, 2006, INVEST OPHTH VIS SCI, V47, P645, DOI 10.1167/iovs.05-1022
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   de Andrade Gabriel Costa, 2017, Int J Retina Vitreous, V3, P4, DOI 10.1186/s40942-016-0057-4
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Detrick B, 2010, IMMUNOL RES, V47, P153, DOI 10.1007/s12026-009-8146-1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Farjood F, 2017, MOL VIS, V23, P431
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Ford KM, 2011, INVEST OPHTH VIS SCI, V52, P9478, DOI 10.1167/iovs.11-8353
   Fronk AH, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416650838
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Graybill C, 2017, J INFECT DIS, V216, P1038, DOI 10.1093/infdis/jix426
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Inoue T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013250
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Kay P, 2013, J CELL MOL MED, V17, P833, DOI 10.1111/jcmm.12070
   Kelly JD, 2015, NEW ENGL J MED, V373, P1981, DOI 10.1056/NEJMc1510459
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Khairallah M, 2004, OPHTHALMOLOGY, V111, P2065, DOI 10.1016/j.ophtha.2004.03.032
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Liu F, 2016, MOL VIS, V22, P352
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merle H, 2018, J FR OPHTALMOL, V41, pE235, DOI 10.1016/j.jfo.2018.05.002
   Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   MISHIMA Y, 1994, PIGM CELL RES, V7, P376, DOI 10.1111/j.1600-0749.1994.tb00065.x
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2018, TRENDS MICROBIOL, Vxx, P1, DOI [10.1016/j.tim.2018.05, DOI 10.1016/J.TIM.2018.05]
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Singh AK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94275
   Singh Mandeep S, 2018, Am J Ophthalmol Case Rep, V10, P6, DOI 10.1016/j.ajoc.2018.01.023
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Smith JR, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.12
   Sparrrow JR, 2010, CURR MOL MED, V10, P802
   Sparrrow JR, 2010, CURR MOL MED, V3
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Torriano S, 2017, HUM MOL GENET, V26, P3573, DOI 10.1093/hmg/ddx244
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tugizov S, 1996, J GEN VIROL, V77, P61, DOI 10.1099/0022-1317-77-1-61
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verhagen F, 2016, EXPERT REV CLIN IMMU, V12, P1359, DOI 10.1080/1744666X.2016.1241709
   Voigt V, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007040
   Wong Chee Wai, 2019, Retin Cases Brief Rep, V13, P171, DOI 10.1097/ICB.0000000000000552
   Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   YOSER SL, 1993, SURV OPHTHALMOL, V37, P313, DOI 10.1016/0039-6257(93)90064-E
   Zaidi Mussaret B, 2018, JMM Case Rep, V5, pe005152, DOI 10.1099/jmmcr.0.005152
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 102
TC 6
Z9 6
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JAN
PY 2019
VL 39
BP 315
EP 331
DI 10.1016/j.ebiom.2018.12.010
PG 17
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA HI8AK
UT WOS:000456677400041
PM 30579862
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petrelli, B
   Bendelac, L
   Hicks, GG
   Fainsod, A
AF Petrelli, Berardino
   Bendelac, Liat
   Hicks, Geoffrey G.
   Fainsod, Abraham
TI Insights into retinoic acid deficiency and the induction of craniofacial
   malformations and microcephaly in fetal alcohol spectrum disorder
SO GENESIS
LA English
DT Review
DE craniofacial malformations; Fetal Alcohol Spectrum Disorder (FASD);
   microcephaly; neurodevelopmental syndromes; retinoic acid deficiency
ID CRANIAL NEURAL CREST; PRENATAL ETHANOL EXPOSURE; SHORT-CHAIN
   DEHYDROGENASE/REDUCTASE; INDUCED BRAIN ABNORMALITIES; DIGEORGE-SYNDROME
   PHENOTYPE; MICROSCOPY-BASED ANALYSES; CENTRAL-NERVOUS-SYSTEM;
   MATTHEW-WOOD-SYNDROME; SONIC HEDGEHOG; VITAMIN-A
AB Fetal Alcohol Spectrum Disorder (FASD) is a set of neurodevelopmental malformations caused by maternal consumption of alcohol during pregnancy. FASD sentinel facial features are unique to the disorder, and microcephaly is common in severe forms of FASD. Retinoic acid deficiency has been shown to cause craniofacial malformations and microcephaly in animal models reminiscent of those caused by prenatal alcohol exposure. Alcohol exposure affects the migration and survival of cranial neural crest cells, which are required for proper frontonasal prominence and pharyngeal arch development. Defects in craniofacial development are further amplified by the many downstream pathways that are transcriptionally controlled retinoic acid target genes, including Shh signaling. Recent evidence shows that alcohol exposure itself is sufficient to induce retinoic acid deficiency in the embryo. These data suggest that retinoic acid deficiency is an important underlying etiology of FASD. In disorders like Vitamin A Deficiency, FASD, DiGeorge (22q11.2 Deletion Syndrome), CHARGE, Smith-Magenis, Matthew-Wood, and Congenital Zika Syndromes, evidence is accumulating to link reduced retinoic acid signaling with developmental defects like craniofacial malformations and microcephaly. Research focus on characterizing the effects of retinoic acid deficiency during early development and on understanding the downstream signaling pathways involved in aberrant head, and craniofacial development will reveal underlying etiologies of these disorders.
C1 [Petrelli, Berardino; Hicks, Geoffrey G.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Regenerat Med Program, Winnipeg, MB R3E 0J9, Canada.
   [Petrelli, Berardino; Hicks, Geoffrey G.] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada.
   [Bendelac, Liat; Fainsod, Abraham] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-9112102 Jerusalem, Israel.
RP Hicks, GG (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Regenerat Med Program, Winnipeg, MB R3E 0J9, Canada.; Hicks, GG (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada.; Fainsod, A (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-9112102 Jerusalem, Israel.
EM geoff.hicks@umanitoba.ca; abraham.fainsod@mail.huji.ac.il
RI Fainsod, Abraham/AAE-5633-2019
OI Hicks, Geoffrey/0000-0003-4688-2312; Fainsod,
   Abraham/0000-0002-6368-0416
FU Canadian Institutes for Health ResearchCanadian Institutes of Health
   Research (CIHR) [128094]; Kids Brain Health Network [48694]; Manitoba
   Liquor Lotteries [316286]; Wolfson Family Chair in Genetics; Israel
   Science FoundationIsrael Science Foundation [668/17]; United
   States-Israel Binational Science FoundationUS-Israel Binational Science
   Foundation [2017199]
FX Canadian Institutes for Health Research, Grant/Award Number: 128094;
   Kids Brain Health Network, Grant/Award Number: 48694; Manitoba Liquor &
   Lotteries, Grant/Award Number: 316286; Wolfson Family Chair in Genetics,
   Grant/Award Number: NA; Health Research; Israel Science Foundation,
   Grant/Award Number: 668/17; United States-Israel Binational Science
   Foundation, Grant/Award Number: 2017199
CR Abbott CW, 2018, CEREB CORTEX, V28, P2908, DOI 10.1093/cercor/bhx168
   Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Adams J, 2010, BIRTH DEFECTS RES A, V88, P895, DOI 10.1002/bdra.20721
   Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199
   Akers KG, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-29
   Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496
   Alexandre D, 1996, DEVELOPMENT, V122, P735
   Alfandari D, 2010, CELL ADHES MIGR, V4, P553, DOI 10.4161/cam.4.4.12202
   Allan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096200
   Ang HL, 1997, DEV DYNAM, V208, P536
   ANG SL, 1994, DEVELOPMENT, V120, P2979
   Ang SL, 1996, DEVELOPMENT, V122, P243
   Aoto K, 2008, BIRTH DEFECTS RES A, V82, P224, DOI 10.1002/bdra.20447
   Ashwell KWS, 1996, PATHOLOGY, V28, P161, DOI 10.1080/00313029600169803
   Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P400, DOI 10.1093/alcalc/35.4.400
   Astley SJ, 2001, ALCOHOL ALCOHOLISM, V36, P147, DOI 10.1093/alcalc/36.2.147
   Astley SJ, 2009, ALCOHOL CLIN EXP RES, V33, P1671, DOI 10.1111/j.1530-0277.2009.01004.x
   Bailey BA, 2011, ALCOHOL RES HEALTH, V34, P86
   Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001
   Ballard MS, 2012, MED HYPOTHESES, V78, P489, DOI 10.1016/j.mehy.2012.01.014
   BALLYCUIF L, 1995, MECH DEVELOP, V49, P49, DOI 10.1016/0925-4773(94)00301-3
   Bar-El Dadon S, 2017, CRIT REV FOOD SCI, V57, P2404, DOI 10.1080/10408398.2015.1060940
   Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684
   Begemann G, 2001, DEVELOPMENT, V128, P3081
   Belyaeva OV, 2012, J BIOL CHEM, V287, P9061, DOI 10.1074/jbc.M111.336727
   Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995
   Blentic A, 2003, DEV DYNAM, V227, P114, DOI 10.1002/dvdy.10292
   Brady ML, 2012, ALCOHOL CLIN EXP RES, V36, P457, DOI 10.1111/j.1530-0277.2011.01644.x
   Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042
   Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444
   Caputo C, 2016, BIRTH DEFECTS RES C, V108, P174, DOI 10.1002/bdrc.21129
   Carlson B. M., 2014, HUMAN EMBRYOLOGY DEV, P294
   Ceni E, 2014, WORLD J GASTROENTERO, V20, P17756, DOI 10.3748/wjg.v20.i47.17756
   Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023
   Chater-Diehl EJ, 2017, ALCOHOL, V60, P41, DOI 10.1016/j.alcohol.2017.01.005
   Chawla B, 2016, BIRTH DEFECTS RES B, V107, P126, DOI 10.1002/bdrb.21177
   Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19010
   Chen SY, 1996, ALCOHOL CLIN EXP RES, V20, P1071, DOI 10.1111/j.1530-0277.1996.tb01948.x
   Chen YL, 2001, MECH DEVELOP, V101, P91, DOI 10.1016/S0925-4773(00)00558-X
   Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0
   Chiodo LM, 2012, ALCOHOL, V46, P261, DOI 10.1016/j.alcohol.2011.11.006
   Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302
   Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385
   COHEN MM, 1992, J CRAN GENET DEV BIO, V12, P196
   Coleman LG, 2012, ALCOHOL, V46, P603, DOI 10.1016/j.alcohol.2012.01.003
   Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399
   CONLON RA, 1992, DEVELOPMENT, V116, P357
   Cook JL, 2016, CAN MED ASSOC J, V188, P191, DOI 10.1503/cmaj.141593
   Crabb David W, 2007, Novartis Found Symp, V285, P4
   Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327
   Crandall JE, 2011, J NEUROCHEM, V119, P723, DOI 10.1111/j.1471-4159.2011.07471.x
   Cravo ML, 1996, AM J CLIN NUTR, V63, P220
   Cui ZJ, 2010, ALCOHOL ALCOHOLISM, V45, P312, DOI 10.1093/alcalc/agq036
   Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932
   Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704
   de Licona HK, 2009, NEUROTOXICOLOGY, V30, P459, DOI 10.1016/j.neuro.2009.01.010
   Deitrich Richard A, 2007, Novartis Found Symp, V285, P23
   del Campo M, 2017, EUR J MED GENET, V60, P55, DOI 10.1016/j.ejmg.2016.10.004
   Deltour L, 1996, FASEB J, V10, P1050
   DEMYER W, 1964, PEDIATRICS, V34, P256
   Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098
   di Masi A, 2015, MOL ASPECTS MED, V41, P1, DOI 10.1016/j.mam.2014.12.003
   DILUZIO NR, 1964, LIFE SCI, V3, P113, DOI 10.1016/0024-3205(64)90189-4
   Dolle Pascal, 2009, Nucl Recept Signal, V7, pe006, DOI 10.1621/nrs.07006
   Drever N, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.017
   Drew PD, 2015, ALCOHOL CLIN EXP RES, V39, P445, DOI 10.1111/acer.12639
   DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813
   Duerinckx S, 2018, SEMIN CELL DEV BIOL, V76, P76, DOI 10.1016/j.semcdb.2017.09.015
   Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+
   DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x
   Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002
   Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100
   Dupe V, 2009, DEV DYNAM, V238, P2701, DOI 10.1002/dvdy.22087
   DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0
   Dworkin S, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4030024
   Dyment DA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0364-1
   Eberhart JK, 2016, ALCOHOL CLIN EXP RES, V40, P1154, DOI 10.1111/acer.13066
   Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86
   Edge R, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010005
   Edison Robin, 2003, Congenital Anomalies, V43, P1, DOI 10.1111/j.1741-4520.2003.tb01022.x
   Ehrhart F, 2019, MOL PSYCHIATR, V24, P10, DOI 10.1038/s41380-018-0095-4
   El Shawa H, 2013, J NEUROSCI, V33, P18893, DOI 10.1523/JNEUROSCI.3721-13.2013
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fainsod A, 2018, BIOCHEM CELL BIOL, V96, P77, DOI 10.1139/bcb-2017-0219
   Fere Ch., 1895, Journal of Anatomy and Physiology, Vxxxi, P161
   Fernandes Y, 2018, BIOCHEM CELL BIOL, V96, P88, DOI 10.1139/bcb-2017-0122
   Fish EW, 2018, BEHAV BRAIN RES, V338, P173, DOI 10.1016/j.bbr.2017.10.020
   Fish EW, 2016, BEHAV BRAIN RES, V311, P70, DOI 10.1016/j.bbr.2016.05.004
   Flentke GR, 2018, BIOCHEM CELL BIOL, V96, P98, DOI 10.1139/bcb-2017-0205
   Franco PG, 1999, DEVELOPMENT, V126, P4257
   GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x
   Gautam P, 2014, NEUROIMAGE-CLIN, V5, P19, DOI 10.1016/j.nicl.2014.05.010
   Gautam P, 2015, HUM BRAIN MAPP, V36, P2318, DOI 10.1002/hbm.22772
   Gerlai R, 2015, DEV PSYCHOBIOL, V57, P787, DOI 10.1002/dev.21318
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x
   Glavas MM, 2007, ALCOHOL CLIN EXP RES, V31, P1598, DOI 10.1111/j.1530-0277.2007.00460.x
   Godin EA, 2010, ALCOHOL CLIN EXP RES, V34, P98, DOI 10.1111/j.1530-0277.2009.01071.x
   Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177
   Gong SG, 2014, EXP CELL RES, V325, P90, DOI 10.1016/j.yexcr.2014.03.015
   Goyal MM, 2010, PROTEIN CELL, V1, P888, DOI 10.1007/s13238-010-0113-z
   Graf D, 2016, CYTOKINE GROWTH F R, V27, P129, DOI 10.1016/j.cytogfr.2015.11.004
   Grandel H, 2002, DEVELOPMENT, V129, P2851
   Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461
   GRUMMER MA, 1990, PEDIATR RES, V28, P186, DOI 10.1203/00006450-199009000-00002
   Gupta KK, 2016, ALCOHOL CLIN EXP RES, V40, P1594, DOI 10.1111/acer.13135
   Hale F, 1933, J HERED, V24, P105, DOI 10.1093/oxfordjournals.jhered.a103720
   Hale LA, 2006, GENE EXPR PATTERNS, V6, P546, DOI 10.1016/j.modgep.2005.10.007
   Halilagic A, 2003, DEVELOPMENT, V130, P2039, DOI 10.1242/dev.00423
   Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021
   Halliwell B, 2015, FREE RADICALS BIOL M
   Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399
   Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611
   Harris LR, 2004, BIOCHEM J, V383, P37, DOI 10.1042/BJ20040715
   Haushalter C, 2017, DEV BIOL, V430, P129, DOI 10.1016/j.ydbio.2017.08.006
   Heit C, 2015, ADV EXP MED BIOL, V815, P375, DOI 10.1007/978-3-319-09614-8_22
   Heller M, 2014, BIRTH DEFECTS RES A, V100, P277, DOI 10.1002/bdra.23232
   Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589
   HENDERSON GI, 1989, J CLIN INVEST, V84, P1287, DOI 10.1172/JCI114296
   HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0
   Hong MI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002999
   Hong M, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0178514, 10.1371/journal.pone.0176440]
   Hoyme HE, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4256
   Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033
   Idrus NM, 2013, J STEROID BIOCHEM, V136, P146, DOI 10.1016/j.jsbmb.2012.10.012
   Iskakova M, 2015, CAN J PHYSIOL PHARM, V93, P1065, DOI 10.1139/cjpp-2014-0522
   Janesick A, 2012, DEVELOPMENT, V139, P1213, DOI 10.1242/dev.071456
   Jarmasz JS, 2017, J NEUROPATH EXP NEUR, V76, P813, DOI 10.1093/jnen/nlx064
   JELINEK R, 1981, TERATOLOGY, V23, P191, DOI 10.1002/tera.1420230204
   Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845
   Johansen AMW, 2008, AM J EPIDEMIOL, V167, P1164, DOI 10.1093/aje/kwn035
   Johnson CS, 2007, BIRTH DEFECTS RES A, V79, P631, DOI 10.1002/bdra.20385
   JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601
   JONES KL, 1973, LANCET, V1, P1267
   JONES KL, 1973, LANCET, V2, P999
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Kahn BM, 2017, DIS MODEL MECH, V10, P29, DOI 10.1242/dmm.026195
   Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x
   Kalisch-Smith JI, 2018, BIOCHEM CELL BIOL, V96, P107, DOI 10.1139/bcb-2017-0133
   KALTER H, 1959, PHYSIOL REV, V39, P69
   Kam RKT, 2010, INT J DEV BIOL, V54, P1355, DOI 10.1387/ijdb.092984rk
   Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11
   Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811
   Kane CJM, 2016, J LEUKOCYTE BIOL, V100, P951, DOI 10.1189/jlb.3MR0416-171R
   Kaneda T, 2012, DEV BIOL, V369, P1, DOI 10.1016/j.ydbio.2012.05.019
   Kapur BM, 2018, BIOCHEM CELL BIOL, V96, P189, DOI 10.1139/bcb-2017-0079
   Karacay B, 2015, ALCOHOL CLIN EXP RES, V39, P221, DOI 10.1111/acer.12615
   Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028
   Keen CL, 2010, BIOFACTORS, V36, P125, DOI 10.1002/biof.89
   KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I
   Keys SA, 1999, EXP EYE RES, V68, P693, DOI 10.1006/exer.1999.0657
   Kiecker C, 2001, CURR OPIN NEUROBIOL, V11, P27, DOI 10.1016/S0959-4388(00)00170-7
   Kiecker C, 2016, DEV BIOL, V415, P314, DOI 10.1016/j.ydbio.2016.01.007
   Kiecker C, 2012, ANNU REV NEUROSCI, V35, P347, DOI 10.1146/annurev-neuro-062111-150543
   Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448
   Kilburn BA, 2006, ALCOHOL CLIN EXP RES, V30, P127, DOI 10.1111/j.1530-0277.2006.00008.x
   Kim JS, 2006, ALCOHOL ALCOHOLISM, V41, P126, DOI 10.1093/alcalc/agh248
   KIRKE PN, 1993, Q J MED, V86, P703
   Kleiber ML, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00161
   Kleiber ML, 2011, BEHAV BRAIN RES, V223, P376, DOI 10.1016/j.bbr.2011.05.005
   Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801
   Koide T, 2002, INT J DEV BIOL, V46, P777
   Kopinke D, 2006, DEV DYNAM, V235, P2695, DOI 10.1002/dvdy.20905
   Koren G, 2003, CAN MED ASSOC J, V169, P1181
   Kot-Leibovich H, 2009, DIS MODEL MECH, V2, P295, DOI 10.1242/dmm.001420
   Koyabu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4625
   KRAFT JC, 1994, BIOCHEM J, V301, P111, DOI 10.1042/bj3010111
   KRAFT JC, 1994, P NATL ACAD SCI USA, V91, P3067, DOI 10.1073/pnas.91.8.3067
   Krishnamoorthy M, 2013, BIRTH DEFECTS RES B, V98, P283, DOI 10.1002/bdrb.21063
   Kulesa PM, 2010, DEV BIOL, V344, P543, DOI 10.1016/j.ydbio.2010.04.010
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004
   Kurosaka H, 2017, HUM MOL GENET, V26, P1268, DOI 10.1093/hmg/ddx031
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lange S, 2017, JAMA PEDIATR, V171, P948, DOI 10.1001/jamapediatrics.2017.1919
   le Maire A, 2014, SUBCELL BIOCHEM, V70, P37, DOI 10.1007/978-94-017-9050-5_3
   LEDIG M, 1980, NEUROCHEM RES, V5, P1155, DOI 10.1007/BF00964895
   Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170
   Legault LM, 2018, BIOCHEM CELL BIOL, V96, P117, DOI 10.1139/bcb-2017-0141
   Lemaire P, 1996, TRENDS GENET, V12, P525, DOI 10.1016/S0168-9525(97)81401-1
   LEMOINE P, 1968, OUEST MED, V21, P476
   Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007
   Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441
   Linney E, 2011, NEUROTOXICOL TERATOL, V33, P631, DOI 10.1016/j.ntt.2011.06.006
   Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067
   LOHNES D, 1994, DEVELOPMENT, V120, P2723
   Lunde ER, 2016, ALCOHOL CLIN EXP RES, V40, P1403, DOI 10.1111/acer.13114
   Lupo G, 2005, DEVELOPMENT, V132, P1737, DOI 10.1242/dev.01726
   Lussier AA, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0439-6
   Lussier AA, 2017, EPIGENOMICS-UK, V9, P291, DOI 10.2217/epi-2016-0163
   Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2
   Maden M, 2001, POSTGRAD MED J, V77, P489, DOI 10.1136/pmj.77.910.489
   Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212
   Mandal C, 2018, J APPL TOXICOL, V38, P100, DOI 10.1002/jat.3504
   Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156
   Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002
   Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004
   MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0
   Martini M, 2018, HEAD FACE MED, V14, DOI 10.1186/s13005-017-0159-8
   Mascrez B, 2009, P NATL ACAD SCI USA, V106, P4272, DOI 10.1073/pnas.0813143106
   Massimino L, 2018, DEV BIOL, V434, P231, DOI 10.1016/j.ydbio.2017.12.020
   May PA, 2018, JAMA-J AM MED ASSOC, V319, P474, DOI 10.1001/jama.2017.21896
   May PA, 2013, ALCOHOL CLIN EXP RES, V37, P818, DOI 10.1111/acer.12033
   May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68
   McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411
   McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71
   MCMARTIN KE, 1989, J NUTR, V119, P1490
   Mello T, 2008, MOL ASPECTS MED, V29, P17, DOI 10.1016/j.mam.2007.10.001
   Melnik BC, 2009, J INVEST DERMATOL, V129, P1868, DOI 10.1038/jid.2009.8
   MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749
   Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812
   Mic FA, 2004, DEV DYNAM, V231, P270, DOI 10.1002/dvdy.20128
   Micucci JA, 2014, HUM MOL GENET, V23, P434, DOI 10.1093/hmg/ddt435
   Minucci S, 1996, P NATL ACAD SCI USA, V93, P1803, DOI 10.1073/pnas.93.5.1803
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328
   Molotkova N, 2007, DEV BIOL, V303, P601, DOI 10.1016/j.ydbio.2006.11.035
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muralidharan P, 2015, ALCOHOL, V49, P149, DOI 10.1016/j.alcohol.2014.11.001
   Muralidharan P, 2013, BRAIN SCI, V3, P964, DOI 10.3390/brainsci3020964
   NAKATSUJI N, 1983, TERATOLOGY, V28, P299, DOI 10.1002/tera.1420280220
   Nallamshetty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071307
   Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735
   Niccols A, 2007, BRAIN COGNITION, V65, P135, DOI 10.1016/j.bandc.2007.02.009
   Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn
   Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788
   Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3
   Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463
   Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599
   Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5
   Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347
   Niehrs C, 2001, EMBO J, V20, P631, DOI 10.1093/emboj/20.4.631
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   O'Leary-Moore SK, 2010, BIRTH DEFECTS RES A, V88, P953, DOI 10.1002/bdra.20719
   Ojeda L, 2018, BIOCHEM CELL BIOL, V96, P178, DOI 10.1139/bcb-2017-0069
   Okubo T., 2014, NEW PRINCIPLES DEV P, P97, DOI [10.1007/978-4-431-54634-4_8, DOI 10.1007/978-4-431-54634-4_8]
   Okubo T, 2011, DEVELOPMENT, V138, P339, DOI 10.1242/dev.054056
   Ornoy A, 2010, INT J ENV RES PUB HE, V7, P364, DOI 10.3390/ijerph7020364
   Orsolits B, 2013, STEM CELLS DEV, V22, P2777, DOI 10.1089/scd.2012.0422
   Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491
   Ozturk NC, 2017, ALCOHOL, V60, P135, DOI 10.1016/j.alcohol.2017.01.006
   Pal-Bhadra M, 2007, LIFE SCI, V81, P979, DOI 10.1016/j.lfs.2007.07.030
   Pappalardo-Carter DL, 2013, ALCOHOL CLIN EXP RES, V37, P1657, DOI 10.1111/acer.12139
   Park JW, 2017, ONCOTARGET, V8, P99382, DOI 10.18632/oncotarget.19544
   Parker HJ, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.286
   Parnell SE, 2013, NEUROTOXICOL TERATOL, V39, P77, DOI 10.1016/j.ntt.2013.07.009
   Parnell SE, 2009, ALCOHOL CLIN EXP RES, V33, P1001, DOI 10.1111/j.1530-0277.2009.00921.x
   Patten AR, 2013, NEUROSCI LETT, V551, P7, DOI 10.1016/j.neulet.2013.05.051
   Petrelli B, 2018, BIOCHEM CELL BIOL, V96, P131, DOI 10.1139/bcb-2017-0280
   Pittlik S, 2008, GENE EXPR PATTERNS, V8, P141, DOI 10.1016/j.gep.2007.11.003
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Popova S, 2017, LANCET GLOB HEALTH, V5, pE290, DOI 10.1016/S2214-109X(17)30021-9
   Popova S, 2016, LANCET, V387, P978, DOI 10.1016/S0140-6736(15)01345-8
   Portales-Casamar E, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0074-4
   Portales-Casamar E, 2015, INT J DEV NEUROSCI, V47, P126, DOI 10.1016/j.ijdevneu.2015.04.336
   PULLARKAT RK, 1991, ALCOHOL CLIN EXP RES, V15, P565, DOI 10.1111/j.1530-0277.1991.tb00561.x
   Raineki C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00005
   Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2
   Ranke MB, 2015, DEV MED CHILD NEUROL, V57, P23, DOI 10.1111/dmcn.12582
   REINKE LA, 1987, P NATL ACAD SCI USA, V84, P9223, DOI 10.1073/pnas.84.24.9223
   Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938
   Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108
   Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204
   Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x
   Roberts C, 2005, DEV DYNAM, V232, P928, DOI 10.1002/dvdy.20268
   Roberts C, 2006, HUM MOL GENET, V15, P3394, DOI 10.1093/hmg/ddl416
   Rodriguez CI, 2016, BEHAV BRAIN RES, V313, P233, DOI 10.1016/j.bbr.2016.07.018
   Rojas-Mayorquin AE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00565
   ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333
   Roussotte FF, 2012, HUM BRAIN MAPP, V33, P920, DOI 10.1002/hbm.21260
   Rufer ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047499
   Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X
   Samarut E, 2015, BBA-GENE REGUL MECH, V1849, P73, DOI 10.1016/j.bbagrm.2014.05.030
   Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407
   Sandell LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030698
   Satiroglu-Tufan NL, 2004, REPROD TOXICOL, V18, P407, DOI 10.1016/j.reprotox.2004.01.005
   SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5
   Schambra UB, 2017, NEUROTOXICOL TERATOL, V62, P42, DOI 10.1016/j.ntt.2017.05.001
   Schneider RA, 2001, DEVELOPMENT, V128, P2755
   Sekiya I, 2001, J CELL BIOCHEM, P71, DOI 10.1002/jcb.1077
   Serrano M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.017
   Shabtai Y, 2018, BIOCHEM CELL BIOL, V96, P148, DOI 10.1139/bcb-2017-0132
   Shabtai Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18719-7
   Shabtai Y, 2017, INT J DEV BIOL, V61, P303, DOI 10.1387/ijdb.160252af
   Shaw W, 2004, CLEFT PALATE-CRAN J, V41, P238, DOI 10.1597/03-214.1
   Shen L, 2013, ALCOHOL, V47, P405, DOI 10.1016/j.alcohol.2013.04.005
   SHENEFELT RE, 1972, TERATOLOGY, V5, P103, DOI 10.1002/tera.1420050115
   Shenoda BB, 2017, NEUROCHEM RES, V42, P1279, DOI 10.1007/s11064-016-2169-5
   Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004
   Singh SP, 1996, P SOC EXP BIOL MED, V212, P349
   SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932
   SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3
   Smiley JF, 2015, ALCOHOL, V49, P571, DOI 10.1016/j.alcohol.2015.04.008
   Smith SM, 2014, BIRTH DEFECTS RES C, V102, P210, DOI 10.1002/bdrc.21078
   Smith SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00224
   Smoak IW, 2005, DEV BIOL, V283, P357, DOI 10.1016/j.ydbio.2005.04.029
   Sogut I, 2015, EXP THER MED, V9, P1023, DOI 10.3892/etm.2014.2164
   Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996
   Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133
   Spohr HL, 2008, DTSCH ARZTEBL INT, V105, P693, DOI 10.3238/arztebl.2008.0693
   Stockard CR, 1914, ANAT REC, V8, P33, DOI 10.1002/ar.1090080202
   Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901
   Stratton K., 1996, FETAL ALCOHOL SYNDRO, DOI [10.17226/4991, DOI 10.17226/4991]
   SULIK KK, 1983, AM J ANAT, V166, P257, DOI 10.1002/aja.1001660303
   SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717
   SULIK KK, 1988, DEVELOPMENT, V103, P213
   Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0
   Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487
   Tabler JM, 2014, DEV BIOL, V396, P1, DOI 10.1016/j.ydbio.2014.09.029
   Thomas JD, 2010, BIRTH DEFECTS RES A, V88, P827, DOI 10.1002/bdra.20713
   Toi A, 2009, PRENATAL DIAG, V29, P355, DOI 10.1002/pd.2211
   Tolosa EJ, 2016, EUR J CELL BIOL, V95, P136, DOI 10.1016/j.ejcb.2016.02.003
   Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056
   Treit S, 2017, NEUROIMAGE-CLIN, V15, P284, DOI 10.1016/j.nicl.2017.05.006
   TWAL W, 1995, DEV BIOL, V168, P225, DOI 10.1006/dbio.1995.1075
   Twal WO, 1997, ALCOHOL CLIN EXP RES, V21, P1137, DOI 10.1097/00000374-199709000-00029
   Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228
   Twigg SRF, 2009, DEV DYNAM, V238, P331, DOI 10.1002/dvdy.21790
   Uban KA, 2013, PSYCHONEUROENDOCRINO, V38, P1953, DOI 10.1016/j.psyneuen.2013.02.017
   Ulven SM, 2000, DEV BIOL, V220, P379, DOI 10.1006/dbio.2000.9634
   Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180
   Vermot J, 2003, P NATL ACAD SCI USA, V100, P1763, DOI 10.1073/pnas.0437920100
   Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407
   Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915
   Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002
   WEINBERG J, 1985, ALCOHOL CLIN EXP RES, V9, P49, DOI 10.1111/j.1530-0277.1985.tb05049.x
   Wells PG, 2016, BIRTH DEFECTS RES C, V108, P108, DOI 10.1002/bdrc.21134
   Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117
   Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029
   Whiting J, 1997, MUTAT RES-FUND MOL M, V396, P97, DOI 10.1016/S0027-5107(97)00177-2
   Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B
   Wu LNY, 2002, J CELL BIOCHEM, V87, P173, DOI 10.1002/jcb.10285
   Xavier GM, 2016, DEV BIOL, V415, P198, DOI 10.1016/j.ydbio.2016.02.009
   Xu YJ, 2008, BRIT J NUTR, V99, P455, DOI 10.1017/S0007114507812074
   Yamagishi C, 2006, PEDIATR RES, V59, P349, DOI 10.1203/01.pdr.0000199911.17287.3e
   Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903
   Yao H, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97440
   Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014
   Yelin R, 2007, DIFFERENTIATION, V75, P393, DOI 10.1111/j.1432-0436.2006.00147.x
   Young JK, 2014, ADV NUTR, V5, P675, DOI 10.3945/an.113.004846
   Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245
   Zoltewicz JS, 1997, DEV BIOL, V192, P482, DOI 10.1006/dbio.1997.8774
NR 342
TC 6
Z9 6
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-954X
EI 1526-968X
J9 GENESIS
JI Genesis
PD JAN
PY 2019
VL 57
IS 1
AR e23278
DI 10.1002/dvg.23278
PG 24
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA HJ6ZY
UT WOS:000457343400010
PM 30614633
DA 2020-07-08
ER

PT J
AU Xie, BP
   Qiu, GH
   Sun, B
   Yang, ZF
   Zhang, WH
   Chen, JX
   Jiang, ZH
AF Xie, Bao-Ping
   Qiu, Gui-Hua
   Sun, Bin
   Yang, Zi-Feng
   Zhang, Wen-Hua
   Chen, Jin-Xiang
   Jiang, Zhi-Hong
TI Synchronous sensing of three conserved sequences of Zika virus using a
   DNAs@MOF hybrid: experimental and molecular simulation studies
SO INORGANIC CHEMISTRY FRONTIERS
LA English
DT Article
ID METAL-ORGANIC FRAMEWORK; FLUORESCENCE ANISOTROPY; RNA SEQUENCES; DS-DNA;
   PLATFORM; MICRORNA; POLYMER; SINGLE; NANOPARTICLES; COMPLEXES
AB A metal-organic framework of Cu(II) supported by a zwitterionic pyridinium dicarboxylate and 4,4'-bipyridine mixed ligands was prepared and impregnated with three dye-labeled DNA sequences with fixed wavelength differences. This hybrid material formed is capable of the synchronous detection of three conserved Zika virus RNA sequences with high sensitivity and selectivity, and low detection limits of 0.56 +/- 0.02, 0.16 +/- 0.04, and 0.19 +/- 0.05 nM, without any cross-reactions, as confirmed by both experimental and molecular simulation studies.
C1 [Yang, Zi-Feng; Jiang, Zhi-Hong] Guangzhou Med Univ, Inst Integrated Tradit Chinese Med & Western Med, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
   [Xie, Bao-Ping; Qiu, Gui-Hua; Sun, Bin; Chen, Jin-Xiang] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.
   [Zhang, Wen-Hua] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Jiang, ZH (corresponding author), Guangzhou Med Univ, Inst Integrated Tradit Chinese Med & Western Med, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.; Chen, JX (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.; Zhang, WH (corresponding author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM whzhang@suda.edu.cn; jxchen@smu.edu.cn; zhihongjiang@gmail.com
RI Zhang, Wen-Hua/B-1898-2010
OI Zhang, Wen-Hua/0000-0001-9047-8881
FU Natural Science Foundation of GuangdongNational Natural Science
   Foundation of Guangdong Province [2018A030313456]; Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [21671143, 21874064, 21871203]
FX This work was financially supported by the Natural Science Foundation of
   Guangdong (2018A030313456) and the Natural Science Foundation of China
   (21671143, 21874064, and 21871203).
CR [Anonymous], 2014, MOL OP ENV MOE 2014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Degliangeli F, 2014, J AM CHEM SOC, V136, P2264, DOI 10.1021/ja412152x
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dong HF, 2012, ANAL CHEM, V84, P4587, DOI 10.1021/ac300721u
   Fang JM, 2014, ANALYST, V139, P801, DOI 10.1039/c3an01975f
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ganeshpandian M, 2014, DALTON T, V43, P1203, DOI 10.1039/c3dt51641e
   Goldberg JM, 2013, J AM CHEM SOC, V135, P18651, DOI 10.1021/ja409709x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hu FL, 2018, ANGEW CHEM INT EDIT, V57, P12696, DOI 10.1002/anie.201806076
   Hu FL, 2015, DALTON T, V44, P18795, DOI 10.1039/c5dt03094c
   Hu PP, 2018, INORG CHEM, V57, P8382, DOI 10.1021/acs.inorgchem.8b01051
   Joye IJ, 2015, FOOD CHEM, V185, P261, DOI 10.1016/j.foodchem.2015.03.128
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li FL, 2016, CHEMISTRYSELECT, V1, P2979, DOI 10.1002/slct.201600554
   Li HX, 2013, CHEM COMMUN, V49, P4259, DOI 10.1039/c2cc36736j
   Liu YL, 2015, ANAL CHIM ACTA, V861, P55, DOI 10.1016/j.aca.2014.12.032
   McCarroll ME, 2001, J AM CHEM SOC, V123, P3173, DOI 10.1021/ja005604h
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Qin L, 2017, ACS APPL MATER INTER, V9, P41378, DOI 10.1021/acsami.7b09608
   Qin L, 2016, CHEM COMMUN, V52, P132, DOI 10.1039/c5cc06697b
   Qiu GH, 2018, TALANTA, V180, P396, DOI 10.1016/j.talanta.2017.12.045
   Stettler K., 2016, SCIENCE, V14, P8505
   Sun B, 2018, TALANTA, V179, P658, DOI 10.1016/j.talanta.2017.11.047
   Thomsson D, 2013, SMALL, V9, P2619, DOI 10.1002/smll.201203272
   Wang GY, 2014, J MATER CHEM A, V2, P2213, DOI 10.1039/c3ta14199c
   Wang LY, 2012, ANALYST, V137, P3667, DOI 10.1039/c2an35396b
   Wang XY, 2013, BIOSENS BIOELECTRON, V41, P569, DOI 10.1016/j.bios.2012.09.023
   Xie BP, 2018, SENSOR ACTUAT B-CHEM, V254, P1133, DOI 10.1016/j.snb.2017.06.085
   Yang SP, 2015, ANAL CHEM, V87, P12206, DOI 10.1021/acs.analchem.5b03084
   Ye T, 2014, ANALYST, V139, P1721, DOI 10.1039/c3an02077k
   Zhang HT, 2014, CHEM COMMUN, V50, P12069, DOI 10.1039/c4cc05571c
   Zhao HQ, 2016, ANAL CHIM ACTA, V922, P55, DOI 10.1016/j.aca.2016.03.054
   Zhao HQ, 2016, DALTON T, V45, P5092, DOI 10.1039/c5dt04410c
   Zhu X, 2013, CHEM COMMUN, V49, P1276, DOI 10.1039/c2cc36661d
   Zou MJ, 2012, BIOSENS BIOELECTRON, V32, P148, DOI 10.1016/j.bios.2011.11.052
NR 40
TC 7
Z9 7
U1 8
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2052-1553
J9 INORG CHEM FRONT
JI Inorg. Chem. Front.
PD JAN 1
PY 2019
VL 6
IS 1
BP 148
EP 152
DI 10.1039/c8qi01031e
PG 5
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA HJ6DU
UT WOS:000457275000012
DA 2020-07-08
ER

PT J
AU Shin, D
   Behura, SK
   Severson, DW
AF Shin, Dongyoung
   Behura, Susanta K.
   Severson, David W.
TI Genome-Wide Transcriptome Profiling Reveals Genes Associated with
   Meiotic Drive System of Aedes aegypti
SO INSECTS
LA English
DT Article
DE Culicidae; microarray; expression profiling; sex ratio distortion
ID SEX-RATIO DISTORTION; MOSQUITO; POPULATION; RAS; RESISTANCE; EFFICIENCY;
   COMPLEX; LOCUS; PCR
AB Aedes aegypti is an important mosquito vector of several arboviruses, including dengue, yellow fever, Zika, and Chikungunya, which cause significant human morbidity and mortality globally. In certain populations of this mosquito, a native meiotic drive system causes abnormal spermatogenesis that results in highly male-biased progenies from some matings. Although the basic genetics and cytogenetics of the drive mechanism were elucidated, very little is known on a transcriptome level about how the meiotic drive phenotype is expressed in individual males. To address this question, we conducted a whole-genome microarray expression study of testes from a meiotic-drive-carrying strain (T37) in comparison with testes from a non-drive-carrying strain (RED). Based on bioinformatics analyses of the microarray data, we identified 209 genes associated with the meiotic drive phenotype that were significantly differentially expressed between the two strains. K-means cluster analysis revealed nine clusters, in which genes upregulated in T37 testes were assigned to five clusters and genes downregulated in T37 testes were assigned to four clusters. Our data further revealed that genes related to protein translation, phosphorylation, and binding, as well as to G-protein-coupled receptor (GPCR) and peptidase activities, are differentially upregulated in testes from males with the meiotic drive genotype. Based on pathway analysis of these differentially expressed genes, it was observed that the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway may play a role in the meiotic drive system. Overall, this investigation enhances our understanding of whole-genome gene expression associated with the meiotic drive system in Ae. aegypti.
C1 [Shin, Dongyoung] Univ Florida, Florida Med Entomol Lab, Dept Entomol & Nematol, Vero Beach, FL 32962 USA.
   [Shin, Dongyoung; Behura, Susanta K.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Behura, Susanta K.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
   [Behura, Susanta K.] Univ Missouri, Inst Informat, Columbia, MO 65211 USA.
RP Severson, DW (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
EM dshin@ufl.edu; behuras@missouri.edu; severson.1@nd.edu
FU National Institutes of Health, National Institute of Allergy and
   Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [RO1-AI059342, R56-AI110721A1]
FX This research was funded in part by the National Institutes of Health,
   National Institute of Allergy and Infectious Disease, grant numbers
   RO1-AI059342 and R56-AI110721A1 to D.W.S.
CR AGULNIK SI, 1993, GENET RES, V61, P91, DOI 10.1017/S0016672300031189
   Bauer H, 2005, NAT GENET, V37, P969, DOI 10.1038/ng1617
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Cha SJ, 2006, AM J TROP MED HYG, V74, P62, DOI 10.4269/ajtmh.2006.74.62
   Cha SJ, 2006, DNA SEQUENCE, V17, P223, DOI 10.1080/10425170600805540
   Cha SJ, 2006, AM J TROP MED HYG, V75, P70, DOI 10.4269/ajtmh.2006.75.70
   Chauhan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047350
   Clemons Anthony, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5507
   CRAIG GB, 1960, SCIENCE, V132, P1887, DOI 10.1126/science.132.3443.1887
   Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5
   FORGY EW, 1965, BIOMETRICS, V21, P768
   Franz Alexander W E, 2014, Curr Trop Med Rep, V1, P21
   Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031
   Hancock JF, 2004, DEV CELL, V6, P743, DOI 10.1016/j.devcel.2004.05.011
   Harker BW, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-29
   HICKEY WA, 1966, CAN J GENET CYTOL, V8, P260, DOI 10.1139/g66-033
   HICKEY WA, 1966, GENETICS, V53, P1177
   Huang YX, 2007, INSECT BIOCHEM MOLEC, V37, P1054, DOI 10.1016/j.ibmb.2007.06.002
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9
   Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   McClelland GAH, 1962, T ROY SOC TROP MED H, V56, P4
   Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742
   Mori A, 2004, J MED ENTOMOL, V41, P1027, DOI 10.1603/0022-2585-41.6.1027
   Morlais I, 2001, GENETICS, V158, P1125
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   NEWTON ME, 1974, CHROMOSOMA, V49, P41, DOI 10.1007/BF00284986
   NEWTON ME, 1976, GENETICA, V46, P297, DOI 10.1007/BF00055473
   OwusuDaaku KO, 1997, HEREDITY, V79, P388, DOI 10.1038/hdy.1997.172
   Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12
   Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969
   Roy SG, 2011, INSECT BIOCHEM MOLEC, V41, P62, DOI 10.1016/j.ibmb.2010.10.001
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shin D, 2012, J HERED, V103, P303, DOI 10.1093/jhered/esr134
   Shin DY, 2011, J INSECT PHYSIOL, V57, P1220, DOI 10.1016/j.jinsphys.2011.05.014
   Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2
   SUGUNA SG, 1977, GENET RES, V29, P123, DOI 10.1017/S0016672300017195
   Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401
   WOOD RJ, 1987, GENETICA, V72, P69, DOI 10.1007/BF00126980
   WOOD RJ, 1991, AM NAT, V137, P379, DOI 10.1086/285171
   Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007
   Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169
NR 45
TC 1
Z9 1
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD JAN
PY 2019
VL 10
IS 1
AR 25
DI 10.3390/insects10010025
PG 11
WC Entomology
SC Entomology
GA HJ5DN
UT WOS:000457198700012
PM 30634571
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Olafuyi, O
   Badhan, RKS
AF Olafuyi, Olusola
   Badhan, Raj K. S.
TI Dose Optimization of Chloroquine by Pharmacokinetic Modeling During
   Pregnancy for the Treatment of Zika Virus Infection
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE physiologically based pharmacokinetics; Zika; malaria; pregnancy
ID PLASMODIUM-VIVAX; URINARY-EXCRETION; PLASMA-VOLUME; MALARIA;
   DISPOSITION; DRUGS; WOMEN; METABOLISM; PARAMETERS; THERAPY
AB The insidious nature of Zika virus (ZIKV) infections can have a devastating consequence for fetal development. Recent reports have highlighted that chloroquine (CQ) is capable of inhibiting ZIKV endocytosis in brain cells. We applied pharmacokinetic modeling to develop a predictive model for CQ exposure to identify an optimal maternal/fetal dosing regimen to prevent ZIKV endocytosis in brain cells. Model validation used 13 nonpregnancy and 3 pregnancy clinical studies, and a therapeutic CQ plasma window of 0.3-2 mu M was derived. Dosing regimens used in rheumatoid arthritis, systemic lupus erythematosus, and malaria were assessed for their ability to target this window. Dosing regimen identified that weekly doses used in malaria were not sufficient to reach the lower therapeutic window; however, daily doses of 150 mg achieved this therapeutic window. The impact of gestational age was further assessed and culminated in a final proposed regimen of 600 mg on day 1, 300 mg on day 2 and 3, and 150 mg thereafter until the end of trimester 2, which resulted in maintaining 65% and 94% of subjects with a trough plasma concentration above the lower therapeutic window on day 6 and at term, respectively. (C) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
C1 [Olafuyi, Olusola; Badhan, Raj K. S.] Aston Univ, Aston Pharm Sch, Aston Hlth Res Grp, Birmingham B4 7ET, W Midlands, England.
   [Badhan, Raj K. S.] Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England.
RP Badhan, RKS (corresponding author), Aston Univ, Aston Pharm Sch, Aston Hlth Res Grp, Birmingham B4 7ET, W Midlands, England.; Badhan, RKS (corresponding author), Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England.
EM r.k.s.badhan@aston.ac.uk
OI Badhan, Raj/0000-0002-0904-9324
FU Aston University
FX The authors would like to thank Aston University for providing the
   Overseas Student Scholar Scheme to fund this project.
CR Abduljalil K, 2018, CLIN PHARMACOKINET, V57, P1149, DOI 10.1007/s40262-017-0618-1
   Abduljalil K, 2012, CLIN PHARMACOKINET, V51, P365, DOI 10.2165/11597440-000000000-00000
   ADELUSI SA, 1982, J PHARM PHARMACOL, V34, P733, DOI 10.1111/j.2042-7158.1982.tb06211.x
   AKINTONWA A, 1988, THER DRUG MONIT, V10, P147, DOI 10.1097/00007691-198802000-00004
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Anger GJ, 2008, CLIN PHARMACOL THER, V83, P184, DOI 10.1038/sj.clpt.6100377
   Badhan R, 2018, J PHARM SCI-US, V107, P2236, DOI 10.1016/j.xphs.2018.03.026
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bustos DG, 2002, TROP MED INT HEALTH, V7, P584, DOI 10.1046/j.1365-3156.2002.00899.x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention (CDC), 2018, CONG ZIK SYNDR OTH B
   Chandra RS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-122
   CHEUNG CK, 1989, CLIN CHEM, V35, P1978
   Chukwuani MC, 2004, TROP MED INT HEALTH, V9, P601, DOI 10.1111/j.1365-3156.2004.01227.x
   Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065
   Dallmann A, 2017, CLIN PHARMACOKINET, V56, P1303, DOI 10.1007/s40262-017-0539-z
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DEAN M, 1980, CLIN PHARMACOL THER, V28, P253, DOI 10.1038/clpt.1980.158
   Delvecchio R, 2016, VIRUSES, V8, P1
   DEVRIES PJ, 1994, DRUG INVEST, V8, P143
   Ducharme J, 1996, CLIN PHARMACOKINET, V31, P257, DOI 10.2165/00003088-199631040-00003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edginton AN, 2006, CLIN PHARMACOKINET, V45, P1013, DOI 10.2165/00003088-200645100-00005
   ERMAN A, 1992, SCAND J CLIN LAB INV, V52, P409, DOI 10.3109/00365519209088376
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Fakeye T O, 2002, West Afr J Med, V21, P286
   Feghali M, 2015, SEMIN PERINATOL, V39, P512, DOI 10.1053/j.semperi.2015.08.003
   Franssen NR, 2006, AM MIDL NAT, V156, P1, DOI 10.1674/0003-0031(2006)156[1:UOSITT]2.0.CO;2
   FRISKHOLMBERG M, 1984, EUR J CLIN PHARMACOL, V26, P521, DOI 10.1007/BF00542151
   Ginsberg G, 2004, J TOXICOL ENV HEAL A, V67, P297, DOI 10.1080/15287390490273550
   Ginsburg H, 2005, ACTA TROP, V96, P16, DOI 10.1016/j.actatropica.2005.06.021
   GUSTAFSSON LL, 1983, BRIT J CLIN PHARMACO, V15, P471, DOI 10.1111/j.1365-2125.1983.tb01532.x
   Hayashi M, 2002, AM J KIDNEY DIS, V39, P392, DOI 10.1053/ajkd.2002.30561
   Hayes DJ, 2015, B WORLD HEALTH ORGAN, V93, P74, DOI 10.2471/BLT.14.139113
   Hoglund R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1181-1
   HYTTEN FE, 1963, J OBSTET GYN BR COMM, V70, P402
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245
   Karunajeewa HA, 2010, ANTIMICROB AGENTS CH, V54, P1186, DOI 10.1128/AAC.01269-09
   Ke AB, 2018, CPT-PHARMACOMET SYST, V7, P103, DOI 10.1002/psp4.12274
   Ke AB, 2013, DRUG METAB DISPOS, V41, P801, DOI 10.1124/dmd.112.050161
   Klinger G, 2001, LANCET, V358, P813, DOI 10.1016/S0140-6736(01)06004-4
   Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002
   Law I, 2008, BRIT J CLIN PHARMACO, V65, P674, DOI 10.1111/j.1365-2125.2008.03111.x
   Lee SJ, 2008, EUR J CLIN PHARMACOL, V64, P987, DOI 10.1007/s00228-008-0500-z
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   Loebstein R, 1997, CLIN PHARMACOKINET, V33, P328, DOI 10.2165/00003088-199733050-00002
   Lu GH, 2012, BRIT J CLIN PHARMACO, V74, P873, DOI 10.1111/j.1365-2125.2012.04363.x
   MACKENZIE AH, 1983, AM J MED, V75, P40, DOI 10.1016/0002-9343(83)91269-X
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11
   Mzayek Fawaz, 2007, PLoS Clin Trials, V2, pe6, DOI 10.1371/journal.pctr.0020006
   NABANGCHANG K, 1994, BRIT J CLIN PHARMACO, V38, P278, DOI 10.1111/j.1365-2125.1994.tb04354.x
   Najmi MH, 2008, PAKISTAN ARMED FORCE, V58
   Obua C, 2006, Afr Health Sci, V6, P86
   Olafuyi O, 2017, BIOPHARM DRUG DISPOS, V38, P464, DOI 10.1002/bdd.2087
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39
   Pan American Health Organisation (PAHO) (WHO), WHO ZIK CUM CAS
   Parrott N, 2011, CLIN PHARMACOKINET, V50, P613, DOI 10.2165/11592640-000000000-00000
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   PIRANI BBK, 1973, J OBSTET GYN BR COMM, V80, P884
   Qasqas Shadi A, 2004, Cardiol Rev, V12, P201, DOI 10.1097/01.crd.0000102420.62200.e1
   Radeva-Petrova D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub3
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   RUBIN M, 1963, ARCH OPHTHALMOL-CHIC, V70, P474, DOI 10.1001/archopht.1963.00960050476009
   RukariaKaumbutho RM, 1996, INT J GYNECOL OBSTET, V53, P235, DOI 10.1016/0020-7292(96)02651-3
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Farias KJS, 2013, SCI WORLD J, DOI 10.1155/2013/282734
   TANARIYA P, 1995, T ROY SOC TROP MED H, V89, P426, DOI 10.1016/0035-9203(95)90039-X
   TITUS EO, 1989, THER DRUG MONIT, V11, P369, DOI 10.1097/00007691-198911040-00001
   TSAI WP, 1990, AIDS RES HUM RETROV, V6, P481, DOI 10.1089/aid.1990.6.481
   TULPULE A, 1982, EUR J CLIN PHARMACOL, V23, P271, DOI 10.1007/BF00547567
   U.S. Food and Drug Administration, 2012, SUMM MIN ADV COMM PH
   Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039
   Virgintino D, 2000, DEV BRAIN RES, V123, P95, DOI 10.1016/S0165-3806(00)00086-9
   WALKER O, 1987, BRIT J CLIN PHARMACO, V23, P295, DOI 10.1111/j.1365-2125.1987.tb03048.x
   Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858
   WETSTEYN JCFM, 1995, BRIT J CLIN PHARMACO, V39, P696, DOI 10.1111/j.1365-2125.1995.tb05731.x
   WHO, 2018, ZIK VIR
   WOLFE MS, 1985, BRIT MED J, V290, P1466, DOI 10.1136/bmj.290.6480.1466
   Zakaria Z, 2018, EUR J PHARM SCI, V119, P90, DOI 10.1016/j.ejps.2018.04.012
   Zakaria ZH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030074
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zhuang XM, 2016, ACTA PHARM SIN B, V6, P430, DOI 10.1016/j.apsb.2016.04.004
NR 87
TC 4
Z9 4
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD JAN
PY 2019
VL 108
IS 1
BP 661
EP 673
DI 10.1016/j.xphs.2018.10.056
PG 13
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA HJ1BY
UT WOS:000456898100069
PM 30399360
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Gomes, PATD
   Pena, LJ
   Leite, ACL
AF Teixeira de Moraes Gomes, Paulo Andre
   Pena, Lindomar J.
   Leite, Ana C. Lima
TI Isatin Derivatives and Their Antiviral Properties Against Arboviruses: A
   Review
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Arbovirus; Chikungunya virus; Dengue virus; Isatin; Japanese
   encephalitis virus; West Nile virus; Zika virus
ID JAPANESE ENCEPHALITIS; WEST NILE; VIRUS; DENGUE; REPLICATION;
   INHIBITION; DESIGN
AB Arboviruses have been spreading rapidly throughout the Western Hemisphere in recent decades. Among the arboviruses with high morbidity and mortality are the members of the Alphavirus and Flavivirus genera. Within the first genus, Chikungunya Virus (CHIKV) is considered one of the most challenging human arboviral infection worldwide, against which there is no specific antivirals. Flaviviruses are some of the main viruses responsible for encephalitis, haemorrhagic disease and developmental defects. Dengue virus (DENV), Japanese Encephalitis Virus (JEV), West Nile Virus (WNV) and Zika Virus (ZIKV) are examples of flaviviruses without clinically approved antiviral agents. Thus, the search for new antivirals becomes highly important. One of the strategies that can be employed to obtain new drugs is the identification and utilization of privileged structures. Isatin is an example of a privileged molecular framework, displaying a broad spectrum of biological activities, including antiviral action. Obtaining and studying the antiviral properties of isatin derivatives have helped to identify important agents with potential activity against different arboviruses. This article reviews some of these isatin derivatives, their structures and antiviral properties reported against this important group of viruses.
C1 [Teixeira de Moraes Gomes, Paulo Andre; Leite, Ana C. Lima] Univ Fed Pernambuco, Dept Pharmaceut Sci, Med Chem Planning Lab, Recife, PE, Brazil.
   [Teixeira de Moraes Gomes, Paulo Andre; Pena, Lindomar J.] Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst, Dept Virol & Expt Therapeut, Recife, PE, Brazil.
RP Gomes, PATD (corresponding author), Univ Fed Pernambuco, Dept Pharmaceut Sci, Med Chem Planning Lab, Recife, PE, Brazil.
EM pauloandretmg@gmail.com
OI Teixeira de Moraes Gomes, Paulo Andre/0000-0001-7089-5653
FU Pernambuco State Foundation for Science and Technology (FACEPE)
FX We would like to thank the Pernambuco State Foundation for Science and
   Technology (FACEPE) for supporting this work (Post doctoral fellowship
   for Paulo Andre Teixeira de Moraes Gomes).
CR Asenjo A, 2008, VIROLOGY, V380, P26, DOI 10.1016/j.virol.2008.06.045
   Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06
   BAUER DJ, 1970, ANN NY ACAD SCI, V173, P314, DOI 10.1111/j.1749-6632.1970.tb53421.x
   BAUER DJ, 1966, SCIENCE, V154, P796, DOI 10.1126/science.154.3750.796
   BAUER DJ, 1965, ANN NY ACAD SCI, V130, P110, DOI 10.1111/j.1749-6632.1965.tb12545.x
   Blazquez A. B., 2016, FRONT MICROBIOL, P7
   Candido-Bacani PD, 2011, MUTAT RES-GEN TOX EN, V719, P47, DOI 10.1016/j.mrgentox.2010.11.006
   Cihan-Ustundag G, 2016, BIOORGAN MED CHEM, V24, P240, DOI 10.1016/j.bmc.2015.12.008
   Costantino L, 2006, CURR MED CHEM, V13, P65, DOI 10.2174/092986706775197944
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107
   Gilbert C, 2005, VIRAL IMMUNOL, V18, P474, DOI 10.1089/vim.2005.18.474
   Jadav S. S., 2014, J PHARM CHEM, V1, P59
   Kang IJ, 2011, BIOORG MED CHEM LETT, V21, P1948, DOI 10.1016/j.bmcl.2011.02.037
   Laursen SR, 2016, EUR J ORG CHEM, V2016, P1881, DOI 10.1002/ejoc.201600143
   Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d
   Minami M, 2006, J NEURAL TRANSM-SUPP, P87
   Mishra P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20122
   Muller VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112351
   Padmanabhan P, 2017, J MED VIROL, V89, P546, DOI 10.1002/jmv.24655
   Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006
   Rashad AA, 2013, J MOL GRAPH MODEL, V44, P241, DOI 10.1016/j.jmgm.2013.07.001
   Ren A, 2015, PANMINERVA MED, V57, P177
   Ren AL, 2016, EXP THER MED, V11, P2225, DOI 10.3892/etm.2016.3232
   Rodrigues Faria N, 2016, PLOS CURR OUTBREAKS
   RONEN D, 1985, ANTIVIR RES, V5, P249, DOI 10.1016/0166-3542(85)90029-4
   Sebastian L, 2012, LETT APPL MICROBIOL, V55, P234, DOI 10.1111/j.1472-765X.2012.03282.x
   Sebastian L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-64
   Solomon T, 2016, INT J INFECT DIS, V45, P24, DOI 10.1016/j.ijid.2016.02.086
   TEITZ Y, 1994, ANTIVIR RES, V24, P305, DOI 10.1016/0166-3542(94)90077-9
   Teitz Y., 1994, ANTIVIR RES, V305, P314
   Vazquez-Calvo A, 2011, J VIROL, V85, P1267, DOI 10.1128/JVI.01717-10
   Vine KL, 2009, ANTI-CANCER AGENT ME, V9, P397, DOI 10.2174/1871520610909040397
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wu RZ, 2010, J MED CHEM, V53, P7958, DOI 10.1021/jm100593s
   Zhang HFM, 2014, ACS CHEM BIOL, V9, P1015, DOI 10.1021/cb400775z
   Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204
   Zou B, 2015, ACS MED CHEM LETT, V6, P344, DOI 10.1021/ml500521r
NR 39
TC 4
Z9 5
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2019
VL 19
IS 1
BP 56
EP 62
DI 10.2174/1389557518666180424093305
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HJ3UD
UT WOS:000457098300006
PM 29692243
DA 2020-07-08
ER

PT J
AU Andrews, J
AF Andrews, Jennifer
TI The time has come to mitigate the risk of lead exposure from blood
   transfusions
SO PEDIATRIC RESEARCH
LA English
DT Editorial Material
ID ZIKA VIRUS-RNA
C1 [Andrews, Jennifer] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol & Pediat, Nashville, TN 37235 USA.
RP Andrews, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol & Pediat, Nashville, TN 37235 USA.
EM jennifer.andrews@vanderbilt.edu
CR [Anonymous], 2011 NATL BLOOD COLL
   Bearer CF, 2000, J PEDIATR-US, V137, P549, DOI 10.1067/mpd.2000.108273
   BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Centers for Disease Control and Prevention, LOW LEV LEAD EXP HAR
   Elabiad MT, 2014, AM J PERINAT, V31, P863, DOI 10.1055/s-0033-1361936
   Elabiad MT, 2013, AM J PERINAT, V30, P765, DOI 10.1055/s-0032-1332803
   Gehrie E, 2013, J PEDIATR-US, V163, P855, DOI 10.1016/j.jpeds.2013.03.003
   Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067
   Joint Food and Agriculture Organization/World Health Organization Expert Committee on Food Additives (JECFA), 2010, 73 M GEN 8 17 JUN
   Pate LL, 2017, TRANSFUSION, V57, p26A
   Saa PP, 2017, TRANSFUSION, V57, p25A
   U.S. Inflation Calculator, INFL CALC CONS PRIC
   White K, 2018, PEDIAT RES
   Zubairi H, 2015, PEDIATR RES, V77, P814, DOI 10.1038/pr.2015.53
NR 15
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD JAN
PY 2019
VL 85
IS 1
BP 7
EP 8
DI 10.1038/s41390-018-0218-2
PG 2
WC Pediatrics
SC Pediatrics
GA HJ5IC
UT WOS:000457212500004
PM 30397277
OA Bronze
DA 2020-07-08
ER

PT J
AU Gordon, A
   Gresh, L
   Ojeda, S
   Katzelnick, LC
   Sanchez, N
   Mercado, JC
   Chowell, G
   Lopez, B
   Elizondo, D
   Coloma, J
   Burger-Calderon, R
   Kuan, G
   Balmaseda, A
   Harris, E
AF Gordon, Aubree
   Gresh, Lionel
   Ojeda, Sergio
   Katzelnick, Leah C.
   Sanchez, Nery
   Mercado, Juan Carlos
   Chowell, Gerardo
   Lopez, Brenda
   Elizondo, Douglas
   Coloma, Josefina
   Burger-Calderon, Raquel
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI Prior dengue virus infection and risk of Zika: A pediatric cohort in
   Nicaragua
SO PLOS MEDICINE
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; REPRODUCTION NUMBER; CROSS-REACTIVITY;
   CHIKUNGUNYA; EPIDEMIC; OUTBREAK; DISEASE; PCR
AB Background
   Zika virus (ZIKV) emerged in northeast Brazil in 2015 and spread rapidly across the Americas, in populations that have been largely exposed to dengue virus (DENV). The impact of prior DENV infection on ZIKV infection outcome remains unclear. To study this potential impact, we analyzed the large 2016 Zika epidemic in Managua, Nicaragua, in a pediatric cohort with well-characterized DENV infection histories.
   Methods and findings
   Symptomatic ZIKV infections (Zika cases) were identified by real-time reverse transcription PCR and serology in a community-based cohort study that follows approximately 3,700 children aged 2-14 years old. Annual blood samples were used to identify clinically inapparent ZIKV infections using a novel, well-characterized serological assay. Multivariable Poisson regression was used to examine the relation between prior DENV infection and incidence of symptomatic and inapparent ZIKV infection. The generalized-growth method was used to estimate the effective reproduction number. From January 1, 2016, to February 28, 2017, 560 symptomatic ZIKV infections and 1,356 total ZIKV infections (symptomatic and inapparent) were identified, for an overall incidence of 14.0 symptomatic infections (95% CI: 12.9, 15.2) and 36.5 total infections (95% CI: 34.7, 38.6) per 100 person-years. Effective reproduction number estimates ranged from 3.3 to 3.4, depending on the ascending wave period. Incidence of symptomatic and total ZIKV infections was higher in females and older children. Analysis of the effect of prior DENV infection was performed on 3,027 participants with documented DENV infection histories, of which 743 (24.5%) had experienced at least 1 prior DENV infection during cohort follow-up. Prior DENV infection was inversely associated with risk of symptomatic ZIKV infection in the total cohort population (incidence rate ratio [IRR]: 0.63; 95% CI: 0.48, 0.81; p < 0.005) and with risk of symptomatic presentation given ZIKV infection (IRR: 0.62; 95% CI: 0.44, 0.86) when adjusted for age, sex, and recent DENV infection (1-2 years before ZIKV infection). Recent DENV infection was significantly associated with decreased risk of symptomatic ZIKV infection when adjusted for age and sex, but not when adjusted for prior DENV infection. Prior or recent DENV infection did not affect the rate of total ZIKV infections. Our findings are limited to a pediatric population and constrained by the epidemiology of the site.
   Conclusions
   These findings support that prior DENV infection may protect individuals from symptomatic Zika. More research is needed to address the possible immunological mechanism(s) of cross-protection between ZIKV and DENV and whether DENV immunity also modulates other ZIKV infection outcomes such as neurological or congenital syndromes.
C1 [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Gresh, Lionel; Ojeda, Sergio; Sanchez, Nery; Mercado, Juan Carlos; Lopez, Brenda; Elizondo, Douglas; Burger-Calderon, Raquel] Sustainable Sci Inst, Managua, Nicaragua.
   [Katzelnick, Leah C.; Coloma, Josefina; Burger-Calderon, Raquel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Mercado, Juan Carlos; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Chowell, Gerardo] Georgia State Univ, Atlanta, GA 30303 USA.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
RI Gordon, Aubree/X-1113-2019
OI Gordon, Aubree/0000-0002-9352-7877; Gresh, Lionel/0000-0002-2333-1748
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI099631, P01 AI106695,
   U19 AI118610]; Pediatric Dengue Vaccine Initiative of the Bill and
   Melinda Gates Foundation [VE-1]
FX This study was supported by grants R01 AI099631 (AB), P01 AI106695 (EH),
   and U19 AI118610 (EH) from the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health, as well as
   grant VE-1 (EH) from the Pediatric Dengue Vaccine Initiative of the Bill
   and Melinda Gates Foundation. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chowell G, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0659
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Katzelnick LC, 2018, CURR OPIN VIROL, V29, P51, DOI 10.1016/j.coviro.2018.03.004
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   R Core Team, 2016, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Terry T AB, 2017, RPART RECURSIVE PART
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   World Health Organization, 1975, TECHN GUID DIAGN SUR
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 55
TC 35
Z9 35
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2019
VL 16
IS 1
AR e1002726
DI 10.1371/journal.pmed.1002726
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA HJ7CL
UT WOS:000457349900007
PM 30668565
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, N
   Preno, A
   Dubaut, J
   Nadeau, H
   Hyatt, K
   Singleton, K
   Martin, A
   Parks, WT
   Papin, JF
   Myers, DA
AF Gurung, Sunam
   Reuter, Nicole
   Preno, Alisha
   Dubaut, Jamie
   Nadeau, Hugh
   Hyatt, Kimberly
   Singleton, Krista
   Martin, Ashley
   Parks, W. Tony
   Papin, James F.
   Myers, Dean A.
TI Zika virus infection at mid-gestation results in fetal cerebral cortical
   injury and fetal death in the olive baboon
SO PLOS PATHOGENS
LA English
DT Article
ID RADIAL GLIAL-CELLS; WEST-NILE-VIRUS; PREGNANCY; RHESUS; BRAIN; MODEL;
   IMMUNIZATION; INOCULATION; PROGENITORS; SYSTEM
AB Zika virus (ZIKV) infection during pregnancy in humans is associated with an increased incidence of congenital anomalies including microcephaly as well as fetal death and miscarriage and collectively has been referred to as Congenital Zika Syndrome (CZS). Animal models for ZIKV infection in pregnancy have been developed including mice and non-human primates (NHPs). In macaques, fetal CZS outcomes from maternal ZIKV infection range from none to significant. In the present study we develop the olive baboon (Papio anubis), as a model for vertical transfer of ZIKV during pregnancy. Four mid-gestation, timed-pregnant baboons were inoculated with the French Polynesian ZIKV isolate (10(4) ffu). This study specifically focused on the acute phase of vertical transfer. Dams were terminated at 7 days post infection (dpi; n = 1), 14 dpi (n = 2) and 21 dpi (n = 1). All dams exhibited mild to moderate rash and conjunctivitis. Viremia peaked at 5-7 dpi with only one of three dams remaining mildly viremic at 14 dpi. An anti-ZIKV IgM response was observed by 14 dpi in all three dams studied to this stage, and two dams developed a neutralizing IgG response by either 14 dpi or 21 dpi, the latter included transfer of the IgG to the fetus (cord blood). A systemic inflammatory response (increased IL2, IL6, IL7, IL15, IL16) was observed in three of four dams. Vertical transfer of ZIKV to the placenta was observed in three pregnancies (n = 2 at 14 dpi and n = 1 at 21 dpi) and ZIKV was detected in fetal tissues in two pregnancies: one associated with fetal death at 14 dpi, and the other in a viable fetus at 21 dpi. ZIKV RNA was detected in the fetal cerebral cortex and other tissues of both of these fetuses. In the fetus studied at 21 dpi with vertical transfer of virus to the CNS, the frontal cerebral cortex exhibited notable defects in radial glia, radial glial fibers, disorganized migration of immature neurons to the cortical layers, and signs of pathology in immature oligodendrocytes. In addition, indices of pronounced neuroinflammation were observed including astrogliosis, increased microglia and IL6 expression. Of interest, in one fetus examined at 14 dpi without detection of ZIKV RNA in brain and other fetal tissues, increased neuroinflammation (IL6 and microglia) was observed in the cortex. Although the placenta of the 14 dpi dam with fetal death showed considerable pathology, only minor pathology was noted in the other three placentas. ZIKV was detected immunohistochemically in two placentas (14 dpi) and one placenta at 21 dpi but not at 7 dpi. This is the first study to examine the early events of vertical transfer of ZIKV in a NHP infected at mid-gestation. The baboon thus represents an additional NHP as a model for ZIKV induced brain pathologies to contrast and compare to humans as well as other NHPs.
   Author summary Zika virus is endemic in the Americas, primarily spread through mosquitos and sexual contact. Zika virus infection during pregnancy in women is associated with a variety of fetal pathologies now referred to as Congenital Zika Syndrome (CZS), with the most severe pathology being fetal microcephaly. Developing model organisms that faithfully recreate Zika infection in humans is critical for future development of treatments and preventions. In our present study, we infected Olive baboons at mid-gestation with Zika virus and studied the acute period of viremia and transfer of Zika virus to the fetus during the first three weeks after infection to better understand the timing and mechanisms of transfer of ZIKV across the placenta, leading to CZS. We observed Zika virus transfer to fetuses resulting in fetal death in one pregnancy and in a second pregnancy, significant damage to the frontal cortex of the fetal brain at a critical period of neurodevelopment in primates. Thus, the baboon provides a promising new non-human primate model to further compare and contrast the consequences of Zika virus infection in pregnancy to humans and other non-human primates.
C1 [Gurung, Sunam; Dubaut, Jamie; Nadeau, Hugh; Hyatt, Kimberly; Singleton, Krista; Martin, Ashley; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA.
   [Reuter, Nicole; Preno, Alisha; Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Div Comparat Med, Oklahoma City, OK USA.
   [Martin, Ashley] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA.
   [Parks, W. Tony] Univ Toronto, Dept Pathol, Toronto, ON, Canada.
RP Myers, DA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA.
EM dean-myers@ouhsc.edu
OI Preno, Alisha/0000-0002-4263-1690; Peregrine, Jamie/0000-0001-6705-3957;
   Parks, W. Tony/0000-0001-7341-3277; Martin, Ashley/0000-0003-1134-8216
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NS103772, OD01988]
FX These studies were supported in part by the National Institutes of
   Health, NS103772 (DAM) and OD01988 (JFP). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Back SA, 2001, J NEUROSCI, V21, P1302
   Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197
   Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Holtzman M, 2018, CLIN OBSTET GYNECOL, V61, P177, DOI 10.1097/GRF.0000000000000343
   Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009
   Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mo ZC, 2009, GLIA, V57, P490, DOI 10.1002/glia.20775
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Myers DA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12643
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shearer MH, 1997, INFECT IMMUN, V65, P3267, DOI 10.1128/IAI.65.8.3267-3270.1997
   Shearer MH, 1999, CLIN DIAGN LAB IMMUN, V6, P953, DOI 10.1128/CDLI.6.6.953-958.1999
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Vargas VE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185272
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watts AM, 1999, NAT MED, V5, P427
   Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 75
TC 10
Z9 10
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2019
VL 15
IS 1
AR e1007507
DI 10.1371/journal.ppat.1007507
PG 33
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HJ7TK
UT WOS:000457400000021
PM 30657788
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ngono, AE
   Young, MP
   Bunz, M
   Xu, ZG
   Hattakam, S
   Vizcarra, E
   Regla-Nava, JA
   Tang, WW
   Yamabhai, M
   Wen, JS
   Shresta, S
AF Ngono, Annie Elong
   Young, Matthew P.
   Bunz, Maximilian
   Xu, Zhigang
   Hattakam, Sararat
   Vizcarra, Edward
   Regla-Nava, Jose Angel
   Tang, William W.
   Yamabhai, Montarop
   Wen, Jinsheng
   Shresta, Sujan
TI CD4(+) T cells promote humoral immunity and viral control during Zika
   virus infection
SO PLOS PATHOGENS
LA English
DT Article
ID WEST-NILE-VIRUS; SEXUAL TRANSMISSION; ANTIBODY-RESPONSES; DENGUE;
   PROTECTION; VACCINE; BRAIN; CLEARANCE; EPITOPE; LEADS
AB Several Zika virus (ZIKV) vaccines designed to elicit protective antibody (Ab) responses are currently under rapid development, but the underlying mechanisms that control the magnitude and quality of the Ab response remain unclear. Here, we investigated the CD4(+) T cell response to primary intravenous and intravaginal infection with ZIKV. Using the LysMCre(+)Ifnar1(fl/fl) (myeloid type I IFN receptor-deficient) C57BL/6 mouse models, we identified six I-A(b)-restricted ZIKV epitopes that stimulated CD4(+) T cells with a predominantly cytotoxic Th1 phenotype in mice primed with ZIKV. Intravenous and intravaginal infection with ZIKV effectively induced follicular helper and regulatory CD4(+) T cells. Treatment of mice with a CD4(+) T cell-depleting Ab reduced the plasma cell, germinal center B cell, and IgG responses to ZIKV without affecting the CD8(+) T cell response. CD4(+) T cells were required to protect mice from a lethal dose of ZIKV after infection intravaginally, but not intravenously. However, adoptive transfer and peptide immunization experiments showed a role for memory CD4(+) T cells in ZIKV clearance in mice challenged intravenously. These results demonstrate that CD4(+) T cells are required mainly for the generation of a ZIKV-specific humoral response but not for an efficient CD8(+) T cell response. Thus, CD4(+) T cells could be important mediators of protection against ZIKV, depending on the infection or vaccination context.
   Author summary Several vaccine candidates are currently under development for Zika virus (ZIKV) infection, which causes life-threatening neurologic diseases, including congenital Zika syndrome in neonates and Guillain-Barre syndrome in adults. However, the mechanisms by which the adaptive immune system contributes to protection against ZIKV have not been fully investigated. In this report, we used mouse models of systemic and genital mucosal infection with ZIKV to evaluate the role of CD4(+) T cells in regulating antiviral humoral and CD8(+) T cell responses and in controlling ZIKV infection. We first defined the antigen specificity and phenotype of the CD4(+) T cell response to ZIKV and then demonstrated that CD4(+) T cells are required for inducing humoral, but not CD8(+) T cell, responses in ZIKV-primed mice. CD4(+) T cells were also required for local control of ZIKV burden in mice infected intravaginally. Although CD4(+) T cells are not necessary for the control of primary ZIKV infection via the intravenous route, CD4(+) T cells can confer protection against lethal intravaginal ZIKV challenge. Our results support ZIKV vaccine strategies that induce a protective CD4(+) T cell response to ZIKV.
C1 [Ngono, Annie Elong; Young, Matthew P.; Bunz, Maximilian; Xu, Zhigang; Hattakam, Sararat; Vizcarra, Edward; Regla-Nava, Jose Angel; Tang, William W.; Yamabhai, Montarop; Wen, Jinsheng; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Xu, Zhigang; Wen, Jinsheng; Shresta, Sujan] Wenzhou Med Univ, Inst Arboviruses, Sch Basic Med Sci, Wenzhou, Zhejiang, Peoples R China.
   [Hattakam, Sararat; Yamabhai, Montarop] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Nakhon Ratchasima, Thailand.
   [Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Shresta, S (corresponding author), Wenzhou Med Univ, Inst Arboviruses, Sch Basic Med Sci, Wenzhou, Zhejiang, Peoples R China.; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
EM sujan@lji.org
OI Bunz, Maximilian/0000-0002-6767-8698; Regla-Nava, Jose
   Angel/0000-0002-5438-1369; Yamabhai, Montarop/0000-0003-2674-2419
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI116813, R21 NS100477, R01 NS106387];
   Chiba-UCSD Center for Mucosal Immunology, Allergy and Vaccine
   Development
FX This work was funded by NIAID/NIH grants R01 AI116813, R21 NS100477, and
   R01 NS106387 to SS and the Chiba-UCSD Center for Mucosal Immunology,
   Allergy and Vaccine Development. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Caligioni Claudia S, 2009, Curr Protoc Neurosci, VAppendix 4, p4I, DOI 10.1002/0471142301.nsa04is48
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8
   Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rojas JM, 2017, J IMMUNOL RES, DOI 10.1155/2017/6104054
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 55
TC 12
Z9 12
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2019
VL 15
IS 1
AR e1007474
DI 10.1371/journal.ppat.1007474
PG 29
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HJ7TK
UT WOS:000457400000011
PM 30677097
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gray, D
   Mishtal, J
AF Gray, Deven
   Mishtal, Joanna
TI Managing an epidemic: Zika interventions and community responses in
   Belize
SO GLOBAL PUBLIC HEALTH
LA English
DT Article
DE Reproductive governance; endemic Zika; health policy; neoliberalism;
   Belize
ID HEALTH; DENGUE; CONTRACEPTION
AB Implementing effective health interventions in recent epidemics has been difficult due to the potentially global nature of their spread and sociocultural dynamics, raising questions concerning how to develop culturally-appropriate preventive measures, and how these health threats are understood locally. In Belize, health policy makers have only been marginally effective in managing infections and mosquito vectors, and Zika has been declared endemic in certain regions, particularly on the island of Caye Caulker. Based on ethnographic research conducted primarily in 2017, we examine how perspectives of Zika-related health consequences are shaped, and how state interventions to manage Zika are understood. We argue that despite its declared endemic status, Zika is not perceived as a true health concern for community members due to numerous neoliberal structural challenges. Moreover, the state's restrictive form of reproductive governance which limits family planning services is forcing individuals to weigh conflicting conceptions of health consequences. This also contributes to an ambiguous healthcare environment for health practitioners, giving them an unclear picture of the scope of Zika as a public health concern. We also consider how critical medical anthropology and feminist analytical approaches are useful in exploring these questions and contributing to understandings of the health impacts of Zika.
C1 [Gray, Deven; Mishtal, Joanna] Univ Cent Florida, Dept Anthropol, Orlando, FL 32816 USA.
RP Gray, D (corresponding author), Univ Cent Florida, Dept Anthropol, Orlando, FL 32816 USA.
EM deveng@knights.ucf.edu
OI Gray, Deven/0000-0002-7756-9225
FU National Geographic SocietyNational Geographic Society [HJ-061ER-17]
FX This work was supported by National Geographic Society [grant number
   HJ-061ER-17].
CR Ali M, 2017, EUR J CONTRACEP REPR, V22, P102, DOI 10.1080/13625187.2017.1288902
   Alley C, 2014, MED ANTHROPOL, V33, P85, DOI 10.1080/01459740.2013.850590
   [Anonymous], 2016, THE SAN PEDRO SUN
   [Anonymous], 2016, ZIK ETH CONS ETH GUI
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Brown P., 2012, COMPANION MED ANTHR, P253
   Center for Reproductive Rights, 2016, CTR HUM RIGHTS RESP
   Centers for Disease Control and Prevention (CDC), 2017, ZIK VIR BEL
   Centers for Disease Control and Prevention (CDC), 2017, PAT COUNS
   DeWalt K. M., 2011, PARTICIPANT OBSERVAT
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Farmer P., 2014, LONDON REV BOOKS, V36, P38
   Farmer Paul, 2005, PATHOLOGIES POWER HL
   Feierman S, 2010, GLOB PUBLIC HEALTH, V5, P122, DOI 10.1080/17441690903401338
   Government of Belize and Caribbean Development Bank, 2010, COUNTR POV ASS
   Gutmann M. C., 2011, REPROD GLOBALIZATION, P53, DOI 10.1215/9780822393948
   Harvey D., 2007, BRIEF HIST NEOLIBERA
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   Humes A., 2016, BREAKING BELIZE 0209
   Humes A., 2016, BREAKING BELIZE 0408
   Inhorn MC, 2006, MED ANTHROPOL Q, V20, P345, DOI 10.1525/maq.2006.20.3.345
   Jones P., 2003, NEWS 5 BELIZE
   KENDALL C, 1991, MED ANTHROPOL Q, V5, P257, DOI 10.1525/maq.1991.5.3.02a00050
   Lara D, 2006, CONTRACEPTION, V74, P394, DOI 10.1016/j.contraception.2006.05.068
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Lindauer D., 2014, LABOR MARKET PERFORM
   Lowy I, 2017, AM J PUBLIC HEALTH, V107, P517, DOI 10.2105/AJPH.2017.303652
   McNeil Jr Donald G., 2016, NY TIMES
   Ministry of Health, 2016, POL PLANN PROJ MAN N
   Morgan LM, 2012, ANTHROPOL MED, V19, P241, DOI 10.1080/13648470.2012.675046
   Nading A.M., 2014, MOSQUITO TRAILS ECOL
   National Women's Commission, 2012, EQ OPP EQ RES SIT AN
   Pan American Health Organization (PAHO), 2017, ZIK EP REP BEL
   Pan American Health Organization (PAHO), 2018, BEL
   Richardson R. B., 2007, TAKING STOCK BELIZE, P30
   SCHEPER-HUGHES N, 1987, Medical Anthropology Quarterly, V1, P6, DOI 10.1525/maq.1987.1.1.02a00020
   Singer M., 2015, ANTHR INFECT DIS
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Smith L, 2012, HUM ORGAN, V71, P65, DOI 10.17730/humo.71.1.t8513653l8111214
   Sobo EJ, 2009, MED ANTHROPOL, V28, P326, DOI 10.1080/01459740903303894
   Stat-Ease Inc, 2016, MULT IND CLUST SURV, P1
   State Oceanic Administration People's Republic of China, 2010, B CHIN MAR ENV STAT, V1, P1
   United Nations, 2017, SOC EC COSTS ZIK CAN
   United Nations, 2017, AB POL GLOB REV
   Uzwiak BA, 2016, MED ANTHROPOL Q, V30, P100, DOI 10.1111/maq.12195
   Women on Waves, 2017, BEL AB LAW WOM WAV
   World Bank, 2017, GDP PER CAP CURR US
   World Health Organization, 2018, HIST ZIK VIR
   World Health Organization (WHO), 2018, KEY COUNTR IND BEL K
NR 49
TC 3
Z9 3
U1 3
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1744-1692
EI 1744-1706
J9 GLOB PUBLIC HEALTH
JI Glob. Public Health
PY 2019
VL 14
IS 1
BP 9
EP 22
DI 10.1080/17441692.2018.1471146
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HI3YJ
UT WOS:000456387300002
PM 29733243
OA Green Published
DA 2020-07-08
ER

PT J
AU Gharbaran, R
   Somenarain, L
AF Gharbaran, Rajendra
   Somenarain, Latchman
TI Putative Cellular and Molecular Roles of Zika Virus in Fetal and
   Pediatric Neuropathologies
SO PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
LA English
DT Review
DE fetal; pediatric; developmental neuropathology; brain development; Zika
   virus; placenta; neuron; embryo; neural cortex
ID NEURAL STEM-CELLS; HUMAN PLACENTAL TROPHOBLASTS; GAP-JUNCTION PROTEINS;
   PROGENITOR CELLS; DENGUE VIRUS; CEREBRAL ORGANOIDS; TAM RECEPTORS;
   CHROMOSOME CONDENSATION; DIFFERENTIAL EXPRESSION; NEOCORTICAL
   DEVELOPMENT
AB Although the World Health Organization declared an end to the recent Zika virus (ZIKV) outbreak and its association with adverse fetal and pediatric outcome, on November 18, 2016, the virus still remains a severe public health threat. Laboratory experiments thus far supported the suspicions that ZIKV is a teratogenic agent. Evidence indicated that ZIKV infection cripples the host cells' innate immune responses, allowing productive replication and potential dissemination of the virus. In addition, studies suggest potential transplacental passage of the virus and subsequent selective targeting of neural progenitor cells (NPCs). Depletion of NPCs by ZIKV is associated with restricted brain growth. And while microcephaly can result from infection at any gestational stages, the risk is greater during the first trimester. Although a number of recent studies revealed some of specific molecular and cellular roles of ZIKV proteins of this mosquito-borne flavivirus, the mechanisms by which it produces it suspected pathophysiological effects are not completely understood. Thus, this review highlights the cellular and molecular evidence that implicate ZIKV in fetal and pediatric neuropathologies.
C1 [Gharbaran, Rajendra; Somenarain, Latchman] CUNY, Bronx Community Coll, Dept Biol Sci, Bronx, NY 10453 USA.
RP Gharbaran, R (corresponding author), CUNY, Bronx Community Coll, Dept Biol Sci, Bronx, NY 10453 USA.
EM rajendra.gharbaran@bcc.cuny.edu
OI Gharbaran, Rajendra/0000-0002-2351-3808
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Ajmone-Cat MA, 2010, J NEUROCHEM, V113, P1060, DOI 10.1111/j.1471-4159.2010.06670.x
   Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931
   Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733
   Awad S, 2013, HUM MOL GENET, V22, P2200, DOI 10.1093/hmg/ddt072
   Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campaner S, 2005, MOL CELL BIOL, V25, P6660, DOI 10.1128/MCB.25.15.6660-6672.2005
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051
   Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885
   Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071
   Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148
   Diaz AL, 2009, CLIN PERINATOL, V36, P503, DOI 10.1016/j.clp.2009.06.008
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063
   Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211
   Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Goeden N, 2016, J NEUROSCI, V36, P6041, DOI 10.1523/JNEUROSCI.2534-15.2016
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Howard BM, 2008, NEUROSCIENTIST, V14, P459, DOI 10.1177/1073858407313512
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Issa L, 2013, CEREB CORTEX, V23, P2245, DOI 10.1093/cercor/bhs212
   Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218
   Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Johnson K, 2015, NEURAL REGEN RES, V10, P344, DOI 10.4103/1673-5374.153671
   Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005
   Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220
   Koyanagi M, 2005, J BIOL CHEM, V280, P12430, DOI 10.1074/jbc.M410420200
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2015, SCIENCE, V350, DOI 10.1126/science.aab2595
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5
   Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Matsuuchi L, 2013, BBA-BIOMEMBRANES, V1828, P94, DOI 10.1016/j.bbamem.2012.05.014
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McLean E, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1304505
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Montiel JF, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00022
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nadarajah B, 1997, J NEUROSCI, V17, P3096
   Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895
   Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   Nicol MB, 1999, NEUROPHARMACOLOGY, V38, P49, DOI 10.1016/S0028-3908(98)00166-X
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019
   Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prieto AL, 1999, BRAIN RES, V816, P646, DOI 10.1016/S0006-8993(98)01159-7
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pujhari S, 2017, HEAT SHOCK PROTEIN 7, V70
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roberts KL, 2015, J VIROL, V89, P1537, DOI 10.1128/JVI.03306-14
   Roberts MR, 2000, J NEUROSCI, V20, P2295
   Robinson S, 2005, EPILEPSY BEHAV, V7, P345, DOI 10.1016/j.yebeh.2005.06.005
   Saadi A, 2016, NEUROGENETICS, V17, P71, DOI 10.1007/s10048-015-0468-7
   Sainaghi PP, 2008, J NEUROL SCI, V269, P138, DOI 10.1016/j.jns.2008.01.005
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182
   Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006
   Shankar SL, 2003, J NEUROSCI, V23, P4208
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh AK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94275
   Smith SK, 2000, HUM REPROD, V15, P59
   Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682
   STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109
   Wang C, 2016, THERANOSTICS, V6, P1205, DOI 10.7150/thno.15083
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005
   Wang XY, 2009, J IMMUNOL, V183, P7471, DOI 10.4049/jimmunol.0900762
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wilsch-Brauninger M, 2016, CURR OPIN NEUROBIOL, V39, P122, DOI 10.1016/j.conb.2016.05.004
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Wu GL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.113
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xu D, 2014, CELL REP, V6, P1176, DOI 10.1016/j.celrep.2014.03.021
   Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7
   YAMAMOTO T, 1992, DEV BRAIN RES, V66, P165, DOI 10.1016/0165-3806(92)90077-A
   Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683
   Zhang XY, 2009, CELL CYCLE, V8, P1206, DOI 10.4161/cc.8.8.8205
   Zhou ZW, 2013, DNA REPAIR, V12, P645, DOI 10.1016/j.dnarep.2013.04.017
   Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339
NR 202
TC 1
Z9 1
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1093-5266
EI 1615-5742
J9 PEDIATR DEVEL PATHOL
JI Pediatr. Dev. Pathol.
PD JAN-FEB
PY 2019
VL 22
IS 1
BP 5
EP 21
DI 10.1177/1093526618790742
PG 17
WC Pathology; Pediatrics
SC Pathology; Pediatrics
GA HI4DB
UT WOS:000456400200003
PM 30149771
DA 2020-07-08
ER

PT J
AU Jackman, JA
   Shi, PY
   Cho, NJ
AF Jackman, Joshua A.
   Shi, Pei-Yong
   Cho, Nam-Joon
TI Targeting the Achilles Heel of Mosquito-Borne Viruses for Antiviral
   Therapy
SO ACS INFECTIOUS DISEASES
LA English
DT Editorial Material
ID ENVELOPED VIRUSES; FUSION INHIBITOR; DENGUE; PEPTIDE; MECHANISMS;
   INFECTION; ENTRY
AB Mosquito-borne viruses encompass a wide range of pathogens, such as dengue and Zika viruses, that often cocirculate geographically. These viruses affect hundreds of millions of people worldwide, yet no clinically approved therapy is currently available for treating these viral infections. Thus, innovative therapies, especially inhibitors with broad antiviral activities against all these viruses, are urgently needed. While traditional therapeutic strategies mainly focus on inhibiting viral replication in a "one lock, one key" manner (e.g., viral protease and polymerase inhibitors), inhibitors targeting virions have recently emerged as a promising approach to achieve broad antiviral activities. Within this approach, Lipid Envelope Antiviral Disruption (LEAD) molecules were shown to broadly inhibit mosquito-borne viruses and other lipid membrane-enveloped viruses. Several LEAD molecules have been demonstrated to act against viral membranes in vitro, some of which have even shown in vivo efficacy to treat mosquito-borne viral infections. This therapeutic potential is further enhanced by molecular engineering to improve the inhibitors' pharmacological properties, laying the foundation for the LEAD antiviral strategy to be explored for possible treatment of mosquito-borne viral infections.
C1 [Jackman, Joshua A.; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.; Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu; njcho@ntu.edu.sg
RI Cho, Nam-Joon/J-7816-2012
OI Cho, Nam-Joon/0000-0002-8692-8955; Jackman, Joshua/0000-0002-1800-8102
FU National Research Foundation of Singapore through a Proof-of-Concept
   grant [NRF2015NRF-P0C0001-19]; Creative Materials Discovery Program
   through the National Research Foundation of Korea - Ministry of Science,
   ICT and Future Planning [NRF-2016M3D1A1024098]; Kleberg Foundation
   Award; UTMB CTSAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR-001439]; Pan American
   Health Organization [SCON2016-01353]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AI127744, AI136126]
FX This publication was supported in part by the National Research
   Foundation of Singapore through a Proof-of-Concept grant
   (NRF2015NRF-P0C0001-19) to N.J.C. Additional support was provided by the
   Creative Materials Discovery Program through the National Research
   Foundation of Korea funded by the Ministry of Science, ICT and Future
   Planning (NRF-2016M3D1A1024098). P.-Y.S. lab was supported by a Kleberg
   Foundation Award, UTMB CTSA UL1TR-001439, Pan American Health
   Organization grant SCON2016-01353, and NIH grants AI127744 and AI136126.
CR Attar A, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-23
   Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015
   Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105
   de Witte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018917
   Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hollmann A, 2015, NANOMED-NANOTECHNOL, V11, P1163, DOI 10.1016/j.nano.2015.02.014
   Iwasaki A, 2017, TRENDS MOL MED, V23, P227, DOI 10.1016/j.molmed.2017.01.004
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Jackman JA, 2016, J AM CHEM SOC, V138, P1406, DOI 10.1021/jacs.5b12491
   Jackman JA, 2015, SMALL, V11, P2372, DOI 10.1002/smll.201403638
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lump E, 2015, ELIFE, V4, DOI 10.7554/eLife.05397
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752
   Speerstra S, 2018, ANTIVIR RES, V149, P164, DOI 10.1016/j.antiviral.2017.11.018
   St Vincent MR, 2010, P NATL ACAD SCI USA, V107, P17339, DOI 10.1073/pnas.1010026107
   Suomalainen M, 2002, TRAFFIC, V3, P705, DOI 10.1034/j.1600-0854.2002.31002.x
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Veazey RS, 2016, ANTIMICROB AGENTS CH, V60, P693, DOI 10.1128/AAC.01925-15
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Vigant F, 2014, J VIROL, V88, P1849, DOI 10.1128/JVI.02907-13
   Vigant F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003297
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 36
TC 5
Z9 5
U1 2
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD JAN
PY 2019
VL 5
IS 1
BP 4
EP 8
DI 10.1021/acsinfecdis.8b00286
PG 9
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA HI3KS
UT WOS:000456349300002
PM 30387343
DA 2020-07-08
ER

PT J
AU do Vale, PRLF
   Cerqueira, S
   Santos, HP
   Black, BP
   Carvalho, ESD
AF Lima Falcao do Vale, Paulo Roberto
   Cerqueira, Sheila
   Santos, Hudson P., Jr.
   Black, Beth P.
   de Santana Carvalho, Evanilda Souza
TI Bad news: Families' experiences and feelings surrounding the diagnosis
   of Zika-related microcephaly
SO NURSING INQUIRY
LA English
DT Article
DE child health; family; family health; maternal-child health;
   microcephaly; neonatal diseases; Zika virus
ID CONGENITAL HEART-DISEASE; QUALITY-OF-LIFE; PARENTS; CHILDREN; VIRUS;
   MOTHERS; INFORMATION; OUTBREAK; BRAZIL; BIRTH
AB The rapidly increasing number of cases of Zika virus and limited understanding of its congenital sequelae (e.g., microcephaly) led to stories of fear and uncertainty across social media and other mass communication networks. In this study, we used techniques generic to netnography, a form of ethnography, using Internet-based computer-mediated communications as a source of data to understand the experience and perceptions of families with infants diagnosed with Zika-related microcephaly. We screened 27 YouTube (TM) videos published online between October 2015 and July 2016, during which the Zika epidemic started, peaked, and declined. We identified three themes: (a) experiencing the news of a diagnosis of Zika-associated microcephaly; (b) experiencing feelings and expectations of the 'imperfect' child; and (c) seeking to understand microcephaly to care for the child. We found that families experienced distressing feelings of shock, sadness, hopelessness, and pain, while dealing with emerging and sometimes conflicting information being transmitted by news outlets, uncertainty about the child's health, and healthcare providers' lack of clarity to guide the family members. The 'unknown' factor of ZIKA was an additional stressful factor in the experience of the families.
C1 [Lima Falcao do Vale, Paulo Roberto; Cerqueira, Sheila; de Santana Carvalho, Evanilda Souza] Univ Estadual Feira De Santana, Dept Hlth, Feira De Santana, BA, Brazil.
   [Santos, Hudson P., Jr.; Black, Beth P.] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27515 USA.
RP do Vale, PRLF (corresponding author), Univ Estadual Feira De Santana, Dept Hlth, COGITARE Res Body Gender Representat & Care Pract, Feira De Santana, BA, Brazil.
EM falcaoenfermeiro@gmail.com
RI ; Santos, Hudson/K-5650-2015
OI SOUZA DE SANTANA CARVALHO, EVANILDA/0000-0003-4564-0768; Santos,
   Hudson/0000-0002-4040-366X; Vale, Paulo Roberto Lima Falcao
   do/0000-0002-1158-5628
CR Alsem MW, 2017, RES DEV DISABIL, V60, P125, DOI 10.1016/j.ridd.2016.11.015
   [Anonymous], 2017, MON CAS DENG FEBR CH, V48, P1
   Arya B, 2013, CONGENIT HEART DIS, V8, P78, DOI 10.1111/j.1747-0803.2012.00706.x
   Baker Danial E, 2016, Hosp Pharm, V51, P275, DOI 10.1310/hpj5104-275
   Bevilacqua F, 2013, J MATERN-FETAL NEO M, V26, P1249, DOI 10.3109/14767058.2013.776536
   Bianco-Feldman B., 1998, DESAFIOS IMAGEM FOTO
   Black B, 2010, WESTERN J NURS RES, V32, P1011, DOI 10.1177/0193945910371215
   Black BP, 2011, J PERINAT NEONAT NUR, V25, P13, DOI 10.1097/JPN.0b013e318201edff
   Bowler GM, 2010, QUAL REP, V15, P1270
   Bratt EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0610-4
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Camargo SPH, 2008, INT PSICOL, V12, P277, DOI DOI 10.1590/S1413-73722007000200008
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dalgalarrondo Paulo, 2007, Arch. Clin. Psychiatry (São Paulo), V34, P25, DOI 10.1590/S0101-60832007000700005
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Fonseca A, 2012, DISABIL HEALTH J, V5, P67, DOI 10.1016/j.dhjo.2011.11.001
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Hamlington B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140705
   Harris A, 2014, NEW GENET SOC, V33, P60, DOI 10.1080/14636778.2014.884456
   Harvey KA, 2013, HEART LUNG, V42, P399, DOI 10.1016/j.hrtlng.2013.08.009
   Janvier A, 2012, PEDIATRICS, V130, P293, DOI 10.1542/peds.2012-0151
   Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962
   Kobler K., 2012, INT J CHILDBIRTH ED, V27, P26
   Kolaitis GA, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00102
   Kozinets RV, 2015, NETNOGRAPHY REDEFINE
   Laidsaar-Powell R, 2016, SUPPORT CARE CANCER, V24, P4131, DOI 10.1007/s00520-016-3237-8
   Lawoko S, 2006, HEART LUNG, V35, P301, DOI 10.1016/j.hrtlng.2006.01.004
   Lemacks J, 2013, INT J ENV RES PUB HE, V10, P3465, DOI 10.3390/ijerph10083465
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marokakis S, 2016, PRENATAL DIAG, V36, P662, DOI 10.1002/pd.4836
   MAXWELL JA, 1992, HARVARD EDUC REV, V62, P279, DOI 10.17763/haer.62.3.8323320856251826
   Nora S., 2016, NY TIMES
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Ost E, 2017, PEDIATR SURG INT, V33, P761, DOI 10.1007/s00383-017-4093-4
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL ZIK VIR INF
   Roecker Simone, 2012, Esc. Anna Nery, V16, P17, DOI 10.1590/S1414-81452012000100003
   Santos HPO, 2015, QUAL HEALTH RES, V25, P134, DOI 10.1177/1049732314549603
   Silva CCB, 2014, CAD BRAS TER OCUP, V22, P15
   Silva Sivaldo Pereira da, 2015, Intercom, Rev. Bras. Ciênc. Comun., V38, P231, DOI 10.1590/1809-58442015111
   Siqueira J. C., 2012, TRADTERM, V20, P129, DOI [10.11606/issn.2317-9511.tradterm.2012.49048, DOI 10.11606/ISSN.2317-9511.TRADTERM.2012.49048]
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
   Wright P. M., 2013, INT J CHILDBIRTH ED, V28, P15
NR 44
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1320-7881
EI 1440-1800
J9 NURS INQ
JI Nurs. Inq.
PD JAN
PY 2019
VL 26
IS 1
AR e12274
DI 10.1111/nin.12274
PG 10
WC Nursing
SC Nursing
GA HI2ZU
UT WOS:000456316800001
PM 30450789
OA Bronze
DA 2020-07-08
ER

PT J
AU Camer, GA
   Oikawa, Y
   Omaki, H
   Endoh, D
AF Amor Camer, Gerry
   Oikawa, Yuki
   Omaki, Hitomi
   Endoh, Daiji
TI Novel synthetic nucleotides of notifiable dengue (1-4), Japanese
   encephalitis, yellow fever and Zika flaviviruses
SO FUTURE SCIENCE OA
LA English
DT Article
DE algorithm; flaviviruses; oligomer; overlap-extension PCR; synthetic
   nucleotides
ID IN-SILICO PCR; PRIMER DESIGN; SAFETY
AB Aim: To produce synthetic nucleotides of notifiable dengue virus (1-4 types), Japanese encephalitis, yellow fever and Zika flaviviruses. These notifiable flaviviruses, particularly dengue and Zika, are problematic mosquito-borne infections in the Philippines, as well as in those countries with tropical and subtropical climates. Method: An algorithmic design formulation of overlap extension -polymerase chain reaction (OE-PCR) was performed to propagate 50-60 oligomer lengths of select notifiable flaviviral RNAs to DNA nucleotides via the two-step process of OE-PCR. Result: Algorithmic OE-PCR design formulation efficiently produced 253-256 bp of notifiable flaviviruses. Comparing the newly designed algorithmic OE-PCR with existing executable programs demonstrated it to be efficient and useful in generating accurate sequences of synthetic flaviviral nucleotides. Conclusion: The efficiently and accurately produced novel synthetic nucleotides of notifiable dengue virus 1-4, Japanese encephalitis, yellow fever and Zika flaviviruses using OE-PCR is useful in understanding the dynamics of flaviviral species and holds potential for the development of synthetic nucleotide-based immunogens.
   Lay abstract: Dengue virus (1-4), Japanese encephalitis and Zika fevers are notable mosquito-borne infections that continue to be problematic in the Philippines and its southeast Asian neighbors. Flaviviral yellow fever affects other tropical countries. This study aimed to effectively and efficiently synthesize flaviviral nucleotides through a predictively accurate algorithmic overlap extension-polymerase chain reaction design. The cost-saving arithmetic formulation has enabled the advanced production of 253-256 bp flaviviral nucleotide lengths. The newly synthesized and sequenced products are now ready for further experimentation and open the door for immunological exploration.
   [GRAPHICS]
C1 [Amor Camer, Gerry] Univ Eastern Philippines, Dept Clin Sci, Coll Vet Med, Catarman 6400, Northern Samar, Philippines.
   [Oikawa, Yuki; Omaki, Hitomi; Endoh, Daiji] Rakuno Gakuen Univ, Dept Radiat Biol, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan.
RP Endoh, D (corresponding author), Rakuno Gakuen Univ, Dept Radiat Biol, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan.
EM dendoh@rakuno.ac.jp
RI CAMER, GERRY AMOR/K-3420-2016
OI CAMER, GERRY AMOR/0000-0002-1607-4384
FU 'Development for the control strategy of vector-borne and zoonotic
   diseases in Okinawa, Japan and formulation of networking among
   stakeholders' part of Okinawa's Communicable Disease Research Hub
   Formation Promotion Project; Guest Researcher Program of Rakuno Gakuen
   University, Japan
FX This research was supported by the 'Development for the control strategy
   of vector-borne and zoonotic diseases in Okinawa, Japan and formulation
   of networking among stakeholders', which is part of Okinawa's
   Communicable Disease Research Hub Formation Promotion Project. Credit is
   also due to the funding support of the Guest Researcher Program of
   Rakuno Gakuen University, Japan.
CR Buchan BW, 2014, CLIN MICROBIOL REV, V27, P783, DOI 10.1128/CMR.00003-14
   Currin A, 2017, METHOD MOL BIOL
   Danko JR, 2018, AM J TROP MED HYG, V98, P849, DOI 10.4269/ajtmh.17-0416
   Holbrook M. R., 2017, VIRUSES, V9, P1
   Horton RM, 2013, BIOTECHNIQUES, V54, P129
   Howard J, 2017, J OCCUP ENVIRON HYG, V14, P224, DOI 10.1080/15459624.2016.1237031
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Kalendar R, 2017, METHOD MOL BIOL
   Kalendar R, 2014, METHODS MOL BIOL, V1116, P271, DOI 10.1007/978-1-62703-764-8_18
   Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009
   Kelwick Richard, 2014, Front Bioeng Biotechnol, V2, P60, DOI 10.3389/fbioe.2014.00060
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514
   O'Halloran DM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45349
   O'Halloran DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20631
   Petronio JAG, 2014, ASIAN PAC J TROP MED, V7, P30, DOI 10.1016/S1995-7645(13)60187-X
   Tee KL, 2013, BIOTECHNOL ADV, V31, P1707, DOI 10.1016/j.biotechadv.2013.08.021
   Zhang PP, 2013, GENE, V524, P347, DOI 10.1016/j.gene.2013.03.126
NR 18
TC 0
Z9 0
U1 0
U2 1
PU FUTURE SCI LTD
PI LONDON
PA UNITED HOUSE, 2 ALBERT PL, LONDON, N3 1QB, ENGLAND
SN 2056-5623
J9 FUTUR SCI OA
JI Futur. Sci. OA
PD JAN
PY 2019
VL 5
IS 1
AR FSO353
DI 10.4155/fsoa-2018-0081
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HI2OM
UT WOS:000456284600009
PM 30652021
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, TT
   He, XE
   Zhang, PR
   Yuan, YW
   Lang, XY
   Yu, JH
   Qin, ZR
   Li, XJ
   Zhang, QW
   Zhu, L
   Zhang, B
   Wu, QH
   Zhao, W
AF Chen, Tingting
   He, Xiaoen
   Zhang, Peiru
   Yuan, Yawen
   Lang, Xinyue
   Yu, Jianhai
   Qin, Zhiran
   Li, Xujuan
   Zhang, Qiwei
   Zhu, Li
   Zhang, Bao
   Wu, Qinghua
   Zhao, Wei
TI Research advancements in the neurological presentation of flaviviruses
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE flavivirus; mechanism; neurological presentation
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; AMINO-ACID SUBSTITUTION;
   ZIKA VIRUS; ENVELOPE PROTEIN; GENE-EXPRESSION; UP-REGULATION; NS1
   PROTEIN; INFECTION; DENGUE
AB Owing to the large-scale epidemic of Zika virus disease and its association with microcephaly, properties that allow flaviviruses to cause nervous system diseases are an important area of investigation. At present, although potential pathogenic mechanisms of flaviviruses in the nervous system have been examined, they have not been completely elucidated. In this paper, we review the possible mechanisms of blood-brain barrier penetration, the pathological effects on neurons, and the association between virus mutations and neurotoxicity. A hypothesis on neurotoxicity caused by the Zika virus is presented. Clarifying the mechanisms of virulence of flaviviruses will be helpful in finding better antiviral drugs and optimizing the treatment of symptoms.
C1 [Chen, Tingting; He, Xiaoen; Zhang, Peiru; Yuan, Yawen; Lang, Xinyue; Yu, Jianhai; Qin, Zhiran; Li, Xujuan; Zhang, Qiwei; Zhu, Li; Zhang, Bao; Wu, Qinghua; Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
RP Wu, QH; Zhao, W (corresponding author), Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
EM wuqh@smu.edu.cn; zhaowei@smu.edu.cn
FU Guangzhou Science and Technology Program key projects [20181201SF0028];
   Guangdong Science and Technology Department [2013A020229004]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [31470271, 81730110]
FX Guangzhou Science and Technology Program key projects, Grant/Award
   Number: 20181201SF0028; Guangdong Science and Technology Department,
   Grant/Award Number: 2013A020229004; National Natural Science Foundation
   of China, Grant/Award Numbers: 31470271 and 81730110
CR Al-Obaidi MMJ, 2017, VIRUS RES, V233, P17, DOI 10.1016/j.virusres.2017.02.012
   Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   [Anonymous], YELL FEV FACT SHEET
   Ariff IM, 2013, J NEUROIMMUNE PHARM, V8, P664, DOI 10.1007/s11481-013-9455-7
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2004, ARCH VIROL, P35
   Bian PY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00303
   Bordignon J, 2008, VIROLOGY, V377, P319, DOI 10.1016/j.virol.2008.04.033
   Castellanos JE, 2016, BIOMEDICA, V36, P156, DOI 10.7705/biomedica.v36i0.2984
   Centers for Disease Control and Prevention, 2015, W NIL VIR OTH NAT NO
   Chambers TJ, 2001, J VIROL, V75, P10912, DOI 10.1128/JVI.75.22.10912-10922.2001
   Chang CY, 2017, BRAIN BEHAV IMMUN, V66, P230, DOI 10.1016/j.bbi.2017.07.003
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004
   Chauhan PS, 2017, PHYSIOL BEHAV, V171, P256, DOI 10.1016/j.physbeh.2017.01.028
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681
   Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13
   Chen CJ, 2012, GLIA, V60, P487, DOI 10.1002/glia.22282
   Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0
   Chen CJ, 2004, J VIROL, V78, P12107, DOI 10.1128/JVI.78.22.12107-12119.2004
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cheng VCC, 2018, EMERG INFECT DIS, V24, P49, DOI 10.3201/eid2401.171297
   Chiou SS, 2005, J MED VIROL, V76, P583, DOI 10.1002/jmv.20406
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x
   De Broucker T, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0590-9
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   HASE T, 1990, INT J EXP PATHOL, V71, P857
   HASE T, 1990, INT J EXP PATHOL, V71, P493
   He W, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00271
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z
   Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341
   Salazar MI, 2013, SCI WORLD J, DOI 10.1155/2013/904067
   Jain N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005329
   JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kobayashi S, 2012, NEUROPATHOLOGY, V32, P398, DOI 10.1111/j.1440-1789.2011.01275.x
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Kuwar RB, 2015, J NEUROL SCI, V358, P243, DOI 10.1016/j.jns.2015.09.003
   Lannes N, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0675-3
   Lee KM, 2016, J NEUROVIROL, V22, P831, DOI 10.1007/s13365-016-0461-4
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Li JR, 2017, IUBMB LIFE, V69, P79, DOI 10.1002/iub.1595
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611
   Mansfield KL, 2010, VECTOR-BORNE ZOONOT, V10, P649, DOI 10.1089/vbz.2009.0259
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mukherjee S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.394
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   Nickells J, 2008, J VIROL, V82, P12510, DOI 10.1128/JVI.00458-08
   Nickells M, 2003, J VIROL, V77, P12232, DOI 10.1128/JVI.77.22.12232-12242.2003
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paul AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04839-7
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   de Souza KPR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-267
   Sengupta N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090211
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Simanjuntak Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00651
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   SZENTPALI-GAVALLER K., 2016, VIRUSES, V8, P2
   Tambonis T, 2017, BIORXIV, DOI [10.1101/105809, DOI 10.1101/105809]
   Tan YH, 2016, CHINA TROP MED, V8, P753
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Usama A, 2015, J IMMUNOL, V195, P2251
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   World Health Organization, JAP ENC FACT SHEET
   World Health Organization, 2016, ZIK VIR SIT REP
   World Health Organization, 2017, DENG SEV DENG FACT S
   Xu QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45375
   Yang J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010020
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 104
TC 0
Z9 0
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD JAN
PY 2019
VL 29
IS 1
AR e2021
DI 10.1002/rmv.2021
PG 12
WC Virology
SC Virology
GA HI1KO
UT WOS:000456204500003
PM 30548722
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Khatua, A
   Khatua, A
   Cambria, E
AF Khatua, Aparup
   Khatua, Apalak
   Cambria, Erik
TI A tale of two epidemics: Contextual Word2Vec for classifying twitter
   streams during outbreaks
SO INFORMATION PROCESSING & MANAGEMENT
LA English
DT Article
DE Epidemics; Ebola; Zika; PubMed; Twitter; Text classification; Word
   Vectors
ID SOCIAL MEDIA; MISINFORMATION
AB Unstructured tweet feeds are becoming the source of real-time information for various events. However, extracting actionable information in real-time from this unstructured text data is a challenging task. Hence, researchers are employing word embedding approach to classify unstructured text data. We set our study in the contexts of the 2014 Ebola and 2016 Zika outbreaks and probed the accuracy of domain-specific word vectors for identifying crisis-related actionable tweets. Our findings suggest that relatively smaller domain-specific input corpora from the Twitter corpus are better in extracting meaningful semantic relationship than generic pre-trained Word2Vec (contrived from Google News) or GloVe (of Stanford NLP group). However, domain specific quality tweet corpora during the early stages of outbreaks are normally scant, and identifying actionable tweets during early stages is crucial to stemming the proliferation of an outbreak. To overcome this challenge, we consider scholarly abstracts, related to Ebola and Zika virus, from PubMed and probe the efficiency of cross-domain resource utilization for word vector generation. Our findings demonstrate that the relevance of PubMed abstracts for the training purpose when Twitter data (as input corpus) would be scant during the early stages of the outbreak. Thus, this approach can be implemented to handle future outbreaks in real time. We also explore the accuracy of our word vectors for various model architectures and hyper-parameter settings. We observe that Skip-gram accuracies are better than CBOW, and higher dimensions yield better accuracy.
C1 [Khatua, Aparup] Univ Calcutta, Dept Comp Sci & Engn, Kolkata, W Bengal, India.
   [Khatua, Aparup; Cambria, Erik] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore.
   [Khatua, Apalak] XLRI Xavier Sch Management, Jamshedpur, Bihar, India.
RP Cambria, E (corresponding author), Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore.
EM akhatua@ntu.edu.sg; apalak@xlri.ac.in; cambria@ntu.edu.sg
RI Cambria, Erik/C-2103-2013
OI Cambria, Erik/0000-0002-3030-1280
CR Ashktorab Z, 2014, P 11 INT C INF SYST, P354
   Cambria E, 2017, IEEE INTELL SYST, V32, P74, DOI 10.1109/MIS.2017.4531228
   Cambria E, 2011, LECT NOTES COMPUT SC, V6677, P601, DOI 10.1007/978-3-642-21111-9_68
   Cambria E, 2010, 2010 IEEE 10TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING PROCEEDINGS (ICSP2010), VOLS I-III, P1279, DOI 10.1109/ICOSP.2010.5657072
   Cambria E, 2010, LECT NOTES ARTIF INT, V6279, P385, DOI 10.1007/978-3-642-15384-6_41
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chiu Billy, 2016, P 15 WORKSH BIOM NAT, P166, DOI DOI 10.18653/V1/W16-2922
   Choi E, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1495, DOI 10.1145/2939672.2939823
   Culotta A., 2010, P 1 WORKSH SOC MED A, P115, DOI DOI 10.1145/1964858.1964874
   Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1
   Fernandez-Luque L, 2015, HEALTHC INFORM RES, V21, P67, DOI 10.4258/hir.2015.21.2.67
   Fernandez-Reyes FC, 2018, INFORM PROCESS MANAG, V54, P1, DOI 10.1016/j.ipm.2017.09.001
   Gao H, 2011, IEEE INTELL SYST, V26, P10, DOI 10.1109/MIS.2011.52
   Ghosh S, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P1129, DOI 10.1145/2983323.298336
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   GLOROT Xavier, 2011, P 28 INT C MACH LEAR, V28, P513, DOI DOI 10.1177/1753193411430810
   Goldberg Yoav, 2014, ARXIV14023722
   Hickmann KS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004239
   Imran M., 2013, P 22 INT C WORLD WID, P1021, DOI DOI 10.1145/2487788.2488109
   Jin F, 2014, COMPUTER, V47, P90, DOI 10.1109/MC.2014.361
   Kalyanam J., 2015, P ACM KDD WORKSH CON
   Khattab A., 2016, 2016 IEEE Sensors Applications Symposium (SAS), P1, DOI 10.1109/SAS.2016.7479827
   Lampos V, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P695, DOI 10.1145/3038912.3052622
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Lilleberg J, 2015, PROCEEDINGS OF 2015 IEEE 14TH INTERNATIONAL CONFERENCE ON COGNITIVE INFORMATICS & COGNITIVE COMPUTING (ICCI*CC), P136, DOI 10.1109/ICCI-CC.2015.7259377
   Liu WS, 2015, PROCEEDINGS OF 2015 IEEE INTERNATIONAL CONFERENCE ON BEHAVIORAL, ECONOMIC, SOCIO-CULTURAL COMPUTING (BESC), P18, DOI 10.1109/BESC.2015.7365951
   Mikolov T, 2013, P NAACL 2013, P746
   Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781, DOI DOI 10.1109/TNN.2003.820440]
   Mikolov Tomas, 2013, ADV NEURAL INFORM PR, V26, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Minarro-Gimenez JA, 2014, STUD HEALTH TECHNOL, V205, P584, DOI 10.3233/978-1-61499-432-9-584
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Pakhomov Serguei, 2010, AMIA Annu Symp Proc, V2010, P572
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Pennington J., 2014, P EMNLP ASS COMP LIN
   Poria S, 2012, INT CONF SIGN PROCES, P1251, DOI 10.1109/ICoSP.2012.6491803
   Rong Xin, 2014, WORD2VEC PARAMETER L
   Rudra K, 2018, INFORM SYST FRONT, V20, P933, DOI 10.1007/s10796-018-9844-9
   Th Muneeb, 2015, P ACL IJCNLP, P158
   Turner CA, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0518-1
   Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486
   Yang X., 2016, USING WORD EMBEDDING
   Zhang X., 2015, ADV NEURAL INFORM PR, P649, DOI DOI 10.1063/1.4906785
   Zhu YJ, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0498-1
NR 45
TC 14
Z9 14
U1 26
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-4573
EI 1873-5371
J9 INFORM PROCESS MANAG
JI Inf. Process. Manage.
PD JAN
PY 2019
VL 56
IS 1
BP 247
EP 257
DI 10.1016/j.ipm.2018.10.010
PG 11
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA HH6SM
UT WOS:000455861300015
DA 2020-07-08
ER

PT J
AU Noorbakhsh, F
   Abdolmohammadi, K
   Fatahi, Y
   Dalili, H
   Rasoolinejad, M
   Rezaei, F
   Salehi-Vaziri, M
   Shafiei-Jandaghi, NZ
   Gooshki, ES
   Zaim, M
   Nicknam, MH
AF Noorbakhsh, Farshid
   Abdolmohammadi, Kamal
   Fatahi, Yousef
   Dalili, Hossein
   Rasoolinejad, Mehrnaz
   Rezaei, Farshid
   Salehi-Vaziri, Mostafa
   Shafiei-Jandaghi, Nazanin Zahra
   Gooshki, Ehsan Shamsi
   Zaim, Morteza
   Nicknam, Mohammad Hossein
TI Zika Virus Infection, Basic and Clinical Aspects: A Review Article
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Review
DE Zika virus; Flaviviridae; Neurological infections; Fetal development;
   Microcephaly
ID ACUTE DISSEMINATED ENCEPHALOMYELITIS; LEGAL; TRANSMISSION; ABORTION;
   BIOLOGY; ASSAY; INACTIVATION; PREPAREDNESS; PATHOGENESIS; SPECIMENS
AB Background: Zika virus infection has recently attracted the attention of medical community. While clinical manifestations of the infection in adult cases are not severe and disease is not associated with high mortality rates, Zika virus infection can have an impact on fetal development and lead to severe neurodevelopmental abnormalities.
   Methods: To gain insight into different aspects of Zika virus infection, a comprehensive literature review was performed. With regard to epidemiology and geographical distribution of Zika virus infection, relevant information was extracted from CDC and WHO websites.
   Results: In this review, we discuss different basic and clinical aspects of Zika virus infection including virology, epidemiology and pathogenesis of disease. Laboratory methods required for the diagnosis of disease together with ethical issues associated with Zika virus infection will also be discussed in detail.
   Conclusion: Herein, we have tried to provide a multi-faceted view of Zika virus infection, with greater emphasis on disease status in Eastern Mediterranean Region.
C1 [Noorbakhsh, Farshid; Abdolmohammadi, Kamal; Nicknam, Mohammad Hossein] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.
   [Abdolmohammadi, Kamal] Kurdistan Univ Med Sci, Fac Med, Dept Immunol, Sanandaj, Iran.
   [Abdolmohammadi, Kamal] Stem Cell Technol Res Ctr, Dept Stem Cell Biol, Tehran, Iran.
   [Fatahi, Yousef] Univ Tehran Med Sci, Sch Pharm, Dept Pharmaceut Nanotechnol, Tehran, Iran.
   [Fatahi, Yousef] Univ Tehran Med Sci, Sch Pharm, Nanotechnol Res Ctr, Tehran, Iran.
   [Dalili, Hossein] Univ Tehran Med Sci, Breastfeeding Res Ctr, Dept Pediat, Tehran, Iran.
   [Rasoolinejad, Mehrnaz] Univ Tehran Med Sci, Sch Med, Dept Infect Dis, Tehran, Iran.
   [Rezaei, Farshid] Minist Hlth & Med Educ, Ctr Control Communicable Dis, Tehran, Iran.
   [Salehi-Vaziri, Mostafa] Pasteur Inst Iran, Natl Reference Lab, Dept Arboviruses & Viral Hemorrhag Fevers, Tehran, Iran.
   [Shafiei-Jandaghi, Nazanin Zahra] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran.
   [Gooshki, Ehsan Shamsi] Univ Tehran Med Sci, Sch Med, Dept Med Eth, Tehran, Iran.
   [Gooshki, Ehsan Shamsi] Univ Tehran Med Sci, Med Eth & Hist Med Res Ctr, Tehran, Iran.
   [Zaim, Morteza] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.
   [Nicknam, Mohammad Hossein] Univ Tehran Med Sci, Mol Immunol Res Ctr, Tehran, Iran.
RP Nicknam, MH (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.; Nicknam, MH (corresponding author), Univ Tehran Med Sci, Mol Immunol Res Ctr, Tehran, Iran.
EM mhnicknam@sina.tums.ac.ir
RI Jandaghi, Nazanin Zahra Shafiei/AAD-6631-2020; Fatahi,
   Yousef/S-6193-2016; Abdolmohammadi, Kamal/U-3924-2017
OI Fatahi, Yousef/0000-0003-0374-2141; Abdolmohammadi,
   Kamal/0000-0001-6174-2620
CR Abbasi M, 2014, IRAN J ALLERGY ASTHM, V13, P71
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Royo-Bordonada MA, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0135-z
   [Anonymous], 2015, B WORLD HEALTH ORGAN, V93, P670, DOI 10.2471/BLT.15.021015
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Baker Danial E, 2016, Hosp Pharm, V51, P275, DOI 10.1310/hpj5104-275
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barnett DJ, 2009, PUBLIC HEALTH REP, V124, P295, DOI 10.1177/003335490912400218
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2017, DIAGN TESTS ZIK VIR
   CHERNESKY M, 1985, J CLIN MICROBIOL, V22, P462, DOI 10.1128/JCM.22.3.462-464.1985
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guttman N, 2004, BIOETHICS, V18, P531, DOI 10.1111/j.1467-8519.2004.00415.x
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hassan Fatima I., 2017, Infectious Disorders - Drug Targets, V17, P3, DOI 10.2174/1871526516666161018104916
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Khodakhah F., 2018, Tehran University Medical Journal, V75, P779
   Kickbusch I, 2015, PUBLIC HEALTH, V129, P838, DOI 10.1016/j.puhe.2015.04.014
   Klingler C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4200-4
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Lencucha R, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-29
   Levels M, 2014, HEALTH POLICY, V118, P95, DOI 10.1016/j.healthpol.2014.06.008
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Macer D, 2005, INSECT BIOCHEM MOLEC, V35, P649, DOI 10.1016/j.ibmb.2005.02.010
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mauk Michael G, 2017, Clin Lab Int, V41, P25
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Noorbakhsh F, 2008, NEUROL CLIN, V26, P759, DOI 10.1016/j.ncl.2008.03.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO, 2016, TIM EM ZIK VIR AM
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Saenz C, 2016, LANCET GLOB HEALTH, V4, pE686, DOI 10.1016/S2214-109X(16)30222-4
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Bueno MAS, 2016, EINSTEIN-SAO PAULO, V14, pXIII, DOI 10.1590/S1679-45082016ED3725
   Shapiro GK, 2014, HEALTH POLICY PLANN, V29, P483, DOI 10.1093/heapol/czt040
   Shrivastava SR, 2017, ANN TROP MED PUBLIC, V10, P1407
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WHO, 2017, ZIK PREP PLAN E MED
   WHO, 2016, 5 WHO
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 85
TC 3
Z9 4
U1 2
U2 7
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD JAN
PY 2019
VL 48
IS 1
BP 20
EP 31
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HH7IF
UT WOS:000455903500003
PM 30847308
DA 2020-07-08
ER

PT J
AU Vega, FLR
   Bezerra, JMT
   Said, RFD
   Neto, AND
   Cotrim, EC
   Mendez, D
   Amancio, FF
   Carneiro, M
AF Romero Vega, Farley Liliana
   Trindade Bezerra, Juliana Maria
   de Carmo Said, Rodrigo Fabiano
   da Gama Neto, Aloysio Nogueira
   Cotrim, Emanuela Cardoso
   Mendez, Dora
   Amancio, Frederico Figueiredo
   Carneiro, Mariangela
TI Emergence of chikungunya and Zika in a municipality endemic to dengue,
   Santa Luzia, MG, Brazil, 2015-2017
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue; Diagnosis; Chikungunya; Outbreak; Symptoms; Zika
ID CO-CIRCULATION; VIRUSES; BURDEN
AB Introduction: The recent circulation of arboviruses transmitted by vectors, such as dengue, chikungunya, and Zika, is concerning due to the high morbidity rates, clinical complications, and increased demand on health services. The objective of this study was to analyze the clinical and epidemiological aspects of an epidemic caused by arboviruses in the municipality of Santa Luzia, Minas Gerais, Brazil. Methods: Longitudinal study of patients with acute febrile disease and suspected arbovirus infection reported to Brazilian Notifiable Disease Information System (Sistema de Informacao de Agravos de Notificacao) from the epidemiological week 44 of 2015 to epidemiological week 52 of 2016. Patients with confirmed chikungunya were followed-up for 18 months and those with Zika for 15 months. Additionally, we analyzed and described the temporal distribution of confirmed cases of these arboviruses in this municipality. Results: Overall 3,531 arboviruses cases, including 3,481 (98.7%) cases of dengue, 38 (1.0%) cases of chikungunya, and 12 (0.3%) cases of Zika were confirmed. The highest incidence of arbovirus infection occurred in the first quarter of 2016 (epidemiological week 7 to 14). The most frequent symptoms were for dengue, which included fever. headache, retro-orbital pain, and exanthema. Chikungunya infection was associated with fever, myalgia, arthralgia, and rash while Zika infection with pruritus and rash. Conclusions: Given the similarities in the initial clinical profiles of these arboviruses, it is important to perform a detailed clinical analysis, laboratory diagnosis, and patient follow-up.
C1 [Romero Vega, Farley Liliana; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
   [Trindade Bezerra, Juliana Maria; Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil.
   [de Carmo Said, Rodrigo Fabiano] Secretaria Saude Estadual Minas Gerais, Subsecretaria Vigilancia & Protecao Saude, Programa Estadual Controle Doencas Transmitidas A, Belo Horizonte, MG, Brazil.
   [da Gama Neto, Aloysio Nogueira; Cotrim, Emanuela Cardoso] Secretaria Municipal Saude Santa Luzia, Santa Luzia, MG, Brazil.
   [Mendez, Dora] Nucleo Acoes & Pesquisa Apoio Diagnost, Lab Genet & Biol Mol, Belo Horizonte, MG, Brazil.
   [Amancio, Frederico Figueiredo] Fundacao Hosp Estado Minas Gerais, Hosp Joao XXIII, Belo Horizonte, MG, Brazil.
RP Vega, FLR (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil.
EM lilianaromerovega@gmail.com
FU Ministry of Health of Brazil, Fundo Nacional de Saude
   [25000.214371/2012-4]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES-Brazil), Post-Graduate Program of Infectology and
   Tropical Medicine, Universidade Federal de Minas Gerais; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (PNPD/CAPES-Brazil),
   Post-Graduation Program in Parasitology, Universidade Federal de Minas
   Gerais; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG -
   Brazil)Minas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq)
FX This study was supported by the Ministry of Health of Brazil, Fundo
   Nacional de Saude. (Grant No. 25000.214371/2012-4). FLRV thanks
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-Brazil), Post-Graduate Program of Infectology and Tropical
   Medicine, Universidade Federal de Minas Gerais for the Doctoral
   schoralship. JMTB thanks to the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (PNPD/CAPES-Brazil), Post-Graduation Program
   in Parasitology, Universidade Federal de Minas Gerais for the
   Postdoctoral fellowship. MC would like to thank to the Fundacao de
   Amparo a Pesquisa de Minas Gerais (FAPEMIG - Brazil) for the grant of
   the Programa Pesquisador Mineiro (PPM-2016) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil) for the research
   fellowship.
CR Aguiar S, 2018, INT J INFECT DIS, P342
   [Anonymous], 2014, PREFEITURA MUNICIPAL
   Araujo Valdelaine Etelvina Miranda de, 2017, Rev Bras Epidemiol, V20Suppl 01, P205, DOI 10.1590/1980-5497201700050017
   Bautista-Reyes E, 2017, REV INVEST CLIN, V69, P299, DOI 10.24875/RIC.17002029
   Baylis M, 2017, ENVIRON HEALTH-GLOB, V16, P45, DOI 10.1186/s12940-017-0326-1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carlson C, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004968
   Center for Disease Control and Prevention, DIV VECT BORN DIS
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P578, DOI 10.1002/art.40384
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137
   Gerardin P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-5
   Instituto brasileiro de geografia e estatistica, 2017, SANT LUZ MG
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Korman AM, 2017, J AM ACAD DERMATOL, V76, P538, DOI 10.1016/j.jaad.2016.08.034
   Magalhaes T, 2017, PLOS NEGLECT TROP D, P11
   Matta L, 2016, BIOMEDICA, V36, P133, DOI 10.7705/biomedica.v36i1.2627
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ministerio de Saude (MS) Brasil, 2017, B EPIDEMIOLOGICO, V35
   Mogami Roberto, 2017, Radiol Bras, V50, P71, DOI 10.1590/0100-3984.2016.0221
   Montibeler EE, 2018, ACTA TROP, V178, P318, DOI 10.1016/j.actatropica.2017.11.016
   PAHO-Pan American Health Organization, 2017, DENG DAT MAPS STAT
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan American Health Organization, 2017, CHIK DAT MAPS STAT
   Pan American Health Organization, 2016, DENG GUID PAT CAR RE, P10
   Pereira AM, 2018, J TURK-GER GYNECOL A, V19, P39, DOI 10.4274/jtgga.2017.0072
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Proenca-Modena JL, 2018, MICROBES INFECT, P30052
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Schawartz O, 2010, NAT MICROBIOL, P497
   Secretaria de Saude Minas Gerais, 2017, B EP MON CAS DENG CH
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sutaria RB, 2018, CURR OPIN RHEUMATOL, V30, P256, DOI 10.1097/BOR.0000000000000486
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Wold Health Organization (WHO), 2012, GLOB STRAT DENG PREV, P22
   Wold Health Organization (WHO), 2016, ZIK CAS CONG SYNDR A
NR 44
TC 1
Z9 1
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR UNSP e-20180347
DI 10.1590/0037-8682-0347-2018
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HI0VR
UT WOS:000456163000001
PM 30652797
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Duan, XQ
   Liao, XZ
   Li, SL
   Li, YJ
   Xu, M
   Wang, YC
   Ye, HY
   Zhao, H
   Yang, CH
   Zhu, X
   Chen, LM
AF Duan, Xiaoqiong
   Liao, Xinzhong
   Li, Shilin
   Li, Yujia
   Xu, Min
   Wang, Yancui
   Ye, Haiyan
   Zhao, Hang
   Yang, Chunhui
   Zhu, Xiang
   Chen, Limin
TI Transmembrane protein 2 inhibits Zika virus replication through
   activation of the Janus kinase/signal transducers and activators of
   transcription signaling pathway
SO FUTURE VIROLOGY
LA English
DT Article
DE IFN-beta; Jak; STAT signaling pathway; MDA5; RIG-I; TMEM2; ZIKV
   replication
ID HEPATITIS-C; IFN-ALPHA; RIG-I; TMEM2; TRANSMISSION; EXPRESSION;
   INFECTION
AB Aim:TMEM2has been demonstrated to suppress HBV infection by activating the Jak/STAT pathway. In this study, we sought to explore the mechanism by which TMEM2 effects on Zika virus (ZIKV)replication. Materials & methods:TMEM2 was overexpressed. Selected gene mRNA, p-STAT1 levels and interferon stimulated response element activity were examined by qRT-PCR, Western blot and luciferase assay respectively. Results: Overexpression of TMEM2 significantly inhibited ZIKV replication, upregulated MDA5 and RIG-I expression, increased IFN- promoter activity and IFN- expression. Overexpression of TMEM2 enhanced the Jak/STAT signaling including increased p-STAT1 level,ISRE activity as well as the expression of several antiviral interferon-stimulated genes. Conclusion:TMEM2 inhibited ZIKV replication through increased IFN- production and enhanced activation of the Jak/STAT signaling pathway.
C1 [Duan, Xiaoqiong; Liao, Xinzhong; Li, Shilin; Li, Yujia; Xu, Min; Wang, Yancui; Ye, Haiyan; Zhao, Hang; Yang, Chunhui; Chen, Limin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu 610052, Sichuan, Peoples R China.
   [Duan, Xiaoqiong; Liao, Xinzhong; Li, Shilin; Li, Yujia; Xu, Min; Wang, Yancui; Ye, Haiyan; Zhao, Hang; Yang, Chunhui; Chen, Limin] Peking Union Med Coll, Chengdu 610052, Sichuan, Peoples R China.
   [Chen, Limin] Univ Toronto, Toronto Gen Res Inst, Toronto, ON M5G 1L6, Canada.
   [Zhu, Xiang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510000, Guangdong, Peoples R China.
RP Chen, LM (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu 610052, Sichuan, Peoples R China.; Chen, LM (corresponding author), Peking Union Med Coll, Chengdu 610052, Sichuan, Peoples R China.; Chen, LM (corresponding author), Univ Toronto, Toronto Gen Res Inst, Toronto, ON M5G 1L6, Canada.
EM limin_chen_99@yahoo.com
RI Chen, Limin/A-8813-2012
FU CAMS Initiative for Innovative Medicine [CAMS-2016-I2M-3-025,
   2017-I2M-BR-15]
FX This work was supported by grants from the CAMS Initiative for
   Innovative Medicine (grant number CAMS-2016-I2M-3-025 and
   2017-I2M-B&R-15 to L Chen). The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guo JH, 2006, FEBS LETT, V580, P581, DOI 10.1016/j.febslet.2005.12.076
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163
   Jacobson I, 2016, WORLD J GASTROENTERO, V22, P3418, DOI 10.3748/wjg.v22.i12.3418
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kato H, 2017, J INTERF CYTOK RES, V37, P207, DOI 10.1089/jir.2016.0095
   Kim C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042983
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lee H, 2016, CANCER RES, V76, P4994, DOI 10.1158/0008-5472.CAN-15-2322
   Liao XZ, 2018, FUTURE VIROL, V13, P353, DOI 10.2217/fvl-2017-0160
   Michael S, 2000, J VIROL, V74, P4957
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355
   Tan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048114
   Totong R, 2011, DEVELOPMENT, V138, P4199, DOI 10.1242/dev.064261
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang W, 2016, SCI REP UK, V6
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wrzesinski T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1530-4
   Wu Y, 2017, CELL DISCOV, V3
   Yamamoto H, 2017, J BIOL CHEM, V292, P7304, DOI 10.1074/jbc.M116.770149
   Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576
   Zhu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.146
NR 42
TC 2
Z9 2
U1 2
U2 6
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JAN
PY 2019
VL 14
IS 1
BP 9
EP 19
DI 10.2217/fvl-2018-0115
PG 11
WC Virology
SC Virology
GA HH3CA
UT WOS:000455595300003
DA 2020-07-08
ER

PT J
AU Kraemer, MUG
   Cummings, DAT
   Funk, S
   Reiner, RC
   Faria, NR
   Pybus, OG
   Cauchemez, S
AF Kraemer, M. U. G.
   Cummings, D. A. T.
   Funk, S.
   Reiner, R. C., Jr.
   Faria, N. R.
   Pybus, O. G.
   Cauchemez, S.
TI Reconstruction and prediction of viral disease epidemics
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Review
DE Geographic spread; real-time prediction; viral epidemics
ID RESPIRATORY SYNDROME CORONAVIRUS; A H1N1 VIRUS; ZIKA VIRUS;
   YELLOW-FEVER; EBOLA-VIRUS; REAL-TIME; HOUSEHOLD TRANSMISSION; ZOONOTIC
   NICHE; SOUTH-KOREA; INFLUENZA
AB A growing number of infectious pathogens are spreading among geographic regions. Some pathogens that were previously not considered to pose a general threat to human health have emerged at regional and global scales, such as Zika and Ebola Virus Disease. Other pathogens, such as yellow fever virus, were previously thought to be under control but have recently re-emerged, causing new challenges to public health organisations. A wide array of new modelling techniques, aided by increased computing capabilities, novel diagnostic tools, and the increased speed and availability of genomic sequencing allow researchers to identify new pathogens more rapidly, assess the likelihood of geographic spread, and quantify the speed of human-to-human transmission. Despite some initial successes in predicting the spread of acute viral infections, the practicalities and sustainability of such approaches will need to be evaluated in the context of public health responses.
C1 [Kraemer, M. U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.
   [Kraemer, M. U. G.; Faria, N. R.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Cummings, D. A. T.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Cummings, D. A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Funk, S.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Funk, S.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Reiner, R. C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] CNRS, UMR2000 Genom Evolut Modelisat & Sante, Paris, France.
RP Kraemer, MUG (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM moritz.kraemer@zoo.ox.ac.uk
RI Pybus, Oliver g/B-2640-2012; Funk, Stefan/B-7629-2015; Faria, Nuno
   Rodrigues/I-2975-2012
OI Pybus, Oliver g/0000-0002-8797-2667; Funk, Stefan/0000-0002-2012-0080;
   Faria, Nuno Rodrigues/0000-0001-8839-2798; Funk,
   Sebastian/0000-0002-2842-3406
FU BrancoWeiss Fellowship Society in Science; National Institute of Child
   Health and Human DevelopmentUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [T32HD040128]; National Library of Medicine of the National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)
   [R01LM010812, R01LM011965]; Oxford Martin School; Investissement
   d'Avenir programFrench National Research Agency (ANR); Laboratoire
   d'Excellence Integrative Biology of Emerging Infectious Diseases program
   [ANR-10-LABX-62-IBEID]; Models of Infectious Disease Agent Study of the
   National Institute of General Medical Sciences; AXA Research Fund; Sir
   Henry Dale Fellowship [204311/Z/16/Z]; internal GCRF grant [005073];
   John Fell Fund grant [005166]; Wellcome Trust Senior Research Fellowship
   in Basic Biomedical ScienceWellcome Trust [210758/Z/18/Z]
FX MUGK is supported by The BrancoWeiss Fellowship Society in Science,
   administered by the ETH Zurich and acknowledges funding from a Training
   Grant from the National Institute of Child Health and Human Development
   (T32HD040128) and the National Library of Medicine of the National
   Institutes of Health (R01LM010812, R01LM011965). OGP acknowledges
   support from the Oxford Martin School. SC acknowledges financial support
   from the Investissement d'Avenir program, the Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program (Grant
   ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of
   the National Institute of General Medical Sciences, the AXA Research
   Fund. NRF is supported by a Sir Henry Dale Fellowship (204311/Z/16/Z),
   internal GCRF grant 005073 and John Fell Fund grant 005166. SF was
   supported by a Wellcome Trust Senior Research Fellowship in Basic
   Biomedical Science (210758/Z/18/Z).
CR Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170
   ANDERSON R M, 1991
   Andronico A, 2017, AM J EPIDEMIOL, V186, P1194, DOI 10.1093/aje/kwx008
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baele G, 2017, SYST BIOL, V66, pE47, DOI 10.1093/sysbio/syw054
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggerstaff M, 2018, EPIDEMICS-NETH, V24, P26, DOI 10.1016/j.epidem.2018.02.003
   Blumberg S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004452
   Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Bromham L, 2018, BIOL REV, V93, P1165, DOI 10.1111/brv.12390
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Camacho A., 2015, PLOS CURR OUTBREAKS, V7, P1, DOI DOI 10.1371/CURRENTS.OUTBREAKS.406AE55E83EC0B5193E3085
   Cauchemez S, 2006, EMERG INFECT DIS, V12, P110
   Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399
   Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108
   Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5
   Dellicour S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03763-2
   Dellicour S, 2017, MOL BIOL EVOL, V34, P2563, DOI 10.1093/molbev/msx176
   Dellicour S, 2016, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-016-0924-x
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.37324, 10.7554/elife.37324, 10.7554/eLife.31257]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Fisman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114548
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Friedrich MJ, 2018, JAMA-J AM MED ASSOC, V319, P1973, DOI 10.1001/jama.2018.5712
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guarani V, 2016, ELIFE, V5, DOI 10.7554/eLife.17163
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Held L, 2017, STAT MED, V36, P3443, DOI 10.1002/sim.7363
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Khan K, 2013, PLOS CURRENT OUTBREA
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Ma Johansson, 2014, PLOS ONE, V9
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Metcalf CJE, 2015, TRENDS IMMUNOL, V36, P753, DOI 10.1016/j.it.2015.10.004
   Metcalf CJE, 2016, LANCET, V6736, P5
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pigott DM, 2016, ELIFE, V5, DOI 10.7554/eLife.16412
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Poon LLM, 2016, NAT GENET, V48, P195, DOI 10.1038/ng.3479
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Reiner RC, 2015, ELIFE, V4, DOI 10.7554/eLife.09520
   Rivers C, 2014, NATURE, V515, P493, DOI 10.1038/515492a
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tsang TK, 2016, TRENDS MICROBIOL, V24, P123, DOI 10.1016/j.tim.2015.10.012
   Tsang TK, 2014, J INFECT DIS, V210, P684, DOI 10.1093/infdis/jiu186
   Viboud C, 2018, EPIDEMICS-NETH, V22, P1, DOI 10.1016/j.epidem.2017.10.003
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   World Health Organization, 2016, SITUATION REPORT
   Zhao S, 2018, PLOS NEGLECT TROP D, V12, P1, DOI DOI 10.1371/J0URNAL.PNTD.0006158
NR 103
TC 10
Z9 10
U1 9
U2 17
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PY 2019
VL 147
AR UNSP e34
DI 10.1017/S0950268818002881
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HG9OV
UT WOS:000455339100033
PM 30394230
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Eick, SM
   Dale, AP
   McKay, B
   Lawrence, C
   Ebell, MH
   Cordero, JF
   Welton, M
AF Eick, Stephanie M.
   Dale, Ariella Perry
   McKay, Brian
   Lawrence, Casey
   Ebell, Mark H.
   Cordero, Jose F.
   Welton, Michael
TI Seroprevalence of Dengue and Zika Virus in Blood Donations: A Systematic
   Review
SO TRANSFUSION MEDICINE REVIEWS
LA English
DT Review
DE Zika virus; Dengue virus; Blood supply; Transmission; Blood donations;
   Surveillance
ID DONOR SCREENING DATA; PUERTO-RICO; TRANSFUSION; INFECTION; VIREMIA;
   STATES; TRANSMISSION; OUTBREAK; DISEASE
AB The presence of antibodies to Zika virus (ZIKV) and dengue virus (DENV) can be detected in blood donations. Donation-based surveillance provides an alternative strategy to estimate population prevalence by detecting antibodies that are circulating. To estimate population prevalence, we conducted a systematic review of literature on the seroprevalence of ZIKV and DENV antibodies in blood donations. We searched PubMed and Web of Science for studies that reported the seroprevalence of ZIKV and DENV in blood donations. The title and abstract of each study were screened by 2 reviewers simultaneously for possible inclusion, and the full text of selected studies was reviewed to ensure that they met inclusion criteria (used primary data collection, reported evidence of immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in the blood supply, and included a representative sample of the total population). Immunoglobin test measuring levels of antibodies to IgM and IgG and number of positive cases were extracted from each study. No exclusions were made based on language or country. Our initial search identified 1890 studies after excluding duplicates, of which 76 were assessed for full text eligibility to ensure that they met our final inclusion criteria. There were 14 studies included in our review; 11 examined the seroprevalence of DENV, and 3 examined ZIKV. The highest seroprevalence by IgM was 2.82% for DENV and 0.53% for ZIKV. Our results indicate that the seroprevalence of ZIKV and DENV antibody presence in countries with active transmission is higher than reports by traditional surveillance in some countries. This finding is expected due to the large percentage of asymptomatic cases. The highest seroprevalence was observed for IgG, which can persist over long periods of time compared to IgM. Screening of blood donations may help supplement traditional surveillance measures, especially during outbreak settings. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Eick, Stephanie M.; Dale, Ariella Perry; McKay, Brian; Lawrence, Casey; Ebell, Mark H.; Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Campus, Athens, GA 30602 USA.
RP Eick, SM (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Campus, Athens, GA 30602 USA.
EM eick.steph@gmail.com; aperrydale@gmail.com; bmckay81@gmail.com;
   crl99301@uga.edu; ebell@uga.edu; jcordero@uga.edu;
   Michael.welton@gmail.com
OI Eick, Stephanie/0000-0001-6695-3291; McKay, Brian/0000-0003-3859-7634
CR Aghaie A, 2014, TRANSFUS APHER SCI, V50, P59, DOI 10.1016/j.transci.2013.07.034
   Arellanos-Soto D, 2015, TRANSFUSION MED, V25, P122, DOI 10.1111/tme.12198
   Aubry M, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.14.30505
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burgdorf KS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169112
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287
   CDC Health Alert Network, 2016, REC MAN REP ZIK VIR
   Centers for Disease Control and Prevention, 2017, DIAGN TESTS ZIK VIR
   Centers for Disease Control and Prevention, 2015, DENG PUERT RIC
   Centers for Disease Control and Prevention, 2018, 2018 NAT NOT INF DIS
   Centers for Disease Control and Prevention, 2017, CLIN EV DIS
   Centers for Disease Control and Prevention, 2017, CONG ZIK SYNDR OTH B
   Centers for Disease Control and Prevention, 2017, 2017 CAS COUNTS US
   Centers for Disease Control and Prevention, 2014, FLAV
   Centers for Disease Control and Prevention, 2017, LAB GUID DIAGN TEST
   Centers for Disease Control and Prevention, 2014, DENG CLIN GUID
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Chen J, 2015, TROP MED, V15, P1014
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Chew CH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3496-9
   Christie J, 1872, Br Med J, V1, P577
   Dantes HG, 2014, EPIDEMIOLOGICAL TREN, V8
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Forshey BM, 2018, PLOS NEGL TROP DI S1, V3
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gao Z, 2018, TRANSFUSION MED, V28, P236, DOI 10.1111/tme.12448
   Goldman M, 2017, TRANSFUSION, V57, P2469, DOI 10.1111/trf.14307
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Liao Q, 2017, J MED VIROL, V89, P2037, DOI 10.1002/jmv.24883
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
   Oh HB, 2015, TRANSFUSION, V55, P1655, DOI 10.1111/trf.13054
   Organization PAH, 2016, DENG REP CAS
   Paixao ES, 2018, BMJ GLOB HLTH S1, V3
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   PILIAVIN JA, 1990, TRANSFUSION, V30, P444, DOI 10.1046/j.1537-2995.1990.30590296381.x
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Pule PI, 2014, BLOOD TRANSFUS, V2014, P7
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawal Gautam, 2016, J Family Med Prim Care, V5, P523, DOI 10.4103/2249-4863.197256
   Rodriguez DR, 2009, TRANSFUSION MED, V19, P125, DOI 10.1111/j.1365-3148.2009.00922.x
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Suemnig A, 2017, TRANSFUSION MED, V27, P413, DOI 10.1111/tme.12450
   Undurraga EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003547
   Vairo F, 2014, EMERG INFECT DIS, V20, P465, DOI 10.3201/eid2003.130150
   Valle J, 2016, SOUTH MED J
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Ward T, 2017, TROP MED INT HEALTH, V22, P960, DOI 10.1111/tmi.12903
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
NR 67
TC 1
Z9 1
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0887-7963
EI 1532-9496
J9 TRANSFUS MED REV
JI Transf. Med. Rev.
PD JAN
PY 2019
VL 33
IS 1
BP 35
EP 42
DI 10.1016/j.tmrv.2018.10.001
PG 8
WC Hematology
SC Hematology
GA HH4KQ
UT WOS:000455691700006
PM 30471867
DA 2020-07-08
ER

PT J
AU Benites, BD
   Rocha, D
   Andrade, E
   Godoy, DT
   Alvarez, P
   Addas-Carvalho, M
AF Benites, Bruno Deltreggia
   Rocha, Daniele
   Andrade, Elisabete
   Godoy, Daniela T.
   Alvarez, Patricia
   Addas-Carvalho, Marcelo
TI Zika Virus and the Safety of Blood Supply in Brazil: A Retrospective
   Epidemiological Evaluation
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SEXUAL TRANSMISSION; CHIKUNGUNYA VIRUS; DENGUE VIREMIA; PUERTO-RICO;
   DONATIONS; DONORS; RNA; INFECTION
AB The potential for transfusion transmission of dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV) has raised concerns about the safety of the blood supply in endemic areas. In this study, nucleic acid testing (NAT) for ZIKV, DENV, and CHIKV RNA was performed in asymptomatic blood donor samples in the city of Campinas, located in the southeast region of Brazil (1962 in 2015 and 1775 in 2016). The prevalence of reactive NAT was 0.15% in 2015 and 0.62% in 2016 for dengue, 0.05% in 2015 and 0.17% in 2016 for Zika, and 0% in both years for chikungunya. These results demonstrate the weakness of the clinical interview in screening these blood donors. Furthermore, positivity for ZIKV was detected in March 2015, 1 year before the first reported cases in the region. These data attest the feasibility of using donor samples held in library as a tool for retrospective epidemiological evaluation, which is particularly interesting considering emerging pathogens, for which data on their spread and penetrance are initially scarce.
C1 [Benites, Bruno Deltreggia; Addas-Carvalho, Marcelo] Univ Estadual Campinas, Hematol & Transfus Med Ctr, Rua Carlos Chagas 480, BR-13083970 Campinas, SP, Brazil.
   [Rocha, Daniele; Andrade, Elisabete; Godoy, Daniela T.; Alvarez, Patricia] Fiocruz MS, Inst Technol Immunobiol Biomanguinhos, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
RP Benites, BD (corresponding author), Univ Estadual Campinas, Hematol & Transfus Med Ctr, Rua Carlos Chagas 480, BR-13083970 Campinas, SP, Brazil.
EM benites@unicamp.br; daniele.ramos@bio.fiocruz.br;
   eferreira@bio.fiocruz.br; daniela.godoy@bio.fiocruz.br;
   palvarez@bio.fiocruz.br; maddas@unicamp.br
RI benites, Bruno/W-9207-2019; Addas-Carvalho, Marcelo/D-9654-2018
OI Addas-Carvalho, Marcelo/0000-0003-0178-6191
CR Anez G, 2015, VOX SANG, V109, P312, DOI 10.1111/vox.12297
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Brasil. Ministerio da Saude. Portal Dengue Chikungunya e Zika, 2015, EP B MON CAS DENG FE
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   CDC, 2016, ZIK VIR
   Department of Health Surveillance Municipal Health Department Campinas, 2016, TECHN REP ZIK VIR
   Diaz-Quinonez JA, 2016, VIRUS GENES, V52, P855
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Junior DL, 2014, REV BRAS HEMATOL HEM, V36, P309
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Lowe R, 2018, INT J ENV RES PUB HE, V9, P15
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marks PW, 2017, TRANSFUSION, V57, P723, DOI 10.1111/trf.14037
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Municipal Health Department of Campinas, 2016, EPIDEMIOLOGICAL B
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   World Health Organization, 2016, WHOZIKVPHR161
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 2
Z9 2
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 1
BP 174
EP 177
DI 10.4269/ajtmh.17-0843
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HG7WU
UT WOS:000455207700037
PM 30398138
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Meltzer, E
   Lustig, Y
   Schwartz, E
AF Meltzer, Eyal
   Lustig, Yaniv
   Schwartz, Eli
TI Zika Virus in Israeli Travelers: Emergence of Asia as a Major Source of
   Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PUERTO-RICO; NOVEMBER 1; DENGUE; TRANSMISSION; EPIDEMIC; VIETNAM;
   DISEASE; RISK
AB Zika virus (ZIKV) had emerged as a global arboviral concern since late 2015. In this study, we describe the results of ZIKV testing in returning Israeli travelers from Zika-endemic countries. We conducted a nation-wide prospective observational study, including all ZIKV tests during January 2016-June 2017. Zika virus infection was defined as confirmed, if diagnosed by polymerase chain reaction (PCR) or serology confirmed by neutralization, and as possible if diagnosed by serology alone. During the study period, 1,188 travelers were tested: 66.7%, 30.5%, 1.6%, and 1.2% had returned from the Americas, Asia, Africa, and Oceania, respectively. Thirty persons were diagnosed with ZIKV. Most travelers tested were women of reproductive age; the gender ratio among infected travelers however was 1.0. During 2016, 19/20 (95%) ZIKV cases were acquired in the Americas; in 2017, however, 6/10 (60%) cases were acquired in Asia. Of 248 symptomatic travelers, 28 (11.3%) were diagnosed with ZIKV infection, whereas only 2/940 (0.2%) of asymptomatic travelers were diagnosed with ZIKV infection Odds ratio = 59.7 (95% confidence interval: 14.1-252.5, P < 0.0001). Our findings suggest that although women are more likely to be referred for ZIKV testing, gender does not affect the likelihood of ZIKV infection and that asymptomatic ZIKV infection appears to be rare in travelers. Furthermore, it appears that in 2017, Southeast Asia emerges as the leading source of travel-related ZIKV infection.
C1 [Meltzer, Eyal; Schwartz, Eli] Sheba Med Ctr, Ctr Geog Med, Tel Hashomer, Israel.
   [Meltzer, Eyal; Schwartz, Eli] Sheba Med Ctr, Dept Med C, Tel Hashomer, Israel.
   [Meltzer, Eyal; Schwartz, Eli] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Lustig, Yaniv] Sheba Med Ctr, Cent Virol Lab, Minist Hlth, Tel Hashomer, Israel.
   [Meltzer, Eyal; Schwartz, Eli] Chaim Sheba Med Ctr, Dept Med C, Ctr Geog Med, IL-52621 Tel Hashomer, Israel.
   [Lustig, Yaniv] Tel Aviv Univ, Cent Virol Lab, Minist Hlth, Chaim Sheba Med Ctr, Tel Aviv, Israel.
RP Meltzer, E (corresponding author), Chaim Sheba Med Ctr, Dept Med C, Ctr Geog Med, IL-52621 Tel Hashomer, Israel.
EM emeltzer@post.tau.ac.il; lustig.yaniv@gmail.com; elischwa@post.tau.ac.il
CR Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   [Anonymous], 2018, GLOBESNEWS
   [Anonymous], 2018, YNETNEWS
   Beattie J, 2018, INFECT DIS CLIN PRAC
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Escutia G, 2018, J COMMUN HEALTH, V43, P566, DOI 10.1007/s10900-017-0453-1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leshem E, 2012, EMERG INFECT DIS, V18, P345, DOI 10.3201/eid1802.111648
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lustig Y, 2016, EURO SURVEILL, V21
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Meltzer E, 2012, AM J TROP MED HYG, V86, P536, DOI 10.4269/ajtmh.2012.10-0670
   PAHO Pan American Health Organization (PAHO), 2017, ZIK CUM CAS
   Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052
   Report S, 2017, ZIK VIR MICR GUILL B
   Septfons A, 2016, TRAVEL ASSOCIATED AU
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
NR 32
TC 2
Z9 2
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 1
BP 178
EP 182
DI 10.4269/ajtmh.18-0379
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HG7WU
UT WOS:000455207700038
PM 30426920
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU da Cruz, TE
   Souza, RP
   Pelloso, SM
   Morelli, F
   Suehiro, TT
   Damke, E
   Bonfim-Mendonca, PD
   da Silva, VRS
   Consolaro, MEL
AF da Cruz, Tais E.
   Souza, Raquel P.
   Pelloso, Sandra M.
   Morelli, Fabricio
   Suehiro, Tamy T.
   Damke, Edilson
   Bonfim-Mendonca, Patricia de S.
   da Silva, Vania R. S.
   Consolaro, Marcia E. L.
TI Case Report: Prolonged Detection of Zika Virus RNA in Vaginal and
   Endocervical Samples from a Brazilian Woman, 2018
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; SECRETIONS; SEMEN
AB Zika virus (ZIKV) infection is an emerging public health problem, associated with increased risk for Guillain-Barre syndrome and adverse fetal outcomes, including congenital microcephaly. Zika virus sexual transmission is known, but detection of the virus in different parts of the female reproductive tract is not well established. In this case report, we describe prolonged detection of ZIKV RNA in the vaginal secretion and endocervical mucosa from a Brazilian woman convalescent to ZIKV infection. A viral load of 2 x 10(2) copies/mL was detected up to 31 days after symptom onset in both samples. Other biological fluids, including whole blood, plasma, serum, urine, and saliva samples, were negative for ZIKV RNA. These findings advance the understanding of ZIKV infection and provide data for additional testing strategies.
C1 [da Cruz, Tais E.; Souza, Raquel P.; Morelli, Fabricio; Suehiro, Tamy T.; Damke, Edilson; Bonfim-Mendonca, Patricia de S.; da Silva, Vania R. S.; Consolaro, Marcia E. L.] Univ Estadual Maringa, Dept Clin Anal & Biomed, Ave Colombo,5790 Zona 7, BR-87020900 Maringa, Parana, Brazil.
   [Pelloso, Sandra M.] Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil.
RP Consolaro, MEL (corresponding author), Univ Estadual Maringa, Dept Clin Anal & Biomed, Ave Colombo,5790 Zona 7, BR-87020900 Maringa, Parana, Brazil.
EM taiselisangela07@gmail.com; raquelpantarotto@gmail.com.br;
   smpelloso@gmail.com; fahmorelli@gmail.com; tamysuehiro89@gmail.com;
   edilsondamke@gmail.com; patbonfim.09@gmail.com; vaniasela@gmail.com;
   melconsolaro@gmail.com
RI Consolaro, Marcia Edilaine Lopes/I-4932-2014
OI Consolaro, Marcia Edilaine Lopes/0000-0001-9102-4865
FU CAPES/Brazilian GovernmentCAPES [88881.130822/2016-01]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico/CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [440521/2016-5]; Departamento de Ciencia e Tecnologia da Secretaria de
   Ciencia, Tecnologia e Insumos Estrategicos do Ministerio da Saude
   (Decit/SCTIE/MS)
FX This work was supported by grants from CAPES/Brazilian Government
   (88881.130822/2016-01); Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico/CNPq (440521/2016-5); and Departamento de Ciencia e
   Tecnologia da Secretaria de Ciencia, Tecnologia e Insumos Estrategicos
   do Ministerio da Saude (Decit/SCTIE/MS).
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nayar R, 2017, ACTA CYTOL, V61, P359, DOI 10.1159/000477556
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, LANCET INFECT DIS, V16, P771, DOI 10.1016/S1473-3099(16)30074-3
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 22
TC 2
Z9 2
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 1
BP 183
EP 186
DI 10.4269/ajtmh.18-0623
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HG7WU
UT WOS:000455207700039
PM 30398145
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rohini, K
   Agarwal, P
   Preethi, B
   Shanthi, V
   Ramanathan, K
AF Rohini, K.
   Agarwal, Pratika
   Preethi, B.
   Shanthi, V.
   Ramanathan, K.
TI Exploring the Lead Compounds for Zika Virus NS2B-NS3 Protein: an
   e-Pharmacophore-Based Approach
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Zika virus; Virtual screening; Enrichment analysis; ASINEX database;
   Prime MM-GBSA; Molecular simulation
ID MOLECULAR-DYNAMICS SIMULATIONS; ACCURATE DOCKING; DENGUE VIRUS;
   INHIBITORS; DISCOVERY; GLIDE; IDENTIFICATION; DESCRIPTORS; RECEPTOR;
   BINDING
AB The rapid spread of the Zika virus and its association with the abnormal brain development constitute a global health emergency. With a continuing spread of the mosquito vector, the exposure is expected to accelerate in the coming years. Despite number of efforts, there is still no proper vaccine or medicine to combat this virus. Of note, the NS2B-NS3 protein is proven to be the potential target for the Zika virus therapeutics. Hence, e-pharmacophore-based drug design strategy was employed to identify potent inhibitors of NS2B-NS3 protein from ASINEX database consisting of 467,802 molecules. A 3D e-pharmacophore model was generated using PHASE module of Schrodinger Suite. The generated model consists of one hydrogen bond acceptor (A), two hydrogen bond donors (D), and two aromatic rings (R), ADDRR. The model was further evaluated for its ability to screen actives using enrichment analysis. Subsequently, high-throughput virtual screening protocol was employed, and the resultant hit molecules were also examined for its binding free energies and ADME properties using Prime MM-GBSA and Qikprop module of Schrodinger packages, respectively. Finally, the screened hit molecule was subjected to molecular dynamics simulation to examine its stability. Overall, the results from our analysis suggest that compound BAS 19192837 could be a potent inhibitor for the NS2B-NS3 protein of the Zika virus. It is also noteworthy to mention that our results are in good agreement with literature evidences. We hope that this result is of immense importance in designing potential drug molecules to combat the spread of Zika virus in the near future.
C1 [Rohini, K.; Agarwal, Pratika; Preethi, B.; Shanthi, V.; Ramanathan, K.] Vellore Inst Technol, Sch Bio Sci & Technol, Dept Biotechnol, Vellore 632014, Tamil Nadu, India.
RP Ramanathan, K (corresponding author), Vellore Inst Technol, Sch Bio Sci & Technol, Dept Biotechnol, Vellore 632014, Tamil Nadu, India.
EM kramanathan@vit.ac.in
OI Veerappapillai, Shanthi/0000-0003-2297-2751
FU Vellore Institute of Technology, Vellore
FX The authors gratefully acknowledge Vellore Institute of Technology,
   Vellore for the support through Seed Grant for Research.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Arya H, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2266-9
   Ash J, 2017, J CHEM INF MODEL, V57, P1286, DOI 10.1021/acs.jcim.7b00048
   Banerjee K, 2011, BIOINFORMATION, V7, P285
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brustle M, 2002, J MED CHEM, V45, P3345, DOI 10.1021/jm011027b
   Cappel D, 2016, J CHEM INF MODEL, V56, P2388, DOI 10.1021/acs.jcim.6b00362
   Carlson HA, 1999, J PHYS CHEM A, V103, P10213, DOI 10.1021/jp991997z
   Chikan NA, 2013, APPL BIOCHEM BIOTECH, V170, P164, DOI 10.1007/s12010-013-0158-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darvas Ferenc, 2002, Current Topics in Medicinal Chemistry, V2, P1287, DOI 10.2174/1568026023392841
   De Falco F, 2016, BIOCHEM PHARMACOL, V104, P83, DOI 10.1016/j.bcp.2016.01.008
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dixon SL, 2006, J COMPUTER AIDED MOL, V52, P2587
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Gaddaguti V, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0346-x
   Gupta KK, 2016, J VECTOR DIS, V53, P179
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   James N, 2018, APPL BIOCHEM BIOTECH, V186, P85, DOI 10.1007/s12010-018-2724-4
   James N, 2018, APPL BIOCHEM BIOTECH, V185, P289, DOI 10.1007/s12010-017-2650-x
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Kalliokoski T, 2009, J CHEM INF MODEL, V49, P2742, DOI 10.1021/ci900364w
   Kandakatla N., 2014, ORIENT J CHEM, V30, P1083
   Kumari M, 2016, BMC STRUCT BIOL, V16, DOI 10.1186/s12900-016-0063-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Meng FW, 2015, J MED CHEM, V58, P8166, DOI 10.1021/acs.jmedchem.5b01154
   Mirza SB, 2018, J MOL GRAPH MODEL, V79, P88, DOI 10.1016/j.jmgm.2017.10.010
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010
   Muralidharan AR, 2014, MED CHEM RES, V23, P2445, DOI 10.1007/s00044-013-0842-7
   Muthusamy K, 2013, INTERDISCIP SCI, V5, P119, DOI 10.1007/s12539-013-0157-x
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Patil R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012029
   Perez-Regidor L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091508
   Pinheiro AS, 2015, APPL BIOCHEM BIOTECH, V176, P1709, DOI 10.1007/s12010-015-1672-5
   Pradeep N, 2015, J BIOMOL STRUCT DYN, V33, P129, DOI 10.1080/07391102.2015.1032834
   Pradhan D, 2014, J BIOMOL STRUCT DYN, V32, P171, DOI 10.1080/07391102.2012.758056
   Preethi B, 2015, APPL BIOCHEM BIOTECH, V177, P528, DOI 10.1007/s12010-015-1760-6
   Priya Swaminathan, 2017, Journal of Applied Pharmaceutical Science, V7, P48
   Rajamanikandan S, 2017, APPL BIOCHEM BIOTECH, V181, P192, DOI 10.1007/s12010-016-2207-4
   Ramatenki V, 2017, APPL BIOCHEM BIOTECH, V182, P1497, DOI 10.1007/s12010-017-2414-7
   Rohini K, 2018, APPL BIOCHEM BIOTECH, V184, P1421, DOI 10.1007/s12010-017-2625-y
   SADOWSKI J, 1992, ANAL CHIM ACTA, V265, P233, DOI 10.1016/0003-2670(92)85029-6
   Saudi M, 2014, EUR J MED CHEM, V87, P529, DOI 10.1016/j.ejmech.2014.09.062
   Saxena S, 2014, J MOL GRAPH MODEL, V47, P37, DOI 10.1016/j.jmgm.2013.08.005
   Shukla S, 2012, APPL BIOCHEM BIOTECH, V167, P1430, DOI 10.1007/s12010-012-9551-9
   Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e
   Van den Driessche G, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0202-6
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Wang HW, 2008, J MOL GRAPH MODEL, V27, P512, DOI 10.1016/j.jmgm.2008.09.002
   Wei Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148181
   Yadav A, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2986-0
   Yoo J, 2011, J COMPUT AID MOL DES, V25, P555, DOI 10.1007/s10822-011-9441-1
   Zhang N, 2003, J MED CHEM, V46, P4149, DOI 10.1021/jm030842j
   Zhou W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020246
NR 65
TC 4
Z9 4
U1 3
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD JAN
PY 2019
VL 187
IS 1
BP 194
EP 210
DI 10.1007/s12010-018-2814-3
PG 17
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA HG9KE
UT WOS:000455325800014
PM 29911269
DA 2020-07-08
ER

PT J
AU Jiang, SB
   Du, LY
AF Jiang, Shibo
   Du, Lanying
TI Advances in the research and development of therapeutic antibodies
   against the Zika virus
SO CELLULAR & MOLECULAR IMMUNOLOGY
LA English
DT Letter
C1 [Jiang, Shibo; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
   [Jiang, Shibo] Fudan Univ, Minist Educ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Minist Hlth, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China.
RP Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM ldu@nybc.org
RI Jiang, Shibo/L-4500-2014
CR Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 10
TC 4
Z9 4
U1 0
U2 3
PU CHIN SOCIETY IMMUNOLOGY
PI BEING
PA 5 DONGDAN SANTIAO, DONGCHEN DISTRICT, BEING, 100005, PEOPLES R CHINA
SN 1672-7681
EI 2042-0226
J9 CELL MOL IMMUNOL
JI Cell. Mol. Immunol.
PD JAN
PY 2019
VL 16
IS 1
BP 96
EP 97
DI 10.1038/s41423-018-0043-x
PG 2
WC Immunology
SC Immunology
GA HG2ZB
UT WOS:000454836400013
PM 29802365
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Sukhralia, S
   Verma, M
   Gopirajan, S
   Dhanaraj, PS
   Lal, R
   Mehla, N
   Kant, CR
AF Sukhralia, Shivani
   Verma, Mansi
   Gopirajan, Shruthi
   Dhanaraj, P. S.
   Lal, Rup
   Mehla, Neeti
   Kant, Chhaya Ravi
TI From dengue to Zika: the wide spread of mosquito-borne arboviruses
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
DE Arbovirus; Dengue; Zika; Chikungunya; YFV
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS; UNITED-STATES; NORTH-AMERICA;
   YELLOW-FEVER; TRANSMISSION; EMERGENCE; CHIKUNGUNYA; DISEASE; GENOME
AB The worldwide invasion of arthropod-borne viruses (arboviruses) in recent decades is responsible for emerging public health threats. Some factors like climate change, urbanisation and uncontrolled population growth are fuelling their widespread. Arboviruses incorporate a vast collection of genetically diverse viral pathogens including that of dengue, Zika and chikungunya. These viruses are peculiar as they are zoonotic and are a serious harm to the society, with no particular therapy to neutralise their effect. So it is the need of the hour to develop an effective treatment against infections caused by them. This review focuses on some of the common families of mosquito-borne arboviruses and their most known members that are a threat to mankind and discusses their genome organisation, worldwide spread and negative influence on public health.
C1 [Sukhralia, Shivani; Verma, Mansi; Gopirajan, Shruthi; Dhanaraj, P. S.; Mehla, Neeti] Univ Delhi, Sri Venkateswara Coll, South Campus, New Delhi 110021, India.
   [Verma, Mansi; Lal, Rup] Univ Delhi, Dept Zool, Mol Biol Lab, Delhi 110007, India.
   [Kant, Chhaya Ravi] Indira Gandhi Delhi Tech Univ, Dept Appl Sci, Delhi 110006, India.
RP Verma, M (corresponding author), Univ Delhi, Sri Venkateswara Coll, South Campus, New Delhi 110021, India.; Verma, M (corresponding author), Univ Delhi, Dept Zool, Mol Biol Lab, Delhi 110007, India.
EM mansiverma20@gmail.com
OI verma, mansi/0000-0003-3170-9576
CR Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Amicizia D, 2018, J Prev Med Hyg, V59, pE99, DOI 10.15167/2421-4248/jpmh2018.59.1.962
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Attoui H, 2005, EMERG INFECT DIS, V11, P1673, DOI 10.3201/eid1111.050868
   Attoui H, 2011, FAMILY REOVIRIDAE, P541
   Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Basu Anirban, 2017, F1000Res, V6, P259, DOI 10.12688/f1000research.9561.1
   Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Brower V, 2001, EMBO REP, V2, P755, DOI 10.1093/embo-reports/kve193
   Burt FJ, 2002, EMERG INFECT DIS, V8, P820, DOI 10.3201/eid0808.020027
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994
   Carrera JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005338
   Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005
   Chiara M, 2016, GENOME BIOL EVOL, V8, P3284, DOI 10.1093/gbe/evw226
   Clarke P, 2005, VIRAL IMMUNOL, V18, P89, DOI 10.1089/vim.2005.18.89
   Coudeville L, 2016, VACCINE, V34, P6426, DOI 10.1016/j.vaccine.2016.08.050
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Danthi P, 2013, ADV EXP MED BIOL, V790, P42, DOI 10.1007/978-1-4614-7651-1_3
   Eifan S, 2013, VIRUSES-BASEL, V5, P2447, DOI 10.3390/v5102447
   Elliott RM, 2009, CLIN MICROBIOL INFEC, V15, P510, DOI 10.1111/j.1469-0691.2009.02849.x
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes CG, 2001, ANN NY ACAD SCI, V951, P25
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Horne KM, 2014, VIRUSES-BASEL, V6, P4373, DOI 10.3390/v6114373
   Hrnjakovic Cvjetkovic Ivana B, 2015, Med Pregl, V68, P122
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493
   Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046
   Jun SR, 2015, FEMS MICROBIOL REV, V39, P764, DOI 10.1093/femsre/fuv031
   Kamtchum-Tatuene J, 2017, CURR OPIN INFECT DIS, V30, P108, DOI 10.1097/QCO.0000000000000342
   King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lamrani A, 2017, EUROSURVEILLANCE, V22, P28, DOI 10.2807/1560-7917.ES.2017.22.50.17-00041
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   LIM EXY, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10020084
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   Marini G, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.37.30612
   McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0
   Miyazaki N, 2008, J VIROL, V82, P11344, DOI 10.1128/JVI.02375-07
   Mohd Jaafar F, 2014, PLOS ONE, V9
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Organization PH, CHIK
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   Osman O, 2008, VIRUS RES, V135, P48, DOI 10.1016/j.virusres.2008.02.006
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Paula Tuma, 2009, Infectious Disorders - Drug Targets, V9, P133
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Rossini Giada, 2013, World J Virol, V2, P49, DOI 10.5501/wjv.v2.i2.49
   SAIZ JC, 2016, FRONT MICROBIOL, V7
   Scherret JH, 2001, EMERG INFECT DIS, V7, P697, DOI 10.3201/eid0704.010418
   Schmaljohn AL McClain D, 1996, MED MICROBIOLOGY
   Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651
   Shope RE, 1996, MED MICROBIOLOGY
   Sim S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0907-2
   SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Solomon T, 2002, CURR TOP MICROBIOL, V267, P171
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang YX, 2010, AM J TROP MED HYG, V83, P1156, DOI 10.4269/ajtmh.2010.10-0052
   Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weiss S, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0843-0
   Wong AH, 2012, EMERG INFECT DIS, V18, P944, DOI 10.3201/eid1806.111688
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628
   Zeidler JD, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030042
NR 93
TC 8
Z9 8
U1 6
U2 38
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD JAN
PY 2019
VL 38
IS 1
BP 3
EP 14
DI 10.1007/s10096-018-3375-7
PG 12
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HG2KR
UT WOS:000454792400002
PM 30267170
DA 2020-07-08
ER

PT J
AU Honein, MA
   Jamieson, DJ
AF Honein, Margaret A.
   Jamieson, Denise J.
TI Revealing the Effects of Zika-Detection of Brain Abnormalities and Other
   Disabilities Associated With Congenital Infection
SO JAMA PEDIATRICS
LA English
DT Editorial Material
ID UPDATE INTERIM GUIDANCE; VIRUS-INFECTION; UNITED-STATES
C1 [Honein, Margaret A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE,Mailstop S106-3, Atlanta, GA 30333 USA.
   [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE,Mailstop S106-3, Atlanta, GA 30333 USA.
EM mhonein@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Chu V, 2018, AM J MED GENET A, V176, P1882, DOI 10.1002/ajmg.a.40378
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Hirai AH, 2018, JAMA PEDIATR, V172, P857, DOI 10.1001/jamapediatrics.2018.1524
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mulkey SB, 2019, JAMA PEDIATR, V173, P52, DOI 10.1001/jamapediatrics.2018.4138
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricci D, 2011, EARLY HUM DEV, V87, P177, DOI 10.1016/j.earlhumdev.2010.12.003
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
NR 12
TC 0
Z9 0
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JAN
PY 2019
VL 173
IS 1
BP 16
EP 18
DI 10.1001/jamapediatrics.2018.4164
PG 4
WC Pediatrics
SC Pediatrics
GA HG8OF
UT WOS:000455261300009
PM 30476947
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   Bulas, DI
   Vezina, G
   Fourzali, Y
   Morales, A
   Arroyave-Wessel, M
   Swisher, CB
   Cristante, C
   Russo, SM
   Encinales, L
   Pacheco, N
   Kousa, YA
   Lanciotti, RS
   Cure, C
   DeBiasi, RL
   du Plessis, AJ
AF Mulkey, Sarah B.
   Bulas, Dorothy, I
   Vezina, Gilbert
   Fourzali, Yamil
   Morales, Armando
   Arroyave-Wessel, Margarita
   Swisher, Christopher B.
   Cristante, Caitlin
   Russo, Stephanie M.
   Encinales, Liliana
   Pacheco, Nelly
   Kousa, Youssef A.
   Lanciotti, Robert S.
   Cure, Carlos
   DeBiasi, Roberta L.
   du Plessis, Adre J.
TI Sequential Neuroimaging of the Fetus and Newborn With In Utero Zika
   Virus Exposure
SO JAMA PEDIATRICS
LA English
DT Article
ID INFECTION; PREGNANCY; SPECTRUM; JANUARY; INFANTS
AB IMPORTANCE The evolution of fetal brain injury by Zika virus (ZIKV) infection is not well described.
   OBJECTIVES To perform longitudinal neuroimaging of fetuses and infants exposed to in utero maternal ZIKV infection using concomitant magnetic resonance imaging (MRI) and ultrasonography (US), as well as to determine the duration of viremia in pregnant women with ZIKV infection and whether the duration of viremia correlated with fetal and/or infant brain abnormalities.
   DESIGN, SETTING, AND PARTICIPANTS A cohort of 82 pregnant women with dinical criteria for probable ZIKV infection in Barranquilla, Colombia, and Washington, DC, were enrolled from June 15, 2016, through June 27, 2017, with Colombian women identified by community recruitment and physician referral and travel-related cases of American women recruited from a Congenital Zika Program.
   INTERVENTIONS AND EXPOSURES Women received tor more MRI and US examinations during the second and/or third trimesters. Postnatally, infants underwent brain MRI and cranial US. Blood samples were tested for ZIKV.
   MAIN OUTCOMES AND MEASURES The neuroimaging studies were evaluated for brain injury and cerebral biometry.
   RESULTS Of the 82 women, 80 were from Colombia and 2 were from the United States. In 3 of 82 cases (4%), fetal MRI demonstrated abnormalities consistent with congenital ZIKV infection. Two cases had heterotopias and malformations in cortical development and 1 case had a parietal encephalocele, Chiari II malformation, and microcephaly. In 1case, US results remained normal despite fetal abnormalities detected on MRI. Prolonged maternal polymerase chain reaction positivity was present in 1 case. Of the remaining 79 cases with normal results of prenatal imaging, postnatal brain MRI was acquired in 53 infants and demonstrated mild abnormalities in 7 (13%). Fifty-seven infants underwent postnatal cranial US, which detected changes of lenticulostriate vasculopathy, choroid plexus cysts. germinolytic/subependymal cysts, and/or calcification in 21infants (37%).
   CONCLUSIONS AND RELEVANCE In a cohort of pregnant women with ZIKV infection, prenatal US examination appeared to detect all but 1 abnormal fetal case. Postnatal neuroimaging in infants who had normal prenatal imaging revealed new mild abnormalities. For most patients, prenatal and postnatal US may identify ZIKV-related brain injury.
C1 [Mulkey, Sarah B.; Arroyave-Wessel, Margarita; Swisher, Christopher B.; Cristante, Caitlin; Russo, Stephanie M.; du Plessis, Adre J.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
   [Mulkey, Sarah B.; DeBiasi, Roberta L.; du Plessis, Adre J.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [Bulas, Dorothy, I; Vezina, Gilbert] Childrens Natl Hlth Syst, Div Radiol, Washington, DC 20010 USA.
   [Fourzali, Yamil; Morales, Armando] Sabbag Radiologos, Barranquilla, Colombia.
   [Encinales, Liliana] Allied Res Soc, Miami, FL USA.
   [Pacheco, Nelly] Bionep, Bacteriologa, Barranquilla, Colombia.
   [Kousa, Youssef A.] Childrens Natl Hlth Syst, Div Neurol, Washington, DC 20010 USA.
   [Lanciotti, Robert S.] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Ft Collins, CO USA.
   [Cure, Carlos] BIOMELAB, Barranquilla, Colombia.
   [DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Div Infect Dis, Washington, DC 20010 USA.
   [DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
RI Youssef A Kousa/AAR-3064-2020
OI Youssef A Kousa/0000-0001-6049-8144; Mulkey, Sarah/0000-0002-8084-526X
FU Children's National Health System, Washington, DC; Ikaria Fund; National
   Institutes of Health National Center for Advancing Translational
   Sciences [UL1TR001876, KL2TR001877]
FX Funding for this study was made possible by a philanthropic gift from
   the Ikaria Fund. Dr Mulkey receives research support for
   neurodevelopmental follow-up in Zika-exposed infants from the Thrasher
   Research Fund. This study was supported by special purpose funds from
   Children's National Health System, Washington, DC, and the Ikaria Fund.
   Dr Mulkey is supported by awards UL1TR001876 and KL2TR001877 from the
   National Institutes of Health National Center for Advancing
   Translational Sciences.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Centers for Disease Control and Prevention National Center for Health Statistics, 2010, WHO GROWTH STAND AR
   Chabrier S, 2011, THROMB RES, V127, P13, DOI 10.1016/j.thromres.2010.10.003
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0051
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   HADLOCK FP, 1984, RADIOLOGY, V152, P497, DOI 10.1148/radiology.152.2.6739822
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Kline-Fath BM, 2015, FUNDAMENTAL ADV FETA
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mulkey SB, 2018, J NEUROL SCI, V387, P109, DOI 10.1016/j.jns.2018.01.032
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 29
TC 5
Z9 5
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JAN
PY 2019
VL 173
IS 1
BP 52
EP 59
DI 10.1001/jamapediatrics.2018.4138
PG 8
WC Pediatrics
SC Pediatrics
GA HG8OF
UT WOS:000455261300015
PM 30476967
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU de Araujo, PSR
   Silva, MLD
   Tenorio, M
   dos Santos, FGT
AF Ramos de Araujo, Paulo S.
   de Melo Silva Junior, Mario L.
   Tenorio, Marli
   Torreao dos Santos, Fabiana G.
TI Co-infection ZIKV and HSV-1 associated with meningoencephalitis: Case
   report and literature review
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE Zika virus; Human herpesvirus 1; Meningoencephalitis; Case report
ID VIRUS-INFECTION; ENCEPHALITIS
AB A man, 26 years-old, presented fever, mental confusion and a progressively worsening headache 6 days prior to admission. The CSF study was suggestive of meningoencephalitis, the PCR study revealed presence of HSV-1 and ZIKV, while other immunology tests were negative. ZIKV was also identified in serum. The MRI showed temporal lobe hyper-intensity in FLAIR-weight sequence with areas of contrast enhancement and the electroencephalogram showed slow wave activity in such region. Patient was treated with acyclovir and supportive measures and had good clinical outcome at evaluation after 6 months. Neurological spectrum of ZIKV manifestations is wide, but meningoencephalitis is not frequent. Co-infection HSV1 plus ZIKV was not yet related in humans, but there is increased cellular damage caused by association of ZIKV and herpes virus family infection. ZIKV may facilitate infection or recrudescence by other viruses or cause concurrently neuronal injury by direct or indirect mechanisms. We suggest that clinicians attempt new manifestations related to ZIKV and include this agent in differential diagnosis of neurological diseases even when other agents were identified. (c) 2018 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Ramos de Araujo, Paulo S.; Tenorio, Marli] Fiocruz MS, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Ramos de Araujo, Paulo S.; Torreao dos Santos, Fabiana G.] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [de Melo Silva Junior, Mario L.] Univ Fed Pernambuco, Hosp Clin, Recife, PE, Brazil.
RP Silva, MLD (corresponding author), Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
RI Araujo, Paulo/AAJ-9988-2020
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Doughty CT, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0724-3
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Roze B, 2016, EURO SURVEILL, P21
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
NR 9
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2019
VL 12
IS 1
BP 97
EP 100
DI 10.1016/j.jiph.2018.04.010
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HG6PZ
UT WOS:000455106200017
PM 29703710
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Leon, F
   Meyer, A
   Reynier, R
   Blanc, E
   Bruyere-Ostells, L
   Bres, JC
   Simonin, Y
   Salinas, S
   Gallian, P
   Leparc-Goffart, I
   Biron, A
   Dupont-Rouzeyrol, M
   Morvan, F
   Vasseur, JJ
   Foulongne, V
   Van de Perre, P
   Cantaloube, JF
   Fournier-Wirth, C
AF Leon, Fanny
   Meyer, Albert
   Reynier, Robin
   Blanc, Emilie
   Bruyere-Ostells, Lilian
   Bres, Jean-Charles
   Simonin, Yannick
   Salinas, Sara
   Gallian, Pierre
   Leparc-Goffart, Isabelle
   Biron, Antoine
   Dupont-Rouzeyrol, Myrielle
   Morvan, Francois
   Vasseur, Jean-Jacques
   Foulongne, Vincent
   Van de Perre, Philippe
   Cantaloube, Jean-Francois
   Fournier-Wirth, Chantal
TI An Innovative Multiplexed and Flexible Molecular Approach for the
   Differential Detection of Arboviruses
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID REVERSE TRANSCRIPTION-PCR; BLOOD-BORNE PATHOGENS; ZIKA VIRUS; DENGUE;
   CHIKUNGUNYA; TRANSMISSION; ASSAY; ENHANCEMENT; DIAGNOSTICS; AFRICA
AB Nucleic acid testing during the preseroconversion viremic phase is required to differentially diagnose arboviral infections. The continuing emergence of arboviruses, such as Zika virus (ZIKV), dengue virus (DENV), and chikungunya virus (CHIKV), necessitates the development of a flexible diagnostic approach. Similar clinical signs and the priority to protect pregnant women from ZIKV infection indicate that the differential diagnosis of arboviruses is essential for effective patient management, clinical care, and epidemiologic surveillance. We describe an innovative diagnostic approach that combines generic RT-PCR amplification and identification by hybridization to specific probes. Original tetra-thiolated probes were designed for the robust, sensitive, and specific detection of amplified arboviral genomes. The limit of detection using cultured and quantified stocks of whole viruses was 1 TCID50/mL for DENV-1, DENV-3, and CHIKV and 10 TCID50/mL for DENV-2, DENV-4, and ZIKV. The assay had 100% specificity with no false-positive results. The approach was evaluated using 179 human samples that previously tested as positive for the presence of ZIKV, DENV, or CHIKV genomes. Accordingly, the diagnostic sensitivity for ZIKV, DENV, and CHIKV was 87.88% (n = 58/66), 96.67% (n = 58/60), and 94.34% (n = 50/53), respectively. This method could be easily adapted to include additional molecular targets. Moreover, this approach may also be adapted to develop highly specific, sensitive, and easy to handle platforms dedicated to the multiplex screening and identification of emerging viruses.
C1 [Leon, Fanny; Reynier, Robin; Blanc, Emilie; Bruyere-Ostells, Lilian; Bres, Jean-Charles; Simonin, Yannick; Salinas, Sara; Foulongne, Vincent; Van de Perre, Philippe; Cantaloube, Jean-Francois; Fournier-Wirth, Chantal] Univ Montpellier, Etab Francais Sang, Pathogenesis & Control Chron Infect, INSERM, Montpellier, France.
   [Meyer, Albert; Morvan, Francois; Vasseur, Jean-Jacques] Univ Montpellier, CNRS, ENSCM, IBMM, Montpellier, France.
   [Reynier, Robin; Biron, Antoine; Dupont-Rouzeyrol, Myrielle] Inst Pasteur Nouvelle Caledonie, URE Dengue & Arboviroses, Noumea, New Caledonia.
   [Gallian, Pierre] Etab Francais Sang Alpes Mediterranee, UMR D190 Emergence Pathol Virales, Marseille, France.
   [Leparc-Goffart, Isabelle] CNR Arbovirus ERRIT, Marseille, France.
RP Fournier-Wirth, C (corresponding author), Etab Francais Sang Transdiag, Lab Pathogenese & Contrale Infect Chron, 240 Ave Pr Jean Louis Viala, F-34184 Montpellier 4, France.
EM chantal.fournier@efs.sante.ir
RI Morvan, Francois/G-8507-2011; Bres, Jean-Charles/U-8812-2019; amsalu,
   ribka/G-8780-2019; Salinas, Sara/O-1150-2019; MEYER, albert
   Louis/E-1744-2013; Van de Perre, Philippe/B-9692-2008
OI Morvan, Francois/0000-0001-5077-0028; Salinas, Sara/0000-0003-4492-2093;
   MEYER, albert Louis/0000-0003-3909-0894; Van de Perre,
   Philippe/0000-0002-3912-0427; LEON, FANNY/0000-0002-8687-706X; simonin,
   yannick/0000-0002-3475-1369; Vasseur, Jean-Jacques/0000-0002-4379-6139
FU Etablissement Francais du Sang; Institut Pasteur de Nouvelle-Caledonie
FX Supported by institutional funding from Etablissement Francais du Sang
   (C.F.-W.) and Institut Pasteur de Nouvelle-Caledonie (M.D.-R.).
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen HX, 2015, J MOL DIAGN, V17, P722, DOI 10.1016/j.jmoldx.2015.06.008
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004073
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duncan R, 2016, EXPERT REV MOL DIAGN, V16, P83, DOI 10.1586/14737159.2016.1112272
   Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Grigorenko E, 2017, J MOL DIAGN, V19, P549, DOI 10.1016/j.jmoldx.2017.03.004
   Grigorenko E, 2014, J MOL DIAGN, V16, P136, DOI 10.1016/j.jmoldx.2013.08.002
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lereau M, 2013, ANAL CHEM, V85, P9204, DOI 10.1021/ac401941x
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Maria AT, 2016, EUROSURVEILLANCE, V2016, P21
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Vina-Rodriguez A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4248756
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774
NR 38
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD JAN
PY 2019
VL 21
IS 1
BP 81
EP 88
DI 10.1016/j.jmoldx.2018.08.005
PG 8
WC Pathology
SC Pathology
GA HG4VU
UT WOS:000454973900011
PM 30268947
OA Bronze
DA 2020-07-08
ER

PT J
AU Gale, TV
   Horton, TM
   Hoffmann, AR
   Branco, LM
   Garry, RF
AF Gale, Trevor V.
   Horton, Timothy M.
   Hoffmann, Andrew R.
   Branco, Luis M.
   Garry, Robert F.
TI Host Proteins Identified in Extracellular Viral Particles as Targets for
   Broad-Spectrum Antiviral Inhibitors
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE liquid chromatography mass spectrometry; proteomics; Lassa virus; HIV;
   dengue virus; Zika virus; virus-like particles; host proteins in
   extracellular viral particles; antiviral target identification; CGP
   3466B maleate (Omigapil)
ID PROTEOMIC ANALYSIS; CELLULAR-PROTEINS; GENE ONTOLOGY; IN-VITRO; VIRUS;
   REVEALS; VIRION; TOOL; PREVALENCE; INFECTION
AB Liquid chromatography mass spectrometry (LCMS) proteomic analyses have revealed that host proteins are often captured in extracellular virions. These proteins may play a role in viral replication or infectivity and can represent targets for broad-spectrum antiviral agent development. We utilized LCMS to determine the host protein composition of Lassa virus-like particles (LASV VLPs). Multiple host proteins incorporated in LASV VLPs are also incorporated in unrelated viruses, notably ribosomal proteins. We assembled a data set of host proteins incorporated into extracellular viral particles. The frequent incorporation of specific host proteins into viruses of diverse families suggests that interactions of these proteins with viral factors may be important for effective viral replication. Drugs that target virion-associated host proteins could affect the protein in the extracellular virion or the host cell. Compounds that target proteins incorporated into virions with high frequency, but with no known antiviral activity, were assayed in a scalable viral screening platform, and hits were tested in competent viral systems. One of these molecules, GAPDH modulating small molecule CGP 3466B maleate (Omigapil), exhibited a dose-dependent inhibition of HIV, dengue virus, and Zika virus.
C1 [Gale, Trevor V.; Horton, Timothy M.; Hoffmann, Andrew R.; Garry, Robert F.] Tulane Univ, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.
   [Branco, Luis M.; Garry, Robert F.] Zalgen Labs LLC, Germantown, MD 20876 USA.
RP Garry, RF (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, SL-38,1430 Tulane Ave,JBJ568, New Orleans, LA 70112 USA.
EM rfgarry@tulane.edu
OI Garry, Robert/0000-0002-5683-3250
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI067188, AI082778, AI088843,
   AI104621, AI115754, AI135995, HSN272200900049C, HHSN272201400048C]
FX We thank the members of the Viral Hemorrhagic Fever Consortium
   (Autoimmune Technologies, the Broad Institute, Harvard University, the
   Scripps Research Institute, Tulane University, the University of
   California-San Diego, the University of Texas Medical Branch, Vybion,
   Zalgen Laboratories, the ISTH Lassa Fever Program, and KGH) and the
   Sierra Leone Ministry of Health and Sanitation, without which this work
   could not have been conducted. Simbirie C. Jalloh, Allyson M. Haislip,
   Christopher M. Bishop, and Tynette D. Hills provided program management
   and logistical support. Funding support came from NIH Grants AI067188,
   AI082778, AI088843, AI104621, AI115754, and AI135995 and Contracts
   HSN272200900049C and HHSN272201400048C.
CR Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baird NL, 2012, J VIROL, V86, P11301, DOI 10.1128/JVI.01635-12
   Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005
   Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536
   Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179
   Borden KLB, 1998, J VIROL, V72, P3819, DOI 10.1128/JVI.72.5.3819-3826.1998
   Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003
   Branco LM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-279
   Bregnard C, 2013, J VIROL, V87, P3729, DOI 10.1128/JVI.02477-12
   Calderone A, 2015, NUCLEIC ACIDS RES, V43, pD588, DOI 10.1093/nar/gku830
   Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005
   Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06
   Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006
   Demby AH, 2001, VECTOR-BORNE ZOONOT, V1, P283, DOI 10.1089/15303660160025912
   Denard J, 2009, PROTEOMICS, V9, P3666, DOI 10.1002/pmic.200800747
   ECDC, 2016, LASS FEV NIG
   Fichet-Calvet E, 2008, VECTOR-BORNE ZOONOT, V8, P41, DOI 10.1089/vbz.2007.0118
   Gui L, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700012
   Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012
   Han ZY, 2014, J VIROL, V88, P7294, DOI 10.1128/JVI.00591-14
   Hastie KM, 2017, SCIENCE, V356, P923, DOI 10.1126/science.aam7260
   Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101
   Kang SM, 2005, PROTEOMICS, V5, P2227, DOI 10.1002/pmic.200401093
   Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302
   Kishimoto N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-107
   Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10
   Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529
   Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08
   Lu JH, 2014, J VIROL, V88, P4736, DOI 10.1128/JVI.03757-13
   Manning JT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01037
   Martinez-Noel G, 2018, J MOL BIOL, V430, P1024, DOI 10.1016/j.jmb.2018.01.021
   Mire CE, 2017, NAT MED, V23, P1146, DOI 10.1038/nm.4396
   Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166
   MULLER G, 1983, ARCH VIROL, V75, P229, DOI 10.1007/BF01314889
   Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794
   Nuss JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093483
   Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570
   Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075
   Plotkin SA, 2017, HUM VACC IMMUNOTHER, V13, P2755, DOI 10.1080/21645515.2017.1306615
   Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651
   Ren XP, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-32
   Robinson JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11544
   Salunkhe V, 2019, PLATELETS, V30, P368, DOI 10.1080/09537104.2018.1447658
   Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65
   Saphire ACS, 2006, J PROTEOME RES, V5, P530, DOI 10.1021/pr050276b
   Segura MM, 2008, J VIROL, V82, P1107, DOI 10.1128/JVI.01909-07
   Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748
   Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085
   Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007
   Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015
   Spurgers KB, 2010, MOL CELL PROTEOMICS, V9, P2690, DOI 10.1074/mcp.M110.003418
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9
   Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004
   Vidick S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083842
   Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001
   WHO, 2017, DIS OUTBREAK NE 0208
   Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319
   Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727
   Yu XB, 2014, THERANOSTICS, V4, P808, DOI 10.7150/thno.8255
   Zhang CW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-242
   Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004
   Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005
NR 66
TC 1
Z9 1
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD JAN
PY 2019
VL 18
IS 1
BP 7
EP 17
DI 10.1021/acs.jproteome.8b00204
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA HG8WE
UT WOS:000455285900002
PM 30351952
DA 2020-07-08
ER

PT J
AU Valle, J
   Eick, SM
   Fairley, JK
   Waggoner, JJ
   Goodman, RA
   Rosenberg, E
   Wu, HM
AF Valle, Javier
   Eick, Stephanie M.
   Fairley, Jessica K.
   Waggoner, Jesse J.
   Goodman, Richard A.
   Rosenberg, Eli
   Wu, Henry M.
TI Evaluation of Patients for Zika Virus Infection in a Travel Clinic in
   the Southeast United States, 2016
SO SOUTHERN MEDICAL JOURNAL
LA English
DT Article
DE patient characterization; public health; travel; Zika
ID DISEASE; AMERICA
AB Objectives: Zika virus is an emerging infection that has posed vexing challenges to the US public health system. Improved characterization of patients with possible and confirmed infection is needed to better understand risks for infection in US travelers and to inform evolving evaluation guidelines.
   Methods: We performed a retrospective electronic health record review of patients evaluated for Zika virus infection at an academic travel clinic in Atlanta, Georgia, from January 1 through August 31, 2016. We evaluated 46 patients who presented to the clinic during this period for evaluation of possible Zika virus infection, including patients with Zika virus symptoms, asymptomatic patients with possible exposure to Zika virus, and referral visits for Zika virus testing.
   Results: Among the 46 patients evaluated, 30 (65.2%) were tested for Zika virus, 8 of whom (17.4%) had laboratory evidence of infection (7 confirmed, 1 probable). Cases, including confirmed and probable infections, most commonly had fever, rash, conjunctivitis, headache, and myalgia, although differences compared with noncases were not statistically significant. Many patients evaluated were not tested because of stringent testing criteria.
   Conclusions: Our findings may help inform improvements in timely clinical decision making for Zika virus testing. This may assist clinicians and public health agencies. Wider access to accurate screening modalities will help providers evaluate and advise patients.
C1 Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA USA.
   Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Valle, J (corresponding author), Emory Univ, Med Off Tower,7th Floor,550 Peachtree St NE, Atlanta, GA 30328 USA.
EM javier.valle@emory.edu
RI Fairley, Jessica K/W-2777-2019
OI Eick, Stephanie/0000-0001-6695-3291
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Centers for Disease Control and Prevention, TEST GUID
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, DIAGN TESTS ZIK VIR
   Centers for Disease Control and Prevention (CDC), PAT COUNS
   Council of State and Territorial Epidemiologists, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Georgia Department of Public Health, 2016, ZIK GUID PHYS HEALTH
   Georgia Department of Public Health, 2017, CONF ZIK CAS COUNT
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Lammert S, 2017, EMERG INFECT DIS, V23, P324, DOI 10.3201/eid2302.161292
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Septfons A, 2016, EURO SURVEILL, V21
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO, 2016, PREV SEX TRANSM ZIK
NR 22
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0038-4348
EI 1541-8243
J9 SOUTH MED J
JI South.Med.J.
PD JAN
PY 2019
VL 112
IS 1
BP 45
EP 51
DI 10.14423/SMJ.0000000000000917
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA HG5WF
UT WOS:000455050000011
PM 30608632
OA Bronze
DA 2020-07-08
ER

PT J
AU Guisado-Vasco, P
AF Guisado-Vasco, Pablo
TI Commentary on "Evaluation of Patients for Zika Virus Infection in a
   Travel Clinic in the Southeast United States, 2016"
SO SOUTHERN MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Guisado-Vasco, Pablo] European Univ Madrid, Internal Med Dept, Madrid, Spain.
RP Guisado-Vasco, P (corresponding author), Complejo Hosp Ruber Juan Bravo, Juan Bravo St 39-49, Madrid 28006, Spain.
EM pablogvasco@gmail.com
RI Guisado-Vasco, Pablo/I-1366-2019
OI Guisado-Vasco, Pablo/0000-0003-3019-4398
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Valle J, 2019, SOUTH MED J, V112, P45, DOI 10.14423/SMJ.0000000000000917
NR 5
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0038-4348
EI 1541-8243
J9 SOUTH MED J
JI South.Med.J.
PD JAN
PY 2019
VL 112
IS 1
BP 52
EP 53
DI 10.14423/SMJ.0000000000000918
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA HG5WF
UT WOS:000455050000012
PM 30608633
DA 2020-07-08
ER

PT J
AU Dodd, RY
   Stramer, SL
AF Dodd, Roger Y.
   Stramer, Susan L.
TI Technical solutions to social issues?
SO TRANSFUSION
LA English
DT Editorial Material
ID HEPATITIS-B-VIRUS; ZIKA VIRUS; C VIRUS; TRANSFUSION; TRANSMISSION;
   INFECTION; HIV; IMPLEMENTATION; SAFETY; RISK
C1 [Dodd, Roger Y.] Amer Red Cross, Sci Affairs, Holland Lab, Rockville, MD 20855 USA.
   [Stramer, Susan L.] Amer Red Cross, Sci Affairs, Gaithersburg, MD USA.
RP Dodd, RY (corresponding author), Amer Red Cross, Sci Affairs, Holland Lab, Rockville, MD 20855 USA.
EM roger.dodd@redcross.org; susan.stramer@redcross.org
CR [Anonymous], 2015, REV REC RED RISK HUM
   BUSCH MP, 1991, TRANSFUSION, V31, P4, DOI 10.1046/j.1537-2995.1991.31191096183.x
   Custer B, 2016, TRANSFUSION, V56, P1499, DOI 10.1111/trf.13632
   Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Galel SA, 2018, TRANSFUSION, V58, P649, DOI [10.1111/trf.15014, 10.1111/trf.14457]
   Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x
   Miller YM, 2018, TRANSFUSION, V58, p8A
   Mitsch A, 2018, MMWR-MORBID MORTAL W, V67, P1025, DOI 10.15585/mmwr.mm6737a2
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154
   Stramer SL, 2003, TRANSFUSION, V43, p40A
   Stramer Susan L, 2018, AM RED CROSS UNPUB
   Vermeulen M, 2019, TRANSFUSION, V59, P267, DOI 10.1111/trf.14959
   Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x
   Ward SJ, 2018, TRANSFUSION, V58, P1916, DOI 10.1111/trf.14912
NR 17
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JAN
PY 2019
VL 59
IS 1
BP 9
EP 11
DI 10.1111/trf.15081
PG 3
WC Hematology
SC Hematology
GA HG8WJ
UT WOS:000455286500004
PM 30615812
OA Bronze
DA 2020-07-08
ER

PT J
AU Fouet, C
   Kamdem, C
AF Fouet, Caroline
   Kamdem, Colince
TI Integrated Mosquito Management: Is Precision Control a Luxury or
   Necessity?
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID WEST NILE VIRUS; AEDES-AEGYPTI; ARBOVIRUS SURVEILLANCE; INSECTICIDE
   RESISTANCE; BORNE DISEASES; VECTOR CONTROL; ZIKA; SCIENCE; DENGUE;
   INTERVENTIONS
AB The versatility of mosquito species that spread emerging arthropod-borne viruses such as Zika has highlighted the urgent need to re-evaluate mosquito-control standards. The prospect of using precise knowledge of the geographic distribution and vector status of local populations to guide targeted interventions has gained renewed attention, but the feasibility and utility of such an approach remain to be investigated. Using the example of mosquito management in the USA, we present ideas for designing, monitoring, and assessing precision vector control tailored to different environmental and epidemiological settings. We emphasize the technical adjustments that could be implemented in mosquito-control districts to enable targeted control while strengthening traditional management.
C1 [Fouet, Caroline; Kamdem, Colince] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
RP Kamdem, C (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
EM colincek@ucr.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5R01AI113248-05]
FX The authors are grateful for the insightful comments of two referees.
   C.F. and C.K. were supported by NIH grant 5R01AI113248-05 to Peter
   Atkinson.
CR Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   American Mosquito Control Association, 2017, BEST PRACTICES INTEG
   Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376
   Batovska J, 2018, MOL ECOL RESOUR, V18, P32, DOI 10.1111/1755-0998.12682
   Batovska J, 2017, J VIROL METHODS, V249, P79, DOI 10.1016/j.jviromet.2017.08.019
   Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401
   Centers for Disease Control and Prevention, 2016, GUID AED AEG AED ALB
   Centers for Disease Control and Prevention, 2012, GUID EV INS RES VECT
   Centers for Disease Control and Prevention, 2017, INT MOSQ MAN AED AEG
   Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU
   Cianci D, 2013, J MED ENTOMOL, V50, P533, DOI 10.1603/ME12126
   Clements ACA, 2013, LANCET INFECT DIS, V13, P709, DOI 10.1016/S1473-3099(13)70140-3
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   Dorigatti I, 2018, TRENDS PARASITOL, V34, P102, DOI 10.1016/j.pt.2017.11.002
   Ebel GD, 2017, CURR OPIN VIROL, V23, P125, DOI 10.1016/j.coviro.2017.05.002
   Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Focks Dana A., 1999, American Entomologist, V45, P173
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Fouet C, 2018, TRENDS PARASITOL, V34, P127, DOI 10.1016/j.pt.2017.10.012
   Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063
   Gonsalves C. M., 2014, PARASITE VECTOR, V320, P1
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grubaugh N.D, 2018, BIORXIV, DOI [10.1101/383513, DOI 10.1101/383513]
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hemingway J, 2017, SCIENCE, V358, P998, DOI 10.1126/science.aaj1644
   Jordan RC, 2017, J AM MOSQUITO CONTR, V33, P241, DOI 10.2987/17-6644R.1
   Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031843
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Miles A, 2017, NATURE, V552, P96, DOI 10.1038/nature24995
   Miller JR, 2001, J URBAN HEALTH, V78, P359, DOI 10.1093/jurban/78.2.359
   Moreno-Madrinan MJ, 2018, EMERG INFECT DIS, V24, P821, DOI 10.3201/eid2405.171609
   National Association of County and City Health Officials, 2017, MOSQ CONTR CAP US
   Palaniyandi M, 2012, J VECTOR DIS, V49, P197
   Palmer JRB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00914-9
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ramirez A. L., 2018, PARASITE VECTOR, V11, P1
   Rinker DC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0966-4
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Russell J.A, 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-017-17765-5
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-513
   Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031
   Tjaden NB, 2018, TRENDS PARASITOL, V34, P227, DOI 10.1016/j.pt.2017.11.006
   Weeramanthri T. S., 2018, FRONT PUBLIC HEALTH, V6, P3
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P138, DOI 10.1016/j.virol.2018.06.004
   Wesolowski A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1181-9
   WHO, 2012, GLOB PLAN INS RES MA
   WILLIAMS LL, 1963, AM J PUBLIC HEALTH N, V53, P17, DOI 10.2105/AJPH.53.1.17
NR 66
TC 1
Z9 1
U1 7
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JAN
PY 2019
VL 35
IS 1
BP 85
EP 95
DI 10.1016/j.pt.2018.10.004
PG 11
WC Parasitology
SC Parasitology
GA HG3GV
UT WOS:000454862800010
PM 30446394
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Walker, CL
   Little, MTE
   Roby, JA
   Armistead, B
   Gale, M
   Rajagopal, L
   Nelson, BR
   Ehinger, N
   Mason, B
   Nayeri, U
   Curry, CL
   Waldorf, KMA
AF Walker, Christie L.
   Little, Marie-Terese E.
   Roby, Justin A.
   Armistead, Blair
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Nelson, Branden R.
   Ehinger, Noah
   Mason, Brittney
   Nayeri, Unzila
   Curry, Christine L.
   Waldorf, Kristina M. Adams
TI Zika virus and the nonmicrocephalic fetus: why we should still worry
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Review
DE birth defect; Congenital Zika Syndrome; microcephaly; pregnancy; Zika
   virus
ID WEST-NILE-VIRUS; HIPPOCAMPAL NEUROGENESIS; BIRTH-DEFECTS; FETAL-BRAIN;
   VERTICAL TRANSMISSION; PREGNANCY OUTCOMES; INTERIM GUIDANCE;
   UNITED-STATES; INFECTION; INTERFERON
AB Zika virus is a mosquito-transmitted flavivirus and was first linked to congenital microcephaly caused by a large outbreak in northeastern Brazil. Although the Zika virus epidemic is now in decline, pregnancies in large parts of the Americas remain at risk because of ongoing transmission and the potential for new outbreaks. This review presents why Zika virus is still a complex and worrisome public health problem with an expanding spectrum of birth defects and how Zika virus and related viruses evade the immune response to injure the fetus. Recent reports indicate that the spectrum of fetal brain and other anomalies associated with Zika virus exposure is broader and more complex than microcephaly alone and includes subtle fetal brain and ocular injuries; thus, the ability to prenatally diagnose fetal injury associated with Zika virus infection remains limited. New studies indicate that Zika virus imparts disproportionate effects on fetal growth with an unusual femur-sparing profile, potentially providing a new approach to identify viral injury to the fetus. Studies to determine the limitations of prenatal and postnatal testing for detection of Zika virus-associated birth defects and long-term neurocognitive deficits are needed to better guide women with a possible infectious exposure. It is also imperative that we investigate why the Zika virus is so adept at infecting the placenta and the fetal brain to better predict other viruses with similar capabilities that may give rise to new epidemics. The efficiency with which the Zika virus evades the early immune response to enable infection of the mother, placenta, and fetus is likely critical for understanding why the infection may either be fulminant or limited. Furthermore, studies suggest that several emerging and related viruses may also cause birth defects, including West Nile virus, which is endemic in many parts of the United States. With mosquito-borne diseases increasing worldwide, there remains an urgent need to better understand the pathogenesis of the Zika virus and related viruses to protect pregnancies and child health.
C1 [Walker, Christie L.] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA.
   [Roby, Justin A.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.] Univ Washington, Dept Microbiol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Obstet & Gynecol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Armistead, Blair] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Armistead, Blair; Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Nelson, Branden R.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.
   [Little, Marie-Terese E.] Fourth Dimens Biomed & Res Consulting, Victoria, BC, Canada.
   [Ehinger, Noah; Mason, Brittney; Nayeri, Unzila; Curry, Christine L.] Univ Miami, Dept Obstet & Gynecol, Miami, FL USA.
   [Waldorf, Kristina M. Adams] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
RP Waldorf, KMA (corresponding author), Univ Washington, Dept Global Hlth, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
EM adamsk@uw.edu
FU Department of Obstetrics and Gynecology, University of Washington;
   Seattle Children's Research Institute, the Keck Foundation; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI100989, AI33976,
   AI083019 AI104002, OD023838]
FX This work was supported by the Department of Obstetrics and Gynecology,
   University of Washington; Seattle Children's Research Institute, the
   Keck Foundation (to Dr Nelson), and the National Institutes of Health
   grants AI100989 and AI33976 (to Drs Rajagopal and Adams Waldorf), grants
   AI083019 AI104002 (to Dr Gale), and grant OD023838 (to Dr Nelson).
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Avirutnan P, 2008, VACCINE, V26, pI100, DOI 10.1016/j.vaccine.2008.11.061
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Best SM, 2017, J VIROL, V91
   Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2
   Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Britt WJ, 2018, SEMIN PERINATOL, V42, P155, DOI 10.1053/j.semperi.2018.02.003
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Centers for Disease Control and Prevention, 2017, GUID LAB TEST ZIK VI
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Glasner A, 2017, J VIROL, P91
   Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Juca E, 2018, CHILD NERV SYST, V34, P101, DOI 10.1007/s00381-017-3636-2
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kempermann G, 2018, CELL STEM CELL
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Kleber de Oliveira W, 2015, MMWR-MORBID MORTAL W, V2016, P242
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MATHUR A, 1985, INDIAN J MED RES, V81, P9
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Mavigner M, 2018, SCI TRANSL MED, P10
   McDonald EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006691
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schaub B, 2017, ULTRASOUND OBST GYN, V49, P658, DOI 10.1002/uog.17210
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Silva AA, 2018, PEDIATRICS, P141
   SINGER DB, 1967, J PEDIATR-US, V71, P665, DOI 10.1016/S0022-3476(67)80202-6
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Sohan K, 2017, INT J GYNECOL OBSTET, V139, P278, DOI 10.1002/ijgo.12313
   Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975
   Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Toda T, 2019, MOL PSYCHIATR, V24, P67, DOI 10.1038/s41380-018-0036-2
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2018, SCI IMMUNOL, P3
   Zhang Y, 2015, VET MICROBIOL, V179, P149, DOI 10.1016/j.vetmic.2015.06.004
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 121
TC 10
Z9 10
U1 3
U2 86
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2019
VL 220
IS 1
BP 45
EP 56
DI 10.1016/j.ajog.2018.08.035
PG 12
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HF4YO
UT WOS:000454239900010
PM 30171843
OA Green Accepted
DA 2020-07-08
ER

PT J
AU McKinney, JR
   Seferovic, M
   Watkin, L
   Prince, A
   Suter, M
   Aagaard, K
AF McKinney, Jennifer R.
   Seferovic, Maxim
   Watkin, Levi
   Prince, Amanda
   Suter, Melissa
   Aagaard, Kjersti
TI Autophagy and ZIKV replication co-occur in only some human and primate
   placental cells: therapeutic implications
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 39th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 11-16, 2019
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [McKinney, Jennifer R.; Seferovic, Maxim; Watkin, Levi; Prince, Amanda; Suter, Melissa; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2019
VL 220
IS 1
SU S
MA 636
BP S421
EP S421
DI 10.1016/j.ajog.2018.11.658
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HF5CE
UT WOS:000454249402118
OA Bronze
DA 2020-07-08
ER

PT J
AU Seferovic, MD
   Valenine, G
   Molina-Pineda, J
   Suter, M
   Meyer, K
   Gorchakov, R
   Berry, R
   Fowler, S
   Murray, K
   Aagaard, K
AF Seferovic, Maxim D.
   Valenine, Gregory
   Molina-Pineda, Julio
   Suter, Melissa
   Meyer, Kristen
   Gorchakov, Rodion
   Berry, Rebecca
   Fowler, Stephanie
   Murray, Kristy
   Aagaard, Kjersti
TI Maternal microbiome diminishes fetal infection and demise in a murine
   model of congenital zika syndrome
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 39th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 11-16, 2019
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Seferovic, Maxim D.; Valenine, Gregory; Molina-Pineda, Julio; Suter, Melissa; Meyer, Kristen; Gorchakov, Rodion; Berry, Rebecca; Fowler, Stephanie; Murray, Kristy; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2019
VL 220
IS 1
SU S
MA 101
BP S81
EP S82
DI 10.1016/j.ajog.2018.11.112
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HF5CE
UT WOS:000454249400102
OA Bronze
DA 2020-07-08
ER

PT J
AU Valentine, G
   Seferovic, M
   Velasquez, M
   Fowler, S
   Gorchakov, R
   Berry, R
   Swennes, A
   Murray, K
   Suter, M
   Aagaard, K
AF Valentine, Gregory
   Seferovic, Maxim
   Velasquez, Miguel
   Fowler, Stephanie
   Gorchakov, Rodion
   Berry, Rebecca
   Swennes, Alton
   Murray, Kristy
   Suter, Melissa
   Aagaard, Kjersti
TI Persistent changes in interferon stimulated genes associated with zika
   virus exposure in offspring through adolescence
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 39th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 11-16, 2019
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Valentine, Gregory; Seferovic, Maxim; Velasquez, Miguel; Fowler, Stephanie; Gorchakov, Rodion; Berry, Rebecca; Swennes, Alton; Murray, Kristy; Suter, Melissa; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2019
VL 220
IS 1
SU S
MA 634
BP S420
EP S420
DI 10.1016/j.ajog.2018.11.656
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HF5CE
UT WOS:000454249402116
OA Bronze
DA 2020-07-08
ER

PT J
AU Villazana-Kretzer, DL
   Schmiedecke, SS
   Estrada, SM
   Wuertz, K
   Go, J
   Gale, M
   Napolitano, PG
   Ieronimakis, N
AF Villazana-Kretzer, Diana L.
   Schmiedecke, Stacey S.
   Estrada, Sarah M.
   Wuertz, Kathryn
   Go, Jennifer
   Gale, Michael
   Napolitano, Peter G.
   Ieronimakis, Nicholas
TI Zika virus perfusion into human placenta cotyledons alters function and
   syncytiotrophoblasts barrier
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 39th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY FEB 11-16, 2019
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Villazana-Kretzer, Diana L.] Madigan Army Med Ctr, Tacoma, WA 98431 USA.
   [Schmiedecke, Stacey S.; Estrada, Sarah M.; Ieronimakis, Nicholas] Madigan Army Med Ctr, Div Maternal Fetal Med, Tacoma, WA 98431 USA.
   [Wuertz, Kathryn; Go, Jennifer; Gale, Michael] UWMC, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA USA.
   [Napolitano, Peter G.] UWMC, Dept OBGYN, Seattle, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2019
VL 220
IS 1
SU S
MA 628
BP S415
EP S416
DI 10.1016/j.ajog.2018.11.650
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HF5CE
UT WOS:000454249402110
OA Bronze
DA 2020-07-08
ER

PT J
AU Beaufrere, A
   Bessieres, B
   Bonniere, M
   Driessen, M
   Alfano, C
   Couderc, T
   Thiry, M
   Thelen, N
   Lecuit, M
   Attie-Bitach, T
   Vekemans, M
   Ville, Y
   Nguyen, L
   Leruez-Ville, M
   Encha-Razavil, F
AF Beaufrere, Aurelie
   Bessieres, Bettina
   Bonniere, Maryse
   Driessen, Marine
   Alfano, Christian
   Couderc, Therese
   Thiry, Marc
   Thelen, Nicolas
   Lecuit, Marc
   Attie-Bitach, Tania
   Vekemans, Michel
   Ville, Yves
   Nguyen, Laurent
   Leruez-Ville, Marianne
   Encha-Razavil, Ferechte
TI A clinical and histopathological study of malformations observed in
   fetuses infected by the Zika virus
SO BRAIN PATHOLOGY
LA English
DT Article
DE ER stress; fetus; meningoencephalitis; micrencephaly; microcephaly; ZIKV
   infection.
ID UNFOLDED PROTEIN RESPONSE; PLACENTAL PATHOLOGY; BRAIN; DAMAGES; INFANTS
AB Background The recent outbreak of Zika virus (ZIKV) infection and the associated increased prevalence of microcephaly in Brazil underline the impact of viral infections on embryo fetal development. The aim of the present study is to provide a detailed clinical and histopathological study of the fetal disruption caused by the ZIKV, with a special focus on the associated neuropathological findings. Methods A detailed feto-placental examination, as well as neuropathological and neurobiological studies were performed on three fetuses collected after pregnancy termination between 22 and 25 weeks of gestation (WG), because brain malformations associated with a maternal and fetal ZIKV infection was diagnosed. Results In all three cases, the maternal infection occurred during the first trimester of pregnancy. A small head was observed on the ultrasound examination of the second trimester of pregnancy and led to the diagnosis of ZIKV fetopathy and pregnancy termination. The fetal histopathological examination was unremarkable on the viscera but showed on the testis an interstitial lymphocytic infiltrate. The placenta contained a Hofbauer cells hyperplasia with signs of inflammation. Neuropathological findings included a meningoencephalitis and an ex vacuo hydrocephalus. Immunohistochemical studies showed the presence of T lymphocytic and histiocytic meningitis associated with an abundant cerebral astroglial and macrophagic reaction. In situ hybridization demonstrated, abundant ZIKV particles within the cerebral parenchyma mainly in the ventricular/subventricular zone and in the cortical plate. In addition massive cells death and endoplasmic reticulum damage were present. Conclusion The present study reports on the clinical and histopathological findings observed in three fetuses infected by the ZIKV. It emphasizes the severity of brain damages and the minimal visceral and placental changes observed upon ZIKV infection. This confirms the selective neurotropism of ZIKV. Finally, it allows us to describe the cascade of multifactorial developmental defects leading to microcephaly.
C1 [Beaufrere, Aurelie; Bessieres, Bettina; Bonniere, Maryse; Attie-Bitach, Tania; Vekemans, Michel; Encha-Razavil, Ferechte] Hop Univ Necker Enfants Malad, AP HP, Serv Histol Embryol Cytogenet, 149 Rue Sevres, F-75015 Paris, France.
   [Driessen, Marine; Ville, Yves] Hop Univ Necker Enfants Malad, AP HP, Serv Gynecol Obstet, Paris, France.
   [Alfano, Christian; Thiry, Marc; Thelen, Nicolas; Nguyen, Laurent] Univ Liege, GIGA Neurosci, Liege, Belgium.
   [Couderc, Therese; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Couderc, Therese; Lecuit, Marc] INSERM, U1117, Paris, France.
   [Lecuit, Marc] Paris Descartes Univ, Sorbonne Paris Cite, Ctr Infectiol Necker Pasteur, Necker Enfants Malad, Paris, France.
   [Attie-Bitach, Tania; Vekemans, Michel] INSERM, U1163, Inst Imagine, Paris, France.
   [Attie-Bitach, Tania; Vekemans, Michel; Ville, Yves; Leruez-Ville, Marianne] Univ Paris 05, Paris, France.
   [Leruez-Ville, Marianne] Hop Univ Necker Enfants Malad, AP HP, Lab Virol, Paris, France.
RP Beaufrere, A (corresponding author), Hop Univ Necker Enfants Malad, AP HP, Serv Histol Embryol Cytogenet, 149 Rue Sevres, F-75015 Paris, France.
EM aurelie.beaufrere@sfr.fr
RI Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013; ATTIE-BITACH,
   Tania/K-1453-2017
OI Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063;
   Thelen, Nicolas/0000-0001-8042-1275; ATTIE-BITACH,
   Tania/0000-0002-1155-3626
FU European Union's Horizon 2020 Research and Innovation Program under
   ZIKAlliance [734548]; LabEx IBEID, Institut Pasteur; INSERMInstitut
   National de la Sante et de la Recherche Medicale (Inserm)
FX This project was funded in part by the European Union's Horizon 2020
   Research and Innovation Program under ZIKAlliance Grant Agreement No
   734548 (to L.N. and M.L.) and by the LabEx IBEID, Institut Pasteur and
   INSERM.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   BENIRSCHKE K, 1974, VIRCHOWS ARCH B, V16, P121, DOI 10.1007/BF02894070
   Besnard M, 2016, EURO SURVEILL B EUR, V21
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cau E, 1997, DEVELOPMENT, V124, P1611
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   GARCIA AGP, 1985, PLACENTA, V6, P281, DOI 10.1016/S0143-4004(85)80038-2
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   GUIHARDCOSTA AM, 1995, FETAL DIAGN THER, V10, P215, DOI 10.1159/000264243
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Merfeld E, 2017, WILEY INTERDISCIP RE, V6
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   WHO, ZIK VIR COMPL 2016 P
NR 39
TC 3
Z9 3
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD JAN
PY 2019
VL 29
IS 1
BP 114
EP 125
DI 10.1111/bpa.12644
PG 12
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HF9WI
UT WOS:000454592900010
PM 30020561
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Smolenski, J
AF Smolenski, Joanna
TI Gene Drives and Genome Modification in Nonhuman Animals: A Concern for
   Informed Consent?
SO CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS
LA English
DT Article
DE CRISPR-Cas9; gene editing; gene drives; informed consent; public health;
   genetic engineering; genome modification; Zika
AB In recent years, CRISPR-Cas9 has become one of the simplest and most cost-effective genetic engineering techniques among scientists and researchers aiming to alter genes in organisms. As Zika came to the fore as a global health crisis, many suggested the use of CRISPR-Cas9 gene drives in mosquitoes as a possible means to prevent the transmission of the virus without the need to subject humans to risky experimental treatments. This paper suggests that using gene drives or other forms of genome editing in nonhumans (like mosquitos) for the purposes of disease prevention raises important issues about informed consent. Additionally, it examines the consequences this line of inquiry could have for the use of gene drives as a tool in public health and suggests that the guidance offered by informed consent protocols could help the scientific community deploy gene drives in a way that ensures that ongoing research is consistent with our ethical priorities.
CR BARUCH S, 2005, HUMAN GERMLINE GENET
   Begley S., 2015, MALARIA KILLS HALF M
   Callaway E., 2017, NATURE          0531
   Cohen J., 2017, SCIENCE
   Corbyn Z., 2015, GUARDIAN
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Knoppers Bartha M., 2006, NATL REGULATORY FRAM
   LaFraniere Sharon., 2011, NY TIMES
   Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a
   Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a
   Neuhaus CP, 2018, HASTINGS CENT REP, V48, P25, DOI 10.1002/hast.808
   Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287
   President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, SPLIC LIF REP SOC ET
   Riordan SM, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0027-9
   Smolenski J, 2015, AM J BIOETHICS, V15, P35, DOI 10.1080/15265161.2015.1103816
NR 15
TC 0
Z9 0
U1 2
U2 24
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0963-1801
EI 1469-2147
J9 CAMB Q HEALTHC ETHIC
JI Camb. Q. Healthc. Ethics
PD JAN
PY 2019
VL 28
IS 1
BP 93
EP 99
DI 10.1017/S0963180118000427
PG 7
WC Health Care Sciences & Services; Health Policy & Services; Social
   Sciences, Biomedical
SC Health Care Sciences & Services; Biomedical Social Sciences
GA HF4MA
UT WOS:000454206100011
PM 30570468
DA 2020-07-08
ER

PT J
AU Martinez, JD
   Cardenas-de la Garza, JA
   Cuellar-Barboza, A
AF Dario Martinez, Jose
   Alberto Cardenas-de la Garza, Jesus
   Cuellar-Barboza, Adrian
TI Going Viral 2019 Zika, Chikungunya, and Dengue
SO DERMATOLOGIC CLINICS
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Academy-of-Dermatology (AAD)
CY MAR 01-05, 2019
CL Washington, DC
SP Amer Acad Dermatol
DE Arbovirus; Aedes aegypti; Travel-related illness; Zika; Microcephaly;
   Chikungunya; Dengue
ID VIRUS-DISEASE; INTERIM GUIDANCE; INFECTION; EPIDEMIOLOGY; AMERICA;
   FEVER; COMPLICATIONS; TRANSMISSION; PREVALENCE; MANAGEMENT
AB Chikungunya and Zika virus infections are emerging diseases in the Americas, and dengue continues to be the most prevalent arthropod-borne virus in the world. These arbovirus diseases may spread by endemic transmission or as travel related infections and have rapidly expanded their geographic distribution secondary to vector spread. All 3 share a similar clinical picture that includes a maculopapular rash. Zika is characterized by pruritic rash, low-grade fever, and arthralgia. Congenital nervous system malformations are a growing public-health concern. Chikungunya distinctive dermatologic manifestations include facial melanosis and bullous eruption. Dengue bleeding complications may be life threatening and require inpatient management.
C1 [Dario Martinez, Jose] UANL, Univ Hosp Dr Jose E Gonzalez, Dept Internal Med, Mitras Ctr, Ave Gonzalitos & Madero S-N, Monterrey 64460, Mexico.
   [Alberto Cardenas-de la Garza, Jesus; Cuellar-Barboza, Adrian] Univ Autonoma Nuevo Leon, Univ Hosp Dr Jose E Gonzalez, Dept Dermatol, Mitras Ctr, Ave Gonzalitos & Madero S-N, Monterrey 64460, Mexico.
RP Martinez, JD (corresponding author), UANL, Univ Hosp Dr Jose E Gonzalez, Dept Internal Med, Mitras Ctr, Ave Gonzalitos & Madero S-N, Monterrey 64460, Mexico.
EM jdariomtz@yahoo.com.mx
RI la Garza, Jesus Alberto Cardenas-de/AAL-9288-2020
OI la Garza, Jesus Alberto Cardenas-de/0000-0002-5099-0079
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDCCENTERS FOR DISEASE CONTROL AND PREVENTION, 2018, TRAV HLTH
   Center for Disease Control and Prevention, 2018, ZIK AND PREGN
   Center for Disease Control and 'Prevention, 2018, CHIK VIR
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grande AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004888
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Handler MZ, 2017, INT J DERMATOL, V56, pe19, DOI 10.1111/ijd.13439
   He A, 2017, AM J CLIN DERMATOL, V18, P231, DOI 10.1007/s40257-016-0243-z
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Korman AM, 2017, J AM ACAD DERMATOL, V76, P538, DOI 10.1016/j.jaad.2016.08.034
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Kumar Ramesh, 2017, Indian Dermatol Online J, V8, P336, DOI 10.4103/idoj.IDOJ_429_16
   Kuno G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004101
   LaRocque RL, 2016, ANN INTERN MED, V165, P589, DOI 10.7326/M16-1397
   Lee TH, 2017, EXPERT REV ANTI-INFE, V15, P67, DOI 10.1080/14787210.2017.1248405
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Mathew AJ, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0680-7
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlacker S, 2016, INT J DERMATOL, V55, P1369, DOI 10.1111/ijd.13399
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Rigau-Perez JG, 1998, AM J TROP MED HYG, V59, P272, DOI 10.4269/ajtmh.1998.59.272
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Sharma SK, 2018, INT J RHEUM DIS, V21, P584, DOI 10.1111/1756-185X.13273
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   Singal Archana, 2017, Indian Dermatol Online J, V8, P307, DOI 10.4103/idoj.IDOJ_93_17
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Staples J, 2017, CDC YELLOW BOOK 2018, P151
   The American College of Obstetricians and Gynecologists, 2017, PRACT ADV
   Thomas Emy Abi, 2010, Indian J Dermatol, V55, P79, DOI 10.4103/0019-5154.60359
   Thomas SJ, 2013, CURR OPIN INFECT DIS, V26, P429, DOI 10.1097/01.qco.0000433310.28771.cc
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   van den Worm L, 2017, INT J DERMATOL, V56, P1470, DOI 10.1111/ijd.13700
   Vasievich MP, 2016, AM J CLIN DERMATOL, V17, P451, DOI 10.1007/s40257-016-0203-7
   Veletzky L, 2017, INT J INFECT DIS, V54, P13, DOI 10.1016/j.ijid.2016.11.004
   Vijayan V, 2016, JCR-J CLIN RHEUMATOL, V22, P203, DOI 10.1097/RHU.0000000000000396
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   World Health Organization, 2017, WHO FACT SHEETS
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2018, WHO IMM VACC BIOL
   World Health Organization, 2018, DIS OUTBREAKS NEWS
   Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
NR 79
TC 7
Z9 8
U1 2
U2 14
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0733-8635
EI 1558-0520
J9 DERMATOL CLIN
JI Dermatol. Clin.
PD JAN
PY 2019
VL 37
IS 1
BP 95
EP +
DI 10.1016/j.det.2018.07.008
PG 12
WC Dermatology
SC Dermatology
GA HF8DD
UT WOS:000454470200012
PM 30466692
DA 2020-07-08
ER

PT J
AU Chen, HI
   Song, HJ
   Ming, GL
AF Chen, H. Isaac
   Song, Hongjun
   Ming, Guo-li
TI Applications of Human Brain Organoids to Clinical Problems
SO DEVELOPMENTAL DYNAMICS
LA English
DT Review
DE brain structure; cerebral organoid; disease model; personalized
   medicine; pluripotent stem cells
ID PLURIPOTENT STEM-CELLS; MAMMALIAN CORTICAL NEUROGENESIS;
   CENTRAL-NERVOUS-SYSTEM; ZIKA VIRUS-INFECTION; CEREBRAL ORGANOIDS; NEURAL
   PROGENITORS; SELF-ORGANIZATION; HUMAN ES; VASCULAR NICHE; GLIAL-CELLS
AB Brain organoids are an exciting new technology with the potential to significantly change how diseases of the brain are understood and treated. These three-dimensional neural tissues are derived from the self-organization of pluripotent stem cells, and they recapitulate the developmental process of the human brain, including progenitor zones and rudimentary cortical layers. Brain organoids have been valuable in investigating different aspects of developmental neurobiology and comparative biology. Several characteristics of organoids also make them attractive as models of brain disorders. Data generated from human organoids are more generalizable to patients because of the match in species background. Personalized organoids also can be generated from patient-derived induced pluripotent stem cells. Furthermore, the three-dimensionality of brain organoids supports cellular, mechanical, and topographical cues that are lacking in planar systems. In this review, we discuss the translational potential of brain organoids, using the examples of Zika virus, autism-spectrum disorder, and glioblastoma multiforme to consider how they could contribute to disease modeling, personalized medicine, and testing of therapeutics. We then discuss areas of improvement in organoid technology that will enhance the translational potential of brain organoids, as well as the possibility of their use as substrates for repairing cerebral circuitry after injury. Developmental Dynamics 248:53-64, 2019. (c) 2018 Wiley Periodicals, Inc.
C1 [Chen, H. Isaac] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.
   [Chen, H. Isaac] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA.
   [Chen, H. Isaac; Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.
   [Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.
RP Chen, HI (corresponding author), 160 Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.
EM isaac.chen@uphs.upenn.edu
OI Ming, Guo-li/0000-0002-2517-6075; Chen, Han-Chiao/0000-0002-7431-6046
FU Department of Veterans Affairs - National Institutes of HealthUS
   Department of Veterans AffairsUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX H.I.C. is supported by the Department of Veterans Affairs and H.J.S. and
   G.-L.M. are funded by the National Institutes of Health.
CR Allende ML, 2018, J LIPID RES, V59, P550, DOI 10.1194/jlr.M081323
   Arlotta P, 2018, NAT METHODS, V15, P27, DOI 10.1038/nmeth.4557
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619
   Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chen HI, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa5ccd
   Chen HI, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00001
   Chu JH, 2015, NEUROPSYCHOPHARMACOL, V40, P16, DOI 10.1038/npp.2014.171
   Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107
   Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039
   Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358
   Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dezonne RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45091
   Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dingle YTL, 2015, TISSUE ENG PART C-ME, V21, P1274, DOI [10.1089/ten.tec.2015.0135, 10.1089/ten.TEC.2015.0135]
   Domingues P, 2016, BRAIN BEHAV IMMUN, V53, P1, DOI 10.1016/j.bbi.2015.07.019
   Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130
   Ebben JD, 2010, EXPERT OPIN THER TAR, V14, P621, DOI 10.1517/14712598.2010.485186
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011
   Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x
   Forsberg SL, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0062-x
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabrusiewicz K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85841
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287
   Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009
   Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003
   Giandomenico SL, 2017, CURR OPIN CELL BIOL, V44, P36, DOI 10.1016/j.ceb.2017.01.001
   Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]
   Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949
   Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001
   Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094
   Ilieva M, 2018, BIOL PSYCHIAT, V83, P558, DOI 10.1016/j.biopsych.2017.11.011
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037
   Kimura M, 2018, ISCIENCE, V4, P294, DOI 10.1016/j.isci.2018.05.007
   Kirwan P, 2015, DEVELOPMENT, V142, P3178, DOI 10.1242/dev.123851
   Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lavazza A, 2018, J MED ETHICS
   Lee SH, 2018, CELL, V173, P515, DOI 10.1016/j.cell.2018.03.017
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mathew RK, 2018, SLAS DISCOV, P3
   Matsui T, 2017, DEVELOPMENT, V144, P1025, DOI 10.1242/dev.143636
   Matsui TK, 2018, NEUROSCI LETT, V670, P75, DOI 10.1016/j.neulet.2018.01.040
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mellios N, 2018, Mol Psychiatry, V23, P791, DOI 10.1038/mp.2018.5
   Michelsen KA, 2015, NEURON, V85, P982, DOI 10.1016/j.neuron.2015.02.001
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/nmat3357, 10.1038/NMAT3357]
   Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Moore AR, 2011, J NEUROSCI, V31, P2391, DOI 10.1523/JNEUROSCI.3886-10.2011
   Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683
   MOSCONA A, 1961, EXP CELL RES, V22, P455, DOI 10.1016/0014-4827(61)90122-7
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984
   Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105
   Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158
   Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003
   Ozone C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10351
   Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031
   Parker NR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00055
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Soliman MA, 2017, MOL PSYCHIATR, V22, P1241, DOI 10.1038/mp.2017.40
   Somaa FA, 2017, CELL REP, V20, P1964, DOI 10.1016/j.celrep.2017.07.069
   Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110
   Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.TEA.2014.0557, 10.1089/ten.tea.2014.0557]
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Stupp R, 2017, JAMA-J AM MED ASSOC, V318, P2306, DOI 10.1001/jama.2017.18718
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tornero D, 2017, BRAIN, V140, P692, DOI 10.1093/brain/aww347
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Varner VD, 2015, P NATL ACAD SCI USA, V112, P9230, DOI 10.1073/pnas.1504102112
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vera E, 2015, DEVELOPMENT, V142, P3085, DOI 10.1242/dev.120667
   Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774
   Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   WEISS P, 1960, P NATL ACAD SCI USA, V46, P1177, DOI 10.1073/pnas.46.9.1177
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye F, 2017, NEURON, V96, P1204, DOI 10.1016/j.neuron.2017.11.034
   Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356
   Zhao TB, 2015, CELL STEM CELL, V17, P353, DOI 10.1016/j.stem.2015.07.021
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
   Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071
NR 141
TC 16
Z9 16
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1058-8388
EI 1097-0177
J9 DEV DYNAM
JI Dev. Dyn.
PD JAN
PY 2019
VL 248
IS 1
SI SI
BP 53
EP 64
DI 10.1002/dvdy.24662
PG 12
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA HF9YC
UT WOS:000454597700006
PM 30091290
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Souza-Neto, JA
   Powell, JR
   Bonizzoni, M
AF Souza-Neto, Jayme A.
   Powell, Jeffrey R.
   Bonizzoni, Mariangela
TI Aedes aegypti vector competence studies: A review
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
ID YELLOW-FEVER VIRUS; DENGUE VIRUS; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS;
   ORAL INFECTION; COMPARATIVE SUSCEPTIBILITY; CULEX-QUINQUEFASCIATUS;
   MOSQUITOS DIPTERA; STEGOMYIA-AEGYPTI; GENETIC-STRUCTURE
AB Aedes aegypti is the primary transmitter of the four viruses that have had the greatest impact on human health, the viruses causing yellow fever, dengue fever, chikungunya, and Zika fever. Because this mosquito is easy to rear in the laboratory and these viruses grow in laboratory tissue culture cells, many studies have been performed testing the relative competence of different populations of the mosquito to transmit many different strains of viruses. We review here this large literature including studies on the effect of the mosquito microbiota on competence. Because of the heterogeneity of both mosquito populations and virus strains used, as well as methods measuring potential to transmit, it is very difficult to perform detailed meta-analysis of the studies. However, a few conclusions can be drawn: (1) almost no population of Ae. aegypti is 100% naturally refractory to virus infection. Complete susceptibility to infection has been observed for Zika (ZIKV), dengue (DENV) and chikungunya (CHIKV), but not yellow fever viruses (YFV); (2) the dose of virus used is directly correlated to the rate of infection; (3) Brazilian populations of mosquito are particularly susceptible to DENV-2 infections; (4) the Asian lineage of ZIKV is less infective to Ae. aegypti populations from the American continent than is the African ZIKV lineage; (5) virus adaptation to different species of mosquitoes has been demonstrated with CHIKV; (6) co-infection with more than one virus sometimes causes displacement while in other cases has little effect; (7) the microbiota in the mosquito also has important effects on level of susceptibility to arboviral infection; (8) resistance to virus infection due to the microbiota may be direct (e.g., bacteria producing antiviral proteins) or indirect in activating the mosquito host innate immune system; (9) non-pathogenic insect specific viruses (ISVs) are also common in mosquitoes including genome insertions. These too have been shown to have an impact on the susceptibility of mosquitoes to pathogenic viruses.
   One clear conclusion is that it would be a great advance in this type of research to implement standardized procedures in order to obtain comparable and reproducible results.
C1 [Souza-Neto, Jayme A.] Sao Paulo State Univ, UNESP, Dept Bioproc & Biotechnol, Sch Agr Sc,Multiuser Cent Lab, Botucatu, SP, Brazil.
   [Souza-Neto, Jayme A.] Sao Paulo State Univ, UNESP, Inst Biotechnol, Botucatu, SP, Brazil.
   [Powell, Jeffrey R.] Yale Univ, New Haven, CT USA.
   [Bonizzoni, Mariangela] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
RP Bonizzoni, M (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
EM m.bonizzoni@unipv.it
RI Souza-Neto, Jayme A/E-7841-2010
OI Souza-Neto, Jayme A/0000-0001-9281-894X
FU Human Frontier Science Program Research GrantHuman Frontier Science
   Program [RGP0007/2017]; Italian Ministry of Education, University and
   Research FARE project [R1623HZAH5]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/11343-6]; US National Institutes of Health, NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
FX We are grateful to Patrizia Chiari (University of Pavia) for providing
   assistance with the manuscript. This work was supported by the Human
   Frontier Science Program Research Grant RGP0007/2017 to M.B. and
   J.A.S.N.; by the Italian Ministry of Education, University and Research
   FARE project R1623HZAH5 to M.B.; by the Sao Paulo Research Foundation
   (FAPESP), Young Investigator Award 2013/11343-6 to J.A.S.N. J.R.P.'s
   research is supported by the US National Institutes of Health, NIAID.
CR Agha SB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005860
   Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Alto BW, 2014, J VECTOR ECOL, V39, P406, DOI 10.1111/jvec.12116
   BANCROFT TL, 1906, AUSTRALAS MED GAZ, V25, P17
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOROMISA RD, 1987, J AM MOSQUITO CONTR, V3, P378
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   Buckner E. A, 2013, J MED ENTOMOL, V31, P1713
   Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637
   Calvez E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2319-x
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Carvalho-Leandro D, 2012, ACTA TROP, V124, P113, DOI 10.1016/j.actatropica.2012.07.006
   Charan SS, 2013, PARASITOL RES, V112, P2627, DOI 10.1007/s00436-013-3428-x
   CHEN WJ, 1993, J MED ENTOMOL, V30, P524, DOI 10.1093/jmedent/30.3.524
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chepkorir E, 2014, INT J INFECT DIS, V21, P3, DOI 10.1016/j.ijid.2014.03.413
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Cornet M, 1979, ENTOMOL MED PARASITO, V17, P47
   Costa AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183840
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Di Luca M, 2016, EURO SURVEILL, V21
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Ellis BR, 2012, T ROY SOC TROP MED H, V106, P387, DOI 10.1016/j.trstmh.2012.02.007
   Fansiri T, 2016, EVOL APPL, V9, P608, DOI 10.1111/eva.12360
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   FISH D, 2008, VECTOR BORNE DIS UND, P65
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373
   Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029
   Girod R, 2011, TROP MED INT HEALTH, V16, P134, DOI 10.1111/j.1365-3156.2010.02613.x
   Gloria-Soria A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1506
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gonsalves C. M., 2014, PARASITE VECTOR, V320, P1
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Guedes D. R, 2017, EMERG MICROBES INFEC, P69
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Guo XX, 2013, ACTA TROP, V128, P566, DOI 10.1016/j.actatropica.2013.08.006
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Heitmann A, 2017, EURO SURVEILL, V22
   Huber Karine, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P81
   Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3
   JUPP PG, 1993, T ROY SOC TROP MED H, V87, P639, DOI 10.1016/0035-9203(93)90271-Q
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   KAY BH, 1979, J MED ENTOMOL, V16, P59, DOI 10.1093/jmedent/16.1.59
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Thi KLP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2422-z
   Knox TB, 2003, J MED ENTOMOL, V40, P950, DOI 10.1603/0022-2585-40.6.950
   KRAMER LD, 1976, AM J TROP MED HYG, V25, P336, DOI 10.4269/ajtmh.1976.25.336
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031
   Lourenco-De-Oliveira R, 2013, BMC INFECT DIS, V13, P1
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   MITCHELL CJ, 1987, J AM MOSQUITO CONTR, V3, P460
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muturi EJ, 2017, TROP MED INT HEALTH, V22, P399, DOI 10.1111/tmi.12846
   Na W, 2017, CLIN EXP VACCINE RES, V6, P104, DOI 10.7774/cevr.2017.6.2.104
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nasar F, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0595-2
   Ngoagouni C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2101-0
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Olson KE, 2017, CURR OPIN INSECT SCI, V22, P45, DOI 10.1016/j.cois.2017.05.010
   Padilha KP, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180290
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Palmer WH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030118
   Pando-Robles V, 2017, VECTOR-BORNE ZOONOT, V17, P361, DOI 10.1089/vbz.2016.2040
   Paupy C, 2003, GENET RES, V82, P171, DOI 10.1017/S0016672303006463
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   Pongsiri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092971
   Poole-Smith B. K, 2015, PLOS NEGLECT TROP D, V9, P1
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Reed W, 1901, Public Health Pap Rep, V27, P113
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Rodgers FH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006391
   ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x
   Serrato IM, 2017, MED VET ENTOMOL, V31, P312, DOI 10.1111/mve.12237
   Short SM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26680-2
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   Tabachnick WJ, 2016, CURR OPIN VIROL, V21, P124, DOI 10.1016/j.coviro.2016.09.008
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Thongrungkiat S, 2003, J VECTOR ECOL, V28, P166
   Tien TK, 1999, T ROY SOC TROP MED H, V93, P581, DOI 10.1016/S0035-9203(99)90056-1
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Turell MJ, 2007, J AM MOSQUITO CONTR, V23, P378, DOI 10.2987/5645.1
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   van den Hurk AF, 2011, AM J TROP MED HYG, V85, P446, DOI 10.4269/ajtmh.2011.11-0061
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   WALLIS GP, 1985, AM J TROP MED HYG, V34, P1225, DOI 10.4269/ajtmh.1985.34.1225
   Wang ZM, 2012, VECTOR-BORNE ZOONOT, V12, P605, DOI 10.1089/vbz.2011.0660
   Watson TM, 1999, J MED ENTOMOL, V36, P508, DOI 10.1093/jmedent/36.4.508
   Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wei XQ, 2017, DEV COMP IMMUNOL, V71, P1, DOI 10.1016/j.dci.2017.01.017
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 151
TC 30
Z9 30
U1 9
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JAN
PY 2019
VL 67
BP 191
EP 209
DI 10.1016/j.meegid.2018.11.009
PG 19
WC Infectious Diseases
SC Infectious Diseases
GA HF6MN
UT WOS:000454351500025
PM 30465912
OA Other Gold
DA 2020-07-08
ER

PT J
AU Cavalcanti, AFC
   Aguiar, YPC
   Melo, ASD
   Leal, JIBD
   Cavalcanti, AL
   Cavalcanti, SDLB
AF Cabral Cavalcanti, Alidianne Fabia
   Costa Aguiar, Yeska Paola
   de Oliveira Melo, Adriana Suely
   Bezerra de Freitas Leal, Jeime Iara
   Cavalcanti, Alessandro Leite
   Lins Bezerra Cavalcanti, Sergio d'Avila
TI Teething symptoms in children with congenital Zika syndrome: A 2-year
   follow-up
SO INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY
LA English
DT Article
DE signs and symptoms; tooth eruption; Zika virus infection
ID INFANTS
AB Background The eruption of primary teeth represents a stage of many challenges for parents. Aim To investigate the occurrence of signs and symptoms related to the eruption of the primary dentition in children with congenital Zika syndrome. Design Longitudinal study developed with 79 children followed up for a period of 24 months. Data on sex, gestational age, low birthweight, microcephaly, signs and symptoms related to the dental eruption phase, and use and type of medication were collected. Data were presented by descriptive and inferential statistics (chi-square test). Results The majority (94.9%) exhibited simultaneously two or more signs and symptoms related to dental eruption. Increased salivation (91.1%), irritability (86.1%), and gingival itching (83.5%) were the most commonly reported signs and symptoms. Bivariate analysis showed association between elevation of body temperature and sex (P < 0.05). Almost two-thirds of mothers (63.3%) reported using medication to relieve symptoms presented by the child; however, the use of topical medication prevailed (57.1%). Conclusion All children with congenital Zika syndrome presented manifestations related to the eruption of primary teeth, with increased salivation, irritability, and gingival pruritus. The use of ointments and gels was the option of mothers in the treatment of the oral discomfort presented by infants.
C1 [Cabral Cavalcanti, Alidianne Fabia; Costa Aguiar, Yeska Paola; Cavalcanti, Alessandro Leite; Lins Bezerra Cavalcanti, Sergio d'Avila] State Univ Paraiba, Postgrad Program Dent, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Univ Fed Campina Grande, Fac Med, Campina Grande, Paraiba, Brazil.
   [Bezerra de Freitas Leal, Jeime Iara] Specialized Ctr Rehabil, Campina Grande, Paraiba, Brazil.
RP Cavalcanti, AFC (corresponding author), Univ Estadual Paraiba, Dept Odontol, Campina Grande, Paraiba, Brazil.
EM alidianne.fabia@gmail.com
RI Cavalcanti, Alessandro Leite/I-4286-2019; Melo, Adriana S O/H-5650-2016;
   d'Avila, Sergio/I-9093-2014
OI Cavalcanti, Alessandro Leite/0000-0003-3572-3332; d'Avila,
   Sergio/0000-0002-7836-896X; Cavalcanti, Alidianne Fabia
   Cabral/0000-0002-7779-2478
FU National Council for Scientific and Technological Development (CNPq)
   Fellowship of Research ProductivityNational Council for Scientific and
   Technological Development (CNPq) [302850/2016-3]; Brazilian Coordination
   of Higher Education, Ministry of Education (CAPES)
FX This study was supported by the National Council for Scientific and
   Technological Development (CNPq) Fellowship of Research Productivity
   (Process 302850/2016-3) and the Brazilian Coordination of Higher
   Education, Ministry of Education (CAPES). The authors would like to
   thank the Centro Especializado de Reabilitacao and Instituto de Pesquisa
   Professor Joaquim Amorim Neto.
CR [Anonymous], 2016, Pediatr Dent, V38, P54
   [Anonymous], 2016, PROT VIG RESP OC MIC
   Azevedo MS, 2015, PESQUI BRAS ODONTOPE, V15, P217, DOI 10.4034/PBOCI.2015.151.23
   Balicer Ran D, 2004, ScientificWorldJournal, V4, P517
   Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Aguiar YPC, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.16
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   de Rezende CFM, 2010, PESQUI BRAS ODONTOPE, V10, P163, DOI 10.4034/1519.0501.2010.0102.0006
   Feldens CA, 2010, J CLIN PEDIATR DENT, V34, P201, DOI 10.17796/jcpd.34.3.h318882h52616225
   Ferreira L, 2015, PESQUI BRAS ODONTOPE, V15, P361, DOI 10.4034/PBOCI.2015.151.38
   Markman L, 2009, PEDIATR REV, V30, pE59, DOI 10.1542/pir.30-8-e59
   Massignan C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3501
   Memarpour M, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0070-2
   Ministerio da Saude Secretaria de AtencAo a Saude, 2016, DIR EST PREC CRIANC
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Ramos-Jorge J, 2011, PEDIATRICS, V128, P471, DOI 10.1542/peds.2010-2697
   Rathore E, 2017, PROF MED J, V24, P205
   Torres LB, 2018, ACTA ODONTOL SCAND, V14, P1
   World Health Organization, 2016, ASS INF MICR CONT ZI
NR 20
TC 3
Z9 3
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7439
EI 1365-263X
J9 INT J PAEDIATR DENT
JI Int. J. Paediatr. Dent.
PD JAN
PY 2019
VL 29
IS 1
BP 74
EP 78
DI 10.1111/ipd.12431
PG 5
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA HF7JC
UT WOS:000454414400014
PM 30302841
OA Bronze
DA 2020-07-08
ER

PT J
AU Guidry, JPD
   Carlyle, KE
   LaRose, JG
   Perrin, P
   Messner, M
   Ryan, M
AF Guidry, Jeanine P. D.
   Carlyle, Kellie E.
   LaRose, Jessica G.
   Perrin, Paul
   Messner, Marcus
   Ryan, Mark
TI Using the Health Belief Model to Analyze Instagram Posts about Zika for
   Public Health Communications
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID VIRUS
AB We analyzed Instagram posts about Zika by using the Health Belief Model. We found a high presence of threat messages, yet little engagement with these posts. Public health professionals should focus on posting messages to increase self-efficacy and benefits of protective behavior, especially when a vaccine becomes available.
C1 [Guidry, Jeanine P. D.; Carlyle, Kellie E.; LaRose, Jessica G.; Perrin, Paul; Messner, Marcus; Ryan, Mark] Virginia Commonwealth Univ, Richmond, VA USA.
RP Guidry, JPD (corresponding author), Virginia Commonwealth Univ, Robertson Sch Media & Culture, 901 Main St,Rm 2216, Richmond, VA 23284 USA.
EM guidryjd@vcu.edu
CR Fung ICH, 2017, DISASTER MED PUBLIC, V11, P656, DOI 10.1017/dmp.2017.23
   Glanz K, 2008, HLTH BEHAV HLTH ED T
   Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Lee ST, 2013, HEALTH COMMUN, V28, P119, DOI 10.1080/10410236.2012.658550
   Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Smith A., 2018, SOCIAL MEDIA USE 201
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
NR 9
TC 1
Z9 1
U1 1
U2 10
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2019
VL 25
IS 1
BP 179
EP 180
DI 10.3201/eid2501.180824
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HE6TK
UT WOS:000453546600030
PM 30561302
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Montalva, C
   Silva, JJ
   Rocha, LFN
   Luz, C
   Humber, RA
AF Montalva, C.
   Silva, J. J.
   Rocha, L. F. N.
   Luz, C.
   Humber, R. A.
TI Characterization of Tolypocladium cylindrosporum (Hypocreales,
   Ophiocordycipitaceae) isolates from Brazil and their efficacy against
   Aedes aegypti (Diptera, Culicidae)
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE Aedes; antagonist; biological control; entomopathogenic fungi;
   Hypocreales; South America; Tolypocladium
ID METARHIZIUM-ANISOPLIAE; OVICIDAL ACTIVITY; LEPTOLEGNIA-CHAPMANII; 1ST
   REPORT; PATHOGEN; EGGS; FORMULATION; EVOLUTION; INSIGHTS; IMPACT
AB Aims To survey and to characterize entomopathogenic fungi as natural enemies of mosquitoes in Central Brazil. Methods and Results Tolypocladium cylindrosporum (Hypocreales, Ophiocordycipitaceae) was isolated for the first time in South America by using Aedes aegypti (Diptera, Culicidae) as sentinel larvae in a stagnant mosquito breeding site in a secondary tropical forest. Two isolates were morphologically and molecularly identified, and their activity tested against A. aegypti eggs, larvae and adults. Conclusions Findings emphasize the importance of T. cylindrosporum as a natural fungal antagonist of mosquitoes. Significance and Impact of the Study Both isolates affected larvae and adults but were less effective against eggs; both have potential for development as a mycoinsecticide especially against larvae of A. aegypti the main vector of dengue, chikungunya, Zika and urban yellow fever.
C1 [Montalva, C.; Silva, J. J.; Rocha, L. F. N.; Luz, C.; Humber, R. A.] Univ Fed Goias, Lab Patol Invertebrados, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Montalva, C.] Univ Austral Chile Uach, Fac Ciencias, Inst Bioquim & Microbiol, Valdivia, Chile.
   [Rocha, L. F. N.] Inst Fed Educ Ciencia & Tecnol Goias, Goiania, Go, Brazil.
   [Humber, R. A.] ARS, USDA, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA.
RP Luz, C (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Ave Esperanca S-N,Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
EM wchrisluz@hotmail.com
FU CSF [PVE 71/2013, 149988]; National Council for Scientific and
   Technological Development - CNPqNational Council for Scientific and
   Technological Development (CNPq); Instituto Federal de EducacAo, Ciencia
   e Tecnologia de Goias [IFG-PROAPP 006/2014]; Coordination of the
   Improvement of Higher Education, CAPESCAPES
FX The authors thank Jeremias Lunardelli for kindly permitting to collect
   fungi at Santa Branca Farm and Karine dos Santos, Juscelino Rodrigues
   and Fernanda Siqueira for technical assistance. This study was supported
   by the Coordination of the Improvement of Higher Education, CAPES, CSF,
   PVE 71/2013, 149988, the National Council for Scientific and
   Technological Development - CNPq and the Instituto Federal de EducacAo,
   Ciencia e Tecnologia de Goias, IFG-PROAPP 006/2014.
CR Albernaz DAS, 2009, MED VET ENTOMOL, V23, P141, DOI 10.1111/j.1365-2915.2008.00792.x
   BISSETT J, 1983, CAN J BOT, V61, P1311, DOI 10.1139/b83-139
   de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001
   Flor-Weiler LB, 2017, J AM MOSQUITO CONTR, V33, P184, DOI 10.2987/16-6596R.1
   Gams W., 1971, PERSOONIA, V6, P185
   Gazis R, 2014, MYCOLOGIA, V106, P1090, DOI 10.3852/13-346
   Gutierrez AC, 2017, ACTA TROP, V169, P112, DOI 10.1016/j.actatropica.2017.01.021
   Hanada RE, 2010, FUNGAL BIOL-UK, V114, P901, DOI 10.1016/j.funbio.2010.08.006
   Humber R.A., 2014, ARSEF ARS COLLECTION
   Humber R. A., 2012, MANUAL TECHNIQUES IN, P153
   Humber RA, 2008, J INVERTEBR PATHOL, V98, P262, DOI 10.1016/j.jip.2008.02.017
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lacey LA, 2017, MICROBIAL CONTROL OF INSECT AND MITE PESTS: FROM THEORY TO PRACTICE, P409, DOI 10.1016/B978-0-12-803527-6.00028-7
   Leles RN, 2013, CAN J MICROBIOL, V59, P425, DOI 10.1139/cjm-2012-0703
   Lima WP, 2009, REV SOC BRAS MED TRO, V42, P638, DOI 10.1590/S0037-86822009000600005
   Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   Luz C, 2007, J MED ENTOMOL, V44, P799, DOI 10.1603/0022-2585(2007)44[799:OAOEHO]2.0.CO;2
   Mascarin GM, 2019, J INVERTEBR PATHOL, V165, P46, DOI 10.1016/j.jip.2018.01.001
   Montalva C, 2016, J INVERTEBR PATHOL, V139, P102, DOI 10.1016/j.jip.2016.08.003
   Montalva C, 2016, J INVERTEBR PATHOL, V136, P109, DOI 10.1016/j.jip.2016.03.012
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   PREISLER HK, 1989, J ECON ENTOMOL, V82, P1534, DOI 10.1093/jee/82.6.1534
   Quandt CA, 2014, IMA FUNGUS, V5, P121, DOI 10.5598/imafungus.2014.05.01.12
   Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84
   Rocha LFN, 2015, J APPL MICROBIOL, V119, P1412, DOI 10.1111/jam.12945
   Rueda-Paramo ME, 2017, J INVERTEBR PATHOL, V149, P114, DOI 10.1016/j.jip.2017.08.010
   SAMSON RA, 1984, J INVERTEBR PATHOL, V43, P133, DOI 10.1016/0022-2011(84)90130-7
   Marquez SS, 2010, FUNGAL DIVERS, V41, P115, DOI 10.1007/s13225-009-0015-7
   SANDERS R D, 1972, Proceedings and Papers of the Annual Conference of the California Mosquito Control Association, V40, P66
   Santos AH, 2009, BIOL CONTROL, V50, P37, DOI 10.1016/j.biocontrol.2009.01.018
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Scorsetti AC, 2012, REV BIOL TROP, V60, P833
   SOARES GG, 1985, J INVERTEBR PATHOL, V46, P115, DOI 10.1016/0022-2011(85)90138-7
   Sosa-Gomez DR, 2010, MYCOPATHOLOGIA, V170, P61, DOI 10.1007/s11046-010-9288-3
   Sousa NA, 2013, LETT APPL MICROBIOL, V57, P193, DOI 10.1111/lam.12097
   Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520
   THRONE JE, 1995, J ECON ENTOMOL, V88, P1510, DOI 10.1093/jee/88.5.1510
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WEISER J, 1981, ENTOMOPHAGA, V26, P357, DOI 10.1007/BF02374710
   White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
   Wright DA, 2009, NEW ZEAL J AGR RES, V52, P315, DOI 10.1080/00288230909510516
   Zabalgogeazcoa I, 2018, MYCOTOXIN RES, V34, P49, DOI 10.1007/s12550-017-0298-6
NR 43
TC 0
Z9 0
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD JAN
PY 2019
VL 126
IS 1
BP 266
EP 276
DI 10.1111/jam.14093
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA HE7OM
UT WOS:000453627700024
PM 30160316
OA Bronze
DA 2020-07-08
ER

PT J
AU Heinisch, MRS
   Diaz-Quijano, FA
   Chiaravalloti-Neto, F
   Pancetti, FGM
   Coelho, RR
   Andrade, PD
   Urbinatti, PR
   de Almeida, RMMS
   Lima-Camara, TN
AF Heinisch, M. R. S.
   Diaz-Quijano, Fredi Alexander
   Chiaravalloti-Neto, Francisco
   Menezes Pancetti, Filipe Gabriel
   Coelho, Ronan Rocha
   Andrade, Pamela dos Santos
   Urbinatti, Paulo Roberto
   Sa de Almeida, Rosa Maria Marques
   Lima-Camara, Tamara Nunes
TI Seasonal and spatial distribution of Aedes aegypti and Aedes albopictus
   in a municipal urban park in Sao Paulo, SP, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Aedes; Seasonality; Spatial distribution; Green areas
ID DIPTERA-CULICIDAE; ZIKA VIRUS; ENVIRONMENTAL-FACTORS; CHIKUNGUNYA VIRUS;
   DENGUE VECTORS; CITY; LARVAL; SKUSE; TRANSMISSION; INFESTATION
AB Dengue, yellow fever, chikungunya and Zika are important arboviruses present in various countries of the world, the etiological agents of which are transmitted to human-beings by the bite of infected females of Aedes aegypti and Aedes albopictus. Biological aspects of these vectors, such as their distribution and abundance, are influenced by climatic variables such as rainfall and temperature. We assess the spatial and seasonal distribution of Ae. aegypti and Ae. albopictus, during spring 2014 and spring 2015 and autumn 2015 and autumn 2016, in an urban Municipal Park, sao Paulo (SP, Brazil), using 36 ovitraps. The Park was divided into three areas: internal, intermediate and peripheral, and 12 geo-referenced ovitraps were randomly installed in each area, We evaluated the association between the environmental variables maximum and minimum temperatures and rainfall with oviposition rates in the park using negative binomial regression models. Further, to estimate the distribution of the species in the three areas during the seasons, we employed the geosta tic interpolation method with the use of kriging. Our results show the presence of the two species in the area in both the seasons but with a greater predominance of Ae. albopictus. Both species were significantly more abundant in spring than autumn. However, our results suggested that this seasonal variation was mediated by the maximum and minimum temperatures, which were significantly associated with the oviposition rate of both species, in all regression models. Cumulative rainfall of the week of collection was not associated with the abundance of the vectors in the multiple models. Moreover, regardless of climatic variables, the oviposition of Ae. aegypti was positively associated with the peripheral area of the park compared with the internal area (oviposition rate ratio [012121: 4.92; 95% CI: 2.46-9.83). On the other hand, the oviposition of Ae. albopictus was negatively associated with the peripheral area as compared with the internal one (ORR: 0.59; 95% CI: 0.38-0.91). The spatial distribution revealed a pattern of spatial segregation, confirming the ecological preferences of each species. Green areas in urban centers can serve as important habitats for various mosquito species, including especially Ae. albopictus. Thus it is that our study highlights the importance of maintaining surveillance for the targeting of control strategies in green areas as well, since most control strategies are focused on Ae. aegypti and urban residential centers.
C1 [Heinisch, M. R. S.; Menezes Pancetti, Filipe Gabriel; Coelho, Ronan Rocha; Andrade, Pamela dos Santos] Univ Sao Paulo, Sch Publ Hlth, Lab Entomol Publ Hlth, Ave Dr Arnaldo 715, BR-03178200 Sao Paulo, SP, Brazil.
   [Diaz-Quijano, Fredi Alexander; Chiaravalloti-Neto, Francisco; Urbinatti, Paulo Roberto; Sa de Almeida, Rosa Maria Marques; Lima-Camara, Tamara Nunes] Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Av Dr Arnaldo 715, BR-03178200 Sao Paulo, SP, Brazil.
RP Lima-Camara, TN (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Av Dr Arnaldo 715, BR-03178200 Sao Paulo, SP, Brazil.
EM mrheinisch@usp.br; frediazq@msn.com; franciscochiara@usp.br;
   filgmp@usp.br; ronan@usp.br; pamelandrade@usp.br; urbinati@usp.br;
   rosasa@usp.br; limacamara@usp.br
RI Diaz-Quijano, Fredi Alexander/I-3740-2012; Neto, Francisco
   Chiaravalloti/F-8006-2012
OI Diaz-Quijano, Fredi Alexander/0000-0002-1134-1930; Neto, Francisco
   Chiaravalloti/0000-0003-2686-8740
FU Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo - FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2014/05016-5]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - Brasil (CAPES)CAPES [001]
FX This research was financially supported by: Grant number: 2014/05016-5,
   Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo - FAPESP). This study was financed in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES) - Finance Code 001.
CR Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Barbosa GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002873
   Bezerra JMT, 2016, ACTA TROP, V164, P431, DOI 10.1016/j.actatropica.2016.10.010
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Wilke ABB, 2017, ACTA TROP, V166, P343, DOI 10.1016/j.actatropica.2016.10.025
   Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P547, DOI 10.1590/S0085-56262002000400009
   Calderon-Arguedas O, 2015, J VECTOR ECOL, V40, P184, DOI 10.1111/jvec.12149
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camargo E. C. G, 1998, GEOESTATISTICA FUNDA
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102
   Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P643
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Correa J. A. M, 2008, ESTUDO PARQUES PAULI
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cundill B, 2011, PARASITOLOGY, V138, P1406, DOI 10.1017/S0031182011001132
   de Castro MG, 2004, MEM I OSWALDO CRUZ, V99, P809, DOI 10.1590/S0074-02762004000800005
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Diaz-Quijano Fredi Alexander, 2016, Rev. Univ. Ind. Santander. Salud, V48, P9, DOI 10.18273/revsal.v48n1-2016001
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Flanagan KL, 2013, AUST VET J, V91, P241, DOI 10.1111/avj.12052
   Focks D. A, 2004, REV ENTOMOLOGICAL SA, P28
   Forattini O.P., 2002, CULICIDOLOGIA MED ID, V2
   Glasser CM, 2002, REV SAUDE PUBL, V36, P166, DOI 10.1590/s0034-89102002000200008
   Gomes AD, 2005, REV SAUDE PUBL, V39, P206, DOI 10.1590/S0034-89102005000200010
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Hoffmann JP, 2016, REGRESSION MODELS FOR CATEGORICAL, COUNT, AND RELATED VARIABLES: AN APPLIED APPROACH, P39
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Instituto Evandro Chagas, 2018, IEC DET VIR FEBR AM
   Khomi H. M, 2011, J FOOD AGRIC ENVIRON, V9, P41
   Krause RJ, 2016, PARASITOLOGY, V143, P1043, DOI 10.1017/S0031182016000366
   Landim P. M. B, 2007, TERRA DIDATICA, V2, P19
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Marengo JA, 2015, REV USP, V106, P31, DOI [10.11606/issn.2316-9036.v0i106p31-44, DOI 10.11606/ISSN.2316-9036.V0I106P31-44]
   MARQUES CCD, 1993, REV SAUDE PUBL, V27, P237, DOI 10.1590/S0034-89101993000400002
   Marques GRAM, 1997, REV SAUDE PUBL, V31, P125, DOI 10.1590/S0034-89101997000200004
   Medeiros-Sousa A. R, 2013, BIOTA NEOTROP, V13, P318
   Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1
   MILLER BR, 1988, T ROY SOC TROP MED H, V82, P476, DOI 10.1016/0035-9203(88)90168-X
   Ministerio da Sande Secretaria de Vigilancia em Sande, 2017, B EP, V48, P1
   Ministerio da Sande Secretaria de Vigilancia em Sande, 2017, COMPT SANT 2016 COMP, P40
   Miyazaki RD, 2009, REV SOC BRAS MED TRO, V42, P392, DOI 10.1590/S0037-86822009000400007
   Natal Delsio, 2002, Biologico (Sao Paulo), V64, P205
   Serpa LLN, 2006, REV SAUDE PUBL, V40, P1101, DOI 10.1590/s0034-89102006000700020
   Serpa LLN, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-321
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   QGIS Development Team, 2015, QGIS GEOGR INF SYST
   R Core Team, 2015, R LANG ENV STAT COMP
   Rabe-Hesketh S, 2008, MULTILEVEL LONGITUDI, V9, P373
   Ray S, 1999, INDIAN J MED RES, V109, P221
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299
   Ribeiro Junior P. J, 2006, R NEWS, P15
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Soares-Pinheiro VC, 2017, BRAZ J BIOL, V77, P396, DOI 10.1590/1519-6984.19815
   StataCorp, 2007, STAT STAT SOFTW REL
   Tauil PL, 2001, CAD SAUDE PUBLICA S, V17, pS99, DOI DOI 10.1590/S0102-311X2001000700018
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Wee LK, 2013, SE ASIAN J TROP MED, V44, P157
   Yu J, 1996, Zhonghua Yu Fang Yi Xue Za Zhi, V30, P360
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 8
Z9 8
U1 1
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JAN
PY 2019
VL 189
BP 104
EP 113
DI 10.1016/j.actatropica.2018.09.011
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HB5LW
UT WOS:000451103300015
PM 30282003
DA 2020-07-08
ER

PT J
AU Dobson, JS
   Levell, NJ
AF Dobson, J. S.
   Levell, N. J.
TI Spotting Zika spots: descriptive features of the rash used in 66
   published cases
SO CLINICAL AND EXPERIMENTAL DERMATOLOGY
LA English
DT Review
ID VIRUS; THROMBOCYTOPENIA
AB Zika virus (ZV) is an important emerging infection. Rash is a key feature, but the summative literature lacks description of the rash beyond 'maculopapular'. Our aim was to identify the cutaneous features described in the published literature. A literature search using defined terms for ZV cases reports and series was performed on the OVID, Clinical Key and University of Dundee's e-library journals databases in December 2016; a later case report was included while the paper was under review. Diagnosis in all cases was via PCR. Exclusion criteria were Zika cases without rash or omitting any description of the rash. Ocular features (conjunctivitis) were not included. In total, 42 publications with 66 cases met the criteria. The most frequent descriptive features included maculopapular (59%), lower limb petechial purpura (11%) and erythematous/red (9%). Pruritus was described in 44% and tenderness in 3%. Lesions were located on the trunk (29%), limbs (5% arms, 11% both arms and legs), face (17%) and extremities (14%) or were diffuse/generalized (12%). There was facial sparing in 3%. Other features were centrifugal spread (6%), palmar and/or plantar involvement (6%), palmoplantar desquamation (2%) and malar erythema with oedema (2%). Mucosal features included gingival bleeding (11%), oral haemorrhagic blisters (8%) and painful blisters/vesicles (4%). Oedema/swelling was described in the upper limbs (5%), lower limbs (5%) and both (3%). Mean rash duration was 6 days (range 3-11 days). The ZV exanthema is most frequently maculopapular, pruritic, sometimes with centrifugal spread from the trunk to extremities. This may include lower limb petechial purpura, palmoplantar lesions, oedema of limb extremities, and gingival bleeding or painful oral bullae. As ZV becomes more prevalent, recognition of the clinical features will enable earlier diagnosis and appropriate testing.
C1 [Dobson, J. S.; Levell, N. J.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England.
RP Dobson, JS (corresponding author), London Rd Community Hosp, Dermatol Dept, London Rd, Derby DE1 2QY, England.
EM jsdobson@doctors.org.uk
CR Andersen LK, 2017, INT J DERMATOL, V56, pe84, DOI 10.1111/ijd.13509
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Paniz Mondolfi A, 2017, CLIN EXP DERMATOL, V1, P208
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Public Health England, 2016, ZIK VIR SAMPL TEST A
   Sharma H, 2018, MEDICINE, V46, P38, DOI [10. 1016/j. mpmed. 2017. 10. 009, DOI 10.1016/J.MPMED.2017.10.009]
   Singh RK, 2016, DERMATOL ONLINE J, V22
   The European Centre for Disease Prevention and Control, MOSQ MAPS
   The European Centre for Disease Prevention and Control, MOSQ AED ALB
   WHO, 2017, ZIK SIT REP ZIK VIR
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organisation, WHOZIKVLAB161
   World Health Organisation, FREQ ASK QUEST ZIK V
NR 19
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0307-6938
EI 1365-2230
J9 CLIN EXP DERMATOL
JI Clin. Exp. Dermatol.
PD JAN
PY 2019
VL 44
IS 1
BP 4
EP 12
DI 10.1111/ced.13733
PG 9
WC Dermatology
SC Dermatology
GA HD0BZ
UT WOS:000452173800002
PM 30206957
DA 2020-07-08
ER

PT J
AU Paniz-Mondolfi, AE
   Blohm, GM
   Hernandez-Perez, M
   Larrazabal, A
   Moya, D
   Marquez, M
   Talamo, A
   Carrillo, A
   de Arocha, JR
   Lednicky, J
   Morris, JG
AF Paniz-Mondolfi, A. E.
   Blohm, G. M.
   Hernandez-Perez, M.
   Larrazabal, A.
   Moya, D.
   Marquez, M.
   Talamo, A.
   Carrillo, A.
   Rothe de Arocha, J.
   Lednicky, J.
   Morris, J. G., Jr.
TI Cutaneous features of Zika virus infection: a clinicopathological
   overview
SO CLINICAL AND EXPERIMENTAL DERMATOLOGY
LA English
DT Review
ID SKIN; MANIFESTATIONS; MECHANISMS
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus transmitted mainly by Aedes species of mosquitos. Although the infection is usually mild and self-limiting, it is emerging as a public health challenge in tropical and subtropical countries owing to its unprecedented pathogenicity and increased risk for fetal malformations and neurological symptoms. Cutaneous manifestations as for other mosquito-borne viruses remain a hallmark of the disease. This article provides a detailed overview on ZIKV infection, including its varied cutaneous clinical manifestations and diagnostic aspects, and also provides detailed insights into its pathogenesis in human skin.
C1 [Paniz-Mondolfi, A. E.; Larrazabal, A.; Moya, D.; Carrillo, A.] Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Infect Dis & Trop Med, Barquisimeto 3023, Lara, Venezuela.
   [Paniz-Mondolfi, A. E.] IVSS, Dept Hlth, Caracas, Venezuela.
   [Blohm, G. M.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA.
   [Hernandez-Perez, M.] Tufts Med Ctr, Miraca Life Sci Res Inst, Dept Dermatopathol, Boston, MA USA.
   [Larrazabal, A.; Moya, D.; Marquez, M.; Talamo, A.; Carrillo, A.] Venezuelan Sci & Zoonosis & Emerging Pathogens Re, Arboviral Dis Branch, Infect Dis Res Branch, Barquisimeto, Lara, Venezuela.
   [Marquez, M.; Talamo, A.] Univ Centroccidental Lisandro Alvarado, Coll Med, Hlth Sci Dept, Barquisimeto, Lara, Venezuela.
   [Carrillo, A.] Univ Nacl Expt Francisco de Miranda, Coll Med, Hlth Sci Dept, Punto Fijo, Falcon, Venezuela.
   [Rothe de Arocha, J.] Soc Anticancerosa Estado Lara, Barquisimeto, Lara, Venezuela.
   [Rothe de Arocha, J.] Hosp Cent Antonio Maria Pineda, Psoriasis Unit, Barquisimeto, Lara, Venezuela.
   [Lednicky, J.; Morris, J. G., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lednicky, J.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.
   [Morris, J. G., Jr.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Hlth, Gainesville, FL USA.
RP Paniz-Mondolfi, AE (corresponding author), Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Infect Dis & Trop Med, Barquisimeto 3023, Lara, Venezuela.
EM albertopaniz@yahoo.com
RI Lednicky, John A/C-5678-2012
OI Paniz-Mondolfi, Alberto E./0000-0003-1259-1736
CR Anderson RC, 2004, J AM ACAD DERMATOL, V51, P820, DOI 10.1016/j.jaad.2004.05.031
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   Fleming I, 2016, CIRC RES, V119, P1149, DOI 10.1161/CIRCRESAHA.116.310001
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Long Kristin M, 2015, Curr Trop Med Rep, V2, P13
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Mlacker S, 2016, INT J DERMATOL, V55, P1369, DOI 10.1111/ijd.13399
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paller A, 2016, HURWITZ CLIN PEDIAT
   Pan American Health Organization, 2016, CAS DEF
   Mondolfi AEP, 2018, CLIN EXP DERMATOL, V43, P171, DOI 10.1111/ced.13294
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
NR 31
TC 2
Z9 2
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0307-6938
EI 1365-2230
J9 CLIN EXP DERMATOL
JI Clin. Exp. Dermatol.
PD JAN
PY 2019
VL 44
IS 1
BP 13
EP 19
DI 10.1111/ced.13793
PG 7
WC Dermatology
SC Dermatology
GA HD0BZ
UT WOS:000452173800003
PM 30267436
OA Bronze
DA 2020-07-08
ER

PT J
AU da Silva, RM
   Vital, WO
   da Fonseca, RN
   Martins, YPM
   Lemos, FJA
   Vaz, ID
   Logullo, C
AF da Silva, Renato Martins
   Vital, Wagner Oliveira
   da Fonseca, Rodrigo Nunes
   Muniz Martins, Yolanda Porto
   Alves Lemos, Francisco Jose
   Vaz, Itabajara da Silva, Jr.
   Logullo, Carlos
TI Hypometabolic strategy and glucose metabolism maintenance of Aedes
   aegypti egg desiccation
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE Desiccation; Glucose metabolism; Gluconeogenesis; Glycolysis; Mosquito
ID MOLECULAR CHARACTERIZATION; OXYGEN-CONSUMPTION; FAT-BODY; DIAPAUSE;
   MOTH; GENE; TERMINATION; HIBERNATION; EXPRESSION; PHYSIOLOGY
AB The mosquito Aedes aegypti is vector of several viruses including yellow fever virus, dengue virus chikungunya virus and Zika virus. One of the major problems involving these diseases transmission is that A. aegypti embryos are resistant to desiccation at the end of embryogenesis, surviving and remaining viable for several months inside the egg. Therefore, a fine metabolism control is essential to support these organisms throughout this period of resistance. The carbohydrate metabolism has been shown to be of great importance during arthropod embryogenesis, changing dramatically in order to promote growth and differentiation and in periods of resistance. This study investigated fundamental aspects of glucose metabolism in three stages of A. aegypti egg development: pre-desiccated, desiccated, and rehydrated. The activities of regulatory enzymes in carbohydrate metabolism such as pyruvate kinase, hexokinase and glucose 6-phosphate dehydrogenase were evaluated. We show that these activities were reduced in A. aegypti desiccated eggs, suggesting a decreased activity of glycolytic and pentose phosphate pathway. In contrast, gluconeogenesis increased in desiccated eggs, which uses protein as substrate to synthesize glucose. Accordingly, protein amount decreased during this stage, while glucose levels increased. Glycogen content, a major carbohydrate reserve in mosquitoes, was evaluated and shown to be lower in desiccated and rehydrated eggs, indicating it was used to supply energy metabolism. We observed a reactivation of carbohydrate catabolism and an increased gluconeogenesis after rehydration, suggesting that controlling glucose metabolism was essential not only to survive the period of desiccation, but also for subsequent larvae hatch. Taken together, these results contribute to a better understanding of metabolism regulation in A. aegypti eggs during desiccation periods. Such regulatory mechanisms enable higher survival rate and consequently promote virus transmission by these important disease vectors, making them interesting subjects in the search for novel control methods.
C1 [da Silva, Renato Martins; Vital, Wagner Oliveira; da Fonseca, Rodrigo Nunes; Logullo, Carlos] Univ Fed Rio de Janeiro, Lab Integrado Bioquim Hatisaburo Masuda, NUPEM, Campus Macae, Macae, RJ, Brazil.
   [Muniz Martins, Yolanda Porto; Alves Lemos, Francisco Jose; Logullo, Carlos] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Sanidade Anim, Lab Biotecnol, Unidade Expt Anim,CCTA,CBB, Campos Dos Goytacazes, RJ, Brazil.
   [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
   [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil.
RP Logullo, C (corresponding author), Univ Fed Rio de Janeiro, NUPEM, Ave Sao Jose Barreto 764, BR-27965045 Macae, RJ, Brazil.
EM logullo@uenf.br
RI Silva Vaz, I/A-5943-2009; Fonseca, Rodrigo/S-3964-2018
OI Silva Vaz, I/0000-0003-0309-9328; Fonseca, Rodrigo/0000-0001-9576-2849
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; INCT-Entomologia Molecular
FX The authors are grateful to Tae Kwon Kim for aiding in the manuscript
   revision and the Brazilian agencies FAPERJ, INCT-Entomologia Molecular,
   CNPq and CAPES for supporting this project.
CR ADEDOKUN TA, 1985, J INSECT PHYSIOL, V31, P229, DOI 10.1016/0022-1910(85)90124-6
   Campos E, 2006, VET PARASITOL, V138, P349, DOI 10.1016/j.vetpar.2006.02.004
   Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479
   CHIPPENDALE GM, 1973, ENTOMOL EXP APPL, V16, P395, DOI 10.1007/BF00334251
   Christophers R., 1960, AEDES AEGYPTI L YELL, V1, P93
   CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9
   Clements A. N., 1992, BIOL MOSQUITOES I DE
   Danks H. V., 1987, BIOL SIRV CANADA, V1, P129
   Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023
   DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323
   Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137
   Funasa-Fundacao Nacional de Saiide, 2001, DENGUE INSTRUCOES CO
   Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645
   Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018
   Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022
   HARVEY WR, 1962, ANNU REV ENTOMOL, V7, P57, DOI 10.1146/annurev.en.07.010162.000421
   KBewer J. W., 1961, Annals of the Entomological Society of America, V54, P912
   Kostal V, 1998, J INSECT PHYSIOL, V44, P165, DOI 10.1016/S0022-1910(97)00047-4
   KUNKEL HO, 1951, J BIOL CHEM, V189, P755
   Lazzaro Rezende Gustavo, 2008, BMC Developmental Biology, V8, P1
   Lee KY, 2002, INSECT BIOCHEM MOLEC, V32, P1457, DOI 10.1016/S0965-1748(02)00066-8
   Lees AD, 1955, CAMBRIDGE MONOGRAPHS
   Lefevere K. S., 1988, WAGENINGEN UR DIGITA
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYMAN CP, 1955, PHYSIOL REV, V35, P403
   MITCHELL CJ, 1989, J MED ENTOMOL, V26, P318, DOI 10.1093/jmedent/26.4.318
   Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009
   Perez MH, 2013, J INSECT PHYSIOL, V59, P318, DOI 10.1016/j.jinsphys.2012.12.007
   Petersen S, 2001, METAB ENG, V3, P344, DOI 10.1006/mben.2001.0198
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   RAHN H, 1974, RESP PHYSIOL, V22, P297, DOI 10.1016/0034-5687(74)90079-6
   Silva HHG, 1999, REV SOC BRAS MED TRO, V32, P349, DOI DOI 10.1590/S0037-86821999000400003
   Singtripop T, 2007, J INSECT PHYSIOL, V53, P933, DOI 10.1016/j.jinsphys.2007.03.005
   Steele J., 1985, COMPREHENSIVE INSECT, P99
   STEWART JR, 1993, J EXP BIOL, V174, P97
   STOREY JM, 1986, J INSECT PHYSIOL, V32, P549, DOI 10.1016/0022-1910(86)90070-3
   SU ZH, 1994, BBA-GENE STRUCT EXPR, V1218, P366, DOI 10.1016/0167-4781(94)90190-2
   Tauber M. J., 1986, SEASONAL ADAPTATIONS, V3, P97
   TAUBER MJ, 1976, ANNU REV ENTOMOL, V21, P81, DOI 10.1146/annurev.en.21.010176.000501
   Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8
   TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225
   Thompson MB, 1997, COMP BIOCHEM PHYS A, V118, P647, DOI 10.1016/S0300-9629(97)00081-9
   Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435
   Trpis M., 1973, B WORLD HEALTH ORGAN, V48
   Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25
   Vleck D., 1991, P245, DOI 10.1017/CBO9780511585739.016
   WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043
   WIPKING W, 1995, J INSECT PHYSIOL, V41, P47, DOI 10.1016/0022-1910(94)00079-V
   Worthington C. C., 1998, WORTHINGTON ENZYME M
   YAGINUMA T, 1990, COMP BIOCHEM PHYS B, V97, P495, DOI 10.1016/0305-0491(90)90150-R
   Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535
   Zaslayski V. A., 1988, INSECT DEV PHOTOPERI, V2, P97
NR 54
TC 1
Z9 1
U1 3
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1096-4959
EI 1879-1107
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD JAN
PY 2019
VL 227
BP 56
EP 63
DI 10.1016/j.cbpb.2018.09.005
PG 8
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA HD5NE
UT WOS:000452576400007
PM 30266630
DA 2020-07-08
ER

PT J
AU Hernandez, J
   Hoffer, L
   Coutard, B
   Querat, G
   Roche, P
   Morelli, X
   Decroly, E
   Barral, K
AF Hernandez, Jessica
   Hoffer, Laurent
   Coutard, Bruno
   Querat, Gilles
   Roche, Philippe
   Morelli, Xavier
   Decroly, Etienne
   Barral, Karine
TI Optimization of a fragment linking hit toward Dengue and Zika virus NS5
   methyltransferases inhibitors
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Fragment growing; Structure-based drug design; Dengue and Zika viruses;
   Flavivirus NS5 methyltransferase inhibitors
ID DISCOVERY; PERSPECTIVES; DERIVATIVES; VALIDATION; REDUCTION; EFFICIENT;
   CHLORIDE; LEAD; 2'-O
AB No antiviral drugs to treat or prevent life-threatening flavivirus infections such as those caused by mosquito-borne Dengue (DENV) and more recently Zika (ZIKV) viruses are yet available. We aim to develop, through a structure-based drug design approach, novel inhibitors targeting the NS5 AdoMet-dependent mRNA methyltransferase (MTase), a viral protein involved in the RNA capping process essential for flaviviruses replication. Herein, we describe the optimization of a hit (5) identified using fragment-based and structure-guided linking techniques, which binds to a proximal site of the AdoMet binding pocket. X-ray crystallographic structures and computational docking were used to guide our optimization process and lead to compounds 30 and 33 (DENV IC50 = 26 mu M and 23 mu M; ZIKV IC50 = 28 mu M and 19 mu M, respectively), two representatives of novel non-nucleoside inhibitors of flavivirus MTases. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Hernandez, Jessica; Hoffer, Laurent; Roche, Philippe; Morelli, Xavier; Barral, Karine] Aix Marseille Univ, CNRS, Inst Paoli Calmettes, INSERM,CRCM,U1068,UMR7258, Marseille, France.
   [Coutard, Bruno; Decroly, Etienne] Aix Marseille Univ, CNRS, AFMB, UMR 7257, Marseille, France.
   [Querat, Gilles] Aix Marseille Univ, Emergence Pathol Virales, IRD French Inst Res Dev, EHESP French Sch Publ Hlth,UMR190, 27 Blvd Jean Moulin, F-13005 Marseille, France.
RP Barral, K (corresponding author), Aix Marseille Univ, CNRS, Inst Paoli Calmettes, INSERM,CRCM,U1068,UMR7258, Marseille, France.
EM karine.barral@inserm.fr
RI HOFFER, LAURENT/R-1724-2016; Morelli, Xavier/A-9218-2016
OI HOFFER, LAURENT/0000-0003-1906-7128; Morelli,
   Xavier/0000-0001-8101-7901; DECROLY, Etienne/0000-0002-6046-024X
FU European program H2020 under the ZIKAlliance project [734548]; EVAg
   Research Infrastructure [653316]; French research agency ANRFrench
   National Research Agency (ANR) [ANR-ST14-ASTR-0026, ANR-13-JS07-0006-01]
FX We wish to thank Manon Garcia and Sarah Attoumani for technical
   assistance. This work was supported by the European program H2020 under
   the ZIKAlliance project (grant agreement 734548), the EVAg Research
   Infrastructure (grant agreement 653316) and by the French research
   agency ANR (VMTaseIn, grant ANR-ST14-ASTR-0026, and FragVir, grant
   ANR-13-JS07-0006-01).
CR Abbassi N, 2011, HETEROCYCLES, V83, P891, DOI 10.3987/COM-11-12149
   Azizian J, 2003, SYNTHETIC COMMUN, V33, P415, DOI 10.1081/SCC-120015771
   Barral K, 2013, ANTIVIR RES, V99, P292, DOI 10.1016/j.antiviral.2013.06.001
   BELLAMY FD, 1984, TETRAHEDRON LETT, V25, P839, DOI 10.1016/S0040-4039(01)80041-1
   Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Benmansour F, 2016, EUR J MED CHEM, V109, P146, DOI 10.1016/j.ejmech.2015.12.046
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   DELEAN A, 1978, AM J PHYSIOL, V235, pE97
   Ding R, 2011, MOLECULES, V16, P5665, DOI 10.3390/molecules16075665
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Ghosh K, 2011, J INCL PHENOM MACRO, V70, P97, DOI 10.1007/s10847-010-9866-5
   Hartenfeller M, 2011, J CHEM INF MODEL, V51, P3093, DOI 10.1021/ci200379p
   Hoffer L, 2015, MOLECULES, V20, P8997, DOI 10.3390/molecules20058997
   Hoffer L, 2013, J CHEM INF MODEL, V53, P836, DOI 10.1021/ci4000163
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jose DA, 2007, TETRAHEDRON, V63, P12007, DOI 10.1016/j.tet.2007.09.008
   Katakawa K, 2014, HETEROCYCLES, V88, P817, DOI 10.3987/COM-13-S(S)66
   Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li ZG, 2008, J COMB CHEM, V10, P484, DOI 10.1021/cc800040z
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Valgeirsson J, 2004, J MED CHEM, V47, P6948, DOI 10.1021/jm030638w
   Venkatesan H, 2010, J ORG CHEM, V75, P3488, DOI 10.1021/jo100392x
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 42
TC 5
Z9 6
U1 3
U2 13
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD JAN 1
PY 2019
VL 161
BP 323
EP 333
DI 10.1016/j.ejmech.2018.09.056
PG 11
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HC0OR
UT WOS:000451498200021
PM 30368131
DA 2020-07-08
ER

PT J
AU Huits, R
   Van den Bossche, D
   Eggermont, K
   Lotgering, E
   Feyens, AM
   Potters, I
   Jacobs, J
   Van Esbroeck, M
   Cnops, L
   Bottieau, E
AF Huits, Ralph
   Van den Bossche, Dorien
   Eggermont, Kaat
   Lotgering, Erica
   Feyens, Anne-Marie
   Potters, Idzi
   Jacobs, Jan
   Van Esbroeck, Marjan
   Cnops, Lieselotte
   Bottieau, Emmanuel
TI Incidence of Zika virus infection in a prospective cohort of Belgian
   travellers to the Americas in 2016
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Americas; Incidence rate; Prospective cohort study;
   Enzyme-linked immunosorbent assay; Virus neutralization testing;
   Real-time reverse transcription polymerase; chain reaction; Filter paper
ID CONFIRMED PATIENTS; ANTIBODY RESPONSE; STATES
AB Background: The incidence rate of Zika virus (ZIKV) infection in travellers from non-endemic areas to the Americas during the ZIKV outbreak in 2016 is unknown. Methods: Belgian adults who planned to travel to South America, Central America, and the Caribbean were recruited prospectively to study the incidence and characteristics of ZIKV. Demographic data and sera were collected at baseline. Participants were trained to collect capillary blood on filter paper (BFP). When ill during travel, the participants completed a questionnaire and they sampled BFP for post-hoc analysis. All symptomatic participants were screened for ZIKV using ZIKV-specific RT-PCR on serum or urine, or BFP, and antibody detection assays (ELISA). Follow-up sera of asymptomatic travellers, obtained at least 20 days post travel, were tested by ZIKV ELISA only. All positive ELISA results were subject to confirmation by virus neutralization testing (VNT). Results: Forty-nine participants completed follow-up: 38 women and 11 men, with a median age of 32 years (range 19-64 years). Travel destinations were countries in South America (n = 20), Central America (n = 24), and the Caribbean (n = 5). The total travel duration was 67.8 person-months. Illness was reported by 24 participants (49.0%). ZIKV infection was confirmed in nine cases, by RT-PCR (n = 5) and by VNT (n = 4). Only one of nine ZIKV cases (11.1%) was asymptomatic. The ZIKV incidence rate was 17.0% (95% confidence interval 7.8-32.2%) per month of travel. Conclusions: The ZIKV incidence rate in adult travellers from non-endemic countries to the epidemic territories during the 2016 outbreak was high. Asymptomatic ZIKV infection was rare in this population. (c) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Huits, Ralph; Van den Bossche, Dorien; Eggermont, Kaat; Lotgering, Erica; Feyens, Anne-Marie; Potters, Idzi; Jacobs, Jan; Van Esbroeck, Marjan; Cnops, Lieselotte; Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.
RP Huits, R (corresponding author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.
EM rhuits@itg.be
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468; Potters, Idzi/0000-0001-7394-7033;
   Cnops, Lieselotte/0000-0003-0658-1291; Van Esbroeck,
   Marjan/0000-0002-7294-6319
FU ZikaPLAN Consortium from the European Union's Horizon 2020 research and
   innovation programme under ZikaPLAN grant [734584]; Belgian Ministry of
   Social Affairs within the Health Insurance System
FX This work was supported by the ZikaPLAN Consortium, which received
   funding from the European Union's Horizon 2020 research and innovation
   programme under ZikaPLAN grant agreement number 734584. This work was
   also supported by the Belgian Ministry of Social Affairs through a fund
   within the Health Insurance System to The National Reference Centre of
   Arboviruses (Institute of Tropical Medicine). The funding organizations
   had no role in the study design, in the collection, analysis and
   interpretation of the data, in the writing of the manuscript, or in the
   decision to submit the manuscript for publication. We thank all
   travellers who volunteered to participate in this study. We thank
   Achilleas Tsoumanis for his comments on the statistical analysis.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Centers for Disease Control and Prevention (CDC), ZIK TRAV INF UPD MAR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Delvecchio R, 2016, VIRUSES, V8, P1
   Diaz-Menendez M, 2018, ENFERM INFEC MICR CL, V36, P4, DOI 10.1016/j.eimc.2016.08.003
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Huits R, 2018, J CLIN VIROL, V106, P33, DOI 10.1016/j.jcv.2018.07.005
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Journel I, 2017, MMWR-MORBID MORTAL W, V66, P172, DOI 10.15585/mmwr.mm6606a4
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   PAHO, 2016, REG ZIK EP UPD
   Pan American Health Organization, 2017, COUNTR TERR AUT TRAN
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   WHO, 2016, WHOZIKV161
   World Health Organization, 2016, INF TRAV VIS ZIK AFF
NR 26
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JAN
PY 2019
VL 78
BP 39
EP 43
DI 10.1016/j.ijid.2018.10.010
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA HD8MH
UT WOS:000452810600007
PM 30368020
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Jaaskelainen, AJ
   Korhonen, EM
   Huhtamo, E
   Lappalainen, M
   Vapalahti, O
   Kallio-Kokko, H
AF Jaaskelainen, Anne J.
   Korhonen, Essi M.
   Huhtamo, Eili
   Lappalainen, Maija
   Vapalahti, Olli
   Kallio-Kokko, Hannimari
TI Validation of serological and molecular methods for diagnosis of zika
   virus infections
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika; IgM; RT-qPCR; Diagnosis; Dengue; TBEV
ID TIME RT-PCR; CLINICAL PRESENTATION; WHOLE-BLOOD; DENGUE; VIREMIA;
   SPECIFICITY; COINFECTION; RNA; IGM
AB The laboratory confirmation of Zika virus (ZIKV) infection, and the differential diagnosis from other flavivirus infections such as dengue virus (DENV), often requires the use of several diagnostic test types. Cross-reactions and secondary infections complicate the serological diagnosis and specific viral RNA detection assays are often needed for confirming the diagnosis.
   The aim of this study was to validate serological and molecular methods for diagnosing ZIKV infection. This included the evaluation of a ZIKV RT-qPCR assay for diagnostics that was previously set up for research use and to compare the ZIKV, DENV and TBEV EIA methods. External and in-house controls and pre-characterized sample panels were tested, and also automated and manual nucleic acid extraction methods were compared.
   A total of ten Finnish traveler patients were diagnosed with acute ZIKV infection during 2015-2017 including one suspected dual DENV and ZIKV infection. These samples along with panels of DENV and tick-bome encephalitis virus (TBEV) infections were used to test the cross-reactive properties of ZIKV, DENV and TBEV IgM assays. Additionally, the diagnosed acute ZIKV patient samples were tested using commercially available diagnostic DENV NS1 antigen assay and a ZIKV NS1 antigen assay intended for research use.
   The ZIKV RT-qPCR assay was demonstrated to be both specific and sensitive (one genome per reaction) and suitable for routine diagnostic use utilizing automated nucleic acid extraction. Of the tested IgM tests the NS1 antigen-based ZIKV IgM (Euroimmun) assay performed with least cross -reactivity with a specificity of 97.4%. The DENV IgM assay (Focus Diagnostics) had specificity of only 86.1%. The results are in line with previous studies and additionally highlight that also acute TBEV patients may give a false positive test result in DENV and ZIKV IgM assays.
C1 [Jaaskelainen, Anne J.; Lappalainen, Maija; Vapalahti, Olli; Kallio-Kokko, Hannimari] Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland.
   [Jaaskelainen, Anne J.; Lappalainen, Maija; Vapalahti, Olli; Kallio-Kokko, Hannimari] Helsinki Univ Hosp, Huslab Finland, Helsinki, Finland.
   [Korhonen, Essi M.; Huhtamo, Eili; Vapalahti, Olli] Univ Helsinki, Fac Med, Dept Virol, Helsinki, Finland.
   [Korhonen, Essi M.; Huhtamo, Eili; Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.
RP Jaaskelainen, AJ (corresponding author), Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland.; Jaaskelainen, AJ (corresponding author), Helsinki Univ Hosp, Huslab Finland, Helsinki, Finland.
EM anne.jaaskelainen@helsinki.fi
OI Korhonen, Essi/0000-0003-4730-7715; Lappalainen,
   Maija/0000-0001-5400-1250; Vapalahti, Olli/0000-0003-2270-6824
FU Helsinki University Hospital, Helsinki, Finland [TYH2016258, TYH2017257,
   TYH 2018258]; Helsinki University Hospital, Helsinki, Finland (Academy
   of Finland, Helsinki, Finland); Helsinki University Hospital, Helsinki,
   Finland (Jane, Helsinki, Finland); Helsinki University Hospital,
   Helsinki, Finland (Aatos Erkko Foundation, Helsinki, Finland)
FX The research was funded by Helsinki University Hospital, Helsinki,
   Finland (TYH2016258, TYH2017257; TYH 2018258, as well as Academy of
   Finland and Jane, Helsinki, Finland and Aatos Erkko Foundation,
   Helsinki, Finland).
CR Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Chien YW, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3058-0
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Erra EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065900
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Jaaskelainen AJ, 2015, J CLIN VIROL, V67, P56, DOI 10.1016/j.jcv.2015.04.003
   Jaaskelainen AJ, 2014, J CLIN VIROL, V61, P444, DOI 10.1016/j.jcv.2014.08.022
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mogling R., 2016, EUROSURVEILLANCE, V22
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Moureau G, 2010, VECTOR-BORNE ZOONOT, V10, P195, DOI 10.1089/vbz.2008.0216
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   VENE S, 1995, CLIN DIAGN VIROL, V4, P43, DOI 10.1016/0928-0197(94)00060-8
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 29
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JAN
PY 2019
VL 263
BP 68
EP 74
DI 10.1016/j.jviromet.2018.10.011
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA HE0DF
UT WOS:000452936300012
PM 30342068
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bastos, MD
   Martins, VDA
   da Silva, NL
   Jezine, S
   Pinto, S
   Aprigio, V
   Monte, RL
   Fragoso, S
   Puccioni-Sohler, M
AF Bastos, Michele de Souza
   Alves Martins, Valquiria do Carmo
   da Silva, Natalia Lessa
   Jezine, Samya
   Pinto, Sergio
   Aprigio, Valderjane
   Monte, Rossicleia Lins
   Fragoso, Silvio
   Puccioni-Sohler, Marzia
TI Importance of cerebrospinal fluid investigation during dengue infection
   in Brazilian Amazonia Region
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE flavivirus; cerebrospinal fluid; dengue virus; immunoglobulin IgM;
   meningitis/encephalitis
ID CENTRAL-NERVOUS-SYSTEM; NEUROLOGICAL MANIFESTATIONS; CHILDREN; STATE;
   HERPESVIRUS; MENINGITIS; SEROTYPES; ADMIXTURE; MANAUS; ZIKA
AB BACKGROUND Amazon, the largest tropical forest of the world, has suffered from dengue outbreaks since 1998. Cerebrospinal fluid (CSF) of patients, from Amazonas state, suspected of central nervous system (CNS) viral infection was studied using molecular and immunological methods.
   OBJECTIVE To evaluate the importance of CSF investigation in patients with acute dengue virus (DENV) infection of CNS.
   METHODS CSF samples of 700 patients were analysed by reverse transcription polymerase chain reaction (RT-PCR) to detect the presence of dengue virus (DENV) RNA and by enzyme-linked immunosorbent assay (ELISA) to detect presence of DENV specific IgM.
   FINDINGS DENV infection was detected in 4.3% of the CSF samples; 85.7% (24/28) by DENV IgM and 14.3% (4/28) by viral RNA. DENV detected by viral RNA were to be found serotypes DENV-2 (three patients) and DENV-1 (one patient). The neurological diagnosis in patients CNS infection of DENV included encephalitis (10), meningoencephalitis (10), meningitis (6), acute myelitis (1), and encephalomyelitis (1). The majority (89.3%) had intrathecal inflammation: pleocytosis, hyperproteinorrachia and DENV IgM antibodies. Hypoglycorrhachia and/or high levels of lactate in CSF were found in 36% of the patients. Co-infection (CMV, HIV, Ely, and/or Mycobacterium tuberculosis) was observed in eight (28.6%) cases.
   CONCLUSIONS We found intense inflammatory CSF that is unusual in CNS disorders caused by dengue infection. It may be due co-infections or the immunogenetic background of the local Amerindian Brazilian population. CSF examination is an important diagnostic support tool for neurological dengue diagnosis.
C1 [Bastos, Michele de Souza; da Silva, Natalia Lessa; Jezine, Samya; Pinto, Sergio; Aprigio, Valderjane; Monte, Rossicleia Lins; Fragoso, Silvio] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, AM, Brazil.
   [Alves Martins, Valquiria do Carmo] Fundacao Ctr Controle Oncol Estado Amazonas, Manaus, AM, Brazil.
   [Puccioni-Sohler, Marzia] Univ Fed Rio de Janeiro, Univ Fed Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
RP Bastos, MD (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, AM, Brazil.
EM michele@fmt.am.gov.br
FU MCTI/CNPQ [14/2014]; FAPEAM Universal Amazonas [021/2012]; FAPERJ
   (Edital Programa Pesquisa em Zika, Chikungunya e Dengue, Brazil)
   [18/2015]
FX MCTI/CNPQ/Universal 14/2014, FAPEAM Universal Amazonas 021/2012, FAPERJ
   (Edital Programa Pesquisa em Zika, Chikungunya e Dengue - No. 18/2015,
   Brazil).
CR Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111552, 10.3201/eid1804.111522]
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   de Oliveira DB, 2017, J NEUROL SCI, V375, P390, DOI 10.1016/j.jns.2017.02.025
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   DOSSANTOS SEB, 1995, REV BRAS GENET, V18, P311
   Ferreira RGM, 2002, HUM BIOL, V74, P607, DOI 10.1353/hub.2002.0041
   FRANCO MHLP, 1982, AM J PHYS ANTHROPOL, V58, P127, DOI 10.1002/ajpa.1330580204
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001
   MS-Ministerio da Saude, 2017, MAN VIG SENT DOENC N
   Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x
   Puccioni-Sohler M., 2008, DIAGNOSTICO NEUROINF, P95
   Puccioni-Sohler M, 2017, ARQ NEURO-PSIQUIAT, V75, P123, DOI [10.1590/0004-282X20160189, 10.1590/0004-282x20160189]
   Rocha LA, 2009, REV SOC BRAS MED TRO, V42, P18
   Sanguansermsri T, 1976, ACUTE ENCEPHALOPATHY, P10
   Marinho PES, 2017, EMERG INFECT DIS, V23, P115, DOI 10.3201/eid2301.160817
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   World Health Organization, 2009, DENG GUID DIAGN TREA
   ZOLL GJ, 1992, J CLIN MICROBIOL, V30, P160, DOI 10.1128/JCM.30.1.160-165.1992
NR 31
TC 0
Z9 0
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR UNSP e180450
DI 10.1590/0074-02760180450
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HD9MD
UT WOS:000452885800001
PM 30540031
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Ladner, JT
   Lemey, P
   Pybus, OG
   Rambaut, A
   Holmes, EC
   Andersen, KG
AF Grubaugh, Nathan D.
   Ladner, Jason T.
   Lemey, Philippe
   Pybus, Oliver G.
   Rambaut, Andrew
   Holmes, Edward C.
   Andersen, Kristian G.
TI Tracking virus outbreaks in the twenty-first century
SO NATURE MICROBIOLOGY
LA English
DT Review
ID NUCLEIC-ACID DETECTION; ANTIGEN RAPID TEST; POINT-OF-CARE; EBOLA-VIRUS;
   MOLECULAR EPIDEMIOLOGY; ZIKA VIRUS; PHYLOGENETIC ANALYSIS; SEXUAL
   TRANSMISSION; EVOLUTIONARY RATES; FIELD VALIDATION
AB Emerging viruses have the potential to impose substantial mortality, morbidity and economic burdens on human populations. Tracking the spread of infectious diseases to assist in their control has traditionally relied on the analysis of case data gathered as the outbreak proceeds. Here, we describe how many of the key questions in infectious disease epidemiology, from the initial detection and characterization of outbreak viruses, to transmission chain tracking and outbreak mapping, can now be much more accurately addressed using recent advances in virus sequencing and phylogenetics. We highlight the utility of this approach with the hypothetical outbreak of an unknown pathogen, 'Disease X', suggested by the World Health Organization to be a potential cause of a future major epidemic. We also outline the requirements and challenges, including the need for flexible platforms that generate sequence data in real-time, and for these data to be shared as widely and openly as possible.
C1 [Grubaugh, Nathan D.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.
   [Lemey, Philippe] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Holmes, Edward C.] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Sydney, NSW, Australia.
   [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA USA.
RP Ladner, JT (corresponding author), No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.; Rambaut, A (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.; Rambaut, A (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.; Holmes, EC (corresponding author), Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Holmes, EC (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Sydney, NSW, Australia.
EM jason.ladner@nau.edu; a.rambaut@ed.ac.uk; edward.holmes@sydney.edu.au
RI Pybus, Oliver g/B-2640-2012; Holmes, Edward/Y-2789-2019; Rambaut,
   Andrew/B-2481-2009
OI Pybus, Oliver g/0000-0002-8797-2667; Holmes, Edward/0000-0001-9596-3552;
   Rambaut, Andrew/0000-0003-4337-3707; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X; Ladner, Jason/0000-0001-7751-4366; Grubaugh,
   Nathan/0000-0003-2031-1933
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33]; European Research
   Council under the European UnionEuropean Research Council (ERC)
   [725422-ReservoirDOCS]; Wellcome Trust Collaborative AwardWellcome Trust
   [206298/Z/17/Z-ARTICnetwork]; Research Foundation-Flanders ('Fonds voor
   Wetenschappelijk Onderzoek -Vlaanderen')FWO [G066215N, G0D5117N,
   G0B9317N]; European Union's Seventh Framework Programme
   (FP7/2007-2013)/European Research CouncilEuropean Union (EU)
   [614725-PATHPHYLODYN]; Oxford Martin School; ARC Australian Laureate
   FellowshipAustralian Research Council [FL170100022]; NIH NCATS
   CTSAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR002550]; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI135995, HHSN272201400048C, R21AI137690]; Ray Thomas Foundation
FX We thank G. Dudas and S. Knemeyer for help with figure creation. N.D.G.
   is supported by NIH training grant 5T32AI007244-33. P.L. and A.R.
   acknowledge funding from the European Research Council under the
   European Union's Horizon 2020 research and innovation programme (grant
   agreement no. 725422-ReservoirDOCS) and from the Wellcome Trust
   Collaborative Award (grant number 206298/Z/17/Z-ARTICnetwork). P.L.
   acknowledges support by the Research Foundation-Flanders ('Fonds voor
   Wetenschappelijk Onderzoek -Vlaanderen', G066215N, G0D5117N and
   G0B9317N). O.G.P. is supported by the European Union's Seventh Framework
   Programme (FP7/2007-2013)/European Research Council
   (614725-PATHPHYLODYN) and by the Oxford Martin School. E.C.H. is
   supported by an ARC Australian Laureate Fellowship (FL170100022). K.G.A.
   is a Pew Biomedical Scholar, and is supported by NIH NCATS CTSA
   UL1TR002550, NIAID contract HHSN272201400048C, NIAID R21AI137690, NIAID
   U19AI135995, and The Ray Thomas Foundation.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P237
   [Anonymous], 2017, WHO R D BLUEPR M PAT
   Baele G, 2017, SYST BIOL, V66, pE47, DOI 10.1093/sysbio/syw054
   Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Boisen ML, 2016, J INFECT DIS, V214, pS203, DOI 10.1093/infdis/jiw261
   Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455
   Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X
   Callaway E., 2016, NATURE, DOI [10.1038/nature.2016.19367, DOI 10.1038/NATURE.2016.19367]
   Campbell F, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006885
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12
   Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245
   Chen YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11387-7
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442
   Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06
   Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Diallo B, 2016, CLIN INFECT DIS, V63, P1353, DOI 10.1093/cid/ciw601
   Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014
   Dietzel E., 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01913-16
   dos Reis M, 2016, NAT REV GENET, V17, P71, DOI 10.1038/nrg.2015.8
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8
   Drummond AJ, 2002, GENETICS, V161, P1307
   Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.37324, 10.7554/elife.37324, 10.7554/eLife.31257]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Dudas Gytis, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Grubaugh N. D., 2017, NATURE, V90, P4864
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5
   Hall MD, 2016, REV SCI TECH OIE, V35, P287, DOI 10.20506/rst.35.1.2433
   Hattersley Samantha M, 2013, Methods Mol Biol, V949, P285, DOI 10.1007/978-1-62703-134-9_19
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Imai M, 2006, VACCINE, V24, P6679, DOI 10.1016/j.vaccine.2006.05.046
   Johansson MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002549
   KIKO H, 1979, MOL GEN GENET, V172, P303, DOI 10.1007/BF00271730
   KINNUNEN L, 1991, J GEN VIROL, V72, P2483, DOI 10.1099/0022-1317-72-10-2483
   Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kuhnert D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1106
   Kuhnert D, 2016, MOL BIOL EVOL, V33, P2102, DOI 10.1093/molbev/msw064
   Lam TTY, 2015, J VIROL, V89, P10130, DOI 10.1128/JVI.01226-15
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75
   MCNEARNEY T, 1990, P NATL ACAD SCI USA, V87, P1917, DOI 10.1073/pnas.87.5.1917
   Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777
   Metsky H. C., 2017, NATURE, V66, P366
   Moller S, 2018, P NATL ACAD SCI USA, V115, P4200, DOI 10.1073/pnas.1713314115
   Morelli MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002768
   Morse S.S., 2001, PLAGUES POLITICS INF, P8
   Muller NF, 2017, MOL BIOL EVOL, V34, P2970, DOI 10.1093/molbev/msx186
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Neher RA, 2016, P NATL ACAD SCI USA, V113, pE1701, DOI 10.1073/pnas.1525578113
   NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615
   Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15
   OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395
   Rambaut A., 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1003
   Rambaut A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3823
   Rasmussen DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002136
   Resik S, 2007, AIDS RES HUM RETROV, V23, P347, DOI 10.1089/aid.2006.0158
   ROSSOUW E, 1991, J MED VIROL, V34, P165, DOI 10.1002/jmv.1890340306
   Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608
   Salazar-Bravo J, 2002, CURR TOP MICROBIOL, V262, P25
   Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486
   Siddle K. J., 2018, BIORXIV, DOI [10.1101/279570, DOI 10.1101/279570]
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f
   Stadler T, 2012, MOL BIOL EVOL, V29, P347, DOI 10.1093/molbev/msr217
   Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004
   Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   Volz Erik, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.6f7025f1271821d4c815385b08f5f80e
   Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021
   Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Whitmer SLM, 2018, CELL REP, V22, P1159, DOI 10.1016/j.celrep.2018.01.008
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Worby CJ, 2017, AM J EPIDEMIOL, V186, P1209, DOI 10.1093/aje/kwx182
   World Health Organization, 2018, LIST BLUEPR PRIOR DI
   Yozwiak NL, 2016, CELL, V166, P5, DOI 10.1016/j.cell.2016.06.029
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 114
TC 27
Z9 26
U1 37
U2 79
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JAN
PY 2019
VL 4
IS 1
BP 10
EP 19
DI 10.1038/s41564-018-0296-2
PG 10
WC Microbiology
SC Microbiology
GA HE1TK
UT WOS:000453056100006
PM 30546099
OA Green Published
DA 2020-07-08
ER

PT J
AU Shaw, WR
   Catteruccia, F
AF Shaw, W. Robert
   Catteruccia, Flaminia
TI Vector biology meets disease control: using basic research to fight
   vector-borne diseases
SO NATURE MICROBIOLOGY
LA English
DT Review
ID ANOPHELES-GAMBIAE DIPTERA; GENE DRIVE SYSTEM; AEDES-AEGYPTI;
   PLASMODIUM-FALCIPARUM; ZIKA VIRUS; GLOSSINA-MORSITANS; MALARIA VECTORS;
   CYTOPLASMIC INCOMPATIBILITY; INSECTICIDE RESISTANCE; HARMONIC
   CONVERGENCE
AB Human pathogens that are transmitted by insects are a global problem, particularly those vectored by mosquitoes; for example, malaria parasites transmitted by Anopheles species, and viruses such as dengue, Zika and chikungunya that are carried by Aedes mosquitoes. Over the past 15 years, the prevalence of malaria has been substantially reduced and virus outbreaks have been contained by controlling mosquito vectors using insecticide-based approaches. However, disease control is now threatened by alarming rates of insecticide resistance in insect populations, prompting the need to develop a new generation of specific strategies that can reduce vector-mediated transmission. Here, we review how increased knowledge in insect biology and insect-pathogen interactions is stimulating new concepts and tools for vector control. We focus on strategies that either interfere with the development of pathogens within their vectors or directly impact insect survival, including enhancement of vector-mediated immune control, manipulation of the insect microbiome, or use of powerful new genetic tools such as CRISPR-Cas systems to edit vector genomes. Finally, we offer a perspective on the implementation hurdles as well as the knowledge gaps that must be filled in the coming years to safely realize the potential of these novel strategies to eliminate the scourge of vector-borne disease.
C1 [Shaw, W. Robert; Catteruccia, Flaminia] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
RP Shaw, WR; Catteruccia, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
EM wrshaw@hsph.harvard.edu; fcatter@hsph.harvard.edu
OI Shaw, Robert/0000-0002-2806-9718; Catteruccia,
   Flaminia/0000-0003-3295-6683
FU Howard Hughes Medical Institute (HHMI)Howard Hughes Medical Institute;
   Bill & Melinda Gates Foundation (BMGF)Gates Foundation [OPP1158190];
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI124165]
FX The authors would like to thank M. Bernardi for graphic assistance and
   D. Abernathy, P. Marcenac and D. Paton for careful reading of this
   manuscript. F.C. is funded on research related to the topic discussed
   here by a Faculty Research Scholar Award by the Howard Hughes Medical
   Institute (HHMI) and the Bill & Melinda Gates Foundation (BMGF) (grant
   ID OPP1158190), and by the National Institutes of Health (NIH) (R01
   AI124165). The findings and conclusions within this publication are
   those of the authors and do not necessarily reflect positions or
   policies of the HHMI, the BMGF or the NIH.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adalja Amesh, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d3
   Aksoy E, 2014, APPL ENVIRON MICROB, V80, P4301, DOI 10.1128/AEM.00079-14
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   [Anonymous], 2017, 196 WHO
   [Anonymous], 2017, WHAT IS CHAG DIS
   [Anonymous], 2017, PAR ONCH ALS KNOWN R
   [Anonymous], 2017, LYMPHATIC FILARIASIS
   [Anonymous], 2017, CDC ZIKA TRAVEL INFO
   Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008
   Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440
   Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007
   Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381
   Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113
   Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985
   Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695
   Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   BEACH R, 1979, SCIENCE, V205, P829, DOI 10.1126/science.205.4408.829
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Castillo JC, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal1505
   Cator LJ, 2011, ANIM BEHAV, V82, P627, DOI 10.1016/j.anbehav.2011.07.013
   Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541
   Champer J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006796
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Childs LM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006060
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602
   Clayton AM, 2013, DEV COMP IMMUNOL, V39, P323, DOI 10.1016/j.dci.2012.10.009
   Clifton ME, 2014, J INSECT PHYSIOL, V64, P40, DOI 10.1016/j.jinsphys.2014.03.006
   da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631
   Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004
   Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303
   Fieck A, 2010, EXP PARASITOL, V125, P342, DOI 10.1016/j.exppara.2010.02.016
   Fraihi W, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005484
   Franco JAR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005585
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019
   Gabrieli P, 2014, P NATL ACAD SCI USA, V111, P16353, DOI 10.1073/pnas.1410488111
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Garver LS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003622
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Garza M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002818
   Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Ghosh AK, 2011, P NATL ACAD SCI USA, V108, P17153, DOI 10.1073/pnas.1103657108
   Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265
   Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gomes B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005504
   Gomes FM, 2017, P NATL ACAD SCI USA, V114, P12566, DOI 10.1073/pnas.1716181114
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Gurtler RE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002894
   Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hammond AM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007039
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hughes GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004182
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652
   JORDAN AM, 1972, B WORLD HEALTH ORGAN, V46, P33
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kawada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111195
   Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330
   Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447
   KNOLS BGJ, 1993, MED VET ENTOMOL, V7, P161, DOI 10.1111/j.1365-2915.1993.tb00670.x
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Kwiatkowski D, 2015, INT HEALTH, V7, P82, DOI 10.1093/inthealth/ihv007
   Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lefevre T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003365
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   LINDQUIST DA, 1992, MED VET ENTOMOL, V6, P2, DOI 10.1111/j.1365-2915.1992.tb00027.x
   LINDSAY SW, 1991, J TROP MED HYG, V94, P313
   Lindsey ARI, 2018, GENOME BIOL EVOL, V10, P434, DOI 10.1093/gbe/evy012
   Lwetoijera DW, 2014, AM J TROP MED HYG, V90, P852, DOI 10.4269/ajtmh.13-0550
   MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613
   *MALERA CONS GROUP, 2011, PLOS MED, V0008
   Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7
   Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114
   Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Miles A, 2017, NATURE, V552, P96, DOI 10.1038/nature24995
   Mitchell SN, 2015, SCIENCE, V347, P985, DOI 10.1126/science.1259435
   Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576
   Molina-Cruz A, 2015, P NATL ACAD SCI USA, V112, P15178, DOI 10.1073/pnas.1520426112
   Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264
   Moraes CS, 2009, EXP PARASITOL, V122, P84, DOI 10.1016/j.exppara.2009.03.004
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093603
   Norris EJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020124
   Norris LC, 2015, P NATL ACAD SCI USA, V112, P815, DOI 10.1073/pnas.1418892112
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287
   Palmer WH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030118
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Sawadogo SP, 2013, J MED ENTOMOL, V50, P285, DOI 10.1603/ME12041
   Sawadogo SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173273
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387
   Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511
   Smith RC, 2016, TRENDS PARASITOL, V32, P979, DOI 10.1016/j.pt.2016.08.012
   Smith RC, 2015, P NATL ACAD SCI USA, V112, pE3412, DOI 10.1073/pnas.1420078112
   Smith RC, 2015, P NATL ACAD SCI USA, V112, P1250, DOI 10.1073/pnas.1424227112
   Smith RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076097
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639
   Takken W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-345
   Tiono AB, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0606-4
   TOBE SS, 1978, ANNU REV ENTOMOL, V23, P283, DOI 10.1146/annurev.en.23.010178.001435
   Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vega-Rodriguez J, 2014, P NATL ACAD SCI USA, V111, pE492, DOI 10.1073/pnas.1315517111
   Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO, 2015, INV OV GLOB IMP NEGL
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2017, GLOB PROGR EL LYMPH
   World Health Organization, 2017, CHIK
   World Health Organization, 1990, CONTR LEISHM REP WHO, P1
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zeldenryk LM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001366
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 204
TC 16
Z9 17
U1 10
U2 51
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JAN
PY 2019
VL 4
IS 1
BP 20
EP 34
DI 10.1038/s41564-018-0214-7
PG 15
WC Microbiology
SC Microbiology
GA HE1TK
UT WOS:000453056100007
PM 30150735
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Boas, TC
   Hidalgo, FD
AF Boas, Taylor C.
   Hidalgo, F. Daniel
TI Electoral incentives to combat mosquito-borne illnesses: Experimental
   evidence from Brazil
SO WORLD DEVELOPMENT
LA English
DT Article
DE Latin America; Brazil; Elections; Accountability; Epidemic disease
ID FIELD EXPERIMENT; DENGUE; RISK; ZIKA; EDUCATION; ACCOUNTABILITY;
   INTERVENTION; CHIKUNGUNYA; PERCEPTION; OUTBREAKS
AB Mosquito-borne illnesses present significant health challenges to the developing world. If citizens are informed about their government's efforts to combat these diseases, will they reward incumbents who have performed well and punish those who have done poorly at this task? Electoral sanctioning requires that combatting disease be a sufficiently salient concern, which, in turn, is likely to depend upon subjective perceptions of the risks posed by particular illnesses. Epidemics typically prompt stronger risk perceptions than endemic diseases, but where both types circulate jointly, the more familiar endemic disease may determine public reactions. The salience of health threats also varies among individuals; those with a self-interest in prevention or a personal connection to the effects of mosquito-borne illnesses may react more strongly.
   This study presents the results of a face-to-face survey experiment in Pernambuco, Brazil, informing subjects about their mayor's use of federal funds to combat mosquito-borne illnesses such as dengue (an endemic disease) and Zika and chikungunya (both epidemics). We examine the effect of this information on intended vote for the mayor's reelection. For the full sample, the treatment has no significant effect. However, we find a large and significant punishment effect among voters who know someone affected by microcephaly or the Zika virus. Drawing on survey and focus group evidence, we argue that most voters fail to act upon our treatment information because mosquito control is a low-salience concern primarily associated with endemic rather than epidemic diseases.
   Our study constitutes the first experimental evidence as to whether informing citizens about government public health efforts affects voting behavior. Our results suggests that, where similar epidemic and endemic diseases circulate together, informational campaigns aiming to induce electoral accountability should also seek to boost the salience of the information by educating the public about the difference between familiar and newer threats. (C) 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Boas, Taylor C.] Boston Univ, Dept Polit Sci, 232 Bay State Rd, Boston, MA 02215 USA.
   [Hidalgo, F. Daniel] MIT, Dept Polit Sci, 77 Massachusetts Ave,Room E53-470, Cambridge, MA 02139 USA.
RP Boas, TC (corresponding author), Boston Univ, Dept Polit Sci, 232 Bay State Rd, Boston, MA 02215 USA.
EM tboas@bu.edu; dhidalgo@mit.edu
FU Evidence in Governance and Politics (EGAP)
FX We are grateful to Mariana Batista for invaluable help throughout
   multiple phases of this project; to Marcos Nobrega and the State
   Accounts Court of Pernambuco for their partnership; to Amanda Domingos,
   Julia Nassar, and Virginia Rocha for research assistance; and to Tewodaj
   Mogues and workshop participants at the International Food Policy
   Research Institute and the Universidade Federal de Pernambuco for
   comments on previous versions. This study is part of the Metaketa
   Initiative on Information and Accountability, funded by Evidence in
   Governance and Politics (EGAP). Approval was obtained from the
   Institutional Review Boards of Boston University (protocol 4094X), MIT
   (protocol 1604551604), and the Universidade Federal de Pernambuco
   (numero de parecer 1571592). Replication materials will be made
   available prior to publication via the Harvard Dataverse Network
   (https://dataverse.harvard.edu).The authors declare no conflicts of
   interest.
CR Adida Claire, 2016, 48 AIDDATA
   Alves JA, 2013, OPEN BUDGETS: THE POLITICAL ECONOMY OF TRANSPARENCY, PARTICIPATION, AND ACCOUNTABILITY, P76
   [Anonymous], 2016, MAK POL WORK DEV HAR
   Ashraf N, 2016, DO GOODERS GOGETTERS
   Ashraf N, 2014, J PUBLIC ECON, V120, P1, DOI 10.1016/j.jpubeco.2014.06.014
   Ashraf N, 2014, J ECON BEHAV ORGAN, V100, P44, DOI 10.1016/j.jebo.2014.01.001
   Avelino G, 2014, HEALTH POLICY PLANN, V29, P694, DOI 10.1093/heapol/czt003
   Banerjee A., 2011, INFORM VOTERS MAKE B
   Banerjee AV, 2008, J EUR ECON ASSOC, V6, P487, DOI 10.1162/JEEA.2008.6.2-3.487
   Banerjee AV, 2010, AM ECON J-ECON POLIC, V2, P1, DOI 10.1257/pol.2.1.1
   Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3
   Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735
   Boas C, 2018, EVALUATING STUDENTS
   Boas T. C., AM J POLITICAL SCI
   Brazil, 2015, PESQUISA TELEFONICA
   Buntaine MT, 2018, WORLD DEV, V106, P407, DOI 10.1016/j.worlddev.2017.10.029
   Burkle F. M., 2006, J INT AFF, P241
   Callen M., 2018, 21180 NAT BUR EC RES
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chicoine L, 2017, WORLD DEV, V99, P419, DOI 10.1016/j.worlddev.2017.05.029
   Chong A, 2015, J POLIT, V77, P55, DOI 10.1086/678766
   de Figueiredo Miguel, 2011, WORKING PAPER
   Deserranno E, 2017, 17105 BUFF I GLOB PO
   Dhaliwal I, 2017, J DEV ECON, V124, P1, DOI 10.1016/j.jdeveco.2016.08.008
   Dionne KY, 2012, WORLD DEV, V40, P2468, DOI 10.1016/j.worlddev.2012.05.016
   Dionne KY, 2018, DOOMED INTERVENTIONS
   Dunning T., INFORM ACCOUNTABILIT
   Ferraz C, 2008, Q J ECON, V123, P703, DOI 10.1162/qjec.2008.123.2.703
   Few R, 2012, CLIM DEV, V4, P301, DOI 10.1080/17565529.2012.728128
   Finan F, 2017, HDB FIELD EXPT, V2
   FOEGE WH, 1988, SOC RES, V55, P331
   Fox JA, 2015, WORLD DEV, V72, P346, DOI 10.1016/j.worlddev.2015.03.011
   Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5
   Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85
   Gerber Alan S., 2012, FIELD EXPT DESIGN AN
   Gertler PJ, 2012, 6100 WORLD BANK
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Humphreys M, 2012, POLICING POLITICIANS
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lieberman ES, 2014, WORLD DEV, V60, P69, DOI 10.1016/j.worlddev.2014.03.014
   Mignozzetti U., 2018, INCENTIVES PREVENTIV
   Miller G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4809
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Nichter S., 2018, VOTES SURVIVAL RELAT
   Nyqvist MB, 2017, AM ECON J-APPL ECON, V9, P33, DOI 10.1257/app.20150027
   Oliveira M. M, 2016, REV BRASILEIRA PROMO, V29, P380
   Palazzo Chiara, 2016, TELEGRAPH
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Phuanukoonnon S, 2006, ACTA TROP, V99, P6, DOI 10.1016/j.actatropica.2006.05.012
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Reis CB, 2013, REV BRAS ENFERM, V66, P74, DOI 10.1590/S0034-71672013000100011
   Santos Solange Laurentino dos, 2011, Ciênc. saúde coletiva, V16, P1319, DOI 10.1590/S1413-81232011000700066
   Setbon M, 2011, EMERGING HLTH THREAT, V2, P7083
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Sugiyama N. B., 2012, DIFFUSION GOOD GOVT
   Torres R, 2009, REV POLI SAUDE EDUCA, V1, P16
   Weitz-Shapiro R, 2017, J POLIT, V79, P60, DOI 10.1086/687287
NR 58
TC 4
Z9 5
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0305-750X
J9 WORLD DEV
JI World Dev.
PD JAN
PY 2019
VL 113
BP 89
EP 99
DI 10.1016/j.worlddev.2018.08.013
PG 11
WC Development Studies; Economics
SC Development Studies; Business & Economics
GA GZ3UC
UT WOS:000449310800007
PM 32287930
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kamal, M
   Kenawy, MA
   Rady, MH
   Khaled, AS
   Samy, AM
AF Kamal, Mahmoud
   Kenawy, Mohamed A.
   Rady, Magda Hassan
   Khaled, Amany Soliman
   Samy, Abdallah M.
TI Mapping the global potential distributions of two arboviral vectors
   Aedes aegypti and Ae. albopictus under changing climate
SO PLOS ONE
LA English
DT Article
ID DIPTERA-CULICIDAE; STEGOMYIA AEGYPTI; YELLOW-FEVER; CHIKUNGUNYA; DENGUE;
   VIRUS; MOSQUITOS; PATTERNS; POPULATIONS; PERFORMANCE
AB Background
   Aedes aegypti and Ae. albopictus are the primary vectors that transmit several arboviral diseases, including dengue, chikungunya, and Zika. The world is presently experiencing a series of outbreaks of these diseases, so, we still require to better understand the current distributions and possible future shifts of their vectors for successful surveillance and control programs. Few studies assessed the influences of climate change on the spatial distributional patterns and abundance of these important vectors, particularly using the most recent climatic scenarios. Here, we updated the current potential distributions of both vectors and assessed their distributional changes under future climate conditions.
   Methods
   We used ecological niche modeling approach to estimate the potential distributions of Ae. aegypti and Ae. albopictus under present-day and future climate conditions. This approach fits ecological niche model from occurrence records of each species and environmental variables. For each species, future projections were based on climatic data from 9 general circulation models (GCMs) for each representative concentration pathway (RCP) in each time period, with a total of 72 combinations in four RCPs in 2050 and 2070. All ENMs were tested using the partial receiver operating characteristic (pROC) and a set of 2,048 and 2,003 additional independent records for Ae. aegypti and Ae. albopictus, respectively. Finally, we used background similarity test to assess the similarity between the ENMs of Ae. aegypti and Ae. albopictus.
   Results
   The predicted potential distribution of Ae. aegypti and Ae. albopictus coincided with the current and historical known distributions of both species. Aedes aegypti showed a markedly broader distributional potential across tropical and subtropical regions than Ae. albopictus. Interestingly, Ae. albopictus was markedly broader in distributional potential across temperate Europe and the United States. All ecological niche models (ENMs) were statistically robust (P < 0.001). ENMs successfully anticipated 98% (1,999/2,048) and 99% (1,985/2,003) of additional independent records for both Ae. aegypti and Ae. albopictus, respectively (P < 0.001). ENMs based on future conditions showed similarity between the overall distributional patterns of future-day and present-day conditions; however, there was a northern range expansion in the continental USA to include parts of Southern Canada in case of Ae. albopictus in both 2050 and 2070. Future models also anticipated further expansion of Ae. albopictus to the East to include most of Europe in both time periods. Aedes aegypti was anticipated to expand to the South in East Australia in 2050 and 2070. The predictions showed differences in distributional potential of both species between diverse RCPs in 2050 and 2070. Finally, the background similarity test comparing the ENMs of Ae. aegypti and Ae. albopictus was unable to reject the null hypothesis of niche similarity between both species (P > 0.05).
   Conclusion
   These updated maps provided details to better guide surveillance and control programs of Ae. aegypti and Ae. albopictus. They have also significant public health importance as a baseline for predicting the emergence of arboviral diseases transmitted by both vectors in new areas across the world.
C1 [Kamal, Mahmoud; Kenawy, Mohamed A.; Rady, Magda Hassan; Khaled, Amany Soliman; Samy, Abdallah M.] Ain Shams Univ, Entomol Dept, Fac Sci, Cairo, Egypt.
   [Khaled, Amany Soliman] Ain Shams Univ, Res & Training Ctr Vectors Dis, Fac Sci, Cairo, Egypt.
RP Kamal, M; Samy, AM (corresponding author), Ain Shams Univ, Entomol Dept, Fac Sci, Cairo, Egypt.
EM mkasu@sci.asu.edu.eg; samy@sci.asu.edu.eg
RI Samy, Abdallah/B-4375-2010
OI Samy, Abdallah/0000-0003-3978-1134
CR Abozeid S, 2018, LANCET INFECT DIS, V18, P142, DOI 10.1016/S1473-3099(18)30018-5
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Benallal KE, 2016, ACTA TROP, V164, P411, DOI 10.1016/j.actatropica.2016.09.027
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Derraik JGB, 2004, AUST NZ J PUBL HEAL, V28, P433, DOI 10.1111/j.1467-842X.2004.tb00025.x
   Doosti S, 2016, IRAN J PUBLIC HEALTH, V45, P1064
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Duncombe J, 2013, GEOSPATIAL HEALTH, V8, P255, DOI 10.4081/gh.2013.71
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5
   European Centre for Disease Prevention and Control (ECDC), 2017, COMM DIS THREATS REP
   Gandon S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0086
   Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1
   Izri A, 2011, CLIN MICROBIOL INFEC, V17, P1116, DOI 10.1111/j.1469-0691.2010.03443.x
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Minard G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2202-9
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Obenauer JF, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0078-1
   Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961
   R Development Core Team, 2015, LANG ENV STAT COMP
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150489
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x
   Zayed A, 2012, ACTA TROP, V123, P62, DOI 10.1016/j.actatropica.2012.03.004
NR 57
TC 18
Z9 18
U1 6
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2018
VL 13
IS 12
AR e0210122
DI 10.1371/journal.pone.0210122
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HG0IO
UT WOS:000454627200144
PM 30596764
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Azevedo-Linhares, M
   Souza, ATC
   Lenz, CA
   Leite, NF
   Brito, IA
   Folle, NMT
   Garcia, JE
   Neto, FF
   Ribeiro, CAO
AF Azevedo-Linhares, M.
   Souza, A. T. C.
   Lenz, C. A.
   Ferreira Leite, N.
   Brito, I. A.
   Folle, N. M. T.
   Garcia, J. E.
   Filipak Neto, F.
   Oliveira Ribeiro, C. A.
TI Microcystin and pyriproxyfen are toxic to early stages of development in
   Rhamdia quelen: An experimental and modelling study
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Microcystin; Pyriproxyfen; Early life stages; Rhamdia quelen; Mixtures;
   Biomarkers
ID POPULATION VIABILITY ANALYSIS; CYANOBACTERIAL TOXINS; SECONDARY
   METABOLITES; ORYZIAS-LATIPES; EMBRYO-LARVAL; LR; ZEBRAFISH; EXPOSURE;
   FISH; EXTINCTION
AB The recent increase of freshwater eutrophication has favored cyanobacteria blooms and consequently the increase of toxins such as microcystin-LR in aquatic environments, but few is know about the associated effect of toxin and other compounds. Pyriproxyfen is an insecticide indicated by WHO (World Health Organization) to control Aedes aegypti mosquito (vector of Dengue, Chikungunya and Zika diseases), however, the effects are not well described to non-target species, such as fish. The early life stages (ELS) of fish are more sensitive to chemical stress due to higher metabolic rate, immature immune system and high superficial area/volume ratio. In the current study, EIS of R. quelen a Neotropical fish were exposed to environmentally realistic concentrations of microcystin (1, 10 and 100 mu g L-1 Ml, M2 and M3 groups, respectively) from an algal extract, pyriproxyfen (1 and 10 mu g L-1, P1 and P2) and their association (co-exposure). The hatching, survival and larvae deformities were analyzed, and applied a mathematical model to evaluate the effects on the population size along further generations. Both compounds were toxic to embryos/larvae of fish, but the effects were more pronounced in M2, P1M2 and P2M1 for hatching and M2, P1M2, P2M1 and P1 for survival. Deformities prevailed in groups exposed to the chemicals at 48 hpf (hours post-fertilization) were suggestions of toxicological interaction in P1M2, P2M1 and P2M2 at 48 and 72 hpf. In 96 hpf, the levels of deformities were lower than in previous times. Model predicted population density over 100 years decreased to lower than 0.5 (50%) in all groups, except for P1M1, indicating risk of extinction. P1M2 had the worse results, followed by M2, P1M3 and P2M1. Cyanobacterial blooms can lead to microcystin-LR levels higher than M2 (10 mu g L-1), and the suggestion of toxicological interaction with pyriproxyfen is relevant because both compounds may potentially coexist in aquatic environments. Finally, mathematical models may provide an ecological interpretation of the risk of exposure of fish.
C1 [Azevedo-Linhares, M.; Lenz, C. A.; Ferreira Leite, N.] Inst Tecnol Parana, Ctr Tecnol Saude & Meio Ambiente, BR-81350010 Curitiba, PR, Brazil.
   [Lenz, C. A.] Univ Fed Parana, Setor Ciencias Biol, Posgrad Ecol & Conservacao, BR-81531990 Curitiba, PR, Brazil.
   [Folle, N. M. T.; Filipak Neto, F.; Oliveira Ribeiro, C. A.] Univ Fed Parana, Dept Biol Celular, Setor Ciencias Biol, BR-81531990 Curitiba, PR, Brazil.
   [Garcia, J. E.] Estacao Piscicultura Panama, BR-88490000 Paulo Lopes, SC, Brazil.
RP Ribeiro, CAO (corresponding author), Univ Fed Parana, Dept Biol Celular, Cx Postal 19031, BR-81531990 Curitiba, PR, Brazil.
EM maristela@tecpar.br; ciro@ufpr.br
RI Ribeiro, Ciro A Oliveira/A-5199-2008; Neto, Francisco
   Filipak/J-8915-2012
OI Ribeiro, Ciro A Oliveira/0000-0002-3168-9272; Neto, Francisco
   Filipak/0000-0003-2838-2242; Souza, Angie/0000-0003-0592-8070
FU National Council of Science and Technology - CNPqNational Council for
   Scientific and Technological Development (CNPq); State Agency of Science
   and Technology of Parana State - Araucaria Foundation
FX This study was supported by the National Council of Science and
   Technology - CNPq and State Agency of Science and Technology of Parana
   State - Araucaria Foundation. The authors thank the technical
   participation of Sabrina Borges Lino Araujo, Magda C V Costa Ribeiro,
   Robson Ribeiro Linhares, Alex Fabiano Paulin and Ronei Ezequiel da
   Paixao. We would like thanks to Health Secretary of Parana State,
   Brazil, for supplying the Sumilarv product for this study and Armando A.
   Henriques Vieira from University Federal of Sao Carlos, for supplying
   the Microcystis aeruginosa cepa.
CR Agencia de Defesa Agropecuaria do Parana (ADAPAR), 2017, BUL PROD CORD 100
   Backer LC, 2008, MAR DRUGS, V6, P389, DOI [10.3390/md20080018, 10.3390/md6020389]
   Belenguer V, 2014, J HAZARD MATER, V265, P271, DOI 10.1016/j.jhazmat.2013.11.016
   Brasil Ministerio da Saude, 2011, PORT 2914 11 DEZ 201
   Brito ID, 2017, ECOL MODEL, V347, P40, DOI 10.1016/j.ecolmodel.2016.12.017
   Caixeta ES, 2016, J TOXICOL ENV HEAL A, V79, P799, DOI 10.1080/15287394.2016.1191400
   CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x
   Ccanccapa A, 2016, ENVIRON POLLUT, V211, P414, DOI 10.1016/j.envpol.2015.12.059
   Chen YW, 2016, J ASIA-PAC ENTOMOL, V19, P589, DOI 10.1016/j.aspen.2016.06.005
   Dahlmann J, 2003, J CHROMATOGR A, V994, P45, DOI 10.1016/S0021-9673(03)00485-0
   Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106
   de Magalhaes VF, 2001, TOXICON, V39, P1077
   dos Santos DR, 2016, ENVIRON SCI POLLUT R, V23, P9625, DOI 10.1007/s11356-015-5995-0
   Dzieciolowska S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40067
   EPA U. S., 2015, DRINK WAT HLTH ADV C
   Fujiwara M, 2007, ECOLOGY, V88, P2345, DOI 10.1890/06-1405.1
   Graeff A., 2008, EPAGRI B TECNICO
   Henle K, 2004, BIODIVERS CONSERV, V13, P9, DOI 10.1023/B:BIOC.0000004312.41575.83
   Hilborn ED, 2005, TOXICON, V46, P218, DOI 10.1016/j.toxicon.2005.04.009
   Huynh-Delerme C, 2005, TOXICON, V46, P16, DOI 10.1016/j.toxicon.2005.03.009
   Invest J., 2008, P 6 INT C URB PESTS, P239
   Jacinavicius F. R., 2017, MANUAL PARS CULTIVO
   Kreutz LC, 2008, CIENC RURAL, V38, P1050, DOI 10.1590/S0103-84782008000400022
   Lee DH, 2015, J EPIDEMIOL COMMUN H, V69, P294, DOI 10.1136/jech-2014-203861
   Liu YD, 2002, TOXICON, V40, P395, DOI 10.1016/S0041-0101(01)00173-8
   Lu X, 2015, COMP BIOCHEM PHYS C, V167, P35, DOI 10.1016/j.cbpc.2014.08.005
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1
   McKenney CL, 2005, INTEGR COMP BIOL, V45, P97, DOI 10.1093/icb/45.1.97
   Oberemm A, 1999, ENVIRON TOXICOL, V14, P77, DOI 10.1002/(SICI)1522-7278(199902)14:1<77::AID-TOX11>3.0.CO;2-F
   Organization W.H, 1999, TOXIC CYANOBACTERIA
   Pavagadhi S, 2013, AQUAT TOXICOL, V142, P1, DOI 10.1016/j.aquatox.2013.07.010
   PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889
   Pimpao C. T., 2013, NEW ADV CONTRIBUTION, P197, DOI [10.5772/45635, DOI 10.5772/45635]
   Powers CM, 2011, NEUROTOXICOL TERATOL, V33, P708, DOI 10.1016/j.ntt.2011.02.002
   Puddick J, 2014, MAR DRUGS, V12, P5372, DOI 10.3390/md12115372
   Rodrigues-Galdino AM, 2010, ZYGOTE, V18, P131, DOI 10.1017/S096719940999013X
   Saraf SR, 2018, AQUAT TOXICOL, V194, P18, DOI 10.1016/j.aquatox.2017.10.026
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Silva-Stenico ME, 2009, J BRAZIL CHEM SOC, V20, P535, DOI 10.1590/S0103-50532009000300019
   Truong L, 2016, ENVIRON POLLUT, V218, P1089, DOI 10.1016/j.envpol.2016.08.061
   U.S. EPA, 2009, 538 US EPA
   Wang PJ, 2005, TOXICON, V45, P303, DOI 10.1016/j.toxicon.2004.10.016
   Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002
   World Health Organization, 2003, CYAN TOX MICR LR DRI
   World Health Organization, 2008, PYR DRINK WAT US VEC
   Yapabandara AMGM, 2004, J AM MOSQUITO CONTR, V20, P395
NR 47
TC 3
Z9 3
U1 8
U2 34
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD DEC 30
PY 2018
VL 166
BP 311
EP 319
DI 10.1016/j.ecoenv.2018.09.064
PG 9
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA GY7CD
UT WOS:000448760800040
PM 30278392
DA 2020-07-08
ER

PT J
AU Jordan, SE
   Hovet, SE
   Fung, ICH
   Liang, H
   Fu, KW
   Tse, ZTH
AF Jordan, Sophie E.
   Hovet, Sierra E.
   Fung, Isaac Chun-Hai
   Liang, Hai
   Fu, King-Wa
   Tse, Zion Tsz Ho
TI Using Twitter for Public Health Surveillance from Monitoring and
   Prediction to Public Response
SO DATA
LA English
DT Review
DE public health; Twitter; classification; data mining; Zika; Ebola
ID CLASSIFICATION
AB Twitter is a social media platform where over 500 million people worldwide publish their ideas and discuss diverse topics, including their health conditions and public health events. Twitter has proved to be an important source of health-related information on the Internet, given the amount of information that is shared by both citizens and official sources. Twitter provides researchers with a real-time source of public health information on a global scale, and can be very important in public health research. Classifying Twitter data into topics or categories is helpful to better understand how users react and communicate. A literature review is presented on the use of mining Twitter data or similar short-text datasets for public health applications. Each method is analyzed for ways to use Twitter data in public health surveillance. Papers in which Twitter content was classified according to users or tweets for better surveillance of public health were selected for review. Only papers published between 2010-2017 were considered. The reviewed publications are distinguished by the methods that were used to categorize the Twitter content in different ways. While comparing studies is difficult due to the number of different methods that have been used for applying Twitter and interpreting data, this state-of-the-art review demonstrates the vast potential of utilizing Twitter for public health surveillance purposes.
C1 [Jordan, Sophie E.] Univ Georgia, Coll Engn, Sch Chem Mat & Biomed Engn, Athens, GA 30602 USA.
   [Hovet, Sierra E.; Tse, Zion Tsz Ho] Univ Georgia, Coll Engn, Sch Elect & Comp Engn, Athens, GA 30602 USA.
   [Fung, Isaac Chun-Hai] Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, Statesboro, GA 30460 USA.
   [Liang, Hai] Chinese Univ Hong Kong, Sch Journalism & Commun, Hong Kong, Peoples R China.
   [Fu, King-Wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Peoples R China.
RP Tse, ZTH (corresponding author), Univ Georgia, Coll Engn, Sch Elect & Comp Engn, Athens, GA 30602 USA.
EM sophie.jordan25@uga.edu; hovetsia@uga.edu; cfung@georgiasouthern.edu;
   hailiang@cuhk.edu.hk; kwfu@hku.hk; ziontse@uga.edu
RI Liang, Hai/F-3797-2015; Fu, King-wa/A-2385-2010; Liang,
   Hai/AAB-2150-2020
OI Liang, Hai/0000-0003-1779-9552; Fu, King-wa/0000-0001-8157-5276; Liang,
   Hai/0000-0003-1779-9552; Tse, Zion/0000-0001-9741-1137; Fung, Isaac
   Chun-Hai/0000-0001-5496-2529
CR Adrover Cosme, 2015, JMIR Public Health Surveill, V1, pe7, DOI 10.2196/publichealth.4488
   Behera P.N., 2015, INT J ENG RES TECHNO, V4, P606
   Biggerstaff M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1669-x
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Cheong F, 2011, SOCIAL MEDIA DATA MI, P46
   Christian KA, 2017, HEALTH SECUR, V15, P453, DOI 10.1089/hs.2017.0004
   Coletta LFS, 2014, 2014 BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS), P210, DOI 10.1109/BRACIS.2014.46
   Coppersmith G., 2014, P WORKSH COMP LING C, P51, DOI DOI 10.3115/V1/W14-3207
   Denecke K, 2013, METHOD INFORM MED, V52, P326, DOI [10.3414/ME12.02-0010, 10.3414/ME12-02-0010]
   Dredze M., 2013, AAAI WORKSH EXP BOUN, P20
   Friss R.H., 1999, EPIDEMIOLOGY, V20, P25
   Fung ICH, 2018, INFECT DIS HEALTH, V23, P10, DOI 10.1016/j.idh.2017.08.005
   Gesualdo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082489
   Ginn Rachel, 2014, P 4 WORKSH BUILD EV
   Go A, 2009, TWITTER SENTIMENT CL, V1
   Gomide J., 2011, P 3 INT WEB SCI C, P3
   Gonzalez-Bailon S, 2014, SOC NETWORKS, V38, P16, DOI 10.1016/j.socnet.2014.01.004
   Griffis HM, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3758
   Ji X, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0253-5
   Kim SJ, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6426
   King G, 2017, AM J POLIT SCI, V61, P971, DOI 10.1111/ajps.12291
   Lee KH, 2011, ACTA HORTIC, V900, P251, DOI 10.1109/ICDMW.2011.171
   Lewis SH, 2016, DISEASE SURVEILLANCE: TECHNOLOGICAL CONTRIBUTIONS TO GLOBAL HEALTH SECURITY, P179
   Liang H., 2016, P NAT C HLTH COMM MA
   Liang H, 2017, NEW MEDIA SOC, V19, P1476, DOI 10.1177/1461444816642210
   Liang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134270
   Martinez-Millana Antonio, 2017, J Med Internet Res, V19, pe181, DOI 10.2196/jmir.6763
   Missier P, 2016, LECT NOTES COMPUT SC, V9881, P80, DOI 10.1007/978-3-319-46963-8_7
   Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Parker J, 2013, 2013 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P562
   Paul M., 2012, HEALTH, V11, P16, DOI DOI 10.1002/YD.20024
   Pennacchiotti M., 2011, P AAAI INT C WEBL SO, V11, P281
   Prier KW, 2011, LECT NOTES COMPUT SC, V6589, P18
   Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191
   Sadilek A., 2013, P 6 ACM INT C WEB SE, P637, DOI 10.1145/2433396.2433476
   Santos JC, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S6
   Sarker A, 2015, J BIOMED INFORM, V53, P196, DOI 10.1016/j.jbi.2014.11.002
   Schulz A., 2014, P MAK SENS MICR MICR, P7
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Sriram B, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P841, DOI 10.1145/1835449.1835643
   Thacker Stephen B, 2012, MMWR Suppl, V61, P3
   Tuarob S, 2014, J BIOMED INFORM, V49, P255, DOI 10.1016/j.jbi.2014.03.005
   Yepes Antonio Jimeno, 2015, ACL IJCNLP, P164, DOI DOI 10.18653/V1/W15-3821
NR 44
TC 5
Z9 5
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2306-5729
J9 DATA
JI Data
PD DEC 29
PY 2018
VL 4
IS 1
AR 6
DI 10.3390/data4010006
PG 20
WC Computer Science, Information Systems; Multidisciplinary Sciences
SC Computer Science; Science & Technology - Other Topics
GA HT1TC
UT WOS:000464346400001
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Niedrig, M
   Patel, P
   Abd El Wahed, A
   Schadler, R
   Yactayo, S
AF Niedrig, Matthias
   Patel, Pranav
   Abd El Wahed, Ahmed
   Schaedler, Regina
   Yactayo, Sergio
TI Find the right sample: A study on the versatility of saliva and urine
   samples for the diagnosis of emerging viruses
SO BMC INFECTIOUS DISEASES
LA English
DT Review
DE Sample type; Emerging diseases; Viruses; Diagnostics
ID WEST-NILE-VIRUS; RESPIRATORY SYNDROME-CORONAVIRUS; SARS-ASSOCIATED
   CORONAVIRUS; REVERSE-TRANSCRIPTASE PCR; EBOLA HEMORRHAGIC-FEVER;
   SQUIRRELS SCIURUS-NIGER; NEW-YORK-CITY; ZIKA VIRUS; DENGUE VIRUS;
   CHIKUNGUNYA VIRUS
AB BackgroundThe emergence of different viral infections during the last decades like dengue, West Nile, SARS, chikungunya, MERS-CoV, Ebola, Zika and Yellow Fever raised some questions on quickness and reliability of laboratory diagnostic tests for verification of suspected cases. Since sampling of blood requires medically trained personal and comprises some risks for the patient as well as for the health care personal, the sampling by non-invasive methods (e.g. saliva and/ or urine) might be a very valuable alternative for investigating a diseased patient.Main bodyTo analyse the usefulness of alternative noninvasive samples for the diagnosis of emerging infectious viral diseases, a literature search was performed on PubMed for alternative sampling for these viral infections. In total, 711 papers of potential relevance were found, of which we have included 128 in this review.ConclusionsConsidering the experience using non-invasive sampling for the diagnostic of emerging viral diseases, it seems important to perform an investigation using alternative samples for routine diagnostics. Moreover, during an outbreak situation, evaluation of appropriate sampling and further processing for laboratory analysis on various diagnostic platforms are very crucial. This will help to achieve optimal diagnostic results for a good and reliable case identification.
C1 [Niedrig, Matthias; Schaedler, Regina] Robert Koch Inst, Berlin, Germany.
   [Patel, Pranav] TIB MOLBIOL Synth Lab GmbH, Berlin, Germany.
   [Abd El Wahed, Ahmed] Univ Goettingen, Div Microbiol & Anim Hyg, Gottingen, Germany.
   [Yactayo, Sergio] WHO, CED, Geneva, Switzerland.
RP Niedrig, M (corresponding author), Robert Koch Inst, Berlin, Germany.
EM niedrigm@gmx.de
OI Niedrig, Matthias/0000-0001-7965-4872
FU World Health OrganizationWorld Health Organization [001]
CR Abd El Wahed A., 2013, PLOS CURR, V5, P1, DOI DOI 10.1371/CURRENTS.OUTBREAKS.62DF1C7C75FFCCD59034531E2E8364
   Al-Tawfiq Jaffar A, 2015, Hosp Pract (1995), V43, P158, DOI 10.1080/21548331.2015.1074029
   Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877
   Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   AVSICZUPANC T, 1994, AM J TROP MED HYG, V51, P393, DOI 10.4269/ajtmh.1994.51.393
   Baggi FM, 2014, EUROSURVEILLANCE, V19, P2
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016
   Banavar SR, 2014, J CLIN DIAGN RES, V8, P229, DOI 10.7860/JCDR/2014/7521.4169
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]
   Baty SA, 2012, J INFECT DIS, V205, P1476, DOI 10.1093/infdis/jis221
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bodur H, 2010, INT J INFECT DIS, V14, pE247, DOI 10.1016/j.ijid.2009.04.018
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Boyd V, 2015, J VIROL METHODS, V223, P5, DOI 10.1016/j.jviromet.2015.07.004
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cha RH, 2015, J KOREAN MED SCI, V30, P1807, DOI 10.3346/jkms.2015.30.12.1807
   Chakravarti A, 2007, CURR MICROBIOL, V55, P461, DOI 10.1007/s00284-007-9040-5
   Chan PKS, 2004, EMERG INFECT DIS, V10, P825, DOI 10.3201/eid1005.030682
   Chaves M, 2009, J NEUROVIROL, V15, P348, DOI 10.1080/13550280903062805
   Cheng VCC, 2004, CLIN INFECT DIS, V38, P467, DOI 10.1086/382681
   Chu CM, 2005, EMERG INFECT DIS, V11, P1882
   Chu CM, 2004, CAN MED ASSOC J, V171, P1349, DOI 10.1503/cmaj.1040398
   Chuansumrit A, 2011, DIAGN MICR INFEC DIS, V71, P467, DOI 10.1016/j.diagmicrobio.2011.08.020
   Chughtai AA, 2016, EPIDEMIOL INFECT, V144, P1652, DOI 10.1017/S0950268816000054
   Chupurnova T S, 2000, Vopr Virusol, V45, P18
   Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951
   Corman VM, 2014, J CLIN VIROL, V60, P168, DOI 10.1016/j.jcv.2014.03.012
   Corman VM, 2014, J VIROL, V88, P717, DOI 10.1128/JVI.01600-13
   Cuzzubbo AJ, 1998, J CLIN MICROBIOL, V36, P3737, DOI 10.1128/JCM.36.12.3737-3739.1998
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira SA, 1999, J VIROL METHODS, V77, P81, DOI 10.1016/S0166-0934(98)00139-6
   Ding XH, 2005, AM J TROP MED HYG, V73, P803, DOI 10.4269/ajtmh.2005.73.803
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10
   Drosten C, 2004, J CLIN MICROBIOL, V42, P2043, DOI 10.1128/JCM.42.5.2043-2047.2004
   Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3
   Du Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11039
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Eckerle I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-359
   EMOND RTD, 1982, BRIT MED J, V285, P1001, DOI 10.1136/bmj.285.6347.1001
   Ergunay K, 2015, J MED VIROL, V87, P1625, DOI 10.1002/jmv.24226
   Formenty P, 2006, CLIN INFECT DIS, V42, P1521, DOI 10.1086/503836
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Fulhorst CF, 1999, J INFECT DIS, V180, P966, DOI 10.1086/315029
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gibney KB, 2011, J INFECT DIS, V203, P344, DOI 10.1093/infdis/jiq057
   Goffard A, 2006, ANN BIOL CLIN-PARIS, V64, P195
   Goh GK, 2013, PLOS CURR, V5, P12
   Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171
   Green E, 2016, LANCET INFECT DIS, V16, P1052, DOI 10.1016/S1473-3099(16)30060-3
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   HARRINGTON DG, 1980, AM J VET RES, V41, P1559
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hung ECW, 2003, CLIN CHEM, V49, P2108, DOI 10.1373/clinchem.2003.025437
   Hung IFN, 2004, EMERG INFECT DIS, V10, P1550, DOI 10.3201/eid1009.040058
   Isakbaeva ET, 2004, EMERG INFECT DIS, V10, P225, DOI 10.3201/eid1002.030734
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jameson LJ, 2014, VIRUSES-BASEL, V6, P3425, DOI 10.3390/v6093425
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Janvier F, 2016, EMERG INFECT DIS, V22, P292, DOI 10.3201/eid2202.151395
   Kim MN, 2016, ANN LAB MED, V36, P450, DOI 10.3343/alm.2016.36.5.450
   Kim SY, 2016, EMERG INFECT DIS, V22, P1813, DOI 10.3201/eid2210.160218
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Kondo M, 2016, J DERMATOL, V43, P697, DOI 10.1111/1346-8138.13253
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lau SKP, 2005, EMERG INFECT DIS, V11, P1108, DOI 10.3201/eid1107.041045
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106
   Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902
   Liu L, 2011, J VIROL, V85, P4025, DOI 10.1128/JVI.02292-10
   Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x
   LUNKENHEIMER K, 1990, J CLIN MICROBIOL, V28, P2689, DOI 10.1128/JCM.28.12.2689-2692.1990
   Ma XZ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-56
   Magurano F, 2012, CLIN MICROBIOL INFEC, V18, pE545, DOI 10.1111/1469-0691.12018
   Mahony JB, 2004, J CLIN MICROBIOL, V42, P1471, DOI 10.1128/JCM.42.4.1471-1476.2004
   Martinez MJ, 2011, VACCINE, V29, P3374, DOI 10.1016/j.vaccine.2011.02.075
   MILLS JN, 1994, AM J TROP MED HYG, V51, P554, DOI 10.4269/ajtmh.1994.51.554
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagy A, 2016, ARCH VIROL, V161, P1797, DOI 10.1007/s00705-016-2844-5
   Ng LFP, 2004, J CLIN MICROBIOL, V42, P347, DOI 10.1128/JCM.42.1.347-350.2004
   Normile D, 2004, SCIENCE, V303, P26, DOI 10.1126/science.303.5654.26
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852
   Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837
   Papa A, 2014, J MED VIROL, V86, P2142, DOI 10.1002/jmv.23949
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Paweska JT, 2015, J INFECT DIS, V212, pS109, DOI 10.1093/infdis/jiv132
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Petrosillo N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1169-4
   Pettersson L, 2008, EMERG INFECT DIS, V14, P406, DOI 10.3201/eid1403.071242
   Pettersson L, 2011, J MED VIROL, V83, P864, DOI 10.1002/jmv.22040
   Platt KB, 2008, VECTOR-BORNE ZOONOT, V8, P225, DOI 10.1089/vbz.2007.0182
   Platt KB, 2007, EMERG INFECT DIS, V13, P831, DOI 10.3201/eid1306.061008
   Poissy J, 2014, J CLIN VIROL, V61, P275, DOI 10.1016/j.jcv.2014.07.002
   POKHODYAEV VA, 1991, VOP VIRUSOL+, V36, P506
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Raut CG, 2016, METHODS MOL BIOL, V1426, P75, DOI 10.1007/978-1-4939-3618-2_7
   Reddy V, 2014, J MED VIROL, V86, P1393, DOI 10.1002/jmv.23875
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Saito Y, 2015, JPN J INFECT DIS, V68, P455, DOI 10.7883/yoken.JJID.2014.441
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Southern TR, 2015, J CLIN MICROBIOL, V53, P2956, DOI 10.1128/JCM.01317-15
   Sow MS, 2016, J INFECT DIS, V214, P1475, DOI 10.1093/infdis/jiw078
   Srikiatkhachorn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051335
   Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153
   Thomas S, 2012, VECTOR-BORNE ZOONOT, V12, P800, DOI 10.1089/vbz.2011.0776
   Tiawsirisup S, 2010, VECTOR-BORNE ZOONOT, V10, P207, DOI 10.1089/vbz.2008.0158
   Tilley PAG, 2006, J INFECT DIS, V193, P1361, DOI 10.1086/503577
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Torres J R, 2000, Clin Infect Dis, V31, pE28, DOI 10.1086/317454
   Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004
   Traiber C, 2011, J PEDIAT-BRAZIL, V87, P269, DOI [10.2223/JPED.2067, 10.1590/S0021-75572011000300015]
   Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   Vanlandingham DL, 2005, AM J TROP MED HYG, V72, P616, DOI 10.4269/ajtmh.2005.72.616
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vazquez S, 2007, INT J INFECT DIS, V11, P256, DOI 10.1016/j.ijid.2006.05.005
   VERETA LA, 1990, LAB DELO, P72
   VERETA LA, 1993, VOP VIRUSOL+, V38, P18
   Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254
   VITULLO AD, 1990, INTERVIROLOGY, V31, P339, DOI 10.1159/000150170
   VITULLO AD, 1987, AM J TROP MED HYG, V37, P663, DOI 10.4269/ajtmh.1987.37.663
   Voutilainen L, 2015, J GEN VIROL, V96, P1238, DOI 10.1099/vir.0.000076
   Wang HB, 2004, CLIN CHEM, V50, P1237, DOI 10.1373/clinchem.2004.031237
   Wang WK, 2004, EMERG INFECT DIS, V10, P1213, DOI 10.3201/eid1007.031113
   Wang XW, 2005, WORLD J GASTROENTERO, V11, P4390
   Wang YD, 2004, CLIN IMMUNOL, V113, P145, DOI 10.1016/j.clim.2004.07.003
   Wong SCC, 2005, J CLIN PATHOL, V58, P276, DOI 10.1136/jcp.2004.016592
   Wu XY, 2008, J GEN VIROL, V89, P3073, DOI 10.1099/vir.0.2008/003210-0
   Xu D, 2005, EUR J CLIN MICROBIOL, V24, P165, DOI 10.1007/s10096-005-1299-5
   Yang Zhan-qing, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1283
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
   Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9
   Zhang Y, 2015, LAB CHIP, V15, P1465, DOI 10.1039/c4lc01127a
   Zhao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27298
NR 170
TC 8
Z9 8
U1 7
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 29
PY 2018
VL 18
AR 707
DI 10.1186/s12879-018-3611-x
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA HF9LK
UT WOS:000454563300006
PM 30594124
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shriver-Lake, LC
   Liu, JL
   Zabetakis, D
   Sugiharto, VA
   Lee, CR
   Defang, GN
   Wu, SJL
   Anderson, GP
   Goldman, ER
AF Shriver-Lake, Lisa C.
   Liu, Jinny L.
   Zabetakis, Dan
   Sugiharto, Victor A.
   Lee, Cheng-Rei
   Defang, Gabriel N.
   Wu, Shuenn-Jue L.
   Anderson, George P.
   Goldman, Ellen R.
TI Selection and Characterization of Anti- Dengue NS1 Single Domain
   Antibodies
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DISULFIDE BOND; PROTEIN NS1; DIAGNOSIS; ASSAY; STABILIZATION;
   SENSITIVITY; GENERATION; FRAGMENTS; INFECTION; PHAGE
AB Reliable detection and diagnosis of dengue virus (DENV) is important for both patient care and epidemiological control. Starting with a llama immunized with a mixture of recombinant nonstructural protein 1 (NS1) antigen from the four DENV serotypes, a phage display immune library of single domain antibodies was constructed and binders selected which exhibited specificity and affinity for DENV NS1. Each of these single domain antibodies was evaluated for its binding affinity to NS1 from the four serotypes, and incorporated into a sandwich format for NS1 detection. An optimal pair was chosen that provided the best combination of sensitivity for all four DENV NS1 antigens spiked into 50% human serum while showing no cross reactivity to NS1 from Zika virus, yellow fever virus, tick-borne encephalitis virus, and minimal binding to NS1 from Japanese encephalitis virus and West Nile virus. These rugged and robust recombinant binding molecules offer attractive alternatives to conventional antibodies for implementation into immunoassays destined for resource limited locals.
C1 [Shriver-Lake, Lisa C.; Liu, Jinny L.; Zabetakis, Dan; Anderson, George P.; Goldman, Ellen R.] US Naval Res Lab, Ctr Biomol Sci & Engn, 4555 Overlook Ave SW, Washington, DC 20375 USA.
   [Sugiharto, Victor A.; Lee, Cheng-Rei; Defang, Gabriel N.; Wu, Shuenn-Jue L.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
RP Goldman, ER (corresponding author), US Naval Res Lab, Ctr Biomol Sci & Engn, 4555 Overlook Ave SW, Washington, DC 20375 USA.
EM ellen.goldman@nrl.navy.mil
FU US Government; Joint Science and Technology Office; DTRA RD Chemical and
   Biological Technologies Department [HDTRA1518114 (CB3636)]; 
   [6000.RAD1.L.A1224]
FX The work at the Naval Medical Research Center was supported by work unit
   number 6000.RAD1.L.A1224. G.D. is a US military service member and S.W.
   is a US government employee. V.S. and C.L. are employed by the Henry M.
   Jackson Foundation for the Advancement of Military Medicine and are
   funded to do this work by the US Government. The work of these
   individuals was prepared as part of official government duties. Title 17
   USC. 105 provides that 'Copyright protection under this title is not
   available for any work for the US Government.' Title 17 USC. 101 defines
   a US government work as a work prepared by a military service member or
   employee of the US government as part of that person's official duties.
   The views expressed are those of the authors and do not necessarily
   reflect the official policy or position of the Department of the Navy,
   Department of the Army, Department of Defense or the US government. The
   work at the US Naval Research Laboratory was supported by the Joint
   Science and Technology Office and DTRA RD Chemical and Biological
   Technologies Department, project number HDTRA1518114 (CB3636).
   Computational work was performed with the resources of the Department of
   Defense High Performance Computer Modernization Program. We thank summer
   interns Lauryn Ashford and Bill Koehler for help with plasmid preps and
   cloning sdAb sequences into the expression vector and Raymond Koehler
   for helping with FPLC purification of the GS3K fusions. Finally, we
   publish this paper in memory of Jerry Blutman, whose support and
   enthusiasm over the years greatly contributed to the success of our
   projects.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Anderson GP, 2008, SENSOR LETT, V6, P213, DOI 10.1166/sl.2008.018
   Anderson GP, 2007, BIOTECHNIQUES, V43, P806, DOI 10.2144/000112600
   [Anonymous], 2017, DENGUE LAB GUIDANCE
   [Anonymous], 2017, TOOL DIAGNOSIS CARE
   Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Cabral-Castro MJ, 2016, J VIROL METHODS, V236, P18, DOI 10.1016/j.jviromet.2016.07.003
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   de Marco A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-44
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED
   Fatima A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095263
   Fernandes CFC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00653
   Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4
   Goldman ER, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00865
   Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053
   Graef RR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-86
   Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200
   HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0
   Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665
   Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351
   Lebani K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180669
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Liu JL, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00478
   Liu JL, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0837-z
   Liu Jinny L, 2016, Biotechnol Rep (Amst), V10, P56, DOI 10.1016/j.btre.2016.03.001
   Liu JL, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0340-3
   Liu JL, 2013, J IMMUNOL METHODS, V393, P1, DOI 10.1016/j.jim.2013.04.001
   Liu JL, 2013, MOL IMMUNOL, V53, P118, DOI 10.1016/j.molimm.2012.07.010
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449
   Pal S, 2016, MIL MED, V181, P756, DOI 10.7205/MILMED-D-15-00231
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Palanivel H, 2015, INDIAN J PATHOL MICR, V58, P328, DOI 10.4103/0377-4929.162865
   Pleschberger M, 2004, BIOCONJUGATE CHEM, V15, P664, DOI 10.1021/bc049964w
   Puttikhunt C, 2011, J CLIN VIROL, V50, P314, DOI 10.1016/j.jcv.2011.01.001
   Ranzoni A, 2015, ANAL CHEM, V87, P6150, DOI 10.1021/acs.analchem.5b00762
   Raphael MP, 2015, PLASMONICS, V10, P1649, DOI 10.1007/s11468-015-9969-3
   Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Sankar SG, 2012, CLIN MICROBIOL INFEC, V18, pE8, DOI 10.1111/j.1469-0691.2011.03694.x
   Sherwood LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061232
   Sherwood LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00807
   Shriver-Lake LC, 2017, TOXICON, V135, P51, DOI 10.1016/j.toxicon.2017.06.002
   Shriver-Lake LC, 2016, TOXINS, V8, DOI 10.3390/toxins8110346
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Turner KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149393
   Turner Kendrick B, 2015, Biotechnol Rep (Amst), V6, P27, DOI 10.1016/j.btre.2015.01.001
   Walper SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106263
   Wasik D, 2018, ANAL CHEM, V90, P679, DOI 10.1021/acs.analchem.7b03407
   Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7
   Wu YL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01802
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 57
TC 4
Z9 4
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 27
PY 2018
VL 8
AR 18086
DI 10.1038/s41598-018-35923-1
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF7IO
UT WOS:000454413000004
PM 30591706
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, YC
   Lopez-Camacho, C
   Nettleship, JE
   Rahman, N
   Hill, ML
   Silva-Reyes, L
   Ortiz-Martinez, G
   Figueroa-Aguilar, G
   Mar, MA
   Vivanco-Cid, H
   Rollier, CS
   Zitzmann, N
   Viveros-Sandoval, ME
   Owens, RJ
   Reyes-Sandoval, A
AF Kim, Young Chan
   Lopez-Camacho, Cesar
   Nettleship, Joanne E.
   Rahman, Nahid
   Hill, Michelle L.
   Silva-Reyes, Laura
   Ortiz-Martinez, Georgina
   Figueroa-Aguilar, Gloria
   Antonieta Mar, Maria
   Vivanco-Cid, Hector
   Rollier, Christine S.
   Zitzmann, Nicole
   Eva Viveros-Sandoval, Martha
   Owens, Raymond J.
   Reyes-Sandoval, Arturo
TI Optimization of Zika virus envelope protein production for ELISA and
   correlation of antibody titers with virus neutralization in Mexican
   patients from an arbovirus endemic region
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Envelope protein; CD4 fusion tag; Protein production; ELISA;
   Mexican patients; Neutralizing antibodies
ID CROSS-REACTIVITY; DENGUE VIRUS; DOMAIN-III; TRANSIENT EXPRESSION;
   TRANSMISSION; INFECTION; RESPONSES; AMERICA; GENOME; BORNE
AB BackgroundZika virus (ZIKV) has become a global threat with immediate need for accurate diagnostics, efficacious vaccines and therapeutics. Several ZIKV envelope (Env)-based vaccines have been developed recently. However, many commercially available ZIKV Env are based on the African lineage and produced in insect cells. Here, we sought to produce Asian-lineage ZIKV Env in mammalian cells for research and clinical applications.MethodsWe designed various gene expression constructs to optimize the production of ZIKV using prM-Env and full or C-terminal truncations of Env; with or without a rat CD4 fusion partner to allow large-scale production of soluble protein in mammalian HEK293 cells. Protein expression was verified by mass spectrometry and western-blot with a pan-flavivirus antibody, a ZIKV Env monoclonal antibody and with immune sera from adenoviral (ChAdOx1) ZIKV Env-vaccinated mice. The resulting Env-CD4 was used as a coating reagent for immunoassay (ELISA) using both mouse and human seropositive sera.ResultsReplacement of the C-terminus transmembrane Env domain by a rat CD4 and addition of prM supported optimal expression and secretion of Env. Binding between the antigens and the antibodies was similar to binding when using commercially available ZIKV Env reagents. Furthermore, antibodies from ZIKV patients bound ZIKV Env-CD4 in ELISA assays, whereas sera from healthy blood donors yielded minimal OD background. The serological outcomes of this assay correlated also with ZIKV neutralisation capacity in vitro.ConclusionsResults obtained from this study indicate the potential of the Asian-lineage Zika Env-CD4 and Env proteins in ELISA assays to monitor humoral immune responses in upcoming clinical trials as well as a sero-diagnostic tool in ZIKV infection.
C1 [Kim, Young Chan; Lopez-Camacho, Cesar; Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7DQ, England.
   [Kim, Young Chan; Nettleship, Joanne E.; Rahman, Nahid; Owens, Raymond J.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford, England.
   [Nettleship, Joanne E.; Rahman, Nahid; Owens, Raymond J.] OPPF UK, Rutherford Appleton Lab, Res Complex Harwell, Oxford, England.
   [Silva-Reyes, Laura; Rollier, Christine S.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.
   [Silva-Reyes, Laura; Rollier, Christine S.] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford, England.
   [Ortiz-Martinez, Georgina; Eva Viveros-Sandoval, Martha] Univ Michoacana, Lab Hemostasia & Biol Vasc, Div Estudios Posgrad, Fac Ciencias Med & Biol Dr Ignacio Chavez,UMSNH, Morelia, Michoacan, Mexico.
   [Ortiz-Martinez, Georgina; Eva Viveros-Sandoval, Martha] Univ Michoacana, UMSNH Oxford Univ Oxford Clin Res Lab UMOCRL, Fac Biol & Med Sci Dr Ignacio Chavez, Morelia, Michoacan, Mexico.
   [Hill, Michelle L.; Zitzmann, Nicole] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.
   [Figueroa-Aguilar, Gloria] Secretaria Salud Michoacan, Lab Estatal Salud Publ, Morelia, Michoacan, Mexico.
   [Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Med Biol, Xalapa, Veracruz, Mexico.
   [Antonieta Mar, Maria] HGZMF, 12 Lazaro Cardenas Michoacan Direcc Ave Lazaro, Veracruz, Mexico.
RP Reyes-Sandoval, A (corresponding author), Univ Oxford, Jenner Inst, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7DQ, England.
EM young.kim@some.ox.ac.uk; arturo.reyes@ndm.ox.ac.uk
OI Silva-Reyes, Laura/0000-0002-3678-1836; Kim, Young
   Chan/0000-0003-2847-9407; LOPEZ-CAMACHO, CESAR/0000-0001-7932-2341
FU Department of Health through SBRI Innovate UK [972216, 72284-493233,
   971557, 94851-557155]
FX This work was supported by the Department of Health through SBRI
   Innovate UK grants references 972216, Application Number: 72284-493233
   and 971557 Application Number: 94851-557155. Arturo Reyes-Sandoval and
   Christine Rollier are Jenner Investigators.
CR Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047
   BROWN MH, 1994, PROTEIN ENG, V7, P515, DOI 10.1093/protein/7.4.515
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Kostyuchenko VA, 2016, NATURE STRUCTURE THE
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Maeda A, 2013, REV DIAGNOSTIC PLAQU
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neffleship Joanne E., 2009, V498, P245, DOI 10.1007/978-1-59745-196-3_16
   Nettleship JE, 2015, METHODS MOL BIOL, V1258, P209, DOI 10.1007/978-1-4939-2205-5_11
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yu S, 2004, BIOCHEMISTRY-US, V43, P9168, DOI 10.1021/bi049324g
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 46
TC 2
Z9 2
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD DEC 27
PY 2018
VL 15
AR 193
DI 10.1186/s12985-018-1104-6
PG 12
WC Virology
SC Virology
GA HF7TP
UT WOS:000454444000002
PM 30587198
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nurtop, E
   Villarroel, PMS
   Pastorino, B
   Ninove, L
   Drexler, JF
   Roca, Y
   Gake, B
   Dubot-Peres, A
   Grard, G
   Peyrefitte, C
   Priet, S
   de Lamballerie, X
   Gallian, P
AF Nurtop, Elif
   Saba Villarroel, Paola Mariela
   Pastorino, Boris
   Ninove, Laetitia
   Drexler, Jan-Felix
   Roca, Yelin
   Gake, Bouba
   Dubot-Peres, Audrey
   Grard, Gilda
   Peyrefitte, Christophe
   Priet, Stephane
   de Lamballerie, Xavier
   Gallian, Pierre
TI Combination of ELISA screening and seroneutralisation tests to expedite
   Zika virus seroprevalence studies
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Seroepidemiology; Virus neutralization test
ID DENGUE VIRUS; INFECTION; ASSAY
AB Here we propose a strategy allowing implementing efficient and practicable large-scale seroepidemiological studies for Zika Virus (ZIKV). It combines screening by a commercial NS1 protein-based Zika IgG ELISA, and confirmation by a cytopathic effect-based virus neutralization test (CPE-based VNT). In post-epidemic samples from Martinique Island blood donors (a population with a dengue seroprevalence above 90%), this strategy allowed reaching specificity and sensitivity values over 98%. The CPE-based VNT consists of recording CPE directly under the optical microscope, which is easy to identify with ZIKV strain H/PF/2013 at day 5 pi. Overall, considered that CPE-based VNT is cost effective and widely automatable, the NS1 protein-based Zika IgG ELISA+CPE-based VNT combination strategy represents a convenient tool to expedite ZIKV seroprevalence studies.
C1 [Nurtop, Elif; Saba Villarroel, Paola Mariela; Pastorino, Boris; Ninove, Laetitia; Gake, Bouba; Dubot-Peres, Audrey; Grard, Gilda; Peyrefitte, Christophe; Priet, Stephane; de Lamballerie, Xavier; Gallian, Pierre] Aix Marseille Univ, IRD 190, Inserm 1207, UVE,IHU Mediterranee Infect, Marseille, France.
   [Saba Villarroel, Paola Mariela; Roca, Yelin] Ctr Nacl Enfermedades Trop CENETROP, Virol 2, Santa Cruz, Bolivia.
   [Drexler, Jan-Felix] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Gake, Bouba] Ctr Pasteur Cameroun, Yaounde, Cameroon.
   [Grard, Gilda; Peyrefitte, Christophe] French Armed Forces Biomed Res Inst, Natl Reference Ctr Arboviruses, Marseille, France.
   [Gallian, Pierre] Etab Francais Sang Alpes Mediterranee EFS, Lab Virol, Marseille, France.
RP Nurtop, E (corresponding author), Aix Marseille Univ, IRD 190, Inserm 1207, UVE,IHU Mediterranee Infect, Marseille, France.
EM enurtop@gmail.com
RI Priet, Stephane/N-7952-2017
OI Priet, Stephane/0000-0001-7102-3654; pastorino,
   boris/0000-0001-5233-5193; Drexler, Jan Felix/0000-0002-3509-0232
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance [734548]; European Virus Archive EVAg; European
   UnionEuropean Union (EU) [653316]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant Agreement no.
   734548 and the European Virus Archive EVAg; European Union- Horizon 2020
   programme under grant agreement no. 653316.
CR Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19
   [Anonymous], 2017, UPDATED GUIDANCE US
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Holdcroft T, 2007, IMMUNIZATION VACCINE
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Touret F, 2018, BIORXIV, DOI [10. 1101/272625, DOI 10.1101/272625]
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
NR 26
TC 9
Z9 10
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD DEC 27
PY 2018
VL 15
AR 192
DI 10.1186/s12985-018-1105-5
PG 6
WC Virology
SC Virology
GA HF7TP
UT WOS:000454444000001
PM 30587193
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Araujo, HRC
   Kojin, BB
   Capurro, ML
AF Correa de Araujo, Helena Rocha
   Kojin, Bianca Burini
   Capurro, Margareth Lara
TI Sex determination and Aedes population control
SO PARASITES & VECTORS
LA English
DT Review
DE Aedes aegypti; vector borne diseases; mass-rearing and population
   suppression
ID STERILE INSECT TECHNIQUE; CERATITIS-CAPITATA; ZIKA VIRUS; HEALTH-CARE;
   MOSQUITO; DENGUE; GENE; WOLBACHIA; STRAINS
AB The global economic cost of Aedes-borne diseases, such as dengue, is estimated to be in the billions of dollars annually. In this scenario, a sustained vector control strategy is the only alternative to control dengue, as well as other diseases transmitted by Aedes, including Zika and chikungunya. The use of transgenic mosquitoes is a promising weapon in the improvement of approaches currently applied in Aedes aegypti control. Field trials using genetically modified mosquitoes for population control have been conducted and offer an excellent opportunity to evaluate what can be improved. In a mass-rearing mosquito facility, the absence of a transgenic line that produces male-only progeny is undoubtedly a limiting factor; thus, being able to manipulate sex determination in this species is a fundamental step for the success of this strategy. Likewise, the possibility of manipulation of the sex determination pathway opens-up a new opportunity for disease control.
C1 [Correa de Araujo, Helena Rocha; Capurro, Margareth Lara] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   [Kojin, Bianca Burini] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
RP Capurro, ML (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
EM mcapurro@icb.usp.br
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH UO1 AI115595-01];
   Sao Paulo Research Foundation, FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/16609-4]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; International
   Atomic Energy Agency (IAEA)International Atomic Energy Agency [17939];
   International Atomic Energy AgencyInternational Atomic Energy Agency
FX HRCA was supported by National Institutes of Health (Grant #NIH UO1
   AI115595-01) and Sao Paulo Research Foundation, FAPESP (#2013/16609-4)
   during this research. BBK was supported by Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). This work was
   funded by CRP Exploring Genetic, Molecular, Mechanical and Behavioural
   Methods of Sex Separation in Mosquitoes (Grant #17939) from the
   International Atomic Energy Agency (IAEA). Publication costs are funded
   by International Atomic Energy Agency.
CR Alexander JL, 2006, JAVMA-J AM VET MED A, V228, P357, DOI 10.2460/javma.228.3.357
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   [Anonymous], 2016, ZIK EP UPD, V2015
   [Anonymous], 2017, YELL FEV BRAZ AL LEV
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Augustinos AA, 2017, ENTOMOL EXP APPL, V164, P305, DOI 10.1111/eea.12612
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38
   BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8
   Caceres C., 2002, P 6 INT FRUIT FLY S, P367
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Concha C, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0296-8
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dyck VA, 2005, STERILE INSECT TECHN
   Enkerlin W, 2017, GUIDANCE PACKING SHI
   Fitzpatrick C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005785
   FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567
   Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hoang KP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1331-x
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   MCDONALD PT, 1970, GENETICS, V66, P475
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mysore K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004213
   Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004
   Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5
   Robinson AS, 2002, GENETICA, V116, P5, DOI 10.1023/A:1020951407069
   Rossetto EV, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759017, 10.1590/S1678-9946201759017]
   Saccone G., 2007, P95, DOI 10.1007/978-1-4020-6059-5_7
   Salvemini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048554
   Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41
   Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms
   Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005
   Schliekelman P, 2005, J ECON ENTOMOL, V98, P18, DOI 10.1603/0022-0493-98.1.18
   Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   VARGAS MV, 1968, MOSQ NEWS, V28, P374
   Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO, 2012, HDB INT VECT MAN OUT, V24, P1
   (WHO). World Health Organization, 2012, GLOB STRAT DENG PREV, P35
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Yakob L, 2017, PLOS CURR, V9, P1
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
NR 53
TC 1
Z9 1
U1 1
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 24
PY 2018
VL 11
SU 2
AR 644
DI 10.1186/s13071-018-3217-6
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HF5KZ
UT WOS:000454272500012
PM 30583731
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hu, WQ
   Tu, ZJ
AF Hu, Wanqi
   Tu, Zhijian Jake
TI Functional analysis of the promoter of an early zygotic gene KLC2 in
   Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Early embryo; male; development; gene drive; vector; infectious disease
ID YELLOW-FEVER MOSQUITO; STERILE INSECT TECHNIQUE; SEX-SEPARATION;
   EXPRESSION; TRANSFORMATION; TRANSPOSITION; SUPPRESSION; SYSTEM; TESTIS
AB BackgroundAedes aegypti is an important mosquito vector that transmits arboviruses that cause devastating diseases including Zika, dengue fever, yellow fever and chikungunya. Improved understanding of gene regulation in the early development of Ae. aegypti will facilitate genetic studies and help the development of novel control strategies of this important disease vector.ResultsIn this study, we demonstrated through transgenic assays that the promoter of an endogenous early zygotic gene KLC2 could drive gene expression in the syncytial blastoderm and early cellular blastoderm, which is a stage that the developing germline and the rest of embryo are accessible to genetic manipulation. An unexpected expression of the reporter gene in transgenic male testes was also observed. Further analysis confirmed the expression of the endogenous KLC2 in the testes, which was not detected in the previous RNA sequencing data.ConclusionsOur finding provided a new promoter element that can be used in future genetic studies and applications in Ae. aegypti. Moreover, our transgenic reporter assays showed that cautions are needed when interpreting RNA sequencing data as transient or tissue-specific transcription may go undetected by RNAseq.
C1 [Hu, Wanqi; Tu, Zhijian Jake] Virginia Tech, Dept Biochem, 303 Fralin, Blacksburg, VA 24061 USA.
   [Hu, Wanqi; Tu, Zhijian Jake] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.
RP Tu, ZJ (corresponding author), Virginia Tech, Dept Biochem, 303 Fralin, Blacksburg, VA 24061 USA.; Tu, ZJ (corresponding author), Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.
EM jaketu@vt.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI077680, AI113643, AI123338];
   Virginia Experimental Station; International Atomic Energy Agency,
   Coordinated Research Project "Exploring genetic, molecular, mechanical
   and behavioural methods of sex separation in mosquitoes"
FX This work was supported by NIH grants AI077680, AI113643, and AI123338
   to ZT and by the Virginia Experimental Station. Publication costs for
   this study was provided by the International Atomic Energy Agency as
   part of the Coordinated Research Project "Exploring genetic, molecular,
   mechanical and behavioural methods of sex separation in mosquitoes"
CR Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104
   Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Akbari OS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03954
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x
   Biedler JK, 2015, G3-GENES GENOM GENET, V5, P157, DOI 10.1534/g3.114.015578
   Biedler JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033933
   Biedler JK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-206
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Wilke ABB, 2012, REV INST MED TROP SP, V54, P287, DOI 10.1590/S0036-46652012000500009
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Cho KH, 2006, INSECT BIOCHEM MOLEC, V36, P273, DOI 10.1016/j.ibmb.2006.01.005
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   Criscione F, 2013, INSECT MOL BIOL, V22, P433, DOI 10.1111/imb.12034
   Criscione F, 2016, ELIFE, V5, DOI 10.7554/eLife.19281
   Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002
   Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x
   Hay BA, 2010, J INSECT PHYSIOL, V56, P1402, DOI 10.1016/j.jinsphys.2010.05.022
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marshall JM, 2011, GENETICS, V187, P535, DOI 10.1534/genetics.110.124479
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   MESCHER A. L., 1966, MOSQUITO NEWS, V26, P45
   Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895
   Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x
   VARGAS MV, 1968, MOSQ NEWS, V28, P374
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   World Health Organization, DENG SEV DENG
   Zhang Y, 2012, DEV BIOL, V366, P101, DOI 10.1016/j.ydbio.2012.04.026
NR 40
TC 1
Z9 1
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 24
PY 2018
VL 11
SU 2
AR 655
DI 10.1186/s13071-018-3210-0
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HF5KZ
UT WOS:000454272500005
PM 30583735
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jiang, X
   Loeb, JC
   Manzanas, C
   Lednicky, JA
   Fan, ZH
AF Jiang, Xiao
   Loeb, Julia C.
   Manzanas, Carlos
   Lednicky, John A.
   Fan, Z. Hugh
TI Valve-Enabled Sample Preparation and RNA Amplification in a Coffee Mug
   for Zika Virus Detection
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE detection; isothermal amplification; RNA; viruses
ID MEDIATED ISOTHERMAL AMPLIFICATION; ANALYTICAL DEVICES LPAD; LOW-COST;
   PAPER; EXTRACTION; DIAGNOSIS
AB The recent outbreaks of Zika virus (ZIKV) infection represent a public health challenge. Rapid, cost-effective, and reliable diagnostic tools for ZIKV detection at the point of care (POC) are highly desirable, especially for resource-limited nations. To address the need, we have developed an integrated device to achieve sample-to-answer ZIKV detection. The device features innovative ball-based valves enabling the storage and sequential delivery of reagents for virus lysis and a paper-based unit for RNA enrichment and purification. The paper unit is placed in a commercially available coffee mug that provides a constant temperature for reverse transcription loop-mediated isothermal amplification (RT-LAMP), followed by colorimetric detection by naked eye or a cellphone camera. Using the device, we demonstrated the reproducible detection of ZIKV in human urine and saliva samples.
C1 [Jiang, Xiao; Fan, Z. Hugh] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   [Loeb, Julia C.; Lednicky, John A.] Univ Florida, Dept Environm & Global Hlth & Emerging Pathogens, Gainesville, FL 32611 USA.
   [Manzanas, Carlos; Fan, Z. Hugh] Univ Florida, Dept Mech & Aerosp Engn, POB 116250, Gainesville, FL 32611 USA.
RP Fan, ZH (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.; Fan, ZH (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, POB 116250, Gainesville, FL 32611 USA.
EM hfan@ufl.edu
RI Fan, Z. Hugh/A-5886-2008; Lednicky, John A/C-5678-2012
OI Fan, Z. Hugh/0000-0002-1812-8016; Jiang, Xiao/0000-0001-8307-2170
FU Florida Department of Health [7ZK22, 7JK07]; University of
   FloridaUniversity of Florida
FX This work was supported in part by Florida Department of Health (7ZK22
   and 7JK07) and the University of Florida.
CR Alberts B, 1971, METHOD ENZYMOL, V21, P198
   Bingham A. M., 2016, COMP TEST RESULTS ZI
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Byrnes SA, 2015, LAB CHIP, V15, P2647, DOI 10.1039/c5lc00317b
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Cassano CL, 2013, MICROFLUID NANOFLUID, V15, P173, DOI 10.1007/s10404-013-1140-x
   Choi JR, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600920
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Govindarajan AV, 2012, LAB CHIP, V12, P174, DOI 10.1039/c1lc20622b
   Horst AL, 2018, BIOMED MICRODEVICES, V20, P1, DOI 10.1007/s10544-018-0280-x
   Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003
   JIANG XPC, UNPUB
   Kaur N, 2018, ANALYST, V143, P2213, DOI 10.1039/c7an01943b
   Koesdjojo MT, 2015, J CHEM EDUC, V92, P737, DOI 10.1021/ed500401d
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Liu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042222
   Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a
   Liu W, 2013, ANAL CHEM, V85, P10270, DOI 10.1021/ac402055n
   Lustig Y, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.11.25
   Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817
   Martinez AW, 2007, ANGEW CHEM, V119, P1340, DOI DOI 10.1002/ANGE.200603817
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Rodriguez NM, 2016, LAB CHIP, V16, P753, DOI 10.1039/c5lc01392e
   Rodriguez NM, 2015, ANAL CHEM, V87, P7872, DOI 10.1021/acs.analchem.5b01594
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Safavieh M, 2016, ACS BIOMATER SCI ENG, V2, P278, DOI 10.1021/acsbiomaterials.5b00449
   Saikar P., 2013, J GENET ENG BIOTECHN, V11, P17, DOI DOI 10.1016/J.JGEB.2013.02.001
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tang RH, 2017, LAB CHIP, V17, P1270, DOI 10.1039/c6lc01586g
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wimbles R, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7070119
   Xu G., 2016, ANGEW CHEM, V128, P15476
   Xu GL, 2016, ANGEW CHEM INT EDIT, V55, P15250, DOI 10.1002/anie.201606060
   Ye X, 2018, ANAL CHIM ACTA, V1018, P78, DOI 10.1016/j.aca.2018.02.068
   Zhang L, 2014, ANAL CHEM, V86, P10461, DOI 10.1021/ac503072a
NR 43
TC 5
Z9 5
U1 16
U2 49
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD DEC 21
PY 2018
VL 57
IS 52
BP 17211
EP 17214
DI 10.1002/anie.201809993
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA HF9QA
UT WOS:000454575500048
PM 30358036
DA 2020-07-08
ER

PT J
AU Pandit, PS
   Doyle, MM
   Smart, KM
   Young, CCW
   Drape, GW
   Johnson, CK
AF Pandit, Pranav S.
   Doyle, Megan M.
   Smart, Katrina M.
   Young, Cristin C. W.
   Drape, Gaylen W.
   Johnson, Christine K.
TI Predicting wildlife reservoirs and global vulnerability to zoonotic
   Flaviviruses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS; YELLOW-FEVER; ZIKA VIRUS;
   DENGUE; EMERGENCE; TAXONOMY; HISTORY; EPIDEMIOLOGY; TRANSMISSION
AB Flaviviruses continue to cause globally relevant epidemics and have emerged or re-emerged in regions that were previously unaffected. Factors determining emergence of flaviviruses and continuing circulation in sylvatic cycles are incompletely understood. Here we identify potential sylvatic reservoirs of flaviviruses and characterize the macro-ecological traits common to known wildlife hosts to predict the risk of sylvatic flavivirus transmission among wildlife and identify regions that could be vulnerable to outbreaks. We evaluate variability in wildlife hosts for zoonotic flaviviruses and find that flaviviruses group together in distinct clusters with similar hosts. Models incorporating ecological and climatic variables as well as life history traits shared by flaviviruses predict new host species with similar host characteristics. The combination of vector distribution data with models for flavivirus hosts allows for prediction of global vulnerability to flaviviruses and provides potential targets for disease surveillance in animals and humans.
C1 [Pandit, Pranav S.; Doyle, Megan M.; Young, Cristin C. W.; Johnson, Christine K.] Univ Calif Davis, Sch Vet Med, EpiCtr Dis Dynam, One Hlth Inst, One Shields Ave, Davis, CA 95616 USA.
   [Smart, Katrina M.; Drape, Gaylen W.] ENSCO Inc, 4849 North Wickham Rd, Melbourne, FL 32940 USA.
RP Pandit, PS; Johnson, CK (corresponding author), Univ Calif Davis, Sch Vet Med, EpiCtr Dis Dynam, One Hlth Inst, One Shields Ave, Davis, CA 95616 USA.
EM pspandit@ucdavis.edu; ckjohnson@ucdavis.edu
RI Pandit, Pranav/H-7484-2019
OI Pandit, Pranav/0000-0001-7649-0649; Doyle, Megan/0000-0002-3784-355X;
   Young, Cristin/0000-0002-0470-6321
FU Defense Threat Reduction Agency, United States Department of Defense
   [HDTRA1-15-C-0017]
FX We thank L. Lerner, J. Rushmore, and P. Sebastian for their help during
   data curation and compilation. This research received funding from the
   Defense Threat Reduction Agency, United States Department of Defense for
   a contract: Data-Driven Framework for Zoonotic Disease Prediction
   (Contract number: HDTRA1-15-C-0017).
CR Adams MJ, 2016, ARCH VIROL, V161, P2921, DOI 10.1007/s00705-016-2977-6
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Benson DA, 2017, NUCLEIC ACIDS RES, V45, pD37, DOI 10.1093/nar/gkw1070
   Bicca-Marques JC, 2010, TROP CONSERV SCI, V3, P78, DOI 10.1177/194008291000300107
   BirdLife International and Nature Serve, 2015, BIRD SPEC DISTR MAPS
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Centers for Disease Control and Prevention, 2010, ARB CAT
   Consortium P. PREDICT. One Health Institute, 2017, PREDICT
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dash AP, 2013, J VECTOR DIS, V50, P77
   de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x
   De Silva AM, 1999, AM J TROP MED HYG, V60, P300, DOI 10.4269/ajtmh.1999.60.300
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edberg SC, 2005, CLIN INFECT DIS, V40, P123, DOI 10.1086/426549
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   FAO, 2017, FAO GEON
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   George TL, 2015, P NATL ACAD SCI USA, V112, P14290, DOI 10.1073/pnas.1507747112
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Han BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004815
   Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112
   Hijmans R., 2004, MESQUITE MODULAR SYS, V1, P3
   Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796
   Hubalek Z, 2012, PARASITOL RES, V111, P9, DOI 10.1007/s00436-012-2910-1
   Jeffries CL, 2014, J GEN VIROL, V95, P1005, DOI 10.1099/vir.0.062356-0
   Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Monath T.P., 1989, ARBOVIRUSES EPIDEMIO, VV
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Nakgoi K, 2014, AM J PRIMATOL, V76, P97, DOI 10.1002/ajp.22213
   O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539
   Organization WH, 2017, EM PREP RESP ZIK VIR
   Organization WH, 2004, EM PREP RESP
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457
   Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401
   Reisen WK, 2016, VECTOR-BORNE ZOONOT, V16, P264, DOI 10.1089/vbz.2015.1888
   Rodrigues SG, 2010, J GEN VIROL, V91, P2420, DOI 10.1099/vir.0.019117-0
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Root JJ, 2013, ARCH VIROL, V158, P735, DOI 10.1007/s00705-012-1516-3
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203, DOI 10.1093/jmedent/2.2.203
   SABATTIN.MS, 1965, AM J TROP MED HYG, V14, P1073, DOI 10.4269/ajtmh.1965.14.1073
   Saxena SK, 2009, J INFECT DEV COUNTR, V3, P517, DOI 10.3855/jidc.470
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sylla M., 2014, African Journal of Microbiology Research, V8, P2368
   Team R. C. R foundation for statistical computing, 2013, R FDN STAT COMP, V3
   Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Zeller H, 2012, EUROSURVEILLANCE, V17, P23
NR 65
TC 6
Z9 6
U1 4
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC 21
PY 2018
VL 9
AR 5425
DI 10.1038/s41467-018-07896-2
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF3LW
UT WOS:000454137600006
PM 30575757
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freppel, W
   Mazeaud, C
   Chatel-Chaix, L
AF Freppel, Wesley
   Mazeaud, Clement
   Chatel-Chaix, Laurent
TI Production, Titration and Imaging of Zika Virus in Mammalian Cells
SO BIO-PROTOCOL
LA English
DT Article
DE Zika virus; NS4B; Double-stranded RNA; Virus titration;
   Immunofluorescence microscopy; Plaque assay
ID REPLICATION; EMERGENCE
AB Since the outbreak of Zika virus (ZIKV) in Latin America and the US in 2016, this flavivirus has emerged as a major threat for public health. Indeed, it is now clear that ZIKV is vertically transmitted from the infected mother to the fetus and this may lead to severe neurological development defects including (but not restricted to) neonate microcephaly. Although ZIKV has been identified in the late 1940s, very little was known about its epidemiology, symptoms and molecular biology before its reemergence 60 years later. Recently, tremendous efforts have been made to develop molecular clones and tools as well as cell culture and animal models to better understand ZIKV fundamental biology and pathogenesis and to develop so-far-unavailable antiviral drugs and vaccines. This bio-protocol describes basic experimental procedures to produce ZIKV stocks and to quantify their concentration in infectious virus particles as well as to image and study this pathogen within infected cells using confocal microscopy-based imaging.
C1 [Freppel, Wesley; Mazeaud, Clement; Chatel-Chaix, Laurent] Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ H7V 1B7, Canada.
RP Chatel-Chaix, L (corresponding author), Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ H7V 1B7, Canada.
EM Laurent.Chatel-Chaix@iaf.inrs.ca
OI Freppel, Wesley/0000-0003-3628-0465
FU Fonds de la Recherche du Quebec-Sante (FRQS); Natural Sciences and
   Engineering Research Council of Canada (NSERC)Natural Sciences and
   Engineering Research Council of Canada [RGPIN-2016-05584]; Canadian
   Institutes of Health Research (CIHR)Canadian Institutes of Health
   Research (CIHR) [PJT153020, ICS154142]; Fonds de la Recherche du
   Quebec-Nature et Technologies (FRQNT) [2018-NC-205593]; Armand-Frappier
   Foundation; Institut National de la Recherche Scientifique
FX LCC is receiving a research scholar (Junior 2) salary support from Fonds
   de la Recherche du Quebec-Sante (FRQS). LCC's research is supported by
   grants from Natural Sciences and Engineering Research Council of Canada
   (NSERC; RGPIN-2016-05584), the Canadian Institutes of Health Research
   (CIHR; PJT153020; ICS154142), Fonds de la Recherche du Quebec-Nature et
   Technologies (FRQNT; 2018-NC-205593), Armand-Frappier Foundation and
   Institut National de la Recherche Scientifique. This protocol is mostly
   adapted from the experimental procedures used in our previous work
   (Chatel-Chaix et al., 2016) in which we have optimized the production
   and detection of ZIKV. We thank the European Virus Archive goes Global
   (EVAg) and Dr. Xavier de Lamballerie (Emergence des Pathologies Virales,
   Aix-Marseille University) for providing ZIKV MR766 and H/PF/2013
   original stocks. We are grateful to Drs Patrick Labonte (Institut
   National de la Recherche Scientifique), Tom Hobman (University of
   Alberta) and Anil Kumar (University of Alberta) for generously providing
   Huh7 and Vero E6 cells.
CR Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   World Health Organization, 2018, FACT SHEETS ZIK VIR
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 17
TC 1
Z9 1
U1 0
U2 1
PU BIO-PROTOCOL
PI SUNNYVALE
PA PO BOX 2073, SUNNYVALE, CA 94087 USA
EI 2331-8325
J9 BIO-PROTOCOL
JI Bio-protocol
PD DEC 20
PY 2018
VL 8
IS 24
AR e3115
DI 10.21769/BioProtoc.3115
PG 18
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HK5TB
UT WOS:000458029300005
DA 2020-07-08
ER

PT J
AU Manning, JE
   Oliveira, F
   Parker, DM
   Amaratunga, C
   Kong, D
   Man, S
   Sreng, S
   Lay, S
   Nang, K
   Kimsan, S
   Sokha, L
   Kamhawi, S
   Fay, MP
   Suon, S
   Ruhl, P
   Ackerman, H
   Huy, R
   Wellems, TE
   Valenzuela, JG
   Leang, R
AF Manning, Jessica E.
   Oliveira, Fabiano
   Parker, Daniel M.
   Amaratunga, Chanaki
   Kong, Dara
   Man, Somnang
   Sreng, Sokunthea
   Lay, Sreyngim
   Nang, Kimsour
   Kimsan, Soun
   Sokha, Ly
   Kamhawi, Shaden
   Fay, Michael P.
   Suon, Seila
   Ruhl, Parker
   Ackerman, Hans
   Huy, Rekol
   Wellems, Thomas E.
   Valenzuela, Jesus G.
   Leang, Rithea
TI The PAGODAS protocol: pediatric assessment group of dengue and Aedes
   saliva protocol to investigate vector-borne determinants of
   Aedes-transmitted arboviral infections in Cambodia
SO PARASITES & VECTORS
LA English
DT Article
DE Arbovirus; Vector; Saliva; Vaccines; Mosquito; Cohort; Seroprevalence
ID CHIKUNGUNYA VIRUS; ZIKA VIRUS; MOSQUITO; LEISHMANIASIS; PROTEIN;
   SURVEILLANCE; POPULATION; BITES; CELLS
AB BackgroundMosquito-borne arboviruses, like dengue virus, continue to cause significant global morbidity and mortality, particularly in Southeast Asia. When the infectious mosquitoes probe into human skin for a blood meal, they deposit saliva containing a myriad of pharmacologically active compounds, some of which alter the immune response and influence host receptivity to infection, and consequently, the establishment of the virus. Previous reports have highlighted the complexity of mosquito vector-derived factors and immunity in the success of infection. Cumulative evidence from animal models and limited data from humans have identified various vector-derived components, including salivary components, that are co-delivered with the pathogen and play an important role in the dissemination of infection. Much about the roles and effects of these vector-derived factors remain to be discovered.Methods/DesignWe describe a longitudinal, pagoda (community)-based pediatric cohort study to evaluate the burden of dengue virus infection and document the immune responses to salivary proteins of Aedes aegypti, the mosquito vector of dengue, Zika, and chikungunya viruses. The study includes community-based seroprevalence assessments in the peri-urban town of Chbar Mon in Kampong Speu Province, Cambodia. The study aims to recruit 771 children between the ages of 2 and 9 years for a three year period of longitudinal follow-up, including twice per year (rainy and dry season) serosurveillance for dengue seroconversion and Ae. aegypti salivary gland homogenate antibody intensity determinations by ELISA assays. Diagnostic tests for acute dengue, Zika and chikungunya viral infections will be performed by RT-PCR.DiscussionThis study will serve as a foundation for further understanding of mosquito saliva immunity and its impact on Aedes-transmitted arboviral diseases endemic to Cambodia.Trial registrationNCT03534245 registered on 23 May 2018.
C1 [Manning, Jessica E.; Oliveira, Fabiano; Amaratunga, Chanaki; Kamhawi, Shaden; Ruhl, Parker; Ackerman, Hans; Wellems, Thomas E.; Valenzuela, Jesus G.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
   [Parker, Daniel M.] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA USA.
   [Kong, Dara; Man, Somnang; Sreng, Sokunthea; Lay, Sreyngim; Nang, Kimsour; Kimsan, Soun; Sokha, Ly; Suon, Seila; Huy, Rekol; Leang, Rithea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Fay, Michael P.] NIAID, Biostat Branch, NIH, Bethesda, MD USA.
RP Manning, JE (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
EM jessica.manning@nih.gov
RI Oliveira, Fabiano/AAG-5388-2019; Fay, Michael P/A-2974-2008; Parker,
   Daniel M./B-5471-2013; Ackerman, Hans/U-9621-2019
OI Oliveira, Fabiano/0000-0002-7924-8038; Fay, Michael
   P/0000-0002-8643-9625; Parker, Daniel M./0000-0002-5352-7338; Ackerman,
   Hans/0000-0003-4940-3305
FU Intramural Research Programme of the National Institute of Allergy and
   Infectious Diseases at the National Institutes of Health; US-Japan
   Collaborative Agreement Award
FX This research was supported by the Intramural Research Programme of the
   National Institute of Allergy and Infectious Diseases at the National
   Institutes of Health. Supplemental funding was received from the
   US-Japan Collaborative Agreement Award.
CR Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8
   Bernard E, 2015, VIROLOGY, V476, P1, DOI 10.1016/j.virol.2014.11.013
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Carnley BP, 2006, HEMOGLOBIN, V30, P463, DOI 10.1080/03630260600868071
   Carvalho AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03345-0
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Dhanoa A, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-017-0384-1
   Doucoure S, 2015, INSECTS, V6, P961, DOI 10.3390/insects6040961
   Doucoure S, 2012, AM J TROP MED HYG, V87, P504, DOI 10.4269/ajtmh.2012.11-0477
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Duong V, 2017, J GEN VIROL, V98, P2287, DOI 10.1099/jgv.0.000892
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051
   Fontaine A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029107
   Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351
   Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006
   Local Indicators of Spatial Association-LISA, ANS 1995 GEOGR AN WI, DOI 10. 1111/j. 1538-4632. 1995. tb00338. x
   Londono-Renteria B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081211
   Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x
   McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019
   MCDONALD PT, 1977, J MED ENTOMOL, V14, P42, DOI 10.1093/jmedent/14.1.42
   Mweya CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162649
   NAKAO S, 1989, BLOOD, V74, P1235
   Natesirinilkul R, 2013, PAEDIATR INT CHILD H, V33, P32, DOI 10.1179/2046905512Y.0000000020
   Ndille EE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005109
   Oliveira F, 2013, J INVEST DERMATOL, V133, P452, DOI 10.1038/jid.2012.315
   Pew Research Center's Religion & Public Life Project, 2012, NW 1615 L ST WASHING
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Puiprom O, 2013, INFECT GENET EVOL, V17, P210, DOI 10.1016/j.meegid.2013.04.005
   Reed SG, 2016, EXPERT REV VACCINES, V15, P81, DOI 10.1586/14760584.2016.1105135
   Ribeiro JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148937
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sagna Andre B, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3030080
   Sornjai W, 2014, VIROLOGY, V471, P61, DOI 10.1016/j.virol.2014.10.004
   Statistics Bureau Japan, 2013, PROJ CAMB GROWTH
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Surasombatpattana P, 2012, J INVEST DERMATOL, V132, P2103, DOI 10.1038/jid.2012.76
   UNICEF-Media Centre, 2016, NAT WID JAP ENC VACC
   Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191
   Vong S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000903
   Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wongkoon S, 2013, INDIAN J MED RES, V138, P347
   Ya-Umphan P, 2017, J INFECT DIS, V215, P396, DOI 10.1093/infdis/jiw543
NR 55
TC 0
Z9 0
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 20
PY 2018
VL 11
AR 664
DI 10.1186/s13071-018-3224-7
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HF3UY
UT WOS:000454161200001
PM 30572920
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Milich, KM
   Koestler, BJ
   Simmons, JH
   Nehete, PN
   Di Fiore, A
   Williams, LE
   Dudley, JP
   Vanchiere, J
   Payne, SM
AF Milich, Krista M.
   Koestler, Benjamin J.
   Simmons, Joe H.
   Nehete, Pramod N.
   Di Fiore, Anthony
   Williams, Lawrence E.
   Dudley, Jaquelin P.
   Vanchiere, John
   Payne, Shelley M.
TI Methods for detecting Zika virus in feces: A case study in captive
   squirrel monkeys (Saimiri boliviensis boliviensis)
SO PLOS ONE
LA English
DT Article
ID YELLOW-FEVER; ARBOVIRUSES; TRANSMISSION; POPULATIONS; INFECTION;
   DISEASES; STATE
AB A strain of Zika virus (ZIKV) of Asian origin associated with birth defects and neurological disorders has emerged and spread through the Americas. ZIKV was first isolated in the blood of nonhuman primates in Africa and has been detected in the blood, saliva, and urine of a few catarrhine species in both Africa and Asia, suggesting that nonhuman primates may serve as both a source and a reservoir of the virus. The recent introduction of ZIKV to human populations in the Americas presents the potential for the virus to spread into nonhuman primate reservoirs. Thus, it is critical to develop efficient and noninvasive detection methods to monitor the spread of the virus in wild nonhuman primate populations. Here, we describe a method for ZIKV detection in noninvasively collected fecal samples of a Neotropical primate. Fecal samples were collected from two captive squirrel monkeys (Saimiri boliviensis boliviensis) that were experimentally infected with ZIKV (Strain Mexico_1_44) and an additional two uninfected squirrel monkeys. Nucleic acids were extracted from these samples, and RT-qPCR was used to assay for the presence of ZIKV using primers flanking a 101 bp region of the NS5 gene. In both ZIKV-inoculated animals, ZIKV was detected 5-11 days post-infection, but was not detected in the uninfected animals. We compare the fecal results to ZIKV detection in serum, saliva, and urine samples from the same individuals. Our results indicate that fecal detection is a cost-effective, noninvasive method for monitoring wild populations of Neotropical primates as possible ZIKV reservoirs.
C1 [Milich, Krista M.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.
   [Milich, Krista M.; Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.
   [Koestler, Benjamin J.; Dudley, Jaquelin P.; Payne, Shelley M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.
   [Koestler, Benjamin J.; Dudley, Jaquelin P.; Payne, Shelley M.] Univ Texas Austin, LaMontagne Ctr Infect Dis, Austin, TX 78712 USA.
   [Simmons, Joe H.; Nehete, Pramod N.; Williams, Lawrence E.] Univ Texas MD Anderson Canc Res Ctr, Bastrop, TX USA.
   [Vanchiere, John] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71105 USA.
RP Milich, KM (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.; Milich, KM (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.
EM krista.milich@wust.edu
RI Vanchiere, John/AAD-8979-2019; Williams, Lawrence/AAD-6685-2020
OI Williams, Lawrence/0000-0003-2267-9918; Koestler,
   Benjamin/0000-0001-7213-0953; Dudley, Jaquelin/0000-0002-1581-1098; Di
   Fiore, Anthony/0000-0001-8893-9052
FU National Science Foundation (NSF)National Science Foundation (NSF)
   [BCS1638822]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R21AI129505, P40OD010938]; University of Texas at Austin;
   University of Texas MD Anderson Cancer Research Center
FX Funding was provided by the National Science Foundation (NSF;
   https://nsf.gov/) award BCS1638822 to ADF, the National Institutes of
   Health (NIH; https://www.nih.gov/) awards R21AI129505 to JPD and
   P40OD010938 to LEW, and the University of Texas at Austin, and the
   University of Texas MD Anderson Cancer Research Center. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.; Funding was provided by the
   National Science Foundation (BCS 1638822), the National Institutes of
   Health (1R21AI129505 and P40OD010938), the University of Texas at
   Austin, and the University of Texas MD Anderson Cancer Research Center.
   We thank Bharti Nehete, Nikos Vasilakis, and Sasha R. Azar for their
   work on the plaque assays.
CR de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Catenacci LS, 2018, ECOHEALTH, V15, P777, DOI 10.1007/s10393-018-1361-2
   CDC, 2016, ALL COUNTR TERR ACT
   Childs JE, 2007, CURR TOP MICROBIOL, V315, P389
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   de Oliveira EF, 2018, TRANSBOUND EMERG DIS, V65, P1094, DOI 10.1111/tbed.12829
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gesquiere LR, 2018, GEN COMP ENDOCR, V260, P9, DOI 10.1016/j.ygcen.2018.02.004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hale VL, 2015, J MICROBIOL METH, V113, P16, DOI 10.1016/j.mimet.2015.03.021
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kowalewski Martin M., 2009, P433, DOI 10.1007/978-0-387-78705-3_17
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Ruch TC, 1959, DIS LAB PRIM
   Sallis ESV, 2003, J VET DIAGN INVEST, V15, P574, DOI 10.1177/104063870301500611
   Strode G.K., 1951, YELLOW FEVER
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Tomori O, 1999, ADV VIRUS RES, V53, P5, DOI 10.1016/S0065-3527(08)60341-3
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wolf TM, 2016, ECOHEALTH, V13, P139, DOI 10.1007/s10393-015-1063-y
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 40
TC 0
Z9 0
U1 1
U2 73
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2018
VL 13
IS 12
AR e0209391
DI 10.1371/journal.pone.0209391
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF0HP
UT WOS:000453841700067
PM 30571742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Vasquez, C
   Petrie, W
   Caban-Martinez, AJ
   Beier, JC
AF Wilke, Andre B. B.
   Vasquez, Chalmers
   Petrie, William
   Caban-Martinez, Alberto J.
   Beier, John C.
TI Construction sites in Miami-Dade County, Florida are highly favorable
   environments for vector mosquitoes
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; GENETIC DIFFERENTIATION; MULTIPLE INTRODUCTIONS;
   AEDES-AEGYPTI; URBANIZATION; BIODIVERSITY; EPIDEMIOLOGY; TRANSMISSION;
   DENGUE
AB Urbanization is increasing globally, and construction sites are an integral part of the urbanization process. It is unknown to what extent construction sites create favorable breeding conditions for mosquitoes. The main objectives of the present study were to identify what species of mosquitoes are present at construction sites and the respective physical features associated with their production. Eleven construction sites were cross-sectionally surveyed for the presence of mosquitoes in Miami-Dade County, Florida including in areas previously affected by the Zika virus outbreak in 2016. A total of 3.351 mosquitoes were collected; 2.680 adults and 671 immatures. Aedes aegypti and Culex quinquefasciatus comprised 95% of all collected mosquitoes and were the only species found in their immature forms breeding inside construction sites. Results for the Shannon and Simpson indices, considering both immature and adult specimens, yielded the highest values for Cx. quinquefasciatus and Ae. aegypti. The individual rarefaction curves indicated that sampling sufficiency was highly asymptotic for Cx. quinquefasciatus and Ae. aegypti, and the plots of cumulative species abundance (In S), Shannon index (H) and log evenness (In E) (SHE) revealed the lack of heterogeneity of species composition, diversity and evenness for the mosquitoes found breeding in construction sites. The most productive construction site breeding features were elevator shafts, Jersey plastic barriers, flooded floors and stair shafts. The findings of this study indicate that vector mosquitoes breed in high numbers at construction sites and display reduced biodiversity comprising almost exclusively Ae. aegypti and Cx. quinquefasciatus. Such findings suggest that early phase construction sites have suitable conditions for the proliferation of vector mosquitoes. More studies are needed to identify modifiable worker- and organizational-level factors to improve mosquito control practices and guide future mosquito control strategies in urban environments.
C1 [Wilke, Andre B. B.; Caban-Martinez, Alberto J.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014; , J/AAG-1499-2019
OI Wilke, Andre B B/0000-0002-6629-7666; , J/0000-0002-5960-1308
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [1U01CK000510-01]
FX This research was supported by CDC (https://www.cdc.gov/) grant
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program to JB. CDC had no role in the
   design of the study and collection, analysis, and interpretation of data
   and in writing the manuscript.
CR Ajelli M, 2017, ACTA TROP, V176, P332, DOI 10.1016/j.actatropica.2017.08.026
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004664)
   Zuluaga WA, 2012, BIOMEDICA, V32, P321, DOI [10.7705/biomedica.v32i3.668, 10.1590/S0120-41572012000300003]
   [Anonymous], 2018, CONSTR CHART BOOK US
   BAUMGARTNER DL, 1987, J AM MOSQUITO CONTR, V3, P26
   Bennet FL, 2003, MANAGEMENT CONSTRUCT
   Brown CA, 2014, INT J SCI TECHNOL RE, V3, P94
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Bureau of Labor Statistics, 2016, LAB FORC STAT CURR P, P230
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Colwell R. K., 2009, PRINCETON GUIDE ECOL, P257, DOI DOI 10.1111/J.1442-9993.2012.02436.X
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Darsie Jr RF, 2000, KEYS ADULT FEMALES 4, V1
   Egizi A, 2016, MOL ECOL, V25, P3033, DOI 10.1111/mec.13653
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Icheku V, 2016, UNIVERS J PUBLIC HLT, V4, P203
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kenea O, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1668-9
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, P1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Legros M, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1515
   Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Sampaio AMM, 2009, WASTE MANAGE, V29, P2867, DOI 10.1016/j.wasman.2009.06.017
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Musso D, 2018, LANCET INFECT DIS, V3099, P1
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Saifur RGM, 2016, 1 RECORD DENGUE VECT, P114, DOI [10.15242/IIE.A.1216020, DOI 10.15242/IIE.A.1216020]
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Semenza JC, 2014, PLOS NEGLECT TROP D, P8
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tserng HP, 2009, AUTOMAT CONSTR, V18, P994, DOI 10.1016/j.autcon.2009.05.005
NR 51
TC 6
Z9 6
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2018
VL 13
IS 12
AR e0209625
DI 10.1371/journal.pone.0209625
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF0HP
UT WOS:000453841700091
PM 30571764
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bullard, BL
   Corder, BN
   Gorman, MJ
   Diamond, MS
   Weaver, EA
AF Bullard, Brianna L.
   Corder, Brigette N.
   Gorman, Matthew J.
   Diamond, Michael S.
   Weaver, Eric A.
TI Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IMMUNE-RESPONSES; MOUSE MODEL; INFECTION; ANTIBODIES; BRAIN; PROTECTION;
   PROTEIN
AB Zika virus (ZIKV) is a major public health concern due to the risk of congenital Zika syndrome in developing fetuses and Guillain-Barre syndrome in adults. Currently, there are no approved vaccines available to protect against infection. Adenoviruses are safe and highly immunogenic vaccine vectors capable of inducing lasting humoral and cellular immune responses. Here, we developed two Adenovirus (Ad) vectored Zika virus vaccines by inserting a ZIKV prM-E gene expression cassette into human Ad types 4 (Ad4-prM-E) and 5 (Ad5-prM-E). Immune correlates indicate that Ad5-prM-E vaccination induces both an anti-ZIKV antibody and T-cell responses whereas Ad4-prM-E vaccination only induces a T-cell response. In a highly lethal challenge in an interferon alpha/beta receptor knockout mice, 80% of Ad5 vaccinated animals and 33% of Ad4 vaccinated animals survived a lethal ZIKV challenge, whereas no animals in the sham vaccinated group survived. In an infection model utilizing immunocompetent C57BL/6 mice that were immunized and then treated with a blocking anti-IFNAR-1 antibody immediately before ZIKV challenge, 100% of Ad4-prM-E and Ad5-prM-E vaccinated mice survived. This indicates that Ad4-prM-E vaccination is protective without the development of detectable anti-ZIKV antibodies. The protection seen in these highly lethal mouse models demonstrate the efficacy of Ad vectored vaccines for use against ZIKV.
C1 [Bullard, Brianna L.; Corder, Brigette N.; Weaver, Eric A.] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA.
   [Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Weaver, EA (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA.
EM eweaver2@unl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Corder,
   Brigette/0000-0001-9424-1398; Bullard, Brianna/0000-0002-6702-0079
FU National Institutes of Health under Ruth L. Kirschstein National
   Research Service Award from the National Institute of Allergy and
   Infectious Diseases [1 T32 AI125207]; NIH NIAIDUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R01
   AI097241, R01 AI073755]
FX We would like to acknowledge Amy Lingel for help in growing the ZIKV
   PRVABC59 strain. We thank the Biodefense and Emerging Infectious Disease
   (BEI) Repository for reagents used in this study. We would also like to
   thank the World Reference Center for Emerging Viruses and Arboviruses
   (University of Texas Medical Branch at Galveston) for the original ZIKV
   41525 strain. This research was supported by the National Institutes of
   Health under Ruth L. Kirschstein National Research Service Award 1 T32
   AI125207 from the National Institute of Allergy and Infectious Diseases
   and by NIH NIAID grant R01 AI097241 and R01 AI073755.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Baden LR, 2015, J INFECT DIS, V211, P518, DOI 10.1093/infdis/jiu485
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fields B.N., 2013, FIELDS VIROLOGY
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Holst P, 2011, VIRAL GENE THERAPY
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lingel A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14891-y
   Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498
   Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145
   Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N., 2017, NATURE ADV ONLINE PU
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013
   Weaver EA, 2014, HUM VACC IMMUNOTHER, V10, P544, DOI 10.4161/hv.27238
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wold WSM, 2013, CURR GENE THER, V13, P421
   World Health Organization, 2018, ANN REV DIS PRIOR RE
   Xu K., 2018, RECOMBINANT CHIMPANZ
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Zhang C, 2016, HUM VACC IMMUNOTHER, V12, P2064, DOI 10.1080/21645515.2016.1165908
NR 53
TC 9
Z9 9
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 20
PY 2018
VL 8
AR 18017
DI 10.1038/s41598-018-35755-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF0GB
UT WOS:000453836700003
PM 30573745
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tricot, T
   Helsen, N
   Kaptein, SJF
   Neyts, J
   Verfaillie, CM
AF Tricot, Tine
   Helsen, Nicky
   Kaptein, Suzanne J. F.
   Neyts, Johan
   Verfaillie, Catherine M.
TI Human stem cell-derived hepatocyte-like cells support Zika virus
   replication and provide a relevant model to assess the efficacy of
   potential antivirals
SO PLOS ONE
LA English
DT Article
ID INFECTION; TRANSMISSION; PATHOGENESIS; OUTBREAK
AB Zika virus (ZIKV) infection during pregnancy has been extensively linked to microcephaly in newborns. High levels of ZIKV RNA were, however, also detected in mice and non-human primates in organs other than the brain, such as the liver. As ZIKV is a flavivirus closely related to the dengue and yellow fever virus, which are known to cause hepatitis, we here examined whether human hepatocytes are susceptible to ZIKV infection. We demonstrated that both human pluripotent stem cell (hPSC)-derived hepatocyte-like cells (HLCs) and the Huh7 hepatoma cell line support the complete ZIKV replication cycle. Of three antiviral molecules that inhibit ZIKV infection in Vero cells, only 7-deaza-2'-C-methyladenosine (7DMA) inhibited ZIKV replication in hPSC-HLCs, while all drugs inhibited ZIKV infection in Huh7 cells. ZIKV-infected hPSC-HLCs but not Huh7 cells mounted an innate immune and NF kappa beta response, which may explain the more extensive cytopathic effect observed in Huh7 cells. In conclusion, ZIKV productively infects human hepatocytes in vitro. However, significant differences in the innate immune response against ZIKV and antiviral drug sensitivity were observed when comparing hPSC-HLCs and hepatoma cells, highlighting the need to assess ZIKV infection as well as antiviral activity not only in hepatoma cells, but also in more physiologically relevant systems.
C1 [Tricot, Tine; Helsen, Nicky; Verfaillie, Catherine M.] Univ Leuven KU Leuven, Stem Cell Inst, Leuven, Belgium.
   [Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Helsen, Nicky] Ismar Healthcare NV, Lier, Belgium.
RP Tricot, T; Verfaillie, CM (corresponding author), Univ Leuven KU Leuven, Stem Cell Inst, Leuven, Belgium.
EM tine.tricot@kuleuven.be; catherine.verfaillie@kuleuven.be
RI Kaptein, Suzanne JF/O-8855-2018; Kaptein, Suzanne JF/O-4714-2019; Neyts,
   Johan/U-8267-2017; Verfaillie, Catherine/H-5148-2013
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Kaptein, Suzanne
   JF/0000-0002-7935-0219; Neyts, Johan/0000-0002-0033-7514; Verfaillie,
   Catherine/0000-0001-7564-4079
FU Research Foundation-Flanders (FWO)FWO [1185918N]; agency for Innovation
   by Science and Technology (IWT)Institute for the Promotion of Innovation
   by Science and Technology in Flanders (IWT) [SB/121396]; KU LeuvenKU
   Leuven; BELSPO-IUAP-BELVIR; IWT-SBO-HILIM-3D; KU LeuvenKU Leuven
   [ETH-C1900-PF]; BELSPO-IUAP-DEVREPAIR; H2020-EuTOX-Risk [681002];
   European UnionEuropean Union (EU) [734584, 734548]
FX T.T. was funded by the Research Foundation-Flanders (FWO) (1185918N)
   (http://www.fwo.be). N.H.was funded by the agency for Innovation by
   Science and Technology (IWT) (SB/121396) (https://www.vlaio.be). Funding
   to J.N. was from KU Leuven, BELSPO-IUAP-BELVIR (http://www.belspo.be),
   IWT-SBO-HILIM-3D (https://www.vlaio.be). Funding to C.M.V. was from KU
   Leuven (ETH-C1900-PF), BELSPO-IUAP-DEVREPAIR (http://www.belspo.be),
   IWT-SBO-HILIM-3D (https://www.vlaio.be) and H2020-EuTOX-Risk (#681002)
   (https://ec.europa.eu/programmes/horizon2020). This work was partially
   funded by the European Union's Horizon 2020 Research and Innovation
   Programme under Grant Agreement no. 734584 (ZikaPLAN) and No 734548
   (ZIKAlliance) (https://ec.europa.eu/programmes/horizon2020) to C.M.V.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, P1, DOI [10.1371/journal.pntd, DOI 10.1371/JOURNAL.PNTD]
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O., 2015, BMJ
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Helsen N, 2016, J HEPATOL, V64, P565, DOI 10.1016/j.jhep.2015.11.013
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   KERR JA, 1973, T ROY SOC TROP MED H, V67, P882, DOI 10.1016/0035-9203(73)90020-5
   Lang JS, 2016, STEM CELL REP, V7, P341, DOI 10.1016/j.stemcr.2016.07.012
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Macnamara FN, 1954, T R SOC TROP MED HYG, V48
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Roelandt P, 2012, J HEPATOL, V57, P246, DOI 10.1016/j.jhep.2012.03.030
   Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414
   Sakurai F, 2017, SCI REP-UK, V7, DOI 10.1038/srep45698
   Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Shlomai A, 2014, P NATL ACAD SCI USA, V111, P12193, DOI 10.1073/pnas.1412631111
   Sumpter R, RIG I, V79, P2689
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vanhove J, 2016, STEM CELL REP, V7, P192, DOI 10.1016/j.stemcr.2016.06.013
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Woodson SE, 2011, J GEN VIROL, V92, P2262, DOI 10.1099/vir.0.031617-0
   Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617
   Wu YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05790-3
   Xia Y, 2017, J HEPATOL, V66, P494, DOI 10.1016/j.jhep.2016.10.009
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhou XL, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.018
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 52
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 19
PY 2018
VL 13
IS 12
AR e0209097
DI 10.1371/journal.pone.0209097
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE9NT
UT WOS:000453779300071
PM 30566505
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Andrews, RJ
   Roche, J
   Moss, WN
AF Andrews, Ryan J.
   Roche, Julien
   Moss, Walter N.
TI ScanFold: an approach for genome-wide discovery of local RNA structural
   elements-applications to Zika virus and HIV
SO PEERJ
LA English
DT Article
DE RNA; RNA structure; Zika virus; Motif discovery; Bioinformatics;
   Sequence analysis; ncRNA; HIV
ID SECONDARY STRUCTURE; NONCODING RNAS; PARTITION-FUNCTION; FLAVIVIRUS RNA;
   PREDICTION; IDENTIFICATION; REPLICATION; TAR; PROBABILITIES;
   VISUALIZATION
AB In addition to encoding RNA primary structures, genomes also encode RNA secondary and tertiary structures that play roles in gene regulation and, in the case of RNA viruses, genome replication. Methods for the identification of functional RNA structures in genomes typically rely on scanning analysis windows, where multiple partially-overlapping windows are used to predict RNA structures and folding metrics to deduce regions likely to form functional structure. Separate structural models are produced for each window, where the step size can greatly affect the returned model. This makes deducing unique local structures challenging, as the same nucleotides in each window can be alternatively base paired. We are presenting here a new approach where all base pairs from analysis windows are considered and weighted by favorable folding. This results in unique base pairing throughout the genome and the generation of local regions/structures that can be ranked by their propensity to form unusually thermodynamically stable folds. We applied this approach to the Zika virus (ZIKV) and HIV-1 genomes. ZIKV is linked to a variety of neurological ailments including microcephaly and Guillain-Barre syndrome and its (+)-sense RNA genome encodes two, previously described, functionally essential structured RNA regions. HIV, the cause of AIDS, contains multiple functional RNA motifs in its genome, which have been extensively studied. Our approach is able to successfully identify and model the structures of known functional motifs in both viruses, while also finding additional regions likely to form functional structures. All data have been archived at the RNAStructuromeDB (www.structurome.bb.iastate.edu), a repository of RNA folding data for humans and their pathogens.
C1 [Andrews, Ryan J.; Roche, Julien; Moss, Walter N.] Iowa State Univ, Roy J Carver Dept Biophys Biochem & Mol Biol, Ames, IA 50011 USA.
RP Moss, WN (corresponding author), Iowa State Univ, Roy J Carver Dept Biophys Biochem & Mol Biol, Ames, IA 50011 USA.
EM wmoss@iastate.edu
OI Andrews, Ryan/0000-0003-0275-0019
FU Iowa State University College of Agriculture and Life Sciences; Roy J.
   Carver Charitable Trust; NIH/NIGMSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R00GM112877]
FX This work was supported by startup funds from the Iowa State University
   College of Agriculture and Life Sciences and the Roy J. Carver
   Charitable Trust, as well as grant R00GM112877 from the NIH/NIGMS. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Andrews RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17510-y
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Babak T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-33
   Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290
   Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014
   Busan S, 2017, RNA, V23, P1012, DOI 10.1261/rna.060194.116
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Das AT, 1998, J VIROL, V72, P9217, DOI 10.1128/JVI.72.11.9217-9223.1998
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106
   Ding YL, 2015, NAT PROTOC, V10, P1050, DOI 10.1038/nprot.2015.064
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008
   Fang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005668
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Forsdyke DR, 2007, J THEOR BIOL, V248, P745, DOI 10.1016/j.jtbi.2007.07.008
   Freyhult E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-241
   Fu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130200
   Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222
   Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Huber RG, 2018, STRUCTURE MAPPING DE, DOI [10.1101/381368, DOI 10.1101/381368]
   Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156906
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389
   Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181
   Lavender CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004230
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lim CS, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02582
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1
   Mathews DH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003665
   Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101
   Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621
   Moss WN, 2018, RNA, V24, P273, DOI 10.1261/rna.063933.117
   Moss WN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-543
   Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511
   Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288
   Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pratt CA, 2013, CURR OPIN CELL BIOL, V25, P99, DOI 10.1016/j.ceb.2012.08.015
   Puton T, 2014, NUCLEIC ACIDS RES, V42, P5403, DOI 10.1093/nar/gku208
   Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129
   Ritchey LE, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx533
   Schlick T, 2017, BIOPHYS J, V113, P225, DOI 10.1016/j.bpj.2016.12.037
   Smyth RP, 2014, J VIROL, V88, P2891, DOI 10.1128/JVI.03014-13
   Stockley PG, 2013, J BIOL PHYS, V39, P277, DOI 10.1007/s10867-013-9313-0
   Thiel BC, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080392
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144
   Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102
   Washietl S, 2012, NUCLEIC ACIDS RES, V40, P4261, DOI 10.1093/nar/gks009
   Washietl Stefan, 2007, V395, P503
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111
   Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589
   Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Zarringhalam K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045160
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
NR 83
TC 5
Z9 5
U1 1
U2 1
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD DEC 18
PY 2018
VL 6
AR e6136
DI 10.7717/peerj.6136
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW8XU
UT WOS:000485278200007
PM 30627482
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nguyen, JT
   Fong, J
   Fong, D
   Fong, T
   Lucero, RM
   Gallimore, JM
   Burata, OE
   Parungao, K
   Rascon, AA
AF Nguyen, James T.
   Fong, Jonathan
   Fong, Daniel
   Fong, Timothy
   Lucero, Rachael M.
   Gallimore, Jamie M.
   Burata, Olive E.
   Parungao, Kamille
   Rascon, Alberto A., Jr.
TI Soluble expression of recombinant midgut zymogen (native propeptide)
   proteases from the Aedes aegypti Mosquito Utilizing E-coli as a host
SO BMC BIOCHEMISTRY
LA English
DT Article
DE Aedes aegypti; Midgut; Proteases; Zymogen; Soluble expression;
   Recombinant protein; Escherichia coli; Disulfide bond; bridge
ID EARLY TRYPSIN; ZIKA VIRUS; PROTEIN; STRATEGIES; BIOLOGY; DENGUE
AB BackgroundStudying proteins and enzymes involved in important biological processes in the Aedes aegypti mosquito is limited by the quantity that can be directly isolated from the mosquito. Adding to this difficulty, digestive enzymes (midgut proteases) involved in metabolizing blood meal proteins require a more oxidizing environment to allow proper folding of disulfide bonds. Therefore, recombinant techniques to express foreign proteins in Escherichia coli prove to be effective in producing milligram quantities of the expressed product. However, with the most commonly used strains having a reducing cytoplasm, soluble expression of recombinant proteases is hampered. Fortunately, new E. coli strains with a more oxidizing cytoplasm are now available to ensure proper folding of disulfide bonds.ResultsUtilizing an E. coli strain with a more oxidizing cytoplasm (SHuffle (R) T7, New England Biolabs) and changes in bacterial growth temperature has resulted in the soluble expression of the four most abundantly expressed Ae. aegypti midgut proteases (AaET, AaSPVI, AaSPVII, and AaLT). A previous attempt of solubly expressing the full-length zymogen forms of these proteases with the leader (signal) sequence and a modified pseudo propeptide with a heterologous enterokinase cleavage site led to insoluble recombinant protein expression. In combination with the more oxidizing cytoplasm, and changes in growth temperature, helped improve the solubility of the zymogen (no leader) native propeptide proteases in E. coli. Furthermore, the approach led to autocatalytic activation of the proteases during bacterial expression and observable BApNA activity. Different time-points after bacterial growth induction were tested to determine the time at which the inactive (zymogen) species is observed to transition to the active form. This helped with the purification and isolation of only the inactive zymogen forms using Nickel affinity.ConclusionsThe difficulty in solubly expressing recombinant proteases in E. coli is caused by the native reducing cytoplasm. However, with bacterial strains with a more oxidizing cytoplasm, recombinant soluble expression can be achieved, but only in concert with changes in bacterial growth temperature. The method described herein should provide a facile starting point to recombinantly expressing Ae. aegypti mosquito proteases or proteins dependent on disulfide bonds utilizing E. coli as a host.
C1 [Nguyen, James T.; Fong, Jonathan; Fong, Daniel; Fong, Timothy; Lucero, Rachael M.; Gallimore, Jamie M.; Burata, Olive E.; Parungao, Kamille; Rascon, Alberto A., Jr.] San Jose State Univ, Dept Chem, Duncan Hall 612,One Washington Sq, San Jose, CA 95192 USA.
RP Rascon, AA (corresponding author), San Jose State Univ, Dept Chem, Duncan Hall 612,One Washington Sq, San Jose, CA 95192 USA.
EM james.t.nguyen91@gmail.com; alberto.rascon@sjsu.edu
OI Rascon, Alberto/0000-0002-0430-1834
FU National Institute of General Medical Sciences (NIGMS) of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [SC3GM116681]
FX Research reported in this publication was supported by the National
   Institute of General Medical Sciences (NIGMS) of the National Institutes
   of Health (NIH) under Award Number SC3GM116681 to AAR. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR ABITA JP, 1969, EUR J BIOCHEM, V8, P314, DOI 10.1111/j.1432-1033.1969.tb00530.x
   Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x
   Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Barillas-Mury C., 1993, Insect Molecular Biology, V2, P7, DOI 10.1111/j.1365-2583.1993.tb00119.x
   Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003
   Casale TB, 2018, J ALLERGY CLIN IMMUN, V141, P482, DOI 10.1016/j.jaci.2017.11.029
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   FELIX CR, 1991, INSECT BIOCHEM, V21, P197, DOI 10.1016/0020-1790(91)90050-O
   Islam J, 2017, ACTA TROP, V174, P56, DOI 10.1016/j.actatropica.2017.06.024
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008
   Jia B, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160196
   Joseph BC, 2015, J CELL SCI R, V6, P1, DOI DOI 10.4172/2157-7013.1000221
   Kalhok S.E., 1993, Insect Molecular Biology, V2, P71, DOI 10.1111/j.1365-2583.1993.tb00127.x
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kaur J, 2018, INT J BIOL MACROMOL, V106, P803, DOI 10.1016/j.ijbiomac.2017.08.080
   Krause M, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0513-8
   Larson HJ, 2019, HUM VACC IMMUNOTHER, V15, P625, DOI 10.1080/21645515.2018.1522468
   Li GY, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040073
   Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56
   Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161
   Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Rascon AA, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-43
   Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172
   Rosenbaum L, 2018, NEW ENGL J MED, V379, P305, DOI 10.1056/NEJMp1804094
   Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063442
   Singha TK, 2017, PROCESS BIOCHEM, V55, P17, DOI 10.1016/j.procbio.2017.01.026
   STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141
   Tharmarajah Kothila, 2017, F1000Res, V6, P2114, DOI 10.12688/f1000research.12461.1
   Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z
   Widmann M, 2000, J BIOL CHEM, V275, P18619, DOI 10.1074/jbc.C000156200
   Wingfield Paul T, 2015, Curr Protoc Protein Sci, V80, DOI 10.1002/0471140864.ps0601s80
   World Health Organization (WHO), 2018, REV SAGE RECOMM US D
   Zhou GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018150
NR 37
TC 1
Z9 1
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2091
J9 BMC BIOCHEM
JI BMC Boichem.
PD DEC 18
PY 2018
VL 19
AR 12
DI 10.1186/s12858-018-0101-0
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HE8HB
UT WOS:000453685500001
PM 30563449
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU VanBlargan, LA
   Himansu, S
   Foreman, BM
   Ebel, GD
   Pierson, TC
   Diamond, MS
AF VanBlargan, Laura A.
   Himansu, Sunny
   Foreman, Bryant M.
   Ebel, Gregory D.
   Pierson, Theodore C.
   Diamond, Michael S.
TI An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted
   Flavivirus Infections
SO CELL REPORTS
LA English
DT Article
ID ANTIBODY-MEDIATED NEUTRALIZATION; REPORTER VIRUS-PARTICLES; POWASSAN
   VIRUS; ZIKA VIRUS; IXODES-SCAPULARIS; DNA VACCINE;
   GENETIC-CHARACTERIZATION; BORNE FLAVIVIRUSES; DOUBLE-BLIND; PHASE-III
AB Powassan virus (POWV) is an emerging tick-transmitted flavivirus that circulates in North America and Russia. Up to 5% of deer ticks now test positive for POWV in certain regions of the northern United States. Although POWV infections cause life-threatening encephalitis, there is no vaccine or countermeasure available for prevention or treatment. Here, we developed a lipid nanoparticle (LNP)-encapsulated modified mRNA vaccine encoding the POWV prM and E genes and demonstrated its immunogenicity and efficacy in mice following immunization with one or two doses. The POWV mRNA vaccine induced high titers of neutralizing antibody and sterilizing immunity against lethal challenge with different POWV strains. The mRNA vaccine also induced cross-neutralizing antibodies against multiple other tick-borne flaviviruses and protected mice against the distantly related Langat virus. These data demonstrate the utility of the LNP-mRNA vaccine platform for the development of vaccines with protective activity against multiple flaviviruses.
C1 [VanBlargan, Laura A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Himansu, Sunny] Moderna Inc, 500 Technol Sq, Cambridge, MA 02139 USA.
   [Foreman, Bryant M.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI073755]; Moderna; NIH-NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID)
FX This work was supported by grants from the NIH-NIAID (R01 AI073755), the
   intramural program of NIH-NIAID (to T.C.P.), and a research grant from
   Moderna. We also thank Brooke Bollman (Moderna) for aiding in the mRNA
   vaccine designs and reviewing the manuscript.
CR Aliota MT, 2014, VECTOR-BORNE ZOONOT, V14, P245, DOI 10.1089/vbz.2013.1475
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Anderson JF, 2012, AM J TROP MED HYG, V87, P754, DOI 10.4269/ajtmh.2012.12-0294
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Brackney DE, 2008, AM J TROP MED HYG, V79, P971, DOI 10.4269/ajtmh.2008.79.971
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Campbell MS, 2000, VIROLOGY, V269, P225, DOI 10.1006/viro.2000.0220
   Chernokhaeva LL, 2016, VACCINE, V34, P2354, DOI 10.1016/j.vaccine.2016.03.041
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Ebel GD, 2001, J GEN VIROL, V82, P1657, DOI 10.1099/0022-1317-82-7-1657
   Ebel GD, 1999, EMERG INFECT DIS, V5, P570, DOI 10.3201/eid0504.990423
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Heinz FX, 1995, VACCINE, V13, P1636, DOI 10.1016/0264-410X(95)00133-L
   Hermance ME, 2017, VECTOR-BORNE ZOONOT, V17, P453, DOI 10.1089/vbz.2017.2110
   Hermance ME, 2015, J VIROL, V89, P7852, DOI 10.1128/JVI.01056-15
   Holbrook MR, 2005, J INFECT DIS, V191, P100, DOI 10.1086/426397
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09
   Knox KK, 2017, VECTOR-BORNE ZOONOT, V17, P463, DOI 10.1089/vbz.2016.2082
   Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   Krow-Lucal ER, 2018, VECTOR-BORNE ZOONOT, V18, P286, DOI 10.1089/vbz.2017.2239
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Leonova GN, 2017, ARCH VIROL, V162, P2211, DOI 10.1007/s00705-017-3309-1
   Leonova GN, 2009, ARCH VIROL, V154, P811, DOI 10.1007/s00705-009-0376-y
   MANDL CW, 1991, VIROLOGY, V185, P891, DOI 10.1016/0042-6822(91)90567-U
   MANDL CW, 1993, VIROLOGY, V194, P173, DOI 10.1006/viro.1993.1247
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   McAuley AJ, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0009-5
   McLEAN D M, 1959, Can Med Assoc J, V80, P708
   Mlera L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005346
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Santos R.I., 2016, VIRUSES, V8, P8
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   THOMAS LA, 1960, P SOC EXP BIOL MED, V104, P355, DOI 10.3181/00379727-104-25836
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 55
TC 4
Z9 5
U1 2
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD DEC 18
PY 2018
VL 25
IS 12
BP 3382
EP +
DI 10.1016/j.celrep.2018.11.082
PG 14
WC Cell Biology
SC Cell Biology
GA HF0CY
UT WOS:000453826600013
PM 30566864
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silveira, ID
   Petersen, MT
   Sylvestre, G
   Garcia, GA
   David, MR
   Pavan, MG
   Maciel-de-Freitas, R
AF da Silveira, Isabella Dias
   Petersen, Martha Thieme
   Sylvestre, Gabriel
   Garcia, Gabriela Azambuja
   David, Mariana Rocha
   Pavan, Marcio Galvao
   Maciel-de-Freitas, Rafael
TI Zika Virus Infection Produces a Reduction on Aedes aegypti Lifespan but
   No Effects on Mosquito Fecundity and Oviposition Success
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Aedes aegypti; Zika; vectorial capacity; survival; fecundity; disease
   transmission
ID RIO-DE-JANEIRO; DAILY SURVIVAL RATES; WEST-NILE-VIRUS; DECREASES
   FECUNDITY; VECTORIAL CAPACITY; GENETIC-VARIATION; FEEDING-BEHAVIOR;
   DENGUE VIRUSES; DIPTERA; TRANSMISSION
AB A Zika virus (ZIKV) pandemic started soon after the first autochthonous cases in Latin America. Although Aedes aegypti is pointed as the primary vector in Latin America, little is known about the fitness cost due to ZIKV infection. We investigated the effects of ZIKV infection on the life-history traits of Ae. aegypti females collected in three districts of Rio de Janeiro, Brazil (Barra, Deodoro, and Porto), equidistant similar to 25 km each other. Aedes aegypti mosquitoes were classified into infected (a single oral challenge with ZIKV) and superinfected (two ZIKV-infected blood meals spaced by 7 days each other). ZIKV infection reduced Ae. aegypti survival in two of the three populations tested, and superinfection produced a sharper increase in mortality in one of those populations. We hypothesized higher mortality with the presence of more ZIKV copies in Ae. aegypti females from Porto. The number of eggs laid per clutch was statistically similar between vector populations and infected and uninfected mosquitoes. Infection by ZIKV not affected female oviposition success. ZIKV infection impacted Ae. aegypti vectorial capacity by reducing its lifespan, although female fecundity remained unaltered. The outcome of these findings to disease transmission intensity still needs further evaluation.
C1 [da Silveira, Isabella Dias; Petersen, Martha Thieme; Sylvestre, Gabriel; Garcia, Gabriela Azambuja; David, Mariana Rocha; Pavan, Marcio Galvao; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Pavan, Marcio Galvao; Maciel-de-Freitas, Rafael] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
RP Maciel-de-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.; Maciel-de-Freitas, R (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
EM freitas@ioc.fiocruz.br
OI Rocha David, Mariana/0000-0003-1241-3585
FU Brazilian Research Council MCTIC [E14/2016 (440929/2016-4]; Brazilian
   Research Council FNDCT-CNPq [E14/2016 (440929/2016-4]; Brazilian
   Research Council MEC-CAPES [E14/2016 (440929/2016-4]; Brazilian Research
   Council MS-Decit [E14/2016 (440929/2016-4]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)CAPES
   [23038.007199/2012-17, 001]; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [E18/2015]
FX This work was supported by the Brazilian Research Councils
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit E14/2016 (440929/2016-4),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil
   (CAPES, 23038.007199/2012-17 and Finance Code 001) and FAPERJ E18/2015.
   Funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Benjamini Y, 2001, ANN STAT, V29, P1165
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cohen J., 1988, STAT POWER ANAL BEHA
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228
   Ehrbar DJ, 2017, INFECT GENET EVOL, V51, P219, DOI 10.1016/j.meegid.2017.04.010
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Harbach R.E., 1980, TAXONOMISTS GLOSSARY
   HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x
   IGARASHI A, 1979, NATURE, V280, P690, DOI 10.1038/280690a0
   Jahan N, 1998, J MED ENTOMOL, V35, P956, DOI 10.1093/jmedent/35.6.956
   Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   KUNO G, 1982, INTERVIROLOGY, V18, P45, DOI 10.1159/000149303
   Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Longdon B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004728
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Maciel-De-Freitas R, 2009, REV SAUDE PUBL, V43, P8, DOI 10.1590/S0034-89102009000100002
   Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8
   Moncayo AC, 2000, J MED ENTOMOL, V37, P701, DOI 10.1603/0022-2585-37.5.701
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119
   PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225
   R Core Team, 2019, R LANG ENV STAT COMP, DOI [10.1007/978-3-540-74686-7, DOI 10.1007/978-3-540-74686-7]
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Robinson A, 2018, P NATL ACAD SCI USA, V115, pE4209, DOI 10.1073/pnas.1721610115
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Schwartz A, 2001, TRENDS PARASITOL, V17, P189, DOI 10.1016/S1471-4922(00)01945-0
   Scott TW, 1998, AM J TROP MED HYG, V59, P341, DOI 10.4269/ajtmh.1998.59.341
   Service M. W., 1993, MOSQUITO ECOLOGY FIE, DOI [10.1007/978-94-015-8113-4, DOI 10.1007/978-94-015-8113-4]
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Vezilier J, 2012, P ROY SOC B-BIOL SCI, V279, P4033, DOI 10.1098/rspb.2012.1394
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
NR 62
TC 2
Z9 2
U1 2
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 18
PY 2018
VL 9
AR 3011
DI 10.3389/fmicb.2018.03011
PG 8
WC Microbiology
SC Microbiology
GA HE7WX
UT WOS:000453652700001
PM 30619118
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Belloto, AC
   Souza, GK
   Perin, PC
   Schuquel, ITA
   Santin, SMO
   Chiavelli, LUR
   Garcia, FP
   Kaplum, V
   Rodrigues, JHS
   Scariot, DB
   Delvecchio, R
   Machado-Ferreira, E
   Aguiar, RS
   Soares, CAG
   Nakamura, CV
   Pomini, AM
AF Belloto, Andrezza C.
   Souza, Gredson K.
   Perin, Paula C.
   Schuquel, Ivania T. A.
   Santin, Silvana M. O.
   Chiavelli, Lucas U. R.
   Garcia, Francielle P.
   Kaplum, Vanessa
   Rodrigues, Jean H. S.
   Scariot, Debora B.
   Delvecchio, Rodrigo
   Machado-Ferreira, Erik
   Aguiar, Renato Santana
   Soares, Carlos A. G.
   Nakamura, Celso V.
   Pomini, Armando M.
TI Crispoic acid, a new compound from Laelia marginata (Orchidaceae), and
   biological evaluations against parasites, human cancer cell lines and
   Zika virus
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE Laelia marginata; Leishmania (Leishmania) amazonensis; bioactive
   metabolites; cytotoxicity; Trypanosoma cruzi; Zika virus; Orchidaceae
ID CONSTITUENTS
AB The phytochemical study of Laelia marginata (Lindl.) L. O. Williams (Orchidaceae) led to the isolation of a new natural product named crispoic acid (1), together with six other known compounds (2-7). The new natural product was identified as a dimer of eucomic acid and was structurally characterised based upon 1D and 2D NMR and HRMS data. Biological assays with plant crude extract, fractions and isolated compounds were performed against two human cancer cell lines (Hela and Siha), and the tropical parasites Trypanosoma cruzi and Leishmania (Leishmania) amazonensis. The phenantrenoid 9,10-dihydro-4-methoxyphenanthren-2,7-diol 2 was active against Hela and Siha cells (CC50 5.86 +/- 0.19 and 20.78 +/- 2.72 mu g/mL, respectively). Sub-lethal concentrations of the flavone rhamnazin 4 were not able to rescue the viability of the Vero cells infected by Zika virus.
   [GRAPHICS]
   .
C1 [Belloto, Andrezza C.; Souza, Gredson K.; Perin, Paula C.; Schuquel, Ivania T. A.; Santin, Silvana M. O.; Chiavelli, Lucas U. R.; Pomini, Armando M.] Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil.
   [Garcia, Francielle P.; Kaplum, Vanessa; Rodrigues, Jean H. S.; Scariot, Debora B.; Nakamura, Celso V.] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil.
   [Delvecchio, Rodrigo; Machado-Ferreira, Erik; Aguiar, Renato Santana; Soares, Carlos A. G.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
RP Pomini, AM (corresponding author), Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil.
EM ampomini@uem.br
RI Nakamura, Celso Vataru/AAA-5620-2019; Aguiar, Renato S/G-3542-2015; de
   Oliveira Santin, Silvana Maria/AAD-8707-2019; Soares, Carlos A
   G/H-9464-2016; Souza, Gredson Keiff/G-2558-2016; Pomini, Armando
   M/P-1277-2018; Garcia, Francielle Pelegrin/L-7691-2018
OI Aguiar, Renato S/0000-0001-5180-3717; Soares, Carlos A
   G/0000-0001-9058-9266; Souza, Gredson Keiff/0000-0001-9724-1131; Garcia,
   Francielle Pelegrin/0000-0001-8966-9154; Perin, Paula
   Cristina/0000-0002-1494-0664
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao
   AraucariaFundacao Araucaria
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior and Fundacao Araucaria.
CR Almeida TL, 2014, QUIM NOVA, V37, P1151
   BRENER Z, 1962, REV INST MED TROP SP, V4, P386
   Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0
   CALVERT DJ, 1979, ORG MAGN RESONANCE, V12, P583, DOI 10.1002/mrc.1270121008
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   JONES HG, 1976, B TORREY BOT CLUB, V103, P117, DOI 10.2307/2484886
   Monteiro JA, 2014, PHYTOCHEM LETT, V9, P141, DOI 10.1016/j.phytol.2014.06.004
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Okada M, 2009, TETRAHEDRON, V65, P2136, DOI 10.1016/j.tet.2008.11.097
   Paula VF, 2006, QUIM NOVA, V29, P213, DOI 10.1590/S0100-40422006000200007
   Peraza-Flores LN, 2016, TAXON, V65, P1249, DOI 10.12705/656.3
   Philchenkov A A, 2015, Ukr Biochem J, V87, P122
   Pomini AM, 2012, PLANTA MED, V78, P1169
   Simmler C, 2011, J NAT PROD, V74, P949, DOI 10.1021/np1006636
   Suttleworth FS, 1994, ORQUIDEAS
   Tenorio-Neto ET, 2015, COLLOID POLYM SCI, V293, P3611, DOI 10.1007/s00396-015-3744-z
   TUCHINDA P, 1988, PHYTOCHEMISTRY, V27, P3267, DOI 10.1016/0031-9422(88)80040-2
   Woo Kyeong Wan, 2014, Natural Product Sciences, V20, P91
NR 18
TC 0
Z9 0
U1 2
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PD DEC 17
PY 2018
VL 32
IS 24
BP 2916
EP 2921
DI 10.1080/14786419.2017.1395428
PG 6
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA HN0NE
UT WOS:000459884600007
PM 29117727
DA 2020-07-08
ER

PT J
AU Tsetsarkin, KA
   Maximova, OA
   Liu, GP
   Kenney, H
   Teterina, N
   Bloom, ME
   Grabowski, JM
   Mlera, L
   Nagata, BM
   Moore, I
   Martens, C
   Amaro-Carambot, E
   Lamirande, EW
   Whitehead, SS
   Pletnev, AG
AF Tsetsarkin, Konstantin A.
   Maximova, Olga A.
   Liu, Guangping
   Kenney, Heather
   Teterina, Natalia
   Bloom, Marshall E.
   Grabowski, Jeffrey M.
   Mlera, Luwanika
   Nagata, Bianca M.
   Moore, Ian
   Martens, Craig
   Amaro-Carambot, Emerito
   Lamirande, Elaine W.
   Whitehead, Stephen S.
   Pletnev, Alexander G.
TI Routes of Zika virus dissemination in the testis and epididymis of
   immunodeficient mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SEXUAL TRANSMISSION; EXPRESSION; MICRORNA; VACCINE; LIVE; MODEL; SEMEN;
   INFECTION; PROFILES; MEMBERS
AB Sexual transmission and persistence of Zika virus (ZIKV) in the male reproductive tract (MRT) poses new challenges for controlling virus outbreaks and developing live-attenuated vaccines. To elucidate routes of ZIKV dissemination in the MRT, we here generate microRNA-targeted ZIKV clones that lose the infectivity for (1) the cells inside seminiferous tubules of the testis, or (2) epithelial cells of the epididymis. We trace ZIKV dissemination in the MRT using an established mouse model of ZIKV pathogenesis. Our results support a model in which ZIKV infects the testis via a hematogenous route, while infection of the epididymis can occur via two routes: (1) hematogenous/lymphogenous and (2) excurrent testicular. Co-targeting of the ZIKV genome with brain-, testis-, and epididymis-specific microRNAs restricts virus infection of these organs, but does not affect virus-induced protective immunity in mice and monkeys. These defined alterations of ZIKV tropism represent a rational design of a safe live-attenuated ZIKV vaccine.
C1 [Tsetsarkin, Konstantin A.; Maximova, Olga A.; Liu, Guangping; Kenney, Heather; Teterina, Natalia; Pletnev, Alexander G.] NIAID, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.
   [Bloom, Marshall E.; Grabowski, Jeffrey M.; Mlera, Luwanika] NIAID, Biol Vector Borne Viruses Sect, Lab Virol, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA.
   [Nagata, Bianca M.; Moore, Ian] NIAID, Infect Dis & Pathogenesis Sect, Comparat Med Branch, NIH, Rockville, MD 20892 USA.
   [Martens, Craig] NIAID, Res Technol RT Sect, RT Branch, Rocky Mt Labs,NIH, Hamilton, MT 58940 USA.
   [Amaro-Carambot, Emerito; Lamirande, Elaine W.; Whitehead, Stephen S.] NIAID, Lab Viral Dis, NIH, Bethesda, MD 20892 USA.
RP Pletnev, AG (corresponding author), NIAID, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.
EM apletnev@niaid.nih.gov
RI Whitehead, Stephen/AAG-2787-2019
FU Division of Intramural Research Program of the National Institute of
   Allergy and Infectious Diseases, National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID)
FX We thank Evgeniya Volkova for her comments and suggestions during
   manuscript preparation. We thank Bryant Maldonado, Stacy Ricklefs, and
   Kimmo Virtaneva for technical assistance. We thank Dr. Gerard Nuovo, Jim
   Williams, and Dr. Adel Mikhail (Phylogeny) for their excellent technical
   support with detection of miRNAs by in situ hybridization. This work was
   supported by the Division of Intramural Research Program of the National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bao JQ, 2012, J BIOL CHEM, V287, P21686, DOI 10.1074/jbc.M111.328054
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Batista L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9959
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Blaney JE, 2006, VIRAL IMMUNOL, V19, P10, DOI 10.1089/vim.2006.19.10
   Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74
   Chakradhar S, 2018, NAT MED, V24, P248, DOI 10.1038/nm0318-248
   Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dabaja AA, 2015, BASIC CLIN ANDROL, V25, DOI 10.1186/s12610-015-0018-z
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hannon Lab, 2018, FASTX TOOLKIT
   Heiss BL, 2011, J VIROL, V85, P1464, DOI 10.1128/JVI.02091-10
   Houzet L, 2018, J VIROL, V92, DOI 10.1128/JVI.00133-18
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   McDonald EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006691
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meissner EG, 2016, J VIRAL HEPATITIS, V23, P496, DOI 10.1111/jvh.12510
   Minami K, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.5
   Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nixon B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132209
   Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605
   Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200
   Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Pletnev AG, 2001, J VIROL, V75, P8259, DOI 10.1128/JVI.75.17.8259-8267.2001
   Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009
   Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Sakurai K, 2016, J APPL TOXICOL, V36, P1614, DOI 10.1002/jat.3326
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Tsetsarkin KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33088
   Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061
   Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573
NR 65
TC 5
Z9 5
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC 17
PY 2018
VL 9
AR 5350
DI 10.1038/s41467-018-07782-x
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE5QV
UT WOS:000453441300018
PM 30559387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tuekprakhon, A
   Puiprom, O
   Sasaki, T
   Michiels, J
   Bartholomeeusen, K
   Nakayama, EE
   Meno, MK
   Phadungsombat, J
   Huits, R
   Arien, KK
   Luplertlop, N
   Shioda, T
   Leaungwutiwong, P
AF Tuekprakhon, Aekkachai
   Puiprom, Orapim
   Sasaki, Tadahiro
   Michiels, Johan
   Bartholomeeusen, Koen
   Nakayama, Emi E.
   Meno, Michael K.
   Phadungsombat, Juthamas
   Huits, Ralph
   Arien, Kevin K.
   Luplertlop, Natthanej
   Shioda, Tatsuo
   Leaungwutiwong, Pornsawan
TI Broad-spectrum monoclonal antibodies against chikungunya virus
   structural proteins: Promising candidates for antibody-based rapid
   diagnostic test development
SO PLOS ONE
LA English
DT Article
ID ALPHAVIRUS CAPSID PROTEIN; PLASMA-MEMBRANE; VIRAL SURFACE; E1; EPITOPE;
   ENTRY; E2; SERODIAGNOSIS; GLYCOPROTEINS; EXPRESSION
AB In response to the aggressive global spread of the mosquito-borne chikungunya virus (CHIKV), an accurate and accessible diagnostic tool is of high importance. CHIKV, an arthritogenic alphavirus, comprises three genotypes: East/Central/South African (ECSA), West African (WA), and Asian. A previous rapid immunochromatographic (IC) test detecting CHIKV E1 protein showed promising performance for detection of the ECSA genotype. Unfortunately, this kit exhibited lower capacity for detection of the Asian genotype, currently in circulation in the Americas, reflecting the low avidity of one of the monoclonal antibodies (mAbs) in this IC kit for the E1 protein of the Asian-genotype because of a variant amino acid sequence. To address this shortcoming, we set out to generate a new panel of broad- spectrum mouse anti-CHIKV mAbs using hybridoma technology. We report here the successful generation of mouse anti-CHIKV mAbs targeting CHIKV E1 and capsid proteins. These mAbs possessed broad reactivity to all three CHIKV genotypes, while most of the mAbs lacked cross-reactivity towards Sindbis, dengue, and Zika viruses. Two of the mAbs also lacked cross-reactivity towards other alphaviruses, including O'nyong-nyong, Ross River, Mayaro, Western Equine Encephalitis, Eastern Equine Encephalitis, and Venezuelan Equine Encephalitis viruses. In addition, another two mAbs cross-reacted weakly only with most closely related O'nyong-nyong virus. Effective diagnosis is one of the keys to disease control but to date, no antibody-based rapid IC platform for CHIKV is commercially available. Thus, the application of the mAbs characterized here in the rapid diagnostic IC kit for CHIKV detection is expected to be of great value for clinical diagnosis and surveillance purposes.
C1 [Tuekprakhon, Aekkachai; Luplertlop, Natthanej; Leaungwutiwong, Pornsawan] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.
   [Tuekprakhon, Aekkachai; Puiprom, Orapim; Sasaki, Tadahiro; Nakayama, Emi E.; Meno, Michael K.; Phadungsombat, Juthamas; Shioda, Tatsuo] Mahidol Univ, Fac Trop Med, MOCID, Bangkok, Thailand.
   [Michiels, Johan; Bartholomeeusen, Koen] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.
   [Nakayama, Emi E.; Arien, Kevin K.; Shioda, Tatsuo] Osaka Univ, RIMD, Osaka, Japan.
   [Huits, Ralph] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
RP Leaungwutiwong, P (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.; Shioda, T (corresponding author), Mahidol Univ, Fac Trop Med, MOCID, Bangkok, Thailand.; Shioda, T (corresponding author), Osaka Univ, RIMD, Osaka, Japan.
EM shioda@biken.osaka-u.ac.jp; pornsawan.lea@mahidol.ac.th
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED); Program: Japan Initiative for
   Global Research Network on Infectious Diseases (J-GRID) [JP18fm0108003]
FX This work was supported by funder Japan Agency for Medical Research and
   Development (AMED), https://www.amed.go.jp/; Program: Japan Initiative
   for Global Research Network on Infectious Diseases (J-GRID)
   JP18fm0108003 to T.S. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahn A, 1999, J VIROL, V73, P10029, DOI 10.1128/JVI.73.12.10029-10039.1999
   Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681
   Angelini R, 2007, EUROSURVEILLANCE, V12
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219
   Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262
   Cho B, 2008, J VIROL METHODS, V154, P154, DOI 10.1016/j.jviromet.2008.07.031
   Damle RG, 2016, ARCH VIROL, V161, P1611, DOI 10.1007/s00705-016-2829-4
   FLYNN DC, 1990, J VIROL, V64, P3643, DOI 10.1128/JVI.64.8.3643-3653.1990
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Goh LYH, 2015, VIRUSES-BASEL, V7, P2943, DOI 10.3390/v7062754
   Goh LYH, 2015, J GEN VIROL, V96, P507, DOI 10.1099/jgv.0.000002
   Hammar L, 2003, J BIOL CHEM, V278, P7189, DOI 10.1074/jbc.M206015200
   Hasan MK, 1997, J GEN VIROL, V78, P2813, DOI 10.1099/0022-1317-78-11-2813
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hong EM, 2006, J VIROL, V80, P8848, DOI 10.1128/JVI.00619-06
   Huits R, 2018, CLIN MICROBIOL INFEC, V24, P78, DOI 10.1016/j.cmi.2017.06.004
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kanai Y, 2010, VIRUS RES, V153, P218, DOI 10.1016/j.virusres.2010.08.005
   Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x
   Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796
   Kishishita N, 2013, J CLIN MICROBIOL, V51, P1389, DOI 10.1128/JCM.03109-12
   Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003
   Kumar S, 2015, ARCH VIROL, V160, P2749, DOI 10.1007/s00705-015-2564-2
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44
   Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   LILJESTROM P, 1991, J VIROL, V65, P147
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025
   MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994
   Nicola AV, 1999, NAT CELL BIOL, V1, P341
   Nsoesie EO, 2016, EUROPEAN COMMUNICABL, V21, P1, DOI DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Phinney BS, 2000, J VIROL, V74, P5667, DOI 10.1128/JVI.74.12.5667-5678.2000
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   SHAPIRA E, 1969, J BIOL CHEM, V244, P1026
   SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648
   Snyder AJ, 2012, J VIROL, V86, P13609, DOI 10.1128/JVI.01805-12
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Stocker J, 1982, RES DISCLOSURE, V217, P155
   Tuekprakhon A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19174-8
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wengler G, 2003, J GEN VIROL, V84, P173, DOI 10.1099/vir.0.18696-0
   Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x
NR 61
TC 5
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 17
PY 2018
VL 13
IS 12
AR e0208851
DI 10.1371/journal.pone.0208851
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE5TK
UT WOS:000453451000050
PM 30557365
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mancera-Paez, O
   Roman, GC
   Pardo-Turriago, R
   Rodriguez, Y
   Anaya, JM
AF Mancera-Paez, Oscar
   Roman, Gustavo C.
   Pardo-Turriago, Rodrigo
   Rodriguez, Yhojan
   Anaya, Juan-Manuel
TI Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis
   post-Zika: A case report and review of the pathogenic role of multiple
   arboviral immunity
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Review
DE Zika virus; Guillain-Barre syndrome; Transverse myelitis; Acute
   disseminated encephalomyelitis; Post-infectious encephalitis; Colombia
ID ACUTE DISSEMINATED ENCEPHALOMYELITIS; VIRUS-INFECTION; DENGUE INFECTION;
   ENTEROVIRUS D68; OUTBREAK; ONSET; MANIFESTATIONS; ENHANCEMENT;
   INFLUENZA; SPECTRUM
AB We review post-infectious and post-vaccination neurological syndromes involving peripheral and central nervous system (CNS) and report an illustrative case of simultaneous occurrence of Guillain-Barre syndrome (GBS), confirmed by nerve conduction velocities, plus MRI-demonstrated transverse myelitis (TM) and acute encephalitis [acute disseminated encephalomyelitis] (ADEM + GBS) affecting a 24-year-old woman from Cucuta, Colombia, who developed acute Zika virus (ZIKV) infection confirmed by serum reverse transcriptase-polymerase chain reaction (RT-PCR) and convalescent ZIKV IgG antibodies. With intensive care treatment, respiratory support, steroids, and intravenous immunoglobulin (IVIg), patient survived with residual flaccid paraparesis. She had preexisting immunity against Chikungunya virus (CHIKV) and Dengue virus (DENV) acquired before the arrival of ZIKV in Colombia. From reports in the Caribbean, Central and South America we review 19 cases of ZIKV-associated TM, encephalitis and ADEM occurring after a mean latent period of 10.5 days (range 1-96) post-infection. Although GBS and ADEM are usually considered post-infectious and associated with development of antibodies against peripheral nerve and CNS epitopes, we postulate that our case of ADEM + GBS is para-infectious, induced by acute ZIKV neurotropism boosted by active immunity against other arboviruses. Animal models of ZIKV demonstrated strong viral neurotropism enhanced by passive immunity with antibodies against arboviruses such as West Nile virus, CHIKV, or DENV. These considerations are relevant to prevent potential ZIKV vaccine-induced reactions involving central and peripheral nervous system.
C1 [Mancera-Paez, Oscar; Pardo-Turriago, Rodrigo] Univ Nacl Colombia, Hosp Univ Nacl, Dept Neurol, Fac Med, Bogota, Colombia.
   [Mancera-Paez, Oscar] Houston Methodist Hosp, David Cabello Int Alzheimer Dis Scholarship Fund, Houston, TX USA.
   [Roman, Gustavo C.] Methodist Neurol Inst, Dept Neurol, Houston, TX USA.
   [Roman, Gustavo C.] Houston Methodist Hosp, Inst Acad Med, Houston Methodist Res Inst, Houston, TX USA.
   [Roman, Gustavo C.] Cornell Univ, Dept Neurol, Weill Cornell Med Coll, New York, NY 10021 USA.
   [Rodriguez, Yhojan; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
RP Roman, GC (corresponding author), 6560 Fannin St,Suite 802, Houston, TX 77030 USA.
EM ogmancerap@unal.edu.co; GCRoman@HoustonMethodist.org;
   rpardot@unal.edu.co; johanintel@hotmail.com; juan.anaya@urosario.edu.co
RI Anaya, Juan-Manuel/J-1960-2016
OI Anaya, Juan-Manuel/0000-0002-6444-1249
FU David Cabello International Alzheimer Disease Scholarship Fund, Houston
   Methodist Hospital, Houston, Texas; Jack S. Blanton Presidential
   Distinguished Chair; Fondren Fund; Wareing Family Fund at Houston
   Methodist Hospital, Houston, Texas, USA
FX The authors would like to thank Dr. Pablo Lorenzana-Pombo and Dr.
   Fernando Ortiz for the review and analysis of the clinical
   neurophysiology and EMG studies in this patient. Dr. Mancera-Paez was
   supported by the David Cabello International Alzheimer Disease
   Scholarship Fund, Houston Methodist Hospital, Houston, Texas. Dr.
   Roman's research is supported by The Jack S. Blanton Presidential
   Distinguished Chair, the Fondren Fund, and the Wareing Family Fund at
   Houston Methodist Hospital, Houston, Texas, USA.
CR ACOSTAAMPUDIA Y, 2018, FRONT MOL NEUROSCI, V11, DOI DOI 10.3389/FNMO1.2018.00116
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111552, 10.3201/eid1804.111522]
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Casagrande B.V.P., 2018, INT ARCH MED, V11, P1, DOI [10.3823/2543, DOI 10.3823/2543]
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   da Silva I.R.F., 2017, JAMA NEUROL, V74, P110, DOI [10.1001/jamaneuro1.2017.1703, DOI 10.1001/JAMANEURO1.2017.1703]
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gerardin P, 2017, NEUROLOGY, V88, P1874, DOI 10.1212/WNL.0000000000003927
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   GULLAND A, 2016, BMJ BRIT MED J, V352
   Gupta M, 2013, J NEUROL SCI, V335, P216, DOI 10.1016/j.jns.2013.08.029
   Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   MILLER HG, 1957, BRIT MED J, V1, P668, DOI 10.1136/bmj.1.5020.668
   MILLER HG, 1956, Q J MED, V25, P427
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Organization Panamericana de la Salud, 2017, EP REP WHO OPS RES S
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   PAHO WHO, ZIK CUM CAS 25 AUG 2
   Palacios E, 2019, NEUROLOGIA, V34, P204, DOI 10.1016/j.nrl.2016.08.006
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pardo-Turriago R., 2017, BIOMEDICA, V37, pS5
   Pardo-Turriago Rodrigo, 2016, Rev. colomb. anestesiol., V44, P86
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Poser C.M., 1969, ACTA NEUROL SCAND, V37, pS1
   POSER CM, 1978, ARCH NEUROL-CHICAGO, V35, P166, DOI 10.1001/archneur.1978.00500270048010
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Puccioni-Sohler M, 2017, ARQ NEURO-PSIQUIAT, V75, P123, DOI [10.1590/0004-282X20160189, 10.1590/0004-282x20160189]
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   ROMAN G, 1978, JAMA-J AM MED ASSOC, V240, P1613, DOI 10.1001/jama.240.15.1613
   Romeu-Mejia R.A., 2017, PM R J, V9, pS247, DOI [10.1016/j.pmrj.2017.08.302, DOI 10.1016/J.PMRJ.2017.08.302]
   Roth W, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000349
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Stubgen JP, 2012, AUTOIMMUN REV, V12, P144, DOI 10.1016/j.autrev.2012.03.008
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Timmings PL, 2017, NEUROLOGY, V88, P1874, DOI 10.1212/WNL.0000000000003928
   Tomar Laxmikant Ramkumarsingh, 2015, Perm J, V19, pe133
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Weeratunga PN, 2014, TRAVEL MED INFECT DI, V12, P189, DOI 10.1016/j.tmaid.2013.11.001
   WHO, 2017, WHO GUILL BARR SYNDR
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 74
TC 8
Z9 9
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD DEC 15
PY 2018
VL 395
BP 47
EP 53
DI 10.1016/j.jns.2018.09.028
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HF6VC
UT WOS:000454375400009
PM 30292020
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mancera-Paez, O
   Roman, GC
   Pardo-Turriago, R
   Rodriguez, Y
   Anaya, JM
AF Mancera-Paez, Oscar
   Roman, Gustavo C.
   Pardo-Turriago, Rodrigo
   Rodriguez, Yhojan
   Anaya, Juan-Manuel
TI Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis
   post-Zika: A case report and review of the pathogenic role of multiple
   arboviral immunity (vol 395, pg 47, 2018)
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Correction
C1 [Mancera-Paez, Oscar; Pardo-Turriago, Rodrigo] Univ Nacl Colombia, Hosp Univ Nacl, Fac Med, Dept Neurol, Bogota, Colombia.
   [Mancera-Paez, Oscar] Houston Methodist Hosp, David Cabello Int Alzheimer Dis Scholarship Fund, Houston, TX USA.
   [Roman, Gustavo C.] Houston Methodist Hosp, Methodist Neurol Inst, Dept Neurol, Houston, TX 77030 USA.
   [Roman, Gustavo C.] Houston Methodist Hosp, Inst Acad Med, Houston Methodist Res Inst, Houston, TX 77030 USA.
   [Roman, Gustavo C.] Cornell Univ, Weill Cornell Med Coll, Dept Neurol, New York, NY 10021 USA.
   [Rodriguez, Yhojan; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
RP Roman, GC (corresponding author), Houston Methodist Hosp, Methodist Neurol Inst, Dept Neurol, Houston, TX 77030 USA.; Roman, GC (corresponding author), Houston Methodist Hosp, Inst Acad Med, Houston Methodist Res Inst, Houston, TX 77030 USA.; Roman, GC (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Neurol, New York, NY 10021 USA.
EM GCRoman@HoustonMethodist.org
CR Mancera-Paez O, 2018, J NEUROL SCI, V395, P47, DOI 10.1016/j.jns.2018.09.028
NR 1
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD DEC 15
PY 2018
VL 395
BP 207
EP 209
DI 10.1016/j.jns.2018.10.021
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HF6VC
UT WOS:000454375400032
PM 30401470
OA Other Gold
DA 2020-07-08
ER

PT J
AU Grifoni, A
   Costa-Ramos, P
   Pham, J
   Tian, Y
   Rosales, SL
   Seumois, G
   Sidney, J
   de Silva, AD
   Premkumar, L
   Collins, MH
   Stone, M
   Norris, PJ
   Romero, CME
   Durbin, A
   Ricciardi, MJ
   Ledgerwood, JE
   de Silva, AM
   Busch, M
   Peters, B
   Vijayanand, P
   Harris, E
   Falconar, AK
   Kallas, E
   Weiskopf, D
   Sette, A
AF Grifoni, Alba
   Costa-Ramos, Priscilla
   Pham, John
   Tian, Yuan
   Rosales, Sandy L.
   Seumois, Gregory
   Sidney, John
   de Silva, Aruna D.
   Premkumar, Lakshmanane
   Collins, Matthew H.
   Stone, Mars
   Norris, Phillip J.
   Romero, Claudia M. E.
   Durbin, Anna
   Ricciardi, Michael J.
   Ledgerwood, Julie E.
   de Silva, Aravinda M.
   Busch, Michael
   Peters, Bjoern
   Vijayanand, Pandurangan
   Harris, Eva
   Falconar, Andrew K.
   Kallas, Esper
   Weiskopf, Daniela
   Sette, Alessandro
TI Cutting Edge: Transcriptional Profiling Reveals Multifunctional and
   Cytotoxic Antiviral Responses of Zika Virus-Specific CD8(+) T Cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID DENGUE; INFECTION
AB Zika virus (ZIKV) constitutes an increasing public health problem. Previous studies have shown that CD8(+) T cells play an important role in ZIKV-specific protective immunity. We have previously defined antigenic targets of the ZIKV-specific CD8(+) T cell response in humans. In this study, we characterized the quality and phenotypes of these responses by a combined use of flow cytometry and transcriptomic methods, using PBMCs from donors deriving from different geographical locations collected in the convalescent phase of infection. We show that ZIKV-specific CD8(+) T cells are characterized by a polyfunctional IFN-gamma signature with upregulation of TNF-alpha, TNF receptors, and related activation markers, such as CD69, as well as a cytotoxic signature characterized by strong upregulation of GZMB and CRTAM. The signature is stable and not influenced by previous dengue virus exposure, geographical location, or time of sample collection postinfection. To our knowledge, this work elucidates the first in-depth characterization of human CD8(+) T cells responding to ZIKV infection.
C1 [Grifoni, Alba; Pham, John; Tian, Yuan; Rosales, Sandy L.; Seumois, Gregory; Sidney, John; de Silva, Aruna D.; Peters, Bjoern; Vijayanand, Pandurangan; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
   [Costa-Ramos, Priscilla; Kallas, Esper] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.
   [de Silva, Aruna D.] Genetech Res Inst, Colombo 08, Sri Lanka.
   [Premkumar, Lakshmanane; Collins, Matthew H.; de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27516 USA.
   [Collins, Matthew H.] Emory Univ, Dept Med, Sch Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30317 USA.
   [Stone, Mars; Norris, Phillip J.; Busch, Michael] Blood Syst Res Inst, San Francisco, CA 94118 USA.
   [Romero, Claudia M. E.; Falconar, Andrew K.] Univ Norte, Barranquilla 1569, Colombia.
   [Durbin, Anna] Univ Vermont, Sch Med, Burlington, VT 05405 USA.
   [Ricciardi, Michael J.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33146 USA.
   [Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Peters, Bjoern; Sette, Alessandro] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vacdnol, Berkeley, CA 94720 USA.
   [de Silva, Aruna D.] Kotelawala Def Univ, Dept Paraclin Sci, Ratmalana, Sri Lanka.
RP Sette, A (corresponding author), 9420 Athena Circle, La Jolla, CA 92037 USA.
EM alex@lji.org
OI , Alba/0000-0002-2209-5966; Seumois, Gregory/0000-0002-8164-6852
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [HHSN272200900042C, HHSN27220140045C, U19 AI118626-01,
   HHSN268201100001I, S10OD016262]; Zika Preparedness Latin American
   Network from the European Union's Horizon 2020 research and innovation
   program [734584]; Shared Instrumentation Grant Program [S10 RR027366];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [S10OD016262]
FX This work was supported by National Institutes of Health (NIH) Contracts
   HHSN272200900042C and HHSN27220140045C, and Grants U19 AI118626-01 to
   A.S., HHSN268201100001I to M.B., and S10OD016262 to P.V. Further support
   was provided by the Zika Preparedness Latin American Network, which has
   received funding from the European Union's Horizon 2020 research and
   innovation program under Grant Agreement 734584. Blood donor samples
   from Puerto Rico and Florida were collected as part of the National
   Heart, Lung, and Blood Institute Recipient Epidemiology and Donor
   Evaluation Study-III. The La Jolla Institute for Allergy and
   Immunology's FACSAria II cell sorter was acquired through Shared
   Instrumentation Grant Program S10 RR027366. The Illumina HiSeq 2500
   Sequencer was purchased through NIH S10OD016262.
CR Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   FERNANDEZ RJ, 1990, MEM I OSWALDO CRUZ, V85, P347, DOI 10.1590/S0074-02761990000300012
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hinz D, 2016, CLIN EXP ALLERGY, V46, P705, DOI 10.1111/cea.12692
   Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0
   Miao TZ, 2017, J EXP MED, V214, P1787, DOI 10.1084/jem.20160553
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Paul Sinu, 2016, Curr Protoc Immunol, V114, DOI 10.1002/cpim.12
   Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101
   Rosales SL, 2018, METHODS MOL BIOL, V1799, P275, DOI 10.1007/978-1-4939-7896-0_21
   Schuster M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-23
   Takeuchi A, 2009, J IMMUNOL, V183, P4220, DOI 10.4049/jimmunol.0901248
   Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5
   Trifilo MJ, 2003, J VIROL, V77, P4004, DOI 10.1128/JVI.77.7.4004-4014.2003
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Yoshimori M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112564
NR 27
TC 15
Z9 15
U1 0
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD DEC 15
PY 2018
VL 201
IS 12
BP 3487
EP 3491
DI 10.4049/jimmunol.1801090
PG 5
WC Immunology
SC Immunology
GA HD6EF
UT WOS:000452626700002
PM 30413672
OA Green Published, Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Adam, A
   Woda, M
   Kounlavouth, S
   Rothman, AL
   Jarman, RG
   Cox, JH
   Ledgerwood, JE
   Gromowski, GD
   Currier, JR
   Friberg, H
   Mathew, A
AF Adam, Awadalkareem
   Woda, Marcia
   Kounlavouth, Sonia
   Rothman, Alan L.
   Jarman, Richard G.
   Cox, Josephine H.
   Ledgerwood, Julie E.
   Gromowski, Gregory D.
   Currier, Jeffrey R.
   Friberg, Heather
   Mathew, Anuja
TI Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika
   Virus-Specific and Cross-Reactive Memory B Cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID ANTIBODY-RESPONSE; INFECTION; ANTIGEN; VACCINE
AB Dengue virus (DENY) and Zika virus (ZIKV) are mosquito-borne pathogens that have a significant impact on human health. Immune sera, mAbs, and memory B cells (MBCs) isolated from patients infected with one DENY type can be cross-reactive with the other three DENY serotypes and even more distantly related flaviviruses such as ZIKV. Conventional ELISPOTs effectively measure Ab-secreting B cells but because they are limited to the assessment of a single Ag at a time, it is challenging to distinguish serotype-specific and cross-reactive MBCs in the same well. We developed a novel multifunction FluoroSpot assay using fluorescently labeled DENY and ZIKV (FLVs) that measures the cross-reactivity of Abs secreted by single B cells. Conjugation efficiency and recognition of FLVs by virus-specific Abs were confirmed by flow cytometry. Using a panel of DENY immune, ZIKV immune, and naive PBMC, FLVs were able to simultaneously detect DENY serotype-specific, ZIKV-specific, DENY serotype cross-reactive, and DENY/ZIKV cross-reactive Abs secreted by individual MBCs. Our findings indicate that the FLVs are sensitive and specific tools to detect specific and cross-reactive MBCs. These reagents will allow the assessment of the breadth as well as the durability of DENY/ZIKV B cell responses following vaccination or natural infection. This novel approach using FLVs in a FluoroSpot assay can be applied to other diseases such as influenza in which prior immunity with homosubtype- or heterosubtype-specific MBCs may influence subsequent infections.
C1 [Adam, Awadalkareem; Woda, Marcia; Kounlavouth, Sonia; Rothman, Alan L.; Mathew, Anuja] Univ Rhode Isl, Dept Cell & Mol Biol, Inst Immunol & Informat, Room 334B,80 Washington St, Providence, RI 02903 USA.
   [Jarman, Richard G.; Gromowski, Gregory D.; Currier, Jeffrey R.; Friberg, Heather] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Cox, Josephine H.; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Mathew, A (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Inst Immunol & Informat, Room 334B,80 Washington St, Providence, RI 02903 USA.
EM mathewa@uri.edu
RI Mathew, Anuja/V-6711-2019
OI Mathew, Anuja/0000-0002-6752-009X; Rothman, Alan/0000-0002-4064-6848;
   Cox, Josephine/0000-0003-1301-7373; Kounlavouth,
   Sonia/0000-0003-2237-0929
FU Military Infectious Diseases Research Program [S0542_16_WR]; Centers of
   Biomedical Research Excellence pilot project Grant [P20GM104317-5];
   American Association of Immunologists Careers in Immunology Award
FX This work was supported by Military Infectious Diseases Research Program
   Grant S0542_16_WR to H.F. and A.M., Centers of Biomedical Research
   Excellence pilot project Grant P20GM104317-5 to A.M., and an American
   Association of Immunologists Careers in Immunology Award to A.M. and
   A.A.
CR Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430
   Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071
   Blackman MA, 2018, VIRAL IMMUNOL, V31, P117, DOI 10.1089/vim.2017.0145
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102
   Yam-Puc JC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00218
   Cedillo-Barron L, 2014, MICROBES INFECT, V16, P711, DOI 10.1016/j.micinf.2014.07.011
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Gagnon SJ, 1996, J VIROL, V70, P141, DOI 10.1128/JVI.70.1.141-147.1996
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hadjilaou A, 2015, J IMMUNOL, V195, P3490, DOI 10.4049/jimmunol.1500918
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Woda M, 2016, J INFECT DIS, V214, P1001, DOI 10.1093/infdis/jiw308
   Woda M, 2015, J IMMUNOL METHODS, V416, P167, DOI 10.1016/j.jim.2014.12.001
NR 42
TC 6
Z9 6
U1 0
U2 8
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD DEC 15
PY 2018
VL 201
IS 12
BP 3804
EP 3814
DI 10.4049/jimmunol.1800892
PG 11
WC Immunology
SC Immunology
GA HD6EF
UT WOS:000452626700033
PM 30413671
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Grab, DJ
   Sharma, A
   Burubulis, I
   Lehrer, AT
   Nerurkar, VR
   Magez, S
   Grab, DJ
AF Grab, D. J.
   Sharma, A.
   Burubulis, I.
   Lehrer, A. T.
   Nerurkar, V. R.
   Magez, S.
   Grab, D. J.
TI Development of camelid nanobody based-LAM Pole diagnostic tests for
   dengue and Zika viruses
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Grab, D. J.; Sharma, A.] Uniformed Serv Univ Hlth Sci, Baltimore, MD USA.
   [Grab, D. J.; Grab, D. J.] Johns Hopkins Univ, Baltimore, MD USA.
   [Burubulis, I.] Univ Virginia, Charlottesville, VA USA.
   [Burubulis, I.] Univ San Sebastian, Puerto Montt, Chile.
   [Lehrer, A. T.; Nerurkar, V. R.] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Magez, S.] Ghent Univ Global Campus, Incheon, South Korea.
   [Magez, S.] Vrije Univ Brussel, Brussels, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD DEC 15
PY 2018
VL 29
IS 26
MA P1041
BP 34
EP 35
PG 2
WC Cell Biology
SC Cell Biology
GA VI6LS
UT WOS:000505772700042
DA 2020-07-08
ER

PT J
AU Long, R
   Jean, F
   Nabi, IR
AF Long, R.
   Jean, F.
   Nabi, I. R.
TI Super resolution STED microscopy of Zika virus induced endoplasmic
   reticulum re-organization.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Long, R.; Nabi, I. R.] Univ British Columbia, Cellular Physiol Sci, Vancouver, BC, Canada.
   [Jean, F.] Univ British Columbia, Microbiol Immunol, Vancouver, BC, Canada.
FU NSERCNatural Sciences and Engineering Research Council of Canada;
   CIHRCanadian Institutes of Health Research (CIHR) [22R76798]; CIHR
   Frederick Banting and Charles Best Canada Graduate Master's
   scholarshipCanadian Institutes of Health Research (CIHR)
FX This project is supported a NSERC Discovery Grant (IRN), CIHR Grant (FJ
   and IRN: No22R76798), and CIHR Frederick Banting and Charles Best Canada
   Graduate Master's scholarship (RL).
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD DEC 15
PY 2018
VL 29
IS 26
MA P3456
PG 2
WC Cell Biology
SC Cell Biology
GA VI6LS
UT WOS:000505772704581
DA 2020-07-08
ER

PT J
AU Miranda, J
   Martin-Tapia, D
   Valdespino-Vazquez, Y
   Espejel-Nunez, A
   Guzman-Huerta, M
   Shibayama, M
   Chavez-Mungia, B
   Estrada-Gutierrez, G
   Lievano, S
   Ludert, JE
   Gonzalez-Mariscal, L
AF Miranda, J.
   Martin-Tapia, D.
   Valdespino-Vazquez, Y.
   Espejel-Nunez, A.
   Guzman-Huerta, M.
   Shibayama, M.
   Chavez-Mungia, B.
   Estrada-Gutierrez, G.
   Lievano, S.
   Ludert, J. E.
   Gonzalez-Mariscal, L.
TI Zika virus infection changes the molecular composition of tight
   junctions and increases the paracellular permeability of the
   syncytiotrophoblast in human placentae.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Miranda, J.; Martin-Tapia, D.; Gonzalez-Mariscal, L.] CINVESTAV, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Mexico City, DF, Mexico.
   [Valdespino-Vazquez, Y.; Espejel-Nunez, A.; Guzman-Huerta, M.; Estrada-Gutierrez, G.] Natl Inst Perinatol INPer, Res Div, Mexico City, DF, Mexico.
   [Shibayama, M.; Chavez-Mungia, B.; Ludert, J. E.] CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
   [Lievano, S.] Mexican Inst Social Secur IMSS, Obstet & Gynecol Hosp 4, Mexico City, DF, Mexico.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD DEC 15
PY 2018
VL 29
IS 26
MA P2450
PG 2
WC Cell Biology
SC Cell Biology
GA VI6LS
UT WOS:000505772703156
DA 2020-07-08
ER

PT J
AU Joyce, AL
   Torres, MM
   Torres, R
   Moreno, M
AF Joyce, Andrea L.
   Murillo Torres, Melany
   Torres, Ryan
   Moreno, Miguel
TI Genetic variability of the Aedes aegypti (Diptera: Culicidae) mosquito
   in El Salvador, vector of dengue, yellow fever, chikungunya and Zika
SO PARASITES & VECTORS
LA English
DT Article
DE AFLPs; Mitochondrial DNAcox1; Dengue; Chikungunya; Yellow fever; Zika;
   Aedes aegypti; Central America; Barcode; Haplotype; Eradication
ID OXIDASE SUBUNIT-I; POPULATION-GENETICS; SOFTWARE; AMERICA;
   PHYLOGEOGRAPHY; SEQUENCE; NUMBER; AFLP
AB BackgroundAedes aegypti is associated with dengue, yellow fever, chikungunya and Zika viruses. This vector is widespread in tropical and subtropical areas, and can also occur in temperate areas at higher latitudes. The geographical distribution of Ae. aegypti continues to spread due to human activities. This is the first study to examine the population genetic structure of this insect in El Salvador, Central America.MethodsAedes aegypti larvae were collected from six geographical regions of El Salvador: Sonsonate, San Salvador, Chalatenango, Usulutan, San Miguel and Morazan. Larvae were raised into adults, identified and preserved. Two molecular markers, amplified fragment length polymorphism (AFLP) genotyping and mitochondrial DNA (mtDNA) cytochrome coxidase subunit 1(cox1) sequencing, were used to investigate population genetic structure.ResultsStructure analysis found two genetically distinct populations; one occurs predominantly in the north and west, and a mix of two populations occurs in the southeast of the country. Genetic distances ranged from 0.028 (2.8%) to 0.091 (9%), and an AMOVA analysis found 11% variation between populations. Mitochondrial DNAcox1 sequences produced a haplotype network which consisted of 3 haplogroups and 10 haplotypes. Haplogroup 1 had low haplotype and nucleotide diversity and was found in all six regions. Haplogroups 2 and 3 had higher haplotype and nucleotide diversity, and were less abundant; haplogroup 3 was found in only 3 of the six regions studied. Bottleneck tests were significant, suggesting that populations had undergone a recent bottleneck. A maximum likelihood tree, which combined samples from this study with available sequences in GenBank, suggested that two genetically divergent lineages had been introduced.ConclusionsRelatively high genetic diversity was found in Ae. aegypti in El Salvador. The mtDNA sequences clustered into two lineages, as found in previous studies. Samples in El Salvador may be introduced from regions in North and South America where past eradication was not complete. Future study of genotypes in surrounding countries would provide a more complete picture of the movement and potential source of introductions of this vector. The distribution of the lineages and haplogroups may further our understanding of the epidemiology of Ae. aegypti associated vector borne diseases.
C1 [Joyce, Andrea L.; Torres, Ryan] Univ Calif Merced, Publ Hlth, 5200 North Lake Rd, Merced, CA 95343 USA.
   [Murillo Torres, Melany; Moreno, Miguel] Univ El Salvador, Dept Biol, Final Ave Martires & Heroes 30 Julio, San Salvador, El Salvador.
RP Joyce, AL (corresponding author), Univ Calif Merced, Publ Hlth, 5200 North Lake Rd, Merced, CA 95343 USA.
EM ajoyce2@ucmerced.edu
FU University of California MercedUniversity of California System
FX The project was supported by the University of California Merced, which
   contributed to the cost of research supplies and supporting
   undergraduate student assistants.
CR [Anonymous], 1995, PUBL CIENT
   [Anonymous], 2006, DNEASY TISSUE HDB
   [Anonymous], 2015, IMPLICACIONES SALUD
   APOSTOL BL, 1994, AM J TROP MED HYG, V51, P89, DOI 10.4269/ajtmh.1994.51.89
   Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Caceres OA, 2007, SERIE INFORMES TECNI, V96, P1
   Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P586
   Cornuet JM, 1996, GENETICS, V144, P2001
   Costa-da-Silva AL, 2005, MEM I OSWALDO CRUZ, V100, P639, DOI 10.1590/S0074-02762005000600007
   Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Gloria-Soria A, 2018, AM J TROP MED HYG, V98, P445, DOI 10.4269/ajtmh.17-0676
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gorrochotegui-Escalante N, 2000, AM J TROP MED HYG, V62, P200, DOI 10.4269/ajtmh.2000.62.200
   Hayes JM, 2003, AM J TROP MED HYG, V69, P629
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Huber K, 2004, ACTA TROP, V90, P23, DOI 10.1016/j.actatropica.2003.09.012
   Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553
   Joyce AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2594-6
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Caldera SM, 2013, BIOMEDICA, V33, P89, DOI 10.7705/biomedica.v33i0.1573
   Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Morlais I, 2002, DNA SEQUENCE, V13, P123, DOI 10.1080/10425170290030051
   Ocampo CB, 2004, AM J TROP MED HYG, V71, P506, DOI 10.4269/ajtmh.2004.71.506
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Pritchard J.K., 2007, DOCUMENTATION STRUCT
   Pritchard JK, 2000, GENETICS, V155, P945
   Ravel S, 2001, ACTA TROP, V78, P241, DOI 10.1016/S0001-706X(01)00083-3
   Duenas JCR, 2009, J MED ENTOMOL, V46, P1344, DOI 10.1603/033.046.0613
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   SLOSEK J, 1986, SOC SCI MED, V23, P249, DOI 10.1016/0277-9536(86)90345-X
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P521
   TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467
   TABACHNICK WJ, 1979, EVOLUTION, V33, P287, DOI 10.1111/j.1558-5646.1979.tb04682.x
   VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407
NR 50
TC 1
Z9 1
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 14
PY 2018
VL 11
DI 10.1186/s13071-018-3226-5
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HE4DD
UT WOS:000453314300002
PM 30547835
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Munoz-Medina, JE
   Garcia-Knight, MA
   Sanchez-Flores, A
   Monroy-Munoz, IE
   Grande, R
   Esbjornsson, J
   Santacruz-Tinoco, CE
   Gonzalez-Bonilla, CR
AF Esteban Munoz-Medina, Jose
   Antonio Garcia-Knight, Miguel
   Sanchez-Flores, Alejandro
   Eloisa Monroy-Munoz, Irma
   Grande, Ricardo
   Esbjornsson, Joakim
   Esperanza Santacruz-Tinoco, Clara
   Raul Gonzalez-Bonilla, Cesar
TI Evolutionary analysis of the Chikungunya virus epidemic in Mexico
   reveals intra-host mutational hotspots in the E1 protein
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; ANTIBODIES; DIVERSITY; MOSQUITOS; GENOTYPE; FITNESS; HUMANS;
   DENGUE
AB The epidemic potential of Chikungunya virus (CHIKV) was recently made evident by its introduction and rapid expansion in the Caribbean and the Americas. We sought to gain a detailed understanding of the dynamics of the epidemic in Mexico, the country with the highest number of confirmed CHIKV cases in the Americas, and to characterise viral evolution at the population and intra-host level. Analysis of the spatiotemporal distribution of 2,739 diagnosed cases in Mexico from December 2014 to December 2015 showed a rapid nationwide expansion of the epidemic with focalisation in the South West of the country. We sequenced the envelope glycoprotein 1 gene (E1) from 25 patients using the Illumina MiSeq platform and report synonymous and non-synonymous consensus mutations. Bayesian phylogenetic analysis using 249 Asian lineage E1 sequences gave updated estimates of nucleotide substitution rates for E1 and time to most recent common ancestor of major lineages. The analysis indicates phylogenetically-related emergent Latin American clusters in South Western Mexico, Nicaragua and Honduras and transmission of American strains in the Pacific islands. Detailed analysis showed that intra-host changes in E1 mainly occurred in two variable regions (E1:189-220 and E1:349-358) in domains II and III, respectively, in residues involved in inter and intra-envelope spike interactions. At the population level, this study sheds light on the introduction and evolutionary dynamics of CHIKV in the Americas. At the intra-host level, this study identifies mutational hotspots of the E1 protein with implications for understanding the relationship between the CHIKV quasispecies, viral fitness and pathogenesis.
C1 [Esteban Munoz-Medina, Jose; Esperanza Santacruz-Tinoco, Clara] Ctr Med Nacl La Raza, Inst Mexicano Seguro Social, Lab Cent Epidemiol, Mexico City, DF, Mexico.
   [Antonio Garcia-Knight, Miguel] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico.
   [Sanchez-Flores, Alejandro; Grande, Ricardo] Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Mas & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Eloisa Monroy-Munoz, Irma] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Lab Genom, Dept Genet & Genom Humana, Mexico City, DF, Mexico.
   [Esbjornsson, Joakim] Lund Univ, Dept Lab Med, Syst Virol, Lund, Sweden.
   [Esbjornsson, Joakim] Univ Oxford, Nuffield Dept Med, NDM Res Bldg, Oxford, England.
   [Raul Gonzalez-Bonilla, Cesar] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Antonio Garcia-Knight, Miguel] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
RP Munoz-Medina, JE (corresponding author), Ctr Med Nacl La Raza, Inst Mexicano Seguro Social, Lab Cent Epidemiol, Mexico City, DF, Mexico.; Garcia-Knight, MA (corresponding author), Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico.; Sanchez-Flores, A (corresponding author), Univ Nacl Autonoma Mexico, Unidad Univ Secuenciac Mas & Bioinformat, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
EM eban10@hotmail.com; miguel.garciaknight@ucsf.edu; alexsf@ibt.unam.mx
RI Esteban, Munoz Medina Jose/B-6186-2015; Sanchez-Flores,
   Alejandro/L-9454-2016
OI Esteban, Munoz Medina Jose/0000-0002-1289-4457; Sanchez-Flores,
   Alejandro/0000-0003-0476-3139; Gonzalez Bonilla,
   Cesar/0000-0002-2225-5069; Garcia Knight, Miguel
   Antonio/0000-0001-9556-3719; Esbjornsson, Joakim/0000-0002-3822-4953
FU Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G16/1575];
   Secretaria de Educacion Publica [103.5/16/10420]; Consejo Nacional de
   Ciencia y TecnologiaConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [264598]; Programa de Laboratorios Nacionales CONACyT
FX This study was supported by the Instituto Mexicano del Seguro Social
   (FIS/IMSS/PROT/G16/1575 to JEMM), the Secretaria de Educacion Publica
   (103.5/16/10420 to MAGK), the Consejo Nacional de Ciencia y Tecnologia
   (264598 to MAGK). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; We would like to thank the Unidad Universitaria de
   Secuenciacion Masiva y Bioinformatica (UUSMB) of the Instituto de
   Biotecnologia, UNAM, for advice on DNA sequencing and bioinformatic
   analysis. The UUSMB is part of the Laboratorio Nacional de Apoyo a las
   Tecnologias en Ciencias Genomicas which was created and funded by the
   Programa de Laboratorios Nacionales CONACyT. We also express our
   gratitude to the working team from the Molecular Biology Department of
   the Laboratorio Central de Epidemiologia for technical assistance.
   Finally, we would like to thank Dr. Carlos Arias for his feedback and
   discussion for this manuscript.
CR Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030
   Abraham R, 2016, INFECT GENET EVOL, V37, P174, DOI 10.1016/j.meegid.2015.11.019
   Diaz-Quinonez JA, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00300-15
   Diaz-Quinonez JA, 2016, VIRUS GENES, V52, P127, DOI 10.1007/s11262-015-1275-9
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Carrera JP, 2017, PLOS NEGLECT TROP D, V11, P1
   Chen R, 2016, J VIROL, V90
   Chien L-J, 2014, LIN VIF EP EP DENG L, P51
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Danis LR, 2017, PLOS ONE, V12
   Direccion General de Epidemiologia I, 2014, LIN VIG EP DIAGN LAB
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Erasmus JH, 2016, J INFECT DIS, V214, pS488, DOI 10.1093/infdis/jiw271
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Forrester NL, 2011, J VIROL, V85, P8709, DOI 10.1128/JVI.00165-11
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Galan-Huerta KA, 2018, VIRUSES, V10, P1
   Geller R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9571
   Gobierno de los Estados Unidos Mexicanos-Presidencia de la Republica, 2016, CUART INF GOV 2015 2
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Organizacion Panamericana de la Salud, 2011, PREP RESP ANT EV INT
   Pan American Health Organization, 2016, CAS CHIK FEV AM CUM
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Rodriguez-Roche R, 2016, J VIROL, V90, P4320, DOI 10.1128/JVI.02647-15
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Secretaria de Salud, 2017, NON TRADITIONAL REF
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Sun S, 2013, ELIFE, V2013, P1
   Tan K- K, 2015, SCI REP, P1
   Tan Y, 2018, PLOS NEGLECT TROP D, V12, P1
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Venturi G, 2017, EUROSURVEILLANCE, V22, P39, DOI [DOI 10.2807/1560-7917.ES.2017.22.39.17-00646, 10.2807/1560-7917.ES.2017.22.39.17-00646]
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wang CL, 2016, AM J TROP MED HYG, V94, P400, DOI 10.4269/ajtmh.15-0497
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
NR 62
TC 1
Z9 1
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2018
VL 13
IS 12
AR e0209292
DI 10.1371/journal.pone.0209292
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE3IQ
UT WOS:000453248000055
PM 30550577
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Croker, C
   Marutani, A
   Santos, M
   Hathaway, S
   Hwang, B
AF Croker, Curtis
   Marutani, Amy
   Santos, Marita
   Hathaway, Susan
   Hwang, Bessie
TI Follow-Up on 11 Infants Born to Women with Evidence of Zika Virus
   Infection During Pregnancy - Los Angeles County, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Croker, Curtis; Marutani, Amy; Santos, Marita; Hathaway, Susan; Hwang, Bessie] Los Angeles Cty Dept Publ Hlth, Acute Communicable Dis Control Program, Los Angeles, CA 90012 USA.
RP Croker, C (corresponding author), Los Angeles Cty Dept Publ Hlth, Acute Communicable Dis Control Program, Los Angeles, CA 90012 USA.
EM ccroker@ph.lacounty.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2017, ZIK VIR 2016 CAS DEF
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 6
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD DEC 14
PY 2018
VL 67
IS 49
BP 1372
EP 1373
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HE0TA
UT WOS:000452979900005
PM 30543603
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Shah, PS
   Link, N
   Jang, GM
   Sharp, PP
   Zhu, TT
   Swaney, DL
   Johnson, JR
   Von Dollen, J
   Ramage, HR
   Satkamp, L
   Newton, B
   Huttenhain, R
   Petit, MJ
   Baum, T
   Everitt, A
   Laufman, O
   Tassetto, M
   Shales, M
   Stevenson, E
   Iglesias, GN
   Shokat, L
   Tripathi, S
   Balasubramaniam, V
   Webb, LG
   Aguirre, S
   Willsey, AJ
   Garcia-Sastre, A
   Pollard, KS
   Cherry, S
   Gamarnik, AV
   Marazzi, I
   Taunton, J
   Fernandez-Sesma, A
   Bellen, HJ
   Andino, R
   Krogan, NJ
AF Shah, Priya S.
   Link, Nichole
   Jang, Gwendolyn M.
   Sharp, Phillip P.
   Zhu, Tongtong
   Swaney, Danielle L.
   Johnson, Jeffrey R.
   Von Dollen, John
   Ramage, Holly R.
   Satkamp, Laura
   Newton, Billy
   Huttenhain, Ruth
   Petit, Marine J.
   Baum, Tierney
   Everitt, Amanda
   Laufman, Orly
   Tassetto, Michel
   Shales, Michael
   Stevenson, Erica
   Iglesias, Gabriel N.
   Shokat, Leila
   Tripathi, Shashank
   Balasubramaniam, Vinod
   Webb, Laurence G.
   Aguirre, Sebastian
   Willsey, A. Jeremy
   Garcia-Sastre, Adolfo
   Pollard, Katherine S.
   Cherry, Sara
   Gamarnik, Andrea V.
   Marazzi, Ivan
   Taunton, Jack
   Fernandez-Sesma, Ana
   Bellen, Hugo J.
   Andino, Raul
   Krogan, Nevan J.
TI Comparative Flavivirus-Host Protein Interaction Mapping Reveals
   Mechanisms of Dengue and Zika Virus Pathogenesis
SO CELL
LA English
DT Article
ID INTERFERON; NEUROGENESIS; REPLICATION; DEPENDENCY; ELONGATION;
   INFECTION; INSERTION; IMMUNITY; COMPLEX; GENOME
AB Mosquito-borne flaviviruses, including dengue virus (DENV) and Zika virus (ZIKV), are a growing public health concern. Systems-level analysis of how flaviviruses hijack cellular processes through virus-host protein-protein interactions (PPIs) provides information about their replication and pathogenic mechanisms. We used affinity purification-mass spectrometry (AP-MS) to compare flavivirus-host interactions for two viruses (DENV and ZIKV) in two hosts (human and mosquito). Conserved virus-host PPIs revealed that the flavivirus NS5 protein suppresses interferon stimulated genes by inhibiting recruitment of the transcription complex PAF1C and that chemical modulation of SEC61 inhibits DENV and ZIKV replication in human and mosquito cells. Finally, we identified a ZIKV-specific interaction between NS4A and ANKLE2, a gene linked to hereditary microcephaly, and showed that ZIKV NS4A causes microcephaly in Drosophila in an ANKLE2-dependent manner. Thus, comparative flavivirus-host PPI mapping provides biological insights and, when coupled with in vivo models, can be used to unravel pathogenic mechanisms.
C1 [Shah, Priya S.; Jang, Gwendolyn M.; Sharp, Phillip P.; Swaney, Danielle L.; Johnson, Jeffrey R.; Von Dollen, John; Satkamp, Laura; Newton, Billy; Huttenhain, Ruth; Shales, Michael; Stevenson, Erica; Shokat, Leila; Taunton, Jack; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.
   [Shah, Priya S.; Laufman, Orly; Tassetto, Michel; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Shah, Priya S.; Jang, Gwendolyn M.; Swaney, Danielle L.; Johnson, Jeffrey R.; Von Dollen, John; Satkamp, Laura; Newton, Billy; Huttenhain, Ruth; Shales, Michael; Stevenson, Erica; Shokat, Leila; Willsey, A. Jeremy; Pollard, Katherine S.; Taunton, Jack; Krogan, Nevan J.] Univ Calif San Francisco, QBI, San Francisco, CA 94143 USA.
   [Shah, Priya S.; Jang, Gwendolyn M.; Swaney, Danielle L.; Johnson, Jeffrey R.; Von Dollen, John; Satkamp, Laura; Newton, Billy; Huttenhain, Ruth; Shales, Michael; Stevenson, Erica; Shokat, Leila; Pollard, Katherine S.; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA.
   [Link, Nichole; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Link, Nichole; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
   [Link, Nichole; Bellen, Hugo J.] Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.
   [Link, Nichole; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.
   [Zhu, Tongtong; Tripathi, Shashank; Webb, Laurence G.; Aguirre, Sebastian; Garcia-Sastre, Adolfo; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Zhu, Tongtong; Webb, Laurence G.; Marazzi, Ivan; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Ramage, Holly R.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Petit, Marine J.] Univ Calif Davis, Dept Chem Engn, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.
   [Baum, Tierney; Everitt, Amanda; Willsey, A. Jeremy] Univ Calif San Francisco, Weill Inst Neurosci, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.
   [Iglesias, Gabriel N.; Gamarnik, Andrea V.] Fdn Inst Leloir CONICET, Buenos Aires, DF, Argentina.
   [Balasubramaniam, Vinod] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Selangor, Malaysia.
   [Willsey, A. Jeremy] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
   [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA.
   [Pollard, Katherine S.] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA.
   [Pollard, Katherine S.] Chan Zuckerberg Biohub, San Francisco, CA USA.
   [Shah, Priya S.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.
   [Shah, Priya S.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.
RP Krogan, NJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Krogan, NJ (corresponding author), Univ Calif San Francisco, QBI, San Francisco, CA 94143 USA.; Krogan, NJ (corresponding author), J David Gladstone Inst, San Francisco, CA 94158 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.
EM hbellen@bcm.edu; raul.andino@ucsf.edu; nevan.krogan@ucsf.edu
RI ; RMT Balasubramaniam, Vinod/B-6957-2017
OI Huttenhain, Ruth/0000-0002-0896-5910; Johnson,
   Jeffrey/0000-0002-4221-298X; Shah, Priya/0000-0001-7518-2839; Bellen,
   Hugo/0000-0001-5992-5989; Webb, Laurence/0000-0001-8307-8492; PETIT,
   marine/0000-0001-7427-7203; RMT Balasubramaniam,
   Vinod/0000-0001-9583-307X; Everitt, Amanda/0000-0001-9720-1922; Zhu,
   Tongtong/0000-0002-8201-2341
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [F32AI112262, U19AI1186101, R01AI07345,
   R21AI116022]; NIH/NINDSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [F32NS092270, U54NS093793];
   DOD/DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [HR0011-11-C-0094]; NIH/NIGMSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [P50
   GM082250]; UCSF Breast Cancer Research Funds; NIH/OD [R24OD022005];
   Huffington Foundation; HHMIHoward Hughes Medical Institute
FX We would like to thank Manon Eckhardt, Judd Hultquist, and Jacqueline
   Fabius for critical reading of the manuscript; the Krogan group for
   valuable comments; and Sima Lev, Michael Diamond, Chris Doe, Jim Skeath,
   BEI Resources, and the Bloomington Drosophila Stock Center for providing
   stocks, and reagents and the IDDRC Microscopy Core (NIH/NICHD
   U54HD083092). This work was supported by NIH/NIAID F32AI112262 to
   P.S.S., NIH/NINDS F32NS092270 to N.L., DOD/DARPA HR0011-11-C-0094
   (PROPHECY) to R.A., A.V.G, A.F.S., and N.J.K., NIH/NIAID U19AI1186101 to
   A.F.S. and N.J.K., NIH/NIGMS P50 GM082250 to N.J.K., NIH/NIAID
   R01AI07345, R21AI116022 to A.F.S., UCSF Breast Cancer Research Funds to
   J.T., and NIH/NINDS U54NS093793, NIH/OD R24OD022005, and the Huffington
   Foundation to H.J.B. H.J.B. and N.L. are supported by HHMI.
CR Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Batra J, 2018, CELL, V175, P1917, DOI 10.1016/j.cell.2018.08.044
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen SH, 2018, EMBO J, V37, DOI 10.15252/embj.201797508
   Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305
   Coin I, 2008, ORG LETT, V10, P3857, DOI 10.1021/ol800855p
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Eckhardt M, 2018, CANCER DISCOV, V8, P1474, DOI 10.1158/2159-8290.CD-17-1018
   Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fontaine KA, 2018, MBIO, V9, DOI [10.1128/mBio.02126-18, 10.1128/mbio.02126-18]
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719
   Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693
   Kane JR, 2015, CELL REP, V11, P1236, DOI 10.1016/j.celrep.2015.04.038
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002
   Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maifeld SV, 2011, CHEM BIOL, V18, P1082, DOI 10.1016/j.chembiol.2011.06.015
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Rialdi A, 2016, SCIENCE, V352, DOI 10.1126/science.aad7993
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Shah PS, 2015, CURR OPIN MICROBIOL, V27, P62, DOI 10.1016/j.mib.2015.07.008
   Shaheen R, 2019, GENET MED, V21, P545, DOI 10.1038/s41436-018-0140-3
   Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125
   Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284
   Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203
   Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426
   Verschueren E, 2015, CURR PROTOC BIOINFOR, V49, P11
   von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wangler MF, 2015, GENETICS, V199, P639, DOI 10.1534/genetics.114.171785
   Weger-Lucarelli J, 2017, J VIROL, V16, P91
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002
   Yim TJ, 1996, VIROLOGY, V218, P61, DOI 10.1006/viro.1996.0166
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895
   Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622
NR 75
TC 38
Z9 38
U1 0
U2 30
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD DEC 13
PY 2018
VL 175
IS 7
BP 1931
EP +
DI 10.1016/j.cell.2018.11.028
PG 33
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA HE3GZ
UT WOS:000453242200020
PM 30550790
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Kum, DB
   Mishra, N
   Boudewijns, R
   Gladwyn-Ng, I
   Alfano, C
   Ma, J
   Schmid, MA
   Marques, RE
   Schols, D
   Kaptein, S
   Nguyen, L
   Neyts, J
   Dallmeier, K
AF Kum, Dieudonne B.
   Mishra, Niraj
   Boudewijns, Robbert
   Gladwyn-Ng, Ivan
   Alfano, Christian
   Ma, Ji
   Schmid, Michael A.
   Marques, Rafael E.
   Schols, Dominique
   Kaptein, Suzanne
   Nguyen, Laurent
   Neyts, Johan
   Dallmeier, Kai
TI A yellow fever-Zika chimeric virus vaccine candidate protects against
   Zika infection and congenital malformations in mice
SO NPJ VACCINES
LA English
DT Article
ID LIVE ATTENUATED VACCINE; IN-VITRO; TRANSMEMBRANE DOMAINS; PRM PROTEIN;
   CONSTRUCTION; CONTRIBUTES; MUTAGENESIS; IMMUNITY; AMERICA; LETHAL
AB The recent Zika virus (ZIKV) epidemic in the Americas led to an intense search for therapeutics and vaccines. Here we report the engineering of a chimeric virus vaccine candidate (YF-ZIKprM/E) by replacing the antigenic surface glycoproteins and the capsid anchor of YFV-17D with those of a prototypic Asian lineage ZIKV isolate. By intracellular passaging, a variant with adaptive mutations in the E protein was obtained. Unlike YFV-17D, YF-ZIKprM/E replicates poorly in mosquito cells. Also, YF-ZIKprM/E does not cause disease nor mortality in interferon alpha/beta, and gamma receptor KO AG129 mice nor following intracranial inoculation of BALB/c pups. A single dose as low as 1 x 10(2) PFU results, as early as 7 days post vaccination, in seroconversion to neutralizing antibodies and confers full protection in AG129 mice against stringent challenge with a lethal inoculum (10(5) LD50) of either homologous or heterologous ZIKV strains. Induction of multi-functional CD4(+) and CD8(+) T cell responses against ZIKV structural and YFV-17D nonstructural proteins indicates that cellular immunity may also contribute to protection. Vaccine immunogenicity and protection was confirmed in other mouse strains, including after temporal blockade of interferon-receptors in wild-type mice to facilitate ZIKV replication. Vaccination of wild-type NMRI dams with YF-ZIKprM/E results in complete protection of foetuses against brain infections and malformations following a stringent intraplacental challenge with an epidemic ZIKV strain. The particular characteristic of YF-ZIKprM/E in terms of efficacy and its marked attenuation in mice warrants further exploration as a vaccine candidate.
C1 [Kum, Dieudonne B.; Mishra, Niraj; Boudewijns, Robbert; Ma, Ji; Schmid, Michael A.; Schols, Dominique; Kaptein, Suzanne; Neyts, Johan; Dallmeier, Kai] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Dept Microbiol & Immunol, Leuven, Belgium.
   [Gladwyn-Ng, Ivan; Alfano, Christian; Nguyen, Laurent] Univ Liege, CHU Sart Tilman, GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium.
   [Marques, Rafael E.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.
RP Neyts, J; Dallmeier, K (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Dept Microbiol & Immunol, Leuven, Belgium.
EM johan.neyts@kuleuven.be; kai.dallmeier@kuleuven.be
RI Kaptein, Suzanne JF/O-8855-2018; Mishra, Niraj/O-3561-2019; Mishra,
   Niraj/T-1375-2018; Neyts, Johan/U-8267-2017; Schols,
   Dominique/S-9057-2017; Kaptein, Suzanne JF/O-4714-2019; Marques, Rafael
   Elias/R-4890-2016
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Mishra,
   Niraj/0000-0002-8679-8847; Mishra, Niraj/0000-0002-8679-8847; Neyts,
   Johan/0000-0002-0033-7514; Schols, Dominique/0000-0003-3256-5850;
   Kaptein, Suzanne JF/0000-0002-7935-0219; Marques, Rafael
   Elias/0000-0002-6949-0947; Kum, Dieudonne Buh/0000-0001-8251-8230
FU European Union's Horizon 2020 research and innovation programme [733176,
   734584, 734548]
FX We appreciate the excellent technical assistance of Katrien Geerts and
   Ruben Pholien and are grateful to Prof. Peter Bredenbeek LUMC, The
   Netherlands for providing cell lines, the European Virus Archive (EVA),
   Prof. Martijn van Hemert, LUMC, The Netherlands and Prof. A. Merits,
   University of Tartu, Estonia for sharing ZIKV strains. The image of the
   mouse used in Fig. 6(a)-'Vector diagram of laboratory mouse (black and
   white)'-created by user'Gwilz', is licenced under a Creative Commons
   Attribution-Share Alike 4.0 International licence and can be found at
   https://commons.wikimedia.org/wiki/File:Vector_diagram_of_laboratory_mou
   se_(black_and_white).svg. This project has received funding from the
   European Union's Horizon 2020 research and innovation programme under
   Grant Agreement Nos. 733176 (RABYD-VAX consortium), 734584 (ZikaPLAN),
   and 734548 (ZIKAlliance).
CR AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   Dayan GH, 2013, VIRUSES-BASEL, V5, P3048, DOI 10.3390/v5123048
   De Beeck AO, 2004, J VIROL, V78, P12591, DOI 10.1128/JVI.78.22.12591-12602.2004
   De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003
   Diamond MS, 2018, NAT REV IMMUNOL, V18, P89, DOI 10.1038/nri.2017.132
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Grifoni A., 2017, J VIROL, V90, P4771
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pletnev AG, 2001, J VIROL, V75, P8259, DOI 10.1128/JVI.75.17.8259-8267.2001
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Seligman SJ, 2014, VACCINE, V32, P5769, DOI 10.1016/j.vaccine.2014.08.051
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 47
TC 7
Z9 7
U1 0
U2 6
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD DEC 13
PY 2018
VL 3
AR 56
DI 10.1038/s41541-018-0092-2
PG 14
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HF5GU
UT WOS:000454261400001
PM 30564463
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baldini, F
   Rouge, J
   Kreppel, K
   Mkandawile, G
   Mapua, SA
   Sikulu-Lord, M
   Ferguson, HM
   Govella, N
   Okumu, FO
AF Baldini, Francesco
   Rouge, Justine
   Kreppel, Katharina
   Mkandawile, Gustave
   Mapua, Salum Abdallah
   Sikulu-Lord, Maggy
   Ferguson, Heather M.
   Govella, Nicodem
   Okumu, Fredros O.
TI First report of natural Wolbachia infection in the malaria mosquito
   Anopheles arabiensis in Tanzania
SO PARASITES & VECTORS
LA English
DT Article
DE Wolbachia; Anopheles; Malaria parasite; Endosymbiont; Pathogen
   interference; Maternal transmission; Vector control; Tanzania
ID ZIKA VIRUS; TRANSMISSION; DIPTERA; STRAIN; RICKETTSIACEAE; POPULATIONS;
   CULICIDAE; DENGUE
AB BackgroundNatural infections of the endosymbiont bacteria Wolbachia have recently been discovered in populations of the malaria mosquito Anopheles gambiae (s.l.) in Burkina Faso and Mali, West Africa. This Anopheles specific strain wAnga limits the malaria parasite Plasmodium falciparum infections in the mosquito, thus it offers novel opportunities for malaria control.ResultsWe investigated Wolbachia presence in Anopheles arabiensis and Anopheles funestus, which are the two main malaria vectors in the Kilombero Valley, a malaria endemic region in south-eastern Tanzania. We found 3.1% (n = 65) and 7.5% (n = 147) wAnga infection prevalence in An. arabiensis in mosquitoes collected in 2014 and 2016, respectively, while no infection was detected in An. funestus (n = 41). Phylogenetic analysis suggests that at least two distinct strains of wAnga were detected, both belonging to Wolbachia supergroup A and B.ConclusionsTo our knowledge, this is the first confirmation of natural Wolbachia in malaria vectors in Tanzania, which opens novel questions on the ecological and genetic basis of its persistence and pathogen transmission in the vector hosts. Understanding the basis of interactions between Wolbachia, Anopheles mosquitoes and malaria parasites is crucial for investigation of its potential application as a biocontrol strategy to reduce malaria transmission, and assessment of how natural wAnga infections influence pathogen transmission in different ecological settings.
C1 [Baldini, Francesco; Rouge, Justine; Kreppel, Katharina; Ferguson, Heather M.; Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
   [Kreppel, Katharina; Mkandawile, Gustave; Mapua, Salum Abdallah; Govella, Nicodem; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, POB 53, Ifakara, Tanzania.
   [Sikulu-Lord, Maggy] Univ Queensland, Sch Publ Hlth, Sydney, NSW, Australia.
   [Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.
RP Baldini, F (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.
EM Francesco.Baldini@glasgow.ac.uk
RI Baldini, Francesco/I-3996-2019
OI Baldini, Francesco/0000-0002-5904-4070; Ferguson,
   Heather/0000-0002-9625-5176
FU AXA RF fellowship [14-AXA-PDOC-130]; EMBO LT fellowship [43-2014];
   Wellcome Trust Intermediate Fellowship in Public Health and Tropical
   MedicineWellcome Trust [WT102350/Z/13]; DELTAS Africa Initiative
FX This work was supported by an AXA RF fellowship (14-AXA-PDOC-130) and an
   EMBO LT fellowship (43-2014) to FB. FO was also funded by a Wellcome
   Trust Intermediate Fellowship in Public Health and Tropical Medicine
   (grant number: WT102350/Z/13). KK was supported by DELTAS Africa
   Initiative (Afrique One-ASPIRE/ DEL-15-008).
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Ayala D, 2018, BIORXIV
   Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bordenstein SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029106
   Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Echaubard P, 2010, HEREDITY, V104, P15, DOI 10.1038/hdy.2009.100
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Gomes FM, 2017, P NATL ACAD SCI USA, V114, P12566, DOI 10.1073/pnas.1716181114
   Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   HERTIG M., 1936, Parasitology, V28, P453, DOI 10.1017/S0031182000022666
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004182
   Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Hurst GDD, 2001, HEREDITY, V87, P220, DOI 10.1046/j.1365-2540.2001.00917.x
   Jeffries Claire L, 2018, Wellcome Open Res, V3, P113, DOI 10.12688/wellcomeopenres.14765.2
   Joshi D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00366
   Kaindoa EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177807
   Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804
   Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163
   Serbus LR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004777
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Strunov A, 2013, J INVERTEBR PATHOL, V114, P22, DOI 10.1016/j.jip.2013.05.001
   Tiawsirisup S, 2008, PARASITOL RES, V102, P731, DOI 10.1007/s00436-007-0825-z
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wiwatanaratanabutr I, 2013, J INVERTEBR PATHOL, V114, P337, DOI 10.1016/j.jip.2013.04.011
   Woodford L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22550-z
   WRIGHT JD, 1980, J ULTRA MOL STRUCT R, V72, P52, DOI 10.1016/S0022-5320(80)90135-5
   Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 47
TC 3
Z9 3
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 13
PY 2018
VL 11
AR 635
DI 10.1186/s13071-018-3249-y
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HE4DN
UT WOS:000453315300003
PM 30545384
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Kafetzopoulou, LE
   Efthymiadis, K
   Lewandowski, K
   Crook, A
   Carter, D
   Osborne, J
   Aarons, E
   Hewson, R
   Hiscox, JA
   Carroll, MW
   Vipond, R
   Pullan, ST
AF Kafetzopoulou, Liana E.
   Efthymiadis, Kyriakos
   Lewandowski, Kuiama
   Crook, Ant
   Carter, Dan
   Osborne, Jane
   Aarons, Emma
   Hewson, Roger
   Hiscox, Julian A.
   Carroll, Miles W.
   Vipond, Richard
   Pullan, Steven T.
TI Assessment of metagenomic Nanopore and Illumina sequencing for
   recovering whole genome sequences of chikungunya and dengue viruses
   directly from clinical samples
SO EUROSURVEILLANCE
LA English
DT Article
ID ZIKA VIRUS; REAL-TIME; MINION; EBOLA; EPIDEMIOLOGY; TRANSMISSION;
   EVOLUTION; BRAZIL; RNA
AB Background: The recent global emergence and re-emergence of arboviruses has caused significant human disease. Common vectors, symptoms and geographical distribution make differential diagnosis both important and challenging. Aim: To investigate the feasibility of metagenomic sequencing for recovering whole genome sequences of chikungunya and dengue viruses from clinical samples. Methods: We performed metagenomic sequencing using both the Illumina MiSeq and the portable Oxford Nanopore MinION on clinical samples which were real-time reverse transcription-PCR (qRT-PCR) positive for chikungunya (CHIKV) or dengue virus (DENV), two of the most important arboviruses. A total of 26 samples with a range of representative clinical Ct values were included in the study. Results: Direct metagenomic sequencing of nucleic acid extracts from serum or plasma without viral enrichment allowed for virus identification, subtype determination and elucidated complete or near-complete genomes adequate for phylogenetic analysis. One PCR-positive CHIKV sample was also found to be coinfected with DENV. Conclusions: This work demonstrates that metagenomic whole genome sequencing is feasible for the majority of CHIKV and DENV PCR-positive patient serum or plasma samples. Additionally, it explores the use of Nanopore metagenomic sequencing for DENV and CHIKV, which can likely be applied to other RNA viruses, highlighting the applicability of this approach to front-line public health and potential portable applications using the MinION.
C1 [Kafetzopoulou, Liana E.; Lewandowski, Kuiama; Crook, Ant; Carter, Dan; Hewson, Roger; Carroll, Miles W.; Vipond, Richard; Pullan, Steven T.] Natl Infect Serv, Publ Hlth England, Porton Down, England.
   [Kafetzopoulou, Liana E.; Carter, Dan; Hewson, Roger; Hiscox, Julian A.; Carroll, Miles W.; Vipond, Richard; Pullan, Steven T.] NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.
   [Efthymiadis, Kyriakos] Vrije Univ Brussel, Artificial Intelligence Lab, Brussels, Belgium.
   [Osborne, Jane; Aarons, Emma] Publ Hlth England, Rare & Imported Pathogens Lab, Porton Down, England.
   [Hiscox, Julian A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Pullan, ST (corresponding author), Natl Infect Serv, Publ Hlth England, Porton Down, England.; Pullan, ST (corresponding author), NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.
EM steven.pullan@phe.gov.uk
OI Hiscox, Julian/0000-0002-6582-0275; Carter, Daniel/0000-0002-8021-9277;
   Pullan, Steven/0000-0002-8983-599X
FU NIHR HPRU in Emerging and Zoonotic Infections PhD studentship
FX This work was funded via an NIHR HPRU in Emerging and Zoonotic
   Infections PhD studentship awarded to L. Kafetzopoulou. The views
   expressed in this publication are those of the author(s) and not
   necessarily those of the NHS, the National Institute for Health
   Research, or the Department of Health. Oxford Nanopore Technologies
   provided some reagents free of charge and funded author conference
   attendance.
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Batovska J, 2017, J VIROL METHODS, V249, P79, DOI 10.1016/j.jviromet.2017.08.019
   Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683
   Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Brown BL, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix007
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Keita M, 2016, EMERG INFECT DIS, V22, P2149, DOI 10.3201/eid2212.160847
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Lewandowski K, 2017, J MOL DIAGN, V19, P303, DOI 10.1016/j.jmoldx.2016.10.005
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Omarjee R, 2013, EUROSURVEILLANCE, P19, DOI DOI 10.2807/1560-
   Papa A, 2017, J MED VIROL, V89, P1315, DOI 10.1002/jmv.24803
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081
   Perera-Lecoin M, 2016, CURRENT TOPICS CHIKU
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   World Health Organization, 2017, WHO PUBL LIST TOP EM
NR 44
TC 13
Z9 13
U1 0
U2 6
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD DEC 13
PY 2018
VL 23
IS 50
BP 18
EP 30
AR 1800228
DI 10.2807/1560-7917.ES.2018.23.50.1800228
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA HE1KY
UT WOS:000453031200004
PM 30563591
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Knutsson, S
   Engdahl, C
   Kumari, R
   Forsgren, N
   Lindgren, C
   Kindahl, T
   Kitur, S
   Wachira, L
   Kamau, L
   Ekstrom, F
   Linusson, A
AF Knutsson, Sofie
   Engdahl, Cecilia
   Kumari, Rashmi
   Forsgren, Nina
   Lindgren, Cecilia
   Kindahl, Tomas
   Kitur, Stanley
   Wachira, Lucy
   Kamau, Luna
   Ekstrom, Fredrik
   Linusson, Anna
TI Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with
   Resistance-Breaking Potency
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID LINEAR CONSTRAINT SOLVER; AMINO-ACID SUBSTITUTION; INSECTICIDE
   RESISTANCE; ANOPHELES-GAMBIAE; MOLECULAR-DYNAMICS; MALARIA MOSQUITO;
   HIGH-THROUGHPUT; WILD-TYPE; VECTOR; SELECTIVITY
AB Resistance development in insects significantly threatens the important benefits obtained by insecticide usage in vector control of disease-transmitting insects. Discovery of new chemical entities with insecticidal activity is highly desired in order to develop new insecticide candidates. Here, we present the design, synthesis, and biological evaluation of phenoxyacetamide-based inhibitors of the essential enzyme acetylcholinesterase 1 (AChE1). AChE1 is a validated insecticide target to control mosquito vectors of, e.g., malaria, dengue, and Zika virus infections. The inhibitors combine a mosquito versus human AChE selectivity with a high potency also for the resistance-conferring mutation G122S; two properties that have proven challenging to combine in a single compound. Structure activity relationship analyses and molecular dynamics simulations of inhibitor protein complexes have provided insights that elucidate the molecular basis for these properties. We also show that the inhibitors demonstrate in vivo insecticidal activity on disease-transmitting mosquitoes. Our findings support the concept of noncovalent, selective, and resistance-breaking inhibitors of AChE1 as a promising approach for future insecticide development.
C1 [Knutsson, Sofie; Engdahl, Cecilia; Kumari, Rashmi; Lindgren, Cecilia; Kindahl, Tomas; Linusson, Anna] Umea Univ, Dept Chem, SE-90182 Umea, Sweden.
   [Forsgren, Nina; Ekstrom, Fredrik] Swedish Def Res Agcy, CBRN Def & Secur, SE-90621 Umea, Sweden.
   [Kitur, Stanley; Wachira, Lucy; Kamau, Luna] Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi, Kenya.
RP Linusson, A (corresponding author), Umea Univ, Dept Chem, SE-90182 Umea, Sweden.; Ekstrom, F (corresponding author), Swedish Def Res Agcy, CBRN Def & Secur, SE-90621 Umea, Sweden.
EM fredrik.ekstrom@foi.se; anna.linusson@umu.se
OI KAMAU, LUNA/0000-0002-2186-0283; Lindgren, Cecilia/0000-0002-4903-9374
FU Swedish Research CouncilSwedish Research Council [2014-4218, 2014-2636];
   Centrum for Miljovetenskaplig Forskning (CMF)
FX This work was funded by grants from the Swedish Research Council (Dnrs
   2014-4218 and 2014-2636) and Centrum for Miljovetenskaplig Forskning
   (CMF). Students at the Medicinal Chemistry course at Umea University are
   acknowledged for their contributions to the synthesis. We are also
   grateful for excellent technical support at the BESSY II electron
   storage ring operated by the Helmholtz-Zentrum in Berlin and at the
   MAX-lab in Lund. The research was conducted on resources provided by the
   Swedish National Infrastructure for Computing (SNIC) at HPC2N Umea,
   Sweden. The research was funded by the Swedish Research Council (grant
   numbers: 2014-4218 and 2014-2636).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Alout H, 2007, INSECT BIOCHEM MOLEC, V37, P41, DOI 10.1016/j.ibmb.2006.10.001
   Alout H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047125
   [Anonymous], 2016, WHO WORLD MAL REP 20
   [Anonymous], 2017, AMBER
   [Anonymous], 1986, CANC PAIN REL, P1
   [Anonymous], 2005, WHO GUID LAB FIELD T
   [Anonymous], 1986, OTT CHART HLTH PROM, P1
   Artursson E, 2009, TOXICOLOGY, V265, P108, DOI 10.1016/j.tox.2009.09.002
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Berg L, 2016, CHEM-EUR J, V22, P2672, DOI 10.1002/chem.201503973
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bonnet J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-17
   Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Camerino E, 2015, BIOORG MED CHEM LETT, V25, P4405, DOI 10.1016/j.bmcl.2015.09.019
   Carlier PR, 2008, CHEM-BIOL INTERACT, V175, P368, DOI 10.1016/j.cbi.2008.04.037
   Cheung J, 2018, STRUCTURE, V26, P130, DOI 10.1016/j.str.2017.11.021
   Clarke ED, 2003, CHIMIA, V57, P731, DOI 10.2533/000942903777678641
   CNN, 2016, CNN
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dou DF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01068
   Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Engdahl C, 2016, J MED CHEM, V59, P9409, DOI 10.1021/acs.jmedchem.6b00967
   Engdahl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138598
   Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185
   Frisch M.J., 2009, GAUSSIAN 09 REVISION
   Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7
   Han Q, 2018, INSECT SCI, V25, P721, DOI 10.1111/1744-7917.12450
   Hao GF, 2011, MOL INFORM, V30, P614, DOI 10.1002/minf.201100020
   Hartsel JA, 2012, BIOORG MED CHEM LETT, V22, P4593, DOI 10.1016/j.bmcl.2012.05.103
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
   Jiang Y, 2013, PESTIC BIOCHEM PHYS, V106, P156, DOI 10.1016/j.pestbp.2013.03.006
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Knutsson S, 2017, EUR J MED CHEM, V134, P415, DOI 10.1016/j.ejmech.2017.03.050
   Kryger G, 1999, STRUCTURE, V7, P297, DOI 10.1016/S0969-2126(99)80040-9
   Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Mutunga JM, 2016, CHIMIA, V70, P704, DOI 10.2533/chimia.2016.704
   Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   Nuss AB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003515
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058
   Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073
   Pang YP, 2012, CURR DRUG TARGETS, V13, P471, DOI 10.2174/138945012799499703
   Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Swale DR, 2015, PEST MANAG SCI, V71, P1158, DOI 10.1002/ps.3899
   Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6
   TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2
   Turner JA, 2016, CHIMIA, V70, P684, DOI 10.2533/chimia.2016.684
   Verma A, 2015, BIOORGAN MED CHEM, V23, P1321, DOI 10.1016/j.bmc.2015.01.026
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b
   Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122
   Wong D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029161
   Wong DM, 2013, CHEM-BIOL INTERACT, V203, P314, DOI 10.1016/j.cbi.2012.09.001
   Zhao PC, 2013, INSECT BIOCHEM MOLEC, V43, P260, DOI 10.1016/j.ibmb.2012.12.005
NR 67
TC 2
Z9 2
U1 3
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD DEC 13
PY 2018
VL 61
IS 23
BP 10545
EP 10557
DI 10.1021/acs.jmedchem.8b01060
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HE6BL
UT WOS:000453488200014
PM 30339371
DA 2020-07-08
ER

PT J
AU Moreira, MEL
   Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Damasceno, L
   Pone, M
   Carvalho, LMA
   Pone, SM
   Vasconcelos, Z
   Ribeiro, IP
   Zin, AA
   Tsui, I
   Adachi, K
   Gaw, SL
   Halai, UA
   Salles, TS
   da Cunha, DC
   Bonaldo, MC
   Gabaglia, CR
   Guida, L
   Malacarne, J
   Costa, RP
   Gomes, SC
   Reis, AB
   Soares, FVM
   Hasue, RH
   Aizawa, CYP
   Genovesi, FF
   Aibe, M
   Einspieler, C
   Marschik, PB
   Pereira, JP
   Portari, EA
   Janzen, C
   Cherry, JD
AF Elisabeth Lopes Moreira, M.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Damasceno, Luana
   Pone, Marcos
   Carvalho, Liege M. A.
   Pone, Sheila M.
   Vasconcelos, Zilton
   Ribeiro, Ieda P.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Gaw, Stephanie L.
   Halai, Umme-Aiman
   Salles, Tania S.
   da Cunha, Denise C.
   Bonaldo, Myrna C.
   Gabaglia, Claudia Raja
   Guida, Leticia
   Malacarne, Jociele
   Costa, Roozemerie P.
   Clair Gomes, S., Jr.
   Beatriz Reis, A.
   Soares, Fernanda V. M.
   Hasue, Renata H.
   Aizawa, Carolina Y. P.
   Genovesi, Fernanda F.
   Aibe, Mitsue
   Einspieler, Christa
   Marschik, Peter B.
   Paulo Pereira, J., Jr.
   Portari, Elyzabeth A.
   Janzen, Carla
   Cherry, James D.
TI Neurodevelopment in Infants Exposed to Zika Virus In Utero
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Elisabeth Lopes Moreira, M.; Brasil, Patricia; Damasceno, Luana; Pone, Marcos; Carvalho, Liege M. A.; Pone, Sheila M.; Vasconcelos, Zilton; Ribeiro, Ieda P.; Zin, Andrea A.; Salles, Tania S.; da Cunha, Denise C.; Bonaldo, Myrna C.; Guida, Leticia; Malacarne, Jociele; Costa, Roozemerie P.; Clair Gomes, S., Jr.; Beatriz Reis, A.; Soares, Fernanda V. M.; Aibe, Mitsue; Paulo Pereira, J., Jr.; Portari, Elyzabeth A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin; Tsui, Irena; Adachi, Kristina; Halai, Umme-Aiman; Janzen, Carla] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, Renata H.; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria.
RP Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Vasconcelos,
   Zilton/AAD-5784-2019; Marschik, Peter B/F-8195-2011
OI Vasconcelos, Zilton/0000-0002-2193-2224; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Marschik, Peter B/0000-0001-8932-0980;
   Moura Pone, Sheila/0000-0002-6246-8915
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil [25000.072811/2016-17]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [88887.116627/2016-01]; Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015TXB]; ZIKAlliance; Thrasher Research Fund [20164370]; National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [AI129847-01]; Wellcome TrustWellcome Trust; United
   Kingdom Department for International Development [205377-Z16-Z];
   European Union Horizon 2020 research and innovation program (ZikaPLAN)
   [734584]
FX Supported by grants from the Departamento de Ciencia e Tecnologia
   (DECIT) do Ministerio da Saude do Brasil (25000.072811/2016-17);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   (88887.116627/2016-01); Brazilian National Council for Scientific and
   Technological Development (CNPq) (441098/2016-9); Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   (E_18/2015TXB); ZIKAlliance; the Thrasher Research Fund (20164370); the
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH) (AI28697 and AI1259534-01); the National Eye
   Institute of the NIH (AI129847-01); the Wellcome Trust and the United
   Kingdom Department for International Development (205377-Z16-Z); and the
   European Union Horizon 2020 research and innovation program (ZikaPLAN
   grant agreement no. 734584).
CR Bayley N, 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 5
TC 14
Z9 14
U1 0
U2 9
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 13
PY 2018
VL 379
IS 24
BP 2377
EP 2379
DI 10.1056/NEJMc1800098
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA HD9HM
UT WOS:000452872600015
PM 30575464
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU da Silva, CMR
   Chura-Chambi, RM
   Pereira, LR
   Cordeiro, Y
   Ferreira, LCD
   Morganti, L
AF Rosa da Silva, Cleide Mara
   Chura-Chambi, Rosa Maria
   Pereira, Lennon Ramos
   Cordeiro, Yraima
   de Souza Ferreira, Luis Carlos
   Morganti, Ligia
TI Association of high pressure and alkaline condition for solubilization
   of inclusion bodies and refolding of the NS1 protein from zika virus
SO BMC BIOTECHNOLOGY
LA English
DT Article
DE Protein refolding; Inclusion bodies; NS1; Dengue virus and Zika virus;
   High hydrostatic pressure; Alkaline pH
ID COLI; OPTIMIZATION; ENDOSTATIN
AB BackgroundProteins in inclusion bodies (IBs) present native-like secondary structures. However, chaotropic agents at denaturing concentrations, which are widely used for IB solubilization and subsequent refolding, unfold these secondary structures. Removal of the chaotropes frequently causes reaggregation and poor recovery of bioactive proteins. High hydrostatic pressure (HHP) and alkaline pH are two conditions that, in the presence of low level of chaotropes, have been described as non-denaturing solubilization agents. In the present study we evaluated the strategy of combination of HHP and alkaline pH on the solubilization of IB using as a model an antigenic form of the zika virus (ZIKV) non-structural 1 (NS1) protein.ResultsPressure-treatment (2.4kbar) of NS1-IBs at a pH of 11.0 induced a low degree of NS1 unfolding and led to solubilization of the IBs, mainly into monomers. After dialysis at pH8.5, NS1 was refolded and formed soluble oligomers. High (up to 68mg/liter) NS1 concentrations were obtained by solubilization of NS1-IBs at pH11 in the presence of arginine (Arg) with a final yield of approximately 80% of total protein content. The process proved to be efficient, quick and did not require further purification steps. Refolded NS1 preserved biological features regarding reactivity with antigen-specific antibodies, including sera of ZIKV-infected patients. The method resulted in an increase of approximately 30-fold over conventional IB solubilization-refolding methods.ConclusionsThe present results represent an innovative non-denaturing protein refolding process by means of the concomitant use of HHP and alkaline pH. Application of the reported method allowed the recovery of ZIKV NS1 at a condition that maintained the antigenic properties of the protein.
C1 [Rosa da Silva, Cleide Mara; Chura-Chambi, Rosa Maria; Morganti, Ligia] IPEN, CNEN, Ctr Biotecnol, SP, Av Prof Lineu Prestes 2242, BR-05508000 Sao Paulo, Brazil.
   [Pereira, Lennon Ramos; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Av Prof Lineu Prestes 1374, BR-05508000 Sao Paulo, Brazil.
   [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
RP Morganti, L (corresponding author), IPEN, CNEN, Ctr Biotecnol, SP, Av Prof Lineu Prestes 2242, BR-05508000 Sao Paulo, Brazil.
EM lmorganti@ipen.br
RI Morganti, Ligia/K-4352-2014
OI Morganti, Ligia/0000-0002-7870-1793
FU FAPESP grantFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/02574-0]; CNPq-Brasil fellowship [130256/2015-3]
FX FAPESP grant (Process number 2015/02574-0) was used for design of the
   study, collection, analysis and interpretation of data. CNPq-Brasil
   fellowship (Process number 130256/2015-3) was for CMRS postgraduate work
   (MS degree).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   Ami D, 2005, FEBS LETT, V579, P3433, DOI 10.1016/j.febslet.2005.04.085
   Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Athmaram TN, 2013, VIRUS GENES, V46, P219, DOI 10.1007/s11262-012-0851-5
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Chura-Chambi RM, 2013, PROCESS BIOCHEM, V48, P250, DOI 10.1016/j.procbio.2012.12.017
   Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024
   Clark ED, 2001, CURR OPIN BIOTECH, V12, P202, DOI 10.1016/S0958-1669(00)00200-7
   Crisman RI, 2009, BIOTECHNOL BIOENG, V102, P483, DOI 10.1002/bit.22082
   Das D, 2009, PROTEIN EXPRES PURIF, V66, P66, DOI 10.1016/j.pep.2009.02.003
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lacowicz J.R., 2006, PRINCIPLES FLUORESCE
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Malavasi NV, 2011, PROCESS BIOCHEM, V46, P512, DOI 10.1016/j.procbio.2010.10.002
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179
   Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34
   Rathore AS, 2013, J CHEM TECHNOL BIOT, V88, P1794, DOI 10.1002/jctb.4152
   Sankar SG, 2013, BIOMED RES INT, DOI 10.1155/2013/343195
   Sen P, 2008, EUR BIOPHYS J BIOPHY, V37, P1303, DOI 10.1007/s00249-008-0335-7
   Silva JL, 2014, CHEM REV, V114, P7239, DOI 10.1021/cr400204z
   Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303
   Singh SM, 2008, J CHEM TECHNOL BIOT, V83, P1126, DOI 10.1002/jctb.1945
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029
   St John RJ, 2002, BIOTECHNOL PROGR, V18, P565, DOI 10.1021/bp0200200
   St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Yongsawatdigul J, 2004, J FOOD SCI, V69, pC499, DOI 10.1111/j.1365-2621.2004.tb13642.x
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 40
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PD DEC 12
PY 2018
VL 18
AR 78
DI 10.1186/s12896-018-0486-2
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA HE0LM
UT WOS:000452958300002
PM 30541520
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, P
   Wei, YF
   Mei, M
   Tang, L
   Sun, L
   Huang, WZ
   Zhou, JY
   Zou, CL
   Zhang, SJ
   Qin, CF
   Jiang, T
   Dai, JF
   Tan, X
   Zhang, QC
AF Li, Pan
   Wei, Yifan
   Mei, Miao
   Tang, Lei
   Sun, Lei
   Huang, Wenze
   Zhou, Jianyu
   Zou, Chunlin
   Zhang, Shaojun
   Qin, Cheng-Feng
   Jiang, Tao
   Dai, Jianfeng
   Tan, Xu
   Zhang, Qiangfeng Cliff
TI Integrative Analysis of Zika Virus Genome RNA Structure Reveals Critical
   Determinants of Viral Infectivity
SO CELL HOST & MICROBE
LA English
DT Article
ID SECONDARY STRUCTURE; DENGUE VIRUS; CODING REGION; LIVING CELLS; PROTEIN;
   ELEMENT; ARCHITECTURE; DYNAMICS
AB Zika virus (ZIKV) strains can be classified into the ancestral African and contemporary Asian lineages, with the latter responsible for recent epidemics associated with neurological conditions. To understand how Asian strains lead to exacerbated disease, a crucial step is identifying genomic variations that affect infectivity and pathogenicity. Here we use two high-throughput sequencing approaches to assess RNA secondary structures and intramolecular RNA-RNA interactions in vivo for the RNA genomes of Asian and African ZIKV lineages. Our analysis identified functional RNA structural elements and a functional long-range intramolecular interaction specific for the Asian epidemic strains. Mutants that disrupt this extended RNA interaction between the 5' UTR and the E protein coding region reduce virus infectivity, which is partially rescued with compensatory mutants, restoring this RNA-RNA interaction. These findings illuminate the structural basis of ZIKV regulation and provide a resource for the discovery of RNA structural elements important for ZIKV infection.
C1 [Li, Pan; Wei, Yifan; Tang, Lei; Sun, Lei; Huang, Wenze; Zhang, Shaojun; Zhang, Qiangfeng Cliff] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Bioinformat,Sch Life Sci, Ctr Synthet & Syst Biol,Tsinghua Peking Ctr Life, Beijing 100084, Peoples R China.
   [Mei, Miao; Tan, Xu] Tsinghua Univ, Sch Pharmaceut Sci, Sch Med, Tsinghua Peking Ctr Life Sci,Ctr Infect Dis Res, Beijing 100084, Peoples R China.
   [Zhou, Jianyu; Jiang, Tao] Tsinghua Univ, Bioinformat Div, Dept Comp Sci & Technol, BNRIST, Beijing 100084, Peoples R China.
   [Zou, Chunlin; Dai, Jianfeng] Soochow Univ, Inst Biol, Suzhou 215123, Peoples R China.
   [Zou, Chunlin; Dai, Jianfeng] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Jiang, Tao] Univ Calif Riverside, Dept Comp Sci & Engn, Riverside, CA 92521 USA.
RP Zhang, QC (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Bioinformat,Sch Life Sci, Ctr Synthet & Syst Biol,Tsinghua Peking Ctr Life, Beijing 100084, Peoples R China.; Tan, X (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Sch Med, Tsinghua Peking Ctr Life Sci,Ctr Infect Dis Res, Beijing 100084, Peoples R China.
EM xutan@tsinghua.edu.cn; qczhang@tsinghua.edu.cn
RI Tan, Xu/E-7170-2011; Qin, Cheng-Feng/I-6839-2019
OI Tan, Xu/0000-0003-4861-4573; Qin, Cheng-Feng/0000-0002-0632-2807
FU National State Key Research Development Program of China
   [2016YFC1200300]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31671355, 91740204, 31761163007,
   31722030]; Beijing Advanced Innovation Center for Structural Biology;
   Tsinghua-Peking Joint Center for Life Sciences; National Thousand Young
   Talents Program of China
FX We thank Xiaohua Shen (Tsinghua University) and Barry Honig (Columbia
   University) for helpful comments on the manuscript. This project is
   supported by the National State Key Research Development Program of
   China (Grant No. 2016YFC1200300 to X.T.) and the National Natural
   Science Foundation of China (Grant Nos. 31671355, 91740204, and
   31761163007 to Q.C.Z. and No. 31722030 to X.T.), the Beijing Advanced
   Innovation Center for Structural Biology to Q.C.Z, the Tsinghua-Peking
   Joint Center for Life Sciences, and the National Thousand Young Talents
   Program of China to Q.C.Z. and X.T.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Aw JGA, 2016, MOL CELL, V62, P603, DOI 10.1016/j.molcel.2016.04.028
   Beaudoin JD, 2018, NAT STRUCT MOL BIOL, V25, P677, DOI 10.1038/s41594-018-0091-z
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DiChiacchio L, 2016, BIOINFORMATICS, V32, P1033, DOI 10.1093/bioinformatics/btv682
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Flynn RA, 2016, NAT PROTOC, V11, P273, DOI 10.1038/nprot.2016.011
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007
   Lu ZP, 2016, CELL, V165, P1267, DOI 10.1016/j.cell.2016.04.028
   Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024
   Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129
   Rivas E, 2017, NAT METHODS, V14, P45, DOI [10.1038/NMETH.4066, 10.1038/nmeth.4066]
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894
   Sharma E, 2016, MOL CELL, V62, P618, DOI 10.1016/j.molcel.2016.04.030
   Smola MJ, 2015, BIOCHEMISTRY-US, V54, P6867, DOI 10.1021/acs.biochem.5b00977
   Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263
   Takata M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006824
   Taliaferro JM, 2016, MOL CELL, V64, P294, DOI 10.1016/j.molcel.2016.08.035
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   Wu Y, 2015, NUCLEIC ACIDS RES, V43, P7247, DOI 10.1093/nar/gkv706
   Yu ZH, 2005, 2005 IEEE International Conference on Multimedia and Expo (ICME), Vols 1 and 2, P686
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Ziv O, 2018, NAT METHODS, V15, P785, DOI 10.1038/s41592-018-0121-0
NR 51
TC 10
Z9 10
U1 2
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD DEC 12
PY 2018
VL 24
IS 6
BP 875
EP +
DI 10.1016/j.chom.2018.10.011
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HE1JR
UT WOS:000453027400014
PM 30472207
OA Bronze
DA 2020-07-08
ER

PT J
AU Chen, SB
AF Chen, Shuibing
TI Screening-Based Chemical Approaches to Unravel Stem Cell Biology
SO STEM CELL REPORTS
LA English
DT Review
ID ZIKA VIRUS-INFECTION; SMALL-MOLECULE; SELF-RENEWAL; COLONIC ORGANOIDS;
   BETA-CELLS; IN-VITRO; DIFFERENTIATION; INDUCTION; FIBROBLASTS;
   GENERATION
AB Cell-permeable compounds provide a convenient and efficient approach to manipulate biological processes. A number of compounds controlling stem cell self-renewal, survival, differentiation, and reprogramming have been identified through highthroughput/content screens. Using these powerful chemical tools, strategies have been developed to direct human pluripotent stem cell (hPSC) differentiation to functional cells. Recently, hPSC-derived cells and organoids are used to model human diseases, which can be adapted to a high-throughput/content platform for chemical screens. The identified compounds provide novel tools for decoding the signaling pathways regulating disease progression and candidates for facilitating future drug discovery. Moreover, humanized mouse models carrying hPSC-derived cells enable an innovative system to evaluate the long-term in vivo efficacy of drug candidates on human cells. In summary, screening-based chemical approaches not only expedite strategy development of controlling stem cell fates, but also provide powerful tools for dissecting the molecular mechanisms regulating disease progression.
C1 [Chen, Shuibing] Weill Cornell Med Coll, Dept Surg & Biochem, 1300 York Ave, New York, NY 10065 USA.
RP Chen, SB (corresponding author), Weill Cornell Med Coll, Dept Surg & Biochem, 1300 York Ave, New York, NY 10065 USA.
EM shc2034@med.cornell.edu
FU New York Stem Cell Foundation; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; American
   Diabetes AssociationAmerican Diabetes Association; American Heart
   AssociationAmerican Heart Association; American Association for Cancer
   Research
FX The author would like to give thanks for the long-term support from
   peer-reviewed competitive grant funds from the New York Stem Cell
   Foundation, the NIH, the American Diabetes Association, the American
   Heart Association, and the American Association for Cancer Research.
CR Amin S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04918-x
   Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014
   Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438
   Brownjohn PW, 2017, STEM CELL REP, V8, P870, DOI 10.1016/j.stemcr.2017.02.006
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cayo MA, 2017, CELL STEM CELL, V20, P478, DOI 10.1016/j.stem.2017.01.011
   Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k
   Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103
   Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154
   Crespo M, 2017, NAT MED, V23, P878, DOI 10.1038/nm.4355
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502
   Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109
   Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951
   Feng LL, 2016, CELL REP, V15, P2063, DOI 10.1016/j.celrep.2016.04.066
   Ghazizadeh Z, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00129-y
   Guo M, 2017, CELL REP, V19, P1512, DOI 10.1016/j.celrep.2017.04.070
   Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005
   Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278
   Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418
   Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012
   Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435
   Li S, 2018, STEM CELL REP, V11, P22, DOI 10.1016/j.stemcr.2018.05.001
   Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108
   Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142
   Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106
   Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106
   Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munera JO, 2017, CELL STEM CELL, V21, P51, DOI 10.1016/j.stem.2017.05.020
   Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048
   Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953
   Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Qi YC, 2017, NAT BIOTECHNOL, V35, P154, DOI 10.1038/nbt.3777
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033
   Sharma A, 2014, CIRC RES, V115, P556, DOI 10.1161/CIRCRESAHA.115.303810
   Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004
   Shi ZD, 2017, CELL STEM CELL, V20, P675, DOI 10.1016/j.stem.2017.01.001
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Sun YP, 2013, ELIFE, V2, DOI 10.7554/eLife.00508
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tchieu J, 2017, CELL STEM CELL, V21, P399, DOI 10.1016/j.stem.2017.08.015
   Trisno SL, 2018, CELL STEM CELL, V23, P501, DOI 10.1016/j.stem.2018.08.008
   Tsai SY, 2015, STEM CELL REP, V4, P1089, DOI 10.1016/j.stemcr.2015.04.015
   Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030
   Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107
   Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005
   Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003
   Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968
   Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X
   Zeng H, 2016, CELL STEM CELL, V19, P326, DOI 10.1016/j.stem.2016.07.002
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001
NR 69
TC 0
Z9 0
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2213-6711
J9 STEM CELL REP
JI Stem Cell Rep.
PD DEC 11
PY 2018
VL 11
IS 6
BP 1312
EP 1323
DI 10.1016/j.stemcr.2018.11.012
PG 12
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA HD9QU
UT WOS:000452898300004
PM 30540959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gunawardana, SA
   Shaw, RH
AF Gunawardana, Shannon A.
   Shaw, Robert H.
TI Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus
   envelope protein: Panacea or Pandora's box?
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Zika virus; Cross-reactive antibodies; Vaccines;
   Antibody-dependent enhancement; Cross-neutralisation; Envelope protein;
   Flavivirus
ID INFECTION; ENHANCEMENT
AB BackgroundDengue Virus (DENV) and Zika Virus (ZIKV) are closely related flaviviruses, circulating in overlapping geographical regions. The recent ZIKV epidemic has been linked to an explosion in reports of microcephaly and neurological defects. It is conceivable that our knowledge of DENV might potentiate the development of a ZIKV vaccine due to the close phylogenetic relationship between these flaviviruses and cross-reactive antibodies, principally to the envelope protein (E protein). Alternatively, cross-reactive antibodies that are generated following vaccination or infection, might become damaging during subsequent infections.Main bodyThe aims of this review are to collate and analyse data from a recent series of DENV-derived monoclonal antibody (mAb) panels from different research groups. These panels measured DENV-mAb activity against ZIKV in terms of antibody-dependent enhancement (ADE) and neutralisation. Methodology used across groups was compared and critiqued. Furthermore, the specific antibody targets on E protein were considered and their therapeutic potential evaluated. Shortcomings of hmAb panels suggest ADE may be over-estimated and neutralisation underestimated, as compared to clinical situations. It remains unknown whether preference of enhancement or neutralisation by antibodies to ZIKV E protein is dictated by quantitative aspects of antibody titre or epitope specific variation. Additionally, little is known about how duration between flavivirus reinfections affect secondary antibody response.ConclusionThis review concludes that our current knowledge of cross-reactive antibodies to E protein is inadequate to anticipate the outcome of deploying an E protein based vaccine to regions co-infected by DENV and ZIKV.
C1 [Gunawardana, Shannon A.] Univ Oxford, Med Sci Div, Oxford, England.
   [Shaw, Robert H.] John Radcliffe Hosp, Oxford Univ Hosp, Oxford OX3 9DU, England.
RP Gunawardana, SA (corresponding author), Univ Oxford, Med Sci Div, Oxford, England.
EM shannon.gunawardana@worc.ox.ac.uk
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Iacobucci G, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1765
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Paul LM, 2016, BIORXIV, V5
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, P1
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Yang ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep43829
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 27
TC 2
Z9 5
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 10
PY 2018
VL 18
AR 641
DI 10.1186/s12879-018-3572-0
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA HD7MO
UT WOS:000452736700002
PM 30526531
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, LH
AF Chen, Lin H.
TI Oral lesions in a patient with confirmed Zika virus infection
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
ID TRAVEL
C1 [Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis & Travel Med, Cambridge, MA 02138 USA.
   [Chen, Lin H.] Harvard Med Sch, Boston, MA 02138 USA.
RP Chen, LH (corresponding author), Mt Auburn Hosp, Div Infect Dis & Travel Med, Cambridge, MA 02138 USA.; Chen, LH (corresponding author), Harvard Med Sch, Boston, MA 02138 USA.
EM lchen@hms.harvard.edu
OI Chen, Lin/0000-0002-5684-8436
CR Bhardwaj VK, 2016, EUR J GEN DENT, V5, P95
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Paniz-Mondolfi AE, 2019, CLIN EXP DERMATOL, V44, P13, DOI 10.1111/ced.13793
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
NR 6
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD DEC 7
PY 2018
VL 25
AR tay113
DI 10.1093/jtm/tay113
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HO3FB
UT WOS:000460803800001
PM 30428083
OA Bronze
DA 2020-07-08
ER

PT J
AU Meena, GG
   Jain, A
   Parks, JW
   Stambaugh, A
   Patterson, JL
   Hawkins, AR
   Schmidt, H
AF Meena, Gopikrishnan G.
   Jain, Aadhar
   Parks, Joshua W.
   Stambaugh, Alexandra
   Patterson, Jean L.
   Hawkins, Aaron R.
   Schmidt, Holger
TI Integration of sample preparation and analysis into an optofluidic chip
   for multi-target disease detection
SO LAB ON A CHIP
LA English
DT Article
ID AMPLIFICATION-FREE; SYSTEM; EBOLA; MICROFLUIDICS; BIOSENSORS; CAPTURE;
   ZIKA
AB Detection of molecular biomarkers with high specificity and sensitivity from biological samples requires both sophisticated sample preparation and subsequent analysis. These tasks are often carried out on separate platforms which increases required sample volumes and the risk of errors, sample loss, and contamination. Here, we present an optofluidic platform which combines an optical detection section with single nucleic acid strand sensitivity, and a sample processing unit capable of on-chip, specific extraction and labeling of nucleic acid and protein targets in complex biological matrices. First, on-chip labeling and detection of individual lambda DNA molecules down to concentrations of 8 fM is demonstrated. Subsequently, we demonstrate the simultaneous capture, fluorescence tagging and detection of both Zika specific nucleic acid and NS-1 protein targets in both buffer and human serum. We show that the dual DNA and protein assay allows for successful differentiation and diagnosis of Zika against cross-reacting species like dengue.
C1 [Meena, Gopikrishnan G.; Jain, Aadhar; Parks, Joshua W.; Stambaugh, Alexandra; Schmidt, Holger] Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
   [Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, 7620 NW Loop 410, San Antonio, TX 78227 USA.
   [Hawkins, Aaron R.] Brigham Young Univ, ECEn Dept, 459 Clyde Bldg, Provo, UT 84602 USA.
RP Schmidt, H (corresponding author), Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
EM hschmidt@soe.ucsc.edu
FU W. M. Keck Center for Nanoscale Optofluidics at UC Santa Cruz; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [4R33AI100229, R01AI116989]; NSFNational Science
   Foundation (NSF) [CBET-1703058]
FX We thank Dr. R. Carrion Jr. from the Texas Biomedical Research Institute
   for help with designing the nucleic acid targets and probes. We also
   thank Dr. Richard Mathies and Dr. Ke Du from the University of
   California, Berkeley for helpful discussions regarding the design of the
   optofluidic chip. We acknowledge support by the W. M. Keck Center for
   Nanoscale Optofluidics at UC Santa Cruz, the NIH under grants
   4R33AI100229 and R01AI116989, and the NSF under grant CBET-1703058.
CR Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107
   [Anonymous], TYP ZIK VIR TESTS ZI
   Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86
   Azmayesh-Fard SM, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/8/087002
   Brunner MC, 1999, J IMMUNOL, V162, P5813
   Cai H, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4968033
   Cai H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14494
   Chang-Yen DA, 2005, J LIGHTWAVE TECHNOL, V23, P2088, DOI 10.1109/JLT.2005.849932
   Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838
   Ding XY, 2012, P NATL ACAD SCI USA, V109, P11105, DOI 10.1073/pnas.1209288109
   Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985
   Du K, 2017, BIOSENS BIOELECTRON, V91, P489, DOI 10.1016/j.bios.2016.12.071
   Du K, 2017, ANAL CHEM, V89, P12433, DOI 10.1021/acs.analchem.7b03527
   Fan X, 2009, INTEGR ANAL SYST, P1, DOI 10.1007/978-0-387-98063-8
   Frei AP, 2016, NAT METHODS, V13, P269, DOI [10.1038/NMETH.3742, 10.1038/nmeth.3742]
   Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304
   Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951
   Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543
   Jung YK, 2015, ANAL CHEM, V87, P3165, DOI 10.1021/ac5048696
   Kim J, 2013, ANAL CHEM, V85, P7682, DOI 10.1021/ac303767m
   Kim J, 2012, ANAL CHEM, V84, P2067, DOI 10.1021/ac202934x
   Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375
   Osterholm MT, 2016, SCIENCE, V353, P1073, DOI 10.1126/science.aai9078
   Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370
   Ozcelik D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12487-0
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Parks JW, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4897226
   Parks JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33008
   Prakadan SM, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.15
   Sarioglu AF, 2015, NAT METHODS, V12, P685, DOI [10.1038/NMETH.3404, 10.1038/nmeth.3404]
   Schmidt H, 2011, NAT PHOTONICS, V5, P598, DOI [10.1038/nphoton.2011.163, 10.1038/NPHOTON.2011.163]
   Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106
   Theel E. S., 2018, J CLIN MICROBIOL, V56
   Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863
   Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d
   Weiss M, 2018, NAT MATER, V17, P89, DOI [10.1038/NMAT5005, 10.1038/nmat5005]
   White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108
   Wu JD, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0014-0
   Zhang M, 2018, TRENDS ENVIRON ANAL, V18, P1, DOI 10.1016/j.teac.2018.03.001
NR 39
TC 6
Z9 7
U1 9
U2 48
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PD DEC 7
PY 2018
VL 18
IS 23
BP 3678
EP 3686
DI 10.1039/c8lc00966j
PG 9
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology; Instruments & Instrumentation
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics; Instruments & Instrumentation
GA HB0VS
UT WOS:000450737200011
PM 30376021
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Smatti, MK
   Al Thani, AA
   Yassine, HM
AF Smatti, Maria K.
   Al Thani, Asmaa A.
   Yassine, Hadi M.
TI Viral-Induced Enhanced Disease Illness
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE antibody-dependent enhancement; Fc receptors; complement; immune
   response; viral infections
ID RESPIRATORY SYNCYTIAL VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT;
   WEST-NILE-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; SEASONAL INFLUENZA
   VACCINE; IMMUNIZED BALB/C MICE; DENGUE VIRUS; ZIKA VIRUS; SYNDROME
   CORONAVIRUS; HIV-1 INFECTION
AB Understanding immune responses to viral infections is crucial to progress in the quest for effective infection prevention and control. The host immunity involves various mechanisms to combat viral infections. Under certain circumstances, a viral infection or vaccination may result in a subverted immune system, which may lead to an exacerbated illness. Clinical evidence of enhanced illness by preexisting antibodies from vaccination, infection or maternal passive immunity is available for several viruses and is presumptively proposed for other viruses. Multiple mechanisms have been proposed to explain this phenomenon. It has been confirmed that certain infection- and/or vaccine-induced immunity could exacerbate viral infectivity in Fc receptor- or complement bearing cells- mediated mechanisms. Considering that antibody dependent enhancement (ADE) is a major obstacle in vaccine development, there are continues efforts to understand the underlying mechanisms through identification of the epitopes and antibodies responsible for disease enhancement or protection. This review discusses the recent findings on virally induced ADE, and highlights the potential mechanisms leading to this condition.
C1 [Smatti, Maria K.; Al Thani, Asmaa A.; Yassine, Hadi M.] Qatar Univ, Biomed Res Ctr, Doha, Qatar.
RP Yassine, HM (corresponding author), Qatar Univ, Biomed Res Ctr, Doha, Qatar.
EM hyassine@qu.edu.qa
FU Qatar National Library
FX The Qatar National Library funded the publication of this article.
CR Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15
   Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688
   ANANABA GA, 1991, J VIROL, V65, P5052, DOI 10.1128/JVI.65.9.5052-5060.1991
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   BAXT B, 1995, VIROLOGY, V207, P503, DOI 10.1006/viro.1995.1110
   Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   Burk R, 2016, FEMS MICROBIOL REV, V40, P494, DOI 10.1093/femsre/fuw010
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Cancel-Tirado SM, 2004, VET IMMUNOL IMMUNOP, V102, P249, DOI 10.1016/j.vetimm.2004.09.017
   CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986
   CARDOSA MJ, 1983, J EXP MED, V158, P258, DOI 10.1084/jem.158.1.258
   Chan AHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033451
   CHANAS AC, 1982, J GEN VIROL, V58, P37, DOI 10.1099/0022-1317-58-1-37
   Cimica V, 2016, CLIN VACCINE IMMUNOL, V23, P451, DOI 10.1128/CVI.00720-15
   Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992
   CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Swart RL, 2007, VACCINE, V25, P8518, DOI 10.1016/j.vaccine.2007.10.022
   de Swart RL, 2002, J VIROL, V76, P11561, DOI 10.1128/JVI.76.22.11561-11569.2002
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095986
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894
   Furuyama W, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006139
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gauger PC, 2012, VET PATHOL, V49, P900, DOI 10.1177/0300985812439724
   Gauger PC, 2011, VACCINE, V29, P2712, DOI 10.1016/j.vaccine.2011.01.082
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405
   GIMENEZ HB, 1989, J GEN VIROL, V70, P89, DOI 10.1099/0022-1317-70-1-89
   GRAHAM BS, 1993, J IMMUNOL, V151, P2032
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guillon C, 2002, J VIROL, V76, P2827, DOI 10.1128/JVI.76.6.2827-2834.2002
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2018, HUM VACC IMMUNOTHER, V14, P2158, DOI 10.1080/21645515.2018.1445448
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hanley KA, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P1
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659
   HOMSY J, 1989, SCIENCE, V244, P1357, DOI 10.1126/science.2786647
   Houser KV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006565
   Huang IC, 2006, ADV EXP MED BIOL, V581, P335
   Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087
   Imai Y, 2007, CELL MOL LIFE SCI, V64, P2006, DOI 10.1007/s00018-007-6228-6
   Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586
   Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11
   Jiang LM, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0963-1
   Johnson TR, 2004, J VIROL, V78, P8753, DOI 10.1128/JVI.78.16.8753-8760.2004
   Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Khurana S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006366
   Killikelly AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34108
   KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955
   Kim JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37341
   Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091
   Knudson CJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004757
   Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171
   KRILOV LR, 1989, J INFECT DIS, V160, P777, DOI 10.1093/infdis/160.5.777
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kurosu Takeshi, 2011, Trop Med Health, V39, P29, DOI 10.2149/tmh.2011-S02
   Kuzmina NA, 2018, CELL REP, V24, P1802, DOI 10.1016/j.celrep.2018.07.035
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   LaLinn M, 1996, J GEN VIROL, V77, P407, DOI 10.1099/0022-1317-77-3-407
   Lambert SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119509
   Li LJ, 2003, J CLIN VIROL, V28, P239, DOI 10.1016/S1386-6532(03)00195-1
   Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000
   Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841
   Luo YY, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-194
   Mahalingam S, 2002, P NATL ACAD SCI USA, V99, P13819, DOI 10.1073/pnas.202415999
   Matsui K, 2010, J GEN VIROL, V91, P2249, DOI 10.1099/vir.0.021220-0
   McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484
   McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4
   McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914
   Melero JA, 2013, CURR TOP MICROBIOL, V372, P59, DOI 10.1007/978-3-642-38919-1_3
   Meyer K, 2008, J VIROL, V82, P2140, DOI 10.1128/JVI.01867-07
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456
   Moi ML, 2011, J INFECT DIS, V203, P1405, DOI 10.1093/infdis/jir053
   MORENS DM, 1987, J GEN VIROL, V68, P91, DOI 10.1099/0022-1317-68-1-91
   Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241
   OCHIAI H, 1990, J MED VIROL, V30, P258, DOI 10.1002/jmv.1890300406
   OCHIAI H, 1988, J VIROL, V62, P20, DOI 10.1128/JVI.62.1.20-26.1988
   Ohimain EI, 2016, VIRUS RES, V211, P174, DOI 10.1016/j.virusres.2015.10.021
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pavot V, 2016, CLIN IMMUNOL, V173, P44, DOI 10.1016/j.clim.2016.10.016
   PEIRIS JSM, 1982, J GEN VIROL, V58, P291, DOI 10.1099/0022-1317-58-2-291
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2010, CELL HOST MICROBE, V7, P85, DOI 10.1016/j.chom.2010.02.004
   Polack FP, 2007, PEDIATR RES, V62, P111, DOI 10.1203/PDR.0b013e3180686ce0
   Polack FP, 2005, P NATL ACAD SCI USA, V102, P8996, DOI 10.1073/pnas.0409478102
   Polack FP, 2003, NAT MED, V9, P1209, DOI 10.1038/nm918
   Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781
   Ponnuraj EM, 2003, J INFECT DIS, V187, P1257, DOI 10.1086/374604
   PORTERFIELD JS, 1981, NATURE, V290, P542, DOI 10.1038/290542a0
   PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008
   Rajao DS, 2016, VIROLOGY, V491, P79, DOI 10.1016/j.virol.2016.01.015
   Rajao DS, 2014, VACCINE, V32, P5170, DOI 10.1016/j.vaccine.2014.07.059
   Ramakrishnan B, 2016, TRENDS MICROBIOL, V24, P933, DOI 10.1016/j.tim.2016.09.003
   ROBINSON WE, 1990, VIROLOGY, V175, P600, DOI 10.1016/0042-6822(90)90449-2
   ROBINSON WE, 1990, P NATL ACAD SCI USA, V87, P3185, DOI 10.1073/pnas.87.8.3185
   ROBINSON WE, 1987, BIOCHEM BIOPH RES CO, V149, P693, DOI 10.1016/0006-291X(87)90423-2
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Sahay Bikash, 2017, J Clin Cell Immunol, V8, DOI 10.4172/2155-9899.1000518
   Sasaki T, 2013, ANTIVIR RES, V98, P423, DOI 10.1016/j.antiviral.2013.03.018
   Schneider-Ohrum K, 2017, J VIROL, V91, DOI 10.1128/JVI.02180-16
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/S0140-6736(17)30938-8, 10.1016/s0140-6736(17)30938-8]
   Shmelkov E, 2014, HUM VACC IMMUNOTHER, V10, P3013, DOI 10.4161/21645515.2014.972148
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086555
   Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258
   Smith DP, 2013, MBIO, V4, DOI 10.1128/mBio.00133-12
   Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405
   Takada A, 2001, J VIROL, V75, P2324, DOI 10.1128/JVI.75.5.2324-2330.2001
   Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581
   Taleb SA, 2018, EUR J CLIN MICROBIOL, V37, P1817, DOI 10.1007/s10096-018-3289-4
   TAMURA M, 1991, VIROLOGY, V182, P211, DOI 10.1016/0042-6822(91)90664-W
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thomas S, 2006, EXPERT REV VACCINES, V5, P409, DOI 10.1586/14760584.5.4.409
   Tian DY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01858-w
   Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Vincent AL, 2008, VET MICROBIOL, V126, P310, DOI 10.1016/j.vetmic.2007.07.011
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090
   Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996
   WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   WHO, 2017, MIDDL E RESP SYNDR C
   WHO, 2018, IMM VACC BIOL QUEST
   WHO, 2018, ZIK VIR 2017
   WHO, 2003, SARS SEV AC RESP SYN
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601
   Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004
   Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927
   Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337
   Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 173
TC 7
Z9 6
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 5
PY 2018
VL 9
AR 2991
DI 10.3389/fmicb.2018.02991
PG 19
WC Microbiology
SC Microbiology
GA HC9KC
UT WOS:000452123900001
PM 30568643
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ricapa-Antay, F
   Diaz-Melon, K
   Silva-Caso, W
   del Valle, LJ
   Aguilar-Luis, MA
   Vasquez-Achaya, F
   Palomares-Reyes, C
   Weilg, P
   Li, DM
   Manrique, C
   del Valle-Mendoza, J
AF Ricapa-Antay, Fiorella
   Diaz-Melon, Katia
   Silva-Caso, Wilmer
   del Valle, Luis J.
   Angel Aguilar-Luis, Miguel
   Vasquez-Achaya, Fernando
   Palomares-Reyes, Carlos
   Weilg, Pablo
   Li, Dongmei
   Manrique, Carlos
   del Valle-Mendoza, Juana
TI Molecular detection and clinical characteristics of Bartonella
   bacilliformis, Leptospira spp., and Rickettsia spp. in the Southeastern
   Peruvian Amazon basin
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Bartonella bacilliformis; Rickettsia; Leptospira; Acute febrile illness;
   Peru
ID ACUTE FEBRILE ILLNESS; EPIDEMIOLOGY; TYPHUS; FEVER
AB BackgroundAcute febrile illness (AFI) represent a significant health challenge in the Peruvian Amazon basin population due to their diverse etiologies and the unavailability of specific on-site diagnostic methods, resulting in underreporting of cases. In Peru, one of the most endemic regions to dengue and leptospirosis is Madre de Dios, a region also endemic to emergent bacterial etiologic agents of AFI, such as bartonellosis and rickettsiosis, whose prevalence is usually underreported.We aimed to molecularly identify the presence of Leptospira spp., Bartonella bacilliformis, and Rickettsia spp. by Polymerase Chain Reaction in serum samples from patients with AFI from Puerto Maldonado-Madre de Dios in Peru.MethodsSerum samples from patients with acute febrile illness were analyzed by real-time PCR for detecting the presence of Bartonella bacilliformis, Leptospira spp. and Rickettsia spp.ResultsBartonella bacilliformis was the most prevalent bacteria identified in 21.6% (30/139) of the samples, followed by Leptospira spp. in 11.5% (16/139) and Rickettsia spp. in 6.5% (9/139) of the samples. No co-infections were observed between these bacteria. The most frequent symptoms associated with fever among all groups, were headaches, myalgias, and arthralgias. We found no statistically significant differences in the clinical presentation between patients infected with each bacterium.ConclusionsIn a previous study, we shown the presence of dengue, chikungunya, Zika and oropouche virus. We were able to identify these pathogens in 29.5% of all the samples, with chikungunya and OROV as the most frequently found in 9.4 and 8.6% of all the samples, respectively. In this study we show that B. bacilliformis (21.6%), Leptospira spp. (11.5%) and Rickettsia spp. (6.5%) accounted for the main etiologies of AFI in samples from Puerto Maldonado-Madre de Dios, Peru. Our analysis of their clinical presentation, further shows the importance of implementing more sensitive and specific on-site diagnostic tools in the national surveillance programs.This study confirms that the un-specificity of signs and symptoms is not only associated with arboviral infections, but also with the clinical presentation of endemic bacterial infections.
C1 [Ricapa-Antay, Fiorella; Diaz-Melon, Katia; Silva-Caso, Wilmer; Angel Aguilar-Luis, Miguel; Vasquez-Achaya, Fernando; Palomares-Reyes, Carlos; Weilg, Pablo; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Sch Med, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru.
   [Silva-Caso, Wilmer; Angel Aguilar-Luis, Miguel; Vasquez-Achaya, Fernando; Palomares-Reyes, Carlos; del Valle-Mendoza, Juana] Inst Invest Nutr, Mol Biol Lab, Lima, Peru.
   [del Valle, Luis J.] UPC, Barcelona Tech, Barcelona Res Ctr Multiscale Sci & Engn, Dept Engn Quim,EEBE, Barcelona, Spain.
   [Angel Aguilar-Luis, Miguel] Inst Invest Enfermedades Infecciosas, Lima, Peru.
   [Li, Dongmei] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.
   [Manrique, Carlos] Direcc Reg Salud Madre Dios DIRESA Madre Dios, Puerto Maldonado, Madre De Dios, Peru.
RP del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Sch Med, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru.; del Valle-Mendoza, J (corresponding author), Inst Invest Nutr, Mol Biol Lab, Lima, Peru.
EM fiorellaricapa@gmail.com; juana.delvalle@upc.pe
RI Aguilar-Luis, Miguel Angel/C-8686-2018; Caso, Wilmer Gianfranco
   Silva/D-2699-2018; del Valle Mendoza, Juana/C-9805-2018; Del Valle, Luis
   J./I-1342-2015; Palomares Reyes, Carlos Cesar/Q-1255-2018
OI Aguilar-Luis, Miguel Angel/0000-0001-7023-3190; Caso, Wilmer Gianfranco
   Silva/0000-0003-1086-8084; del Valle Mendoza, Juana/0000-0002-6011-5040;
   Del Valle, Luis J./0000-0001-9916-1741; Palomares Reyes, Carlos
   Cesar/0000-0002-7027-1952
FU Cienciativa of CONCYTEC Peru [193-2015-FONDECYT, 164-2016-FONDECYT]
FX This work was supported by Cienciativa of CONCYTEC Peru, under the
   contract No 193-2015-FONDECYT and contract No 164-2016-FONDECYT. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abela-Ridder B, 2018, PRINC MAH AW C
   Aguilar-Leon Pool, 2016, Infez Med, V24, P172
   Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Anaya E, BARTONELLOSIS MADRE
   [Anonymous], 2018, NUMERO CASOS LEPTOSP
   [Anonymous], VIG SINDR FEBR AR AL
   Baisley KJ, 1998, AM J TROP MED HYG, V59, P710, DOI 10.4269/ajtmh.1998.59.710
   Blanton LS, 2013, CURR OPIN INFECT DIS, V26, P435, DOI 10.1097/QCO.0b013e328363811b
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Centro Nacional De Epidemiologia Prevencion Y Con., 2018, NUM CAS ENF CARR PER
   Cespedes M, 2003, REV PERU MED EXP SAL, V20, P180
   Clemente NS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001819
   Mendoza JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092283
   Ellis BA, 1999, AM J TROP MED HYG, V61, P344
   Faruque LI, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2239-6
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Forshey BM, 2010, AM J TROP MED HYG, V82, P683, DOI 10.4269/ajtmh.2010.09-0355
   García María P, 2016, Rev. perú. med. exp. salud publica, V33, P380, DOI 10.17843/rpmesp.2016.332.2098
   Gomes C, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0197-7
   Gomes C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004529
   Huerta Anderson, 2014, Rev Peru Med Exp Salud Publica, V31, P380
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Kato CY, 2013, J CLIN MICROBIOL, V51, P314, DOI 10.1128/JCM.01723-12
   Kocher C, 2017, EMERG INFECT DIS, V23, P1389, DOI 10.3201/eid2308.170050
   Kocher C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004843
   Levy-Blitchtein S, 2016, ASIAN PAC J TROP MED, V9, P997, DOI 10.1016/j.apjtm.2016.07.030
   [栗冬梅 Li Dongmei], 2015, [微生物学通报, Microbiology China], V42, P427
   Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373
   Luce-Fedrow A, 2015, FUTURE MICROBIOL, V10, P537, DOI [10.2217/FMB.14.141, 10.2217/fmb.14.141]
   Ministerio de Salud (MINSA), MINS EMIT ALERT EP A
   Ministerio de Salud (MINSA), MAP LEPT DISTR PERU
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Pachas PE, 2001, ENFERMEDAD CARRION B
   Palacios-Salvatierra Rosa, 2017, Rev. perú. med. exp. salud publica, V34, P76, DOI 10.17843/rpmesp.2017.341.2769
   Ramal A César, 2007, Rev. perú. med. exp. salud publica, V24, P99
   Red Nacional de Epidemiologia (RENACE), 2016, CAS DENG DEP PER
   Silva-Caso W, 2015, J GLOB ANTIMICROB RE, V3, P222, DOI 10.1016/j.jgar.2015.05.004
   Silva-Caso Wilmer, 2017, BMC Res Notes, V10, P656, DOI 10.1186/s13104-017-2977-y
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Tam PYI, 2016, J PEDIAT INF DIS SOC, V5, P190, DOI 10.1093/jpids/piw016
   Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003866
   Tubiana S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001991
NR 42
TC 1
Z9 1
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 4
PY 2018
VL 18
AR 618
DI 10.1186/s12879-018-3541-7
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA HC9MW
UT WOS:000452131500004
PM 30514235
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Soto-Acosta, R
   Xie, XP
   Shan, C
   Baker, CK
   Shi, PY
   Rossi, SL
   Garcia-Blanco, MA
   Bradrick, S
AF Soto-Acosta, Ruben
   Xie, Xuping
   Shan, Chao
   Baker, Coleman K.
   Shi, Pei-Yong
   Rossi, Shannan L.
   Garcia-Blanco, Mariano A.
   Bradrick, Shelton
TI Fragile X mental retardation protein is a Zika virus restriction factor
   that is antagonized by subgenomic flaviviral RNA
SO ELIFE
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; STRESS GRANULE FORMATION; 3'-UNTRANSLATED
   REGION; MESSENGER-RNAS; TRANSLATION; BIOLOGY; TARGETS; BINDS;
   IDENTIFICATION; ASSOCIATION
AB Subgenomic flaviviral RNA (sfRNA) accumulates during infection due to incomplete degradation of viral genomes and interacts with cellular proteins to promote infection. Here we identify host proteins that bind the Zika virus (ZIKV) sfRNA. We identified fragile X mental retardation protein (FMRP) as a ZIKV sfRNA-binding protein and confirmed this interaction in cultured cells and mouse testes. Depletion of FMRP elevated viral translation and enhanced ZIKV infection, indicating that FMRP is a ZIKV restriction factor. We further observed that an attenuated ZIKV strain compromised for sfRNA production was disproportionately stimulated by FMRP knockdown, suggesting that ZIKV sfRNA antagonizes FMRP activity. Importantly, ZIKV infection and expression of ZIKV sfRNA upregulated endogenous FMRP target genes in cell culture and ZIKV-infected mice. Together, our observations identify FMRP as a ZIKV restriction factor whose activity is antagonized by the sfRNA. Interaction between ZIKV and FMRP has significant implications for the pathogenesis of ZIKV infections.
C1 [Soto-Acosta, Ruben; Xie, Xuping; Shan, Chao; Shi, Pei-Yong; Garcia-Blanco, Mariano A.; Bradrick, Shelton] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Baker, Coleman K.; Rossi, Shannan L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong; Rossi, Shannan L.; Garcia-Blanco, Mariano A.; Bradrick, Shelton] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Bradrick, Shelton] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
RP Garcia-Blanco, MA; Bradrick, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Garcia-Blanco, MA; Bradrick, S (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Bradrick, S (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Garcia-Blanco, MA (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
RI Xie, Xuping/AAD-7406-2019
OI Garcia-Blanco, Mariano/0000-0001-8538-1997; Soto-Acosta,
   Ruben/0000-0003-0570-5483; Bradrick, Shelton/0000-0003-1566-9797; Shan,
   Chao/0000-0002-3953-3782
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI089526, R01AI101431, R01AI127744]; University of Texas Medical
   Branch; University of Texas System; Robert J. Kleberg, Jr. and Helen C.
   Kleberg Foundation; University of Texas Medical Branch [CTSA
   UL1TR-001439]
FX National Institute of Allergy and Infectious Diseases R01AI089526
   Mariano A Garcia-Blanco; University of Texas Medical Branch Start-up
   funds Mariano A Garcia-Blanco Shelton Bradrick; National Institute of
   Allergy and Infectious Diseases R01AI101431 Mariano A Garcia-Blanco;
   National Institute of Allergy and Infectious Diseases R01AI127744
   Pei-Yong Shi; University of Texas System STARs award Pei-Yong Shi;
   Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Award Pei-Yong
   Shi; University of Texas Medical Branch CTSA UL1TR-001439 Pei-Yong Shi;
   The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Anderson BR, 2016, NUCLEIC ACIDS RES, V44, P6649, DOI 10.1093/nar/gkw593
   Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos RK, 2018, CURR TOP MICROBIOL, V419, P43, DOI 10.1007/82_2017_26
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023
   Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10
   Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805
   Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9
   Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Goeijenbier M, 2016, NETH J MED, V74, P104
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Goncalves KD, 2011, FEBS LETT, V585, P2556, DOI 10.1016/j.febslet.2011.07.010
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845
   Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36
   Hirano M, 2017, P NATL ACAD SCI USA, V114, P9960, DOI 10.1073/pnas.1704454114
   Hoeft F, 2010, P NATL ACAD SCI USA, V107, P9335, DOI 10.1073/pnas.1002762107
   Kim DY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005810
   Korb E, 2017, CELL, V170, P1209, DOI 10.1016/j.cell.2017.07.033
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liao KC, 2018, RNA, V24, P803, DOI 10.1261/rna.064006.117
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Maurin T, 2018, NUCLEIC ACIDS RES, V46, P6344, DOI 10.1093/nar/gky267
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Muto M, 2018, VIRUS RES, V249, P52, DOI 10.1016/j.virusres.2018.03.006
   PAHO-WHO, 2018, ZIK SUSP CONF CAS RE
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Ward AM, 2014, METHODS MOL BIOL, V1138, P253, DOI 10.1007/978-1-4939-0348-1_16
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5
   Zhou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4259
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 77
TC 8
Z9 8
U1 0
U2 3
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD DEC 4
PY 2018
VL 7
AR e39023
DI 10.7554/eLife.39023
PG 28
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HC7PJ
UT WOS:000451993500001
PM 30511641
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mazeaud, C
   Freppel, W
   Chatel-Chaix, L
AF Mazeaud, Clement
   Freppel, Wesley
   Chatel-Chaix, Laurent
TI The Multiples Fates of the Flavivirus RNA Genome During Pathogenesis
SO FRONTIERS IN GENETICS
LA English
DT Review
DE flavivirus; dengue virus; Zika virus; West Nile virus; viral RNA
   replication; translation; RNA encapsidation; innate immunity
ID JAPANESE ENCEPHALITIS-VIRUS; HEPATITIS-C VIRUS; MINUS-STRAND RNA;
   RECOMBINANT SUBVIRAL PARTICLES; NUCLEOLAR HELICASE DDX56; DENGUE VIRUS;
   WEST-NILE; VIRAL-RNA; RIG-I; 3'-UNTRANSLATED REGION
AB The Flavivirus genus comprises many viruses (including dengue, Zika, West Nile and yellow fever viruses) which constitute important public health concerns worldwide. For several of these pathogens, neither antivirals nor vaccines are currently available. In addition to this unmet medical need, flaviviruses are of particular interest since they constitute an excellent model for the study of spatiotemporal regulation of RNA metabolism. Indeed, with no DNA intermediate or nuclear step, the flaviviral life cycle entirely relies on the cytoplasmic fate of a single RNA species, namely the genomic viral RNA (vRNA) which contains all the genetic information necessary for optimal viral replication. From a single open reading frame, the vRNA encodes a polyprotein which is processed to generate the mature viral proteins. In addition to coding for the viral polyprotein, the vRNA serves as a template for RNA synthesis and is also selectively packaged into newly assembled viral particles. Notably, vRNA translation, replication and encapsidation must be tightly coordinated in time and space via a fine-tuned equilibrium as these processes cannot occur simultaneously and hence, are mutually exclusive. As such, these dynamic processes involve several vRNA secondary and tertiary structures as well as RNA modifications. Finally, the vRNA can be detected as a foreign molecule by cytosolic sensors which trigger upon activation antiviral signaling pathways and the production of antiviral factors such as interferons and interferon-stimulated genes. However, to create an environment favorable to infection, flaviviruses have evolved mechanisms to dampen these antiviral processes, notably through the production of a specific vRNA degradation product termed subgenomic flavivirus RNA (sfRNA). In this review, we discuss the current understanding of the fates of flavivirus vRNA and how this is regulated at the molecular level to achieve an optimal replication within infected cells.
C1 [Mazeaud, Clement; Freppel, Wesley; Chatel-Chaix, Laurent] Inst Armand Frappier, Ctr INRS, Inst Natl Rech Sci, Laval, PQ, Canada.
RP Chatel-Chaix, L (corresponding author), Inst Armand Frappier, Ctr INRS, Inst Natl Rech Sci, Laval, PQ, Canada.
EM Laurent.Chatel-Chaix@iaf.inrs.ca
OI Freppel, Wesley/0000-0003-3628-0465
FU Fonds de la Recherche du Quebec-Sante (FRQS); Natural Sciences and
   Engineering Research Council of Canada (NSERC)Natural Sciences and
   Engineering Research Council of Canada [RGPIN-2016-05584]; Canadian
   Institutes of Health Research (CIHR)Canadian Institutes of Health
   Research (CIHR) [PJT153020, ICS154142]; Fonds de la Recherche du
   Quebec-Nature et Technologies (FRQNT) [2018-NC-205593]; Armand-Frappier
   Foundation; Institut National de la Recherche Scientifique (INRS)
FX LC-C is receiving a research scholar (Junior 2) salary support from
   Fonds de la Recherche du Quebec-Sante (FRQS). LC-C's research is
   supported by grants from Natural Sciences and Engineering Research
   Council of Canada (NSERC; RGPIN-2016-05584), the Canadian Institutes of
   Health Research (CIHR; PJT153020; ICS154142), Fonds de la Recherche du
   Quebec-Nature et Technologies (FRQNT; 2018-NC-205593), Armand-Frappier
   Foundation, and Institut National de la Recherche Scientifique (INRS).
CR Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082
   Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07
   Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0
   Juarez-Martinez AB, 2013, ARCH VIROL, V158, P583, DOI 10.1007/s00705-012-1525-2
   Bhullar D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114931
   Bidet Katell, 2017, PLoS Pathog, V13, pe1006295, DOI 10.1371/journal.ppat.1006295
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Bradrick SS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02374
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Brunetti JE, 2015, VIRUS RES, V203, P84, DOI 10.1016/j.virusres.2015.04.001
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chang YS, 1999, J VIROL, V73, P6257, DOI 10.1128/JVI.73.8.6257-6264.1999
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chatel-Chaix L, 2013, J VIROL, V87, P11704, DOI 10.1128/JVI.01474-13
   Chatel-Chaix L, 2011, J VIROL, V85, P11022, DOI 10.1128/JVI.00719-11
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chiang C, 2015, J VIROL, V89, P8011, DOI 10.1128/JVI.00845-15
   Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10
   Chiu HP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007166
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Comas-Garcia M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090246
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Dechtawewat T, 2015, VIROL J, V12, DOI 10.1186/s12985-014-0219-7
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Dong YC, 2015, INT J MOL MED, V35, P1683, DOI 10.3892/ijmm.2015.2169
   DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emara MM, 2008, J VIROL, V82, P10657, DOI 10.1128/JVI.00991-08
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Friebe P, 2012, VIROLOGY, V422, P346, DOI 10.1016/j.virol.2011.10.025
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Friedrich S, 2018, J VIROL, V92, DOI 10.1128/JVI.01647-17
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gao D, 2017, PROTEINS, V85, P3, DOI 10.1002/prot.25179
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687
   Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590
   Groat-Carmona AM, 2012, VIROLOGY, V432, P511, DOI 10.1016/j.virol.2012.06.028
   Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6
   Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663
   Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950
   Hodge K, 2016, J BIOL CHEM, V291, P17437, DOI 10.1074/jbc.M116.724013
   Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Ivanyi-Nagy R, 2012, VIRUS RES, V167, P226, DOI 10.1016/j.virusres.2012.05.003
   Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11
   Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kim YG, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-59
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Lei YF, 2011, J GEN VIROL, V92, P796, DOI 10.1099/vir.0.028597-0
   Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR
   Leon-Juarez M, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0456-4
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li C, 2014, VIROLOGY, V449, P70, DOI 10.1016/j.virol.2013.11.008
   Li C, 2013, ANTIVIR RES, V100, P487, DOI 10.1016/j.antiviral.2013.09.002
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Li W, 2001, VIROLOGY, V287, P49, DOI 10.1006/viro.2001.1015
   Li XD, 2015, J GEN VIROL, V96, P1264, DOI 10.1099/vir.0.000044
   Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346
   Liao KC, 2018, RNA, V24, P803, DOI 10.1261/rna.064006.117
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Olsthoorn RCL, 2001, RNA, V7, P1370
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Perard J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2611
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pesko KN, 2012, VIROLOGY, V427, P10, DOI 10.1016/j.virol.2012.01.028
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Poenisch M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004573
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Reid CR, 2017, VIROLOGY, V500, P169, DOI 10.1016/j.virol.2016.10.025
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Shi G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005441
   Shrivastava G, 2017, VIRULENCE, V8, P1450, DOI 10.1080/21505594.2017.1356540
   Shulla A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004758
   Shustov AV, 2010, VIROLOGY, V400, P8, DOI 10.1016/j.virol.2009.12.015
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sprokholt JK, 2017, J IMMUNOL, V198, P4764, DOI 10.4049/jimmunol.1602121
   Sun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03932-1
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Swarbrick CMD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1127
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023
   Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Upadhyay A, 2013, MOL CELL PROTEOMICS, V12, P1539, DOI 10.1074/mcp.M112.017020
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12
   Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114
   Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Vossmann S, 2015, J VIROL, V89, P4951, DOI 10.1128/JVI.03351-14
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Winkelmann ER, 2011, VIROLOGY, V421, P96, DOI 10.1016/j.virol.2011.09.007
   Wu RH, 2015, J VIROL, V89, P4281, DOI 10.1128/JVI.03011-14
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yoshii K, 2008, J GEN VIROL, V89, P200, DOI 10.1099/vir.0.82824-0
   You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 210
TC 10
Z9 10
U1 3
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD DEC 4
PY 2018
VL 9
AR 595
DI 10.3389/fgene.2018.00595
PG 19
WC Genetics & Heredity
SC Genetics & Heredity
GA HC9BW
UT WOS:000452101300001
PM 30564270
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abreu, CM
   Gama, L
   Krasemann, S
   Chesnut, M
   Odwin-Dacosta, S
   Hogberg, HT
   Hartung, T
   Pamies, D
AF Abreu, Celina Monteiro
   Gama, Lucio
   Krasemann, Susanne
   Chesnut, Megan
   Odwin-Dacosta, Shelly
   Hogberg, Helena T.
   Hartung, Thomas
   Pamies, David
TI Microglia Increase Inflammatory Responses in iPSC-Derived Human
   BrainSpheres
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE zika virus; organoids; microglial cells; in vitro culture; BrainSpheres
ID PURIFIED LIPOTEICHOIC ACID; PLURIPOTENT STEM-CELLS; CEREBRAL ORGANOIDS;
   NEURAL PROGENITORS; DOPAMINERGIC-NEURONS; BRAIN-DEVELOPMENT; GLIA
   ACTIVATION; MODEL; ROLES; FLAVIVIRUSES
AB Human induced pluripotent stem cells (iPSCs), together with 21st century cell culture methods, have the potential to better model human physiology with applications in toxicology, disease modeling, and the study of host-pathogen interactions. Several models of the human brain have been developed recently, demonstrating cell-cell interactions of multiple cell types with physiologically relevant 3D structures. Most current models, however, lack the ability to represent the inflammatory response in the brain because they do not include a microglial cell population. Microglia, the resident immunocompetent phagocytes in the central nervous system (CNS), are not only important in the inflammatory response and pathogenesis; they also function in normal brain development, strengthen neuronal connections through synaptic pruning, and are involved in oligodendrocyte and neuronal survival. Here, we have successfully introduced a population of human microglia into 3D human iPSC-derived brain spheres (BrainSpheres, BS) through co-culturing cells of the Immortalized Human Microglia - SV40 cell line with the BS model (mu BS). We detected an inflammatory response to lipopolysaccharides (LPS) and flavivirus infection, which was only elicited in the model when microglial cells were present. A concentration of 20 ng/mL of LPS increased gene expression of the inflammatory cytokines interleukin-6 (IL-6), IL-10, and IL-1 beta, with maximum expression at 6-12 h post-exposure. Increased expression of the IL6, IL-1 beta, tumor necrosis factor alpha (TNF-alpha), and chemokine (C-C motif) ligand 2 (CCL2) genes was observed in mu BS following infection with Zika and Dengue Virus, suggesting a stronger inflammatory response in the model when microglia were present than when only astrocyte, oligodendrocyte, and neuronal populations were represented. Microglia innately develop within cerebral organoids (Nature communications)(1), our findings suggest that the mu BS model is more physiologically relevant and has potential applications in infectious disease and host-pathogen interactions research.
C1 [Abreu, Celina Monteiro; Gama, Lucio] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA.
   [Gama, Lucio] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Krasemann, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.
   [Chesnut, Megan; Odwin-Dacosta, Shelly; Hogberg, Helena T.; Hartung, Thomas; Pamies, David] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21205 USA.
   [Hartung, Thomas] Univ Konstanz, CART Europe, Constance, Germany.
RP Pamies, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21205 USA.
EM david.pamies@unil.ch
OI Pamies, David/0000-0002-1224-573X
FU NIH NCATSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [U18TR000547]
FX This work was supported by NIH NCATS (Grant U18TR000547 "A 3D Model of
   Human Brain Development for Studying Gene/Environment Interactions," PI
   Hartung). We are grateful for additional financial support by Dorothy
   Frankel.
CR Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3
   Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253
   Baby N, 2014, CURR MED CHEM, V21, P4215, DOI 10.2174/0929867321666140716101258
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011
   Boveri M, 2006, NEUROSCIENCE, V137, P1193, DOI 10.1016/j.neuroscience.2005.10.011
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Derecki NC, 2014, ACTA NEUROPATHOL, V128, P333, DOI 10.1007/s00401-014-1321-z
   Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491
   Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Mesa Y, 2017, J NEUROVIROL, V23, P47, DOI 10.1007/s13365-016-0499-3
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045
   Hu XM, 2012, J NEUROIMMUNE PHARM, V7, P187, DOI 10.1007/s11481-011-9309-0
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318
   Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x
   Kinsner A, 2006, J NEUROCHEM, V99, P596, DOI 10.1111/j.1471-4159.2006.04085.x
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Marx U, 2016, ALTEX-ALTERN ANIM EX, V33, P272, DOI 10.14573/altex.1603161
   Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Olajide OA, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/459723
   Pamies D, 2018, TOXICOL APPL PHARM, V354, P101, DOI 10.1016/j.taap.2018.02.003
   Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P362, DOI 10.14573/altex.1609122
   Pamies D, 2017, CHEM RES TOXICOL, V30, P43, DOI 10.1021/acs.chemrestox.6b00269
   Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Patel AB, 2016, P NATL ACAD SCI USA, V113, pE7049, DOI 10.1073/pnas.1604992113
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887
   Salick MR, 2017, JOVE-J VIS EXP, DOI 10.3791/56404
   Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397
   Sandstrom J, 2017, TOXICOL IN VITRO, V38, P124, DOI 10.1016/j.tiv.2016.10.001
   Smirnova L, 2018, ALTEX-ALTERN ANIM EX, V35, P139, DOI 10.14573/altex.1804051
   Sousa C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00198
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thompson KK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030504
   Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu W, 2016, CARCINOGENESIS, V37, P839, DOI 10.1093/carcin/bgw068
NR 57
TC 9
Z9 9
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 4
PY 2018
VL 9
AR 2766
DI 10.3389/fmicb.2018.02766
PG 12
WC Microbiology
SC Microbiology
GA HC8AR
UT WOS:000452024200001
PM 30619100
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Tissera, H
   AbuBakar, S
   Kittayapong, P
   Logan, J
   Neumayr, A
   Rocklov, J
   Byass, P
   Louis, VR
   Tozan, Y
   Massad, E
   Preet, R
AF Wilder-Smith, Annelies
   Tissera, Hasitha
   AbuBakar, Sazaly
   Kittayapong, Pattamaporn
   Logan, James
   Neumayr, Andreas
   Rocklov, Joacim
   Byass, Peter
   Louis, Valerie R.
   Tozan, Yesim
   Massad, Eduardo
   Preet, Raman
TI Novel tools for the surveillance and control of dengue: findings by the
   dengueTools research consortium
SO GLOBAL HEALTH ACTION
LA English
DT Review
DE Dengue; DengueTools; surveillance; impregnated clothing; schools; Aedes;
   vectorial capacity; predictive modelling; importation; travel; Zika;
   reverse transcription-recombinase polymerase amplification
ID RIO-DE-JANEIRO; ZIKA VIRUS; SENTINEL SURVEILLANCE; SRI-LANKA; TRAVELERS;
   RISK; IMPREGNATION; IMPORTATIONS; INFECTIONS; PERMETHRIN
AB Background: Dengue fever persists as a major global disease burden, and may increase as a consequence of climate change. Along with other measures, research actions to improve diagnosis, surveillance, prevention, and predictive models are highly relevant. The European Commission funded the DengueTools consortium to lead a major initiative in these areas, and this review synthesises the outputs and findings of this work conducted from 2011 to 2016.
   Research areas: DengueTools organised its work into three research areas, namely [1] Early warning and surveillance systems; [2] Strategies to prevent dengue in children; and [3] Predictive models for the global spread of dengue.
   Research area 1 focused on case-studies undertaken in Sri Lanka, including developing laboratory-based sentinel surveillance, evaluating economic impact, identifying drivers of transmission intensity, evaluating outbreak prediction capacity and developing diagnostic capacity. Research area 2 addressed preventing dengue transmission in school children, with case-studies undertaken in Thailand. Insecticide-treated school uniforms represented an intriguing potential approach, with some encouraging results, but which were overshadowed by a lack of persistence of insecticide on the uniforms with repeated washing. Research area 3 evaluated potential global spread of dengue, particularly into dengue-naive areas such as Europe. The role of international travel, changing boundaries of vectors, developing models of vectorial capacity under different climate change scenarios and strategies for vector control in outbreaks was all evaluated.
   Concluding remarks: DengueTools was able to make significant advances in methods for understanding and controlling dengue transmission in a range of settings. These will have implications for public health agendas to counteract dengue, including vaccination programmes.
   Outlook: Towards the end of the DengueTools project, Zika virus emerged as an unexpected epidemic in the central and southern America. Given the similarities between the dengue and Zika viruses, with vectors in common, some of the DengueTools thinking translated readily into the Zika situation.
C1 [Wilder-Smith, Annelies; Rocklov, Joacim; Byass, Peter; Preet, Raman] Umea Univ, Unit Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [Tissera, Hasitha] Hlth, Epidemiol Unit, Colombo, Sri Lanka.
   [AbuBakar, Sazaly] Univ Malaya, CWHO Collaborating Ctr Arbovirus Reference & Res, TIDREC, Kuala Lumpur, Malaysia.
   [Kittayapong, Pattamaporn] Mahidol Univ, Ctr Excellence Vectors & Vector Borne Dis, Dept Biol, Fac Sci, Bangkok, Thailand.
   [Logan, James] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Neumayr, Andreas] Swiss Trop & Publ Hlth Inst, Dept Med Serv, Basel, Switzerland.
   [Louis, Valerie R.; Tozan, Yesim] Heidelberg Univ, Heidelberg Inst Global Hlth, Med Sch, Heidelberg, Germany.
   [Tozan, Yesim] NYU, Coll Global Publ Hlth, New York, NY USA.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
RP Wilder-Smith, A (corresponding author), Umea Univ, Unit Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden.
EM anneliesws@gmail.com
RI abubakar, sazaly/B-3957-2010; Tissera, Hasitha/AAQ-2516-2020
OI abubakar, sazaly/0000-0002-9267-1420; Byass, Peter/0000-0001-5474-4361;
   Rocklov, Joacim/0000-0003-4030-0449; Tozan, Yesim/0000-0001-8997-8897;
   Preet, Raman Kaur/0000-0002-4371-5941
FU Health theme of the Seventh Framework Programme of the European
   Community [282589]; Innovative tools and strategies for surveillance and
   control of dengue - DengueTools
FX This project was funded under the Health theme of the Seventh Framework
   Programme of the European Community, Grant Agreement number 282589.
   Project: Innovative tools and strategies for surveillance and control of
   dengue - DengueTools.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384
   Angelo KM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax046
   Arya SC, 2013, J TRAVEL MED, V20, P268, DOI 10.1111/jtm.12036
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   Bodinayake CK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004995
   Boubidi SC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1881-y
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   de Laval F, 2013, J TRAVEL MED, V20, P259, DOI 10.1111/j.1708-8305.2012.00674.x
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472
   Ferguson RW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw010
   Franco L, 2015, CLIN MICROBIOL INFEC, V21, p713e5
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Griffiths KM, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay007
   Harris CL, 2013, BIOTECHNIQUES, V54, P95, DOI 10.2144/000113951
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Horstick O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003632
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Liyanage P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111087
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Louis VR, 2016, PATHOG GLOB HEALTH, V110, P79, DOI 10.1080/20477724.2016.1175158
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Massad E, 2016, LANCET, V388, P658, DOI 10.1016/S0140-6736(16)31228-4
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20473
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   Mues KE, 2014, CLIN INFECT DIS, V58, P546, DOI 10.1093/cid/cit746
   Murray N, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24887
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neuberger A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw003
   Neumayr A, 2017, EURO SURVEILL, V22
   Neumayr AM, 2016, EURO SURVEILL, V22
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Poddighe D, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav013
   Quam MB, 2015, J TRAVEL MED
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Ratanawong P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161895
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Riddell A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax015
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Sebeny PJ, 2013, J TRAVEL MED, V20, P214, DOI 10.1111/jtm.12033
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Stevens AM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw099
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259
   Tan KK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3065-1
   Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Thalagala N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004466
   Tissera H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004477
   Torresi J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax064
   Tozan Y, 2016, EXPERT REV VACCINES, V15, P519, DOI 10.1586/14760584.2016.1129278
   Tozan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108017
   Uehara A, 2017, AM J TROP MED HYG, V97, P130, DOI 10.4269/ajtmh.16-0540
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2011, MED HYPOTHESES, V76, P861, DOI 10.1016/j.mehy.2011.02.037
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   Wilder-Smith A, 2018, LANCET INFECT DIS
   Wilder-Smith A, 2012, GLOB HLTH ACTION, V5
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31620
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   Zhang J., 2016, J TRAVEL MED, V23
NR 92
TC 3
Z9 3
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD DEC 3
PY 2018
VL 11
IS 1
AR 1549930
DI 10.1080/16549716.2018.1549930
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HC5MO
UT WOS:000451847300001
PM 30560735
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Marcombe, S
   Chonephetsarath, S
   Thammavong, P
   Brey, PT
AF Marcombe, Sebastien
   Chonephetsarath, Somsanith
   Thammavong, Phoutmany
   Brey, Paul T.
TI Alternative insecticides for larval control of the dengue vector Aedes
   aegypti in Lao PDR: insecticide resistance and semi-field trial study
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Vector control; Temephos; Bti; Diflubenzuron;
   Pyriproxyfen; Spinosad; IGR; Laos; Dengue
ID BACILLUS-THURINGIENSIS; MOSQUITOS; CULICIDAE; DIPTERA; DIFLUBENZURON;
   PYRIPROXYFEN; FORMULATIONS; LARVICIDES; TOLERANCE; EFFICACY
AB BackgroundThe mosquito Aedes aegypti is the primary vector of several arboviruses, such as dengue, chikungunya and Zika, and represents a major public health problem in Southeast Asia. In Laos, where dengue is reemerging, several Ae. aegypti populations from the capital Vientiane have shown resistance to the organophosphate temephos, a commonly-used larvicide for public health interventions.MethodsHere, we tested the insecticide susceptibility of a wild larval population of Ae. aegypti against Bacillus thuringiensis israelensis (Bti), diflubenzuron, pyriproxyfen and spinosad. Residual efficacies of Bti (VectobacWG (R)), diflubenzuron (Killmos (R)) and temephos (Abate (R)) were then evaluated under simulated field conditions against the wild Ae. aegypti population.ResultsThe larval bioassays showed that the wild Ae. aegypti strain was moderately resistant to temephos and spinosad (resistance ratio, RR < 5) and fully susceptible to the other insecticides (RR = 1). The simulated field trial bioassays showed that all of the insecticides tested remained above the WHO acceptable larvicide threshold after 28 weeks.ConclusionsThese results suggest that Bti and diflubenzuron may be promising alternative larvicides for controlling dengue vectors in water-storage containers in Laos, especially against Ae. aegypti populations, in which resistance to temephos has been detected.
C1 [Marcombe, Sebastien; Chonephetsarath, Somsanith; Thammavong, Phoutmany; Brey, Paul T.] Minist Hlth, Inst Pasteur Laos, Viangchan, Laos.
RP Marcombe, S (corresponding author), Minist Hlth, Inst Pasteur Laos, Viangchan, Laos.
EM s.marcombe@pasteur.la
FU Institut Pasteur du Laos
FX This work was supported by the Institut Pasteur du Laos.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Ahmed MAI, 2016, ACTA TROP, V155, P1, DOI 10.1016/j.actatropica.2015.11.015
   [Anonymous], 2017, DENG BIW REP 2017 10
   [Anonymous], 2004, 7 WHOPES WORK GOUP M
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Becker N., 2003, MOSQUITOES THEIR CON
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Bill and Melinda Gates Foundation, 2007, MAL FOR FIN REP
   Chandel K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005235
   Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280
   Chen C D, 2005, Trop Biomed, V22, P195
   Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U
   Corriveau R, 2003, DENGUE DEP FRANCAIS
   Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Dias LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173689
   Finney D.T., 1971, PROBIT ANAL
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hirano M, 1998, REV TOXICOL, V2, P357
   JENNINGS CD, 1995, AM J TROP MED HYG, V53, P324, DOI 10.4269/ajtmh.1995.53.324
   Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2
   Julo-Reminiac J-E, 2014, FIELD ACTIONS SCI RE, V7, P3759
   Khun S, 2007, ACTA TROP, V101, P139, DOI 10.1016/j.actatropica.2007.01.002
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115569
   Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019
   Mahilum MM, 2005, J VECTOR ECOL, V30, P277
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Matsumura F, 2010, PESTIC BIOCHEM PHYS, V97, P133, DOI 10.1016/j.pestbp.2009.10.001
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Nambanya S., 1997, Dengue Bulletin, V21, P115
   Pereira BB, 2016, J TOXICOL ENV HEAL A, V79, P477, DOI 10.1080/15287394.2016.1176974
   Phommasak B., 1990, DENGUE HAEMMORRHAGIC
   Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P398, DOI 10.2987/5697.1
   Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2
   Su T, 2016, INSECTICIDES RESISTA
   Suter T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2364-5
   Tetreau G, 2013, AQUAT TOXICOL, V140, P389, DOI 10.1016/j.aquatox.2013.07.004
   Thavara Usavadee, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P269
   WHO, 2016, MON MAN INS RES AED
   WHO, 2010, SPIN DT DRINK WAT US
   Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2008, PYR DRINK WAT US VEC
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization, 2008, DIFL DRINK WAT US VE
   Yunta C, 2016, INSECT BIOCHEM MOLEC, V78, P50, DOI 10.1016/j.ibmb.2016.09.001
NR 52
TC 6
Z9 6
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 3
PY 2018
VL 11
AR 616
DI 10.1186/s13071-018-3187-8
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HC8UO
UT WOS:000452080300001
PM 30509299
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Han, YS
   Mesplede, T
AF Han, Yingshan
   Mesplede, Thibault
TI Investigational drugs for the treatment of Zika virus infection: a
   preclinical and clinical update
SO EXPERT OPINION ON INVESTIGATIONAL DRUGS
LA English
DT Review
DE Zika virus; ZIKV inhibitors; flavivirus; repurposing; small molecules;
   host factors; in vivo; clinical trial
ID FDA-APPROVED DRUG; BROAD-SPECTRUM; INHIBITS ZIKA; DENGUE VIRUS;
   IN-VITRO; NUCLEOSIDE INHIBITORS; ANTIVIRAL ACTIVITY; NS2B-NS3 PROTEASE;
   RNA-POLYMERASE; NS5 PROTEIN
AB Introduction: The Zika virus (ZIKV) infection results in severe neurological complications and has emerged as a threat to public health worldwide. No drugs or vaccines are available for use in the clinic and the need for novel and effective therapeutic agents is urgent. Areas covered: This review describes the latest progress of antiviral development for the treatment of ZIKV infection; it primarily focuses on the literature describing 20 potential anti-ZIKV drugs/agents currently being tested in vivo or in clinical trials. The paper also discusses the need for novel ZIKV inhibitors and the critical issues for successful antiviral drug development. Expert opinion: So far, 20 compounds have been tested in vivo and three in the clinical trials; progressing these compounds to the clinic is a challenge. Novel ZIKV inhibitors that target virus or host factors are urgently needed. Knowledge-driven drug repurposing, structure-based discovery, RNA interference, long noncoding RNAs, miRNAs, and peptide inhibitors may pave the way for the discovery of such novel agents.
C1 [Han, Yingshan; Mesplede, Thibault] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ, Canada.
RP Han, YS (corresponding author), McGill Univ, AIDS Ctr, Jewish Gen Hosp, 3755 Cote Sainte Catherine, Montreal, PQ H3T 1E2, Canada.
EM yingshan_han@yahoo.com
RI Mesplede, Thibault/E-8550-2014
OI Mesplede, Thibault/0000-0003-0515-9128
CR Abdelmohsen UR, 2017, LANCET INFECT DIS, V17, pE30, DOI 10.1016/S1473-3099(16)30323-1
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Boto A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020311
   Bruzzoni-Giovanelli H, 2018, DRUG DISCOV TODAY, V23, P272, DOI 10.1016/j.drudis.2017.10.016
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Chew MF, 2017, INT J MED SCI, V14, P1342, DOI 10.7150/ijms.21875
   Chopra D, 2018, INFECT DISORD DRUG T, V18, P1
   Connelly CM, 2016, CELL CHEM BIOL, V23, P1077, DOI 10.1016/j.chembiol.2016.05.021
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Crosse KM, 2018, J INNATE IMMUN, V10, P85, DOI 10.1159/000484258
   Da Silva S, 2018, VIRUSES, V10, P5
   de la Guardia C, 2018, MOLECULES, V23, DOI 10.3390/molecules23030672
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Devillers J, 2018, SAR QSAR ENVIRON RES, V29, P103, DOI 10.1080/1062936X.2017.1411642
   Drury RE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01182
   Elgner F, 2018, VIRUSES, V10, P4
   Esteves E, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1734151
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Giulietti M, 2018, VIRUS RES, V255, P133, DOI 10.1016/j.virusres.2018.07.010
   Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4
   Goertz GP, 2017, VIRUS RES, V254, P41
   Gomes B, 2018, BIOTECHNOL ADV, V36, P415, DOI 10.1016/j.biotechadv.2018.01.004
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   He J, 2013, INFLUENZA OTHER RESP, V7, P922, DOI 10.1111/irv.12035
   He M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00722
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hermann T, 2016, WIRES RNA, V7, P726, DOI 10.1002/wrna.1373
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Jin GX, 2014, DRUG DISCOV TODAY, V19, P637, DOI 10.1016/j.drudis.2013.11.005
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kazmirchuk T, 2017, COMPUT BIOL CHEM, V71, P180, DOI 10.1016/j.compbiolchem.2017.10.011
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lee I, 2018, VIRUSES, V10, P5
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li L, 2018, ACTA CRYSTALLOGR F, V74, P205, DOI 10.1107/S2053230X18003813
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418
   Meng XY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01663
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Mushtaque M, 2015, EUR J MED CHEM, V90, P280, DOI 10.1016/j.ejmech.2014.11.022
   Musiol R, 2017, EXPERT OPIN DRUG DIS, V12, P583, DOI 10.1080/17460441.2017.1319357
   Oliveira AF, 2017, MOLECULES, V22, P3
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Parhizgar AR, 2017, IRAN J MED SCI, V42, P115
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Prantner D, 2017, J BIOL CHEM, V292, P292, DOI 10.1074/jbc.M116.763268
   Pryke KM, 2017, MBIO, V8, DOI [10.1128/mBio.00452-17, 10.1128/mbio.00452-17]
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, P6, DOI DOI 10.1128/AAC.00411-17.E00411-17
   Schoggins John W, 2018, F1000Res, V7, P309, DOI 10.12688/f1000research.12450.1
   Schor S, 2018, DNA CELL BIOL, V37, P63, DOI 10.1089/dna.2017.4033
   Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004
   Shi Y, 2018, ADV EXP MED BIOL, V1062, P77, DOI 10.1007/978-981-10-8727-1_6
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Sinigaglia A, 2018, EXPERT OPIN DRUG DIS, V13, P825, DOI 10.1080/17460441.2018.1515909
   Sperandio S, 2015, P NATL ACAD SCI USA, V112, pE3392, DOI 10.1073/pnas.1500857112
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Warfield KL, 2017, ANTIVIR RES, V138, P22, DOI 10.1016/j.antiviral.2016.11.019
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wong G, 2017, VIROL SIN, V32, P545, DOI 10.1007/s12250-017-4057-9
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xie YC, 2016, CURR DRUG TARGETS, V17, P1560, DOI 10.2174/1389450117666151209123751
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang HT, 2017, BRIEF BIOINFORM, V18, P488, DOI 10.1093/bib/bbw030
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 119
TC 5
Z9 5
U1 3
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-3784
EI 1744-7658
J9 EXPERT OPIN INV DRUG
JI Expert Opin. Investig. Drugs
PD DEC 2
PY 2018
VL 27
IS 12
BP 951
EP 962
DI 10.1080/13543784.2018.1548609
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HC1RH
UT WOS:000451579300002
PM 30430882
DA 2020-07-08
ER

PT J
AU Callender, DM
AF Callender, David Michael
TI Factors contributing to and strategies to combat emerging arboviruses
SO GLOBAL PUBLIC HEALTH
LA English
DT Article
DE Emerging infectious diseases; yellow fever; zika; globalisation
ID YELLOW-FEVER; ZIKA VIRUS; OLYMPIC GAMES; BRAZIL; EPIDEMIC; EMERGENCE;
   THREAT; RISK
AB Less than half a century ago infectious diseases appeared to be destined to be extinguished via as a culmination of medical triumphs. As focus turned towards combating non-communicable diseases, emerging and re-emerging diseases (EIDs) have bloomed from those ashes. Five epidemic mosquito-borne arboviruses (Yellow Fever virus (YFV), Dengue virus, West Nile virus, Chikungunya virus, and Zika virus) have emerged in the recent past. Arboviruses are of the utmost importance with respect to EIDs due to intensive growth of globalisation, arthropod urban fitness/adaption, and environmental changes. We focus on recent outbreaks of the arthropod borne viruses (arboviruses) Zika virus and YFV. Factors contributing to the blossoming of EIDs (environmental, globalisation, and urbanisation) and combating strategies (surveillance, containment, and prevention) will be discussed. Specifically, Zika virus and YFV will be used in the context of these factors and strategies. YFV is discussed in detail as it pertains to these factors and strategies in the United States (US), 2017 Brazil Outbreak, 2016 Africa Outbreak, and global risk. Vigilance is needed to focus on, prevent, and control the current and next arbovirus EIDs.
C1 [Callender, David Michael] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.
   [Callender, David Michael] US Embassy, Dept State, Brasilia, DF, Brazil.
RP Callender, DM (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.; Callender, DM (corresponding author), US Embassy, Dept State, Brasilia, DF, Brazil.
EM callenderdm@umass.edu
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alfani G, 2017, J ECON HIST, V77, P314, DOI 10.1017/S0022050717000092
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P442
   Centers for Disease Control and Prevention, 2017, ZIK VIR INT MOSQ MAN
   Centers for Disease Control and Prevention, 2017, ZIK VIR EST RANG AED
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   de Noronha TG, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00060917, 10.1590/0102-311X00060917]
   Department of State, 2017, FREQ ASK QUEST REG Z
   DOWNS WG, 1968, B NEW YORK ACAD MED, V44, P721
   Gershman M. D., 2017, MORBIDITY MORTALITY, V66
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Henry B., 2016, ZIKA CASES OLYMPIC A
   International Society for Infectious Diseases, 2017, PROMED MAIL POST YEL
   Lederer S. E., 2008, OXFORD TXB CLIN RES, P9
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Lucey DR, 2017, ANN INTERN MED, V167, P664, DOI 10.7326/M17-1337
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Mayer K.H., 2011, SOCIAL ECOLOGY INFEC
   Mir D., 2017, SCI REPORTS, V7, P198, DOI [10.1038/s41598-017-00223-7, DOI 10.1038/S41598-017-00223-7]
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   National Center for Emerging and Zoonotic Infectious Diseases, 2017, WHO WE AR OUR NAM
   Nava A, 2017, ILAR J, V58, P393, DOI 10.1093/ilar/ilx034
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   Pan American Health Organization, 2017, 10 JULY 2017 YELL FE
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Resende-Santos J, 2016, INT MIGR, V54, P82, DOI 10.1111/imig.12212
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647
   Vasconcelos PFC, 2018, MEM I OSWALDO CRUZ, V113, P135, DOI 10.1590/0074-02760170347
   Washer P., 2010, EMERGING INFECT DIS
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   WHO, 2016, GLOB STRAT EL YELL F
   Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789
NR 40
TC 2
Z9 2
U1 3
U2 61
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1744-1692
EI 1744-1706
J9 GLOB PUBLIC HEALTH
JI Glob. Public Health
PD DEC 2
PY 2018
VL 13
IS 12
BP 1846
EP 1852
DI 10.1080/17441692.2018.1464588
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GX1IH
UT WOS:000447468500010
PM 29663859
DA 2020-07-08
ER

PT J
AU Kakkar, F
   Boucoiran, I
AF Kakkar, F.
   Boucoiran, I.
TI The Women and Children's Infectious Diseases Center: An integrated
   approach to congenital infectious diseases
SO CLINICAL AND INVESTIGATIVE MEDICINE
LA English
DT Editorial Material
AB Congenital infectious diseases, transmitted during the course of pregnancy, are estimated to affect nearly one in every hundred births worldwide. These infections may be associated with fetal and infant adverse health outcomes, due to congenital malformations caused by in utero transmission of the infectious organism itself (as is the case with cytomegalovirus, toxoplasmosis, syphilis and Zika virus), or due to chronic infection in the infant (as is the case with human immunodeficiency virus [HIV] and hepatitis B and C). In addition, children who are exposed, yet uninfected, may still suffer from the consequences of exposure to infectious pathogens or to the drugs given to treat pregnant women and prevent in utero transmission (as may be the case with HIV infection).
C1 [Boucoiran, I.] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada.
   [Kakkar, F.] Univ Montreal, Fac Med, Dept Obstet & Gynecol, Montreal, PQ, Canada.
RP Kakkar, F (corresponding author), Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada.
EM Fatima.Kakkar@umontreal.ca
RI Boucoiran, Isabelle/AAO-4683-2020
NR 0
TC 1
Z9 1
U1 0
U2 0
PU CANADIAN SOC CLINICAL INVESTIGATION
PI OTTAWA
PA CSCI HEAD OFFICE, 774 ECHO DRIVE, OTTAWA, ON K1S 5N8, CANADA
SN 0147-958X
EI 1488-2353
J9 CLIN INVEST MED
JI Clin. Invest. Med.
PD DEC
PY 2018
VL 41
IS 4
BP E211
EP E212
PG 2
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA IS4RR
UT WOS:000482141700006
DA 2020-07-08
ER

PT J
AU Mattar, S
   Gonzalez, M
AF Mattar, Salim
   Gonzalez, Marco
TI The Madariaga virus follows the footsteps of the Chikungunya and Zika
   viruses
SO REVISTA MVZ CORDOBA
LA English
DT Editorial Material
ID ALPHAVIRUSES
C1 [Mattar, Salim; Gonzalez, Marco] Univ Cordoba, Fac Med Vet & Zootecnia, Monteria, Colombia.
RP Mattar, S (corresponding author), Univ Cordoba, Fac Med Vet & Zootecnia, Monteria, Colombia.
OI Gonzalez Tous, Marco/0000-0001-6500-5601; MATTAR,
   SALIM/0000-0003-0526-4630
CR Blohm GM, 2018, CLIN INFECT DIS, V67, P619, DOI 10.1093/cid/ciy224
   Burgueno A, 2018, AM J TROP MED HYG, V98, P1811, DOI 10.4269/ajtmh.17-0980
   Carrera JP, 2018, AM J TROP MED HYG, V98, P1798, DOI 10.4269/ajtmh.17-0679
   Hoyos R, 2015, REV MVZ CORDOBA, V20, P4800, DOI 10.21897/rmvz.49
   Mattar S, 2017, REV MVZ CORDOBA, V22, P6089, DOI 10.21897/rmvz.1078
   Silva MLCR, 2017, TRANSBOUND EMERG DIS, V64, P990, DOI 10.1111/tbed.12441
   Vittor AY, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004554
NR 7
TC 2
Z9 2
U1 0
U2 0
PU UNIV CORDOBA
PI MONTERIA
PA FAC MEDICINA VETERINARIA Y ZOOTECNIA, KM 26, VIA CIENEGA DE ORO,
   APARTADO AEREO NO 354, MONTERIA, 00000, COLOMBIA
SN 0122-0268
J9 REV MVZ CORDOBA
JI Rev. MVZ Cordoba
PD DEC
PY 2018
VL 23
SU S
BP 6937
EP 6941
DI 10.21897/rmvz.1480
PG 5
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA II6LC
UT WOS:000475304400001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Yupari-Azabache, I
   Benites, SM
   Otiniano, NM
   Aguilar, P
   Romero, CV
   Sergent, S
AF Yupari-Azabache, Irma
   Benites, Santiago M.
   Milly Otiniano, Nelida
   Aguilar Ch, Pablo
   Romero, Cecilia, V
   Sergent, Shane
TI Knowledge level, attitudes and preventive practices towards Zika
SO REVISTA MVZ CORDOBA
LA English
DT Article
DE Knowledge about zika; prevention of zika; Zika's preventive attitude
ID HEALTH-CARE STUDENTS; WORKERS KNOWLEDGE; CITIES
AB Objective. This correlational descriptive cross-sectional study was conducted to determine the level of knowledge and its relationship with attitudes and Zika's preventive practices in the district of Chepen, La Libertad, Peru, 2017. Materials and methods. A questionnaire on knowledge, attitudes and preventive practices was applied to a sample of 284 adult persons, with an average age of 37 years. Results. The results showed that the level of general knowledge about zika was regular at 79% and good at 21%. As for the most common zika's preventive practices carried out by the inhabitants of Chepen, 83% mentioned that they frequently washed their water tanks, 77% used a brush and detergent to wash the tanks with water and 75% placed a lid over the tanks with water. Conclusions. There is a significant relationship between level of knowledge and sika's preventive practices (p<0.05). In addition, regular knowledge is a risk factor (OR: 5, CI: 2.073-10.063) for inadequate zika's preventive practice; people with regular knowledge are 5 times more likely to have inadequate preventive practices. However, the level of knowledge does not have a significant relationship with attitudes towards the prevention of zika (p>0.05).
C1 [Yupari-Azabache, Irma; Benites, Santiago M.; Milly Otiniano, Nelida; Aguilar Ch, Pablo] Cesar Vallejo Univ, Res, Trujillo, Peru.
   [Romero, Cecilia, V] Natl Univ Trujillo, Trujillo, Peru.
   [Sergent, Shane] Michigan State Univ, E Lansing, MI 48824 USA.
RP Benites, SM (corresponding author), Cesar Vallejo Univ, Res, Trujillo, Peru.
EM sbenites@ucv.edu.pe
RI BENITES, SANTIAGO M./H-7210-2018
OI BENITES, SANTIAGO M./0000-0002-8511-7106; ROMERO, CECILIA
   V./0000-0003-3799-3897; OTINIANO, NELIDA MILLY/0000-0001-9838-4847;
   YUPARI, IRMA/0000-0002-0030-0172
CR Alvis-Guzman N, 2017, REV MVZ CORDOBA, V22, P5994, DOI 10.21897/rmvz.1069
   BEHAR D, 2008, INTRO METODOLOGIA IN
   Castañeda Oneida, 2011, Rev. salud pública, V13, P514
   Delcid-Morazan A, 2017, ARCH MED, V13, P1
   González Morales Asunción, 2011, Rev Cubana Hig Epidemiol, V49, P247
   Hernandez R., 2010, METODOLOGIA INVESTIG
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Ministerio de Salud, 2017, MAP ZIK DISTR
   Ministerio de Salud, 2016, PLAN NAC PREP RESP F
   Ministerio de Salud, 2017, CAS ZIK PER 2017 201
   Naresth M, 2014, INVESTIGACION MERCAD
   Organizacion Mundial de la Salud, 2017, PREG RESP VIR ZIK SU
   Organizacion Mundial de la Salud, 2016, ENF VIR ZIK
   Organizacion Panamericana de la Salud / Organizacion Mundial de la Salud, 2017, ZIK CAS CONG SYNDR A
   Rivera-Garcia O., 2014, REDVET, V15, P1
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
NR 18
TC 0
Z9 0
U1 0
U2 1
PU UNIV CORDOBA
PI MONTERIA
PA FAC MEDICINA VETERINARIA Y ZOOTECNIA, KM 26, VIA CIENEGA DE ORO,
   APARTADO AEREO NO 354, MONTERIA, 00000, COLOMBIA
SN 0122-0268
J9 REV MVZ CORDOBA
JI Rev. MVZ Cordoba
PD DEC
PY 2018
VL 23
SU S
BP 6981
EP 6990
DI 10.21897/rmvz.1421
PG 10
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA II6LC
UT WOS:000475304400006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tawatsin, A
   Phumee, A
   Thavara, U
   Sirisopa, P
   Ritthison, W
   Thammakosol, K
   Intayot, P
   Joyjinda, Y
   Wacharapluesadee, S
   Hemachudha, T
   Siriyasatien, P
AF Tawatsin, Apiwat
   Phumee, Atchara
   Thavara, Usavadee
   Sirisopa, Patcharawan
   Ritthison, Wanapa
   Thammakosol, Kitsanaphong
   Intayot, Proawpilart
   Joyjinda, Yutthana
   Wacharapluesadee, Supaporn
   Hemachudha, Thiravat
   Siriyasatien, Padet
TI High infection rate of Zika virus in mosquitoes collected from an area
   of active Zika virus transmission in eastern Thailand
SO THAI JOURNAL OF VETERINARY MEDICINE
LA English
DT Article
DE Zika; Chikungunya; Dengue; Mosquitoes; Thailand
ID AEDES-AEGYPTI; CHIKUNGUNYA; DENGUE; OUTBREAK; FEVERS
AB Zika virus (ZIKV), chikungunya virus (CHIKV) and dengue virus (DENV) are emerging and re-emerging arboviral diseases. These viruses are transmitted to humans through the bites of Aedes mosquitoes. Recently, ZIKV infection has been described as an emerging disease in Thailand and many countries, especially in tropical and subtropical areas. Specific drugs and vaccines against these infections are unavailable; therefore, effective disease control relies on vector control measures only. To understand the transmission cycle of these viruses and mosquito vectors, this study is designed to investigate the natural infection of ZIKV, CHIKV and DENV in field-caught mosquitoes by molecular techniques. Adults and larvae of mosquitoes were collected in and around the patients' homes in the Klaeng District, Rayong Province, Thailand. CHIKV and DENV were detected by Multiplex Real-time RT-PCR and ZIKV was detected by Hemi-nested RT-PCR. ZIKV RNA was detected in 8 (10.3%) samples (5 (6.4%) females and 2 (2.6%) males of Aedes aegypti and 1 (1.3%) female Armigeres subalbatus) and CHIKV RNA in 5 (6.4%) (3 (3.8%) females and 2 (2.6%) larvae of Ae. aegypti), while DENV RNA was not detected in any samples. The Maximum Likelihood tree of nucleotide sequences of positive samples showed that ZIKV in mosquitoes were cladded within the Asian lineage. This study was a preliminary survey of the potential vectors of ZIKV, CHIKV and DENV in an affected area. Information obtained from this study helps to understand the natural infection rates in mosquitoes with ZIKV, CHIKV and DENV and may be valuable in creating the most effective mosquito vector control strategies in the future.
C1 [Tawatsin, Apiwat; Thavara, Usavadee; Sirisopa, Patcharawan] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand.
   [Phumee, Atchara; Joyjinda, Yutthana; Wacharapluesadee, Supaporn; Hemachudha, Thiravat] Chulalongkorn Univ, Thai Red Cross Emerging Infect Hlth Sci Ctr, Neurosci Ctr Res & Dev, King Chulalongkorn Mem Hosp,Fac Med, Bangkok, Thailand.
   [Phumee, Atchara; Joyjinda, Yutthana; Wacharapluesadee, Supaporn; Hemachudha, Thiravat] Chulalongkorn Univ, Fac Med, King Chulalongkorn Mem Hosp, WHO CC Res & Training Viral Zoonoses, Bangkok, Thailand.
   [Ritthison, Wanapa] Minist Publ Hlth, Off Dis Prevent & Control Chonburi 6, Dept Dis Control, Chon Buri, Thailand.
   [Thammakosol, Kitsanaphong; Intayot, Proawpilart] Chulalongkorn Univ, Med Sci Program, Fac Med, Bangkok, Thailand.
   [Phumee, Atchara; Siriyasatien, Padet] Chulalongkorn Univ, Vector Biol & Vector Borne Dis Res Unit, Dept Parasitol, Fac Med, Bangkok, Thailand.
RP Siriyasatien, P (corresponding author), Chulalongkorn Univ, Vector Biol & Vector Borne Dis Res Unit, Dept Parasitol, Fac Med, Bangkok, Thailand.
EM Padet.S@chula.ac.th
RI PHUMEE, ATCHARA/AAG-4881-2020
FU National Research Council of ThailandNational Research Council of
   Thailand (NRCT); Health Systems Research Institute [61-003]; National
   Science and Technology Development Agency (Thailand) [P-16-50702];
   Rachadapisek Sompote Fund for Postdoctoral Fellowship , Chulalongkorn
   University [RA/MF 11/61]
FX This study was supported by the National Research Council of Thailand
   and Health Systems Research Institute (Grant No. 61-003), National
   Science and Technology Development Agency (Thailand) (Grant No.
   P-16-50702) and for the Research Chair Grant, Rachadapisek Sompote Fund
   for Postdoctoral Fellowship Grant No. RA/MF 11/61, Chulalongkorn
   University.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Diallo D, 2014, PLOS ONE, V9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005052
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   MOURYA DT, 1987, INDIAN J MED RES, V85, P593
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pastula DM, 2016, NEUROHOSPITALIST, V6, P93, DOI 10.1177/1941874416637409
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Shinohara K., 2014, ZIKA VIRUS JAPAN EX
   Suangto P, CHIKUNGUNYA FEVER AN
   Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Ungchusak K, 2008, CHIKUNGUNYA THAILAND
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wanlapakorn N, 2014, EMERG INFECT DIS, V20, P1404, DOI 10.3201/eid2008.140481
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   2016, MEM I O CRUZ, V111, P655, DOI DOI 10.1590/0074-02760160332
   2009, SE ASIAN J TROP MED, V40, P951
   2015, AM J TROP MED HYG, V93, P380, DOI DOI 10.4269/AJTMH.15-0022
   2016, VECTOR-BORNE ZOONOT, V16, P295, DOI DOI 10.1089/VBZ.2016.1952
NR 36
TC 3
Z9 3
U1 0
U2 0
PU CHULALONGKORN UNIV
PI BANGKOK
PA FAC VETERINARY SCI, HENRI DUNANT RD, BANGKOK, 10330, THAILAND
SN 0125-6491
J9 THAI J VET MED
JI Thai J. Vet. Med.
PD DEC
PY 2018
VL 48
IS 4
BP 551
EP 558
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA HX9RP
UT WOS:000467746300002
DA 2020-07-08
ER

PT J
AU O'Sullivan, S
   Sajid, MI
   Agusto, FB
   Mwangangi, J
   Manguvo, A
   Wichmann, D
   Kharoshah, M
AF O'Sullivan, Shane
   Sajid, Mohammed Imran
   Agusto, Folashade B.
   Mwangangi, Joseph
   Manguvo, Angellar
   Wichmann, Dominic
   Kharoshah, Magdy
TI Virtual autopsy and community engagement for outbreak response in
   Africa: traditional, religious and sociocultural perspectives
SO EGYPTIAN JOURNAL OF FORENSIC SCIENCES
LA English
DT Review
DE Minimally invasive autopsy; Non-invasive autopsy; Ebola; Zika;
   Quarantine; Islamic medicine; Traditional medicine; Witchcraft;
   Scarification; Witch doctor
AB Background: In response to outbreaks, the manner in which the medical field engages with the process of death is significantly important, not only in the pathological but also in the sociocultural aspect. Certain response-methodology used could be a critical catalyst for community resistance to post-mortem examinations (e.g. hiding corpses, violence), considering how the deceased are handled in different cultures. We reviewed the traditional, religious and sociocultural aspects of post-mortem response-methodology in Africa. With no means to take blood samples, innovative sampling techniques were developed and frequently adopted in post-mortem cases. However, this approach can be met with resistance.
   Main body: To avoid resistance, virtual autopsy (virtopsy) involving a non-invasive or minimally invasive imaging-guided biopsy (e.g. portable ultrasound guidance) is recommended as a proper entry point to negotiations around examination of the deceased. We outline how adapting virtopsy and community engagement strategies can have many benefits to communicable disease prevention or control, public health and communities in Africa and elsewhere. This paper provides a completely new perspective by applying imaging autopsy to field studies. These are usually hospital-based procedures. Many countries can train their response and military personnel on how to perform a safe straightforward virtopsy procedure in an outbreak situation. Just as relevant, Islam is now the fastest growing religion in the world-virtopsy might appease fears and increase the autopsy rate among large Muslim populations (in Africa and elsewhere).
   Conclusions: Virtopsy use and its application might have proved very useful in the recent outbreak of Ebola in 2014 and microcephaly associated with Zika virus. Use of virtopsy may have reduced the number of Ebola cases worldwide and enabled an earlier diagnosis linking Zika virus to microcephaly during the recent outbreak in Northeast Brazil. If the diagnosis was made earlier, additional cases of Ebola or Zika may have been prevented. The issue of invasive autopsy was in all likelihood one of the greatest factors that drove Ebola underground; it prevented communities from cooperating with non-native response teams and contributed to the excessive duration and length of the outbreak. Healers may unknowingly infect others (via scarification) and themselves (via contact with others). Adapting sociocultural engagement methods and conducting a virtopsy may be more acceptable, thereby ameliorating the spread of a deadly virus more efficiently.
C1 [O'Sullivan, Shane] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, SP, Brazil.
   [Sajid, Mohammed Imran] Wirral Univ, Teaching Hosp, Dept Upper GI Surg, Birkenhead, Merseyside, England.
   [Agusto, Folashade B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Kansas City, KS USA.
   [Mwangangi, Joseph] KEMRI, Ctr Geog Med Res, Coast, Kilifi, Kenya.
   [Manguvo, Angellar] Univ Missouri, Sch Med, Kansas City, MO 64110 USA.
   [Wichmann, Dominic] Univ Hosp Hamburg Eppendorf, Dept Intens Care, Hamburg, Germany.
   [Kharoshah, Magdy] Forens Med Ctr Dammam, Dammam, Saudi Arabia.
RP O'Sullivan, S (corresponding author), Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, SP, Brazil.
EM doctorshaneosullivan@gmail.com
OI O'Sullivan, Shane/0000-0003-4287-7380; Agusto,
   Folashade/0000-0001-6137-6480
CR Al-Saif DM, 2016, AUST J FORENSIC SCI, V48, P557, DOI 10.1080/00450618.2015.1110200
   Chaudhary V, 2017, FORGOTTEN MUSLIM HER
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1134
   Manguvo Angellar, 2015, Pan Afr Med J, V22 Suppl 1, P9, DOI 10.11694/pamj.supp.2015.22.1.6190
   Marshall K, 2015, LANCET, V386, pE24, DOI 10.1016/S0140-6736(15)61082-0
   Mohammed M, 2014, J FORENSIC LEG MED, V23, P80, DOI 10.1016/j.jflm.2014.02.005
   O'Sullivan Shane, 2017, Autops Case Rep, V7, P3, DOI 10.4322/acr.2017.037
   Pew Research Center, 2015, FUT WORLD REL POP GR
   Redzic E, 2005, BOSNIA HERZEGOVINA S, P143
   Sajid MI, 2007, STUDENT BMJ, V15, P307, DOI [10.1136/sbmj.0709307, DOI 10.1136/SBMJ.0709307]
   Sajid MI, 2015, QUALITY HLTH CARE D, DOI [10.13140/RG.2.1.2161.0007, DOI 10.13140/RG.2.1.2161.0007]
   Sajid MI, 2016, COMPLEMENT THER CLIN, V23, P9, DOI 10.1016/j.ctcp.2016.01.003
   Sajid MI, 2016, AM J FOREN MED PATH, V37, P29, DOI 10.1097/PAF.0000000000000207
   Sayligil O, 2014, ANN SAUDI MED, V34, P433, DOI 10.5144/0256-4947.2014.433
   Shah ZH, 2011, THE MUSLIM TIMES
   Sterns O, 2015, MUSLIM INVENTIONS SH
   Wagensveld IM, 2018, EUR HEART J-CARD IMG, V19, P739, DOI 10.1093/ehjci/jey015
NR 18
TC 0
Z9 0
U1 0
U2 0
PU INT ASSOC LAW & FORENSIC SCIENCES
PI CAIRO
PA 1 AWAL MAYO BLDG, EL-NASR RD, CAIRO, 11371, EGYPT
SN 2090-536X
EI 2090-5939
J9 EGYPT J FORENSIC SCI
JI Egypt. J. Forensic Sci.
PD DEC
PY 2018
VL 8
IS 1
AR 67
DI 10.1186/s41935-018-0096-0
PG 6
WC Medicine, Legal
SC Legal Medicine
GA HO7ST
UT WOS:000461150100067
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mavridou, A
   Pappa, O
   Papatzitze, O
   Dioli, C
   Kefala, AM
   Drossos, P
   Beloukas, A
AF Mavridou, Athena
   Pappa, Olga
   Papatzitze, Olga
   Dioli, Chrysa
   Kefala, Anastasia Maria
   Drossos, Panagiotis
   Beloukas, Apostolos
TI Exotic Tourist Destinations and Transmission of Infections by Swimming
   Pools and Hot SpringsA Literature Review
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE swimming pools; tropics; subtropics; pool assessment; infectious
   diseases
ID FREE-LIVING AMEBAS; TRAVEL-RELATED LEPTOSPIROSIS; ZIKA VIRUS-INFECTION;
   WEST NILE VIRUS; MICROSPORIDIAL KERATITIS; WATERBORNE TRANSMISSION;
   PROTOZOAN PARASITES; ACANTHAMOEBA SPP.; ACUTE SCHISTOSOMIASIS;
   ENVIRONMENTAL SOURCES
AB A growing number of people undertake international travel, and yet faster growth of such travel is expected in the tropics. Information on the hazards presented by pool and hot spring waters in tropical countries is very limited. This review aims to collate available information on pool water quality, alongside data on cases and outbreaks associated with swimming in pools in tropical regions affecting both local populations and travellers. Bacteria species commonly causing cases and outbreaks in the tropics as well as elsewhere in the world were excluded, and the review focuses on studies related to pathogens that, with the exception of Cryptosporidium, are unusual in more temperate climates. Studies concerning subtropical countries were included in the light of climate change. Diseases transmitted by vectors breeding in poorly maintained, neglected or abandoned pools were also included. 83 studies dealing with Microsporidia, Leptospira spp., Schistosomas spp., Cryptosporidium spp., Acanthamoeba spp., Naegleria spp., Clostridium trachomatis, viruses, and vectors breeding in swimming pool and hot tub waters, and fulfilling predefined criteria, have been included in our survey of the literature. In conclusion, prevention strategies for pool safety in the tropics are imperative. Public health authorities need to provide guidance to westerners travelling to exotic destinations on how to protect their health in swimming pools.
C1 [Mavridou, Athena; Pappa, Olga; Papatzitze, Olga; Dioli, Chrysa; Kefala, Anastasia Maria; Drossos, Panagiotis; Beloukas, Apostolos] Univ West Attica, Dept Biomed Sci, Egaleo 12243, Greece.
   [Pappa, Olga] Hellen Ctr Dis Control & Prevent, Cent Publ Hlth Lab, Maroussi 15123, Greece.
   [Papatzitze, Olga] West Attica Gen Hosp Santa Barbara, Santa Barbara 12351, Greece.
   [Beloukas, Apostolos] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.
RP Mavridou, A (corresponding author), Univ West Attica, Dept Biomed Sci, Egaleo 12243, Greece.
EM amavridou@teiath.gr; olpap79@gmail.com; olgapapat@hotmail.com;
   chrysrose57@gmail.com; anastasia.m.kefala@gmail.com;
   pdrossos2006@yahoo.gr; abeloukas@uniwa.gr
OI Drossos, Panagiotis/0000-0003-2025-1678; Beloukas,
   Apostolos/0000-0001-5639-0528
CR Abd El-Salam MM, 2012, ENVIRON MONIT ASSESS, V184, P7395, DOI 10.1007/s10661-011-2508-6
   Abdou Mamdouh H M, 2005, J Egypt Public Health Assoc, V80, P263
   ABDRABBO H, 1968, J TROP MED HYG, V71, P18
   Al-Herrawy A, 2013, IRAN J PARASITOL, V8, P302
   Al-Herrawy AZ, 2017, IRAN J PARASITOL, V12, P196
   Al-Khatib IA, 2003, INT J ENVIRON HEAL R, V13, P17, DOI 10.1080/0960312021000063278
   Ali-Shtayeh MS, 2003, MYCOPATHOLOGIA, V156, P193, DOI 10.1023/A:1023311411004
   [Anonymous], 2004, WKLY REP, V53, P793
   Baker D.M., 2015, INT J SAF SECUR TOUR, V12, P1
   Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013
   Bandara M, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0061-0
   Barna Z, 2012, ANN I SUPER SANITA, V48, P374, DOI 10.4415/ANN_12_04_05
   Boissier J, 2016, LANCET INFECT DIS, V16, P971, DOI 10.1016/S1473-3099(16)00175-4
   Brinker Alyson J, 2017, Trop Dis Travel Med Vaccines, V3, P16, DOI 10.1186/s40794-017-0059-8
   Caillouet KA, 2008, J VECTOR ECOL, V33, P166, DOI 10.3376/1081-1710(2008)33[166:COASPB]2.0.CO;2
   Castor ML, 2004, PEDIATR INFECT DIS J, V23, P866, DOI 10.1097/01.inf.0000138081.84891.30
   Caumo K, 2009, ANN TROP MED PARASIT, V103, P477, DOI 10.1179/136485909X451825
   Centers for Disease Control and Prevention, PAR CRYPT
   Centers for Disease Control and Prevention, PAR AC
   Chalmers RM, 2012, ANN I SUPER SANITA, V48, P429, DOI 10.4415/ANN_12_04_10
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Clerinx J, 2011, J TRAVEL MED, V18, P367, DOI 10.1111/j.1708-8305.2011.00552.x
   CliQ, CLEAN FUT SWIMM POOL
   Coetzee N., 2008, Eurosurveillance, V13, P19028
   Colebunders, 1995, J Travel Med, V2, P235, DOI 10.1111/j.1708-8305.1995.tb00667.x
   Coltart CEM, 2015, T ROY SOC TROP MED H, V109, P214, DOI 10.1093/trstmh/tru195
   CORACHAN M, 1992, AM J TROP MED HYG, V47, P6, DOI 10.4269/ajtmh.1992.47.6
   Coulibaly B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1242-5
   Courtright P, 2018, BRIT J OPHTHALMOL, V102, P1324, DOI 10.1136/bjophthalmol-2018-312476
   Curry A, 2007, J MED MICROBIOL, V56, P1250, DOI 10.1099/jmm.0.47297-0
   Dale K, 2010, AUST NZ J PUBL HEAL, V34, P527, DOI 10.1111/j.1753-6405.2010.00602.x
   DANGELO LJ, 1979, J INFECT DIS, V140, P42, DOI 10.1093/infdis/140.1.42
   de Roda Husman A.M., 2010, CLIMATE CHANGE RECRE
   De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563
   de Vries SG, 2014, INT J INFECT DIS, V28, P47, DOI 10.1016/j.ijid.2014.06.013
   DEJONCKHEERE JF, 1979, ANN INST PASTEUR MIC, VB130, P205
   Dibo MR, 2013, REV SOC BRAS MED TRO, V46, P502, DOI 10.1590/0037-8682-1432-2013
   Dowd SE, 1998, APPL ENVIRON MICROB, V64, P3332
   Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036
   El-Khoby T, 2000, AM J TROP MED HYG, V62, P88, DOI 10.4269/ajtmh.2000.62.88
   Enk MJ, 2003, MEM I OSWALDO CRUZ, V98, P745, DOI 10.1590/S0074-02762003000600006
   EVENPAZ Z, 1976, BRIT J DERMATOL, V94, P435, DOI 10.1111/j.1365-2133.1976.tb06122.x
   Evyapan G, 2015, T ROY SOC TROP MED H, V109, P221, DOI 10.1093/trstmh/tru179
   Fabres LF, 2016, ACTA PARASITOL, V61, P221, DOI 10.1515/ap-2016-0031
   Fadaei Abdolmajid, 2014, Glob J Health Sci, V7, P240, DOI 10.5539/gjhs.v7n3p240
   Fan NW, 2012, J CLIN MICROBIOL, V50, P414, DOI 10.1128/JCM.05007-11
   Faustini A, 2006, INT J INFECT DIS, V10, P291, DOI 10.1016/j.ijid.2005.06.008
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fournier S, 2002, FEMS IMMUNOL MED MIC, V33, P209, DOI 10.1111/j.1574-695X.2002.tb00592.x
   Gadiaga L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-312
   Gelman SS, 2002, J TRAVEL MED, V9, P165, DOI 10.2310/7060.2002.23165
   Giampaoli S, 2014, J WATER HEALTH, V12, P564, DOI 10.2166/wh.2014.211
   Goodman RA, 2009, EMERG INFECT DIS, V15, P508, DOI 10.3201/eid1503.081489
   Gossling S, 2012, TOURISM MANAGE, V33, P1, DOI 10.1016/j.tourman.2011.03.015
   Grobusch MP, 2003, J TRAVEL MED, V10, P164, DOI 10.2310/7060.2003.35759
   Grobusch MP, 2003, J TRAVEL MED, V10, P55, DOI 10.2310/7060.2003.30683
   Harley D, 2001, Commun Dis Intell, V25, P9
   Hauri AM, 2005, EPIDEMIOL INFECT, V133, P291, DOI 10.1017/S0950268804003437
   Heggie TW, 2010, TRAVEL MED INFECT DI, V8, P201, DOI 10.1016/j.tmaid.2010.06.001
   Hlavsa MC, 2018, MMWR-MORBID MORTAL W, V67, P547, DOI 10.15585/mmwr.mm6719a3
   Hlavsa Michele C, 2016, MMWR Surveill Summ, V65, P1, DOI 10.15585/mmwr.ss6505a1
   Horney J., 2017, PLOS CURR, V9, DOI [10.1371/currents.outbreaks, DOI 10.1371/CURRENTS.OUTBREAKS]
   Hutin YJF, 1998, J INFECT DIS, V178, P904, DOI 10.1086/515353
   Ichinohe S, 2005, JPN J INFECT DIS, V58, P400
   Impoinvil DE, 2008, J AM MOSQUITO CONTR, V24, P457, DOI 10.2987/5739.1
   Impoinvil DE, 2008, J VECTOR ECOL, V33, P107, DOI 10.3376/1081-1710(2008)33[107:AOIAAC]2.0.CO;2
   Init I, 2010, TROP BIOMED, V27, P566
   Insulander M, 2005, SCAND J INFECT DIS, V37, P354, DOI 10.1080/00365540410021072
   Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327
   Joseph J, 2005, Indian J Med Microbiol, V23, P80
   Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Kpoda NW, 2013, CR BIOL, V336, P284, DOI 10.1016/j.crvi.2013.04.008
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lal A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004078
   Lambertucci JR, 2013, CLIN INFECT DIS, V57, pE1, DOI 10.1093/cid/cit157
   Leshem E, 2010, AM J TROP MED HYG, V82, P459, DOI 10.4269/ajtmh.2010.09-0239
   Li J, 2018, INT J INFECT DIS, V75, P89, DOI 10.1016/j.ijid.2018.08.009
   Li XD, 2006, J EUKARYOT MICROBIOL, V53, pS77, DOI 10.1111/j.1550-7408.2006.00180.x
   Lim Yvonne A L, 2017, Food Waterborne Parasitol, V8-9, P75, DOI 10.1016/j.fawpar.2017.08.001
   Logan S, 2013, AM J TROP MED HYG, V88, P1032, DOI 10.4269/ajtmh.12-0646
   LYONS TB, 1977, APPL ENVIRON MICROB, V33, P551, DOI 10.1128/AEM.33.3.551-555.1977
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MAGHAZY SMN, 1989, ZBL MIKROBIOL, V144, P213, DOI 10.1016/S0232-4393(89)80107-6
   MAHONEY FJ, 1992, J INFECT DIS, V165, P613, DOI 10.1093/infdis/165.4.613
   Marchese V, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0440-5
   Marten G., 2013, USE FAMILY PLANNING, P1
   Matthys B, 2010, ANN TROP MED PARASIT, V104, P649, DOI 10.1179/136485910X12851868780108
   Maunula L, 2004, EPIDEMIOL INFECT, V132, P737, DOI 10.1017/S0950268804002249
   Mavridou A, 2014, J WATER HEALTH, V12, P359, DOI 10.2166/wh.2014.188
   Meltzer E, 2006, EMERG INFECT DIS, V12, P1696, DOI 10.3201/eid1211.060340
   Alves DDMM, 2012, EXP PARASITOL, V131, P239, DOI 10.1016/j.exppara.2012.04.011
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Ndassa A, 2007, ANN TROP MED PARASIT, V101, P469, DOI 10.1179/136485907X193752
   Ng-Hublin JSY, 2015, EPIDEMIOL INFECT, V143, P1037, DOI 10.1017/S095026881400106X
   Onichandran S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-244
   Page SJ, 2014, TOUR MANAG PERSPECT, V10, P57, DOI 10.1016/j.tmp.2014.01.004
   Patil DY, 2017, J INFECT PUBLIC HEAL, V10, P247, DOI 10.1016/j.jiph.2016.05.009
   Patsoula E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2450682
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pimenta Dominic, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-201075
   Plutzer J, 2016, WATER RES, V101, P318, DOI 10.1016/j.watres.2016.05.085
   Rabi Atallah, 2008, Int J Environ Res Public Health, V5, P152
   Rafiei A, 2010, IRAN J PUBLIC HEALTH, V39, P124
   Rahdar M, 2012, IRAN J PARASITOL, V7, P22
   Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126
   Rinder H., 2004, SE ASIAN J TROP MED, V35, P54
   RIVERA F, 1993, ENVIRON RES, V62, P43, DOI 10.1006/enrs.1993.1087
   RIVERA F, 1983, ENVIRON RES, V32, P205, DOI 10.1016/0013-9351(83)90207-4
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Roser Dennis, 2018, JMM Case Rep, V5, pe005141, DOI 10.1099/jmmcr.0.005141
   Ryan U, 2017, J WATER HEALTH, V15, P1, DOI 10.2166/wh.2016.160
   Saba C. K. S., 2015, Research Journal of Microbiology, V10, P14, DOI 10.3923/jm.2015.14.23
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Sehgal S C, 2006, Indian J Med Microbiol, V24, P310
   Sharma S, 2011, SURV OPHTHALMOL, V56, P1, DOI 10.1016/j.survophthal.2010.03.006
   Shields JM, 2008, EMERG INFECT DIS, V14, P948, DOI 10.3201/eid1406.071495
   Shih YJ, 2017, ENVIRON SCI POLLUT R, V24, P18392, DOI 10.1007/s11356-017-9513-4
   Sinclair RG, 2009, J APPL MICROBIOL, V107, P1769, DOI 10.1111/j.1365-2672.2009.04367.x
   Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487
   Staggemeier R, 2016, AN ACAD BRAS CIENC, V88, P635, DOI 10.1590/0001-3765201620150151
   Su MY, 2013, KOREAN J PARASITOL, V51, P203, DOI 10.3347/kjp.2013.51.2.203
   Succo T, 2018, EUROSURVEILLANCE, V23, P25, DOI 10.2807/1560-7917.ES.2018.23.23.1700482
   Tallis G, 1997, Commun Dis Intell, V21, P353
   TropNet, EUR NETW TROP MED TR
   Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727
   van de Werve C, 2013, J TRAVEL MED, V20, P228, DOI 10.1111/jtm.12035
   van Heerden J, 2005, J APPL MICROBIOL, V99, P1256, DOI 10.1111/j.1365-2672.2005.02607.x
   Vemuganti Geeta K, 2005, BMC Ophthalmol, V5, P19, DOI 10.1186/1471-2415-5-19
   VISSER LG, 1995, CLIN INFECT DIS, V20, P280, DOI 10.1093/clinids/20.2.280
   Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x
   Warren JM, 2016, AUST NZ J PUBL HEAL, V40, pS48, DOI 10.1111/1753-6405.12396
   Wei XH, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071416
   Wheeler C, 2007, EPIDEMIOL INFECT, V135, P302, DOI 10.1017/S0950268806006777
   World Health Organization, 2012, INT TRAV HLTH
   World Health Organization, 2006, WAT SAN HLTH TEAM GU, V2
   World Tourism Organization, 2017, TOURISM HIGHLIGHTS
   Xiao SM, 2017, KOREAN J PARASITOL, V55, P129, DOI 10.3347/kjp.2017.55.2.129
   Yamazaki T, 2004, LETT APPL MICROBIOL, V38, P406, DOI 10.1111/j.1472-765X.2004.01506.x
   Yeats J, 2005, EPIDEMIOL INFECT, V133, P1123, DOI 10.1017/S0950268805004462
NR 141
TC 2
Z9 2
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD DEC
PY 2018
VL 15
IS 12
AR UNSP 2730
DI 10.3390/ijerph15122730
PG 21
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HI5XH
UT WOS:000456527000121
PM 30513967
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Peck, GW
   Castro-Llanos, F
   Lopez-Sifuentes, VM
   Vasquez, GM
   Lindroth, E
AF Peck, George W.
   Castro-Llanos, Fanny
   Lopez-Sifuentes, Victor M.
   Vasquez, Gissella M.
   Lindroth, Erica
TI COMPARATIVE ANALYSIS OF MOSQUITO TRAP COUNTS IN THE PERUVIAN AMAZON:
   EFFECT OF TRAP TYPE AND OTHER COVARIATES ON COUNTS AND DIVERSITY
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Bayesian analysis; carbon dioxide-baited trap; mosquito vectors; passive
   box trap; ultraviolet-light trap
ID HUMAN ATTRACTION PATTERNS; SEASONAL DISTRIBUTION; DIPTERA-CULICIDAE;
   ANOPHELES-DARLINGI; CARBON-DIOXIDE; IQUITOS; FIELD; FOREST; COLLECTION;
   BIOLOGY
AB Efficient detection of multiple species of adult mosquitoes in various habitats using effective traps is a crucial 1st step in any disease prevention program. Novel trap types that target tropical vectors of human diseases require field testing in the habitat of the vector-disease system in question. This paper analyzes a series of mosquito trapping studies conducted at Mapacocha, San Juan Bautista District, Loreto, Peru, during August- September 2013 and April-May 2014. Six trap configurations were evaluated in forest and rural locations. Adult mosquito counts were analyzed using full Bayesian inference of multilevel generalized linear models and posterior probability point estimates of the difference of means of the combined trap catch by trap type comparisons of all species. Light traps (Centers for Disease Control and Prevention [CDC] incandescent, white light-emitting diode [LED], and ultraviolet LED). caught greater numbers of mosquitoes compared with traps baited with yeast-generated CO2 and Biogents Sentinel (TM) traps (battery powered traps without light and passive box traps). However, diversity measures (species richness, evenness, and similarity) were consistently nearly equal among trap types. Arbovirus vectors were more common in forest locations, while malaria vectors were more common near human habitations. Location had a significant effect on trap effectiveness and mosquito diversity, with traps from forest locations having greater numbers and greater species richness, compared with traps set near human habitations. The results of this study will inform mosquito surveillance trap choices in remote regions of central South America, including regions with emerging tropical diseases, such and dengue and Zika virus.
C1 [Peck, George W.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Peck, George W.] Portland State Univ, Maseeh Coll Engn & Comp Sci, Portland, OR 97207 USA.
   [Castro-Llanos, Fanny; Lopez-Sifuentes, Victor M.; Vasquez, Gissella M.] US Naval Med Res Unit 6, Callao, Peru.
   [Lindroth, Erica] Armed Forces Pest Management Board, Silver Spring, MD USA.
RP Peck, GW (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.; Peck, GW (corresponding author), Portland State Univ, Maseeh Coll Engn & Comp Sci, Portland, OR 97207 USA.
FU Ministerio Agricultura y Riego de Peru, Direccion General Forestal y de
   Fauna Silvestre [0306-2013-MINAGRI-DGFFS/DGEFFS]; Walter Reed's Army
   Institute of Research [MIDRP-U0341-13-WR]
FX Jason Richardson and Robert Lowen contributed to study design and
   supported study logistics; John Paul Benante, Hugo Jaba, Jonny Hidalgo,
   Daniel Nunez, Renan Chota, Juan Huayunga, and Josias Chavez gave
   technical support during field experiments; Roberto Fernandez and Carmen
   Flores provided a critical review of the manuscript. We are grateful to
   the Ministerio de Defensa, Ejercito del Peru, Quinta Division de
   Ejercito for permission to conduct these studies, and the Ministerio
   Agricultura y Riego de Peru, Direccion General Forestal y de Fauna
   Silvestre for permission to conduct mosquito collections under the
   auspices of Resolucion Directoral No. 0306-2013-MINAGRI-DGFFS/DGEFFS.
   The views expressed in this article are those of the authors and do not
   necessarily reflect the official policy or position of the Department of
   Defense nor the US government. Mention of a trademark, vendor, or
   proprietary product does not constitute a guarantee or warranty of the
   product by the US Military and does not imply its approval to the
   exclusion of other products that may also be suitable. Some of the
   authors are military service members or employees of the US government.
   This work was prepared as part of their official duties. Title 17 U.S.C.
   105 provides that "Copyright protection under this title is not
   available for any work of the United States Government.'' Title 17
   U.S.C. 101 defines a US government work as a work prepared by a military
   service member or employee of the US government as part of that person's
   official duties. Funding was provided by Walter Reed's Army Institute of
   Research under MIDRP-U0341-13-WR Evaluation of Surveillance Equipment.
CR Bhalala H, 2009, J AM MOSQUITO CONTR, V25, P134, DOI 10.2987/08-5821.1
   Burkett DA, 1998, J AM MOSQUITO CONTR, V14, P186
   Burnham KP, 2011, MODEL SELECTION MULT
   Connelly CR, 2016, J VECTOR ECOL, V41, P195, DOI 10.1111/jvec.12213
   Consoli R, 1994, EDITORIA FIOCRUZ
   Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Fernandez Roberto, 2014, Rev Peru Med Exp Salud Publica, V31, P310
   Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250
   GALINDO PEDRO, 1954, ANN ENT SOC AMER, V47, P107
   Gelman A., 2007, DATA ANAL USING REGR
   Gelman A., 2014, BAYESIAN DATA ANAL
   Hiwat H, 2011, J MED ENTOMOL, V48, P1039, DOI 10.1603/ME10245
   Jones JW, 2004, J MED ENTOMOL, V41, P349, DOI 10.1603/0022-2585-41.3.349
   Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x
   Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1
   Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2
   Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146
   Lane J., 1953, DEINOCERITES URANOTA, V2
   Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x
   Link WA, 2010, BAYESIAN INFERENCE A
   McElreath R, 2016, STAT RETHINKING BAYE
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Morales-Ayala F., 1971, Mosquito Syst Newsl, V3, P138
   NEED JT, 1993, J MED ENTOMOL, V30, P634, DOI 10.1093/jmedent/30.3.634
   Obenauer PJ, 2014, ENVIRON ENTOMOL, V39, P1608
   Overgaard HJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-56
   Padilla-Torres SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058420
   Pecor JE, 2000, J AM MOSQUITO CONTR, V16, P210
   Lima JBP, 2014, MEM I OSWALDO CRUZ, V109, P685, DOI 10.1590/0074-0276140134
   PRATT HARRY D., 1953, PROC ENT SOC WASHINGTON, V55, P9
   R Core Team, 2017, R LANG ENV STAT COMP
   REEVES WC, 1953, AM J TROP MED HYG, V2, P325, DOI 10.4269/ajtmh.1953.2.325
   Reiczigel J, 2010, STOCH ENV RES RISK A, V24, P455, DOI 10.1007/s00477-009-0333-z
   Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547
   Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P105
   Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P24
   Ritchie SA, 2013, J MED ENTOMOL, V50, P185, DOI 10.1603/ME12112
   ROGERS E, 1993, PAN-PAC ENTOMOL, V69, P141
   RStudio Programming Team, 2017, RSTUDIO COMP PROGR V
   Rueda LM, 2008, HYDROBIOLOGIA, V595, P477, DOI 10.1007/s10750-007-9037-x
   Ryan PA, 2004, J MED ENTOMOL, V41, P1143, DOI 10.1603/0022-2585-41.6.1143
   Saitoh Y, 2004, J AM MOSQUITO CONTR, V20, P261
   Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230
   Service MW, 1993, MOSQUITO ECOLOGY FIE
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292
   SOUTHWOOD TRE, 2000, ECOLOGICAL METHODS
   Stan Development Team, 2017, RSTAN R INT STAN
   Steiger BM, 2014, J MED ENTOMOL, V51, P39, DOI 10.1603/ME12216
   Turell MJ, 2008, J MED ENTOMOL, V45, P1165, DOI 10.1603/0022-2585(2008)45[1165:SDBAHA]2.0.CO;2
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
NR 53
TC 1
Z9 1
U1 0
U2 7
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD DEC
PY 2018
VL 34
IS 4
BP 291
EP 301
DI 10.2987/17-6724.1
PG 11
WC Entomology
SC Entomology
GA HJ4HW
UT WOS:000457136100006
PM 31442143
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Pless, E
   Raman, V
AF Pless, Evlyn
   Raman, Vivek
TI ORIGIN OF AEDES AEGYPTI IN CLARK COUNTY, NEVADA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; invasion; Las Vegas; Nevada; population genetics
ID INSECTICIDE RESISTANCE; POPULATION; ALBOPICTUS; DISPERSAL; MOSQUITOS;
   SOFTWARE; VECTORS; PROGRAM
AB Aedes aegypti is the primary vector for serious diseases, including those caused by chikungunya, dengue, and Zika viruses. In 2017, the Southern Nevada Health District fast detected this invasive species in Clark County, NV, including in the city of Las Vegas. We analyzed Ae. aegypti from the city of North Las Vegas to determine the likely source of the invasion. We genotyped a sample of Ae. aegypti at 12 highly variable microsatellites and analyzed the data in reference to published data from 25 sites in the southern USA. We found that the Ae. aegypti in Las Vegas most likely invaded from southern California. Knowing the source of new invasions may provide information about the invading population (e.g., previous insecticide exposure) and can help prevent future invasions from the region.
C1 [Pless, Evlyn] Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St, New Haven, CT 06511 USA.
   [Raman, Vivek] Southern Nevada Hlth Dist, POB 3902, Las Vegas, NV 89127 USA.
RP Pless, E (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St, New Haven, CT 06511 USA.
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI101112]
CR Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   California Department of Public Health, 2018, AED AEG AED ALB MOSQ
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Gloria-Soria A, 2018, AM J TROP MED HYG, V98, P445, DOI 10.4269/ajtmh.17-0676
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Merced County Mosquito Abatement District, 2018, INV AED AEG MOSQ FOU
   Metzger ME, 2017, J MED ENTOMOL, V54, P533, DOI 10.1093/jme/tjw237
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Pritchard JK, 2000, GENETICS, V155, P945
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
NR 24
TC 0
Z9 0
U1 0
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD DEC
PY 2018
VL 34
IS 4
BP 302
EP 305
DI 10.2987/18-6776.1
PG 4
WC Entomology
SC Entomology
GA HJ4HW
UT WOS:000457136100007
PM 31442147
OA Bronze
DA 2020-07-08
ER

PT J
AU Levine, D
AF Levine, Deborah
TI Can Ultrasound Be Used to Reassure Pregnant Women Infected by Zika
   Virus?
SO JAMA NETWORK OPEN
LA English
DT Editorial Material
C1 [Levine, Deborah] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.
RP Levine, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.
EM dlevine@bidmc.harvard.edu
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, 2015, OUTC PREGN LAB EV PO
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Levine D, 2017, RADIOGRAPHICS, V37, P1850, DOI 10.1148/rg.2017170164
   Pan American Health Organization; World Health Organization, 2017, REG ZIK EP UPD
   Pereira JP, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6529
NR 7
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD DEC
PY 2018
VL 1
IS 8
AR e186537
DI 10.1001/jamanetworkopen.2018.6537
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA HI2SJ
UT WOS:000456295400035
PM 30646325
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Pereira, JP
   Nielsen-Saines, K
   Sperling, J
   Maykin, MM
   Damasceno, L
   Cardozo, RF
   Valle, HA
   Dutra, BRT
   Gama, HD
   Adachi, K
   Zin, AA
   Tsui, I
   Vasconcelos, Z
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Pereira Jr, Jose Paulo
   Nielsen-Saines, Kann
   Sperling, Jeffrey
   Maykin, Melanie M.
   Damasceno, Luana
   Cardozo, Renan Fonseca
   Valle, Helena Abreu
   Torres Dutra, Beatriz Ribeiro
   Gama, Helder Dona
   Adachi, Kristina
   Zin, Andrea A.
   Tsui, Irena
   Vasconcelos, Zilton
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Association of Prenatal Ultrasonographic Findings With Adverse Neonatal
   Outcomes Among Pregnant Women With Zika Virus Infection in Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID INTERIM GUIDANCE; BIRTH-DEFECTS; INFANTS; DIAGNOSIS; REGISTRY; FETUSES;
   WEIGHT; UPDATE; HEAD
AB IMPORTANCE Congenital Zika virus infection causes a spectrum of adverse birth outcomes, including severe birth defects of the central nervous system. The association of prenatal ultrasonographic findings with adverse neonatal outcomes, beyond structural anomalies such as microcephaly, has not been described to date.
   OBJECTIVE To determine whether prenatal ultrasonographic examination results are associated with abnormal neonatal outcomes in Zika virus-affected pregnancies.
   DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study conducted at a single regional referral center in Rio de Janeiro, Brazil, from September 1, 2015, to May 31, 2016, among 92 pregnant women diagnosed during pregnancy with Zika virus infection by reverse-transcription polymerase chain reaction, who underwent subsequent prenatal ultrasonographic and neonatal evaluation.
   EXPOSURES Prenatal ultrasonography.
   MAIN OUTCOMES AND MEASURES The primary outcome measure was composite adverse neonatal outcome (perinatal death, abnormal finding on neonatal examination, or abnormal finding on postnatal neuroimaging). Secondary outcomes include association of specific findings with neonatal outcomes.
   RESULTS Of 92 mother-neonate dyads (mean [SD] maternal age, 29.4 [6.3] years), 55 (60%) had normal results and 37 (40%) had abnormal results on prenatal ultrasonographic examinations. The median gestational age at delivery was 38.6 weeks (interquartile range, 37.9-39.3). Of the 45 neonates with composite adverse outcome, 23 (51%) had normal results on prenatal ultrasonography. Eleven pregnant women (12%) had a Zika virus-associated finding that was associated with an abnormal result on neonatal examination (adjusted odds ratio [aOR], 11.6; 95% CI, 1.8-72.8), abnormal result on postnatal neuroimaging (aOR, 6.7; 95% CI, 1.1-38.9), and composite adverse neonatal outcome (aOR, 27.2; 95% CI, 2.5-296.6). Abnormal results on middle cerebral artery Doppler ultrasonography were associated with neonatal examination abnormalities (aOR, 12.8; 95% CI, 2.6-63.2), postnatal neuroimaging abnormalities (aOR, 8.8; 95% CI, 1.7-45.9), and composite adverse neonatal outcome (aOR, 20.5; 95% CI, 3.2-132.6). There were 2 perinatal deaths. Abnormal findings on prenatal ultrasonography had a sensitivity of 48.9% (95% CI, 33.7%-64.2%) and a specificity of 68.1% (95% CI, 52.9%-80.1%) for association with composite adverse neonatal outcomes. For a Zika virus-associated abnormal result on prenatal ultrasonography, the sensitivity was lower (22.2%; 95% CI, 11.2%-37.1%) but the specificity was higher (97.9%; 95% CI, 88.7%-99.9%).
   CONCLUSIONS AND RELEVANCE Abnormal results on prenatal ultrasonography were associated with adverse outcomes in congenital Zika infection. The absence of abnormal findings on prenatal ultrasonography was not associated with a normal neonatal outcome. Comprehensive evaluation is recommended for all neonates with prenatal Zika virus exposure.
C1 [Pereira Jr, Jose Paulo; Cardozo, Renan Fonseca; Valle, Helena Abreu; Torres Dutra, Beatriz Ribeiro; Gama, Helder Dona; Zin, Andrea A.; Vasconcelos, Zilton; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Kann; Adachi, Kristina] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Sperling, Jeffrey; Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Damasceno, Luana; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,16HSE Box 0556, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224
FU Reproductive Scientist Development Program of the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development of the National
   Institutes of Health [K12 HD000849]; Departamento de Ciencia e
   Tecnologia do Ministerio da Saude do Brasil [441098/2016-9]; Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015TXB]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI28697, R21AI29534-01]; National Eye
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318]; Wellcome TrustWellcome Trust [205377/Z/16/Z]; European
   Union's Horizon 2020 Research and Innovation Programme [734584];
   Burroughs Wellcome Fund for the Reproductive Scientist Development
   Program; Queenan Fellowship from the Foundation for the Society of
   Maternal-Fetal Medicine; UK Department for International Development;
   University of California, San Francisco National Center of Excellence in
   Women's HealthUniversity of California System
FX This work was supported by grants K12 HD000849 from the Reproductive
   Scientist Development Program of the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development of the National
   Institutes of Health (Dr Gaw), 441098/2016-9 from the Departamento de
   Ciencia e Tecnologia do Ministerio da Saude do Brasil (Dr Moreira),
   E_18/2015TXB from Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (Dr Moreira), R21AI28697 and R21AI29534-01 from the National
   Institute of Allergy and Infectious Diseases (Dr Nielsen-Saines),
   R21EY028318 from the National Eye Institute (Drs Nielsen-Saines and
   Tsui), 205377/Z/16/Z from Wellcome Trust (Dr Moreira), and 734584 from
   European Union's Horizon 2020 Research and Innovation Programme (Dr
   Moreira); the Burroughs Wellcome Fund for the Reproductive Scientist
   Development Program (Dr Gaw), the Queenan Fellowship from the Foundation
   for the Society of Maternal-Fetal Medicine (Dr Gaw), UK Department for
   International Development, and the University of California, San
   Francisco National Center of Excellence in Women's Health.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Azam AZ, 2001, OBSTET GYNECOL, V97, P443, DOI 10.1016/S0029-7844(00)01140-6
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Granild-Jensen JB, 2015, DEV MED CHILD NEUROL, V57, P931, DOI 10.1111/dmcn.12760
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Hobbins JC, 2018, OBSTET GYNECOL, V131, P661, DOI 10.1097/AOG.0000000000002538
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 27
TC 3
Z9 3
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD DEC
PY 2018
VL 1
IS 8
AR e186529
DI 10.1001/jamanetworkopen.2018.6529
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HI2SJ
UT WOS:000456295400050
PM 30646333
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vliet, SM
   Dasgupta, S
   Volz, DC
AF Vliet, Sara M.
   Dasgupta, Subham
   Volz, David C.
TI Niclosamide Induces Epiboly Delay During Early Zebrafish Embryogenesis
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE niclosamide; zebrafish; epiboly; development; cytoskeleton
ID ANTHELMINTIC DRUG NICLOSAMIDE; ZIKA VIRUS; CELL-DEATH; IDENTIFICATION;
   CANCER; ORGANIZATION; PROGRESSION; METABOLISM; TRANSITION; INHIBITORS
AB Niclosamide is an antihelminthic drug used worldwide for the treatment of tapeworm infections. Recent drug repurposing screens have revealed that niclosamide exhibits diverse mechanisms of action and, as a result, demonstrates promise for a number of applications, including the treatment of cancer, bacterial infections, and Zika virus. As new applications of niclosamide will require non-oral delivery routes that may lead to exposure in utero, the objective of this study was to investigate the mechanism of niclosamide toxicity during early stages of embryonic development. Using zebrafish as a model, we found that niclosamide induced a concentration-dependent delay in epiboly progression during late-blastula and early-gastrula, an effect that was dependent on exposure during the maternal-to-zygotic transition-a period characterized by degradation of maternally derived transcripts, zygotic genome activation, and initiation of cell motility. Moreover, we found that niclosamide did not affect embryonic oxygen consumption, suggesting that oxidative phosphorylation-a well-established target for niclosamide within intestinal parasites-may not play a role in niclosamide-induced epiboly delay. However, mRNA-sequencing revealed that niclosamide exposure during blastula and early-gastrula significantly impacted the timing of zygotic genome activation as well as the abundance of cytoskeleton- and cell cycle regulation-specific transcripts. In addition, we found that niclosamide inhibited tubulin polymerization in vitro, suggesting that niclosamide-induced delays in epiboly progression may, in part, be driven by disruption of microtubule formation and cell motility within the developing embryo.
C1 [Vliet, Sara M.; Dasgupta, Subham; Volz, David C.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
RP Volz, DC (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.
EM david.volz@ucr.edu
RI Vliet, Sara/M-1103-2015
OI Vliet, Sara/0000-0002-7429-0771
FU UCR's Graduate Division; NRSA T32 Training Program [T32ES018827];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01ES027576]; USDA
   National Institute of Food and Agriculture Hatch Project [1009609]
FX This work was supported by UCR's Graduate Division and NRSA T32 Training
   Program (T32ES018827) to S.M.V, as well as a National Institutes of
   Health grant (R01ES027576) and the USDA National Institute of Food and
   Agriculture Hatch Project (1009609) to D.C.V.
CR ABELRAHEEM K, 1980, HYDROBIOLOGIA, V74, P11, DOI 10.1007/BF00009009
   ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X
   Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124
   Bestman JE, 2015, DIFFERENTIATION, V89, P51, DOI 10.1016/j.diff.2015.01.001
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677
   Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001
   DUHM B, 1961, Z NATURFORSCH PT B, VB 16, P509
   Gwisai T, 2017, BIOMED MATER, V12, DOI 10.1088/1748-605X/aa7105
   Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091
   Imperi F, 2013, ANTIMICROB AGENTS CH, V57, P996, DOI 10.1128/AAC.01952-12
   Jesuthasan S, 1997, CURR BIOL, V7, P31, DOI 10.1016/S0960-9822(06)00025-X
   Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950
   Kane DA, 1996, DEVELOPMENT, V123, P47
   KIMMEL CB, 1990, DEVELOPMENT, V108, P581
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Lai K, 2013, ACS CHEM BIOL, V8, P257, DOI 10.1021/cb300495e
   Langley AR, 2014, DEVELOPMENT, V141, P3834, DOI 10.1242/dev.102368
   Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632
   Lee SLO, 2014, BIOMED PHARMACOTHER, V68, P619, DOI 10.1016/j.biopha.2014.03.018
   Legradi J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050970
   Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl
   Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lu DY, 2016, XENOBIOTICA, V46, P1, DOI 10.3109/00498254.2015.1047812
   McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401
   Mendelsohn BA, 2008, DEV DYNAM, V237, P1789, DOI 10.1002/dvdy.21584
   Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290
   Park JP, 2006, PARASITOL RES, V98, P200, DOI 10.1007/s00436-005-0020-z
   Rajamuthiah R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124595
   Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z
   Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016
   SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443
   Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652
   STRAHLE U, 1993, DEVELOPMENT, V119, P909
   Suliman MA, 2016, INT J MOL MED, V38, P776, DOI 10.3892/ijmm.2016.2689
   Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699
   Tharmalingam N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22037-x
   Vliet SM, 2017, TOXICOL APPL PHARM, V329, P241, DOI 10.1016/j.taap.2017.06.011
   WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0
   WILSON DF, 1988, J BIOL CHEM, V263, P2712
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yartseva V, 2015, CURR TOP DEV BIOL, V113, P191, DOI 10.1016/bs.ctdb.2015.07.020
   YORKE RE, 1974, Z PARASITENKD, V45, P1, DOI 10.1007/BF00636524
NR 44
TC 7
Z9 9
U1 4
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD DEC
PY 2018
VL 166
IS 2
BP 306
EP 317
DI 10.1093/toxsci/kfy214
PG 12
WC Toxicology
SC Toxicology
GA HI6HD
UT WOS:000456554100007
PM 30165700
OA Green Published
DA 2020-07-08
ER

PT J
AU Chan, MPS
   Farhadloo, M
   Winneg, K
   Jamieson, KH
   Albarracin, D
AF Chan, Man-pui Sally
   Farhadloo, Mohsen
   Winneg, Kenneth
   Jamieson, Kathleen Hall
   Albarracin, Dolores
TI Sources affecting knowledge and behavior responses to the Zika virus in
   US households with current pregnancy, intended pregnancy and a high
   probability of unintended pregnancy
SO JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE attitude; behavior; communication; health; information sources;
   knowledge; pregnancy; public health; Zika
ID UNITED-STATES; WOMEN
AB Background This study examined the influences of information sources on Zika-relevant knowledge and behaviors in US households containing members who are pregnant, intend to become pregnant, or have a higher probability of unintended pregnancy in Zika-affected regions (i.e. respondents who are younger, are black, have less education, are unmarried, and reside in the southern USA).
   Methods Over 32 000 US adults completed a survey measuring Zika-relevant knowledge and behaviors along with information sources (e.g. discussing Zika with practitioners), general media usage (e.g. TV) and demographic information over 30 weeks.
   Results Respondents in the group with (versus without) either pregnancy or intended pregnancy were more likely to use all information sources, which in turn created differences in knowledge and behavior responses. To gauge information sources in US-South respondents with a high probability of having a household member with unintended pregnancy based on demographics, younger, less-educated, unmarried, black respondents had fewer Zika discussion with practitioners than another group.
   Conclusions Efforts to increase Zika-related knowledge and protective behaviors should target households with members who are pregnant or intending to become pregnant via practitioners, family and friends. Additional efforts should target information channels to reach younger, less educated, unmarried, black respondents, which are at risk for unintended pregnancy.
C1 [Chan, Man-pui Sally; Farhadloo, Mohsen; Albarracin, Dolores] Univ Illinois, Dept Psychol, 603 E Daniel St, Champaign, IL 61820 USA.
   [Farhadloo, Mohsen; Winneg, Kenneth; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
RP Chan, MPS (corresponding author), Univ Illinois, Dept Psychol, 603 E Daniel St, Champaign, IL 61820 USA.
EM sallycmp@illinois.edu
OI Chan, Man-pui Sally/0000-0003-2984-0487
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R56 AI114501];
   Science of Science Communication endowment of the Annenberg Public
   Policy Center of the University of Pennsylvania
FX This work was supported by the National Institutes of Health [R56
   AI114501 to D.A.] and the Science of Science Communication endowment of
   the Annenberg Public Policy Center of the University of Pennsylvania.
CR Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   CDC, 2016, AR ZIK CAS COUNTS US
   CDC, 2016, ZIK VIR HOM HLTH EFF
   Dehlendorf C, 2010, AM J OBSTET GYNECOL, V202, P214, DOI 10.1016/j.ajog.2009.08.022
   Dwyer Marge, 2018, MANY US FAMILIES CON
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x
   Harvard TH Chan School of Public Health HORP, PUBL VIEWS ZIK VIR O
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i786
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mosher WD, 2012, INTENDED UNINTENDED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petty R.E, 1986, ADV EXPT SOCIAL PSYC, P1, DOI [DOI 10.1016/S0065-2601(08)60214-2, 10.1007/978-1-4612-4964-1_1]
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Stagg Denise, 2016, Nurs Womens Health, V20, P299, DOI 10.1016/j.nwh.2016.03.001
   Tapales A, 2015, DEMOGR RES, V33, P1257, DOI 10.4054/DemRes.2015.33.45
   The Annenberg Public Policy Center, 2018, HALF AM ZIK WILL SPR
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, 2018, ZIK VIR INF DIS OUTB
NR 22
TC 3
Z9 3
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-3842
EI 1741-3850
J9 J PUBLIC HEALTH-UK
JI J. Public Health
PD DEC
PY 2018
VL 40
IS 4
BP 776
EP 786
DI 10.1093/pubmed/fdy085
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HH9VC
UT WOS:000456087600040
PM 29860509
OA Green Published
DA 2020-07-08
ER

PT J
AU Ophir, Y
   Jamieson, KH
AF Ophir, Yotam
   Jamieson, Kathleen Hall
TI Intentions to use a novel Zika vaccine: the effects of misbeliefs about
   the MMR vaccine and perceptions about Zika
SO JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE beliefs; communicable diseases; immunization
ID ATTITUDE-BEHAVIOR RELATIONS; VIRUS-INFECTION; BIRTH-DEFECTS; AUTISM;
   METAANALYSIS; INFANTS
AB Background People's intentions to use vaccines are influenced by their beliefs about both the specific vaccine and the disease it prevents. In the absence of firm beliefs about Zika virus (ZIKV), individuals may base their intentions to vaccinate against it on beliefs about other vaccines, and specifically the misbelief that MMR causes autism.
   Methods A survey of 3337 Americans, using a random-digit-dialing sample of landline telephone households and cell-phones.
   Results Intentions to use a Zika vaccine were influenced by beliefs about Zika, science in general, and MMR. Intentions were positively influenced by perceived severity of and vulnerability to Zika, as well as belief in science's efficacy. However, intentions were negatively influenced by the belief that MMR causes autism in children.
   Conclusion The misbelief about MMR and autism may reduce people's intentions to use a new Zika vaccine. However, perceptions of severity of and vulnerability to Zika may increase intentions. Implications for science educators and public health officials are discussed.
C1 [Ophir, Yotam] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA.
   [Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.
RP Ophir, Y (corresponding author), Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA.
EM yophir@asc.upenn.edu
RI Ophir, Yotam/J-8397-2019
OI Ophir, Yotam/0000-0001-5049-7906
FU Science of Science Communication endowment of the Annenberg Public
   Policy Center of the University of Pennsylvania
FX The study was funded by the Science of Science Communication endowment
   of the Annenberg Public Policy Center of the University of Pennsylvania.
CR AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888
   Ajzen I, 1985, ACTION CONTROL COGNI, DOI DOI 10.1007/978-3-642-69746-3_2
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   [Anonymous], CAS COUNTS US
   Baker JP, 2008, AM J PUBLIC HEALTH, V98, P244, DOI 10.2105/AJPH.2007.113159
   Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647
   Bolsen T, 2014, PUBLIC OPIN QUART, V78, P1, DOI 10.1093/poq/nft044
   Broniatowski DA, 2016, VACCINE, V34, P3225, DOI 10.1016/j.vaccine.2016.04.044
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention (CDC), SYMPT
   Centers for Disease Control and Prevention (CDC), ZIK GUILL BARR SYNDR
   Deer Brian, 2011, BMJ, V342, pc5347, DOI 10.1136/bmj.c5347
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dyer O., 2016, BMJ-BRIT MED J, V352, pi630
   Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x
   FISHBEIN M, 1972, ANNU REV PSYCHOL, V23, P487, DOI 10.1146/annurev.ps.23.020172.002415
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerber JS, 2009, CLIN INFECT DIS, V48, P456, DOI 10.1086/596476
   Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87
   HALE JL, 2002, PERSUASION HDB DEV T
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   JONES JW, 1980, PSYCHOL REP, V47, P71, DOI 10.2466/pr0.1980.47.1.71
   Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022
   KIM MS, 1993, J COMMUN, V43, P101, DOI 10.1111/j.1460-2466.1993.tb01251.x
   National Consumer League Communications, SURV ON 3 AM PAR MIS
   National Institute of Allery and Infectious Diseases, PHAS 2 ZIK VACC TRIA
   National Institute of Health (NIH), NIH BEG TEST INV ZIK
   Offit P, 2010, AUTISMS FALSE PROPHE
   Offit PA, 2009, VACCINATED ONE MANS
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Smailbegovic MS, 2003, CHILD CARE HLTH DEV, V29, P303, DOI 10.1046/j.1365-2214.2003.00347.x
   Stephenson T., 2009, SWINE FLU H1N1 FACTS
   Taylor LE, 2014, VACCINE, V32, P3623, DOI 10.1016/j.vaccine.2014.04.085
   Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381
   WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004
   YouGov, YOUGOV WHAT WORLD TH
NR 44
TC 3
Z9 3
U1 1
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-3842
EI 1741-3850
J9 J PUBLIC HEALTH-UK
JI J. Public Health
PD DEC
PY 2018
VL 40
IS 4
BP E531
EP E537
DI 10.1093/pubmed/fdy042
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HH9VC
UT WOS:000456087600013
PM 29554290
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Priya, S
   Senthil, KN
   Hemalatha, S
AF Priya, S.
   Senthil, Kumar Nachimuthu
   Hemalatha, S.
TI Antiviral phytocompounds target envelop protein to control Zika virus
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE ZIKA Virus; Phytocompound; Tannic acid; Envelope protein; Fusion loop;
   UPR arm protein
ID INFECTION
AB Zika virus infection causes serious birth defects, including microcephaly, when expectant mothers are infected during pregnancy. Zika outbreaks have been reported in the Pacific Islands, South America, the Caribbean, Africa and parts of South East Asia. Currently, there is no specific treatment available for Zika virus infection. Hence, the current study is focused to identify natural phytocompounds to control Zika virus from few endemic anti-viral herbs by in silica approach. Molecular interactions, Pharmacokinetic Study, Molecular dynamic simulation and annealing were carried out with the phytocompounds and checked using Lipinski filter. The interactions between the phytocompounds and Envelope protein (PDB id: 5JHM) of Zika virus was assessed with SYBYL-X 1.3. The results showed that tannic acid from Terminalia arjuna had better interaction, total score, CScore (6.792 and 5) and formed more number of Hydrogen bonds within 2.5 angstrom bond length, best activity in pharmacokinetic study, Molecular dynamic simulation and annealing temperature at 310 K. Our results suggested that tannic acid can be utilized as lead candidate to control Zika virus infection.
C1 [Priya, S.; Hemalatha, S.] Crescent Inst Sci & Technol, Sch Life Sci, Chennai, India.
   [Senthil, Kumar Nachimuthu] Mizoram Univ, Dept Biotechnol, Aizawl, Mizoram, India.
RP Hemalatha, S (corresponding author), Crescent Inst Sci & Technol, Sch Life Sci, Chennai, India.
EM hemalatha.sls@bsauniv.ac.in
RI Senthil Kumar, Nachimuthu/G-1777-2017
OI Senthil Kumar, Nachimuthu/0000-0002-0192-2133
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Based P, 2009, J PROTEOM BIOINFORM, V2, P481, DOI [10.4172/jpb.1000109, DOI 10.4172/JPB.1000109]
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dolma K, 2016, J RES DEV, V4, P2, DOI [10.4172/2311-3278.1000148, DOI 10.4172/2311-3278.1000148]
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   El-Saadi Madison Wynne, 2015, In Silico Pharmacology, V3, P6, DOI 10.1186/s40203-015-0010-5
   Fang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23634
   Ferreira LG, 2015, MOLECULES, V20, P13384, DOI 10.3390/molecules200713384
   Ganguly B, 2016, BIORXIV, DOI [10.1101/054486, DOI 10.1101/054486]
   Ganjhu Rajesh Kumar, 2015, VirusDisease, V26, P225, DOI 10.1007/s13337-015-0276-6
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Huo XW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091343
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Moreno V, 2016, RENEW ENERG, P1, DOI [10.1016/j.idm.2016.12.002, DOI 10.1016/J.IDM.2016.12.002]
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Orlowski P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104113
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   RIos-Gonzalez CM, 2016, MED UNIVER, V18, P134, DOI DOI 10.1016/J.RMU.2016.04.004
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, P6, DOI DOI 10.1128/AAC.00411-17.E00411-17
   Singh MV, 2017, J NEUROVIROL, V23, P347, DOI 10.1007/s13365-017-0513-4
   Sirohi D, 2016, SCIENCE, P1, DOI [10.1126/science.aaf5316.5316, DOI 10.1126/SCIENCE.AAF5316]
   Wang Y, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070629
   Xu M, 2017, HHS PUBLIC ACCESS, V22, P1101, DOI [10.1038/nm.4184.1dentification, DOI 10.1038/NM.4184.1DENTIFICATION]
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 28
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD DEC
PY 2018
VL 77
BP 402
EP 412
DI 10.1016/j.compbiolchem.2018.08.008
PG 11
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA HH6RJ
UT WOS:000455858400040
PM 30471642
DA 2020-07-08
ER

PT J
AU Mohr, EL
AF Mohr, Emma L.
TI Modeling Zika Virus-Associated Birth Defects in Nonhuman Primates
SO JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
LA English
DT Review
DE congenital Zika infection; nonhuman primate
ID CYTOMEGALOVIRUS-INFECTION; RHESUS-MONKEYS; VISUAL-ACUITY; HEARING-LOSS;
   BRAIN; INFANTS; BRAZIL; MISCARRIAGE; CHILDREN; NEURONS
AB In utero infection with Zika virus (ZIKV) during pregnancy can lead to the development of birth defects and postnatal deficits. A nonhuman primate (NHP) model of congenital ZIKV infection can help fill the gaps in knowledge where tissue studies are required to define viral pathogenesis and identify targets for therapeutic intervention. This model system has already identified critical features of ZIKV pathogenesis in congenital infection. Before translating these NHP studies to human clinical trials, we must understand the similarities and differences between human and NHP fetal immune system development, neural development, and infant assessment tools. Because of the overall similarity between fetal and infant development in humans and NHPs, this NHP model can complement human clinical trials by defining immune correlates of protection and evaluating therapeutic interventions.
C1 [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Madison, WI USA.
RP Mohr, EL (corresponding author), 600 Highland Ave, Madison, WI 53792 USA.
EM emohr@uwhealth.org
FU St. Jude Children's Research Hospital, Memphis, Tennessee; Sanofi
   Pasteur; Institutional Clinical and Translational Science Award (CTSA)
   program through NIH National Center for Advancing Translational Sciences
   [UL1TR002373-02, TL1002375-02]
FX This supplement was sponsored by St. Jude Children's Research Hospital,
   Memphis, Tennessee.; The Pediatric Infectious Diseases Society
   Fellowship Award was funded by Stanley A. Plotkin and Sanofi Pasteur.
   This work was funded by Institutional Clinical and Translational Science
   Award (CTSA) program, through the NIH National Center for Advancing
   Translational Sciences, Grants UL1TR002373-02 and TL1002375-02.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Barry PA, 2006, ILAR J, V47, P49, DOI 10.1093/ilar.47.1.49
   Bell SG, 2017, NEONATAL NETW, V36, P103, DOI 10.1891/0730-0832.36.2.103
   Benavente I, 2005, DOC OPHTHALMOL, V110, P255, DOI 10.1007/s10633-005-0818-0
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Britt WJ, 2018, SEMIN PERINATOL, V42, P155, DOI 10.1053/j.semperi.2018.02.003
   Burbacher TM, 2000, NEUROTOXICOL TERATOL, V22, P475, DOI 10.1016/S0892-0362(00)00073-8
   Buse Eberhard, 2005, J Immunotoxicol, V2, P211, DOI 10.1080/15476910500362937
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Church JT, 2018, J PEDIATR SURG, V53, P1234, DOI 10.1016/j.jpedsurg.2018.02.091
   Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   DAVIGNON RW, 1980, ANAT EMBRYOL, V159, P317, DOI 10.1007/BF00317654
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Diau GY, 2003, INVEST OPHTH VIS SCI, V44, P4559, DOI 10.1167/iovs.03-0478
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El-Dib M, 2011, BRAIN DEV-JPN, V33, P95, DOI 10.1016/j.braindev.2010.04.004
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fujikawa Tomoko, 2003, International Journal of Infectious Diseases, V7, P215, DOI 10.1016/S1201-9712(03)90055-5
   FULTON AB, 1981, SURV OPHTHALMOL, V25, P325, DOI 10.1016/0039-6257(81)90158-2
   Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060
   Golub MS, 2007, BRAIN RES, V1151, P102, DOI 10.1016/j.brainres.2007.03.001
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Grindle CR, 2014, PEDIATR REV, V35, P456, DOI 10.1542/pir.35-11-456
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jeffrey BG, 2002, LIPIDS, V37, P839, DOI 10.1007/s11745-002-0969-0
   Kempermann G, 2014, CELL, V156, P870, DOI 10.1016/j.cell.2014.02.027
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kublin JL, 2018, VIRUS RES, V254, P15, DOI 10.1016/j.virusres.2017.07.025
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Latvala S, 2017, J HISTOCHEM CYTOCHEM, V65, P321, DOI 10.1369/0022155417705095
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Makori N, 2003, CLIN DIAGN LAB IMMUN, V10, P140, DOI 10.1128/CDLI.10.1.140-153.2003
   Marsico C, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0358-8
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McCollister F P, 1996, J Am Acad Audiol, V7, P57
   Michejda M, 1985, Prog Clin Biol Res, V163B, P243
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morrison JL, 2018, J PHYSIOL-LONDON, V596, P5535, DOI 10.1113/JP274948
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mota-Rojas D, 2014, ANIMAL PRODUCTION SC, V55, P93
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Ould MAE, 2004, PEDIATR RES, V55, P280, DOI 10.1203/01.PDR.0000104150.85437.FE
   Parness-Yossifon R, 2008, CURR OPIN OPHTHALMOL, V19, P398, DOI 10.1097/ICU.0b013e32830abf11
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Sackett GP, 2008, PRIMATE MODELS OF CHILDREN'S HEALTH AND DEVELOPMENTAL DISABILITIES, P1, DOI 10.1016/B978-012373743-4.50003-5
   Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801
   SCHNEIDER ML, 1992, INFANT BEHAV DEV, V15, P155, DOI 10.1016/0163-6383(92)80021-L
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Stebbins WC, 1970, ANIMAL PSYCHOPHYSICS, P41
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Stouffer RL, 2017, ILAR J, V58, P281, DOI 10.1093/ilar/ilx027
   STRAUSS M, 1990, AM J OTOLARYNG, V11, P292, DOI 10.1016/0196-0709(90)90057-3
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   WILLIAMSON WD, 1992, PEDIATRICS, V90, P862
   Yuan TF, 2014, CELL TISSUE RES, V358, P17, DOI 10.1007/s00441-014-1980-z
NR 88
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-7193
EI 2048-7207
J9 J PEDIAT INF DIS SOC
JI J. Pediatr. Infect. Dis. Soc.
PD DEC
PY 2018
VL 7
SU 2
BP S60
EP S66
DI 10.1093/jpids/piy120
PG 7
WC Infectious Diseases; Pediatrics
SC Infectious Diseases; Pediatrics
GA HI0KC
UT WOS:000456129500006
DA 2020-07-08
ER

PT J
AU van Vuren, PJ
   Kgaladi, J
   Patharoo, V
   Paweska, JT
AF van Vuren, Petrus Jansen
   Kgaladi, Joe
   Patharoo, Venessa
   Paweska, Janusz T.
TI Complete Genome Sequences of Spondweni Viruses Isolated between 1958 and
   1960
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID ZIKA
AB Here, we report the complete genome sequences of 14 Spondweni viruses isolated in South Africa and Mozambique between 1958 and 1960. The sequences comprise 13 mosquito isolates and 1 human isolate following a documented laboratory infection. This study expands the publicly available data for this neglected virus from 4 to 18 sequences.
C1 [van Vuren, Petrus Jansen; Kgaladi, Joe; Patharoo, Venessa; Paweska, Janusz T.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.
RP van Vuren, PJ (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.
EM petrusv@nicd.ac.za
FU Poliomyelitis Research Foundation [PRF12/63]
FX The study was funded by the Poliomyelitis Research Foundation (grant
   PRF12/63).
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Deen GF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005723
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   WOLFE MS, 1982, LANCET, V2, P1306
NR 17
TC 1
Z9 1
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD DEC
PY 2018
VL 7
IS 23
AR e01278-18
DI 10.1128/MRA.01278-18
PG 3
WC Microbiology
SC Microbiology
GA HH9MG
UT WOS:000456062000006
PM 30574581
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ji, ZL
   Li, FF
   Xia, ZQ
   Guo, XC
   Gao, MJ
   Sun, F
   Cheng, YT
   Wu, YL
   Li, WX
   Ali, SA
   Cao, ZJ
AF Ji, Zhenglin
   Li, Fangfang
   Xia, Zhiqiang
   Guo, Xingchen
   Gao, Minjun
   Sun, Fang
   Cheng, Yuting
   Wu, Yingliang
   Li, Wenxin
   Ali, Syed Abid
   Cao, Zhijian
TI The Scorpion Venom Peptide Smp76 Inhibits Viral Infection by Regulating
   Type-I Interferon Response
SO VIROLOGICA SINICA
LA English
DT Article
DE Dengue virus (DENV); Zika virus (ZIKV); Scorpion venom peptide; Smp76;
   Antiviral mechanism; Type-I interferon response
ID HERPES-SIMPLEX-VIRUS; DENDRITIC CELLS; ZIKA VIRUS; DENGUE; REPLICATION;
   BIOAVAILABILITY; ALPHA/BETA; IMMUNITY
AB Dengue virus (DENV) and Zika virus (ZIKV) have spread throughout many countries in the developing world and infect millions of people every year, causing severe harm to human health and the economy. Unfortunately, there are few effective vaccines and therapies available against these viruses. Therefore, the discovery of new antiviral agents is critical. Herein, a scorpion venom peptide (Smp76) characterized from Scorpio maurus palmatus was successfully expressed and purified in Escherichia coli BL21(DE3). The recombinant Smp76 (rSmp76) was found to effectively inhibit DENV and ZIKV infections in a dose-dependent manner in both cultured cell lines and primary mouse macrophages. Interestingly, rSmp76 did not inactivate the viral particles directly but suppressed the established viral infection, similar to the effect of interferon (IFN)-. Mechanistically, rSmp76 was revealed to upregulate the expression of IFN- by activating interferon regulatory transcription factor 3 (IRF3) phosphorylation, enhancing the type-I IFN response and inhibiting viral infection. This mechanism is significantly different from traditional virucidal antimicrobial peptides (AMPs). Overall, the scorpion venom peptide Smp76 is a potential new antiviral agent with a unique mechanism involving type-I IFN responses, demonstrating that natural AMPs can enhance immunity by functioning as immunomodulators.
C1 [Ji, Zhenglin; Li, Fangfang; Xia, Zhiqiang; Guo, Xingchen; Gao, Minjun; Sun, Fang; Cheng, Yuting; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
   [Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Biodrug Res Ctr, Wuhan 430072, Hubei, Peoples R China.
   [Ali, Syed Abid] Univ Karachi, HEJ Res Inst Chem, ICCBS, Karachi 75270, Pakistan.
   [Cao, Zhijian] Wuhan Univ, Ctr Fluorinated Pharmaceut, Hubei Prov Engn & Technol Res, Wuhan 430072, Hubei, Peoples R China.
RP Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.; Cao, ZJ (corresponding author), Wuhan Univ, Biodrug Res Ctr, Wuhan 430072, Hubei, Peoples R China.; Cao, ZJ (corresponding author), Wuhan Univ, Ctr Fluorinated Pharmaceut, Hubei Prov Engn & Technol Res, Wuhan 430072, Hubei, Peoples R China.
EM zjcao@whu.edu.cn
FU National Science Fund of ChinaNational Natural Science Foundation of
   China [31572289, 31872239, 81630091]; International S&T Cooperation
   Program of China [S2016G3110]; Hubei Science Fund [2015CFA042,
   2016CFA018]; China-Kazakhstan Cooperation Program [CK-07-09];
   Fundamental Research Funds for the Central Universities in China
   [2042017kf0242, 2042017kf0199]; Higher Education Commission (HEC) of
   PakistanHigher Education Commission of Pakistan
FX We are indebted to Dr. Bo Zhang from the Wuhan Institute of Virology,
   Chinese Academy of Sciences for kindly providing DENV serotype-2 TSV01
   strain. We thank Dr. Ren Sun and Dr. Danyang Gong from the University of
   California, Los Angeles for sharing pBR322-Z2 plasmid. We gratefully
   acknowledge Prof. Wu Jianguo and Prof. Bo Zhong from Wuhan University
   for their kindly providing DENV-2 (NGC) and Ifnar1<SUP>-/-</SUP> mice,
   respectively. This work was supported by grants from National Science
   Fund of China (Nos. 31572289, 31872239 and 81630091), International S&T
   Cooperation Program of China (No. S2016G3110), Hubei Science Fund (Nos.
   2015CFA042 and 2016CFA018), China-Kazakhstan Cooperation Program (No.
   CK-07-09), and Fundamental Research Funds for the Central Universities
   in China (Nos. 2042017kf0242 and 2042017kf0199). SAA is grateful for
   financial support from Higher Education Commission (HEC) of Pakistan.
CR Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064
   Alesha Grant SS, 2016, CELL HOST MICROBE, V19, P882, DOI [10.1016/j.chom.2016.05.009, DOI 10.1016/J.CHOM.2016.05.009]
   [Anonymous], 2016, Br Dent J, V220, P449, DOI 10.1038/sj.bdj.2016.330
   Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8
   Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3
   Cui XY, 2018, ANTIVIR RES, V155, P20, DOI 10.1016/j.antiviral.2018.04.018
   Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468
   Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004
   Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]
   Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081
   Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018
   Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013
   Hong W, 2013, BIOMATERIALS, V34, P3511, DOI 10.1016/j.biomaterials.2013.01.075
   JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843
   Uawonggul N, 2014, BIOCHEM GENET, V52, P459, DOI 10.1007/s10528-014-9660-y
   Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699
   Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004
   Yu JS, 2017, ANTIVIR RES, V137, P49, DOI 10.1016/j.antiviral.2016.11.010
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zeng ZY, 2018, THERANOSTICS, V8, P199, DOI 10.7150/thno.21425
   Zhao ZH, 2012, J BIOL CHEM, V287, P30181, DOI 10.1074/jbc.M112.370312
NR 43
TC 4
Z9 5
U1 5
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD DEC
PY 2018
VL 33
IS 6
BP 545
EP 556
DI 10.1007/s12250-018-0068-4
PG 12
WC Virology
SC Virology
GA HH8CF
UT WOS:000455958600011
PM 30569290
OA Green Published
DA 2020-07-08
ER

PT J
AU Madad, S
   Tate, A
   Rand, M
   Quinn, C
   Vora, NM
   Allen, M
   Cagliuso, NV
   Rakeman, JL
   Studer, S
   Masci, J
   Varma, JK
   Wilson, R
AF Madad, Syra
   Tate, Anna
   Rand, Maytal
   Quinn, Celia
   Vora, Neil M.
   Allen, Machelle
   Cagliuso, Nicholas V., Sr.
   Rakeman, Jennifer L.
   Studer, Sean
   Masci, Joseph
   Varma, Jay K.
   Wilson, Ross
TI Zika Virus Preparedness and Response Efforts Through the Collaboration
   Between a Health Care Delivery System and a Local Public Health
   Department
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE Zika; healthcare delivery; local public health department; public health
   emergency
ID NEW-YORK-CITY; DISEASE
AB The Zika virus was largely unknown to many health care systems before the outbreak of 2015. The unique public health threat posed by the Zika virus and the evolving understanding of its pathology required continuous communication between a health care delivery system and a local public health department. By leveraging an existing relationship, NYC Health + Hospitals worked closely with New York City Department of Health and Mental Hygiene to ensure that Zika-related processes and procedures within NYC Health + Hospitals facilities aligned with the most current Zika virus guidance. Support given by the public health department included prenatal clinical and laboratory support and the sharing of data on NYC Health + Hospitals Zika virus screening and testing rates, thus enabling this health care delivery system to make informed decisions and practices. The close coordination, collaboration, and communication between the health care delivery system and the local public health department examined in this article demonstrate the importance of working together to combat a complex public health emergency and how this relationship can serve as a guide for other jurisdictions to optimize collaboration between external partners during major outbreaks, emerging threats, and disasters that affect public health.
C1 [Madad, Syra; Cagliuso, Nicholas V., Sr.] New York City Hlth Hosp, Emergency Management, New York, NY USA.
   [Allen, Machelle; Studer, Sean; Wilson, Ross] New York City Hlth Hosp, 125 Worth St,Suite 412, New York, NY 10013 USA.
   [Masci, Joseph] New York City Hlth Hosp, Elmhurst, NY USA.
   [Quinn, Celia; Vora, Neil M.; Varma, Jay K.] Ctr Dis Control & Prevent, NYC Dept Hlth & Mental Hyg, New York, NY USA.
   [Quinn, Celia; Vora, Neil M.] Ctr Dis Control & Prevent, Career Epidemiol Field Officer Program, New York, NY USA.
   [Varma, Jay K.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, New York, NY USA.
RP Madad, S (corresponding author), New York City Hlth Hosp, 125 Worth St,Suite 412, New York, NY 10013 USA.
EM Syra.Madad@nychhc.org
CR Cagliuso NV, 2015, J BUS CONTIN EMER PL, V8, P263
   CDC, 2016, ZIK VIR CAS COUNTS U
   Health and Hospitals Corporation, HLTH HOSP CORP REP C
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   New York City Department of Health and Mental Hygiene, 2016, ZIK VIR INF PROV
   New York City Department of Health and Mental Hygiene, 2016, ZIK VIR
   New York City Department of Health and Mental Hygiene, 2015, AL 38 LEG DIS CLUST
   New York City Department of Health and Mental Hygiene, 2016, HLTH AL 48 NEW REC C
   Varma JK, 2017, DISASTER MED PUBLIC, V11, P370, DOI 10.1017/dmp.2016.132
NR 10
TC 0
Z9 0
U1 4
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD DEC
PY 2018
VL 12
IS 6
BP 689
EP 691
DI 10.1017/dmp.2018.5
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HH2VH
UT WOS:000455577000006
PM 29510763
DA 2020-07-08
ER

PT J
AU Molefe, PF
   Masamba, P
   Oyinloye, BE
   Mbatha, LS
   Meyer, M
   Kappo, AP
AF Molefe, Philisiwe Fortunate
   Masamba, Priscilla
   Oyinloye, Babatunji Emmanuel
   Mbatha, Londiwe Simphiwe
   Meyer, Mervin
   Kappo, Abidemi Paul
TI Molecular Application of Aptamers in the Diagnosis and Treatment of
   Cancer and Communicable Diseases
SO PHARMACEUTICALS
LA English
DT Review
DE aptamers; cancer; diagnostics; therapeutics; infectious diseases; SELEX
ID VIRUS VP35 PROTEIN; G-QUARTET OLIGONUCLEOTIDES; NUCLEIC-ACID APTAMERS;
   DOUBLE-STRANDED-RNA; EBOLA-VIRUS; REVERSE TRANSCRIPTION; DNA APTAMERS;
   SIGNAL TRANSDUCER; DRUG-RESISTANCE; SELECTION
AB Cancer and infectious diseases such as Ebola, HIV, tuberculosis, Zika, hepatitis, measles and human schistosomiasis are serious global health hazards. The increasing annual morbidities and mortalities of these diseases have been blamed on drug resistance and the inefficacy of available diagnostic tools, particularly those which are immunologically-based. Antibody-based tools rely solely on antibody production for diagnosis and for this reason they are the major cause of diagnostic delays. Unfortunately, the control of these diseases depends on early detection and administration of effective treatment therefore any diagnostic delay is a huge challenge to curbing these diseases. Hence, there is a need for alternative diagnostic tools, discovery and development of novel therapeutic agents. Studies have demonstrated that aptamers could potentially offer one of the best solutions to these problems. Aptamers are short sequences of either DNA or RNA molecules, which are identified in vitro through a SELEX process. They are sensitive and bind specifically to target molecules. Their promising features suggest they may serve as better diagnostic agents and can be used as drug carriers for therapeutic purposes. In this article, we review the applications of aptamers in the theranostics of cancer and some infectious diseases.
C1 [Molefe, Philisiwe Fortunate; Masamba, Priscilla; Oyinloye, Babatunji Emmanuel; Mbatha, Londiwe Simphiwe; Kappo, Abidemi Paul] Univ Zululand, Biotechnol & Struct Biochem BSB Grp, Dept Biochem & Microbiol, Fac Sci & Agr, ZA-3886 Kwa Dlangezwa, South Africa.
   [Oyinloye, Babatunji Emmanuel] Afe Babalola Univ, Coll Sci, Dept Biochem, PMB 5454, Ado Ekiti 360001, Nigeria.
   [Meyer, Mervin] Univ Western Cape, DST Mintek Nanotechnol Innovat Ctr, Biolabels Node, Dept Biotechnol, ZA-7535 Bellville, South Africa.
RP Kappo, AP (corresponding author), Univ Zululand, Biotechnol & Struct Biochem BSB Grp, Dept Biochem & Microbiol, Fac Sci & Agr, ZA-3886 Kwa Dlangezwa, South Africa.
EM philisiwefmolefe@gmail.com; presh4u@rocketmail.com;
   tunji4reele@yahoo.com; mbathalondy@gmail.com; memeyer@uwc.ac.za;
   KappoA@unizulu.ac.za
RI Oyinloye, Babatunji Emmanuel/J-1943-2017
OI Oyinloye, Babatunji Emmanuel/0000-0003-2165-7936; Meyer,
   Mervin/0000-0002-8296-4860; MOLEFE, PHILISIWE/0000-0002-9425-7928;
   Kappo, Abidemi Paul/0000-0003-2521-8957
FU South African Medical Research Council (SAMRC) [PC57009]; SAMRC Grant
   [PC57009]
FX This research was funded by the South African Medical Research Council
   (SAMRC) Grant Number PC57009. The APC was funded by the SAMRC Grant
   PC57009.
CR Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x
   Adjei CA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3215-6
   Alexander KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003652
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Ashrafuzzaman M, 2014, BIOMED RES INT, DOI 10.1155/2014/697923
   Bang YJ, 2010, LANCET, V376, P1302
   Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003
   Bates PJ, 2017, BBA-GEN SUBJECTS, V1861, P1414, DOI 10.1016/j.bbagen.2016.12.015
   Binning JM, 2013, BIOCHEMISTRY-US, V52, P8406, DOI 10.1021/bi400704d
   Binzel DW, 2016, MOL THER, V24, P1267, DOI 10.1038/mt.2016.85
   Boogerd W, 2012, J CANCER RES CLIN, V138, P1395, DOI 10.1007/s00432-012-1218-y
   Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16
   Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5
   Bruno JG, 2015, MOLECULES, V20, P6866, DOI 10.3390/molecules20046866
   Bukhtoyarov O. V., 2015, J CANC THER, V6, P399, DOI DOI 10.4236/jct.2015.65043
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111201
   Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05
   Cerchia L, 2018, CANCERS, V10, DOI 10.3390/cancers10050132
   Cheng CS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.59
   Cho M, 2013, P NATL ACAD SCI USA, V110, P18460, DOI 10.1073/pnas.1315866110
   Cho Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160822
   Coeli R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002596
   Darmostuk M, 2015, BIOTECHNOL ADV, V33, P1141, DOI 10.1016/j.biotechadv.2015.02.008
   Ospina-Villa JD, 2016, BRAZ J INFECT DIS, V20, P610, DOI 10.1016/j.bjid.2016.08.011
   de Almeida CEB, 2017, INT J PHARMACEUT, V525, P334, DOI 10.1016/j.ijpharm.2017.03.086
   de Soultrait VR, 2002, J MOL BIOL, V324, P195, DOI 10.1016/S0022-2836(02)01064-1
   Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2
   Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084
   Dey AK, 2005, RNA, V11, P873, DOI 10.1261/rna.7205405
   Doggrell SA, 2005, EXPERT OPIN PHARMACO, V6, P1421, DOI 10.1517/14656566.6.8.1421
   Donovan M.J., 2015, VERAPTUS THERAPEUTIC
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faure-Perraud A, 2011, ANTIVIR THER, V16, P383, DOI 10.3851/IMP1756
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862
   Feng Hui, 2008, Virologica Sinica, V23, P315, DOI 10.1007/s12250-008-2979-y
   Feng XY, 2013, J INFECTION, V66, P366, DOI 10.1016/j.jinf.2012.10.029
   Feng ZD, 2007, J VIROL, V81, P182, DOI 10.1128/JVI.01006-06
   Fernandez-Soto P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003126
   Furqan M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-90
   Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI [10.1586/era.10.226, 10.1586/ERA.10.226]
   Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27
   Gijs M, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9020029
   Goncalves LS, 2013, ARCH ORAL BIOL, V58, P657, DOI 10.1016/j.archoralbio.2012.10.007
   Gonzalez VM, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040078
   Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2
   Gormally MV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6165
   Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231
   Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086
   He P, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0116-y
   Heiat M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.17632
   Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006
   Hori S, 2018, CANCERS, V10, DOI 10.3390/cancers10010009
   Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651
   Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186
   Imaz A, 2011, AIDS REV, V13, P180
   Janknegt RA, 1997, UROLOGY, V49, P411, DOI 10.1016/S0090-4295(96)00496-7
   Jasinski D, 2017, ACS NANO, V11, P1142, DOI 10.1021/acsnano.6b05737
   Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041
   Jing NJ, 2006, MOL CANCER THER, V5, P279, DOI 10.1158/1535-7163.MCT-05-0302
   Kim SJ, 2002, BIOCHEM BIOPH RES CO, V291, P925, DOI 10.1006/bbrc.2002.6521
   Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085
   Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009
   Kulbachinskiy AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1505, DOI 10.1134/S000629790713007X
   Kumar PKR, 2016, BIOSENSORS-BASEL, V6, DOI 10.3390/bios6030040
   Lakhin AV, 2013, ACTA NATURAE, V5, P34, DOI 10.32607/20758251-2013-5-4-34-43
   Lee CH, 2013, J VIROL, V87, P7064, DOI 10.1128/JVI.00405-13
   Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Leung Daisy W, 2010, Virulence, V1, P526, DOI 10.4161/viru.1.6.12984
   Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006
   Li YY, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12374
   Lin XN, 2018, J NANOSCI NANOTECHNO, V18, P2325, DOI 10.1166/jnn.2018.14379
   Liu M, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0311-4
   Locarnini S, 2007, ANTIVIR THER, V12, pH15
   Long YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24986
   Ma HT, 2015, CHEM SOC REV, V44, P1240, DOI 10.1039/c4cs00357h
   Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504
   Mencin N, 2014, J PHARMACEUT BIOMED, V91, P151, DOI 10.1016/j.jpba.2013.12.031
   Meng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033434
   Mescalchin A, 2011, MOLECULES, V16, P1271, DOI 10.3390/molecules16021271
   Mirian M, 2017, RES PHARM SCI, V12, P88, DOI 10.4103/1735-5362.202447
   Moghadam Saeed Reza Jamali, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P260, DOI 10.1016/S2221-1691(15)30341-5
   Mori M, 2015, CURR TOP MICROBIOL, V389, P53, DOI 10.1007/82_2015_433
   Mori N, 2006, J CLIN MICROBIOL, V44, P3268, DOI 10.1128/JCM.00803-06
   Morita Y, 2018, CANCERS, V10, DOI 10.3390/cancers10030080
   Mudiyanselage APKKK, 2018, J AM CHEM SOC, V140, P8739, DOI 10.1021/jacs.8b03956
   Muhlberger E, 2007, FUTURE VIROL, V2, P205, DOI 10.2217/17460794.2.2.205
   Musumeci D, 2017, CANCERS, V9, DOI 10.3390/cancers9120174
   Musumeci D, 2015, MOLECULES, V20, P17511, DOI 10.3390/molecules200917511
   Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856
   Nelson EV, 2016, J VIROL, V90, P7268, DOI 10.1128/JVI.00459-16
   Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955
   Ni SJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081683
   Nour Nawal M, 2010, Rev Obstet Gynecol, V3, P28
   Pan Q, 2018, J INFECTION, V77, P83, DOI 10.1016/j.jinf.2018.04.007
   Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262
   Pereira Ricardo L, 2018, Oncotarget, V9, P26934, DOI 10.18632/oncotarget.25260
   Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003
   Pi FM, 2018, NAT NANOTECHNOL, V13, P82, DOI 10.1038/s41565-017-0012-z
   Pi FM, 2017, NANOMED-NANOTECHNOL, V13, P1183, DOI 10.1016/j.nano.2016.11.015
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Platella C, 2017, BBA-GEN SUBJECTS, V1861, P1429, DOI 10.1016/j.bbagen.2016.11.027
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prakash JS, 2015, BIOMEDICINES, V3, P248, DOI 10.3390/biomedicines3030248
   Prasad VM, 2013, P NATL ACAD SCI USA, V110, P20105, DOI 10.1073/pnas.1316681110
   Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024
   Revello MG, 1997, J CLIN MICROBIOL, V35, P708, DOI 10.1128/JCM.35.3.708-713.1997
   Reyes-Reyes EM, 2015, MOL ONCOL, V9, P1392, DOI 10.1016/j.molonc.2015.03.012
   Romanucci V, 2016, ACS MED CHEM LETT, V7, P256, DOI 10.1021/acsmedchemlett.5b00408
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654
   Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071
   Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002
   Schwarz-Schilling M, 2018, NANO LETT, V18, P2650, DOI 10.1021/acs.nanolett.8b00526
   Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x
   Shu D, 2015, ACS NANO, V9, P9731, DOI 10.1021/acsnano.5b02471
   Shum KT, 2013, PHARMACEUTICALS, V6, P1507, DOI 10.3390/ph6121507
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Somasunderam A, 2005, BIOCHEMISTRY-US, V44, P10388, DOI 10.1021/bi0507074
   Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612
   Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001
   Sun HG, 2015, MOLECULES, V20, P11959, DOI 10.3390/molecules200711959
   Sypabekova M, 2017, TUBERCULOSIS, V104, P70, DOI 10.1016/j.tube.2017.03.004
   Szeto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082667
   Tai WY, 2010, J CONTROL RELEASE, V146, P264, DOI 10.1016/j.jconrel.2010.04.009
   Nyuyen TV, 2015, EBIOMEDICINE, V2, P59, DOI 10.1016/j.ebiom.2014.10.021
   Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006
   Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475
   Vinores SA, 2006, INT J NANOMED, V1, P263
   Virgilio A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25720-1
   Wahl-Jensen VM, 2005, J VIROL, V79, P10442, DOI 10.1128/JVI.79.16.10442-10450.2005
   Wandtke T, 2015, VIRUSES-BASEL, V7, P751, DOI 10.3390/v7020751
   Wang DN, 2011, J VIROL, V85, P6403, DOI 10.1128/JVI.02389-10
   Wang YJ, 2018, NUCLEIC ACIDS RES, V46, P8133, DOI 10.1093/nar/gky577
   White Sarah J, 2012, Clin Obstet Gynecol, V55, P550, DOI 10.1097/GRF.0b013e31824df256
   Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87
   Wu NY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-242
   Wu X, 2015, THERANOSTICS, V5, P322, DOI 10.7150/thno.10257
   Yadav R, 2010, FOOD ENVIRON VIROL, V2, P53, DOI 10.1007/s12560-010-9034-5
   Zaghloul MS, 2012, J EGYPT NATL CANCER, V24, P151, DOI 10.1016/j.jnci.2012.08.002
   Zhang YF, 2010, BIOANALYSIS, V2, P907, DOI 10.4155/BIO.10.46
   Zhang ZW, 2014, INT J MOL MED, V34, P1423, DOI 10.3892/ijmm.2014.1908
   Zhou HH, 2011, J BIOL CHEM, V286, P31676, DOI 10.1074/jbc.M111.235184
   Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185
   Zhou ZZ, 2018, ANAL BIOCHEM, V549, P91, DOI 10.1016/j.ab.2018.03.008
   Zimbres FM, 2013, BIOMED RES INT, DOI 10.1155/2013/731516
NR 148
TC 2
Z9 2
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD DEC
PY 2018
VL 11
IS 4
AR UNSP 93
DI 10.3390/ph11040093
PG 24
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HH3NN
UT WOS:000455626400004
PM 30274155
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez, JSV
AF Vargas Rodriguez, Juan Sebastian
TI The challenge given by Zika virus
SO FAMILY MEDICINE AND COMMUNITY HEALTH
LA English
DT Letter
ID TRANSMISSION; INFECTION
C1 [Vargas Rodriguez, Juan Sebastian] Simon Bolivar Univ, Invest Dept, Med Program, Barranquilla, Colombia.
RP Rodriguez, JSV (corresponding author), Simon Bolivar Univ, Invest Dept, Med Program, Barranquilla, Colombia.
EM vargassebastian152@gmail.com
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pierson TC, 2014, FIELDS VIROLOGY, P746
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
NR 10
TC 1
Z9 1
U1 0
U2 1
PU COMPUSCRIPT
PI SHANNON
PA BAY 11A, SHANNON INDUSTRIAL EST, SHANNON, CLARE 00000, IRELAND
SN 2009-8774
J9 FAM MED COMMUNITY HE
JI Fam. Med. Community Health
PD DEC 1
PY 2018
VL 6
IS 4
BP 208
EP 210
DI 10.15212/FMCH.2018.0117
PG 3
WC Primary Health Care
SC General & Internal Medicine
GA HH1EI
UT WOS:000455461600007
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ke, PY
AF Ke, Po-Yuan
TI The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE Flaviviridae; Autophagy; selective autophagy; Hepatitis C virus; Dengue
   virus; Japanese encephalitis virus; West Nile virus; Zika virus
ID HEPATITIS-C-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS;
   GUILLAIN-BARRE-SYNDROME; UNFOLDED PROTEIN RESPONSE;
   HERPES-SIMPLEX-VIRUS; HUMAN DENDRITIC CELLS; B TYPE-I; DENGUE-VIRUS;
   ZIKA VIRUS
AB Autophagy is an evolutionarily conserved cellular process in which intracellular components are eliminated via lysosomal degradation to supply nutrients for organelle biogenesis and metabolic homeostasis. Flavivirus infections underlie multiple human diseases and thus exert an immense burden on public health worldwide. Mounting evidence indicates that host autophagy is subverted to modulate the life cycles of flaviviruses, such as hepatitis C virus, dengue virus, Japanese encephalitis virus, West Nile virus and Zika virus. The diverse interplay between autophagy and flavivirus infection not only regulates viral growth in host cells but also counteracts host stress responses induced by viral infection. In this review, we summarize the current knowledge on the role of autophagy in the flavivirus life cycle. We also discuss the impacts of virus-induced autophagy on the pathogeneses of flavivirus-associated diseases and the potential use of autophagy as a therapeutic target for curing flavivirus infections and related human diseases.
C1 [Ke, Po-Yuan] Chang Gung Univ, Dept Biochem & Mol Biol, Coll Med, Taoyuan 33302, Taiwan.
   [Ke, Po-Yuan] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 33302, Taiwan.
   [Ke, Po-Yuan] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan 33305, Taiwan.
   [Ke, Po-Yuan] Chang Gung Mem Hosp, Div Allergy Immunol & Rheumatol, Taoyuan 33305, Taiwan.
RP Ke, PY (corresponding author), Chang Gung Univ, Dept Biochem & Mol Biol, Coll Med, Taoyuan 33302, Taiwan.; Ke, PY (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 33302, Taiwan.; Ke, PY (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan 33305, Taiwan.; Ke, PY (corresponding author), Chang Gung Mem Hosp, Div Allergy Immunol & Rheumatol, Taoyuan 33305, Taiwan.
EM pyke0324@mail.cgu.edu.tw
OI Ke, Po-Yuan/0000-0002-0471-0806
FU Ministry of Science and Technology, Taipei [MOST 102-2320-B-182-037-MY3,
   MOST 105-2628-B-182-001-MY3]; Chang Gung Memorial Hospital, Taoyuan,
   TaiwanChang Gung Memorial Hospital [CMRPD1C0211, CMRPD1D0021,
   CMRPD1D0022, CMRPD1D0023, CMRPD1G0281, CRRPD1F0031, CMRPG3F0571];
   National Health Research Institute, MiaoliNational Health Research
   Institutes - Taiwan [NHRI-EX103-10322SC, NHRI-EX104-10322SC,
   NHRI-EX105-10322SC, NHRI-EX106-10322SC]
FX This study was supported by research grants from the Ministry of Science
   and Technology (MOST 102-2320-B-182-037-MY3 and MOST
   105-2628-B-182-001-MY3), Taipei, National Health Research Institute
   (NHRI-EX103-10322SC, NHRI-EX104-10322SC, NHRI-EX105-10322SC and
   NHRI-EX106-10322SC), Miaoli and Chang Gung Memorial Hospital
   (CMRPD1C0211, CMRPD1D0021, CMRPD1D0022, CMRPD1D0023, CMRPD1G0281,
   CRRPD1F0031 and CMRPG3F0571), Taoyuan, Taiwan.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abdellatif M, 2018, CIRC RES, V123, P803, DOI 10.1161/CIRCRESAHA.118.312208
   Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104
   Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595
   Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833
   An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x
   Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016
   Andoh T, 1998, J NEUROVIROL, V4, P627, DOI 10.3109/13550289809114229
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137
   Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004
   Bandiera S, 2016, CURR OPIN VIROL, V20, P99, DOI 10.1016/j.coviro.2016.09.010
   Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155
   Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046
   Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200
   Baumert TF, 2019, GASTROENTEROLOGY, V156, P431, DOI 10.1053/j.gastro.2018.10.024
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016
   Bellelli R, 2016, CELL REP, V14, P411, DOI 10.1016/j.celrep.2015.12.065
   Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09
   Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418
   Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128
   BLANKSON H, 1995, EXP CELL RES, V218, P522, DOI 10.1006/excr.1995.1187
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Boland B, 2018, NAT REV DRUG DISCOV, V17, P660, DOI 10.1038/nrd.2018.109
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   BURCH GE, 1979, EXP MOL PATHOL, V31, P23, DOI 10.1016/0014-4800(79)90004-2
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Canete R, 2010, W INDIAN MED J, V59, P607
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424
   Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036
   Chan ST, 2016, J VIROL, V90, P10928, DOI 10.1128/JVI.01365-16
   Charles ED, 2009, KIDNEY INT, V76, P818, DOI 10.1038/ki.2009.247
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x
   Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chiou SS, 2005, J MED VIROL, V76, P583, DOI 10.1002/jmv.20406
   Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076
   Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406
   Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Chu LW, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.011018
   Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551
   Chuang CK, 2015, J GEN VIROL, V96, P793, DOI 10.1099/jgv.0.000015
   CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349
   Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226
   Clement S, 2009, VIRUSES-BASEL, V1, P126, DOI 10.3390/v1020126
   Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251
   Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001
   Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819
   Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016
   Diagana M, 2007, J NEUROL SCI, V262, P165, DOI 10.1016/j.jns.2007.06.041
   Diamond MS, 2018, NAT REV IMMUNOL, V18, P89, DOI 10.1038/nri.2017.132
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147
   DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1002/hep.1840140603
   DIBISCEGLIE AM, 1991, AM J GASTROENTEROL, V86, P335
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Doherty J, 2018, NAT CELL BIOL, V20, P1110, DOI 10.1038/s41556-018-0201-5
   Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   El-Serag HB, 2016, HEPATOLOGY, V64, P130, DOI 10.1002/hep.28535
   Ellul MA, 2016, J ROY COLL PHYS EDIN, V46, P103, DOI 10.4997/JRCPE.2016.209
   Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185
   Estrabaud E, 2011, J HEPATOL, V55, P1150, DOI 10.1016/j.jhep.2011.04.025
   Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fan WC, 2017, RES VET SCI, V111, P67, DOI 10.1016/j.rvsc.2016.12.007
   Fang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110655
   Feinstone SM, 2001, REV MED VIROL, V11, P3, DOI 10.1002/rmv.304
   Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168
   FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402
   Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0
   Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007
   FINE DL, 1970, J VIROL, V5, P226, DOI 10.1128/JVI.5.2.226-229.1970
   Fracchiolla D, 2017, AUTOPHAGY, V13, P978, DOI 10.1080/15548627.2016.1277311
   Fracchiolla D, 2016, ELIFE, V5, DOI 10.7554/eLife.18544
   Francis T, 1940, J EXP MED, V72, P717, DOI 10.1084/jem.72.6.717
   Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007
   Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697
   Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22
   Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006
   Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139
   Gao F, 2010, BIOCHEM BIOPH RES CO, V391, P952, DOI 10.1016/j.bbrc.2009.11.172
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z
   Gigi E, 2018, WORLD J HEPATOL, V10, P595, DOI 10.4254/wjh.v10.i9.595
   Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009
   GORDON PB, 1987, BIOCHIM BIOPHYS ACTA, V929, P128, DOI 10.1016/0167-4889(87)90167-4
   GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6
   Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003
   Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256
   Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422
   Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555
   Guarino M, 2018, WORLD J GASTROENTERO, V24, P2582, DOI 10.3748/wjg.v24.i24.2582
   Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032
   Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230
   Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hara Y, 2014, AM J PATHOL, V184, P3026, DOI 10.1016/j.ajpath.2014.07.024
   HARB JM, 1975, BEITR PATHOL, V156, P122
   Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621
   Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200
   Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07
   Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836
   Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8
   Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016
   Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z
   HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823
   HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633
   Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227
   Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703
   HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1
   Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366
   HOURI JJ, 1995, BIOCHEM J, V309, P521, DOI 10.1042/bj3090521
   Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791
   Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111
   Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003
   Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031
   Ioannou GN, 2018, J HEPATOL, V68, P25, DOI 10.1016/j.jhep.2017.08.030
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Ishimura R, 2014, FEBS LETT, V588, P822, DOI 10.1016/j.febslet.2014.01.045
   Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709
   Jackson WT, 2015, VIROLOGY, V479, P450, DOI 10.1016/j.virol.2015.03.042
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Jacomin AC, 2016, AUTOPHAGY, V12, P1945, DOI 10.1080/15548627.2016.1207016
   Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370
   Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131
   Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104
   Kanwal F, 2017, GASTROENTEROLOGY, V153, P996, DOI 10.1053/j.gastro.2017.06.012
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6
   Kaushik S, 2016, AUTOPHAGY, V12, P432, DOI 10.1080/15548627.2015.1124226
   Ke PY, 2011, AUTOPHAGY, V7, P533, DOI 10.4161/auto.7.5.14732
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Khambu B, 2018, SEMIN LIVER DIS, V38, P308, DOI 10.1055/s-0038-1669939
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Kim JY, 2018, J VIROL, V92, DOI 10.1128/JVI.00211-18
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Kim JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124318
   Kim JH, 2017, J VIROL, V91, DOI 10.1128/JVI.01206-16
   Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35
   Kim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10631
   Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105
   Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111
   Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811
   Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005
   Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026
   Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020
   Klionsky DJ, 2008, AUTOPHAGY, V4, P740, DOI 10.4161/auto.6398
   Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661
   Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244
   Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X
   Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129
   Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016
   Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kriegenburg F, 2018, CURR BIOL, V28, pR512, DOI 10.1016/j.cub.2018.02.034
   Kroemer G, 2015, J CLIN INVEST, V125, P1, DOI 10.1172/JCI78652
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Kurt R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125962
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696
   Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   LEWIS L, 1947, ARCH NEURO PSYCHIATR, V57, P430, DOI 10.1001/archneurpsyc.1947.02300270048004
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Liu CH, 2015, INT J CLIN EXP MED, V8, P15787
   Liu H, 2004, J MED VIROL, V72, P618, DOI 10.1002/jmv.20025
   Liu K, 2017, J VIROL, V91, DOI [10.1128/jvi.01348-16, 10.1128/JVI.01348-16]
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Llovet JM, 2016, NAT REV GASTRO HEPAT, V13, P561, DOI 10.1038/nrgastro.2016.140
   Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048
   Luo Huanle, 2018, F1000Res, V7, P338, DOI 10.12688/f1000research.13362.1
   Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171
   Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005
   Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308
   Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148
   Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6
   Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014
   Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   Masmejan S, 2018, EXPERT REV ANTI-INFE, V16, P471, DOI 10.1080/14787210.2018.1483239
   Mason CP, 2015, MOLECULES, V20, P2229, DOI 10.3390/molecules20022229
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Matsui C, 2018, J VIROL, V92, DOI 10.1128/JVI.00639-18
   Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179
   Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141
   Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846
   Maximova OA, 2018, ANNU REV VIROL, V5, P255, DOI 10.1146/annurev-virology-092917-043439
   McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006
   McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Meijer AJ, 1995, BIOCHEM J, V312, P987, DOI 10.1042/bj3120987
   Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x
   Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022
   Mercer TJ, 2018, J BIOL CHEM, V293, P5386, DOI 10.1074/jbc.R117.810366
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9
   Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506
   Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889
   Mizushima N, 2018, NAT CELL BIOL, V20, P521, DOI 10.1038/s41556-018-0092-5
   Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005
   Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004
   Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506
   Mohl BP, 2012, J VIROL, V86, P10724, DOI 10.1128/JVI.01667-12
   Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645
   Mori H, 2018, J GEN VIROL, V99, P1643, DOI 10.1099/jgv.0.001161
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mortimore G E, 1976, Front Biol, V45, P157
   MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0
   Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151
   Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   Nain M, 2016, REV MED VIROL, V26, P129, DOI 10.1002/rmv.1868
   Nakamura S, 2017, J CELL SCI, V130, P1209, DOI 10.1242/jcs.196352
   Nakashima A, 2006, VIROLOGY, V349, P254, DOI 10.1016/j.virol.2006.03.029
   Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   NII S, 1976, BIKEN J, V19, P53
   NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   NOVIKOFF AB, 1959, J BIOPHYS BIOCHEM CY, V6, P136, DOI 10.1083/jcb.6.1.136
   NOVIKOFF AB, 1962, J CELL BIOL, V15, P140, DOI 10.1083/jcb.15.1.140
   NOVIKOFF AB, 1962, FED PROC, V21, P1130
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13
   Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054
   Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172
   Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128
   Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130
   Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007
   Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904
   Pankiv S, 2010, AUTOPHAGY, V6, P550, DOI 10.4161/auto.6.4.11670
   Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010
   Panyasrivanit M, 2009, AUTOPHAGY, V5, P434, DOI 10.4161/auto.5.3.7925
   Park JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060333
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13
   Paul P, 2016, ADV VIRUS RES, V95, P149, DOI 10.1016/bs.aivir.2016.02.002
   Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   PFEIFER U, 1977, ACTA BIOL MED GER, V36, P1691
   PFEIFER U, 1981, J MOL CELL CARDIOL, V13, P37, DOI 10.1016/0022-2828(81)90227-3
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938
   Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015
   PLOMP PJAM, 1987, EUR J BIOCHEM, V164, P197, DOI 10.1111/j.1432-1033.1987.tb11011.x
   Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684
   Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003
   Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200
   Puri C, 2018, DEV CELL, V45, P114, DOI 10.1016/j.devcel.2018.03.008
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Quan M, 2014, J VIRAL HEPATITIS, V21, P405, DOI 10.1111/jvh.12155
   Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005
   Ran MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0845-x
   Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078
   Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840
   Reggiori F, 2017, J MOL BIOL, V429, P486, DOI 10.1016/j.jmb.2017.01.002
   Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008
   Ren HM, 2016, J VIROL, V90, P5989, DOI 10.1128/JVI.00551-16
   Ren J, 2018, TRENDS ENDOCRIN MET, V29, P699, DOI 10.1016/j.tem.2018.08.001
   Rey-Jurado E, 2015, FEBS LETT, V589, P3461, DOI 10.1016/j.febslet.2015.07.047
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Robinson M, 2018, CELL MOL LIFE SCI, V75, P3693, DOI 10.1007/s00018-018-2882-0
   Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014
   Rogov VV, 2017, EMBO REP, V18, P1382, DOI 10.15252/embr.201643587
   Roingeard P, 2013, J VIRAL HEPATITIS, V20, P77, DOI 10.1111/jvh.12035
   Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581
   Saito T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12030
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sargent G, 2016, J CELL BIOL, V214, P677, DOI 10.1083/jcb.201511034
   Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529
   Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R
   Schaefer EAK, 2011, SEMIN LIVER DIS, V31, P375, DOI 10.1055/s-0031-1297926
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996
   Schlumpberger M, 1997, J BACTERIOL, V179, P1068, DOI 10.1128/jb.179.4.1068-1076.1997
   Schuh AJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002411
   Schwarz AK, 2009, J VIROL, V83, P12407, DOI 10.1128/JVI.01552-09
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004
   Sharma M, 2018, BIOCHEM BIOPH RES CO, V502, P232, DOI 10.1016/j.bbrc.2018.05.149
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Sharma NR, 2011, J BIOL CHEM, V286, P30361, DOI 10.1074/jbc.M111.263350
   Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7
   Shibata M, 2010, BIOCHEM BIOPH RES CO, V393, P274, DOI 10.1016/j.bbrc.2010.01.121
   Shibata M, 2009, BIOCHEM BIOPH RES CO, V382, P419, DOI 10.1016/j.bbrc.2009.03.039
   Shibata M, 2013, PLANT CELL, V25, P4967, DOI 10.1105/tpc.113.116947
   Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159
   Shinohara Y, 2013, BIOCHEM BIOPH RES CO, V432, P326, DOI 10.1016/j.bbrc.2013.01.103
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15
   Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12
   Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Farias KJS, 2013, SCI WORLD J, DOI 10.1155/2013/282734
   Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287
   Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   SMITH JD, 1978, J VIROL, V26, P102, DOI 10.1128/JVI.26.1.102-109.1978
   Sorbo MC, 2018, DRUG RESIST UPDATE, V37, P17, DOI 10.1016/j.drup.2018.01.004
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979
   Straub M, 1997, J BACTERIOL, V179, P3875, DOI 10.1128/jb.179.12.3875-3883.1997
   Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986
   Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11
   Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000
   Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971
   Suzuki T, 2011, MICROBIOL IMMUNOL, V55, P12, DOI 10.1111/j.1348-0421.2010.00274.x
   Syed GH, 2014, J VIROL, V88, P2519, DOI 10.1128/JVI.02727-13
   Taguwa S, 2011, J VIROL, V85, P13185, DOI 10.1128/JVI.06099-11
   Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211
   TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301
   Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299
   Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176
   Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128
   Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243
   Tasaki T, 2016, MICROBIOL IMMUNOL, V60, P708, DOI 10.1111/1348-0421.12440
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237
   Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004
   Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006
   TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185
   Uno N, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0168-0
   Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937
   Valenzuela JG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006365
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785
   Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008
   Vescovo T, 2012, GASTROENTEROLOGY, V142, P644, DOI 10.1053/j.gastro.2011.11.033
   Vicenzi E, 2018, BIOCHEM SOC T, V46, P609, DOI [10.1042/BST20170399, 10.1042/bst20170399]
   Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311
   Viret C, 2018, J MOL BIOL, V430, P1696, DOI 10.1016/j.jmb.2018.04.018
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Wang LY, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006609
   Wang XJ, 2015, VET MICROBIOL, V178, P217, DOI 10.1016/j.vetmic.2015.05.026
   Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012
   Wichit S, 2011, MICROBIOL IMMUNOL, V55, P135, DOI 10.1111/j.1348-0421.2010.00293.x
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405
   Wiwanitkit V, 2016, ARQ NEURO-PSIQUIAT, V74, P692, DOI 10.1590/0004-282X20160089
   Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501
   Wu XF, 2014, J VIROL, V88, P8433, DOI 10.1128/JVI.00081-14
   Wu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32243
   Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663
   Xiao B, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.463
   Xiao B, 2017, J BIOL CHEM, V292, P16697, DOI 10.1074/jbc.M117.787739
   Xu QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45375
   Xu Y, 2015, J VIROL, V89, P3846, DOI 10.1128/JVI.03647-14
   Yang JY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3428
   Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762
   Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
   Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075
   Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180
   Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838
   Yu SL, 2017, CURR OPIN CELL BIOL, V47, P92, DOI 10.1016/j.ceb.2017.03.010
   Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100
   Yun SI, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030068
   Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004
   Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
   Zhang MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02176
   Zhang YM, 2018, NAT REV ENDOCRINOL, V14, P356, DOI 10.1038/s41574-018-0009-1
   Zhao Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11105-3
   Zhao YG, 2018, CURR OPIN CELL BIOL, V53, P29, DOI 10.1016/j.ceb.2018.04.003
   Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
   Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0
   Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006
NR 514
TC 11
Z9 11
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2018
VL 19
IS 12
AR 3940
DI 10.3390/ijms19123940
PG 62
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HG9JM
UT WOS:000455323500242
PM 30544615
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Krauss, A
AF Krauss, Amy
TI Zika: From the Brazilian Backlands to Global Threat.
SO LUSO-BRAZILIAN REVIEW
LA English
DT Book Review
C1 [Krauss, Amy] Princeton Univ, Princeton, NJ 08544 USA.
RP Krauss, A (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.
EM akrauss@princeton.edu
CR Diniz D., 2017, ZIKA BRAZILIAN BACKL
NR 1
TC 0
Z9 0
U1 0
U2 0
PU UNIV WISCONSIN PRESS
PI MADISON
PA JOURNAL DIVISION, 1930 MONROE ST, 3RD FL, MADISON, WI 53711 USA
SN 0024-7413
EI 1548-9957
J9 LUSO-BRAZ REV
JI Luso-Braz. Rev.
PD DEC 1
PY 2018
VL 55
IS 2
SI SI
BP E13
EP E15
DI 10.3368/lbr.55.2.E13
PG 3
WC Humanities, Multidisciplinary
SC Arts & Humanities - Other Topics
GA HH1RW
UT WOS:000455498400005
DA 2020-07-08
ER

PT J
AU Ghaffar, KA
   Ng, LFP
   Renia, L
AF Ghaffar, Khairunnisa Abdul
   Ng, Lisa F. P.
   Renia, Laurent
TI Fast Tracks and Roadblocks for Zika Vaccines
SO VACCINES
LA English
DT Review
DE Zika virus; vaccine; immune responses; delivery systems
ID NEUTRALIZING IMMUNE-RESPONSES; DNA VACCINE; PROTECTIVE EFFICACY;
   VIRUS-VACCINE; IMMUNOGENICITY; ANTIBODIES; INFECTION; DENGUE; BRAZIL
AB In early 2014, a relatively obscure virus, the Zika virus, made headlines worldwide following an increase in the number of congenital malformations. Since then, research on Zika virus, treatment and vaccines have progressed swiftly with various drugs being repurposed and vaccines heading into clinical trials. Nonetheless, the need for a vaccine is crucial in order to eradicate this re-emerging arthropod-borne virus which remained silent since its first discovery in 1947. In this review, we focused on how the inconspicuous virus managed to spread, the key immunological factors required for a vaccine and the various vaccine platforms that are currently being studied.
C1 [Ghaffar, Khairunnisa Abdul; Ng, Lisa F. P.; Renia, Laurent] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
RP Renia, L (corresponding author), ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.
EM khairunnisa_ghaffar@immunol.a-star.edu.sg;
   lisa_ng@immunol.a-star.edu.sg; renia_laurent@immunol.a-star.edu.sg
FU BMRC A*STAR-led Zika Virus Consortium Fund, A*STAR, SingaporeAgency for
   Science Technology & Research (ASTAR) [15/1/82/27/001]
FX This work was supported by core research grants provided to the
   Singapore Immunology Network (SIgN) and by the BMRC A*STAR-led Zika
   Virus Consortium Fund (project number 15/1/82/27/001), A*STAR,
   Singapore.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aberle JH, 2018, J CLIN VIROL, V108, P126, DOI 10.1016/j.jcv.2018.09.020
   Albrecht MT, 2012, FEMS IMMUNOL MED MIC, V65, P505, DOI 10.1111/j.1574-695X.2012.00974.x
   Alves MP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110593
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bonaldo MC, 2014, HUM VACC IMMUNOTHER, V10, P1256, DOI 10.4161/hv.28117
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Burgess DJ, 2012, NAT REV MOL CELL BIO, V13, P65, DOI 10.1038/nrm3271
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Cheng PC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004459
   Cherif MS, 2011, VACCINE, V29, P9038, DOI 10.1016/j.vaccine.2011.09.031
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   Devillers J, 2018, SAR QSAR ENVIRON RES, V29, P103, DOI 10.1080/1062936X.2017.1411642
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hanley Kathryn A, 2011, Evolution (N Y), V4, P635
   Janeway Jr CA, 2001, IMMUNOBIOLOGY IMMUNE
   Khan F.A., 2009, ELEMENTS IMMUNOLOGY, P343
   Khan Kishwar Hayat, 2013, Germs, V3, P26, DOI 10.11599/germs.2013.1034
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Li XM, 2012, CLIN VACCINE IMMUNOL, V19, P723, DOI 10.1128/CVI.05700-11
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lundstrom K, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0151
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martins P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26508-z
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nascimento IP, 2012, BRAZ J MED BIOL RES, V45, P1102, DOI 10.1590/S0100-879X2012007500142
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630
   Plitnick L.M., 2013, NONCLINICAL DEV NOVE, P225
   Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Touret F, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0161-7
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang R, 2018, VACCINE, V36, P3522, DOI 10.1016/j.vaccine.2018.04.051
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhu XL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0572-7
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 85
TC 3
Z9 3
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2018
VL 6
IS 4
AR 77
DI 10.3390/vaccines6040077
PG 18
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HG9FH
UT WOS:000455312000012
PM 30469444
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, GY
   Teleki, C
   Wang, T
AF Li, Guangyu
   Teleki, Cody
   Wang, Tian
TI Memory T Cells in Flavivirus Vaccination
SO VACCINES
LA English
DT Review
DE flavivirus; memory T cells; vaccine
ID JAPANESE ENCEPHALITIS-VIRUS; TETRAVALENT DENGUE VACCINE; TICK-BORNE
   ENCEPHALITIS; YELLOW-FEVER; IMMUNE-RESPONSES; PROTECTIVE EFFICACY;
   INFECTION; ANTIBODY; 17D; IMMUNIZATION
AB Flaviviruses include many medically important viruses, such as Dengue virus (DENV), Japanese encephalitis (JEV), tick-borne encephalitis (TBEV), West Nile (WNV), yellow fever (YFV), and Zika viruses (ZIKV). Currently, there are licensed human vaccines for DENV, JEV, TBEV and YFV, but not for WNV or ZIKV. Memory T cells play a central role in adaptive immunity and are important for host protection during flavivirus infection. In this review, we discuss recent findings from animal models and clinical trials and provide new insights into the role of memory T cells in host protective immunity upon vaccination with the licensed flavivirus vaccines.
C1 [Li, Guangyu; Teleki, Cody; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Wang, Tian] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Wang, Tian] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
RP Wang, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Wang, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Wang, T (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Wang, T (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
EM guli@UTMB.EDU; ccteleki@UTMB.EDU; ti1wang@utmb.edu
OI Li, Guangyu/0000-0002-7768-5584; Teleki, Cody/0000-0002-5922-1268
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI099123, R01AI127744]; Sealy
   Institute for Vaccine Sciences at UTMB; NIAID T35 training grant
   [AI078878]
FX This work was supported in part by NIH grant R01 AI099123 (T.W.),
   R01AI127744 (T.W.) and a grant from Sealy Institute for Vaccine Sciences
   at UTMB (T.W.). C.T. was a recipient of a summer internship from NIAID
   T35 training grant (AI078878, PI: L Soong).
CR Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Aguilar-Valenzuela R, 2018, J VIROL, V92, DOI [10.1128/JVI.00014-18, 10.1128/jvi.00014-18]
   AKBAR AN, 1988, J IMMUNOL, V140, P2171
   Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633
   Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Aktepe TE, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12884
   Andersen MH, 2006, J INVEST DERMATOL, V126, P32, DOI 10.1038/sj.jid.5700001
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Bassi MR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004464
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Beran J, 2019, VACCINE, V37, P4623, DOI 10.1016/j.vaccine.2017.12.081
   Blom K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004622
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   Chu HY, 2015, J INFECT DIS, V212, P1618, DOI 10.1093/infdis/jiv258
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Feroldi E, 2017, J INFECT DIS, V215, P221, DOI 10.1093/infdis/jiw533
   Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grifoni A, 2017, J VIROL, V91, DOI 10.1128/JVI.02133-16
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   Hopf S, 2016, VACCINE, V34, P2027, DOI 10.1016/j.vaccine.2015.12.057
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]
   Kongsgaard M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00798-1
   Kreil TR, 1998, VACCINE, V16, P1083, DOI 10.1016/S0264-410X(98)80102-3
   Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078
   Lam JH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94500
   Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10
   Lee EY, 2016, MICROBIOL IMMUNOL, V60, P846, DOI 10.1111/1348-0421.12458
   Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004
   Li JQ, 2013, VACCINE, V31, P4136, DOI 10.1016/j.vaccine.2013.06.099
   Lindenbach B.D., 2013, FLAVIVIRIDAE
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Marusina AI, 2017, J AUTOIMMUN, V77, P76, DOI 10.1016/j.jaut.2016.11.001
   MATHEWS JH, 1992, J VIROL, V66, P6555, DOI 10.1128/JVI.66.11.6555-6562.1992
   Michlmayr D, 2016, J IMMUNOL, V196, P4622, DOI 10.4049/jimmunol.1502452
   Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Neves PCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081953
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Omilusik KD, 2017, NATURE, V552, DOI 10.1038/d41586-017-08280-8
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412
   Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14
   SHARMA S, 1991, CLIN EXP IMMUNOL, V85, P85, DOI 10.1111/j.1365-2249.1991.tb05687.x
   Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Smit R, 2015, EXPERT REV VACCINES, V14, P737, DOI 10.1586/14760584.2015.985661
   Sohn YM, 2008, VACCINE, V26, P1638, DOI 10.1016/j.vaccine.2008.01.021
   Sun PF, 2018, METHODS MOL BIOL, V1808, P187, DOI 10.1007/978-1-4939-8567-8_17
   Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5
   Torresi J, 2017, HUM VACC IMMUNOTHER, V13, P1059, DOI 10.1080/21645515.2016.1261770
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Waggoner JJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00827-18
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34
   White JT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11291
   Wieten RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149871
   Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yoshii K, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.69
   Zhang WJ, 2013, J VIROL METHODS, V187, P304, DOI 10.1016/j.jviromet.2012.10.002
NR 82
TC 4
Z9 4
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2018
VL 6
IS 4
AR 73
DI 10.3390/vaccines6040073
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HG9FH
UT WOS:000455312000008
PM 30340377
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roberts, CC
   Maslow, JN
AF Roberts, Christine C.
   Maslow, Joel N.
TI Assay Challenges for Emerging Infectious Diseases: The Zika Experience
SO VACCINES
LA English
DT Review
DE emerging infectious disease; vaccines; immune response; virus detection;
   zika virus; flaviviruses; clinical trials
ID REVERSE TRANSCRIPTION-PCR; DNA VACCINE; HEALTHY-ADULTS; VIRUS OUTBREAK;
   NEUTRALIZING ANTIBODY; PROLONGED DETECTION; DENGUE; TRANSMISSION;
   CHIKUNGUNYA; PHASE-1
AB From the perspective of vaccine development, it is imperative to accurately diagnose target infections in order to exclude subjects with prior exposure from evaluations of vaccine effectiveness, to track incident infection during the course of a clinical trial and to differentiate immune reactions due to natural infections from responses that are vaccine related. When vaccine development is accelerated to a rapid pace in response to emerging infectious disease threats, the challenges to develop such diagnostic tools is even greater. This was observed through the recent expansion of Zika virus infections into the Western Hemisphere in 2014-2017. When initial Zika vaccine clinical trials were being designed and launched in response to the outbreak, there were no standardized sets of viral and immunological assays, and no approved diagnostic tests for Zika virus infection. The diagnosis of Zika virus infection is still an area of active research and development on many fronts. Here we review emerging infectious disease vaccine clinical assay development and trial execution with a special focus on the state of Zika virus clinical assays and diagnostics.
C1 [Roberts, Christine C.; Maslow, Joel N.] GeneOne Life Sci Inc, Seoul 60606, South Korea.
RP Roberts, CC (corresponding author), GeneOne Life Sci Inc, Seoul 60606, South Korea.
EM croberts@geneonels-us.com; jmaslow@geneonels-us.com
OI Roberts, Christine/0000-0003-4359-7946; Maslow, Joel/0000-0003-0305-5608
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   CDC U, 2017, INT NUCL AC IMM TEST
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FDA, FDA PROV NEW TOOLS D
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hobson-Peters J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/379738
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Kudchodkar SB, 2018, MICROBES INFECT, V20, P676, DOI 10.1016/j.micinf.2018.03.001
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   LI HB, 2017, FRONT MICROBIOL, V8, DOI DOI 10.3389/FMICB.2017.02677
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Madore DV, 2010, VACCINE, V28, P4539, DOI 10.1016/j.vaccine.2010.04.094
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Maslow JN, 2017, HUM VACC IMMUNOTHER, V13, P2918, DOI 10.1080/21645515.2017.1358325
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Organization W. H, COLL STUD EV CAND WH
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Ramanathan MP, 2009, VACCINE, V27, P6444, DOI 10.1016/j.vaccine.2009.06.061
   Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   WHO, WHO EM US LIST PROC
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Yang JS, 2001, J INFECT DIS, V184, P809, DOI 10.1086/323395
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 94
TC 1
Z9 1
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2018
VL 6
IS 4
AR 70
DI 10.3390/vaccines6040070
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HG9FH
UT WOS:000455312000005
PM 30279372
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schwartz, DA
AF Schwartz, David A.
TI Clinical Trials and Administration of Zika Virus Vaccine in Pregnant
   Women: Lessons (that Should Have Been) Learned from Excluding
   Immunization with the Ebola Vaccine during Pregnancy and Lactation
SO VACCINES
LA English
DT Article
DE Zika virus; vaccine; Zika vaccine; congenital Zika syndrome; pregnancy;
   Ebola virus; Ebola vaccine; women's rights; clinical trials; epidemic;
   vaccination; congenital infections; exclusion pregnant women
ID ANTIBODY-DEPENDENT ENHANCEMENT; PLACENTAL PATHOLOGY; VIRAL-INFECTION;
   INFANTS; DISEASE; PROLIFERATION; CHILDREN; FETUSES; DRUGS; BORN
AB As evidenced from recent epidemics, both Ebola and Zika virus infection are potentially catastrophic when occurring in pregnant women. Ebola virus causes extremely high rates of mortality in both mothers and infants; Zika virus is a TORCH infection that produces a congenital malformation syndrome and pediatric neurodevelopmental abnormalities. Production of efficacious vaccines has been a public health priority for both infections. Unfortunately, during the clinical trials and subsequent deployment of a vaccine for the Ebola virus, pregnant and lactating women were, and continue to be, excluded from receiving the life-saving vaccine. The most serious consequence of Zika virus infection, congenital Zika syndrome, results from fetal infection during pregnancy. Thus, pregnant women have a major stake in the ongoing development of a vaccine for Zika virus. The exclusion of pregnant women from the development, clinical trials and administration of a potential Zika vaccine unfairly deprives them and their infants of the protection they need against this potentially catastrophic intrauterine infection. When creating policy about these issues, it is important to critically evaluate vaccine safety in pregnancy in the context of the substantial risk of infection for the pregnant woman and her fetus in the absence of immunization.
C1 [Schwartz, David A.] Augusta Univ, Med Coll Georgia, Augusta, GA 30912 USA.
RP Schwartz, DA (corresponding author), Augusta Univ, Med Coll Georgia, Augusta, GA 30912 USA.
EM davidalanschwartz@gmail.com
RI amsalu, ribka/G-8780-2019
OI Schwartz, David/0000-0002-7486-8545
CR Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318
   Alholm A., 2017, OPEN FORUM INFECT DI, V4, pS458, DOI [10.1093/ofid/ofx163.1167, DOI 10.1093/OFID/OFX163.1167]
   Alirol E, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0201-1
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   [Anonymous], 2018, NEW EBOLA OUTBREAK D
   [Anonymous], 2016, ZIKA GUILLAIN BARRE
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bello O O, 2016, Case Rep Obstet Gynecol, V2016, P9673683, DOI 10.1155/2016/9673683
   Breman JG, 2016, J INFECT DIS, V214, pS93, DOI 10.1093/infdis/jiw207
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Caluwaerts S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0429-8
   Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS713, DOI 10.1093/infdis/jir489
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faucette AN, 2015, HUM VACC IMMUNOTHER, V11, P2549, DOI 10.1080/21645515.2015.1070984
   Faucette AN, 2015, HUM REPROD UPDATE, V21, P119, DOI 10.1093/humupd/dmu041
   Goldfarb I, 2018, OBSTET GYNECOL, V131, p111S, DOI 10.1097/01.AOG.0000533473.70546.80
   Gomes MF, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0430-2
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Macklin R, 2010, LANCET, V375, P632, DOI 10.1016/S0140-6736(10)60257-7
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   MERKATZ RB, 1993, NEW ENGL J MED, V329, P292, DOI 10.1056/NEJM199307223290429
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Morelli SS, 2015, RES REP BIOL, V6, P171, DOI 10.2147/RRB.S80652
   Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048
   Ouandaogo CR, 2012, VACCINE, V30, pB46, DOI 10.1016/j.vaccine.2011.12.112
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Republique Democratique du Congo, 2018, SIT EP PROV NORD KIV
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Ryan MAK, 2008, AM J EPIDEMIOL, V168, P434, DOI 10.1093/aje/kwn159
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schwartz D.A., 2018, FAMILY PLANNING
   Schwartz D.A., 2018, P 2 INT C ZIK VIR AE
   Schwartz D.A., 2019, PREGNANT TIME EBOLA
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Shields KE, 2013, OBSTET GYNECOL, V122, P1077, DOI 10.1097/AOG.0b013e3182a9ca67
   Siedner MJ, 2018, LANCET PUBLIC HEALTH, V3, pE109, DOI 10.1016/S2468-2667(18)30029-X
   SMITHELLS RW, 1978, ARCH DIS CHILD, V53, P93, DOI 10.1136/adc.53.2.93
   Strong A., 2019, PREGNANT TIME EBOLA
   Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
   Zheteyeva YA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.006
NR 51
TC 4
Z9 4
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD DEC
PY 2018
VL 6
IS 4
AR 81
DI 10.3390/vaccines6040081
PG 16
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HG9FH
UT WOS:000455312000016
PM 30518082
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Magalhaes, T
   Robison, A
   Young, MC
   Black, WC
   Foy, BD
   Ebel, GD
   Ruckert, C
AF Magalhaes, Tereza
   Robison, Alexis
   Young, Michael C.
   Black, William C.
   Foy, Brian D.
   Ebel, Gregory D.
   Ruckert, Claudia
TI Sequential Infection of Aedes aegypti Mosquitoes with Chikungunya Virus
   and Zika Virus Enhances Early Zika Virus Transmission
SO INSECTS
LA English
DT Article
DE mosquitoes; arboviruses; coinfection; chikungunya; Zika; sequential
   infection
ID DENGUE VIRUS; RNA INTERFERENCE; COINFECTIONS; EMERGENCE; C6/36; CELLS
AB In urban settings, chikungunya, Zika, and dengue viruses are transmitted by Aedes aegypti mosquitoes. Since these viruses co-circulate in several regions, coinfection in humans and vectors may occur, and human coinfections have been frequently reported. Yet, little is known about the molecular aspects of virus interactions within hosts and how they contribute to arbovirus transmission dynamics. We have previously shown that Aedes aegypti exposed to chikungunya and Zika viruses in the same blood meal can become coinfected and transmit both viruses simultaneously. However, mosquitoes may also become coinfected by multiple, sequential feeds on single infected hosts. Therefore, we tested whether sequential infection with chikungunya and Zika viruses impacts mosquito vector competence. We exposed Ae. aegypti mosquitoes first to one virus and 7 days later to the other virus and compared infection, dissemination, and transmission rates between sequentially and single infected groups. We found that coinfection rates were high after sequential exposure and that mosquitoes were able to co-transmit both viruses. Surprisingly, chikungunya virus coinfection enhanced Zika virus transmission 7 days after the second blood meal. Our data demonstrate heterologous arbovirus synergism within mosquitoes, by unknown mechanisms, leading to enhancement of transmission under certain conditions.
C1 [Magalhaes, Tereza; Robison, Alexis; Young, Michael C.; Black, William C.; Foy, Brian D.; Ebel, Gregory D.; Ruckert, Claudia] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
RP Magalhaes, T; Ruckert, C (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
EM Tereza.Magalhaes@colostate.edu; lexir5394@gmail.com;
   emceeyoung@gmail.com; William.Black@colostate.edu;
   Brian.Foy@colostate.edu; Gregory.Ebel@colostate.edu;
   Claudia.Rueckert@Colostate.edu
RI Magalhaes, Tereza/V-6632-2019
OI Ruckert, Claudia/0000-0003-3732-6752
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [A1067380, R21AI129464]
FX This research was funded by the NIH, grant numbers A1067380 and
   R21AI129464.
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Bara JJ, 2014, ACTA TROP, V130, P71, DOI 10.1016/j.actatropica.2013.10.016
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Doughty CT, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0724-3
   Edman J.D., 2004, ECOLOGICAL ASPECTS A, P63
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kantor AM, 2017, INSECT MOL BIOL, V26, P113, DOI 10.1111/imb.12275
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Mourya DT, 2018, INDIAN J MED RES, V147, P88, DOI 10.4103/ijmr.IJMR_1142_17
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sirisena PDNN, 2018, J MED ENTOMOL, V55, P1580, DOI 10.1093/jme/tjy097
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   White SK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006505
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 38
TC 8
Z9 8
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2018
VL 9
IS 4
AR 177
DI 10.3390/insects9040177
PG 12
WC Entomology
SC Entomology
GA HG6DG
UT WOS:000455070600055
PM 30513725
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paris, V
   Cottingham, E
   Ross, PA
   Axford, JK
   Hoffmann, AA
AF Paris, Veronique
   Cottingham, Ellen
   Ross, Perran A.
   Axford, Jason K.
   Hoffmann, Ary A.
TI Effects of Alternative Blood Sources on Wolbachia Infected Aedes aegypti
   Females within and across Generations
SO INSECTS
LA English
DT Article
DE mosquitoes; Aedes aegypti; Wolbachia; blood meal
ID MOSQUITO HOST; ZIKA VIRUS; DENGUE; ESTABLISHMENT; CHOLESTEROL; SYMBIONT;
   DIPTERA
AB Wolbachia bacteria have been identified as a tool for reducing the transmission of arboviruses transmitted by Aedes aegypti. Research groups around the world are now mass rearing Wolbachia-infected Ae. aegypti for deliberate release. We investigated the fitness impact of a crucial element of mass rearing: the blood meal required by female Ae. aegypti to lay eggs. Although Ae. aegypti almost exclusively feed on human blood, it is often difficult to use human blood in disease-endemic settings. When females were fed on sheep or pig blood rather than human blood, egg hatch rates decreased in all three lines tested (uninfected, or infected by wMel, or wAlbB Wolbachia). This finding was particularly pronounced when fed on sheep blood, although fecundity was not affected. Some of these effects persisted after an additional generation on human blood. Attempts to keep populations on sheep and pig blood sources only partly succeeded, suggesting that strong adaptation is required to develop a stably infected line on an alternative blood source. There was a decrease in Wolbachia density when Ae. aegypti were fed on non-human blood sources. Density increased in lines kept for multiple generations on the alternate sources but was still reduced relative to lines kept on human blood. These findings suggest that sheep and pig blood will entail a cost when used for maintaining Wolbachia-infected Ae. aegypti. These costs should be taken into account when planning mass release programs.
C1 [Paris, Veronique; Cottingham, Ellen; Ross, Perran A.; Axford, Jason K.; Hoffmann, Ary A.] Univ Melbourne, Pest & Environm Adaptat Res Grp, Sch BioSci, Bio21 Inst, Melbourne, Vic 3010, Australia.
RP Hoffmann, AA (corresponding author), Univ Melbourne, Pest & Environm Adaptat Res Grp, Sch BioSci, Bio21 Inst, Melbourne, Vic 3010, Australia.
EM Veronique_paris@hotmail.de; ellenpc@student.unimelb.edu.au;
   perran.ross@unimelb.edu.au; jkaxford@unimelb.edu.au; ary@unimelb.edu.au
RI Hoffmann, Ary/R-2972-2019; Ross, Perran/L-5778-2019
OI Hoffmann, Ary/0000-0001-9497-7645; Ross, Perran/0000-0001-7645-7523
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [1132412, 1118640]
FX This research was funded by the National Health and Medical Research
   Council through a Program (1132412) and Fellowship (1118640) grant.
CR Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Baughman T., 2017, PLOS NEGLECT TROP D, V11, DOI DOI 10.1371/JOURNAL.PNTD.0006142
   Berman R., SCI INTRO 20 MILLION
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16045-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gonzales KK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29415-5
   Gonzales KK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121267
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003
   Luo YP, 2014, J VECTOR ECOL, V39, P271, DOI 10.1111/jvec.12101
   Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-28
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Richardson KM, 2019, HEREDITY, V122, P428, DOI 10.1038/s41437-018-0133-7
   Ross P.A., 2017, BIORXIV, DOI 10.1101/237776
   Ross PA, 2017, JOVE-J VIS EXP, DOI 10.3791/56124
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Suh E, 2016, J MED ENTOMOL, V53, P1156, DOI 10.1093/jme/tjw084
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WASHINO RK, 1983, ANNU REV ENTOMOL, V28, P179, DOI 10.1146/annurev.en.28.010183.001143
   Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yeap HL, 2016, HEREDITY, V116, P265, DOI 10.1038/hdy.2015.97
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
NR 42
TC 3
Z9 3
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2018
VL 9
IS 4
AR 140
DI 10.3390/insects9040140
PG 17
WC Entomology
SC Entomology
GA HG6DG
UT WOS:000455070600018
PM 30314399
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reinhold, JM
   Lazzari, CR
   Lahondere, C
AF Reinhold, Joanna M.
   Lazzari, Claudio R.
   Lahondere, Chloe
TI Effects of the Environmental Temperature on Aedes aegypti and Aedes
   albopictus Mosquitoes: A Review
SO INSECTS
LA English
DT Review
DE blood-feeding; dispersion; pathogen transmission; gonotrophic cycle;
   thermotolerance; dengue virus complex; chikungunya virus; Zika virus;
   West Nile virus; yellow fever virus
ID EASTERN EQUINE ENCEPHALITIS; EXTRINSIC INCUBATION-TEMPERATURE; DENGUE
   VIRUS-INFECTION; YELLOW-FEVER VIRUS; CLIMATE-CHANGE; DIPTERA-CULICIDAE;
   VECTOR COMPETENCE; CHIKUNGUNYA VIRUS; UNITED-STATES; GLOBAL DISTRIBUTION
AB The temperature of the environment is one of the most important abiotic factors affecting the life of insects. As poikilotherms, their body temperature is not constant, and they rely on various strategies to minimize the risk of thermal stress. They have been thus able to colonize a large spectrum of habitats. Mosquitoes, such as Ae. aegypti and Ae. albopictus, vector many pathogens, including dengue, chikungunya, and Zika viruses. The spread of these diseases has become a major global health concern, and it is predicted that climate change will affect the mosquitoes' distribution, which will allow these insects to bring new pathogens to naive populations. We synthesize here the current knowledge on the impact of temperature on the mosquito flight activity and host-seeking behavior (1); ecology and dispersion (2); as well as its potential effect on the pathogens themselves and how climate can affect the transmission of some of these pathogens (3).
C1 [Reinhold, Joanna M.; Lahondere, Chloe] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.
   [Lazzari, Claudio R.] Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 7261, F-37200 Tours, France.
RP Lahondere, C (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.
EM reinjm0@vt.edu; claudio.lazzari@univ-tours.fr; lahonder@vt.edu
RI Lazzari, Claudio/H-6286-2019
OI Lazzari, Claudio/0000-0003-3703-0302; Lahondere,
   Chloe/0000-0003-1949-7865
FU Biochemistry Department, Virginia Tech (USA); University of Tours
   (France); CNRS (France)Centre National de la Recherche Scientifique
   (CNRS)
FX Biochemistry Department, Virginia Tech (USA); University of Tours and
   CNRS (France).
CR AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Angilletta MJ, 2009, BIO HABIT, P35
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499
   BAR-ZEEV MICHA, 1957, BULL ENT RES, V48, P593, DOI 10.1017/S0007485300002765
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276
   Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benoit JB, 2011, P NATL ACAD SCI USA, V108, P8026, DOI 10.1073/pnas.1105195108
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BISHOP A, 1946, PARASITOLOGY, V37, P85, DOI 10.1017/S0031182000013202
   BOWEN MF, 1991, ANNU REV ENTOMOL, V36, P139, DOI 10.1146/annurev.en.36.010191.001035
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   CARVALHO MDD, 1991, RES VIROLOGY, V142, P25
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Center for Disease Control and Prevention, CHIK VIR HOM GEOGR D
   Center for Disease Control and Prevention, TRANSM YELL FEV VIR
   CHAMBERLAIN RW, 1955, AM J HYG, V62, P295, DOI 10.1093/oxfordjournals.aje.a119780
   Chaves L.F., 2017, INVERTEBRATES GLOBAL, P126, DOI DOI 10.1002/9781119070894.CH8
   Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x
   Chaves LF, 2016, INT J BIOMETEOROL, V60, P1727, DOI 10.1007/s00484-016-1162-7
   Chaves LF, 2014, ACTA TROP, V129, P15, DOI 10.1016/j.actatropica.2013.02.025
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Connor M.E., 1924, AM J TROP MED HYG, V1, P277, DOI [10.4269/ajtmh.1924.s1-4.277, DOI 10.4269/AJTMH.1924.S1-4.277]
   Corfas RA, 2015, ELIFE, V4, DOI [10.7554/eLife.11751, 10.7554/eLife.11750]
   Cossio V., 1931, B CONS NAT HIG URUGU, V23, P1664
   Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Davis NC, 1932, AM J HYG, V16, P163, DOI 10.1093/oxfordjournals.aje.a117853
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7
   Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221
   Elbers ARW, 2015, REV SCI TECH OIE, V34, P123, DOI 10.20506/rst.34.1.2349
   Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heinrich B., 1993, HOT BLOODED INSECTS, P600
   Higa Yukiko, 2007, Medical Entomology and Zoology, V58, P1
   Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   HUEY RB, 1979, AM ZOOL, V19, P357
   IPCC, 2014, CLIMATE CHANGE 2014
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565
   KARTMAN L, 1953, EXP PARASITOL, V2, P27, DOI 10.1016/0014-4894(53)90005-8
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Klenk K, 2004, EMERG INFECT DIS, V10, P2150, DOI 10.3201/eid1012.040264
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Lahondere C, 2012, CURR BIOL, V22, P40, DOI 10.1016/j.cub.2011.11.029
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Ledesma N, 2015, VET PARASITOL, V209, P93, DOI 10.1016/j.vetpar.2015.02.003
   Ledesma N, 2011, TOP COMPANION ANIM M, V26, P178, DOI 10.1053/j.tcam.2011.09.005
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lewis D. J., 1933, Bulletin of Entomological Research London, V24, P363, DOI 10.1017/S0007485300031692
   Lewontin R, 2000, CAPITALISM NAT SOCIA, V11, P103, DOI DOI 10.1080/10455750009358943)
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Marchoux E., 1903, FIEVRE JAUNE RAPPORT
   Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822
   Matthews G, 2011, INTEGRATED VECTOR MA
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   MCGREEVY PB, 1982, T ROY SOC TROP MED H, V76, P288, DOI 10.1016/0035-9203(82)90170-5
   McMichael AJ, 2008, SOCIAL ECOLOGY OF INFECTIOUS DISEASES, P378, DOI 10.1016/B978-012370466-5.50019-4
   MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985
   Mogi M, 1996, J MED ENTOMOL, V33, P438, DOI 10.1093/jmedent/33.3.438
   Mogi M, 2014, J MED ENTOMOL, V51, P572, DOI 10.1603/ME13178
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   MORI A, 1981, Tropical Medicine, V23, P79
   Neto PL, 2004, NEOTROP ENTOMOL, V33, P29, DOI 10.1590/S1519-566X2004000100006
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1
   Otto M., 1905, Z HYG INFEKTIONSKR, V51, P357, DOI 10.1007/BF02141134
   Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Patz JA, 2003, CLIMATE CHANGE HUMAN, P103
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Romi R, 1999, J AM MOSQUITO CONTR, V15, P425
   ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P1251, DOI 10.1016/0022-1910(68)90018-8
   Rozeboom LE, 1938, P OKLA ACAD SCI, P81
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Simon F, 2005, VET PARASITOL, V133, P181, DOI 10.1016/j.vetpar.2005.03.033
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536
   Sutherst RW, 1998, INT J PARASITOL, V28, P935, DOI 10.1016/S0020-7519(98)00056-3
   Suwonkerd W, 1997, TROP MED, V38, P101
   Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40
   Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Tsunoda T, 2015, J MED ENTOMOL, V52, P1203, DOI 10.1093/jme/tjv122
   Tsunoda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095606
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   VANDERBE.JP, 1966, J PARASITOL, V52, P559, DOI 10.2307/3276326
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   W.H.O, CHIK
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   WHO, ZIK VIR
   WHO (World Health Organization), 2018, MON HLTH SDGS SUST D
   World Health Organization, DENG SEV DENG
   World Health Organization, W NIL VIR
   World Health Organization, 2012, HDB INT VECT MAN
   World Health Organization, YELL FEV VIR
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Zermoglio PF, 2017, J INSECT PHYSIOL, V100, P9, DOI 10.1016/j.jinsphys.2017.04.010
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 141
TC 18
Z9 18
U1 12
U2 31
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2018
VL 9
IS 4
AR 158
DI 10.3390/insects9040158
PG 17
WC Entomology
SC Entomology
GA HG6DG
UT WOS:000455070600036
PM 30404142
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Azevedo, RSS
   Araujo, MT
   Oliveira, CS
   Martins, AJ
   Nunes, BTD
   Henriques, DF
   Silva, EVP
   Carvalho, VL
   Chiang, JO
   Martins, LC
   Vasconcelos, BCB
   Sousa, JR
   Araujo, FMC
   Ribeiro, EM
   Castro, ARP
   de Queiroz, MGL
   Verotti, MP
   Nunes, MRT
   Cruz, ACR
   Rodrigues, SG
   Shi, PY
   Quaresma, JAS
   Tesh, RB
   Vasconcelos, PFC
AF Azevedo, Raimunda S. S.
   Araujo, Marialva T.
   Oliveira, Consuelo S.
   Martins Filho, Arnaldo Jorge
   Nunes, Bruno T. D.
   Henriques, Daniele F.
   Silva, Eliana V. P.
   Carvalho, Valeria L.
   Chiang, Jannifer O.
   Martins, Livia C.
   Vasconcelos, Barbara C. B.
   Sousa, Jorge R.
   Araujo, Fernanda Montenegro C.
   Ribeiro, Erlane M.
   Castro, Andrezza R. P.
   de Queiroz, Maria G. L.
   Verotti, Mariana P.
   Nunes, Marcio R. T.
   Cruz, Ana C. R.
   Rodrigues, Sueli G.
   Shi, Pei-Yong
   Quaresma, Juarez A. S.
   Tesh, Robert B.
   Vasconcelos, Pedro F. C.
TI Zika Virus Epidemic in Brazil. II. Post-Mortem Analyses of Neonates with
   Microcephaly, Stillbirths, and Miscarriage
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE Zika virus; microcephaly; congenital syndrome; ZIKV RNA; ZIKV antigen
ID HUMAN LIVER; INFECTION; DISEASE; DAMAGE
AB Introduction: The recent Zika virus(ZIKV) epidemic in Brazil was characterized by a range of different clinical presentations, particularly microcephaly, Guillain-Barre syndrome, and death. In this context, we determined the causal relationship between fatal microcephaly cases and ZIKV infection. Methods: Twelve fatal cases of neonates, whose mothers were infected with ZIKV during pregnancy, were examined; cases included nine neonatal deaths due to microcephaly, one miscarriage, and two stillbirths. Tissue samples were obtained from all cases at necropsy and were submitted for virological investigation (RT-qPCR and virus isolation) and/or histopathology (hematoxylin and eosin staining) and immunohistochemical assay for the detection of ZIKV antigens. Results: ZIKV antigens and/or ZIKV RNA were detected in tissue samples of all 12 cases examined. ZIKV was recovered in one case. Results of the virological and immunohistochemical analyses, as well as the anatomic abnormalities and histopathologic changes observed at necropsy on the 12 fatal cases, are presented. Conclusions: Data from these 12 cases provide strong evidence of the causal relationship between ZIKV and congenital disease in fetuses of women who were infected with the virus during pregnancy.
C1 [Azevedo, Raimunda S. S.; Araujo, Marialva T.; Oliveira, Consuelo S.; Martins Filho, Arnaldo Jorge; Nunes, Bruno T. D.; Henriques, Daniele F.; Silva, Eliana V. P.; Carvalho, Valeria L.; Chiang, Jannifer O.; Martins, Livia C.; Sousa, Jorge R.; Nunes, Marcio R. T.; Cruz, Ana C. R.; Rodrigues, Sueli G.; Vasconcelos, Pedro F. C.] Minist Saude, Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Rodovia BR-316,Km-07, BR-67030000 Ananindeua, Brazil.
   [Oliveira, Consuelo S.; Vasconcelos, Barbara C. B.; Quaresma, Juarez A. S.; Vasconcelos, Pedro F. C.] Univ Estado Para, Ctr Ciencias Biol & Saude, Travessa Perebebui 2623, BR-66087670 Belem, Para, Brazil.
   [Sousa, Jorge R.; Quaresma, Juarez A. S.] Univ Fed Para, Programa Posgrad Doencas Trop, Ave Generalissimo Deodoro 92, BR-66055240 Belem, Para, Brazil.
   [Araujo, Fernanda Montenegro C.] Secretaria Saude Publ Ceara, Lab Cent, Ave Barao de Studart 2405, BR-60120002 Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane M.; Castro, Andrezza R. P.] Secretaria Saude Publ Ceara, Hosp Geral Cesar Cals, Ave Imperador 545, BR-60015152 Fortaleza, Ceara, Brazil.
   [de Queiroz, Maria G. L.] Secretaria Saude Publ Rio Grande do Norte, Lab Cent, Rua Conego Monte 410, BR-59037170 Natal, RN, Brazil.
   [Verotti, Mariana P.] Fundacao Osvaldo Cruz Fiocruz, Fundacao Desenvolvimento Cient & Tecnol Saude FIO, SMPW Quadra 4 Conj 1 Lote 3 Unidade E, BR-71735401 Brasilia, DF, Brazil.
   [Shi, Pei-Yong; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Vasconcelos, PFC (corresponding author), Minist Saude, Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Rodovia BR-316,Km-07, BR-67030000 Ananindeua, Brazil.; Vasconcelos, PFC (corresponding author), Univ Estado Para, Ctr Ciencias Biol & Saude, Travessa Perebebui 2623, BR-66087670 Belem, Para, Brazil.
EM raimundaazevedo@iec.gov.br; marialvaaraujo@iec.gov.br;
   consuelooliveira@iec.gov.br; arnaldofilho@iec.gov.br;
   brunonunes@iec.gov.br; danielehenriques@iec.gov.br;
   elianapinto@iec.gov.br; valeriacarvalho@iec.gov.br;
   janniferchiang@iec.gov.br; liviamartins@iec.gov.br;
   barbaravasconcelos@globo.com; krekrodrigues@gmail.com;
   fernandamontenegrocaraujo@gmail.com; erlaneribeiro@yahoo.com.br;
   andrezzaporto@hotmail.com; lacenrn@yahoo.com.br;
   mpastorelloverotti@gmail.com; marcionunesbrasil@yahoo.com.br;
   anacecilia@iec.gov.br; suelirodrigues@iec.gov.br; peshi@utmb.edu;
   juarez.quaresma@gmail.com; rtesh@utmb.edu; pedrovasconcelos@iec.gov.br
RI Azevedo, Raimunda/T-4656-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019;
   Filho, Arnaldo Jorge Martins/AAJ-2779-2020; Martins Filho, Arnaldo
   Jorge/B-9329-2019; QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012;
   Vasconcelos, Pedro/AAH-3142-2019; Quaresma, Juarez AS/M-4190-2014
OI Azevedo, Raimunda/0000-0003-1932-9976; Filho, Arnaldo Jorge
   Martins/0000-0001-9153-1234; Martins Filho, Arnaldo
   Jorge/0000-0001-9153-1234; QUARESMA, JUAREZ ANTONIO
   SIMOES/0000-0002-6267-9966; Quaresma, Juarez AS/0000-0002-6267-9966;
   Montenegro de Carvalho Araujo, Fernanda/0000-0002-2202-9109
FU Evandro Chagas Institute, Ministry of Health of Brazil; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [303999/2016-0, 439971/2016-0, 440405/2016-5]; CAPESCAPES
FX This study is supported by the Evandro Chagas Institute, Ministry of
   Health of Brazil, CNPq by PFCV (303999/2016-0, 439971/2016-0 and
   440405/2016-5), CAPES by PFCV (Zika Fast-track).
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bollweg BC, 2018, J PATHOL CLIN RES, V4, P19, DOI 10.1002/cjp2.84
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Sousa JR, 2018, AM J PATHOL, V188, P2644, DOI [10.1016/j.ajpath.2018.07.009, 10.1016/j.ajpat]
   de Sousa JR, 2018, CYTOKINE, V111, P255, DOI 10.1016/j.cyto.2018.08.008
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pagliari C, 2016, J CLIN VIROL, V75, P16, DOI 10.1016/j.jcv.2015.12.005
   Pagliari C, 2014, J MED VIROL, V86, P1193, DOI 10.1002/jmv.23758
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON
   PAHO/WHO Case Definitions, ZIK RES CAS DEF
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2017, ZIK EP UPD 25 AUG 20
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2016, ZIK EP UPD 8 APR 201
   Quaresma JAS, 2005, ACTA TROP, V94, P116, DOI 10.1016/j.actatropica.2005.03.003
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD DEC
PY 2018
VL 7
IS 12
AR 496
DI 10.3390/jcm7120496
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA HH0LW
UT WOS:000455409100033
PM 30487475
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, T
   Ahn, JH
   Park, SY
   Kim, GH
   Kim, J
   Kim, TH
   Nam, I
   Park, C
   Lee, MH
AF Lee, Taek
   Ahn, Jae-Hyuk
   Park, Sun Yong
   Kim, Ga-Hyeon
   Kim, Jeonghyun
   Kim, Tae-Hyung
   Nam, Inho
   Park, Chulhwan
   Lee, Min-Ho
TI Recent Advances in AIV Biosensors Composed of Nanobio Hybrid Material
SO MICROMACHINES
LA English
DT Review
DE avian influenza virus biosensor; avian influenza virus; electrochemical
   detection; electrical detection; localized surface plasmon resonance;
   fluorescence; nanobio hybrid materials
ID AVIAN INFLUENZA-VIRUS; SURFACE-PLASMON RESONANCE; FIELD-EFFECT
   TRANSISTOR; LABEL-FREE DETECTION; RAPID DETECTION; SENSITIVE DETECTION;
   ELECTROCHEMICAL IMMUNOSENSOR; MAGNETIC NANOPARTICLE; ELECTRICAL
   DETECTION; SELECTIVE DETECTION
AB Since the beginning of the 2000s, globalization has accelerated because of the development of transportation systems that allow for human and material exchanges throughout the world. However, this globalization has brought with it the rise of various pathogenic viral agents, such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), Zika virus, and Dengue virus. In particular, avian influenza virus (AIV) is highly infectious and causes economic, health, ethnical, and social problems to human beings, which has necessitated the development of an ultrasensitive and selective rapid-detection system of AIV. To prevent the damage associated with the spread of AIV, early detection and adequate treatment of AIV is key. There are traditional techniques that have been used to detect AIV in chickens, ducks, humans, and other living organisms. However, the development of a technique that allows for the more rapid diagnosis of AIV is still necessary. To achieve this goal, the present article reviews the use of an AIV biosensor employing nanobio hybrid materials to enhance the sensitivity and selectivity of the technique while also reducing the detection time and high-throughput process time. This review mainly focused on four techniques: the electrochemical detection system, electrical detection method, optical detection methods based on localized surface plasmon resonance, and fluorescence.
C1 [Lee, Taek; Park, Sun Yong; Kim, Ga-Hyeon; Park, Chulhwan] Kwangwoon Univ, Dept Chem Engn, Seoul 01899, South Korea.
   [Ahn, Jae-Hyuk] Kwangwoon Univ, Dept Elect Engn, Seoul 01899, South Korea.
   [Kim, Jeonghyun] Kwangwoon Univ, Dept Elect Convergence Engn, Seoul 01899, South Korea.
   [Kim, Tae-Hyung; Lee, Min-Ho] Chung Ang Univ, Sch Integrat Engn, Seoul 06974, South Korea.
   [Nam, Inho] Seoul Womens Univ, Div Chem & Bioenvironm Sci, Seoul 01797, South Korea.
RP Lee, T; Park, C (corresponding author), Kwangwoon Univ, Dept Chem Engn, Seoul 01899, South Korea.; Lee, MH (corresponding author), Chung Ang Univ, Sch Integrat Engn, Seoul 06974, South Korea.
EM nanotlee@gmail.com; jaehahn@kw.ac.kr; tnsdyd5015@naver.com;
   1497rg@hanmail.net; jkim@kw.ac.kr; thkim@cau.ac.kr; inhonam@swu.ac.kr;
   chpark@kw.ac.kr; mhlee7@cau.ac.kr
OI Lee, Min-Ho/0000-0002-7028-4745
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2018R1D1A1B07049407]; Basic
   Science Research Program through the National Research Foundation of
   Korea (NRF) - Ministry of Health and Welfare [HG18C0012]; Bio & Medical
   Technology Development Program of the NRF - Korean government, MSIT
   [NRF-2018M3A9H3020459]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (grant number 2018R1D1A1B07049407) and by the Ministry of
   Health and Welfare (grant number HG18C0012) and by the Bio & Medical
   Technology Development Program of the NRF funded by the Korean
   government, MSIT (grant number NRF-2018M3A9H3020459).
CR Afzal A, 2017, CHEMOSENSORS, V5, DOI 10.3390/chemosensors5010007
   Ahmed SR, 2018, GLOB CHALL, V2, DOI 10.1002/gch2.201700071
   Ahn JH, 2015, J BIOMED NANOTECHNOL, V11, P1640, DOI 10.1166/jbn.2015.1501
   Ahn JH, 2010, NANO LETT, V10, P2934, DOI 10.1021/nl1010965
   Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856
   Alimova A, 2004, PHOTOCHEM PHOTOBIOL, V80, P41, DOI 10.1562/2004-02-11-RA-080.1
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Arya SK, 2014, SENSOR ACTUAT B-CHEM, V194, P127, DOI 10.1016/j.snb.2013.12.066
   Auewarakul P, 2007, J CLIN MICROBIOL, V45, P1637, DOI 10.1128/JCM.00382-07
   Bai H, 2012, SENSORS-BASEL, V12, P12506, DOI 10.3390/s120912506
   Baker SF, 2015, VACCINE, V33, P3562, DOI 10.1016/j.vaccine.2015.05.049
   Baumann J, 2016, J VIROL, V90, P1569, DOI 10.1128/JVI.02332-15
   Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480
   Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4
   Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003
   Butler D, 2015, NATURE, V522, P139, DOI 10.1038/522139a
   Callaway Z, 2016, T ASABE, V59, P421
   Chan CY, 2017, SENSOR ACTUAT B-CHEM, V251, P927, DOI 10.1016/j.snb.2017.05.147
   Chang YF, 2018, ANAL CHEM, V90, P1861, DOI 10.1021/acs.analchem.7b03934
   Charlton B, 2009, COMP IMMUNOL MICROB, V32, P341, DOI 10.1016/j.cimid.2008.01.009
   Chen WJ, 2007, J MED MICROBIOL, V56, P603, DOI 10.1099/jmm.0.47014-0
   Chou TC, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-52
   Cueno ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076764
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Bao DT, 2017, THERANOSTICS, V7, P1835, DOI 10.7150/thno.18857
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcia-Canas V, 2007, ANAL CHEM, V79, P3164, DOI 10.1021/ac0621120
   Grabowska I, 2014, ACTA BIOCHIM POL, V61, P471
   Gu B, 2009, SMALL, V5, P2407, DOI 10.1002/smll.200900450
   Guo D, 2013, ANAL CHIM ACTA, V773, P83, DOI 10.1016/j.aca.2013.02.019
   Ha Y, 2018, ACS APPL NANO MATER, V1, P512, DOI 10.1021/acsanm.7b00025
   Hall WP, 2011, J PHYS CHEM C, V115, P1410, DOI 10.1021/jp106912p
   Hassanpour S, 2018, TRAC-TREND ANAL CHEM, V98, P201, DOI 10.1016/j.trac.2017.11.012
   He QG, 2007, CLIN VACCINE IMMUNOL, V14, P617, DOI 10.1128/CVI.00444-06
   Hideshima S, 2013, ANAL CHEM, V85, P5641, DOI 10.1021/ac401085c
   Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002
   Hung LY, 2014, NANOMED-NANOTECHNOL, V10, P819, DOI 10.1016/j.nano.2013.11.009
   Hwang SG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31311-x
   Jarocka U, 2016, SENSOR ACTUAT B-CHEM, V228, P25, DOI 10.1016/j.snb.2016.01.001
   Kamikawa TL, 2012, IEEE T NANOTECHNOL, V11, P88, DOI 10.1109/TNANO.2011.2157936
   Karash S, 2016, J VIROL METHODS, V236, P147, DOI 10.1016/j.jviromet.2016.07.018
   Kim SA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355503
   Kim SA, 2009, J OPT SOC KOREA, V13, P392, DOI 10.3807/JOSK.2009.13.3.392
   Kim S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148340
   Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-1
   Krishna VD, 2018, FOOD MICROBIOL, V75, P47, DOI 10.1016/j.fm.2018.01.025
   Krishna VD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00400
   Kuriakose T, 2012, AVIAN DIS, V56, P90, DOI 10.1637/9828-060211-Reg.1
   Ladhani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174314
   Li BM, 2015, CRIT REV BIOTECHNOL, V35, P82, DOI 10.3109/07388551.2013.804487
   Lin CH, 2009, BIOSENS BIOELECTRON, V24, P3019, DOI 10.1016/j.bios.2009.03.014
   Malecka K, 2013, ELECTROANAL, V25, P1871, DOI 10.1002/elan.201300113
   Mandenius CF, 2008, ANAL CHIM ACTA, V623, P66, DOI 10.1016/j.aca.2008.06.005
   Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056
   Nidzworski D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15806-7
   Oh BK, 2004, BIOSENS BIOELECTRON, V19, P1497, DOI 10.1016/j.bios.2003.12.009
   Oh S, 2018, ACS APPL MATER INTER, V10, P12534, DOI 10.1021/acsami.8b02735
   Ono T, 2017, JPN J APPL PHYS, V56, DOI 10.7567/JJAP.56.030302
   Pang YF, 2015, BIOSENS BIOELECTRON, V66, P527, DOI 10.1016/j.bios.2014.10.052
   Park S, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700371
   Park TJ, 2012, TALANTA, V89, P246, DOI 10.1016/j.talanta.2011.12.021
   Pashazadeh P, 2017, BIOSENS BIOELECTRON, V87, P1050, DOI 10.1016/j.bios.2016.08.012
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   Piliarik Marek, 2009, V503, P65, DOI 10.1007/978-1-60327-567-5_5
   Pinar A, 2017, J BIOL CHEM, V292, P826, DOI 10.1074/jbc.M116.756379
   Pollock FJ, 2010, APPL ENVIRON MICROB, V76, P5282, DOI 10.1128/AEM.00330-10
   Poltronieri P, 2014, FOODS, V3, P511, DOI 10.3390/foods3030511
   Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Song L, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1106-4
   Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Takemura K, 2017, BIOSENS BIOELECTRON, V89, P998, DOI 10.1016/j.bios.2016.10.045
   Tepeli Y, 2018, SENSOR ACTUAT B-CHEM, V254, P377, DOI 10.1016/j.snb.2017.07.126
   Thi Hoa Nguyen, 2012, Advances in Natural Sciences: Nanoscience & Nanotechnology, V3, DOI 10.1088/2043-6262/3/3/035014
   Tian JZ, 2017, INT J ELECTROCHEM SC, V12, P2658, DOI 10.20964/2017.04.30
   van den Kieboom CH, 2015, TRAC-TREND ANAL CHEM, V74, P58, DOI 10.1016/j.trac.2015.05.012
   Nguyen VT, 2016, BIOSENS BIOELECTRON, V86, P293, DOI 10.1016/j.bios.2016.06.064
   Veerapandian M, 2016, TALANTA, V155, P250, DOI 10.1016/j.talanta.2016.04.047
   Verhagen JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173470
   Vidic J, 2017, VET RES, V48, DOI 10.1186/s13567-017-0418-5
   Vyboh K, 2012, JOVE-J VIS EXP, DOI 10.3791/4002
   Woolcock PR, 2001, AVIAN DIS, V45, P1030, DOI 10.2307/1592884
   Wu K, 2017, ACS SENSORS, V2, P1594, DOI 10.1021/acssensors.7b00432
   Wu LT, 2013, J CLIN MICROBIOL, V51, P3031, DOI 10.1128/JCM.00740-13
   Wu Z, 2015, BIOSENS BIOELECTRON, V68, P586, DOI 10.1016/j.bios.2015.01.051
   Xie ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109419
   Xu LZ, 2016, SENSOR ACTUAT B-CHEM, V234, P98, DOI 10.1016/j.snb.2016.04.156
   Yeo SJ, 2016, THERANOSTICS, V6, P231, DOI 10.7150/thno.14023
   Zeng SW, 2014, CHEM SOC REV, V43, P3426, DOI 10.1039/c3cs60479a
   Zhao W, 2012, ANAL CHEM, V84, P2358, DOI 10.1021/ac203102u
   Zhao XH, 2016, J VIROL METHODS, V233, P15, DOI 10.1016/j.jviromet.2016.03.007
   Zhou CH, 2013, ELECTROCHEM COMMUN, V31, P129, DOI 10.1016/j.elecom.2013.03.024
   Zhu M, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-528
   Zhu XB, 2009, ELECTROCHEM COMMUN, V11, P1543, DOI 10.1016/j.elecom.2009.05.055
   Zou L, 2018, TALANTA, V189, P137, DOI 10.1016/j.talanta.2018.06.051
NR 96
TC 2
Z9 2
U1 15
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-666X
J9 MICROMACHINES-BASEL
JI Micromachines
PD DEC
PY 2018
VL 9
IS 12
AR 651
DI 10.3390/mi9120651
PG 17
WC Nanoscience & Nanotechnology; Instruments & Instrumentation
SC Science & Technology - Other Topics; Instruments & Instrumentation
GA HG6EC
UT WOS:000455072800042
PM 30544883
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carlin, AF
   Wen, JS
   Vizcarra, EA
   McCauley, M
   Chaillon, A
   Akrami, K
   Kim, C
   Ngono, AE
   Lara-Marquez, ML
   Smith, DM
   Glass, CK
   Schooley, RT
   Benner, C
   Shresta, S
AF Carlin, Aaron F.
   Wen, Jinsheng
   Vizcarra, Edward A.
   McCauley, Melanie
   Chaillon, Antoine
   Akrami, Kevan
   Kim, Cheryl
   Ngono, Annie Elong
   Lara-Marquez, Maria Luz
   Smith, Davey M.
   Glass, Christopher K.
   Schooley, Robert T.
   Benner, Christopher
   Shresta, Sujan
TI A longitudinal systems immunologic investigation of acute Zika virus
   infection in an individual infected while traveling to Caracas,
   Venezuela
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BLOOD MONONUCLEAR-CELLS; WEST-NILE-VIRUS; T-CELLS; DENGUE; MONOCYTES;
   REPLICATION; ANTIBODIES; RESPONSES; GENOME; TARGET
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus linked to devastating neurologic diseases. Immune responses to flaviviruses may be pathogenic or protective. Our understanding of human immune responses to ZIKV in vivo remains limited. Therefore, we performed a longitudinal molecular and phenotypic characterization of innate and adaptive immune responses during an acute ZIKV infection. We found that innate immune transcriptional and genomic responses were both cell type- and time-dependent. While interferon stimulated gene induction was common to all innate immune cells, the upregulation of important inflammatory cytokine genes was primarily limited to monocyte subsets. Additionally, genomic analysis revealed substantial chromatin remodeling at sites containing cell type specific transcription factor binding motifs that may explain the observed changes in gene expression. In this dengue virus-experienced individual, adaptive immune responses were rapidly mobilized with T cell transcriptional activity and ZIKV neutralizing antibody responses peaking 6 days after the onset of symptoms. Collectively this study characterizes the development and resolution of an in vivo human immune response to acute ZIKV infection in an individual with pre-existing flavivirus immunity.
C1 [Carlin, Aaron F.; McCauley, Melanie; Chaillon, Antoine; Akrami, Kevan; Lara-Marquez, Maria Luz; Smith, Davey M.; Glass, Christopher K.; Schooley, Robert T.; Benner, Christopher; Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
   [Wen, Jinsheng; Vizcarra, Edward A.; McCauley, Melanie; Kim, Cheryl; Ngono, Annie Elong; Shresta, Sujan] La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Chaillon, Antoine; Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA.
   [Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
RP Carlin, AF; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Shresta, S (corresponding author), La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM acarlin@ucsd.edu; sujan@lji.org
OI Lara-Marquez, Maria Luz/0000-0003-1014-6524; Smith,
   Davey/0000-0003-3603-1733; Benner, Christopher/0000-0002-4618-0719
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI036214, AI116813, AI140063]; La Jolla
   Institute for Immunology; Burroughs Wellcome Career Award for Medical
   ScientistsBurroughs Wellcome Fund;  [1KL2TR001444]
FX This research was supported by NIAID/NIH grants AI116813 and AI140063
   and the La Jolla Institute for Immunology institutional support to SS,
   KL2 Scholars: 1KL2TR001444 and Burroughs Wellcome Career Award for
   Medical Scientists to AFC, and NIAID/NIH AI036214 to DMS. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Garcia-Tapia D, 2006, VET IMMUNOL IMMUNOP, V110, P229, DOI 10.1016/j.vetimm.2005.10.003
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
NR 46
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2018
VL 12
IS 12
AR e0007053
DI 10.1371/journal.pntd.0007053
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HG6OX
UT WOS:000455103100050
PM 30596671
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hay, JA
   Nouvellet, P
   Donnelly, CA
   Riley, S
AF Hay, James A.
   Nouvellet, Pierre
   Donnelly, Christl A.
   Riley, Steven
TI Potential inconsistencies in Zika surveillance data and our
   understanding of risk during pregnancy
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS-INFECTION; DENGUE VIRUS; BRAZIL; EPIDEMIC; OUTBREAK; SALVADOR;
   JANUARY; BIRTH
AB Background
   A significant increase in microcephaly incidence was reported in Northeast Brazil at the end of 2015, which has since been attributed to an epidemic of Zika virus (ZIKV) infections earlier that year. Further incidence of congenital Zika syndrome (CZS) was expected following waves of ZIKV infection throughout Latin America; however, only modest increases in microcephaly and CZS incidence have since been observed. The quantitative relationship between ZIKV infection, gestational age and congenital outcome remains poorly understood.
   Methodology/Principle findings
   We characterised the gestational-age-varying risk of microcephaly given ZIKV infection using publicly available incidence data from multiple locations in Brazil and Colombia. We found that the relative timings and shapes of ZIKV infection and microcephaly incidence curves suggested different gestational risk profiles for different locations, varying in both the duration and magnitude of gestational risk. Data from Northeast Brazil suggested a narrow window of risk during the first trimester, whereas data from Colombia suggested persistent risk throughout pregnancy. We then used the model to estimate which combination of behavioural and reporting changes would have been sufficient to explain the absence of a second microcephaly incidence wave in Bahia, Brazil; a population for which we had two years of data. We found that a 18.9-fold increase in ZIKV infection reporting rate was consistent with observed patterns.
   Conclusions
   Our study illustrates how surveillance data may be used in principle to answer key questions in the absence of directed epidemiological studies. However, in this case, we suggest that currently available surveillance data are insufficient to accurately estimate the gestational age-varying risk of microcephaly from ZIKV infection. The methods used here may be use in future outbreaks and may help to inform improved surveillance and interpretation in countries yet to experience an outbreak of ZIKV infection.
C1 [Hay, James A.; Nouvellet, Pierre; Donnelly, Christl A.; Riley, Steven] Imperial Coll, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England.
   [Nouvellet, Pierre] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.
   [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England.
RP Riley, S (corresponding author), Imperial Coll, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England.
EM s.riley@imperial.ac.uk
OI Hay, James/0000-0002-1998-1844; Riley, Steven/0000-0001-7904-4804
FU Wellcome TrustWellcome Trust [200861/Z/16/Z]; Medical Research Council,
   UKMedical Research Council UK (MRC); National Institute for Health
   Research HPRU
FX For funding, we thank: The Wellcome Trust ww.wellcome.ac.uk
   (Investigator Award, 200861/Z/16/Z, SR); The Medical Research Council,
   UK (www.mrc.ac.uk, JAH, SR, PN, CAD); National Institute for Health
   Research HPRU (SR, CAD, PN). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2016, PROT VIG RESP MICR A
   [Anonymous], 2015, 0043 MIN SAL PROT SO
   [Anonymous], GEN SUMM OUTC EM COM
   [Anonymous], 2017, NACIMIENTOS AREA OCU
   [Anonymous], 2016, PROC SER AD VIG FEBR
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   COLLUCCI C, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/bmj.i4657
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diaz-Quijano FA, 2018, AM J PUBLIC HEALTH, V108, P514, DOI [10.2105/AJPH.2017.304260, 10.2105/ajph.2017.304260]
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epidemiological Alert, 2015, EPIDEMIOLOGICAL ALER
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kucharski A, 2017, LANCET INFECT DIS, V17, P13, DOI 10.1016/S1473-3099(16)30524-2
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7
   MILLER E, 1982, LANCET, V2, P781
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   PAHO/WHO, 2016, ZIK EP UPD
   PAHO/WHO. Pan American Health Organization / World Health Organization, 2017, ZIK EP REP COL
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rodrigues LC, 2017, LANCET, V390, P824, DOI 10.1016/S0140-6736(17)31478-2
   Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Santa Rita Ticiane Henriques, 2017, BMC Res Notes, V10, P457, DOI 10.1186/s13104-017-2796-1
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 52
TC 4
Z9 4
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2018
VL 12
IS 12
AR e0006991
DI 10.1371/journal.pntd.0006991
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HG6OX
UT WOS:000455103100028
PM 30532143
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roiz, D
   Wilson, AL
   Scott, TW
   Fonseca, DM
   Jourdain, F
   Muller, P
   Velayudhan, R
   Corbel, V
AF Roiz, David
   Wilson, Anne L.
   Scott, Thomas W.
   Fonseca, Dina M.
   Jourdain, Frederic
   Mueller, Pie
   Velayudhan, Raman
   Corbel, Vincent
TI Integrated Aedes management for the control of Aedes-borne diseases
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID COMMUNITY EFFECTIVENESS; DENGUE; AEGYPTI; CHIKUNGUNYA; STRATEGIES;
   MOSQUITO; EFFICACY; PROGRAM; TIGER; AREAS
AB Background
   Diseases caused by Aedes-borne viruses, such as dengue, Zika, chikungunya, and yellow fever, are emerging and reemerging globally. The causes are multifactorial and include global trade, international travel, urbanisation, water storage practices, lack of resources for intervention, and an inadequate evidence base for the public health impact of Aedes control tools. National authorities need comprehensive evidence-based guidance on how and when to implement Aedes control measures tailored to local entomological and epidemiological conditions.
   Methods and findings
   This review is one of a series being conducted by the Worldwide Insecticide resistance Network (WIN). It describes a framework for implementing Integrated Aedes Management (IAM) to improve control of diseases caused by Aedes-borne viruses based on available evidence. IAM consists of a portfolio of operational actions and priorities for the control of Aedes-borne viruses that are tailored to different epidemiological and entomological risk scenarios. The framework has 4 activity pillars: (i) integrated vector and disease surveillance, (ii) vector control, (iii) community mobilisation, and (iv) intra- and intersectoral collaboration as well as 4 supporting activities: (i) capacity building, (ii) research, (iii) advocacy, and (iv) policies and laws.
   Conclusions
   IAM supports implementation of the World Health Organisation Global Vector Control Response (WHO GVCR) and provides a comprehensive framework for health authorities to devise and deliver sustainable, effective, integrated, community-based, locally adapted vector control strategies in order to reduce the burden of Aedes-transmitted arboviruses. The success of IAM requires strong commitment and leadership from governments to maintain proactive disease prevention programs and preparedness for rapid responses to outbreaks.
C1 [Roiz, David; Jourdain, Frederic; Corbel, Vincent] Univ Montpellier, CNRS, IRD, MIVEGEC, Montpellier, France.
   [Wilson, Anne L.] Univ Durham, Dept Biosci, Durham, England.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
   [Mueller, Pie] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Mueller, Pie] Univ Basel, Basel, Switzerland.
   [Velayudhan, Raman] WHO, Dept Control Neglected Trop Dis HTM NTD, Geneva, Switzerland.
RP Roiz, D; Corbel, V (corresponding author), Univ Montpellier, CNRS, IRD, MIVEGEC, Montpellier, France.
EM david.roiz@ird.fr; Vincent.corbel@ird.fr
RI Roiz, David/F-2082-2011; Muller, Pie/R-7275-2018; Fonseca,
   Dina/B-9951-2011
OI Roiz, David/0000-0002-5819-3648; Muller, Pie/0000-0003-0181-5781;
   Fonseca, Dina/0000-0003-4726-7100; Wilson, Anne/0000-0001-7387-353X
FU WIN network from the World Health Organization's Special Programme for
   Research and Training in Tropical Diseases; ANR grant INVACOSTFrench
   National Research Agency (ANR)
FX This review was funded by an award to VC and the WIN network from the
   World Health Organization's Special Programme for Research and Training
   in Tropical Diseases (http://www.who.int/tdr/). DR was partially
   supported by the ANR grant INVACOST. The funders had no role in the
   study design, data collection and analysis, nor the writing of the
   manuscript, nor the decision to publish.
CR Achee N, 2018, PLOS NEGL TROP DIS
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Azevedo-Santos VM, 2017, BIOSCIENCE, V67, P83, DOI 10.1093/biosci/biw156
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera-Perez MA, 2015, SALUD PUBLICA MEXICO, V57, P201
   Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358
   Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   Dusfour I, PLOS NEGL TROP DIS
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   European Food Safety Authority (EFSA), 2012, TECHNICAL REPORT
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Fitzpatrick C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005785
   FOCKS DA, 2003, TDRIDEDEN031 WHO
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0000
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Halstead Scott B., 2000, Dengue Bulletin, V24, P60
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Johnson BJ, 2017, INSECTS, V8, DOI 10.3390/insects8010005
   Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Lessler J, 2017, AM J TROP MED HYG, V96, P1270, DOI 10.4269/ajtmh.16-0427
   Lindsay SW, 2017, B WORLD HEALTH ORGAN, V95, P607, DOI 10.2471/BLT.16.189688
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maoz D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005651
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Parks W., 2004, PLANNING SOCIAL MOBI
   Porta M, 2014, DICT EPIDEMIOLOGY
   Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   Samuel M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005837
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965
   Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   WHO, 2011, COMPR GUID PREV CONT
   WHO, 2007, MAN IND RES SPRAYING
   WHO, 2016, MON MAN INS RES AED
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   WHO (World Health Organization), 2016, VECT SURV CONTR PORT
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   World Health Organization, 2012, HDB INT VECT MAN
   World Health Organization, 2012, COMM BEH IMP COMBI T
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   2013, INFECT DIS SURV 2 ED, P1
NR 74
TC 21
Z9 22
U1 3
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2018
VL 12
IS 12
AR e0006845
DI 10.1371/journal.pntd.0006845
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HG6OX
UT WOS:000455103100005
PM 30521524
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Tennant, W
   Recker, M
AF Tennant, Warren
   Recker, Mario
TI Robustness of the reproductive number estimates in vector-borne disease
   systems
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; TRANSMISSION DYNAMICS; DENGUE-FEVER; ZIKA VIRUS;
   TEMPERATURE; SURVIVAL; MALARIA; AGE; POPULATIONS; CULICIDAE
AB Background
   The required efforts, feasibility and predicted success of an intervention strategy against an infectious disease are partially determined by its basic reproduction number, R-0. In its simplest form R-0 can be understood as the product of the infectious period, the number of infectious contacts and the per-contact transmission probability, which in the case of vector transmitted diseases necessarily extend to the vector stages. As vectors do not usually recover from infection, they remain infectious for life, which places high significance on the vector's life expectancy. Current methods for estimating the R-0 for a vector-borne disease are mostly derived from compartmental modelling frameworks assuming constant vector mortality rates. We hypothesised that some of the assumptions underlying these models can lead to unrealistic high vector life expectancies with important repercussions for R-0 estimates.
   Methodology and principal findings
   Here we used a stochastic, individual-based model which allowed us to directly measure the number of secondary infections arising from one index case under different assumptions about vector mortality. Our results confirm that formulas based on age-independent mortality rates can overestimate R-0 by nearly 100% compared to our own estimate derived from first principles. We further provide a correction factor that can be used with a standard R-0 formula and adjusts for the discrepancies due to erroneous vector age distributions.
   Conclusion
   Vector mortality rates play a crucial role for the success and general epidemiology of vector transmitted diseases. Many modelling efforts intrinsically assume these to be age-independent, which, as clearly demonstrated here, can lead to severe over-estimation of the disease's reproduction number. Our results thus re-emphasise the importance of obtaining field-relevant and species-dependent vector mortality rates, which in turn would facilitate more realistic intervention impact predictions.
C1 [Tennant, Warren; Recker, Mario] Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, England.
RP Recker, M (corresponding author), Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, England.
EM m.recker@exeter.ac.uk
OI Tennant, Warren/0000-0001-5822-6887; Recker, Mario/0000-0001-9489-1315
FU EPSRC DTP studentshipEngineering & Physical Sciences Research Council
   (EPSRC)
FX This work was supported by an EPSRC DTP studentship to WT. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   [Anonymous], 2017, PLAG MAD
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276
   Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brand SPC, 2016, PLOS COMPUTATIONAL B, V12, P1
   Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282
   CAIRNS AJG, 1991, MATH BIOSCI, V107, P451, DOI 10.1016/0025-5564(91)90019-F
   Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006
   CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98
   Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2
   Hartfield M., 2013, PLOS BIOL, V9, P9, DOI DOI 10.1371/J0URNAL.PPAT.1003277
   Heesterbeek J. A. P., 1996, STAT NEERL, V50, P89, DOI DOI 10.1111/J.1467-9574.1996.TB01482.X
   Huber JH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1537-6
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambert B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22712-z
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Lloyd AL, 2017, BASIC REPROD NUMBER
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Perkins TA, 2018, EPIDEMICS
   Reiner RC, 2015, ELIFE, V4, DOI 10.7554/eLife.09520
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10
   Rock KS, 2015, EPIDEMICS-NETH, V12, P20, DOI 10.1016/j.epidem.2015.02.006
   Ross R., 1911, PREVENTATION MALARIA
   Siraj AS, 2017, PLOS NEGLECT TROP D, P1
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183
   Valdez LD, 2017, J THEOR BIOL, V421, P28, DOI 10.1016/j.jtbi.2017.03.024
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
NR 55
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2018
VL 12
IS 12
AR e0006999
DI 10.1371/journal.pntd.0006999
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HG6OX
UT WOS:000455103100032
PM 30557351
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ziyaeyan, M
   Behzadi, MA
   Leyva-Grado, VH
   Azizi, K
   Pouladfar, G
   Dorzaban, H
   Ziyaeyan, A
   Salek, S
   Hashemi, AJ
   Jamalidoust, M
AF Ziyaeyan, Mazyar
   Behzadi, Mohammad Amin
   Leyva-Grado, Victor Hugo
   Azizi, Kourosh
   Pouladfar, Gholamreza
   Dorzaban, Hedayat
   Ziyaeyan, Atoosa
   Salek, Sanaz
   Hashemi, Aghyl Jaber
   Jamalidoust, Marzieh
TI Widespread circulation of West Nile virus, but not Zika virus in
   southern Iran
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PREVALENCE; OUTBREAK; POPULATION; COMPETENCE; ALBOPICTUS; INFECTION;
   MOSQUITOS; VECTORS; PIPIENS; EQUINES
AB West Nile virus (WNV) and Zika virus (ZIKV) are mosquito-borne viral infections. Over the past few decades, WNV has been associated with several outbreaks involving high numbers of neuroinvasive diseases among humans. The recent re-emergence of ZIKV has been associated with congenital malformation and also with Guillain Barre syndrome in adults. The geographic range of arthropod-borne viruses has been rapidly increasing in recent years. The objectives of this study were to determine the presence of IgG specific antibodies and the genome of WNV and ZIKV in human samples, as well as WNV and ZIKV genomes in wild-caught mosquitoes in urban and rural areas of the Hormozgan province, in southern Iran. A total of 494 serum samples were tested for the presence of WNV and ZIKV IgG antibodies using ELISA assays. One hundred and two (20.6%) samples were reactive for WNV IgG antibodies. All serum samples were negative for ZIKV IgG antibodies. Using the multivariable logistic analysis, age (45+vs. 1-25; OR = 3.4, 95% C.I.: 1.8-6.3), occupation (mostly outdoor vs. mostly indoor; OR = 2.4, 95% C.I.: 1.1-5.2), and skin type(type I/II vs. type III/IV and type VNI; OR = 4.3, 95% C.I.: 1.7-10.8 and OR = 2.7, 95% C.I.: 1.3-5.5 respectively, skin types based on Fitzpatrick scale) showed significant association with WNV seroreactivity. We collected 2,015 mosquitoes in 136 pools belonging to 5 genera and 14 species. Three pools of Culex pipiens complex were positive for WNV RNA using real-time reverse transcription polymerase chain reaction (rtRT-PCR). ZIKV RNA was not detected in any of the pools. All WNV ELISA reactive serum samples were negative for WNV RNA. In conclusion, we provided evidence of the establishment of WNV in southern Iran and no proof of ZIKV in serum samples or in mosquito vectors. The establishment of an organized arbovirus surveillance system and active case finding strategies seems to be necessary.
C1 [Ziyaeyan, Mazyar; Salek, Sanaz; Jamalidoust, Marzieh] Shiraz Univ Med Sci, Clin Microbiol Res Ctr, Dept Clin Virol, Namazi Hosp, Shiraz, Iran.
   [Behzadi, Mohammad Amin; Leyva-Grado, Victor Hugo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Azizi, Kourosh; Dorzaban, Hedayat; Hashemi, Aghyl Jaber] Shiraz Univ Med Sci, Sch Hlth, Res Ctr Hlth Sci, Dept Med Entomol & Vector Control, Shiraz, Iran.
   [Pouladfar, Gholamreza] Shiraz Univ Med Sci, Namazi Hosp, Clin Microbiol Res Ctr, Dept Infect Dis, Shiraz, Iran.
   [Ziyaeyan, Atoosa] Univ Toronto, Toronto, ON, Canada.
RP Ziyaeyan, M (corresponding author), Shiraz Univ Med Sci, Clin Microbiol Res Ctr, Dept Clin Virol, Namazi Hosp, Shiraz, Iran.
EM ziyaeyanm@sums.ac.ir
RI Leyva-Grado, Victor/AAF-1108-2019; Pouladfar, Gholamreza/Q-4347-2017;
   Azizi, Kourosh/P-8446-2017; Behzadi, Mohammadamin/AAD-4808-2019;
   Ziyaeyan, Mazyar/U-2620-2017
OI Leyva-Grado, Victor/0000-0002-9211-6160; Pouladfar,
   Gholamreza/0000-0001-8676-4607; Azizi, Kourosh/0000-0001-7051-2536;
   Behzadi, Mohammadamin/0000-0002-1691-6123; Ziyaeyan,
   Mazyar/0000-0001-9371-7518
FU Clinical Microbiology Research Center, Shiraz University of Medical
   Sciences, Namazi Hospital, Shiraz, Iran
FX The work was supported by the Clinical Microbiology Research Center,
   Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran.
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aghaie A, 2016, INDIAN J HEMATOL BLO, V32, P343, DOI 10.1007/s12288-015-0567-5
   Ahmadnejad F, 2011, EPIDEMIOL INFECT, V139, P1587, DOI 10.1017/S0950268811000173
   Ahmadnejad F, 2016, J ARTHROPOD-BORNE DI, V10, P317
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Bagheri M, 2015, VECTOR-BORNE ZOONOT, V15, P750, DOI 10.1089/vbz.2015.1778
   Bassal R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179774
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chinikar S, 2013, VECTOR-BORNE ZOONOT, V13, P586, DOI 10.1089/vbz.2012.1207
   Chinikar S, 2013, TRAVEL MED INFECT DI, V11, P166, DOI 10.1016/j.tmaid.2012.10.001
   Daniel LC, 2009, CANCER CAUSE CONTROL, V20, P313, DOI 10.1007/s10552-008-9245-3
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Doosti S, 2016, IRAN J PUBLIC HEALTH, V45, P1064
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028
   Fereidouni SR, 2011, VECTOR-BORNE ZOONOT, V11, P1377, DOI 10.1089/vbz.2010.0244
   Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956
   Guedes DRD, 2016, BIORXIV, DOI [10.1101/073197, DOI 10.1101/073197]
   Hadjichristodoulou C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143803
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Londono-Renteria B, 2016, METHODS MOL BIOL, V1435, P1, DOI 10.1007/978-1-4939-3670-0_1
   Mardani M, 2013, INT J PREVENTIVE MED, V4, P1075
   Martinez D, 2017, EMERG INFECT DIS, V23, P1372, DOI 10.3201/eid2308.170384
   Mavridis K, 2018, ACTA TROP, V182, P64, DOI 10.1016/j.actatropica.2018.02.024
   Meshkat Z, 2015, ASIAN PAC J TROP MED, V8, P203, DOI 10.1016/S1995-7645(14)60315-1
   Nagy A, 2016, ARCH VIROL, V161, P1797, DOI 10.1007/s00705-016-2844-5
   Nejati J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01660
   Patel CB, 2018, NEUROL SCI, V39, P251, DOI 10.1007/s10072-017-3164-6
   Pathak MA, 2004, J INVEST DERMATOL, V122, pXX, DOI 10.1046/j.1523-1747.2003.22248.x
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pezzotti P, 2011, EURO SURVEILL, V16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shahhosseini N, 2017, TROP MED INT HEALTH, V22, P1343, DOI 10.1111/tmi.12935
   Shaibi T, 2017, J VECTOR DIS, V54, P183
   Spiteri G, 2017, EURO SURVEILL, V22
   Tan CH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010044
   Vazquez A, 2016, J VIROL METHODS, V236, P266, DOI 10.1016/j.jviromet.2016.07.026
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zohaib A, 2015, EPIDEMIOL INFECT, V143, P1931, DOI 10.1017/S0950268814002878
NR 47
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2018
VL 12
IS 12
AR e0007022
DI 10.1371/journal.pntd.0007022
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HG6OX
UT WOS:000455103100043
PM 30557321
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xia, X
   Peng, CW
   Lu, YJ
   Zheng, XY
   Hong, XY
AF Xia, Xue
   Peng, Chang-Wu
   Lu, Yi-Jia
   Zheng, Xiao-Ying
   Hong, Xiao-Yue
TI Transfection and colonization of Tetranychus truncatus Wolbachia strain
   wTtru in cell lines of the mosquito Aedes albopictus
SO SYSTEMATIC AND APPLIED ACAROLOGY
LA English
DT Article
DE transfection; spider mite; mosquito; Wolbachia; wTtru; cell line
ID CYTOPLASMIC INCOMPATIBILITY; STRAIN WMEL; ZIKA VIRUS; ESTABLISHMENT;
   PIPIENTIS; MICROINJECTION; PROTOCOL; GENOME
AB Wolbachia are endosymbiotic bacteria that commonly infect arthropods and cause reproductive manipulations in hosts. Artificial transfection is one of the best methods for the study of Wolbachia-induced reproductive manipulations and its application in production practice. However, the low success rate of artificial transfection laid burden for investigation. The success rate of artificial transfection of Wolbachia between closely related hosts is usually higher than distant hosts, but the mechanism of transfection is unknown. In our study, the wTtru strain (supergroup B) infecting the Arachnida Tetranychus truncatus was transfected into the Aedes albopictus cell line (native-infected with wAlB strain from supergroup B). The wTtru strain was quantified and localized in the cell line to observe dynamic changes after transfection. A phylogenetic analysis of the relationship between the wTtru strain and the wAlB strain showed that the wTtru (ST=278) strain belonged to supergroup B and was closely related to the mosquitoes native Wolbachia wAlbB (ST=464), so we speculate that successful transfection was related to the Wolbachia strain, and furthermore, Wolbachia strain may be more important than host relationship. Our results provide a factual basis for studying artificial transfection of Wolbachia, and show that Wolbachia transfection between distant hosts can be achieved.
C1 [Xia, Xue; Peng, Chang-Wu; Lu, Yi-Jia; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing 210095, Jiangsu, Peoples R China.
   [Zheng, Xiao-Ying] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.
RP Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing 210095, Jiangsu, Peoples R China.
EM xyhong@njau.edu.cn
RI Hong, Xiao-Yue/AAF-4759-2020
OI Zheng, Xiaoying/0000-0001-6264-8433; Xia, Xue/0000-0002-1888-1235
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31672035, 31871976]
FX We sincerely thank Drs. Hai-Jian Huang and Xiao-Li Bing of Nanjing
   Agricultural University, China for their helpful comments on the
   manuscript. This study was supported in part by a grant-in-aid for
   Scientific Research (31672035, 31871976) from the National Natural
   Science Foundation of China.
CR Aksoy S., 2008, TRANSGENESIS MANAGEM, pvii, DOI [10.1038/srep28792, DOI 10.1038/SREP28792]
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587
   Breeuwer JAJ, 1997, HEREDITY, V79, P41, DOI 10.1038/hdy.1997.121
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chang NW, 1996, CAN J MICROBIOL, V42, P711, DOI 10.1139/m96-097
   Christodoulou M, 2011, LANCET INFECT DIS, V11, P84, DOI 10.1016/S1473-3099(11)70017-2
   Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002
   Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Gotoh T, 2003, HEREDITY, V91, P208, DOI 10.1038/sj.hdy.6800329
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Herbert RI, 2018, SYMBIOSIS, V74, P225, DOI 10.1007/s13199-017-0503-6
   Hermans PG, 2001, J ANTIMICROB CHEMOTH, V47, P659, DOI 10.1093/jac/47.5.659
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hurst GDD, 1997, GENET RES, V70, P1, DOI 10.1017/S0016672397002838
   Iturbe-Ormaetxe I, 2011, J MICROBIOL METH, V84, P134, DOI 10.1016/j.mimet.2010.10.019
   Lefoulon E, 2016, PEERJ, V4, DOI 10.7717/peerj.1840
   Mavingui P, 2005, APPL ENVIRON MICROB, V71, P6910, DOI 10.1128/AEM.71.11.6910-6917.2005
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Schilthuizen M, 1998, HEREDITY, V81, P270, DOI 10.1046/j.1365-2540.1998.00385.x
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0
   SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154
   Siozios S, 2018, CURR BIOL, V28, pR269, DOI 10.1016/j.cub.2018.02.008
   Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71
   Van Meer MMM, 1999, HEREDITY, V82, P163, DOI 10.1038/sj.hdy.6884610
   Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   White PM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03425-16
   Xi ZY, 2005, APPL ENVIRON MICROB, V71, P3199, DOI 10.1128/AEM.71.6.3199-3204.2005
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Xie RR, 2011, APPL ENTOMOL ZOOL, V46, P95, DOI 10.1007/s13355-010-0014-x
   Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101
   Zhou XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39200
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 41
TC 2
Z9 2
U1 4
U2 13
PU SYSTEMATIC & APPLIED ACAROLOGY SOC LONDON, NATURAL HISTORY MUSEUM
PI LONDON
PA DEPT ENTOMOLOGY, LONDON, SW7 5BD, ENGLAND
SN 1362-1971
J9 SYST APPL ACAROL-UK
JI Syst. Appl. Acarol.
PD DEC
PY 2018
VL 23
IS 12
BP 2420
EP 2431
DI 10.11158/saa.23.12.11
PG 12
WC Entomology
SC Entomology
GA HG6GU
UT WOS:000455079900011
DA 2020-07-08
ER

PT J
AU Barnard, TR
   Rajah, MM
   Sagan, SM
AF Barnard, Trisha R.
   Rajah, Maaran M.
   Sagan, Selena M.
TI Contemporary Zika Virus Isolates Induce More dsRNA and Produce More
   Negative-Strand Intermediate in Human Astrocytoma Cells
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; flavivirus; astrocytomas; dsRNA; viral fitness
ID EPIDEMIC; STRAINS; OUTBREAK; AFRICAN; BRAIN
AB The recent emergence and rapid geographic expansion of Zika virus (ZIKV) poses a significant challenge for public health. Although historically causing only mild febrile illness, recent ZIKV outbreaks have been associated with more severe neurological complications, such as Guillain-Barre syndrome and fetal microcephaly. Here we demonstrate that two contemporary (2015) ZIKV isolates from Puerto Rico and Brazil may have increased replicative fitness in human astrocytoma cells. Over a single infectious cycle, the Brazilian isolate replicates to higher titers and induces more severe cytopathic effects in human astrocytoma cells than the historical African reference strain or an early Asian lineage isolate. In addition, both contemporary isolates induce significantly more double-stranded RNA in infected astrocytoma cells, despite similar numbers of infected cells across isolates. Moreover, when we quantified positive- and negative-strand viral RNA, we found that the Asian lineage isolates displayed substantially more negative-strand replicative intermediates than the African lineage isolate in human astrocytoma cells. However, over multiple rounds of infection, the contemporary ZIKV isolates appear to be impaired in cell spread, infecting a lower proportion of cells at a low MOI despite replicating to similar or higher titers. Taken together, our data suggests that contemporary ZIKV isolates may have evolved mechanisms that allow them to replicate with increased efficiency in certain cell types, thereby highlighting the importance of cell-intrinsic factors in studies of viral replicative fitness.
C1 [Barnard, Trisha R.; Rajah, Maaran M.; Sagan, Selena M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
   [Sagan, Selena M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada.
RP Sagan, SM (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.; Sagan, SM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada.
EM trisha.barnard@mail.mcgill.ca; michael.rajah@mail.mcgill.ca;
   selena.sagan@mcgill.ca
OI Sagan, Selena/0000-0002-8484-3632
FU Radcliffe Bequeath; Fonds de Recherche du Quebec Nature et Technologies
   [189120]; McGill University; Canada Research Chairs programCanada
   Research Chairs
FX This work was supported by the Radcliffe Bequeath, operating funds from
   the Fonds de Recherche du Quebec Nature et Technologies (#189120), and
   start-up funds provided by McGill University (S.M.S). In addition, this
   research was undertaken, in part, thanks to funding from the Canada
   Research Chairs program.
CR Airo AM, 2018, VIROLOGY, V516, P147, DOI 10.1016/j.virol.2018.01.009
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Barnard T.R., 2018, COMMUNICATION
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heldt CL, 2006, J VIROL METHODS, V135, P56, DOI 10.1016/j.jviromet.2006.01.022
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Kuivanen S, 2017, J GEN VIROL, V98, P1744, DOI 10.1099/jgv.0.000857
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wakerley BR, 2015, EXPERT REV NEUROTHER, V15, P847, DOI 10.1586/14737175.2015.1065732
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   WISE J, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/bmj.i1242
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
NR 48
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2018
VL 10
IS 12
AR 728
DI 10.3390/v10120728
PG 17
WC Virology
SC Virology
GA HG9FQ
UT WOS:000455313100067
PM 30572570
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bhadra, S
   Saldana, MA
   Han, HG
   Hughes, GL
   Ellington, AD
AF Bhadra, Sanchita
   Saldana, Miguel A.
   Han, Hannah Grace
   Hughes, Grant L.
   Ellington, Andrew D.
TI Simultaneous Detection of Different Zika Virus Lineages via Molecular
   Computation in a Point-of-Care Assay
SO VIRUSES-BASEL
LA English
DT Article
DE point-of-care diagnostics; isothermal nucleic acid amplification;
   nucleic acid computation; nucleic acid strand exchange; zika virus;
   mosquito; mosquito surveillance; multiplex nucleic acid detection;
   boolean logic-processing nucleic acid probes
ID MEDIATED ISOTHERMAL AMPLIFICATION; RECOMBINASE POLYMERASE AMPLIFICATION;
   CHAIN-REACTION; NUCLEIC-ACIDS; DIAGNOSTICS; LAMP; ALIGNMENT; ACCURACY;
   CIRCUITS; PLATFORM
AB We have developed a generalizable smart molecular diagnostic capable of accurate point-of-care (POC) detection of variable nucleic acid targets. Our isothermal assay relies on multiplex execution of four loop-mediated isothermal amplification reactions, with primers that are degenerate and redundant, thereby increasing the breadth of targets while reducing the probability of amplification failure. An easy-to-read visual answer is computed directly by a multi-input Boolean OR logic gate (gate output is true if either one or more gate inputs is true) signal transducer that uses degenerate strand exchange probes to assess any combination of amplicons. We demonstrate our methodology by using the same assay to detect divergent Asian and African lineages of the evolving Zika virus (ZIKV), while maintaining selectivity against non-target viruses. Direct analysis of biological specimens proved possible, with crudely macerated ZIKV-infected Aedes aegypti mosquitoes being identified with 100% specificity and sensitivity. The ease-of-use with minimal instrumentation, broad programmability, and built-in fail-safe reliability make our smart molecular diagnostic attractive for POC use.
C1 [Bhadra, Sanchita; Han, Hannah Grace; Ellington, Andrew D.] Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA.
   [Saldana, Miguel A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Hughes, Grant L.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Hughes, Grant L.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Hughes, Grant L.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
RP Bhadra, S (corresponding author), Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA.
EM sanchitabhadra@utexas.edu; misaldan@utmb.edu; whitehannahhan@gmail.com;
   Grant.Hughes@lstmed.ac.uk; ellingtonlab@gmail.com
OI Saldana, Miguel/0000-0003-0470-1667; Hughes, Grant/0000-0002-7567-7185;
   Bhadra, Sanchita/0000-0002-4956-2405
FU Bill and Melinda Gates FoundationGates Foundation [OPP1128792]; National
   Science Foundation BEACON [DBI-0939454]; National Institute of Allergy
   and Infectious Diseases Small Business Innovation Research [R43
   AI131948]; Wolfson Foundation; University of Texas Rising Star award;
   Western Gulf Center of Excellence for Vector-borne Diseases [R21AI1380];
   Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [CK17-005]; Robert J. and Helen Kleberg Foundation; Gulf Coast
   Consortia; National Institutes of Health T32 fellowship [2T32AI007526]; 
   [Roy74];  [R21AI124452];  [R21AI129507]
FX This work was supported by a Bill and Melinda Gates Foundation grant
   (OPP1128792) and the National Science Foundation BEACON (DBI-0939454)
   grant to ADE and a National Institute of Allergy and Infectious Diseases
   Small Business Innovation Research grant (R43 AI131948) to ADE and GLH.
   GLH was also supported by the Wolfson Foundation and Roy74, R21AI124452
   and R21AI129507); a University of Texas Rising Star award; the Western
   Gulf Center of Excellence for Vector-borne Diseases (al Society;
   National Institutes of Health grants (R21AI1380Centers for Disease
   Control and Prevention grant CK17-005); the Robert J. and Helen Kleberg
   Foundation; and the Gulf Coast Consortia. MS was supported by a National
   Institutes of Health T32 fellowship (2T32AI007526). The papers contents
   are solely the responsibility of the authors and do not necessarily
   represent the official views of the Centers for Disease Control and
   Prevention or the Department of Health and Human Services.
CR Allen PB, 2012, LAB CHIP, V12, P2951, DOI 10.1039/c2lc40373k
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bhadra Sanchita, 2018, PLoS Negl Trop Dis, V12, pe0006671, DOI 10.1371/journal.pntd.0006671
   Bhadra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123126
   Bi S, 2017, CHEM SOC REV, V46, P4281, DOI 10.1039/c7cs00055c
   Blaser S, 2018, PEST MANAG SCI, V74, P1504, DOI 10.1002/ps.4866
   Bruen D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081866
   Carter C, 2017, J VIROL METHODS, V244, P32, DOI 10.1016/j.jviromet.2017.02.013
   Chen HW, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00415
   Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Du Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11039
   Ebbinghaus P, 2012, EXP PARASITOL, V131, P40, DOI 10.1016/j.exppara.2012.02.024
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x
   Gandelman O, 2011, INT J MOL SCI, V12, P9108, DOI 10.3390/ijms12129108
   Ge YY, 2017, INT J NANOMED, V12, P2645, DOI 10.2147/IJN.S132670
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Gnoth C, 2014, GEBURTSH FRAUENHEILK, V74, P661, DOI 10.1055/s-0034-1368589
   Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Howson ELA, 2017, TRANSBOUND EMERG DIS, V64, P861, DOI 10.1111/tbed.12451
   Jiang YS, 2018, WATER RES, V131, P186, DOI 10.1016/j.watres.2017.12.023
   Jiang YS, 2017, CHEMBIOCHEM, V18, P1692, DOI 10.1002/cbic.201700317
   Jiang YS, 2015, ANAL CHEM, V87, P3314, DOI 10.1021/ac504387c
   Jung C, 2014, ACCOUNTS CHEM RES, V47, P1825, DOI 10.1021/ar500059c
   Kaushik A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28035-3
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17
   Kubota R, 2015, INT J MOL SCI, V16, P4786, DOI 10.3390/ijms16034786
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738
   Lemmon Gordon H, 2008, Ann Clin Microbiol Antimicrob, V7, P18, DOI 10.1186/1476-0711-7-18
   Li BL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr504
   Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808
   Mamba TS, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/7659730
   Maples B.K., 2009, U.S. Patent, Patent No. [US 2009/0017453 A1, 20090017453, 20090017453A1]
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Nakiyingi L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2992-1
   Nilsson M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf065
   Nolte FS, 2016, J CLIN MICROBIOL, V54, P2763, DOI 10.1128/JCM.01586-16
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Nunes MRT, 2015, J VIROL METHODS, V226, P40, DOI 10.1016/j.jviromet.2015.10.003
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Poon LLM, 2005, J CLIN MICROBIOL, V43, P427, DOI 10.1128/JCM.43.1.427-430.2005
   Powell ML, 2018, ANAL BIOCHEM, V543, P108, DOI 10.1016/j.ab.2017.12.003
   Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262
   Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang JS, 2017, NAT CHEM, V9, P1222, DOI [10.1038/NCHEM.2820, 10.1038/nchem.2820]
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong YP, 2018, J APPL MICROBIOL, V124, P626, DOI 10.1111/jam.13647
   Xing WW, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2182-6
   Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596
   Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532
   Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 73
TC 1
Z9 1
U1 3
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2018
VL 10
IS 12
AR 714
DI 10.3390/v10120714
PG 22
WC Virology
SC Virology
GA HG9FQ
UT WOS:000455313100053
PM 30558136
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simon, D
   Fajardo, A
   Moreno, P
   Moratorio, G
   Cristina, J
AF Simon, Diego
   Fajardo, Alvaro
   Moreno, Pilar
   Moratorio, Gonzalo
   Cristina, Juan
TI An Evolutionary Insight into Zika Virus Strains Isolated in the Latin
   American Region
SO VIRUSES-BASEL
LA English
DT Article
DE Zika; viral evolution; genetic variability; Bayesian analyses
ID CODON USAGE; PRM PROTEIN; EPIDEMIC; DIVERSIFICATION; INFECTION;
   SELECTION; OUTBREAK; BIOLOGY
AB Zika virus (ZIKV) is an emerging pathogen member of the Flaviviridae family. ZIKV has spread rapidly in the Latin American region, causing hundreds of thousands of cases of ZIKV disease, as well as microcephaly in congenital infections. Detailed studies on the pattern of evolution of ZIKV strains have been extremely important to our understanding of viral survival, fitness, and evasion of the host's immune system. For these reasons, we performed a comprehensive phylogenetic analysis of ZIKV strains recently isolated in the Americas. The results of these studies revealed evidence of diversification of ZIKV strains circulating in the Latin American region into at least five different genetic clusters. This diversification was also reflected in the different trends in dinucleotide bias and codon usage variation. Amino acid substitutions were found in E and prM proteins of the ZIKV strains isolated in this region, revealing the presence of novel genetic variants circulating in Latin America.
C1 [Simon, Diego; Fajardo, Alvaro; Moreno, Pilar; Moratorio, Gonzalo; Cristina, Juan] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Igua 4225, Montevideo 11400, Uruguay.
   [Simon, Diego] Univ Republica, Fac Ciencias, Lab Org & Evoluc Genoma, Unidad Genom Evolut, Igua 4225, Montevideo 11400, Uruguay.
   [Moratorio, Gonzalo] Inst Pasteur Montevideo, Lab Inmunovirol, Mataojo 2020, Montevideo 11400, Uruguay.
RP Moratorio, G; Cristina, J (corresponding author), Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Igua 4225, Montevideo 11400, Uruguay.; Moratorio, G (corresponding author), Inst Pasteur Montevideo, Lab Inmunovirol, Mataojo 2020, Montevideo 11400, Uruguay.
EM dsimon@fcien.edu.uy; afajardo32@gmail.com; pmoreno@cin.edu.uy;
   gonzalo.moratorio@pasteur.fr; cristina@cin.edu.uy
OI Simon, Diego/0000-0002-6317-3991; Moreno, Pilar/0000-0001-6155-7206
FU Agencia Nacional de Investigacion e Innovacion; PEDECIBA, Uruguay;
   Comision Sectorial de Investigaciones Cientifica, Universidad de la
   Republica, Uruguay; DARPA PREEMPT program [HR001118S0017-PREEMPT-FP001]
FX This research was funded by Agencia Nacional de Investigacion e
   Innovacion and PEDECIBA, Uruguay. We acknowledge the Comision Sectorial
   de Investigaciones Cientifica, Universidad de la Republica, Uruguay, for
   support through Grupos I + D grant. This work was also funded by the
   DARPA PREEMPT program managed by Jim Gimlett and administered though
   DARPA Cooperative Agreement #HR001118S0017-PREEMPT-FP001 (the content of
   the information does not necessarily reflect the position or the policy
   of the U.S. government, and no official endorsement should be inferred).
CR Aldunate F, 2017, J MED VIROL, V89, P2059, DOI 10.1002/jmv.24910
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo E, 2018, EUR BIOPHYS J BIOPHY, V47, P443, DOI 10.1007/s00249-018-1282-6
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Holmes E.C., 2009, EVOLUTION EMERGENCE, P113
   Costafreda MI, 2014, J VIROL, V88, P5029, DOI 10.1128/JVI.00087-14
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Oliveira ERA, 2017, J COMPUT AID MOL DES, V31, P1009, DOI 10.1007/s10822-017-0076-8
   Piontkivska H, 2017, ECOL EVOL, V7, P4475, DOI 10.1002/ece3.3033
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Simon D, 2017, BIOCHEM BIOPH RES CO, V492, P572, DOI 10.1016/j.bbrc.2017.06.088
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166
   Wang HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166260
   World Health Organization, 2018, WHO VACC PIP TRACK
   Yoshii K, 2012, J GEN VIROL, V93, P27, DOI 10.1099/vir.0.035964-0
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 45
TC 3
Z9 3
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2018
VL 10
IS 12
AR 698
DI 10.3390/v10120698
PG 11
WC Virology
SC Virology
GA HG9FQ
UT WOS:000455313100037
PM 30544785
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thurmond, S
   Wang, BX
   Song, JK
   Hai, R
AF Thurmond, Stephanie
   Wang, Boxiao
   Song, Jikui
   Hai, Rong
TI Suppression of Type I Interferon Signaling by Flavivirus NS5
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; ZIKV; NS5; type I IFN antagonist
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN 5; NF-KAPPA-B; DENGUE VIRUS;
   ZIKA-VIRUS; JAPANESE-ENCEPHALITIS; ALPHA/BETA-INTERFERON;
   NUCLEAR-LOCALIZATION; ANTAGONIST FUNCTION; BORNE FLAVIVIRUS
AB Type I interferon (IFN-I) is the first line of mammalian host defense against viral infection. To counteract this, the flaviviruses, like other viruses, have encoded a variety of antagonists, and use a multi-layered molecular defense strategy to establish their infections. Among the most potent antagonists is non-structural protein 5 (NS5), which has been shown for all disease-causing flaviviruses to target different steps and players of the type I IFN signaling pathway. Here, we summarize the type I IFN antagonist mechanisms used by flaviviruses with a focus on the role of NS5 in regulating one key regulator of type I IFN, signal transducer and activator of transcription 2 (STAT2).
C1 [Thurmond, Stephanie; Hai, Rong] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
   [Thurmond, Stephanie; Hai, Rong] Univ Calif Riverside, Grad Program Cell Mol & Dev Biol, Riverside, CA 92521 USA.
   [Wang, Boxiao; Song, Jikui] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
RP Hai, R (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.; Hai, R (corresponding author), Univ Calif Riverside, Grad Program Cell Mol & Dev Biol, Riverside, CA 92521 USA.; Song, JK (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
EM sthur002@ucr.edu; bwang030@ucr.edu; jikui.song@ucr.edu; ronghai@ucr.edu
FU UCR Regent Fellowships; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1R35GM11972]
FX We apologize to those with relevant work who could not be
   discussed/cited due to space limitations. This research was supported by
   UCR Regent Fellowships to R.H. and J.S. and provided in part by the
   National Institutes of Health grant 1R35GM11972 to J.S.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09
   Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0
   Blaszczyk K, 2016, CYTOKINE GROWTH F R, V29, P71, DOI 10.1016/j.cytogfr.2016.02.010
   Blaszczyk K, 2015, BIOCHEM J, V466, P511, DOI 10.1042/BJ20140644
   Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600
   Bowick GC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-122
   Bradrick SS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02374
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203
   Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Dethoff EA, 2018, P NATL ACAD SCI USA, V115, P11513, DOI 10.1073/pnas.1716689115
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Keating JA, 2013, VECTOR-BORNE ZOONOT, V13, P590, DOI 10.1089/vbz.2012.1110
   Keating JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-242
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lopez-Denman AJ, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12848
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Morozova OV, 1997, VIRUS RES, V49, P9, DOI 10.1016/S0168-1702(96)01433-5
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Ousman SS, 2005, J VIROL, V79, P7514, DOI 10.1128/JVI.79.12.7514-7527.2005
   Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06
   Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297
   Petering H, 1999, BLOOD, V93, P694, DOI 10.1182/blood.V93.2.694.402k31_694_702
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998
   ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143
   Saisawang C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193133
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Slonchak A, 2018, ANTIVIR RES, V159, P13, DOI 10.1016/j.antiviral.2018.09.006
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Stabell AC, 2018, ELIFE, V7, DOI [10.7554/eLife.31919, 10.7554/elife.31919]
   Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16
   Sun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03932-1
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209
   Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Ziv O, 2018, NAT METHODS, V15, P785, DOI 10.1038/s41592-018-0121-0
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 123
TC 5
Z9 5
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2018
VL 10
IS 12
AR 712
DI 10.3390/v10120712
PG 16
WC Virology
SC Virology
GA HG9FQ
UT WOS:000455313100051
PM 30558110
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, LZ
   Ji, W
   Lyu, S
   Qiao, LH
   Luo, GX
AF Zhang, Lizhou
   Ji, Wei
   Lyu, Shuang
   Qiao, Luhua
   Luo, Guangxiang
TI Tet-Inducible Production of Infectious Zika Virus from the Full-Length
   cDNA Clones of African- and Asian-Lineage Strains
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; reverse genetics; infectious cDNA; Tet-inducible; MR766;
   FSS13025
ID SEXUAL TRANSMISSION; SYSTEMS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged as an important human viral pathogen, causing congenital malformation including microcephaly among infants born to mothers infected with the virus during pregnancy. Phylogenetic analysis suggested that ZIKV can be classified into African and Asian lineages. In this study, we have developed a stable plasmid-based reverse genetic system for robust production of both ZIKV prototype African-lineage MR766 and clinical Asian-lineage FSS13025 strains using a tetracycline (Tet)-controlled gene expression vector. Transcription of the full-length ZIKV RNA is under the control of the Tet-responsive P-tight promoter at the 5 end and an antigenomic ribozyme of hepatitis delta virus at the 3 end. The transcription of infectious ZIKV RNA genome was efficiently induced by doxycycline. This novel ZIKV reverse genetics system will be valuable for the study of molecular viral pathogenesis of ZIKV and the development of new vaccines against ZIKV infection.
C1 [Zhang, Lizhou; Lyu, Shuang; Qiao, Luhua; Luo, Guangxiang] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA.
   [Ji, Wei; Luo, Guangxiang] Peking Univ, Dept Microbiol, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100191, Peoples R China.
RP Luo, GX (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA.; Luo, GX (corresponding author), Peking Univ, Dept Microbiol, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100191, Peoples R China.
EM lizhou8728@gmail.com; jiwei_yunlong@126.com; shuanglv@uab.edu;
   luhuaq@gmail.com; gluo@uab.edu
OI Luo, Guangxiang/0000-0002-0354-6020
FU University of Alabama at Birmingham; Development Program (973) of China
   [2012CB518900]
FX This work was partially supported by Development Fund from the
   University of Alabama at Birmingham and the Development Program (973) of
   China (2012CB518900).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005
   Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lewin A, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-19
   Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018197
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
NR 37
TC 1
Z9 1
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2018
VL 10
IS 12
AR 700
DI 10.3390/v10120700
PG 16
WC Virology
SC Virology
GA HG9FQ
UT WOS:000455313100039
PM 30544871
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yew, CHT
   Azari, P
   Choi, JR
   Muhamad, F
   Pingguan-Murphy, B
AF Yew, Chee Hong Takahiro
   Azari, Pedram
   Choi, Jane Ru
   Muhamad, Farina
   Pingguan-Murphy, Belinda
TI Electrospun Polycaprolactone Nanofibers as a Reaction Membrane for
   Lateral Flow Assay
SO POLYMERS
LA English
DT Article
DE electrospun PCL nanofibers; lateral flow assay; nucleic acid detection;
   point-of-care applications
ID SURFACE MODIFICATION; CONTACT-ANGLE; POINT; FUNCTIONALIZATION;
   HYDROPHILICITY; PLATFORMS; BIOSENSOR; FIBERS; PET
AB Electrospun polycaprolactone (PCL) nanofibers have emerged as a promising material in diverse biomedical applications due to their various favorable features. However, their application in the field of biosensors such as point-of-care lateral flow assays (LFA) has not been investigated. The present study demonstrates the use of electrospun PCL nanofibers as a reaction membrane for LFA. Electrospun PCL nanofibers were treated with NaOH solution for different concentrations and durations to achieve a desirable flow rate and optimum detection sensitivity in nucleic acid-based LFA. It was observed that the concentration of NaOH does not affect the physical properties of nanofibers, including average fiber diameter, average pore size and porosity. However, interestingly, a significant reduction of the water contact angle was observed due to the generation of hydroxyl and carboxyl groups on the nanofibers, which increased their hydrophilicity. The optimally treated nanofibers were able to detect synthetic Zika viral DNA (as a model analyte) sensitively with a detection limit of 0.5 nM. Collectively, the benefits such as low-cost of fabrication, ease of modification, porous nanofibrous structures and tunability of flow rate make PCL nanofibers a versatile alternative to nitrocellulose membrane in LFA applications. This material offers tremendous potential for a broad range of point-of-care applications.
C1 [Yew, Chee Hong Takahiro; Azari, Pedram; Muhamad, Farina; Pingguan-Murphy, Belinda] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
   [Azari, Pedram] Univ Malaya, Dept Biomed Engn, Fac Engn, Ctr Appl Biomech, Kuala Lumpur 50603, Malaysia.
   [Choi, Jane Ru] Univ British Columbia, Dept Mech Engn, 2054-6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada.
   [Choi, Jane Ru] Univ British Columbia, Life Sci Ctr, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.
RP Muhamad, F; Pingguan-Murphy, B (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
EM yewcheehongtakahiro@gmail.com; pedram.azari@gmail.com;
   janeruchoi@gmail.com; farinamuhamad@um.edu.my; bpingguan@um.edu.my
RI Pingguan-Murphy, Belinda/B-8332-2010; Choi, Jane Ru/A-1245-2015; Azari,
   Pedram/Q-7407-2016
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141; Choi, Jane
   Ru/0000-0002-1537-6989; Azari, Pedram/0000-0002-1918-4247
FU University Malaya UMRG Programme Grant-AET (Innovative Technology
   Research ITRC) [RP041B-17AET]; University Malaya Grant-the Frontier
   Research Grant [FG021-17AFR]; RU Grant-Fakulti Program [GPF013A-2018]
FX This research was financially supported by the University Malaya UMRG
   Programme Grant-AET (Innovative Technology Research ITRC) RP041B-17AET,
   University Malaya Grant-the Frontier Research Grant (FG021-17AFR) and RU
   Grant-Fakulti Program Project No. GPF013A-2018.
CR Akram H, 2014, MATER RES INNOV, V18, P520, DOI 10.1179/1432891714Z.0000000001039
   Alisch-Mark M, 2006, BIOTECHNOL LETT, V28, P681, DOI 10.1007/s10529-006-9041-7
   Asadian M, 2015, J IRAN CHEM SOC, V12, P1089, DOI 10.1007/s13738-014-0569-5
   Azari P, 2015, INT J POLYM MATER PO, V64, P785, DOI 10.1080/00914037.2015.1030648
   Chen BY, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10111259
   Choi JR, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600920
   Choi JR, 2016, ANAL CHEM, V88, P6254, DOI 10.1021/acs.analchem.6b00195
   Choi JR, 2016, LAB CHIP, V16, P611, DOI 10.1039/c5lc01388g
   de Puig H, 2017, TRENDS BIOTECHNOL, V35, P1169, DOI 10.1016/j.tibtech.2017.09.001
   Donelli I, 2009, BIOTECHNOL BIOENG, V103, P845, DOI 10.1002/bit.22316
   Guarino V, 2012, INT MATER REV, V57, P256, DOI 10.1179/0950660812Z.00000000021
   Guler Z, 2015, MATER EXPRESS, V5, P269, DOI 10.1166/mex.2015.1249
   Hai T, 2019, MATER DESIGN, V162, P70, DOI 10.1016/j.matdes.2018.11.036
   Kosorn W, 2013, ADV MATER RES-SWITZ, V747, P178, DOI 10.4028/www.scientific.net/AMR.747.178
   Li DP, 2006, J MEMBRANE SCI, V279, P354, DOI 10.1016/j.memsci.2005.12.036
   Li JJ, 2018, EUR J PHARM SCI, V122, P195, DOI 10.1016/j.ejps.2018.07.002
   Li LY, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10101061
   Lin WC, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10030231
   Liu XK, 2019, CHEM ENG J, V356, P886, DOI 10.1016/j.cej.2018.09.096
   Luo YL, 2012, IEEE T NANOTECHNOL, V11, P676, DOI 10.1109/TNANO.2011.2174801
   Luo YL, 2010, BIOSENS BIOELECTRON, V26, P1612, DOI 10.1016/j.bios.2010.08.028
   Manavitehrani I, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8010020
   Mao W, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201700057
   Reinholt SJ, 2014, ANAL BIOANAL CHEM, V406, P3297, DOI 10.1007/s00216-013-7372-5
   Rouxhet L, 1998, J BIOMAT SCI-POLYM E, V9, P1279, DOI 10.1163/156856298X00398
   Sanchez LD, 2016, BIOMATERIALS, V106, P24, DOI 10.1016/j.biomaterials.2016.08.011
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Shahmoradi S, 2017, MAT SCI ENG C-MATER, V73, P300, DOI 10.1016/j.msec.2016.11.076
   Shao XY, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030480
   Stalder AF, 2010, COLLOID SURFACE A, V364, P72, DOI 10.1016/j.colsurfa.2010.04.040
   Thenmozhi S, 2017, MATER SCI ENG B-ADV, V217, P36, DOI 10.1016/j.mseb.2017.01.001
   Varesano A, 2010, POLYM INT, V59, P1606, DOI 10.1002/pi.2893
   Walper SA, 2018, ACS SENSORS, V3, P1894, DOI 10.1021/acssensors.8b00420
   Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005
   Wang X, 2009, POLYM ENG SCI, V49, P1582, DOI 10.1002/pen.21377
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   Worsley GJ, 2012, BIOSENS BIOELECTRON, V34, P215, DOI 10.1016/j.bios.2012.02.005
   Wu H, 2010, J BIOMED MATER RES A, V92A, P238, DOI 10.1002/jbm.a.32376
   Yang YY, 2019, CARBOHYD POLYM, V203, P228, DOI 10.1016/j.carbpol.2018.09.061
   Yu DG, 2018, J CONTROL RELEASE, V292, P91, DOI 10.1016/j.jconrel.2018.08.016
   Zhang JJ, 2016, ACS SENSORS, V1, P1091, DOI 10.1021/acssensors.6b00270
NR 41
TC 9
Z9 9
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD DEC
PY 2018
VL 10
IS 12
AR 1387
DI 10.3390/polym10121387
PG 14
WC Polymer Science
SC Polymer Science
GA HG1VI
UT WOS:000454748700095
PM 30961312
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Supriyo, E
   Abidin, Z
   Nugraheni
   Handayani, D
AF Supriyo, Edy
   Abidin, Zainal
   Nugraheni
   Handayani, Dwi
TI Effective Emulsifier Concentrate Liquid Insecticide to Eradicate
   Mosquito Aedes aegypti to Prevent Dengue Fever and Zika
SO ADVANCED SCIENCE LETTERS
LA English
DT Proceedings Paper
CT International Conference on Engineering Application, Physics and
   Sciences (ICEAPS)
CY OCT 26-27, 2017
CL Johor Bahru, MALAYSIA
DE Aedes aegypti; Emulsifier Concentrate; Insectiside; Malathion
AB To prevent spread out of dengue fever and zyka, fogging is carried out to kill the mosquito of Aedes aegypti. But the formulation of liquid insecticide is usually only kill the mosquito but not the larvae in the water. Therefore it is needed to seek the emulsion of insectiside that will kill the larvae in the water. In the emulsion formulation, the important point is unite insoluble matter become a homogeny and stable formulation for long period. The selection of emulsifier type is very important because it is influenced by quality and EC formulation stability. The result of present work revealed that the best formula is 15% propoxure, 4% malathion, 6% perytroid, 20% DBS, 50% Xyline dan 5% additive (%w/w). Emulsion stability tests run in oil and water phase showed that terpentine is best solvent because it is more stable in the emulsion form, separated oil percentage at concentration 3 mg/I was 40% in water phase with oil phase, while coaslence between droplet formed micro emulsion in water phase, there no seperation in the water at emulsifier concentration of 3 pprn. The efficacy test in glass chamber using sprayer method, the best dose concentration was 0,5-0,25% (v/v), for mosquito and larvae of Aedes aegypti (45-90% mortality at 24 hours).
C1 [Supriyo, Edy; Abidin, Zainal; Nugraheni; Handayani, Dwi] Diponegoro Univ, Sch Vocat, Chem Engn Dept, Jl Prof Sudharto SH, Tembalang 50275, Semarang, Indonesia.
RP Supriyo, E (corresponding author), Diponegoro Univ, Sch Vocat, Chem Engn Dept, Jl Prof Sudharto SH, Tembalang 50275, Semarang, Indonesia.
CR [Anonymous], 2004, PESTISIDA DAN HIGIEN, P60
   Hendartini, 2003, PENELITIAN PEMBUATAN, P23
   Kristina, 2004, JURNAL KAJIAN MASALA, V2, P23
   Supriyo E., 2004, EVALUASI SISTEM FOGI, P23
   Supriyo E., 2009, PROS SEM KIM DAN PEN, P581
NR 5
TC 0
Z9 0
U1 0
U2 2
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
EI 1936-7317
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD DEC
PY 2018
VL 24
IS 12
BP 9607
EP 9609
DI 10.1166/asl.2018.13089
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF9RL
UT WOS:000454579800138
DA 2020-07-08
ER

PT J
AU Chanampa, M
   Gil, JF
   Aparicio, JP
   Castillo, P
   Mangudo, C
   Copa, GN
   Gleiser, RM
AF Chanampa, Mariana
   Gil, Jose F.
   Aparicio, Juan P.
   Castillo, Paola
   Mangudo, Carolina
   Copa, Griselda N.
   Gleiser, Raquel M.
TI Field comparison of oviposition substrates used in ovitraps for Aedes
   aegypti surveillance in Salta, Argentina
SO JOURNAL OF APPLIED ENTOMOLOGY
LA English
DT Article
DE Culicidae; dengue; eggs; monitoring; mosquitoes; zika
ID DIPTERA-CULICIDAE EGGS; DENGUE VECTOR; ALBOPICTUS; CHIKUNGUNYA;
   PREFERENCE; HABITATS; PATTERNS; EFFICACY; BEHAVIOR; SPREAD
AB Aedes aegypti L. (Diptera: Culicidae) is a mosquito broadly found in tropical and temperate areas of the world. It is the main vector of dengue, chikungunya, zika and yellow fever (urban cycle), among other viruses. Aedes aegypti immatures develop in water holding containers, and frequently use artificial containers in urban settings as larval habitat. Ovitraps are artificial oviposition sites, a tool developed for mosquito population surveillance and to assess effectiveness of control measures. The preference for different oviposition substrate materials was assessed in the field, in two localities of Salta province, northern Argentina, where dengue outbreaks are frequent. The proportion of positive traps did not differ between oviposition substrates. However, higher numbers of eggs were laid in cotton fabric and velour paper, which were better than wooden paddle and blotting paper if the aim was to maximize the numbers of eggs collected. The results also evidenced that substrate preference for oviposition did not differ between geographic regions.
C1 [Chanampa, Mariana; Gil, Jose F.; Aparicio, Juan P.; Mangudo, Carolina] Univ Nacl Salta, CONICET, UNSa, Inst Invest Energia No Convenc INENCO, Av Bolivia 5150,A4400FVY, Salta, Argentina.
   [Gil, Jose F.; Copa, Griselda N.] Univ Nacl Salta, Sede Reg Oran, Inst Invest Enfermedades Trop, Salta, Argentina.
   [Aparicio, Juan P.] Arizona State Univ, Computat & Modeling Sci Ctr, Math, Tempe, AZ USA.
   [Castillo, Paola] Univ Nacl Salta, Fac Ciencias Nat, Salta, Argentina.
   [Gleiser, Raquel M.] Univ Nacl Cordoba, CONICET, Ctr Relevamiento & Evaluac Recursos Agr & Nat CRE, IMBIV, Av Valparaiso SN, RA-5016 Cordoba, Argentina.
   [Gleiser, Raquel M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Ecol, Cordoba, Argentina.
RP Chanampa, M (corresponding author), Univ Nacl Salta, CONICET, UNSa, Inst Invest Energia No Convenc INENCO, Av Bolivia 5150,A4400FVY, Salta, Argentina.; Gleiser, RM (corresponding author), Univ Nacl Cordoba, CONICET, Ctr Relevamiento & Evaluac Recursos Agr & Nat CRE, IMBIV, Av Valparaiso SN, RA-5016 Cordoba, Argentina.
EM marianamchanampa@gmail.com; raquel.gleiser@unc.edu.ar
RI aparicio, juan p/F-1246-2011
OI Mangudo, Carolina/0000-0002-1527-3015; Chanampa, Mariana del
   Milagro/0000-0002-0656-3029; Aparicio, Juan Pablo/0000-0001-5434-7454;
   Gil, Jose/0000-0003-3994-1265
FU Fondo para la Investigacion Cientifica y Tecnologica [PICT 2014/2476];
   Consejo de Investigacion, Universidad Nacional de Salta [CIUNSA 2140]
FX Fondo para la Investigacion Cientifica y Tecnologica, Grant/Award
   Number: PICT 2014/2476; Consejo de Investigacion, Universidad Nacional
   de Salta, Grant/Award Number: CIUNSA 2140
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632
   Zambrini DAB, 2011, REV SAUDE PUBL, V45, P428, DOI 10.1590/S0034-89102011000200023
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brooks D., 2018, TROPICAL SUBTROPICAL
   Byttebier B, 2014, J MED ENTOMOL, V51, P97, DOI 10.1603/ME13066
   Cabrera AL, 1971, B SOC ARGENT BOT, V41, P1
   Campos Raul E., 1996, Revista de la Sociedad Entomologica Argentina, V55, P67
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Fischer S, 2011, J VECTOR ECOL, V36, P94, DOI 10.1111/j.1948-7134.2011.00145.x
   FRANK JH, 1985, J AM MOSQUITO CONTR, V1, P28
   Gil JF, 2016, ACTA TROP, V158, P24, DOI 10.1016/j.actatropica.2016.02.003
   Gopalakrishnan R, 2012, TROP BIOMED, V29, P598
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Harburguer L, 2016, J MED ENTOMOL, V53, P647, DOI 10.1093/jme/tjw022
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1
   Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lima EP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2199-y
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   Maguina Vargas C., 2015, REV MED HEREDIANA, V26, P202
   Mangudo C, 2018, B ENTOMOL RES, V108, P203, DOI 10.1017/S0007485317000700
   Mangudo C, 2011, J VECTOR ECOL, V36, P227, DOI 10.1111/j.1948-7134.2011.00162.x
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Ministerio de Salud de Bolivia, 2016, PROGR NAC PREV CONTR
   Ministerio de Salud de la Nacion Argentina, 2016, B INT VIG, V310-EW 52
   Ministerio de Salud Publica y Bienestar Social de Paraguay, 2015, SE SUM 8 NUEV CAS AU
   O'Gower A. K., 1963, ANIM BEHAV, V11, P190
   de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125
   PAHO (Pan American Health Organization/World Health Organization), 2016, COMM DIS HLTH AN HLT
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   R Core Team, 2017, R LANG ENV STAT COMP
   Reiter P, 2001, GUIDELINES ASSESSING
   Ritchie SA, 2001, J AM MOSQUITO CONTR, V17, P206
   Rodriguez-Tovar ML, 2000, SOUTHWEST ENTOMOL, V25, P55
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003
   de Abreu FVS, 2015, MEM I OSWALDO CRUZ, V110, P669, DOI 10.1590/0074-02760140490
   Seijo A, 2009, ARCH ARGENT PEDIATR, V107, P387, DOI 10.1590/S0325-00752009000500002
   STEINLY BA, 1991, J AM MOSQUITO CONTR, V7, P649
   WHO (World Health Organization), 2016, FIEBR CHIK ARG BROT
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149
   World Health Organization, 2015, EPIDEMIOLOGICAL WEEK
NR 50
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2048
EI 1439-0418
J9 J APPL ENTOMOL
JI J. Appl. Entomol.
PD DEC
PY 2018
VL 142
IS 10
BP 985
EP 990
DI 10.1111/jen.12554
PG 6
WC Entomology
SC Entomology
GA HF9QU
UT WOS:000454578100008
OA Bronze
DA 2020-07-08
ER

PT J
AU Siramaneerat, I
AF Siramaneerat, Issara
TI Perception of the Zika virus infection and its influence on Zika
   prevention practices by pregnant women at the Region 5 Health Promotion
   Center in Thailand (vol 27, pg 201, 2018)
SO MEDICAL JOURNAL OF INDONESIA
LA English
DT Correction
C1 [Siramaneerat, Issara] Rajamangala Univ Technol Thanyaburi, Dept Social Sci, Fac Liberal Arts, Khlong Hok, Thailand.
RP Siramaneerat, I (corresponding author), Rajamangala Univ Technol Thanyaburi, Dept Social Sci, Fac Liberal Arts, Khlong Hok, Thailand.
EM issara_s@rmutt.ac.th
CR Siramaneerat I, 2018, MED J INDONES, V27, P201, DOI 10.13181/mji.v27i3.2424
NR 1
TC 0
Z9 0
U1 0
U2 0
PU UNIV INDONESIA, FAC MEDICINE
PI JAKARTA PUSAT
PA JALAN SALEMBA 6, JAKARTA PUSAT, 10430, INDONESIA
SN 0853-1773
EI 2252-8083
J9 MED J INDONES
JI Med. J. Indones.
PD DEC
PY 2018
VL 27
IS 4
BP 310
EP 310
DI 10.13181/mji.v27i4.3415
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA HG0OJ
UT WOS:000454645300015
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kumar, A
   Liang, B
   Aarthy, M
   Singh, SK
   Garg, N
   Mysorekar, IU
   Giri, R
AF Kumar, Ankur
   Liang, Brooke
   Aarthy, Murali
   Singh, Sanjeev Kumar
   Garg, Neha
   Mysorekar, Indira U.
   Giri, Rajanish
TI Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
SO ACS OMEGA
LA English
DT Article
ID DENGUE VIRUS; WEST-NILE; MEDICINAL CHEMISTRY; NS3 PROTEASE; KIX DOMAIN;
   C-MYB; BINDING; MECHANISM; RECOGNITION; STATE
AB Zika virus is a mosquito-transmitted flavivirus that causes devastating fetal outcomes in the context of maternal infection during pregnancy. An important target for drugs combatting Zika virus pathogenicity is NS2B-NS3 protease, which plays an essential role in hydrolysis and maturation of the flavivirus polyprotein. We identify hydroxychloroquine, a drug that already has approved uses in pregnancy, as a possible inhibitor of NS2B-NS3 protease by using a Food and Drug Administration-approved drug library, molecular docking, and molecular dynamics simulations. Further, to gain insight into its inhibitory potential toward NS2B-NS3 protease, we performed enzyme kinetic studies, which revealed that hydroxychloroquine inhibits protease activity with an inhibition constant (K-i) of 92.34 +/- 11.91 mu M. Additionally, hydroxychloroquine significantly decreases Zika virus infection in placental cells.
C1 [Kumar, Ankur; Garg, Neha; Giri, Rajanish] Indian Inst Technol Mandi, Mandi 175005, Himachal Prades, India.
   [Liang, Brooke; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Liang, Brooke; Mysorekar, Indira U.] Washington Univ, Sch Med, Ctr Reprod Hlth Sci, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Aarthy, Murali; Singh, Sanjeev Kumar] Alagappa Univ, Comp Aided Drug Design & Mol Modeling Lab, Dept Bioinformat, Sci Block, Karaikkudi 630003, Tamil Nadu, India.
   [Garg, Neha; Giri, Rajanish] Indian Inst Technol Mandi, BioX Ctr, Mandi 175005, Himachal Prades, India.
RP Giri, R (corresponding author), Indian Inst Technol Mandi, Mandi 175005, Himachal Prades, India.; Giri, R (corresponding author), Indian Inst Technol Mandi, BioX Ctr, Mandi 175005, Himachal Prades, India.
EM rajanishgiri@iitmandi.ac.in
RI Singh, Kumar/AAP-1954-2020; Garg, Neha/AAG-5180-2020; Giri,
   Rajanish/Q-6530-2018
OI Singh, Kumar/0000-0003-4153-6437; Garg, Neha/0000-0003-2227-8292; Giri,
   Rajanish/0000-0002-2046-836X
FU DST grant, India [YSS/2015/000613]; National Institutes of Health/Eunice
   Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01HD091218]
FX This work was partially funded by a DST grant, India (YSS/2015/000613)
   (to R.G.), and a National Institutes of Health/Eunice Kennedy Shriver
   National Institute of Child Health and Human Development grant
   R01HD091218 (to I.U.M.). The authors declare that the research was
   conducted in the absence of any commercial or financial relationships
   that could be construed as a potential conflict of interest.
CR Anderson Jeffrey, 2009, V189, P85, DOI 10.1007/978-3-540-79086-0_4
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   BECHTOLD CM, 1995, ANTIMICROB AGENTS CH, V39, P374, DOI 10.1128/AAC.39.2.374
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Costedoat-Chalumeau N, 2003, ARTHRITIS RHEUM, V48, P3207, DOI 10.1002/art.11304
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Foloppe N, 2016, BIOORGAN MED CHEM, V24, P2159, DOI 10.1016/j.bmc.2016.03.022
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Gunasekaran D, 2017, J BIOMOL STRUCT DYN, V35, P1654, DOI 10.1080/07391102.2016.1190791
   Gupta S, 2017, INT J BIOL MACROMOL, V98, P357, DOI 10.1016/j.ijbiomac.2017.01.098
   Gupta S, 2017, INT J BIOL MACROMOL, V94, P621, DOI 10.1016/j.ijbiomac.2016.10.008
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lenselink EB, 2016, ACS OMEGA, V1, P293, DOI 10.1021/acsomega.6b00086
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lin KH, 2017, J VIROL, V91, DOI 10.1128/JVI.00045-17
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta Mario, 2005, J Perinatol, V25, P86, DOI 10.1038/sj.jp.7211208
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Nabuurs SB, 2007, J MED CHEM, V50, P6507, DOI 10.1021/jm070593p
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Shiryaev SA, 2010, FUTURE VIROL, V5, P593, DOI 10.2217/FVL.10.39
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sperber K, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-9
   Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f
   Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994
   Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
NR 64
TC 18
Z9 18
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD DEC
PY 2018
VL 3
IS 12
BP 18132
EP 18141
DI 10.1021/acsomega.8b01002
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA HF5AJ
UT WOS:000454244600188
PM 30613818
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pooransingh, S
   Parasram, R
   Nandram, N
   Bhagwandeen, B
   Dialsingh, I
AF Pooransingh, S.
   Parasram, R.
   Nandram, N.
   Bhagwandeen, B.
   Dialsingh, I
TI Zika virus disease-knowledge, attitudes and practices among pregnant
   women-implications for public health practice
SO PUBLIC HEALTH
LA English
DT Article
DE Zika; Pregnancy; Knowledge; Attitudes; Practices; Global health
ID SEXUAL TRANSMISSION; UNITED-STATES; OUTBREAK; TRAVEL
AB Objective: Mosquito-borne diseases continue to pose a threat to Latin America and the Caribbean. Zika virus disease entered the Caribbean in 2013 with increased reporting of cases across the region in 2016, affecting more than 50 countries. This study aimed to ascertain the knowledge of, attitudes and practices towards Zika virus disease among antenatal clinic attenders in Trinidad and Tobago during the 2016 outbreak.
   Study design: A cross-sectional questionnaire survey was undertaken.
   Methods: A knowledge attitudes and practices survey was conducted among antenatal clinic attenders at publicly funded primary care health centres. All counties of Trinidad (except St Patrick, Caroni and Victoria) and Tobago were included in the study. Within each county, three health centres were selected at random. At the antenatal clinic of each selected health centre, antenatal clients were selected by randomly selecting their patient file from that days antenatal clinic patient files. Data collection occurred from September to November 2016. The knowledge, attitudes and practice survey was administered by an interviewer-administered questionnaire. The World Health Organization Knowledge, Attitudes and Practice surveys Zika virus disease and potential complications Resource pack was adapted for use as the data collection tool. All data collected were analysed using SPSS software, version 23. Tests with P-values less than 0.05 were deemed significant.
   Results: Seventy-four percent (74%) of responders did not think there was a link between sexual transmission and Zika. About 19% stated that abstaining could prevent Zika but only 6.6% actually practiced this. Seventy-six percent knew the risk of microcephaly, and this knowledge of the risk of microcephaly was found to be significantly associated with the number of weeks gestation. Less than 40% knew the risk of Guillain-Barre syndrome. Doctors at health centres followed by private doctors were the top two trusted information sources for responders. Responders thought that the government could spray insecticide, clean drains, educate community members and clean overgrown vacant lots of land.
   Conclusion: The government and healthcare workers need to reach specific target groups with accurate messages to minimize the associated morbidity and thereby safeguarding national and global health security. (C) 2018 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
C1 [Pooransingh, S.] Univ West Indies, Fac Med Sci, St Augustine, Trinidad Tobago.
   [Parasram, R.] Minist Hlth Trinidad & Tobago, Off Chief Med Officer, Port Of Spain, Trinidad Tobago.
   [Nandram, N.] Minist Hlth, Insect Vector Control Div, Port Of Spain, Trinidad Tobago.
   [Bhagwandeen, B.; Dialsingh, I] Univ West Indies, Fac Sci & Technol, St Augustine, Trinidad Tobago.
RP Pooransingh, S (corresponding author), Univ West Indies, Fac Med Sci, St Augustine, Trinidad Tobago.
EM shalini.pooransingh@sta.uwi.edu
OI Pooransingh, Shalini/0000-0001-5534-3762; Dialsingh,
   Isaac/0000-0002-6121-6126
CR [Anonymous], 2016, WHOZIKVRCCE162
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esposito G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145873
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nilsen RM, 2016, ITAL J PEDIATR, V42, DOI 10.1186/s13052-016-0278-z
   Porse CC, 2018, EMERG INFECT DIS, V24, P1626, DOI 10.3201/eid2409.180203
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Wilhelmova R, 2015, ZDRAV VARST, V54, P27, DOI 10.1515/sjph-2015-0004
   WILKINSON R, 1996, UNHEALTHY SOC AFFLIC
   Zorrilla Carmen D, 2016, Obstet Gynecol Int J, V5, DOI 10.15406/ogij.2016.05.00180
NR 20
TC 2
Z9 2
U1 2
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD DEC
PY 2018
VL 165
BP 146
EP 151
DI 10.1016/j.puhe.2018.09.025
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF3RX
UT WOS:000454153300021
PM 30448643
DA 2020-07-08
ER

PT J
AU Liu, WH
   Han, RQ
   Wu, H
   Han, DS
AF Liu, Weihua
   Han, Ruiqin
   Wu, Han
   Han, Daishu
TI Viral threat to male fertility
SO ANDROLOGIA
LA English
DT Review
DE infertility; male reproduction; orchitis; viral infection; Zika virus
ID HUMAN-PAPILLOMAVIRUS DNA; ZIKA VIRUS-INFECTION; HEPATITIS-C VIRUS;
   SEXUAL TRANSMISSION; TESTICULAR ATROPHY; MALE-INFERTILITY; HUMAN SPERM;
   GERM-CELLS; SEMEN; MUMPS
AB The detrimental effects of Zika virus (ZIKV) infection on mouse testicular functions have reminded a viral threat to male fertility. A broad range of virus families has tropism for male reproductive system, particularly the testes. Certain virus types of these viruses, such as mumps virus and human immunodeficiency virus (HIV), may severely damage the testes and consequently lead to male infertility. ZIKV has been recently found to damage testicular functions and lead to male infertility in mice. Many other viruses also have detrimental effects on host reproduction. Public attention has been paid to sexually transmitted viruses, such as HIV and hepatitis B and C viruses in humans and likewise in economically important farm animals. This article provides an overview on main viruses affecting the male reproductive system and their detrimental effects on fertility, and outlines some important issues for future study.
C1 [Liu, Weihua; Han, Ruiqin; Wu, Han; Han, Daishu] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing, Peoples R China.
RP Han, DS (corresponding author), CAMS, Dept Cell Biol, Beijing, Peoples R China.; Han, DS (corresponding author), PUMC, Beijing, Peoples R China.
EM dshan@ibms.pumc.edu.cn
FU Major State Basic Research Project of China [2015CB943001,
   2016YFA0101001]; CAMS Initiative for Innovative Medicine [2017-IZM-B
   R-06, 2017-IZM-3-007]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31371518]
FX This work was supported by grants from the Major State Basic Research
   Project of China (Nos. 2015CB943001 and 2016YFA0101001), CAMS Initiative
   for Innovative Medicine (Nos. 2017-IZM-B & R-06, 2017-IZM-3-007) and the
   National Natural Science Foundation of China (No. 31371518).
CR AIMAN J, 1980, J CLIN ENDOCR METAB, V50, P380, DOI 10.1210/jcem-50-2-380
   Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704
   Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053
   Apari P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004111
   BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005
   Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109
   Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007
   BJORVATN B, 1973, Scandinavian Journal of Infectious Diseases, V5, P3, DOI 10.3109/inf.1973.5.issue-1.02
   Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022
   Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d
   BROGI A, 1995, J SUBMICR CYTOL PATH, V27, P565
   Cardona-Maya W, 2006, AM J REPROD IMMUNOL, V55, P241, DOI 10.1111/j.1600-0897.2005.00340.x
   Casella R, 1997, J UROLOGY, V158, P2158, DOI 10.1016/S0022-5347(01)68186-2
   Cassuto NG, 2002, HUM REPROD, V17, P3153, DOI 10.1093/humrep/17.12.3153
   Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   CROXSON TS, 1989, J CLIN ENDOCR METAB, V68, P317, DOI 10.1210/jcem-68-2-317
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   DEPAEPE ME, 1989, HUM PATHOL, V20, P210, DOI 10.1016/0046-8177(89)90125-1
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Fijak M, 2018, HUM REPROD UPDATE, V24, P416, DOI 10.1093/humupd/dmy009
   Foresta C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015036
   Foresta C, 2010, FERTIL STERIL, V94, P1723, DOI 10.1016/j.fertnstert.2009.11.012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gimenes F, 2014, NAT REV UROL, V11, P672, DOI 10.1038/nrurol.2014.285
   Goldberg-Bittman L, 2008, CANCER GENET CYTOGEN, V180, P20, DOI 10.1016/j.cancergencyto.2007.09.009
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644
   HADCHOUEL M, 1985, J MED VIROL, V16, P61, DOI 10.1002/jmv.1890160109
   Haidl G, 2008, ANDROLOGIA, V40, P92, DOI 10.1111/j.1439-0272.2007.00819.x
   Hofny ERM, 2011, FERTIL STERIL, V95, P2557, DOI 10.1016/j.fertnstert.2011.05.014
   Huang JM, 2002, ASIAN J ANDROL, V4, P209
   Jiang Q., 2017, ENDOCRINOLOGY TESTIS, P1052
   Jiang Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.560
   Kang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033471
   KOSSAKOWSKA AE, 1993, DIAGN MOL PATHOL, V2, P233, DOI 10.1097/00019606-199300020-00034
   Kotronias D, 1998, IN VIVO, V12, P391
   Ku JH, 1999, BJU INT, V84, P839
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   La Vignera S, 2012, EUR J INTERN MED, V23, pE19, DOI 10.1016/j.ejim.2011.08.011
   Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9
   Laprise C, 2014, HUM REPROD, V29, P640, DOI 10.1093/humrep/det453
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Tortorec A, 2008, HUM REPROD, V23, P2095, DOI 10.1093/humrep/den207
   Lorusso F, 2010, ANDROLOGIA, V42, P121, DOI 10.1111/j.1439-0272.2009.00970.x
   Lyu ZY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2812-z
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Masarani M, 2006, J ROY SOC MED, V99, P573, DOI 10.1258/jrsm.99.11.573
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meinhardt A, 2017, NAT REV UROL, V14, P135, DOI 10.1038/nrurol.2016.265
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Moretti E, 2008, ANDROLOGIA, V40, P173, DOI 10.1111/j.1439-0272.2007.00818.x
   Muciaccia B, 1998, J REPROD IMMUNOL, V41, P81, DOI 10.1016/S0165-0378(98)00050-3
   Muciaccia B, 2007, HUM REPROD, V22, P2868, DOI 10.1093/humrep/dem288
   Muciaccia B, 1998, FASEB J, V12, P151
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4
   Nguyen O, 2010, J CLIN VIROL, V49, P65, DOI 10.1016/j.jcv.2010.06.008
   NUOVO GJ, 1994, AM J PATHOL, V144, P1142
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Patel LN, 2017, CLIN INFECT DIS, V64, P408, DOI 10.1093/cid/ciw762
   Perez C.V., 2013, SPERMATOGENESIS, V3, P23870, DOI DOI 10.4161/SPMG.23870
   Pickar A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174444
   PORETSKY L, 1995, METABOLISM, V44, P946, DOI 10.1016/0026-0495(95)90250-3
   PUDNEY J, 1991, AM J PATHOL, V139, P149
   Rintala MAM, 2002, J INFECT DIS, V185, P1664, DOI 10.1086/340421
   ROGERS C, 1988, HISTOPATHOLOGY, V12, P659, DOI 10.1111/j.1365-2559.1988.tb01990.x
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rubin S, 2015, J PATHOL, V235, P242, DOI 10.1002/path.4445
   Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x
   Schuppe HC, 2017, DTSCH ARZTEBL INT, V114, P339, DOI 10.3238/arztebl.2017.0339
   Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Shevchuk MM, 1998, J REPROD IMMUNOL, V41, P69, DOI 10.1016/S0165-0378(98)00049-7
   Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240
   Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207
   Tung KSK, 2017, J CLIN INVEST, V127, P1046, DOI 10.1172/JCI89927
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wald A, 1999, SEX TRANSM DIS, V26, P1, DOI 10.1097/00007435-199901000-00001
   Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203
   Wang X, 2003, FERTIL STERIL, V80, P844, DOI 10.1016/S0015-0282(03)00983-X
   Willocks LJ, 2017, EPIDEMIOL INFECT, V145, P3219, DOI [10.1017/S0950268817002102, 10.1017/s0950268817002102]
   Wu H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00117
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Xu P, 2013, J VIROL, V87, P8158, DOI 10.1128/JVI.01028-13
   Yang Y, 2013, ASIAN J ANDROL, V15, P529, DOI 10.1038/aja.2013.36
   Yeniyol CO, 2000, UROLOGY, V55, P931, DOI 10.1016/S0090-4295(00)00491-X
NR 94
TC 3
Z9 3
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD DEC
PY 2018
VL 50
IS 11
SI SI
AR e13140
DI 10.1111/and.13140
PG 9
WC Andrology
SC Endocrinology & Metabolism
GA HE9SW
UT WOS:000453795800008
PM 30569651
OA Bronze
DA 2020-07-08
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, JD
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Adachi, K
   Pone, MVD
   Pone, SM
   Molleri, N
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Vasconcelos, Z
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia D.
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Molleri, Natalia
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Vasconcelos, Zilton
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Visual function in infants with antenatal Zika virus exposure
SO JOURNAL OF AAPOS
LA English
DT Article
ID OPHTHALMIC MANIFESTATIONS; MACULAR ATROPHY; BIRTH; IMPAIRMENT;
   PREGNANCY; CHILDREN; IMPACT
AB PURPOSE To report the findings of a cross-sectional study of visual function in infants with confirmed or suspected antenatal Zika virus (ZIKV) infection seen at a single referral center in Rio de Janeiro.
   METHODS Infants were examined following the ZIKV outbreak period at Instituto Fernandes Figueira/FIOCRUZ. Visual function was considered abnormal if an infant could not fix and follow a standardized high-contrast target (10 cm) by 3-6 months of age. Visual function and associations with structural eye abnormalities, central nervous system (CNS) abnormalities, microcephaly, and nystagmus were assessed. Sensitivity and specificity of screening criteria for structural eye abnormalities was assessed.
   RESULTS A total of 173 infants met inclusion criteria. Abnormal visual function was found in 52 infants (30.0%) and was significantly associated with eye abnormalities (40/52; OR = 44.2; 95% CI, 16.6-117.6), CNS abnormalities (50/52; OR = 64.0; 95% CI, 14.7-277.6), microcephaly (44/52; OR = 31.5; 95% CI, 12.7-77.8), and nystagmus (26/52; OR = 120.0; 95% CI, 15.6-924.5). Using microcephaly as screening criteria for the detection of eye abnormalities provided a sensitivity of 88.9% (95% CI, 76.0-96.3) and specificity of 82.8% (95% CI, 75.1-88.9). Using both abnormal visual function and microcephaly increased sensitivity to 100% (95% CI, 92.1-100.0) and decreased specificity to 80.5% (95% CI, 72.5-86.9).
   CONCLUSIONS Infants with suspected antenatal ZIKV infection and reduced visual function should be referred to an ophthalmologist. Visual function assessments are helpful in screening for antenatal ZIKV exposure in resource-limited settings and can identify infants who may benefit from visual habilitation.
C1 [Zin, Andrea A.; Rossetto, Julia D.; Neves, Luiza M.; Haefeli, Lorena; da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Molleri, Natalia; Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Tsui, Irena; Adachi, Kristina; Arumugaswami, Vaithilingaraja; Nielsen-Saines, Karin] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Dept Pesquisa Clin, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM andreazin@iff.fiocruz.br
RI Vasconcelos, Zilton/AAD-5784-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; da Silva Pone, Marcos Vinicius/N-1285-2019
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-01, R01AI1121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB); Queenan Fellowship in Global Health from the Foundation
   for the Society of Maternal Fetal Medicine; UCSF National Center of
   Excellence in Women's Health
FX Brazilian National Council for Scientific and Technological Development
   (441098/2016-9), National Eye Institute [R21EY028318-01 and
   R01AI1121207], and National Institute of Allergy and Infectious Diseases
   (R21AI129534-02). Dr. Tsui was supported in part by an unrestricted
   Research to Prevent Blindness grant given to the Stein Eye Institute.
   Dr. Gaw was supported in part by the Queenan Fellowship in Global Health
   from the Foundation for the Society of Maternal Fetal Medicine, and the
   UCSF National Center of Excellence in Women's Health. Funding sources
   had no involvement in design, data collection/interpretation, or
   manuscript preparation.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diretrizes de Atencao a Sande Ocular na Infancia, 2013, DIRETRIZES ATENCAO S
   Donahue SP, 2016, PEDIATRICS, V137
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Harvey EM, 1999, INVEST OPHTH VIS SCI, V40, P1565
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Luke B, 2017, AM J OBSTET GYNECOL, V217, P270, DOI 10.1016/j.ajog.2017.03.012
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Sherrell H, 2018, EUR J OBSTET GYN R B, V225, P26, DOI 10.1016/j.ejogrb.2018.03.059
   Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782
   Sonnander K, 2000, ACTA PAEDIATR, V89, P17, DOI 10.1080/080352500750027358
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 31
TC 1
Z9 1
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD DEC
PY 2018
VL 22
IS 6
BP 452
EP 456
DI 10.1016/j.jaapos.2018.07.352
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA HE7RQ
UT WOS:000453638000012
PM 30359768
OA Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU de Laval, F
   d'Aubigny, H
   Matheus, S
   Labrousse, T
   Ensargueix, AL
   Lorenzi, EM
   Le Flem, FX
   Andre, N
   Belleoud, D
   Leparc-Goffart, I
   Rousset, D
   Simon, F
   Briolant, S
AF de Laval, Franck
   d'Aubigny, Hubert
   Matheus, Severine
   Labrousse, Thomas
   Ensargueix, Anne Laure
   Lorenzi, Enguerrane Martinez
   Le Flem, Francois Xavier
   Andre, Nathalie
   Belleoud, Didier
   Leparc-Goffart, Isabelle
   Rousset, Dominique
   Simon, Fabrice
   Briolant, Sebastien
TI Evolution of symptoms and quality of life during Zika virus infection: A
   1-year prospective cohort study
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; Clinical follow up; Chronicity.; Quality of life
ID DENGUE; EXANTHEMA
AB Background: Although the complications of Zika virus infection have been well described, the clinical pattern has not been reported in enough detail to differentiate this infection from those with other arboviroses, and no longitudinal study has yet been published on the persistence of symptoms and quality of life.
   Objectives: were to describe bio-clinical pattern and quality of life during ZIKV infection, and their evolution.
   Study design: We present a 1-year clinical follow-up of 49 people infected with Zika virus in French Guiana, for whom the diagnosis was confirmed by RT-PCR in serum or urine.
   Results: Fever was inconsistent (95% confidence interval (CI), 39-67). Exanthema (CI, 84-100) was maculopapular, with pruritus and conjunctivitis, variable over time and disappeared 12 days after the onset of symptoms (CI, 10-14). Joint pain (CI, 39-67) occurred mainly in the hands, wrists, knees and ankles and lasted for 10 days (CI, 7-13). Asthenia (CI, 61-85) scored low (3/10) but lasted for 19 days (CI, 16-22). The last two symptoms strongly limited patients' activities in the acute stage of the disease (RAPID-3 score, CI, 5-8). None of the patients had neurological complications, but 41% (CI, 27-55) had areflexia during the first month.
   Conclusions: We found no real chronic evolution or decreased quality of life, function or ability to work from the first month after symptom onset.
C1 [de Laval, Franck; Labrousse, Thomas; Ensargueix, Anne Laure; Lorenzi, Enguerrane Martinez; Le Flem, Francois Xavier; Andre, Nathalie; Belleoud, Didier; Briolant, Sebastien] French Armed Forces Hlth Serv French Guiana, Cayenne, French Guiana.
   [de Laval, Franck] CESPA, SSA, Marseille, France.
   [de Laval, Franck] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.
   [d'Aubigny, Hubert] St Anne Mil Teaching Hosp, Toulon, France.
   [Matheus, Severine; Rousset, Dominique] Inst Pasteur, Natl Reference Ctr Arboviruses, Cayenne, French Guiana.
   [Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Natl Reference Ctr Arboviruses, Marseille, France.
   [Leparc-Goffart, Isabelle] Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
   [Simon, Fabrice] Laveran Mil Teaching Hosp, Marseille, France.
   [Briolant, Sebastien] Inst Rech Biomed Armees, Dept Malad Infect, Unite Parasitol & Entomol, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, UMR Vecteurs Infect Trop & Mediterraneennes VITRO, IHU Mediterranee Infect, IRD,AP HM,SSA, Marseille, France.
RP de Laval, F (corresponding author), Direct Interarmees Serv Sante Guyane, Base Def Guyane, CS 56019, F-97306 Cayenne, France.
EM franck.de-laval@intradef.gouv.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147
FU Direction centrale du Service de sante des armees [2016RC10]
FX We thank the Direction centrale du Service de sante des armees who have
   funded the research (Grant IDs: 2016RC10). We thank the patients, the
   medical team, especially the nurses, for their care of patients, and the
   laboratory technicians (Okrutny M, Masotta M, Balmer D, Terraz G,
   Nieroda H, Marchand C, Nguyen C, Moua D, Labeau B, Gravier P).
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, LANCET INFECT DIS, V16, P866, DOI 10.1016/S1473-3099(16)30117-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso C.W., 2017, PLOS NEGLECT TROP D, V11, P1
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   dAubigny H., 2017, THESIS
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Laval F, 2016, MED SANTE TROP, V26, P145, DOI 10.1684/mst.2016.0575
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Ho HJ, 2017, EMERG INFECT DIS, V23, P2085, DOI 10.3201/eid2312.171224
   Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Nicastri E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1973-5
   Pincus T, 2007, BULL HOSP JT DIS, V65, P150
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Roimicher L, 2017, J RHEUMATOL, V44, DOI 10.3899/jrheum.160722
   Singh R. K., 2016, DERMATOL ONLINE J, V22, P19
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Yan G, 2018, EMERG INFECT DIS, V24, P1565, DOI 10.3201/eid2408.171883
NR 32
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 2018
VL 109
BP 57
EP 62
DI 10.1016/j.jcv.2018.09.015
PG 6
WC Virology
SC Virology
GA HE6YU
UT WOS:000453568100011
PM 30523784
OA Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Microcephaly caused by Zika virus and viral detection in maternal urine
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Letter
ID INFECTION
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok 10160, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok 10160, Thailand.
EM beuyjoob@hotmail.com
CR Joob B, 2017, CLIN NEUROPHYSIOL, V128, P289, DOI 10.1016/j.clinph.2016.12.009
   Regadas VC, 2018, REV ASSOC MED BRAS, V64, P11, DOI 10.1590/1806-9282.64.01.11
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD DEC
PY 2018
VL 64
IS 12
BP 1060
EP 1060
DI 10.1590/1806-9282.64.12.1060
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA HE5ID
UT WOS:000453410200002
PM 30569977
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Silva, JVJ
   Ludwig-Begall, LF
   de Oliveira, EF
   Oliveira, RAS
   Duraes-Carvalho, R
   Lopes, TRR
   Silva, DEA
   Gil, LHVG
AF Silva, Jose V. J., Jr.
   Ludwig-Begall, Louisa F.
   de Oliveira-Filho, Edmilson F.
   Oliveira, Renato A. S.
   Duraes-Carvalho, Ricardo
   Lopes, Thaisa R. R.
   Silva, Daisy E. A.
   Gil, Laura H. V. G.
TI A scoping review of Chikungunya virus infection: epidemiology, clinical
   characteristics, viral co-circulation complications, and control
SO ACTA TROPICA
LA English
DT Review
DE Chikungunya fever; Arboviruses; Dengue; Zika
ID GUILLAIN-BARRE-SYNDROME; SEMLIKI-FOREST-VIRUS; AEDES-AEGYPTI; VERTICAL
   TRANSMISSION; NONHUMAN-PRIMATES; IN-VITRO; BIOLOGICAL-CONTROL;
   MOSQUITO-CONTROL; VECTOR CONTROL; PROTECTS MICE
AB Chikungunya fever is a mosquito-borne viral illness characterized by a sudden onset of fever associated with joint pains. It was first described in the 1950s during a Chikungunya virus (CHIKV) outbreak in southern Tanzania and has since (re-) emerged and spread to several other geographical areas, reaching large populations and causing massive epidemics. In recent years, CHIKV has gained considerable attention due to its quick spread to the Caribbean and then in the Americas, with many cases reported between 2014 and 2017. CHIKV has further garnered attention due to the clinical diagnostic difficulties when Zika (ZIKV) and dengue (DENV) viruses are simultaneously present. In this review, topical CHIKV-related issues, such as epidemiology and transmission, are examined. The different manifestations of infection (acute, chronic and atypical) are described and a particular focus is placed upon the diagnostic handling in the case of ZIKV and DENV co-circulating. Natural and synthetic compounds under evaluation for treatment of chikungunya disease, including drugs already licensed for other purposes, are also discussed. Finally, previous and current vaccine strategies, as well as the control of the CHIKV transmission through an integrated vector management, are reviewed in some detail.
C1 [Silva, Jose V. J., Jr.; de Oliveira-Filho, Edmilson F.; Duraes-Carvalho, Ricardo; Silva, Daisy E. A.; Gil, Laura H. V. G.] Fundacao Oswaldo Cruz, Aggeu Magalhcaes Inst, Dept Virol, Recife, PE, Brazil.
   [Silva, Jose V. J., Jr.] Univ Fed Santa Maria, Virol Sect, Dept Prevent Vet Med, Santa Maria, RS, Brazil.
   [Ludwig-Begall, Louisa F.] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium.
   [Oliveira, Renato A. S.] Univ Fed Paraiba, Dept Fisiol & Pathol, Joao Pessoa, PB, Brazil.
   [Lopes, Thaisa R. R.] Univ Fed Pernambuco, Virol Sect, Lab Immunopathol Keizo Asami, Recife, PE, Brazil.
RP Silva, JVJ (corresponding author), Fed Univ Santa Maria UFSM, Virol Sect, Dept Prevent Vet Med, BR-97105900 Santa Maria, RS, Brazil.; Gil, LHVG (corresponding author), Oswald Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Dept Virol, BR-50670420 Recife, PE, Brazil.
EM josevalterjsilvajr@gmail.com; laura@cpqam.fiocruz.br
RI Oliveira, Renato/AAN-9394-2020; Oliveira, Renato/AAN-9879-2020;
   Oliveira-Filho, Edmilson/A-6305-2012; Duraes-Carvalho,
   Ricardo/X-3065-2018
OI Oliveira, Renato/0000-0002-4044-0794; Oliveira-Filho,
   Edmilson/0000-0002-3771-1565; Duraes-Carvalho,
   Ricardo/0000-0001-5734-7601
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE); MCT/CNPq DCR grants; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX E.F. Oliveira-Filho and R. Duraes-Carvalho are supported by Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and
   MCT/CNPq DCR grants. J.V.J. Silva Junior is supported by Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). T.R.R. Lopes is
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq).
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Althouse BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03332-7
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Armengol G, 2006, J ECON ENTOMOL, V99, P1590, DOI 10.1603/0022-0493-99.5.1590
   ATKINSON T, 1986, J GEN VIROL, V67, P1189, DOI 10.1099/0022-1317-67-6-1189
   Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Azami NAM, 2016, METHODS MOL BIOL, V1426, P273, DOI 10.1007/978-1-4939-3618-2_25
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Benelli G, 2019, SAUDI J BIOL SCI, V26, P921, DOI 10.1016/j.sjbs.2018.06.007
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Boyer S, 2012, Med Trop (Mars), V72 Spec No, P60
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Brasil, 2014, PREPARACAO RESPOSTA
   BRIGHTON SW, 1984, S AFR MED J, V66, P217
   Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calisher C. H., 1988, ARBOVIRUSES EPIDEMIO, VI
   CDC, 2016, REV DIAGN TEST ZIK C
   CDC, 2018, CHIK VIR GEOGR DISTR
   CDC, 2015, CLIN EV DIS
   Center for Disease Control and Prevention (CDC), 2018, INF DIS REL TRAV
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   CIRE, 2006, CIR REUN MAYOTT EP C
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Danis-Lozano R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186923
   DAS M K, 1991, Indian Journal of Malariology, V28, P171
   Dash Muktikesh, 2011, Indian J Med Sci, V65, P83, DOI 10.4103/0019-5359.104781
   Cavalcanti LPD, 2007, REV SAUDE PUBL, V41, P638, DOI 10.1590/s0034-89102006005000041
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Dickens BL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw103
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   ECKELS KH, 1970, APPL MICROBIOL, V19, P321, DOI 10.1128/AEM.19.2.321-325.1970
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Ernould S, 2008, ARCH PEDIATRIE, V15, P253, DOI 10.1016/j.arcped.2007.10.019
   Ferreira CP, 2008, J BIOL SYST, V16, P565, DOI 10.1142/S0218339008002691
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Girgin NK, 2014, TURK J ANAESTHESIOL, V42, P100, DOI 10.5152/TJAR.2013.51
   Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1019-1
   Gopakumar H, 2012, J CLIN NEONATOL, V1, P155, DOI 10.4103/2249-4847.101704
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Goupil Brad A, 2016, Open Rheumatol J, V10, P129, DOI 10.2174/1874312901610010129
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002
   Heikema AP, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.031
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   HOY JB, 1985, J AM MOSQUITO CONTR, V1, P295
   Hua C, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0694-0
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   ICTV, 2017, VIR TAX 2017 REL
   Islam J, 2017, ACTA TROP, V167, P216, DOI 10.1016/j.actatropica.2016.12.031
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003
   Kamareddine L, 2012, TOXINS, V4, P748, DOI 10.3390/toxins4090748
   Kaur P, 2013, DRUG DISCOV TODAY, V18, P969, DOI 10.1016/j.drudis.2013.05.002
   Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kim SY, 2016, KOREAN J INTERN MED, V31, P1191, DOI 10.3904/kjim.2015.033
   Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11
   Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z
   Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071
   Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lee SS, 2013, J THEOR BIOL, V331, P78, DOI 10.1016/j.jtbi.2013.04.014
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lim E. X. Y., 2018, VIRUSES, V10
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Manrique-Saide P, 1998, MED VET ENTOMOL, V12, P386, DOI 10.1046/j.1365-2915.1998.00126.x
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   McIntosh B M, 1970, S Afr J Med Sci, V35, P65
   최현길, 2016, Pediatric Infection and Vaccine, V23, P236
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060
   Mylonas AD, 2004, JCR-J CLIN RHEUMATOL, V10, P326, DOI 10.1097/01.rhu.0000147052.11190.36
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657
   Ngoagouni C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2101-0
   NOVAK RJ, 1985, J AM MOSQUITO CONTR, V1, P449
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14
   Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Padmakumar B., 2009, INDIAN J RHEUMATOL, V4, P4
   PAHO, 2017, TOOL DIAGN CAR PAT S
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-91
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-8
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pereira Boscolli Barbosa, 2014, Cad. saúde colet., V22, P241, DOI 10.1590/1414-462X201400030004
   Perri S, 2000, J VIROL, V74, P9802, DOI 10.1128/JVI.74.20.9802-9807.2000
   PHILLIPS PE, 1973, LANCET, V1, P720
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Pruetz J.D., 2010, African Primates, V7, P64
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rawlins SC, 1997, J AM MOSQUITO CONTR, V13, P18
   Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406
   Resnik DB, 2014, DEV WORLD BIOETH, V14, P37, DOI 10.1111/dewb.12011
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   Robin S, 2010, EUR J PEDIATR, V169, P67, DOI 10.1007/s00431-009-0986-0
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Russell C. A., LANCET, V370, P1840
   Sankari T, 2008, LANCET INFECT DIS, V8, P3, DOI 10.1016/S1473-3099(07)70295-5
   Schaper S, 1999, J AM MOSQUITO CONTR, V15, P510
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Sharma A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-301
   Sharma S, 2010, MOL BIOTECHNOL, V45, P49, DOI 10.1007/s12033-009-9238-9
   Shulse CD, 2013, J APPL ECOL, V50, P1244, DOI 10.1111/1365-2664.12126
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Steger CM, 2012, CASE REP CARDIOL, V2012, DOI 10.1155/2012/506290
   Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031
   Subudhi BB, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050235
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062
   Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   van den Doel P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003101
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Venugopalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111305
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walton WE, 2007, J AM MOSQUITO CONTR, V23, P184, DOI 10.2987/8756-971X(2007)23[184:LFIG]2.0.CO;2
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   WHO, 2018, CHIK
   WHO, 2016, MON MAN INS RES AED
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Wintachai P, 2015, MICROBIOL IMMUNOL, V59, P129, DOI 10.1111/1348-0421.12230
   Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403
   World Health Organisation, 2008, GUID CLIN MAN CHIK F
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
NR 217
TC 10
Z9 10
U1 1
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2018
VL 188
BP 213
EP 224
DI 10.1016/j.actatropica.2018.09.003
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GX9BH
UT WOS:000448093000026
PM 30195666
OA Green Published
DA 2020-07-08
ER

PT J
AU Arumugasaamy, N
   Ettehadieh, LE
   Kuo, CY
   Paquin-Proulx, D
   Kitchen, SM
   Santoro, M
   Placone, JK
   Silveira, PP
   Aguiar, RS
   Nixon, DF
   Fisher, JP
   Kim, PCW
AF Arumugasaamy, Navein
   Ettehadieh, Leila E.
   Kuo, Che-Ying
   Paquin-Proulx, Dominic
   Kitchen, Shannon M.
   Santoro, Marco
   Placone, Jesse K.
   Silveira, Paola P.
   Aguiar, Renato S.
   Nixon, Douglas F.
   Fisher, John P.
   Kim, Peter C. W.
TI Biomimetic Placenta-Fetus Model Demonstrating Maternal-Fetal
   Transmission and Fetal Neural Toxicity of Zika Virus
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Hydrogels; Tissue engineering; Placental transport; Zika virus; Tissue
   model
ID IN-VITRO SIMULATION; BIRTH-DEFECTS; CELLS; INFECTION; TRANSPORT;
   ESTABLISHMENT; PROTECTION; ANTIBODIES; BARRIER; WOMEN
AB Recent global epidemics of viral infection such as Zika virus (ZIKV) and associated birth defects from maternal-fetal viral transmission highlights the critical unmet need for experimental models that adequately recapitulates the biology of the human maternal-fetal interface and downstream fetal development. Herein, we report an in vitro biomimetic placenta-fetus model of the maternal-fetal interface and downstream fetal cells. Using a tissue engineering approach, we built a 3D model incorporating placental trophoblast and endothelial cells into an extracellular matrix environment and validated formation of the maternal-fetal interface. We utilized this model to study ZIKV exposure to the placenta and neural progenitor cells. Our results indicated ZIKV infects both trophoblast and endothelial cells, leading to a higher viral load exposed to fetal cells downstream of the barrier. Viral inhibition by chloroquine reduced the amount of virus both in the placenta and transmitted to fetal cells. A sustained downstream neural cell viability in contrast to significantly reduced viability in an acellular model indicates that the placenta sequesters ZIKV consistent with clinical observations. These findings suggest that the placenta can modulate ZIKV exposure-induced fetal damage. Moreover, such tissue models can enable rigorous assessment of potential therapeutics for maternal-fetal medicine.
C1 [Arumugasaamy, Navein; Ettehadieh, Leila E.; Kuo, Che-Ying; Santoro, Marco; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Arumugasaamy, Navein; Ettehadieh, Leila E.; Kuo, Che-Ying; Santoro, Marco; Fisher, John P.] Univ Maryland, Ctr Engn Complex Tissues, College Pk, MD 20742 USA.
   [Arumugasaamy, Navein; Ettehadieh, Leila E.; Kuo, Che-Ying; Fisher, John P.; Kim, Peter C. W.] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA.
   [Paquin-Proulx, Dominic; Kitchen, Shannon M.; Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.
   [Placone, Jesse K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Silveira, Paola P.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.
   [Kim, Peter C. W.] George Washington Univ, Dept Surg, Washington, DC USA.
RP Kim, PCW (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM pcwkim@email.gwu.edu
RI Aguiar, Renato S/G-3542-2015; Placone, Jesse K/M-6388-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Placone, Jesse
   K/0000-0002-3464-8177; Paquin Proulx, Dominic/0000-0003-1407-3414;
   Arumugasaamy, Navein/0000-0001-5688-0236
CR Baba UA, 2014, ANN MED HEALTH SCI R, V4, P298, DOI 10.4103/2141-9248.141975
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003
   Blundell C, 2016, LAB CHIP, V16, P3065, DOI 10.1039/c6lc00259e
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Costa MA, 2016, REPROD BIOMED ONLINE, V32, P14, DOI 10.1016/j.rbmo.2015.10.005
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Elad D, 2014, TRAFFIC, V15, P122, DOI 10.1111/tra.12130
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gedeon C, 2006, PLACENTA, V27, P861, DOI 10.1016/j.placenta.2005.09.001
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang X, 2016, MOL HUM REPROD, V22, P442, DOI 10.1093/molehr/gaw018
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8
   Kuo CY, 2016, ACS BIOMATER SCI ENG, V2, P1817, DOI 10.1021/acsbiomaterials.6b00031
   Leach L, 2002, J ANAT, V200, P599, DOI 10.1046/j.1469-7580.2002.00062.x
   Levkovitz R, 2013, PLACENTA, V34, P699, DOI 10.1016/j.placenta.2013.03.014
   Levkovitz R, 2013, PLACENTA, V34, P708, DOI 10.1016/j.placenta.2013.05.006
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   PATTILLO RA, 1968, CANCER RES, V28, P1231
   Poulsen MS, 2009, TOXICOL IN VITRO, V23, P1380, DOI 10.1016/j.tiv.2009.07.028
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sastry BVR, 1999, ADV DRUG DELIVER REV, V38, P17, DOI 10.1016/S0169-409X(99)00004-6
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 39
TC 10
Z9 10
U1 2
U2 58
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2018
VL 46
IS 12
BP 1963
EP 1974
DI 10.1007/s10439-018-2090-y
PG 12
WC Engineering, Biomedical
SC Engineering
GA HC7QU
UT WOS:000451997300001
PM 30003503
DA 2020-07-08
ER

PT J
AU Phoo, WW
   Zhang, ZZ
   Wirawan, M
   Chew, EJC
   Chew, ABL
   Kouretova, J
   Steinmetzer, T
   Luo, DH
AF Phoo, Wint Wint
   Zhang, Zhenzhen
   Wirawan, Melissa
   Chew, Edwin Jun Chen
   Chew, Alvin Bing Liang
   Kouretova, Jenny
   Steinmetzer, Torsten
   Luo, Dahai
TI Structures of Zika virus NS2B-NS3 protease in complex with
   peptidomimetic inhibitors
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; NS3 protease; Flaviviral protease; Drug discovery; Protease
   inhibitor; X-ray crystallography; Peptide inhibitors
ID YELLOW-FEVER VIRUS; WEST-NILE; NS3 PROTEASE; MOLECULAR REPLACEMENT;
   FLAVIVIRAL PROTEASES; PEPTIDE INHIBITORS; CRYSTAL-STRUCTURE; DENGUE;
   POLYPROTEIN; SPECIFICITY
AB Zika virus NS2B-NS3 protease plays an essential role in viral replication by processing the viral polyprotein into individual proteins. The viral protease is therefore considered as an ideal antiviral drug target. To facilitate the development of protease inhibitors, we report three high-resolution co-crystal structures of bZiPro with pepti-domimetic inhibitors composed of a P1-P4 segment and different P1' residues. Compounds 1 and 2 possess small P1' groups that are split off by bZiPro, which could be detected by mass spectrometry. On the other hand, the more potent compound 3 contains a bulky P1' benzylamide structure that is resistant to cleavage by bZiPro, demonstrating that presence of an uncleavable C-terminal cap contributes to a slightly improved inhibitory potency. The N-terminal phenylacetyl residue occupies a position above the P1 side chain and therefore stabilizes a horseshoe-like backbone conformation of the bound inhibitors. The P4 moieties show unique intra- and intermolecular interactions. Our work reports the detailed binding mode interactions of substrate-analogue inhibitors within the S4-S1' pockets and explains the preference of bZiPro for basic P1-P3 residues. These new structures of protease-inhibitor complexes will guide the design of more effective NS2B-NS3 protease inhibitors with improved potency and bioavailability.
C1 [Phoo, Wint Wint; Zhang, Zhenzhen; Wirawan, Melissa; Chew, Edwin Jun Chen; Chew, Alvin Bing Liang; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint; Zhang, Zhenzhen; Wirawan, Melissa; Chew, Alvin Bing Liang; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Chew, Alvin Bing Liang] Nanyang Technol Univ, Interdisciplinary Grad Sch, NTU Inst Hlth Technol, RTP 02-07,50 Nanyang Dr, Singapore 637553, Singapore.
   [Kouretova, Jenny; Steinmetzer, Torsten] Philipps Univ, Inst Pharmaceut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.
RP Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Steinmetzer, T (corresponding author), Philipps Univ, Inst Pharmaceut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.
EM luodahai@ntu.edu.sg; steinmetzer@uni-marburg.de
RI Luo, Dahai/J-6022-2012; Chew, Bing Liang Alvin/B-9860-2015
OI Luo, Dahai/0000-0001-7637-7275; Chew, Bing Liang
   Alvin/0000-0002-2748-9366; Wirawan, Melissa/0000-0001-6114-2633
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; National Medical Research
   CouncilMedical Research Council UK (MRC) [CBRG15May045]; National
   Research Foundation [NRF2016NRF-CRP001-063]; Ministry of Education grant
   [MOE2016-T2-2-097]; German Center for Infection Research [DZIF-TTU
   01.902]; LOEWE Center DRUID (Novel Drug Targets against Poverty-Related
   and Neglected Tropical Infectious Diseases)
FX We thank Drs. Liew Chong Wai and El Sahili Abbas for the help with
   diffraction data collection. We acknowledge SOLEIL for provision of
   synchrotron radiation facilities (proposals ID 20170003) in using
   Proxima beamlines. We thank scientists and staff from Australian Light
   Source MX beam-line, Taiwan Photon Source beamline 05A, Swiss Light
   Source PX beam-line, and Proxima 2A Beamline, SOLEIL for their expert
   assistance with diffraction data collection. We thank Ms Hai Ning Pee
   and colleagues from Waters Pacific Pte Ltd for their technical support
   in the UPLC installation and use. This work was supported by (1) a
   start-up grant from Lee Kong Chian School of Medicine, Nanyang
   Technological University, (2) National Medical Research Council grant
   CBRG15May045, (3) National Research Foundation grant
   NRF2016NRF-CRP001-063, (4) Ministry of Education grant MOE2016-T2-2-097
   grant to D.L. and a grant by the German Center for Infection Research
   [DZIF-TTU 01.902] to T.S. T.S. obtained funding from the LOEWE Center
   DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical
   Infectious Diseases).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   DeLano WL, 2009, ABSTR PAP AM CHEM S, V238
   DELANO WL, 2004, ABSTR PAP AM CHEM 1, V228
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975
   Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Shannon AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep37539
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 43
TC 14
Z9 16
U1 3
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2018
VL 160
BP 17
EP 24
DI 10.1016/j.antiviral.2018.10.006
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HC6UA
UT WOS:000451936000003
PM 30315877
DA 2020-07-08
ER

PT J
AU Chan, JFW
   Zhu, Z
   Chu, H
   Yuan, SF
   Chik, KKH
   Chan, CCS
   Poon, VKM
   Yip, CCY
   Zhang, X
   Tsang, JOL
   Zou, ZJ
   Tee, KM
   Shuai, HP
   Lu, G
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Zhu, Zheng
   Chu, Hin
   Yuan, Shuofeng
   Chik, Kenn Ka-Heng
   Chan, Chris Chung-Sing
   Poon, Vincent Kwok-Man
   Yip, Cyril Chik-Yan
   Zhang, Xi
   Tsang, Jessica Oi-Ling
   Zou, Zijiao
   Tee, Kah-Meng
   Shuai, Huiping
   Lu, Gang
   Yuen, Kwok-Yung
TI The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits
   Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika
   virus infected A129 mice: A host-targeting treatment strategy
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Antiviral; AR-12; Flavivirus; Kinase; Inhibitor; Zika
ID RESPIRATORY SYNDROME CORONAVIRUS; IN-VITRO; ANTIVIRAL ACTIVITY;
   REPLICATION; DISCOVERY; FEVER
AB Zika virus (ZIKV) is a human-pathogenic flavivirus that has recently emerged as a global public health threat. ZIKV infection may be associated with congenital malformations in infected fetuses and severe neurological and systemic complications in infected adults. There are currently limited treatment options for ZIKV infection. AR-12 (OSU-03012) is a celecoxib derivative cellular kinase inhibitor that has broad-spectrum antiviral activities. In this study, we investigated the antiviral activity and mechanism of AR-12 against ZIKV. We evaluated the in vitro anti-ZIKV activity of AR-12, using cell protection and virus yield reduction assays, in multiple clinically relevant cell lines, and the in vivo treatment effects of AR-12 in a lethal mouse model using type I interferon receptor deficient A129 mice. AR-12 inhibited ZIKV strains belonging to both the African and Asian/American lineages in Huh-7 and/or neuronal cells. AR12's IC50 against ZIKV was consistently < 2 mu M in these cells. ZIKV-infected A129 mice treated with intraperitoneally or orally administered AR-12 had significantly higher survival rate (50.0%-83.3% vs 0%, P < 0.05), less body weight loss, and lower blood and tissue ZIKV RNA loads than untreated control A129 mice. These anti-ZIKV effects were likely the results of down-regulation of the PI3K/Akt pathway by AR-12. Clinical trials using the clinically available and broad-spectrum AR-12 as an empirical treatment should be considered especially for patients residing in or returning from areas endemic of ZIKV and other arboviral infections who present with an acute undifferentiated febrile illness.
C1 [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Zhu, Zheng; Chu, Hin; Yuan, Shuofeng; Chik, Kenn Ka-Heng; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Yip, Cyril Chik-Yan; Zhang, Xi; Tsang, Jessica Oi-Ling; Zou, Zijiao; Tee, Kah-Meng; Shuai, Huiping; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Lu, Gang; Yuen, Kwok-Yung] Hainan Med Univ, Univ Hong Kong, Joint Lab Trop Infect Dis, Haikou, Hainan, Peoples R China.
   [Chan, Jasper Fuk-Woo; Lu, Gang; Yuen, Kwok-Yung] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.
   [Lu, Gang] Hainan Med Univ, Dept Pathogen Biol, Haikou 571101, Hainan, Peoples R China.
   [Lu, Gang] Hainan Med Univ, Key Lab Translat Trop Med, Haikou 571101, Hainan, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China.
RP Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Carol Yu Ctr Infect,Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
RI Chan, Jasper F. W./D-8007-2013; ZHU, ZHENG/P-2173-2016
OI Chan, Jasper F. W./0000-0001-6336-6657; ZHU, ZHENG/0000-0002-2035-0804;
   CHU, HIN/0000-0003-2855-9837; Yuan, Shuofeng/0000-0001-7996-1119
FU High Level Hospital -Summit Program in Guangdong; University of Hong
   Kong-Shenzhen Hospital; Collaborative Innovation Center for Diagnosis
   and Treatment of Infectious Diseases, the Ministry of Education of
   ChinaMinistry of Education, China; European Union's Horizon 2020
   research and innovation programme [653316]
FX The data were in part submitted and/or presented at the 22nd Research
   Postgraduate Symposium at the Li Ka Shing Faculty of Medicine, The
   University of Hong Kong, Hong Kong; the 28th European Congress of
   Clinical Microbiology and Infectious Diseases, Madrid, Spain; and the
   2nd International Zika Virus and Aedes Related Infections, Tallinn,
   Estonia. This work was partly supported by the donations of Michael
   Seak-Kan Tong, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited,
   Chan Yin Chuen Memorial Charitable Foundation, and the Hong Kong Hainan
   Commercial Association South China Microbiology Research Fund; and
   funding from the High Level Hospital -Summit Program in Guangdong, The
   University of Hong Kong-Shenzhen Hospital, and the Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   the Ministry of Education of China. The European Virus Archive goes
   Global (EVAg) project has received funding from the European Union's
   Horizon 2020 research and innovation programme under grant agreement NO
   653316. The sponsors had no role in the design and conduct of the study,
   in the collection, analysis and interpretation of data, or in the
   preparation, review or approval of the manuscript.
CR Booth L, 2016, ONCOTARGET, V7, P12975, DOI 10.18632/oncotarget.7349
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chan CM, 2016, J VIROL, V90, P9114, DOI 10.1128/JVI.01133-16
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chen HH, 2017, ANTIVIR RES, V142, P158, DOI 10.1016/j.antiviral.2017.02.015
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Chiu HC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-110
   Chiu HC, 2009, ANTIMICROB AGENTS CH, V53, P5236, DOI 10.1128/AAC.00555-09
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Collier MA, 2016, INT J PHARMACEUT, V499, P186, DOI 10.1016/j.ijpharm.2016.01.004
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Hassandarvish P, 2017, J ANTIMICROB CHEMOTH, V72, P2438, DOI 10.1093/jac/dkx191
   Hoang KV, 2016, ANTIMICROB AGENTS CH, V60, P2052, DOI 10.1128/AAC.02228-15
   Hung IFN, 2017, CHEST, V151, P1069, DOI 10.1016/j.chest.2016.11.012
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Koselny K, 2016, ANTIMICROB AGENTS CH, V60, P7115, DOI 10.1128/AAC.01061-16
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Lee TX, 2009, EUR J CANCER, V45, P1709, DOI 10.1016/j.ejca.2009.03.013
   Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011
   Linero FN, 2009, VIRUS RES, V145, P166, DOI 10.1016/j.virusres.2009.07.004
   MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546
   Marsh GA, 2012, CURR OPIN VIROL, V2, P242, DOI 10.1016/j.coviro.2012.03.006
   Mohr EL, 2015, ANTIVIR RES, V120, P40, DOI 10.1016/j.antiviral.2015.05.003
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tao X., 2017, ANTIMICROB AGENTS CH, V2017, P62
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1
   Tsai TT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003320
   Urata S, 2012, J VIROL, V86, P4578, DOI 10.1128/JVI.06604-11
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 48
TC 5
Z9 5
U1 4
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2018
VL 160
BP 38
EP 47
DI 10.1016/j.antiviral.2018.10.007
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HC6UA
UT WOS:000451936000005
PM 30326204
OA Green Published
DA 2020-07-08
ER

PT J
AU Coronado, MA
   Eberle, RJ
   Bleffert, N
   Feuerstein, S
   Olivier, DS
   de Moraes, FR
   Willbold, D
   Arni, RK
AF Coronado, Monika Aparecida
   Eberle, Raphael Josef
   Bleffert, Nicole
   Feuerstein, Sophie
   Olivier, Danilo Silva
   de Moraes, Fabio Rogerio
   Willbold, Dieter
   Arni, Raghuvir Krishnaswamy
TI Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a
   lead compound for NS2B/NS3 proteinase inhibition
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; NS2B/NS3 proteinase; Suramin; Inhibitor; Lead compound
ID NS2B-NS3 PROTEASE; DENGUE VIRUS; CRYSTAL-STRUCTURE; BINDING; DYNAMICS;
   LIGAND; NMR; IDENTIFICATION; REPLICATION; PARAMETERS
AB Zika virus infection is the focus of much research due to the medical and social repercussions. Due the role of the viral NS2B/NS3 proteinase in maturation of the viral proteins, it had become an attractive antiviral target. Numerous investigations on viral epidemiology, structure and function analysis, vaccines, and therapeutic drugs have been conducted around the world. At present, no approved vaccine or even drugs have been reported. Thus, there is an urgent need to develop therapeutic agents to cure this epidemic disease. In the present study, we identified the polyanion suramin, an approved antiparasitic drug with antiviral properties, as a potential inhibitor of Zika virus complex NS2B/NS3 proteinase with IC50 of 47 mu M. Using fluorescence spectroscopy results we could determine a k(d) value of 28 mu M and had shown that the ligand does not affect the thermal stability of the protein. STD NMR spectroscopy experiments and molecular docking followed by molecular dynamics simulation identified the binding epitopes of the molecule and shows the mode of interaction, respectively. The computational analysis showed that suramin block the Ser135 residue and interact with the catalytically histidine residue.
C1 [Coronado, Monika Aparecida; Eberle, Raphael Josef; Olivier, Danilo Silva; de Moraes, Fabio Rogerio; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista, UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Bleffert, Nicole; Feuerstein, Sophie; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, Julich, Germany.
   [Bleffert, Nicole; Feuerstein, Sophie; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Univ Str, Dusseldorf, Germany.
RP Coronado, MA; Arni, RK (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias Letras & Ciencias Exatas Ibilce, Dept Fis,Ctr Multiusuario Inovacao Biomol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM monikacoronado@gmail.com; arni@sjrp.unesp.br
RI de Moraes, Fabio R/B-8331-2017; Olivier, Danilo/M-7566-2016; Arni,
   Raghuvir K/B-2222-2013; Willbold, Dieter/A-6280-2013
OI de Moraes, Fabio R/0000-0002-0425-0352; Olivier,
   Danilo/0000-0003-1269-3783; Arni, Raghuvir K/0000-0003-2460-1145;
   Willbold, Dieter/0000-0002-0065-7366
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [435913/2016-6, 401270/2014-9, 307338/2014-2]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/13765-0, 2015/18868-2,
   2016/08104-8, 2016/12904-0, 2009/53989-4]; CAPESCAPES; PROPe UNESP
FX The authors want to thank you Professor Dr. Marcos R. de Mattos Fontes
   for providing access to the fluorescence machine, Prof. Dr. Marcos S. do
   Amaral for providing time on his computer cluster to run MD simulations,
   Dr. Dayane dos Santos Alvarez to support the DSC experiments and Dr.
   Melanie Schwarten. This research was supported by grants from CNPq
   [Grant numbers 435913/2016-6, 401270/2014-9, 307338/2014-2], FAPESP
   [Grant numbers 2015/13765-0, 2015/18868-2, 2016/08104-8; 2016/12904-0;
   2009/53989-4], CAPES and PROPe UNESP.
CR Ahumada M, 2017, ANALYST, V142, P2067, DOI 10.1039/c7an00288b
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Centers for Disease Control and Prevention, 2018, WORLD MAP AR RISK ZI
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Ehrlich P., 1904, BERL KLIN WCHNSCHR, VXii, P329
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Frisch D. J., 2009, GAUSSIAN 09 REVISION
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Shaikh SMT, 2007, DYES PIGMENTS, V73, P211, DOI 10.1016/j.dyepig.2005.11.008
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Trott O., 2009, J COMPUT CHEM, V31
   Wang GK, 2015, COLLOID SURFACE B, V135, P261, DOI 10.1016/j.colsurfb.2015.07.063
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   WASYLEWSKI Z, 1992, EUR J BIOCHEM, V206, P235, DOI 10.1111/j.1432-1033.1992.tb16921.x
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 49
TC 6
Z9 6
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2018
VL 160
BP 118
EP 125
DI 10.1016/j.antiviral.2018.10.019
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HC6UA
UT WOS:000451936000014
PM 30393012
DA 2020-07-08
ER

PT J
AU Guerrero, NAS
   Sharma, S
   Neyts, J
   Kaptein, SJF
AF Guerrero, Nidya A. Segura
   Sharma, Sapna
   Neyts, Johan
   Kaptein, Suzanne J. F.
TI Favipiravir inhibits in vitro Usutu virus replication and delays disease
   progression in an infection model in mice
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Emerging flavivirus; Usutu virus; Mouse model; AG129 mice; Antivirals
ID WEST NILE VIRUS; VIVO ACTIVITIES; T-705; FLAVIVIRUS; INDUCTION;
   SENSITIVITY; CHALLENGE; EMERGENCE; COMPOUND; PROTECTS
AB Usutu virus (USUV) is an emerging flavivirus that causes Usutu disease mainly in birds, but infection of mammals such as rodents, bats and horses has also been demonstrated. In addition, human cases (both in immunocompromised and-competent individuals) were also reported. Large outbreaks with other flaviviruses, such as West Nile virus and Zika virus, indicate that one should be vigilant for yet other outbreaks. To allow the identification of inhibitors of USUV replication, we established in vitro antiviral assays, which were validated using a small selection of known flavivirus inhibitors, including the broad-spectrum viral RNA polymerase inhibitor favipiravir (T-705). Next, an USUV infection model in AG129 (IEN-alpha/beta and IFN-gamma receptor knockout) mice was established. AG129 mice proved highly susceptible to USUV; an inoculum as low as 10(2) PFU (1.3 x 10(5) TCID50) resulted in the development of symptoms as early as 3 days post infection with viral RNA being detectable in various tissues. Treatment of mice with favipiravir (150 mg/kg/dose, BID, oral gavage) significantly reduced viral load in blood and tissues and significantly delayed virus-induced disease. This USUV mouse model is thus amenable for assessing the potential in vivo efficacy of (novel) USUV/flavivirus inhibitors.
C1 [Guerrero, Nidya A. Segura; Sharma, Sapna; Neyts, Johan; Kaptein, Suzanne J. F.] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Herestr 49,Box 1043, B-3000 Leuven, Belgium.
   [Guerrero, Nidya A. Segura] Univ Pedag & Tecnol Colombia, Tunja, Colombia.
RP Neyts, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Herestr 49,Box 1043, B-3000 Leuven, Belgium.
EM johan.neyts@kuleuven.be
RI Kaptein, Suzanne JF/O-8855-2018; Kaptein, Suzanne JF/O-4714-2019; Neyts,
   Johan/U-8267-2017; segura, alexandra/J-2783-2016
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Kaptein, Suzanne
   JF/0000-0002-7935-0219; Neyts, Johan/0000-0002-0033-7514; segura,
   alexandra/0000-0001-5810-4847
FU European UnionEuropean Union (EU) [734584, 734548]
FX This research was partially funded by the European Union's Horizon 2020
   Research and Innovation Programme under Grant Agreement no. 734584
   (ZikaPLAN) and 734548 (ZIKAlliance).
CR Allering L, 2012, EUROSURVEILLANCE, V17, P2
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Cacciotti G, 2015, VIROLOGY, V485, P189, DOI 10.1016/j.virol.2015.07.015
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008
   Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cvjetkovic I. H., 2016, Arhiv Veterinarske Medicine, V9, P23
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Eiden M, 2018, INFECT GENET EVOL, V61, P151, DOI 10.1016/j.meegid.2018.03.020
   Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Gaibani P, 2017, MICROBES INFECT, V19, P382, DOI 10.1016/j.micinf.2017.05.003
   Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813
   Garigliany M, 2017, INFECT GENET EVOL, V48, P116, DOI 10.1016/j.meegid.2016.12.023
   Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Hubalek Z, 2008, VECTOR-BORNE ZOONOT, V8, P659, DOI 10.1089/vbz.2007.0283
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Lecollinet S, 2016, EMERG INFECT DIS, V22, P2225, DOI 10.3201/eid2212.161272
   Martin-Acebes MA, 2016, VACCINE, V34, P2066, DOI 10.1016/j.vaccine.2016.03.015
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Musso D., 2018, LANCET INFECT DIS, DOI [10.1016/S1473-3099(18)30269-X, DOI 10.1016/S1473-3099(18)30269-X.JUN19]
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V424, P777, DOI 10.1016/j.bbrc.2012.07.034
   Rocha-Pereira J, 2013, J VIROL, V87, P11798, DOI 10.1128/JVI.02064-13
   Scagnolari C, 2013, J GEN VIROL, V94, P789, DOI 10.1099/vir.0.046433-0
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Steinmetz HW, 2011, VET MICROBIOL, V148, P207, DOI 10.1016/j.vetmic.2010.09.018
   Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 46
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2018
VL 160
BP 137
EP 142
DI 10.1016/j.antiviral.2018.10.026
PG 6
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HC6UA
UT WOS:000451936000016
PM 30385306
DA 2020-07-08
ER

PT J
AU Dantas, E
   Tosin, M
   Cunha, A
AF Dantas, Eber
   Tosin, Michel
   Cunha, Americo, Jr.
TI Calibration of a SEIR-SEI epidemic model to describe the Zika virus
   outbreak in Brazil
SO APPLIED MATHEMATICS AND COMPUTATION
LA English
DT Article
DE Zika virus dynamics; Nonlinear dynamics; Mathematical biology; SEIR
   epidemic model; Model calibration; Inverse problem
ID TRANSMISSION; DYNAMICS; AMERICA; REGION; ISLAND
AB Multiple instances of Zika virus epidemic have been reported around the world in the last two decades, turning the related illness into an international concern. In this context the use of mathematical models for epidemics is of great importance, since they are useful tools to study the underlying outbreak numbers and allow one to test the effectiveness of different strategies used to combat the associated diseases. This work deals with the development and calibration of an epidemic model to describe the 2016 outbreak of Zika virus in Brazil. A system of 8 differential equations with 8 parameters is employed to model the evolution of the infection through two populations. Nominal values for the model parameters are estimated from the literature. An inverse problem is formulated and solved by comparing the system response to real data from the outbreak. The calibrated results presents realistic parameters and returns reasonable descriptions, with the curve shape similar to the outbreak evolution and peak value close to the highest number of infected people during 2016. Considerations about the lack of data for some initial conditions are also made through an analysis over the response behavior according to their change in value. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Dantas, Eber; Tosin, Michel; Cunha, Americo, Jr.] Univ Estado Rio De Janeiro, Nucleus Modeling & Experimentat Comp NUMERICO, Rua Sao Francisco Xavier 524, BR-20550900 Rio De Janeiro, RJ, Brazil.
RP Cunha, A (corresponding author), Univ Estado Rio De Janeiro, Nucleus Modeling & Experimentat Comp NUMERICO, Rua Sao Francisco Xavier 524, BR-20550900 Rio De Janeiro, RJ, Brazil.
EM eber.paiva@uerj.br; michel.tosin@uerj.br; americo@ime.uerj.br
RI Dantas, Eber/Q-2010-2019; Cunha, Americo/D-5261-2009
OI Dantas, Eber/0000-0003-2693-0719; Cunha, Americo/0000-0002-8342-0363
FU CNPq (National Council for Scientific and Technological
   Development)National Council for Scientific and Technological
   Development (CNPq); CAPES (Coordination for the Improvement of Higher
   Education Personnel)CAPES; FAPERJ (Research Support Foundation of the
   State of Rio de Janeiro)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX The authors are indebted to the Brazilian agencies CNPq (National
   Council for Scientific and Technological Development), CAPES
   (Coordination for the Improvement of Higher Education Personnel) and
   FAPERJ (Research Support Foundation of the State of Rio de Janeiro) for
   the financial support given to this research. They are also grateful to
   Joao Peterson and Vinicius Lopes, both engineering students at UERJ, for
   the collaboration in the initial stages of this work. The anonymous
   reviewers made a series of comments and suggestions that greatly
   enriched this paper, for which the authors are very grateful.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Aster R.C., 2012, PARAMETER ESTIMATION
   Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148
   Brasil P., 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/JOURNAL.PNTD.004636, DOI 10.1371/JOURNAL.PNTD.004636]
   Brauer F., 2012, MATH MODELS POPULATI, DOI [10.1007/9781461416869, DOI 10.1007/9781461416869]
   Brauer F., 2008, MATH EPIDEMIOLOGY, DOI [10.1007/9/83-4078911, DOI 10.1007/9/83-4078911]
   Cai YL, 2017, APPL MATH COMPUT, V305, P221, DOI 10.1016/j.amc.2017.02.003
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chavent G., 2010, NONLINEAR LEAST SQUA, DOI [10.1007/978-90-481-2785-6, DOI 10.1007/978-90-481-2785-6]
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023
   Conn AR, 2000, TRUST REGION METHODS
   Constantine P.G, 2015, ACTIVE SUBSPACES EME, DOI [10.1137/1.9781611973860, DOI 10.1137/1.9781611973860]
   Constantine PG, 2014, SIAM J SCI COMPUT, V36, pA1500, DOI 10.1137/130916138
   Cunha Jr A., 2017, UNCERTAINTIES PROBAB, P127, DOI [10.1007/978-3-319-55852-3_8, DOI 10.1007/978-3-319-55852-3_8]
   Dantas E., 2018, P SERIES BRAZILAIN S, V6, DOI [10.5540/03.2018.006.01.0460, DOI 10.5540/03.2018.006.01.0460]
   Dantas E., 2016, P 4 C COMP INT SCI C
   Diaz P, 2018, APPL MATH COMPUT, V324, P141, DOI 10.1016/j.amc.2017.11.039
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes R. S., 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/JOURNAL.PPTD.0004993, DOI 10.1371/JOURNAL.PPTD.0004993]
   Fundacao Institute Brasileiro de Geografia e Estatistica, 2016, DIAR OF UN, P47
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hirsch MW, 2013, DIFFERENTIAL EQUATIONS, DYNAMICAL SYSTEMS, AND AN INTRODUCTION TO CHAOS, 3RD EDITION, P1
   Huppert A, 2013, CLIN MICROBIOL INFEC, V19, P999, DOI 10.1111/1469-0691.12308
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Martcheva M., 2015, INTRO MATH EPIDEMIOL, DOI [10.1007/9781448899-76123_1, DOI 10.1007/9781448899-76123_1]
   Ministetio da Saude, 2017, OBT NUM CAS CONF ZIK
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Naheed A, 2014, APPL MATH COMPUT, V229, P480, DOI 10.1016/j.amc.2013.12.062
   National Center for Emerging and Zoonotic Infectious Diseases, 2012, DENG AED AEG MOS
   Nelson M.J., 1986, AEDES AEGYPTI BIOL E
   Oberkampf W. L., 2010, VERIFICATION VALIDAT
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Lizarralde-Bejarano DP, 2017, APPL MATH MODEL, V43, P566, DOI 10.1016/j.apm.2016.11.022
   Perko L, 2006, DIFFERENTIAL EQUATIO
   Safi MA, 2013, APPL MATH COMPUT, V219, P10627, DOI 10.1016/j.amc.2013.03.126
   Secretaria de Vigilancia em Satide Boletim Epidemiololico, 2017, FEBR CHIK FEBR PEL V, V48
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang XY, 2014, APPL MATH COMPUT, V232, P479, DOI 10.1016/j.amc.2014.01.090
   Wang Y, 2017, COMMUN NONLINEAR SCI, V45, P35, DOI 10.1016/j.cnsns.2016.09.014
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, ZIK VIR
   Yaman F., 2013, MATH PROBL ENG, V2013, DOI [10.1155/12013/9/6837, DOI 10.1155/12013/9/6837]
NR 61
TC 6
Z9 6
U1 6
U2 177
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0096-3003
EI 1873-5649
J9 APPL MATH COMPUT
JI Appl. Math. Comput.
PD DEC 1
PY 2018
VL 338
BP 249
EP 259
DI 10.1016/j.amc.2018.06.024
PG 11
WC Mathematics, Applied
SC Mathematics
GA GQ6XB
UT WOS:000441871500020
DA 2020-07-08
ER

PT J
AU Mudd, J
   Hollins, A
   Ashton, S
   Gair, R
   Donohue, S
AF Mudd, Julie
   Hollins, Aaron
   Ashton, Sian
   Gair, Richard
   Donohue, Steven
TI Zika prevention: lessons from the Australian front line
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID SEXUAL TRANSMISSION; VIRUS; WOLBACHIA
C1 [Mudd, Julie; Donohue, Steven] Townsville Hosp & Hlth Serv, Townsville Publ Hlth Unit, 242 Walker St, Townsville, Qld 4810, Australia.
   [Mudd, Julie; Hollins, Aaron] James Cook Univ, Div Trop Hlth & Med, Coll Med & Dent, Townsville, Qld, Australia.
   [Ashton, Sian; Gair, Richard] Cairns & Hinterland Hosp & Hlth Serv, Trop Publ Hlth Serv, Cairns, Qld, Australia.
RP Mudd, J (corresponding author), Townsville Hosp & Hlth Serv, Townsville Publ Hlth Unit, 242 Walker St, Townsville, Qld 4810, Australia.
EM julie.mudd@health.qld.gov.au
OI Mudd, Julie/0000-0002-7499-0241
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darbro JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2004-0
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   McBride J H, 1999, Aust Fam Physician, V28, P319
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Pan American Health Organization, 2016, ZIK VIR INF STEP STE
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Queenland Health, 2016, ZIK DENG DIY SPRAYIN
   Queensland Health, 2015, DENG MAN PLAN 2015 2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009
NR 25
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD DEC
PY 2018
VL 42
IS 6
BP 510
EP 512
DI 10.1111/1753-6405.12814
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HC7SE
UT WOS:000452001100004
PM 30088678
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ferreira, JCOA
   Trindade, VC
   Espada, G
   Morel, Z
   Bonfa, E
   Magalhaes, CS
   Silva, CA
AF Ferreira, Juliana C. O. A.
   Trindade, Vitor C.
   Espada, Graciela
   Morel, Zoilo
   Bonfa, Eloisa
   Magalhaes, Claudia S.
   Silva, Clovis Artur
TI Epidemiology and management practices for childhood-onset systemic lupus
   erythematosus patients: a survey in Latin America
SO CLINICAL RHEUMATOLOGY
LA English
DT Article
DE Adolescent; Childhood-onset systemic lupus erythematosus; Children;
   Epidemiology; Latin America; Survey
ID RHEUMATIC-DISEASES; MULTICENTER; DIAGNOSIS; CARE; MANIFESTATIONS;
   ADOLESCENTS; FERTILITY; INFECTION; PREGNANCY; CHILDREN
AB To assess epidemiology and management practices of Latin America Pediatric Rheumatologists (LAPR) about childhood-onset systemic lupus erythematosus (cSLE). A cross-sectional study was performed in 288 LAPR PANLAR members based on online survey about cSLE practices. The response rate of web-based survey by LAPR was 170/288(59%) and the majority worked in university hospitals (63%). The ACR and/or SLICC classification criteria (99%) and disease activity tools (97%) were almost universally used by LAPR, whereas damage index (70%) and CHAQ (58%) instruments were less frequently used. Laboratory exams, diagnostic imaging, and biopsies were generally available (>75%), however low availability for densitometry (66%). Drug access was excellent for the most common prescribed medications (>75%), except for belimumab (11%). Emerging mosquito-borne diseases were also reported: dengue (20%), chikungunya (11%), and Zika (8%). Groups were further divided in two, according to the median number of cSLE patients followed by LAPR in the last year: groups A and B (25 and <25, respectively). Frequencies of condom in combination with other contraceptive methods were significantly higher in group A than B (p=0.01). The frequencies of reported pregnancy (p<0.001) and non-adherence to therapy were significantly higher in group A (p=0.023). Alcohol intake (p=0.004) and illicit drug use (p=0.007) were also reported more frequently by LAPR of group A in at least one cSLE patient. This first large web-based survey demonstrated an overall excellent access for diagnosis and therapy by LAPR, probably related to their high rate of practices in tertiary care of university hospitals. Adherence to therapy, pregnancy, and substance abuse was identified as major challenges in this population, particularly in larger centers.
C1 [Ferreira, Juliana C. O. A.; Trindade, Vitor C.; Silva, Clovis Artur] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Pediat Rheumatol Unit,Childrens Inst, Ave Dr Eneas Carvalho de Aguiar 647, BR-05403000 Sao Paulo, SP, Brazil.
   [Espada, Graciela] Hosp Ninos Dr Ricardo Gutierrez, Pediat Rheumatol Unit, Buenos Aires, DF, Argentina.
   [Morel, Zoilo] Univ Nacl Asuncion, Hosp Clin, Serv Pediat, Pediat Rheumatol Unit, Asuncion, Paraguay.
   [Bonfa, Eloisa] Univ Sao Paulo, Div Rheumatol, Hosp Clin HCFMUSP, Fac Med, Sao Paulo, SP, Brazil.
   [Magalhaes, Claudia S.] Sao Paulo State Univ UNESP, Pediat Rheumatol Unit, Fac Med Botucatu, Sao Paulo, Brazil.
RP Silva, CA (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Pediat Rheumatol Unit,Childrens Inst, Ave Dr Eneas Carvalho de Aguiar 647, BR-05403000 Sao Paulo, SP, Brazil.
EM clovisaasilva@gmail.com
RI Bonfa, Eloisa/B-8438-2012; Silva, Clovis/J-3640-2017; de Oliveira A,
   Juliana Caires/AAC-9229-2019
OI Bonfa, Eloisa/0000-0002-0520-4681; de Oliveira A, Juliana
   Caires/0000-0002-9249-2318
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP 2015/03756-4]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [CNPq 305068/2014-8,
   301479/2015-1, 303422/2015-7]; Federico Foundation; Nucleo de Apoio a
   Pesquisa "Saude da Crianca e do Adolescente" da USP (NAP-CriAd)
FX This study was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP 2015/03756-4 to EB and CAS), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 305068/2014-8
   to EB, 301479/2015-1 to CSMand 303422/2015-7 to CAS), Federico
   Foundation (to EB, and CAS), and by Nucleo de Apoio a Pesquisa "Saude da
   Crianca e do Adolescente" da USP (NAP-CriAd) to CAS.
CR Anelli CG, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0176-y
   Anuardo P, 2017, PEDIATR CARDIOL, V38, P234, DOI 10.1007/s00246-016-1504-6
   Beswick DM, 2016, AM J RHINOL ALLERGY, V30, P418, DOI 10.2500/ajra.2016.30.4373
   Boneparth A, 2017, J RHEUMATOL, V44, P1619, DOI 10.3899/jrheum.170502
   Bundhun PK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008086
   Casey C, 2017, CLIN RHEUMATOL, V36, P97, DOI 10.1007/s10067-016-3487-3
   Ferreira JCOA, 2016, LUPUS, V25, P754, DOI 10.1177/0961203315627203
   Ugarte-Gil MF, 2017, ANN RHEUM DIS, V76, P2071, DOI 10.1136/annrheumdis-2017-211814
   Gomes RC, 2016, ARTHRIT CARE RES, V68, P1736, DOI 10.1002/acr.22881
   Gormezano NWS, 2015, PEDIATR INFECT DIS J, V34, P905, DOI 10.1097/INF.0000000000000756
   Groot N, 2017, ANN RHEUM DIS, P1
   Salinas MJH, 2017, LUPUS, V26, P1368, DOI 10.1177/0961203317699284
   Jung JY, 2017, KOREAN J INTERN MED, V32, P429, DOI 10.3904/kjim.2016.234
   Kahwage PP, 2017, CLIN RHEUMATOL, V36, P547, DOI 10.1007/s10067-016-3534-0
   Klumb EM, 2015, REV BRAS REUMATOL, V55, P1, DOI 10.1016/j.rbr.2014.09.008
   Koneru S, 2008, JCR-J CLIN RHEUMATOL, V14, P195, DOI 10.1097/RHU.0b013e31817a242a
   Ferriani MPL, 2015, INT ARCH ALLERGY IMM, V167, P186, DOI 10.1159/000438723
   Lopes SRM, 2017, LUPUS, V26, P996, DOI 10.1177/0961203317690616
   Lourenco B, 2017, REV BRAS REUMATOL, V57, P73, DOI [10.1016/j.rbre.2016.07.016, 10.1016/j.rbr.2016.06.005]
   Lube GE, 2016, PEDIATR BLOOD CANCER, V63, P1238, DOI 10.1002/pbc.25976
   Marques VLS, 2016, J PEDIATR GASTR NUTR, V62, P328, DOI 10.1097/MPG.0000000000000990
   Mina R, 2016, ARTHRIT CARE RES, V68, P179, DOI 10.1002/acr.22666
   Novak GV, 2017, AUTOIMMUN REV, V16, P132, DOI 10.1016/j.autrev.2016.12.004
   Ostensen M, 2011, RHEUMATOLOGY, V50, P657, DOI 10.1093/rheumatology/keq350
   Pons-Estel GJ, 2015, LUPUS, V24, P536, DOI 10.1177/0961203314567753
   Pons-Estel GJ, 2012, RHEUMATOLOGY, V51, P1293, DOI 10.1093/rheumatology/ker514
   Rathore Mobeen H, 2017, Adv Pediatr, V64, P27, DOI 10.1016/j.yapd.2017.04.002
   Sakamoto AP, 2017, ACTA REUMATOL PORT, V42, P250
   Sakamoto AP, 2017, REV BRAS REUMATOL, V57, P583, DOI 10.1016/j.rbre.2017.09.002
   Sakamoto AP, 2016, RHEUMATOL INT, V36, P1641, DOI 10.1007/s00296-016-3564-6
   Silva CA, 2010, ARTHRIT CARE RES, V62, P1682, DOI 10.1002/acr.20323
   Silva CAA, 2008, J RHEUMATOL, V35, P1414
   Silva CA, 2016, EXPERT REV CLIN IMMU, V12, P907, DOI 10.1080/1744666X.2016.1195685
   Silva MF, 2015, J RHEUMATOL, V42, P2296, DOI 10.3899/jrheum.150142
   Thakral A, 2016, RHEUMATOL THER, V3, P209, DOI 10.1007/s40744-016-0044-0
   Tiseo BC, 2016, INT BRAZ J UROL, V42, P11, DOI 10.1590/S1677-5538.IBJU.2014.0595
   Valoes CCM, 2017, LUPUS, V26, P484, DOI 10.1177/0961203316676386
   van Weelden M, 2016, REV BRAS REUMATOL, V56, P228, DOI 10.1016/j.rbre.2016.02.001
   Wenderfer SE, 2017, PEDIATR RES, V81, P406, DOI 10.1038/pr.2016.247
   Yang Xiao-Lie, 2016, Sichuan Da Xue Xue Bao Yi Xue Ban, V47, P594
NR 40
TC 0
Z9 1
U1 2
U2 6
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD DEC
PY 2018
VL 37
IS 12
BP 3299
EP 3307
DI 10.1007/s10067-018-4254-4
PG 9
WC Rheumatology
SC Rheumatology
GA HC3UW
UT WOS:000451729300018
PM 30094748
OA Green Published
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
AF Wilder-Smith, Annelies
TI Risk of Dengue in Travelers: Implications for Dengue Vaccination
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Dengue; Travelers; Dengue vaccine; Personal protection; Seroconversion;
   GeoSentinel
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; ZIKA VIRUS; FEVER; ILLNESS;
   GEOSENTINEL; MANIFESTATIONS; IMPORTATIONS; OUTBREAK; CHILDREN
AB Purpose of ReviewDengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers.Recent FindingsGeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades. In Southeast Asia, annual proportionate morbidity increased from 50 dengue cases per 1000 ill-returned travelers in non-epidemic years to an average of 159 cases per 1000 travelers during epidemic years. Dengue is the leading cause of fever in returning travelers, having overtaken malaria for travelers to Southeast Asia. Most dengue seroconversion studies in travelers report an attack rate of around 5% depending on duration of travel and destination.SummaryDengue vaccination would be justified for travelers. The first licensed dengue vaccine CYD-TDV is only recommended in seropositive individuals. This review considers preventive measures including how best to use the first licensed dengue vaccine CYD-TDV.
C1 [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, Bloomsbury, England.
RP Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, Bloomsbury, England.
EM annelies.wilder-smith@lshtm.ac.uk
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE830, DOI 10.1016/S2214-109X(18)30295-X
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Basurko C, 2018, AM J TROP MED HYG, V98, P1826, DOI 10.4269/ajtmh.16-0794
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boo YL, 2016, TZU CHI MED J, V28, P157, DOI 10.1016/j.tcmj.2015.09.007
   Caci Jennifer B, 2014, J Spec Oper Med, V14, P111
   Chen LH, 2018, J TRAVEL MED, V25
   Cnops L, 2014, J TRAVEL MED, V21, P344, DOI 10.1111/jtm.12113
   Vieira MADES, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759022, 10.1590/S1678-9946201759022]
   Dalugama Chamara, 2018, J Med Case Rep, V12, P137, DOI 10.1186/s13256-018-1626-y
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Ferguson RW, 2016, J TRAVEL MED, V23
   Flaherty G, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw038
   Flaherty GT, 2018, J TRAVEL MED
   Fragoso YD, 2016, ARQ NEURO-PSIQUIAT, V74, P1039, DOI [10.1590/0004-282X20160161, 10.1590/0004-282x20160161]
   Freedman DO, 1999, J TRAVEL MED, V6, P94, DOI 10.1111/j.1708-8305.1999.tb00839.x
   Fuchs I, 2014, J MED VIROL, V86, P2005, DOI 10.1002/jmv.23879
   Gautret P, 2012, J TRAVEL MED, V19, P169, DOI 10.1111/j.1708-8305.2012.00613.x
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadinegoro SR, 2015, N ENGL J MED
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P261
   Hariyanto Hori, 2016, J Med Case Rep, V10, P357, DOI 10.1186/s13256-016-1129-7
   Huang ZJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-33
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kirawittaya T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003943
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Kobayashi K, 2015, J TRAVEL MED, V22, P64, DOI 10.1111/jtm.12158
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar J, 2009, BMJ CASE REP, V2009
   L'Azou M, 2016, NEW ENGL J MED, V374, P1155, DOI 10.1056/NEJMoa1503877
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lee YH, 2016, J GEN VIROL, V97, P3103, DOI 10.1099/jgv.0.000637
   Lim M., 2005, SMJ Singapore Medical Journal, V46, P645
   Ling LM, 2007, J CLIN VIROL, V38, P265, DOI 10.1016/j.jcv.2006.12.011
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Loconsole D, 2018, VECTOR-BORNE ZOONOT, V18, P331, DOI 10.1089/vbz.2017.2260
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   McCarthy AE, 2013, CLIN INFECT DIS, V56, P925, DOI 10.1093/cid/cis1016
   Moncayo AC, 2015, AM J TROP MED HYG, V92, P69, DOI 10.4269/ajtmh.14-0341
   Neuberger A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw003
   Neumayr A, 2017, EURO SURVEILL, V22
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Olanwijitwong J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax013
   Olivero RM, 2016, AM J TROP MED HYG
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Pang JX, 2017, SCI REP-UK, V7, DOI 10.1038/srep39872
   Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641
   Pavli A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax016
   Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594
   Piyaphanee W, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw041
   Poddighe D, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav013
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Rabinowicz S, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax062
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Ramos JM, 2015, J TRAVEL MED, V22, P133, DOI 10.1111/jtm.12157
   Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1
   Ritchie SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay084
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rocklov J, 2014, SCAND J INFECT DIS, V46, P412, DOI 10.3109/00365548.2014.887222
   Rosenberger KD, 2016, TROP MED INT HEALTH, V21, P445, DOI 10.1111/tmi.12666
   Rowe K, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax038
   Sadarangani SP, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax014
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Sanchez-Vegas C, 2013, J TRAVEL MED, V20, P352, DOI 10.1111/jtm.12057
   Schwartz E, 2013, EURO SURVEILL, V18
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Seet RCS, 2005, J CLIN VIROL, V33, P336, DOI 10.1016/j.jcv.2005.03.002
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Shivanthan MC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-156
   Simkhada PP, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax021
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Sohail A, 2018, INTERN MED J
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tang XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187830
   Bich TD, 2015, LANCET, V385, P1260, DOI 10.1016/S0140-6736(15)60239-2
   Tissera H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004477
   Torresi J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax064
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith A, 2018, CLIN MICROBIOL INFEC, V24, P680, DOI 10.1016/j.cmi.2018.03.024
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   Wilder-Smith A, 2018, LANCET
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2015, J TRAVEL MED, V22, P200, DOI 10.1111/jtm.12198
   Willen SM, 2014, J TRAVEL MED, V21, P332, DOI 10.1111/jtm.12142
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
   Xu CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201441
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
   Zea D, 2014, AM J TROP MED HYG, V91, P156, DOI 10.4269/ajtmh.13-0637
NR 109
TC 4
Z9 4
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD DEC
PY 2018
VL 20
IS 12
AR 50
DI 10.1007/s11908-018-0656-3
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA GY7HV
UT WOS:000448780000001
PM 30374664
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Heide, M
   Huttner, WB
   Mora-Bermudez, F
AF Heide, Michael
   Huttner, Wieland B.
   Mora-Bermudez, Felipe
TI Brain organoids as models to study human neocortex development and
   evolution
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Review
ID PLURIPOTENT STEM-CELLS; ZIKA VIRUS-INFECTION; MICROGLIA-LIKE CELLS;
   CEREBRAL ORGANOIDS; CORTICAL DEVELOPMENT; NEURAL PROGENITORS;
   SELF-ORGANIZATION; IN-VITRO; HUMAN ES; DIFFERENTIATION
AB Since their recent development, organoids that emulate human brain tissue have allowed in vitro neural development studies to go beyond the limits of monolayer culture systems, such as neural rosettes. We present here a review of organoid studies that focuses on cortical wall development, starting with a technical comparison between pre-patterning and self-patterning brain organoid protocols. We then follow neocortex development in space and time and list those aspects where organoids have succeeded in emulating in vivo development, as well as those aspects that continue to be pending tasks. Finally, we present a summary of medical and evolutionary insight made possible by organoid technology.
C1 [Heide, Michael; Huttner, Wieland B.; Mora-Bermudez, Felipe] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.
   [Mora-Bermudez, Felipe] Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.
RP Huttner, WB; Mora-Bermudez, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.; Mora-Bermudez, F (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.
EM huttner@mpi-cbg.de; felipe_mora@eva.mpg.de
RI Huttner, Wieland B./P-4080-2018
FU DFGGerman Research Foundation (DFG) [SFB 655]; ERCEuropean Research
   Council (ERC) [250197]
FX We apologize to all researchers whose work could not be cited due to
   space limitation. Work in the laboratory of W.B.H. was supported by
   grants from the DFG (SFB 655, A2) and the ERC (250197).
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Arlotta P, 2018, NAT METHODS, V15, P27, DOI 10.1038/nmeth.4557
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011
   Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060
   di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292
   Dougherty ML, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1163-9
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005
   Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701
   Florio M, 2018, ELIFE, V7, DOI 10.7554/eLife.32332
   Florio M, 2017, CURR OPIN NEUROBIOL, V42, P33, DOI 10.1016/j.conb.2016.11.004
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Heide M, 2017, CURR OPIN CELL BIOL, V49, P22, DOI 10.1016/j.ceb.2017.11.008
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Malatesta P, 2013, DEVELOPMENT, V140, P483, DOI 10.1242/dev.085852
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Matsui T, 2017, DEVELOPMENT, V144, P1025, DOI 10.1242/dev.143636
   Mitchell C, 2018, SEMIN CELL DEV BIOL, V76, P23, DOI 10.1016/j.semcdb.2017.08.045
   Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683
   Mora-Bermudez F, 2015, MOL BIOL CELL, V26, P4302, DOI 10.1091/mbc.E15-03-0152
   Mora-Bermudez F, 2014, ELIFE, V3, DOI 10.7554/eLife.02875
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Namba T, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.256
   Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Rigamonti A, 2016, STEM CELL REP, V6, P993, DOI 10.1016/j.stemcr.2016.05.010
   Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37
   Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 66
TC 13
Z9 13
U1 4
U2 23
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD DEC
PY 2018
VL 55
BP 8
EP 16
DI 10.1016/j.ceb.2018.06.006
PG 9
WC Cell Biology
SC Cell Biology
GA HB6QB
UT WOS:000451195000003
PM 30006054
DA 2020-07-08
ER

PT J
AU Mansuy, JM
   Lhomme, S
   Cazabat, M
   Pasquier, C
   Martin-Blondel, G
   Izopet, J
AF Mansuy, Jean-Michel
   Lhomme, Sebastien
   Cazabat, Michelle
   Pasquier, Christophe
   Martin-Blondel, Guillaume
   Izopet, Jacques
TI Detection of Zika, dengue and chikungunya viruses using single-reaction
   multiplex real-time RT-PCR
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika; Dengue; Chikungunya; PCR; Molecular; Multiplex
ID WHOLE-BLOOD; COINFECTION; INFECTION; OUTBREAK; FRANCE
AB Zika (ZIKV), Dengue (DENV) and Chikungunya viruses (CHIKV) co-circulate in the same geographical areas during the same seasonal period through the same biting arthropods.
   Therefore a rapid sensitive and specific molecular assay for these viruses would be a considerable help in the disease management and the epidemiological survey.
   We developed a one-step multiplex real-time PCR for the simultaneous detection of these viruses.
   Intra and inter-reproducibilities varied from 0.41% to 3.29% and from 1.13% to 4.93% for each virus respectively. The specificity was 100%. Whole blood, plasma and urines were used for comparison with commercially available monoplex assays (RealStar (R) kits, Altona Diagnostics GmbH, Hamburg, Germany). The concordance was 96%, 92.9% and 95.7% for ZIKV, DENV and CHIKV respectively. No cross reaction and no PCR inhibition were observed for any of the clinical samples.
   This test can thus be used as a rapid molecular assay for ZIKV, DENVI-4 and CHIKV infections. (C) 2018 Published by Elsevier Inc.
C1 [Mansuy, Jean-Michel; Lhomme, Sebastien; Cazabat, Michelle; Pasquier, Christophe; Izopet, Jacques] CHU Purpan, Dept Virol, Toulouse, France.
   [Lhomme, Sebastien; Cazabat, Michelle; Pasquier, Christophe; Martin-Blondel, Guillaume; Izopet, Jacques] INSERM, UMR1043, Toulouse, France.
   [Lhomme, Sebastien; Cazabat, Michelle; Pasquier, Christophe; Martin-Blondel, Guillaume; Izopet, Jacques] Univ Paul Sabatier, Toulouse, France.
   [Martin-Blondel, Guillaume] CHU Purpan, Dept Infect & Trop Dis, Toulouse, France.
RP Mansuy, JM (corresponding author), CHU Purpan, Dept Virol, Toulouse, France.
EM mansuy.jm@chu-toulouse.fr; lhomme.s@chu-toulouse.fr;
   cazabat.m@chu-toulouse.fr; pasquier.c@chu-toulouse.fr;
   martin-blondel.g@chu-toulouse.fr; izopet.j@chu-toulouse.fr
RI Martin-Blondel, Guillaume/K-6762-2014; Lhomme, Sebastien/AAA-9426-2020
OI Martin-Blondel, Guillaume/0000-0002-8363-7028; Lhomme,
   Sebastien/0000-0001-7908-1576; IZOPET, JACQUES/0000-0002-8462-3234;
   PASQUIER, Christophe/0000-0001-9223-0150
FU Delegation Regionale a la Recherche Clinique des Hopitaux de Toulouse
FX This work was supported by a grant from the Delegation Regionale a la
   Recherche Clinique des Hopitaux de Toulouse "2016".
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kampen H, 2015, BUNDESGESUNDHEITSBLA, V58, P1101, DOI 10.1007/s00103-015-2218-2
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Seyler T, 2008, EUROSURVEILLANCE, V13, P3
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   World Health O, 2016, ZIK VIR RES AG
NR 26
TC 6
Z9 7
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD DEC
PY 2018
VL 92
IS 4
BP 284
EP 287
DI 10.1016/j.diagmicrobio.2018.06.019
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HD8NB
UT WOS:000452812700005
PM 30029808
DA 2020-07-08
ER

PT J
AU Teich, A
   Lowenfels, AB
   Solomon, L
   Wormser, GP
AF Teich, Alice
   Lowenfels, Albert B.
   Solomon, Lori
   Wormser, Gary P.
TI Gender disparities in Zika virus knowledge in a potentially at-risk
   population from suburban New York City
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Gender; Transmission; Survey; Knowledge
ID PREPAREDNESS; PREVENTION; DISEASE
AB Zika virus is an emerging infection transmitted in multiple ways. In 2016 we assessed the level of knowledge about Zika virus transmission in an underserved, predominantly Hispanic, mixed gender population living in suburban New York City, many of whom potentially travel to affected regions. Based on a convenience sample of 147 participants, 134 (91%) were aware of Zika virus transmission by mosquitoes; 116 (79%) knew about transmission from a pregnant female to the fetus; and 89 (61%) were aware of sexual transmission. Age, marital status, education, and native language were unrelated to knowledge (P>0.10). Women, however, were significantly more likely than men to know about sexual transmission (P = 0.023) and about maternal transmission to the fetus (P = 0.044). Travel to Zika virus endemic areas was unrelated to level of knowledge (P = 0.40). Greater awareness of the risk of sexual transmission of Zika virus is needed for at risk populations in the US, especially for males. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Teich, Alice; Lowenfels, Albert B.; Solomon, Lori] New York Med Coll, Dept Family Med, Valhalla, NY 10595 USA.
   [Lowenfels, Albert B.] New York Med Coll, Surg, Valhalla, NY 10595 USA.
   [Wormser, Gary P.] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA.
RP Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA.
EM gwormser@nymc.edu
CR Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Ellingson MK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1516-0
   Guo Fangjian, 2017, Prev Med Rep, V7, P26, DOI 10.1016/j.pmedr.2017.05.003
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Morain SR, 2017, NEW ENGL J MED, V377, P1505, DOI 10.1056/NEJMp1707273
   Trumbo CW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1918-8
NR 10
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD DEC
PY 2018
VL 92
IS 4
BP 315
EP 318
DI 10.1016/j.diagmicrobio.2018.07.003
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HD8NB
UT WOS:000452812700012
PM 30097295
DA 2020-07-08
ER

PT J
AU Catenacci, LS
   Ferreira, M
   Martins, LC
   De Vleeschouwer, KM
   Cassano, CR
   Oliveira, LC
   Canale, G
   Deem, SL
   Tello, JS
   Parker, P
   Vasconcelos, PFC
   da Rosa, EST
AF Catenacci, L. S.
   Ferreira, M.
   Martins, L. C.
   De Vleeschouwer, K. M.
   Cassano, C. R.
   Oliveira, L. C.
   Canale, G.
   Deem, S. L.
   Tello, J. S.
   Parker, P.
   Vasconcelos, P. F. C.
   Travassos da Rosa, E. S.
TI Surveillance of Arboviruses in Primates and Sloths in the Atlantic
   Forest, Bahia, Brazil
SO ECOHEALTH
LA English
DT Article
DE Arbovirus; Leontopithecus sp.; Sapajus sp.; Bradypus sp.; Emerging
   infectious diseases; Atlantic Forest
ID LOUIS ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; DENGUE VIRUS; ZIKA VIRUS;
   NONHUMAN-PRIMATES; CONSERVATION MEDICINE; SEROLOGICAL EVIDENCE;
   MATO-GROSSO; SAO-PAULO; STATE
AB From 2006 through 2014, we conducted seroepidemiological surveys on non-human primates and sloths to investigate the possible circulation of arboviruses in Bahia Atlantic Forest, Brazil. We collected a total of 196 samples from 103 Leontopithecus chrysomelas, 7 Sapajus xanthosternos, 22 Bradypus torquatus and 7 Bradypus variegatus. Serum samples were tested using neutralization test and hemagglutination inhibition test to detect total antibodies against 26 different arboviruses. The overall prevalence of arboviruses was 36.6% (51/139), with the genus Flavivirus having the highest prevalence (33.1%; 46/139), followed by Phlebovirus (5.0%; 7/139), Orthobunyavirus (4.3%; 6/139) and Alphavirus (0.7%; 1/139). Monotypic reactions suggest that the wild animals were exposed naturally to at least twelve arboviruses. Added results from the neutralization test, animals were exposed to thirteen arboviruses. Most of these viruses are maintained in transmission cycles independent of human hosts, although antibodies against dengue virus serotypes 1, 2 and 3 were found in this study. To our knowledge, this is the first study reporting exposure to arboviruses in L. chrysomelas, S. xanthosternos and B. torquatus. Our results also highlight that the Southern Bahia Atlantic Forest has a variety of vertebrate hosts and potential vectors, which may support the emergence or re-emergence of arboviruses, including those pathogenic to humans.
C1 [Catenacci, L. S.] Fed Univ Piaui State, Campus Professora Cinobelina Elvas, BR135,Km 1, B-64900000 Bom Jesus, PI, Brazil.
   [Catenacci, L. S.; Ferreira, M.; Martins, L. C.; Vasconcelos, P. F. C.; Travassos da Rosa, E. S.] Evandro Chagas Inst, Virol Grad Program, BR-67030000 Ananindeua, PA, Brazil.
   [Catenacci, L. S.; De Vleeschouwer, K. M.] Royal Zool Soc Antwerp, Ctr Res & Conservat, B-2018 Antwerp, Belgium.
   [De Vleeschouwer, K. M.] Bicho Mato Inst Pesquisa, BR-30360082 Belo Horizonte, MG, Brazil.
   [Cassano, C. R.] Univ Estadual Santa Cruz, BR-45662900 Ilheus, BA, Brazil.
   [Oliveira, L. C.] Univ Estado Rio De Janeiro, Fac Formacao Prof, BR-24435005 Rio De Janeiro, RJ, Brazil.
   [Canale, G.] Univ Fed Mato Grosso, ICNHS NEBAM, Campus Sinop, BR-78557000 Cuiaba, MT, Brazil.
   [Catenacci, L. S.; Deem, S. L.] St Louis Zoo Inst Conservat Med, St Louis, MO 63110 USA.
   [Tello, J. S.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA.
   [Deem, S. L.; Parker, P.] Univ Missouri, St Louis, MO 63105 USA.
RP Catenacci, LS (corresponding author), Fed Univ Piaui State, Campus Professora Cinobelina Elvas, BR135,Km 1, B-64900000 Bom Jesus, PI, Brazil.; Catenacci, LS (corresponding author), Evandro Chagas Inst, Virol Grad Program, BR-67030000 Ananindeua, PA, Brazil.; Catenacci, LS (corresponding author), Royal Zool Soc Antwerp, Ctr Res & Conservat, B-2018 Antwerp, Belgium.; Catenacci, LS (corresponding author), St Louis Zoo Inst Conservat Med, St Louis, MO 63110 USA.
EM li_vet@yahoo.com.br
RI Vasconcelos, Pedro/AAH-3142-2019; De Vleeschouwer,
   Kristel/AAE-4719-2019; Cassano, Camila R/E-6761-2014; Oliveira, Leonardo
   C/G-1290-2012
OI De Vleeschouwer, Kristel/0000-0002-6358-5603; Cassano, Camila
   R/0000-0002-0585-5222; Oliveira, Leonardo C/0000-0002-1774-0713
FU Saint Louis Zoo WildCare Institute (USA); Wild Animal Fund; American
   Association of Zoological Veterinarians (USA); CNPq (Brazil)National
   Council for Scientific and Technological Development (CNPq); Lion
   Tamarins of Brazil Fund; National Lottery of Belgium; Primate Action
   Fund; Zoological Society of London; Royal Zoological Society of Antwerp
   (Belgium); Conservacao Internacional; Fundacao o Boticario de Protecao a
   Natureza
FX The authors thank the important contributions of the Municipal and Bahia
   State Health Department and the colleagues from the Evandro Chagas
   Institute for assistance with the laboratory diagnostics and logistical
   support in the field. Additional thanks go to Project BioBrasil/Centre
   for Research and Conservation, ICMBio and the Bicho-da mata NGO for
   their logistical support and ICMBio for permits to conduct research in
   the Una Biological Reserve and Una Wildlife Refuge. We also thank the
   owners of the private areas (Almada, Santa Rita, Ribeiro, Ozawa, Manoel
   Rosa and SAo Jose, Ecoparque de Una, Bonfim) and the Zoobotanical
   Reserve Rehabilitation Center for permit to conduct the research. We
   also thank the sponsoring institutions that made this project possible:
   Saint Louis Zoo WildCare Institute (USA), The Wild Animal Fund, from the
   American Association of Zoological Veterinarians (USA), CNPq (Brazil),
   the Center for Research and Conservation of the Royal Zoological Society
   of Antwerp (Belgium), Lion Tamarins of Brazil Fund, National Lottery of
   Belgium, Primate Action Fund, Zoological Society of London, Conservacao
   Internacional, FundacAo o Boticario de Protecao a Natureza. The Flemish
   Ministry of Science (Belgium) provided structural support to the Center
   for Research and Conservation of the Royal Zoological Society of
   Antwerp.
CR Al-Shorbaji F, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.46
   Alger K., 1994, Environmentalist, V14, P107, DOI 10.1007/BF01901304
   Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Batista PM, 2012, REV SOC BRAS MED TRO, V45, P168, DOI 10.1590/S0037-86822012000200006
   Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797
   Brazil, 2017, FEBR AM INF OR
   Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Canale GR, 2013, DEV PRIMATOL-PROG PR, P299, DOI 10.1007/978-1-4614-8839-2_20
   Caron A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0217-9
   Cassano CR, 2011, MAMM BIOL, V76, P243, DOI 10.1016/j.mambio.2010.06.008
   Casseb Alexandre Rosário, 2015, Ciênc. anim. bras., V16, P428, DOI 10.1590/1089-6891v16i327208
   Catenacci LS, 2016, INT J PRIMATOL, V37, P136, DOI 10.1007/s10764-016-9889-x
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Crawley M. J., 2007, R BOOK
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   da Silva Azevedo RS, 2010, REV PAN AMAZONICA SA, V1, P73, DOI DOI 10.5123/S2176-62232010000100011
   Daszak P, 2004, ANN NY ACAD SCI, V1026, P1, DOI 10.1196/annals.1307.001
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Deem SL, 2016, DEV PRIMATOL-PROG PR, P63, DOI 10.1007/978-3-319-30469-4_4
   Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008
   Figueiredo LTM, 1998, AM J TROP MED HYG, V59, P357, DOI 10.4269/ajtmh.1998.59.357
   Figueiredo Luiz Tadeu M., 1999, Medicina (Ribeirao Preto), V32, P154
   Gilmore DP, 2001, BRAZ J MED BIOL RES, V34, P9, DOI 10.1590/S0100-879X2001000100002
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   IUCN, 2017, IUCN RED LIST THREAT
   Jansen AM, 2015, ACTA TROP, V151, P1, DOI 10.1016/j.actatropica.2015.07.018
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Lara-Ruiz P, 2005, J ZOOL, V267, P63, DOI 10.1017/S0952836905007259
   Laroque PO, 2014, PESQUI VET BRASIL, V34, P462, DOI 10.1590/S0100-736X2014000500013
   Lima MA, 2010, REV INST MED TROP SP, V52, P11, DOI 10.1590/S0036-46652010000100002
   Mb P, 2015, J ENV ANAL CHEM, DOI [10. 4172/2380-2391. 1000155, DOI 10.4172/2380-2391.1000155]
   Medlin S, 2016, J WILDLIFE DIS, V52, P883, DOI 10.7589/2015-02-040
   Miller KE, 2005, INT J PRIMATOL, V26, P1291, DOI 10.1007/s10764-005-8854-7
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Moreira G. V., 2000, Revista Brasileira de Medicina Veterinaria, V22, P252
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Nakgoi K, 2014, AM J PRIMATOL, V76, P97, DOI 10.1002/ajp.22213
   Oliveira LC, 2011, ENVIRON MANAGE, V48, P248, DOI 10.1007/s00267-010-9582-3
   Oliver W. L., 1991, THREATENED ENDEMIC M
   Omatsu T, 2012, J MED PRIMATOL, V41, P289, DOI 10.1111/j.1600-0684.2012.00552.x
   Pautasso A, 2013, TRANSBOUND EMERG DIS, V60, P154, DOI 10.1111/tbed.12123
   Pereira LE, 2001, REV SAUDE PUBL, V35, P119, DOI 10.1590/S0034-89102001000200003
   R Core Team, R LANG ENV STAT COMP
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021
   Rodrigues SG, 2010, REV PAN AMAZ SAUDE, V1, P81
   SEYMOUR C, 1983, AM J TROP MED HYG, V32, P854, DOI 10.4269/ajtmh.1983.32.854
   SEYMOUR C, 1983, AM J TROP MED HYG, V32, P1435, DOI 10.4269/ajtmh.1983.32.1435
   Melo MSS, 2010, REV SOC BRAS MED TRO, V43, P139, DOI 10.1590/S0037-86822010000200007
   Sollberg I, 2014, REV ARVORE, V38, P241, DOI 10.1590/S0100-67622014000200004
   Svoboda WK, 2014, REV SOC BRAS MED TRO, V47, P280, DOI 10.1590/0037-8682-0083-2014
   Tauro L, 2012, MEM I OSWALDO CRUZ, V107, P553, DOI 10.1590/S0074-02762012000400019
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thompson NN, 2012, VECTOR-BORNE ZOONOT, V12, P969, DOI 10.1089/vbz.2012.0959
   Tranquilin MV, 2013, REV SOC BRAS MED TRO, V46, P522, DOI 10.1590/0037-8682-0106-2013
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vaz Sergio Maia, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P21
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   ZARNKE RL, 1983, J WILDLIFE DIS, V19, P175, DOI 10.7589/0090-3558-19.3.175
NR 75
TC 6
Z9 6
U1 3
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD DEC
PY 2018
VL 15
IS 4
BP 777
EP 791
DI 10.1007/s10393-018-1361-2
PG 15
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA HC1VP
UT WOS:000451591600009
PM 30117001
DA 2020-07-08
ER

PT J
AU Earle-Richardson, G
   Prue, C
   Turay, K
   Thomas, D
AF Earle-Richardson, Giulia
   Prue, Christine
   Turay, Khadija
   Thomas, Dana
TI Influences of Community Interventions on Zika Prevention Behaviors of
   Pregnant Women, Puerto Rico, July 2016-June 2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MASS-MEDIA CAMPAIGNS; RELATIVE RISK; ODDS RATIO; VIRUS; COHORT; CARE;
   TRANSMISSION
AB We assessed how community education efforts influenced pregnant women's Zika prevention behaviors during the 2016 Centers for Disease Control and Prevention-Puerto Rico Department of Health Zika virus response. Efforts included Zika virus training, distribution of Zika prevention kits, a mass media campaign, and free home mosquito spraying. We used telephone interview data from pregnant women participating in Puerto Rico's Women, Infants, and Children Program to test associations between program participation and Zika prevention behaviors. Behavior percentages ranged from 4% (wearing long-sleeved shirt) to 90% (removing standing water). Appropriate mosquito repellent use (28%) and condom use (44%) were common. Receiving a Zika prevention kit was significantly associated with larvicide application (odds ratio [OR] 8.0) and bed net use (OR 3.1), suggesting the kit's importance for lesser-known behaviors. Offer of free residential spraying was associated with spraying home for mosquitoes (OR 13.1), indicating that women supported home spraying when barriers were removed.
C1 [Earle-Richardson, Giulia; Prue, Christine; Turay, Khadija; Thomas, Dana] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H16-5, Atlanta, GA 30329 USA.
RP Earle-Richardson, G (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H16-5, Atlanta, GA 30329 USA.
EM evy8@cdc.gov
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038
   BusinessWire, BUSINESSWIRE
   Centers for Disease Control and Prevention National Center for Health Statistics, US TERR 2016 NAT PUB
   Colindres R, 2008, AIDS CARE, V20, P139, DOI 10.1080/09540120701506804
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Gainforth HL, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-59
   Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981
   International RTI, DET ZIK STOP ZIK CAM
   Jambulingam P, 2008, MEM I OSWALDO CRUZ, V103, P165, DOI 10.1590/S0074-02762008005000009
   Jeong M, 2018, HEALTH COMMUN, V33, P988, DOI 10.1080/10410236.2017.1331184
   Jones KE, 2018, J PERINATOL, V38, P315, DOI 10.1038/s41372-017-0035-1
   Katz E, 2005, PERSONAL INFLUENCE
   Mabude ZA, 2008, AIDS CARE, V20, P931, DOI 10.1080/09540120701768438
   McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074
   McNutt LA, 1999, JAMA-J AM MED ASSOC, V282, P529, DOI 10.1001/jama.282.6.529
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Michie S, 2014, BEHAV CHANGE WHEEL G
   Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robinson MN, 2014, AM J PREV MED, V47, P360, DOI [10.1016/j.amepre.2014.05.034, 10.1016/j.amepre.2014.]
   Rogers EM, 2004, J HEALTH COMMUN, V9, P13, DOI 10.1080/10810730490271449
   Rogers EM, 2003, DIFFUSION INNOVATION
   Samaritan's Purse, SAMARITANS PURSE LAU
   Sifferlin A., THIS IS HOW EBOLA PA
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4
   Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
NR 33
TC 0
Z9 0
U1 1
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2018
VL 24
IS 12
BP 2251
EP 2261
DI 10.3201/eid2412.181056
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HA9JM
UT WOS:000450617500014
PM 30457546
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hermanns, K
   Gohner, C
   Kopp, A
   Schmidt, A
   Merz, WM
   Markert, UR
   Junglen, S
   Drosten, C
AF Hermanns, Kyra
   Goehner, Claudia
   Kopp, Anne
   Schmidt, Andre
   Merz, Waltraut M.
   Markert, Udo R.
   Junglen, Sandra
   Drosten, Christian
TI Zika virus infection in human placental tissue explants is enhanced in
   the presence of dengue virus antibodies in-vitro
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID RECEPTOR; PATHOGENESIS; BRAZIL; CELLS
AB The current Zika virus (ZIKV) outbreak is associated with neurological malformations and disorders in neonates. Areas of increased incidence of malformations may overlap with dengue-hyperendemic areas. ZIKV infection is enhanced by antibodies against dengue virus (DENV) in cell culture and inbred mice. Sufficiently powered clinical studies or primate studies addressing the enhancement of fetal ZIKV infection after previous dengue infection are not available. The human placenta is susceptible to ZIKV in vitro, but it is unknown whether antibody-dependent enhancement of ZIKV infection occurs at the placental barrier. Here we studied ZIKV infection in placental tissue in the presence of DENV-immune sera. Explants from the amniochorionic membrane, the chorionic villi, and the maternal decidua were infected with ZIKV in the presence of DENV type 1-, 2-, or 4-immune sera, or controls. Presence of DENV antibodies of any type enhanced the percentage of successful infections of organ explants between 1.42- and 2.67-fold, and led to a faster replication as well as significantly increased virus production. No enhancement was seen with yellow fever or chikungunya virus control sera. Pre-existing DENV antibodies may pose an increased risk of trans-placental ZIKV transmission.
C1 [Hermanns, Kyra; Kopp, Anne; Junglen, Sandra; Drosten, Christian] Charite Univ Med Berlin, Campus Charite Mitte, Inst Virol, Berlin, Germany.
   [Hermanns, Kyra; Goehner, Claudia; Kopp, Anne; Junglen, Sandra] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Goehner, Claudia; Schmidt, Andre; Markert, Udo R.] Univ Hosp Jena, Dept Obstet, Placenta Lab, Jena, Germany.
   [Merz, Waltraut M.] Univ Bonn, Med Sch, Dept Obstet & Prenatal Med, Bonn, Germany.
   [Drosten, Christian] Berlin Inst Hlth, Berlin, Germany.
RP Drosten, C (corresponding author), Charite Univ Med Berlin, Campus Charite Mitte, Inst Virol, Berlin, Germany.
EM christian.drosten@charite.de
OI Junglen, Sandra/0000-0002-3799-6011
FU Department of Obstetrics and Prenatal Medicine, University Bonn Medical
   Centre; German Ministry of Research and Education (German Center for
   Infection Research); Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [JU 2857/3]; European Horizon 2020 project PREPARE;
   German Research Foundation (DFG)German Research Foundation (DFG); Open
   Access Publication Fund of Charite - Universitatsmedizin Berlin
FX We acknowledge the labor ward team of the Department of Obstetrics and
   Prenatal Medicine, University Bonn Medical Centre, for their support in
   this project. We thank Petra Emmerich (Bernhard Nocht Institute for
   Tropical Medicine, Hamburg) for providing human dengue-immune sera. We
   thank Professor Hubert Schorle and Caroline Kubaczka from the Department
   of Developmental Pathology, University of Bonn Medical Center, for
   providing the VSC cell line. The work was funded by an infrastructural
   grant to C.D. by the German Ministry of Research and Education (German
   Center for Infection Research), by the Deutsche Forschungsgemeinschaft
   (grant agreement number JU 2857/3) to S.J., as well as European Horizon
   2020 project PREPARE. We acknowledge support from the German Research
   Foundation (DFG) and the Open Access Publication Fund of Charite -
   Universitatsmedizin Berlin.
CR Aldo PB, 2014, AM J REPROD IMMUNOL, V72, P270, DOI 10.1111/aji.12288
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   BRIGHT NA, 1994, PLACENTA, V15, P247, DOI 10.1016/0143-4004(94)90016-7
   BRIGHT NA, 1994, J ANAT, V184, P297
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5
   Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
NR 31
TC 9
Z9 9
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD DEC 1
PY 2018
VL 7
AR 198
DI 10.1038/s41426-018-0199-6
PG 8
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HD2AF
UT WOS:000452312800001
PM 30504926
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Darrow, W
   Bhatt, C
   Rene, C
   Thomas, L
AF Darrow, William
   Bhatt, Chintan
   Rene, Cassandra
   Thomas, Lakisha
TI Zika Virus Awareness and Prevention Practices Among University Students
   in Miami: Fall 2016
SO HEALTH EDUCATION & BEHAVIOR
LA English
DT Article
DE college health; evaluation; health communications; health promotion;
   health protective behavior; Latino; race/ethnicity; school-based
ID UNITED-STATES; TRANSMISSION; EPIDEMIOLOGY; RISK
AB In January 2016, the first case of mosquito-borne Zika infection in the mainland United States was confirmed in Miami, Florida. The first locally acquired case was reported 6 months later. Local public health and school officials began warning students of the outbreak on their return to the classroom in August 2016. In November-December 2016, we conducted a survey of students attending a large public university in Miami to determine how well informed they were about Zika. A multistage sampling design was used to contact teaching assistants and ask them for help in recruiting their students. Eligible students had to be 18 years of age or older and enrolled in at least one three-credit course during fall semester. A 25-item questionnaire based on the World Health Organization Zika Knowledge, Attitudes, and Practice Resource Pack was developed, pretested, and approved by the university's institutional review board before it was made available to eligible students through Blackboard Learn or a survey link. About half (50.4%) of the 139 respondents had heard about Zika prior to 2016. Only one student was unaware of Zika before our survey. Most (47.1%) first learned about Zika through television, 18.8% from family or friends, and 15.2% from the Internet, social media, or university e-mail. Two thirds (66.2%) believed Zika could be prevented, 15.1% thought it might be prevented, and 85.7% had taken some precautions. A high level of awareness of the risk of Zika infection was apparent. Most students reported taking steps to avoid exposure to the Zika virus.
C1 [Darrow, William; Bhatt, Chintan; Rene, Cassandra; Thomas, Lakisha] Florida Int Univ, Miami, FL 33199 USA.
RP Darrow, W (corresponding author), Florida Int Univ, Stempel Coll Publ Hlth & Social Work, MMC, AHC-5,419, Miami, FL 33199 USA.
EM darroww@fiu.edu
CR Abramson D., 2016, US PUBLICS PERCEPTIO
   American College Health Association, 2014, NAT COLL HLTH ASS 2
   Annenberg Public Policy Center, 2016, FLOR MOR ZIK MOR AR
   Annenberg Public Policy Center, 2016, GUID EFF ZIK COV VID
   [Anonymous], 2016, ADV PEOPL LIV TRAV S
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Bontempi JB, 2009, AM J HEALTH EDUC, V40, P97, DOI 10.1080/19325037.2009.10599084
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Centers for Disease Control and Prevention, 2016, ZIK COMM PLANN GUID
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention, 2016, CDC SUPP TEX INV POS
   Centers for Disease Control and Prevention (CDC), 2016, ZIK COMM EFF
   Centers for Disease Control and Prevention Foundation, 2016, COMPR ZIK PREV CAMP
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Florida Department of Education, 2016, SCH YEAR BEG U COLL
   Florida Department of Health, 2017, ZIK VIR
   Florida International University, 2017, AN INF MAN OFF SOURC
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kovacs Kasia, 2016, INSIDE HIGHER ED
   Leonard Kimberley, 2016, US NEWS
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   March of Dimes and National Opinion Research Center, 2016, ZIK VIR GAPS AM KNOW
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   Merritt A, 2017, STRATEGIC COMMUNICAT
   Monaghan A. J., 2016, SEASONAL OCCURRENCE
   National Institutes of Health, 2011, GUILL BARR SYNDR FAC
   National Institutes of Health, 2016, TEST INV IN ZIK VACC
   NIH, 2016, NIH BEG TEST INV ZIK
   Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization, 2017, REG ZIK EP UPD AM ZI
   State of Florida, 2016, GOV SCOTT AUTH 25 MI
   Trepka MJ, 2008, J AM COLL HEALTH, V57, P77, DOI 10.3200/JACH.57.1.77-84
   US Department of Health and Human Services, 2016, OP RISK COMM COMM EN
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO, 2017, ZIK VIR COMPL 2016 P
   World Health Organization, 2016, WHOZIKVSRF161
   World Health Organization, 2016, WHOZIKVRCCE161
   World Health Organization, 2016, WHOZIKVRCCE162
NR 48
TC 3
Z9 3
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1090-1981
EI 1552-6127
J9 HEALTH EDUC BEHAV
JI Health Educ. Behav.
PD DEC
PY 2018
VL 45
IS 6
BP 967
EP 976
DI 10.1177/1090198118760687
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HD4EA
UT WOS:000452478900013
PM 29534620
DA 2020-07-08
ER

PT J
AU Selvan, SM
   Anand, KV
   Govindaraju, K
   Tamilselvan, S
   Kumar, VG
   Subramanian, KS
   Kannan, M
   Raja, K
AF Selvan, Sekaran Muthamil
   Anand, Kabali Vijai
   Govindaraju, Kasivelu
   Tamilselvan, Selvaraj
   Kumar, Vijayakumar Ganesh
   Subramanian, Kizhaeral Sevathapandian
   Kannan, Malaisamy
   Raja, Kalimuthu
TI Green synthesis of copper oxide nanoparticles and mosquito larvicidal
   activity against dengue, zika and chikungunya causing vector Aedes
   aegypti
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
DE photoluminescence; spectrophotometry; thermal analysis; chromatography;
   nanoparticles; antibacterial activity; field emission electron
   microscopy; microorganisms; wide band gap semiconductors; scanning
   electron microscopy; X-ray diffraction; copper compounds; ultraviolet
   spectra; nanofabrication; X-ray chemical analysis; crystallites; visible
   spectra; field emission scanning electron microscopy; nanobiotechnology;
   semiconductor materials; semiconductor growth; fluorescence; mass
   spectra; energy dispersive spectroscopy; ultraviolet-visual
   spectrophotometry; fluorescence spectroscopy; chikungunya; green
   synthesis; mosquito larvicidal activity; zika; X-ray diffraction
   analysis; field-emission scanning electron microscopy; XRD; gas
   chromatography-mass spectrometry; copper oxide nanoparticles; dengue;
   tridax procumben leaf extract; nanomosquitocides; FTIR; monoclinic
   structure; crystallite size; photoluminescence spectra; near-band-edge
   emission band; phytochemical constituents; Aedes aegypti species; yellow
   fever transmit vector; CuO
ID CUO NANOPARTICLES; LEAF EXTRACT; AQUEOUS EXTRACT; PHOTOLUMINESCENCE;
   NANOSTRUCTURES; ZNO
AB In the present study, high purity copper oxide nanoparticles (NPs) were synthesised using Tridax procumbens leaf extract. Green syntheses of nano-mosquitocides rely on plant compounds as reducing and stabilising agents. Copper oxide NPs were characterised using X-ray diffraction (XRD) analysis, Fourier transform infrared (FT-IR), Field-emission scanning electron microscopy with energy dispersive spectroscopy, Ultraviolet-visible spectrophotometry and fluorescence spectroscopy. XRD studies of the NPs indicate crystalline nature which was perfectly matching with a monoclinic structure of bulk CuO with an average crystallite size of 16nm. Formation of copper oxide NPs was confirmed by FT-IR studies and photoluminescence spectra with emission peaks at 331, 411 and 433nm were assigned to a near-band-edge emission band of CuO in the UV, violet and blue region. Gas chromatography-mass spectrometry studies inferred the phytochemical constituents of the leaf extract. Larvicidal activity of synthesised NPs using T. procumbens leaf extract was tested against Aedes aegypti species (dengue, chikungunya, zika and yellow fever transmit vector).
C1 [Selvan, Sekaran Muthamil; Anand, Kabali Vijai] Sathyabama Inst Sci & Technol, Dept Phys, Madras 600119, Tamil Nadu, India.
   [Govindaraju, Kasivelu; Tamilselvan, Selvaraj; Kumar, Vijayakumar Ganesh] Sathyabama Inst Sci & Technol, Nanosci Div, Ctr Ocean Res, Madras 600119, Tamil Nadu, India.
   [Subramanian, Kizhaeral Sevathapandian; Kannan, Malaisamy; Raja, Kalimuthu] Tamilnadu Agr Univ, Dept Nanosci & Technol, Coimbatore 641003, Tamil Nadu, India.
RP Anand, KV (corresponding author), Sathyabama Inst Sci & Technol, Dept Phys, Madras 600119, Tamil Nadu, India.
EM anandkvijai@gmail.com
RI Govindaraju, Kasivelu/F-4753-2017; K, VIJAI ANAND/P-6740-2014
OI Govindaraju, Kasivelu/0000-0002-9687-2174; K, VIJAI
   ANAND/0000-0003-0770-5479; Malaichamy, Kannan/0000-0002-3439-9254
CR Aslani A, 2011, PHYSICA B, V406, P150, DOI 10.1016/j.physb.2010.10.017
   Benelli G, 2017, J CLUST SCI, V28, P3, DOI 10.1007/s10876-016-1131-7
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Cantrell CL, 2011, J MED ENTOMOL, V48, P836, DOI 10.1603/ME10244
   Cao HQ, 2004, ADV FUNCT MATER, V14, P243, DOI 10.1002/adfm.200305033
   Dhas TS, 2014, SPECTROCHIM ACTA A, V120, P416, DOI 10.1016/j.saa.2013.10.044
   Erdogan IY, 2010, J ALLOY COMPD, V492, P378, DOI 10.1016/j.jallcom.2009.11.109
   Ga'al H., 2017, ARTIF CELL NANOMED B, V31, P1
   Ghidan Alaa Y., 2016, Environmental Nanotechnology, Monitoring and Management, V6, P95, DOI 10.1016/j.enmm.2016.08.002
   Gopalakrishnan K, 2012, DIG J NANOMATER BIOS, V7, P833
   Gunalan S, 2012, SPECTROCHIM ACTA A, V97, P1140, DOI 10.1016/j.saa.2012.07.096
   Honary S, 2012, DIG J NANOMATER BIOS, V7, P999
   Kumari L, 2009, CRYST GROWTH DES, V9, P3874, DOI 10.1021/cg800711m
   Kung ML, 2017, COLLOID SURFACE B, V155, P399, DOI 10.1016/j.colsurfb.2017.04.041
   Mageshwari K, 2013, J MATER SCI TECHNOL, V29, P909, DOI 10.1016/j.jmst.2013.04.020
   Mukherjee N, 2011, MATER LETT, V65, P3248, DOI 10.1016/j.matlet.2011.07.016
   Nasrollahzadeh M, 2015, J COLLOID INTERF SCI, V455, P245, DOI 10.1016/j.jcis.2015.05.045
   Nasrollahzadeh M, 2015, RSC ADV, V5, P40628, DOI 10.1039/c5ra04012d
   Ningthoujam RS, 2008, J NANOSCI NANOTECHNO, V8, P3059, DOI 10.1166/jnn.2008.152
   REDDY PJ, 1992, COMPUT APPL BIOSCI, V8, P209
   Rubilar O, 2013, BIOTECHNOL LETT, V35, P1365, DOI 10.1007/s10529-013-1239-x
   Sahoo M, 1998, PHYTOMORPHOLOGY, V48, P195
   Saini A, 2016, IMPERIAL J INTERDISC, V2, P308
   Sankar R, 2014, SPECTROCHIM ACTA A, V121, P746, DOI 10.1016/j.saa.2013.12.020
   Sharma JK, 2015, J ALLOY COMPD, V632, P321, DOI 10.1016/j.jallcom.2015.01.172
   Singh AV, 2010, CURR NANOSCI, V6, P365
   Singh S, 2017, CHEM ENG J, V313, P283, DOI 10.1016/j.cej.2016.12.049
   Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Velu K, 2015, ENVIRON SCI POLLUT R, V22, P17769, DOI 10.1007/s11356-015-4919-3
   Yasoubi P., 2007, Journal of Agricultural Science and Technology, V9, P35
NR 33
TC 8
Z9 8
U1 3
U2 22
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
EI 1751-875X
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD DEC
PY 2018
VL 12
IS 8
BP 1042
EP 1046
DI 10.1049/iet-nbt.2018.5083
PG 5
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA HC4JZ
UT WOS:000451770900007
PM 30964011
DA 2020-07-08
ER

PT J
AU Peloggia, A
   Ali, M
   Nanda, K
   Bahamondes, L
AF Peloggia, Alessandra
   Ali, Moazzam
   Nanda, Kavita
   Bahamondes, Luis
TI Zika virus exposure in pregnancy and its association with newborn visual
   anomalies and hearing loss
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Review
DE Hearing loss; Microcephaly; Neonates; Ophthalmologic disorder;
   Pregnancy; Zika virus
ID WEST-NILE VIRUS; INFANTS; INFECTION; OUTBREAK; STATES; BRAZIL
AB Exposure to Zika virus (ZIKV) in pregnancy leads to a spectrum of congenital effects in the newborn. Recent studies have begun to evaluate the impact of ZIKV during pregnancy. Among 39 relevant studies, nine were related specifically to clinical studies of ophthalmologic disorders and one was related to hearing loss impairment; most of these studies were case reports and case series reports. Importantly, congenital toxoplasmosis was ruled out in all studies. The data show that, in addition to microcephaly, ZIKV exposure in pregnancy may result in subtle ocular impairments in the newborn. The most common anomalies are macular pigment mottling and/or chorioretinal atrophy, and optic nerve disorders. Sensorineural hearing loss has also been noted in 5.8% of infants with microcephaly. The effects of ZIKV infection during pregnancy are potentially devastating to the fetus and newborn. Although microcephaly is an important signal, the current information emphasizes the importance of ocular and auditory screenings, otherwise sight and hearing anomalies may be underestimated. Healthcare providers should fully understand the spectrum of anomalies related to ZIKV exposure in pregnancy in order to counsel pregnant women living in high-risk areas, in addition to those wanting to become pregnant.
C1 [Peloggia, Alessandra; Bahamondes, Luis] Univ Estadual Campinas, Fac Med Sci, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Ali, Moazzam] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Nanda, Kavita] Contracept Technol Innovat Dept, Durham, NC USA.
RP Peloggia, A (corresponding author), 169 Batista Scavone, BR-12327130 Jacarei, SP, Brazil.
EM apeloggia@hotmail.com
FU Fundacao de Apoio a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
FX Fundacao de Apoio a Pesquisa do Estado de Sao Paulo
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P866
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, AB ZIK
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministerio da Saude, 2016, B EP 3 MON CAS DENG
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, UNM NEED FAM PLANN
   WHO, MICR GUILL BARR SYND
   World Health Organization (WHO), EP AL NEUR SYNDR CON
NR 39
TC 7
Z9 7
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD DEC
PY 2018
VL 143
IS 3
BP 277
EP 281
DI 10.1002/ijgo.12663
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GZ9MN
UT WOS:000449823700004
PM 30191558
OA Other Gold
DA 2020-07-08
ER

PT J
AU Kastrinos, A
   Damiani, R
   Treise, D
AF Kastrinos, Amanda
   Damiani, Rachel
   Treise, Debbie
TI Print to Podium: Exploring Media Coverage of 2016 Olympic Athletes'
   Perceptions About the Zika Virus
SO INTERNATIONAL JOURNAL OF SPORT COMMUNICATION
LA English
DT Article
DE disease epidemics; Olympics; parasocial interaction theory; sports
   reporting; uncertainty
ID PARASOCIAL INTERACTION; SOCIAL-PROBLEMS; PUBLIC-HEALTH; SARS;
   COMMUNICATION; CELEBRITIES; EPIDEMIC; RISK
AB The 2016 Olympic Games in Rio de Janeiro, Brazil, thrust potential Olympians into the midst of the unprecedented outbreak of the Zika virus. Because parasocial interaction theory purports that athletes can have tremendous influence on fans' attitudes and behavior, particularly in the context of public health, it is important to understand how media framed athletes' response to their risk of contracting Zika at the Games and the possibility of a global epidemic. To understand how athletes' safety concerns were portrayed by news outlets, the authors conducted a framing analysis of articles reporting on the intersection of the Olympics and Zika published in The New York Times, Los Angeles Times, Wall Street Journal, and Washington Post between January and November of 2016. This analysis revealed that media employed three main frames in their coverage of athletes: Athletes perceived the risk of Zika as small compared with potential Olympic glory, the decision to participate in the Games is an athletes' personal choice between family and career, and athletes used Zika concerns as a convenient excuse to pull out of a troubled Games. The combination of these frames painted a contradictory portrait of athletes' risk perception, both emphasizing and downplaying the threat of contracting the virus at the Games and an ensuing worldwide outbreak. These conflicting athlete narratives could have created uncertainty regarding the actual safety risk of the Zika virus and the Olympic Games for the fans who admire the athletes.
C1 [Kastrinos, Amanda; Damiani, Rachel] Univ Florida, Journalism Dept, Gainesville, FL 32611 USA.
   [Treise, Debbie] Univ Florida, Coll Journalism & Commun, Advertising Dept, Gainesville, FL 32611 USA.
RP Kastrinos, A (corresponding author), Univ Florida, Journalism Dept, Gainesville, FL 32611 USA.
EM akastrinos@ufl.edu
CR Bergeron SL, 2005, EMERG INFECT DIS, V11, P732, DOI 10.3201/eid1105.040512
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Brown WJ, 2010, HEALTH COMMUN, V25, P601, DOI 10.1080/10410236.2010.496830
   Brown WJ, 2010, J HEALTH COMMUN, V15, P358, DOI 10.1080/10810730903460575
   Brown WJ, 2003, J HEALTH COMMUN, V8, P41, DOI 10.1080/10810730305733
   BROWN WJ, 1995, HEALTH COMMUN, V7, P345, DOI 10.1207/s15327027hc0704_4
   Centers for Disease Control and Prevention, 2016, CDC ISS ADV TRAV 201
   Centers for Disease Control and Prevention, 2016, WHATS NEW
   Chang SM, 2005, J EMERG MED, V28, P395, DOI 10.1016/j.jemermed.2004.11.022
   Cohen J, 1999, J BROADCAST ELECTRON, V43, P327, DOI 10.1080/08838159909364495
   Creswell J. W., 2013, RES DESIGN QUALITATI
   Donnelly Christl, 2004, Signif (Oxf), V1, P176, DOI 10.1111/j.1740-9713.2004.00066.x
   DRACHE D, 2003, MEDIA COVERAGE 2003
   Drazen JM, 2003, NEW ENGL J MED, V349, P319, DOI 10.1056/NEJMp038118
   Eisen G., 1992, International Review for the Sociology of Sport, V27, P165, DOI 10.1177/101269029202700206
   Eldridge J, 2005, SOCIAL AMPLIFICATION, P138
   ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x
   Feng P.H., 2003, INT J RHEUM DIS, V6, P158, DOI [10.1046/j.0219-0494.2003, DOI 10.1046/J.0219-0494.2003]
   GAMSON WA, 1989, AM J SOCIOL, V95, P1, DOI 10.1086/229213
   Giles DC, 2002, MEDIA PSYCHOL, V4, P279, DOI 10.1207/S1532785XMEP0403_04
   GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070
   HILGARTNER S, 1988, AM J SOCIOL, V94, P53, DOI 10.1086/228951
   Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875
   HORTON D, 1956, PSYCHIATR, V19, P215, DOI 10.1080/00332747.1956.11023049
   International Olympic Committee, 2013, FACTSH LOND 2012 FAC
   Kasperson R. E, 2005, SOCIAL AMPLIFICATION, P13
   KITSUSE JI, 1973, SOC PROBL, V20, P407, DOI 10.1525/sp.1973.20.4.03a00020
   Lerner Barron, 2006, ILLNESS GOES PUBLIC
   Lewison G, 2008, HEALTH RISK SOC, V10, P241, DOI 10.1080/13698570802160962
   MacKendrick NA, 2010, SOCIOL INQ, V80, P126, DOI 10.1111/j.1475-682X.2009.00319.x
   MCQUAIL D, 1972, SOCIOLOGY MASS COMMU, P135, DOI DOI 10.1177/1354856510394539
   MediaPost, MEDIAPOST
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Rezza G, 2004, EMERG INFECT DIS, V10, P381, DOI 10.3201/eid1002.030743
   Settimi C, 2016, FORBES
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Sun T., 2010, Journal of Sport Behavior, V33, P194
   Villa R, 2016, CLIN TER, V167, P7, DOI 10.7417/CT.2016.1907
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zaharopoulos Thimios, 2007, MASS COMMUNICATION S, V10, P235, DOI DOI 10.1080/15205430701265752
NR 40
TC 1
Z9 1
U1 2
U2 10
PU HUMAN KINETICS PUBL INC
PI CHAMPAIGN
PA 1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA
SN 1936-3915
EI 1936-3907
J9 INT J SPORT COMMUN
JI Int. J. Sport Commun.
PD DEC
PY 2018
VL 11
IS 4
BP 447
EP 461
DI 10.1123/ijsc.2018-0056
PG 15
WC Communication
SC Communication
GA HD6MS
UT WOS:000452654800002
DA 2020-07-08
ER

PT J
AU Chen, Z
   Liu, F
   Liu, NN
AF Chen, Zhou
   Liu, Feng
   Liu, Nannan
TI Neuronal Responses of Antennal Olfactory Sensilla to Insect Chemical
   Repellents in the Yellow Fever Mosquito, Aedes aegypti
SO JOURNAL OF CHEMICAL ECOLOGY
LA English
DT Article
DE Aedes aegypti; Single sensillum recording; Olfactory receptor neuron;
   Inhibitory neuron; Odor space
ID COMMON BED BUG; TRICHOID SENSILLA; MALARIA MOSQUITO; ESSENTIAL OILS;
   REPRESENTATIONS; PREFERENCE; HUMANS; ODORS
AB The yellow fever mosquito, Aedes aegypti, is a vector of many human diseases such as yellow fever, dengue fever, and Zika. As insecticide resistance has been widely reported, chemical repellents have been adopted as alternative options for mosquito and mosquito-borne disease control. This study characterized the responses of olfactory receptor neurons (ORNs) in different types of antennal olfactory sensilla in Ae. aegypti to 48 chemicals that exhibited repellent activity in various insect species. Both excitatory and inhibitory responses were observed from ORNs in response to these chemicals and differential tuning properties were also observed among ORNs. Remarkable excitatory responses were recorded from the ORNs in sensilla SST1, SST2, SBTI, SBTII, and LST2, while inhibitory activities were detected from a neuron in sensillum SST2 in response to several terpene/terpenoid compounds. Moreover, the temporal dynamics of neuronal responses were found to be compound-specific and concentration-dependent. Hierarchical cluster analysis and principal component analysis of the response to each compound across ORNs in seven types of olfactory sensilla in Ae. aegypti revealed that odor reception depended not only on chemical class but also specific chemical structure. Results of this study give new insights into the sensory physiology of Aedes mosquitoes to the chemical repellents and should contribute to the development of new repellent reagents for human protection.
C1 [Chen, Zhou; Liu, Feng; Liu, Nannan] Auburn Univ, Dept Entomol & Plant Pathol, 301 Funchess Hall, Auburn, AL 36849 USA.
RP Liu, NN (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, 301 Funchess Hall, Auburn, AL 36849 USA.
EM liunann@auburn.edu
FU Award Alabama Agricultural Experiment Station (AAES) Multistate/Hatch
   Grants [ALA08-045, ALA015-1-10026]
FX This project was supported by Award Alabama Agricultural Experiment
   Station (AAES) Multistate/Hatch Grants ALA08-045 and ALA015-1-10026 to
   N.L.
CR Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028
   BUTENANDT A, 1959, Z NATURFORSCH PT B, V14, P283
   Campbell C, 2011, ENTOMOL EXP APPL, V138, P21, DOI 10.1111/j.1570-7458.2010.01072.x
   Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   DENOTTER CJ, 1980, J INSECT PHYSIOL, V26, P465, DOI 10.1016/0022-1910(80)90117-1
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Gertler S. I., 1946, U.S. Patent, Patent No. [2,408,389, 2408389]
   Ghaninia M, 2007, EUR J NEUROSCI, V26, P1611, DOI 10.1111/j.1460-9568.2007.05786.x
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050
   Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Joseph RM, 2015, TRENDS GENET, V31, P683, DOI 10.1016/j.tig.2015.09.005
   Laurent G, 1996, J NEUROSCI, V16, P3837
   Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004
   Liu F, 2017, INSECT BIOCHEM MOLEC, V82, P62, DOI 10.1016/j.ibmb.2017.01.012
   Liu F, 2015, SCI REP-UK, V5, DOI 10.1038/srep15558
   Liu F, 2014, J CHEM ECOL, V40, P522, DOI 10.1007/s10886-014-0435-z
   Liu F, 2013, J INSECT PHYSIOL, V59, P1169, DOI 10.1016/j.jinsphys.2013.08.016
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCIVER S, 1978, J INSECT PHYSIOL, V24, P383, DOI 10.1016/0022-1910(78)90079-3
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267
   Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027
   Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850
   Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Ufkes LL, 2007, J ESSENT OIL RES, V19, P167, DOI 10.1080/10412905.2007.9699252
NR 35
TC 1
Z9 1
U1 3
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0098-0331
EI 1573-1561
J9 J CHEM ECOL
JI J. Chem. Ecol.
PD DEC
PY 2018
VL 44
IS 12
BP 1120
EP 1126
DI 10.1007/s10886-018-1022-5
PG 7
WC Biochemistry & Molecular Biology; Ecology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology
GA HA8ER
UT WOS:000450522200005
PM 30291492
DA 2020-07-08
ER

PT J
AU Pena, LJ
   Guarines, KM
   Silva, AJD
   Leal, LRS
   Felix, DM
   Silva, A
   de Oliveira, SA
   Ayres, CFJ
   Silva, A
   de Freitas, AC
AF Pena, Lindomar Jose
   Guarines, Klarissa Miranda
   Duarte Silva, Anna Jessica
   Sales Leal, Ligia Rosa
   Felix, Daniele Mendes
   Silva, Adalucia
   de Oliveira, Sheilla Andrade
   Junqueira Ayres, Constancia Flavia
   Silva Junior, Abelardo
   de Freitas, Antonio Carlos
TI In vitro and in vivo models for studying Zika virus biology
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Review
DE ZIKV; animal models; in vitro; ex vivo; in vivo
ID ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN PLACENTAL TROPHOBLASTS;
   FDA-APPROVED DRUG; GUINEA-PIG MODEL; MOUSE MODEL; NEURAL PROGENITORS;
   CEREBRAL ORGANOIDS; IMMUNE-RESPONSES; DENGUE VIRUS; INFECTION
AB The emergence and rapid spread of Zika virus (ZIKV) in the Americas has prompted the development of in vitro and in vivo models to understand several aspects of ZIKV biology and boost the development of vaccines and antivirals. In vitro model studies include reverse genetics systems, two-dimensional (2D) cell models, such as primary cells and cell lines, and ex vivo three-dimensional (3D) models derived from skin, brain and placenta. While these models are cost-effective and allow rigorous control of experimental variables, they do not always recapitulate in vivo scenarios. Thus, a number of in vivo models have been developed, including mosquitoes (Aedes sp. and Culex sp.), embryonated chicken eggs, immunocompetent and immunodeficient mice strains, hamsters, guinea pigs, conventional swine and non-human primates. In this review, we summarize the main research systems that have been developed in recent years and discuss their advantages, limitations and main applications.
C1 [Pena, Lindomar Jose; Guarines, Klarissa Miranda; Felix, Daniele Mendes; Silva, Adalucia] Oswaldo Cruz Fdn Fiocruz, Dept Virol, Aggeu Magalhaes Inst IAM, Recife, PE, Brazil.
   [Duarte Silva, Anna Jessica; Sales Leal, Ligia Rosa; de Freitas, Antonio Carlos] Fed Univ Pernambuco UFPE, Dept Genet, Lab Mol Studies & Expt Therapy LEMTE, Ctr Biol Sci, Recife, PE, Brazil.
   [de Oliveira, Sheilla Andrade] Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst IAM, Dept Immunol, Recife, PE, Brazil.
   [Junqueira Ayres, Constancia Flavia] Oswaldo Cruz Fdn Fiocruz, Aggeu Magalhaes Inst IAM, Dept Entomol, Recife, PE, Brazil.
   [Silva Junior, Abelardo] Fed Univ Vicosa UFV, Dept Vet Med, Vicosa, MG, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol, Aggeu Magalhaes Inst IAM, Recife, PE, Brazil.
EM lindomar.pena@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020
OI Oliveira, Sheilla A/0000-0003-4759-8436
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)CAPES; Pernambuco State Foundation for Science and
   Technology (FACEPE)
FX We would like to thank the Brazilian National Council for Scientific and
   Technological Development (CNPq), the Brazilian Federal Agency for
   Support and Evaluation of Graduate Education (CAPES) and the Pernambuco
   State Foundation for Science and Technology (FACEPE) for the grants and
   scholarships that made this work possible.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Amraoui F, 2016, EURO SURVEILL, V21
   Atieh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14522-6
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bierle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187720
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bosco-Lauth A, 2011, AM J TROP MED HYG, V84, P727, DOI 10.4269/ajtmh.2011.11-0012
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Charles A. S., 2016, PLOS CURR, V8
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Davey MG, 2007, CYTOGENET GENOME RES, V117, P231, DOI 10.1159/000103184
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hickey AJ, 2011, CURR DRUG TARGETS, V12, P1018
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x
   Jain S, 2015, AM J PATHOL, V185, P3102, DOI 10.1016/j.ajpath.2015.07.021
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   LABUDA M, 1993, MED VET ENTOMOL, V7, P193, DOI 10.1111/j.1365-2915.1993.tb00674.x
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HH, 2012, APPL BIOCHEM BIOTECH, V167, P259, DOI 10.1007/s12010-012-9668-x
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   (PAHO) Pan American Health Organization, 2018, ZIK CUM CAS
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pena L, 2012, J GEN VIROL, V93, P2204, DOI 10.1099/vir.0.045005-0
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   REAGAN REGINALD L., 1955, TRANS AMER MICROSC SOC, V74, P77, DOI 10.2307/3223847
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SHEPHERD R. C, 1964, ZOONOSES RES, V3, P125
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P422, DOI 10.1080/00034983.1968.11686579
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   WINKLER GC, 1986, AM J PATHOL, V122, P541
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 167
TC 6
Z9 6
U1 0
U2 11
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD DEC
PY 2018
VL 99
IS 12
BP 1529
EP 1550
DI 10.1099/jgv.0.001153
PG 22
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA HC6OL
UT WOS:000451921000001
PM 30325302
OA Bronze
DA 2020-07-08
ER

PT J
AU Varjak, M
   Leggewie, M
   Schnettler, E
AF Varjak, Margus
   Leggewie, Mayke
   Schnettler, Esther
TI The antiviral piRNA response in mosquitoes?
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Review
DE RNA interference; viral piRNA; mosquito; innate immunity; arbovirus
ID SELFISH GENETIC ELEMENTS; PIWI-INTERACTING RNAS; FUSING AGENT VIRUS;
   AEDES-AEGYPTI; PYRETHROID RESISTANCE; ANOPHELES-GAMBIAE; IN-VIVO;
   INTERFERENCE; IMMUNITY; PATHWAY
AB There are several RNA interference (RNAi) pathways in insects. The small interfering RNA pathway is considered to be the main antiviral mechanism of the innate immune system; however, virus-specific P-element-induced Wimpy testis gene (PIWI)-interacting RNAs (vpiRNAs) have also been described, especially in mosquitoes. Understanding the antiviral potential of the RNAi pathways is important, given that many human and animal pathogens are transmitted by mosquitoes, such as Zika virus, dengue virus and chikungunya virus. In recent years, significant progress has been made to characterize the piRNA pathway in mosquitoes (including the possible antiviral activity) and to determine the differences between mosquitoes and the model organism Drosophila melanogaster. The new findings, especially regarding vpiRNA in mosquitoes, as well as important questions that need to be tackled in the future, are discussed in this review.
C1 [Varjak, Margus] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Leggewie, Mayke; Schnettler, Esther] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Leggewie, Mayke; Schnettler, Esther] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel Riems, D-20359 Hamburg, Germany.
RP Varjak, M (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.; Schnettler, E (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Schnettler, E (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel Riems, D-20359 Hamburg, Germany.
EM margus.varjak@glasgow.ac.uk; schnettler@bnitm.de
OI Varjak, Margus/0000-0003-2608-5148
FU European Union's Horizon 2020 research and innovation programme under
   ZIKAlliance grant [734548]; Deutsches Zentrum fur Infektionsforschung
   (DZIF); UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation programme (https://ec.europa.eu/programmes/horizon2020/)
   under ZIKAlliance grant agreement no. 734548 (E. S.) and by Deutsches
   Zentrum fur Infektionsforschung (DZIF) (M. L. and E. S.). This work was
   also supported by the UK Medical Research Council (MC_UU_12014) (M. V.).
CR Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Chandler CH, 2013, TRENDS GENET, V29, P358, DOI 10.1016/j.tig.2013.01.009
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113
   Eifan S, 2013, VIRUSES-BASEL, V5, P2447, DOI 10.3390/v5102447
   Ernst C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01049-7
   Feltzin VL, 2015, AGING CELL, V14, P443, DOI 10.1111/acel.12323
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Girardi E, 2017, NUCLEIC ACIDS RES, V45, P4881, DOI 10.1093/nar/gkw1368
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Guo JX, 2017, J MED ENTOMOL, V54, P1013, DOI 10.1093/jme/tjx043
   Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hoa NT, 2003, INSECT BIOCHEM MOLEC, V33, P949, DOI 10.1016/S0965-1748(03)00101-2
   Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030
   Huang XW, 2017, TRENDS GENET, V33, P882, DOI 10.1016/j.tig.2017.09.002
   Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112
   Lee M, 2017, J GEN VIROL, V98, P1892, DOI 10.1099/jgv.0.000832
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lewis SH, 2018, NAT ECOL EVOL, V2, P174, DOI 10.1038/s41559-017-0403-4
   Lewis SH, 2016, GENOME BIOL EVOL, V8, P507, DOI 10.1093/gbe/evw018
   Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027
   Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104
   Lin HF, 1997, DEVELOPMENT, V124, P2463
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Macias V, 2014, INSECT MOL BIOL, V23, P579, DOI 10.1111/imb.12106
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Nag DK, 2016, VIROLOGY, V498, P164, DOI 10.1016/j.virol.2016.08.022
   Ohtani H, 2013, GENE DEV, V27, P1656, DOI 10.1101/gad.221515.113
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021
   Sienski G, 2015, GENE DEV, V29, P2258, DOI 10.1101/gad.271908.115
   Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Varble A, 2013, CELL HOST MICROBE, V14, P346, DOI 10.1016/j.chom.2013.08.007
   Varjak M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020088
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Wang YH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040213
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Ye WY, 2017, PARASITOL RES, V116, P2489, DOI 10.1007/s00436-017-5554-3
   Yu Y, 2015, SCIENCE, V350, P339, DOI 10.1126/science.aab0700
   Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhou X, 2007, BIOCHEM BIOPH RES CO, V362, P126, DOI 10.1016/j.bbrc.2007.07.179
NR 90
TC 8
Z9 8
U1 0
U2 10
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD DEC
PY 2018
VL 99
IS 12
BP 1551
EP 1562
DI 10.1099/jgv.0.001157
PG 12
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA HC6OL
UT WOS:000451921000002
PM 30372405
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Wazny, K
   Chan, KY
AF Wazny, Kerri
   Chan, Kit Yee
CA Crowdsourcing CHNRi Collaborators
TI Identifying potential uses of crowdsourcing in global health, conflict,
   and humanitarian settings: an adapted CHNRI (Child Health and Nutrition
   initiative) exercise
SO JOURNAL OF GLOBAL HEALTH
LA English
DT Article
ID RESEARCH PRIORITIES; CARE
AB Background Crowdsourcing, outsourcing problems and tasks to a crowd, has grown exponentially since the term was coined a decade ago. Being a rapid and inexpensive approach, it is particularly amenable to addressing problems in global health, conflict and humanitarian settings, but its potential has not been systematically assessed. We employed the Child Health and Nutrition Research Initiative's (CHNRI) method to generate a ranked list of potential uses of crowdsourcing in global health and conflict.
   Process 94 experts in global health and crowdsourcing submitted their ideas, and 239 ideas were scored. Each expert scored ideas against three of seven criteria, which were tailored specifically for the exercise. A relative ranking was calculated, along with an Average Expert Agreement (AEA).
   Findings On a scale from 0-100, the scores assigned to proposed ideas ranged from 80.39 to 42.01. Most ideas were related to problem solving (n = 112) or data generation (n = 91). Using health care workers to Share information about disease outbreaks to ensure global response had the highest score and agreement. Within the top 15, four additional ideas related to containing communicable diseases, two ideas related to using crowdsourcing for vital registration and two to improve maternal and child health. The top conflict ideas related to epidemic responses and various aspects of disease spread. Wisdom of the crowds and machine learning scored low despite being promising in literature.
   Interpretations Experts were invited to generate ideas during the Ebola crisis and to scare during reports of Zika, Which may have affected the scoring. However, crowdsourcing's rapid, inexpensive characteristics make it suitable for addressing epidemics. Given that many ideas reflected Sustainable Development. Goals (SDGs), crowdsourcing may be an innovative solution to achieving some of the SDGs.
C1 [Wazny, Kerri; Chan, Kit Yee] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
RP Wazny, K (corresponding author), Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
EM kerri.wazny@alumni.utoronto.ca
OI Chan, Kit Yee/0000-0002-3465-8383; Hamer, Davidson/0000-0002-4700-1495
CR [Anonymous], 2014, LANCET, V384, P637, DOI 10.1016/S0140-6736(14)61377-5
   [Anonymous], 2011, MON MAT NEWB CHILD H
   Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0
   Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6
   Chunara R, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-43
   Dua T, 2016, LANCET GLOB HEALTH, V4, pE887, DOI 10.1016/S2214-109X(16)30218-2
   Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638
   Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376
   Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0
   Howe J, 2006, WIRED MAGAZINE, V14, P1, DOI DOI 10.1086/599595
   Kamajian SD, 2015, OSTEOPATHIC FAMILY P, V7, P26
   Kennedy HP, 2016, LANCET GLOB HEALTH, V4, pE777, DOI 10.1016/S2214-109X(16)30183-8
   King S., 2017, COMMUNICATION
   Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2
   Mavandadi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037245
   Pedersen J, 2013, SYST SCI HICSS 2013
   Philips M, 2014, LANCET, V384, P1181, DOI 10.1016/S0140-6736(14)61606-8
   Ramanathan A, 2013, 4 WKSHP INT TEXT VIS
   Ranard BL, 2014, J GEN INTERN MED, V29, P187, DOI 10.1007/s11606-013-2536-8
   Ross JS, 2013, JAMA INTERN MED, V173, P825, DOI 10.1001/jamainternmed.2013.136
   Rudan I, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.011004
   Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720
   Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015
   Tamrat T, 2012, MATERN CHILD HLTH J, V16, P1092, DOI 10.1007/s10995-011-0836-3
   United Nations High Commissioner for Refugees, 2016, GLOB TRENDS FORC DIS
   Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9
   Wazny K, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010502
   Wazny K, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020601
   Xie Y, 2013, P 23 INT JOINT C ART
   Zhao YX, 2014, INFORM SYST FRONT, V16, P417, DOI 10.1007/s10796-012-9350-4
NR 30
TC 3
Z9 2
U1 1
U2 3
PU UNIV EDINBURGH, GLOBAL HEALTH SOC
PI EDINBURGH
PA CENTRE POPULATION HEALTH SCIENCES, OLD MEDICAL SCH, TEVIOT PL,
   EDINBURGH, EH8 9AG, SCOTLAND
SN 2047-2978
EI 2047-2986
J9 J GLOB HEALTH
JI J. Glob. Health
PD DEC
PY 2018
VL 8
IS 2
AR 020704
DI 10.7189/jogh.08.020704
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HD6JT
UT WOS:000452645100042
PM 30410741
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saad-Roy, CM
   Ma, JL
   van den Driessche, P
AF Saad-Roy, C. M.
   Ma, Junling
   van den Driessche, P.
TI The effect of sexual transmission on Zika virus dynamics
SO JOURNAL OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Zika virus; Global stability; Hopf bifurcation; Backward bifurcation
ID REPRODUCTION NUMBER; NONLINEAR INCIDENCE; EPIDEMIOLOGIC MODELS;
   INFECTION; STABILITY; OUTBREAK; BEHAVIOR
AB Zika virus is a human disease that may lead to neurological disorders in affected individuals, and may be transmitted vectorially (by mosquitoes) or sexually. A mathematical model of Zika virus transmission is formulated, taking into account mosquitoes, sexually active males and females, inactive individuals, and considering both vector transmission and sexual transmission from infectious males to susceptible females. Basic reproduction numbers are computed, and disease control strategies are evaluated. The effect of the incidence function used to model sexual transmission from infectious males to susceptible females is investigated. It is proved that for such functions that are sublinear, if the basic reproduction then the disease dies out and is a sharp threshold. Moreover, under certain conditions on model parameters and assuming mass action incidence for sexual transmission, it is proved that if , there exists a unique endemic equilibrium that is globally asymptotically stable. However, under nonlinear incidence, it is shown that for certain functions backward bifurcation and Hopf bifurcation may occur, giving rise to subthreshold equilibria and periodic solutions, respectively. Numerical simulations for various parameter values are displayed to illustrate these behaviours.
C1 [Saad-Roy, C. M.; Ma, Junling; van den Driessche, P.] Univ Victoria, Dept Math & Stat, Victoria, BC V8W 2Y2, Canada.
RP Saad-Roy, CM (corresponding author), Univ Victoria, Dept Math & Stat, Victoria, BC V8W 2Y2, Canada.
EM saadroy@uvic.ca; junlingm@uvic.ca; pvdd@uvic.math.ca
FU NSERCNatural Sciences and Engineering Research Council of Canada;
   NSERC-USRANatural Sciences and Engineering Research Council of Canada
FX This research is supported by NSERC, through NSERC Discovery Grants
   (J.M. and P.vdD.) and NSERC-USRA (C.M.S.-R.). C.M.S.-R. thanks Simon A.
   Levin (Princeton University) for helpful discussions. The authors also
   thank the Editors and two anonymous referees for good suggestions that
   improved the exposition.
CR Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Cushing JM, 2016, J THEOR BIOL, V404, P295, DOI 10.1016/j.jtbi.2016.06.017
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   HADELER KP, 1995, MATH BIOSCI, V128, P41, DOI 10.1016/0025-5564(94)00066-9
   Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013
   HETHCOTE HW, 1991, J MATH BIOL, V29, P271, DOI 10.1007/BF00160539
   Korobeinikov A, 2005, MATH MED BIOL, V22, P113, DOI 10.1093/imammb/dqi001
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   LaSalle JP, 1976, CBMS NSF REGIONAL C, V25
   LIU WM, 1986, J MATH BIOL, V23, P187, DOI 10.1007/BF00276956
   LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Martcheva M, 2015, INTRO MATH EPIDEMIOL
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Shuai ZS, 2013, J MATH BIOL, V67, P1067, DOI 10.1007/s00285-012-0579-9
   Shuai ZS, 2013, SIAM J APPL MATH, V73, P1513, DOI 10.1137/120876642
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2000, J MATH BIOL, V40, P525, DOI 10.1007/s002850000032
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Zhang WJ, 2016, J MATH BIOL, V73, P947, DOI 10.1007/s00285-016-0976-6
NR 39
TC 5
Z9 5
U1 2
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0303-6812
EI 1432-1416
J9 J MATH BIOL
JI J. Math. Biol.
PD DEC
PY 2018
VL 77
IS 6-7
SI SI
BP 1917
EP 1941
DI 10.1007/s00285-018-1230-1
PG 25
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA HC4GH
UT WOS:000451760500010
PM 29696377
DA 2020-07-08
ER

PT J
AU Herrada, CA
   Kabir, MA
   Altamirano, R
   Asghar, W
AF Herrada, Carlos A.
   Kabir, Md. Alamgir
   Altamirano, Rommel
   Asghar, Waseem
TI Advances in Diagnostic Methods for Zika Virus Infection
SO JOURNAL OF MEDICAL DEVICES-TRANSACTIONS OF THE ASME
LA English
DT Review
ID MOLECULAR-DETECTION; POINT; ASSAY; AMPLIFICATION; TECHNOLOGIES;
   OUTBREAK; PAPER; EPIDEMIOLOGY; STATE
AB The Zika virus (ZIKV) is one of the most infamous mosquito-borne flavivirus on recent memory due to its potential association with high mortality rates in fetuses, microcephaly and neurological impairments in neonates, and autoimmune disorders. The severity of the disease, as well as its fast spread over several continents, has urged the World Health Organization (WHO) to declare ZIKV a global health concern. In consequence, over the past couple of years, there has been a significant effort for the development of ZIKV diagnostic methods, vaccine development, and prevention strategies. This review focuses on the most recent aspects of ZIKV research which includes the outbreaks, genome structure, multiplication and propagation of the virus, and more importantly, the development of serological and molecular detection tools such as Zika IgM antibody capture enzyme-linked immunosorbent assay (Zika MAC-ELISA), plaque reduction neutralization test (PRNT), reverse transcription quantitative real-time polymerase chain reaction (qRT-PCR), reverse transcription-loop mediated isothermal amplification (RT-LAMP), localized surface plasmon resonance (LSPR) biosensors, nucleic acid sequence-based amplification (NASBA), and recombinase polymerase amplification (RPA). Additionally, we discuss the limitations of currently available diagnostic methods, the potential of newly developed sensing technologies, and also provide insight into future areas of research.
C1 [Herrada, Carlos A.; Kabir, Md. Alamgir; Altamirano, Rommel; Asghar, Waseem] Florida Atlantic Univ, Dept Comp Engn & Elect Engn & Comp Sci, Boca Raton, FL 33431 USA.
   [Herrada, Carlos A.; Kabir, Md. Alamgir; Altamirano, Rommel; Asghar, Waseem] Coll Engn & Comp Sci, Asghar Lab Micro & Nanotechnol Med, Boca Raton, FL 33431 USA.
   [Asghar, Waseem] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.
RP Asghar, W (corresponding author), Florida Atlantic Univ, Dept Comp Engn & Elect Engn & Comp Sci, Boca Raton, FL 33431 USA.; Asghar, W (corresponding author), Coll Engn & Comp Sci, Asghar Lab Micro & Nanotechnol Med, Boca Raton, FL 33431 USA.; Asghar, W (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.
EM wasghar@fau.edu
RI Kabir, Alamgir/M-4273-2019
OI Kabir, Alamgir/0000-0002-1659-3125
FU Florida Department of Health (FDOH) [7ZK10]; National Institute of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R15AI127214]
FX Florida Department of Health (FDOH) 7ZK10.; National Institute of
   Allergy and Infectious Diseases (R15AI127214).
CR Abbott, 2016, REAL TIM ZIK INSTR U
   Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Altona Diagnostics, 2017, REALSTAR ZIK VIR RT
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   ARUP Laboratories, 2016, ZIK VIR DET RT PCR T
   Asghar W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21163
   Asghar W, 2010, J MANUF SCI E-T ASME, V132, DOI 10.1115/1.4001664
   Baliga Sharmila, 2013, J Indian Soc Periodontol, V17, P461, DOI 10.4103/0972-124X.118317
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   CDC, 2017, ZIK MAC ELISA INSTR
   CDC, 2017, TRIOPL REAL TIM RT P
   Chan K, 2018, ANAL BIOCHEM, V545, P4, DOI 10.1016/j.ab.2018.01.008
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chembio Diagnostic, 2018, DPP ZIKA IGM ASS SYS
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Coarsey CT, 2017, CRIT REV MICROBIOL, V43, P779, DOI [10.1080/1040841X.2017.1313814, 10.1080/1040841x.2017.1313814]
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   DiaSorin, 2017, LIAISON 40 ZIK CAPT
   Draz MS, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201707161
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   ELITechGroup, 2016, ZIK ELITE MGB KIT IN
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fennel R., 2017, NANOWORLD, V1, P10
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hologic, 2018, APT ZIK VIR ASS
   Ilyas A, 2014, ANAL METHODS-UK, V6, P7166, DOI 10.1039/c4ay00781f
   Ilyas A, 2014, BIOSENS BIOELECTRON, V62, P343, DOI 10.1016/j.bios.2014.06.048
   InBios International, 2017, ZIKV DET IGM CAPT EL
   Islam M., 2014, British Journal of Medicine and Medical Research, V4, P2129
   Kanakasabapathy MK, 2017, LAB CHIP, V17, P2910, DOI 10.1039/c7lc00273d
   Karthik K, 2014, METHODSX, V1, P137, DOI 10.1016/j.mex.2014.08.009
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   Lin Z, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-0022-2
   Martinez A W, 2009, DIAGNOSTICS DEV WORL
   Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Mok J, 2014, P NATL ACAD SCI USA, V111, P2110, DOI 10.1073/pnas.1323998111
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nanobiosym Diagnostics, 2017, GEN RADAR ZIK VIR TE
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Okafor I.I., 2016, DIVERSITY EQUALITY H, V13, P394, DOI 10.21767/2049-5471.100083
   Pacheco O., NEW ENGL J MED
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quest Diagnostics, 2017, ZIK VIR RNA QUAL REA
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   Safavieh M, 2017, CRIT REV BIOTECHNOL, V37, P441, DOI 10.3109/07388551.2016.1167667
   Safavieh M, 2016, ACS BIOMATER SCI ENG, V2, P278, DOI 10.1021/acsbiomaterials.5b00449
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08719
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sharma S, 2018, BIOTECHNOL ADV, V36, P1063, DOI 10.1016/j.biotechadv.2018.03.007
   Sher M, 2017, EXPERT REV MOL DIAGN, V17, P351, DOI 10.1080/14737159.2017.1285228
   Siemens, 2016, VERSANT ZIK RNA 1 0
   Siemens Diagnostics, 2017, ADVIA CENT ZIK TEST
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thermo Fisher Scientific, 2017, TAQPATH ZIK VIR KIT
   Tokel O, 2014, CHEM REV, V114, P5728, DOI 10.1021/cr4000623
   U. S. CDC, 2018, FACTS MICR
   U. S. CDC, 2017, TRIOPL REAL TIM RT P
   U. S. CDC, 2017, TYP ZIK VIR TEST
   U. S FDA, 2018, ZIK MAC ELISA INSTR
   Valera E, 2018, LAB CHIP, V18, P1461, DOI 10.1039/c8lc00033f
   Vela Diagnostics, 2016, SENT SA ZIKV RT PCR
   Viracor Eurofins, 2017, ZIK VIR REAL TIM RT
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Yang L, 2014, UROLOGY, V84, DOI 10.1016/j.urology.2014.04.048
   Yu S, 2018, ANDROLOGY-US, V6, P10, DOI 10.1111/andr.12441
NR 96
TC 6
Z9 6
U1 8
U2 31
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1932-6181
EI 1932-619X
J9 J MED DEVICES
JI J. Med. Devices
PD DEC
PY 2018
VL 12
IS 4
SI SI
AR 040802
DI 10.1115/1.4041086
PG 11
WC Engineering, Biomedical
SC Engineering
GA GZ6GT
UT WOS:000449533600003
PM 30662580
OA Green Published
DA 2020-07-08
ER

PT J
AU Leonhard, S
   Barreira, A
   da Fonseca, BL
   Van Der Eijk, A
   Esposito, D
   Klein, T
   Munts, A
   Jacobs, B
AF Leonhard, Sonja
   Barreira, Amilton
   da Fonseca, Benedito Lopes
   Van Der Eijk, Annemiek
   Esposito, Danillo
   Klein, Taline
   Munts, Alexander
   Jacobs, Bart
TI Two cases of chronic inflammatory demyelinating polyneuropathy (CIDP)
   adter Zika virus infection
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory
C1 [Leonhard, Sonja; Jacobs, Bart] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands.
   [Barreira, Amilton] Univ Sao Paulo, Dept Neurosci, Med Sch, Ribeirao Preto, Brazil.
   [da Fonseca, Benedito Lopes; Esposito, Danillo; Klein, Taline] Univ Sao Paulo, Med Sch, Dept Internal Med, Ribeirao Preto, Brazil.
   [Van Der Eijk, Annemiek] Erasmus MC, Univ Med Ctr Rotterdam, Dept Virosci, Rotterdam, Netherlands.
   Spaarne Gasthuis Hosp, Dept Neurol, Haarlem, Netherlands.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
FU European UnionEuropean Union (EU) [734584]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation programme under grant agreement No 734584.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
BP 262
EP 262
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700034
DA 2020-07-08
ER

PT J
AU Szepanowski, F
   Speiseder, T
   Mausberg, A
   Kleinschnitz, C
   Gabriel, G
   Stettner, M
AF Szepanowski, Fabian
   Speiseder, Thomas
   Mausberg, Anne
   Kleinschnitz, Christoph
   Gabriel, Guelsah
   Stettner, Mark
TI Development of hindlimb paresis following Zika and Dengue virus
   infections in adult immunocompetent mice
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory; Other
C1 [Szepanowski, Fabian; Mausberg, Anne; Kleinschnitz, Christoph; Stettner, Mark] Univ Hosp Essen, Dept Neurol, Essen, Germany.
   [Speiseder, Thomas; Gabriel, Guelsah] Heinrich Pette Inst, Leipniz Inst Expt Virol, Hamburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
MA 51
BP 271
EP 271
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700056
DA 2020-07-08
ER

PT J
AU Munoz, L
   Quintero, J
   Jimenez, J
   Lopez, R
   Vargas, J
   Dominguez, S
   Lizarazo, J
   Luque, K
   Ruiz, A
   Gonzalez, G
   Herrera, E
   Beltran, C
   Angarita, J
   Zea, A
   Zuniga, G
   Urrego, J
   Rojas, C
   Ramos, G
   Benavides, J
   Acero, D
   Barreras, P
   Moyano, M
   Cornblath, D
   Parra, B
   Osorio, L
   Pardo, C
AF Munoz, Laura
   Quintero, Jaime
   Jimenez, Jorge
   Lopez, Reydmar
   Vargas, Jose
   Dominguez, Susana
   Lizarazo, Jairo
   Luque, Karina
   Ruiz, Adriana
   Gonzalez, Guillermo
   Herrera, Emilio
   Beltran, Cindy
   Angarita, Jorge
   Zea, Andres
   Zuniga, Gonzalo
   Urrego, Jonathan
   Rojas, Christian
   Ramos, Gustavo
   Benavides, Julie
   Acero, David
   Barreras, Paula
   Moyano, Martha
   Cornblath, David
   Parra, Beatriz
   Osorio, Lyda
   Pardo, Carlos
TI Comparison of Guillain-Barre syndrome between the epidemic and
   post-epidemic phases of Zika virus in Colombia
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory
C1 [Munoz, Laura; Barreras, Paula; Cornblath, David; Pardo, Carlos] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.
   [Quintero, Jaime; Acero, David; Moyano, Martha; Parra, Beatriz; Osorio, Lyda] Univ Valle, Cali, Colombia.
   [Jimenez, Jorge; Lopez, Reydmar] Clin Leon XIII, Medellin, Colombia.
   [Vargas, Jose; Dominguez, Susana] Clin La Misericordia Int, Barranquilla, Colombia.
   [Lizarazo, Jairo; Luque, Karina; Ruiz, Adriana] Hosp Univ Erasmo Meoz, Cucuta, Colombia.
   [Gonzalez, Guillermo; Herrera, Emilio; Beltran, Cindy] Hosp Univ Neiva, Neiva, Colombia.
   [Angarita, Jorge] Clin Medilaser, Neiva, Colombia.
   [Zea, Andres] Univ Valle, Hosp Univ Valle, Cali, Colombia.
   [Zuniga, Gonzalo] Hosp Univ Valle, Cali, Colombia.
   [Urrego, Jonathan] Ctr Med Imbanaco, Cali, Colombia.
   [Rojas, Christian] Fdn Clin Infantil Club Noel, Ctr Med Imbanaco, Cali, Colombia.
   [Ramos, Gustavo] Clin Rey David, Cali, Colombia.
   [Benavides, Julie] Univ Cooperat Colombia, Pasto, Colombia.
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
MA 71
BP 279
EP 279
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700076
DA 2020-07-08
ER

PT J
AU Sejvar, J
   Walteros, D
   Styczinsky, A
   Soares, J
   Galindo, J
   Acosta, J
   Bravo, E
   Artero, Z
   Solano, A
   Prieto, F
   Gonzales, M
   Navarro, E
   Salinas, J
   Belay, E
   Schonberger, L
   Abrams, J
   Ospina, M
   Damon, I
AF Sejvar, James
   Walteros, Diana
   Styczinsky, Ashley
   Soares, Jesus
   Galindo, Jose
   Acosta, Jorge
   Bravo, Elsa
   Artero, Zuleima
   Solano, Alma
   Prieto, Franklyn
   Gonzales, Maritza
   Navarro, Edgar
   Salinas, Jorge
   Belay, Ermias
   Schonberger, Lawrence
   Abrams, Joseph
   Ospina, Martha
   Damon, Inger
TI Zika virus-associated Guillain-Barre syndrome long-term outcomes: A
   case-control assessment
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory; Axonal Biology; Other
C1 [Sejvar, James; Styczinsky, Ashley; Soares, Jesus; Salinas, Jorge; Belay, Ermias; Schonberger, Lawrence; Abrams, Joseph; Damon, Inger] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Walteros, Diana; Prieto, Franklyn; Gonzales, Maritza; Ospina, Martha] Inst Nacl Salud, Bogota, Colombia.
   [Galindo, Jose] Tephinet, Bogota, Colombia.
   [Acosta, Jorge; Navarro, Edgar] Univ Norte, Barranquilla, Colombia.
   [Bravo, Elsa; Artero, Zuleima; Solano, Alma] Secretaria Salud Barranquilla, Barranquilla, Colombia.
RI Acosta-Reyes, Jorge/D-1906-2011; Soares, Jesus/D-2992-2016
OI Acosta-Reyes, Jorge/0000-0003-4303-3243; Soares,
   Jesus/0000-0002-8640-8618
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
BP 289
EP 289
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700100
DA 2020-07-08
ER

PT J
AU Leonhard, S
   Barreira, A
   Van Doorn, P
   Amorelli, M
   Araujo, W
   Gondim, FDA
   Brito, M
   Tan, CY
   Cornblath, D
   Dourado, ME
   Fonseca, B
   Souza, DGB
   Islam, Z
   Maciel, E
   Marques, W
   Matos, L
   Mohammad, QD
   Osorio, L
   Pardo, C
   Parra, B
   Reisin, R
   Resende, G
   Dos Santos, D
   Sejvar, J
   Shahrizaila, N
   Mendonca, HS
   Solomon, T
   Thirugnanam, U
   Willison, H
   Jacobs, B
AF Leonhard, Sonja
   Barreira, Amilton
   Van Doorn, Pieter
   Amorelli, Manuela
   Araujo, Wildo
   Aquino Gondim, Francisco De Assis
   Brito, Maria
   Tan Cheng-Yin
   Cornblath, David
   Dourado, Mario Emilio
   Fonseca, Benedito
   Brum Souza, Doralina Guimaraes
   Islam, Zhahirul
   Maciel, Ernane
   Marques, Wilson
   Matos, Luiza
   Mohammad, Quazi Deen
   Osorio, Lyda
   Pardo, Carlos
   Parra, Beatriz
   Reisin, Ricardo
   Resende, Glaucia
   Dos Santos, Diogo
   Sejvar, James
   Shahrizaila, Nortina
   Mendonca, Helena Silva
   Solomon, Tom
   Thirugnanam, Umapathi
   Willison, Hugh
   Jacobs, Bart
TI International Zika virus related Guillain-Barre Syndrome Outcome Study
   (IGOS-Zika): Update of a case-controlled study
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory; Other
C1 [Leonhard, Sonja; Van Doorn, Pieter; Jacobs, Bart] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Barreira, Amilton; Marques, Wilson] Univ Sao Paulo, Med Sch, Dept Neurosci, Ribeirao Preto, Brazil.
   [Amorelli, Manuela] Secretary State Fed Dist, Dept Infect Dis, Brasilia, DF, Brazil.
   [Araujo, Wildo] Univ Brasilia, Ceilandia Fac, Dept Epidemiol, Brasilia, DF, Brazil.
   [Aquino Gondim, Francisco De Assis] Hosp Univ Walter Cantidio Fortaleza, Fortaleza, Ceara, Brazil.
   [Brito, Maria] Hosp Restauracao, Recife, PE, Brazil.
   [Tan Cheng-Yin; Shahrizaila, Nortina] Univ Malaya, Dept Neurol, Kuala Lumpur, Malaysia.
   [Cornblath, David; Pardo, Carlos] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Dourado, Mario Emilio] Hosp Univ Onofre Lopes, Natal, RN, Brazil.
   [Fonseca, Benedito] Med Sch Ribeirao Preto, Dept Virol, Ribeirao Preto, Brazil.
   [Brum Souza, Doralina Guimaraes] Hosp Clin Fac Med Botucatu, Botucatu, SP, Brazil.
   [Islam, Zhahirul] Icddr B, Lab Sci & Serv Div, Dhaka, Bangladesh.
   [Maciel, Ernane; Matos, Luiza] Hosp Base Dist Fed, Brasilia, DF, Brazil.
   [Mohammad, Quazi Deen] Inst Neurosci & Hosp NINS, Dhaka, Bangladesh.
   [Osorio, Lyda; Parra, Beatriz] Univ Valle, Cali, Colombia.
   [Reisin, Ricardo] Hosp Britanico, Buenas Aires, Argentina.
   [Resende, Glaucia] Hosp Municipal Odilon Behrens MG, Belo Horizonte, MG, Brazil.
   [Dos Santos, Diogo] Hosp Clin Univ Fed Oberlandia, Oberlandia, Brazil.
   [Sejvar, James] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Mendonca, Helena Silva] Univ Fed Goias, Goiania, Go, Brazil.
   [Solomon, Tom] Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Thirugnanam, Umapathi] Natl Neurosci Inst, Singapore, Singapore.
   [Willison, Hugh] Univ Glasgow, Dept Neurol, Glasgow, Lanark, Scotland.
RI Marques, Wilson/G-4240-2012; Pardo, Carlos A./A-5192-2008; Araujo, Wildo
   Navegantes/AAD-9163-2020
OI Marques, Wilson/0000-0002-4589-2749; Pardo, Carlos
   A./0000-0002-4128-5335; Araujo, Wildo Navegantes/0000-0002-6856-4094
FU European Union's Horizon 2020 research and innovation programme [734584]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation programme under grant agreement No 734584
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
BP 321
EP 322
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700182
DA 2020-07-08
ER

PT J
AU Ng, BCJ
   Premikha, M
   Ohnmar, O
   Kam, YW
   Ng, YX
   Leo, YS
   Ng, L
   Umapathi, T
AF Ng, Brandon C. J.
   Premikha, M.
   Ohnmar, O.
   Kam, Yiu-Wing
   Ng, Yixiang
   Leo, Yee-sin
   Ng, Lisa
   Umapathi, T.
TI The 2016 Singapore ZIKV outbreak did not cause a surge in Guillain-Barre
   Syndrome
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory
C1 [Ng, Brandon C. J.; Premikha, M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Ohnmar, O.; Umapathi, T.] Natl Neurosci Inst, Singapore, Singapore.
   [Kam, Yiu-Wing; Ng, Lisa] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.
   [Ng, Yixiang] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore.
   [Leo, Yee-sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore.
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund, Agency for
   Science, Technology and Research (A*STAR), Singapore [15/1/82/27/001]
FX This work was supported by core research grants provided to the
   Singapore Immunology Network by the Biomedical Research Council (BMRC)
   and also partially supported by the BMRC A*STAR-led Zika Virus
   Consortium Fund [project number: 15/1/82/27/001], Agency for Science,
   Technology and Research (A*STAR), Singapore. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
BP 323
EP 324
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700186
DA 2020-07-08
ER

PT J
AU Ferreiral, JM
   Galeigo, D
   Passos, P
   Pagliarini, LF
   Silva, I
   Hygino, C
   Pupe, C
   Nascimento, O
AF Ferreiral, Joao Marcos
   Galeigo, Diogo
   Passos, Pamela
   Pagliarini, Luiz Felipe
   Silva, Ivan
   Hygino, Celso
   Pupe, Camila
   Nascimento, Osvaldo
TI Neuroimaging findings post zika virus infection associated with
   neurological complications in adults
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory
C1 [Ferreiral, Joao Marcos; Passos, Pamela; Pagliarini, Luiz Felipe; Pupe, Camila; Nascimento, Osvaldo] Univ Fed Fluminense, Rio De Janeiro, Brazil.
   [Galeigo, Diogo; Hygino, Celso] DASA, Rio De Janeiro, Brazil.
   [Silva, Ivan] Rush Univ, Med Ctr, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
BP 359
EP 359
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700270
DA 2020-07-08
ER

PT J
AU Salinas, S
   Erkilic, N
   Damodar, K
   Moles, JP
   Fournier-Wirth, C
   Van de Perre, P
   Kalatzis, V
   Simonin, Y
AF Salinas, Sara
   Erkilic, Nejla
   Damodar, Krishna
   Moles, Jean-Pierre
   Fournier-Wirth, Chantal
   Van de Perre, Philippe
   Kalatzis, Vasiliki
   Simonin, Yannick
TI Zika Virus Efficiently Replicates in Human Retinal Epithelium and
   Disturbs Its Permeability (vol 91, e02144-16, 2017)
SO JOURNAL OF VIROLOGY
LA English
DT Correction
C1 [Salinas, Sara; Moles, Jean-Pierre; Fournier-Wirth, Chantal; Van de Perre, Philippe; Simonin, Yannick] Univ Montpellier, Etab Francais Sang Pathogenesis & Control Chron I, INSERM, UMR 1058, Montpellier, France.
   [Erkilic, Nejla; Damodar, Krishna; Kalatzis, Vasiliki] INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France.
   [Erkilic, Nejla; Damodar, Krishna; Kalatzis, Vasiliki; Simonin, Yannick] Univ Montpellier, Montpellier, France.
   [Fournier-Wirth, Chantal] Etab Francais Sang, Montpellier, France.
   [Van de Perre, Philippe] Ctr Hosp Univ Montpellier, Montpellier, France.
RP Salinas, S (corresponding author), Univ Montpellier, Etab Francais Sang Pathogenesis & Control Chron I, INSERM, UMR 1058, Montpellier, France.
RI Van de Perre, Philippe/B-9692-2008; Moles, Jean-Pierre/M-2286-2017;
   Salinas, Sara/O-1856-2013
OI Van de Perre, Philippe/0000-0002-3912-0427; Moles,
   Jean-Pierre/0000-0002-6863-6350; Salinas, Sara/0000-0003-4492-2093
CR Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
NR 1
TC 1
Z9 1
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2018
VL 92
IS 23
AR e01546-18
DI 10.1128/JVI.01546-18
PG 1
WC Virology
SC Virology
GA HA1SI
UT WOS:000450002000035
PM 30420418
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zupin, L
   Caracciolo, I
   Tricarico, PM
   Ottaviani, G
   D'Agaro, P
   Crovella, S
AF Zupin, Luisa
   Caracciolo, Ilaria
   Tricarico, Paola Maura
   Ottaviani, Giulia
   D'Agaro, Pierlanfranco
   Crovella, Sergio
TI Photobiomodulation therapy reduces viral load and cell death in
   ZIKV-infected glioblastoma cell line
SO LASERS IN MEDICAL SCIENCE
LA English
DT Letter
ID VIRUS
C1 [Zupin, Luisa; Caracciolo, Ilaria; Tricarico, Paola Maura; Ottaviani, Giulia; D'Agaro, Pierlanfranco; Crovella, Sergio] Univ Trieste, Trieste, Italy.
   [Crovella, Sergio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
RP Zupin, L (corresponding author), Univ Trieste, Trieste, Italy.
EM luisa.zupin@burlo.trieste.it; crc.ilaria@gmail.com;
   tricaricopa@gmail.com; ottavianigiulia7@gmail.com; pdagaro@units.it;
   sergio.crovella@burlo.trieste.it
RI Ottaviani, Giulia/W-4164-2019; tricarico, paola/AAB-8972-2019; Zupin,
   Luisa/I-5228-2018
OI Ottaviani, Giulia/0000-0002-3427-0514; tricarico,
   paola/0000-0002-1954-4126; Zupin, Luisa/0000-0001-5886-9129
FU University of Trieste [U22SCFRA15]; IRCCS Burlo Garofolo/Italian
   Ministry of Health [RC 15/2017]
FX This work was supported by University of Trieste - "University funding
   for scientific research project"(U22SCFRA15) and by IRCCS Burlo
   Garofolo/Italian Ministry of Health (RC 15/2017).
CR Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Donnarumma G, 2010, INT J IMMUNOPATH PH, V23, P1167, DOI 10.1177/039463201002300420
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Percival SL, 2015, FUTURE MICROBIOL, V10, P255, DOI [10.2217/fmb.14.109, 10.2217/FMB.14.109]
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zupin L, 2018, MICROBIOL IMMUNOL, V62, P477, DOI 10.1111/1348-0421.12600
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD DEC
PY 2018
VL 33
IS 9
BP 2011
EP 2013
DI 10.1007/s10103-018-2568-8
PG 3
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA HA2AY
UT WOS:000450033200023
PM 29971518
DA 2020-07-08
ER

PT J
AU Danbaba, UA
   Garba, SM
AF Danbaba, Usman A.
   Garba, Salisu M.
TI Modeling the transmission dynamics of Zika with sterile insect technique
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article
DE bifurcation; equilibria; reproduction number; stability; sterile insect
   technique; zika virus
ID SEXUAL TRANSMISSION; MATHEMATICAL-MODEL; SENSITIVITY-ANALYSIS; VIRUS
   DYNAMICS; INFECTION
AB A deterministic model for the transmission dynamics of Zika is designed and rigorously analysed. A model consisting of mutually exclusive compartments representing the human and mosquito dynamics takes into account both direct (human-human) and indirect modes of transmissions. The basic offspring number of the mosquito population is computed and condition for existence and stability of equilibria is investigated. Using the centre manifold theory, the model (with and without direct transmission) is shown to exhibit the phenomenon of backward bifurcation (where a locally asymptotically stable disease free equilibrium coexists with a locally asymptotically stable endemic equilibrium) whenever the associated reproduction number is less than unity. The study shows that the models with and without direct transmission exhibit the same qualitative dynamics with respect to the local stability of their associated disease-free equilibrium and backward bifurcation phenomenon. The main cause of the backward bifurcation is identified as Zika induced mortality in humans. Sensitivity (local and global) analysis of the model parameters are conducted to identify crucial parameters that influence the dynamics of the disease. Analysis of the model shows that an increase in the mating rate with sterile mosquito decreases the mosquito population. Numerical simulations, using parameter values relevant to the transmission dynamics of Zika are carried out to support some of the main theoretical findings.
C1 [Danbaba, Usman A.; Garba, Salisu M.] Univ Pretoria, Dept Math & Appl Math, ZA-0002 Pretoria, South Africa.
RP Garba, SM (corresponding author), Univ Pretoria, Dept Math & Appl Math, ZA-0002 Pretoria, South Africa.
EM salisu.garba@up.ac.za
RI Garba, Salisu/AAE-5777-2019
OI Garba, Salisu/0000-0003-1622-1951; Danbaba, Usman
   Ahmed/0000-0001-9470-3775
FU South African DST/NRF SARChI chair on Mathematical Models andMethods in
   Bioengineering and Biosciences (M2B2); DST-NRF Centre of Excellence in
   Mathematical and Statistical Sciences (CoE-MaSS)
FX The authors acknowledges with thanks to the support of South African
   DST/NRF SARChI chair on Mathematical Models andMethods in Bioengineering
   and Biosciences (M<SUP>3</SUP>B<SUP>2</SUP>) and DST-NRF Centre of
   Excellence in Mathematical and Statistical Sciences (CoE-MaSS). The
   authors are grateful to the anonymous reviewers and handling editor for
   their constructive comments.
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Anguelov R, 2012, COMPUT MATH APPL, V64, P374, DOI 10.1016/j.camwa.2012.02.068
   BARCLAY HJ, 1990, ROCKY MT J MATH, V20, P847, DOI 10.1216/rmjm/1181073046
   Bowman C, 2005, B MATH BIOL, V67, P1107, DOI 10.1016/j.bulm.2005.01.002
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427
   Clemons A, 2010, NON TRADITIONAL REF
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Danbaba U.A., 2018, BIOMATH FORUM SOFIA, P81, DOI DOI 10.11145/TEXTS.2018.01.083
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Esteva L, 2005, MATH BIOSCI, V198, P132, DOI 10.1016/j.mbs.2005.06.004
   Esteva L, 2006, MAT APL COMPUT, V7, P259
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Garba SM, 2010, INT J COMPUT MATH, V87, P2361, DOI 10.1080/00207160802660608
   Garba SM, 2013, ACTA MATH SCI, V33, P1439
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hole PI, 2009, MALARIA J S2, V8, pS8, DOI [10.1186/1475-2875-8-s2-s8, DOI 10.1186/1475-2875-8-S2-S8]
   Imran M., 2017, DIFFER EQU DYN SYST, DOI [10.1007/s12591-017-0374-6, DOI 10.1007/S12591-017-0374-6]
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Korn G.A., 2000, MATH HDB SCI ENG DEF
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Watmough J, 2012, MATH BIOSCI, V180, P29
   World Health Organization, ZIK VIR FACT SHEET
   Zika Virus Vaccine, NON TRADITIONAL REF
NR 40
TC 1
Z9 1
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
PD DEC
PY 2018
VL 41
IS 18
SI SI
BP 8871
EP 8896
DI 10.1002/mma.5336
PG 26
WC Mathematics, Applied
SC Mathematics
GA HD5ZS
UT WOS:000452611500031
OA Bronze
DA 2020-07-08
ER

PT J
AU Ndairou, F
   Area, I
   Nieto, JJ
   Silva, CJ
   Torres, DFM
AF Ndairou, Faical
   Area, Ivan
   Nieto, Juan J.
   Silva, Cristiana J.
   Torres, Delfim F. M.
TI Mathematical modeling of Zika disease in pregnant women and newborns
   with microcephaly in Brazil
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article
DE Brazil; epidemiology; mathematical modeling; positivity and boundedness
   of solutions; stability; Zika virus and microcephaly
AB We propose a new mathematical model for the spread of Zika virus. Special attention is paid to the transmission of microcephaly. Numerical simulations show the accuracy of the model with respect to the Zika outbreak occurred in Brazil.
C1 [Ndairou, Faical] AIMS Cameroon, African Inst Math Sci, POB 608, Limbe Crystal Gardens, South West Regi, Cameroon.
   [Ndairou, Faical; Area, Ivan] Univ Vigo, Dept Matemat Aplicada 2, EE Aeronaut & Espazo, Campus As Lagoas S-N, Orense 32004, Spain.
   [Nieto, Juan J.] Univ Santiago de Compostela, Inst Matemat, Santiago De Compostela 15782, Spain.
   [Silva, Cristiana J.; Torres, Delfim F. M.] Univ Aveiro, Dept Math, Ctr Res & Dev Math & Applicat CIDMA, P-3810193 Aveiro, Portugal.
RP Torres, DFM (corresponding author), Univ Aveiro, Dept Math, Ctr Res & Dev Math & Applicat CIDMA, P-3810193 Aveiro, Portugal.
EM delfim@ua.pt
RI Area, Ivan/E-9007-2016; Silva, Cristiana J./H-7908-2012; Torres, Delfim
   F. M./A-7682-2008; Silva, Cristiana J./L-1549-2019
OI Area, Ivan/0000-0003-0872-5017; Silva, Cristiana J./0000-0002-7238-546X;
   Torres, Delfim F. M./0000-0001-8641-2505; Silva, Cristiana
   J./0000-0002-7238-546X; Ndairou, Faical/0000-0002-0119-6178; Nieto, Juan
   J./0000-0001-8202-6578
FU Agencia Estatal de Innovacion [MTM2016-75140-P]; Xunta de GaliciaXunta
   de Galicia [GRC 2015-004, R 2016/022]; FCTPortuguese Foundation for
   Science and Technology [CIDMA UID/MAT/04106/2013, TOCCATA
   PTDC/EEI-AUT/2933/2014, SFRH/BPD/72061/2010]
FX Agencia Estatal de Innovacion, Grant/Award Number: MTM2016-75140-P;
   Xunta de Galicia, Grant/Award Number: GRC 2015-004 and R 2016/022; FCT,
   Grant/Award Number: CIDMA UID/MAT/04106/2013, TOCCATA
   PTDC/EEI-AUT/2933/2014 and SFRH/BPD/72061/2010
CR Abate A, 2009, AUTOMATICA, V45, P1601, DOI 10.1016/j.automatica.2009.02.028
   Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Kong QK, 2011, MATH CONTROL RELAT F, V1, P493, DOI 10.3934/mcrf.2011.1.493
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Moreno Victor M, 2017, Infect Dis Model, V2, P21, DOI 10.1016/j.idm.2016.12.002
   Rodrigues HS, 2016, MATH METHOD APPL SCI, V39, P4671, DOI 10.1002/mma.3319
   Rodrigues HS, 2012, INT J COMPUT MATH, V89, P334, DOI 10.1080/00207160.2011.554540
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
NR 12
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
PD DEC
PY 2018
VL 41
IS 18
SI SI
BP 8929
EP 8941
DI 10.1002/mma.4702
PG 13
WC Mathematics, Applied
SC Mathematics
GA HD5ZS
UT WOS:000452611500035
OA Bronze
DA 2020-07-08
ER

PT J
AU Estallo, EL
   Sangermano, F
   Grech, M
   Luduena-Almeida, F
   Frias-Cespedes, M
   Ainete, M
   Almiron, W
   Livdahl, T
AF Estallo, E. L.
   Sangermano, F.
   Grech, M.
   Luduena-Almeida, F.
   Frias-Cespedes, M.
   Ainete, M.
   Almiron, W.
   Livdahl, T.
TI Modelling the distribution of the vector Aedes aegypti in a central
   Argentine city
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; mosquito; MaxEnt; risk; prediction; species distribution
   models; SDMs; Cordoba; Argentina
ID CORDOBA CITY; DENGUE-FEVER; SUITABILITY; ALBOPICTUS; INDEX; RISK
AB Aedes aegypti (Diptera: Culicidae) is an urban mosquito involved in the transmission of numerous viruses, including dengue, chikungunya and Zika. In Argentina, Ae. aegypti is the main vector of dengue virus and has been involved in several outbreaks in regions ranging from northern to central Argentina since 2009. In order to evaluate areas of potential vector-borne disease transmission in the city of Cordoba, Argentina, the present study aimed to identify the environmental, socioeconomic and demographic factors driving the distribution of Ae. aegypti larvae through spatial analysis in the form of species distribution models (SDMs). These models elucidate relationships between known occurrences of a species and environmental data in order to identify areas with suitable habitats for that species and the consequent risk for disease transmission. The maximum entropy species distribution model was able to fit the training data well, with an average area under the receiver operating characteristic curve (AUC) of > 0.8, and produced models with fair extrapolation capacity (average test AUC: > 0.75). Human population density, distance to vegetation and water channels were the main variables predictive of the vector suitability of an area. The results of this work will be used to target surveillance and prevention measures, as well as in mosquito management.
C1 [Estallo, E. L.; Luduena-Almeida, F.; Almiron, W.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat FCEFyN, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Biol & Tecnol IIByT,Ctr Invest Entomo, Edificio Invest Biol & Tecnol, Cordoba, Argentina.
   [Estallo, E. L.; Livdahl, T.] Clark Univ, Dept Biol, Worcester, MA 01610 USA.
   [Sangermano, F.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA.
   [Grech, M.] Univ Nacl Patagonia San Juan Bosco, CONICET, Fac Ciencias Nat, Ctr Invest Esquel Montana & Estepa Patagon CIEME, Esquel, Argentina.
   [Frias-Cespedes, M.; Ainete, M.] Minist Salud Provincia Cordoba, Area Epidemiol, Cordoba, Argentina.
RP Estallo, EL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat FCEFyN, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Biol & Tecnol IIByT,Ctr Invest Entomo, Edificio Invest Biol & Tecnol, Cordoba, Argentina.
EM eelizabet@gmail.com
RI Sangermano, Florencia/AAN-8744-2020
OI Sangermano, Florencia/0000-0003-4437-4293
FU Fulbright Program; CONICET as a Fulbright visiting scholar at Clark
   University (Worcester, MA, U.S.A.)
FX Data used for this study were part of surveillance and control measures,
   conducted annually by the Epidemiology Section of the Provincial Health
   Ministry of Cordoba, with the collaboration of the Cordoba Entomological
   Research Centre (CIEC) from the Biological and Technological Research
   Institute (IIByT) of Cordoba University (UNC) and the National
   Scientific and Technical Research Council (CONICET). The authors thank
   the personnel of the Epidemiology Section of the Provincial Health
   Ministry of Cordoba. The authors also thank Comision Nacional de
   Actividades Espaciales (CONAE) for providing the SPOT 5 HRG imagery
   (CONAE (c) Le site du Centre national d'etudes spatiales-CNES). E.L.E.
   received support from the Fulbright Program and CONICET as a Fulbright
   visiting scholar at Clark University (Worcester, MA, U.S.A.). E.L.E.
   thanks Clark University, the Department of Biology and Clark Labs at
   Clark University and the kind personnel of each. E.L.E., M.G. and W.A.
   are CONICET researchers.
CR Alimi TO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1052-1
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Carbajo AE, 2004, MEDICINA-BUENOS AIRE, V64, P231
   Center for Disease Control and Prevention [CDC], 2018, DENG ENT EC
   Christophers S.R., 1960, AED AEG L YELL FEV M
   Cianci D, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0001-0
   Dewald JR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1534-9
   Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283
   Eastman J. R., 2016, TERRSET
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Fenoglio MS, 2009, ACTA OECOL, V35, P318, DOI 10.1016/j.actao.2008.12.001
   Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002
   Franklin J, 2010, MAPPING SPECIES DIST
   Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3
   Getachew D, 2015, INTERDISCIP PERSPECT, V2015
   Gill NS, 2016, APPL GEOGR, V76, P14, DOI 10.1016/j.apgeog.2016.09.002
   Grech M, 2012, REV SAUDE PUBL, V46, P387, DOI [10.1590/S0034-89102012005000007, 10.1590/s0034-89102012005000007]
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Khatchikian C, 2011, MED VET ENTOMOL, V25, P268, DOI 10.1111/j.1365-2915.2010.00935.x
   Estallo EL, 2016, IEEE J-STARS, V9, P5461, DOI 10.1109/JSTARS.2016.2604577
   Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011
   Ministerio de Salud de la Nacion, 2017, B INT VIG
   Ministerio de Salud de la Nacion, 2017, B INT VIG
   Ministerio de Salud de la Provincia de Cordoba, 2016, DENG 77 NEW CAS DENG
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Municipalidad de Cordoba, 2017, CORD CIUD CIFR
   Natiello M, 2008, EMERG INFECT DIS, V14, P1498, DOI 10.3201/eid1409.080143
   National Meteorological Service, 2018, CAR EST LARG PLAZ
   Nihei N, 2014, GEOSPATIAL HEALTH, V8, P417, DOI 10.4081/gh.2014.30
   Osipova L, 2016, J NAT CONSERV, V34, P107, DOI 10.1016/j.jnc.2016.10.002
   Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183
   Pan American Health Organization (PAHO), 2017, ZIK EP REP ARG
   Peterson AT, 2006, EMERG INFECT DIS, V12, P1822
   Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2
   Philbert A, 2013, J ENV RES MANAG, V4, P344
   Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI DOI 10.1145/1015330.1015412
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   REISEN WK, 1990, J MED ENTOMOL, V27, P356, DOI 10.1093/jmedent/27.3.356
   Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5
   Roiz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128112
   SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577
   Skowronek S, 2017, BIOL INVASIONS, V19, P239, DOI 10.1007/s10530-016-1276-1
   Stewart DR, 2018, CONSERV BIOL, V32, P183, DOI 10.1111/cobi.12967
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Cid CV, 2013, ACTA TROP, V125, P303, DOI 10.1016/j.actatropica.2012.12.005
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010
   Zha Y, 2003, INT J REMOTE SENS, V24, P583, DOI 10.1080/01431160304987
   Zhao J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1653-5
NR 52
TC 6
Z9 6
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD DEC
PY 2018
VL 32
IS 4
BP 451
EP 461
DI 10.1111/mve.12323
PG 11
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GZ8CO
UT WOS:000449714300008
PM 30027565
OA Bronze
DA 2020-07-08
ER

PT J
AU Stolow, J
   Castro, A
AF Stolow, Jeni
   Castro, Arachu
TI Zika: From the Brazilian Backlands to Global Threat
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Book Review
C1 [Stolow, Jeni] Tulane Univ, New Orleans, LA 70118 USA.
RP Stolow, J (corresponding author), Tulane Univ, New Orleans, LA 70118 USA.
RI Castro, Arachu/L-6664-2014
OI Castro, Arachu/0000-0003-0428-9174
CR DINIZ D, 2016, ZIKA BRAZILIAN BACKL
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0745-5194
EI 1548-1387
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD DEC
PY 2018
VL 32
IS 4
DI 10.1111/maq.12445
PG 2
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA HC9PO
UT WOS:000452138800004
DA 2020-07-08
ER

PT J
AU Lee, CYP
   Ng, LFP
AF Lee, Cheryl Yi-Pin
   Ng, Lisa F. P.
TI Zika virus: from an obscurity to a priority
SO MICROBES AND INFECTION
LA English
DT Article
DE Zika virus; Animal models; Immune responses; Therapeutics
ID WEST-NILE-VIRUS; BLOOD MONONUCLEAR-CELLS; DENGUE VIRUS;
   CROSS-REACTIVITY; HUMAN-ANTIBODIES; STRUCTURAL BASIS; SOUTH-PACIFIC;
   INFECTION; PROTECTION; VACCINE
AB Despite being discovered approximately 70 years ago, Zika virus (ZIKV) has received little attention, until the occurrence of alarming epidemics in the Pacific Islands and Latin America between 2013 and 2016. These series of outbreaks resulted in crippling neurological complications in adults, and congenital deformities in new-borns. The dire outcomes marked ZIKV as a re-emerging pathogen of public health concern. Over a period of two years, extensive studies have been conducted to understand different aspects of ZIKV from pathogen biology to infection, including the immune response during virus-host interplay in established animal models, as well as potential therapeutics against ZIKV infection. The vast diversity of novel findings has added value to ZIKV research, and a strategic consolidation is crucial to encompass the latest advances and developments, as well as missing pieces of the puzzle. This review thus aims to provide a concise yet extensive update on current ZIKV studies. (C) 2018 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.
C1 [Lee, Cheryl Yi-Pin; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Lee, Cheryl Yi-Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Ng, Lisa F. P.] 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
RP Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.; Ng, LFP (corresponding author), 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
OI Ng, Lisa/0000-0003-4071-5222
FU A*STAR Graduate scholarshipAgency for Science Technology & Research
   (ASTAR)
FX We acknowledge Kai-Er Eng from Singapore Immunology Network (SIgN),
   A*STAR, for her critical comments of this manuscript. Cheryl Yi-Pin Lee
   is supported by A*STAR Graduate scholarship.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Anderson JF, 2002, EMERG INFECT DIS, V8, P107, DOI 10.3201/eid0801.010252
   Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Best SM, 2006, FUTURE VIROL, V1, P447, DOI 10.2217/17460794.1.4.447
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcia-Tapia D, 2006, VET IMMUNOL IMMUNOP, V110, P229, DOI 10.1016/j.vetimm.2005.10.003
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hou HQ, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0202-3
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Larsson M, 2005, SPRINGER SEMIN IMMUN, V26, P309, DOI 10.1007/s00281-004-0178-y
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lustig Y, 2016, EURO SURVEILL, V21
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mahla RS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00248
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sautto G, 2013, BIOMED RES INT, DOI 10.1155/2013/838491
   Scheerlinck JPY, 2010, EXPERT REV VACCINES, V9, P351, DOI 10.1586/ERV.10.14
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Srivastava S, 1999, INT J EXP PATHOL, V80, P17, DOI 10.1046/j.1365-2613.1999.00092.x
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vaughan AT, 2011, INT J BIOCHEM CELL B, V43, P280, DOI 10.1016/j.biocel.2010.12.005
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu MH, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0003-3
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 152
TC 7
Z9 7
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2018
VL 20
IS 11-12
BP 635
EP 645
DI 10.1016/j.micinf.2018.02.009
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HC7TC
UT WOS:000452003500001
PM 29530643
OA Other Gold
DA 2020-07-08
ER

PT J
AU Boyer, S
   Calvez, E
   Chouin-Carneiro, T
   Diallo, D
   Failloux, AB
AF Boyer, Sebastien
   Calvez, Elodie
   Chouin-Carneiro, Thais
   Diallo, Diawo
   Failloux, Anna-Bella
TI An overview of mosquito vectors of Zika virus
SO MICROBES AND INFECTION
LA English
DT Article
DE Arbovirus; Mosquito vectors; Aedes aegypti; Vector competence
ID AEDES-AEGYPTI MOSQUITOS; YELLOW-FEVER EPIDEMIC; ARBOVIRUS INFECTIONS;
   SEROLOGICAL SURVEY; CULEX-QUINQUEFASCIATUS; VERTICAL TRANSMISSION;
   FRENCH-POLYNESIA; SEROEPIDEMIOLOGICAL SURVEY; CHIKUNGUNYA VIRUS; BORNE
   VIRUSES
AB The mosquito-borne arbovirus Zika virus (ZIKV, Flavivirus, Flaviviridae), has caused an outbreak impressive by its magnitude and rapid spread. First detected in Uganda in Africa in 1947, from where it spread to Asia in the 1960s, it emerged in 2007 on the Yap Island in Micronesia and hit most islands in the Pacific region in 2013. Subsequently, ZIKV was detected in the Caribbean, and Central and South America in 2015, and reached North America in 2016. Although ZIKV infections are in general asymptomatic or causing mild self-limiting illness, severe symptoms have been described including neurological disorders and microcephaly in newborns. To face such an alarming health situation, WHO has declared Zika as an emerging global health threat. This review summarizes the literature on the main vectors of ZIKV (sylvatic and urban) across all the five continents with special focus on vector competence studies. (C) 2018 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.
C1 [Boyer, Sebastien] Inst Pasteur Cambodia, Unit Med Entomol, Phnom Penh, Cambodia.
   [Calvez, Elodie] Inst Pasteur New Caledonia, URE Dengue & Other Arboviruses, Noumea, New Caledonia.
   [Chouin-Carneiro, Thais] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Diallo, Diawo] Inst Pasteur, Unit Med Entomol, Dakar, Senegal.
   [Failloux, Anna-Bella] Inst Pasteur, URE Arboviruses & Insect Vectors, Paris, France.
RP Failloux, AB (corresponding author), Inst Pasteur, URE Arboviruses & Insect Vectors, Paris, France.
EM anna-bella.failloux@pasteur.fr
OI FAILLOUX, Anna-Bella/0000-0001-6890-0820; Boyer,
   Sebastien/0000-0002-2946-586X; DIALLO, Diawo/0000-0002-7478-5248
FU European Union's Horizon 2020 Research and innovation programme under
   "ZIKALLIANCE" [734548]; French Government's Investissement d'Avenir
   programFrench National Research Agency (ANR); Laboratoire d'Excellence
   "Integrative Biology of Emerging Infectious Diseases, IBEID"
   [ANR-10-LABX-62-IBEID]
FX This study was partly supported by the European Union's Horizon 2020
   Research and innovation programme under "ZIKALLIANCE" (Grant Agreement
   no 734548), the French Government's Investissement d'Avenir program and
   Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases, IBEID" (grant no ANR-10-LABX-62-IBEID). We thank Richard Paul
   for correcting the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   AITKEN THG, 1954, AM J HYG, V60, P37, DOI 10.1093/oxfordjournals.aje.a119702
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Akoua-Koffi C, 2004, PHARMACIEN AFRIQUE, V173, P7
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Alera MT, 2012, EMERG INFECT DIS, V2015, P722
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amraoui F, 2016, EURO SURVEILL, V21
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   B G. Culicides et arbovirus de Centrafrique, 1982, B G CULICIDES ARBOVI
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Boccolini D, 2016, EURO SURVEILL, V21
   Boche R, 1974, Bull Soc Pathol Exot Filiales, V67, P126
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2017, CAS COUNTS US
   CDC, 2017, ZIK CAS REP US
   CHAMBON L, 1967, B WORLD HEALTH ORGAN, V36, P113
   CHIPPAUX.C, 1966, B WORLD HEALTH ORGAN, V34, P105
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Control EECfDP, 2017, CONTROL EECFDP RAPID
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CURTIN TJ, 1967, J MED ENTOMOL, V4, P48, DOI 10.1093/jmedent/4.1.48
   Dakar, 1981, RAPP ANN
   Dao-NdSdCV-SdViera Epidemias, 2016, B INF SURT CAS SUSP
   Delaunay P, 2009, ARCH PEDIATRIE, V16, pS66, DOI 10.1016/S0929-693X(09)75304-7
   Di Luca M, 2016, EURO SURVEILL, V21
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516, DOI 10.4269/ajtmh.1975.24.516
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   FONTENILLE D, 1988, B SOC PATHOL EXOT, V81, P58
   FONTENILLE D, 1988, Archives de l'Institut Pasteur de Madagascar, V54, P101
   FONTENILLE D, 1988, ANN SOC BELG MED TR, V68, P43
   Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   GONZALEZ JP, 1979, B SOC PATHOL EXOT, V72, P416
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Gulland A, 2016, BR MED J, V352
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hervy JPLF, 1981, ENQUETES CIRCULATION, P9
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kirya BG, 1970, ARBOVIRUS SEROLOGY, V19, P30
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Margarita Y, 2006, ACTA PARASITOL, V1, P59
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MONATH TP, 1974, T ROY SOC TROP MED H, V68, P30, DOI 10.1016/0035-9203(74)90248-X
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E., 2016, EURO SURVEILL, V21
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OMER AHS, 1981, J TROP MED HYG, V84, P63
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   PELLISSIER AIME, 1954, BULL SOC PATHOL EXOT, V47, P223
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PINTO MR, 1967, B WORLD HEALTH ORGAN, V37, P101
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589
   Rallu J-L, 1989, FRANCE PACIFIQUE, V76, P45, DOI [10.3406/outre.1989.2742, DOI 10.3406/OUTRE.1989.2742]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Renaudet JRY, 1976, RECHERCHES EFFECTUEE
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   ROBERT V, 1993, B SOC PATHOL EXOT, V86, P90
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   RODHAIN F, 1987, B SOC PATHOL EXOT, V80, P155
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodier GR, 1996, T ROY SOC TROP MED H, V90, P237, DOI 10.1016/S0035-9203(96)90228-X
   ROSEN L, 1986, AM J TROP MED HYG, V35, P642, DOI 10.4269/ajtmh.1986.35.642
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   SALAUN JJ, 1967, B WORLD HEALTH ORGAN, V37, P343
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Septfons A, 2016, EURO SURVEILL, V21
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P879
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   STRICKMAN D, 1993, J MED ENTOMOL, V30, P947, DOI 10.1093/jmedent/30.5.947
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Theiler M, 1961, ANN REPORT
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   TSAI TF, 1987, B WORLD HEALTH ORGAN, V65, P855
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   VANDERWAALS FW, 1986, TROP GEOGR MED, V38, P203
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Virus d'Afrique (Base de Donnees) CRORA, 2013, VIRUS AFRIQUE BASE D
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, WHO STAT 5 M EM COMM
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, STAT 1 M INT HLTH RE
   World Health Organization, 2017, SIT REP 10 MARCH 201
   World Health Organization, 2016, SIT REP ZIK VIR MICR, P2016
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 201
TC 46
Z9 47
U1 1
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2018
VL 20
IS 11-12
BP 646
EP 660
DI 10.1016/j.micinf.2018.01.006
PG 15
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HC7TC
UT WOS:000452003500002
PM 29481868
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Proenca-Modena, JL
   Milanez, GP
   Costa, ML
   Judice, CC
   Costa, FTM
AF Proenca-Modena, Jose Luiz
   Milanez, Guilherme Paier
   Costa, Maria Laura
   Judice, Carla C.
   Maranhao Costa, Fabio Trindade
TI Zika virus: lessons learned in Brazil
SO MICROBES AND INFECTION
LA English
DT Article
DE Zika virus; Epidemics setting; Transmission; Pathogenesis; Arboviruses;
   Brazil
ID NEURAL PROGENITORS; INFECTION; CELLS; AMERICA; BRAIN; TRANSMISSION;
   PATHOGENESIS; ENHANCEMENT; MONOCYTES; GUILLAIN
AB Zika virus (ZIKV) greatly impacted the international scientific and public health communities in the last two years due to its association with microcephaly and other neonatal alterations. This review will discuss lessons learned from viral pathogenesis, epidemiology and clinical findings observed during the ZIKV outbreak occurred between 2014 and 2016 in Brazil. (C) 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Proenca-Modena, Jose Luiz; Milanez, Guilherme Paier] Univ Estadual Campinas, Lab Emerging Viruses, Dept Genet Evolut Microbiol & Immunol, Inst Biol,Unicamp, Campinas, SP, Brazil.
   [Costa, Maria Laura] Univ Estadual Campinas, Obstet & Gynecol Dept, Sch Med Sci, UNICAMP, Campinas, SP, Brazil.
   [Judice, Carla C.; Maranhao Costa, Fabio Trindade] Univ Estadual Campinas, Lab Trop Dis, Dept Genet Evolut Microbiol & Immunol, Inst Biol,Unicamp, Campinas, SP, Brazil.
RP Proenca-Modena, JL (corresponding author), Univ Estadual Campinas, Lab Emerging Viruses, Dept Genet Evolut Microbiol & Immunol, Inst Biol, Rua Monteiro Lobato 255, BR-13083862 Campinas, SP, Brazil.; Costa, FTM (corresponding author), Univ Estadual Campinas, Lab Trop Dis, Dept Genet Evolut Microbiol & Immunol, Inst Biol, Rua Carl Von Linaeus 2-238, BR-13083864 Campinas, SP, Brazil.
EM jlmodena@unicamp.br; costaftm@unicamp.br
RI Modena, Jose Luiz Proenca/C-8231-2014; Costa, Fabio/E-1181-2012;
   Milanez, Guilherme/G-6457-2016; Judice, Carla/P-4738-2014
OI Modena, Jose Luiz Proenca/0000-0002-4996-3153; Costa,
   Fabio/0000-0001-9969-7300; Milanez, Guilherme/0000-0002-8599-1098;
   Judice, Carla/0000-0003-1839-053X
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2016/00194-8]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [440761/2016-6]
FX We thank Ana Carolina Andrade Vitor Kayano for all figures included in
   this review. All studies with arbovirus in Unicamp (University of
   Campinas) were supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (grant 2016/00194-8 and fellowship to J. A. L.); and the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant
   440761/2016-6, including research fellowships to C. C. J., G. P. M, and
   F. T. M. C.).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Assis AMO, 2007, CAD SAUDE PUBLICA, V23, P2337, DOI 10.1590/S0102-311X2007001000009
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Blom K, 2017, J INTERN MED, V282, P206, DOI 10.1111/joim.12638
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2017, ZIK VIR COLL SUBM SP
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   da Silva Voorham JM, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0029957
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guimarães Reinaldo, 2006, Cad. Saúde Pública, V22, P1775, DOI 10.1590/S0102-311X2006000900002
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hunter FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01248
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pan American Health Organization, 2017, ZIK EP REP BRAZ
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 70
TC 7
Z9 7
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2018
VL 20
IS 11-12
BP 661
EP 669
DI 10.1016/j.micinf.2018.02.008
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HC7TC
UT WOS:000452003500003
PM 29501560
DA 2020-07-08
ER

PT J
AU Khongwichit, S
   Wikan, N
   Auewarakul, P
   Smith, DR
AF Khongwichit, Sarawut
   Wikan, Nitwara
   Auewarakul, Prasert
   Smith, Duncan R.
TI Zika virus in Thailand
SO MICROBES AND INFECTION
LA English
DT Article
DE Zika; Thailand; Seroprevalence; History
ID ENHANCEMENT; INFECTION; FLAVIVIRUSES; DENGUE
AB This review examines the historic reports of the presence of Zika virus (ZIKV) in Thailand, as well as collates such information as exists on the current situation in Thailand with regards to ZIKV. We suggest that considerable caution must be applied in interpreting early serological studies, but that ZIKV is presently circulating over much of Thailand, with increasing numbers of cases being reported. (C) 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Khongwichit, Sarawut; Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonthol Sai 4, Phutthamonthon 73170, Nakhon Pathom, Thailand.
   [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, 2 Prannok Rd, Bangkok 10700, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonthol Sai 4, Phutthamonthon 73170, Nakhon Pathom, Thailand.
EM duncan_r_smith@hotmail.com
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU National Science and Technology Development Agency [P-16-50685,
   FDAeCOe2559-1569-TH]; Thailand Research FundThailand Research Fund
   (TRF); Mahidol University [BRG6080006, IRN58W0002]
FX DRS is supported by the National Science and Technology Development
   Agency (P-16-50685 and FDAeCOe2559-1569-TH) and the Thailand Research
   Fund and Mahidol University (BRG6080006 and IRN58W0002). The funders had
   no role in the preparation of this review, nor in the decision to
   publish.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Berge T., 1975, INT CATALOGUE ARBOVI
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CASALS J, 1954, J EXP MED, V99, P429, DOI 10.1084/jem.99.5.429
   CASALS JORDI, 1957, TRANS NEW YORK ACAD SCI, V19, P219
   CDC, 1985, JAP ENC ARB CAT
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   ECDC, 2017, ZIK VIR DIS EP 10 UP
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   King AMQ, 2012, VIRUS TAXONOMY, V9
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LAEMMERT HW, 1947, J IMMUNOL, V55, P61
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022
   Paul JR, 1935, J EXP MED, V62, P245, DOI 10.1084/jem.62.6.827
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   SABIN AB, 1950, P SOC EXP BIOL MED, V74, P222, DOI 10.3181/00379727-74-17861
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   Smithburn KC, 1940, AM J TROP MED HYG  S
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   TAT, 2013, ANN REPORT
   Thipmontree W, 2014, INT J ENV RES PUB HE, V11, P8542, DOI 10.3390/ijerph110808542
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 50
TC 7
Z9 7
U1 3
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2018
VL 20
IS 11-12
BP 670
EP 675
DI 10.1016/j.micinf.2018.01.007
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HC7TC
UT WOS:000452003500004
PM 29477878
DA 2020-07-08
ER

PT J
AU Kudchodkar, SB
   Choi, H
   Reuschel, EL
   Esquivel, R
   Kwon, JJA
   Jeong, M
   Maslow, JN
   Reed, CC
   White, S
   Kim, JJ
   Kobinger, GP
   Tebas, P
   Weiner, DB
   Muthumani, K
AF Kudchodkar, Sagar B.
   Choi, Hyeree
   Reuschel, Emma L.
   Esquivel, Rianne
   Kwon, Jackie Jin-Ah
   Jeong, Moonsup
   Maslow, Joel N.
   Reed, Charles C.
   White, Scott
   Kim, J. Joseph
   Kobinger, Gary P.
   Tebas, Pablo
   Weiner, David B.
   Muthumani, Kar
TI Rapid response to an emerging infectious disease - Lessons learned from
   development of a synthetic DNA vaccine targeting Zika virus
SO MICROBES AND INFECTION
LA English
DT Article
DE Flaviviruses; ZIKV vaccine; Animal models; Immunopathology; DNA
   vaccines; Immunity
ID DENGUE VIRUS; NEUTRALIZING ANTIBODIES; SEXUAL TRANSMISSION;
   CROSS-REACTIVITY; BIRTH-DEFECTS; CELLS; INFANTS; BRAZIL; ENHANCEMENT;
   EMERGENCE
AB Vaccines are considered one of the greatest advances in modern medicine. The global burden of numerous infectious diseases has been significantly reduced, and in some cases, effectively eradicated through the deployment of specific vaccines. However, efforts to develop effective new vaccines against infectious pathogens such as influenza, Human immunodeficiency virus (HIV), dengue virus (DENY), chikungunya virus (CHIKV), Ebola virus, and Zika virus (ZIKV) have proven challenging. Zika virus is a mosquito-vectored flavivirus responsible for periodic outbreaks of disease in Africa, Southeast Asia, and the Pacific Islands dating back over 50 years. Over this period, ZIKV infections were subclinical in most infected individuals and resulted in mild cases of fever, arthralgia, and rash in others. Concerns about ZIKV changed over the past two years, however, as outbreaks in Brazil, Central American countries, and Caribbean islands revealed novel aspects of infection including vertical and sexual transmission modes. Cases have been reported showing dramatic neurological pathologies including microcephaly and other neuro-developmental problems in babies born to ZIKV infected mothers, as well as an increased risk of Guillain-Barre syndrome in adults. These findings prompted the World Health Organization to declare ZIKV a public health emergency in 2016, which resulted in expanded efforts to develop ZIKV vaccines and immunotherapeutics. Several ZIKV vaccine candidates that are immunogenic and effective at blocking ZIKV infection in animal models have since been developed, with some of these now being evaluated in the clinic. Additional therapeutics under investigation include anti-ZIKV monoclonal antibodies (mAbs) that have been shown to neutralize infection in vitro as well as protect against morbidity in mouse models of ZIKV infection. In this review, we summarize the current understanding of ZIKV biology and describe our efforts to rapidly develop a vaccine against ZIKV. (C) 2018 The Author(s). Published by Elsevier Masson SAS on behalf of Institut Pasteur.
C1 [Kudchodkar, Sagar B.; Choi, Hyeree; Reuschel, Emma L.; Esquivel, Rianne; Weiner, David B.; Muthumani, Kar] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Kwon, Jackie Jin-Ah; Jeong, Moonsup; Maslow, Joel N.] GeneOne Life Sci Inc, Blue Bell, PA USA.
   [Reed, Charles C.; White, Scott; Kim, J. Joseph] Inovio Pharmaceut, Plymouth Meeting, PA USA.
   [Kobinger, Gary P.] Univ Laval, Quebec City, PQ, Canada.
   [Tebas, Pablo] Univ Penn, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.
RP Muthumani, K (corresponding author), Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM kmuthumani@wistar.org
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065; Kudchodkar,
   Sagar/0000-0003-1754-6803
FU Wistar Science Discovery Award; Inovio Pharmaceuticals Inc. PA, USA;
   Gene One Life Science Inc. Seoul, Korea; Wistar Institute
FX The authors would like to acknowledge other members of the Weiner
   laboratory for significant contributions and/or critical reading and
   editing of the review. K.M. received support from the Wistar Science
   Discovery Award. KM and DBW also note funding by Inovio Pharmaceuticals
   Inc. PA, USA and Gene One Life Science Inc. Seoul, Korea, through
   scientific research agreements with the Wistar Institute.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dowd K.A., 2016, SCIENCE
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, BIORXIV
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grifoni A, 2017, J VIROL
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu YC, 2017, CHIN CONTR CONF, P7655, DOI 10.23919/ChiCC.2017.8028567
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Organizacion Panamericana de la Salud, 2015, EP AL NEUR SYNDR CON, P1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pulendran B, 2009, NAT REV IMMUNOL
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61
   Shedlock DJ, 2011, VACCINE, V29, P6755, DOI 10.1016/j.vaccine.2010.12.064
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 3 8 RESOLUTION CRYO
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tebas P, 2017, NEW ENGL J MED
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Trimble CL, 2009, CLIN CANCER RES, V15, P361, DOI 10.1158/1078-0432.CCR-08-1725
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
NR 85
TC 6
Z9 6
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2018
VL 20
IS 11-12
BP 676
EP 684
DI 10.1016/j.micinf.2018.03.001
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HC7TC
UT WOS:000452003500005
PM 29555345
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Olmo, RP
   Ferreira, AGA
   Izidoro-Toledo, TC
   Aguiar, ERGR
   de Faria, IS
   de Souza, KPR
   Osorio, KP
   Kuhn, L
   Hammann, P
   de Amadou, EG
   Todjro, YM
   Rocha, MN
   Leite, THJF
   Amadou, SCG
   Armache, JN
   Paro, S
   de Oliveira, CD
   Carvalho, FD
   Moreire, LA
   Marois, E
   Imler, JL
   Marques, JT
AF Olmo, Roenick P.
   Ferreira, Alvaro G. A.
   Izidoro-Toledo, Tatiane C.
   Aguiar, Eric R. G. R.
   de Faria, Isaquel S.
   de Souza, Katia P. R.
   Osorio, Katia P.
   Kuhn, Lauriane
   Hammann, Philippe
   de Amadou, Elisa G.
   Todjro, Yaovi Mathias
   Rocha, Marcele N.
   Leite, Thiago H. J. F.
   Amadou, Siad C. G.
   Armache, Juliana N.
   Paro, Simona
   de Oliveira, Caroline D.
   Carvalho, Fabiano D.
   Moreire, Luciano A.
   Marois, Eric
   Imler, Jean-Luc
   Marques, Joao T.
TI Control of dengue virus in the midgut of Aedes aegypti by ectopic
   expression of the dsRNA-binding protein Loqs2
SO NATURE MICROBIOLOGY
LA English
DT Article
ID RNA INTERFERENCE; ANTIVIRAL IMMUNITY; ANOPHELES-GAMBIAE; DISTINCT ROLES;
   IDENTIFICATION; PATHWAYS; MOSQUITO; RDE-1; GENE
AB Dengue virus (DENV) is an arbovirus transmitted to humans by Aedes mosquitoes'. In the insect vector, the small interfering RNA (siRNA) pathway is an important antiviral mechanism against DENV2-5. However, it remains unclear when and where the siRNA pathway acts during the virus cycle. Here, we show that the siRNA pathway fails to efficiently silence DENV in the midgut of Aedes aegypti although it is essential to restrict systemic replication. Accumulation of DENV-derived siRNAs in the midgut reveals that impaired silencing results from a defect downstream of small RNA biogenesis. Notably, silencing triggered by endogenous and exogenous dsRNAs remained effective in the midgut where known components of the siRNA pathway, including the double-stranded RNA (dsRNA)-binding proteins Loquacious and r2d2, had normal expression levels. We identified an Aedes-specific paralogue of loquacious and r2d2, hereafter named loqs2, which is not expressed in the midgut. Loqs2 interacts with Loquacious and r2d2 and is required to control systemic replication of DENV and also Zika virus. Furthermore, ectopic expression of Loqs2 in the midgut of transgenic mosquitoes is sufficient to restrict DENV replication and dissemination. Together, our data reveal a mechanism of tissue-specific regulation of the mosquito siRNA pathway controlled by Loqs2.
C1 [Olmo, Roenick P.; Ferreira, Alvaro G. A.; Izidoro-Toledo, Tatiane C.; Aguiar, Eric R. G. R.; de Faria, Isaquel S.; de Souza, Katia P. R.; Osorio, Katia P.; de Amadou, Elisa G.; Todjro, Yaovi Mathias; Leite, Thiago H. J. F.; Amadou, Siad C. G.; Armache, Juliana N.; Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Olmo, Roenick P.; de Faria, Isaquel S.; de Amadou, Elisa G.; Paro, Simona; Marois, Eric; Imler, Jean-Luc; Marques, Joao T.] Univ Strasbourg, CNRS, UPR9022, INSERM U1257, Strasbourg, France.
   [Kuhn, Lauriane; Hammann, Philippe] Inst Biol Mol & Cellulaire, Plateforme Prote Strasbourg Esplanade FRC 1589, Strasbourg, France.
   [Rocha, Marcele N.; de Oliveira, Caroline D.; Carvalho, Fabiano D.; Moreire, Luciano A.] Inst Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.; Marques, JT (corresponding author), Univ Strasbourg, CNRS, UPR9022, INSERM U1257, Strasbourg, France.
EM jtm@ufmg.br
RI Ferreira, Alvaro G A/O-3649-2015; Aguiar, Eric/T-5076-2019; Aguiar, Eric
   RGR/L-7989-2018; Olmo, Roenick/AAF-6412-2020; Oliveira,
   Caroline/D-8667-2014; Marques, Joao T/F-7683-2012
OI Aguiar, Eric/0000-0002-8143-5756; Aguiar, Eric RGR/0000-0002-8143-5756;
   Marques, Joao T/0000-0002-3457-3320; Dantas de Oliveira,
   Caroline/0000-0001-5849-6457; Proveti Olmo, Roenick/0000-0002-3849-8591
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Agence
   Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-11-ASV3-002]; Investissement d'Avenir ProgramsFrench National
   Research Agency (ANR) [ANR-10-LABX-36, ANR-11-EQPX-0022]; Inserm, CNRS;
   University of Strasbourg, IdEx Equipement mi-lourd 2015; CAPESCAPES;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX The authors thank C.N.D. dos Santos for providing 4G2 monoclonal
   antibodies. This work was supported with funding from Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) to J.T.M., Agence
   Nationale de la Recherche (ANR-11-ASV3-002) and Investissement d'Avenir
   Programs (ANR-10-LABX-36; ANR-11-EQPX-0022) to J.T.M and J.-L.I., and
   Inserm, CNRS and the University of Strasbourg to E.M. and J.-L.I. Mass
   spectrometry instrumentation was funded by the University of Strasbourg,
   IdEx Equipement mi-lourd 2015 to L.K. and P.H. National and/or
   international fellowships from CAPES were granted to R.P.O., T.C.I.-T.,
   A.G.A.F., E.R.G.R.A., K.P.R.S., K.P.O. and C.D.O., and national and/or
   international fellowships from CNPq were granted to I.J.S.F., L.A.M. and
   J.T.M.
CR Ashe A, 2013, ELIFE, V2, DOI 10.7554/eLife.00994
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chicher J, 2015, PROTEOMICS, V15, P2417, DOI 10.1002/pmic.201400628
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x
   Engler C, 2013, METHODS MOL BIOL, V1073, P141, DOI 10.1007/978-1-62703-625-2_12
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Haac ME, 2015, NUCLEIC ACIDS RES, V43, P3688, DOI 10.1093/nar/gkv152
   Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324
   Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Jasinskiene Nijole, 2007, J Vis Exp, P219, DOI 10.3791/219
   Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   LANFORD RE, 1994, VIROLOGY, V202, P606, DOI 10.1006/viro.1994.1381
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x
   Parrish S, 2001, RNA, V7, P1397
   Pereira TN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25236-8
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sarkies P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002061
   Sedda L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2662-6
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stoetzel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13586
   Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Villalon JM, 2003, J INSECT PHYSIOL, V49, P891, DOI 10.1016/S0022-1910(03)00135-5
   Volohonsky G, 2015, G3-GENES GENOM GENET, V5, P1151, DOI 10.1534/g3.115.016808
NR 48
TC 9
Z9 9
U1 1
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD DEC
PY 2018
VL 3
IS 12
BP 1385
EP 1393
DI 10.1038/s41564-018-0268-6
PG 9
WC Microbiology
SC Microbiology
GA HB7LP
UT WOS:000451259600012
PM 30374169
DA 2020-07-08
ER

PT J
AU Geoghegan, JL
   Holmes, EC
AF Geoghegan, Jemma L.
   Holmes, Edward C.
TI The phylogenomics of evolving virus virulence
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID WEST-NILE-VIRUS; INFLUENZA-VIRUS; ZIKA VIRUS; EBOLA-VIRUS; PARALLEL
   EVOLUTION; IMPERFECT VACCINES; BIOLOGICAL-CONTROL; H5N1 INFLUENZA; LESS
   VIRULENT; MYXOMA VIRUS
AB How virulence evolves after a virus jumps to a new host species is central to disease emergence. Our current understanding of virulence evolution is based on insights drawn from two perspectives that have developed largely independently: long-standing evolutionary theory based on limited real data examples that often lack a genomic basis, and experimental studies of virulence-determining mutations using cell culture or animal models. A more comprehensive understanding of virulence mutations and their evolution can be achieved by bridging the gap between these two research pathways through the phylogenomic analysis of virus genome sequence data as a guide to experimental study.
C1 [Geoghegan, Jemma L.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
RP Holmes, EC (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.; Holmes, EC (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
EM edward.holmes@sydney.edu.au
RI Holmes, Edward/Y-2789-2019
OI Holmes, Edward/0000-0001-9596-3552; Geoghegan, Jemma/0000-0003-0970-0153
FU Australian Research Council Australian Laureate FellowshipAustralian
   Research Council [FL170100022]
FX E.C.H. is funded by an Australian Research Council Australian Laureate
   Fellowship (FL170100022). The authors thank J. Bull for helpful
   discussions.
CR Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x
   Alizon S, 2015, TRENDS ECOL EVOL, V30, P248, DOI 10.1016/j.tree.2015.02.009
   Alizon S, 2011, P ROY SOC B-BIOL SCI, V278, P3738, DOI 10.1098/rspb.2011.0471
   Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123
   Allison AB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004475
   Allocati N, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.48
   ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360
   Andre JB, 2005, EVOLUTION, V59, P1406, DOI 10.1111/j.0014-3820.2005.tb01791.x
   Ansari MA, 2017, NAT GENET, V49, P666, DOI 10.1038/ng.3835
   Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594
   Bae JY, 2018, J VIROL, V92, DOI 10.1128/JVI.00259-18
   Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303
   Balinsky CA, 2007, J VIROL, V81, P11392, DOI 10.1128/JVI.01093-07
   BAUER PH, 1995, J VIROL, V69, P7925, DOI 10.1128/JVI.69.12.7925-7931.1995
   Bedhomme S, 2015, CURR OPIN VIROL, V10, P1, DOI 10.1016/j.coviro.2014.10.006
   Bergstrom CT, 1999, P NATL ACAD SCI USA, V96, P5095, DOI 10.1073/pnas.96.9.5095
   Betancourt M, 2013, EVOL APPL, V6, P875, DOI 10.1111/eva.12073
   Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044
   Blanie S, 2009, VET RES, V40, DOI 10.1051/vetres:2008049
   Blanquart F, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001855
   Blanquart F, 2016, ELIFE, V5, DOI 10.7554/eLife.20492
   Bolker BM, 2010, J R SOC INTERFACE, V7, P811, DOI 10.1098/rsif.2009.0384
   Bourhy H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000839
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005
   Bull JJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004387
   BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carre N, 1997, AIDS, V11, P1611, DOI 10.1097/00002030-199713000-00010
   Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Claiborne DT, 2015, P NATL ACAD SCI USA, V112, pE1480, DOI 10.1073/pnas.1421607112
   Cotter CR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003831
   Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950
   de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102
   Di Giallonardo F, 2016, J VIROL, V90, P862, DOI 10.1128/JVI.02305-15
   Di Giallonardo F, 2015, TRENDS MICROBIOL, V23, P83, DOI 10.1016/j.tim.2014.10.004
   Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014
   DIETZSCHOLD B, 1983, P NATL ACAD SCI-BIOL, V80, P70, DOI 10.1073/pnas.80.1.70
   Dolan PT, 2018, CELL HOST MICROBE, V23, P435, DOI 10.1016/j.chom.2018.03.012
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3
   Ebert D, 1999, EVOLUTION IN HEALTH AND DISEASE, P161
   Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073
   Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636
   EWALD PW, 1994, EVOLUTION INFECT DIS
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791
   Feng KH, 2015, J VIROL, V89, P6860, DOI 10.1128/JVI.00521-15
   FENNER F., 1957, JOUR HYG, V55, P149
   FENNER F, 1983, PROC R SOC SER B-BIO, V218, P259, DOI 10.1098/rspb.1983.0039
   FENNER F, 1965, MYXOMATOSIS
   Firth C, 2013, ANNU REV GENOM HUM G, V14, P281, DOI 10.1146/annurev-genom-091212-153446
   Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104
   Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727
   Frickel J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03990-7
   Furio V, 2012, J VIROL, V86, P12228, DOI 10.1128/JVI.00755-12
   Galai N, 1996, AM J EPIDEMIOL, V143, P278
   Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Garver KA, 2006, J AQUAT ANIM HEALTH, V18, P232, DOI 10.1577/H05-038.1
   Geoghegan JL, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170189
   Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882
   He W, 2018, ARCH VIROL, V163, P1489, DOI 10.1007/s00705-018-3760-7
   Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418
   Holmes E. C., 2016, P BIOL SCI, V283, P1837
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208
   Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105
   Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07
   Jimenez-Guardeno JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004320
   Kamil JP, 2005, J VIROL, V79, P6984, DOI 10.1128/JVI.79.11.6984-6996.2005
   Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181
   Kataoka C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005033
   Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200
   Kerr PJ, 2017, P NATL ACAD SCI USA, V114, P9397, DOI 10.1073/pnas.1710336114
   Kerr PJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006252
   Kerr PJ, 2015, VIRUSES-BASEL, V7, P1020, DOI 10.3390/v7031020
   Kerr PJ, 2013, J VIROL, V87, P12900, DOI 10.1128/JVI.02060-13
   Kerr PJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002950
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304
   LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829
   Lassig M, 2014, ELIFE, V3, DOI 10.7554/eLife.05060
   Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X
   Lighten J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0087
   Lion S, 2018, TRENDS ECOL EVOL, V33, P458, DOI 10.1016/j.tree.2018.02.004
   Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6
   Lipsitch M, 2016, ELIFE, V5, DOI 10.7554/eLife.18491
   Liu J, 2017, J VIROL, V91, DOI 10.1128/JVI.01289-17
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Longdon B, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006951
   Longdon B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004728
   Mackinnon MJ, 2004, PLOS BIOL, V2, P1286, DOI 10.1371/journal.pbio.0020230
   Marshall J, 2018, SCIENCE, V359, P877, DOI 10.1126/science.aar7827
   Marzi A, 2018, CELL REP, V23, P1806, DOI 10.1016/j.celrep.2018.04.027
   McColl KA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0134
   McColl KA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0666-4
   McMahon DP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0811
   Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10
   Monne I, 2014, J VIROL, V88, P4375, DOI 10.1128/JVI.03181-13
   Morley VJ, 2017, EVOLUTION, V71, P872, DOI 10.1111/evo.13193
   Neher RA, 2014, ELIFE, V3, DOI 10.7554/eLife.03568
   Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785
   Nogales A, 2017, J VIROL, V91, DOI 10.1128/JVI.01930-16
   NOVELLA IS, 1995, J VIROL, V69, P2869, DOI 10.1128/JVI.69.5.2869-2872.1995
   Oh DY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00080
   Panzarin V, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey019
   Parrish CR, 2015, J VIROL, V89, P2990, DOI 10.1128/JVI.03146-14
   Pearce MB, 2017, VIROLOGY, V502, P114, DOI 10.1016/j.virol.2016.12.024
   Penaranda MMD, 2009, J GEN VIROL, V90, P2172, DOI 10.1099/vir.0.012286-0
   Power RA, 2017, NAT REV GENET, V18, P41, DOI 10.1038/nrg.2016.132
   Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001
   Qi WB, 2018, J VIROL, V92, DOI 10.1128/JVI.00921-17
   Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198
   Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526
   Sackman AM, 2017, MOL BIOL EVOL, V34, P3243, DOI 10.1093/molbev/msx257
   Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102
   Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275
   Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7
   Shi M, 2018, VIRUS RES, V243, P83, DOI 10.1016/j.virusres.2017.10.016
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smith T, 2002, TRENDS ECOL EVOL, V17, P154, DOI 10.1016/S0169-5347(02)02450-3
   Sofonea MT, 2018, J EVOLUTION BIOL, V31, P382, DOI 10.1111/jeb.13229
   Song HC, 2005, J VIROL, V79, P10289, DOI 10.1128/JVI.79.16.10289-10299.2005
   Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013
   STEWART CB, 1988, NATURE, V332, P788, DOI 10.1038/332788a0
   Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230
   Trimpert J, 2017, EVOL APPL, V10, P1091, DOI 10.1111/eva.12515
   Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021
   Uraki R, 2013, J VIROL, V87, P2226, DOI 10.1128/JVI.01565-12
   Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013
   Vanhems P, 1999, J INFECT DIS, V180, P1803, DOI 10.1086/315110
   Walter S, 2017, J VIROL, V91, DOI [10.1128/JVI.01711-16, 10.1128/jvi.01711-16]
   Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335
   Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350
   Willemsen A, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0881-7
   Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11
   Yang L., 2017, J VIROL, V91
   Yu X., 2017, SCI REP, V7
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 156
TC 11
Z9 11
U1 13
U2 53
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD DEC
PY 2018
VL 19
IS 12
BP 756
EP 769
DI 10.1038/s41576-018-0055-5
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA HA7UG
UT WOS:000450489300007
PM 30305704
OA Green Published
DA 2020-07-08
ER

PT J
AU Ho, CY
   Castillo, N
   Encinales, L
   Porras, A
   Mendoza, AR
   Lynch, R
   Nemirovsky, A
   Mantus, G
   DeBiasi, RL
   Bethony, JM
   Simon, GL
   Chang, AY
AF Ho, Cheng-Ying
   Castillo, Nicolas
   Encinales, Liliana
   Porras, Alexandra
   Rico Mendoza, Alejandro
   Lynch, Rebecca
   Nemirovsky, Amy
   Mantus, Grace
   DeBiasi, Roberta L.
   Bethony, Jeffrey M.
   Simon, Gary L.
   Chang, Aileen Y.
TI Second-trimester Ultrasound and Neuropathologic Findings in Congenital
   Zika Virus Infection
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE Zika; microcephaly; fetal brain anomalies; congenital infection;
   neuronal apoptosis
ID BIRTH-DEFECTS; AMERICA; INFANTS; WOMEN
AB Zika virus is a mosquito-borne virus that causes congenital Zika syndrome, characterized by microcephaly and other fetal brain anomalies. This case report presents a case of Zika virus-related fetal brain anomalies including pathologic evidence of cerebral neuronal apoptosis and macrophage infiltrates and intracerebral calcification, ventriculomegaly and corpus callosum dysgenesis detected by ultrasound at 18 weeks of pregnancy.
C1 [Ho, Cheng-Ying; Nemirovsky, Amy] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   [Castillo, Nicolas] Allied Res Soc LLC, Dept Maternal Fetal Hlth, Baranquilla, Atlantico, Colombia.
   [Encinales, Liliana] Allied Res Soc LLC, Dept Med, Baranquilla, Atlantico, Colombia.
   [Porras, Alexandra; Rico Mendoza, Alejandro] Univ El Bosque, Grp Med Comunitaria, Bogota, Colombia.
   [Lynch, Rebecca; Mantus, Grace; Bethony, Jeffrey M.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
   [DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Div Pediat Infect Dis, Washington, DC USA.
   [DeBiasi, Roberta L.] George Washington Univ, Dept Pediat, Washington, DC 20052 USA.
   [DeBiasi, Roberta L.; Simon, Gary L.; Chang, Aileen Y.] George Washington Univ, Dept Med, Washington, DC USA.
RP Chang, AY (corresponding author), George Washington Univ, 2150 Penn Ave 5-416, Washington, DC 20037 USA.
EM chang@email.gwu.edu
RI Ho, Cheng-Ying/AAA-5098-2019
OI Chang, Aileen/0000-0001-7410-9867; Porras-Ramirez,
   Alexandra/0000-0002-0800-1388
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19 AI131130]; NIH
   National Center for Advancing Translational Sciences [UL1TR001876,
   KL2TR001877]
FX Supported by the National Institutes of Health U19 AI131130 (awarded to
   C.Y.H.) and UL1TR001876 and KL2TR001877 from the NIH National Center for
   Advancing Translational Sciences (awarded to A.Y.C.). Its contents are
   solely the responsibility of the authors and do not necessary represent
   the official views of the National Center for Advancing Translational
   Science or the National Institute of Health. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   COLLUCCI C, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I6716
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miranda Rajesh C., 2012, Frontiers in Genetics, V3, P77, DOI 10.3389/fgene.2012.00077
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 21
TC 0
Z9 0
U1 0
U2 52
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD DEC
PY 2018
VL 37
IS 12
BP 1290
EP 1293
DI 10.1097/INF.0000000000002080
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA HB0VF
UT WOS:000450735800037
PM 30408008
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Brossard, D
   Jamieson, KH
   Hallman, W
AF Brossard, Dominique
   Jamieson, Kathleen Hall
   Hallman, William
TI Introduction to Special Series: Communicating About Zika
SO RISK ANALYSIS
LA English
DT Editorial Material
ID VIRUS
CR Branswell H., 2016, ZIKA CARRYING MOSQUI
   Centers for Disease Control and Prevention, 2018, PREGN WOM AN LAB EV
   Centers for Disease Control and Prevention (CDC), 2016, ZIK COMM EFF
   Centers for Disease Control and Prevention (CDC), 2018, ZIK BAB US TERR
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   McNeil Jr Donald G., 2016, NY TIMES
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Seipel T., 2016, MERCURY NEWS    0306
   Sternberg S., 2016, US NEWS WORLD REPORT
   Sun L., 2016, WASHINGTON POST
NR 11
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2504
EP 2506
DI 10.1111/risa.13242
PG 3
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700002
PM 30537244
DA 2020-07-08
ER

PT J
AU Allen, MP
AF Allen, Marin Pearson
TI Chronicling the Risk and Risk Communication by Governmental Officials
   During the Zika Threat
SO RISK ANALYSIS
LA English
DT Editorial Material
DE Collaborations; communication; risk; Zika
ID UNITED-STATES; VIRUS; IMMUNOGENICITY; TRANSMISSION; PHASE-1; SAFETY
AB The unique circumstances surrounding Zika, including the fact that it is both mosquito-borne and sexually transmissible, brought to the fore concerns about optimal ways to communicate risk in an environment characterized by rapidly evolving knowledge. The difficulty in doing so is magnified by the fact that science-based health messages from governmental agencies must be developed in an evidence-based, audience-participative, and collaborative manner. A recent reminder in JAMA asserted the importance of preparing now for future threats. Understanding how the knowledge and messaging about Zika changed across time should help public health officials prepare for such challenges.
C1 [Allen, Marin Pearson] 5807 Johnson Court, Bethesda, MD 20817 USA.
RP Allen, MP (corresponding author), 5807 Johnson Court, Bethesda, MD 20817 USA.
EM marinpallen@gmail.com
CR Adebayo G., 2017, BMJ GLOBAL HLTH, V2, P1
   [Anonymous], 2016, GOV SCOTT MOSQ BORN
   Boadle Anthony, 2017, REUTERS
   Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567
   Brucculieri J., 2017, HUFFINGTON POST
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) & Division of Vector Borne Diseases (DVBD), 2018, INF AER SPRAYING
   Centers for Disease Control and Prevention (CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) & Division of Vector Borne Diseases (DVBD), 2018, ADV PEOPL LIV TRAV S
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Fauci A. S., 2016, SCI HLTH PUBLIC 0511
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Funk C, 2017, VAST MAJORITY AM SAY
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Iannelli J., 2016, MIAMI NEW TIMES 0810
   Kahan D. M., 2012, HDB RISK THEORY EPIS, P725, DOI [DOI 10.1007/978-94-007-1433-5_28, 10.1007/978-94-007-1433-5_28]
   Marques ETA, 2018, LANCET, V391, P516, DOI 10.1016/S0140-6736(17)33107-0
   McNeil D. G., 2017, NY TIMES
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   National Institutes of Health (NIH) & National Institute of Allergy and Infectious Diseases (NIAID), 2017, NIAID IS ADDR ZIK VI
   NBC, 2016, COMMUNICATION
   *NIH, 2002, MAK HLTH COMM PROGR
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization (PAHO) & World Health Organization (WHO), 2016, PAHO AIMS FAST DIAGN
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rich K, 2016, VARIETY         0327
   Sanchez R., 2016, CNN             0909
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Spears M., 2016, ZIKA AERIAL SPRAYING
   Thorpe Vanessa, 2016, GUARDIAN
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 36
TC 1
Z9 1
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2507
EP 2513
DI 10.1111/risa.13232
PG 7
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700003
PM 30419154
OA Bronze
DA 2020-07-08
ER

PT J
AU Sell, TK
   Watson, C
   Meyer, D
   Kronk, M
   Ravi, S
   Pechta, LE
   Lubell, KM
   Rose, DA
AF Sell, Tara Kirk
   Watson, Crystal
   Meyer, Diane
   Kronk, Marissa
   Ravi, Sanjana
   Pechta, Laura E.
   Lubell, Keri M.
   Rose, Dale A.
TI Frequency of Risk-Related News Media Messages in 2016 Coverage of Zika
   Virus
SO RISK ANALYSIS
LA English
DT Article
DE Communication; news media; risk perception; Zika
ID SOCIAL AMPLIFICATION; PERCEPTION; AGREEMENT
AB News media plays a large role in the information the public receives during an infectious disease outbreak, and may influence public knowledge and perceptions of risk. This study analyzed and described the content of U.S. news media coverage of Zika virus and Zika response during 2016. A random selection of 800 Zika-related news stories from 25 print and television news sources was analyzed. The study examined 24 different messages that appeared in news media articles and characterized them using theories of risk perception as messages with characteristics that could increase perception of risk (risk-elevating messages; n = 14), messages that could decrease perception of risk (risk-minimizing messages; n = 8), or messages about travel or testing guidance (n = 2). Overall, 96% of news stories in the study sample contained at least one or more risk-elevating message(s) and 61% contained risk-minimizing message(s). The frequency of many messages changed after local transmission was confirmed in Florida, and differed between sources in locations with or without local transmission in 2016. Forty percent of news stories included messages about negative potential outcomes of Zika virus infection without mentioning ways to reduce risk. Findings from this study may help inform current federal, state, and local Zika responses by offering a detailed analysis of how news media are covering the outbreak and response activities as well as identifying specific messages appearing more or less frequently than intended. Findings identifying the types of messages that require greater emphasis may also assist public health communicators in responding more effectively to future outbreaks.
C1 [Sell, Tara Kirk; Watson, Crystal; Meyer, Diane; Kronk, Marissa; Ravi, Sanjana] Johns Hopkins Ctr Hlth Secur, 621 East Pratt St,Suite 210, Baltimore, MD 21202 USA.
   [Sell, Tara Kirk; Watson, Crystal; Meyer, Diane; Kronk, Marissa; Ravi, Sanjana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA.
   [Pechta, Laura E.; Lubell, Keri M.; Rose, Dale A.] Ctr Dis Control & Prevent, Div Emergency Operat, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
RP Sell, TK (corresponding author), Johns Hopkins Ctr Hlth Secur, 621 East Pratt St,Suite 210, Baltimore, MD 21202 USA.
EM tksell@jhu.edu
RI Rose, Dale A/P-2721-2018
OI Rose, Dale A/0000-0002-0943-6121
FU Centers for Disease Control and Prevention (CDC)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention - USA
FX The research was funded under a contract with the Centers for Disease
   Control and Prevention (CDC). The findings and conclusions in this
   report are those of the authors and do not necessarily represent the
   official position of the Centers for Disease Control and Prevention.
CR Bakir V, 2005, J RISK RES, V8, P679, DOI 10.1080/13669870500166898
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65
   Callaghan K, 2001, POLIT COMMUN, V18, P183, DOI 10.1080/105846001750322970
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2014, ZIK SYMPT
   CDC, 2014, ZIK VIR
   Centers for Disease Control and Prevention, 2014, CRIS EM RISK COMM
   Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054
   de Vreese CH, 2006, ACTA POLIT, V41, P317, DOI 10.1057/palgrave.ap.5500164
   FISCHHOFF B, 1993, ANNU REV PUBL HEALTH, V14, P183, DOI 10.1146/annurev.pu.14.050193.001151
   Fischhoff Baruch, 2003, Biosecur Bioterror, V1, P255, DOI 10.1089/153871303771861450
   Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062
   Frisby BN, 2014, HEALTH COMMUN, V29, P347, DOI 10.1080/10410236.2012.755604
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Krippendorff K, 2004, CONTENT ANAL INTRO I
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x
   MAZUR A, 1984, MINERVA, V22, P45, DOI 10.1007/BF02207556
   MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Renn O., 1991, COMMUNICATING RISKS, V4, P287, DOI DOI 10.1007/978-94-009-1952-5
   Reynolds MR, 2016, MMWR-MORBID MORTAL W, V66
   Rossmann C, 2018, RISK ANAL, V38, P357, DOI 10.1111/risa.12841
   Scheufele DA, 2007, J COMMUN, V57, P9, DOI 10.1111/j.1460-2466.2006.00326.x
   Sell TK, 2017, EMERG INFECT DIS, V23, P108, DOI 10.3201/eid2301.160589
   Sellnow DD, 2015, J CONTING CRISIS MAN, V23, P149, DOI 10.1111/1468-5973.12066
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Viera AJ, 2005, FAM MED, V37, P360
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   WILKINS L, 1987, J COMMUN, V37, P80, DOI 10.1111/j.1460-2466.1987.tb00996.x
NR 31
TC 6
Z9 6
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2514
EP 2524
DI 10.1111/risa.12961
PG 11
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700004
PM 29314118
OA Bronze
DA 2020-07-08
ER

PT J
AU Lu, H
   Schuldt, JP
AF Lu, Hang
   Schuldt, Jonathon P.
TI Communicating Zika Risk: Using Metaphor to Increase Perceived Risk
   Susceptibility
SO RISK ANALYSIS
LA English
DT Article
DE Affect; communication; metaphor; risk perception; Zika
ID METAANALYSIS; TWITTER; FEAR
AB Effectively communicating the risks associated with emerging zoonotic diseases remains an important challenge. Drawing on research into the psychological effects of metaphoric framing, we explore the conditions under which exposure to the "nation as a body" metaphor influences perceived risk susceptibility, behavioral intentions, and policy support in the context of Zika virus. In a between-subjects experiment, 354 U.S. adults were randomly assigned to one of four experimental conditions as part of a 2 (severity message: high vs. low) x 2 (U.S. framing: metaphoric vs. literal) design. Results revealed an interaction effect such that metaphoric (vs. literal) framing increased perceived risk susceptibility in the high-severity condition only. Further analyses revealed that perceived risk susceptibility and negative affect mediated the path between the two-way interaction and policy support and behavioral intentions regarding Zika prevention. Overall, these findings complement prior work on the influence of metaphoric framing on risk perceptions, while offering practical insights for risk communicators seeking to communicate about Zika and other zoonotic diseases.
C1 [Lu, Hang; Schuldt, Jonathon P.] Cornell Univ, Dept Commun, Ithaca, NY 14853 USA.
RP Lu, H (corresponding author), Cornell Univ, Dept Commun, Ithaca, NY 14853 USA.
EM hl896@cornell.edu
CR Barry CL, 2009, MILBANK Q, V87, P7, DOI 10.1111/j.1468-0009.2009.00546.x
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Center for Disease and Control and Prevention, 2017, SYMPT
   Center for Disease Control and Prevention, 2017, PREV MOSQ BIT
   Centers for Disease Control and Prevention, 2017, 2017 CAS COUNTS US
   Chavez Leo R., 2013, LATINO THREAT CONSTR
   Clarke C., 2009, Human Dimensions of Wildlife, V14, P314, DOI 10.1080/10871200903096155
   CUMMINGS KM, 1978, HEALTH EDUC QUART, V6, P394, DOI 10.1177/109019818700600406
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Gibbs R. W., 1994, POETICS MIND FIGURAT
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Hauser DJ, 2015, PERS SOC PSYCHOL B, V41, P66, DOI 10.1177/0146167214557006
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Henry J, 2016, KAISER HLTH TRACKING
   Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553
   Janssen E, 2011, BRIT J HEALTH PSYCH, V16, P92, DOI 10.1348/135910710X514120
   Jia LL, 2013, J EXP SOC PSYCHOL, V49, P492, DOI 10.1016/j.jesp.2013.01.009
   Johnson BB, 2017, J RISK RES, V20, P1338, DOI 10.1080/13669877.2016.1153507
   Johnson BB, 2015, HEALTH RISK SOC, V17, P458, DOI 10.1080/13698575.2015.1113237
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lakoff G, 1980, METAPHORS WE LIVE BY
   Landau MJ, 2014, SOC PERSONAL PSYCHOL, V8, P463, DOI 10.1111/spc3.12125
   Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970
   Landau MJ, 2009, PSYCHOL SCI, V20, P1421, DOI 10.1111/j.1467-9280.2009.02462.x
   Lee SWS, 2014, J EXP SOC PSYCHOL, V54, P61, DOI 10.1016/j.jesp.2014.04.007
   Lehnert JD, 2017, J PUBLIC HEALTH MAN, V23, P608, DOI 10.1097/PHH.0000000000000537
   Leventhal H., 1970, ADV EXPT SOCIAL PSYC, V5, P119, DOI DOI 10.1016/S0065-2601(08)60091-X
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   March of Dimes, 2016, ZIK VIR GAPS AM KNOW
   McComas KA, 2006, J HEALTH COMMUN, V11, P75, DOI 10.1080/10810730500461091
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Rogers RW, 1983, SOCIAL PSYCHOPHYSIOL, P1, DOI DOI 10.1002/9780470479216.CORPSY0897
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Santa Ana O, 1999, DISCOURSE SOC, V10, P191
   Santa Ana O, 2002, BROWN TIDE RISING ME
   Schmidt S, 2015, J ADVERTISING, V44, P415, DOI 10.1080/00913367.2015.1018460
   Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x
   Sopory P, 2002, HUM COMMUN RES, V28, P382, DOI 10.1111/j.1468-2958.2002.tb00813.x
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Steen GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113536
   Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729
   Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   World Health Organization, 2016, ZIK VIR
   Yang JZ, J RISK RES
NR 45
TC 1
Z9 1
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2525
EP 2534
DI 10.1111/risa.12982
PG 10
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700005
PM 29486059
OA Bronze
DA 2020-07-08
ER

PT J
AU Yang, C
   Dillard, JP
   Li, RB
AF Yang, Chun
   Dillard, James Price
   Li, Ruobing
TI Understanding Fear of Zika: Personal, Interpersonal, and Media
   Influences
SO RISK ANALYSIS
LA English
DT Article
DE Fear; infectious disease; interpersonal; media; risk; Zika
ID EMOTIONS; HEALTH; RISK; COMMUNICATION; PERCEPTIONS; PERSUASION;
   RESISTANCE; RESPONSES; EXPOSURE; ATTACKS
AB Fear of infectious disease often motivates people to protect themselves. But, it can also produce negative bio-social-psychological effects whose severity is on par with those of the disease. The WHO declaration of Zika as a world health crisis presented an opportunity to study factors that bring about fear. Beginning nine days after the WHO announcement, data were gathered from women aged 18-35 living in the southern United States (N = 719). Respondents reported experiencing fear of Zika at levels akin to those reported following other significant crises/disasters (e.g., the terrorist attacks of 9/11). Fear increased as a function of (1) personal, but not other-relevance, (2) frequency of media exposure, but not media content, and (3) frequency of interpersonal exposure and interpersonal content. It is argued that media and interpersonal message sources may be innately predisposed to amplify, rather than attenuate, risk.
C1 [Yang, Chun; Li, Ruobing] Louisiana State Univ, Manship Sch Mass Commun, Baton Rouge, LA 70803 USA.
   [Dillard, James Price] Penn State Univ, Dept Commun Arts & Sci, State Coll, PA USA.
RP Yang, C (corresponding author), Louisiana State Univ, Manship Sch Mass Commun, Baton Rouge, LA 70803 USA.
EM cyang10@lsu.edu
OI Dillard, James/0000-0001-8109-1562
FU Department of Communication Arts & Sciences, Pennsylvania State
   University
FX This research was supported by a Faculty Research Grant from the
   Department of Communication Arts & Sciences, Pennsylvania State
   University.
CR Altheide David L., 2002, CREATING FEAR NEWS C
   Alvarez Lizette, 2016, NY TIMES
   Anderson JR, 1983, ARCHITECTURE COGNITI
   Barrett R, 2008, J INFECT DIS, V197, pS34, DOI 10.1086/524986
   Baumeister RF, 2007, PERS SOC PSYCHOL REV, V11, P167, DOI 10.1177/1088868307301033
   Binder AR, 2011, RISK ANAL, V31, P324, DOI 10.1111/j.1539-6924.2010.01516.x
   Blumberg SJ, 2000, HEALTH EDUC BEHAV, V27, P780, DOI 10.1177/109019810002700611
   BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305
   Caro Tim, 2005, pXIII
   Claes de Vreese HB, 2003, COMMUNICATIONS, V28, P361, DOI [10.1515/comm. 2003.024, DOI 10.1515/COMM.2003.024]
   COLEMAN CL, 1993, COMMUN RES, V20, P611, DOI 10.1177/009365093020004006
   Compton J., 2013, SAGE HDB PERSUASION, V2, P220, DOI DOI 10.4135/9781452218410
   Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811
   Damme W, 2000, TROP MED INT HEALTH, V5, P511
   De Vreese CH, 2006, JCMS-J COMMON MARK S, V44, P419, DOI 10.1111/j.1468-5965.2006.00629.x
   Dillard J. P., 2006, HDB RES ELECT SURVEY, P330
   Dillard JP, 2016, ANN M NAT COMM ASS N
   DOSHER BA, 1989, J EXP PSYCHOL GEN, V118, P191, DOI 10.1037/0096-3445.118.2.191
   Dunlop SM, 2010, COMMUN MONOGR, V77, P518, DOI 10.1080/03637751.2010.502537
   Frijda N. H., 1986, EMOTIONS
   Greco P, J SCI COMMUNICATION, V4, P1
   Greenwald A. G., 1968, PSYCHOL FDN ATTITUDE, P147, DOI DOI 10.1016/B978-1-4832-3071-9.50012-X
   Hendriks H, 2014, J HEALTH COMMUN, V19, P625, DOI 10.1080/10810730.2013.837552
   Hill AL, 2010, P ROY SOC B-BIOL SCI, V277, P3827, DOI 10.1098/rspb.2010.1217
   Ivanov B, 2012, J COMMUN, V62, P701, DOI 10.1111/j.1460-2466.2012.01658.x
   Kasperson J., 2003, SOCIAL AMPLIFICATION, P13, DOI DOI 10.1017/CBO9780511550461
   Kim HK, 2013, J PUBLIC RELAT RES, V25, P30, DOI 10.1080/1062726X.2013.739100
   Kubzansky LD, 2000, J PSYCHOSOM RES, V48, P323, DOI 10.1016/S0022-3999(99)00091-4
   Kubzansky LD, 1997, CIRCULATION, V95, P818
   Lancet, 2005, LANCET, V366, P1751
   Lazarus R.S, 1994, EMOTION ADAPTATION
   Lederman SA, 2004, ENVIRON HEALTH PERSP, V112, P1772, DOI 10.1289/ehp.7348
   Lewis RE, 2009, RISK ANAL, V29, P714, DOI 10.1111/j.1539-6924.2008.01188.x
   LOGAN GD, 1990, COGNITIVE PSYCHOL, V22, P1, DOI 10.1016/0010-0285(90)90002-L
   McDonnell WM, 2012, AM J EMERG MED, V30, P275, DOI 10.1016/j.ajem.2010.11.027
   MCGUIRE WJ, 1964, ADV EXP SOC PSYCHOL, V1, P191, DOI 10.1016/S0065-2601(08)60052-0
   McNeil Jr Donald G., 2016, NY TIMES
   Meyers RA, 1998, COMMUN MONOGR, V65, P261, DOI 10.1080/03637759809376454
   MORGAN M, 1997, COMMUNICATION YB, V20, P1, DOI DOI 10.1080/23808985.1997.11678937
   Morton TA, 2001, COMMUN RES, V28, P602, DOI 10.1177/009365001028005002
   NABI RL, 2009, SAGE HDB MEDIA PROCE
   Nelissen S, 2014, J CANCER EDUC, V30, P68
   Nellis AM, 2012, CRIME DELINQUENCY, V58, P748, DOI 10.1177/0011128712452961
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PETTY RE, 1990, PSYCHOL BULL, V107, P367, DOI 10.1037/0033-2909.107.3.367
   Prager F, 2017, RISK ANAL, V37, P4, DOI 10.1111/risa.12625
   Rojas R., 2016, NY TIMES
   Romero S, 2016, NY TIMES
   Scherer K.R., 2001, APPRAISAL PROCESSES, P92, DOI DOI 10.1016/J.PHYSBEH.2006.11.008
   Segerstrom SC, 1998, J BEHAV MED, V21, P433, DOI 10.1023/A:1018732309353
   Shavit T, 2013, J ENVIRON PSYCHOL, V36, P129, DOI 10.1016/j.jenvp.2013.07.018
   Shrum LJ, 2008, MEDIA EFFECTS ADV TH, P69
   Shultz JM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0741-y
   Silver RC, 2013, PSYCHOL SCI, V24, P1623, DOI 10.1177/0956797612460406
   Skitka LJ, 2004, PERS SOC PSYCHOL B, V30, P743, DOI 10.1177/0146167204263968
   Smits L, 2006, J PSYCHOSOM RES, V61, P715, DOI 10.1016/j.jpsychores.2006.04.020
   Steimer Thierry, 2002, Dialogues Clin Neurosci, V4, P231
   Tavernise S, 2016, NY TIMES
   Trumbo CW, 1996, RISK ANAL, V16, P429, DOI 10.1111/j.1539-6924.1996.tb01477.x
   Valentino NA, 2008, POLIT PSYCHOL, V29, P247, DOI 10.1111/j.1467-9221.2008.00625.x
   Warr M, 2000, AM J SOCIOL, V106, P551, DOI 10.1086/318964
   Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077
NR 62
TC 4
Z9 4
U1 5
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2535
EP 2545
DI 10.1111/risa.12973
PG 11
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700006
PM 29392760
OA Bronze
DA 2020-07-08
ER

PT J
AU Winneg, KM
   Stryker, JE
   Romer, D
   Jamieson, KH
AF Winneg, Kenneth M.
   Stryker, Jo Ellen
   Romer, Daniel
   Jamieson, Kathleen Hall
TI Differences Between Florida and the Rest of the United States in
   Response to Local Transmission of the Zika Virus: Implications for
   Future Communication Campaigns
SO RISK ANALYSIS
LA English
DT Article
DE Attitudes; behaviors; community response; knowledge; perception of risk;
   Zika virus
ID SEXUAL TRANSMISSION; BORNE TRANSMISSION; NONRESPONSE
AB For those at risk for Zika virus infection, prevention requires an approach that includes individual, interpersonal, and community-level support for behavior change. In August 2016, the announcement of local Zika transmission in Florida provided an opportunity to determine whether Zika-related knowledge, attitudes, and behaviors might be affected differentially in Florida compared to the rest of the nation. From August 8-October 3, 2016, we conducted nationally representative weekly surveys (N = 12,236), oversampling Florida residents, measuring Zika virus news exposure, knowledge about transmission and prevention of the infection, and attitudes and behaviors toward prevention. We tested two classes of models: those focused on individual Zika risk perceptions (e.g., protection motivation theory) and one focused on community action beyond those directly at risk (social consensus model). Analyses assessed differences between Florida and the rest of the nation by survey week. Consistent with both models, Floridians demonstrated significantly higher levels of perceived susceptibility and knowledge, more positive attitudes toward Zika virus prevention, and higher likelihood of engaging in protective behavior than non-Floridians. Consistent with theories of individual risk perception, response was greater among respondents who saw themselves at risk of infection. However, consistent with the SCM, irrespective of personal risk, response was greater among Floridians. Nevertheless, more than half of the public took no direct action to prevent the spread of Zika. Communities at increased risk for a novel infection such as Zika may quickly acquire Zika-related knowledge, attitudes, and behavior, but large-scale community-wide response might be difficult without further community-level public education.
C1 [Winneg, Kenneth M.; Romer, Daniel; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
   [Stryker, Jo Ellen] US Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Winneg, KM (corresponding author), Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
EM ken.winneg@appc.upenn.edu
FU Science of Science Communication endowment of the Annenberg Public
   Policy Center of the University of Pennsylvania
FX This work was supported by the Science of Science Communication
   endowment of the Annenberg Public Policy Center of the University of
   Pennsylvania. The endowment was established by the Annenberg Foundation.
CR [Anonymous], 2016, COMMUNICATION
   Centers for Disease Control and Prevention, 2016, CDC ISS INT TRAV GUI
   Coto D., 2016, PUERTO RICO REJECTS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033
   Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035
   Kelly BJ, 2016, HEALTH COMMUN, V31, P1284, DOI 10.1080/10410236.2015.1062976
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Monaghan AJ, 2016, PLOS CURRENTS
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pew Research Center, 2012, ASSESSING REPRESENTA
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Rogers RW, 1983, SOCIAL PSYCHOPHYSIOL, P1, DOI DOI 10.1002/9780470479216.CORPSY0897
   ROMER D, 1992, AIDS CARE, V4, P285, DOI 10.1080/09540129208253100
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Strecher V. J., 1997, HLTH BEHAV HLTH ED T, P41
   Visser P. S., 2000, HDB RES METHODS SOCI
   WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132
NR 22
TC 6
Z9 6
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2546
EP 2560
DI 10.1111/risa.13010
PG 15
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700007
PM 29738625
OA Bronze
DA 2020-07-08
ER

PT J
AU Johnson, BB
AF Johnson, Branden B.
TI Residential Location and Psychological Distance in Americans' Risk Views
   and Behavioral Intentions Regarding Zika Virus
SO RISK ANALYSIS
LA English
DT Article
DE Distance; location; protective behavior; psychological distance; risk
   communication; risk perception; Zika
ID SELF-GENERATED VALIDITY; CLIMATE-CHANGE; NORTHEAST ENGLAND;
   AIR-POLLUTION; MENTAL MODELS; MAP FEATURES; PERCEPTIONS; PROXIMITY;
   NUCLEAR; COMMUNICATION
AB Two 2017 experiments with a U.S. national opportunity sample tested effects of location, psychological distance (PD), and exposure to location-related information on Americans' Zika risk views and behavioral intentions. Location-distance from mosquito transmission of the virus in Florida and Texas; residence within states with 100+ Zika infections; residence within potential mosquito vector ranges-had small, inconsistent effects. Hazard proximity weakly enhanced personal risk judgments and concern about Zika transmission locally. It also increased psychological proximity, and intentions of mosquito control, avoiding travel to Zika-infected areas, and practicing safe sex. PD-particularly social and geographical distance, followed by temporal distance, with few effects for uncertainty-modestly and inconsistently decreased risk views and intentions. Exposure to location-related information from the U.S. Centers for Disease Control and Prevention website-naming states with 100+ Zika cases; maps of potential mosquito vector habitat-increased risk views and psychological closeness, but not intentions; maps had slightly stronger if inconsistent effects versus prevalence information. Structural equation modeling (SEM) of a location > PD > risk views > intention path explained modest variance in intentions. This varied in degree and kind (e.g., which location measures were significant) across behaviors, and between pre- and postinformation exposure analyses. These results suggest need for both theoretical and measurement advances regarding effects of location and PD on risk views and behavior. PD mediates location effects on risk views. Online background information, like that used here, will not enhance protective behavior without explicitly focused communication and perhaps higher objective risk.
C1 [Johnson, Branden B.] Decis Res, 1201 Oak St,Ste 200, Eugene, OR 97401 USA.
RP Johnson, BB (corresponding author), Decis Res, 1201 Oak St,Ste 200, Eugene, OR 97401 USA.
EM branden@decisionresearch.org
OI Johnson, Branden/0000-0003-2264-5419
FU U.S. National Science FoundationNational Science Foundation (NSF)
   [1644853]
FX Marcus Mayorga supervised data collection and conducted the SEM
   analyses. This material is based on work supported by the U.S. National
   Science Foundation under Grant No. 1644853.
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Arlikatti S, 2006, ENVIRON BEHAV, V38, P226, DOI 10.1177/0013916505277603
   Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939
   Baxter J, 2005, CAN GEOGR-GEOGR CAN, V49, P61, DOI 10.1111/j.0008-3658.2005.00080.x
   Bickerstaff K, 2001, GLOBAL ENVIRON CHANG, V11, P133, DOI 10.1016/S0959-3780(00)00063-7
   BOSTROM A, 1994, RISK ANAL, V14, P789, DOI 10.1111/j.1539-6924.1994.tb00290.x
   BOSTROM A, 1992, J SOC ISSUES, V48, P85, DOI 10.1111/j.1540-4560.1992.tb01946.x
   Bostrom A, 2008, ANN NY ACAD SCI, V1128, P29, DOI 10.1196/annals.1399.005
   Botzen WJW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR007743
   Brody SD, 2008, ENVIRON BEHAV, V40, P72, DOI 10.1177/0013916506298800
   Brugger A, 2015, NAT CLIM CHANGE, V5, P1031, DOI 10.1038/NCLIMATE2760
   Carlton JS, 2013, J ENVIRON MANAGE, V130, P32, DOI 10.1016/j.jenvman.2013.08.038
   Chandon P, 2005, J MARKETING, V69, P1, DOI 10.1509/jmkg.69.2.1.60755
   Colblinder, 2018, COL BLINDN LEARN ALL
   COTE JA, 1989, ADV CONSUM RES, V16, P105
   Dransch D, 2010, INT J DIGIT EARTH, V3, P292, DOI 10.1080/17538941003774668
   EASTERLING D, 1995, DILEMMA SITING HIGH
   Elliott SJ, 1999, RISK ANAL, V19, P621, DOI 10.1023/A:1007029518897
   Eranen L, 1997, PATIENT EDUC COUNS, V30, P83, DOI 10.1016/S0738-3991(96)00959-7
   FELDMAN JM, 1988, J APPL PSYCHOL, V73, P421, DOI 10.1037/0021-9010.73.3.421
   Frewer LJ, 2002, PUBLIC UNDERST SCI, V11, P363, DOI 10.1088/0963-6625/11/4/304
   Frye C., 2001, ARCUSER, V2001, P38
   Gallagher L, 2008, J ENVIRON PLANN MAN, V51, P233, DOI 10.1080/09640560701864878
   Gawande K, 2001, J ENVIRON ECON MANAG, V42, P207, DOI 10.1006/jeem.2000.1155
   Giordano A, 2010, ENVIRON HAZARDS-UK, V9, P167, DOI 10.3763/ehaz.2010.0031
   Golledge RG, 2002, ANN ASSOC AM GEOGR, V92, P1, DOI 10.1111/1467-8306.00276
   Hagemeier-Klose M, 2009, NAT HAZARD EARTH SYS, V9, P563, DOI 10.5194/nhess-9-563-2009
   Haynes K, 2007, B VOLCANOL, V70, P123, DOI 10.1007/s00445-007-0124-7
   Howel D, 2002, RISK ANAL, V22, P121, DOI 10.1111/0272-4332.t01-1-00010
   INHABER H, 1991, J AIR WASTE MANAGE, V41, P808, DOI 10.1080/10473289.1991.10466877
   Johnson BB, 1993, RISK ISSUES HLTH SAF, V4, P189
   Johnson BB, 2017, J RISK RES, V20, P1338, DOI 10.1080/13669877.2016.1153507
   Jones C, 2017, RISK ANAL, V37, P331, DOI 10.1111/risa.12601
   Joslyn S, 2013, CURR DIR PSYCHOL SCI, V22, P308, DOI 10.1177/0963721413481473
   Kahan DM, 2017, J RISK RES, V20, P1, DOI 10.1080/13669877.2016.1260631
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Keenan K, 2018, URBAN STUD, V55, P461, DOI 10.1177/0042098016643285
   KIM MS, 1993, COMMUN RES, V20, P331, DOI 10.1177/009365093020003001
   Lahr J, 2010, SCI TOTAL ENVIRON, V408, P3899, DOI 10.1016/j.scitotenv.2009.10.045
   Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958
   Liberman N, 2009, J PERS SOC PSYCHOL, V97, P203, DOI 10.1037/a0015671
   Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x
   Lindell MK, 1994, INT J MASS EMERGENCI, V12, P303
   Lu H, 2018, RISK ANAL, V38, P2525, DOI 10.1111/risa.12982
   Ludy J, 2012, NAT HAZARDS, V61, P829, DOI 10.1007/s11069-011-0072-6
   MACEACHREN A. M., 2005, CARTOGR GOEGR INFOR, V32, P139, DOI [10.1559/1523040054738936., DOI 10.1559/1523040054738936]
   MACEACHREN AM, 1992, ANN ASSOC AM GEOGR, V82, P245, DOI 10.1111/j.1467-8306.1992.tb01907.x
   Mayorga MW, 2019, J RISK RES, V22, P1280, DOI 10.1080/13669877.2018.1466827
   McDonald RI, 2015, J ENVIRON PSYCHOL, V44, P109, DOI 10.1016/j.jenvp.2015.10.003
   Mileti DS, 1997, SOC PROBL, V44, P89, DOI 10.1525/sp.1997.44.1.03x0214f
   Moffatt S, 2003, J RISK RES, V6, P125, DOI 10.1080/1366987032000078901
   Monmonier M., 1997, CARTOGRAPHIES DANGER
   MONMONIER MB, 1997, DESIGN GUIDE ENV MAP
   MONTELLO DR, 1991, J ENVIRON PSYCHOL, V11, P101, DOI 10.1016/S0272-4944(05)80071-4
   Morgan M. G., 2002, RISK COMMUNICATION M
   Nakayachi K, 2018, RISK ANAL, V38, P666, DOI 10.1111/risa.12883
   O'Neill E, 2016, RISK ANAL, V36, P2158, DOI 10.1111/risa.12597
   Pagneux E, 2011, NAT HAZARDS, V58, P269, DOI 10.1007/s11069-010-9665-8
   Pahl S, 2011, ENVIRON BEHAV, V45, P155
   PALM R, 1990, EARTHQUAKE INSURANCE
   Patt A, 2005, CR GEOSCI, V337, P425, DOI 10.1016/j.crte.2004.10.004
   Peacock WG, 2005, LANDSCAPE URBAN PLAN, V73, P120, DOI 10.1016/j.landurbplan.2004.11.004
   PERRY RW, 1982, J SOC PSYCHOL, V116, P199, DOI 10.1080/00224545.1982.9922771
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rickard LN, 2017, WEATHER CLIM SOC, V9, P471, DOI 10.1175/WCAS-D-16-0048.1
   Rickard LN, 2016, GLOBAL ENVIRON CHANG, V38, P97, DOI 10.1016/j.gloenvcha.2016.03.003
   Rickard LN, 2011, PUBLIC UNDERST SCI, V20, P642, DOI 10.1177/0963662509360295
   Scannell L, 2013, ENVIRON BEHAV, V45, P60, DOI 10.1177/0013916511421196
   Schneider B., 2018, HDB CLIMATE CHANGE C, V2, P289
   SCHNEIDER Y, 2013, SJES, V149, P357, DOI DOI 10.1007/BF03399395
   Severtson DJ, 2014, APPL GIS, V10, P1
   Severtson DJ, 2013, RISK ANAL, V33, P818, DOI 10.1111/j.1539-6924.2012.01893.x
   Severtson DJ, 2012, J HEALTH COMMUN, V17, P836, DOI 10.1080/10810730.2011.650933
   Severtson DJ, 2012, RISK ANAL, V32, P259, DOI 10.1111/j.1539-6924.2011.01700.x
   SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170
   Shwom R, 2008, CLIMATIC CHANGE, V90, P343, DOI 10.1007/s10584-008-9428-7
   Slovic P, 1999, RISK ANAL, V19, P689, DOI 10.1023/A:1007041821623
   SMITH VK, 1990, J POLICY ANAL MANAG, V9, P41, DOI 10.2307/3325112
   Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x
   Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002
   Suls J, 2013, PERS SOC PSYCHOL B, V39, P691, DOI 10.1177/0146167213477457
   Trumbo C, 2011, RISK ANAL, V31, P1907, DOI 10.1111/j.1539-6924.2011.01633.x
   US Centers for Disease Control and Prevention, 2017, CDCS RESP ZIK ESTIMA
   US National Research Council, 2006, COMPL FOR CHAR COMM
   WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355
   Weller JA, 2013, J BEHAV DECIS MAKING, V26, P198, DOI 10.1002/bdm.1751
   Williams BL, 1999, RISK ANAL, V19, P1019, DOI 10.1023/A:1007095808381
   Winneg KM, 2018, RISK ANAL, V38, P2546, DOI 10.1111/risa.13010
   Woods J, 2008, HUM ECOL REV, V15, P63
   Zhang Y, 2004, NAT HAZARDS REV, V5, P115, DOI DOI 10.1061/(ASCE)1527-6988(2004)5:3(115)
   Zhang Y, 2010, ENVIRON BEHAV, V42, P597, DOI 10.1177/0013916509334564
   Zwickle A., 2014, EFFECTIVE RISK COMMU, P190
NR 92
TC 4
Z9 4
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2561
EP 2579
DI 10.1111/risa.13184
PG 19
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700008
PM 30176187
OA Bronze
DA 2020-07-08
ER

PT J
AU Vos, SC
   Sutton, J
   Yu, Y
   Renshaw, SL
   Olson, MK
   Ben Gibson, C
   Butts, CT
AF Vos, Sarah C.
   Sutton, Jeannette
   Yu, Yue
   Renshaw, Scott Leo
   Olson, Michele K.
   Ben Gibson, C.
   Butts, Carter T.
TI Retweeting Risk Communication: The Role of Threat and Efficacy
SO RISK ANALYSIS
LA English
DT Article
DE Efficacy; risk communication; social media; threat
ID SOCIAL MEDIA MESSAGES; PUBLIC-HEALTH; FEAR APPEALS; TWITTER;
   UNCERTAINTY; RELIABILITY; SELECTION; BEHAVIOR; MODEL
AB Social media platforms like Twitter and Facebook provide risk communicators with the opportunity to quickly reach their constituents at the time of an emerging infectious disease. On these platforms, messages gain exposure through message passing (called "sharing" on Facebook and "retweeting" on Twitter). This raises the question of how to optimize risk messages for diffusion across networks and, as a result, increase message exposure. In this study we add to this growing body of research by identifying message-level strategies to increase message passing during high-ambiguity events. In addition, we draw on the extended parallel process model to examine how threat and efficacy information influence the passing of Zika risk messages. In August 2016, we collected 1,409 Twitter messages about Zika sent by U.S. public health agencies' accounts. Using content analysis methods, we identified intrinsic message features and then analyzed the influence of those features, the account sending the message, the network surrounding the account, and the saliency of Zika as a topic, using negative binomial regression. The results suggest that severity and efficacy information increase how frequently messages get passed on to others. Drawing on the results of this study, previous research on message passing, and diffusion theories, we identify a framework for risk communication on social media. This framework includes four key variables that influence message passing and identifies a core set of message strategies, including message timing, to increase exposure to risk messages on social media during high-ambiguity events.
C1 [Vos, Sarah C.; Sutton, Jeannette; Olson, Michele K.] Univ Kentucky, Lexington, KY USA.
   [Yu, Yue; Renshaw, Scott Leo; Ben Gibson, C.; Butts, Carter T.] Univ Calif Irvine, Irvine, CA USA.
RP Sutton, J (corresponding author), Univ Kentucky, Dept Commun, Lexington, KY 40506 USA.
EM jeannette.sutton@uky.edu
RI Ahmed, Mohamed/AAG-9664-2019
FU National Science FoundationNational Science Foundation (NSF)
   [CMMI-1536347, CMMI-1536319]
FX This research was support by grants from the National Science Foundation
   (CMMI-1536347; CMMI-1536319). The views presented here represent the
   views of the authors, not the National Science Foundation.
CR Bail CA, 2016, AM J PUBLIC HEALTH, V106, P1173, DOI 10.2105/AJPH.2016.303181
   Bolker B., 2017, GLMMADMB GEN LINEAR
   Bostrom A, 2008, ANN NY ACAD SCI, V1128, P29, DOI 10.1196/annals.1399.005
   Bruns A., 2011, 6 EUR CONS POL RES G
   Burnap P, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0206-4
   BURNKRANT RE, 1995, J CONSUM RES, V22, P17, DOI 10.1086/209432
   Centers for Disease Control and Prevention, 2017, ZIK VIR OV
   Centers for Disease Control and Prevention, 2016, CDC ISS TRAV GUID RE
   Chang C, 2013, HEALTH COMMUN, V28, P822, DOI 10.1080/10410236.2012.726403
   Chung JE, 2016, J HEALTH COMMUN, V21, P517, DOI 10.1080/10810730.2015.1103332
   Cleveland WS, 1992, STAT MODELS S
   Coombs W. T., 1998, J PUBLIC RELAT RES, P177
   Dawkins Richard., 1976, SELFISH GENE
   ELLERY PJ, 2008, J COMMUNICATION HEAL, V1, P441, DOI DOI 10.1179/175380608790912905
   Epstein LG, 1999, REV ECON STUD, V66, P579, DOI 10.1111/1467-937X.00099
   Ferrara E, 2016, COMMUN ACM, V59, P96, DOI 10.1145/2818717
   FUNKHOUSER GR, 1971, PUBLIC OPIN QUART, V35, P107, DOI 10.1086/267871
   Geisser Seymour, 1993, PREDICTIVE INFERENCE
   Hall MG, 2015, INT J ENV RES PUB HE, V12, P13195, DOI 10.3390/ijerph121013195
   Harris JK, 2014, J MED INTERNET RES, V16, P162, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]
   Harris JK, 2013, AM J PUBLIC HEALTH, V103, P1700, DOI 10.2105/AJPH.2012.301166
   Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664
   Heath C, 2001, J PERS SOC PSYCHOL, V81, P1028, DOI 10.1037//0022-3514.81.6.1028
   Hilbe JM, 2011, NEGATIVE BINOMIAL RE
   HORNIK R, 2002, PUBLIC HLTH COMMUNIC, P1
   HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663
   Kim E, 2016, J HEALTH COMMUN, V21, P479, DOI 10.1080/10810730.2015.1103326
   Kollanyi Bence, 2016, BOTS AUTOMATION TWIT
   Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x
   Long Ma, 2012, Proceedings of the 2012 Ninth International Conference on Information Technology: New Generations (ITNG), P726, DOI 10.1109/ITNG.2012.143
   Malhotra A, 2012, MIT SLOAN MANAGE REV, V53, P61
   McGuire W. J., 1989, PUBLIC COMMUNICATION, P43
   Mileti DS, 1990, ORNL6609
   Neiger BL, 2013, HEALTH PROMOT PRACT, V14, P157, DOI 10.1177/1524839912469378
   Noar SM, 2016, TOB CONTROL, V25, P341, DOI 10.1136/tobaccocontrol-2014-051978
   Noar SM, 2015, MED DECIS MAKING, V35, P16, DOI 10.1177/0272989X14556130
   Park H, 2014, J MASS COMMUN Q, V91, P487, DOI 10.1177/1077699014538827
   Peters GJY, 2013, HEALTH PSYCHOL REV, V7, pS8, DOI 10.1080/17437199.2012.703527
   R Core Team, 2016, R LANG ENV STAT COMP
   Rogers EM, 2000, JOURNALISM MASS COMM, V77, P561, DOI 10.1177/107769900007700307
   Rogers EM, 2003, DIFFUSION INNOVATION
   Shen L., 2012, SAGE HDB PERSUASION, P20, DOI DOI 10.4135/9781452218410.N2
   Smith A., 2017, RECORD SHARE AM NOW
   So J, 2016, HEALTH COMMUN, V31, P193, DOI 10.1080/10410236.2014.940675
   Sopory P, 2002, HUM COMMUN RES, V28, P382, DOI 10.1111/j.1468-2958.2002.tb00813.x
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Spence PR, 2015, COMMUN Q, V63, P171, DOI 10.1080/01463373.2015.1012219
   Spitzberg BH, 2014, COMMUN THEOR, V24, P311, DOI 10.1111/comt.12042
   Suh B., 2010, 2010 IEEE INT C SOC, P177
   Sutton Jeannette, 2013, International Journal of Information Systems for Crisis Response and Management, V5, P58, DOI 10.4018/jiscrm.2013010104
   Sutton J., 2017, WEATHER CLIMATE SOC, DOI 10. 1175/WCAS-D-17-0032. 1
   Sutton J, 2015, P NATL ACAD SCI USA, V112, P14793, DOI 10.1073/pnas.1508916112
   Sutton J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134452
   Sutton J, 2015, HEALTH COMMUN, V30, P135, DOI 10.1080/10410236.2014.974124
   Sutton J, 2014, INFORM COMMUN SOC, V17, P765, DOI 10.1080/1369118X.2013.862561
   Tan C, 2014, ARXIV14051438
   Venables W. N., 2002, MODERN APPL STAT S
   Vos S. C., 2016, NAT COMM ASS PHIL PA
   Vos S. C., 2018, OXFORD ENCY HLTH RIS
   Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
NR 62
TC 5
Z9 5
U1 6
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2580
EP 2598
DI 10.1111/risa.13140
PG 19
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700009
PM 30080933
OA Bronze
DA 2020-07-08
ER

PT J
AU Wirz, CD
   Xenos, MA
   Brossard, D
   Scheufele, D
   Chung, JH
   Massarani, L
AF Wirz, Christopher D.
   Xenos, Michael A.
   Brossard, Dominique
   Scheufele, Dietram
   Chung, Jennifer H.
   Massarani, Luisa
TI Rethinking Social Amplification of Risk: Social Media and Zika in Three
   Languages
SO RISK ANALYSIS
LA English
DT Article
DE Blame; GE mosquitoes; SARF
ID GENETICALLY-MODIFIED FOODS; ECONOMIC-IMPACTS; STIGMA; ATTENUATION;
   COMMUNICATION; PERCEPTIONS; COVERAGE; DISEASE; TWITTER; CRISIS
AB Using the Zika outbreak as a context of inquiry, this study examines how assigning blame on social media relates to the social amplification of risk framework (SARF). Past research has discussed the relationship between the SARF and traditional mass media, but the role of social media platforms in amplification or attenuation of risk perceptions remains understudied. Moreover, the communication and perceptions of Zika-related risk are not limited to discussions in English. To capture conversations in languages spoken by affected countries, this study combines data in English, Spanish, and Portuguese. To better understand the assignment of blame and perceptions of risk in new media environments, we looked at three different facets of conversations surrounding Zika on Facebook and Twitter: the prominence of blame in each language, how specific groups were discussed throughout the Zika outbreak, and the sentiment expressed about genetically engineered (GE) mosquitoes. We combined machine learning with human coding to analyze public discourse in all three languages. We found differences between languages and platforms in the amount of blame assigned to different groups. We also found more negative sentiments expressed about GE mosquitoes on Facebook than on Twitter. These meaningful differences only emerge from analyses across the three different languages and platforms, pointing to the importance of multilingual approaches for risk communication research. Specific recommendations for outbreak and risk communication practitioners are also discussed.
C1 [Wirz, Christopher D.; Xenos, Michael A.; Brossard, Dominique; Scheufele, Dietram; Chung, Jennifer H.] Univ Wisconsin, Dept Life Sci Commun, Hiram Smith Hall,1545 Observ Dr, Madison, WI 53706 USA.
   [Brossard, Dominique; Scheufele, Dietram] Morgridge Inst Res, Madison, WI USA.
   [Massarani, Luisa] Fiocruz MS, Natl Inst Publ Commun Sci & Technol, Rio De Janeiro, Brazil.
   [Massarani, Luisa] Fiocruz MS, Commun Sci Technol & Hlth, Rio De Janeiro, Brazil.
RP Wirz, CD (corresponding author), Univ Wisconsin, Dept Life Sci Commun, Hiram Smith Hall,1545 Observ Dr, Madison, WI 53706 USA.
EM cwirz@wisc.edu
RI Wirz, Christopher/L-3675-2019
OI Wirz, Christopher/0000-0002-8990-5505; Xenos,
   Michael/0000-0002-2604-172X
CR Akin H, 2019, J RESPONSIBLE INNOV, V6, P50, DOI 10.1080/23299460.2018.1495026
   [Anonymous], 2018, ALL YOU CAN READ WOR
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Bakir V, 2005, J RISK RES, V8, P679, DOI 10.1080/13669870500166898
   Barnett J, 2003, HEALTH RISK SOC, V5, P301, DOI 10.1080/13698570310001606996
   Bawa AS, 2013, J FOOD SCI TECH MYS, V50, P1035, DOI 10.1007/s13197-012-0899-1
   Belluck P., 2016, NY TIMES
   Bennett WL, 2008, J COMMUN, V58, P707, DOI 10.1111/j.1460-2466.2008.00410.x
   Berkrot B., 2016, UPDATE 1 US HLTH OFF
   Binder A. R., 2014, SAGE HDB RISK COMMUN, V69
   Binder AR, 2011, RISK ANAL, V31, P324, DOI 10.1111/j.1539-6924.2010.01516.x
   Brenkert-Smith H, 2013, RISK ANAL, V33, P800, DOI 10.1111/j.1539-6924.2012.01917.x
   Burgess A, 2012, RISK ANAL, V32, P1693, DOI 10.1111/j.1539-6924.2012.01803.x
   BURNS WJ, 1993, RISK ANAL, V13, P611, DOI 10.1111/j.1539-6924.1993.tb01323.x
   Busby JS, 2013, J OPER RES SOC, V64, P638, DOI 10.1057/jors.2012.80
   Busby JS, 2009, ENVIRON SCI POLICY, V12, P297, DOI 10.1016/j.envsci.2008.12.001
   Busby J, 2012, J RISK RES, V15, P1049, DOI 10.1080/13669877.2012.670130
   Cacciatore MA, 2016, MASS COMMUN SOC, V19, P7, DOI 10.1080/15205436.2015.1068811
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Ceron A, 2014, NEW MEDIA SOC, V16, P340, DOI 10.1177/1461444813480466
   Chan M., 2016, WHO DIRECTOR GEN SUM
   Chong M, 2018, HEALTH COMMUN, V33, P14, DOI 10.1080/10410236.2016.1242031
   Chung IJ, 2011, RISK ANAL, V31, P1883, DOI 10.1111/j.1539-6924.2011.01623.x
   Chung JB, 2013, DISASTER PREV MANAG, V22, P148, DOI 10.1108/09653561311325299
   Dennis B., 2016, WASHINGTON POST
   Douglas M., 1992, RISK BLAME ESSAYS CU
   Duckett D, 2013, RISK MANAG-UK, V15, P132, DOI 10.1057/rm.2013.2
   Eichelberger L, 2007, SOC SCI MED, V65, P1284, DOI 10.1016/j.socscimed.2007.04.022
   ELDRIDGE J., 2003, SOCIAL AMPLIFICATION, P138, DOI DOI 10.1017/CBO9780511550461
   Ellen PS, 2008, J PUBLIC POLICY MARK, V27, P69, DOI 10.1509/jppm.27.1.69
   Fellenor J, 2018, J RISK RES, V21, P1163, DOI 10.1080/13669877.2017.1281339
   Flew Terry, 2016, GLOBAL MEDIA NATL PO, P1
   Flynn J, 1998, RISK ANAL, V18, P715, DOI 10.1023/B:RIAN.0000005918.67810.6d
   Fox M, 2016, NBC NEWS
   Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062
   Gonzalez-Bailon S., 2017, DECODING SOCIAL WORL
   Greenwood S., 2016, SOCIAL MEDIA UPDATE
   Gregory RS, 2002, RISK ANAL, V22, P347, DOI 10.1111/0272-4332.00017
   Griffin A., 2016, INDEPENDENT
   Guo Y, 2018, INFORM COMMUN SOC, V21, P80, DOI 10.1080/1369118X.2016.1261170
   Hallin D. C., 2012, COMP MEDIA SYSTEMS W, P72
   Hallin D. C., 2004, COMP MEDIA SYSTEMS 3
   Hallin Daniel C., 2012, COMP MEDIA SYSTEMS W
   Hallin DC, 2002, MEDIA CULT SOC, V24, P175, DOI 10.1177/016344370202400202
   Hart PS, 2011, SOC NATUR RESOUR, V24, P276, DOI 10.1080/08941920802676464
   Heberlein T. A., 2009, Human Dimensions of Wildlife, V14, P326, DOI 10.1080/10871200903115435
   Herek GM, 2003, HEALTH PSYCHOL, V22, P533, DOI 10.1037/0278-6133.22.5.533
   HILL A, 2001, J RISK RES, V4, P209, DOI DOI 10.1080/13669870152023773
   Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x
   Ibitayo OO, 2004, J HAZARD MATER, V114, P15, DOI 10.1016/j.jhazmat.2004.08.020
   Internet World Stats, 2016, FAC US WORLD
   Jacobs A., 2016, NY TIMES
   Kandiah V, 2017, RISK ANAL, V37, P2005, DOI 10.1111/risa.12760
   Kasperson J., 2003, SOCIAL AMPLIFICATION, P13, DOI DOI 10.1017/CBO9780511550461
   Kasperson RE, 1996, ANN AM ACAD POLIT SS, V545, P95, DOI 10.1177/0002716296545001010
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   KASPERSON RE, 2001, RISK MEDIA STIGMA UN, P9
   Kim KH, 2015, ENVIRON SCI POLLUT R, V22, P7612, DOI 10.1007/s11356-015-4107-5
   Lewis RE, 2009, RISK ANAL, V29, P714, DOI 10.1111/j.1539-6924.2008.01188.x
   Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363
   Lotan G, 2011, INT J COMMUN-US, V5, P1375
   MACGREGOR DG, 2003, SOCIAL AMPLIFICATION, P243
   MACHLIS GE, 1990, RISK ANAL, V10, P161, DOI 10.1111/j.1539-6924.1990.tb01030.x
   Mase AS, 2015, J ENVIRON PSYCHOL, V41, P166, DOI 10.1016/j.jenvp.2014.12.004
   Masuda JR, 2006, RISK ANAL, V26, P437, DOI 10.1111/j.1539-6924.2006.00749.x
   MAZUR A, 1984, MINERVA, V22, P45, DOI 10.1007/BF02207556
   McComas KA, 2003, RISK ANAL, V23, P1257, DOI 10.1111/j.0272-4332.2003.00399.x
   McNeil Jr Donald G., 2016, NY TIMES
   Metz WC, 1996, RISK ANAL, V16, P185
   Mitchell D., 2016, FORTUNE
   Moussaid M, 2015, P NATL ACAD SCI USA, V112, P5631, DOI 10.1073/pnas.1421883112
   MURDOCK G, 2003, SOCIAL AMPLIFICATION, P156, DOI DOI 10.1017/CBO9780511550461
   Nebehay S, 2016, REUTERS
   Newman N., 2017, REUTERS I DIGITAL NE
   Newman Nic, 2016, REUTERS I DIGITAL NE
   Newton-Small J., 2016, TIME
   Pan American Health Organization, 2017, ZIK CUM CAS
   Panagiotopoulos P, 2016, TECHNOL FORECAST SOC, V111, P86, DOI 10.1016/j.techfore.2016.06.010
   Petts J, 2004, HEALTH RISK SOC, V6, P7, DOI 10.1080/13698570410001678284
   Petts J., 2000, SOCIAL AMPLIFICATION
   Pidgeon N. F., 2003, SOCIAL AMPLIFICATION, P179, DOI DOI 10.1017/CBO9780511550461
   Poumadere M., 2003, SOCIAL AMPLIFICATION, P209, DOI 10.1017/CBO9780511550461.010
   Raude J, 2004, HEALTH RISK SOC, V6, P173, DOI 10.1080/1369857042000219760
   Raupp J, 2014, HEALTH RISK SOC, V16, P565, DOI 10.1080/13698575.2014.950203
   RAYNER S, 1988, RISK ANAL, V8, P201, DOI 10.1111/j.1539-6924.1988.tb01172.x
   RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x
   Renn O., 2003, SOCIAL AMPLIFICATION, P374
   Renn O., 1991, RISK COMMUNICATION S, P287
   Rickard LN, 2013, J RISK RES, V16, P145, DOI 10.1080/13669877.2012.725673
   RIP A, 1988, RISK ANAL, V8, P193, DOI 10.1111/j.1539-6924.1988.tb01170.x
   Rossmann C, 2018, RISK ANAL, V38, P357, DOI 10.1111/risa.12841
   Runge KK, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1381-8
   Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306
   Shakeela A, 2015, J SUSTAIN TOUR, V23, P65, DOI 10.1080/09669582.2014.918135
   Shan LR, 2014, PUBLIC UNDERST SCI, V23, P911, DOI 10.1177/0963662512472315
   Simis-Wilkinson M, 2018, SCI COMMUN, V40, P314, DOI 10.1177/1075547018766557
   SLOVIC P, 1991, RISK ANAL, V11, P683, DOI 10.1111/j.1539-6924.1991.tb00658.x
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Specter M, 2016, NEW YORKER
   Strekalova YA, 2016, HEALTH EDUC BEHAV, V44, P332
   Strekalova YA, 2017, J HEALTH COMMUN, V22, P849, DOI 10.1080/10810730.2017.1367336
   Su LYF, 2018, NEW MEDIA SOC, V20, P3678, DOI 10.1177/1461444818757205
   Su LYF, 2017, SCI COMMUN, V39, P569, DOI 10.1177/1075547017734226
   Su LYF, 2017, INFORM COMMUN SOC, V20, P406, DOI 10.1080/1369118X.2016.1182197
   Sutton J, 2015, P NATL ACAD SCI USA, V112, P14793, DOI 10.1073/pnas.1508916112
   Urquhart J, 2017, ENVIRON SCI POLICY, V77, P172, DOI 10.1016/j.envsci.2017.08.020
   Wagner L., 2016, ZIKA VIRUS ACQUIRED
   Williams J, 2011, ATI, V4, P58
   World Health Organization, 2017, ZIK SIT REP 10 MARCH
   World Health Organization, 2017, HIST ZIK VIR
   World Health Organization, 2016, ZIK EP REP
   Yeo S, 2017, J SCI COMMUNICATION, V16, P1
   Yeo SK, 2017, PUBLIC UNDERST SCI, V26, P937, DOI 10.1177/0963662516649806
   Zhang L, 2017, ASIAN J COMMUN, V27, P322, DOI 10.1080/01292986.2017.1290124
   Zhou M, 2017, INT J DISAST RISK RE, V24, P209, DOI 10.1016/j.ijdrr.2017.06.013
NR 115
TC 8
Z9 8
U1 8
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD DEC
PY 2018
VL 38
IS 12
SI SI
BP 2599
EP 2624
DI 10.1111/risa.13228
PG 26
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA HD5ZM
UT WOS:000452610700010
PM 30408201
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rosso, F
   Rodriguez, S
   Cedano, JA
   Mora, BL
   Moncada, PA
   Velez, JD
AF Rosso, Fernando
   Rodriguez, Sarita
   Cedano, Jorge A.
   Mora, Barbara L.
   Moncada, Pablo A.
   Velez, Juan D.
TI Chikungunya in solid organ transplant recipients, a case series and
   literature review
SO TRANSPLANT INFECTIOUS DISEASE
LA English
DT Review
DE Chikungunya; infection; solid organ transplant; transplant recipients
ID DENGUE VIRUS; INFECTION; OUTBREAK; AMERICA; DISEASE; FEVER; ZIKA
AB Chikungunya virus is a recent emerging arbovirus in Latin America, and the clinical manifestations can vary from fever and rash to severe chronic inflammatory arthritis. Few reports have been published regarding this infection in immunocompromised patients, including solid organ transplant recipients. We report a case series of solid organ transplant recipients with confirmed Chikungunya infection by positive reverse transcription polymerase chain reaction (RT-PCR), identified between January 2014 and December 2016. In addition, we conducted a literature review searching PubMed, EMBASE, and LILACS databases on Chikungunya infection in solid organ transplant recipients. Ten solid organ transplant recipients were included, consisting of 5 kidney, 4 liver, and 1 liver/kidney transplant recipient. Mean age of the transplant recipients was 47 years, and the most frequent symptoms of Chikungunya infection were arthralgia and fever. None of the patients required treatment in the intensive care unit, no deaths or graft rejection occurred. None of our patients had recurrent arthritis during 3-month follow-up period after the infection. Twenty-one cases of Chikungunya virus were identified in the literature review. Most cases had a benign clinical course with no severe complications, death, or chronic inflammatory arthritis. In conclusion, Chikungunya infection in solid organ transplant recipients has a benign course and has no chronic recurrent arthritis. It is possible that the immunosuppression regimen could decrease the risk of severe or chronic inflammatory manifestations in solid organ transplant recipients infected with Chikungunya.
C1 [Rosso, Fernando; Moncada, Pablo A.; Velez, Juan D.] Fdn Valle del Lili, Infect Dis Serv, Cali, Colombia.
   [Rosso, Fernando; Rodriguez, Sarita; Cedano, Jorge A.; Mora, Barbara L.] Fdn Valle del Lili, Clin Res Ctr, Cali, Colombia.
   [Rosso, Fernando] Univ Icesi, Fac Ciencies Salud, Cali, Colombia.
RP Rosso, F (corresponding author), Fdn Valle del Lili, Cali, Colombia.
EM frosso07@gmail.com
RI Rodriguez, Sarita/AAP-5022-2020
OI Rodriguez, Sarita/0000-0002-1916-0747; Cedano, Jorge/0000-0001-7579-9556
CR Alvis-Guzman N, 2017, REV MVZ CORDOBA, V22, P5994, DOI 10.21897/rmvz.1069
   Amaral JK, 2018, ARTHRIT CARE RES, V70, P1501, DOI 10.1002/acr.23519
   Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Delogu I, 2011, J MED VIROL, V83, P1058, DOI 10.1002/jmv.22019
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Espinosa N., 2016, OPEN J MED MICROBIOL, V6, P23
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Girao ES, 2017, TRANSPL P, V49, P2076, DOI 10.1016/j.transproceed.2017.07.004
   Goupil Brad A, 2016, Open Rheumatol J, V10, P129, DOI 10.2174/1874312901610010129
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Laiton-Donato K, 2016, BIOMEDICA, V36, P25, DOI 10.7705/biomedica.v36i0.2990
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Machado CM, 2017, BLOOD ADV, V1, P624, DOI 10.1182/bloodadvances.2016003285
   Padmakumar B, 2009, INDIAN J RHEUMATOL, V4, P94, DOI DOI 10.1016/S0973-3698(10)60189-6
   Pierrotti LC, 2017, INT J INFECT DIS, V64, P96, DOI 10.1016/j.ijid.2017.09.009
   Reddy V, 2014, J MED VIROL, V86, P1393, DOI 10.1002/jmv.23875
   Rosen J, 2013, INFECT DIS CLIN N AM, V27, P429, DOI 10.1016/j.idc.2013.02.009
   Rosso F, 2018, BRAZ J INFECT DIS, V22, P63, DOI 10.1016/j.bjid.2018.01.001
   Rosso F, 2016, REV CHIL INFECTOL, V33, P464, DOI 10.4067/S0716-10182016000400013
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weerakkody RM, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0428-y
   White SL, 2014, B WORLD HEALTH ORGAN, V92, P826, DOI 10.2471/BLT.14.137653
NR 30
TC 6
Z9 6
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-2273
EI 1399-3062
J9 TRANSPL INFECT DIS
JI Transpl. Infect. Dis.
PD DEC
PY 2018
VL 20
IS 6
AR e12978
DI 10.1111/tid.12978
PG 6
WC Immunology; Infectious Diseases; Transplantation
SC Immunology; Infectious Diseases; Transplantation
GA HD3HV
UT WOS:000452406900010
PM 30120808
DA 2020-07-08
ER

PT J
AU Trujillo, CA
   Muotri, AR
AF Trujillo, Cleber A.
   Muotri, Alysson R.
TI Brain Organoids and the Study of Neurodevelopment
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID PLURIPOTENT STEM-CELLS; CEREBRAL ORGANOIDS; SELF-ORGANIZATION; DNA
   RECOGNITION; HUMAN ES; DIFFERENTIATION; MODEL; GENERATION; DYNAMICS;
   NEURONS
AB Brain organoids are 3D self-assembled structures composed of hundreds of thousands to millions of cells that resemble the cellular organization and transcriptional and epigenetic signature of a developing human brain. Advancements using brain organoids have been made to elucidate the genetic basis of certain neurodevelopmental disorders, such as microcephaly and autism; and to investigate the impact of environmental factors to the brain, such as during Zika virus infection. It remains to be explored how far brain organoids can functionally mature and process external information. An improved brain organoid model might reproduce important aspects of the human brain in a more reproducible and high-throughput fashion. This novel and complementary approach in the neuroscience toolbox opens perspectives to understand the fundamental features of the human neurodevelopment, with implications to personalize therapeutic opportunities for neurological disorders.
C1 [Trujillo, Cleber A.; Muotri, Alysson R.] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp San Diego, Sch Med, San Diego, CA 92037 USA.
   [Muotri, Alysson R.] Kavli Inst Brain & Mind, Dept Cellular & Mol Med, Stem Cell Program, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92037 USA.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp San Diego, Sch Med, San Diego, CA 92037 USA.; Muotri, AR (corresponding author), Kavli Inst Brain & Mind, Dept Cellular & Mol Med, Stem Cell Program, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92037 USA.
EM muotri@ucsd.edu
OI muotri, alysson/0000-0003-0867-2875
FU California Institute for Regenerative Medicine (CIRM)California
   Institute for Regenerative Medicine [DISC2-09649]; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01MH108528, R01MH094753, R01MH109885,
   R01MH100175, R56MH109587]; SFARI [345469]; NARSAD Independent
   Investigator awardNARSAD
FX Dr Muotri is supported by grants from the California Institute for
   Regenerative Medicine (CIRM) DISC2-09649, the National Institutes of
   Health through R01MH108528, R01MH094753, R01MH109885, R01MH100175,
   R56MH109587, SFARI grant #345469, and a NARSAD Independent Investigator
   award.
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Beltrao-Braga PCB, 2013, CYTOM PART A, V83A, P11, DOI 10.1002/cyto.a.22231
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043
   Bosl WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24318-x
   Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chin EWM, 2015, NEURAL REGEN RES, V10, P1720, DOI 10.4103/1673-5374.169607
   Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x
   Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817
   Florez CM, 2015, CEREB CORTEX, V25, P578, DOI 10.1093/cercor/bht235
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018
   Giandomenico SL, 2017, CURR OPIN CELL BIOL, V44, P36, DOI 10.1016/j.ceb.2017.01.001
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005
   Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kawakami T, 2015, INT J CARDIOL, V194, P39, DOI 10.1016/j.ijcard.2015.05.056
   Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x
   Kirwan P, 2015, DEVELOPMENT, V142, P3178, DOI 10.1242/dev.123851
   Kuijlaars J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36529
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Marinho PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09834
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817
   Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544
   Muotri AR, 2009, EPILEPSY BEHAV, V14, P81, DOI 10.1016/j.yebeh.2008.09.021
   Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, CURR OPIN CELL BIOL, V49, P47, DOI 10.1016/j.ceb.2017.11.010
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7
   Spaethling JM, 2017, CELL REP, V18, P791, DOI 10.1016/j.celrep.2016.12.066
   ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013
   Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009
   Trujillo C.A., 2018, BIORXIV, DOI [10.1101/358622, DOI 10.1101/358622]
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936
   Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37
NR 77
TC 12
Z9 12
U1 8
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD DEC
PY 2018
VL 24
IS 12
BP 982
EP 990
DI 10.1016/j.molmed.2018.09.005
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HB9UL
UT WOS:000451438800003
PM 30377071
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Gutierrez-Bugallo, G
   Rodriguez-Roche, R
   Diaz, G
   Perez, M
   Mendizabal, ME
   Peraza, I
   Vazquez, AA
   Alvarez, M
   Rodriguez, M
   Bisset, JA
   Guzman, MG
AF Gutierrez-Bugallo, Gladys
   Rodriguez-Roche, Rosmari
   Diaz, Gisell
   Perez, Magaly
   Elena Mendizabal, Maria
   Peraza, Iris
   Vazquez, Antonio A.
   Alvarez, Mayling
   Rodriguez, Magdalena
   Bisset, Juan A.
   Guzman, Maria G.
TI Spatio-temporal distribution of vertically transmitted dengue viruses by
   Aedes aegypti (Diptera: Culicidae) from Arroyo Naranjo, Havana, Cuba
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE vertical transmission; arbovirus; entomo-virological surveillance;
   xenomonitoring; more than one DENV type
ID TRANSOVARIAL TRANSMISSION; ENCEPHALITIS-VIRUS; ZIKA VIRUS; MOSQUITOS;
   DISPERSAL; INFECTION
AB Objective To study the distribution of vertical transmission of dengue viruses in field-collected Aedes aegypti larvae in the municipality of Arroyo Naranjo in Havana, Cuba.
   Methods Aedes aegypti larvae and pupae were collected monthly between September 2013 and July 2014 in the seven Municipal Health Areas of Arroyo Naranjo. Pools formed of 30-55 larvae were examined through PCR and sequencing to detect the presence of each serotype.
   Results We analysed 111 pools of larvae and pupae (4102 individuals) of which 37 tested positive for at least one DENV. More than one DENV type was observed in 10 of the 37 positive pools. Infected pools were detected every month, except in January, suggesting a sustained circulation of DENV in the vector populations. DENV-1 and DENV-3 were the most frequent and dispersed, though all four DENV types were detected. Nucleotide sequencing from positive pools confirmed RT-PCR results for DENV-1 (genotype V), DENV-3 (genotype III) and DENV-4 (genotype II). DENV-2 was detected by RT-PCR but could not be confirmed by nucleotide sequencing.
   Conclusion Our study of the distribution of natural vertical transmission of dengue virus types highlights extrinsic virus activity patterns in the area and could be used as a new surveillance tool.
C1 [Gutierrez-Bugallo, Gladys; Vazquez, Antonio A.; Rodriguez, Magdalena; Bisset, Juan A.] PAHO WHO Collaborating Ctr Dengue & Its Control, Inst Trop Med Pedro Kouri, Dept Vector Control, Ctr Res Diagnost & Reference, Havana, Cuba.
   [Rodriguez-Roche, Rosmari] Roche Diagnost, Havana, Cuba.
   [Diaz, Gisell; Alvarez, Mayling; Guzman, Maria G.] PAHO WHO Collaborating Ctr Dengue & Its Control, Inst Trop Med Pedro Kouri, Ctr Res Diagnost & Reference, Dept Virol, Havana, Cuba.
   [Perez, Magaly; Elena Mendizabal, Maria; Peraza, Iris] Ctr Prov Higiene & Epidemiol, Unidad Prov Vigilancia & Lucha Antivectorial, Havana, Cuba.
RP Gutierrez-Bugallo, G (corresponding author), Inst Trop Med Pedro Kouri, Dept Vector Control, Autopista Novia Mediodaa Km 6,POB 601,Marianao 13, Havana 11400, Cuba.
EM gladysg@ipk.sld.cu
OI Bisset Lazcano, Juan Andres/0000-0002-3447-4947; Gutierrez-Bugallo,
   Gladys/0000-0003-4415-7045
CR Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Angel A, 2016, ACTA TROP, V155, P20, DOI 10.1016/j.actatropica.2015.11.018
   Angel B, 2015, ACTA TROP, V150, P107, DOI 10.1016/j.actatropica.2015.07.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisset Lazcano J. A., 2008, REV BIOMEDICA, V19, P92
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   CALISHER CH, 1988, ACTA VIROL, V32, P469
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Christophers R, 1960, AEDES AEGYPTI L YELL
   Corp M, 2011, CORP M MAPINFO V11 0
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111
   de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025
   Diaz G, 2014, THESIS
   Direccion Municipal de Salud Publica Arroyo Naranjo, 2010, BAS DAT IND CAS AED
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Edillo FE, 2015, J VECTOR ECOL, V40, P282, DOI 10.1111/jvec.12166
   Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9
   Fauver JR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006348
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Gonzalez R., 2006, CULICIDOS CUBA
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman Tirado C Maria G, 2012, Rev Cubana Med Trop, V64, P5
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Laboratorio Nacional de Referencia de Arbovirus IPK, 2013, BAS DAT DIAGN VIR MO
   Laboratorio Nacional de Referencia de Arbovirus IPK, 2013, BAS DAT DIAGN SER DE
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   de Mendonca MCL, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180036
   Perez Perez O., 2013, THESIS
   PEREZPEREZ J, 2017, BIOMEDICA S2, V37
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Rodriguez-Roche R, 2012, INFECT GENET EVOL, V12, P332, DOI 10.1016/j.meegid.2011.12.005
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   TESH RB, 1980, AM J TROP MED HYG, V29, P1394, DOI 10.4269/ajtmh.1980.29.1394
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thongrungkiat S, 2011, J VECTOR ECOL, V36, P147, DOI 10.1111/j.1948-7134.2011.00151.x
   Tittarelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111017
   TURELL MJ, 1982, AM J TROP MED HYG, V31, P1252, DOI 10.4269/ajtmh.1982.31.1252
   WHO/TDR, 2009, DENG GUID DIAGN TREA
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
NR 54
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD DEC
PY 2018
VL 23
IS 12
BP 1342
EP 1349
DI 10.1111/tmi.13162
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HC5FV
UT WOS:000451829800007
PM 30307674
OA Bronze
DA 2020-07-08
ER

PT J
AU Walker, C
   Ehinger, N
   Mason, B
   Nayeri, U
   Curry, C
   Waldorf, KA
AF Walker, C.
   Ehinger, N.
   Mason, B.
   Nayeri, U.
   Curry, C.
   Waldorf, K. Adams
TI A disproportionately small fetal head circumference with respect to
   femur length correlates with abnormal postnatal intracranial imaging and
   eye deficits following zika virus infection in pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 02-04, 2018
CL Philadelphia, PA
SP Infect Dis Soc Obstet & Gynecol
C1 [Walker, C.; Waldorf, K. Adams] Univ Washington, Seattle, WA 98195 USA.
   [Ehinger, N.; Mason, B.; Nayeri, U.; Curry, C.] Univ Miami Hlth Syst, Miami, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2018
VL 219
IS 6
MA 1
BP 635
EP 635
DI 10.1016/j.ajog.2018.10.068
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HB2RJ
UT WOS:000450889400040
DA 2020-07-08
ER

PT J
AU Maykin, M
   Pereira, JP
   Moreira, M
   Nielsen-Saines, K
   Gawl, S
AF Maykin, M.
   Pereira, J. P., Jr.
   Moreira, M.
   Nielsen-Saines, K.
   Gawl, S.
TI Role of amniocentesis in the diagnosis of congenital zika syndrome
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 02-04, 2018
CL Philadelphia, PA
SP Infect Dis Soc Obstet & Gynecol
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2018
VL 219
IS 6
MA 22
BP 652
EP 652
DI 10.1016/j.ajog.2018.10.059
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HB2RJ
UT WOS:000450889400085
OA Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V.
TI Psoriasis triggered by Zika virus infection
SO CLINICAL AND EXPERIMENTAL DERMATOLOGY
LA English
DT Letter
C1 [Joob, B.] Sanitat Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, V.] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Cordel N, 2018, BRIT J DERMATOL, V178, pE108, DOI 10.1111/bjd.16096
   Mondolfi AEP, 2018, CLIN EXP DERMATOL, V43, P171, DOI 10.1111/ced.13294
NR 2
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0307-6938
EI 1365-2230
J9 CLIN EXP DERMATOL
JI Clin. Exp. Dermatol.
PD DEC
PY 2018
VL 43
IS 8
BP 937
EP 937
DI 10.1111/ced.13654
PG 1
WC Dermatology
SC Dermatology
GA HA2ZC
UT WOS:000450115100037
PM 29808536
DA 2020-07-08
ER

PT J
AU Catenacci, LS
   Nunes-Neto, J
   Deem, SL
   Palmer, JL
   Travassos-da Rosa, ES
   Tello, JS
AF Catenacci, Lilian S.
   Nunes-Neto, Joaquim
   Deem, Sharon L.
   Palmer, Jamie L.
   Travassos-da Rosa, Elizabeth S.
   Sebastian Tello, J.
TI Diversity patterns of hematophagous insects in Atlantic forest fragments
   and human-modified areas of southern Bahia, Brazil
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Arbovirus; mosquito; Culicidae; abundance; richness; Brazil
ID GRANDE-DO-SUL; DIPTERA-CULICIDAE; YELLOW-FEVER; SAO-PAULO;
   LEONTOPITHECUS-CHRYSOMELAS; MOSQUITO DIPTERA; MAYARO-VIRUS; SAND FLIES;
   STATE; HAEMAGOGUS
AB There have been several important outbreaks of mosquito-borne diseases in the Neotropics in recent years, particularly in Brazil. Some taxa are also considered to be indicators of environmental health. Despite the importance of understanding insect abundance and distribution to the understanding of disease dynamics and design strategies to manage them, very little is known about their ecology in many tropical regions. We studied the abundance and diversity of mosquitoes and sand flies in the Bahia State of Brazil, a point of origin for arbovirus outbreaks, including Zika and Chikungunya fever. During 2009-2014, 51 mosquito taxa were identified, belonging to three dipteran families, Ceratopogonidae, Culicidae, and Psychodidae. The family Culicidae, including the Sabethini tribe, were the most abundant (81.5%) and most taxa-rich (n=45). While season (winter and summer) was a strong factor determinant of the occurrence of the most abundant taxa, the stratification level in the forest (ground or tree level) had a strong effect and the dominant taxa at ground level were completely different from the dominant species collected at tree level. We suggest that sites with a mix of forest and agroforestry systems support the highest biodiversity of hematophagous insects as compared to highly disturbed landscapes.
C1 [Catenacci, Lilian S.] Fed Univ Piaui State CPCE, Curso Med Vet, Bom Jesus, PI, Brazil.
   [Catenacci, Lilian S.; Nunes-Neto, Joaquim; Travassos-da Rosa, Elizabeth S.] Evandro Chagas Inst, Div Arbovirol & Hemorrhag Fevers, Anannindeua, PA, Brazil.
   [Catenacci, Lilian S.] Ctr Res & Conservat, Royal Zool Soc Antwerp, Antwerp, Belgium.
   [Catenacci, Lilian S.; Deem, Sharon L.; Palmer, Jamie L.] St Louis Zoo, Inst Conservat Med, St Louis, MO 63110 USA.
   [Sebastian Tello, J.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO USA.
   [Sebastian Tello, J.] Pontificia Univ Catolica Ecuador, Escuela Biol, Quito, Ecuador.
RP Catenacci, LS (corresponding author), Fed Univ Piaui State CPCE, Curso Med Vet, Bom Jesus, PI, Brazil.; Catenacci, LS (corresponding author), Evandro Chagas Inst, Div Arbovirol & Hemorrhag Fevers, Anannindeua, PA, Brazil.; Catenacci, LS (corresponding author), Ctr Res & Conservat, Royal Zool Soc Antwerp, Antwerp, Belgium.; Catenacci, LS (corresponding author), St Louis Zoo, Inst Conservat Med, St Louis, MO 63110 USA.
EM catenacci@ufpi.edu.br
RI Neto, Joaquim Pinto Nunes/Y-5703-2019
OI PINTO NUNES NETO, JOAQUIM/0000-0001-5981-0065
FU Saint Louis Zoo WildCare Institute (U.S.A.); American Association of
   Zoological Veterinarians Wild Animal Fund (AAZV, U.S.A.); CNPq
   (Brasil)National Council for Scientific and Technological Development
   (CNPq); Centre for Research and Conservation of the Royal Zoological
   Society of Antwerp (Belgium); Lion Tamarins of Brazil Fund; National
   Lottery of Belgium; Primate Action Fund; Zoological Society of London
FX We are much indebted to the technical staff of the Department of the
   Health of Bahia State (6a DIRES) who helped the authors to collect the
   material in the field and the Evandro Chagas Institute team, especially
   Bruna Lais Sena do Nascimento, Helio Augusto Cardoso Saraiva, Jose
   Wilson Rosa Junior, Francisco Correa de Castro, Durval Bertran Rodrigues
   Vieira, and Hamilton Monteiro for assistance with the identification of
   the arthropods. Additional thanks go to Kristel M. de Vleeschouwer from
   the Project BioBrasil/Centre for Research and Conservation Antwerpia
   Zoo, ICMBIO, Kathleen Apakupakul at the Saint Louis Zoo Institute for
   Conservation Medicine, and Leonardo Oliveira from the Bicho do Mato
   Instituto de Pesquisa for their logistical support. We sincerely
   acknowledge the owner of the areas. This study was funded by Saint Louis
   Zoo WildCare Institute (U.S.A.), The American Association of Zoological
   Veterinarians Wild Animal Fund (AAZV, U.S.A.), CNPq (Brasil), the Centre
   for Research and Conservation of the Royal Zoological Society of Antwerp
   (Belgium), Lion Tamarins of Brazil Fund, National Lottery of Belgium,
   Primate Action Fund, Zoological Society of London. The Flemish Ministry
   of Science (Belgium) provided structural support to the Centre for
   Research and Conservation of the Royal Zoological Society of Antwerp.
CR Alger K., 1994, Environmentalist, V14, P107, DOI 10.1007/BF01901304
   Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, P1
   Braga DL, 2010, NEOTROP ENTOMOL, V39, P464, DOI 10.1590/S1519-566X2010000400002
   Cardoso C.W., 2017, PLOS NEGLECT TROP D, V11, P1
   Cardoso JD, 2012, J AM MOSQUITO CONTR, V28, P1, DOI 10.2987/11-6205.1
   Cardoso JD, 2010, REV SOC BRAS MED TRO, V43, P552, DOI 10.1590/S0037-86822010000500016
   Santos HLC, 2014, REV SOC BRAS MED TRO, V47, P101, DOI 10.1590/0037-8682-0078-2012
   Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x
   Cassano CR, 2011, MAMM BIOL, V76, P243, DOI 10.1016/j.mambio.2010.06.008
   Catenacci LS, 2016, INT J PRIMATOL, V37, P136, DOI 10.1007/s10764-016-9889-x
   Catenacci LS, 2009, BIOTROPICA, V41, P744, DOI 10.1111/j.1744-7429.2009.00530.x
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Davis N C, 1930, J Exp Med, V52, P405
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   de Paula MB, 2015, BIOTA NEOTROP, V15, DOI 10.1590/1676-0611-BN-2014-0026
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Dias-Lima AG, 2003, MEM I OSWALDO CRUZ, V98, P733, DOI 10.1590/S0074-02762003000600004
   Distler T, 2009, ANN MO BOT GARD, V96, P470, DOI 10.3417/2008034
   Fontoura T, 2010, BIOTA NEOTROP, V10, P351, DOI 10.1590/S1676-06032010000400041
   Forattini O.P., 1995, CAD SAUDE PUBLICA, V11, P157
   GALINDO P, 1958, AM J TROP MED HYG, V7, P429, DOI 10.4269/ajtmh.1958.7.429
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Gomes AD, 2007, REV SOC BRAS MED TRO, V40, P487, DOI 10.1590/S0037-86822007000400025
   Gomes AD, 2010, EPIDEMIOL SERV SAUDE, V19, P101
   GUIMARAES A E, 1986, Memorias do Instituto Oswaldo Cruz, V81, P93, DOI 10.1590/S0074-02761986000100013
   Guimaraes A. E., 1984, Memorias do Instituto Oswaldo Cruz, V79, P309, DOI 10.1590/S0074-02761984000300004
   Guimaraes A.E., 1985, MEM I O CRUZ, V80, P171, DOI DOI 10.1590/S0074-02761985000200008
   Harbach R. E., 2017, MOSQUITO TAXONOMIC I
   Lima MA, 2010, REV INST MED TROP SP, V52, P11, DOI 10.1590/S0036-46652010000100002
   Medeiros-Sousa AR, 2013, BIOTA NEOTROP, V13, P317, DOI 10.1590/S1676-06032013000100030
   Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307
   Melo Adriano Sanchez, 2008, Biota Neotropica, V8, P21
   Ministerio da Saude Brazil., 2016, B ENT SECR SAUD EST, V3, P1
   Montes J, 2005, REV SAUDE PUBL, V39, P578, DOI 10.1590/S0034-89102005000400010
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Muller GC, 2011, J VECTOR ECOL, V36, pS195, DOI 10.1111/j.1948-7134.2011.00131.x
   Navarro J.C., 2015, Journal of Entomology and Zoology Studies, V3, P169
   Nnko HJ, 2017, J VECTOR ECOL, V42, P24, DOI 10.1111/jvec.12236
   Oliveira LC, 2011, ENVIRON MANAGE, V48, P248, DOI 10.1007/s00267-010-9582-3
   Paterno U, 2004, REV SAUDE PUBL, V38, P133, DOI 10.1590/s0034-89102004000100019
   Pauvolid-Correa A, 2010, REV INST MED TROP SP, V52, P17, DOI 10.1590/S0036-46652010000100003
   Pinto CS, 2009, MEM I OSWALDO CRUZ, V104, P592, DOI 10.1590/S0074-02762009000400010
   PITTENDRIGH CS, 1950, EVOLUTION, V4, P43, DOI 10.2307/2405533
   Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021
   Sawalha SS, 2017, J VECTOR ECOL, V42, P120, DOI 10.1111/jvec.12246
   Schmidt LS, 2007, IHERINGIA SER ZOOL, V97, P73, DOI 10.1590/S0073-47212007000100011
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Sollberg I, 2014, REV ARVORE, V38, P241, DOI 10.1590/S0100-67622014000200004
   Souza R.L., 2015, SAUDE PUBL, V39, P136
   Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
NR 51
TC 0
Z9 0
U1 0
U2 4
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD DEC
PY 2018
VL 43
IS 2
BP 293
EP 304
DI 10.1111/jvec.12313
PG 12
WC Entomology
SC Entomology
GA GZ5PV
UT WOS:000449478600010
PM 30408294
OA Bronze
DA 2020-07-08
ER

PT J
AU Suwanmanee, S
   Surasombatpattana, P
   Soonthornworasiri, N
   Hamel, R
   Maneekan, P
   Misse, D
   Luplertlop, N
AF Suwanmanee, San
   Surasombatpattana, Pornnapat
   Soonthornworasiri, Ngamphol
   Hamel, Rodolphe
   Maneekan, Pannamas
   Misse, Dorothee
   Luplertlop, Natthanej
TI Monitoring arbovirus in Thailand: Surveillance of dengue, chikungunya
   and zika virus, with a focus on coinfections
SO ACTA TROPICA
LA English
DT Article
DE Arboviruses; Mosquito vector; Co-infection; Arbovirus vector;
   Mosquito-borne diseases
ID HEMORRHAGIC-FEVER; CLINICAL-MANIFESTATIONS; INFECTION; CHALLENGES;
   MOSQUITO; MANAGEMENT; SEROTYPES; EPIDEMIC
AB Infections caused by arboviruses such as dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV) frequently occur in tropical and subtropical regions. These three viruses are transmitted by Aedes (Ae.) aegypti and Ae. albopictus. In Thailand, the highest incidence of arbovirus infection and the high circulation of Aedes mosquito mainly occurs in the Southern provinces of the country. Few studies have focused on the incidence of co-infection of arboviruses in this region. In the present study, a cross-sectional study was conducted on a cohort of 182 febrile patients from three hospitals located in Southern Thailand. Surveillance of DENV, CHIKV and ZIKV was conducted from May to October 2016 during the rainy season. The serological analysis and molecular detection of arboviruses were performed by ELISA and multiplex RT-PCR respectively. The results demonstrated that 163 cases out of 182 patients (89.56%) were infected with DENY, with a predominance of DENV-2. Among these DENY positive cases, a co-infection with CHIKV for 6 patients (3.68%) and with ZIKV for 1 patient (0.61%) were found. 19 patients out of 182 were negative for arboviruses. This study provides evidence of co-infection of arboviruses in Southern Thailand and highlight the importance of testing DENV and other medically important arboviruses, such as CHIKV and ZIKV simultaneously.
C1 [Suwanmanee, San; Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, 420-6 Rajchawithi Rd, Bangkok 10400, Thailand.
   [Surasombatpattana, Pornnapat] Prince Songkla Univ, Fac Med, Dept Pathol, Hat Yai, Thailand.
   [Soonthornworasiri, Ngamphol; Maneekan, Pannamas] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.
   [Hamel, Rodolphe; Misse, Dorothee] Univ Montpellier, CNRS, IRD, MIVEGEC UMR 224, Montpellier, France.
RP Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, 420-6 Rajchawithi Rd, Bangkok 10400, Thailand.
EM natthanej.lup@mahidol.ac.th
RI Hamel, Rodolphe/AAG-1714-2020
OI Hamel, Rodolphe/0000-0001-8603-7039; luplertlop,
   natthanej/0000-0001-7964-5298; Soonthornworasiri,
   Ngamphol/0000-0003-1031-7979
FU Jeunes Equipes Associees a l'IRD program through the Institut de
   Recherche pour le Developpement (DENCHICTHAI-JEAI-IRD); Royal Golden
   Jubilee scholarship through Thailand Research Fund [PHD/0001/2557];
   Thailand One Health University Network (THOHUN) through the United
   States Agency for International DevelopmentUnited States Agency for
   International Development (USAID) [017/2016]; Mahidol University;
   European Union's Horizon 2020 research and innovation programme under
   ZIKAlliance [734548]
FX This work was supported by grants from Jeunes Equipes Associees a l'IRD
   program through the Institut de Recherche pour le Developpement
   (DENCHICTHAI-JEAI-IRD), the Royal Golden Jubilee scholarship through
   Thailand Research Fund (scholarship contract no. PHD/0001/2557) to NL
   and SS, Thailand One Health University Network (THOHUN) through the
   United States Agency for International Development (agreement no.
   017/2016), Mahidol University, and the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement No.
   734548.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonklong O, 2016, CAN J INFECT DIS MED, V2016, P1, DOI 10.1155/2016/8062360
   Bottieau E, 2009, EUROSURVEILLANCE, V14, P2
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chan KS, 2009, J MICROBIOL IMMUNOL, V42, P471
   Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529
   Chumsri A, 2018, TROP BIOMED, V35, P111
   de Fuentes-Vicente JA, 2018, ACTA TROP, V183, P23, DOI 10.1016/j.actatropica.2018.04.008
   Deen J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002182
   Ditsuwan T, 2011, ANN EPIDEMIOL, V21, P253, DOI 10.1016/j.annepidem.2010.12.002
   Feder Henry M Jr, 2016, JAAD Case Rep, V2, P422
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   HAMMON WM, 1964, AM J TROP MED HYG, V13, P629, DOI 10.4269/ajtmh.1964.13.629
   HAMMON WM, 1973, AM J TROP MED HYG, V22, P82, DOI 10.4269/ajtmh.1973.22.82
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673
   Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kumaria R, 2010, BRAZ J INFECT DIS, V14, P141, DOI 10.1590/S1413-86702010000200005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241
   Londhey Vikram, 2016, J Assoc Physicians India, V64, P36
   Alvarado-Castro VM, 2016, B MED HOSP INFANT M, V73, P237, DOI 10.1016/j.bmhimx.2016.06.004
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Polwiang S, 2015, J TRAVEL MED, V22, P194, DOI 10.1111/jtm.12193
   Preechaporn W., 2007, INT J BIOENG LIFE SC, V1, P174
   Priya SP, 2017, ACTA TROP, V176, P206, DOI 10.1016/j.actatropica.2017.08.007
   Priya SP, 2017, ACTA TROP, V171, P213, DOI 10.1016/j.actatropica.2017.04.010
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Tuiskunen A., 2011, INFECT ECOL EPIDEMIO, V1, DOI [10.3402/iee.vli0.7240, DOI 10.3402/IEE.VLI0.7240]
   Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO-SEARO, 2011, COMPR GUID PREV CONT, P17
   World Health Organization, 2016, WHOZIKVLAB161
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0
NR 53
TC 4
Z9 4
U1 0
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2018
VL 188
BP 244
EP 250
DI 10.1016/j.actatropica.2018.09.012
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GX9BH
UT WOS:000448093000030
PM 30248317
DA 2020-07-08
ER

PT J
AU Bain, LE
   Ngwain, CG
   Nwobegahay, J
   Sumboh, JG
   Nditanchou, R
   Awah, PK
AF Bain, Luchuo Engelbert
   Ngwain, Chia Gerald
   Nwobegahay, Julius
   Sumboh, Jeffery Gabriel
   Nditanchou, Rogers
   Awah, Paschal Kum
TI Research Ethics Committees (RECs) and epidemic response in low and
   middle income countries
SO PAN AFRICAN MEDICAL JOURNAL
LA English
DT Article
DE Luchuo Engelbert Bain; Athena Institute for Research on Innovation and
   Communication in Health and Life Sciences; Vrije Universiteit Amsterdam
ID BIOETHICS
AB The recent Ebola and Zika virus epidemics in some parts of Africa and Asia have showcased the porosity in disaster preparedness and response, not only in the affected countries, but on a global scale. For the Ebola epidemic, scientifically robust research was started late during the course of the epidemic, with waste of resources and lost research opportunities. Research Ethics Committees have a significant role to play with regards to epidemic response for the future. This paper presents key challenges and opportunities for ethics review during emergencies, specifically for low and middle income countries. There is no better moment to test the efficacy and safety of drugs or vaccines for infected, or at risk populations than during the disaster itself. The main mantras that form the back bone of research ethics review (Helsinki Declaration, the CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects, WHO and the ICH guidelines for Good Clinical Practice) are increasingly showing their limitations. Most protocols are generally from developed countries where the funding originates. Not only is the direct transposition to Low and Middle Income Country (LMIC) settings inappropriate on its own, also, using such guidelines in times of public health disasters might be time consuming, and might also lead to wastage of research opportunities, especially when sociocultural peculiarities, and anthropological research arms are completely excluded or avoided within the care and research packages. Governments should include RECs as key members during the elaboration, and daily functioning of their national public emergency response packages. Developing simple research ethics review guidelines, involvement of health care staff in ethics training, community mobilization, and incorporation of anthropological research during the medical response, research and communication phases, are imperatives in epidemic response.
C1 [Bain, Luchuo Engelbert] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands.
   [Bain, Luchuo Engelbert; Awah, Paschal Kum] CPSHP, BP 7535, Yaounde, Cameroon.
   [Ngwain, Chia Gerald] Northwest Hosp, 5401 Old Court Rd, Randallstown, MD 21133 USA.
   [Nwobegahay, Julius] Mil Hlth Res Ctr CRESAR, Yaounde, Cameroon.
   [Nwobegahay, Julius] Yaounde Mil Hosp, Yaounde, Cameroon.
   [Sumboh, Jeffery Gabriel] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, POB 581, Legon, Ghana.
   [Nditanchou, Rogers] Natl Programme Fight TB, North Region, Cameroon.
   [Awah, Paschal Kum] Univ Yaounde I, FALSS, Dept Anthropol, Yaounde, Cameroon.
RP Bain, LE (corresponding author), Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands.
CR Alirol E, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0204-y
   Awah PK, 2015, PAN AFR MED J S1, V22
   Ayukekbong JA, 2016, J EPIDEMIOL COMMUN H, V70, P1, DOI 10.1136/jech-2015-206138
   Bain LE, 2017, RES ETHICS
   Calain P., 2016, J MED ETHICS
   Eckenwiler L, 2015, BIOETHICS, V29, P653, DOI 10.1111/bioe.12193
   Ejeta LT, 2015, PLOS CURR, P7
   Eyal N, 2014, J MED ETHICS, V40, P437, DOI 10.1136/medethics-2012-100490
   Folayan MO, 2015, PAN AFR MED J S1, V22
   Mezinska S, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0148-7
   Oukem-Boyer OOM, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0110-8
   Richardson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168975
   Rishu AH, 2017, J CRIT CARE, V40, P7, DOI 10.1016/j.jcrc.2017.02.009
   Saenz C, 2016, LANCET GLOB HEALTH, V4, pE686, DOI 10.1016/S2214-109X(16)30222-4
   Tangwa GB, 2017, THEOR MED BIOETH, V38, P101, DOI 10.1007/s11017-017-9402-3
   Thielman NM, 2016, CLIN TRIALS, V13, P83, DOI 10.1177/1740774515619897
   Thompson AK, 2016, BRIT MED BULL, V117, P5, DOI 10.1093/bmb/ldv055
   2017, J MED ETHICS, V43, P334, DOI DOI 10.1136/MEDETHICS-2016-103862
   2017, LANCET, V389, P2455
NR 19
TC 1
Z9 1
U1 0
U2 1
PU AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET
PI KAMPALA
PA PO BOX 12874, KAMPALA, 00000, UGANDA
SN 1937-8688
J9 PAN AFR MED J
JI Pan Afr. Med. J.
PD NOV 28
PY 2018
VL 31
AR 209
DI 10.11604/pamj.2018.31.209.17076
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HY0EO
UT WOS:000467783800001
PM 31447968
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Van Vlack, ER
   Seeliger, JC
AF Van Vlack, Erik R.
   Seeliger, Jessica C.
TI Acid Trip: Zika Virus Goes Off-Pathway during pH-Triggered Membrane
   Fusion
SO ACS CENTRAL SCIENCE
LA English
DT Editorial Material
C1 [Van Vlack, Erik R.; Seeliger, Jessica C.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.
RP Seeliger, JC (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.
EM jessica.seeliger@stonybrook.edu
RI Seeliger, Jessica/J-3344-2014
OI Seeliger, Jessica/0000-0001-7148-1073
CR Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Goodsell DS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002140
   Rawle RJ, 2018, ACS CENTRAL SCI, V4, P1503, DOI 10.1021/acscentsci.8b00494
   Rawle RJ, 2016, BIOPHYS J, V111, P123, DOI 10.1016/j.bpj.2016.05.048
   White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 6
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2374-7943
EI 2374-7951
J9 ACS CENTRAL SCI
JI ACS Central Sci.
PD NOV 28
PY 2018
VL 4
IS 11
BP 1454
EP 1456
DI 10.1021/acscentsci.8b00706
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA HC0XY
UT WOS:000451524400003
PM 30555896
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rawle, RJ
   Webster, ER
   Jelen, M
   Kasson, PM
   Boxer, SG
AF Rawle, Robert J.
   Webster, Elizabeth R.
   Jelen, Marta
   Kasson, Peter M.
   Boxer, Steven G.
TI pH Dependence of Zika Membrane Fusion Kinetics Reveals an Off-Pathway
   State
SO ACS CENTRAL SCIENCE
LA English
DT Article
ID VIRUS ENVELOPE PROTEIN; DENGUE VIRUS; SINGLE-PARTICLE; WEST-NILE;
   MATURATION; INFECTION; GLYCOPROTEIN; DYNAMICS; ENTRY; STAGE
AB The recent spread of Zika virus stimulated extensive research on its structure, pathogenesis, and immunology, but mechanistic study of entry has lagged behind, in part due to the lack of a defined reconstituted system. Here, we report Zika membrane fusion measured using a platform that bypasses these barriers, enabling observation of single-virus fusion kinetics without receptor reconstitution. Surprisingly, target membrane binding and low pH are sufficient to trigger viral hemifusion to liposomes containing only neutral lipids. Second, although the extent of hemifusion strongly depends on pH, hemifusion rates are relatively insensitive to pH. Kinetic analysis shows that an off-pathway state is required to capture this pH-dependence and suggests this may be related to viral inactivation. Our surrogate-receptor approach thus yields new understanding of flaviviral entry mechanisms and should be applicable to many emerging viruses.
C1 [Rawle, Robert J.; Jelen, Marta; Kasson, Peter M.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
   [Rawle, Robert J.; Jelen, Marta; Kasson, Peter M.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Webster, Elizabeth R.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
   [Kasson, Peter M.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, S-75124 Uppsala, Sweden.
RP Kasson, PM (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.; Kasson, PM (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.; Kasson, PM (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, S-75124 Uppsala, Sweden.; Boxer, SG (corresponding author), 380 Roth Way, Stanford, CA 94305 USA.
EM kasson@virginia.edu; sboxer@stanford.edu
OI Webster, Elizabeth/0000-0003-2764-1118
FU University of Virginia Research Development Award; Wallenberg Academy
   Fellowship; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R35
   GM118044]; NSFNational Science Foundation (NSF); Stanford ChEM-H
   Chemistry/Biology Interface Predoctoral Training Program
FX This work was supported by a University of Virginia Research Development
   Award and a Wallenberg Academy Fellowship to P.M.K. and National
   Institutes of Health Grant R35 GM118044 to S.G.B. E.R.W. was supported
   by an NSF predoctoral fellowship and from the Stanford ChEM-H
   Chemistry/Biology Interface Predoctoral Training Program. The authors
   thank Isabel Goronzy (Stanford) for designing and performing the RT-qPCR
   measurements and Stephen Harrison and Luke Chao for helpful discussions
   on kinetic modeling.
CR Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Chan YHM, 2007, P NATL ACAD SCI USA, V104, P18913, DOI 10.1073/pnas.0706114104
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Costello DA, 2012, ANAL CHEM, V84, P8480, DOI 10.1021/ac3006473
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Esposito DLA, 2015, J GEN VIROL, V96, P1702, DOI 10.1099/vir.0.000113
   Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hsu HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35537
   Hughes L. D., 2013, THESIS
   Ivanovic T, 2013, ELIFE, V2, DOI 10.7554/eLife.00333
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kim IS, 2017, P NATL ACAD SCI USA, V114, pE28, DOI 10.1073/pnas.1618883114
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kyoung MJ, 2013, NAT PROTOC, V8, P1, DOI 10.1038/nprot.2012.134
   Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095
   Matos PM, 2013, J BIOL CHEM, V288, P12416, DOI 10.1074/jbc.M113.462028
   Medina F, 2012, CURR PROTOC MICROBIO, V27
   Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Rawle RJ, 2016, BIOPHYS J, V111, P123, DOI 10.1016/j.bpj.2016.05.048
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Wessels L, 2007, BIOPHYS J, V93, P526, DOI 10.1529/biophysj.106.097485
   White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]
   White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389
   Yang ST, 2010, BIOPHYS J, V99, P2525, DOI 10.1016/j.bpj.2010.08.029
   Zaitseva E, 2017, CELL HOST MICROBE, V22, P99, DOI 10.1016/j.chom.2017.06.012
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877
NR 52
TC 7
Z9 7
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2374-7943
EI 2374-7951
J9 ACS CENTRAL SCI
JI ACS Central Sci.
PD NOV 28
PY 2018
VL 4
IS 11
BP 1503
EP 1510
DI 10.1021/acscentsci.8b00494
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA HC0XY
UT WOS:000451524400009
PM 30555902
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jansen, S
   Heitmann, A
   Luhken, R
   Jost, H
   Helms, M
   Vapalahti, O
   Schmidt-Chanasit, J
   Tannich, E
AF Jansen, Stephanie
   Heitmann, Anna
   Luehken, Renke
   Joest, Hanna
   Helms, Michelle
   Vapalahti, Olli
   Schmidt-Chanasit, Jonas
   Tannich, Egbert
TI Experimental transmission of Zika virus by Aedes japonicus japonicus
   from southwestern Germany
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID DIPTERA-CULICIDAE; ENCEPHALITIS-VIRUS; VECTOR COMPETENCE; 1ST RECORD;
   MOSQUITOS; IDENTIFICATION; INFECTION; KOREICUS
AB The invasive mosquito species Aedes japonicus japonicus (Ae. japonicus) is widely distributed in Central Europe and is a known vector of various arboviruses in the laboratory, including flaviviruses such as Japanese Encephalitis virus or West Nile virus. However, the vector competence of Ae. japonicus for the recently emerging Zika virus (ZIKV) has not been determined. Therefore, field-caught Ae. japonicus from Germany were orally infected with ZIKV and incubated at 21, 24, or 27 degrees C to evaluate the vector competence under climate conditions representative of the temperate regions (21 degrees C) in the species' main distribution area in Europe and of Mediterranean regions (27 degrees C). Aedes japonicus was susceptible to ZIKV at all temperatures, showing infection rates between 10.0% (21 degrees C) and 66.7% (27 degrees C). However, virus transmission was detected exclusively at 27 degrees C with a transmission rate of 14.3% and a transmission efficiency of 9.5%. Taking into account the present distribution of Ae. japonicus in the temperate regions of Central Europe, the risk of ZIKV transmission by the studied Ae. japonicus population in Central Europe has to be considered as low. Nevertheless, due to the species' vector competence for ZIKV and other mosquito-borne viruses, in combination with the possibility of further spread to Mediterranean regions, Ae. japonicus must be kept in mind as a potential vector of pathogens inside and outside of Europe.
C1 [Jansen, Stephanie; Heitmann, Anna; Luehken, Renke; Joest, Hanna; Helms, Michelle; Schmidt-Chanasit, Jonas; Tannich, Egbert] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas; Tannich, Egbert] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel Riems, D-20359 Hamburg, Germany.
   [Vapalahti, Olli] Univ Helsinki, SF-00100 Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki 00100, Finland.
RP Heitmann, A (corresponding author), Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
EM heitmann@bnitm.de
RI Heitmann, Anna/K-4523-2019
OI Heitmann, Anna/0000-0002-9584-0947; Luhken, Renke/0000-0002-1984-839X;
   Vapalahti, Olli/0000-0003-2270-6824
FU German Federal Ministry of Food and Agriculture (BMEL) through the
   Federal Office for Agriculture and Food (BLE) [28 191.048-15]; German
   Federal Ministry for the Environment, Nature Conservation, Building and
   Nuclear Safety (BMUB) through the Federal Environment Agency (UBA) [FKZ
   3717 48 432 0]
FX We thank Branka Zibrat and Annabell Kuhl for excellent technical
   assistance and Esther Schnettler for reading the manuscript. This work
   was financially supported by the German Federal Ministry of Food and
   Agriculture (BMEL) through the Federal Office for Agriculture and Food
   (BLE) (grant number 28 191.048-15) and by the German Federal Ministry
   for the Environment, Nature Conservation, Building and Nuclear Safety
   (BMUB) through the Federal Environment Agency (UBA) (grant number FKZ
   3717 48 432 0).
CR Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106
   Ayres C, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.86
   Becker N, 2017, PARASITOL RES, V116, P847, DOI 10.1007/s00436-016-5356-z
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciocchetta S, 2018, PATHOG GLOB HEALTH, V112, P107, DOI 10.1080/20477724.2018.1464780
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   ECDC, 2012, GUID SURV INV MOSQ E
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016
   European Centre for Disease Prevention and Control, 2018, AED JAP FACT SHEET E
   European Centre for Disease Prevention and Control (ECDC), VECTORNET EUR NETW S
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huber K, 2014, PARASITOL RES, V113, P3195, DOI 10.1007/s00436-014-3983-9
   Ibanez-Justicia A, 2018, J MED ENTOMOL, V55, P673, DOI 10.1093/jme/tjy002
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   Lambert AJ, 2009, J CLIN MICROBIOL, V47, P2398, DOI 10.1128/JCM.00182-09
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   MILES J. A. R., 1964, BULL WORLD HLTH ORGAN, V30, P197
   Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1
   Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   R Core Team, 2014, R LANG ENV STAT COMP
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Riles MT, 2017, J AM MOSQUITO CONTR, V33, P340, DOI 10.2987/17-6696.1
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Sardelis MR, 2003, J AM MOSQUITO CONTR, V19, P159
   Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635
   Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x
   Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141
   Schonenberger AC, 2016, MED VET ENTOMOL, V30, P39, DOI 10.1111/mve.12155
   Scott J, 2003, THESIS
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tesla B., 2018, TEMPERATURE DRIVES Z
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Veronesi E, 2018, PARASITOL RES, V117, P1925, DOI 10.1007/s00436-018-5886-7
   Versteirt V, 2012, J MED ENTOMOL, V49, P1226, DOI 10.1603/ME11170
   Wagner S, 2018, MED VET ENTOMOL, V32, P175, DOI 10.1111/mve.12292
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Werner D, 2016, PARASITOL RES, V115, P1331, DOI 10.1007/s00436-015-4848-6
   Wickham H., 2016, GGPLOTS2 ELEGANT GRA
   Wickham H., 2017, TIDYR EASILY TIDY DA
   Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01
   Willard A. K., 2017, VIRUSES, V9, pE383
   Wilson AJ, 2018, CURR OPIN INSECT SCI, V28, P105, DOI 10.1016/j.cois.2018.05.007
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 61
TC 8
Z9 8
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD NOV 28
PY 2018
VL 7
AR 192
DI 10.1038/s41426-018-0195-x
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HD1ZT
UT WOS:000452311600005
PM 30482893
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Perez, P
   Marin, MQ
   Lazaro-Frias, A
   de Oya, NJ
   Blazquez, AB
   Escribano-Romero, E
   Sorzano, COS
   Ortego, J
   Saiz, JC
   Esteban, M
   Martin-Acebes, MA
   Garcia-Arriaza, J
AF Perez, Patricia
   Marin, Maria Q.
   Lazaro-Frias, Adrian
   Jimenez de Oya, Nereida
   Blazquez, Ana-Belen
   Escribano-Romero, Estela
   Sorzano, Carlos Oscar S.
   Ortego, Javier
   Saiz, Juan-Carlos
   Esteban, Mariano
   Martin-Acebes, Miguel A.
   Garcia-Arriaza, Juan
TI A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing
   Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CELL IMMUNE-RESPONSES; ENCEPHALITIS-VIRUS; PROTECTS MICE; DNA VACCINE;
   PARTICLE; SYSTEM; LENGTH; MODEL; ACTIVATION; CHALLENGE
AB Zika virus (ZIKV) is a re-emerging mosquito-borne flavivirus that affects humans and can cause severe neurological complications, including Guillain-Barre syndrome and microcephaly. Since 2007 there have been three large outbreaks; the last and larger spread in the Americas in 2015. Actually, ZIKV is circulating in the Americas, Southeast Asia, and the Pacific Islands, and represents a potential pandemic threat. Given the rapid ZIKV dissemination and the severe neurological and teratogenic sequelae associated with ZIKV infection, the development of a safe and efficacious vaccine is critical. In this study, we have developed and characterized the immunogenicity and efficacy of a novel ZIKV vaccine based on the highly attenuated poxvirus vector modified vaccinia virus Ankara (MVA) expressing the ZIKV prM and E structural genes (termed MVA-ZIKV). MVA-ZIKV expressed efficiently the ZIKV structural proteins, assembled in virus-like particles (VLPs) and was genetically stable upon nine passages in cell culture. Immunization of mice with MVA-ZIKV elicited antibodies that were able to neutralize ZIKV and induced potent and polyfunctional ZIKV-specific CD8(+) T cell responses that were mainly of an effector memory phenotype. Moreover, a single dose of MVA-ZIKV reduced significantly the viremia in susceptible immunocompromised mice challenged with live ZIKV. These findings support the use of MVA-ZIKV as a potential vaccine against ZIKV.
C1 [Perez, Patricia; Marin, Maria Q.; Lazaro-Frias, Adrian; Esteban, Mariano; Garcia-Arriaza, Juan] CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain.
   [Jimenez de Oya, Nereida; Blazquez, Ana-Belen; Escribano-Romero, Estela; Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
   [Sorzano, Carlos Oscar S.] CSIC, CNB, Biocomp Unit, Madrid, Spain.
   [Ortego, Javier] CISA, INIA, Madrid, Spain.
RP Esteban, M; Garcia-Arriaza, J (corresponding author), CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain.; Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
EM mesteban@cnb.csic.es; emailmartin.mangel@inia.es; jfgarcia@cnb.csic.es
RI de Oya, Nereida Jimenez/T-6449-2019; ortego, javier/K-6020-2014;
   Blazquez, Ana/G-9791-2015; Ortego, Javier/M-6810-2019; Escribano-Romero,
   Estela/H-1495-2015; Martin-Acebes, Miguel A./L-2258-2014
OI de Oya, Nereida Jimenez/0000-0003-3129-813X; ortego,
   javier/0000-0002-4275-7277; Blazquez, Ana/0000-0002-0847-0977; Ortego,
   Javier/0000-0002-4275-7277; Escribano-Romero,
   Estela/0000-0002-5036-7607; Martin-Acebes, Miguel A./0000-0001-6015-3613
FU Spanish grants [SAF2013-45232-R, SAF2017-88089-R, AGL2014-56518-JIN,
   RTA2001300013-C04-01-E, ZIKA-BIO-2016-02]; Spanish Ministry of Health
   and Education
FX This research was supported by Spanish grants SAF2013-45232-R and
   SAF2017-88089-R (AEI/MINECO/FEDER-EU) to Mariano Esteban;
   AGL2014-56518-JIN (MINECO) to Miguel A. Martin-Acebes; and
   RTA2001300013-C04-01-E (MINECO) and ZIKA-BIO-2016-02 (INIA) to
   Juan-Carlos Saiz. Patricia Perez received a Formacion de Personal
   Investigador PhD fellowship from the Spanish Ministry of Health and
   Education. We thank Cristina Sanchez Corzo and Victoria Jimenez for
   expert technical assistance in cell culture, virus growth and
   purification. We also thank Silvia Gutierrez and Ana Ona from the CNB
   Advanced Light Microscopy Facility for their valuable support in
   confocal microscopy experiments, Cristina Patino from the CNB Electron
   Microscopy Service for their valuable work with the electron microscopy
   and Ivan Jareno from the CNB Animal Facilities for their help and
   assistance.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Di Pilato M, 2015, J GEN VIROL, V96, P2360, DOI 10.1099/vir.0.000183
   Di Pilato M, 2013, J GEN VIROL, V94, P2771, DOI 10.1099/vir.0.057299-0
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Eudailey JA, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00505-17
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Garcia-Arriaza J, 2014, J VIROL, V88, P3392, DOI 10.1128/JVI.02723-13
   Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894
   Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244
   Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gomez CE, 2013, J VIROL, V87, P7282, DOI 10.1128/JVI.03246-12
   Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazaro-Frias A, 2018, J VIROL, V92, DOI 10.1128/JVI.00363-18
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Martin-Acebes MA, 2016, VACCINE, V34, P2066, DOI 10.1016/j.vaccine.2016.03.015
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pellegrino P, 2015, AUTOIMMUN REV, V14, P880, DOI 10.1016/j.autrev.2015.05.014
   Platt A, 2013, CURR TOP MED CHEM, V13, P2597, DOI 10.2174/15680266113136660185
   Price PJR, 2013, VACCINE, V31, P4231, DOI 10.1016/j.vaccine.2013.03.017
   Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000
   Roques P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.83527
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sanchez-Sampedro L, 2015, VIRUSES-BASEL, V7, P1726, DOI 10.3390/v7041726
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001
   Watad A, 2017, LUPUS, V26, P675, DOI 10.1177/0961203316686406
   Zhang S, 2009, MOL IMMUNOL, V46, P1988, DOI 10.1016/j.molimm.2009.03.008
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 68
TC 7
Z9 7
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 26
PY 2018
VL 8
AR 17385
DI 10.1038/s41598-018-35724-6
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB6LV
UT WOS:000451182100057
PM 30478418
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rusanov, T
   Kent, T
   Saeed, M
   Hoang, TM
   Thomas, C
   Rice, CM
   Pomerantz, RT
AF Rusanov, Timur
   Kent, Tatiana
   Saeed, Mohsan
   Hoang, Trung M.
   Thomas, Crystal
   Rice, Charles M.
   Pomerantz, Richard T.
TI Identification of a Small Interface between the Methyltransferase and
   RNA Polymerase of NS5 that is Essential for Zika Virus Replication
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSCRIPTION INITIATION; DENGUE;
   INHIBITION; MECHANISM; REVEALS; ANALOGS
AB The spread of Zika virus (ZIKV) has caused an international health emergency due to its ability to cause microcephaly in infants. Yet, our knowledge of how ZIKV replicates at the molecular level is limited. For example, how the non-structural protein 5 (NS5) performs replication, and in particular whether the N-terminal methytransferase (MTase) domain is essential for the function of the C-terminal RNA-dependent RNA polymerase (RdRp) remains unclear. In contrast to previous reports, we find that MTase is absolutely essential for all activities of RdRp in vitro. For instance, the MTase domain confers stability onto the RdRp elongation complex (EC) and and is required for de novo RNA synthesis and nucleotide incorporation by RdRp. Finally, structure function analyses identify key conserved residues at the MTase-RdRp interface that specifically activate RdRp elongation and are essential for ZIKV replication in Huh-7.5 cells. These data demonstrate the requirement for the MTase-RdRp interface in ZIKV replication and identify a specific site within this region as a potential site for therapeutic development.
C1 [Rusanov, Timur; Kent, Tatiana; Hoang, Trung M.; Thomas, Crystal; Pomerantz, Richard T.] Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, Fels Inst Canc Res, Philadelphia, PA 19122 USA.
   [Saeed, Mohsan; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
RP Pomerantz, RT (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, Fels Inst Canc Res, Philadelphia, PA 19122 USA.
EM richard.pomerantz@temple.edu
OI Rusanov, Timur/0000-0002-4054-3611
CR Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482
   Calmels C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03038-8
   Chatrin C, 2018, ONCOTARGET, V9, P3160, DOI 10.18632/oncotarget.23223
   Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Elfiky AA, 2018, SAR QSAR ENVIRON RES, V29, P409, DOI 10.1080/1062936X.2018.1454981
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467
   Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685
   Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200
   Mehellou Y, 2018, J MED CHEM, V61, P2211, DOI 10.1021/acs.jmedchem.7b00734
   Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   van de Beek D, 2017, NAT REV NEUROL, V13, P69, DOI 10.1038/nrneurol.2016.202
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Zhao BT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14586
   Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010
NR 47
TC 5
Z9 5
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 26
PY 2018
VL 8
AR 17384
DI 10.1038/s41598-018-35511-3
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB6LV
UT WOS:000451182100056
PM 30478404
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matthews, BJ
   Dudchenko, O
   Kingan, SB
   Koren, S
   Antoshechkin, I
   Crawford, JE
   Glassford, WJ
   Herre, M
   Redmond, SN
   Rose, NH
   Weedall, GD
   Wu, Y
   Batra, SS
   Brito-Sierra, CA
   Buckingham, SD
   Campbell, CL
   Chan, SK
   Cox, E
   Evans, BR
   Fansiri, T
   Filipovic, I
   Fontaine, A
   Gloria-Soria, A
   Hall, R
   Joardar, VS
   Jones, AK
   Kay, RGG
   Kodali, VK
   Lee, J
   Lycett, GJ
   Mitchell, SN
   Muehling, J
   Murphy, MR
   Omer, AD
   Partridge, FA
   Peluso, P
   Aiden, AP
   Ramasamy, V
   Rasic, G
   Roy, S
   Saavedra-Rodriguez, K
   Sharan, S
   Sharma, A
   Smith, ML
   Turner, J
   Weakley, AM
   Zhao, ZL
   Akbari, OS
   Black, WC
   Cao, H
   Darby, AC
   Hill, CA
   Johnston, JS
   Murphy, TD
   Raikhel, AS
   Sattelle, DB
   Sharakhov, IV
   White, BJ
   Zhao, L
   Aiden, EL
   Mann, RS
   Lambrechts, L
   Powell, JR
   Sharakhova, MV
   Tu, ZJ
   Robertson, HM
   McBride, CS
   Hastic, AR
   Korlach, J
   Neafsey, DE
   Phillippy, AM
   Vosshall, LB
AF Matthews, Benjamin J.
   Dudchenko, Olga
   Kingan, Sarah B.
   Koren, Sergey
   Antoshechkin, Igor
   Crawford, Jacob E.
   Glassford, William J.
   Herre, Margaret
   Redmond, Seth N.
   Rose, Noah H.
   Weedall, Gareth D.
   Wu, Yang
   Batra, Sanjit S.
   Brito-Sierra, Carlos A.
   Buckingham, Steven D.
   Campbell, Corey L.
   Chan, Saki
   Cox, Eric
   Evans, Benjamin R.
   Fansiri, Thanyalak
   Filipovic, Igor
   Fontaine, Albin
   Gloria-Soria, Andrea
   Hall, Richard
   Joardar, Vinita S.
   Jones, Andrew K.
   Kay, Raissa G. G.
   Kodali, Vamsi K.
   Lee, Joyce
   Lycett, Gareth J.
   Mitchell, Sara N.
   Muehling, Jill
   Murphy, Michael R.
   Omer, Arina D.
   Partridge, Frederick A.
   Peluso, Paul
   Aiden, Aviva Presser
   Ramasamy, Vidya
   Rasic, Gordana
   Roy, Sourav
   Saavedra-Rodriguez, Karla
   Sharan, Shruti
   Sharma, Atashi
   Smith, Melissa Laird
   Turner, Joe
   Weakley, Allison M.
   Zhao, Zhilei
   Akbari, Omar S.
   Black, William C.
   Cao, Han
   Darby, Alistair C.
   Hill, Catherine A.
   Johnston, J. Spencer
   Murphy, Terence D.
   Raikhel, Alexander S.
   Sattelle, David B.
   Sharakhov, Igor V.
   White, Bradley J.
   Zhao, Li
   Aiden, Erez Lieberman
   Mann, Richard S.
   Lambrechts, Louis
   Powell, Jeffrey R.
   Sharakhova, Maria V.
   Tu, Zhijian
   Robertson, Hugh M.
   McBride, Carolyn S.
   Hastic, Alex R.
   Korlach, Jonas
   Neafsey, Daniel E.
   Phillippy, Adam M.
   Vosshall, Leslie B.
TI Improved reference genome of Aedes aegypti informs arbovirus vector
   control
SO NATURE
LA English
DT Article
ID READ ALIGNMENT; GENE-COMPLEX; DE-NOVO; MOSQUITO; SEX; CHROMOSOME;
   CHROMATIN; PROGRAM; LOCI; HOX
AB Female Aedes aegypti mosquitoes infect more than 400 million people each year with dangerous viral pathogens including dengue, yellow fever, Zika and chikungunya. Progress in understanding the biology of mosquitoes and developing the tools to fight them has been slowed by the lack of a high-quality genome assembly. Here we combine diverse technologies to produce the markedly improved, fully re-annotated AaegL5 genome assembly, and demonstrate how it accelerates mosquito science. We anchored physical and cytogenetic maps, doubled the number of known chemosensory ionotropic receptors that guide mosquitoes to human hosts and egg-laying sites, provided further insight into the size and composition of the sex-determining M locus, and revealed copy-number variation among glutathione S-transferase genes that are important for insecticide resistance. Using high-resolution quantitative trait locus and population genomic analyses, we mapped new candidates for dengue vector competence and insecticide resistance. AaegL5 will catalyse new biological insights and intervention strategies to fight this deadly disease vector.
C1 [Matthews, Benjamin J.; Herre, Margaret; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.
   [Matthews, Benjamin J.; Vosshall, Leslie B.] Howard Hughes Med Inst, New York, NY USA.
   [Matthews, Benjamin J.; Herre, Margaret; Vosshall, Leslie B.] Kavli Neural Syst Inst, New York, NY USA.
   [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA.
   [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Aiden, Erez Lieberman] Rice Univ, Dept Comp Sci, Houston, TX USA.
   [Dudchenko, Olga; Aiden, Erez Lieberman] Rice Univ, Ctr Theoret & Biol Phys, Houston, TX USA.
   [Kingan, Sarah B.; Hall, Richard; Muehling, Jill; Peluso, Paul; Smith, Melissa Laird; Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA.
   [Koren, Sergey; Phillippy, Adam M.] NHGRI, NIH, Bethesda, MD 20892 USA.
   [Antoshechkin, Igor] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Crawford, Jacob E.; Mitchell, Sara N.; Weakley, Allison M.; White, Bradley J.] Verily Life Sci, San Francisco, CA USA.
   [Glassford, William J.; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY USA.
   [Redmond, Seth N.; Neafsey, Daniel E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Redmond, Seth N.; Neafsey, Daniel E.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Rose, Noah H.; Zhao, Zhilei; McBride, Carolyn S.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Rose, Noah H.; Zhao, Zhilei; McBride, Carolyn S.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.
   [Weedall, Gareth D.; Lycett, Gareth J.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.
   [Weedall, Gareth D.] Liverpool John Moores Univ, Liverpool, Merseyside, England.
   [Wu, Yang] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China.
   [Wu, Yang; Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA.
   [Wu, Yang; Sharma, Atashi; Sharakhov, Igor V.; Sharakhova, Maria V.; Tu, Zhijian] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA.
   [Brito-Sierra, Carlos A.; Sharan, Shruti; Hill, Catherine A.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   [Brito-Sierra, Carlos A.; Sharan, Shruti; Hill, Catherine A.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN USA.
   [Buckingham, Steven D.; Partridge, Frederick A.; Sattelle, David B.] UCL, Ctr Resp Biol, UCL Resp, London, England.
   [Campbell, Corey L.; Saavedra-Rodriguez, Karla; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Chan, Saki; Cao, Han; Hastic, Alex R.] Bionano Genom, San Diego, CA USA.
   [Cox, Eric; Joardar, Vinita S.; Kodali, Vamsi K.; Murphy, Michael R.; Murphy, Terence D.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA.
   [Evans, Benjamin R.; Gloria-Soria, Andrea; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.
   [Fansiri, Thanyalak] Armed Forces Res Inst Med Sci AFRIMS, Dept Entomol, Vector Biol & Control Sect, Bangkok, Thailand.
   [Filipovic, Igor; Rasic, Gordana] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.
   [Fontaine, Albin; Lambrechts, Louis] Inst Pasteur, Dept Genomes & Genet, Insect Virus Interact Grp, Paris, France.
   [Fontaine, Albin] Inst Rech Biomed Armees, Dept Malad Infectieuses, Unite Parasitol & Entomol, Marseille, France.
   [Fontaine, Albin; Lambrechts, Louis] CNRS, Unite Mixte Rech 2000, Paris, France.
   [Fontaine, Albin] Aix Marseille Univ, IRD, AP HM,IHU Mediterranee Infect, SSA,UMR Vecteurs Infect Trop & Mediterraneennes V, Marseille, France.
   [Gloria-Soria, Andrea] Connecticut Agr Expt Stn, New Haven, CT 06504 USA.
   [Jones, Andrew K.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford, England.
   [Kay, Raissa G. G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Aiden, Aviva Presser] Rice Univ, Dept Bioengn, Houston, TX USA.
   [Aiden, Aviva Presser] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA.
   [Roy, Sourav; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Ctr Dis Vector Res, Riverside, CA 92521 USA.
   [Roy, Sourav; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
   [Sharma, Atashi; Sharakhov, Igor V.] Virginia Tech, Dept Entomol, Blacksburg, VA USA.
   [Turner, Joe; Darby, Alistair C.] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Akbari, Omar S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.
   [Akbari, Omar S.] Univ Calif San Diego, Tata Inst Genet & Soc, La Jolla, CA USA.
   [Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX USA.
   [Sharakhov, Igor V.; Sharakhova, Maria V.] Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk, Russia.
   [Zhao, Li] Rockefeller Univ, Lab Evolutionary Genet & Genom, 1230 York Ave, New York, NY 10021 USA.
   [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL USA.
RP Matthews, BJ (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.; Matthews, BJ (corresponding author), Howard Hughes Med Inst, New York, NY USA.; Matthews, BJ (corresponding author), Kavli Neural Syst Inst, New York, NY USA.
EM bnmtthws@gmail.com
RI Mitchell, Sara/AAB-5536-2020; Fontaine, Albin/K-4345-2019; Koren,
   Sergey/AAE-8314-2019; Rasic, Gordana/AAO-4360-2020; Sharakhov,
   Igor/B-1972-2008; Phillippy, Adam M/U-5731-2018; Aiden, Erez
   Lieberman/A-2908-2010; Gloria-Soria, Andrea/AAJ-3304-2020; Darby,
   Alistair/I-6485-2012; Turner, Joe/F-7636-2017
OI Fontaine, Albin/0000-0001-6869-6516; Rasic, Gordana/0000-0002-3057-0093;
   Sharakhov, Igor/0000-0003-0752-3747; Phillippy, Adam
   M/0000-0003-2983-8934; Gloria-Soria, Andrea/0000-0002-5401-3988; Darby,
   Alistair/0000-0002-3786-6209; Koren, Sergey/0000-0002-1472-8962; Evans,
   Benjamin/0000-0003-2069-4938; Brito-Sierra, Carlos
   A/0000-0002-9616-6149; Turner, Joe/0000-0003-3138-1427; redmond,
   seth/0000-0003-2653-760X; Lycett, Gareth/0000-0002-2422-053X; Matthews,
   Benjamin/0000-0002-8697-699X; Campbell, Corey L./0000-0002-6384-1259;
   Glassford, William/0000-0003-4007-6731; Zhao, Li/0000-0001-6776-1996;
   Jones, Andrew/0000-0002-7835-0890; Wu, Yang/0000-0002-1207-5566;
   Partridge, Frederick/0000-0001-6236-4297
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110818]; USDAUnited States Department of
   Agriculture (USDA) [2017-05741]; NIH Intramural Research ProgramUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; National Library of MedicineUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM); National Human Genome Research
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Human Genome Research
   Institute (NHGRI); NSFNational Science Foundation (NSF) [PHY-1427654];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI101112, R35GM118336, R21AI121853,
   R01AI123338, T32GM007739, NIH/NCATS UL1TR000043, DP2OD008540,
   U01AI088647, 1R01AI121211, D43TW001130-08, U01HL130010, UM1HG009375,
   5K22AI113060, 1R21AI123937, R00DC012069]; Defence Advanced Research
   Project Agency [HR0011-17-2-0047]; Jane Coffin Childs Memorial Fund;
   Center for Theoretical Biological Physics postdoctoral fellowship;
   Robertson Foundation; McNair Foundation; Welch FoundationThe Welch
   Foundation [Q-1866]; French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious DiseasesFrench National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]; Agence Nationale de la RechercheFrench National
   Research Agency (ANR) [ANR-17-ERC2-0016-01]; European UnionEuropean
   Union (EU) [734584]; Pew and Searle Scholars Programs;
   Klingenstein-Simons Fellowship in the Neurosciences; Verily Life
   Sciences
FX We thank R. Andino; S. Emrich and D. Lawson (Vectorbase); A. A. James,
   M. Kunitomi, C. Nusbaum, D. Severson, N. Whiteman; T. Dickinson, M.
   Hartley and B. Rice (Dovetail Genomics) for early participation in the
   AGWG; C. Bargmann, D. Botstein, E. Jarvis and E. Lander for
   encouragement and facilitation. N. Keivanfar, D. Jaffe and D. M. Church
   (10X Genomics) prepared DNA for structural-variant analysis. We thank A.
   Harmon of the New York Times and acknowledge generous pro bono data and
   analysis from our corporate collaborators. This research was supported
   in part by federal funds from the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health, Department of Health
   and Human Services, under grant number U19AI110818 to the Broad
   Institute (S.N.R. and D.E.N.); USDA 2017-05741 (E.L.A.); NSF PHY-1427654
   Center for Theoretical Biological Physics (E.L.A.); NIH Intramural
   Research Program, National Library of Medicine and National Human Genome
   Research Institute (A.M.P. and S.K.) and the following extramural NIH
   grants: R01AI101112 (J.R.P.), R35GM118336 (R.S.M. and W.J.G.),
   R21AI121853 (M.V.S., I.V.S. and A. S.), R01AI123338 (Z.T.), T32GM007739
   (M.H.), NIH/NCATS UL1TR000043 (Rockefeller University), DP2OD008540
   (E.L.A.), U01AI088647, 1R01AI121211 (W.C.B. IV), Fogarty Training Grant
   D43TW001130-08, U01HL130010 (E.L.A.), UM1HG009375 (E.L.A), 5K22AI113060
   (O.S.A.), 1R21AI123937 (O.S.A.), and R00DC012069 (C.S.M.); Defence
   Advanced Research Project Agency: HR0011-17-2-0047 (O.S.A.). Other
   support was provided by Jane Coffin Childs Memorial Fund (B.J.M.),
   Center for Theoretical Biological Physics postdoctoral fellowship
   (O.D.), Robertson Foundation (L.Z.), and McNair & Welch (Q-1866)
   Foundations (E.L.A.), French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases (grant ANR-10-LABX-62-IBEID to L.L.), Agence
   Nationale de la Recherche grant ANR-17-ERC2-0016-01 (L.L.), European
   Union's Horizon 2020 research and innovation program under ZikaPLAN
   grant agreement no. 734584 (L.L.), Pew and Searle Scholars Programs
   (C.S.M.), Klingenstein-Simons Fellowship in the Neurosciences (C.S.M.).
   A.M.W., B.J.W., J.E.C. and S.N.M. were supported by Verily Life
   Sciences. L.B.V. is an investigator of the Howard Hughes Medical
   Institute.
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   [Anonymous], 2017, GEN DIV AFR MAL VECT, V552, P96
   APOSTOL BL, 1994, AM J TROP MED HYG, V51, P89, DOI 10.4269/ajtmh.1994.51.89
   Artemov GN, 2017, G3-GENES GENOM GENET, V7, P155, DOI 10.1534/g3.116.034959
   Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189
   BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BLACK WC, 1997, MOL BIOL INSECT DIS, P361
   Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112
   Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]
   Cabanettes F, 2018, PEERJ, V6, DOI 10.7717/peerj.4958
   Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354
   Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240
   Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238
   Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697
   Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]
   Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]
   Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065
   Dudchenko O., 2018, JUICEBOX ASSEMBLY TO
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002
   Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x
   English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Fontaine A, 2017, GENOME BIOL EVOL, V9, P2322, DOI 10.1093/gbe/evx171
   Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382
   GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049
   GARRISON E, 2012, GENOMICS, V1207, P3907, DOI DOI 10.1101/1207.3907
   George P, 2010, INSECT MOL BIOL, V19, P675, DOI 10.1111/j.1365-2583.2010.01025.x
   GILCHRIST BM, 1947, HEREDITAS, V33, P175
   Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4
   Goulielmaki E, 2014, INFECT IMMUN, V82, P4865, DOI 10.1128/IAI.02080-14
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002
   Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273
   Hare EE, 2011, METHODS MOL BIOL, V772, P3, DOI 10.1007/978-1-61779-228-1_1
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Jimenez LV, 2004, INSECT MOL BIOL, V13, P37, DOI 10.1046/j.0962-1075.2004.00456.x
   Jones AK, 2010, ADV EXP MED BIOL, V683, P25
   Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110
   Kosambi D.D., 2016, ESTIMATION MAP DISTA, P125, DOI DOI 10.1007/978-81-322-3676-4_16
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Li H, 2013, ALIGNING SEQUENCE RE
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   McClelland GAH, 1962, T ROY SOC TROP MED H, V56, P4
   Merabet S, 2016, TRENDS GENET, V32, P334, DOI 10.1016/j.tig.2016.03.004
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   NEWTON ME, 1978, GENETICA, V48, P137, DOI 10.1007/BF00127510
   Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135
   R Core Team, 2017, R LANG ENV STAT COMP
   Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021
   Rasic G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005096
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Riehle MM, 2017, ELIFE, V6, DOI [10.7554/eLife.25813, 10.7554/elife.25813]
   Robertson HM, 2015, CHEM SENSES, V40, P609, DOI 10.1093/chemse/bjv046
   Sharakhova MV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001335
   Smit A. F. A., 2008, REPEATMODELER OPEN V
   Smit A. F. A., 2013, REPEATMASKER OPEN VE
   Thibaud-Nissen F., 2013, NCBI HDB
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27
   Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052
   Timoshevskiy VA, 2012, JOVE-J VIS EXP, DOI 10.3791/4215
   Turner J, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3090-3
   Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
NR 92
TC 70
Z9 70
U1 14
U2 68
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 22
PY 2018
VL 563
IS 7732
BP 501
EP +
DI 10.1038/s41586-018-0692-z
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB3OD
UT WOS:000450960000043
PM 30429615
OA Green Published
DA 2020-07-08
ER

PT J
AU Yang, CF
   Gopula, B
   Liang, JJ
   Li, JK
   Chen, SY
   Lee, YL
   Chen, CS
   Lin, YL
AF Yang, Chao-Fu
   Gopula, Balraj
   Liang, Jian-Jong
   Li, Jin-Kun
   Chen, Si-Yu
   Lee, Yi-Ling
   Chen, Ching S.
   Lin, Yi-Ling
TI Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus
   replication by blocking host de novo pyrimidine biosynthesis
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID DENGUE VIRUS-REPLICATION; NONNUCLEOSIDE INHIBITOR; ANTIVIRAL ACTIVITY;
   INFECTION; OSU-03012; CELECOXIB; TARGET; INTERFERES; EXPRESSION;
   INDUCTION
AB The genus Flavivirus contains many important pathogens, including dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV). AR-12 is a celecoxib-derived anticancer agent that possesses antiviral activity against a broad range of viruses. We pharmacologically exploited this unique activity to develop additional antiviral agents, resulting in the production of the AR-12 derivatives P12-23 and P12-34. At nanomolar concentrations, these compounds were effective in suppressing DENV, ZIKV and JEV replication, exhibiting 10-fold improvements in the efficacy and selectivity indices as compared to AR-12. Regarding the mode of antiviral action, P12-23 and P12-34 inhibited viral RNA replication but had no effect on viral binding, entry or translation. Moreover, these AR-12 derivatives co-localized with mitochondrial markers, and their antiviral activity was lost in mitochondria-depleted cells. Interestingly, exogenous uridine or orotate, the latter being a metabolite of the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH), abolished the antiviral activity of AR-12 and its derivatives. As DHODH is a key enzyme in the de novo pyrimidine biosynthesis pathway, these AR-12 derivatives may act by targeting pyrimidine biosynthesis in host cells to inhibit viral replication. Importantly, treatment with P12-34 significantly improved the survival of mice that were subcutaneously challenged with DENV. Thus, P12-34 may warrant further evaluation as a therapeutic to control flaviviral outbreaks.
C1 [Yang, Chao-Fu; Liang, Jian-Jong; Li, Jin-Kun; Chen, Si-Yu; Lee, Yi-Ling; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.
   [Yang, Chao-Fu; Gopula, Balraj; Chen, Ching S.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.
   [Gopula, Balraj; Chen, Ching S.] China Med Univ, Drug Dev Ctr, Taichung 40402, Taiwan.
   [Chen, Ching S.] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40447, Taiwan.
   [Lin, Yi-Ling] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.
RP Lin, YL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.; Chen, CS (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.; Chen, CS (corresponding author), China Med Univ, Drug Dev Ctr, Taichung 40402, Taiwan.; Chen, CS (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40447, Taiwan.; Lin, YL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.
EM cschencmu@gmail.com; yll@ibms.sinica.edu.tw
RI Lin, Yi-Ling/N-7128-2018
OI Lin, Yi-Ling/0000-0002-1838-6410
FU Academia SinicaAcademia Sinica - Taiwan [106-2101-01-11-01,
   107-2101-01-18-03]; Ministry of Science and Technology, TaiwanMinistry
   of Science and Technology, Taiwan [MOST 107-0210-01-19-01, MOST
   107-2321-B-001-027]
FX This work was supported by Academia Sinica (106-2101-01-11-01 &
   107-2101-01-18-03) and the Ministry of Science and Technology, Taiwan
   (MOST 107-0210-01-19-01 and MOST 107-2321-B-001-027).
CR Aminizadeh E, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.28537
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108
   Booth L, 2016, J CELL PHYSIOL, V231, P2286, DOI 10.1002/jcp.25431
   Chen HH, 2017, ANTIVIR RES, V142, P158, DOI 10.1016/j.antiviral.2017.02.015
   Chen YC, 2016, ONCOTARGET, V7, P50401, DOI 10.18632/oncotarget.10409
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chiu HC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-110
   Chiu HC, 2009, ANTIMICROB AGENTS CH, V53, P5236, DOI 10.1128/AAC.00555-09
   Collier MA, 2016, INT J PHARMACEUT, V499, P186, DOI 10.1016/j.ijpharm.2016.01.004
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200
   GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279
   GOLDRING ES, 1970, J MOL BIOL, V52, P323, DOI 10.1016/0022-2836(70)90033-1
   Hamed HA, 2010, CANCER BIOL THER, V9, P526, DOI 10.4161/cbt.9.7.11116
   Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108
   Johnson AJ, 2005, BLOOD, V105, P2504, DOI 10.1182/blood-2004-05-1957
   KARLE JM, 1984, J BIOL CHEM, V259, P67
   Khutornenko AA, 2014, ACTA NATURAE, V6, P69, DOI 10.32607/20758251-2014-6-1-69-75
   Koselny K, 2016, ACS INFECT DIS, V2, P268, DOI 10.1021/acsinfecdis.5b00134
   Lai JH, 2017, BIOCHEM PHARMACOL, V129, P14, DOI 10.1016/j.bcp.2017.01.005
   Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005
   Liang JJ, 2009, VACCINE, V27, P2746, DOI 10.1016/j.vaccine.2009.03.007
   Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Luthra P, 2018, ANTIVIR RES, V158, P288, DOI 10.1016/j.antiviral.2018.08.012
   Mohr EL, 2015, ANTIVIR RES, V120, P40, DOI 10.1016/j.antiviral.2015.05.003
   Park MA, 2008, MOL PHARMACOL, V73, P1168, DOI 10.1124/mol.107.042697
   PETERS GJ, 1987, INVEST NEW DRUG, V5, P235
   Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10
   Raveh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082318
   Reis RAG, 2017, ARCH BIOCHEM BIOPHYS, V632, P175, DOI 10.1016/j.abb.2017.06.019
   Ren Z, 2017, TOXICOLOGY, V392, P11, DOI 10.1016/j.tox.2017.10.002
   Sawamukai N, 2007, J IMMUNOL, V179, P6479, DOI 10.4049/jimmunol.179.10.6479
   Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377
   Smee Donald F., 2012, Antiviral Chemistry & Chemotherapy, V22, P263, DOI 10.3851/IMP2105
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tseng PH, 2005, BLOOD, V105, P4021, DOI 10.1182/blood-2004-07-2967
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063
NR 49
TC 4
Z9 4
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD NOV 21
PY 2018
VL 7
AR 187
DI 10.1038/s41426-018-0191-1
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HB7FR
UT WOS:000451243400004
PM 30459406
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Engle, SJ
   Blaha, L
   Kleiman, RJ
AF Engle, Sandra J.
   Blaha, Laura
   Kleiman, Robin J.
TI Best Practices for Translational Disease Modeling Using Human
   iPSC-Derived Neurons
SO NEURON
LA English
DT Review
ID PLURIPOTENT STEM-CELLS; REPROGRAMMED HUMAN NEURONS; ZIKA
   VIRUS-INFECTION; MICROGLIA-LIKE CELLS; ON-A-CHIP; HIGH-THROUGHPUT;
   CEREBRAL ORGANOIDS; NEURAL PROGENITORS; EXCITATORY NEURONS; HUMAN
   FIBROBLASTS
AB From the beginning, induced pluripotent stem cell (iPSC) technology was touted as a path to improve our understanding of disease biology and enable drug discovery. Advances in iPSC culture, genome engineering, and differentiation protocols have rapidly expanded the use of iPSC-derived disease models from the specialized work of stem cell biology into the mainstream toolkit of cellular neuroscience. Here we provide guidance for using iPSC-derived neurons for disease modeling with a focus on enabling screening platforms amenable to therapeutic drug discovery. We also highlight the potential for incorporating three-dimensional systems that may create more translational in vitro models.
C1 [Engle, Sandra J.; Blaha, Laura; Kleiman, Robin J.] Biogen, Translat Biol Res & Early Dev, 115 Broadway, Cambridge, MA 02142 USA.
RP Kleiman, RJ (corresponding author), Biogen, Translat Biol Res & Early Dev, 115 Broadway, Cambridge, MA 02142 USA.
EM robin.kleiman@biogen.com
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Adriani G, 2017, LAB CHIP, V17, P448, DOI 10.1039/c6lc00638h
   [Anonymous], 2016, CELL SYST, V3, P209, DOI 10.1016/j.cels.2016.09.007
   Arguel MJ, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1242
   Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335
   Bardy C, 2016, MOL PSYCHIATR, V21, P1573, DOI 10.1038/mp.2016.158
   Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013
   Berry BJ, 2015, BIOTECHNOL PROGR, V31, P1613, DOI 10.1002/btpr.2160
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Brown JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4934713
   Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007
   Burrows CK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005793
   Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chambers Stuart M, 2016, Methods Mol Biol, V1307, P329, DOI 10.1007/7651_2013_59
   Chandrasekaran A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00215
   Chang CW, 2015, CELL REP, V12, P1668, DOI 10.1016/j.celrep.2015.08.013
   Cheng C, 2017, CURR PROTOC HUM GEN, V92, P21
   Choi SH, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0139-7
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358
   Connor B, 2018, STEM CELLS, V36, P146, DOI 10.1002/stem.2747
   D'Antonio M, 2017, STEM CELL REP, V8, P1101, DOI 10.1016/j.stemcr.2017.03.011
   Dandapani Sivaraman, 2012, Curr Protoc Chem Biol, V4, P177
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis-Dusenbery BN, 2014, DEVELOPMENT, V141, P491, DOI 10.1242/dev.097410
   De Sousa PA, 2017, STEM CELL RES, V20, P105, DOI 10.1016/j.scr.2017.03.002
   DeBoever C, 2017, CELL STEM CELL, V20, P533, DOI 10.1016/j.stem.2017.03.009
   Douvaras P, 2017, STEM CELL REP, V8, P1516, DOI 10.1016/j.stemcr.2017.04.023
   Efremova L, 2015, BRIT J PHARMACOL, V172, P4119, DOI 10.1111/bph.13193
   Efthymiou A, 2014, J BIOMOL SCREEN, V19, P32, DOI 10.1177/1087057113501869
   Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156
   Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556
   Flynn R, 2015, EXP HEMATOL, V43, P838, DOI 10.1016/j.exphem.2015.06.002
   Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444
   Garcia-Leon JA, 2018, STEM CELL REP, V10, P655, DOI 10.1016/j.stemcr.2017.12.014
   Germain PL, 2017, STEM CELL REP, V8, P1784, DOI 10.1016/j.stemcr.2017.05.012
   Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017
   Handel AE, 2016, HUM MOL GENET, V25, P989, DOI 10.1093/hmg/ddv637
   Hardingham GE, 2018, NAT REV NEUROSCI, V19, P9, DOI 10.1038/nrn.2017.138
   Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171
   Ho SM, 2016, METHODS, V101, P113, DOI 10.1016/j.ymeth.2015.11.019
   Hollingsworth EW, 2017, EMBO MOL MED, V9, P1742, DOI 10.15252/emmm.201708191
   Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290
   Keller A, 2018, HUM REPROD UPDATE
   Kelley KW, 2016, NEURON, V89, P1, DOI 10.1016/j.neuron.2015.12.030
   Kerman BE, 2015, DEVELOPMENT, V142, P2213, DOI 10.1242/dev.116517
   Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704
   Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403
   Kim Y, 2018, CELL REP, V23, P2550, DOI 10.1016/j.celrep.2018.04.105
   Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011
   Kondo T, 2017, CELL REP, V21, P2304, DOI 10.1016/j.celrep.2017.10.109
   Kummel A, 2010, J BIOMOL SCREEN, V15, P95, DOI 10.1177/1087057109351311
   Kurtz A, 2018, STEM CELL REP, V10, P1, DOI 10.1016/j.stemcr.2017.12.002
   Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009
   La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177499
   Li M, 2017, STEM CELLS, V35, P158, DOI 10.1002/stem.2463
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002
   Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002
   Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]
   Masuda Yoshinobu, 1998, CNS Drug Reviews, V4, P341
   Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618
   Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014
   Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312
   Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001
   Miyagishima KJ, 2016, STEM CELL TRANSL MED, V5, P1562, DOI 10.5966/sctm.2016-0037
   Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876
   Nehme R, 2018, CELL REP, V23, P2509, DOI 10.1016/j.celrep.2018.04.066
   Nishino K, 2016, HUM CELL, V29, P97, DOI 10.1007/s13577-016-0139-5
   Ntai A, 2017, BIOPRESERV BIOBANK, V15, P384, DOI 10.1089/bio.2016.0097
   Odawara A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26181
   Odawara A, 2014, BIOCHEM BIOPH RES CO, V443, P1176, DOI 10.1016/j.bbrc.2013.12.142
   Palmer A. M, 2013, PSYCHIAT NEUROL, V2013
   Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P95, DOI 10.14573/altex.1607121
   Pamies D, 2017, CHEM RES TOXICOL, V30, P43, DOI 10.1021/acs.chemrestox.6b00269
   Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534
   Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4
   Parmar M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156117
   Pre D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103418
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Raj B, 2018, NAT BIOTECHNOL, V36, P442, DOI 10.1038/nbt.4103
   Rao M, 2013, CELL STEM CELL, V13, P389, DOI 10.1016/j.stem.2013.09.005
   Rao MS, 2012, STEM CELL TRANSL MED, V1, P15, DOI 10.5966/sctm.2011-0032
   Roberts B, 2017, MOL BIOL CELL, V28, P2854, DOI 10.1091/mbc.E17-03-0209
   Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999
   Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197
   Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432
   Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b
   Salomonis N, 2016, STEM CELL REP, V7, P110, DOI 10.1016/j.stemcr.2016.05.006
   Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026
   Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070
   Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001
   Shi MJ, 2013, LAB CHIP, V13, P3008, DOI 10.1039/c3lc50249j
   Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA
   Skardal A, 2016, DRUG DISCOV TODAY, V21, P1399, DOI 10.1016/j.drudis.2016.07.003
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014
   Stacey G, 2012, PROG BRAIN RES, V200, P41, DOI 10.1016/B978-0-444-59575-1.00003-X
   Stevens B, 2018, DEV NEUROBIOL, V78, P559, DOI 10.1002/dneu.22594
   Streeter I, 2017, NUCLEIC ACIDS RES, V45, pD691, DOI 10.1093/nar/gkw928
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomas SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005216
   Uzel SGM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501429
   Valenza M, 2015, CELL DEATH DIFFER, V22, P690, DOI 10.1038/cdd.2014.162
   Vincent F, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1201
   Vitale AM, 2012, STEM CELL TRANSL MED, V1, P641, DOI 10.5966/sctm.2012-0043
   Vitaloni M, 2014, J BIOL CHEM, V289, P2084, DOI 10.1074/jbc.M113.538702
   Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019
   Wehling M, 2009, NAT REV DRUG DISCOV, V8, P541, DOI 10.1038/nrd2898
   Wen L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0941-0
   Wendler A, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1329-y
   Wendler A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-39
   Wevers NR, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0108-3
   Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu XH, 2013, STEM CELL RES, V10, P213, DOI 10.1016/j.scr.2012.11.005
   Xu ZQ, 2016, J ALZHEIMERS DIS, V51, P179, DOI 10.3233/JAD-150634
   Yang QZ, 2017, BIOMICROFLUIDICS, V11, DOI 10.1063/1.4982945
   Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011
   Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yumlu S, 2017, METHODS, V121, P29, DOI 10.1016/j.ymeth.2017.05.009
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3
   Zhang NZ, 2016, BRAIN RES, V1638, P42, DOI 10.1016/j.brainres.2015.09.020
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113
   Zhao J, 2017, HUM MOL GENET, V26, P2690, DOI 10.1093/hmg/ddx155
   Zhao PL, 2015, BRAIN RES, V1615, P51, DOI 10.1016/j.brainres.2015.04.027
   Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 139
TC 22
Z9 22
U1 2
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD NOV 21
PY 2018
VL 100
IS 4
BP 783
EP 797
DI 10.1016/j.neuron.2018.10.033
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA HB0VN
UT WOS:000450736600008
PM 30465765
OA Bronze
DA 2020-07-08
ER

PT J
AU Sornjai, W
   Jaratsittisin, J
   Auewarakul, P
   Wikan, N
   Smith, DR
AF Sornjai, Wannapa
   Jaratsittisin, Janejira
   Auewarakul, Prasert
   Wikan, Nitwara
   Smith, Duncan R.
TI Analysis of Zika virus neutralizing antibodies in normal healthy Thais
SO SCIENTIFIC REPORTS
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; DENGUE VIRUS; INFECTION; VACCINE;
   FLAVIVIRUSES; OUTBREAK; ASSAY; IGM
AB Zika virus (ZIKV) infections have been reported from all over Thailand, but the number of reported cases remains low, suggesting a degree of immune protection against ZIKV infection. To address this possibility, the presence of ZIKV neutralizing antibodies was determined in serum from 135 healthy Thai adults with a plaque reduction neutralization test (PRNT), and a number of samples were subsequently analyzed for the presence of neutralizing antibodies to dengue virus (DENV) and Japanese encephalitis virus (JEV). Results showed that 70.4% (PRNT50 >= 10), 55.6 (PRNT50 >= 20) or 22.2% (PRNT90 >= 20) of the samples showed neutralizing antibodies to ZIKV. Detailed analysis showed no association between the presence of neutralizing antibodies to other flaviviruses (DENV, JEV) and the presence of ZIKV neutralizing antibodies. These results suggest that the level of ZIKV neutralizing antibodies in the Thai population is enough to dampen the transmission of the virus in Thailand.
C1 [Sornjai, Wannapa; Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.
   [Jaratsittisin, Janejira; Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Bangkok, Thailand.
RP Wikan, N; Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Bangkok, Thailand.
EM nitwara.wik@mahidol.ac.th; duncan_r_smith@hotmail.com
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU National Science and Technology Development Agency [P-16-50685,
   FDA-CO-2559-1569-TH]; Thailand Research FundThailand Research Fund
   (TRF); Mahidol University [BRG6080006, IRN58W0002]; Office of Higher
   Education CommissionOffice of Higher Education Commission (OHEC);
   Thailand Research FundThailand Research Fund (TRF) [MRG5980168]; Mahidol
   University Post-Doctoral Fellowship
FX D.R.S. is supported by the National Science and Technology Development
   Agency (P-16-50685 and FDA-CO-2559-1569-TH) and the Thailand Research
   Fund and Mahidol University (BRG6080006 and IRN58W0002). N.W. is
   supported by the Office of Higher Education Commission and the Thailand
   Research Fund (MRG5980168). W.S. is supported by a Mahidol University
   Post-Doctoral Fellowship. The funders had no role in the design or
   interpretation of this work, or in the decision to submit for
   publication.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buddhari D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003230
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chanthavanich P, 2018, HUM VACC IMMUNOTHER, V14, P900, DOI 10.1080/21645515.2017.1414763
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fortuna C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2320-1
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   Lindholm DA, 2017, AM J TROP MED HYG, V96, P903, DOI 10.4269/ajtmh.16-0635
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nealon J., 2018, J INFECT DIS
   Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07
   Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paulke-Korinek M, 2015, VACCINE, V33, P3600, DOI 10.1016/j.vaccine.2015.05.037
   Pengsaa K, 2003, ANN TROP PAEDIATR, V23, P159, DOI 10.1179/027249303322296466
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Perret C, 2005, J INFECTION, V51, P287, DOI 10.1016/j.jinf.2004.10.003
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rungruengphol C, 2015, MICROB PATHOGENESIS, V86, P18, DOI 10.1016/j.micpath.2015.07.003
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48
   Sithisarn P, 2003, J MED VIROL, V71, P532, DOI 10.1002/jmv.10520
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tappe D, 2013, EURO SURVEILL, V19
   Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   WHO, 2007, GUID PLAQ RED NEUTR
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 57
TC 5
Z9 5
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 21
PY 2018
VL 8
AR 17193
DI 10.1038/s41598-018-35643-6
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB1FV
UT WOS:000450767000028
PM 30464242
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, TJ
   Ma, F
   Ma, XC
   Jia, WZ
   Pan, EX
   Cheng, GH
   Chen, L
   Sun, CJ
AF Wu, Tongjin
   Ma, Feng
   Ma, Xiuchang
   Jia, Weizhe
   Pan, Enxiang
   Cheng, Genhong
   Chen, Ling
   Sun, Caijun
TI Regulating Innate and Adaptive Immunity for Controlling SIV Infection by
   25-Hydroxycholesterol
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE HIV/SIV; inflammation; CTL; immunotherapy; 25-HC
ID CD4(+) T-CELLS; HIV VACCINE DEVELOPMENT; LIPID RAFTS; FOLLOW-UP;
   CHOLESTEROL; MACROPHAGES; INFLAMMATION; ACTIVATION; INTERFERON;
   ACQUISITION
AB Persistent inflammation and extensive immune activation have been associated with HIV-1/SIV pathogenesis. Previously, we reported that cholesterol-25-hydroxylase (CH25H) and its metabolite 25-hydroxycholesterol (25-HC) had a broad antiviral activity in inhibiting Zika, Ebola, and HIV-1 infection. However, the underlying immunological mechanism of CH25H and 25-HC in inhibiting viral infection remains poorly understood. We report here that 25-HC effectively regulates immune responses for controlling viral infection. CH25H expression was interferon-dependent and induced by SIV infection in monkey-derived macrophages and PBMC cells, and 25-HC inhibited SIV infection both in permissive cell lines and primary monkey lymphocytes. 25-HC also strongly inhibited bacterial lipopolysaccharide (LPS)-stimulated inflammation and restricted mitogen-stimulated proliferation in primary monkey lymphocytes. Strikingly, 25-HC promoted SIV-specific IFN-y-producing cellular responses, but selectively suppressed proinflammatory CD4+ T lymphocytes secreting IL-2 and INF-a cytokines in vaccinated mice. In addition, 25-HC had no significant immunosuppressive effects on cytotoxic CD8+ T lymphocytes or antibody-producing B lymphocytes. Collectively, 25-HC modulated both innate and adaptive immune responses toward inhibiting HIV/SIV infection. This study provides insights into improving vaccination and immunotherapy regimes against HIV-1 infection.
   HIGHLIGHTS
   - The expression of CH25H was induced by interferon stimulation and SIV infection.
   - 25-HC strongly inhibited inflammation and restricted mitogen-stimulated proliferation in primary monkey lymphocytes.
   -25-HC promoted the SIV vaccine-elicited antigen-specific IFN-y-producing cellular responses, but selectively suppressed proinflammatory CD4+ T lymphocytes secreting IL-2 and TNF-alpha cytokines in vaccinated mice.
   - 25-HC had no significant immunosuppressive effects on cytotoxic CD8+ T lymphocytes or antibody-producing B lymphocytes.
   - These results demonstrate that 25-HC is beneficial for regulating the inflammation, innate immunity and adaptive immune responses toward inhibiting HIV-1/SIV virus infection.
C1 [Wu, Tongjin; Jia, Weizhe; Sun, Caijun] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Guangdong, Peoples R China.
   [Wu, Tongjin; Ma, Xiuchang; Pan, Enxiang; Chen, Ling; Sun, Caijun] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
   [Ma, Feng; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.
   [Ma, Feng; Cheng, Genhong] Peking Union Med Coll, Beijing, Peoples R China.
   [Ma, Feng; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou, Peoples R China.
   [Wu, Tongjin] Anhui Univ, Sch Life Sci, Hefei, Anhui, Peoples R China.
   [Jia, Weizhe] Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Shijiazhuang, Hebei, Peoples R China.
   [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA.
RP Sun, CJ (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Guangdong, Peoples R China.; Chen, L; Sun, CJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
EM chen_ling@gibh.ac.cn; suncaijun@mail.sysu.edu.cn
FU Municipal Health and Medical cooperation innovation Major Project of
   Guangzhou City [201704020219, 201803040002]; Science and Technology
   Planning Project of Guangdong Province [2017A020212005]; National
   Science and Technology Major Project of China [2018ZX10731101-002];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31370923, 81471606, 31670883, 31870912]; CAMS
   Initiative for Innovative Medicine [2016-I2M-1-005]
FX We would like to thank Yichu Liu, Xuehua Zheng and the staff at the
   Animal Center of GIBH for their excellent technical assistance. We
   appreciate the NIH AIDS Research and Reference Reagent Program for
   providing SIV peptide pools. This work was supported by the Municipal
   Health and Medical cooperation innovation Major Project of Guangzhou
   City (201704020219, 201803040002), the Science and Technology Planning
   Project of Guangdong Province (2017A020212005), the National Science and
   Technology Major Project of China (2018ZX10731101-002), the National
   Natural Science Foundation of China (No. 31370923, 81471606, 31670883
   and 31870912) and the CAMS Initiative for Innovative Medicine (No.
   2016-I2M-1-005).
CR Bahbouhi B, 2004, BLOOD, V103, P4581, DOI 10.1182/blood-2003-12-4172
   Bernal E, 2008, AIDS PATIENT CARE ST, V22, P569, DOI 10.1089/apc.2007.0186
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Brichacek B, 2014, AIDS RES HUM RETROV, V30, P947, DOI 10.1089/aid.2014.0156
   Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112
   Chalmin F, 2015, J AUTOIMMUN, V56, P45, DOI 10.1016/j.jaut.2014.10.001
   Chen YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07242
   Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487
   Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119
   Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755
   Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029
   Doms A, 2018, J VIROL, V92, DOI [10.1128/jvi.01047-18, 10.1128/JVI.01047-18]
   Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a
   Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342
   Forwell AL, 2016, J NEUROIMMUNOL, V291, P70, DOI 10.1016/j.jneuroim.2015.12.014
   Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111
   Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9
   Hanley TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000981
   Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111
   Jang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13129
   Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093143
   Kaplan R, 2002, J LIPID RES, V43, P952
   Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005
   Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318
   Penaloza-MacMaster P, 2015, SCIENCE, V347, P278, DOI 10.1126/science.aaa2148
   Preuss I, 2014, BIOCHEM BIOPH RES CO, V446, P663, DOI 10.1016/j.bbrc.2014.01.069
   Rappocciolo G, 2014, MBIO, V5, DOI 10.1128/mBio.01031-13
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   Shive CL, 2014, J INFECT DIS, V210, P619, DOI 10.1093/infdis/jiu125
   Simon A, 2014, NEW ENGL J MED, V371, P1933, DOI 10.1056/NEJMcibr1412016
   Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054
   Sun CJ, 2013, J VIROL, V87, P5669, DOI 10.1128/JVI.03247-12
   Sun CJ, 2010, J INFECTION, V60, P371, DOI 10.1016/j.jinf.2010.03.005
   Terahara K, 2014, J VIROL, V88, P14232, DOI 10.1128/JVI.02032-14
   Tsai MY, 2005, J LAB CLIN MED, V145, P323, DOI 10.1016/j.lab.2005.03.009
   Vaidya SA, 2014, J INFECT DIS, V210, P1042, DOI 10.1093/infdis/jiu206
   Vu CN, 2013, METABOLISM, V62, P1014, DOI 10.1016/j.metabol.2013.01.020
NR 41
TC 4
Z9 4
U1 2
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 21
PY 2018
VL 9
AR 2686
DI 10.3389/fimmu.2018.02686
PG 14
WC Immunology
SC Immunology
GA HB1TL
UT WOS:000450809000001
PM 30524435
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU El Ghouzzi, V
   Bianchi, FT
   Molineris, I
   Mounce, BC
   Berto, GE
   Rak, M
   Lebon, S
   Aubry, L
   Tocco, C
   Gai, M
   Chiotto, AMA
   Sgro, F
   Pallavicini, G
   Simon-Loriere, E
   Passemard, S
   Vignuzzi, M
   Gressens, P
   Di Cunto, F
AF El Ghouzzi, Vincent
   Bianchi, Federico T.
   Molineris, Ivan
   Mounce, Bryan C.
   Berto, Gaia E.
   Rak, Malgorzata
   Lebon, Sophie
   Aubry, Laetitia
   Tocco, Chiara
   Gai, Marta
   Chiotto, Alessandra M. A.
   Sgro, Francesco
   Pallavicini, Gianmarco
   Simon-Loriere, Etienne
   Passemard, Sandrine
   Vignuzzi, Marco
   Gressens, Pierre
   Di Cunto, Ferdinando
TI ZIKA virus elicits P53 activation and genotoxic stress in human neural
   progenitors similar to mutations involved in severe forms of genetic
   microcephaly (vol 7, e2440, 2016)
SO CELL DEATH & DISEASE
LA English
DT Correction
C1 [El Ghouzzi, Vincent; Rak, Malgorzata; Lebon, Sophie; Passemard, Sandrine; Gressens, Pierre] Unversite Paris Diderot, Sorbonne Paris Cite, INSERM, PROTECT, Paris, France.
   [Bianchi, Federico T.; Molineris, Ivan; Berto, Gaia E.; Tocco, Chiara; Gai, Marta; Chiotto, Alessandra M. A.; Sgro, Francesco; Pallavicini, Gianmarco; Di Cunto, Ferdinando] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.
   [Mounce, Bryan C.; Vignuzzi, Marco] Inst Pasteur, Ctr Natl Rech Sci, UMR 3569, Viral Populat & Pathogenesis Unit, Paris, France.
   [Aubry, Laetitia] AFM, UEVE, UMR 861, I Stem, Evry, France.
   [Simon-Loriere, Etienne] Inst Pasteur, Funct Genet Infect Dis Unit, F-75724 Paris, France.
   [Simon-Loriere, Etienne] CNRS, URA3012, F-75015 Paris, France.
   [Passemard, Sandrine] Hop Robert Debre, Dept Genet, Paris, France.
   [Gressens, Pierre] Kings Coll London, Ctr Developing Brain, London, England.
   [Di Cunto, Ferdinando] Neurosci Inst Turin, Turin, Italy.
RP Gressens, P (corresponding author), Unversite Paris Diderot, Sorbonne Paris Cite, INSERM, PROTECT, Paris, France.; Di Cunto, F (corresponding author), Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.; Gressens, P (corresponding author), Kings Coll London, Ctr Developing Brain, London, England.; Di Cunto, F (corresponding author), Neurosci Inst Turin, Turin, Italy.
EM pierre.gressens@inserm.fr; ferdinando.dicunto@unito.it
RI gressens, pierre/M-7557-2017; Pallavicini, Gianmarco/AAQ-3254-2020
OI gressens, pierre/0000-0002-0909-4221; Pallavicini,
   Gianmarco/0000-0002-7735-3010; Molineris, Ivan/0000-0003-2102-0804
CR El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
NR 1
TC 1
Z9 1
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD NOV 20
PY 2018
VL 9
AR 1155
DI 10.1038/s41419-018-1159-8
PG 1
WC Cell Biology
SC Cell Biology
GA HA8TE
UT WOS:000450565400002
PM 30459303
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lum, FM
   Zhang, W
   Lim, KC
   Malleret, B
   Teo, TH
   Koh, JJ
   Lee, KJ
   Chua, TK
   Kam, YW
   Yee, WX
   Huen, I
   Tan, JJL
   Amrun, SN
   Prakash, KNB
   Cozzone, PJ
   Renia, L
   Lee, PTH
   Ng, LFP
AF Lum, Fok-Moon
   Zhang, Wei
   Lim, Kheng-Choon
   Malleret, Benoit
   Teo, Teck-Hui
   Koh, Jun-Jia
   Lee, Kuan J.
   Chua, Tze-Kwang
   Kam, Yiu-Wing
   Yee, Wearn-Xin
   Huen, Isaac
   Tan, Jeslin J. L.
   Amrun, Siti Naqiah
   Prakash, Bhanu K. N.
   Cozzone, Patrick J.
   Renia, Laurent
   Lee, Philip T. H.
   Ng, Lisa F. P.
TI Multimodal assessments of Zika virus immune pathophysiological responses
   in marmosets
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NONHUMAN-PRIMATES; VIRAL DYNAMICS; WHOLE-BLOOD; CASE SERIES; INFECTION;
   RHESUS; OUTBREAK; MODELS; INFLAMMATION; RESOLUTION
AB Animal models that recapitulate the human pathophysiology have been developed as useful research tools. Although laboratory mice are widely used, they are phylogenetically "distant" to humans. New world monkeys, such as the common marmoset (Callithrix jacchus) have steadily gained prominence. In this report, marmosets are explored as an alternate in vivo model to investigate infection and immunity of Zika virus (ZIKV). Multimodal platforms, including ultrasound and magnetic resonance imaging (MRI), flow cytometry, and multiplex microbead immunoassays were established to comprehensively decipher immune responses and pathophysiological outcomes. While ZIKV-infected marmosets had detectable ZIKV RNA load in various body fluids, animals did not develop any observable lesions in their testes and brains as shown by ultrasound and MRI. Immune-phenotyping detected differences in the numbers of B cells, CD8+ T cells and HLADR+ NK cells during the first two weeks of infection. Neutralizing ZIKV-specific antibodies were elicited to high levels and targeted epitopes in the E protein. This study presents a one-stop-shop platform to study infection and pathophysiology in marmosets. While marmoset-specific research tools are being refined, the research values of these animals present them as a good model for immune-based therapies.
C1 [Lum, Fok-Moon; Malleret, Benoit; Teo, Teck-Hui; Chua, Tze-Kwang; Kam, Yiu-Wing; Yee, Wearn-Xin; Tan, Jeslin J. L.; Amrun, Siti Naqiah; Renia, Laurent; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.
   [Zhang, Wei; Koh, Jun-Jia] ASTAR, Biol Resource Ctr, Singapore 138668, Singapore.
   [Lim, Kheng-Choon; Lee, Kuan J.; Huen, Isaac; Prakash, Bhanu K. N.; Cozzone, Patrick J.; Lee, Philip T. H.] ASTAR, Singapore Bioimaging Consortium, Singapore 138667, Singapore.
   [Lim, Kheng-Choon] Singapore Gen Hosp, Dept Diagnost Radiol, Singapore 169608, Singapore.
   [Malleret, Benoit; Renia, Laurent] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117545, Singapore.
   [Ng, Lisa F. P.] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3GL, Merseyside, England.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore.
RP Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore 138648, Singapore.; Lee, PTH (corresponding author), ASTAR, Singapore Bioimaging Consortium, Singapore 138667, Singapore.; Ng, LFP (corresponding author), Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3GL, Merseyside, England.; Ng, LFP (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.; Ng, LFP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore.
EM philip_lee@sbic.a-star.edu.sg; lisa_ng@immunol.a-star.edu.sg
RI Malleret, Benoit/AAK-4048-2020; Prakash, KN/AAI-7884-2020; Malleret,
   Benoit/E-9159-2011
OI Malleret, Benoit/0000-0001-9658-7528; Prakash, KN/0000-0002-7555-7431;
   Malleret, Benoit/0000-0001-9658-7528; Ng, Lisa/0000-0003-4071-5222; Lee,
   Kuan/0000-0002-5853-6321; Lum, Fok Moon/0000-0002-5645-7048
FU Singapore Immunology Network (SIgN)Agency for Science Technology &
   Research (ASTAR); Singapore Bioimaging Consortium (SBIC) by BMRC; BMRC
   A*STAR-led Zika Virus Consortium Fund, A*STAR, Singapore
   [15/1/82/27/001]
FX We would like to thank Leslie Retnam, Hannes Hentze, Arun Kumar
   Manickam, Jan Bibay Antonio, Shiela Margallo, Frannie Teo, Mandy Tan,
   Pierce Lee, Marcel Kng, Muhd Farhan Bin Abu Alias Abdul Majid, Mohamad
   Yusuf Bin Ali from Biological Resource Centre, A*STAR and John C. Allen,
   Duke-NUS Graduate Medical School for assisting in this study. We would
   also like to thank Tan Bien Soo, Tay Kiang Hiong, Thng Choon Hua,
   Winston Lim and Chan Lai Peng, RADSC ACP Singhealth for their support
   through the SGH-SBIC attachment programme. We would also want to thank
   Benjamin Seet and Shih-Wee Seow from the Biomedical Research Council
   (BMRC), A*STAR, for the initiation of this work. This work was supported
   by core research grants provided to the Singapore Immunology Network
   (SIgN) and the Singapore Bioimaging Consortium (SBIC) by BMRC, and also
   by the BMRC A*STAR-led Zika Virus Consortium Fund (project number
   15/1/82/27/001), A*STAR, Singapore.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594
   Baronti C, 2014, GENOME ANNOUNC, V2
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erickson AK, 2015, J GEN VIROL, V96, P1328, DOI 10.1099/vir.0.000075
   Ericsson Aaron C, 2013, Mo Med, V110, P201
   Favoretto S., 2016, BIORXIV, DOI [10.1101/049395049395, DOI 10.1101/049395049395]
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gao GF, 2017, J VIROL, V91
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grocott T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20732
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hsieh ML, 2009, ASIAN J ANDROL, V11, P261, DOI 10.1038/aja.2008.48
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lankau EW, 2014, J AM ASSOC LAB ANIM, V53, P278
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Orsi A, 2011, REGUL TOXICOL PHARM, V59, P19, DOI 10.1016/j.yrtph.2010.12.003
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014
   Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281
   Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Radbruch A, 2009, EUR J IMMUNOL, V39, P1991, DOI 10.1002/eji.200939772
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tardif S, 2006, ILAR J, V47, P307, DOI 10.1093/ilar.47.4.307
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Woollard SM, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030070
   Xu BY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2032-y
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
NR 76
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 20
PY 2018
VL 8
AR 17125
DI 10.1038/s41598-018-35481-6
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HA9EI
UT WOS:000450598700005
PM 30459473
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Song, JZ
   Mauk, MG
   Hackett, BA
   Cherry, S
   Bau, HH
   Liu, CC
AF Song, Jinzhao
   Mauk, Michael G.
   Hackett, Brent A.
   Cherry, Sara
   Bau, Haim H.
   Liu, Changchun
TI Instrument-Free Point-of-Care Molecular Detection of Zika Virus (vol 88,
   pg 7289, 2016)
SO ANALYTICAL CHEMISTRY
LA English
DT Correction
CR Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
NR 1
TC 1
Z9 1
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD NOV 20
PY 2018
VL 90
IS 22
BP 13814
EP 13814
DI 10.1021/acs.analchem.8b04878
PG 1
WC Chemistry, Analytical
SC Chemistry
GA HB7GS
UT WOS:000451246100090
PM 30379066
OA Bronze
DA 2020-07-08
ER

PT J
AU Pagliusi, S
   Dennehy, M
   Kim, H
AF Pagliusi, Sonia
   Dennehy, Maureen
   Kim, Hun
CA DCVMN AGM Organizing Comm
TI Vaccines, inspiring innovation in health
SO VACCINE
LA English
DT Article; Proceedings Paper
CT Annual General Meeting of the
   Developing-Countries-Vaccine-Manufacturers-Network
CY SEP 25-27, 2017
CL Seoul, SOUTH KOREA
SP Developing Countries Vaccine Manufacturers Network
DE Vaccine manufacturing; Procurement; Epidemic; Stockpiling; Developing
   countries; Technology
ID ROTAVIRUS VACCINE; CELL; ADULTS
AB This report covers the topics of pandemics, epidemics and partnerships, including regulatory convergence initiatives, new technologies and novel vaccines, discussed by leading public and private sector stakeholders at the 18th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers' Network (DCVMN). Contributions of Gavi and the vaccine industry from emerging countries to the growing global vaccine market, by improving the supply base from manufacturers in developing countries and contributing to 58% of doses, were highlighted. The Coalition for Epidemic Preparedness Innovations (CEPI), the International Vaccine Institute (IVI) and others reported on new strategies to ensure speedy progress in preclinical and clinical development of innovative vaccines for future MERS, Zika or other outbreak response. Priorities for vaccine stockpiling, to assure readiness during emergencies and to prevent outbreaks due to re-emerging diseases such as yellow fever, cholera and poliomyelitis, were outlined. The role of partnerships in improving global vaccine access, procurement and immunization coverage, and shared concerns were reviewed. The World Health Organization (WHO) and other international collaborating partners provided updates on the Product, Price and Procurement database, the prequalification of vaccines, the control of neglected tropical diseases, particularly the new rabies elimination initiative, and regulatory convergence proposals to accelerate vaccine registration in developing countries. Updates on supply chain innovations and novel vaccine platforms were presented. The discussions enabled members and partners to reflect on efficiency of research & development, supply chain tools and trends in packaging technologies improving delivery of existing vaccines, and allowing a deeper understanding of the current public-health objectives, industry financing, and global policies, required to ensure optimal investments, alignment and stability of vaccine supply in developing countries. (C) 2018 The Authors. Published by Elsevier Ltd.
C1 [Pagliusi, Sonia; Dennehy, Maureen] DCVMN Int, Route Crassier 7, CH-1262 Nyon, Switzerland.
   [Kim, Hun] SK Chem, Vaccine Business Grp, SK Chem Complex 332, Seongnam Si 13493, Gyeonggi Do, South Korea.
RP Pagliusi, S (corresponding author), DCVMN Int, Route Crassier 7, CH-1262 Nyon, Switzerland.
EM s.pagliusi@dcvmn.net; maureen@qast.co.za; ebolakim@sk.com
FU Merck GroupMerck & Company; Temp time Corporation; GE HealthcareGE
   Healthcare; Bioengineering; Biozeen; GEA; Bosch; OMPI (Stevanato Group);
   Applikon Biotechnology; Alfa Wasserman; Munters; Gihon Laboratories;
   Univercells; Bill & Melinda Gates FoundationGates Foundation
   [OPP1175118]
FX We are grateful to SK Chemicals for hosting and supporting the
   participation of DCVMN members. We are indebted to all speakers and
   moderators. We thank corporate partners for supporting DCVMN with
   unrestricted educational grants: Merck Group, Temp time Corporation, GE
   Healthcare, Bioengineering, Biozeen, GEA, Bosch, OMPI (Stevanato Group),
   Applikon Biotechnology, Alfa Wasserman, Munters, Gihon Laboratories,
   Univercells. This conference was partly supported by a grant from the
   Bill & Melinda Gates Foundation, Grant No. OPP1175118.
CR Akanmori B, 2015, WHO DRUG INFORM, V29, P127
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P193
   [Anonymous], 2015, GS1 HEALTHCARE REFER
   AVMI. Vaccine manufacturing and procurement in Africa, 2017, VACC MAN PROC AFR AN
   Baik YO, 2015, VACCINE, V33, P6360, DOI 10.1016/j.vaccine.2015.08.075
   Burton RL, 2017, CLIN VACCINE IMMUNOL, V24, P1, DOI [10.1128/CV1.00457-16, DOI 10.1128/CV1.00457-16]
   Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06
   CEPI, 2017, PREL BUS PLAN 2017 2
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Dellepiane N, CHALLENGES REGISTRAT
   Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6
   Gavi, 2016, ANN PROGR REP, P65
   Gavi, 2017, SUPPL PROC ROADM
   Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165
   Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085
   Isanaka S, 2017, NEW ENGL J MED, V376, P1121, DOI [10.1056/NEJMoa1609462, 10.1056/nejmoa1609462]
   Kile JC, 2017, MMWR-MORBID MORTAL W, V66, P928, DOI 10.15585/mmwr.mm6635a2
   Kothari S, 2013, VACCINE, V31, P4714, DOI 10.1016/j.vaccine.2013.08.037
   Kwon DC, 2017, INAUGRAL ADDRESS DCV
   Lee LA, 2013, VACCINE, V31, pB61, DOI 10.1016/j.vaccine.2012.11.035
   Maiga D, 2009, VACCINE, V28, P571, DOI 10.1016/j.vaccine.2009.09.117
   Millman AJ, 2015, EMERG INFECT DIS, V21, P741, DOI 10.3201/eid2105.141756
   MSF, 2015, RIGHT SHOT BRING DOW
   MSF, 2017, FAIR SHOT VACC AFF U, P37
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Naik SP, 2017, VACCINE, V35, P2962, DOI 10.1016/j.vaccine.2017.04.025
   Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446
   SAGE, 2017, ASS REP GLOB VACC AC, P30
   Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382
   UNICEF, 2017, SUPPL ANN REP, P103
   WHO, 2017, WHOIVB17
   WHO, 2016, JOINT EXT EV TOOL IN, P92
   WHO, 2015, GEN PREF PROD PROF V
   WHO, 2017, PROGR CHALL ACH UN I
   WHO, 2017, OUT COLD CHAIN OCC C
   WHO, 2017, V3P PRIC DAT
   WHO, 2014, WHOIVB14
   WHO, 2017, NAT IMM COV SCOR EST
   WHO, 2006, WHOPQSE0
   World Health Organization, 2017, INT NEGL TROP DIS GL
   World Health Organization, 2015, EM US ASS LIST PROC
   Wu UI, 2017, VACCINE, V35, P4099, DOI 10.1016/j.vaccine.2017.06.044
NR 43
TC 2
Z9 2
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 19
PY 2018
VL 36
IS 48
BP 7430
EP 7437
DI 10.1016/j.vaccine.2018.05.035
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HB8PV
UT WOS:000451353700024
PM 29789241
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Horstick, O
   Boyce, R
   Runge-Ranzinger, S
AF Horstick, Olaf
   Boyce, Ross
   Runge-Ranzinger, Silvia
TI Building the evidence base for dengue vector control: searching for
   certainty in an uncertain world
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Review
DE Dengue; vector control; efficacy; community; effectiveness; summary;
   evidence
ID COMMUNITY EFFECTIVENESS; TRANSMISSION; EFFICACY; BURDEN
AB This review discusses biological and chemical methods for dengue vector control, using recently emerging summary evidence, meta-analyses and systematic reviews to conclude on practical public health recommendations for Aedes control, which is increasingly relevant in an era of widespread Chikungunya, yellow feer and Zika outbreaks. The analysis follows an a priori framework of systematic reviews by the authors on vector control methods, distinguishing vector control methods into biological, chemical and environmental methods. Findings of each published systematic review by the authors, following each individual vector control method, are summarised and compared in the discussion against the findings of existing meta-analyses covering all vector control methods. Analysing nine systematic reviews and comparing to two existing meta-analyses provided low-to-moderate evidence that the control of Aedes mosquitoes can be achieved using 1) chemical methods, particularly indoor residual spraying and insecticide treated materials, and 2) biological methods, where appropriate. The level of efficacy and community effectiveness of the methods in most studies analysed is low, as was the overall assessment of study quality. Furthermore, the results show that too optimise results, larvae and adults should be targeted simultaneously. The quality of service delivery is probably one of the most important features of this analysis - and including high coverage. The analysis also highlights the urgent need for standards to guide the design and reporting of vector control studies, ensuring the validity and comparability of results. These studies should aim to include measurements of human transmission data - where and when possible.
C1 [Horstick, Olaf; Runge-Ranzinger, Silvia] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
   [Boyce, Ross] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA.
RP Horstick, O (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
EM Olaf.Horstick@uni-heidelberg.de
OI Boyce, Ross/0000-0002-9489-6324
CR Alonso P, 2017, LANCET, V389, P2270, DOI 10.1016/S0140-6736(17)31376-4
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, P3, DOI DOI 10.1371/J0URNAL.PNTD.0004551
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Gartlehner G, 2006, AHRQ PUBLICATION, V06-0046
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Horstick O, 2018, LANCET INFECT DIS, V18, pE147, DOI 10.1016/S1473-3099(17)30422-X
   Horstick Olaf, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P131
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Maoz D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005651
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Nagpal S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002238
   Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704
   Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Saadatian-Elahi M, 2016, VACCINE, V34, P1139, DOI 10.1016/j.vaccine.2016.01.021
   Samuel M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005837
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   WHO, 2004, GLOB STRAT FRAM INT
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
NR 28
TC 0
Z9 0
U1 2
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD NOV 17
PY 2018
VL 112
IS 8
BP 395
EP 403
DI 10.1080/20477724.2018.1547541
PG 9
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA HG7YX
UT WOS:000455214000001
PM 30521408
OA Green Published
DA 2020-07-08
ER

PT J
AU Kunamneni, A
   Ye, CY
   Bradfute, SB
   Durvasula, R
AF Kunamneni, Adinarayana
   Ye, Chunyan
   Bradfute, Steven B.
   Durvasula, Ravi
TI Ribosome display for the rapid generation of high-affinity
   Zika-neutralizing single-chain antibodies
SO PLOS ONE
LA English
DT Article
ID PHAGE DISPLAY; IN-VITRO; LIBRARIES; VIRUS; SELECTION; MATURATION;
   DOMAIN; MICE
AB Background
   Zika virus (ZIKV) is an emerging pathogen with no approved therapeutics and only limited diagnostics available. To address this gap, six mouse single-chain antibodies (scFvs) to ZIKV envelope (E) protein were isolated rapidly and efficiently from a ribosome-displayed antibody library constructed from the spleens of five immunized mice.
   Methodology/Results
   In this report, we have generated a panel of mouse scFvs to ZIKV E protein using ribosome display. The six scFvs demonstrated no cross-reactivity with DENV2 NGC envelope protein, suggesting specificity for ZIKV E protein. These scFvs showed differences in their affinity: two (scFv45-3, scFv63-1) of them were dominant after four rounds of panning, and showed higher affinity (an apparent Kd values from 19 to 27 nM) than the other four (scFv5-1, scFv7-2, scFv38-1, and scFv51-2). All six scFvs showed ZIKV-neutralizing activity in the plaque reduction neutralization test (PRNT) assay and their neutralizing activity was positively correlated with their affinities.
   Conclusions/Significance
   The scFvs (45-3 and 63-1) with highest affinity may have dual utility as diagnostics capable of recognizing ZIKV E subtypes and may be further developed to treat ZIKV infection. Our approach has the added advantage of generating Fc receptor-deficient antibodies, minimizing concern of antibody-dependent enhancement (ADE) of infection.
C1 [Kunamneni, Adinarayana; Ye, Chunyan; Bradfute, Steven B.; Durvasula, Ravi] Univ New Mexico, Dept Internal Med, Ctr Global Hlth, Albuquerque, NM 87131 USA.
   [Kunamneni, Adinarayana; Durvasula, Ravi] Loyola Univ, Med Ctr, Dept Med, Chicago, IL 60611 USA.
RP Durvasula, R (corresponding author), Univ New Mexico, Dept Internal Med, Ctr Global Hlth, Albuquerque, NM 87131 USA.; Durvasula, R (corresponding author), Loyola Univ, Med Ctr, Dept Med, Chicago, IL 60611 USA.
EM tuanravi@gmail.com
OI Kunamneni, Adinarayana/0000-0002-9952-2209
CR Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250
   Azizi A, 2012, APPL ENVIRON MICROB, V78, P2638, DOI 10.1128/AEM.07807-11
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Chin SE, 2015, J IMMUNOL METHODS, V416, P49, DOI 10.1016/j.jim.2014.10.013
   Cong C, 2016, PROTEOMICS, V16, P1291, DOI 10.1002/pmic.201500412
   Cordy JC, 2015, CLIN EXP IMMUNOL, V182, P139, DOI 10.1111/cei.12680
   Council NR, 1996, NAT SCI ED STAND
   Dong-din-on F, 2015, VIRUSES-BASEL, V7, P154, DOI 10.3390/v7010154
   Dufner P, 2006, TRENDS BIOTECHNOL, V24, P523, DOI 10.1016/j.tibtech.2006.09.004
   Farajnia S, 2014, IMMUNOPHARM IMMUNOT, V36, P297, DOI 10.3109/08923973.2014.945126
   Froude JW, 2017, MABS-AUSTIN, V9, P696, DOI 10.1080/19420862.2017.1299848
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Groves M, 2006, J IMMUNOL METHODS, V313, P129, DOI 10.1016/j.jim.2006.04.002
   Groves MA, 2012, METHODS MOL BIOL, V805, P163, DOI 10.1007/978-1-61779-379-0_10
   Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130
   He MY, 2007, NAT METHODS, V4, P281, DOI 10.1038/NMETH1001
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Ono KI, 2003, J BIOSCI BIOENG, V95, P231, DOI 10.1016/S1389-1723(03)80022-1
   Osbourn J, 2006, Ribosome display, Patent No. [US 7074557 B2, 7074557B2]
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0
   Shen ZH, 2007, ANAL CHEM, V79, P1283, DOI 10.1021/ac061211a
   Tang Jie, 2012, Human Antibodies, V21, P1, DOI 10.3233/HAB-2011-0257
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao XL, 2009, J BIOTECHNOL, V144, P253, DOI 10.1016/j.jbiotec.2009.09.022
NR 26
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2018
VL 13
IS 11
AR e0205743
DI 10.1371/journal.pone.0205743
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HA6WB
UT WOS:000450420900004
PM 30444865
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mumtaz, N
   Koedam, M
   van den Doel, PB
   van Leeuwen, JPTM
   Koopmans, MPG
   van der Eerden, BCJ
   Rockx, B
AF Mumtaz, Noreen
   Koedam, Marijke
   van den Doel, Petra B.
   van Leeuwen, Johannes P. T. M.
   Koopmans, Marion P. G.
   van der Eerden, Bram C. J.
   Rockx, Barry
TI Zika virus infection perturbs osteoblast function
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CHIKUNGUNYA VIRUS; CELLS; EXPRESSION; HISTORY
AB Zika virus (ZIKV) infection is typically characterized by a mild self-limiting disease presenting with fever, rash, myalgia and arthralgia and severe fetal complications during pregnancy such as microcephaly, subcortical calcifications and arthrogyropsis. Virus-induced arthralgia due to perturbed osteoblast function has been described for other arboviruses. In case of ZIKV infection, the role of osteoblasts in ZIKV pathogenesis and bone related pathology remains unknown. Here, we study the effect of ZIKV infection on osteoblast differentiation, maturation and function by quantifying activity and gene expression of key biomarkers, using human bone marrow-derived mesenchymal stromal cells (MSCs, osteoblast precursors). MSCs were induced to differentiate into osteoblasts and we found that osteoblasts were highly susceptible to ZIKV infection. While infection did not cause a cytopathic effect, a significant reduction of key osteogenic markers such as ALP, RUNX2, calcium contents and increased expression of IL6 in ZIKV-infected MSCs implicated a delay in osteoblast development and maturation, as compared to uninfected controls. In conclusion, we have developed and characterized a new in vitro model to study the role of bone development in ZIKV pathogenesis, which will help to identify possible new targets for developing therapeutic and preventive measures.
C1 [Mumtaz, Noreen; van den Doel, Petra B.; Koopmans, Marion P. G.; Rockx, Barry] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
   [Koedam, Marijke; van Leeuwen, Johannes P. T. M.; van der Eerden, Bram C. J.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.
RP Rockx, B (corresponding author), Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.; van der Eerden, BCJ (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.
EM b.vandereerden@erasmusmc.nl; b.rockx@erasmusmc.nl
RI van Leeuwen, Johannes/D-5015-2014
OI van Leeuwen, Johannes/0000-0002-2282-4006
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance [734548]
FX Fatih Anfasa, Widagdo Widagdo, Jurre Y. Siegers, Melanie van Heteren
   (Department of Viroscience, Erasmus MC) and Iris. J. Robbesom - van den
   Berge (Department of Internal Medicine, Erasmus MC) are acknowledged for
   technical support. This work was partially supported by the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   Grant Agreement no. 734548. (NM, BR, MK).
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P298, DOI 10.3201/eid1102.041016
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Both T, 2018, J CELL MOL MED, V22, P873, DOI 10.1111/jcmm.13373
   BRINTON MA, 1982, VIROLOGY, V116, P84, DOI 10.1016/0042-6822(82)90405-6
   Bruedigam C, 2011, CURR PROTOC STEM CEL
   Brzustewicz E, 2015, CYTOKINE, V76, P527, DOI 10.1016/j.cyto.2015.08.260
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111
   Colavita F, 2018, J RHEUMATOL, V45, P443, DOI 10.3899/jrheum.170835
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   Golub E. E, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Granchi D, 2010, TISSUE ENG PART C-ME, V16, P511, DOI [10.1089/ten.tec.2009.0405, 10.1089/ten.TEC.2009.0405]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Jayamali W D, 2017, J Med Case Rep, V11, P307, DOI 10.1186/s13256-017-1483-0
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368
   Roimicher L, 2017, J RHEUMATOL, V44, DOI 10.3899/jrheum.160722
   SCHMALJOHN C, 1977, J VIROL, V24, P580, DOI 10.1128/JVI.24.2.580-589.1977
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stephens AS, 2011, J BIOL CHEM, V286, P30071, DOI 10.1074/jbc.M111.253518
   Terrier CSP, 2017, J INFECTION, V75, P281, DOI 10.1016/j.jinf.2017.07.007
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 26
TC 0
Z9 0
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 16
PY 2018
VL 8
AR 16975
DI 10.1038/s41598-018-35422-3
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HA6TB
UT WOS:000450411700006
PM 30451958
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, YC
   Hu, Y
   Wu, XY
   Huo, NF
   Li, J
   Zhang, S
   Jiang, T
   Kang, XP
AF Li, Yu-Chang
   Hu, Yi
   Wu, Xiao-Yan
   Huo, Nai-Fan
   Li, Jing
   Zhang, Sen
   Jiang, Tao
   Kang, Xiao-Ping
TI A Sensitive Nano Luciferase Immune Complex Assay System for Highly
   Sensitive and Specific Detection of Antibodies Against Tick-Borne
   Encephalitis Virus
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE tick-borne encephalitis; Nano luciferase; envelope domain III; immune
   complex assay
ID IGG ANTIBODIES; FLAVIVIRUSES; DIAGNOSIS
AB Tick-borne encephalitis virus (TBEV) can cause fever, headache, neurological disorders, and/or peripheral flaccid paralysis; therefore, it is a major threat to public health. A rapid, sensitive, and simple method for detecting anti-TBEV antibodies is needed urgently to determine infection and for vaccine evaluation. Here, a luciferase-based immunocomplex assay system (Luc-IC) was developed to detect TBEV antibodies. The system is based on a reporter Nano luciferase (NLuc) that is co-expressed as a fusion protein with viral envelope domain III (ED3) in COS7 cells. The cell supernatant was used directly to detect antigen without the need for a purification step. This simple procedure effectively improved the sensitivity of the assay. Sera from 50 patients with an acute tick-borne encephalitis infection were tested to determine the sensitivity of the NLuc-IC assay. Furthermore, 62 sera from individuals infected with Japanese encephalitis virus, West Nile virus, yellow fever virus, dengue virus, or Zika virus were also tested to determine specificity. The results demonstrated that the assay was 100% sensitive and 100% specific for TBEV antibodies. Thus, this very simple NLuc-IC assay is potentially useful for rapid and accurate diagnosis of TBEV infection in both humans and animals.
C1 [Li, Yu-Chang; Hu, Yi; Wu, Xiao-Yan; Huo, Nai-Fan; Li, Jing; Zhang, Sen; Jiang, Tao; Kang, Xiao-Ping] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China.
   [Jiang, Tao] Anhui Med Univ, Grad Sch, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
RP Kang, XP (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China.; Jiang, T (corresponding author), Anhui Med Univ, Grad Sch, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
EM jiangtao@bmi.ac.cn; kangxiaoping@163.com
RI Tao, Jiang/AAE-6623-2019
OI Tao, Jiang/0000-0003-1908-2926; Li, Jing/0000-0002-6860-6135
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81501789]; National Major Special Program of
   Science and Technology of China Foundation [2018ZX10302401,
   2018ZX10101001-003, AWS15J006]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81501789) and by the National Major Special Program of
   Science and Technology of China Foundation (2018ZX10302401,
   2018ZX10101001-003 and AWS15J006).
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Burbelo PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08
   Burbelo PD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-45
   Burbelo PD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000438
   Burbelo PD, 2009, CLIN VACCINE IMMUNOL, V16, P621, DOI 10.1128/CVI.00474-08
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Chidumayo NN, 2014, DIAGN MICR INFEC DIS, V78, P373, DOI 10.1016/j.diagmicrobio.2013.12.014
   Holbrook MR, 2004, J CLIN MICROBIOL, V42, P4101, DOI 10.1128/JCM.42.9.4101-4110.2004
   Klaus C, 2011, BERL MUNCH TIERARZTL, V124, P443, DOI 10.2376/0005-9366-124-443
   Larsen AL, 2014, SCAND J INFECT DIS, V46, P181, DOI 10.3109/00365548.2013.865140
   Ludolfs D, 2009, J CLIN VIROL, V45, P125, DOI 10.1016/j.jcv.2009.03.016
   Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0
   Morozova OV, 2014, VACCINE, V32, P3101, DOI 10.1016/j.vaccine.2014.02.046
   Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07
   Obara M, 2006, J VIROL METHODS, V134, P55, DOI 10.1016/j.jviromet.2005.11.018
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Schmitz H, 2011, MED MICROBIOL IMMUN, V200, P233, DOI 10.1007/s00430-011-0195-0
   Stenkova AM, 2017, PROTEIN PEPTIDE LETT, V24, P974, DOI 10.2174/0929866524666170724151917
   Stock NK, 2015, J VIROL METHODS, V222, P110, DOI 10.1016/j.jviromet.2015.06.006
   Zhang Y, 2012, VIRUS RES, V167, P310, DOI 10.1016/j.virusres.2012.05.015
NR 21
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAY 1
PY 2019
VL 19
IS 5
BP 365
EP 369
DI 10.1089/vbz.2018.2330
EA NOV 2018
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HW1LF
UT WOS:000450420100001
PM 30431406
DA 2020-07-08
ER

PT J
AU Anderka, M
   Mai, CT
   Judson, EM
   Langlois, PH
   Lupo, PJ
   Hauser, K
   Salemi, JL
   Correia, J
   Canfield, MA
   Kirby, RS
AF Anderka, Marlene
   Mai, Cara T.
   Judson, Emily M.
   Langlois, Peter H.
   Lupo, Philip J.
   Hauser, Kimberlea
   Salemi, Jason L.
   Correia, Jane
   Canfield, Mark A.
   Kirby, Russell S.
CA Natl Birth Defects Prevention Netw
TI Status of population-based birth defects surveillance programs before
   and after the Zika public health response in the United States
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE birth defects; congenital anomalies; population-based surveillance;
   public health emergency response; Zika virus
AB Background Methods The 2016 Zika public health response in the United States highlighted the need for birth defect surveillance (BDS) programs to collect population-based data on birth defects potentially related to Zika as rapidly as possible through enhanced case ascertainment and reporting. The National Birth Defects Prevention Network (NBDPN) assessed BDS program activities in the United States before and after the Zika response. The NBDPN surveyed 54 BDS programs regarding activities before and after the Zika response, lessons learned, and programmatic needs. Follow-up emails were sent and phone calls were held for programs with incomplete or no response to the online survey. Survey data were cleaned and tallied, and responses to open-ended questions were placed into best-fit categories. Results Conclusions A 100% response rate was achieved. Of the 54 programs surveyed, 42 reported participation in the Zika public health response that included BDS activities. Programs faced challenges in expanding their surveillance effort given the response requirements but reported mitigating factors such as establishing and enhancing partnerships and program experience with surveillance and clinical activities. Beyond funding, reported program needs included training, surveillance tools/resources, and availability of clinical experts. Existing BDS programs with experience implementing active case-finding and case verification were able to adapt their surveillance efforts rapidly to collect and report data necessary for the Zika response. Program sustainability for BDS remains challenging; thus, continued support, training, and resource development are important to ensure that the infrastructure built during the Zika response is available for the next public health response.
C1 [Anderka, Marlene] Massachusetts Ctr Birth Defects Res & Prevent, Boston, MA USA.
   [Mai, Cara T.; Judson, Emily M.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Langlois, Peter H.; Canfield, Mark A.] Texas Dept State Hlth Serv, Austin, TX USA.
   [Lupo, Philip J.] Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA.
   [Hauser, Kimberlea] Penn Dept Hlth, Bur Epidemiol, Harrisburg, PA 17108 USA.
   [Salemi, Jason L.] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA.
   [Correia, Jane] Natl Birth Defects Prevent Network, Houston, TX USA.
   [Kirby, Russell S.] Univ S Florida, Dept Community & Family Hlth, Tampa, FL USA.
RP Anderka, M (corresponding author), Bur Family Hlth & Nutr, Massachusetts Ctr Birth Defects Res & Prevent, 250 Washington St, Boston, MA 02108 USA.
EM manderka@live.com
RI Lupo, Philip/R-8314-2019; Salemi, Jason/N-9492-2013
OI Lupo, Philip/0000-0003-0978-5863; Salemi, Jason/0000-0002-0077-6023
FU Intramural CDC HHS [CC999999]
CR Anderka M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2223-2
   Centers for Disease Control and Prevention (CDC), 2016, FUND OPP ANN SURV IN
   Centers for Disease Control and Prevention (CDC), 2018, STOR FIELD FEAT FRON
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lin AE, 2006, BIRTH DEFECTS RES A, V76, P781, DOI 10.1002/bdra.20282
   Lin AE, 2009, BIRTH DEFECTS RES A, V85, P69, DOI 10.1002/bdra.20548
   Mai CT, 2016, J PUBLIC HEALTH MAN, V22, pE1, DOI 10.1097/PHH.0000000000000221
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Toufaily MH, 2018, BIRTH DEFECTS RES, V110, P87, DOI 10.1002/bdr2.1105
NR 10
TC 0
Z9 0
U1 1
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD NOV 15
PY 2018
VL 110
IS 19
SI SI
BP 1388
EP 1394
DI 10.1002/bdr2.1391
PG 7
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA HB9BY
UT WOS:000451387600003
PM 30230268
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Romo, H
   Kenney, JL
   Blitvich, BJ
   Brault, AC
AF Romo, Hannah
   Kenney, Joan L.
   Blitvich, Bradley J.
   Brault, Aaron C.
TI Restriction of Zika virus infection and transmission in Aedes aegypti
   mediated by an insect-specific flavivirus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID WEST-NILE-VIRUS; FUSING AGENT VIRUS; CULEX FLAVIVIRUS; SUPERINFECTION
   EXCLUSION; MOSQUITO; CELLS; COINFECTION; POPULATION; CHICAGO
AB Previous studies demonstrated an insect-specific flavivirus, Nhumirim virus (NHUV), can suppress growth of West Nile virus (WNV) and decrease transmission rates in NHUV/WNV co-inoculated Culex quinquefasciatus. To assess whether NHUV might interfere with transmission of other medically important flaviviruses, the ability of NHUV to suppress viral growth of Zika virus (ZIKV) and dengue-2 virus (DENV-2) was assessed in Aedes albopictus cells. Significant reductions in ZIKV (100,000-fold) and DENV-2 (10,000-fold) were observed in either cells concurrently inoculated with NHUV or pre-inoculated with NHUV. In contrast, only a transient 10-fold titer reduction was observed with an alphavirus, chikungunya virus. Additionally, restricted in vitro mosquito growth of ZIKV was associated with lowered levels of intracellular ZIKV RNA in NHUV co-inoculated cultures. To assess whether NHUV could modulate vector competence for ZIKV, NHUV-inoculated Aedes aegypti were orally exposed to ZIKV. NHUV-inoculated mosquitoes demonstrated significantly lower ZIKV infection rates (18%) compared to NHUV unexposed mosquitoes (51%) (p < 0.002). Similarly, lower ZIKV transmission rates were observed for NHUV/ZIKV dually intrathoracically inoculated mosquitoes (41%) compared to ZIKV only inoculated mosquitoes (78%) (p < 0.0001), suggesting that NHUV can interfere with both midgut infection and salivary gland infection of ZIKV in Ae. aegypti. These results indicate NHUV could be utilized to model superinfection exclusion mechanism(s) and to study the potential for the mosquito virome to impact transmission of medically important flaviviruses.
C1 [Romo, Hannah; Kenney, Joan L.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging Zoonot Infect Dis, Ft Collins, CO 80521 USA.
   [Blitvich, Bradley J.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging Zoonot Infect Dis, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
RI Blitvich, Brad/P-3168-2019; Kenney, Joan L./AAE-7416-2019
OI Kenney, Joanie/0000-0002-6761-4272
FU Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID); National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI114720]; CDCCentre National de la
   Recherche Scientifique (CNRS)United States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX This research was made possible through support provided by the Office
   of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International Development, under the terms of an Interagency Agreement
   with CDC. We gratefully thank Sean Masters and Jason Velez at the CDC
   for mosquito rearing and cell culture support. This work was also
   supported in part by the National Institute of Allergy and Infectious
   Diseases grant AI114720.
CR Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   EATON BT, 1979, J VIROL, V30, P45, DOI 10.1128/JVI.30.1.45-55.1979
   Ellenberg P, 2007, J GEN VIROL, V88, P2730, DOI 10.1099/vir.0.83041-0
   Farfan-Ale JA, 2010, VECTOR-BORNE ZOONOT, V10, P777, DOI 10.1089/vbz.2009.0196
   Goenaga S, 2017, VIRUSES, V7, P5801
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2
   Newman CM, 2017, VECTOR-BORNE ZOONOT, V17, P567, DOI 10.1089/vbz.2017.2124
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011
   VENUGOPAL K, 1992, ARCH VIROL, V125, P251, DOI 10.1007/BF01309642
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Weaver S., 2016, ANNU REV MED, V69, P1
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09
NR 33
TC 11
Z9 12
U1 2
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD NOV 15
PY 2018
VL 7
AR 181
DI 10.1038/s41426-018-0180-4
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HB7FP
UT WOS:000451243200001
PM 30429457
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reyes, L
   Golos, TG
AF Reyes, Leticia
   Golos, Thaddeus G.
TI Hofbauer Cells: Their Role in Healthy and Complicated Pregnancy
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE Hofbauer cells; placental macrophages; preeclampsia; villitis;
   chorioamnionitis; Zika; TORCH
ID HUMAN PLACENTAL MACROPHAGES; SEVERE PREECLAMPSIA; UNKNOWN ETIOLOGY;
   CHORIONIC-VILLI; GESTATIONAL-AGE; VIRAL-INFECTION; IN-VITRO; DC-SIGN;
   FETAL; EXPRESSION
AB Hofbauer cells are placental villous macrophages of fetal origin that are present throughout pregnancy. Although Hofbauer cell populations are antigenically and morphologically heterogeneous, their epigenetic, antigenic, and functional profiles most closely resemble alternatively activated macrophages or what are referred to as M2a, M2b, M2c, and M2d polarity subtypes. Consistent with an M2-like profile, these cells play an important role in placental development including vasculogenesis and angiogenesis. During placental inflammation Hofbauer cells may produce pro-inflammatory cytokines or mediators that damage the villous cell barrier, and induce fibrotic responses within the villi as a continuum of chronic inflammation. However, to date, there is no evidence that Hofbauer cells become classically activated or adopt an M1 polarity phenotype that is able to kill microbes. To the contrary, their predominant M2 like qualities may be why these cells are ineffective in controlling most TORCH infections. Moreover, Hofbauer cells may contribute to vertical transmission of various pathogens to the fetus since they can harbor live virus and serve as reservoirs within the placenta. The goal of this review is to summarize what is currently known about the role of Hofbauer cells in normal and complicated pregnancies that involve immunologic disorders, inflammation, and/or infection.
C1 [Reyes, Leticia] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
RP Reyes, L (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM lreyes2@wisc.edu
RI Reyes, Leticia/H-7338-2019
FU  [R21AI136014-01]
FX This work was supported by award number R21AI136014-01. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883
   Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008
   Ben Amara A, 2013, J IMMUNOL, V191, P5501, DOI 10.4049/jimmunol.1300988
   Benirschke K., 1973, TERATOLOGY, V8, p[1970, 77], DOI [10.1002/tera.1420080118, DOI 10.1002/TERA.1420080118]
   Benirschke K.B.G., 2012, PATHOLOGY HUMAN PLAC
   Bittencourt AL, 2002, PEDIATR PATHOL MOL M, V21, P401, DOI 10.1080/152279502760157768
   Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003
   Breburda EE, 2006, PLACENTA, V27, P11, DOI 10.1016/j.placenta.2004.11.006
   BULMER JN, 1988, IMMUNOLOGY, V63, P707
   BULMER JN, 1984, CLIN EXP IMMUNOL, V57, P393
   CASTELLUCCI M, 1984, GYNECOL OBSTET INVES, V18, P95, DOI 10.1159/000299056
   CASTELLUCCI M, 1980, CELL TISSUE RES, V210, P235
   Cervar M, 1999, CELL TISSUE RES, V295, P297, DOI 10.1007/s004410051236
   Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Rijk EPCT, 2008, TOXICOL PATHOL, V36, p108S, DOI 10.1177/0192623308326095
   Dekel N, 2014, AM J REPROD IMMUNOL, V72, P141, DOI 10.1111/aji.12266
   Demir R, 2004, PLACENTA, V25, P560, DOI 10.1016/j.placenta.2003.11.011
   Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587
   Evsen MS, 2013, ANAL QUANT CYTOL, V35, P283
   Faye-Petersen OM, 2008, J CLIN PATHOL, V61, P1261, DOI 10.1136/jcp.2008.055244
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Genest DR, 1996, HUM PATHOL, V27, P366, DOI 10.1016/S0046-8177(96)90110-0
   GOLDSTEIN J, 1988, AM J PATHOL, V133, P648
   Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khan S, 2000, BIOL REPROD, V62, P1075, DOI 10.1095/biolreprod62.4.1075
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834
   Kim SY, 2012, AM J REPROD IMMUNOL, V68, P8, DOI 10.1111/j.1600-0897.2012.01108.x
   Loegl J, 2016, REPRODUCTION, V152, P447, DOI 10.1530/REP-16-0159
   LUCKETT WP, 1970, ANAT RECORD, V167, P141, DOI 10.1002/ar.1091670203
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   QURESHI F, 1993, HUM PATHOL, V24, P779, DOI 10.1016/0046-8177(93)90016-A
   Reyes L, 2017, RESULTS PROBL CELL D, V62, P45, DOI 10.1007/978-3-319-54090-0_3
   Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Schliefsteiner C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00888
   SCHWARTZ DA, 1992, ARCH PATHOL LAB MED, V116, P21
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Seval Y, 2007, PLACENTA, V28, P841, DOI 10.1016/j.placenta.2007.01.010
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Sultana Z, 2018, AM J OBSTET GYNECOL, V218, pS762, DOI 10.1016/j.ajog.2017.11.567
   SUTTON L, 1983, IMMUNOLOGY, V49, P103
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tamblyn JA, 2013, PLACENTA, V34, P846, DOI 10.1016/j.placenta.2013.07.002
   Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112
   Vinnars MT, 2008, HYPERTENSION, V51, P1295, DOI 10.1161/HYPERTENSIONAHA.107.104844
   Vinnars MTN, 2010, PEDIATR DEVEL PATHOL, V13, P300, DOI 10.2350/09-03-0632-OA.1
   Wolfe B, 2017, MBIO, V8, DOI 10.1128/mBio.01938-16
   Yang SW, 2017, J REPROD IMMUNOL, V124, P30, DOI 10.1016/j.jri.2017.09.012
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
NR 57
TC 14
Z9 14
U1 1
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 15
PY 2018
VL 9
AR 2628
DI 10.3389/fimmu.2018.02628
PG 8
WC Immunology
SC Immunology
GA HA3TS
UT WOS:000450179100001
PM 30498493
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Benelli, G
   Pavela, R
   Petrelli, R
   Cappellacci, L
   Canale, A
   Senthil-Nathan, S
   Maggi, F
AF Benelli, Giovanni
   Pavela, Roman
   Petrelli, Riccardo
   Cappellacci, Loredana
   Canale, Angelo
   Senthil-Nathan, Sengottayan
   Maggi, Filippo
TI Not just popular spices! Essential oils from Cuminum cyminum and
   Pimpinella anisum are toxic to insect pests and vectors without
   affecting non-target invertebrates
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Cuminum cyminum; Pimpinella anisurn; Culex quinquefasciatus;
   Insecticides; Harmonic axyrictis; Eisenia fetida
ID PLANT ESSENTIAL OILS; CULEX-QUINQUEFASCIATUS SAY; APIACEAE ESSENTIAL
   OILS; CHEMICAL-COMPOSITION; MUSCA-DOMESTICA; MYZUS-PERSICAE;
   CABBAGE-LOOPER; TRANS-ANETHOLE; L.; MOSQUITO
AB Each year the flavor and fragrance industry produces more than hundred thousand tons of essential oils. An important portion of this production might be directed to the fabrication of green pesticides relying on the well documented efficacy of many essential oils against insect pests as well as vectors, besides their safety for human health and the environment. In this regard, two popular spices of economic importance, such as cumin (Cuminum cyminum) and anise (Pimpinella anisum), which are not only cheap, readily available, generally recognized as safe (GRAS), but also produces larger amounts of essential oils, are gaining interest for botanical insecticide development. Herein, we evaluated the efficacy of the essential oils obtained from seeds of these two spices on two agricultural pests, i.e., the peach-potato aphid Myzus persicae and the tobacco cutworm Spodoptera hoorahs, and on two insect vectors, i.e., the common housefly Musca domestica and the lymphatic filariasis and Zika virus vector Culex quinquefasciatus. Furthermore, their safety on beneficial organisms such as the earthworm Eisenia fetida and the aphid predator Harmonia axyridis was assessed. The two essential oils, characterized by alpha-terpinen-7-al (35.3%), cumin aldehyde (21.8%), and alpha-terpinen-7-al (15.4%), and (E)-anethole (93.0%), respectively, showed noteworthy effects against all pest targets, with anise more effective on larvae of C. quinquefasciatus (LC50 = 25.4 mu l L-1) and S. hoorahs (LD50 = 57.3 mu g larva(-1)), whereas cumin was more active on adults of M. persicae (LC50 = 3.2 ml L-1) and M. domestica (LD50 = 31.8 mu g adult(1)). Moreover, when compared at sub-lethal concentrations with the commercial insecticide alpha-cypermethrin, they were definitely devoid of toxic effects on E. fetida and H. cayridis. These results represent a milestone to manufacture and commercialize green formulations to be used in crop protection and to combat insect vectors of public importance.
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
   [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106, Czech Republic.
   [Pavela, Roman] Czech Univ Life Sci Prague, Dept Plant Protect, Kamycka 129, Prague 6, Suchdol, Czech Republic.
   [Petrelli, Riccardo; Cappellacci, Loredana; Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Maggi, Filippo] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Pavela, Roman/Q-8647-2016
OI Pavela, Roman/0000-0001-7866-4278
FU BIM Tronto (Bacino Imbrifero Montano, Ascoli Piceno); University of
   Camerino (FAR2014/15, Fondo di Ateneo per la Ricerca) [FPI 000,044];
   Ministry of Agriculture of the Czech RepublicMinistry of Agriculture,
   Czech Republic [RO0417]
FX The authors thank BIM Tronto (Bacino Imbrifero Montano, Ascoli Piceno)
   and its President, Mr. Luigi Contisciani, for financial support, and Mr.
   Sergio Corradetti for furnishing the anise sample. In addition, the
   authors are grateful to University of Camerino (FAR2014/15, Fondo di
   Ateneo per la Ricerca, FPI 000,044). Dr. R. Pavela would like to thank
   the Ministry of Agriculture of the Czech Republic for its financial
   support concerning botanical pesticide and basic substances research
   (Project No. RO0417).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Afshar FH, 2017, IND CROP PROD, V98, P46, DOI 10.1016/j.indcrop.2017.01.004
   Aruna K, 1996, PHYTOTHER RES, V10, P577, DOI 10.1002/(SICI)1099-1573(199611)10:7&lt;577::AID-PTR906&gt;3.0.CO;2-Q
   Benelli G, 2019, SAUDI J BIOL SCI, V26, P921, DOI 10.1016/j.sjbs.2018.06.007
   Benelli G, 2018, IND CROP PROD, V122, P308, DOI 10.1016/j.indcrop.2018.05.032
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700376
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Chang CL, 2009, J ECON ENTOMOL, V102, P203, DOI 10.1603/029.102.0129
   Chaubey Mukesh Kumar, 2017, Journal of Entomology, V14, P148, DOI 10.3923/je.2017.148.154
   Chellappandian M, 2018, ENVIRON INT, V113, P214, DOI 10.1016/j.envint.2017.12.038
   Chen QQ, 2012, SEP PURIF TECHNOL, V98, P136, DOI 10.1016/j.seppur.2012.06.011
   Clark L, 1998, J WILDERNESS MANAGEM, V61, P1352
   Costa AV, 2015, J ESSENT OIL BEAR PL, V18, P374, DOI 10.1080/0972060X.2014.1001200
   Davies MP, 2016, J HOSP INFECT, V94, P263, DOI 10.1016/j.jhin.2016.08.023
   Deletre E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0934-y
   Derakhshan S, 2008, INT J ANTIMICROB AG, V32, P432, DOI 10.1016/j.ijantimicag.2008.05.009
   European Pharmacopoeia, 2005, EUROPEAN PHARMACOPOE, V2
   FFNSC 2, 2012, MASS SPECTR DAT
   Finney D.T., 1971, PROBIT ANAL
   Gondaliya SB, 2018, IND CROP PROD, V111, P908, DOI 10.1016/j.indcrop.2017.10.054
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Iacobellis NS, 2005, J AGR FOOD CHEM, V53, P57, DOI 10.1021/jf0487351
   Iannarelli R, 2018, IND CROP PROD, V114, P81, DOI 10.1016/j.indcrop.2018.01.076
   Iannarelli R, 2017, IND CROP PROD, V104, P99, DOI 10.1016/j.indcrop.2017.04.028
   Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X
   Khanavi M, 2017, J ASIA-PAC ENTOMOL, V20, P1234, DOI 10.1016/j.aspen.2017.08.028
   Kimbaris AC, 2012, PARASITOL RES, V111, P2403, DOI 10.1007/s00436-012-3097-1
   Lashgari Aliasghar, 2014, Archives of Phytopathology and Plant Protection, V47, P324, DOI 10.1080/03235408.2013.809230
   LEUNG AY, 1996, ENCY COMMON NATURAL
   Li R, 2004, FLAVOUR FRAG J, V19, P311, DOI 10.1002/ffj.1302
   Lubbe A, 2011, IND CROP PROD, V34, P785, DOI 10.1016/j.indcrop.2011.01.019
   Maggi F, 2015, FLAVOUR FRAG J, V30, P139, DOI 10.1002/ffj.3221
   Martinez-Velazquez M, 2011, PARASITOL RES, V108, P481, DOI 10.1007/s00436-010-2069-6
   Moghaddam M, 2017, IND CROP PROD, V99, P205, DOI 10.1016/j.indcrop.2017.02.003
   Mollafilabi A, 2010, ACTA HORTIC, V853, P139
   MST 17, 2017, MASS SPECTR LIB NIST
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Nenaah GE, 2011, J PEST SCI, V84, P393, DOI 10.1007/s10340-011-0354-5
   Newberne P, 1999, FOOD CHEM TOXICOL, V37, P789, DOI 10.1016/S0278-6915(99)00037-X
   *OECD, 1984, 207 OECD
   Orav A, 2008, NAT PROD RES, V22, P227, DOI 10.1080/14786410701424667
   Park IK, 2006, PEST MANAG SCI, V62, P723, DOI 10.1002/ps.1228
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10904, DOI 10.1007/s11356-018-1398-3
   Pavela R, 2018, IND CROP PROD, V113, P46, DOI 10.1016/j.indcrop.2018.01.021
   Pavela R, 2017, IND CROP PROD, V109, P603, DOI 10.1016/j.indcrop.2017.09.013
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pavela R, 2013, IND CROP PROD, V51, P87, DOI 10.1016/j.indcrop.2013.08.073
   Pavela R, 2011, PARASITOL RES, V109, P1547, DOI 10.1007/s00436-011-2395-3
   Pavela R, 2008, J ESSENT OIL BEAR PL, V11, P451, DOI 10.1080/0972060X.2008.10643653
   Pinheiro PF, 2013, CIENC AGROTEC, V37, P138, DOI 10.1590/S1413-70542013000200004
   Ponsankar A, 2016, ECOTOX ENVIRON SAFE, V133, P260, DOI 10.1016/j.ecoenv.2016.06.043
   Sahana K, 2011, NUTS AND SEEDS IN HEALTH AND DISEASE PREVENTION, P417, DOI 10.1016/B978-0-12-375688-6.10050-7
   Sayed-Ahmad B, 2017, IND CROP PROD, V109, P661, DOI 10.1016/j.indcrop.2017.09.027
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI 10.1007/978-81-322-2056-5_3.
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Singh R. P., 2017, Pharmacognosy Journal, V9, P292, DOI 10.5530/pj.2017.3.51
   Sut S, 2017, IND CROP PROD, V109, P266, DOI 10.1016/j.indcrop.2017.08.048
   Tabanca N, 2006, J CHROMATOGR A, V1117, P194, DOI 10.1016/j.chroma.2006.03.075
   Tunc I, 2000, J STORED PROD RES, V36, P161, DOI 10.1016/S0022-474X(99)00036-3
   Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006
   Ullah H, 2013, IND CROP PROD, V42, P489, DOI 10.1016/j.indcrop.2012.06.011
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Wanner J, 2010, NAT PROD COMMUN, V5, P1355
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Yeom HJ, 2012, J AGR FOOD CHEM, V60, P7194, DOI 10.1021/jf302009w
   Zahran HEM, 2011, J ASIA-PAC ENTOMOL, V14, P46, DOI 10.1016/j.aspen.2010.11.013
   Ziaee M, 2014, J PEST SCI, V87, P691, DOI 10.1007/s10340-014-0590-6
NR 84
TC 20
Z9 19
U1 4
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD NOV 15
PY 2018
VL 124
BP 236
EP 243
DI 10.1016/j.indcrop.2018.07.048
PG 8
WC Agricultural Engineering; Agronomy
SC Agriculture
GA GX2RZ
UT WOS:000447569100030
DA 2020-07-08
ER

PT J
AU Harsh, S
   Ozakman, Y
   Kitchen, SM
   Paquin-Proulx, D
   Nixon, DF
   Eleftherianos, I
AF Harsh, Sneh
   Ozakman, Yaprak
   Kitchen, Shannon M.
   Paquin-Proulx, Dominic
   Nixon, Douglas F.
   Eleftherianos, Ioannis
TI Dicer-2 Regulates Resistance and Maintains Homeostasis against Zika
   Virus Infection in Drosophila
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HEPATITIS-C VIRUS; ANTIVIRAL IMMUNITY; RNA INTERFERENCE;
   VIRAL-INFECTION; LIPID DROPLETS; DISTINCT ROLES; METABOLIC-RATE; FAT
   STORAGE; PATHWAY; GENES
AB Zika virus (ZIKV) outbreaks pose a massive public health threat in several countries. We have developed an in vivo model to investigate the host-ZIKV interaction in Drosophila. We have found that a strain of ZIKV replicates in wild-type flies without reducing their survival ability. We have shown that ZIKV infection triggers RNA interference and that mutating Dicer-2 results in enhanced ZIKV load and increased susceptibility to ZIKV infection. Using a flavivirus-specific Ab, we have found that ZIKV is localized in the gut and fat body cells of the infected wild-type flies and results in their perturbed homeostasis. In addition, Dicer-2 mutants display severely reduced insulin activity, which could contribute toward the increased mortality of these flies. Our work establishes the suitability of Drosophila as the model system to study host-ZIKV dynamics, which is expected to greatly advance our understanding of the molecular and physiological processes that determine the outcome of this disease.
C1 [Harsh, Sneh; Ozakman, Yaprak; Eleftherianos, Ioannis] George Washington Univ, Dept Biol Sci, Inst Biomed Sci, Washington, DC 20052 USA.
   [Kitchen, Shannon M.; Paquin-Proulx, Dominic; Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, GW Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Paquin-Proulx, Dominic] Henry M Jackson Fdn, US Mil HIV Res Program, Bethesda, MD USA.
RP Eleftherianos, I (corresponding author), George Washington Univ, Dept Biol Sci, Sci & Engn Hall,800 22nd St NW, Washington, DC 20052 USA.
EM ioannise@gwu.edu
OI Paquin Proulx, Dominic/0000-0003-1407-3414; Nixon,
   Douglas/0000-0002-2801-1786; HARSH, SNEH/0000-0002-3224-9586
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI110675]; George Washington University SMHS IMP program
FX This work was supported by an administrative supplement through Grant
   R01AI110675 from the National Institute of Allergy and Infectious
   Diseases and by funds through The George Washington University SMHS IMP
   program (to D.F.N.).
CR Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2
   Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Arnold PA, 2013, J EXP BIOL, V216, P3350, DOI 10.1242/jeb.088138
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Beebe K, 2015, G3-GENES GENOM GENET, V5, P1517, DOI 10.1534/g3.115.019117
   Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504
   Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001
   Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Berrigan D, 1997, COMP BIOCHEM PHYS A, V118, P1301, DOI 10.1016/S0300-9629(97)00030-3
   Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Bonfini A, 2016, DEV COMP IMMUNOL, V64, P22, DOI 10.1016/j.dci.2016.02.008
   Brandt SM, 2008, GENETICS, V180, P1671, DOI 10.1534/genetics.108.089748
   Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763
   Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Castorena Kathryn M, 2010, BMC Genomics, V11, P183, DOI 10.1186/1471-2164-11-183
   Chambers MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050679
   Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808
   Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Chtarbanova S, 2014, J VIROL, V88, P14057, DOI 10.1128/JVI.02320-14
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   Coste F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033416
   Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   DUTTA D, 2013, CURR PROTOC STEM CEL, V27, P2, DOI DOI 10.1002/9780470151808
   Dutta Devanjali, 2015, Curr Protoc Stem Cell Biol, V34, DOI 10.1002/9780470151808.sc02f02s34
   Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951
   Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074
   Figueroa-Clarevega A, 2015, DEV CELL, V33, P47, DOI 10.1016/j.devcel.2015.03.001
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834
   Goto A, 2010, J BIOL CHEM, V285, P15731, DOI 10.1074/jbc.M109.082115
   Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6
   Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232
   Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72
   Hughes TT, 2012, VIROLOGY, V423, P1, DOI 10.1016/j.virol.2011.11.016
   Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671
   Kwon Y, 2015, DEV CELL, V33, P36, DOI 10.1016/j.devcel.2015.02.012
   Lamiable O, 2016, P NATL ACAD SCI USA, V113, P698, DOI 10.1073/pnas.1516122113
   LAUTIEHARIVEL N, 1990, BIOL CELL, V69, P35, DOI 10.1016/0248-4900(90)90326-X
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lu XY, 2001, MAMM GENOME, V12, P741, DOI 10.1007/s00335-01-2055-5
   McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Monsanto-Hearne V, 2017, J GEN VIROL, V98, P1904, DOI 10.1099/jgv.0.000831
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Myllymaki H, 2014, SCAND J IMMUNOL, V79, P377, DOI 10.1111/sji.12170
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   Negro F, 2004, J HEPATOL, V40, P533, DOI 10.1016/j.jhep.2004.01.011
   Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101
   Roingeard P, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12688
   Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schmitt S, 2015, J CELL SCI, V128, P4395, DOI 10.1242/jcs.173740
   Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432
   Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Taracena ML, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006498
   Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Thomson TC, 2012, GENESIS, V50, P453, DOI 10.1002/dvg.22004
   Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Wang ZL, 2016, TUMOR BIOL, V37, P15509, DOI 10.1007/s13277-015-3846-8
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004
   Wen JY, 2015, MOL CELL, V58, P1133, DOI 10.1016/j.molcel.2015.06.015
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002
   Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x
   Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102
   Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535
NR 123
TC 7
Z9 7
U1 2
U2 10
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD NOV 15
PY 2018
VL 201
IS 10
BP 3058
EP 3072
DI 10.4049/jimmunol.1800597
PG 15
WC Immunology
SC Immunology
GA GZ5CN
UT WOS:000449433800020
PM 30305326
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Koo, B
   Hong, KH
   Jin, CE
   Kim, JY
   Kim, SH
   Shin, Y
AF Koo, Bonhan
   Hong, Ki Ho
   Jin, Choong Eun
   Kim, Ji Yeun
   Kim, Sung-Han
   Shin, Yong
TI Arch-shaped multiple-target sensing for rapid diagnosis and
   identification of emerging infectious pathogens
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Emerging infectious pathogen; Middle East respiratory syndrome; Zika;
   Ebola; Diagnosis; Pathogens identification
ID AMPLIFICATION; GENERATION; DISEASES; VIRUS; ASSAY; GLASS; CARE
AB Rapid identification of emerging infectious pathogens is crucial for preventing public health threats. Various pathogen detection techniques have been introduced; however, most techniques are time-consuming and lack multiple-target detection specificity. Although multiple-target detection techniques can distinguish emerging infectious pathogens from related pathogens, direct amplification methods have not been widely examined. Here, we present a novel arch-shaped multiple-target sensor capable of rapid pathogen identification using direct amplification in clinical samples. In this study, an arch-shaped amplification containing primer sequences was designed to rapidly amplify multiple targets. Further, the sensing platform allowed for sensitive and specific detection of human coronavirus, Middle East respiratory syndrome, Zika virus, and Ebola virus down to several copies. This platform also simultaneously distinguished between Middle East respiratory syndrome and human coronavirus in clinical specimens within 20 min. This arch-shaped multiple-target sensing assay can provide rapid, sensitive, and accurate diagnoses of emerging infectious diseases in clinical applications.
C1 [Koo, Bonhan; Jin, Choong Eun; Shin, Yong] Univ Ulsan, Biomed Engn Res Ctr, Dept Convergence Med, Asan Med Ctr,Coll Med,Asan Inst Life Sci, 88 Olympicro 43Gil, Seoul, South Korea.
   [Hong, Ki Ho] Seoul Med Ctr, Dept Lab Med, Seoul, South Korea.
   [Kim, Ji Yeun; Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.
RP Shin, Y (corresponding author), Univ Ulsan, Biomed Engn Res Ctr, Dept Convergence Med, Asan Med Ctr,Coll Med,Asan Inst Life Sci, 88 Olympicro 43Gil, Seoul, South Korea.; Kim, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.
EM kimsunghanmd@hotmail.com; shinyongno1@gmail.com
FU Korea Health Technology R & D Project through the Korea Health Industry
   Development Institute (KHIDI); Ministry of Health & Welfare, Republic of
   KoreaMinistry of Health & Welfare, Republic of Korea [HI15C-2774-020015]
FX This study was supported by a grant from the Korea Health Technology R &
   D Project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea
   [HI15C-2774-020015].
CR Adessi C, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e87
   Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4
   Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004
   Biava M, 2018, J VIROL METHODS, V252, P70, DOI 10.1016/j.jviromet.2017.11.009
   Brinkmann A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006075
   Chung HJ, 2013, NAT NANOTECHNOL, V8, P369, DOI [10.1038/nnano.2013.70, 10.1038/NNANO.2013.70]
   Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023
   GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456
   Huang FC, 2006, ELECTROPHORESIS, V27, P3297, DOI 10.1002/elps.200600458
   Kim JY, 2018, CLIN CHEM, V64, P556, DOI 10.1373/clinchem.2017.280230
   Koo B, 2017, BIOSENS BIOELECTRON, V90, P187, DOI 10.1016/j.bios.2016.11.051
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Rao S, 2014, CURR OPIN INFECT DIS, V27, P342, DOI 10.1097/QCO.0000000000000079
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486
   Shin Y, 2014, SENSOR ACTUAT B-CHEM, V199, P220, DOI 10.1016/j.snb.2014.03.051
   WHO, 2016, MIDDL E RESP SYNDR C
   World Health Organization, 2015, MIDDL E RESP SYNDR C
   World Health Organization (WHO), 2015, LAB TEST MIDDL E RES
   Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 24
TC 4
Z9 4
U1 5
U2 68
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD NOV 15
PY 2018
VL 119
BP 79
EP 85
DI 10.1016/j.bios.2018.08.007
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA GT6VV
UT WOS:000444659900011
PM 30103157
OA Green Published
DA 2020-07-08
ER

PT J
AU Maciejewski, S
   Pierson, TC
AF Maciejewski, Sonia
   Pierson, Theodore C.
TI Cross-Reactive Flavivirus Antibody: Friend and Foe?
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID ZIKA VIRUS; DEPENDENT ENHANCEMENT
AB The introduction of Zika virus (ZIKV) into the Americas sparked interest in the influence of heterologous antibodies on sequential ZIKV and dengue virus (DENV) infections. In this issue of Cell Host & Microbe, Fowler et al. (2018) demonstrate in mice that maternally acquired anti-ZIKV antibodies exacerbate disease following DENV challenge.
C1 [Maciejewski, Sonia; Pierson, Theodore C.] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM piersontc@niaid.nih.gov
FU Division of Intramural Research of NIAID, NIH
FX S.M. and T.C.P. are supported by the Division of Intramural Research of
   NIAID, NIH.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 11
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 14
PY 2018
VL 24
IS 5
BP 622
EP 624
DI 10.1016/j.chom.2018.10.016
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HE1JD
UT WOS:000453025800006
PM 30439339
OA Bronze
DA 2020-07-08
ER

PT J
AU Zimmerman, MG
   Quicke, KM
   O'Neal, JT
   Arora, N
   Machiah, D
   Priyamvada, L
   Kauffman, RC
   Register, E
   Adekunle, O
   Swieboda, D
   Johnson, EL
   Cordes, S
   Haddad, L
   Chakraborty, R
   Coyne, CB
   Wrammert, J
   Suthar, MS
AF Zimmerman, Matthew G.
   Quicke, Kendra M.
   O'Neal, Justin T.
   Arora, Nitin
   Machiah, Deepa
   Priyamvada, Lalita
   Kauffman, Robert C.
   Register, Emery
   Adekunle, Oluwaseyi
   Swieboda, Dominika
   Johnson, Erica L.
   Cordes, Sarah
   Haddad, Lisa
   Chakraborty, Rana
   Coyne, Carolyn B.
   Wrammert, Jens
   Suthar, Mehul S.
TI Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of
   Human Placental Macrophages
SO CELL HOST & MICROBE
LA English
DT Article
ID DEPENDENT ENHANCEMENT; FC-RECEPTOR; IMMUNOGLOBULIN-G; PROTEIN-A; CELLS;
   BIRTH; TRANSMISSION; MOTHER; STATES; SURVEILLANCE
AB Zika virus (ZIKV), which emerged in regions endemic to dengue virus (DENV), is vertically transmitted and results in adverse pregnancy outcomes. Antibodies to DENV can cross-react with ZIKV, but whether these antibodies influence ZIKV vertical transmission remains unclear. Here, we find that DENV antibodies increase ZIKV infection of placental macrophages (Hofbauer cells [HCs]) from 10% to over 80% and enhance infection of human placental explants. ZIKV-anti-DENV antibody complexes increase viral binding and entry into HCs but also result in blunted type I interferon, pro-inflammatory cytokine, and antiviral responses. Additionally, ZIKV infection of HCs and human placental explants is enhanced in an immunoglobulin G subclass-dependent manner, and targeting FcRn reduces ZIKV replication in human placental explants. Collectively, these findings support a role for pre-existing DENV antibodies in enhancement of ZIKV infection of select placental cell types and indicate that pre-existing immunity to DENV should be considered when addressing ZIKV vertical transmission.
C1 [Zimmerman, Matthew G.; Quicke, Kendra M.; O'Neal, Justin T.; Priyamvada, Lalita; Kauffman, Robert C.; Register, Emery; Adekunle, Oluwaseyi; Swieboda, Dominika; Johnson, Erica L.; Chakraborty, Rana; Wrammert, Jens; Suthar, Mehul S.] Emory Univ, Div Infect Dis, Dept Pediat, Sch Med, Atlanta, GA 30322 USA.
   [Zimmerman, Matthew G.; Quicke, Kendra M.; O'Neal, Justin T.; Machiah, Deepa; Priyamvada, Lalita; Kauffman, Robert C.; Register, Emery; Adekunle, Oluwaseyi; Wrammert, Jens; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Arora, Nitin] Univ Alabama Birmingham, Dept Pediat, Div Neonatol, Birmingham, AL USA.
   [Machiah, Deepa] Yerkes Natl Primate Res Ctr, Mol Pathol Core Lab, Atlanta, GA 30329 USA.
   [Cordes, Sarah; Haddad, Lisa] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
   [Coyne, Carolyn B.] UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
RP Suthar, MS (corresponding author), Emory Univ, Div Infect Dis, Dept Pediat, Sch Med, Atlanta, GA 30322 USA.; Suthar, MS (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM msuthar@emory.edu
RI Priyamvada, Lalita/J-6252-2019
OI Priyamvada, Lalita/0000-0002-0479-0164; Arora, Nitin/0000-0001-6840-4333
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P30A050509, U19AI083019, U01AI131566,
   2U19AI057266]; ORIP/OD [P51OD011132]; Emory Department of Pediatrics
   CCVI Pilot project; REVIS Supplement [5U19AI057266-13]; Emory University
   Department of Pediatrics Junior Faculty Focused Award; Children's
   Healthcare of Atlanta; Emory Vaccine Center; Georgia Research Alliance
FX We thank the Department of Pediatrics flow cytometry core and the Emory
   Vaccine Center flow cytometry core, which is supported in part by the
   NIH grant P30A050509. We also thank Siddhartha Bhaumik for providing us
   with anti-DENV monoclonal antibodies, and Dr. Hedda Wardemann for
   providing the IgG subclass vectors. This work was funded in part by NIH
   grants U19AI083019 (M.S.S.), U01AI131566 (M.S.S. and R.C.), and
   2U19AI057266 (M.S.S.); ORIP/OD P51OD011132 (M.S.S.); Emory Department of
   Pediatrics CCVI Pilot project (M.S.S. and J.W.); 5U19AI057266-13REVIS
   Supplement (M.S.S. and J.W.); Emory University Department of Pediatrics
   Junior Faculty Focused Award (M.S.S.); Children's Healthcare of Atlanta
   (M.S.S.); Emory Vaccine Center (M.S.S.); and The Georgia Research
   Alliance (M.S.S.). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Christianson GJ, 2012, MABS-AUSTIN, V4, P208, DOI 10.4161/mabs.4.2.19397
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Melo ASD, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0051
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jendeberg L, 1997, J IMMUNOL METHODS, V201, P25, DOI 10.1016/S0022-1759(96)00215-3
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Michlmayr D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00264
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ribeiro CF, 2017, INT J INFECT DIS, V55, P109, DOI 10.1016/j.ijid.2017.01.002
   Schliefsteiner C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00888
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8
   Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762
   STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x
   Tsai TT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003320
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
NR 57
TC 30
Z9 30
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 14
PY 2018
VL 24
IS 5
BP 731
EP +
DI 10.1016/j.chom.2018.10.008
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HE1JD
UT WOS:000453025800015
PM 30439342
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Fowler, AM
   Tang, WW
   Young, MP
   Mamidi, A
   Viramontes, KM
   McCauley, MD
   Carlin, AF
   Schooley, RT
   Swanstrom, J
   Baric, RS
   Govero, J
   Diamond, MS
   Shresta, S
AF Fowler, Angela M.
   Tang, William W.
   Young, Matthew P.
   Mamidi, Anila
   Viramontes, Karla M.
   McCauley, Melanie D.
   Carlin, Aaron F.
   Schooley, Robert T.
   Swanstrom, Jesica
   Baric, Ralph S.
   Govero, Jennifer
   Diamond, Michael S.
   Shresta, Sujan
TI Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in
   Mice
SO CELL HOST & MICROBE
LA English
DT Article
ID ALPHA TNF-ALPHA; VIRUS-INFECTION; NEUTRALIZING ANTIBODIES; DEPENDENT
   ENHANCEMENT; CROSS-REACTIVITY; DENDRITIC CELLS; I INTERFERON; MOUSE
   MODEL; PATHOGENESIS; MACROPHAGES
AB Antibody (Ab)-dependent enhancement can exacerbate dengue virus (DENV) infection due to cross-reactive Abs from an initial DENV infection, facilitating replication of a second DENV. Zika virus (ZIKV) emerged in DENV-endemic areas, raising questions about whether existing immunity could affect these related flaviviruses. We show that mice born with circulating maternal Abs against ZIKV develop severe disease upon DENV infection. Compared with pups of naive mothers, those born to ZIKV-immune mice lacking type I interferon receptor in myeloid cells (LysMCre(+)lfnar1(fl/fl)) exhibit heightened disease and viremia upon DENV infection. Passive transfer of IgG isolated from mice born to ZIKV-immune mothers resulted in increased viremia in naive recipient mice. Treatment with Abs blocking inflammatory cytokine tumor necrosis factor linked to DENV disease or Abs blocking DENV entry improved survival of DENV-infected mice born to ZIKV-immune mothers. Thus, the maternal Ab response to ZIKV infection or vaccination might predispose to severe dengue disease in infants.
C1 [Fowler, Angela M.; Tang, William W.; Young, Matthew P.; Mamidi, Anila; Viramontes, Karla M.; McCauley, Melanie D.; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Inflammat Biol, La Jolla, CA 92037 USA.
   [Carlin, Aaron F.; Schooley, Robert T.; Shresta, Sujan] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Swanstrom, Jesica; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Inflammat Biol, La Jolla, CA 92037 USA.; Shresta, S (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
EM sujan@lji.org
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI116813, NS100477, AI104972,
   HD091218, AI106695, AI125198]; NIH/La Jolla Institute for Allergy and
   Immunology Training grant [T32AI125179]
FX This research was funded by NIH grants AI116813 and NS100477 to S.S.,
   AI104972 and HD091218 to M.S.D., and AI106695 and AI125198 to R.S.B. and
   by the NIH/La Jolla Institute for Allergy and Immunology Training grant
   T32AI125179 to A.M.F.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deligny C, 2014, J CLIN VIROL, V61, P442, DOI 10.1016/j.jcv.2014.08.011
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   GEORGE J, 2017, SCI REP UK, V7
   Gomez JMM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004536
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kittigul L, 2000, J VIROL METHODS, V90, P51, DOI 10.1016/S0166-0934(00)00215-9
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Phanthanawiboon S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148564
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Wang L, 2007, AM J TROP MED HYG, V77, P297, DOI 10.4269/ajtmh.2007.77.297
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 47
TC 23
Z9 23
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 14
PY 2018
VL 24
IS 5
BP 743
EP +
DI 10.1016/j.chom.2018.09.015
PG 13
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HE1JD
UT WOS:000453025800016
PM 30439343
OA Bronze, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Whiteman, A
   Mejia, A
   Hernandez, I
   Loaiza, JR
AF Whiteman, A.
   Mejia, A.
   Hernandez, I.
   Loaiza, J. R.
TI Socioeconomic and demographic predictors of resident knowledge,
   attitude, and practice regarding arthropod-borne viruses in Panama
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Socioeconomic factors; Demographic characteristics; Arthropod-borne
   viruses; Knowledge; Attitude; And practice; Panama City
ID RISK-FACTORS; HEALTH; KAP; COMMUNITIES; INFECTION; AWARENESS; EDUCATION;
   SMOKING; DENGUE
AB Background: We sought to identify if socioeconomic and demographic factors play a role in resident knowledge, attitude, and practice regarding Dengue, Chikungunya, and Zika in order to inform effective management procedures for disease prevention in Panama, a middle-income tropical country in Central America. All three are arthropod-borne viruses transmitted by Aedes mosquito vectors present in the focal region of Panama City, the largest city in Central America and an urban region of extreme socioeconomic polarization.
   Methods: Between November 2017 and February 2018, we administered standardized, anonymous knowledge, attitude, and practice surveys to 263 residents split between two neighborhoods of high socioeconomic status (SES) and two neighborhoods of low SES. We then summed the knowledge, attitude, and practice scores respectively, and used linear and logistic regressions to quantify relationships with socioeconomic and demographic factors.
   Results: Low-SES neighborhoods with high proportions of low income residents, residents over 70 years old had lower mean knowledge scores compared to other groups. Furthermore, residents in neighborhoods of low SES reported more mosquito biting relative to residents in neighborhoods of high SES, yet comparably lower level of concerns for disease transmission. Additionally, knowledge was lower for the more novel emergent threats of Chikungunya and Zika, compared to the endemic Dengue.
   Conclusion: Findings suggest that low-SES neighborhoods with high proportions of low income, low education, and elderly residents should be targeted for outreach programs designed to prevent DENV, CHIKV, or ZIKV in Panama City. These outcomes support our initial hypotheses as lower relative knowledge and fewer practices related to the prevention of Dengue, Chikungunya, and Zika were found in low-SES neighborhoods. There is also a widespread lack of adequate knowledge regarding these diseases as well as low levels of concern in areas of highly reported mosquito biting. We provide suggestions for taking neighborhood socioeconomic status and specific aspects resident health literacy and attitude into account for creating more effective outreach campaigns as both endemic and novel arthropod-borne disease rates continue to increase throughout Latin America.
C1 [Whiteman, A.] Univ N Carolina, Dept Geog & Earth Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA.
   [Whiteman, A.; Loaiza, J. R.] Smithsonian Trop Res Inst, POB 0843-03092, Balboa, Ancon, Panama.
   [Mejia, A.; Hernandez, I.; Loaiza, J. R.] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, POB 0843-01103, Panama City, Panama.
   [Loaiza, J. R.] Univ Panama, Programa Centroamer Maestria Entomol, Panama City, Panama.
RP Whiteman, A (corresponding author), Univ N Carolina, Dept Geog & Earth Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA.; Whiteman, A (corresponding author), Smithsonian Trop Res Inst, POB 0843-03092, Balboa, Ancon, Panama.
EM ari.whiteman@gmail.com
FU Smithsonian Tropical Research Institute (STRI)Smithsonian
   InstitutionSmithsonian Tropical Research Institute; Instituto de
   Investigaciones Cientificas y Servicios de Alta Tecnologia (INDICASAT);
   STRI's short-term fellowship program; Secretariat for Science,
   Technology and Innovation of Panama (SENACYT), through the National
   System of Investigation (SNI)
FX The Smithsonian Tropical Research Institute (STRI) and Instituto de
   Investigaciones Cientificas y Servicios de Alta Tecnologia (INDICASAT)
   supported this work financially. AW was supported by STRI's short-term
   fellowship program and the Secretariat for Science, Technology and
   Innovation of Panama (SENACYT), through the National System of
   Investigation (SNI), supported research activities by AM and JRL. The
   funding bodies had no role in the design of the study, data collection,
   analysis, interpretation, or writing.
CR Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x
   Agresti A., 2007, INTRO CATEGORICAL DA
   Alaimo K, 2008, J NUTR EDUC BEHAV, V40, P94, DOI 10.1016/j.jneb.2006.12.003
   [Anonymous], 2015, STAT STAT SOFTW REL
   [Anonymous], 2014, AB HLTH PEOPL
   Uma Deavi Ayyamani, 1986, Medical Journal of Malaysia, V41, P108
   Barcena A, 2016, LATIN AM IS WORLDS M
   Bashar K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1084
   Berrigan D, 2008, PREV MED, V47, P239, DOI 10.1016/j.ypmed.2008.07.010
   Bhui K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090718
   Blasi PR, 2015, HEALTH PROMOT PRACT, V16, P897, DOI 10.1177/1524839915596133
   Burkett-Cadena ND, 2008, J AM MOSQUITO CONTR, V24, P228, DOI 10.2987/5662.1
   Casapulla SL, 2018, AIMS PUBLIC HEALTH, V5, P49, DOI 10.3934/publichealth.2018.1.49
   Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520
   Chadee DD, 2010, ACTA TROP, V116, P212, DOI 10.1016/j.actatropica.2010.08.008
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012
   Dawaki S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1394-3
   Delucchi KL, 2009, J DRUG ISSUES, V39, P347, DOI 10.1177/002204260903900207
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Doherty M., 1994, NZ STAT REV, V1994, P21
   Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010
   Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   GALTON F, 1886, J ANTHR I, V15, P246, DOI DOI 10.2307/2841583
   Ghosh A, 2013, J MOSQUITO RES, V3, P54, DOI DOI 10.5376/JMR.2013.03.0007
   Goni E, 2011, WORLD DEV, V39, P1558, DOI 10.1016/j.worlddev.2011.04.025
   GYIMAHBREMPONG K, 1989, J APPL ECONOM, V4, P57, DOI 10.1002/jae.3950040105
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37
   Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8
   Herrington JE, 2003, VECTOR-BORNE ZOONOT, V3, P157, DOI 10.1089/153036603322662156
   Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Jaramillo Ramirez GI, 2017, OPEN PUBLIC HLTH J, V10, P80, DOI [10.2174/1874944501710010080, DOI 10.2174/1874944501710010080]
   JOHNSTONE D, 1988, PSYCHOL REP, V63, P319, DOI 10.2466/pr0.1988.63.1.319
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21
   Launiala A., 2009, ANTHR MATTERS, V11, P1
   Li D, 2015, ACTA TROP, V147, P17, DOI 10.1016/j.actatropica.2015.02.018
   Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P60, DOI 10.1053/j.spid.2004.09.013
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lu PJ, 2017, VACCINE, V35, P3104, DOI 10.1016/j.vaccine.2017.04.028
   Marmot M., 2005, SOCIAL DETERMINANTS
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Mayxay M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-434
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Moore JC, 2000, J OFF STAT, V16, P331
   Mouallif M, 2014, VACCINE, V32, P409, DOI 10.1016/j.vaccine.2013.10.069
   Okechukwu C, 2014, SOC EPIDEMIOL, V365
   Owen L, 1998, BRIT MED J, V317, P728, DOI 10.1136/bmj.317.7160.728
   Patel AB, 2011, NATL J MED RES, V1, P45
   Paulander J, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1839
   Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Rada V, 2014, OPEN J STAT, V4, P391, DOI DOI 10.4236/ojs.2014.45038
   Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543
   Higuera-Mendieta DR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005016
   ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319
   Shuaib F, 2010, W INDIAN MED J, V59, P139
   Springe L, 2016, SCAND J PUBLIC HEALT, V44, P411, DOI 10.1177/1403494816631394
   Taksande A, 2013, SHIRAZ E MED J, V13, P146
   Tanaka Y, 2008, HEALTH PLACE, V14, P434, DOI 10.1016/j.healthplace.2007.07.005
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   The World Bank, 2015, GINI IND WORLD BANK, P1
   Tram TT, 2003, DENGUE B, V27, P174
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816
   Yang KM, 2014, SOCIOL RES ONLINE, V19, DOI 10.5153/sro.3199
NR 71
TC 7
Z9 7
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD NOV 14
PY 2018
VL 18
AR 1261
DI 10.1186/s12889-018-6172-4
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HA7XV
UT WOS:000450500600006
PM 30428861
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, LH
   Hamer, DH
AF Chen, Lin H.
   Hamer, Davidson H.
TI Zika virus and sexual transmission: updated preconception guidance
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
DE Zika; sexual transmission; preconception; travel; recommendations;
   congenital infection
C1 [Chen, Lin H.] Mt Auburn Hosp, Dept Med, Div Infect Dis & Travel Med, Cambridge, MA 02138 USA.
   [Chen, Lin H.] Harvard Med Sch, Dept Med, Boston, MA USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02118 USA.
   [Hamer, Davidson H.] Boston Med Ctr, Infect Dis Sect, Dept Med, Boston, MA 02118 USA.
RP Chen, LH (corresponding author), 330 Mt Auburn Hosp, Mt Auburn Hosp, Div Infect Dis & Travel Med, Cambridge, MA 02138 USA.
EM lchen@hms.harvard.edu
RI Hamer, Davidson/J-2020-2019
OI Hamer, Davidson/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436
CR Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Graciaa DS, 2018, ANN INTERN MED, V169, P337, DOI 10.7326/M18-1112
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Vouga M, 2018, LANCET, V392, P818, DOI 10.1016/S0140-6736(18)31827-0
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 11
TC 4
Z9 4
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD NOV 13
PY 2018
VL 25
AR tay095
DI 10.1093/jtm/tay095
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0ZY
UT WOS:000451529800001
PM 30289482
OA Bronze
DA 2020-07-08
ER

PT J
AU Zakaria, MK
   Carletti, T
   Marcello, A
AF Zakaria, Mohammad Khalid
   Carletti, Tea
   Marcello, Alessandro
TI Cellular Targets for the Treatment of Flavivirus Infections
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE avivirus; antiviral; host-directed therapy; screening tools; mechanism
   of action
ID DENGUE VIRUS-INFECTION; RNA CHAPERONE ACTIVITY; ZIKA VIRUS;
   3-DIMENSIONAL ARCHITECTURE; HELICASE ACTIVITY; DOUBLE-BLIND; NS1
   PROTEIN; REPLICATION; INHIBITOR; BINDS
AB Classical antiviral therapy targets viral functions, mostly viral enzymes or receptors. Successful examples include precursor herpesvirus drugs, antiretroviral drugs that target reverse transcriptase and protease, influenza virus directed compounds as well as more recent direct antiviral agents (DAA) applied in the treatment of hepatitis C virus (HCV). However, from early times, the possibility of targeting the host cell to contain the infection has frequently re-emerged as an alternative and complementary antiviral strategy. Advantages of this approach include an increased threshold to the emergence of resistance and the possibility to target multiple viruses. Major pitfalls are related to important cellular side effects and cytotoxicity. In this mini-review, the concept of host directed antiviral therapy will be discussed with a focus on the most recent advances in the field of Flaviviruses, a family of important human pathogens for which we do not have antivirals available in the clinics.
C1 [Zakaria, Mohammad Khalid; Carletti, Tea; Marcello, Alessandro] Int Ctr Genet Engn & Biotechnol, Lab Mol Virol, Trieste, Italy.
RP Marcello, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Lab Mol Virol, Trieste, Italy.
EM marcello@icgeb.org
FU Beneficientia Stiftung, Vaduz Lichtenstein; Regionez FVG of Italy
FX Work on flaviviruses in AM's laboratory is supported by the
   Beneficientia Stiftung, Vaduz Lichtenstein, and by the FLAVIPOC, SEVARE,
   and ZIDECHIP projects from the Regionez FVG of Italy. We thank present
   and past members of the lab for fruitful discussions and excellent
   cooperation.
CR Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111
   Anwar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023246
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Carletti T, 2017, BIOCHEM BIOPH RES CO, V492, P533, DOI 10.1016/j.bbrc.2017.02.006
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chang JH, 2011, ANTIVIR RES, V92, P369, DOI 10.1016/j.antiviral.2011.08.003
   Chang JH, 2011, ANTIVIR RES, V89, P26, DOI 10.1016/j.antiviral.2010.11.002
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Duan XQ, 2008, BIOCHEM BIOPH RES CO, V373, P319, DOI 10.1016/j.bbrc.2008.06.041
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   ELION GB, 1993, J MED VIROL, P2
   Friedrich S, 2016, RNA, V22, P1574, DOI 10.1261/rna.055269.115
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kobayashi S, 2016, J BIOL CHEM, V291, P6559, DOI 10.1074/jbc.M115.712760
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li MY, 2015, CELL REP, V10, P1496, DOI 10.1016/j.celrep.2015.02.021
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Marques RE, 2015, IMMUNOLOGY, V145, P583, DOI 10.1111/imm.12476
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Munoz MD, 1998, FEMS MICROBIOL LETT, V168, P251
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   PALU G, 1992, VIRUS RES, V25, P133, DOI 10.1016/0168-1702(92)90105-I
   Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Piccini LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140824
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Sood R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004255
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 100
TC 9
Z9 9
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD NOV 12
PY 2018
VL 8
AR 398
DI 10.3389/fcimb.2018.00398
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HA0DH
UT WOS:000449876600001
PM 30483483
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hraber, P
   Bradfute, S
   Clarke, E
   Ye, CY
   Pitard, B
AF Hraber, Peter
   Bradfute, Steven
   Clarke, Elizabeth
   Ye, Chunyan
   Pitard, Bruno
TI Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus
SO VACCINE
LA English
DT Article
DE Block copolymer; Zika virus; DNA vaccine; Flavivirus; Mouse model;
   Nanotechnology
ID WEST-NILE-VIRUS; GENOMIC CHARACTERIZATION; IN-VIVO; FLAVIVIRUSES;
   EPIDEMIOLOGY; PERSPECTIVE; PROTECTION; SKELETAL; AMERICA
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that was first discovered in 1947. Since then, outbreaks have been reported in tropical Africa, Southeast Asia, the Pacific Islands, and, in 2015, in the Americas. Since 2013, many countries have reported cases of microcephaly and other central nervous system malformation associated with ZIKV. Because the initial target population for a ZIKV vaccine is expected to be women of child-bearing age, including those who may be pregnant, it is necessary to develop safe, easily administered, and non-viral vaccines. Here, we show that a single tetrafunctional Amphiphilic Block Copolymer (ABC) delivers DNA that encodes the full natural sequence of prM-E, among other antigen designs tested, induces the highest antibody titer and neutralization activity against three divergent ZIKV isolates. Vaccination with a single tetrafunctional block copolymer delivering low dose (10 mu g) DNA plasmid rapidly induces protection from detectable viremia during acute infection in mice challenged by ZIKV more than 7 months after their first vaccination and boosted 2 weeks before challenge. This use of tetrafunctional ABCs is a new approach to deliver DNA antigens against flaviviruses. The data demonstrate that DNA formulated by a tetrafunctional block copolymer rapidly elicits protective responses against multiple diverse ZIKV isolates. This represents potential for an easy-to-administer and simple to manufacture vaccine candidate against ZIKV and possibly other emerging threats to global health. Published by Elsevier Ltd.
C1 [Hraber, Peter] Los Alamos Natl Lab, Theoret Biol & Biophys, MS K710, Los Alamos, NM 87545 USA.
   [Bradfute, Steven; Clarke, Elizabeth; Ye, Chunyan] Univ New Mexico, Ctr Global Hlth, Div Infect Dis, Dept Internal Med, MSC10 5550, Albuquerque, NM 87131 USA.
   [Pitard, Bruno] In Cell Art, 21 Rue La Noue Bras de Fer, F-44200 Nantes, France.
   [Pitard, Bruno] Univ Nantes, Univ Angers, INSERM, CRCINA, Nantes, France.
RP Hraber, P (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys, MS K710, Los Alamos, NM 87545 USA.
EM pth@lanl.gov
OI Hraber, Peter/0000-0002-2920-4897
FU LANLUnited States Department of Energy (DOE)Los Alamos National
   Laboratory; US Department of Energy under NNSA [DE-AC52-06NA25396]
FX This research was supported by LANL discretionary program development
   funds and In-Cell-Art's contribution in kind of animals and reagents.
   LANL is operated by LANS, LLC for the US Department of Energy under NNSA
   Contract No. DE-AC52-06NA25396. The authors of this report were solely
   responsible for study design; collection, analysis, and interpretation
   of data; writing the report; and the decision to submit the paper for
   publication.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Beilvert F, 2012, HUM GENE THER, V23, P597, DOI 10.1089/hum.2012.024
   Cany J, 2011, J HEPATOL, V54, P115, DOI 10.1016/j.jhep.2010.06.027
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GULLAND A, 2016, BMJ BRIT MED J, V352
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2007, LANCET, V369, P1410, DOI 10.1016/S0140-6736(07)60645-X
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Korber B, 2017, IMMUNOL REV, V275, P230, DOI 10.1111/imr.12516
   KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lappala A, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020025
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Le Moigne V, 2015, VACCINE, V33, P2118, DOI 10.1016/j.vaccine.2015.03.030
   Le Moigne V, 2016, INFECT IMMUN, V84, P2895, DOI 10.1128/IAI.00359-16
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   McIlroy D, 2009, MOL THER, V17, P1473, DOI 10.1038/mt.2009.84
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pitard B, 2002, HUM GENE THER, V13, P1767, DOI 10.1089/104303402760293592
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richard P, 2005, HUM GENE THER, V16, P1318, DOI 10.1089/hum.2005.16.1318
   Richard-Fiardo P, 2008, HUM GENE THER, V19, P331, DOI 10.1089/hum.2006.0101
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 46
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD NOV 12
PY 2018
VL 36
IS 46
BP 6911
EP 6917
DI 10.1016/j.vaccine.2018.10.022
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HB7EP
UT WOS:000451240100003
PM 30337177
DA 2020-07-08
ER

PT J
AU Pinkham, AM
   Yu, Z
   Cowan, JA
AF Pinkham, Andrew M.
   Yu, Zhen
   Cowan, J. A.
TI Broad- spectrum catalytic metallopeptide inactivators of Zika and West
   Nile virus NS2B/ NS3 proteases+
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID DENGUE VIRUS; THERAPEUTICS; REACTIVITY; INHIBITORS; BINDING
AB Flaviviruses possess a conserved protease that is vital for viral maturation. We have designed catalytic metallopeptides for inactivation of both Zika and West Nile viral proteases, and potentially other viral homologues, by irreversible target destruction and low off-target activity against host proteases. Oxidative damage promoted by metallopeptides was characterized by mass spectrometry, localized to specific active site residues, and correlated with catalyst activity.
C1 [Pinkham, Andrew M.; Yu, Zhen; Cowan, J. A.] Ohio State Univ, Dept Chem & Biochem, 100 West 18th Ave, Columbus, OH 43210 USA.
RP Cowan, JA (corresponding author), Ohio State Univ, Dept Chem & Biochem, 100 West 18th Ave, Columbus, OH 43210 USA.
EM cowan.2@osu.edu
RI Yu, Zhen/S-8325-2016
OI Yu, Zhen/0000-0003-2092-9960
CR Alexander JL, 2017, J MED CHEM, V60, P10047, DOI 10.1021/acs.jmedchem.7b01117
   Benham M. A. M., 2015, J MED CHEM, P9354
   Benham M. A. M., 2014, ACS MED CHEM LETT, P1037
   Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Bradford SS, 2014, CHEMMEDCHEM, V9, P1275, DOI 10.1002/cmdc.201400070
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Flutsch A, 2011, BIOORG MED CHEM LETT, V21, P1162, DOI 10.1016/j.bmcl.2010.12.103
   Kellett A, 2013, CURR MED CHEM, V20, P3134
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Pinkham AM, 2018, J MED CHEM, V61, P980, DOI 10.1021/acs.jmedchem.7b01409
   Ross MJ, 2015, DALTON T, V44, P20972, DOI 10.1039/c5dt02837j
   Yu Z, 2018, CURR OPIN CHEM BIOL, V43, P37, DOI 10.1016/j.cbpa.2017.10.029
   Yu Z, 2017, CHEM-EUR J, V23, P14113, DOI 10.1002/chem.201701714
   Yu Z, 2017, ANGEW CHEM INT EDIT, V56, P2763, DOI 10.1002/anie.201612079
   Yu Z, 2015, ANGEW CHEM INT EDIT, V54, P1901, DOI 10.1002/anie.201410434
NR 17
TC 9
Z9 9
U1 0
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD NOV 11
PY 2018
VL 54
IS 87
BP 12357
EP 12360
DI 10.1039/c8cc07448h
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA GY7VC
UT WOS:000448823200016
PM 30324214
DA 2020-07-08
ER

PT J
AU Lee, HJ
   Cho, Y
   Kang, HJ
   Choi, H
   Han, KR
   Chong, CK
   Kim, YB
AF Lee, Hee-Jung
   Cho, Yeondong
   Kang, Hyeon Jeong
   Choi, Hanul
   Han, Kang Rok
   Chong, Chom Kyu
   Kim, Young Bong
TI Identification of peptide based B-cell epitopes in Zika virus NS1
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; NS1; Epitope; Peptide; Diagnosis
ID MEMBRANE ASSOCIATION; INFECTION; EPIDEMIOLOGY; FLAVIVIRUS; DIAGNOSIS
AB Zika virus (ZIKV), a mosquito-borne flavivirus that has recently emerged globally, poses a major threat to public health. To control this emerging disease, accurate diagnostics are required for monitoring current ZIKV outbreaks. Owing to the high nucleotide sequence similarity and cross-reactivity of ZIKV with other members of the Flaviviridae family, discrimination from other flavivirus infections is often difficult in endemic areas. ZIKV NS1 induces major virus-specific antibodies and is therefore utilized as a serological marker for ZIKV diagnosis. To identify ZIKV specific epitopes for clinical application, 33 NS1 peptides that are 15-30 amino acid in length covering whole NS1 were synthesized and analyzed linear B-cell epitopes with 38 human serum samples (20 ZIKV-positive and 18 ZIKV-negative). As a result of screening, eight epitope regions were identified. In particular, the Z8 and Z14 peptides located in the 13-ladder surface region showed higher levels of binding activity in ZIKV-positive sera without cross-reactivity to other flaviviruses. These identified sensitive and specific epitopes provide a tool for design of diagnostics and structure-based vaccine antigens for ZIKV infection. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Lee, Hee-Jung; Cho, Yeondong; Kang, Hyeon Jeong; Choi, Hanul; Kim, Young Bong] Konkuk Univ, Dept Biomed Sci & Engn, Seoul 05029, South Korea.
   [Cho, Yeondong; Kang, Hyeon Jeong; Choi, Hanul; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul 05029, South Korea.
   [Han, Kang Rok] KRBIOTECH Inc, Seoul 05029, South Korea.
   [Chong, Chom Kyu] Genbody Inc, Cheonan 31077, South Korea.
RP Kim, YB (corresponding author), Konkuk Univ, Dept Biomed Sci & Engn, 120 Neungdong Ro, Seoul 143701, South Korea.
EM ziniga@konkuk.ac.kr; suhosaint@nate.com; kang_smo@naver.com;
   chlgksmf9977@hanmail.net; han.kangrok@gmail.com; ckchong@genbody.co.kr;
   kimera@konkuk.ac.kr
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Ministry of Science ICT [2016M3A9B6913600]; Research
   of Korea Centers for Disease Control and Prevention [2017N-ER-5305-00];
   Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI18C2177]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) funded by the Ministry
   of Science & ICT (No. 2016M3A9B6913600), the Research of Korea Centers
   for Disease Control and Prevention (2017N-ER-5305-00), and a grant of
   the Korea Health Technology R&D Project through the Korea Health
   Industry Development Institute (KHIDI), funded by the Ministry of Health
   & Welfare, Republic of Korea (grant number: HI18C2177). This paper was
   written as part of Konkuk University's research support program for its
   faculty on sabbatical leave in 2016.
CR Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Chao DY, 2015, J CLIN MICROBIOL, V53, P557, DOI 10.1128/JCM.02735-14
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huzly D, 2016, EURO SURVEILL, V21
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 25
TC 2
Z9 3
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 10
PY 2018
VL 505
IS 4
BP 1010
EP 1014
DI 10.1016/j.bbrc.2018.10.024
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA HA1WR
UT WOS:000450019400009
PM 30309651
DA 2020-07-08
ER

PT J
AU Zheng, B
   Yu, JS
   Xi, ZY
   Tang, MX
AF Zheng, Bo
   Yu, Jianshe
   Xi, Zhiyong
   Tang, Moxun
TI The annual abundance of dengue and Zika vector Aedes albopictus and its
   stubbornness to suppression
SO ECOLOGICAL MODELLING
LA English
DT Article
DE Aedes albopictus; Population dynamics; Age-stage structure; Insecticide
   resistance
ID ASIAN TIGER MOSQUITO; INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; MODEL;
   TEMPERATURE; WOLBACHIA; LARVAL; ESTABLISHMENT; SURVIVAL; IMPACT
AB The mosquito Aedes albopictus is a competent vector for more than 25 arboviruses, including dengue and Zika, and the sole vector for the 2014 unprecedented dengue outbreak in southern China. Due to the lack of a deep understanding of how its seasonal abundance is tied to environments, current methods have failed to control its prevalence and expansion on a large scale. In this paper, we develop a comprehensive model of difference equations that incorporates mosquito age at the four developmental stages, egg diapause, larval density competition, and the meteorological data for temperature, precipitation, and humidity, to predict the mosquito abundance over time in southern China. The generated temporal profile is robust against the variation of initial inputs, and matches well with the measurements in a northeast district in Guangzhou in 2013 and 2014 with a correlation coefficient R-2 approximate to 0.9511. We find that chemical interventions have only a temporary effect; once the intervention is terminated, mosquito population bounces back quickly. Moreover, improper adulticide applications facilitate a fast spread of insecticide resistance. The resistance spread is quantified and the optimal intensity and frequency of chemical interventions are simulated. These findings remain to be tested by more real data and our methods can be adapted to other geographic areas and/or mosquito species for designing better mosquito control strategies.
C1 [Zheng, Bo; Yu, Jianshe] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Zheng, Bo; Yu, Jianshe] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
   [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
RP Xi, ZY (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.; Tang, MX (corresponding author), Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
EM xizy@msu.edu; tangm@msu.edu
FU NSFCNational Natural Science Foundation of China [11631005, 11626246];
   Scientific and Technological Leading Talents of Guangzhou Development
   District [2013L-P116]; National Program for Changjiang Scholars and
   Innovative Research Team in University [IRT_16R16]; Department of
   Education of Guangdong ProvinceNational Natural Science Foundation of
   Guangdong Province [2017KTSCX148]
FX This work was supported by NSFC(11631005, 11626246), Scientific and
   Technological Leading Talents of Guangzhou Development District
   (2013L-P116), National Program for Changjiang Scholars and Innovative
   Research Team in University(IRT_16R16) and Department of Education of
   Guangdong Province(2017KTSCX148).
CR Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027
   Cheng Q, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004417
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Estrada-Franco R., 1995, 42 PAN AM HLTH ORG
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Huang MG, 2018, J THEOR BIOL, V440, P1, DOI 10.1016/j.jtbi.2017.12.012
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2
   Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4
   Lee Shae-Jinn, 1994, Chinese Journal of Entomology, V14, P13
   Li J, 2013, J DIFFER EQU APPL, V19, P649, DOI 10.1080/10236198.2012.672566
   Li Y, 2018, RIC MAT, P1
   Liu Fusheng, 1992, Acta Scientiarum Naturalium Universitatis Sunyatseni, V31, P84
   Lord CC, 1998, J MED ENTOMOL, V35, P825, DOI 10.1093/jmedent/35.5.825
   Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799
   Maciá Arnaldo, 2009, Rev. Soc. Entomol. Argent., V68, P107
   McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054
   Meng Feng-xia, 2015, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V26, P4
   Monaghan AJ, 2018, CLIMATIC CHANGE, V146, P487, DOI 10.1007/s10584-016-1679-0
   Petric M, 2017, CLIMATIC CHANGE, V142, P361, DOI 10.1007/s10584-017-1946-8
   Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Vinogradova E., 2007, DIAPAUSE AQUATIC INV, V112, P218
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wang X, 2016, J THEOR BIOL, V411, P27, DOI 10.1016/j.jtbi.2016.09.015
   Wang YG, 2017, J ECON ENTOMOL, V110, P239, DOI 10.1093/jee/tow254
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yan Zi-qiang, 2010, Redai Yixue Zazhi, V10, P606
   Zheng B, 2018, J MATH BIOL, V76, P235, DOI 10.1007/s00285-017-1142-5
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 33
TC 8
Z9 8
U1 3
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3800
EI 1872-7026
J9 ECOL MODEL
JI Ecol. Model.
PD NOV 10
PY 2018
VL 387
BP 38
EP 48
DI 10.1016/j.ecolmodel.2018.09.004
PG 11
WC Ecology
SC Environmental Sciences & Ecology
GA HC2TC
UT WOS:000451653800005
DA 2020-07-08
ER

PT J
AU D'Aiuto, L
   McNulty, J
   Hartline, C
   Demers, M
   Kalkeri, R
   Wood, J
   McClain, L
   Chattopadhyay, A
   Zhi, Y
   Naciri, J
   Smith, A
   Yolken, R
   Chowdari, K
   Zepeda-Velazquez, C
   Dokuburra, CB
   Marques, E
   Ptak, R
   Kinchington, P
   Watkins, S
   Prichard, M
   Bloom, D
   Nimgaonkar, V
AF D'Aiuto, Leonardo
   McNulty, James
   Hartline, Caroll
   Demers, Matthew
   Kalkeri, Raj
   Wood, Joel
   McClain, Lora
   Chattopadhyay, Ansuman
   Zhi, Yun
   Naciri, Jennifer
   Smith, Adam
   Yolken, Robert
   Chowdari, Kodavali
   Zepeda-Velazquez, Carlos
   Dokuburra, Chanti Babu
   Marques, Ernesto
   Ptak, Roger
   Kinchington, Paul
   Watkins, Simon
   Prichard, Mark
   Bloom, David
   Nimgaonkar, Vishwajit
TI R430: A potent inhibitor of DNA and RNA viruses
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HERPES-SIMPLEX-VIRUS; HOST SHUTOFF RNASE; GENE-EXPRESSION; NEONATAL
   HERPES; MESSENGER-RNAS; INFECTION; AMARYLLIDACEAE; NEURONS; REPLICATION;
   DEGRADATION
AB Acyclovir (ACV) is an effective antiviral agent for treating lytic Herpes Simplex virus, type 1 (HSV-1) infections, and it has dramatically reduced the mortality rate of herpes simplex encephalitis. However, HSV-1 resistance to ACV and its derivatives is being increasingly documented, particularly among immunocompromised individuals. The burgeoning drug resistance compels the search for a new generation of more efficacious anti-herpetic drugs. We have previously shown that trans-dihydrolycoricidine (R430), a lycorane-type alkaloid derivative, effectively inhibits HSV-1 infections in cultured cells. We now report that R430 also inhibits ACV-resistant HSV-1 strains, accompanied by global inhibition of viral gene transcription and enrichment of H3K27me3 methylation on viral gene promoters. Furthermore, we demonstrate that R430 prevents HSV-1 reactivation from latency in an ex vivo rodent model. Finally, among a panel of DNA viruses and RNA viruses, R430 inhibited Zika virus with high therapeutic index. Its therapeutic index is comparable to standard antiviral drugs, though it has greater toxicity in non-neuronal cells than in neuronal cells. Synthesis of additional derivatives could enable more efficacious antivirals and the identification of active pharmacophores.
C1 [D'Aiuto, Leonardo; Demers, Matthew; Wood, Joel; Naciri, Jennifer; Smith, Adam; Chowdari, Kodavali; Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.
   [McNulty, James; Zepeda-Velazquez, Carlos; Dokuburra, Chanti Babu] McMaster Univ, Dept Chem & Chem Biol, 1280 Main St West, Hamilton, ON L8S 4M1, Canada.
   [Hartline, Caroll; Prichard, Mark] Univ Alabama Birmingham, UAB Sch Med, 1720 2nd Ave S, Birmingham, AL 35294 USA.
   [Kalkeri, Raj; Ptak, Roger] Southern Res Inst, Drug Dev, Dept Infect Dis Res, 431 Aviat Way, Frederick, MD 21701 USA.
   [McClain, Lora] Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA.
   [Zhi, Yun] Tsinghua Univ, Sch Med, Dept Pharmacol & Pharmaceut Sci, Beijing, Peoples R China.
   [Yolken, Robert] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neurovirol, 600 North Wolfe St,Blalock 1105, Baltimore, MD 21287 USA.
   [Marques, Ernesto] Univ Pittsburgh, Dept Infect Dis & Microbiol, 9022 BST3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.
   [Kinchington, Paul] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Eye & Ear Inst 1016, Pittsburgh, PA 15213 USA.
   [Watkins, Simon] Univ Pittsburgh, Dept Cell Biol, 3500 Terrace St,S362 Biomed Sci Tower South, Pittsburgh, PA 15261 USA.
   [Bloom, David] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Box 100266 JHMHC, Gainesville, FL 32610 USA.
   [Nimgaonkar, Vishwajit] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA.
   [Chattopadhyay, Ansuman] Hlth Sci Lib Syst, Mol Biol Informat Serv, 3550 Terrace St, Pittsburgh, PA 15261 USA.
RP Nimgaonkar, V (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.; Nimgaonkar, V (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA.
EM vishwajitNL@upmc.edu
RI McNulty, James/E-7871-2011; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; McNulty,
   James/0000-0002-7123-7588; Zepeda-Velazquez, Carlos
   Armando/0000-0002-8130-2232
FU Stanley Medical Research Institute [07R-1712]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [MH63480, NS096405, AI22640, EY08098]; National Institutes of
   Allergy and Infectious Diseases, National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272201100016I, HHSN27200013]; Research to Prevent
   Blindness IncResearch to Prevent Blindness (RPB); Eye & Ear Foundation
   of Pittsburgh
FX We thank the CuraZika Pilot Grant Program. Funded in part by grants from
   the Stanley Medical Research Institute (07R-1712) and NIH (MH63480,
   NS096405). We thank the NIAID Division of Microbiology and Infectious
   Diseases for facilitating the antiviral assays. Work performed in the
   laboratory of MNP was funded in whole or in part by the National
   Institutes of Allergy and Infectious Diseases, National Institutes of
   Health, under contract HHSN272201100016I, Task Order HHSN27200013. PRK
   acknowledges NIH awards AI22640 and EY08098; and unrestricted grants
   from Research to Prevent Blindness Inc and Eye & Ear Foundation of
   Pittsburgh.
CR Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chowdhury M. A, 2016, AM J THER, V23
   D'Aiuto L, 2017, ANTIVIR RES, V142, P136, DOI 10.1016/j.antiviral.2017.03.016
   D'Aiuto L, 2014, ORGANOGENESIS, V10, P365, DOI 10.1080/15476278.2015.1011921
   D'Aiuto L, 2015, SCHIZOPHRENIA BULL, V41, P123, DOI 10.1093/schbul/sbu032
   DEVIRAO GB, 1994, J VIROL, V68, P1271, DOI 10.1128/JVI.68.3.1271-1282.1994
   Dimitrion Peter, 2017, Mol Neuropsychiatry, V3, P28, DOI 10.1159/000476034
   Evidente A, 2009, PLANTA MED, V75, P501, DOI 10.1055/s-0029-1185340
   FARRELL MJ, 1991, P NATL ACAD SCI USA, V88, P790, DOI 10.1073/pnas.88.3.790
   GABRIELSEN B, 1992, J NAT PROD, V55, P1569, DOI 10.1021/np50089a003
   Gardella C, 2011, BJOG-INT J OBSTET GY, V118, P187, DOI 10.1111/j.1471-0528.2010.02785.x
   Grout P, 1976, J R Coll Gen Pract, V26, P428
   Hellden A, 2003, NEPHROL DIAL TRANSPL, V18, P1135, DOI 10.1093/ndt/gfg119
   HONESS RW, 1977, J VIROL, V21, P584, DOI 10.1128/JVI.21.2.584-600.1977
   Kim JJ, 2004, AM J MED GENET B, V130B, P19
   Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004
   King CA, 2015, J VIROL, V89, P11347, DOI 10.1128/JVI.02008-15
   KORBA BE, 1991, ANTIVIR RES, V15, P217, DOI 10.1016/0166-3542(91)90068-3
   Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kuo T, 2014, VACCINE, V32, P6733, DOI 10.1016/j.vaccine.2014.10.002
   Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Maiti M, 2016, ORG BIOMOL CHEM, V14, P8743, DOI 10.1039/c6ob01189f
   Malvy D, 2005, CLIN INFECT DIS, V41, P320, DOI 10.1086/431585
   McClain L, 2015, ANTIVIR RES, V121, P16, DOI 10.1016/j.antiviral.2015.06.005
   McNulty J, 2016, ACS MED CHEM LETT, V7, P46, DOI 10.1021/acsmedchemlett.5b00318
   Prichard MN, 2009, ANTIMICROB AGENTS CH, V53, P5251, DOI 10.1128/AAC.00417-09
   Ramachandran S, 2008, VIROLOGY, V378, P254, DOI 10.1016/j.virol.2008.05.034
   REARDON JE, 1989, J BIOL CHEM, V264, P7405
   RENARDNOZAKI J, 1989, RES VIROLOGY, V140, P115, DOI 10.1016/S0923-2516(89)80089-5
   Revu O, 2016, CHEMISTRYSELECT, V1, P5895
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Shu MF, 2013, J VIROL, V87, P13569, DOI 10.1128/JVI.02603-13
   Shu M, 2013, P NATL ACAD SCI USA, V110, pE1669, DOI 10.1073/pnas.1305475110
   SPIVACK JG, 1987, J VIROL, V61, P3841, DOI 10.1128/JVI.61.12.3841-3847.1987
   Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3
   STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993
   Stranska R, 2005, J CLIN VIROL, V32, P7, DOI 10.1016/j.jcv.2004.04.002
   Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952
   Wang K, 2007, J VIROL, V81, P6817, DOI 10.1128/JVI.00166-07
   Young RC, 2010, ARCH OPHTHALMOL-CHIC, V128, P1178, DOI 10.1001/archophthalmol.2010.187
NR 41
TC 1
Z9 1
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 9
PY 2018
VL 8
AR 16662
DI 10.1038/s41598-018-33904-y
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ7CL
UT WOS:000449632300071
PM 30413769
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kanyaboon, P
   Saelee, T
   Suroengrit, A
   Hengphasatporn, K
   Rungrotmongkol, T
   Chavasiri, W
   Boonyasuppayakorn, S
AF Kanyaboon, Parichat
   Saelee, Thanaphon
   Suroengrit, Aphinya
   Hengphasatporn, Kowit
   Rungrotmongkol, Thanyada
   Chavasiri, Warinthorn
   Boonyasuppayakorn, Siwaporn
TI Cardol triene inhibits dengue infectivity by targeting kl loops and
   preventing envelope fusion
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANACARDIUM-OCCIDENTALE; RESORCINOLIC LIPIDS; MOLECULAR-DYNAMICS;
   HEMORRHAGIC-FEVER; DOUBLE-BLIND; VIRAL LOAD; PRODUCTS; POCKET
AB Dengue virus causes a global burden that specific chemotherapy has not been established. A previous report suggested that anacardic acid inhibited hepatitis C virus infection. Here, we explored structure activity relationship of anacardic acid, cardanol, and cardol homologues with anti-DENV cellular infectivities. Cardol triene showed the highest therapeutic index at 29.07 with the CC50 and EC50 of 207.30 +/- 5.24 and 7.13 +/- 0.72 mu M, respectively. Moreover, we observed that the more unsaturated the hydrocarbon tail, the higher the CC(50)s in all head groups. High CC(50)s were also found in HepG-2, THP-1, and HEK-293 cell lines where cardol triene CC(50)s were 140.27 +/- 8.44, 129.77 +/- 12.08, and 92.80 +/- 3.93 mu M, respectively. Cardol triene expressed pan-dengue inhibition with the EC(50)s of 5.35 to 8.89 mu M and kl loops of dengue envelope proteins were major targets. The strong binding energy at T48, E49, A50, P53, K128, V130, L135, M196, L198, Q200, W206, L207, I270, and L277 prevented cellular pH-dependent fusion. Zika virus kl loops were aligned in the closed position preventing cardol triene to bind and inhibit fusion and infectivity. This study showed for the first time that cardol triene had a potential for further development as anti-dengue inhibitors.
C1 [Kanyaboon, Parichat; Saelee, Thanaphon; Suroengrit, Aphinya; Boonyasuppayakorn, Siwaporn] Chulalongkorn Univ, Fac Med, Dept Microbiol, Appl Med Virol Res Unit, Bangkok 10330, Thailand.
   [Kanyaboon, Parichat] Chulalongkorn Univ, Grad Sch, Interdisciplinary Program, Med Microbiol, Bangkok 10330, Thailand.
   [Saelee, Thanaphon] Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok 10330, Thailand.
   [Hengphasatporn, Kowit; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Graduated Sch, Bioinformat & Computat Biol Program, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok 10330, Thailand.
   [Chavasiri, Warinthorn] Chulalongkorn Univ, Fac Sci, Dept Chem, Ctr Excellence Nat Prod Chem, Bangkok 10330, Thailand.
RP Boonyasuppayakorn, S (corresponding author), Chulalongkorn Univ, Fac Med, Dept Microbiol, Appl Med Virol Res Unit, Bangkok 10330, Thailand.
EM siwaporn.b@chula.ac.th
OI Boonyasuppayakorn, Siwaporn/0000-0002-3631-3573
FU Chulalongkorn UniversityChulalongkorn University
FX This work was supported by Chulalongkorn University; Government Budget.
   Reference dengue viruses are the courtesy of Drs. Kiat Ruxrungtham,
   Chutitorn Ketloy, and Padet Siriyasatien, Faculty of Medicine,
   Chulalongkorn University. HepG2, Vero, HEK-293, and THP-1 cells are the
   courtesy of Drs. Nattiya Hirankarn, Parvapan Bhattarakosol, Tanapat
   Palaga, Chulalongkorn University, respectively. We thanked the Armed
   Forces Research Institute of Medical Science, and the Department of
   Disease Control, Ministry of Public Health, Thailand for Zika virus. We
   thanked Dr. Radhakrishnan Padmanabhan, Georgetown University,
   Washington, D.C., for DENV2/BHK replicon cells.
CR Alam-Escamilla D, 2015, MUTAT RES-GEN TOX EN, V777, P43, DOI 10.1016/j.mrgentox.2014.11.008
   Alvarenga TA, 2016, J AGR FOOD CHEM, V64, P8821, DOI 10.1021/acs.jafc.6b04200
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonyasuppayakorn S, 2016, J VIROL METHODS, V237, P25, DOI 10.1016/j.jviromet.2016.08.009
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Cieslik-Boczula K, 2009, BIOPHYS CHEM, V140, P51, DOI 10.1016/j.bpc.2008.11.009
   Csizmadia F, 1997, J PHARM SCI-US, V86, P865, DOI 10.1021/js960177k
   Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330
   DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hamad FB, 2015, INT J MOL SCI, V16, P8569, DOI 10.3390/ijms16048569
   Hundt J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117514
   Ichiyama K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002188
   Jadav SS, 2015, BIOORG MED CHEM LETT, V25, P1747, DOI 10.1016/j.bmcl.2015.02.059
   Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kustiawan Paula M, 2015, Asian Pac J Cancer Prev, V16, P6581
   Kustiawan Paula M., 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P549, DOI 10.12980/APJTB.4.2014APJTB-2013-0039
   Kustiawan PM, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0139-4
   Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Marimuthu Priya, 2016, Perspect Clin Res, V7, P161
   Masuoka N, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00169
   Meeprasert A, 2012, J MOL GRAPH MODEL, V38, P148, DOI 10.1016/j.jmgm.2012.06.007
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nutho B, 2014, BEILSTEIN J ORG CHEM, V10, P2789, DOI 10.3762/bjoc.10.296
   Poh M. K, ANTIVIRAL RES, V84, P260
   Pollastri Michael P, 2010, Curr Protoc Pharmacol, VChapter 9, DOI 10.1002/0471141755.ph0912s49
   Przeworska E, 2001, BBA-BIOMEMBRANES, V1513, P75, DOI 10.1016/S0005-2736(01)00346-7
   RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845
   Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005
   Sangpheak W, 2014, J MOL GRAPH MODEL, V50, P10, DOI 10.1016/j.jmgm.2014.03.001
   Schaeffer E, 2018, ANTIVIR RES, V154, P116, DOI 10.1016/j.antiviral.2018.04.005
   Siwko ME, 2009, BIOPHYS J, V96, P3140, DOI 10.1016/j.bpj.2009.01.040
   Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4
   Srivarangkul P, 2018, ANTIVIR RES, V151, P27, DOI 10.1016/j.antiviral.2018.01.010
   Stasiuk M, 2008, FEBS LETT, V582, P3607, DOI 10.1016/j.febslet.2008.09.039
   Stasiuk M, 2010, CELL MOL LIFE SCI, V67, P841, DOI 10.1007/s00018-009-0193-1
   Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19
   SUMMERS PL, 1989, VIRUS RES, V12, P383, DOI 10.1016/0168-1702(89)90095-6
   Suroengrit A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14121-5
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tambunan USF, 2015, DRUG TARGET INSIGHT, V9, P33, DOI 10.4137/DTI.S31566
   Teixeira RR, 2014, MOLECULES, V19, P8151, DOI 10.3390/molecules19068151
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203
   Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306
   Yasutake Tetsuo, 2013, F1000Res, V2, P78, DOI 10.12688/f1000research.2-78.v1
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 59
TC 3
Z9 3
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 9
PY 2018
VL 8
AR 16643
DI 10.1038/s41598-018-35035-w
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ7CL
UT WOS:000449632300052
PM 30413789
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matsuda, M
   Yamanaka, A
   Yato, K
   Yoshii, K
   Watashi, K
   Aizaki, H
   Konishi, E
   Takasaki, T
   Kato, T
   Muramatsu, M
   Wakita, T
   Suzuki, R
AF Matsuda, Mami
   Yamanaka, Atsushi
   Yato, Keigo
   Yoshii, Kentaro
   Watashi, Koichi
   Aizaki, Hideki
   Konishi, Eiji
   Takasaki, Tomohiko
   Kato, Takanobu
   Muramatsu, Masamichi
   Wakita, Takaji
   Suzuki, Ryosuke
TI High-throughput neutralization assay for multiple flaviviruses based on
   single-round infectious particles using dengue virus type 1 reporter
   replicon
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS; CROSS-REACTIVITY; WEST NILE; USUTU VIRUS; DIAGNOSIS; EUROPE;
   CIRCULATION; TESTS; SERA
AB Diseases caused by the genus Flavivirus, including dengue virus (DENV) and Zika virus (ZIKV), have a serious impact on public health worldwide. Due to serological cross-reactivity among flaviviruses, current enzyme-linked immunosorbent assay (ELISA) for IgM/G cannot reliably distinguish between infection by different flaviviruses. In this study, we developed a reporter-based neutralization assay using single-round infectious particles (SRIPs) derived from representative flaviviruses. SRIPs were generated by transfection of human embryonic kidney 293 T cells with a plasmid encoding premembrane and envelope (prME) proteins from DENV1-4, ZIKV, Japanese encephalitis virus, West Nile virus, yellow fever virus, Usutu virus, and tick-borne encephalitis virus, along with a plasmid carrying DENV1 replicon containing the luciferase gene and plasmid for expression of DENV1 capsid. Luciferase activity of SRIPs-infected cells was well correlated with number of infected cells, and each reporter SRIP was specifically neutralized by sera from mice immunized with each flavivirus antigen. Our high-throughput reporter SRIP-based neutralization assay for multiple flaviviruses is a faster, safer, and less laborious diagnostic method than the conventional plaque reduction neutralization test to screen the cause of primary flavivirus infection. The assay may also contribute to the evaluation of vaccine efficacy and assist in routine surveillance and outbreak response to flaviviruses.
C1 [Matsuda, Mami; Yato, Keigo; Watashi, Koichi; Aizaki, Hideki; Kato, Takanobu; Muramatsu, Masamichi; Wakita, Takaji; Suzuki, Ryosuke] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Yamanaka, Atsushi; Konishi, Eiji] Mahidol Univ, Fac Trop Med, BIKEN Endowed Dept Dengue Vaccine Dev, 420-6 Ratchawithi Rd, Bangkok 10440, Thailand.
   [Yamanaka, Atsushi; Konishi, Eiji] Osaka Univ, Res Inst Microbial Dis, BIKEN Endowed Dept Dengue Vaccine Dev, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Yoshii, Kentaro] Hokkaido Univ, Fac Vet Med, Lab Publ Hlth, Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.
   [Takasaki, Tomohiko] Kanagawa Prefectural Inst Publ Hlth, 1-3-1,Shimomachiya, Chigasaki, Kanagawa 2530087, Japan.
   [Suzuki, Ryosuke] Natl Inst Infect Dis, Dept Virol 2, 4-7-1 Gakuen, Musashimurayama, Tokyo 2080011, Japan.
RP Suzuki, R (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.; Suzuki, R (corresponding author), Natl Inst Infect Dis, Dept Virol 2, 4-7-1 Gakuen, Musashimurayama, Tokyo 2080011, Japan.
EM ryosuke@nih.go.jp
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP18fk0108035]
FX We are grateful to M. Sasaki for technical assistance and Y. Hirama for
   secretarial assistance. We also thank M. Yamazaki, M. Kuwahara, S.
   Tajima, T. Maeki, and C.K. Lim for helpful discussions. This research
   was supported by the Japan Agency for Medical Research and Development
   (AMED) under Grant Number JP18fk0108035.
CR Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Hirota J, 2010, J VET MED SCI, V72, P369, DOI 10.1292/jvms.09-0311
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Song KY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-44
   Stauft C. B, 2016, BIORXIV, DOI [10.1101/075747, DOI 10.1101/075747]
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Tajima S, 2017, JPN J INFECT DIS, V70, P45, DOI 10.7883/yoken.JJID.2016.086
   Yamanaka A, 2017, J VIROL METHODS, V243, P164, DOI 10.1016/j.jviromet.2017.02.011
   Yamanaka A, 2014, VACCINE, V32, P4289, DOI 10.1016/j.vaccine.2014.06.017
NR 22
TC 9
Z9 9
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 9
PY 2018
VL 8
AR 16624
DI 10.1038/s41598-018-34865-y
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ7CL
UT WOS:000449632300033
PM 30413742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kikuti, M
   Cardoso, CW
   Prates, APB
   Paploski, IAD
   Kitron, U
   Reis, MG
   Mochida, GH
   Ribeiro, GS
AF Kikuti, Mariana
   Cardoso, Cristiane W.
   Prates, Ana P. B.
   Paploski, Igor A. D.
   Kitron, Uriel
   Reis, Mitermayer G.
   Mochida, Ganeshwaran H.
   Ribeiro, Guilherme S.
TI Congenital brain abnormalities during a Zika virus epidemic in Salvador,
   Brazil, April 2015 to July 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID HEAD CIRCUMFERENCE; BIRTH-DEFECTS; INFECTION; INFANTS; OUTBREAK; JANUARY
AB Background: North-eastern Brazil was the region most affected by the outbreak of congenital Zika syndrome that followed the 2015 Zika virus (ZIKV) epidemics, with thousands of suspected microcephaly cases reported to the health authorities, mostly between late 2015 and early 2016. Aim: To describe clinical and epidemiological aspects of the outbreak of congenital brain abnormalities (CBAs) and to evaluate the accuracy of different head circumference screening criteria in predicting CBAs. Method: Between April 2015 and July 2016, the Centers for Information and Epidemiologic Surveillance of Salvador, Brazil investigated the reported cases suspected of microcephaly and, based on intracranial imaging studies, confirmed or excluded a diagnosis of CBA. Sensitivity, specificity and positive and negative predictive values of different head circumference screening criteria in predicting CBAs were calculated. Results: Of the 365 investigated cases, 166 (45.5%) had confirmed CBAs. The most common findings were intracranial calcifications and ventriculomegaly in 143 (86.1%) and 111 (66.9%) of the 166 CBA cases, respectively. Prevalence of CBAs peaked in December 2015 (2.24 cases/100 live births). Cases of CBAs were significantly more likely to have been born preterm and to mothers who had clinical manifestations of arboviral infection during pregnancy. None of the head circumference screening criteria performed optimally in predicting CBAs. Conclusion: This study highlights the magnitude of neurological consequences of the ZIKV epidemic and the limitations of head circumference in accurately identifying children with CBA. Gestational symptoms compatible with ZIKV infection should be combined with imaging studies for efficient detection of suspect CBAs during ZIKV epidemics.
C1 [Kikuti, Mariana; Paploski, Igor A. D.; Kitron, Uriel; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Kikuti, Mariana; Paploski, Igor A. D.; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Cardoso, Cristiane W.; Prates, Ana P. B.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
   [Mochida, Ganeshwaran H.] Boston Childrens Hosp, Boston, MA USA.
   [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Mochida, Ganeshwaran H.] Harvard Med Sch, Boston, MA USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Kikuti, Mariana/G-2313-2017; Ribeiro,
   Guilherme/B-6624-2008; Paploski, Igor AD/D-7015-2014
OI Reis, Mitermayer/0000-0002-3051-9060; Kikuti,
   Mariana/0000-0001-8119-7236; Ribeiro, Guilherme/0000-0002-6798-2059;
   Paploski, Igor AD/0000-0002-3689-2042; Mochida,
   Ganeshwaran/0000-0001-7912-4097; Cardoso, Cristiane/0000-0001-5432-1174
FU Brazilian National Council of Technological and Scientific Development;
   Bahia Foundation for Research Support; National Institute of
   Neurological Disease and StrokeUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS); Manton Center for
   Orphan Disease Research, Boston Children's Hospital Faculty Career
   Development Award; David Rockefeller Center for Latin American Studies
   at Harvard University; Brazilian Coordination for the Improvement of
   Higher Education
FX The Brazilian National Council of Technological and Scientific
   Development, the Brazilian Coordination for the Improvement of Higher
   Education, the Bahia Foundation for Research Support, the National
   Institute of Neurological Disease and Stroke, the Manton Center for
   Orphan Disease Research, Boston Children's Hospital Faculty Career
   Development Award and the David Rockefeller Center for Latin American
   Studies at Harvard University provided funding for the study, but they
   played no role in data analyses.
CR Alarcon A, 2016, NEONATOLOGY, V110, P277, DOI 10.1159/000446690
   ARAGAO MDV, 2016, BMJ BRIT MED J, V353
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   DATASUS, 2016, SIST NAC NASC VIV
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   De Paepe B, 2017, J IND MICROBIOL BIOT, V44, P623, DOI 10.1007/s10295-016-1862-3
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FENTON TR, 2013, BMC PEDIATR, V13
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kwak M, 2018, PEDIATR NEUROL, V83, P14, DOI 10.1016/j.pediatrneurol.2018.03.008
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Pan American Health Organization (PAHO), 2016, LIN PREL VIG MICR RE
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Secretaria de Vigilancia em Saude, 2015, PROT VIG RESP OC MIC
   Secretaria de Vigilancia em Saude, 2015, PROC PREL SER AD VIG
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2016, PROT VIG RESP OC MIC
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization (WHO), 2016, WHO CHILD GROWTH STA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 2
Z9 2
U1 0
U2 31
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD NOV 8
PY 2018
VL 23
IS 45
BP 44
EP 53
AR 1700757
DI 10.2807/1560-7917.ES.2018.23.45.1700757
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA GZ7GD
UT WOS:000449645200005
PM 30424827
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stefopoulou, A
   Balatsos, G
   Petraki, A
   LaDeau, SL
   Papachristos, D
   Michaelakis, A
AF Stefopoulou, Angeliki
   Balatsos, George
   Petraki, Angeliki
   LaDeau, Shannon L.
   Papachristos, Dimitrios
   Michaelakis, Antonios
TI Reducing Aedes albopictus breeding sites through education: A study in
   urban area
SO PLOS ONE
LA English
DT Article
ID ASIAN TIGER MOSQUITO; DIPTERA-CULICIDAE; SOURCE REDUCTION; KNOWLEDGE;
   AEGYPTI; IMPACT; POPULATIONS; PREVENTION; MANAGEMENT; STRATEGY
AB Aedes albopictus tends to proliferate in small, often man-made bodies of water, largely present in urban private areas. For this reason, education and community participation are considered crucial for source reduction and mosquito control. In the current study, we identify mosquito breeding habitat and evaluate the effectiveness of resident education. Since 2010 several outbreaks of West Nile virus infection occurred in Greece however urban population has no previous experience with mosquito-borne disease related to Aedes species, such as Dengue, Zika and Chikungunya. After the introduction of Ae. albopictus in Greece, urban areas have been considered to be at risk of epidemic arboviral outbreaks and identifying effective control strategies is imperative. Our study examines the relationship between mosquito breeding sources and socioeconomic or demographic characteristics of different households in a Greek municipality and evaluates efficacy of resident education. The results revealed that only a minority of residents knew where mosquitoes breed (18.6%) and only 46% felt that residents had any responsibility for managing breeding habitat. Our findings strongly suggest that only the presence of scientific staff inspecting possible habitats in their properties, could be enough to stimulate practices towards source reduction. However, educational interventions alone with printed education material cannot enhance significant community participation and source reduction.
C1 [Stefopoulou, Angeliki; Balatsos, George; Petraki, Angeliki; Papachristos, Dimitrios; Michaelakis, Antonios] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece.
   [LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Millbrook, NY USA.
RP Michaelakis, A (corresponding author), Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece.
EM a.michaelakis@bpi.gr
RI Michaelakis, Antonios/AAL-1594-2020
OI Papachristos, Dimitrios/0000-0002-0524-0180; LaDeau,
   Shannon/0000-0003-4825-5435
FU Region of Attica; LIFE CONOPS project; European CommissionEuropean
   Commission Joint Research Centre [LIFE12 ENV/GR/000466]
FX This study was supported by Region of Attica and LIFE CONOPS project.
   The project "A systematic surveillance of vector mosquitoes for the
   control of mosquito-borne diseases in the Region of Attica" financed by
   the Region of Attica. The project LIFE CONOPS (LIFE12 ENV/GR/000466),
   "Development & demonstration of management plans against -the climate
   change enhanced-invasive mosquitoes in South Europe", funded by the
   European Commission in the framework of the programme LIFE + Environment
   Policy and Governance (www.conops.gr;
   http://ec.europa.eu/environment/life/index.htm).The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Ali Arshad, 1997, Medical Entomology and Zoology, V48, P1
   Badieritakis E, 2018, PARASITOL RES, V117, P453, DOI 10.1007/s00436-017-5721-6
   Baldacchino F, 2017, PEST MANAG SCI, V73, P87, DOI 10.1002/ps.4417
   Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358
   Becker N., 2003, MOSQUITOES THEIR CON
   Bellini R, 2016, VECTOR BIOL J, V1, P2
   Bodner D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155011
   Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6
   Elsinga J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2371-6
   Estrada-Franco JG, 1995, OPS CUADERNO TECNICO
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Giangaspero A, 2013, PARASITOL RES, V112, P1357, DOI 10.1007/s00436-012-3206-1
   Giatropoulos A, 2013, PARASITOL RES, V112, P1113, DOI 10.1007/s00436-012-3239-5
   Giatropoulos A, 2012, PARASITOL RES, V111, P2253, DOI 10.1007/s00436-012-3074-8
   Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096
   Grantham A, 2009, INT J ENV RES PUB HE, V6, P2150, DOI 10.3390/ijerph6082150
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Huber K, 2014, PARASITOL RES, V113, P3201, DOI 10.1007/s00436-014-4000-z
   Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y
   Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6
   Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692
   Mahroum N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197337
   Manica M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.44.17-00685
   McNaughton D, 2010, ACTA TROP, V116, P74, DOI 10.1016/j.actatropica.2010.05.012
   Patsoula E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2450682
   Samanidou-Voyadjoglou A., 2005, European Mosquito Bulletin, V19, P10
   SCHREIBER ET, 1995, J AM MOSQUITO CONTR, V11, P186
   Soedarmo Sumarmo Poorwo, 1993, Tropical Medicine, V35, P315
   Tsiodras S, 2016, PATHOG GLOB HEALTH, V110, P68, DOI 10.1080/20477724.2016.1176311
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Warner DG, 2005, J MED LIBR ASSOC, V93, P243
   Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1
   WHO, 2015, WORLD MALARIA REPORT
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   World Health Organization (WHO) regional office for Europe, 2013, REG FRAM SURV CONTR
   Zeller H, 2013, CLIN MICROBIOL INFEC, V19, P693, DOI 10.1111/1469-0691.12230
NR 39
TC 0
Z9 0
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2018
VL 13
IS 11
AR e0202451
DI 10.1371/journal.pone.0202451
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ5ZX
UT WOS:000449512300004
PM 30408031
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Medina, LO
   To, A
   Lieberman, MM
   Wong, TAS
   Namekar, M
   Nakano, E
   Andersen, H
   Yalley-Ogunro, J
   Greenhouse, J
   Higgs, S
   Huang, YJS
   Vanlandingham, DL
   Horton, JS
   Clements, DE
   Lehrer, AT
AF Medina, Liana O.
   To, Albert
   Lieberman, Michael M.
   Wong, Teri Ann S.
   Namekar, Madhuri
   Nakano, Eileen
   Andersen, Hanne
   Yalley-Ogunro, Jake
   Greenhouse, Jack
   Higgs, Stephen
   Huang, Yan-Jang S.
   Vanlandingham, Dana L.
   Horton, Jaime S.
   Clements, David E.
   Lehrer, Axel T.
TI A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in
   Non-human Primates
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE zika virus (ZIKV); recombinant subunit; cynomolgus macaque; vaccine;
   CoVaccine HT (TM); microsphere immunoassay (MIA)
ID ENCEPHALITIS-VIRUS; MONOCLONAL-ANTIBODIES; PROTECTIVE EFFICACY;
   CLINICAL-TRIALS; RHESUS-MONKEYS; DNA VACCINE; INFECTION; MICE;
   CHALLENGE; IMMUNOGENICITY
AB Zika Virus (ZIKV), a virus with no severe clinical symptoms or sequelae previously associated with human infection, became a public health threat following an epidemic in French Polynesia 2013-2014 that resulted in neurological complications associated with infection. Although no treatment currently exists, several vaccines using different platforms are in clinical development. These include nucleic acid vaccines based on the prM-E protein from the virus and purified formalin-inactivated ZIKV vaccines (ZPIV) which are in Phase 1/2 clinical trials. Using a recombinant subunit platform consisting of antigens produced in Drosophila melanogaster S2 cells, we have previously shown seroconversion and protection against viremia in an immunocompetent mouse model. Here we demonstrate the efficacy of our recombinant subunits in a non-human primate (NHP) viremia model. High neutralizing antibody titers were seen in all protected macaques and passive transfer demonstrated that plasma from these NHPs was sufficient to protect against viremia in mice subsequently infected with ZIKV. Taken together our data demonstrate the immunogenicity and protective efficacy of the recombinant subunit vaccine candidate in NHPs as well as highlight the importance of neutralizing antibodies in protection against ZIKV infection and their potential implication as a correlate of protection.
C1 [Medina, Liana O.; To, Albert; Lieberman, Michael M.; Wong, Teri Ann S.; Namekar, Madhuri; Nakano, Eileen; Lehrer, Axel T.] Univ Hawaii Manoa, John A Bums Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Andersen, Hanne; Yalley-Ogunro, Jake; Greenhouse, Jack] Bioqual Inc, Rockville, MD USA.
   [Higgs, Stephen; Huang, Yan-Jang S.; Vanlandingham, Dana L.] Kansas State Univ, Coll Vet Med, Biosecur Res Inst, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
   [Horton, Jaime S.; Clements, David E.] Hawaii Biotech Inc, Honolulu, HI USA.
RP Lehrer, AT (corresponding author), Univ Hawaii Manoa, John A Bums Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
EM lehrer@hawaii.edu
FU Pacific Center for Emerging Infectious Diseases Research (COBRE grant)
   [P30GM114737]; National Institute of General Medical Sciences (NIGMS),
   NIH/NIAID [1R01AI119185]
FX Funding for this project was provided in part by Pacific Center for
   Emerging Infectious Diseases Research (COBRE grant P30GM114737), by the
   National Institute of General Medical Sciences (NIGMS), NIH/NIAID grant
   1R01AI119185, and institutional funds. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Bernardo L, 2008, ARCH VIROL, V153, P849, DOI 10.1007/s00705-008-0050-9
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   CULP JS, 1991, BIO-TECHNOL, V9, P173, DOI 10.1038/nbt0291-173
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   Estes JD, 2018, NAT REV IMMUNOL, V18, P390, DOI 10.1038/s41577-018-0005-7
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998
   Kreil TR, 1997, J VIROL, V71, P2921, DOI 10.1128/JVI.71.4.2921-2927.1997
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lehrer AT, 2018, VACCINE, V36, P3090, DOI 10.1016/j.vaccine.2017.01.068
   Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101
   MATHEWS JH, 1984, J IMMUNOL, V132, P1533
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Namekar M, 2013, J CLIN MICROBIOL, V51, P3102, DOI 10.1128/JCM.00351-13
   Namekar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045851
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, 2017, ZIK SIT REP
   WHO, 2017, ZIK VIR VACC PROD DE
   Zent O, 2003, VACCINE, V21, P738, DOI 10.1016/S0264-410X(02)00592-3
   Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10
NR 53
TC 7
Z9 7
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 8
PY 2018
VL 9
AR 2464
DI 10.3389/fimmu.2018.02464
PG 10
WC Immunology
SC Immunology
GA GZ6GW
UT WOS:000449533900001
PM 30467501
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baldwin, WR
   Livengood, JA
   Giebler, HA
   Stovall, JL
   Boroughs, KL
   Sonnberg, S
   Bohning, KJ
   Dietrich, EA
   Ong, YT
   Danh, HK
   Patel, HK
   Huang, CYH
   Dean, HJ
AF Baldwin, Whitney R.
   Livengood, Jill A.
   Giebler, Holli A.
   Stovall, Janae L.
   Boroughs, Karen L.
   Sonnberg, Stephanie
   Bohning, Kelly J.
   Dietrich, Elizabeth A.
   Ong, Yee Tsuey
   Danh, Hoang K.
   Patel, Hetal K.
   Huang, Claire Y-H
   Dean, Hansi J.
TI Purified Inactivated Zika Vaccine Candidates Afford Protection against
   Lethal Challenge in Mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NILE-VIRUS-INFECTION; DENGUE VIRUS; MEMBRANE ASSOCIATION;
   ENCEPHALITIS-VIRUS; STRUCTURAL BASIS; NS1 STRUCTURE; MOUSE MODEL;
   ANTIBODIES; IMMUNOGENICITY; FLAVIVIRUSES
AB In response to the 2016 global public health emergency of international concern announced by the World Health Organization surrounding Zika virus (ZIKV) outbreaks, we developed a purified inactivated Zika virus vaccine (PIZV) candidate from ZIKV strain PRVABC59, isolated during the outbreak in 2015. The virus isolate was plaque purified, creating six sub-isolated virus stocks, two of which were selected to generate PIZV candidates for preclinical immunogenicity and efficacy evaluation in mice. The alum-adjuvanted PIZV candidates were highly immunogenic in both CD-1 and AG129 mice after a 2-dose immunization. Further, AG129 mice receiving 2 doses of PIZV formulated with alum were fully protected against lethal ZIKV challenge and mouse immune sera elicited by the PIZV candidates were capable of neutralizing ZIKVs of both African and Asian genetic lineages in vitro. Additionally, passive immunization of naive mice with ZIKV-immune serum showed strong positive correlation between neutralizing ZIKV antibody (NAb) titers and protection against lethal challenge. This study supported advancement of the PIZV candidate toward clinical development.
C1 [Baldwin, Whitney R.; Livengood, Jill A.; Giebler, Holli A.; Sonnberg, Stephanie; Bohning, Kelly J.; Danh, Hoang K.; Patel, Hetal K.; Dean, Hansi J.] Takeda Vaccines Inc, Cambridge, MA 02139 USA.
   [Baldwin, Whitney R.; Giebler, Holli A.; Stovall, Janae L.; Boroughs, Karen L.; Dietrich, Elizabeth A.; Ong, Yee Tsuey; Huang, Claire Y-H] Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
RP Livengood, JA (corresponding author), Takeda Vaccines Inc, Cambridge, MA 02139 USA.; Huang, CYH (corresponding author), Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM jill.livengood@takeda.com; yxh0@cdc.gov
OI Dietrich, Elizabeth/0000-0002-1698-9568
FU TakedaTakeda Pharmaceutical Company Ltd; Department of Health and Human
   Services; Office of the Assistant Secretary for Preparedness and
   Response; Biomedical Advanced Research and Development Authority
   [HHS0100201600015C]
FX This work was part of a collaboration between the Division of
   Vector-Borne Diseases, CDC and Takeda under a Cooperative Research and
   Development Agreement (CRADA) #D-33-16. W.R.B. and H.A.G. were DVBD/CDC
   guest researchers funded by Takeda. In addition, Takeda received funds
   from the Department of Health and Human Services; Office of the
   Assistant Secretary for Preparedness and Response; Biomedical Advanced
   Research and Development Authority, under Contract No. HHS0100201600015C
   to support the development of PIZV. We thank Mark Delorey (CDC) and
   James Oksanish (CDC) for assistance with statistical analysis. The Zika
   virus strains used in the study were kindly provided by Brandy Russell
   from the Arbovirus Reference Collection at ADB/DVBD/CDC.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ambuel Y, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00263
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvert AE, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00234-18, 10.1128/jcm.00234-18]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2018, CDC ZIK TRAV INF
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HAMMON WMD, 1973, AM J TROP MED HYG, V22, P524, DOI 10.4269/ajtmh.1973.22.524
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024
   World Health Organization, 2016, WHO UNICEF ZIK TARG
   World Health Organization, 2017, ZIK VIR SIT REP MAR
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 62
TC 2
Z9 2
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 7
PY 2018
VL 8
AR 16509
DI 10.1038/s41598-018-34735-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ4LS
UT WOS:000449367700055
PM 30405178
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bittar, C
   Machado, RRG
   Comelis, MT
   Bueno, LM
   Morielle-Versute, E
   Beguelini, MR
   de Souza, RP
   Nogueira, ML
   Rahal, P
AF Bittar, Cintia
   Machado, Rafael R. G.
   Comelis, Manuela T.
   Bueno, Larissa M.
   Morielle-Versute, Eliana
   Beguelini, Matheus R.
   de Souza, Renato P.
   Nogueira, Mauricio L.
   Rahal, Paula
TI Lack of serological and molecular evidence of arbovirus infections in
   bats from Brazil
SO PLOS ONE
LA English
DT Article
ID LOUIS ENCEPHALITIS-VIRUS; DENGUE VIRUS; NO EVIDENCE; SEROTYPES 1;
   HOST-RANGE; SAO-PAULO; TRANSMISSION; FEVER; REPLICATION; EVOLUTION
AB Viruses are important agents of emerging zoonoses and are a substantial public health issue. Among emerging viruses, an important group are arboviruses, which are characterized by being maintained in nature in cycles involving hematophagous arthropod vectors and a wide range of vertebrate hosts. Recently, bats have received increasing attention as an important source for the emergence of zoonoses and as possible viral reservoirs. Among the arboviruses, there are many representatives of the genera Fla vi virus and Alpha virus, which are responsible for important epidemics such as Dengue virus, Zika virus and Chikungunya virus. Due to the importance of analyzing potential viral reservoirs for zoonosis control and expanding our knowledge of bat viruses, this study aimed to investigate the presence of viruses of the Alpha virus and Fla vi virus genera in bats. We analyzed serum, liver, lungs and intestine from 103 bats sampled in northeast and southern Brazil via Nested-PCR and the hemagglutination inhibition test. All samples tested in this study were negative for arboviruses, suggesting that no active or past infection was present in the captured bats. These data indicate that the bats examined herein probably do not constitute a reservoir for these viruses in the studied areas. Further studies are needed to clarify the role of bats as reservoirs and sources of infection of these viral zoonoses.
C1 [Bittar, Cintia; Machado, Rafael R. G.; Rahal, Paula] Univ Estadual Paulista, UNESP, Inst Biociencias Letras & Ciencias Exatas, Lab Estudos Genom, Sao Jose Do Rio Preto, SP, Brazil.
   [Comelis, Manuela T.; Bueno, Larissa M.; Morielle-Versute, Eliana; Beguelini, Matheus R.] Univ Estadual Paulista, Lab Chiroptera, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil.
   [Beguelini, Matheus R.] UFOB, Ctr Ciencias Biol & Saude, Barreiras, BA, Brazil.
   [de Souza, Renato P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [Nogueira, Mauricio L.] FAMERP Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Sao Jose Do Rio Preto, SP, Brazil.
RP Machado, RRG (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias Letras & Ciencias Exatas, Lab Estudos Genom, Sao Jose Do Rio Preto, SP, Brazil.
EM rafarahalmachado@gmail.com
RI Bittar, Cintia/A-5042-2015; Rahal, Paula/D-3871-2012; Nogueira, Mauricio
   L/B-7599-2012
OI Bittar, Cintia/0000-0002-2048-4589; Rahal, Paula/0000-0001-5693-6148;
   Nogueira, Mauricio L/0000-0003-1102-2419; Pereira de Souza,
   Renato/0000-0003-1315-7085; Rahal Guaragna Machado,
   Rafael/0000-0001-6974-5092; Beguelini, Mateus/0000-0002-9568-4446
FU FAPESP (Sao Paulo Research Foundation)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2015/09704-6]; CNPq (National Council for
   Scientific and Technological Development)National Council for Scientific
   and Technological Development (CNPq) [165802/2015-4]
FX This work was financially supported by FAPESP (Sao Paulo Research
   Foundation -http://www.fapesp.br/) grant number 2015/09704-6, received
   by RRGM and by CNPq (National Council for Scientific and Technological
   Development http://cnpq.br/) grant number 165802/2015-4, received by
   CB.; The authors would also like to thank all members of the Laboratory
   of Genomics Studies (IBILCE-UNESP, BR) for their helpful suggestions and
   discussions. This work was financially supported by FAPESP (Sao Paulo
   Research Foundation) grant number 2015/09704-6 and by CNPq (National
   Council for Scientific and Technological Development) grant number
   165802/2015-4.
CR Aguilar-Setien A, 2008, EPIDEMIOL INFECT, V136, P1678, DOI 10.1017/S0950268808000460
   Bahia S da S do E da, 2017, B EPIDEMIOLOGICO FEB, P3
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Cabrera-Romo S, 2016, ZOONOSES PUBLIC HLTH, V63, P579, DOI 10.1111/zph.12276
   Cabrera-Romo S, 2014, AM J TROP MED HYG, V91, P1227, DOI 10.4269/ajtmh.14-0361
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Casseb Alexandre do Rosario, 2013, Veterinaria e Zootecnia, V20, P391
   Chen LH, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau021
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Estofolete CF, 2016, REV SOC BRAS MED TRO, V49, P648, DOI 10.1590/0037-8682-0093-2016
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Feldhamer GA, 2015, MAMMALOGY ADAPTATION
   Gregorim R., 2016, B SOC BRASILEIRA EST, P28
   Hill JE, 1984, BATS NATURAL HIST
   Institute for Laboratory Animal Resources Comission on Life Sciences National Research Council, 2011, GUIDE CARE USE LAB A, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   LaVal R.K., 1973, Natural Hist Mus Los Angeles Co Sci Bull, VNo. 15, P1
   Lopez-Roig M, 2014, VIRUSES-BASEL, V6, P3386, DOI 10.3390/v6093386
   Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753
   Machain-williams C, 2014, J WILDLIFE DIS, V49, P1, DOI [10.7589/2012-12-318.Serologic, DOI 10.7589/2012-12-318.SEROLOGIC]
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Miranda JMD, 2006, ZOOTAXA, P57, DOI 10.11646/zootaxa.1383.1.4
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Moreira-Soto A, 2017, COMP IMMUNOL MICROB, V50, P101, DOI 10.1016/j.cimid.2016.12.004
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/S0037-86822011005000041, 10.1590/s0037-86822011005000041]
   Nogueira Marcelo Rodrigues, 2014, Check List, V10, P808
   Nogueira ML, 2017, EUROPEAN SOC CLIN MI, DOI DOI 10.1016/J.CMI.2017.11.004
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Mota MTO, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01341-15
   Perea-Martinez L, 2013, COMP IMMUNOL MICROB, V36, P193, DOI 10.1016/j.cimid.2012.12.002
   Costa IMP, 2016, EPIDEMIOL SERV SAUDE, V25, P735, DOI [10.5123/S1679-49742016000400007, 10.5123/s1679-49742016000400007]
   Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/S1679-49742016000300009, 10.5123/s1679-49742016000300009]
   Saude S de V em M da, 2017, B EPIDEMIOLOGICO, V48, P1
   Serra-Cobo J, 2017, ADV EXP MED BIOL, V972, P35, DOI 10.1007/5584_2016_131
   Serra-Cobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064467
   SHEPHERD R. C, 1964, ZOONOSES RES, V3, P125
   Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005
   SULKIN SE, 1966, SCIENCE, V152, P223, DOI 10.1126/science.152.3719.223
   Thompson NN, 2015, ZOONOSES PUBLIC HLTH, V62, P53, DOI 10.1111/zph.12118
   Vicente-Santos A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005537
   Vizotto LD, 1973, CHAVE DETERMINAC SP
   Wang L-F, 2015, BATS VIRUSES NEW FRO
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   WILLIAMS M. C., 1964, ZOONOSES HITS, V3, P141
   WILLIAMS MC, 1964, NATURE, V203, P670, DOI 10.1038/203670a0
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
NR 55
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 7
PY 2018
VL 13
IS 11
AR e0207010
DI 10.1371/journal.pone.0207010
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ4PQ
UT WOS:000449379500091
PM 30403749
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Priye, A
   Ball, CS
   Meagher, RJ
AF Priye, Aashish
   Ball, Cameron S.
   Meagher, Robert J.
TI Colorimetric-Luminance Readout for Quantitative Analysis of Fluorescence
   Signals with a Smartphone CMOS Sensor
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID QUANTUM DOTS; PLATFORM
AB Smartphones have shown promise as an enabling technology for portable and distributed point-of-care diagnostic tests. The CMOS camera sensor can be used for detecting optical signals, including fluorescence for applications such as isothermal nucleic acid amplification tests. However, such analysis is typically limited mostly to end point detection of single targets. Here we present a smartphone-based image analysis pipeline that utilizes the CIE xyY (chromaticity-luminance) color space to measure the luminance (in lieu of RGB intensities) of fluorescent signals arising from nucleic acid amplification targets, with a discrimination sensitivity (ratio between the positive to negative signals), which is an order of magnitude more than traditional RGB intensity based analysis. Furthermore, the chromaticity part of the analysis enables reliable multiplexed detection of different targets labeled with spectrally separated fluorophores. We apply this chromaticity-luminance formulation to simultaneously detect Zika and chikungunya viral RNA via end point RT-LAMP (Reverse transcription Loop-Mediated isothermal amplification). We also show real time LAMP detection of Neisseria gonorrhoeae samples down to a copy number of 3.5 copies per 10 mu L of reaction volume in our smartphone-operated portable LAMP box. Our chromaticity-luminance analysis is readily adaptable to other types of multiplexed fluorescence measurements using a smartphone camera.
C1 [Priye, Aashish] Univ Cincinnati, Dept Chem & Environm Engn, Cincinnati, OH 45221 USA.
   [Ball, Cameron S.; Meagher, Robert J.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94550 USA.
RP Priye, A (corresponding author), Univ Cincinnati, Dept Chem & Environm Engn, Cincinnati, OH 45221 USA.; Meagher, RJ (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94550 USA.
EM priyeah@uc.edu; rmeaghe@sandia.gov
OI Meagher, Robert/0000-0002-6262-2126
FU National Institute of Allergy and Infectious Disease (NIH: NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [1R21AI120973]; U.S. Department of Energy's National
   Nuclear Security AdministrationNational Nuclear Security Administration
   [DE-NA0003525]
FX This paper describes objective technical results and analysis. Any
   subjective views or opinions that might be expressed in the paper do not
   necessarily represent the views of the U.S. Department of Energy or the
   United States Government. This work was funded by the National Institute
   of Allergy and Infectious Disease (NIH: NIAID) Grant 1R21AI120973 (R.
   Meagher). Sandia National Laboratories is a multimission laboratory
   managed and operated by National Technology and Engineering Solutions of
   Sandia LLC, a wholly owned subsidiary of Honeywell International Inc.,
   for the U.S. Department of Energy's National Nuclear Security
   Administration under contract DE-NA0003525.
CR Algar WR, 2007, ANAL CHIM ACTA, V581, P193, DOI 10.1016/j.aca.2006.08.026
   Ball CS, 2016, ANAL CHEM, V88, P3562, DOI 10.1021/acs.analchem.5b04054
   Forsyth D. A, 2003, COMPUTER VISION MODE, V88
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Hunt RWG, 2011, WILEY-ISTE, P1, DOI 10.1002/9781119975595
   Knowlton SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15022
   Lee S, 2014, LAB CHIP, V14, P1437, DOI 10.1039/c3lc51375k
   Lee SA, 2014, LAB CHIP, V14, P3056, DOI 10.1039/c4lc00523f
   Lopez-Ruiz N, 2014, ANAL CHEM, V86, P9554, DOI 10.1021/ac5019205
   Oncescu V, 2013, LAB CHIP, V13, P3232, DOI 10.1039/c3lc50431j
   Ozcan A, 2014, LAB CHIP, V14, P3187, DOI 10.1039/c4lc00010b
   Petryayeva E, 2013, APPL SPECTROSC, V67, P215, DOI 10.1366/12-06948
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Priye A, 2017, METHODS MOL BIOL, V1571, P251, DOI 10.1007/978-1-4939-6848-0_16
   Priye A, 2016, ANAL CHEM, V88, P4651, DOI 10.1021/acs.analchem.5b04153
   Roda A, 2014, ANAL CHEM, V86, P7299, DOI 10.1021/ac502137s
   Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177
   Shen L, 2012, LAB CHIP, V12, P4240, DOI [10.1039/c2lc40741, 10.1039/c2lc40741h]
   Wei QS, 2013, ACS NANO, V7, P9147, DOI 10.1021/nn4037706
   Wyszecki G., 1982, COLOR SCI, V8
   Yu H, 2016, J PHARMACEUT BIOMED, V125, P85, DOI 10.1016/j.jpba.2016.03.018
NR 21
TC 14
Z9 14
U1 22
U2 82
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD NOV 6
PY 2018
VL 90
IS 21
BP 12385
EP 12389
DI 10.1021/acs.analchem.8b03521
PG 5
WC Chemistry, Analytical
SC Chemistry
GA GZ8FJ
UT WOS:000449722500013
PM 30272954
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Keeffe, JR
   Van Rompay, KKA
   Olsen, PC
   Wang, Q
   Gazumyan, A
   Azzopardi, SA
   Schaefer-Babajew, D
   Lee, YE
   Stuart, JB
   Singapuri, A
   Watanabe, J
   Usachenko, J
   Ardeshir, A
   Saeed, M
   Agudelo, M
   Eisenreich, T
   Bournazos, S
   Oliveira, TY
   Rice, CM
   Coffey, LL
   MacDonald, MR
   Bjorkman, PJ
   Nussenzweig, MC
   Robbiani, DF
AF Keeffe, Jennifer R.
   Van Rompay, Koen K. A.
   Olsen, Priscilla C.
   Wang, Qiao
   Gazumyan, Anna
   Azzopardi, Stephanie A.
   Schaefer-Babajew, Dennis
   Lee, Yu E.
   Stuart, Jackson B.
   Singapuri, Anil
   Watanabe, Jennifer
   Usachenko, Jodie
   Ardeshir, Amir
   Saeed, Mohsan
   Agudelo, Marianna
   Eisenreich, Thomas
   Bournazos, Stylianos
   Oliveira, Thiago Y.
   Rice, Charles M.
   Coffey, Lark L.
   MacDonald, Margaret R.
   Bjorkman, Pamela J.
   Nussenzweig, Michel C.
   Robbiani, Davide F.
TI A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus
   Escape Mutations in Non-human Primates
SO CELL REPORTS
LA English
DT Article
ID DENGUE VIRUS; NEUTRALIZING ANTIBODIES; HALF-LIFE; EPITOPE; DISEASE;
   PATHOGENESIS; ENHANCEMENT; PROTECTION; CELLS
AB Zika virus (ZIKV) causes severe neurologic complications and fetal aberrations. Vaccine development is hindered by potential safety concerns due to antibody cross-reactivity with dengue virus and the possibility of disease enhancement. In contrast, passive administration of anti-ZIKV antibodies engineered to prevent enhancement may be safe and effective. Here, we report on human monoclonal antibody Z021, a potent neutralizer that recognizes an epitope on the lateral ridge of the envelope domain III (EDIII) of ZIKV and is protective against ZIKV in mice. When administered to macaques undergoing a high-dose ZIKV challenge, a single anti-EDIII antibody selected for resistant variants. Co-administration of two antibodies, Z004 and Z021, which target distinct sites on EDIII, was associated with a delay and a 3-to 4-log decrease in peak viremia. Moreover, the combination of these antibodies engineered to avoid enhancement prevented viral escape due to mutation in macaques, a natural host for ZIKV.
C1 [Keeffe, Jennifer R.; Lee, Yu E.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Van Rompay, Koen K. A.; Watanabe, Jennifer; Usachenko, Jodie; Ardeshir, Amir] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Olsen, Priscilla C.; Gazumyan, Anna; Schaefer-Babajew, Dennis; Agudelo, Marianna; Eisenreich, Thomas; Oliveira, Thiago Y.; Nussenzweig, Michel C.; Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Azzopardi, Stephanie A.; Saeed, Mohsan; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Bournazos, Stylianos] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
   [Olsen, Priscilla C.] Univ Fed Rio de Janeiro, Fac Farm, BR-21941901 Rio De Janeiro, Brazil.
   [Wang, Qiao] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE MOH, Shanghai 200032, Peoples R China.
   [Van Rompay, Koen K. A.; Stuart, Jackson B.; Singapuri, Anil; Coffey, Lark L.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
RP Nussenzweig, MC; Robbiani, DF (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
EM nussen@rockefeller.edu; drobbiani@rockefeller.edu
RI Nussenzweig, Michel/AAE-7292-2019; Robbiani, Davide F./AAF-7662-2019;
   Olsen, Priscilla C/I-8994-2012; ARDESHIR, AMIR/Q-1258-2017; Oliveira,
   Thiago/B-7073-2014
OI Robbiani, Davide F./0000-0001-7379-3484; Olsen, Priscilla
   C/0000-0002-8795-037X; ARDESHIR, AMIR/0000-0002-4330-4659; Wang,
   Qiao/0000-0001-6416-1733; Oliveira, Thiago/0000-0002-2654-0879
FU US Department of EnergyUnited States Department of Energy (DOE); NIH
   (NIGMS)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS); NIH (National Cancer Institute)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI); NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [1R21AI129479-01, U19AI111825, UL1TR001866, R01AI037526, UM1AI100663,
   P01AI138938, R01AI124690, U19AI057229]; Lyda Hill; Rockefeller
   University Development Office; Office of Research Infrastructure
   Programs/OD [P51OD011107]; Pathology, Microbiology and Immunology
   Department; Molecular Observatory at Caltech; Gordon and Betty Moore
   FoundationGordon and Betty Moore Foundation; Robertson Therapeutic
   Development Fund; Pew Latin American Fellows Program in the Biomedical
   Sciences; Studienstiftung des deutschen Volkes
FX We thank Kai-Hui Yao, Daniel Yost, and Jovana Golijanin at Rockefeller,
   as well as the veterinary staff, pathology staff, and the staff of
   Colony Management and Research Services and Clinical Laboratory at the
   California National Primate Center for expert assistance. We thank Alisa
   Voll, Tiffany Luong, and the Caltech Protein Expression Center directed
   by Dr. Jost Vielmetter for cloning and expression and purification of
   proteins and Anthony P. West, Jr., Harry B. Gristick, Beth Stadtmueller,
   and Christopher Barnes for help with crystallographic methods and
   helpful discussions. We also thank Jens Kaiser from the Molecular
   Observatory at the Beckman Institute at the California Institute of
   Technology, Ruslan Sanishvili at APS beamline 23-ID-D (Argonne National
   Laboratory), and the staff at beamline 12-2, Stanford Synchrotron
   Radiation Lightsource (SSRL), for their assistance with crystallographic
   data collection and processing. Operations at SSRL are supported by the
   US Department of Energy and NIH, and operations at APS are supported by
   the NIH (NIGMS and National Cancer Institute). This work was supported
   by the NIH (pilot awards U19AI111825 and UL1TR001866 to D.F.R.; grants
   R01AI037526, UM1AI100663, U19AI111825, P01AI138938, and UL1TR001866 to
   M.C.N.), funding by Lyda Hill (to M.C.N.), NIH grants R01AI124690 and
   U19AI057229 (CCHI pilot project), The Rockefeller University Development
   Office and anonymous donors (C.M.R. and M.R.M.), the Office of Research
   Infrastructure Programs/OD (grant P51OD011107), start-up funds from the
   Pathology, Microbiology and Immunology Department (to L.L.C.), NIH grant
   1R21AI129479-01 (to K.K.A.V.R.), and the Molecular Observatory at
   Caltech supported by the Gordon and Betty Moore Foundation (P.J.B.).
   Support was also provided by the Robertson Therapeutic Development Fund
   (D.F.R. and M.C.N.). P.C.O. is supported by the Pew Latin American
   Fellows Program in the Biomedical Sciences, D. S.-B. is supported by
   Studienstiftung des deutschen Volkes, and M.C.N. is an HHMI
   Investigator.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Daffis S, 2005, VIROLOGY, V337, P262, DOI 10.1016/j.virol.2005.04.031
   de Silva AM, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029371
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   Drake JW, 1998, GENETICS, V148, P1667
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Elena SF, 2000, IUBMB LIFE, V49, P5, DOI 10.1080/713803585
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Griffin MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01714-16, 10.1128/aac.01714-16]
   Halstead SB, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a030700
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HOLZMANN H, 1989, J GEN VIROL, V70, P219, DOI 10.1099/0022-1317-70-1-219
   Horton HM, 2008, CANCER RES, V68, P8049, DOI 10.1158/0008-5472.CAN-08-2268
   Iwasaki A, 2017, TRENDS MOL MED, V23, P227, DOI 10.1016/j.molmed.2017.01.004
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li TZ, 2017, P NATL ACAD SCI USA, V114, P3485, DOI 10.1073/pnas.1702173114
   LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410
   Lok SM, 2001, J MED VIROL, V65, P315, DOI 10.1002/jmv.2036
   Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Magnani DM, 2017, MOL THER, V25, P2323, DOI 10.1016/j.ymthe.2017.06.020
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452
   Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Sapkal GN, 2011, VIRUS RES, V158, P130, DOI 10.1016/j.virusres.2011.03.023
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029520
   Shimoda H, 2013, J VET MED SCI, V75, P1077, DOI 10.1292/jvms.12-0558
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110
   Whitehead SS, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028811
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601
   Zou G, 2012, ANTIVIR RES, V95, P216, DOI 10.1016/j.antiviral.2012.06.010
NR 68
TC 17
Z9 17
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 6
PY 2018
VL 25
IS 6
BP 1385
EP +
DI 10.1016/j.celrep.2018.10.031
PG 17
WC Cell Biology
SC Cell Biology
GA GZ5PB
UT WOS:000449476500001
PM 30403995
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Wu, YH
   Cui, XY
   Yang, W
   Fan, DY
   Liu, D
   Wang, PG
   An, J
AF Wu, Yan-Hua
   Cui, Xiao-Yun
   Yang, Wei
   Fan, Dong-Ying
   Liu, Dong
   Wang, Pei-Gang
   An, Jing
TI Zika Virus Infection in Hypothalamus Causes Hormone Deficiencies and
   Leads to Irreversible Growth Delay and Memory Impairment in Mice
SO CELL REPORTS
LA English
DT Article
ID CHILDREN; MODELS; AXIS
AB Zika virus (ZIKV) can cause microcephaly in the fetus. However, its effects on body growth and the development of children with postnatal ZIKV infection are largely unknown. To examine this, we intraperitoneally challenged mouse pups with ZIKV. Infection causes an irreversible growth delay and deficits in spatial learning and memory, with growth-relevant hormones significantly reduced during infection. These effects are associated with ZIKV RNA expression in the hypothalamus, blood, and brain but not in the pituitary and thyroid. Infection is also associated with hypothalamic inflammation, and ZIKV antigen is detectable in neuroendocrine cells producing thyrotropin-releasing hormone. Moreover, early administration of growth hormone could significantly improve growth delay. Our results demonstrate that ZIKV can infect the hypothalamus, causing multi-hormone deficiencies and delayed growth and development in a mouse model. Therefore, prospective multidisciplinary follow-up of ZIKV-infected children may be necessary to understand potential effects of this virus on childhood development.
C1 [Wu, Yan-Hua; Cui, Xiao-Yun; Yang, Wei; Fan, Dong-Ying; Wang, Pei-Gang; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
   [Liu, Dong; An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100093, Peoples R China.
RP Wang, PG; An, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.; An, J (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100093, Peoples R China.
EM pgwang@ccmu.edu.cn; anjing@ccmu.edu.cn
OI Wang, Peigang/0000-0001-6045-2007
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471957, 81671971, 81401676, U1602223, 81372935];
   Scientific Research Plan of the Beijing Municipal Education Committee
   [11720629, KZ201810025035]; Foundation of Key Laboratory of Beijing
   Ditan Hospital [DTKF201705]
FX We thank Mr. Jian-Feng Lei and Prof. Hai-Hong Ye at Capital Medical
   University and Prof. Mei Zhao at China Academy Science for CT, MRI, and
   mirror water maze experiments, and we thank Prof. Yu-Lan Dong at China
   Agriculture University and Dr. Bo Qiu at Shandong Academy of
   Pharmaceutical Sciences for pituitary and thyroid dissection and
   analysis. This work was supported by grants from the National Natural
   Science Foundation of China (81471957, 81671971, 81401676, U1602223, and
   81372935), the Scientific Research Plan of the Beijing Municipal
   Education Committee (11720629 and KZ201810025035), and the Foundation of
   Key Laboratory of Beijing Ditan Hospital (DTKF201705).
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Clarke IJ, 2015, COMPR PHYSIOL, V5, P217, DOI 10.1002/cphy.c140019
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Frohman LA, 2002, TRENDS ENDOCRIN MET, V13, P299, DOI 10.1016/S1043-2760(02)00613-6
   Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y
   Gesing A, 2014, EXP GERONTOL, V58, P219, DOI 10.1016/j.exger.2014.08.010
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin IJ, 2015, NESTLE NUTR WORKS SE, V81, P87, DOI 10.1159/000365806
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Joseph-Bravo P, 2015, J ENDOCRINOL, V226, pT85, DOI 10.1530/JOE-15-0124
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Langlet F, 2013, CELL METAB, V17, P607, DOI 10.1016/j.cmet.2013.03.004
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   LOOIJ BJ, 1995, J ENDOCRINOL INVEST, V18, P214, DOI 10.1007/BF03347804
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2007, EMERG INFECT DIS, V13, P479, DOI 10.3201/eid1303.060602
   Nurhidayat, 1999, BRAIN RES, V821, P309, DOI 10.1016/S0006-8993(99)01081-1
   Pekic S, 2005, ENDOCRINE, V26, P79, DOI 10.1385/ENDO:26:2:079
   Plant TM, 2015, FRONT NEUROENDOCRIN, V38, P73, DOI 10.1016/j.yfrne.2015.04.002
   Prodam F, 2012, PANMINERVA MED, V54, P323
   ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheikh Amin A, 2015, Biomed Sci Instrum, V51, P309
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
NR 36
TC 1
Z9 1
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 6
PY 2018
VL 25
IS 6
BP 1537
EP +
DI 10.1016/j.celrep.2018.10.025
PG 15
WC Cell Biology
SC Cell Biology
GA GZ5PB
UT WOS:000449476500013
PM 30404008
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Therkelsen, MD
   Klose, T
   Vago, F
   Jiang, W
   Rossmann, MG
   Kuhn, RJ
AF Therkelsen, Matthew D.
   Klose, Thomas
   Vago, Frank
   Jiang, Wen
   Rossmann, Michael G.
   Kuhn, Richard J.
TI Flaviviruses have imperfect icosahedral symmetry
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE flaviviruses; cryo-electron microscopy; assembly; budding; asymmetry
ID CRYO-EM STRUCTURE; ENVELOPE PROTEIN COMPLEX; TICK-BORNE ENCEPHALITIS;
   IN-SITU STRUCTURES; WEST-NILE VIRUS; ZIKA VIRUS; DENGUE VIRUS;
   CRYOELECTRON MICROSCOPY; ELECTRON-MICROGRAPHS; CAPSID PROTEIN
AB Flaviviruses assemble initially in an immature, noninfectious state and undergo extensive conformational rearrangements to generate mature virus. Previous cryo-electron microscopy (cryo-EM) structural studies of flaviviruses assumed icosahedral symmetry and showed the concentric organization of the external glycoprotein shell, the lipid membrane, and the internal nucleocapsid core. We show here that when icosahedral symmetry constraints were excluded in calculating the cryo-EM reconstruction of an immature flavivirus, the nucleocapsid core was positioned asymmetrically with respect to the glycoprotein shell. The core was positioned closer to the lipid membrane at the proximal pole, and at the distal pole, the outer glycoprotein spikes and inner membrane leaflet were either perturbed or missing. In contrast, in the asymmetric reconstruction of a mature flavivirus, the core was positioned concentric with the glycoprotein shell. The deviations from icosahedral symmetry demonstrated that the core and glycoproteins have varied interactions, which likely promotes viral assembly and budding.
C1 [Therkelsen, Matthew D.; Klose, Thomas; Vago, Frank; Jiang, Wen; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP Kuhn, RJ (corresponding author), Purdue Univ, Dept Biol Sci, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
EM kuhnr@purdue.edu
OI Jiang, Wen/0000-0002-1292-2411
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI076331,
   R01AI073755]
FX We thank the members of the R.J.K. and M.G.R. laboratories for their
   help with experimental design. In particular, we acknowledge Yue Liu for
   many discussions on data processing. We thank Valorie Bowman, Steve
   Wilson, and the Purdue Cryo-EM Facility for cryo-EM training and
   computer support. We acknowledge Rodney McPhail for the artwork of Fig.
   3 and Sheryl Kelly and Anita Robinson for administrative support. This
   work was supported by National Institutes of Health Grants R01AI076331
   and R01AI073755 (to M.G.R. and R.J.K.).
CR Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0
   Dai XH, 2017, NATURE, V541, P112, DOI 10.1038/nature20589
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Gorzelnik KV, 2016, P NATL ACAD SCI USA, V113, P11519, DOI 10.1073/pnas.1609482113
   Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284
   Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19
   Guo F, 2013, P NATL ACAD SCI USA, V110, P6811, DOI 10.1073/pnas.1215563110
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487
   Koning RI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12524
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Lazaro GR, 2018, BIOPHYS J, V114, P619, DOI 10.1016/j.bpj.2017.11.3782
   Lee H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501929
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liu HR, 2015, SCIENCE, V349, P1347, DOI 10.1126/science.aaa4938
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson EE, 2014, J AM CHEM SOC, V136, P3536, DOI 10.1021/ja411460w
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]
   Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008
   Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Wang JCY, 2015, ACS NANO, V9, P8898, DOI 10.1021/acsnano.5b02632
   Yan R, 2017, J STRUCT BIOL, V197, P210, DOI 10.1016/j.jsb.2016.11.001
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang X, 2015, NATURE, V527, P531, DOI 10.1038/nature15767
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J STRUCT BIOL, V157, P356, DOI 10.1016/j.jsb.2006.09.002
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
NR 45
TC 6
Z9 6
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 6
PY 2018
VL 115
IS 45
BP 11608
EP 11612
DI 10.1073/pnas.1809304115
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ5KM
UT WOS:000449459000078
PM 30348794
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Solimini, AG
   Manica, M
   Rosa, R
   della Torre, A
   Caputo, B
AF Solimini, Angelo G.
   Manica, Mattia
   Rosa, Roberto
   della Torre, Alessandra
   Caputo, Beniamino
TI Estimating the risk of Dengue, Chikungunya and Zika outbreaks in a large
   European city
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AEDES-ALBOPICTUS; VIRUS; SPREAD; FEVER
AB Outbreaks of arbovirus infections vectored by invasive Aedes albopictus have already occurred and are predicted to become increasingly frequent in Southern Europe. We present a probabilistic model to assess risk of arbovirus outbreaks based on incident cases worldwide, on the probability of arrival of infected travelers, and on the abundance of the vector species. Our results show a significant risk of Chikungunya outbreak in Rome from mid June to October in simulations with high human biting rates (i.e. when >= 50% of the population is bitten every day). The outbreak risk is predicted to be highest for Chikungunya and null for Zika. Simulated increase of incident cases in selected endemic countries has no major impact on the outbreak risk. The model correctly estimated the number of imported cases and can be easily adapted to other urban areas where Ae. albopictus is the only potential vector present.
C1 [Solimini, Angelo G.; Manica, Mattia; della Torre, Alessandra; Caputo, Beniamino] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Manica, Mattia; Rosa, Roberto] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy.
RP Solimini, AG (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
EM angelo.solimini@uniroma1.it
RI Rosa, Roberto/B-8562-2011
OI Rosa, Roberto/0000-0002-8655-2230; MANICA, MATTIA/0000-0003-3709-1199;
   Solimini, Angelo/0000-0002-5281-7624
FU internal Sapienza Grant; European Union's Horizon 2020 Research and
   Innovation Programme under ZIKAlliance [734548]
FX We thank Luca Delucchi for technical assistance with cluster computing
   and Stefano Merler for useful suggestions on methodological issues. The
   study was partially supported by an internal Sapienza Grant (Ateneo
   2016). R.R. and M.M. were partly supported by the European Union's
   Horizon 2020 Research and Innovation Programme under ZIKAlliance Grant
   Agreement no. 734548.
CR Banca d'Italia, 2016, IND TUR INT
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Cianci D, 2013, J MED ENTOMOL, V50, P533, DOI 10.1603/ME12126
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cunze S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1853-2
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Guzzetta G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004762
   Johansson M. A., 2011, PLOS ONE, V6, P1
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Manica M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.44.17-00685
   Manica M, 2017, PEERJ, V5, DOI 10.7717/peerj.2998
   Manica M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004758
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Ministero della Salute, 2017, SORV CAS UM CHIK DEN
   Ministero della Salute, 2015, SORV CAS UM CHIK DEN
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Ng V., 2017, ENV HLTH PERSPECT, V125, P1
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   R Core Development Team, 2015, R LANG ENV STAT COMP
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Vairo F, 2016, INT J INFECT DIS, V53, P16, DOI 10.1016/j.ijid.2016.11.044
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Wearing HJ, 2016, PARASITOLOGY, V143, P860, DOI 10.1017/S0031182016000421
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 40
TC 3
Z9 3
U1 3
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 6
PY 2018
VL 8
AR 16435
DI 10.1038/s41598-018-34664-5
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ3GD
UT WOS:000449274200021
PM 30401870
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mendoza, I
   Gonzalez, K
   Morr, I
   Marques, J
   Meza, Y
   Allison, T
   Lopez, F
   Terzic, C
   Martinez, N
   Finizola, V
   Mendoza, IJ
AF Mendoza, Ivan
   Gonzalez, Karina
   Morr, Igor
   Marques, Juan
   Meza, Yolimar
   Allison, Thomas
   Lopez, Francisco
   Terzic, Carmen
   Martinez, Nahir
   Finizola, Vicente
   Mendoza, Ivan J.
TI A Rash From the Heart. Zika Myocarditis Manifesting With Coexisting
   Acute Atrial and Ventricular Arrhythmias and Itchy Rash
SO CIRCULATION
LA English
DT Meeting Abstract
DE Viruses; Atrial fibrillation; Ventricular arrhythmia; Atrial
   arrhythmias; Sudden cardiac death
C1 [Mendoza, Ivan] Jackson Mem Hosp, Cardiol, Miami, FL 33136 USA.
   [Gonzalez, Karina; Allison, Thomas; Lopez, Francisco; Terzic, Carmen] Mayo Clin, Cardiol, Rochester, MN USA.
   [Morr, Igor] Trop Cardiol, Cardiol, Marcacay, Venezuela.
   [Marques, Juan; Meza, Yolimar; Mendoza, Ivan J.] Trop Cardiol UCV, Cardiol, Caracas, Venezuela.
   [Martinez, Nahir] Cardiol Trop UCV, Cardiol, Caracas, Venezuela.
   [Finizola, Vicente] Ascardio, Cardiol, Barquisimeto, Venezuela.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 6
PY 2018
VL 138
SU 1
MA A13257
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA VJ0TD
UT WOS:000528619403105
DA 2020-07-08
ER

PT J
AU Park, S
   Choi, JS
   Kim, Y
AF Park, Seungmi
   Choi, Jeong Sil
   Kim, Youngji
TI Prevention of Zika virus infection: Knowledge, attitudes, and practices
   of pregnant women in Korea
SO HEALTH CARE FOR WOMEN INTERNATIONAL
LA English
DT Article
DE Zika virus infection; knowledge; attitude
AB This study was performed to investigate the association of knowledge, attitudes, and preventive practices for the prevention of Zika virus infection. The study sample consisted of 185 pregnant women in Korea. The Zika virus-related knowledge and attitude of pregnant women significantly affected preventive practices. The younger pregnant women and pregnant women who had not taken the influenza vaccine had lesser preventive practices of the Zika virus, thereby necessitating educating them and emphasizing good preventive practices. Our results suggest that systematic education and effective prevention programs for Zika virus will contribute to the prevention of infection.
C1 [Park, Seungmi] Hoseo Univ, Coll Nursing, Asan, South Korea.
   [Choi, Jeong Sil; Kim, Youngji] Gachon Univ, Coll Nursing, 191 Hambakmoero, Incheon 21936, South Korea.
RP Kim, Y (corresponding author), Gachon Univ, Coll Nursing, 191 Hambakmoero, Incheon 21936, South Korea.
EM superdr1@hanmail.net
FU Hoseo University research grant in 2017
FX This research was supported by the Hoseo University research grant in
   2017.
CR Al-Dubai SAR, 2013, SE ASIAN J TROP MED, V44, P37
   Arief M, 2017, JPPCM, V3, P81, DOI DOI 10.5530/jppcm.2017.2.20
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellingson MK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1516-0
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Halstead SB, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a030700
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Korea Centers for Disease Control and Prevention [KCDC], 2017, ZIK CAS REP KOR PUBL
   Korea Centers for Disease Control and Prevention [KCDC], 2017, ZIK VIR PREV GUID
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Park Seungmi, 2010, [The Journal of Korean Academic Society of Nursing Education, 한국간호교육학회지], V16, P249
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Wan Rozita WM, 2006, MALAYS J PUBLIC HLTH, V6, P62
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   World Health Organization, 2016, SAUDI MED J, V37, P334
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   최정실, 2015, [THE JOURNAL OF THE KOREAN SOCIETY OF SCHOOL HEALTH, 한국학교보건학회지], V28, P150
NR 26
TC 0
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-9332
EI 1096-4665
J9 HEALTH CARE WOMEN IN
JI Health Care Women Int.
PD NOV 2
PY 2018
VL 39
IS 11
BP 1209
EP 1220
DI 10.1080/07399332.2018.1506455
PG 12
WC Public, Environmental & Occupational Health; Women's Studies
SC Public, Environmental & Occupational Health; Women's Studies
GA HQ5PI
UT WOS:000462464700005
PM 30592701
DA 2020-07-08
ER

PT J
AU Kamradt-Scott, A
AF Kamradt-Scott, Adam
TI Securing Indo-Pacific health security: Australia's approach to regional
   health security
SO AUSTRALIAN JOURNAL OF INTERNATIONAL AFFAIRS
LA English
DT Article
DE Global health security; Indo-Pacific; regional security; disease
   outbreaks
ID ASIA; DISEASE; HIV/AIDS; DEFENSE; SHIFTS; CHINA
AB In the wake of several prominent disease outbreaks like Ebola and Zika, global health security is once again high on the international agenda. For its part, the Australian government has committed itself to strengthening regional health security. This policy direction - focusing on the Indo-Pacific region - is both consistent with Australia's traditional foreign policy approach of concentric circles informing strategic priorities, and is therefore understandable, even predictable. But given that local disease outbreaks in remote locations around the world now have the opportunity to travel rapidly internationally, is the adoption of an exclusively regional focus the most sensible one? This article considers the implications of Australia's new regional health security initiative, its focus and direction. The paper weighs the benefits and drawbacks of Australia's new programme and considers whether a wider focus is more appropriate for responding to the health threats of the twenty-first century.
C1 [Kamradt-Scott, Adam] Univ Sydney, Dept Govt & Int Relat, Sydney, NSW, Australia.
RP Kamradt-Scott, A (corresponding author), Univ Sydney, Sch Social & Polit Sci, Social Sci Bldg A02, Sydney, NSW 2006, Australia.
EM adam.kamradt-scott@sydney.edu.au
RI Kamradt-Scott, Adam/B-9205-2013
OI Kamradt-Scott, Adam/0000-0002-4901-4898
FU University of Sydney SOAR Fellowship
FX This work was supported by The University of Sydney SOAR Fellowship.
CR ADB, 2018, REG MAL OTH COMM DIS
   Aldis W, 2008, HEALTH POLICY PLANN, V23, P369, DOI 10.1093/heapol/czn030
   [Anonymous], 2018, THE POSTCOURIER 0220
   Aspalter C, 2006, INT J SOC WELF, V15, P290, DOI 10.1111/j.1468-2397.2006.00413.x
   AusAID, 2006, PAND EM INF DIS STRA
   AusAID, 2010, ANN THEM PERF REP HL
   Australian Broadcasting Corporation, 2014, ABC NEWS
   Australian Government, 2008, AUSTR HLTH EM INFL P
   Australian Government, 2017, 2017 FOR POL WHIT PA
   Ayson R, 2007, AUST J INT AFF, V61, P215, DOI 10.1080/10357710701358360
   Bernard KW, 2013, BIOSECUR BIOTERROR, V11, P157, DOI 10.1089/bsp.2013.8522
   Bishop Julie., 2017, LAUNCH INDO PACIFIC
   Bishop Julie., 2017, AMBASSADOR REGIONAL
   Bordier M, 2013, ANIM HEALTH RES REV, V14, P40, DOI 10.1017/S1466252313000017
   Brookes T., 2005, MASK WORLD SURVIVED
   Byrne Patrick., 2015, NEWS WEEKLY, V2943, P7
   Chiu HH, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24516
   Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7
   Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3
   Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1
   Commonwealth of Australia, 2010, PORTF BUDG STAT 2010
   Corbett J, 2016, AUST J INT AFF, V70, P87, DOI 10.1080/10357718.2015.1085955
   Cornish Lisa., 2018, DEVEX           0214
   Cornish Lisa., 2017, DEVEX           1010
   Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892
   Cullen Simon, 2014, ABC NEWS
   Davies Sara., SECURITY SOVEREIGNTY
   Davies SE, 2008, INT AFF, V84, P295, DOI 10.1111/j.1468-2346.2008.00704.x
   DeLaet DL, 2015, ROUTLEDGE HANDBOOK OF GLOBAL HEALTH SECURITY, P339
   Department of Defence, 2009, DEF AUSTR AS PAC CEN
   Department of Foreign Affairs and Trade, 2015, HLTH DEV STRAT 2015
   DFAT, 2018, WE GIV AID
   DFAT, 2018, IND PAC CTR HLTH SEC
   DFAT, 2018, BUDG 2018 19 PORTF B
   DFAT, 2017, BUDG 2017 18 PORTF B
   DFAT, 2015, DFAT CONS PAP TAK FO
   DoHA, 2008, AUSTR HLTH EM INFL P
   Elbe S, 2006, INT STUD QUART, V50, P119, DOI 10.1111/j.1468-2478.2006.00395.x
   Enemark C, 2009, SURVIVAL, V51, P191, DOI 10.1080/00396330902749798
   Executive Board, 2015, SPEC SESS EB EM GEN
   Executive Board, 2008, EX BOARD 122 SESS GE
   Fawcett L, 2004, INT AFF, V80, P429, DOI 10.1111/j.1468-2346.2004.00391.x
   Fidler DP, 2005, CHIN J INT LAW, V4, P325, DOI DOI 10.1093/CHINESEJIL/JMI029
   Fisher D, 2011, RESPIROLOGY, V16, P876, DOI 10.1111/j.1440-1843.2011.02003.x
   George Anna., 2017, AUSTR OUTLOOK
   Ghebreyesus Tedros Adhanom., 2018, EXCHANGE VIEWS IMPOR
   Greenberg Daniel., 2002, LANCET, V358, P2137
   Harrison Dan., 2015, SYDNEY MORNING HERAL
   Heymann DL, 2005, SEVERE ACUTE RESPIRATORY SYNDROME, P13
   Hoeffler A, 2011, REV DEV ECON, V15, P237, DOI 10.1111/j.1467-9361.2011.00605.x
   Howes Stephen., 2017, HLTH SECURITY 1
   Hui DSC, 2017, J THORAC DIS, V9, P4808, DOI 10.21037/jtd.2017.11.17
   Inglesby T, 2014, BIOSECUR BIOTERROR, V12, P63, DOI 10.1089/bsp.2014.3314
   Ingram A, 2011, GEOPOLITICS, V16, P655, DOI 10.1080/14650045.2010.494001
   JEE Alliance, 2017, AUSTR COCH JEE ALL
   Johnson Chris., 2017, AUSTR MED, V29, P16
   Kamradt-Scott A., 2015, MANAGING GLOBAL HLTH
   Kamradt-Scott A, 2009, AUST J INT AFF, V63, P550, DOI 10.1080/10357710903312595
   Kang CI, 2013, INFECT CHEMOTHER, V45, P22, DOI 10.3947/ic.2013.45.1.22
   Kehoe John., 2014, AUSTR FINANCIAL REV
   Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341
   King NB, 2002, SOC STUD SCI, V32, P763, DOI 10.1177/030631202128967406
   Kumar S Ganesh, 2013, J Nat Sci Biol Med, V4, P286, DOI 10.4103/0976-9668.116970
   Lakoff Andrew, 2008, BIOSECURITY INTERVEN, P7, DOI DOI 10.7312/LAKO14606-001
   Lanteigne M, 2012, POLIT SCI, V64, P21, DOI 10.1177/0032318712447732
   Liberal Party of Australia, 2016, COAL POL SAF PROSP A
   Lin SJ, 2009, APPL ECON, V41, P519, DOI 10.1080/00036840701720754
   Lowther Adam., 2013, ASIA PACIFIC CENTURY, P25
   LYON R, 2005, ASIAN SECURITY, V1, P25
   McDonald M, 2015, AUST J INT AFF, V69, P651, DOI 10.1080/10357718.2015.1056514
   Medcalf R, 2014, AUST J INT AFF, V68, P470, DOI 10.1080/10357718.2014.911814
   Medew Julia, 2016, SYDNEY MORNING HERAL
   Michaud Josh, 2017, US GOVT GLOBAL HLTH
   Morgan Angus., 2017, BURNETT WELCOMES NEW
   Nohrstedt D, 2018, DISASTERS, V42, P41, DOI 10.1111/disa.12238
   Patel Mahomed, 2017, EFFECT AUSTR REGIONA
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Plianbangchang Samlee., 2013, REG M ZOON DIS 20 22
   Plibersek T, 2016, AUST J INT AFF, V70, P460, DOI 10.1080/10357718.2016.1199657
   Rushton S, 2011, POLIT STUD-LONDON, V59, P779, DOI 10.1111/j.1467-9248.2011.00919.x
   Sands Peter., 2018, THE GLOBAL FUND 0202
   Schierhout Gill, 2017, EVALUATING DECADE AU
   Schultz J, 2014, AUST J INT AFF, V68, P548, DOI 10.1080/10357718.2014.917271
   SEARO WPRO, 2016, BIR M TECHN ADV GROU
   Shashikant Sangeeta., 2008, WHO BOARD DEBATES GL
   Shashikant Sangeeta., 2007, WHO M AV FLU VIR END
   Shin Young-soo., 2017, COMMUNICATION
   SPC, 2017, MEAS PROGR HLTH ISL
   SPC, 2016, ZIK VIR MON CONT PAC
   Stevenson MA, 2015, ROUTLEDGE HANDBOOK OF GLOBAL HEALTH SECURITY, P328
   Tucker JB, 2005, BIOSECUR BIOTERROR, V3, P338, DOI 10.1089/bsp.2005.3.338
   Tukuitonga Colin., 2017, PACIFIC DYNAMICS, V1, P340
   Uhlmann Chris, 2014, ABC NEWS
   United Nations, 2016, UN NEWS
   Weir L., 2015, ROUTLEDGE HDB GLOBAL
   Wenham C, 2018, CONTEMP SE ASIA, V40, P126, DOI 10.1355/cs40-1f
   Wesley M, 2016, SECUR CHALL, V12, P19
   WHO, 2016, 69 WORLD HLTH ASS GE
   Wong Penny., 2017, AID IS POOR HLTH
   Woo PCY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0016-7
   World Health Organization, 2010, SEC OUR REG HLTH AS
   World Health Organization Regional Office for South East Asia, 2008, HLTH AS PAC
   WPRO, 2004, CONS REV INT HLTH RE
   WPRO, 2015, KEEP W PAC REG SAF T
   Youde Jeremy, 2012, GLOBAL HLTH GOVERNAN
   Zweynert Astrid., 2015, THOMSON REUTERS 1124
NR 106
TC 2
Z9 2
U1 2
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1035-7718
EI 1465-332X
J9 AUST J INT AFF
JI Aust. J. Int. Aff.
PD NOV 2
PY 2018
VL 72
IS 6
SI SI
BP 500
EP 519
DI 10.1080/10357718.2018.1534942
PG 20
WC International Relations
SC International Relations
GA HE7RM
UT WOS:000453637600004
OA Bronze
DA 2020-07-08
ER

PT J
AU Britto, C
   Dold, C
   Reyes-Sandoval, A
   Rollier, CS
AF Britto, Carl
   Dold, Christina
   Reyes-Sandoval, Arturo
   Rollier, Christine S.
TI Rapid travel to a Zika vaccine: are we heading towards success or more
   questions?
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Article
DE Antibody dependent enhancement; diagnostic; neurological complications;
   serology; vaccines; zika virus
ID ANTIBODY-DEPENDENT ENHANCEMENT; VIRUS-INFECTION; DENGUE VIRUS;
   CROSS-REACTIVITY; AUTOIMMUNITY; DIAGNOSIS; OUTBREAK; IMMUNITY; DISEASE
AB Introduction: The emergence of the Zika virus (ZIKV) in Latin America in 2015-2016 led to an expeditious search for vaccine candidates, with a DNA-based candidate having progressed to Phase II. However, several features of ZIKV infection and epidemiology are not understood, which may be key to maximizing efficacy and ensuring safety of ZIKV vaccines. Areas covered: Conceivable problems related to vaccine development and policy include: (1) paucity of diagnostics to satisfactorily discriminate between past ZIKV and dengue virus (DENV) exposure; (2) insufficient knowledge of the mechanisms of ZIKV neurovirulence, amongst other unknowns in the biology of this infection, is particularly relevant from a vaccine safety perspective; and (3) the potential for disease enhancement, as observed with DENV infection and vaccine. Expert opinion: Vaccine candidates that entered phase I/II trials have demonstrated protection in naive animal models, while ZIKV epidemics occurred in populations that had encountered DENV before. The resulting cross-reactive antibodies pose problems for reliable serologic diagnostic assays, and for the potential of disease enhancement. The alleged neurological complications also warrant further exploration in order to reassure regulators of the safety profile of these vaccines in target populations. These research aspects should be an integral part of the efforts to develop a vaccine.
C1 [Britto, Carl; Dold, Christina; Rollier, Christine S.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Churchill Dr, Oxford, England.
   [Britto, Carl; Dold, Christina; Rollier, Christine S.] Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Churchill Dr, Oxford, England.
   [Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England.
RP Rollier, CS (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Churchill Dr, Oxford, England.; Rollier, CS (corresponding author), Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Churchill Dr, Oxford, England.
EM christine.rollier@paediatrics.ox.ac.uk
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2017, REG ZIK EP UPD AM AU
   [Anonymous], 2016, TARGET PRODUCT PROFI
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, STRUCTURAL BASIS POT
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Blackman MA, 2017, VIRAL IMMUNOL, V31, P1
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S., 2016, LANCET, V6736, P1
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Darton TC, 2015, LANCET INFECT DIS, V15, P840, DOI 10.1016/S1473-3099(15)00068-7
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Doherty M, 2016, VACCINE, V34, P6707, DOI 10.1016/j.vaccine.2016.10.025
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Liuzzi G, 2016, NEW MICROBIOL, V39, P83
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PLOTKIN SA, 1987, PEDIATR RES, V21, pA332, DOI 10.1203/00006450-198704010-00989
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   PORTERFIELD JS, 1986, ADV VIRUS RES, V31, P335, DOI 10.1016/S0065-3527(08)60268-7
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro GS, DOES IMMUNITY ZIKA V
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shah SK, 2017, ETHICAL CONSIDERATIO
   Simmins CH, 2016, ESTABLISHING BASE LE
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO/UNICEF, 2017, ZIK VIR VACC TARG PR
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhu Z, 2017, J EXP MED, V214, P314
NR 83
TC 3
Z9 3
U1 2
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD NOV 2
PY 2018
VL 18
IS 11
BP 1171
EP 1179
DI 10.1080/14712598.2018.1526277
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA GX9RR
UT WOS:000448143400008
PM 30235422
DA 2020-07-08
ER

PT J
AU Foo, SS
   Chen, WQ
   Chan, Y
   Lee, WS
   Lee, SA
   Cheng, GH
   Nielsen-Saines, K
   Brasil, P
   Jung, JU
AF Foo, Suan-Sin
   Chen, Weiqiang
   Chan, Yen
   Lee, Wai-Suet
   Lee, Shin-Ae
   Cheng, Genhong
   Nielsen-Saines, Karin
   Brasil, Patricia
   Jung, Jae U.
TI Biomarkers and immunoprofiles associated with fetal abnormalities of
   ZIKV-positive pregnancies
SO JCI INSIGHT
LA English
DT Article
ID VIRUS; MONOCYTES; MICRONESIA; INFECTION; OUTCOMES; STATES
AB BACKGROUND. An intricate fetal-maternal immune crosstalk during pregnancy is essential for a healthy birth. Hence, the infection-induced alterations of maternal immunity often lead to adverse outcomes for mother and/or child. The emergence of Zika virus (ZIKV) infection in pregnant women has been associated with more than 3,000 cases of microcephaly and nervous system malformations.
   METHODS. To explore the potential correlation of ZIKV-induced alteration of maternal immunity with fetal abnormalities, we performed extensive sera immunoprofiling of 74 pregnant women: 30 symptomatic ZIKV(+) pregnant patients and 30 healthy pregnant controls in ZIKV-endemic Rio de Janeiro, along with 14 healthy pregnant controls in non-endemic Los Angeles.
   RESULTS. Extensive multiplexing analysis of 69 cytokines revealed that CXCL10, CCL2, and CCL8 chemokines were specifically associated with symptomatic ZIKV(+) infection during pregnancy, and distinct immunoprofiles were detected at different trimesters in ZIKV-infected pregnant women. Intriguingly, the high CCL2 level and its inverse correlation with CD163, TNFRSF1A, and CCL22 levels was apparently associated with ZIKV-induced abnormal birth.
   CONCLUSION. Our findings provide insights into the alteration of ZIKV-elicited maternal immunity, serving as a potential clinical biomarker platform.
C1 [Foo, Suan-Sin; Chen, Weiqiang; Lee, Wai-Suet; Lee, Shin-Ae; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Microbiol & Immunol, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Chan, Yen] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Obstet & Gynecol,Div Maternal Fetal Med, 1501 San Pablo St, Los Angeles, CA 90033 USA.
   [Lee, Wai-Suet] Griffith Univ, Inst Glycom, Southport, Qld, Australia.
   [Cheng, Genhong] UCLA, David Geffen Sch Med, Marion Davies Childrens Hlth Ctr, Dept Microbiol & Mol Genet, Los Angeles, CA USA.
   [Nielsen-Saines, Karin] UCLA, David Geffen Sch Med, Marion Davies Childrens Hlth Ctr, Div Pediat Infect Dis, Los Angeles, CA USA.
   [Brasil, Patricia] Fiocruz MS, Fondacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
RP Foo, SS; Chen, WQ; Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Microbiol & Immunol, 1501 San Pablo St, Los Angeles, CA 90033 USA.
EM foos@usc.edu; weiqchen@usc.edu; jaeujung@med.usc.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI129534-01, R01AI40718, CA200422,
   CA180779, DE023926, AI073099, AI116585, AI129496, AI140705, AI069120,
   AI056154, AI078389, AI28697]; Hastings Foundation; Fletcher Jones
   Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [CAPES/88887.116627/2016-01]; Departamento de Ciencia e
   Tecnologia do Ministerio da Saude do Brasil [DECIT/25000.072811/2016-17]
FX This work was partly supported by NIH grants CA200422, CA180779,
   DE023926, AI073099, AI116585, AI129496, and AI140705, the Hastings
   Foundation, and the Fletcher Jones Foundation (JUJ); NIH grants
   AI069120, AI056154, AI078389, and AI28697 (GC); NIH grants AI129534-01
   (KNS) and R01AI40718 (JUU, GC, and KNS) and Departamento de Ciencia e
   Tecnologia (DECIT/25000.072811/2016-17) do Ministerio da Saude do Brasil
   and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   CAPES/88887.116627/2016-01 (PB).
CR Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   Bezie S, 2015, J CLIN INVEST, V125, P3952, DOI 10.1172/JCI81227
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, OUTC PREGN LAB EV PO
   Oliveira RAD, 2017, J CLIN VIROL, V89, P39, DOI 10.1016/j.jcv.2017.02.007
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045
   Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681
   Ginsberg Y, 2017, RAMBAM MAIMONIDES ME, V8, DOI 10.5041/RMMJ.10305
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Herrero LJ, 2013, PHARMACOL THERAPEUT, V137, P266, DOI 10.1016/j.pharmthera.2012.10.007
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788
   Kaufman B, 1997, CLIN INFECT DIS, V24, P334, DOI 10.1093/clinids/24.3.334
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   PAHO and WHO, 2015, ZIK SUSP CONF CAS RE
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   WHO:, 2017, GLOB STRAT WOM CHILD
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 28
TC 6
Z9 6
U1 0
U2 1
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD NOV 2
PY 2018
VL 3
IS 21
AR e124152
DI 10.1172/jci.insight.124152
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GZ2OG
UT WOS:000449225900016
PM 30385728
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Osuna-Ramos, JF
   Reyes-Ruiz, JM
   del Angel, RM
AF Fidel Osuna-Ramos, Juan
   Manuel Reyes-Ruiz, Jose
   del Angel, Rosa Maria
TI The Role of Host Cholesterol During Flavivirus Infection
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE flavivirus; arbovirus infection; host cholesterol; IFN response;
   lipid-lowering drugs
ID DENGUE VIRUS-INFECTION; PLASMA-MEMBRANE CHOLESTEROL; ELEMENT-BINDING
   PROTEIN; WEST-NILE; AEDES-AEGYPTI; ENDOPLASMIC-RETICULUM; LIPID PROFILE;
   ZIKA VIRUS; 3-DIMENSIONAL ARCHITECTURE; MOLECULAR-BIOLOGY
AB In recent years the emergence and resurgence of arboviruses have generated a global health alert. Among arboviruses, Dengue (DENV), Zika (ZIKV), Yellow Fever (YFV), and West Nile (WNV) virus, belong to the genus Flavivirus, cause high viremia and occasionally fatal clinical disease in humans. Given the genetic austerity of the virus, they depend on cellular factors and organelles to complete its replication. One of the cellular components required for flavivirus infection is cholesterol. Cholesterol is an abundant lipid in biomembranes of eukaryotes cells and is necessary to maintain the cellular homeostasis. Recently, it has been reported, that cholesterol is fundamental during flavivirus infection in both mammal and insect vector models. During infection with DENV, ZIKV, YFV, and WNV the modulation of levels of host-cholesterol facilitates viral entry, replicative complexes formation, assembly, egress, and control of the interferon type I response. This modulation involves changes in cholesterol uptake with the concomitant regulation of cholesterol receptors as well as changes in cholesterol synthesis related to important modifications in cellular metabolism pathways. In view of the flavivirus dependence of cholesterol and the lack of an effective anti-flaviviral treatment, this cellular lipid has been proposed as a therapeutic target to treat infection using FDA-approved cholesterol-lowering drugs. This review aims to address the dependence of cholesterol by flaviviruses as well as the basis for anti flaviviral therapy using drugs which target is cholesterol synthesis or uptake.
C1 [Fidel Osuna-Ramos, Juan; Manuel Reyes-Ruiz, Jose; del Angel, Rosa Maria] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
RP del Angel, RM (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
EM rmangel@cinvestav.mx
RI Reyes-Ruiz, Jose Manuel/AAF-2306-2020
OI Reyes-Ruiz, Jose Manuel/0000-0002-2379-8591; Osuna-Ramos, Juan
   Fidel/0000-0001-8280-9812
FU National Council of Science and Technology of Mexico (CONACYT)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [220824]; Fundacion Miguel
   Aleman; CONACYT (Mexico)Consejo Nacional de Ciencia y Tecnologia
   (CONACyT)
FX This work was supported by the National Council of Science and
   Technology of Mexico (CONACYT) 220824 and Fundacion Miguel Aleman. JO-R
   and JR-R are both CONACYT (Mexico) scholarship recipients.
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07
   Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Basler CF, 2007, NAT CHEM BIOL, V3, P20, DOI 10.1038/nchembio0107-20
   Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342
   Chen JM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091957
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022
   Ciota AT, 2010, VIRUSES-BASEL, V2, P2594, DOI 10.3390/v2122594
   CLAYTON RB, 1964, J LIPID RES, V5, P3
   CLAYTON RB, 1962, NATURE, V195, P1125, DOI 10.1038/1951125a0
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7
   CROFFORD OB, 1995, NEW ENGL J MED, V333, P588, DOI 10.1056/NEJM199508313330910
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Desplanques AS, 2010, VIRUS RES, V152, P180, DOI 10.1016/j.virusres.2010.06.008
   Diwaker D, 2015, VIRAL IMMUNOL, V28, P153, DOI 10.1089/vim.2014.0095
   Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713
   Duran A, 2015, ARCH VIROL, V160, P1687, DOI 10.1007/s00705-015-2433-z
   Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Foretz M, 2011, J HEPATOL, V54, P827, DOI 10.1016/j.jhep.2010.09.014
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Cordero JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090704
   Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102
   Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Htun HL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21612-6
   Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200
   Koren-Gluzer M, 2013, BIOCHEM BIOPH RES CO, V439, P396, DOI 10.1016/j.bbrc.2013.08.062
   Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lange Y, 1999, J LIPID RES, V40, P2264
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070390
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Bryan-Marrugo OL, 2016, MOL MED REP, V14, P2155, DOI 10.3892/mmr.2016.5519
   Lucifora J, 2013, ANTIVIR RES, V97, P195, DOI 10.1016/j.antiviral.2012.12.008
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miorin L, 2016, METHODS, V98, P82, DOI 10.1016/j.ymeth.2015.11.002
   Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Osuna-Ramos JF, 2018, J MED VIROL, V90, P1160, DOI 10.1002/jmv.25056
   PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0
   Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   Reyes-del Valle J, 2014, CURR TROP MED REP, V1, P36, DOI DOI 10.1007/s40475-013-0002-7
   Reyes-Ruiz JM, 2018, VIROLOGY, V515, P74, DOI 10.1016/j.virol.2017.12.014
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Rumlova M, 2018, BIOTECHNOL ADV, V36, P557, DOI 10.1016/j.biotechadv.2017.12.016
   Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200
   Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721
   Sirtori CR, 2014, PHARMACOL RES, V88, P3, DOI 10.1016/j.phrs.2014.03.002
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003
   Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x
   Takahashi T., 2009, OPEN DERMATOLOGY J, V3, P178, DOI DOI 10.2174/1874372200903010178
   Talero-Gutierrez C, 2018, EPIDEMIOL INFECT, V146, P673, DOI 10.1017/S0950268818000419
   Thepparit C, 2004, INTERVIROLOGY, V47, P78, DOI 10.1159/000077830
   Uchida L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07395
   Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
   Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247
   van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026
NR 141
TC 13
Z9 13
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD NOV 2
PY 2018
VL 8
AR 388
DI 10.3389/fcimb.2018.00388
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GZ1BV
UT WOS:000449101400002
PM 30450339
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rana, J
   Campos, JLS
   Leccese, G
   Francolini, M
   Bestagno, M
   Poggianella, M
   Burrone, OR
AF Rana, Jyoti
   Campos, Jose Luis Slon
   Leccese, Gabriella
   Francolini, Maura
   Bestagno, Marco
   Poggianella, Monica
   Burrone, Oscar R.
TI Role of Capsid Anchor in the Morphogenesis of Zika Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE capsid anchor; flavivirus; morphogenesis; pseudovirus; viral assembly;
   Zika virus
ID BORNE ENCEPHALITIS-VIRUS; YELLOW-FEVER-VIRUS; HEPATITIS-C VIRUS;
   IN-VITRO; SIGNAL PEPTIDE; 3-DIMENSIONAL ARCHITECTURE; TERMINAL DOMAIN;
   LINKED GLYCANS; PROTEIN; REPLICATION
AB The flavivirus capsid protein (C) is separated from the downstream premembrane (PrM) protein by a hydrophobic sequence named capsid anchor (Ca). During polyprotein processing, Ca is sequentially cleaved by the viral NS2B/NS3 protease on the cytosolic side and by signal peptidase on the lumina! side of the endoplasmic reticulum (ER). To date, Ca is considered important mostly for directing translocation of PrM into the ER lumen. In this study, the role of Ca in the assembly and secretion of Zika virus was investigated using a pseudovirus-based approach. Our results show that, while Ca-mediated anchoring of C to the ER membrane is not needed for the production of infective particles, Ca expression in cis with respect to PrM is strictly required to allow proper assembly of infectious particles. Finally, we show that the presence of heterologous, but not homologous, Ca induces degradation of E through the autophagy/lysosomal pathway.
   IMPORTANCE The capsid anchor (Ca) is a single-pass transmembrane domain at the C terminus of the capsid protein (C) known to function as a signal for the translocation of PrM into the ER lumen. The objective of this study was to further examine the role of Ca in Zika virus life cycle, whether involved in the formation of nucleocapsid through association with C or in the formation of viral envelope. In this study, we show that Ca has a function beyond the one of translocation signal, controlling protein E stability and therefore its availability for assembly of infectious particles.
C1 [Rana, Jyoti; Campos, Jose Luis Slon; Leccese, Gabriella; Bestagno, Marco; Poggianella, Monica; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Trieste, Italy.
   [Francolini, Maura] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.
   [Campos, Jose Luis Slon] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Bestagno, Marco] Int Ctr Genet Engn & Biotechnol, Cellular Immunol Grp, Trieste, Italy.
RP Rana, J; Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Trieste, Italy.
EM burrone@icgeb.org; burrone@icgeb.org
RI Rana, Jyoti/AAP-3614-2020
OI Rana, Jyoti/0000-0001-9683-4592; Slon Campos, Jose
   Luis/0000-0002-0012-5247
FU Arturo Falaschi ICGEB postdoctoral fellowships
FX J.R. and J.L.S.C. were supported by Arturo Falaschi ICGEB postdoctoral
   fellowships.
CR AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bennett KM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0194-0
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Casini A, 2015, J VIROL, V89, P2966, DOI 10.1128/JVI.02634-14
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Choi SH, 2005, WORLD J GASTROENTERO, V11, P3887
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068
   HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   HELLEN CUT, 1989, BIOCHEMISTRY-US, V28, P9881, DOI 10.1021/bi00452a001
   Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09
   Ivanyi-Nagy R, 2010, PROTEIN PEPTIDE LETT, V17, P1019, DOI 10.2174/092986610791498911
   Jhaveri R, 2009, J INFECT DIS, V200, P1781, DOI 10.1086/648094
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Lindenbach BD, 2013, FIELDS VIROLOGY, P713
   LINDENBACH BD, 2001, FIELDS VIROLOGY, P991
   LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001
   Mason PW, 2006, VIROLOGY, V351, P432, DOI 10.1016/j.virol.2006.04.003
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Orlinger KK, 2006, J VIROL, V80, P12197, DOI 10.1128/JVI.01540-06
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Sambrook J., 1989, MOL CLONING LAB MANU
   Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697
   VanBlargan LA, 2015, J VIROL, V89, P8632, DOI 10.1128/JVI.01253-15
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   YAMSHCHIKOV VF, 1993, VIROLOGY, V192, P38, DOI 10.1006/viro.1993.1006
   Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200
   Yoshii K, 2008, J GEN VIROL, V89, P200, DOI 10.1099/vir.0.82824-0
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 54
TC 7
Z9 7
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2018
VL 92
IS 22
AR e01174-18
DI 10.1128/JVI.01174-18
PG 15
WC Virology
SC Virology
GA GY4ZA
UT WOS:000448576900014
PM 30158295
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Rovin, R
   Akhtar, P
   Zwernik, S
   Kassam, A
AF Rovin, Richard
   Akhtar, Parvez
   Zwernik, Samuel
   Kassam, Amin
TI ZIKA VIRUS ONCOTROPISM TOWARDS GLIOBLASTOMA PROGENITOR CELLS IS MEDIATED
   BY THE TYROSINE KINASE RECEPTOR Axl
SO NEURO-ONCOLOGY
LA English
DT Meeting Abstract
CT 23rd Annual Scientific Meeting and Education Day of the
   Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and
   Development Conference
CY NOV 14-18, 2018
CL New Orleans, LA
SP Soc Neuro Oncol, CNS, SPARC
C1 [Rovin, Richard; Kassam, Amin] Aurora Neurosci Innovat Inst, Milwaukee, WI USA.
   [Akhtar, Parvez; Zwernik, Samuel] Aurora Res Inst, Milwaukee, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1522-8517
EI 1523-5866
J9 NEURO-ONCOLOGY
JI Neuro-Oncology
PD NOV
PY 2018
VL 20
SU 6
MA EXTH-68
BP 99
EP 99
PG 1
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA HO1DT
UT WOS:000460646300417
DA 2020-07-08
ER

PT J
AU Jash, A
   Govero, J
   Shi, PY
   Rich, J
   Diamond, MS
   Chheda, MG
AF Jash, Arijita
   Govero, Jennifer
   Shi, Pei-Yong
   Rich, Jeremy
   Diamond, Michael S.
   Chheda, Milan. G.
TI HARNESSING ZIKA VIRUS (ZIKV) ONCOLYTIC ACTIVITY IN BRAIN TUMORS
SO NEURO-ONCOLOGY
LA English
DT Meeting Abstract
CT 23rd Annual Scientific Meeting and Education Day of the
   Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and
   Development Conference
CY NOV 14-18, 2018
CL New Orleans, LA
SP Soc Neuro Oncol, CNS, SPARC
C1 [Jash, Arijita; Govero, Jennifer; Diamond, Michael S.] Washington Univ, St Louis, MO USA.
   [Shi, Pei-Yong] UTMB, Dept Biochem & Mol Biol, Galveston, TX USA.
   [Rich, Jeremy] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Chheda, Milan. G.] Washington Univ, Div Oncol, St Louis, MO USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1522-8517
EI 1523-5866
J9 NEURO-ONCOLOGY
JI Neuro-Oncology
PD NOV
PY 2018
VL 20
SU 6
MA IMMU-47
BP 131
EP 132
PG 2
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA HO1DT
UT WOS:000460646300552
DA 2020-07-08
ER

PT J
AU Vetchinin, SS
   Shevyakov, AG
   Fedyukina, GN
   Baranova, EV
   Biketov, SF
AF Vetchinin, S. S.
   Shevyakov, A. G.
   Fedyukina, G. N.
   Baranova, E. V.
   Biketov, S. F.
TI Generation of Hybridomas Producing Monoclonal Antibodies to the NS1
   Protein of the Zika Virus
SO RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
LA English
DT Article
DE NS1 protein; Zika virus; monoclonal antibodies; enzyme immunoassay;
   immunochromatography
ID GLYCOSYLATION; ANTIGENICITY; DENGUE; IMMUNOGENICITY; INFECTIONS;
   DIAGNOSIS
AB Hybridomas producing monoclonal antibodies (mABs) to the recombinant protein NS1 of the Zika virus synthesized in human embryonic kidney HEK293 (ZV293) cells have been obtained. The specificity of antibodies has been examined by the enzyme-linked immunosorbent assay (ELISA) using the similarly synthesized NS1 proteins of flaviviruses: the Dengue 1-4 serotype virus, Japanese encephalitis virus, yellow fever virus, tick-borne encephalitis virus, and the West Nile fever virus. Two types of hybridomas whose mABs interact with thermolabile (mABs 2F6 and 3F3) and thermostable epitopes (mABs 1B9, 6D7, and 6F2) of the NS1ZV protein have been selected. It has been shown that the 3F3 mAB, which is specific to the thermolabile determinant, can be used as both binding and detecting antibodies in the sandwich ELISA. Based on the 3F3 mAB, an experimental immunochromatographic test for the detection of the NS1ZV antigen has been developed. It has also been found that mABs 1B9, 6D7, and 6F2 against thermostable epitopes of the NS1 protein specifically recognize the NS1ZV protein after its heating for 15 min to 98 degrees C.
C1 [Vetchinin, S. S.; Shevyakov, A. G.; Fedyukina, G. N.; Baranova, E. V.; Biketov, S. F.] Rospotrebnadzor, State Res Ctr Appl Microbiol & Biotechnol, Obolensk 142279, Moscow Oblast, Russia.
RP Vetchinin, SS (corresponding author), Rospotrebnadzor, State Res Ctr Appl Microbiol & Biotechnol, Obolensk 142279, Moscow Oblast, Russia.
EM vetchinin@obolensk.org
FU  [6-D of 18.07.16]
FX The study was performed under the Rospotrebnadzor State Contract (no.
   6-D of 18.07.16).
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Blitvich BJ, 2001, J GEN VIROL, V82, P2251, DOI 10.1099/0022-1317-82-9-2251
   Bu GH, 2015, FOOD RES INT, V76, P511, DOI 10.1016/j.foodres.2015.08.004
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Dowling W, 2007, J VIROL, V81, P1821, DOI 10.1128/JVI.02098-06
   Fediukina G. N., 2015, Biotekhnologiya, P85
   Gavrilov BK, 2011, VIROLOGY, V420, P135, DOI 10.1016/j.virol.2011.08.025
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Handly D. A., 1989, COLLOIDAL GOLD PRINC, V1, P14
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lisowska E, 2002, CELL MOL LIFE SCI, V59, P445, DOI 10.1007/s00018-002-8437-3
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   NOWINSKI RC, 1979, VIROLOGY, V93, P111, DOI 10.1016/0042-6822(79)90280-0
   Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14
   Oliver C, 1994, Methods Mol Biol, V34, P321
   Rocha LB, 2017, ANTIBODIES, V6, DOI 10.3390/antib6040014
   Shan C., 2016, ACS INFECT DIS
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun XJ, 2013, J VIROL, V87, P8756, DOI 10.1128/JVI.00593-13
   World Health Organization, 2016, ZIK VIRS DIS INT CAS
NR 28
TC 0
Z9 0
U1 1
U2 3
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1068-1620
EI 1608-330X
J9 RUSS J BIOORG CHEM+
JI Russ. J. Bioorg. Chem.
PD NOV
PY 2018
VL 44
IS 6
BP 745
EP 754
DI 10.1134/S1068162019010187
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA HM5CM
UT WOS:000459492400020
DA 2020-07-08
ER

PT J
AU da Cruz, LCH
   Nascimento, OJM
   Lopes, FPPL
   da Silva, IRF
AF Hygino da Cruz, L. C., Jr.
   Nascimento, O. J. M.
   Lopes, F. P. P. L.
   da Silva, I. R. F.
TI Neuroimaging Findings of Zika Virus-Associated Neurologic Complications
   in Adults
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; INFECTION; MENINGOENCEPHALITIS; ENCEPHALITIS;
   GUIDELINES; ANTIBODIES
AB When the first suspected cases of neurologic disorders associated with the Zika virus were noticed in Brazil in late 2015, several studies had been conducted to understand the pathophysiology of the disease and its associated complications. In addition to its well-established association with microcephaly in neonates, the Zika virus infection has also been suggested to trigger other severe neurologic complications in adults, such as Guillain-Barre syndrome, radiculomyelitis, and meningoencephalitis. Hence, the Zika virus should be deemed a global threat that can cause devastating neurologic complications among individuals in all age ranges. The aim of this review was to further describe neuroimaging findings of Zika virus infection and associated neurologic complications found in adults.
C1 [Hygino da Cruz, L. C., Jr.; Lopes, F. P. P. L.] Clin Diagnost Imagem, Dept Radiol, Rio De Janeiro, Brazil.
   [Hygino da Cruz, L. C., Jr.] Alta Excelecia Diagnost, Rio De Janeiro, Brazil.
   [Hygino da Cruz, L. C., Jr.] Amer Med City, Dept Radiol, Rio De Janeiro, Brazil.
   [Nascimento, O. J. M.] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [da Silva, I. R. F.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.
RP da Cruz, LCH (corresponding author), Ave Pasteur,162 Apto,401 Botafogo, BR-22290240 Rio De Janeiro, RJ, Brazil.
EM celsohygino@hotmail.com
OI Hygino da Cruz Jr, Luiz Celso/0000-0002-9771-5832
FU Conselho Nacional de Desenvolvimento e Pesquisa; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the Conselho Nacional de Desenvolvimento e
   Pesquisa and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro.
CR [Anonymous], 2016, GUILLAIN BARRE SYNDR
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, FACT SHEET HEALTHC P
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Kumar S, 1997, NEURORADIOLOGY, V39, P180, DOI 10.1007/s002340050388
   Leonhard SE, 2018, J NEUROL NEUROSUR PS, V89, P1118, DOI 10.1136/jnnp-2017-317346
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Palacios E, 2019, NEUROLOGIA, V34, P204, DOI 10.1016/j.nrl.2016.08.006
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petropoulou KA, 2005, AM J NEURORADIOL, V26, P1986
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, WHO STAT 1 M INT HLT
NR 33
TC 6
Z9 6
U1 0
U2 0
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD NOV
PY 2018
VL 39
IS 11
BP 1967
EP 1974
DI 10.3174/ajnr.A5649
PG 8
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA HL4LT
UT WOS:000458693600009
PM 29773562
OA Other Gold
DA 2020-07-08
ER

PT J
AU Fourie, T
   Grard, G
   Leparc-Goffart, I
   Briolant, S
   Fontaine, A
AF Fourie, Toscane
   Grard, Gilda
   Leparc-Goffart, Isabelle
   Briolant, Sebastien
   Fontaine, Albin
TI Variability of Zika Virus Incubation Period in Humans
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE arbovirus; incubation period; prevention guidelines; Zika
ID CENSORED-DATA
AB Zika virus (ZIKV) has recently emerged in numerous tropical countries worldwide. In this study, we estimated ZIKV incubation period distribution using time-to-event models adapted to interval-censored data based on declared date of travels from 123 symptomatic travelers returning from areas with active ZIKV transmission. The median time and 95th percentile of ZIKV incubation period was estimated to 6.8 days (95% confidence interval [CI], 5.8-7.7 days) and 15.4 days (95% CI, 12.7-19.7 days), respectively. Determining the incubation period for ZIKV is beneficial to improve protection guidelines.
C1 [Fourie, Toscane; Grard, Gilda; Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Ctr Natl Reference Arbovirus, Marseille, France.
   [Fourie, Toscane; Grard, Gilda; Leparc-Goffart, Isabelle] Aix Marseille Univ, IHU Mediterranee Infect, IRD 190, UMR Unite Virus Emergents,INSERM 1207,Mediterrane, Marseille, France.
   [Briolant, Sebastien; Fontaine, Albin] Inst Rech Biomed Armees, Unite Parasitol & Entomol, Dept Malad Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
   [Briolant, Sebastien; Fontaine, Albin] Aix Marseille Univ, IRD, IHU,AP H,Mediterranee Infect, SSA,UMR Vecteurs Infect Trop & Mediterraneennes V, Marseille, France.
RP Fontaine, A (corresponding author), Inst Rech Biomed Armees, Unite Parasitol & Entomol, Dept Malad Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
EM albinfont@gmail.com
OI Fontaine, Albin/0000-0001-6869-6516
FU Direction Generale de l'Armement (DGA) [PDH-2-NRBC-2-B-2113]
FX This work was funded by the Direction Generale de l'Armement (DGA)
   (Grant No. PDH-2-NRBC-2-B-2113).
CR Anderson C., 2017, J STAT SOFTW, V81
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Fay MP, 2010, J STAT SOFTW, V36, P1
   Gentleman R, 2001, J COMPUT GRAPH STAT, V10, P403, DOI 10.1198/106186001317114901
   Jackson CH, 2016, J STAT SOFTW, V70, P1, DOI 10.18637/jss.v070.i08
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1
   Therneau T, 2016, PACKAGE SURVIVAL ANA
NR 14
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD NOV
PY 2018
VL 5
IS 11
AR UNSP ofy261
DI 10.1093/ofid/ofy261
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HK0MT
UT WOS:000457594300014
PM 30397624
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sethi, N
AF Sethi, Nayha
TI Research and Global Health Emergencies: On the Essential Role of Best
   Practice
SO PUBLIC HEALTH ETHICS
LA English
DT Article
ID DECISION-MAKING; INFLUENZA-VIRUS; PREGNANT-WOMEN; LAW; PRINCIPLES;
   ETHICS; VULNERABILITY; SURVEILLANCE; MODEL
AB This article addresses an important, overlooked regulatory challenge during global health emergencies (GHEs). It provides novel insights into how, and why, best practice can support decision makers in interpreting and implementing key guidance on conducting research during GHEs. The ability to conduct research before, during and after such events is crucial. The recent West-African Ebola outbreaks and the Zika virus have highlighted considerable room for improvement in meeting the imperative to research and rapidly develop effective therapies. A means of effectively capturing these experiences and folding them into future decision-making is lacking; the need for effective practical translational measures remains. The challenge for the research community lies in extracting meaningful action-guiding content from pre-existing guidelines-which draw upon practical examples of guidelines 'in action'-that assist in determining how to act in a particular (future) situation. Insights are provided into the role of best practice as a means to do so; such examples can provide invaluable support to decision makers in interpreting high-level guidance; overarching guidelines retain their necessary level of generality and flexibility, whilst corresponding best practice examples-which incorporate important lessons learned-illustrate how such guidelines can be interpreted at a practical level.
C1 [Sethi, Nayha] Univ Edinburgh, Mason Inst, Liminal Spaces, Edinburgh, Midlothian, Scotland.
RP Sethi, N (corresponding author), Univ Edinburgh, Mason Inst, Sch Law, Edinburgh EH8 9YL, Midlothian, Scotland.
EM nayha.sethi@ed.ac.uk
RI amsalu, ribka/G-8780-2019
FU Wellcome [WT103360MA]
FX This work was funded by the Wellcome funded project 'Confronting the
   Liminal Spaces of Health Research Regulation' Award No. WT103360MA.
CR Aellah Gemma, 2016, GLOBAL HLTH RES UNEQ
   Albertzart Maike, 2014, MORAL PRINCIPLES
   ALEXY R, 2002, THEORY CONSTITUTIONA, P44
   [Anonymous], 2016, INT ETH GUID HLTH RE
   Aveling EL, 2016, SOCIOL HEALTH ILL, V38, P216, DOI 10.1111/1467-9566.12370
   Baker MG, 2006, EMERG INFECT DIS, V12, P1058
   Beauchamp TL, 2003, J MED ETHICS, V29, P269, DOI 10.1136/jme.29.5.269
   Beauchamp TL, 2013, PRINCIPLES BIOMEDICA
   Bix B, 1998, U PENN LAW REV, V146, P1651, DOI 10.2307/3312818
   Black J., 2010, LSE LAW SOC EC WORKI
   Calain P, 2009, PUBLIC HEALTH ETH-UK, V2, P7, DOI 10.1093/phe/phn037
   Caplan AL, 2015, AM J BIOETHICS, V15, P4, DOI 10.1080/15265161.2015.1010993
   CLOUSER KD, 1990, J MED PHILOS, V15, P219, DOI 10.1093/jmp/15.2.219
   Cohen J., 2014, SCI MAGAZINE
   COYLE D, 2009, NEW TECHNOLOGIES EME
   Devaney S., 2011, MED LAW INT, V11, P53
   DWORKIN RM, 1967, U CHICAGO LAW REV, V35, P14, DOI 10.2307/1598947
   Eckenwiler L, 2015, BIOETHICS, V29, P653, DOI 10.1111/bioe.12193
   Fidler DP, 2008, EMERG INFECT DIS, V14, P88, DOI 10.3201/eid1401.070700
   Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247
   FRANTZ LB, 1963, CALIF LAW REV, V51, P729, DOI 10.2307/3478937
   Ganguli Mitra A., 2016, CONDUCTING RES CONTE
   Ganguli-Mitra A, 2017, BIOETHICS, V31, P87, DOI 10.1111/bioe.12324
   Gert B, 2000, J MED PHILOS, V25, P308, DOI 10.1076/0360-5310(200006)25:3;1-H;FT308
   Goodin Robert E., 1982, POLITICAL THEORY PUB
   Gostin LO, 2015, PUBLIC HEALTH, V129, P854, DOI 10.1016/j.puhe.2015.05.002
   Greer Steven, 2004, CAMB LAW J, V63, P412
   Grill K, 2017, HEALTH CARE ANAL, V25, P291, DOI 10.1007/s10728-015-0299-6
   Harris J, 2003, J MED ETHICS, V29, P303, DOI 10.1136/jme.29.5.303
   Hunt Matthew R, 2012, Am J Disaster Med, V7, P211
   Irwin R, 2010, GLOBAL HLTH GOVERNAN, V3
   JONSEN AR, 1991, THEOR MED, V12, P295, DOI 10.1007/BF00489890
   Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133
   Keusch G, 2017, INTEGRATING CLIN RES
   Kieny M., 2016, GUIDANCE MANAGING ET
   Krubiner CB, 2017, J MED ETHICS, V43, P664, DOI 10.1136/medethics-2017-104446
   Laurie G, 2017, MED LAW REV, V25, P47, DOI 10.1093/medlaw/fww029
   Laurie G, 2013, EUR J RISK REGUL, V4, P43, DOI 10.1017/Sl867299XO0002786
   Laurie GT, 2018, CAMB Q HEALTHC ETHIC, V27, P333, DOI 10.1017/S0963180117000664
   Levine C, 2004, AM J BIOETHICS, V4, P44, DOI 10.1080/15265160490497083
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   Lyall C., 2009, LIMITS GOVERNANCE CH
   MacIntyre CR, 2015, AM J BIOETHICS, V15, P65, DOI 10.1080/15265161.2015.1010017
   Martin D, 2003, HEALTH CARE ANAL, V11, P59, DOI 10.1023/A:1025338013629
   Mezinska S, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0148-7
   Moorthy VS, 2016, B WORLD HEALTH ORGAN, V94, P234, DOI 10.2471/BLT.16.172882
   Morin SF, 2008, CLIN TRIALS, V5, P147, DOI 10.1177/1740774508090211
   Moses L.B., 2007, U ILL J L TECH POLY, V7, P239
   Muirhead W, 2012, J MED ETHICS, V38, P195, DOI 10.1136/medethics-2011-100136
   Mullis K., 2009, AM U INT LAW REV, V24, P944
   Musschenga AW, 2005, J MED PHILOS, V30, P467, DOI 10.1080/03605310500253030
   *NAT COMM PROT HUM, 1979, BELM REP ETH PRINC G
   Nuffield Council on Bioethics, 2016, COND RES INN GLOB HL
   Nuffield Council on Bioethics, 2015, COLL LINK US DAT BIO
   O'Mathuna D, 2016, HUM AFF, V26, P8, DOI 10.1515/humaff-2016-0002
   Quinn SC, 2004, AM J PUBLIC HEALTH, V94, P918, DOI 10.2105/AJPH.94.6.918
   Rawls J., 1971, THEORY JUSTICE
   Richardson HS, 2000, J MED PHILOS, V25, P285, DOI 10.1076/0360-5310(200006)25:3;1-H;FT285
   Robeyns I, 2008, SOCIAL THEORY PRACTI, V34, P341, DOI DOI 10.5840/soctheorpract200834321
   Sane J, 2015, OVERCOMING BARRIERS
   Schopper D, 2017, PUBLIC HEALTH ETH-UK, V10, P49, DOI 10.1093/phe/phw039
   Schopper D, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0002-3
   Schuklenk Udo, 2017, Indian J Med Ethics, V2, P169, DOI 10.20529/IJME.2017.047
   Schwartz L, 2014, PUB HEALTH ETHICS AN, V2, P33, DOI 10.1007/978-94-007-3864-5_3
   Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482
   Sethi N, 2015, SCRIPTED, V12, P91, DOI DOI 10.2966/scrip.120215.91
   Siedner MJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001804
   Smith FL, 2012, GLOB CHANG PEACE SEC, V24, P71, DOI 10.1080/14781158.2012.641292
   Smith MJ, 2015, PUBLIC HEALTH ETH-UK, V8, P305, DOI 10.1093/phe/phv028
   Stinchcomb D., 2016, LESSONS WE CAN LEARN
   Sumathipala A., 2011, DRAFT STATEMENT GUID
   Taylor-Alexander Samuel, 2016, Law Innov Technol, V8, P149, DOI 10.1080/17579961.2016.1250378
   The Ethics Working Group on ZIKV Research & Pregnancy, 2017, PREGN WOM ZIK VIR VA
   van Delden J. J. M., 2016, REVISING 2002 CIOMS
   van Delden JJM, 2017, JAMA-J AM MED ASSOC, V317, P135, DOI 10.1001/jama.2016.18977
   van der Zande ISE, 2017, J MED ETHICS, V43, P657, DOI 10.1136/medethics-2016-103955
   WHO, 2015, INT HLTH REG
   WHO, 2013, EM RESP FRAM
   Willison DJ, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-61
   WOLF SM, 1994, AM J LAW MED, V20, P395
   World Health Organisation, 2015, WHO LEAD STAT EB RES
   World Health Organization, 2014, ETH CONS US UNR INT
   World Health Organization, 2016, GUID MAN ETH ISS INF
NR 83
TC 4
Z9 4
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1754-9973
EI 1754-9981
J9 PUBLIC HEALTH ETH-UK
JI Public Health Ethics
PD NOV
PY 2018
VL 11
IS 3
BP 237
EP 250
DI 10.1093/phe/phy014
PG 14
WC Ethics; Public, Environmental & Occupational Health; Medical Ethics
SC Social Sciences - Other Topics; Public, Environmental & Occupational
   Health; Medical Ethics
GA HI7XN
UT WOS:000456669800001
PM 30429871
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mulatier, M
   Porciani, A
   Nadalin, L
   Alou, LPA
   Chandre, F
   Pennetier, C
   Dormont, L
   Cohuet, A
AF Mulatier, Margaux
   Porciani, Angelique
   Nadalin, Louis
   Alou, Ludovic Phamien Ahoua
   Chandre, Fabrice
   Pennetier, Cedric
   Dormont, Laurent
   Cohuet, Anna
TI DEET Efficacy Increases With Age in the Vector Mosquitoes Anopheles
   gambiae s.s. and Aedes albopictus (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE vector; mosquito; aging; DEET; repellency
ID GLUTATHIONE-S-TRANSFERASE; SYNTHETIC REPELLENTS; GONOTROPHIC CYCLES;
   AEGYPTI; INSECTICIDE; PERMETHRIN; RESISTANCE; MORTALITY; MALATHION; SEX
AB Old mosquitoes are the most likely to transmit pathogens due to the higher probability that they will be exposed to pathogens, and the time required before a mosquito becomes infectious, the extrinsic incubation period (EIP). However, old mosquitoes are rarely considered in the evaluation of control tools. This study evaluated the effect of mosquito aging on the repellent efficacy of N,N-diethyl-3-methylbenzamide (DEET) in two vector mosquitoes, Anopheles gambiae s.s. (Giles) (Diptera: Culicidae) and Aedes albopictus (Skuse) (Diptera: Culicidae), respective vectors of malaria parasites and arboviruses such as dengue, chikungunya, and Zika viruses. For both mosquito species, DEET-induced inhibition of blood-feeding was assessed in three age classes. Life-history traits related to mosquito fecundity and survival following DEET exposure were also measured. Results showed that, in both species, bloodmeal inhibition induced by DEET was significantly higher in old females (>18 d old) than in younger ones (< 13 d old). Life history traits recording showed no combined effects of DEET and aging on mosquito blood engorgement, oviposition rate, number of eggs laid nor survival; however, age effects are reported for all these traits. These results highlight the need for taking into account mosquito age in the evaluation of integrated mosquito management tools. They also suggest that the control of vector-borne pathogens with a long EIP could be improved by targeting old mosquitoes and supports the efficacy of repellents in the fight against mosquito-borne diseases.
C1 [Mulatier, Margaux; Porciani, Angelique; Nadalin, Louis; Chandre, Fabrice; Pennetier, Cedric; Cohuet, Anna] Univ Montpellier, CNRS, MIVEGEC, IRD, 911 Ave Agropolis,BP 64501, F-34394 Montpellier 5, France.
   [Mulatier, Margaux; Dormont, Laurent] Univ Montpellier, Univ Paul Valery Montpellier 3, CNRS, CEFE,EPHE,IRD, Montpellier, France.
   [Alou, Ludovic Phamien Ahoua; Pennetier, Cedric] Inst Pierre Richet, Bouake, Cote Ivoire.
RP Mulatier, M (corresponding author), Univ Montpellier, CNRS, MIVEGEC, IRD, 911 Ave Agropolis,BP 64501, F-34394 Montpellier 5, France.; Mulatier, M (corresponding author), Univ Montpellier, Univ Paul Valery Montpellier 3, CNRS, CEFE,EPHE,IRD, Montpellier, France.
EM margaux.mulatier@ird.fr
RI Chandre, Fabrice/Q-3429-2019
OI Chandre, Fabrice/0000-0002-1994-9705; Pennetier,
   Cedric/0000-0002-3362-6371; NADALIN, Louis/0000-0002-6420-346X;
   Mulatier, Margaux/0000-0001-9604-8479; Porciani,
   Angelique/0000-0003-2816-1212
FU French National Research Program for Environmental and Occupational
   Health of Anses [EST-2016/1/39]; Languedoc-Roussillon (LR)/Occitanie
   region; EU-FEDER under the name 'Chercheur(se)s d'Avenir'French National
   Research Agency (ANR); LabEx CeMEB, under an ANR 'Investissements
   d'avenir' programFrench National Research Agency (ANR)
   [ANR-10-LABX-04-01]
FX We acknowledge the technical/ research platform dedicated on vectors at
   IRD center for providing mosquitoes and technical support. This platform
   is a member of the Vectopole Sud network and of the LabEX CEMEB (Center
   Mediterraneen de l'Environnement et de la Biodiversite) in Montpellier.
   This study was supported by The French National Research Program for
   Environmental and Occupational Health of Anses (EST-2016/1/39), by the
   Languedoc-Roussillon (LR)/Occitanie region and EU-FEDER under the name
   'Chercheur(se)s d'Avenir', and by the LabEx CeMEB, under an ANR
   'Investissements d'avenir' program (ANR-10-LABX-04-01). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aizoun Nazaire, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P312, DOI 10.12980/APJTB.4.2014C1093
   Aldridge RL, 2017, J MED ENTOMOL, V54, P1692, DOI 10.1093/jme/tjx160
   Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849
   [Anonymous], 2009, GUID EFF TEST MOSQ R
   Barnard DR, 1998, J MED ENTOMOL, V35, P340, DOI 10.1093/jmedent/35.3.340
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   BECKETT EB, 1990, INT J INSECT MORPHOL, V19, P277, DOI 10.1016/0020-7322(90)90013-F
   Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165
   BRIEGEL H, 1980, EXPERIENTIA, V36, P1428, DOI 10.1007/BF01960142
   Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0
   Carnevale P, 2009, ANOPHELES BIOL TRANS
   Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087
   Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214
   Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47
   CRNJAR R, 1990, J INSECT PHYSIOL, V36, P917, DOI 10.1016/0022-1910(90)90079-U
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   DENOTTER CJ, 1991, PHYSIOL ENTOMOL, V16, P173, DOI 10.1111/j.1365-3032.1991.tb00554.x
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Glunt KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024968
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Hagmann R, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-15
   HAZELTON GA, 1983, BIOCHEM J, V210, P281, DOI 10.1042/bj2100281
   Hellestad VJ, 2011, CELL BIOL TOXICOL, V27, P149, DOI 10.1007/s10565-010-9177-z
   Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x
   Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462
   Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425
   Huijben S., 2017, EVOLUTIONARY APPL, P1
   Jones C. M., 2012, MALARIA J, V11, P1
   Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x
   Kulma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058322
   Legeay S, 2018, EUR J PHARMACOL, V825, P92, DOI 10.1016/j.ejphar.2018.02.033
   Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x
   LINES JD, 1991, MED VET ENTOMOL, V5, P261, DOI 10.1111/j.1365-2915.1991.tb00550.x
   McCann S, 2009, J VECTOR ECOL, V34, P174, DOI [10.1111/j.1948-7134.2009.00024.x, 10.3376/038.034.0202]
   Mollahosseini A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-122
   MOURYA DT, 1993, MED VET ENTOMOL, V7, P11, DOI 10.1111/j.1365-2915.1993.tb00645.x
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   N'Guessan R, 2006, T ROY SOC TROP MED H, V100, P1091, DOI 10.1016/j.trstmh.2006.04.005
   Ohm JR, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2761-4
   Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81
   Pridgeon JW, 2009, J AM MOSQUITO CONTR, V25, P168, DOI 10.2987/08-5837.1
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   ROWLAND M, 1987, PESTIC BIOCHEM PHYS, V28, P239, DOI 10.1016/0048-3575(87)90022-8
   ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P719, DOI 10.1016/0022-1910(68)90230-8
   Ryan SJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00094.1
   SEABROOK WD, 1979, J CHEM ECOL, V5, P587, DOI 10.1007/BF00987843
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Swale DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103713
   Therneau T. M., 2015, COXME MIXED EFFECTS
   Therneau TM, 2000, STAT BIOL HEALTH
   Vanderberg J. P., 2016, J PARASITOL, V52, P559
   Vaughan J., 2016, J PARASITOL, V80, P674
   Vaughan J., 2016, J PARASITOL, V78, P716
   WHO, 2016, WORLD MAL REP 2016
   World Health Organization, 2009, DENG GUID DIAGN TREA
   XUE RD, 1995, J AM MOSQUITO CONTR, V11, P50
   Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08
NR 59
TC 1
Z9 1
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2018
VL 55
IS 6
BP 1542
EP 1548
DI 10.1093/jme/tjy134
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0MC
UT WOS:000456134700019
PM 30137424
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Sirisena, PDNN
   Kumar, A
   Sunil, S
AF Sirisena, P. D. N. N.
   Kumar, Ankit
   Sunil, Sujatha
TI Evaluation of Aedes aegypti (Diptera: Culicidae) Life Table Attributes
   Upon Chikungunya Virus Replication Reveals Impact on Egg-Laying Pathways
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito egg-laying pathway; Chikungunya virus; life table attribute
ID COMPETENCE FACTOR BETA-FTZ-F1; JUVENILE-HORMONE; POPULATION PARAMETERS;
   EARLY TRYPSIN; ZIKA VIRUS; MOSQUITO; DENGUE; INSULIN; TRANSMISSION;
   INFECTION
AB Arthropod-borne virus disease cycles constitute interactions among three primary players-the host, the vector, and the virus-in which the virus needs to interact with the host and the vector to establish its survival. While in the host, some arboviruses replicate aggressively, resulting in host pathogenicity, and manifest as a disease condition. These viruses more often utilize the vectors as reservoirs before they are transmitted to the host and therefore do not amplify to as large titers as they do in the hosts. In spite of this, the vector undergoes stress and activates several of its defense systems, resulting in alterations in its physiology. The present study was undertaken to evaluate the physiological changes that the mosquito vector Aedes aegypti (L.) (Diptera: Culicidae) undergoes during the replication of an arbovirus, Chikungunya virus (CHIKV). After the mosquitoes were infected with CHIKV, dissemination of the virus into various tissues and physiological parameters such as fecundity, vector mortality, egg laying, survival rate, overall fitness were monitored throughout the lifespan of the mosquitoes. Our study reveals that there is a fitness cost to the mosquitoes due to the infection of CHIKV. This fitness cost is manifested as higher mortality and low survival rate of the CHIKV-infected mosquitoes. Further evaluation revealed that the egg-laying pathway was affected, resulting in lower number of eggs. Expression analysis of six transcripts in the egg-laying pathway revealed that these transcripts were downregulated during the gonotrophic cycles in CHIKV-infected mosquitoes as compared to normal blood-fed mosquitoes.
C1 [Sirisena, P. D. N. N.; Kumar, Ankit; Sunil, Sujatha] Int Ctr Genet Engn & Biotechnol, Vector Borne Dis Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.
RP Sunil, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Vector Borne Dis Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.
EM sujatha@icgeb.res.in
OI Sunil, Sujatha/0000-0002-6531-7768
FU International Centre for Genetic Engineering and Biotechnology (ICGEB)
FX We thank Mr. Dinesh Singh for providing technical support in maintaining
   the mosquitoes. This work was supported by core funds from the
   International Centre for Genetic Engineering and Biotechnology (ICGEB).
   The manuscript was proof read by Edit My Manuscript (editmy.ms).
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003
   BRIEGEL H, 1973, GERONTOLOGY, V19, P240, DOI 10.1159/000211976
   Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Clements A.N, 1992, BIOL MOSQUITOES
   CONWAY GR, 1974, J ANIM ECOL, V43, P289, DOI 10.2307/3366
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4
   Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gulia-Nuss M, 2015, J INSECT PHYSIOL, V82, P8, DOI 10.1016/j.jinsphys.2015.08.001
   Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401
   Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Lucas KJ, 2015, RNA BIOL, V12, P1383, DOI 10.1080/15476286.2015.1101525
   LUDWIG GV, 1989, VIROLOGY, V171, P108, DOI 10.1016/0042-6822(89)90516-3
   Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Raquin V, 2017, VIROLOGY, V507, P75, DOI 10.1016/j.virol.2017.04.009
   Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3
   Riehle MA, 2002, CELL TISSUE RES, V308, P409, DOI 10.1007/s00441-002-0561-8
   ROUBAUD E., 1929, COMPT REND ACAD SCI PARIS, V188, P735
   Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004
   Saeaue L, 2011, SE ASIAN J TROP MED, V42, P542
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   Shrinet J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-100
   Sterkel M, 2017, TRENDS PARASITOL, V33, P633, DOI 10.1016/j.pt.2017.04.008
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   TSUJI N, 1990, J MED ENTOMOL, V27, P446, DOI 10.1093/jmedent/27.4.446
   Vogel Kevin J, 2013, Front Endocrinol (Lausanne), V4, P193, DOI 10.3389/fendo.2013.00193
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang JL, 2017, J BIOL CHEM, V292, P10306, DOI 10.1074/jbc.M116.761387
   Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59
   Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06
   Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100
NR 47
TC 5
Z9 5
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2018
VL 55
IS 6
BP 1580
EP 1587
DI 10.1093/jme/tjy097
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0MC
UT WOS:000456134700025
PM 29931258
DA 2020-07-08
ER

PT J
AU Manges, AB
   Simmons, TW
   Hutchinson, ML
AF Manges, Anna B.
   Simmons, Thomas W.
   Hutchinson, Michael L.
TI First Record of Aedes albopictus (Diptera: Culicidae) and Second Record
   of Aedes japonicus (Diptera: Culicidae) Parasitized by Water Mites
   (Acari: Hydrachnidiae) in North America
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito; water mite; parasitism; new record; Pennsylvania
ID UNITED-STATES; MOSQUITOS DIPTERA; IMPACT; VIRUS; ASSOCIATIONS; HISTORY
AB The primary aim of this study was to determine if the Asian tiger mosquito (Aedes albopictus (Skuse)) (Diptera: Culicidae), that vectors a number of arboviruses, is parasitized by water mites (Acari: Prostigmata: Parasitengonina: Hydrachnidiae). Larval water mite parasitism of adult mosquitoes has been shown to reduce mosquito fecundity and life span in the laboratory, and impact some populations in the field. Water mites have been considered for biocontrol purposes and used to age-grade mosquito populations. Consequently, there is interest in water mite-mosquito associations from public health and integrated pest management perspectives. In 2016, the Pennsylvania Department of Environmental Protection West Nile Virus Control Program examined 146,607 mosquitoes representing 31 species for parasitic mites. Ten mosquitoes representing four species rarely or not previously known to be parasitized by mites were saved from destructive West Nile virus and Zika virus testing. Twelve parasitic mites were identified to the lowest taxonomic level possible. An Asian tiger mosquito and an Asian bush mosquito (Aedes japonicus) (Theobald) were each parasitized by a Parathyas sp. Lundblad (Hydryphantoidea: Hydryphantidae: Euthyadinae) water mite, and are the first and second records of these associations in North America, respectively. Two Culex restuans Theobald (Diptera: Culicidae) mosquitoes parasitized by either a Euthyas sp. Piersig (Hydryphantoidea: Hydryphantidae: Euthyadinae) or a Parathyas sp. water mite are new associations, and a Culex pipiens Linnaeus mosquito parasitized by a Parathyas sp. water mite represents a new record for this association in North America.
C1 [Manges, Anna B.; Simmons, Thomas W.] Indiana Univ Penn, Dept Biol, 114 Weyandt Hall,975 Oakland Ave, Indiana, PA 15705 USA.
   [Hutchinson, Michael L.] Bur Labs Vector Management, Dept Environm Protect, POB 1467, Harrisburg, PA 17110 USA.
RP Simmons, TW (corresponding author), Indiana Univ Penn, Dept Biol, 114 Weyandt Hall,975 Oakland Ave, Indiana, PA 15705 USA.
EM tsimmons@iup.edu
FU Indiana University of Pennsylvania Department of Biology
FX The authors would like to thank the WNV county coordinators and
   PADEP-WNV staff for collecting mosquitoes, and the Indiana University of
   Pennsylvania Department of Biology for supporting A.B.M.
CR Atwa AA, 2017, REV BRAS ENTOMOL, V61, P101, DOI 10.1016/j.rbe.2017.03.005
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   BIESIADKA E, 1990, Annales Zoologici (Warsaw), V43, P461
   (CDC) Centers for Disease Control and Prevention, 2017, ZIK CDC INT RESP PLA
   Centers for Disease Control and Prevention, 2017, SURV CONTR AED AEG A
   CORBET PHILIP S., 1963, ENTOMOL EXP APPL, V6, P215, DOI 10.1007/BF00300528
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10
   Hutchinson M. L., 2009, TECHNICAL B PENNSYLV
   Kirkhoff CJ, 2013, J PARASITOL, V99, P31, DOI 10.1645/GE-3105.1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lanciani C. A., 1983, SPEC PUBL U CALIFORN, V3304, P86
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Linham J. H., 1962, P ENTOMOL SOC WASH, V64, P234
   Marfin AA, 2001, EMERG INFECT DIS, V7, P730
   Miyazaki I., 1936, FUKUOKA ACTA MED, V29, P1
   Mlynarek JJ, 2015, CAN J ZOOL, V93, P741, DOI 10.1139/cjz-2015-0077
   Mlynarek JJ, 2014, EVOL BIOL, V41, P115, DOI 10.1007/s11692-013-9251-6
   Mlynarek JJ, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-50
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Mullen G.R., 1976, WATER MITES SUBGENUS
   MULLEN GR, 1974, MOSQ NEWS, V34, P183
   MULLEN GR, 1975, J MED ENTOMOL, V12, P27, DOI 10.1093/jmedent/12.1.27
   MULLEN GR, 1977, J MED ENTOMOL, V13, P475, DOI 10.1093/jmedent/13.4-5.475
   (PADEP) Pennsylvania Department of Environmental Protection, 2017, PENNS ZIK VIR RESP P
   Pesic V, 2010, ZOOTAXA, P1
   Prasad V., 1972, Memoirs Am Ent Inst, V18, P1
   REISEN WK, 1978, ENVIRON ENTOMOL, V7, P769, DOI 10.1093/ee/7.5.769
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Simmons TW, 2016, J MED ENTOMOL, V53, P737, DOI 10.1093/jme/tjw052
   Smith B. P., 1983, AGR EXPT STATION SPE, V3304, P79
   SMITH BP, 1988, ANNU REV ENTOMOL, V33, P487, DOI 10.1146/annurev.en.33.010188.002415
   SMITH BP, 1984, CAN J ZOOL, V62, P1121, DOI 10.1139/z84-163
   Smith I. M., 2016, THORP COVICHS FRESHW, V2, P312
   SMITH IM, 1986, CAN ENTOMOL, V118, P407, DOI 10.4039/Ent118407-5
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Tuzovsky P. V., 2007, Acarina, V15, P173
   Viets K., 1936, TIERWELT DEUTSCHLAND, V31, P1
   Wainstein B. A., 1980, OPREDELITEL LICHINOK
   (WRBU) Walter Reed Biosystematics Unit, 2015, VECT MAP
   Zawal A, 2008, ZOOTAXA, P1
NR 45
TC 1
Z9 1
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2018
VL 55
IS 6
BP 1617
EP 1621
DI 10.1093/jme/tjy105
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0MC
UT WOS:000456134700031
PM 30020480
DA 2020-07-08
ER

PT J
AU Timmins, DR
   Staunton, KM
   Meyer, DB
   Townsend, M
   Paton, CJ
   Ramirez, AL
   Ritchie, SA
AF Timmins, Daniel R.
   Staunton, Kyran M.
   Meyer, Dagmar B.
   Townsend, Michael
   Paton, Christopher J.
   Ramirez, Ana L.
   Ritchie, Scott A.
TI Modifying the Biogents Sentinel Trap to Increase the Longevity of
   Captured Aedes aegypti
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Biogents Sentinel; Aedes aegypti; dengue; Zika; mosquito trap; alive
ID BG-MALARIA TRAP; DIPTERA; RNA
AB Aedes aegypti (L.) (Diptera: Culicidae) is a vector of viruses causing dengue, Zika, chikungunya, and yellow fever and subsequently pose a significant global threat to public health. While sampling live mosquitoes is useful for surveillance purposes, most traps targeting Aedes kill captured mosquitoes. The Biogents Sentinel (BGS) trap, the gold standard for capturing Ae. aegypti, is one such trap. In our study, we modified the BGS trap to increase the survival of captured Ae. aegypti by replacing the trap's catch bag with a catch pot that protects mosquitoes from desiccation by airflow. A sucrose-soaked sponge or nucleic acid preservative card can also be placed inside the pot to enhance mosquito survival and augment arbovirus detection. These modifications to the BGS significantly increased the longevity of mosquitoes captured with weekly survivals of 93% in a semifield structure and 86% in the field. These high survival rates resulted in 3.5 times more alive Ae. aegypti captured weekly in the modified BGS compared to the original BGS, despite 40% lower overall catch rates. These cheap and simple trap modifications facilitate easier specimen identification as well as experiments requiring live field-collected samples such as virus detection from mosquito saliva and excreta.
C1 [Timmins, Daniel R.] Denison Univ, Granville, OH 43023 USA.
   [Staunton, Kyran M.; Meyer, Dagmar B.; Townsend, Michael; Paton, Christopher J.; Ramirez, Ana L.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.
   [Staunton, Kyran M.; Meyer, Dagmar B.; Townsend, Michael; Paton, Christopher J.; Ramirez, Ana L.; Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
RP Staunton, KM (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia.; Staunton, KM (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia.
EM kyran.staunton@jcu.edu.au
RI Staunton, Kyran/W-2263-2019
OI Staunton, Kyran/0000-0001-6812-3320; Ramirez, Ana/0000-0003-4973-4833
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia [1044698]
FX We acknowledge SIT Study Abroad, especially Tony Cummings, facilitating
   and funding research. Additionally, we received funding from the
   National Health and Medical Research Council of Australia (Senior
   Research Fellowship 1044698) and are grateful to Jason Anderson,
   Catherine Liddington, and Lania Lynch.
CR Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Gama RA, 2013, MEM I OSWALDO CRUZ, V108, P763, DOI 10.1590/0074-0276108062013013
   Girod R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004876
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Johnson BJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1114-9
   Kramer LD, 2001, J AM MOSQUITO CONTR, V17, P213
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Ramirez AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2901-x
   Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988
   Rodrigues MS, 2014, J AM MOSQUITO CONTR, V30, P184, DOI 10.2987/14-6423R.1
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P383, DOI 10.1089/vbz.2010.0022
   Turell MJ, 2002, J MED ENTOMOL, V39, P1, DOI 10.1603/0022-2585-39.1.1
NR 16
TC 2
Z9 2
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2018
VL 55
IS 6
BP 1638
EP 1641
DI 10.1093/jme/tjy125
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0MC
UT WOS:000456134700035
PM 30053026
DA 2020-07-08
ER

PT J
AU Suzuki, Y
   Kotoura, M
   Yashima, S
   Wu, H
   Nakano, T
   Sano, K
AF Suzuki, Youichi
   Kotoura, Mami
   Yashima, Shun
   Wu, Hong
   Nakano, Takashi
   Sano, Kouichi
TI Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells
   by Real-time Quantitative Polymerase Chain Reaction
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology and Infection; Issue 141; Direct RT-qPCR assay; viral RNA
   detection; culture supernatant; no RNA purification step; dengue virus;
   yellow fever virus; Chikungunya virus; measles virus
ID RT-PCR; MYCOPHENOLIC-ACID; ZIKA VIRUS; REPLICATION; QUANTIFICATION;
   DIAGNOSIS; ASSAYS
AB At present, real-time polymerase chain reaction (PCR) technology is an indispensable tool for the detection and quantification of viral genomes in research laboratories, as well as for molecular diagnosis, because of its sensitivity, specificity, and convenience. However, in most cases, the quantitative PCR (qPCR) assay generally used to detect virus infection has relied on the purification of viral nucleic acid prior to the PCR step. In this study, the fluorescence-based reverse transcription qPCR (RT-qPCR) assay is developed through the combination of a processing buffer and a one-step RT-PCR reagent so that the whole process, from the harvest of the culture supernatant of virus-infected cells until real-time detection, can be performed without viral RNA purification. The established protocol enables the quantification of a wide range of RNA concentrations of dengue virus (DENV) within 90 min. In addition, the adaptability of the direct RT-qPCR assay to the evaluation of an antiviral agent is demonstrated by an in vitro experiment using a previously reported DENV inhibitor, mycophenolic acid (MPA). Moreover, other RNA viruses, including yellow fever virus (YFV), Chikungunya virus (CHIKV), and measles virus (MeV), can be quantified by direct RT-qPCR with the same protocol. Therefore, the direct RT-qPCR assay described in this report is useful for monitoring RNA virus replication in a simple and rapid manner, which will be further developed into a promising platform for a high-throughput screening study and clinical diagnosis.
C1 [Suzuki, Youichi; Kotoura, Mami; Yashima, Shun; Wu, Hong; Nakano, Takashi; Sano, Kouichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka, Japan.
RP Suzuki, Y (corresponding author), Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka, Japan.
EM californiacircle@gmail.com
FU MEXT KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP16737900]
FX The authors thank Subhash G. Vasudevan (Duke-NUS Graduate Medical
   School, Singapore) for the DENV-2 isolate EDEN2 3295 and Shunro Imura
   (Kobe Quarantine Station, Japan) for the YFV 17D vaccine strain. The
   authors are also grateful to the members of the Department of
   Microbiology and Infection Control for their assistance. This work is
   supported by MEXT KAKENHI Grant Number JP16737900.
CR Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Colton L, 2005, J AM MOSQUITO CONTR, V21, P49, DOI 10.2987/8756-971X(2005)21[49:QOWNVI]2.0.CO;2
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081
   Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006
   Kang K, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-45
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Nishimura N, 2010, J VIROL METHODS, V163, P282, DOI 10.1016/j.jviromet.2009.10.011
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Rudenko N, 2004, ACTA VIROL, V48, P167
   SUKHAVAC.P, 1966, B WORLD HEALTH ORGAN, V35, P65
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
NR 26
TC 0
Z9 0
U1 2
U2 5
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD NOV
PY 2018
IS 141
AR e58407
DI 10.3791/58407
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HI5CF
UT WOS:000456469400063
PM 30451226
OA Bronze
DA 2020-07-08
ER

PT J
AU Powell, JR
   Gloria-Soria, A
   Kotsakiozi, P
AF Powell, Jeffrey R.
   Gloria-Soria, Andrea
   Kotsakiozi, Panayiota
TI Recent History of Aedes aegypti: Vector Genomics and Epidemiology
   Records
SO BIOSCIENCE
LA English
DT Article
DE Aedes aegypti; history; yellow fever; dengue; slave trade
ID YELLOW-FEVER VIRUS; DENGUE; EVOLUTION
AB Aedes aegypti bears the common name "the yellow fever mosquito," although, today, it is of more concern as the major vector of dengue, chikungunya, and, most recently, Zika viruses. In the present article, we review recent work on the population genetics of this mosquito in efforts to reconstruct its recent (approximately 600 years) history and relate these findings to epidemiological records of occurrences of diseases transmitted by this species. The two sources of information are remarkably congruent. Ae. aegypti was introduced to the New World 400-550 years ago from its ancestral home in West Africa via European slave trade. Ships from the New World returning to their European ports of origin introduced the species to the Mediterranean region around 1800, where it became established until about 1950. The Suez Canal opened in 1869 and Ae. aegypti was introduced into Asia by the 1870s, then on to Australia (1887) and the South Pacific (1904).
C1 [Powell, Jeffrey R.; Gloria-Soria, Andrea; Kotsakiozi, Panayiota] Yale Univ, New Haven, CT 06520 USA.
RP Powell, JR (corresponding author), Yale Univ, New Haven, CT 06520 USA.
EM jeffrey.powell@yale.edu
RI Gloria-Soria, Andrea/AAJ-3304-2020
OI Gloria-Soria, Andrea/0000-0002-5401-3988
FU National Institutes of Health, National Institutes of Allergies and
   Infectious Diseases
FX We thank Nigel Beebe and Anna-Bella Failloux for information on first
   introductions into Australia and South Pacific Islands, respectively.
   Frances Schaffner kindly provided information on Europe and as well as
   figure 4. Ronald Smith provided guidance in understanding the history of
   climates in Africa. Scott Ritchie and John McNeill made helpful
   comments. Research in our laboratory, on which this article is partly
   based, is supported by the National Institutes of Health, National
   Institutes of Allergies and Infectious Diseases.
CR AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Augustin G, 1909, HIST YELLOW FEVER
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Buxton P. A., 1927, Bull Soc Etudes Ocean Papeete, V21, P306
   Buxton PA, 1927, LONDON SCH TROPICAL
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Christophers R, 1960, AEDES AEGYPTI YELLOW
   Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   Cunha Cheston B., 2008, Journal of Vector Borne Diseases, V45, P194
   CURTIN TJ, 1967, J MED ENTOMOL, V4, P48, DOI 10.1093/jmedent/4.1.48
   Dickson LB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004626
   Eltis D., 2010, ATLAS TRANSATLANTIC
   Frost A, 2012, 1 FLEET REAL STORY
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680
   Hare FE, 1898, AUSTR MED GAZ, V17, P98
   HOLSTEIN M, 1967, B WORLD HEALTH ORGAN, V36, P541
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913
   Lee DJ, 1987, SCH PUBLIC HLTH TROP, V2, P324
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   Mangudo C, 2015, B ENTOMOL RES, V105, P679, DOI 10.1017/S0007485315000590
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McNeill John, 2010, MOSQUITO EMPIRES
   MCNEILL WH, 1976, PLAGUES PEOPLE
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Petersen JL, 1977, THESIS
   Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967
   Powell JR, 2016, NATURE, V540, P525, DOI 10.1038/540525c
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Powell JR, 2018, AM J TROPICAL MED HY
   Pritchard JK, 2000, GENETICS, V155, P945
   Rigau-Perez JG, 1998, AM J TROP MED HYG, V59, P272, DOI 10.4269/ajtmh.1998.59.272
   ROSEN L, 1986, AM J TROP MED HYG, V35, P642, DOI 10.4269/ajtmh.1986.35.642
   Sawchuk LA, 1998, J HIST MED ALL SCI, V53, P3, DOI 10.1093/jhmas/53.1.3
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   TABACHNICK W J, 1991, American Entomologist, V37, P14
NR 42
TC 16
Z9 17
U1 2
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-3568
EI 1525-3244
J9 BIOSCIENCE
JI Bioscience
PD NOV
PY 2018
VL 68
IS 11
BP 854
EP 860
DI 10.1093/biosci/biy119
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HG7JX
UT WOS:000455168300008
PM 30464351
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kirkham, FJ
   Zafeiriou, D
   Howe, D
   Czarpran, P
   Harris, A
   Gunny, R
   Vollmer, B
AF Kirkham, Fenella J.
   Zafeiriou, Dimitrios
   Howe, David
   Czarpran, Philippa
   Harris, Ashley
   Gunny, Roxanna
   Vollmer, Brigitte
TI Fetal stroke and cerebrovascular disease Advances in understanding from
   lenticulostriate and venous imaging, alloimmune thrombocytopaenia and
   monochorionic twins
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Review
DE Fetus; Stroke; Focal ischemia; Intraparenchymal hemorrhage; Posterior
   fossa hemorrhage; Subarachnoid hemorrhage; Periventricular hemorrhage;
   Intraventricular hemorrhage; Periventricular leukomalacia;
   Encephalomalcia; Porencephaly; Polymicrogyria; Schizencephaly;
   Hydrancephaly; Focal cortical dysplasia; Vascular disruption;
   Monochorionic diamniotic twins; Parabiotic; Placental anastomoses; Twin
   twin transfusion syndrome; Twin oligohydramnios polyhydramnios syndrome;
   Selective intrauterine growth retardation; Twin anemia polycythemia
   syndrome; Twin reverse arterial perfusion; TTTS; TOPS; sIUGR; TAPS;
   TRAP; Fetal and neonatal alloimmune thrombocytopenia; FNAIT; Endothelial
   dysfunction; Venous sinus thrombosis; Dural venous ectasia with
   thrombosis; Fetal periventricular venous infarction; Lenticulostriate
   vasculopathy; Middle cerebral artery peak systolic velocity; Vein of
   Galen malformation; Hypovolemia; Anemia; Polycythemia; Embolus;
   Pulmonary hypertension; Right ventricular outflow tract obstruction;
   Cytomegalovirus; Zika; Parvovirus B19; Thermolabile methylene
   tetrahydrofolate reductase polymorphism; Factor V leiden; Prothrombotic;
   COL4A1; COL4A2; Trauma; Maternal warfarin; Maternal cocaine
ID SINGLE INTRAUTERINE DEATH; ARTERIAL ISCHEMIC-STROKE; MIDDLE
   CEREBRAL-ARTERY; PEAK SYSTOLIC VELOCITY; INTRACRANIAL HEMORRHAGE;
   PRENATAL-DIAGNOSIS; TRANSFUSION SYNDROME; RISK-FACTORS; MULTICYSTIC
   ENCEPHALOMALACIA; VASCULAR DISRUPTION
AB Fetal stroke is an important cause of cerebral palsy but is difficult to diagnose unless imaging is undertaken in pregnancies at risk because of known maternal or fetal disorders. Fetal ultrasound or magnetic resonance imaging may show haemorrhage or ischaemic lesions including multicystic encephalomalacia and focal porencephaly. Serial imaging has shown the development of malformations including schizencephaly and polymicrogyra after ischaemic and haemorrhagic stroke. Recognised causes of haemorrhagic fetal stroke include alloimmune and autoimmune thrombocytopaenia, maternal and fetal clotting disorders and trauma but these are relatively rare. It is likely that a significant proportion of periventricular and intraventricular haemorrhages are of venous origin. Recent evidence highlights the importance of arterial endothelial dysfunction, rather than thrombocytopaenia, in the intraparenchymal haemorrhage of alloimmune thrombocytopaenia. In the context of placental anastomoses, monochorionic diamniotic twins are at risk of twin twin transfusion syndrome (TTTS), or partial forms including Twin Oligohydramnios Polyhydramnios Sequence (TOPS), differences in estimated weight (selective Intrauterine growth Retardation; sIUGR), or in fetal haemoglobin (Twin Anaemia Polycythaemia Sequence; TAPS). There is a very wide range of ischaemic and haemorrhagic injury in a focal as well as a global distribution. Acute twin twin transfusion may account for intraventricular haemorrhage in recipients and periventricular leukomalacia in donors but there are additional risk factors for focal embolism and cerebrovascular disease. The recipient has circulatory overload, with effects on systemic and pulmonary circulations which probably lead to systemic and pulmonary hypertension and even right ventricular outflow tract obstruction as well as the polycythaemia which is a risk factor for thrombosis and vasculopathy. The donor is hypovolaemic and has a reticulocytosis in response to the anaemia while maternal hypertension and diabetes may influence stroke risk. Understanding of the mechanisms, including the role of vasculopathy, in well studied conditions such as alloimmune thrombocytopaenia and monochorionic diamniotic twinning may lead to reduction of the burden of antenatally sustained cerebral palsy. (C) 2018 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.
C1 [Kirkham, Fenella J.; Gunny, Roxanna] UCL Great Ormond St Inst Child Hlth, Dev Neurosci Sect, London WC1N 1EH, England.
   [Kirkham, Fenella J.; Gunny, Roxanna] UCL Great Ormond St Inst Child Hlth, Biomed Res Ctr, London WC1N 1EH, England.
   [Kirkham, Fenella J.; Howe, David; Czarpran, Philippa; Harris, Ashley; Vollmer, Brigitte] Univ Hosp Southampton, Dept Child Hlth, Southampton, Hants, England.
   [Kirkham, Fenella J.; Howe, David; Czarpran, Philippa; Harris, Ashley; Vollmer, Brigitte] Univ Hosp Southampton, Dept Obstet & Gynaecol, Southampton, Hants, England.
   [Kirkham, Fenella J.; Howe, David; Czarpran, Philippa; Harris, Ashley; Vollmer, Brigitte] Univ Hosp Southampton, Dept Radiol, Southampton, Hants, England.
   [Kirkham, Fenella J.; Howe, David; Vollmer, Brigitte] Univ Southampton, Clin & Expt Sci, Southampton, Hants, England.
   [Zafeiriou, Dimitrios] Aristotle Univ Thessaloniki, Hippokratio Gen Hosp, Dept Pediat 1, Thessaloniki, Greece.
   [Gunny, Roxanna] St George Hosp, Dept Radiol, London, England.
RP Kirkham, FJ (corresponding author), UCL Great Ormond St Inst Child Hlth, Dev Neurosci Sect, London WC1N 1EH, England.; Kirkham, FJ (corresponding author), UCL Great Ormond St Inst Child Hlth, Biomed Res Ctr, London WC1N 1EH, England.
EM Fenella.Kirkham@ucl.ac.uk
RI vollmer, brigitte/AAB-3132-2020; Kirkham, Fenella/C-2442-2009
OI vollmer, brigitte/0000-0003-4088-5336; Kirkham,
   Fenella/0000-0002-2443-7958
FU Action Medical Research, United Kingdom [GN2509]
FX Dr Kirkham is funded by Action Medical Research, United Kingdom, GN2509.
CR Abdelkader MA, 2017, J MATERN-FETAL NEO M, V30, P2250, DOI 10.1080/14767058.2016.1245283
   AICARDI J, 1972, J NEUROL SCI, V15, P357, DOI 10.1016/0022-510X(72)90165-7
   AMATO M, 1991, NEUROPEDIATRICS, V22, P100, DOI 10.1055/s-2008-1071425
   Amlie-Lefond CM, 2008, PEDIATR NEUROL, V38, P140, DOI 10.1016/j.pediatrneurol.2007.10.003
   Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001
   Aziz NA, 2016, ULTRASOUND OBST GYN, V47, P785, DOI 10.1002/uog.15772
   Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619
   BARKOVICH AJ, 1988, AM J NEURORADIOL, V9, P297
   Batukan C, 2002, ULTRASOUND OBST GYN, V19, P407, DOI 10.1046/j.1469-0705.2002.00683.x
   Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602
   Benders MJNL, 2007, STROKE, V38, P1759, DOI 10.1161/STROKEAHA.106.479311
   Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584
   Brooks JC, 2014, DEV MED CHILD NEUROL, V56, P1059, DOI 10.1111/dmcn.12520
   Brossard-Racine M, 2015, CEREBELLUM, V14, P151, DOI 10.1007/s12311-014-0597-9
   CARLSON NJ, 1989, OBSTET GYNECOL, V73, P685
   Carr SR, 2004, FETAL DIAGN THER, V19, P370, DOI 10.1159/000077968
   Coley BD, 2000, PEDIATR RADIOL, V30, P846, DOI 10.1007/s002470000322
   Conde JRC, 2005, PEDIATR NEUROL, V32, P346, DOI 10.1016/j.pediatrneurol.2004.11.008
   Conte G, 2018, RADIOLOGY, V288, P582, DOI 10.1148/radiol.2018171267
   Cota F, 2008, J MATERN-FETAL NEO M, V21, P852, DOI 10.1080/14767050802320316
   COULSON CC, 1994, AM J PERINAT, V11, P253, DOI 10.1055/s-2007-994585
   Craze JL, 1996, DEV MED CHILD NEUROL, V38, P84
   Crespin M, 2009, PEDIATR NEUROL, V41, P291, DOI 10.1016/j.pediatrneurol.2009.04.027
   Crighton GL, 2017, J MATERN-FETAL NEO M, V30, P2488, DOI 10.1080/14767058.2016.1253064
   Curry CJ, 2005, AM J MED GENET A, V137A, P181, DOI 10.1002/ajmg.a.30862
   Dale ST, 2002, AM J NEURORADIOL, V23, P1457
   DALTON ME, 1984, ACTA GENET MED GEMEL, V33, P43, DOI 10.1017/S0001566000007480
   Das S, 2008, AM J PERINAT, V25, P381, DOI 10.1055/s-2008-1078755
   De Haan TR, 2006, ACTA PAEDIATR, V95, P863, DOI 10.1080/08035250500516664
   de Laveaucoupet J, 2001, PRENATAL DIAG, V21, P729, DOI 10.1002/pd.135
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   de Spirlet M, 2000, ULTRASOUND OBST GYN, V16, P72, DOI 10.1046/j.1469-0705.2000.00167.x
   de Vries L S, 2001, Eur J Paediatr Neurol, V5, P139, DOI 10.1053/ejpn.2001.0494
   DELAVEAUCOUPET J, 1995, PEDIATR RADIOL, V25, P211, DOI 10.1007/BF02021539
   Delbos F, 2016, TRANSFUSION, V56, P59, DOI 10.1111/trf.13274
   Delle Urban LAB, 2004, PRENATAL DIAG, V24, P808, DOI 10.1002/pd.987
   Demir F, 2016, J TURKISH GER GYNECO, V17, pS209
   Denbow ML, 1998, AM J OBSTET GYNECOL, V178, P479, DOI 10.1016/S0002-9378(98)70424-7
   DESOUSA C, 1988, ARCH DIS CHILD-FETAL, V63, P1168, DOI 10.1136/adc.63.10_Spec_No.1168
   deVries LS, 1995, PEDIATR RADIOL, V25, pS41
   Diamandis P, 2017, BRAIN DEV-JPN, V39, P23, DOI 10.1016/j.braindev.2016.06.005
   DURKIN MV, 1976, EUR J PEDIATR, V123, P67, DOI 10.1007/BF00442637
   Durrani-Kolarik S, 2017, PEDIATR NEUROL, V66, P100, DOI 10.1016/j.pediatrneurol.2016.04.010
   Eikelboom JW, 1998, AUST NZ J MED, V28, P849, DOI 10.1111/j.1445-5994.1998.tb01576.x
   El Ayoubi M, 2003, PEDIATR RADIOL, V33, P697, DOI 10.1007/s00247-003-0948-z
   Elchalal U, 2005, ULTRASOUND OBST GYN, V26, P233, DOI 10.1002/uog.1969
   Ellestad SC, 2004, OBSTET GYNECOL, V104, P1298, DOI 10.1097/01.AOG.0000141568.66660.0f
   Emamian SA, 2002, PEDIATR RADIOL, V32, P593, DOI 10.1007/s00247-002-0710-y
   Eschbach SJ, 2017, ULTRASOUND OBST GYN, V49, P737, DOI 10.1002/uog.16008
   Fanou EM, 2013, PEDIATR RADIOL, V43, P1591, DOI 10.1007/s00247-013-2745-7
   Feng BB, 2018, TAIWAN J OBSTET GYNE, V57, P351, DOI 10.1016/j.tjog.2018.03.002
   Fernandez-Bouzas A, 2006, NEURORADIOLOGY, V48, P171, DOI 10.1007/s00234-005-0006-7
   FISK NM, 1990, ARCH DIS CHILD-FETAL, V65, P657, DOI 10.1136/adc.65.7_Spec_No.657
   Folkerth RD, 2001, J ULTRAS MED, V20, P1233
   Fujiwara K, 2014, CLIN CASE REP, V2, DOI 10.1002/ccr3.75
   Furuta K, 2014, EARLY HUM DEV, V90, P455, DOI 10.1016/j.earlhumdev.2014.06.002
   FUSI L, 1991, OBSTET GYNECOL, V78, P517
   FUSI L, 1990, BRIT J OBSTET GYNAEC, V97, P511, DOI 10.1111/j.1471-0528.1990.tb02521.x
   Ganesan V, 1997, DEV MED CHILD NEUROL, V39, P628
   Garne E, 2008, EUR J PAEDIATR NEURO, V12, P82, DOI 10.1016/j.ejpn.2007.07.001
   Gherman RB, 2014, J REPROD MED, V59, P501
   Ghevaert C, 2007, TRANSFUSION, V47, P901, DOI 10.1111/j.1537-2995.2007.01208.x
   Ghi T, 2003, ULTRASOUND OBST GYN, V22, P121, DOI 10.1002/uog.191
   Ghi T, 2004, ULTRASOUND OBST GYN, V23, P428, DOI 10.1002/uog.1035
   Ghidini A, 2006, J REPROD MED, V51, P321
   Gijtenbeek M, 2017, NEONATOLOGY, V112, P402, DOI 10.1159/000478844
   Glenn OA, 2005, J ULTRAS MED, V24, P711, DOI 10.7863/jum.2005.24.5.711
   Glinianaia SV, 2002, ARCH DIS CHILD-FETAL, V86, pF9, DOI 10.1136/fn.86.1.F9
   Glinianaia SV, 2018, ULTRASOUND OBSTET GY
   Golomb MR, 2008, PEDIATR NEUROL, V38, P329, DOI 10.1016/j.pediatrneurol.2007.12.012
   Golomb MR, 2006, PEDIATR NEUROL, V35, P75, DOI 10.1016/j.pediatrneurol.2005.12.008
   Golomb MR, 2001, ANN NEUROL, V50, P163, DOI 10.1002/ana.1078
   Govaert P, 2009, SEMIN FETAL NEONAT M, V14, P250, DOI 10.1016/j.siny.2009.07.008
   Gratacos E, 2004, ULTRASOUND OBST GYN, V24, P159, DOI 10.1002/uog.1105
   Griffiths PD, 2015, PRENATAL DIAG, V35, P583, DOI 10.1002/pd.4577
   Gul A, 2009, ARCH GYNECOL OBSTET, V279, P697, DOI 10.1007/s00404-008-0776-3
   Harada T, 2017, YONAGO ACTA MED, V60, P241, DOI [10.33160/yam.2017.12.005, 10.24563/yam.2017.12.005]
   Hayashi M, 2015, PEDIATR NEUROL, V52, P529, DOI 10.1016/j.pediatrneurol.2015.01.011
   Hildebrandt T, 2002, ARCH DIS CHILD-FETAL, V87, P222
   Hino-Fukuyo N, 2016, PEDIATR NEUROL, V54, P39, DOI 10.1016/j.pediatrneurol.2015.08.016
   Howe DT, 2012, ULTRASOUND OBST GYN, V39, P75, DOI 10.1002/uog.9069
   Hsu TL, 2008, TAIWAN J OBSTET GYNE, V47, P106, DOI 10.1016/S1028-4559(08)60068-6
   Huang Ying-Fen, 2006, Taiwan J Obstet Gynecol, V45, P135
   HUGHES HE, 1986, PEDIATRICS, V78, P85
   Inklaar MJ, 2014, PRENATAL DIAG, V34, P205, DOI 10.1002/pd.4298
   Ito H, 2009, JPN J NEUROSURG, V18, P56
   Jean-Pierre Lin, 1999, EUR J PAEDIATR NEURO, V3, pA96
   Jelin AC, 2008, AM J OBSTET GYNECOL, V199, P1
   JUNG JH, 1984, PEDIATRICS, V73, P467
   Kandasamy Y, 2006, J PERINATOL, V26, P780, DOI 10.1038/sj.jp.7211607
   Khalid R, 2018, NEUROLOGY, V90, P232, DOI 10.1212/WNL.0000000000004890
   Kirkinen P, 1997, J REPROD MED, V42, P467
   Kirton A, 2008, ANN NEUROL, V63, P436, DOI 10.1002/ana.21334
   Kirton A, 2010, ARCH NEUROL-CHICAGO, V67, P842, DOI 10.1001/archneurol.2010.140
   Kirton A, 2009, PEDIATR NEUROL, V40, P205, DOI 10.1016/j.pediatrneurol.2008.09.018
   Kocaman C, 2012, BRAIN DEV-JPN, V34, P133, DOI 10.1016/j.braindev.2011.04.003
   Komiyama M, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.031
   Kosinska-Kaczynska K, 2018, FETAL DIAGN THER
   Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3
   Krsek P, 2010, EPILEPSIA, V51, P2440, DOI 10.1111/j.1528-1167.2010.02730.x
   Kulak W, 2011, ADV MED SCI-POLAND, V56, P64, DOI 10.2478/v10039-011-0006-2
   Kutuk MS, 2014, CHILD NERV SYST, V30, P2147, DOI 10.1007/s00381-014-2473-9
   Kutuk MS, 2014, CHILD NERV SYST, V30, P411, DOI 10.1007/s00381-013-2243-0
   Landy H J, 1989, Obstet Gynecol Surv, V44, P171, DOI 10.1097/00006254-198903000-00003
   LARROCHE JC, 1994, BIOL NEONATE, V65, P343
   Lee HC, 2003, J KOREAN MED SCI, V18, P764, DOI 10.3346/jkms.2003.18.5.764
   Li C, 2017, EUR J NEUROL, V24, P1006, DOI 10.1111/ene.13337
   Li D, 2012, STROKE, V43, P1404, DOI 10.1161/STROKEAHA.111.645077
   Lichtenbelt KD, 2012, ULTRASOUND OBST GYN, V39, DOI 10.1002/uog.11070
   Lopriore E, 2013, ULTRASOUND OBST GYN, V41, P702, DOI 10.1002/uog.12337
   Lucatelli P, 2013, ATHEROSCLEROSIS, V231, P205, DOI 10.1016/j.atherosclerosis.2013.08.032
   Lucca J, 2013, PEDIATR RADIOL, V43, P212, DOI 10.1007/s00247-012-2528-6
   Machino H, 2017, OXF MED CASE REP, V2017
   Mackie FL, 2016, TWIN RES HUM GENET, V19, P262, DOI 10.1017/thg.2016.39
   Mackie FL, 2018, AM J OBSTET GYNECOL
   Manterola A, 1966, J NEUROPATHOL EXP NE, P479
   Fernandez-Mayoralas DM, 2014, J CHILD NEUROL, V29, P118, DOI 10.1177/0883073812467508
   Martinez-Payo C, 2017, J CLIN ULTRASOUND, V45, P621, DOI 10.1002/jcu.22478
   Masamoto H, 2009, AM J PERINAT, V26, P597, DOI 10.1055/s-0029-1220781
   MERCURI E, 1995, ARCH DIS CHILD-FETAL, V73, pF67, DOI 10.1136/fn.73.2.F67
   Merhar SL, 2013, J PERINATOL, V33, P112, DOI 10.1038/jp.2012.87
   MINKOFF H, 1985, OBSTET GYNECOL, V65, pS22
   Miralles-Gutierrez A, 2017, J PERINAT MED
   Mohila CA, 2010, PEDIATR DEVEL PATHOL, V13, P55, DOI 10.2350/08-11-0562.1
   MOORE CM, 1969, J PEDIATR, V74, P523, DOI 10.1016/S0022-3476(69)80034-X
   NAEYE RL, 1963, NEW ENGL J MED, V268, P804, DOI 10.1056/NEJM196304112681502
   Nicolini U, 1998, AM J OBSTET GYNECOL, V179, P800, DOI 10.1016/S0002-9378(98)70086-9
   Nicolini U, 1999, ULTRASOUND OBST GYN, V14, P297, DOI 10.1046/j.1469-0705.1999.14050297.x
   O'Donoghue K, 2009, BJOG-INT J OBSTET GY, V116, P804, DOI 10.1111/j.1471-0528.2009.02128.x
   Oda N, 2008, FETAL DIAGN THER, V24, P345, DOI 10.1159/000161573
   Oh KY, 2005, RADIOGRAPHICS, V25, P647, DOI 10.1148/rg.253045103
   OKAMURA K, 1994, OBSTET GYNECOL, V83, P975, DOI 10.1097/00006250-199406000-00016
   Ortibus E, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.048
   Oswal K, 2008, J CLIN ULTRASOUND, V36, P451, DOI 10.1002/jcu.20464
   Ozduman K, 2004, PEDIATR NEUROL, V30, P151, DOI 10.1016/j.pediatrneurol.2003.08.004
   PATI S, 1994, REPROD TOXICOL, V8, P115, DOI 10.1016/0890-6238(94)90018-3
   Peterson JA, 2013, BRIT J HAEMATOL, V161, P3, DOI 10.1111/bjh.12235
   Pharoah P O D, 2002, Semin Neonatol, V7, P223, DOI 10.1053/siny.2002.0109
   Quarello E, 2007, J MATERN-FETAL NEO M, V20, P589, DOI 10.1080/14767050701449638
   Radder CM, 2004, EARLY HUM DEV, V80, P65, DOI 10.1016/j.earlhumdev.2004.05.007
   Refsum E, 2018, TRANSFUSION, V58, P223, DOI 10.1111/trf.14394
   Robertson CMT, 2017, CAN J NEUROL SCI, V44, P366, DOI 10.1017/cjn.2017.33
   Robinson A, 2017, PRENATAL DIAG, V37, P611, DOI 10.1002/pd.5059
   Robinson C, 2009, AM J OBSTET GYNECOL, V201, pS282, DOI 10.1016/j.ajog.2009.10.802
   Robyr R, 2006, AM J OBSTET GYNECOL, V194, P796, DOI 10.1016/j.ajog.2005.08.069
   Sainz JA, 2014, J MATERN-FETAL NEO M, V27, P1174, DOI 10.3109/14767058.2013.850662
   Sawarkar DP, 2016, WORLD NEUROSURG, V96, DOI 10.1016/j.wneu.2016.09.075
   Schrey S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.005
   Sellier E, 2016, DEV MED CHILD NEUROL, V58, P85, DOI 10.1111/dmcn.12865
   Sharif U, 2001, J CHILD NEUROL, V16, P838, DOI 10.1177/08830738010160111001
   Sherer DM, 1998, AM J PERINAT, V15, P431, DOI 10.1055/s-2007-993971
   Shue EH, 2012, J PEDIATR SURG, V47, P1938, DOI 10.1016/j.jpedsurg.2012.08.021
   Silva F, 2011, BMJ CASE REP, V2011
   Slaghekke F, 2015, ULTRASOUND OBST GYN, V46, P432, DOI 10.1002/uog.14925
   Spencer JA, 2001, AUST NZ J OBSTET GYN, V41, P45, DOI 10.1111/j.1479-828X.2001.tb01293.x
   Spruijt M, 2012, OBSTET GYNECOL, V120, P15, DOI 10.1097/AOG.0b013e31825b9841
   Steggerda S, 2006, PEDIATR DEVEL PATHOL, V9, P52, DOI 10.2350/06-05-0060.1
   STEINLIN M, 1993, NEUROPEDIATRICS, V24, P224, DOI 10.1055/s-2008-1071545
   Stevenson LD, 1942, ARCH PATHOL, V34, P286
   SUCHET IB, 1994, CAN ASSOC RADIOL J, V45, P193
   SUGAMA S, 1994, PEDIATR NEUROL, V11, P62, DOI 10.1016/0887-8994(94)90094-9
   Swamy RS, 2018, ARCH DIS CHILD-FETAL, V103, pF512, DOI 10.1136/archdischild-2017-313691
   SZYMONOWICZ W, 1986, ARCH DIS CHILD, V61, P454, DOI 10.1136/adc.61.5.454
   Takahashi H, 2014, ACTA OBSTET GYN SCAN, V93, P1336, DOI 10.1111/aogs.12484
   Takanashi J, 2003, NEUROLOGY, V61, P531, DOI 10.1212/01.WNL.0000079370.28310.EA
   TAN KL, 1979, CLIN PEDIATR, V18, P111, DOI 10.1177/000992287901800206
   Tattoli L, 2017, FORENSIC SCI INT, V280, pE1, DOI 10.1016/j.forsciint.2017.10.016
   Tavil B, 2016, BLOOD COAGUL FIBRIN, V27, P163, DOI 10.1097/MBC.0000000000000403
   Tiller H, 2015, TRUE RISK FETAL NEON, P738
   Tiller H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002490
   Tomas-Vila M, 2000, REV NEUROLOGIA, V31, P952, DOI 10.33588/rn.3110.2000362
   Tortora D, 2017, ARCH DIS CHILD, P59
   van der Knoop BJ, 2017, J PERINAT MED
   van Klink JMM, 2015, ULTRASOUND OBST GYN, V45, P294, DOI 10.1002/uog.14722
   Verbeek E, 2012, EUR J HUM GENET, V20, P844, DOI 10.1038/ejhg.2012.20
   Verbeek L, 2017, ARCH DIS CHILD-FETAL, V102, pF324, DOI 10.1136/archdischild-2016-311822
   Verbeek L, 2017, EXPERT REV HEMATOL, V10, P525, DOI 10.1080/17474086.2017.1324290
   Verdu A, 2005, BRAIN DEV-JPN, V27, P451, DOI 10.1016/j.braindev.2004.10.004
   Vergani P, 1996, AM J OBSTET GYNECOL, V175, P536
   Vermeulen RJ, 2011, NEUROPEDIATRICS, V42, P1, DOI 10.1055/s-0031-1275343
   WANG HS, 1995, AM J NEURORADIOL, V16, P97
   Ward MJ, 2006, AM J PERINAT, V23, P487, DOI 10.1055/s-2006-954958
   Weig SG, 1995, PEDIATR NEUROL, V13, P279, DOI 10.1016/0887-8994(95)00219-7
   Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P563, DOI 10.1016/S0002-9378(03)00824-X
   WESSEL J, 1988, J PERINAT MED, V16, P467, DOI 10.1515/jpme.1988.16.5-6.467
   Winkelhorst D, 2017, BLOOD, V129, P1538, DOI 10.1182/blood-2016-10-739656
   Xia W, 2018, J STROKE CEREBROVASC, V27, P1068, DOI 10.1016/j.jstrokecerebrovasdis.2017.11.014
   Yamanoi K, 2018, CASE REPORT DELAYED, V2018, P1
   Yapicioglu-Yildizdas H, 2017, TURKISH J PEDIATR, V59, P724, DOI 10.24953/turkjped.2017.06.020
   Yoneda Y, 2013, ANN NEUROL, V73, P48, DOI 10.1002/ana.23736
   Yoneda Y, 2012, AM J HUM GENET, V90, P86, DOI 10.1016/j.ajhg.2011.11.016
   YOSHIOKA H, 1979, J PEDIATR-US, V95, P798, DOI 10.1016/S0022-3476(79)80739-8
   Yougbare I, 2015, J CLIN INVEST, V125, P1545, DOI 10.1172/JCI77820
   Zanders EHJ, 2003, FETAL DIAGN THER, V18, P324, DOI 10.1159/000071974
   Zhou LX, 2017, J MAGN RESON IMAGING, V46, P1535, DOI 10.1002/jmri.25478
NR 195
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV
PY 2018
VL 22
IS 6
BP 989
EP 1005
DI 10.1016/j.ejpn.2018.08.008
PG 17
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA HG6BD
UT WOS:000455065100012
PM 30467085
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Fontaine, KA
   Leon, KE
   Khalid, MM
   Tomar, S
   Jimenez-Morales, D
   Dunla, M
   Kaye, JA
   Shah, PS
   Finkbeiner, S
   Krogan, NJ
   Ott, M
AF Fontaine, Krystal A.
   Leon, Kristoffer E.
   Khalid, Mir M.
   Tomar, Sakshi
   Jimenez-Morales, David
   Dunla, Mariah
   Kaye, Julia A.
   Shah, Priya S.
   Finkbeiner, Steve
   Krogan, Nevan J.
   Ott, Melanie
TI The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted
   by the Viral Capsid Protein
SO MBIO
LA English
DT Article
DE Zika virus; nonsense-mediated mRNA decay pathway; virus-host
   interactions
ID MESSENGER-RNA DECAY; EXON JUNCTION COMPLEX; STEM; BRAIN; UPF1;
   COLOCALIZATION; PURIFICATION; ADULT
AB Zika virus (ZIKV) infection of neural progenitor cells (NPCs) in utero is associated with neurological disorders, such as microcephaly, but a detailed molecular understanding of ZIKV-induced pathogenesis is lacking. Here we show that in vitro ZIKV infection of human cells, including NPCs, causes disruption of the nonsense-mediated mRNA decay (NMD) pathway. NMD is a cellular mRNA surveillance mechanism that is required for normal brain size in mice. Using affinity purification-mass spectrometry, we identified multiple cellular NMD factors that bind to the viral capsid protein, including the central NMD regulator up-frameshift protein 1 (UPF1). Endogenous UPF1 interacted with the ZIKV capsid protein in coimmunoprecipitation experiments, and capsid expression posttranscriptionally downregulated UPF1 protein levels, a process that we confirmed occurs during ZIKV infection. Cellular fractionation studies show that the ZIKV capsid protein specifically targets nuclear UPF1 for degradation via the proteasome. A further decrease in UPF1 levels by RNAi significantly enhanced ZIKV infection in NPC cultures, consistent with a model in which NMD restricts ZIKV infection in the fetal brain. We propose that ZIKV, via the capsid protein, has evolved a strategy to lower UPF1 levels and dampen antiviral activities of NMD, which in turn contributes to neuropathology in vivo.
   IMPORTANCE Zika virus (ZIKV) is a significant global health threat, as infection has been linked to serious neurological complications, including microcephaly. Using a human stem cell-derived neural progenitor model system, we find that a critical cellular quality control process called the nonsense-mediated mRNA decay (NMD) pathway is disrupted during ZIKV infection. Importantly, disruption of the NMD pathway is a known cause of microcephaly and other neurological disorders. We further identify an interaction between the capsid protein of ZIKV and up-frameshift protein 1 (UPF1), the master regulator of NMD, and show that ZIKV capsid targets UPF1 for degradation. Together, these results offer a new mechanism for how ZIKV infection can cause neuropathology in the developing brain.
C1 [Fontaine, Krystal A.; Leon, Kristoffer E.; Khalid, Mir M.; Tomar, Sakshi; Jimenez-Morales, David; Dunla, Mariah; Kaye, Julia A.; Finkbeiner, Steve; Krogan, Nevan J.; Ott, Melanie] Gladstone Inst, San Francisco, CA USA.
   [Leon, Kristoffer E.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA.
   [Leon, Kristoffer E.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.
   [Jimenez-Morales, David; Shah, Priya S.; Krogan, Nevan J.] Univ Calif San Francisco, QBI, San Francisco, CA 94143 USA.
   [Jimenez-Morales, David; Shah, Priya S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.
   [Finkbeiner, Steve] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Finkbeiner, Steve] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.
   [Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Jimenez-Morales, David] Stanford Univ, Dept Med, Stanford, CA 94305 USA.
   [Shah, Priya S.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.
   [Shah, Priya S.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.
RP Ott, M (corresponding author), Gladstone Inst, San Francisco, CA USA.; Ott, M (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
EM melanie.ott@gladstone.ucsf.edu
RI Jimenez-Morales, David/AAE-9289-2019; Tomar, Sakshi/AAL-6766-2020;
   Khalid, Mir/P-4123-2015
OI Jimenez-Morales, David/0000-0003-4356-6461; Tomar,
   Sakshi/0000-0001-5994-4178; Khalid, Mir/0000-0002-1862-6795; Leon,
   Kristoffer/0000-0003-2424-0458
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI097552, U19AI1186101, F32AI112262];
   DOD/DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [HR0011-11-C-0094]; James B. Pendleton
   Charitable Trust; BioFulcrum; NIH/NINDSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS) [R01
   NS101996-01]
FX This work was supported by NIH/NIAID F32AI112262 to P.S.S., NIH/NINDS
   R01 NS101996-01 to S.F., NIH/NIAID U19AI1186101 to N.J.K., DOD/DARPA
   HR0011-11-C-0094 (PROPHECY) to N.J.K., NIH/NIAID R01 AI097552 to M.O.,
   BioFulcrum, and the James B. Pendleton Charitable Trust.
CR Balistreri G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010024
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   Brazao TF, 2012, FEBS LETT, V586, P1101, DOI 10.1016/j.febslet.2012.03.015
   Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330
   Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010
   Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freire JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081450
   Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Han X, 2018, NUCLEIC ACIDS RES, V46, P1038, DOI 10.1093/nar/gkx1272
   Harris E, 2006, NOVART FDN SYMP, V277, P253
   Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010
   Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007
   Jauhiainen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033208
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li TL, 2015, EMBO J, V34, P1630, DOI 10.15252/embj.201489947
   Lim RG, 2017, NAT NEUROSCI, V20, P648, DOI 10.1038/nn.4532
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617
   Mao HQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006282
   Mao HQ, 2015, J NEUROSCI, V35, P7003, DOI 10.1523/JNEUROSCI.0018-15.2015
   Molleston JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010002
   Nelson JO, 2016, ELIFE, V5, DOI 10.7554/eLife.12876
   Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Peccarelli M, 2014, EUKARYOT CELL, V13, P1126, DOI 10.1128/EC.00090-14
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawlinson SM, 2015, CELL MICROBIOL, V17, P1108, DOI 10.1111/cmi.12465
   Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001
   Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1
   Serquina AKP, 2013, J VIROL, V87, P8853, DOI 10.1128/JVI.00925-13
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Slomnicki LP, 2017, SCI REP, V7, P1
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360
   Teo G, 2016, PROTEOMICS, V16, P2238, DOI 10.1002/pmic.201500499
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   Varsally W, 2012, BIOCHEM SOC T, V40, P778, DOI 10.1042/BST20120052
   von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008
   Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
NR 56
TC 13
Z9 13
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD NOV-DEC
PY 2018
VL 9
IS 6
AR e02126-18
DI 10.1128/mBio.02126-18
PG 12
WC Microbiology
SC Microbiology
GA HG1PH
UT WOS:000454730100053
PM 30401782
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Sousa, JR
   Azevedo, RDD
   Martins, AJ
   de Araujo, MTF
   Cruz, EDM
   Vasconcelos, BCB
   Cruz, ACR
   de Oliveira, CS
   Martins, LC
   Vasconcelos, BHB
   Casseb, LMN
   Chiang, JO
   Quaresma, JAS
   Vasconcelos, PFD
AF de Sousa, Jorge Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Martins Filho, Arnaldo Jorge
   Ferreira de Araujo, Marialva Tereza
   Moutinho Cruz, Ermelinda do Rosario
   Baldez Vasconcelos, Barbara Cristina
   Ribeiro Cruz, Ana Cecilia
   de Oliveira, Consuelo Silva
   Martins, Livia Caricio
   Baldez Vasconcelos, Beatriz Helena
   Neves Casseb, Livia Medeiros
   Chiang, Jannifer Oliveira
   Simoes Quaresma, Juarez Antonio
   da Costa Vasconcelos, Pedro Fernando
TI In situ inflammasome activation results in severe damage to the central
   nervous system in fatal Zika virus microcephaly cases
SO CYTOKINE
LA English
DT Article
DE Zika virus; Microcephaly; Inflammasome; Neuroinflammatory response
ID STRUCTURAL BIOLOGY; GLIAL-CELLS; TRANSMISSION; EPIDEMIOLOGY;
   PATHOGENESIS; MECHANISMS; INFECTION
AB Zika virus (ZIKV) has caused substantial concern worldwide owing to its association with severe birth defects, such as microcephaly and other congenital malformations. Inflammasomes, i.e., multi-protein complexes that induce inflammation and pyroptosis, are predicted to contribute to the immune response to this flavivirus. Accordingly, in this study, the in situ inflammasome response was evaluated in fatal cases of ZIKV-linked microcephaly. Brain tissue samples were collected from eight babies, including four ZIKV-positive microcephalic neonates who died after birth and four flavivirus-negative neonatal controls who died of other causes and whose central nervous system (CNS) architecture was preserved. In the ZIKV-positive newborn/stillbirth babies, the major histopathological alterations included atrophy of the cortical layer, a predominance of mononuclear cell infiltration in the Virchow Robin space, neuronal necrosis, vacuolization and neuronal degeneration, neuronophagy, and gliosis. An immunohistochemical analysis of tissues in the neural parenchyma showed significantly higher expression of the receptors NLRP1, NLRP3, and AIM2, cytokines IL-1 beta, IL-18, and IL-33, and enzymes caspase 1, iNOS, and arginase 1 in ZIKV-positive microcephaly cases than in flavivirus-negative controls. These results suggest that inflammasome activation can aggravate the neuroinflammatory response and consequently increase CNS damage in neonates with fetal neural ZIKV infection and microcephaly.
C1 [de Sousa, Jorge Rodrigues; da Silva Azevedo, Raimunda do Socorro; Ribeiro Cruz, Ana Cecilia; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Neves Casseb, Livia Medeiros; Chiang, Jannifer Oliveira; da Costa Vasconcelos, Pedro Fernando] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Martins Filho, Arnaldo Jorge; Ferreira de Araujo, Marialva Tereza; Moutinho Cruz, Ermelinda do Rosario; Simoes Quaresma, Juarez Antonio] Minist Hlth, Evandro Chagas Inst, Dept Pathol, Ananindeua, Para, Brazil.
   [Baldez Vasconcelos, Barbara Cristina; Ribeiro Cruz, Ana Cecilia; Simoes Quaresma, Juarez Antonio; da Costa Vasconcelos, Pedro Fernando] State Univ Para, Ctr Biol & Hlth Sci, Belem, Para, Brazil.
   [Baldez Vasconcelos, Beatriz Helena; Simoes Quaresma, Juarez Antonio] Fed Univ Para, Trop Med Ctr, Belem, Para, Brazil.
RP Vasconcelos, PFD (corresponding author), Rodovia BR-316,Km-07 S-N, BR-67030000 Ananindeua, Brazil.
EM pedrovasconcelos@iec.gov.br
RI Quaresma, Juarez AS/M-4190-2014; QUARESMA, JUAREZ ANTONIO
   SIMOES/F-8390-2012; Vasconcelos, Pedro/AAH-3142-2019; Filho, Arnaldo
   Jorge Martins/AAJ-2779-2020; Cruz, Ana Cecilia Ribeiro/V-9276-2019;
   Azevedo, Raimunda/T-4656-2019
OI Quaresma, Juarez AS/0000-0002-6267-9966; QUARESMA, JUAREZ ANTONIO
   SIMOES/0000-0002-6267-9966; Filho, Arnaldo Jorge
   Martins/0000-0001-9153-1234; Azevedo, Raimunda/0000-0003-1932-9976
FU Ministry of Science, Technology and Innovation/National Council for
   Scientific and Technological Development [440405/2016-5, 439971/2016-0,
   303999/2016-0]
FX We are grateful to the staff of the Department of Pathology for their
   assistance in the experiments, especially Valter Miranda Campos, Orlando
   Pereira Amador Neto, and Maria de Lourdes Gomes Lima. This work was
   supported by the Ministry of Science, Technology and Innovation/National
   Council for Scientific and Technological Development (Grant numbers:
   440405/2016-5, 439971/2016-0, and 303999/2016-0).
CR Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bollweg BC, 2018, J PATHOL CLIN RES, V4, P19, DOI 10.1002/cjp2.84
   Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dub T, 2017, REV NEUROL-FRANCE, V173, P361, DOI 10.1016/j.neurol.2017.03.033
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   GAJDAMOVIC SJ, 1973, B WORLD HEALTH ORGAN, V49, P471
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95
   Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Merfeld E, 2017, WILEY INTERDISCIP RE, V6
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   SARTORELLI AC, 1966, J IMMUNOL, V96, P676
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yang ZH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00533
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 49
TC 7
Z9 7
U1 0
U2 14
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD NOV
PY 2018
VL 111
BP 255
EP 264
DI 10.1016/j.cyto.2018.08.008
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA HG1XG
UT WOS:000454753800035
PM 30199767
DA 2020-07-08
ER

PT J
AU Riley, LW
   Blanton, RE
AF Riley, Lee W.
   Blanton, Ronald E.
TI Advances in Molecular Epidemiology of Infectious Diseases: Definitions,
   Approaches, and Scope of the Field
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID SEXUAL TRANSMISSION; MYCOBACTERIUM-TUBERCULOSIS; ZIKA VIRUS; BACTERIAL
AB Molecular epidemiology is a discipline that uses molecular microbiology tools to study the distribution and determinants of diseases in human populations and veterinary animals. Our understanding of epidemiology of infectious diseases has evolved with technological advancements made in molecular biology that refine our perception of the identity and dynamics of microorganisms. This review is an introduction to the Microbiology Spectrum Curated Collection: Advances in Molecular Epidemiology of Infectious Diseases that will discuss how these advancements have contributed to investigations of infectious disease outbreaks/epidemics, surveillance, transmission dynamics, risk factor identification, pathogenesis, and etiologic attribution of bacterial, viral, protozoan, and helminthic pathogens to a disease. Here we define "molecular epidemiology" and distinguish it from other disciplines that use many of the same molecular biology tools-taxonomy, phylogenetics, and molecular evolution of microorganisms. The Curated Collection will be spread throughout multiple issues of Microbiology Spectrum and will be divided into four general sections: (i) laboratory methods used to strain type microbial pathogens, (ii) methods used to analyze genotyping data, (iii) examples of molecular epidemiologic investigations of bacterial, viral, and parasitic diseases, and (iv) applications of molecular epidemiology to address new research questions in communicable and noncommunicable diseases. The major theme of this Curated Collection is to address the following question frequently asked by clinicians, clinical microbiologists, and public health professionals: what is the advantage or unique contribution of molecular epidemiology in solving infectious disease problems in the clinical and public health arenas? *This article is part of a curated collection.
C1 [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Blanton, Ronald E.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.
RP Riley, LW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM lwriley@berkeley.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI121330]
CR Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004
   BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601
   Blaser M. J, 2014, MISSING MICROBES OVE
   Brandt Lawrence J, 2012, Gastroenterol Hepatol (N Y), V8, P191
   Brock Thomas D., 1988, R KOCH LIFE MED BACT
   CALDWELL GG, 1990, AM J EPIDEMIOL, V132, pS43
   CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   ELWELL LP, 1978, ANTIMICROB AGENTS CH, V13, P312, DOI 10.1128/AAC.13.2.312
   Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Francis SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160201
   Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151
   Harrison L, 1993, INFECT DIS, DOI [10.1016/B978-0-08-092566-0.50016-1, DOI 10.1016/B978-0-08-092566-0.50016-1]
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hitchens AP, 1939, J BACTERIOL, V37, P485, DOI 10.1128/JB.37.5.485-493.1939
   HUANG ES, 1980, NEW ENGL J MED, V303, P958, DOI 10.1056/NEJM198010233031702
   KHOURY MJ, 1993, FUNDAMENTALS GENETIC
   Lopes JS, 2013, INFECT GENET EVOL, V18, P238, DOI 10.1016/j.meegid.2013.04.028
   LUCKEY TD, 1972, AM J CLIN NUTR, V25, P1292
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mausner JS, 1974, EPIDEMIOLOGY INTRO T
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256
   [Anonymous], 2000, MMWR Recomm Rep, V49, P1
   Riley Lee W, 2013, Front Public Health, V1, P69, DOI 10.3389/fpubh.2013.00069
   Riley LW., 2004, MOL EPIDEMIOLOGY INF, DOI [10.1128/9781555817688, DOI 10.1128/9781555817688]
   Ritacco V, 2012, INFECT GENET EVOL, V12, P711, DOI 10.1016/j.meegid.2011.06.006
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   SADOWSKI PL, 1979, ANTIMICROB AGENTS CH, V15, P616, DOI 10.1128/AAC.15.4.616
   Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   SCHABERG DR, 1981, J CLIN MICROBIOL, V13, P1105, DOI 10.1128/JCM.13.6.1105-1108.1981
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Singh A, 2006, CLIN MICROBIOL REV, V19, P512, DOI 10.1128/CMR.00025-05
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Thun MJ, 2004, CA-CANCER J CLIN, V54, P273, DOI 10.3322/canjclin.54.5.273
   TOMPKINS LS, 1980, J INFECT DIS, V141, P625, DOI 10.1093/infdis/141.5.625
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190
   Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763
NR 47
TC 1
Z9 1
U1 1
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD NOV
PY 2018
VL 6
IS 6
AR UNSP AME-0001-2018
DI 10.1128/microbiolspec.AME-0001-2018
PG 12
WC Microbiology
SC Microbiology
GA HF3BC
UT WOS:000454109500001
PM 30387413
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Reid, S
   Rimmer, K
   Thakur, K
AF Reid, Savina
   Rimmer, Kathryn
   Thakur, Kiran
TI Zika Virus and Neurologic Disease
SO NEUROLOGIC CLINICS
LA English
DT Article
DE Zika virus; Neurologic manifestations of Zika virus; Congenital Zika
   syndrome; Guillain-Barre syndrome
ID GUILLAIN-BARRE-SYNDROME; UPDATE INTERIM GUIDANCE; CASE SERIES;
   UNITED-STATES; PUERTO-RICO; INFECTION; TRANSMISSION; COLOMBIA; OUTBREAK;
   INFANTS
AB Zika virus (ZIKV) is an arthropod-borne virus that belongs to the Flaviviridae family. Although most cases are mild or go undetected, rare severe neurologic effects, including congenital ZIKV syndrome (CZS) and Guillain-Barre syndrome, have been identified. The serious neurologic complications associated with ZIKV prompted the declaration of the public health emergency of international concern by the World Health Organization. Overall, transmission occurred throughout South and Central America as well as the Caribbean, affecting 48 countries and territories from March 2015 to March 2017. Long-term management of CZS requires a comprehensive combination of supportive services throughout early development.
C1 [Reid, Savina; Rimmer, Kathryn] Columbia Univ, Med Ctr, Dept Neurol, 177 Ft Washington Ave,8GS-300, New York, NY 10032 USA.
   [Thakur, Kiran] Columbia Univ, Med Ctr, Dept Neurol, Div Crit Care & Hospitalist Neurol,Milstein Hosp, 177 Ft Washington Ave,8G5-300, New York, NY 10032 USA.
RP Thakur, K (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, Div Crit Care & Hospitalist Neurol,Milstein Hosp, 177 Ft Washington Ave,8G5-300, New York, NY 10032 USA.
EM ktt2115@cumc.columbia.edu
OI Rimmer, Kathryn/0000-0001-7900-5215
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2017, DIAGNOSTIC TESTS ZIK
   [Anonymous], 2017, CLIN GUIDANCE HEALTH
   [Anonymous], 2016, 1 FEMALE TO MALE SEX
   [Anonymous], 2016, ASSESSMENT MANAGEMEN
   [Anonymous], 2017, TESTING GUIDANCE
   [Anonymous], 2017, CDC ANAL DATA US TER
   [Anonymous], 2017, 1 10 US PREGNANT WOM
   [Anonymous], 2016, GUILLAIN BARRE SYNDR
   [Anonymous], 2017, OUTCOMES PREGNANCIES
   [Anonymous], 2017, ITAL SIGNS UPDATE ZI
   [Anonymous], 2017, UPDATE INTERIM GUIDA
   [Anonymous], 2017, REGIONAL ZIKA EPIDEM
   [Anonymous], 2017, RAPID MOL DETECTION
   [Anonymous], 2017, SITUATION REPORT ZIK
   [Anonymous], 2016, ZIKA ORIGIN SPREAD M
   [Anonymous], 2017, CONGENITAL ZIKA SYND
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Belfort R, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1305
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castro M, 2017, AM J TROP MED HYG, V97, P311, DOI 10.4269/ajtmh.16-0906
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, PREGN WOM
   Centers for Disease Control and Prevetion-CDC, 2017, UPD GUID US LAB TEST
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cohen J, 2017, DENGUE MAY BRING OUT
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   De Broucker T, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0590-9
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Joob B, 2018, CHILD NERV SYST, V34, P183, DOI 10.1007/s00381-017-3656-y
   Juca E, 2018, CHILD NERV SYST, V34, P185, DOI 10.1007/s00381-017-3683-8
   Juca E, 2018, CHILD NERV SYST, V34, P101, DOI 10.1007/s00381-017-3636-2
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Mailand MT, 2017, J NEUROL, V264, P1035, DOI 10.1007/s00415-016-8263-4
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nicastri E., 2016, EURO SURVEILL, V21
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2016, TIM EM ZIK VIR AM
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prevention ECfD Control, 2014, RAP RISK ASS ZIK VIR
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Roth W, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000349
   Roza B, 2016, EURO SURVEILL, V21
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2017, ZIK VIR
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 112
TC 2
Z9 2
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0733-8619
EI 1557-9875
J9 NEUROL CLIN
JI Neurol. Clin.
PD NOV
PY 2018
VL 36
IS 4
BP 767
EP +
DI 10.1016/j.ncl.2018.06.003
PG 22
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HE4NF
UT WOS:000453342900007
PM 30366554
DA 2020-07-08
ER

PT J
AU Poveda-Cuevas, SA
   Etchebest, C
   da Silva, FLB
AF Poveda-Cuevas, Sergio A.
   Etchebest, Catherine
   Barroso da Silva, Fernando L.
TI Insights into the ZIKV NS1 Virology from Different Strains through a
   Fine Analysis of Physicochemical Properties
SO ACS OMEGA
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; DENGUE VIRUS; MEMBRANE ASSOCIATION;
   STRUCTURAL BIOLOGY; ELECTROSTATICS; GLYCOPROTEIN; COMPLEXATION;
   DATABASE; SPREAD
AB The flavivirus genus has several organisms responsible for generating various diseases in humans. Recently, especially in tropical regions, Zika virus (ZIKV) has raised great health concerns due to the high number of cases affecting the area during the last years that has been accompanied by a rise in the cases of the Guillain-Barre syndrome and fetal and neonatal microcephaly. Diagnosis is still difficult since the clinical symptoms between ZIKV and other flaviviruses (e.g., dengue and yellow fever) are highly similar. The understanding of their common physicochemical properties that are pH-dependent and biomolecular interaction features and their differences sheds light on the relation strain-virulence and might suggest alternative strategies toward differential serological diagnostics and therapeutic intervention. Due to their immunogenicity, the primary focus of this study was on the ZIKV nonstructural proteins 1 (NS1). By means of computational studies and semiquantitative theoretical analyses, we calculated the main physicochemical properties of this protein from different strains that are directly responsible for the biomolecular interactions and, therefore, can be related to the differential infectivity of the strains. We also mapped the electrostatic differences at both the sequence and structural levels for the strains from Uganda to Brazil, which could suggest possible molecular mechanisms for the increase of the virulence of ZIKV in Brazil. Exploring the interfaces used by NS1 to self-associate in some different oligomeric states and interact with membranes and the antibody, we could map the strategy used by the ZIKV during its evolutionary process. This indicates possible molecular mechanisms that can be correlated with the different immunological responses. By comparing with the known antibody structure available for the West Nile virus, we demonstrated that this antibody would have difficulties to neutralize the NS1 from the Brazilian strain. The present study also opens up perspectives to computationally design high-specificity antibodies.
C1 [Poveda-Cuevas, Sergio A.; Barroso da Silva, Fernando L.] Univ Sao Paulo, Programa Interunidades Bioinformat, BR-05508090 Sao Paulo, Brazil.
   [Poveda-Cuevas, Sergio A.; Barroso da Silva, Fernando L.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Fis & Quim, BR-14040903 Ribeirao Preto, SP, Brazil.
   [Etchebest, Catherine] Inst Natl Transfus Sanguine, F-75015 Paris, France.
   [Etchebest, Catherine] INSERM, UMR S 1134, Dynam Struct & Interact Mol, Biol Integree Globule Rouge,Equipe 2, F-75015 Paris, France.
   [Etchebest, Catherine] Univ Sorbonne Paris Cite, F-75013 Paris, France.
   [Etchebest, Catherine] Univ Paris Diderot, F-75013 Paris, France.
   [Poveda-Cuevas, Sergio A.; Etchebest, Catherine; Barroso da Silva, Fernando L.] Univ Sao Paulo & Univ Sorbonne Paris Cite Joint I, Sao Paulo, Brazil.
   [Barroso da Silva, Fernando L.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27606 USA.
RP da Silva, FLB (corresponding author), Univ Sao Paulo, Programa Interunidades Bioinformat, BR-05508090 Sao Paulo, Brazil.; da Silva, FLB (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Fis & Quim, BR-14040903 Ribeirao Preto, SP, Brazil.; da Silva, FLB (corresponding author), Univ Sao Paulo & Univ Sorbonne Paris Cite Joint I, Sao Paulo, Brazil.; da Silva, FLB (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27606 USA.
EM flbarroso@usp.br
RI etchebest, catherine/O-2485-2019; da Silva, Fernando Luis
   Barroso/B-9532-2009
OI etchebest, catherine/0000-0002-5871-2372; da Silva, Fernando Luis
   Barroso/0000-0003-2526-2085
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [Fapesp 2015/16116-3];
   "Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior"-CAPESCAPES; University of Sao Paulo (USP) through the
   NAP-CatSinQ (Research Core in Catalysis and Chemical Synthesis)
FX This work has been supported in part by the "Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo" [Fapesp 2015/16116-3 (F.L.B.d.S.)] and
   the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES
   (S.A.P.-C.). F.L.B.d.S. and S.A.P.-C. acknowledge the support of the
   University of Sao Paulo (USP) through the NAP-CatSinQ (Research Core in
   Catalysis and Chemical Synthesis) and the computing hours at Rice
   University through the international collaboration program with USP.
   F.L.B.d.S. and C.E. acknowledge the mobility support from the joint
   Universite Sorbonne Paris Cite-USP Research program.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   AssadiPorter FM, 1995, BIOCHEMISTRY-US, V34, P16186, DOI 10.1021/bi00049a034
   Barroso da Silva Fernando Luis, 2017, Biophysical Reviews, V9, P699, DOI 10.1007/s12551-017-0311-5
   da Silva FLB, 2017, J CHEM THEORY COMPUT, V13, P2915, DOI 10.1021/acs.jctc.6b01114
   da Silva FLB, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4972986
   da Silva FLB, 2016, SOFT MATTER, V12, P5600, DOI 10.1039/c6sm00860g
   da Silva FLB, 2014, LANGMUIR, V30, P4078, DOI 10.1021/la500027f
   da Silva FLB, 2009, SOFT MATTER, V5, P2862, DOI 10.1039/b902039j
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bozic AL, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5037044
   Bozic AL, 2017, BIOPHYS J, V113, P1454, DOI 10.1016/j.bpj.2017.08.017
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chaudhury Sidhartha, 2015, Biochem Biophys Rep, V4, P375, DOI 10.1016/j.bbrep.2015.10.014
   Chen CR, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0531-2
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Darre L, 2015, J CHEM THEORY COMPUT, V11, P723, DOI 10.1021/ct5007746
   de Carvalho SJ, 2006, J PHYS CHEM B, V110, P8832, DOI 10.1021/jp054891e
   Delboni LA, 2016, FOOD HYDROCOLLOID, V55, P89, DOI 10.1016/j.foodhyd.2015.11.010
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   ESWAR N, 2006, CURR PROTOC BIOINFOR, pCH5, DOI DOI 10.1002/0471250953.BI0506S15
   FALCONAR AKI, 1990, J VIROL METHODS, V30, P323, DOI 10.1016/0166-0934(90)90075-Q
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Figueiredo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07865
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hernando-Perez M, 2015, NANOSCALE, V7, P17289, DOI 10.1039/c5nr04274g
   Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201
   Jonsson B, 2007, ROY SOC CH, P129, DOI 10.1039/9781847557698-00127
   KAPLAN H, 1971, BIOCHEM J, V124, P289, DOI 10.1042/bj1240289
   Kjellander R, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/49/494209
   Knipe D. M., 2014, FIELDS VIROLOGY
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   LINDENBACH BD, 2007, FIELDS VIROLOGY
   Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703
   Lund M, 2005, LANGMUIR, V21, P8385, DOI 10.1021/la050607z
   Lund M, 2003, BIOPHYS J, V85, P2940, DOI 10.1016/S0006-3495(03)74714-6
   Lund M, 2006, ELECT INTERACTIONS B
   Lund M, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-1
   McQuarrie D. A., 1976, STAT MECH
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Duran NM, 2018, INT J BIOL MACROMOL, V107, P949, DOI 10.1016/j.ijbiomac.2017.09.076
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   NOZAKI Y, 1967, METHOD ENZYMOL, V11, P715, DOI DOI 10.1016/S0076-6879(67)11088-4
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PHILLIES GD, 1974, J CHEM PHYS, V60, P2721, DOI 10.1063/1.1681434
   Prakash MK, 2010, BIOPHYS J, V99, P588, DOI 10.1016/j.bpj.2010.04.024
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Teixeira AAR, 2010, J CHEM THEORY COMPUT, V6, P3259, DOI 10.1021/ct1003093
   Rocha LB, 2017, ANTIBODIES, V6, DOI 10.3390/antib6040014
   Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Srivastava D, 2017, LANGMUIR, V33, P11417, DOI 10.1021/acs.langmuir.7b02271
   Striolo A, 2002, J CHEM PHYS, V116, P7733, DOI 10.1063/1.1467343
   Talero-Gutierrez C, 2018, EPIDEMIOL INFECT, V146, P673, DOI 10.1017/S0950268818000419
   Tavares FW, 2004, J CHEM PHYS, V120, P9859, DOI 10.1063/1.1697387
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zeidler JD, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030042
NR 81
TC 2
Z9 2
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD NOV
PY 2018
VL 3
IS 11
BP 16212
EP 16229
DI 10.1021/acsomega.8b02081
PG 18
WC Chemistry, Multidisciplinary
SC Chemistry
GA HC7PB
UT WOS:000451992500181
PM 31458257
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alayed, MS
   Qureshi, MA
   Ahmed, S
   Alqahtani, AS
   Al-qahtani, AM
   Alshaybari, K
   Alshahrani, M
   Asaad, AM
AF Alayed, Mohammed S.
   Qureshi, Mohamed A.
   Ahmed, Saif
   Alqahtani, Ali S.
   Al-qahtani, Awad M.
   Alshaybari, Khalid
   Alshahrani, Majed
   Asaad, Ahmed M.
TI Seroprevalence of Zika virus among asymptomatic pregnant mothers and
   their newborns in the Najran region of southwest Saudi Arabia
SO ANNALS OF SAUDI MEDICINE
LA English
DT Article
ID CROSS-REACTIVITY; DENGUE; CHIKUNGUNYA; INFECTION; DIAGNOSIS; VIREMIA
AB BACKGROUND: Zika virus (ZIKV) is a teratogenic flavivirus that can cause microcephaly. Its main vector, Aedes aegypti, has been previously identified in Saudi Arabia, but no ZIKV infection has yet been reported. Nevertheless, the country is at risk from ZIKV because it receives many travelers throughout the year, including pilgrims from ZIKV-endemic countries.
   OBJECTIVES: Screen asymptomatic pregnant mothers and their newborns attending a major hospital in the Najran region for subclinical or past infections with ZIKV, using ELISA and RT-PCR.
   DESIGN: Cross-sectional.
   SETTING: Najran Maternity and Children Hospital (NMCH).
   SUBJECTS AND METHODS: All pregnant women admitted to NMCH in labor between November 2016 and July 2017 were included in the study. Clinical and demographic data were collected by pre-validated physician-administered questionnaires. Paired umbilical and maternal serum samples were collected and frozen at -60 degrees C, using ELISA to measure anti-ZIKA IgG and IgM antibodies and RT-PCR to further investigate positive samples.
   MAIN OUTCOME MEASURES: Maternal and newborn serum anti-ZIKV IgM and IgG and ZIKV RT-PCR.
   SAMPLE SIZE: 410 mother-newborn pairs.
   RESULTS: The median gestational age was 38.5 weeks (range 33-42). Most (n=342, 83.41%) of the women were from Najran city. All of the newborns had normal growth parameters with no congenital malformations. None of the mothers had symptoms suggestive of ZIKV infection; 3 (0.7%) exhibited a low-grade fever (38 degrees C), but did not test positive for anti-ZIKV antibodies. Thirty-five (8.53%) of mothers had travelled inside Saudi Arabia, but none outside the country. Twenty-four (5.85%) mothers tested positive for anti-ZIKV IgM and 52 (12.68%) tested positive for anti-ZIKV IgG, but all infant samples were negative. All seropositive ZIKV IgM were also ZIKV IgG positive, but RT-PCR testing of all seropositive samples was negative.
   CONCLUSION: Although previous (resolved) ZIKV infection and cross-reactivity of the ELISA method with other flaviviruses cannot be excluded, the study found no confirmed cases of acute ZIKV infection. However, given the presence of the vector in Saudi Arabia, the presence of presumptive positive serology and the ongoing risk of ZIKV entry via a regular influx of travelers from endemic areas, we propose that continuous surveillance be conducted for ZIKV as well for other flaviviruses. Larger-scale nationwide studies are strongly recommended to gain a broader view of the potential threat from ZIKV in the country.
C1 [Alayed, Mohammed S.; Alshaybari, Khalid] Najran Univ, Coll Med, Dept Pediat, Najran 1988, Saudi Arabia.
   [Qureshi, Mohamed A.] Najran Univ, Coll Med, Dept Microbiol, Najran, Saudi Arabia.
   [Ahmed, Saif; Alqahtani, Ali S.] Najran Univ, Coll Appl Med Sci, Dept Med Lab Sci, Najran, Saudi Arabia.
   [Al-qahtani, Awad M.] Najran Univ, Dept Family & Community Med, Najran, Saudi Arabia.
   [Alshahrani, Majed] Najran Univ, Coll Med, Dept Obstet & Gynecol, Najran, Saudi Arabia.
   [Asaad, Ahmed M.] Zagazig Univ, Coll Med, Dept Microbiol, Zagazig, Egypt.
RP Alayed, MS (corresponding author), Najran Univ, Coll Med, Dept Pediat, Najran 1988, Saudi Arabia.
EM drmza-yed2000@yahoo.com
RI Asaad, Ahmed Morad/P-1650-2018; amsalu, ribka/G-8780-2019; Alayed,
   Mohammed/AAI-5057-2020; Sadeq, Khaled/N-3461-2017
OI Asaad, Ahmed Morad/0000-0002-1422-1117; Alqahtani, Ali
   S./0000-0002-5923-371X; Sadeq, Khaled/0000-0001-8578-0824; AlAyed,
   Mohammed/0000-0002-1696-9145
CR Al-Abdely HM, 2016, SAUDI MED J, V37, P831, DOI 10.15537/smj.2016.8.15676
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Al-Saeed MS, 2017, J MED VIROL, V89, P1339, DOI 10.1002/jmv.24785
   Aziz A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0487-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Casale TB, 2018, J ALLERGY CLIN IMMUN, V141, P482, DOI 10.1016/j.jaci.2017.11.029
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Hakami WS, 2011, SAUDI MED J, V32, P1137
   Hussain R, 2013, E MEDITERR HEALTH J, V19, P506
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Zayed MS, 2014, CONSANGUINEOUS MARRI, V76, P155
NR 17
TC 2
Z9 2
U1 0
U2 1
PU K FAISAL SPEC HOSP RES CENTRE
PI RIYADH
PA PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
SN 0256-4947
EI 1319-9226
J9 ANN SAUDI MED
JI Ann. Saudi Med.
PD NOV-DEC
PY 2018
VL 38
IS 6
BP 408
EP 412
DI 10.5144/0256-4947.2018.408
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA HD3AW
UT WOS:000452385200003
PM 30531174
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia-Nicolas, O
   V'kovski, P
   Vielle, NJ
   Ebert, N
   Zust, R
   Portmann, J
   Stalder, H
   Gaschen, V
   Vieyres, G
   Stoffel, M
   Schweizer, M
   Summerfield, A
   Engler, O
   Pietschmann, T
   Todt, D
   Alves, MP
   Thiel, V
   Pfaender, S
AF Garcia-Nicolas, Obdulio
   V'kovski, Philip
   Vielle, Nathalie J.
   Ebert, Nadine
   Zust, Roland
   Portmann, Jasmine
   Stalder, Hanspeter
   Gaschen, Veronique
   Vieyres, Gabrielle
   Stoffel, Michael
   Schweizer, Matthias
   Summerfield, Artur
   Engler, Olivier
   Pietschmann, Thomas
   Todt, Daniel
   Alves, Marco P.
   Thiel, Volker
   Pfaender, Stephanie
TI The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity
   against Different Members of the Family Flaviviridae and Offers
   Potential as a Panviral Inhibitor
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE flavivirus; pestivirus; hepacivirus; K22; antiviral; panviral inhibitor;
   Flaviviridae
ID HEPATITIS-C; REPLICATION FACTORIES; VIRUS-INFECTION; ZIKA VIRUS; RNA;
   ENCEPHALITIS; INTERFERON; RIBAVIRIN; EMERGENCE; VACCINES
AB The virus family Flaviviridae encompasses several viruses, including (re)emerging viruses which cause widespread morbidity and mortality throughout the world. Members of this virus family are positive-strand RNA viruses and replicate their genome in close association with reorganized intracellular host cell membrane compartments. This evolutionarily conserved strategy facilitates efficient viral genome replication and contributes to evasion from host cell cytosolic defense mechanisms. We have previously described the identification of a small-compound inhibitor, K22, which exerts a potent antiviral activity against a broad range of coronaviruses by targeting membrane-bound viral RNA replication. To analyze the antiviral spectrum of this inhibitor, we assessed the inhibitory potential of K22 against several members of the Flaviviridae family, including the reemerging Zika virus (ZIKV). We show that ZIKV is strongly affected by K22. Time-of-addition experiments revealed that K22 acts during a postentry phase of the ZIKV life cycle, and combination regimens of K22 together with ribavirin (RBV) or interferon alpha (IFN-a) further increased the extent of viral inhibition. Ultrastructural electron microscopy studies revealed severe alterations of ZIKV-induced intracellular replication compartments upon infection of K22-treated cells. Importantly, the antiviral activity of K22 was demonstrated against several other members of the Flaviviridae family. It is tempting to speculate that K22 exerts its broad antiviral activity against several positive-strand RNA viruses via a similar mechanism and thereby represents an attractive candidate for development as a panviral inhibitor.
C1 [Garcia-Nicolas, Obdulio; V'kovski, Philip; Vielle, Nathalie J.; Ebert, Nadine; Portmann, Jasmine; Stalder, Hanspeter; Schweizer, Matthias; Summerfield, Artur; Alves, Marco P.; Thiel, Volker; Pfaender, Stephanie] Inst Virol & Immunol, Bern, Switzerland.
   [Garcia-Nicolas, Obdulio; V'kovski, Philip; Vielle, Nathalie J.; Ebert, Nadine; Portmann, Jasmine; Stalder, Hanspeter; Schweizer, Matthias; Summerfield, Artur; Alves, Marco P.; Thiel, Volker; Pfaender, Stephanie] Inst Virol & Immunol, Mittelhausern, Switzerland.
   [Garcia-Nicolas, Obdulio; V'kovski, Philip; Vielle, Nathalie J.; Ebert, Nadine; Portmann, Jasmine; Stalder, Hanspeter; Schweizer, Matthias; Summerfield, Artur; Alves, Marco P.; Thiel, Volker; Pfaender, Stephanie] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [V'kovski, Philip; Vielle, Nathalie J.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
   [Zust, Roland; Engler, Olivier] Spiez Lab, Spiez, Switzerland.
   [Gaschen, Veronique; Stoffel, Michael] Univ Bern, Vetsuisse Fac, Dept Clin Res, Div Vet Anat, Bern, Switzerland.
   [Vieyres, Gabrielle; Pietschmann, Thomas] Twincore Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany.
   [Todt, Daniel] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany.
RP Thiel, V; Pfaender, S (corresponding author), Inst Virol & Immunol, Bern, Switzerland.; Thiel, V; Pfaender, S (corresponding author), Inst Virol & Immunol, Mittelhausern, Switzerland.; Thiel, V; Pfaender, S (corresponding author), Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
EM volker.thle@vetsuisse.unlbe.ch; stephanie.pfaender@vetsuisse.unibech
RI Stoffel, Michael Hubert/I-6939-2015; Thiel, Volker/AAI-2391-2019;
   Summerfield, Artur/H-6025-2019; Todt, Daniel/W-9362-2019
OI Stoffel, Michael Hubert/0000-0002-4699-5125; Summerfield,
   Artur/0000-0001-8292-4634; Todt, Daniel/0000-0002-3564-1014; V'kovski,
   Philip/0000-0002-8366-1220; Pfaender, Stephanie/0000-0002-3957-5448;
   Thiel, Volker/0000-0002-5783-0887
FU European Union's Seventh Framework Program for Research, Technological
   Development and DemonstrationEuropean Union (EU) [278433-PREDEMICS];
   European Union's Horizon 2020 Research and Innovation Program [734548
   ZIKAlliance]; Helmholtz Alberta Initiative for Infectious Disease
   Research (HAI-IDR); Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [165076, 173085]; European Union's Horizon
   2020 Research and Innovation Program under Marie Sklodowska-Curie grant
   [748627]
FX O.G.-N. and A.S. were supported by the European Union's Seventh
   Framework Program for Research, Technological Development and
   Demonstration under grant agreement no. 278433-PREDEMICS. N.J.V., A.S.,
   and M.P.A. were funded by the European Union's Horizon 2020 Research and
   Innovation Program under grant no. 734548 ZIKAlliance. T.P. was
   supported by the Helmholtz Alberta Initiative for Infectious Disease
   Research (HAI-IDR). V.T., P.V., and N.E. were supported by a grant from
   the Swiss National Science Foundation (SNF numbers 165076 and 173085).
   S.P. was supported by the European Union's Horizon 2020 Research and
   Innovation Program under Marie Sklodowska-Curie grant agreement no.
   748627.
CR Angelini MM, 2013, MBIO, V4, DOI 10.1128/mBio.00524-13
   Braun U, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1472-6
   Chou T, 2005, COMPUTER PROGRAM QUA
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   de Oliveira AMA, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00287-13
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haid S, 2010, J VIROL, V84, P964, DOI 10.1128/JVI.01504-09
   Hartlage AS, 2016, ANNU REV VIROL, V3, P53, DOI 10.1146/annurev-virology-100114-055104
   Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4
   ICTV, 2017, VIR TAX 2017 REL
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kaiser V, 2017, BMC VET RES, V13, DOI 10.1186/s12917-016-0932-0
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lundin A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004166
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6
   Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Neufeldt CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005428
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pawlotsky JM, 2015, HEPATOLOGY, V62, P1013, DOI 10.1002/hep.27960
   Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006
   Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103
   Rappe JCF, 2018, VIRUS RES, V246, P28, DOI 10.1016/j.virusres.2018.01.002
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Schatz G, 2013, CELLS TISSUES ORGANS, V198, P457, DOI 10.1159/000360155
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schweizer M, 2014, ANNU REV ANIM BIOSCI, V2, P141, DOI 10.1146/annurev-animal-022513-114209
   Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0
   Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08
   Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342
NR 44
TC 3
Z9 3
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD NOV
PY 2018
VL 62
IS 11
AR e01206-18
DI 10.1128/AAC.01206-18
PG 17
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA GY0ET
UT WOS:000448186900043
PM 30181371
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Mehand, MS
   Al-Shorbaji, F
   Millett, P
   Murgue, B
AF Mehand, Massinissa Si
   Al-Shorbaji, Farah
   Millett, Piers
   Murgue, Bernadette
TI The WHO R&D Blueprint: 2018 review of emerging infectious diseases
   requiring urgent research and development efforts
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Severe emerging infectious diseases; Prioritization; Multi-criteria
   decision analysis; Experts' opinions; Multidisciplinary method
ID CRITERIA DECISION-ANALYSIS; PRACTICES TASK-FORCE
AB The Research and Development (R&D) Blueprint is a World Health Organization initiative to reduce the time between the declaration of a public health emergency and the availability of effective diagnostic tests, vaccines, and treatments that can save lives and avert a public health crisis. The scope of the Blueprint extends to severe emerging diseases for which there are insufficient or no presently existing medical countermeasures or pipelines to produce them. In February 2018, WHO held an informal expert consultation to review and update the list of priority diseases, employing a prioritization methodology which uses the Delphi technique, questionnaires, multi-criteria decision analysis, and expert review to identify relevant diseases. The committee determined that, given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated R&D for (in no order of priority) Crimean-Congo haemorrhagic fever, Ebola virus and Marburg virus disease, Lassa fever, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), Nipah and henipaviral diseases, Rift Valley fever and Zika virus disease. The experts also included "Disease X," representing the awareness that a previously unknown pathogen could cause a major public health emergency. This report describes the methods and results of the 2018 prioritization review.
C1 [Mehand, Massinissa Si; Al-Shorbaji, Farah; Murgue, Bernadette] WHO, Geneva, Switzerland.
   [Millett, Piers] Univ Oxford, Future Humanity Inst, Oxford, England.
RP Mehand, MS (corresponding author), WHO, Geneva, Switzerland.
EM simehandm@who.int
OI , Farah/0000-0002-3517-2457
FU UK Department for International Development
FX WHO is grateful to UK Department for International Development for
   financing this work and for members of the Prioritization Committee: Dr
   David Brett-Major, Dr Miles Carroll, Dr Gail Carson, Dr Inger Damon, Dr
   Peter Daszak, Dr Xavier De Lamballerie, Dr Christian Drosten, Dr Souha S
   Kanj, Dr Nadia Khellef, Dr Albert Icksang Ko, Dr Gary Kobinger, Dr
   Hilary Marston, Dr Stefano Messori, Dr Devendra Mourya, Dr Peninah
   Munyua, Dr Joshua Obasanya, Dr Janusz Paweska, Dr Chantal Reusken, Dr.
   Alfonso Rodriguez-Morales, Dr Pierre Rollin, Dr Cathy Roth, Dr Muhammad
   Salman, Dr Pedro Vasconcelos, Dr Supaporn Wacharapluesadee, Dr Jimmy
   Whitworth, Dr Annie Wilkinson, Dr Melissa Willis, Dr Yazdan Yazdanpanah,
   Dr Herve Zeller for their time and input, and especially to Dr David
   Brett-Major, Dr Martine Denis, Dr Christian Drosten, Dr Peter Horby, Dr
   Xavier de Lamballerie, Dr Stefano Messori, Dr Alfonso Javier Rodriguez
   Morales, Dr Munyua Peninah, Dr Pedro Vasconcelo, Dr Herve Zeller, and Dr
   Jee Youngmee for compiling the background information on the candidate
   pathogens.
CR Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016
   Mehand Massinissa Si, 2018, Emerg Infect Dis, V24, DOI 10.3201/eid2409.171427
   Thokala P, 2016, VALUE HEALTH, V19, P1, DOI 10.1016/j.jval.2015.12.003
   WHO, 2016, REV WHO R D BLUEPR P
   WHO, 2015, 2015 WHO R BLUEPR PR
   World Health Organization, 2017, ANN REV DIS PRIOR RE
   World Health Organization, 2016, R D BLUEPR ACT PREV
   World Health Organization, 2017, METH PRIOR SEV EM DI
NR 8
TC 26
Z9 28
U1 5
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD NOV
PY 2018
VL 159
BP 63
EP 67
DI 10.1016/j.antiviral.2018.09.009
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GZ1MR
UT WOS:000449132700007
PM 30261226
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Chaw, LL
   Tuah, NAA
   Wong, JYY
   Naing, L
AF Chaw, Li Ling
   Tuah, Nik A. A.
   Wong, Justin Yun Yaw
   Naing, Lin
TI Knowledge, attitudes and practice survey on Zika virus infection among
   pregnant women in Brunei Darussalam
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Knowledge; Attitudes; Practices; Zika virus; Pregnant women; Brunei
ID OUTBREAK
AB Objective: To assess the knowledge, attitudes, and practices (KAP) on Zika virus infection among pregnant women in Brunei Darussalam by a cross-sectional survey. Methods: Between February and June 2017, we recruited 234 pregnant women from all government healthcare centres at Brunei-Muara district, using a modified systematic sampling approach. A pre-tested and self-administered questionnaire was used and data analysis was conducted using descriptive statistics and multiple logistic regression analyses. Results: The study participants were mainly Malay (87.2%) and their mean age was 28.0 years. The median knowledge score was 13, out of a possible score of 28. Most participants (92.7%) knew that Zika virus was transmitted by mosquito bites whereas some (34.6%) knew that sexual transmission was also possible. Media (radio, television or newspapers) was the preferred source of updated information on Zika virus, followed by healthcare workers (44.0%), government announcements (43.2%), and social media (38.0%). Pregnant women who were 25 years old or older [Adj. OR=3.62 (95% CI: 1.57, 9.51)], not Malays [Adj. OR=3.32 (95% CI: 1.35, 8.55)], and had an average monthly household income of more than BND $3 000 [Adj. OR=4.06 (95% CI: 1.81, 19.44)] were more likely to score higher for knowledge on Zika virus. The median prevention practice score was 23, out of a possible score of 36. Most participants reported wearing covering clothes (98.3%) and kept their living surroundings clean (99.6%). Most participants (88.0%) agreed that Zika is an important issue in their community. Conclusion: We found a lack of knowledge on Zika virus infection among pregnant women attending government maternal and child healthcare centres in Brunei Darussalam, in particular that Zika virus can be sexually transmitted. Such information could be well disseminated at the healthcare centre level. Health literacy studies should be conducted to understand the facilitators and barriers of KAP on Zika virus infection among pregnant women.
C1 [Chaw, Li Ling; Tuah, Nik A. A.; Naing, Lin] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link BE1410, Brunei.
   [Tuah, Nik A. A.] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.
   [Wong, Justin Yun Yaw] Minist Hlth, Dis Control Div, Bandar Seri Begawan, Brunei.
RP Chaw, LL (corresponding author), Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Biostat Publ Heal, Jalan Tungku Link BE1410, Brunei.
EM liling.chaw@ubd.edu.bn
RI Chaw, Liling/R-1591-2019
OI Chaw, Liling/0000-0003-3301-7565; Tuah, Nik/0000-0002-7149-4349
CR [Anonymous], 2016, DEPUTY SULTAN URGE W
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Besnard M, 2014, EURO SURVEILL, V19
   Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Ellingson MK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1516-0
   Grimes HA, 2014, MIDWIFERY, V30, pE26, DOI 10.1016/j.midw.2013.10.007
   Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z
   Heitzinger Kristen, 2018, Prev Med Rep, V10, P20, DOI 10.1016/j.pmedr.2018.01.002
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Idris FH, 2013, J VECTOR ECOL, V38, P197, DOI 10.1111/j.1948-7134.2013.12029.x
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   MACDONAL.WW, 1972, B WORLD HEALTH ORGAN, V46, P203
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   McArthur L, 2001, INT J OBESITY, V25, P1262, DOI 10.1038/sj.ijo.0801674
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Meragang National Housing Scheme Cleaning Campaign, 2016, BRUNEI NEWS GAZETTE
   Michael GC, 2017, S AFR FAM PRACT, V59, P148, DOI 10.1080/20786190.2017.1313484
   Ministry of Health Brunei Darussalam, STAY INF STAY PROT Z
   Ministry of Health Brunei Darussalam, HLTH INF BOOKL 2016
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D., 2014, EURO SURVEILL, V19
   R Core Team, 2017, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80
   Thompson Erika L, 2018, Health Lit Res Pract, V2, pe78, DOI 10.3928/24748307-20180226-01
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, ZIK VIR COMPL 2016 P
   WHO, PREV SEX TRANSM ZIK
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, KNOWL ATT PRACT SURV
NR 37
TC 2
Z9 3
U1 1
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD NOV
PY 2018
VL 11
IS 11
BP 638
EP 644
DI 10.4103/1995-7645.246340
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HD3QA
UT WOS:000452431900005
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vasic, A
   Silaghi, C
AF Vasic, Ana
   Silaghi, Cornelia
TI Driving factors for the changing epidemiology of vector-borne diseases -
   a review
SO BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT
LA English
DT Article
DE Arthropod; vectors; vector-borne diseases; epidemiology; climate change;
   Europe
ID WEST-NILE-VIRUS; AEDES-JAPONICUS-JAPONICUS; USUTU-VIRUS; MECHANICAL
   TRANSMISSION; ENCEPHALITIS-VIRUS; NEUROINVASIVE INFECTION; HUMAN
   DIROFILARIASIS; CHIKUNGUNYA VIRUS; CENTRAL-EUROPE; CLIMATE-CHANGE
AB Vector-borne diseases regularly occurred in moderate climate areas of Europe in past decades. The changing epidemiology of vector-borne diseases in Europe is caused by changes of environmental factors - amongst these climate change-and human activity (transport mobility, urbanisation, renaturation etc.). The occurrence of invasive vector species (for example the Asian tiger mosquito [Aedes albopictus] and the Asian bush mosquito [Aedes japonicus japonicus]) in new habitats pose a risk of pathogen transmission in naive host populations. On the other hand, the presence of native competent vectors and adequate habitats are sufficient for the effective spread of a pathogen as seen in the Bluetongue Virus epidemic in Europe in 2006 onwards or the spread of West Nile Virus (WNV) lineage 1 in USA in 1999. The vector-borne diseases posing threat of spread are very often of viral origin (WNV fever, Chikungunya fever, Dengue fever, Tick-borne encephalitis, Yellow fever, Japanese encephalitis), but there is also the potential for parasitic (Malaria, Dirofilariosis, Piroplasmosis and Leishmaniosis) or bacterial diseases (Tularaemia, Rickettsiosis). Recently, the fast spreading epidemic of mosquito-borne Zika virus infection implicated the need of preparedness and constant monitoring of vector-borne diseases and their vectors in order to provide fast answers to emerging disease control and prevention. In this paper, we review major driving factors for the changing epidemiology of selected vector borne diseases, provide a risk assessment for the introduction of new emerging diseases to Europe and present a new concept to face future challenges.
C1 [Vasic, Ana; Silaghi, Cornelia] Friedrich Loeffler Inst, Inst Infectol, Sudufer 10, D-17493 Greifswald, Germany.
   [Silaghi, Cornelia] Univ Zurich, Vetsuisse Fac, Inst Parasitol, Natl Ctr Vector Entomol, Zurich, Switzerland.
   [Silaghi, Cornelia] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany.
RP Silaghi, C (corresponding author), Friedrich Loeffler Inst, Inst Infectol, Sudufer 10, D-17493 Greifswald, Germany.
EM cornelia.silaghi@fli.de
FU SCOPES programme of the Swiss National Science Foundation (SNFS); Swiss
   Agency for Development and Cooperation (SDC)
FX The authors thank Alexander Mathis for comments on the manuscript. AMSAR
   project was financed by the SCOPES programme of the Swiss National
   Science Foundation (SNFS) and the Swiss Agency for Development and
   Cooperation (SDC).
CR Agianniotaki EI, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomea.00550-17, 10.1128/genomeA.00550-17]
   Anderson RC, 2000, NEMATODE PARASITES V, P650
   Auer H, 2008, WIEN KLIN WOCHENSCHR, V120, P250
   Babal P, 2008, BRATISL MED J, V109, P486
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   Balling A, 2015, BERL MUNCH TIERARZTL, V128, P297, DOI 10.2376/0005-9366-128-297
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Becker N, 2014, WARNSIGNAL KLIMA GEF
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bohm B, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1192-3
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Chihota CM, 2003, MED VET ENTOMOL, V17, P294, DOI 10.1046/j.1365-2915.2003.00445.x
   Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179
   Cielecka D, 2012, ANN AGR ENV MED, V19, P445
   Danforth ME, 2016, J MED ENTOMOL, V53, P681, DOI 10.1093/jme/tjw013
   DANIS K, 2011, EUROSURVEILLANCE, V16, P2
   de Wispelaere M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005294
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788
   Donoso Mantke O, 2011, EURO SURVEILL, V16
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   European Food Safety, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4773
   Farkas R, 2011, VECTOR-BORNE ZOONOT, V11, P823, DOI 10.1089/vbz.2010.0186
   Fortuna C, 2015, MED VET ENTOMOL, V29, P430, DOI 10.1111/mve.12133
   Frimmel S, 2014, BIOMED RES INT, DOI 10.1155/2014/308371
   Fuehrer HP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004547
   Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002
   Geier M, 1999, ENTOMOL EXP APPL, V92, P9, DOI 10.1023/A:1003797623701
   Genchi C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2434-8
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Goffredo M, 2015, VET ITAL, V51, P131, DOI 10.12834/VetIt.771.3854.1
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Hamel D, 2013, PARASITE, V20, DOI 10.1051/parasite/2013010
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Henningsson AJ, 2016, EMERG INFECT DIS, V22, P1485, DOI 10.3201/eid2208.151962
   Jansen A, 2008, PARASITOL RES, V103, pS11, DOI 10.1007/s00436-008-1049-6
   Kampen H, 2017, PARASITOL RES, V116, P3253, DOI 10.1007/s00436-017-5619-3
   Kaufmann C, 2011, MED VET ENTOMOL, V25, P32, DOI 10.1111/j.1365-2915.2010.00927.x
   Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336
   Leggewie M, 2016, ONE HEALTH, V2, P88, DOI 10.1016/j.onehlt.2016.04.001
   Luhken R, 2017, EMERG INFECT DIS, V23, P1991, DOI 10.3201/eid2312.171257
   Maroli M, 2008, TROP MED INT HEALTH, V13, P256, DOI [10.1111/j.1365-3156.2007.01998.x, 10.1111/j.1365-3156.2007.01998]
   Mateju J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1505-3
   Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7
   MELLOR PS, 1987, RES VET SCI, V43, P109, DOI 10.1016/S0034-5288(18)30753-7
   Menn B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-34
   Mettler M, 2005, BERL MUNCH TIERARZTL, V118, P37
   Michel F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010171
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MMWR, 1991, AED ALB INTRO CONT A, V40, P836
   Montarsi F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0800-y
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Obwaller AG, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1750-8
   Olaso A, 2017, ENFERM INFEC MICR CL, V35, P541, DOI [10.1016/j.eimce.2016.11.005, 10.1016/j.eimc.2016.11.003]
   Pantchev Nikola, 2011, Parasitol Res, V109 Suppl 1, pS61, DOI 10.1007/s00436-011-2403-7
   Papa A, 2010, EUROSURVEILLANCE, V15
   Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pfeffer M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-59
   Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241
   Platonov AE, 2001, ANN NY ACAD SCI, V951, P102
   Popovic N., 2013, EURO SURVEILL, V18
   Purse BV, 2006, MED VET ENTOMOL, V20, P335, DOI 10.1111/j.1365-2915.2006.00636.x
   Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Rieille N, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1136-y
   Rinker DC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0966-4
   Rushton JO, 2013, EMERG INFECT DIS, V19, P635, DOI 10.3201/eid1904.121450
   Rushton J, 2015, VET ITAL, V51, P401, DOI 10.12834/VetIt.646.3183.1
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Salat J, 2017, EMERG INFECT DIS, V23, P2065, DOI 10.3201/eid2312.170166
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Sassnau R, 2014, PARASITOL RES, V113, P3057, DOI 10.1007/s00436-014-3970-1
   Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600
   Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x
   Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142
   Schonenberger AC, 2016, MED VET ENTOMOL, V30, P39, DOI 10.1111/mve.12155
   Scott TW, 1989, ADV VIRUS RES, V37
   Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shihada S, 2017, EMERG INFECT DIS, V23, P272, DOI 10.3201/eid2302.160751
   Silaghi C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2015-x
   Sperlova A, 2011, VET MED-CZECH, V56, P430, DOI 10.17221/3206-VETMED
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Tamas B, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.72
   Tappe D, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.17.20790
   Tuppurainen E. S. M., 2015, THESIS
   Vaselek S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2386-z
   Venturi G., 2017, EURO SURVEILL, V22
   Vogels CBF, 2017, MED VET ENTOMOL, V31, P358, DOI 10.1111/mve.12251
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Vrhovec MG, 2017, PARASITOL RES, V116, pS131, DOI 10.1007/s00436-017-5499-6
   Wagner S, 2018, MED VET ENTOMOL, V32, P121, DOI 10.1111/mve.12273
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   Werner D, 2012, EUROSURVEILLANCE, V17, P14
   Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091
   Zivicnjak T, 2005, VET PARASITOL, V131, P35, DOI 10.1016/j.vetpar.2005.04.036
NR 112
TC 0
Z9 0
U1 7
U2 35
PU SCHLUETERSCHE VERLAGSGESELLSCHAFT MBH & CO KG
PI HANNOVER
PA HANS-BOCKLER-ALLEE 7, 30173 HANNOVER, GERMANY
SN 0005-9366
EI 1439-0299
J9 BERL MUNCH TIERARZTL
JI Berliner Munchener Tierarztl. Wochenschr.
PD NOV-DEC
PY 2018
VL 131
IS 11-12
BP 496
EP 505
DI 10.2376/0005-9366-18005
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA HB5NB
UT WOS:000451106400006
DA 2020-07-08
ER

PT J
AU Sasmal, SK
   Ghosh, I
   Huppert, A
   Chattopadhyay, J
AF Sasmal, Sourav Kumar
   Ghosh, Indrajit
   Huppert, Amit
   Chattopadhyay, Joydev
TI Modeling the Spread of Zika Virus in a Stage-Structured Population:
   Effect of Sexual Transmission
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Zika virus; Basic reproduction number; Vector transmission; Direct
   (sexual) transmission; Parameter inference; Sensitivity analysis
ID REPRODUCTION NUMBERS; COMPUTATION; OUTBREAK
AB The recent Zika virus outbreak has been spreading rapidly all over the world, expanding its traditionally geographical affected regions, making it a global public health hazard and endangering millions of people. One unique property of the Zika virus compared to most vector-borne diseases is the fact that the virus is transmitted both by mosquitoes and by direct sexual contact. In the present manuscript, we formulate and analyze five mathematical compartmental models of Zika transmission. We model both transmission routes (i.e., vector-borne and sexual transmission). In order to make the model more realistic, heterogeneity in the sexual transmission is modeled in several ways. We fitted the five different models to data, inferred the parameters and selected the most appropriated model, which describes the Zika outbreak in Columbia. For all the models, we estimate the reproduction numbers, namely direct (sexual) transmission, vector transmission and the basic reproduction number (R-0). The analysis revealed that the sexual transmission contribution to R-0 is highest [15.36% (95% CI 12.83-17.4)] for the model which stratifies each gender to high-risk and low-risk individuals in their sexual behavior. For this model, the estimated R-0 is 1.89 (95% CI 1.21-2.13), the direct transmission reproduction number is 0.42 (95% CI 0.290.64), and the vector transmission reproduction number is 1.51 (95% CI 1.23-1.87). The sensitivity analysis demonstrated that the value of R-0 depends on three controllable parameters: the biting rate, the sexual transmission rate and the average ratio of mosquito to human.
C1 [Sasmal, Sourav Kumar] Aoyama Gakuin Univ, Dept Math & Phys, Sagamihara, Kanagawa 2525258, Japan.
   [Ghosh, Indrajit; Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, 203 BT Rd, Kolkata 700108, India.
   [Huppert, Amit] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Biostat & Biomath Unit, Ramat Gan, Israel.
   [Huppert, Amit] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel.
RP Huppert, A (corresponding author), Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Biostat & Biomath Unit, Ramat Gan, Israel.; Huppert, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel.
EM amith@gertner.health.gov.il
OI Ghosh, Indrajit/0000-0002-0492-2948
FU Japan Society for the Promotion of Science (JSPS), Government of
   JapanMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of Science; University Grant
   Commission (UGC), Government of IndiaUniversity Grants Commission, India
FX We would like to thank the editor and two anonymous reviewers for their
   helpful comments. SKS is supported by the postdoctoral fellowship from
   Japan Society for the Promotion of Science (JSPS), Government of Japan.
   IG is supported by the research fellowship from University Grant
   Commission (UGC), Government of India. The Funders had no role in study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Abate A, 2009, AUTOMATICA, V45, P1601, DOI 10.1016/j.automatica.2009.02.028
   Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Akaike H, 1973, P 2 INT S INF THEOR, DOI DOI 10.1007/978-1-4612-1694-0_15
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Allard A, 2017, P NATL ACAD SCI USA, V114, P8969, DOI 10.1073/pnas.1703073114
   ANDERSON R M, 1991
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Castillo-Chavez C, 2002, IMA VOL MATH APPL, V125, P229
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Countrymeters, COL POP CLOCK
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gelman A., 2014, BAYESIAN DATA ANAL
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013
   Keeling M. J., 2008, MODELING INFECT DIS
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Pan American Health Organization WHO Regional Office for the Americas, 2016, ZIK CAS CONG SYNDR A
   Pan American Health Organization/World Health Organization, 2016, ZIK EP REP
   Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007
   Sardar T, 2016, VIRULENCE, V7, P187, DOI 10.1080/21505594.2015.1096470
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   Shapshak P, 2015, GLOBAL VIROLOGY I ID
   Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization (WHO), 2015, ZIK VIR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 4
Z9 4
U1 1
U2 19
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD NOV
PY 2018
VL 80
IS 11
BP 3038
EP 3067
DI 10.1007/s11538-018-0510-7
PG 30
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA GW0BN
UT WOS:000446527200011
PM 30229426
DA 2020-07-08
ER

PT J
AU Mottin, M
   Borba, JVVB
   Braga, RC
   Torres, PHM
   Martini, MC
   Proenca-Modena, JL
   Judice, CC
   Costa, FTM
   Ekins, S
   Perryman, AL
   Andrade, CH
AF Mottin, Melina
   Borba, Joyce V. V. B.
   Braga, Rodolpho C.
   Torres, Pedro H. M.
   Martini, Matheus C.
   Proenca-Modena, Jose Luiz
   Judice, Carla C.
   Costa, Fabio T. M.
   Ekins, Sean
   Perryman, Alexander L.
   Andrade, Carolina Horta
TI The A-Z of Zika drug discovery
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID VIRUS NS2B-NS3 PROTEASE; NORDIHYDROGUAIARETIC ACID NDGA; INTERFERENCE
   COMPOUNDS PAINS; SMALL-MOLECULE INHIBITORS; DEPENDENT RNA-POLYMERASE;
   INFECTION IN-VITRO; DENGUE VIRUS; BROAD-SPECTRUM; CRYSTAL-STRUCTURE;
   ANTIVIRAL ACTIVITY
AB Despite the recent outbreak of Zika virus (ZIKV), there are still no approved treatments, and early-stage compounds are probably many years away from approval. A comprehensive A-Z review of the recent advances in ZIKV drug discovery efforts is presented, highlighting drug repositioning and computationally guided compounds, including discovered viral and host cell inhibitors. Promising ZIKV molecular targets are also described and discussed, as well as targets belonging to the host cell, as new opportunities for ZIKV drug discovery. All this knowledge is not only crucial to advancing the fight against the Zika virus and other flaviviruses but also helps us prepare for the next emerging virus outbreak to which we will have to respond.
C1 [Mottin, Melina; Borba, Joyce V. V. B.; Braga, Rodolpho C.; Andrade, Carolina Horta] Univ Fed Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, BR-74605170 Goiania, Go, Brazil.
   [Torres, Pedro H. M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Torres, Pedro H. M.] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.
   [Martini, Matheus C.; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Lab Emerging Viruses LEVE, Dept Genet Evolut Microbiol & Immunol, Inst Biol, BR-13083864 Campinas, SP, Brazil.
   [Judice, Carla C.; Costa, Fabio T. M.; Andrade, Carolina Horta] Univ Estadual Campinas, Lab Trop Dis Prof Dr Luiz Jacintho da Silva, Dept Genet Evolut Microbiol & Immunol, Inst Biol, BR-13083864 Campinas, SP, Brazil.
   [Ekins, Sean] Collaborat Pharmaceut Inc, 840 Main Campus Dr,Lab 3510, Raleigh, NC 27606 USA.
   [Perryman, Alexander L.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.
RP Andrade, CH (corresponding author), Univ Fed Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, BR-74605170 Goiania, Go, Brazil.; Andrade, CH (corresponding author), Univ Estadual Campinas, Lab Trop Dis Prof Dr Luiz Jacintho da Silva, Dept Genet Evolut Microbiol & Immunol, Inst Biol, BR-13083864 Campinas, SP, Brazil.
EM carolina@ufg.br
RI Mottin, Melina/D-8700-2016; Costa, Fabio/E-1181-2012; Modena, Jose Luiz
   Proenca/C-8231-2014; Borba, Joyce V. B./S-7813-2018; Braga, Rodolpho
   C/A-9655-2011; Torres, Pedro Henrique Monteiro/C-7657-2015; Martini,
   Matheus C/E-9416-2015; Judice, Carla/P-4738-2014
OI Mottin, Melina/0000-0003-0878-9029; Costa, Fabio/0000-0001-9969-7300;
   Modena, Jose Luiz Proenca/0000-0002-4996-3153; Borba, Joyce V.
   B./0000-0002-2663-5173; Braga, Rodolpho C/0000-0003-3814-3464; Torres,
   Pedro Henrique Monteiro/0000-0002-0945-1495; Martini, Matheus
   C/0000-0003-0135-4364; Judice, Carla/0000-0003-1839-053X
FU Brazilian CNPq/FAPEG DCR [300508/2017-4]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [16/00194-8, 2017/02353-9, 2016/13805-5, 2012/16525-2]; FAPESP Visiting
   Researcher Program [2017/02353-9]; CNPqNational Council for Scientific
   and Technological Development (CNPq); L'Oreal-UNESCO-ABC Para Mulheres
   na Ciencia; L'Oreal-UNESCO International Rising Talents Program
FX This work was partially supported by the Brazilian CNPq/FAPEG DCR Grant
   300508/2017-4 and by the Sao Paulo Research Foundation (FAPESP) Grants
   16/00194-8, 2017/02353-9, 2016/13805-5, 2012/16525-2. C.H.A. thanks the
   FAPESP Visiting Researcher Program (grant 2017/02353-9). F.T.M.C. and
   C.H.A. have CNPq productivity fellowships. C.H.A. also thanks the
   L'Oreal-UNESCO-ABC Para Mulheres na Ciencia and L'Oreal-UNESCO
   International Rising Talents Program for the awards and fellowships
   received. We sincerely thank the OpenZika project
   (http://openzika.ufg.br), the wonderful ongoing support and
   encouragement of the IBM's World Community Grid team and the community
   of volunteers who donate their computer time.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Bahramsoltani R, 2016, EXPERT REV ANTI-INFE, V14, P57, DOI 10.1586/14787210.2016.1120670
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrow-Grint K, 2016, PLOS NEGLECT TROP D, V10, P1
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Blecha JE, 2007, BIOORG MED CHEM LETT, V17, P4026, DOI 10.1016/j.bmcl.2007.04.092
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Browning D.J., 2014, HYDROXYCHLOROQUINE C
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011
   Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281
   Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dar HA, 2017, INFECT GENET EVOL, V51, P143, DOI 10.1016/j.meegid.2017.03.027
   De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Duan D, 2015, ACS CHEM BIOL, V10, P978, DOI 10.1021/cb5009487
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638
   Food and Drug Administration HHS, 2014, Fed Regist, V79, P72063
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Goder V, 2012, CURR PROTEIN PEPT SC, V13, P425, DOI 10.2174/138920312802430572
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462
   Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kanno Tomoko, 2002, Physiological Chemistry and Physics and Medical NMR, V34, P1
   Kota S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032207
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leon D, 2016, FEBS OPEN BIO, V6, P1000, DOI 10.1002/2211-5463.12106
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lu G, 2017, ANTIMICROB AGENTS CH, V61, P1
   Lu J.-M, 2010, MED SCI MONITOR, DOI [10.1111/j.1600-6143.2008.02497.x.Plasma, DOI 10.1111/J.1600-6143.2008.02497.X.PLASMA]
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y
   McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Metz JT, 2007, J COMPUT AID MOL DES, V21, P139, DOI 10.1007/s10822-007-9109-z
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mohr EL, 2015, ANTIVIR RES, V120, P40, DOI 10.1016/j.antiviral.2015.05.003
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Mottin M., 2017, BIOCHEM BIOPH RES CO, V2017, P1
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Patkar CG, 2009, ANTIMICROB AGENTS CH, V53, P4103, DOI 10.1128/AAC.00074-09
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pernia Sonia, 2016, P T, V41, P713
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pouliot M, 2016, J MED CHEM, V59, P497, DOI 10.1021/acs.jmedchem.5b00361
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Qu XW, 2011, ANTIMICROB AGENTS CH, V55, P1036, DOI 10.1128/AAC.01319-10
   Ram B. M., 1843, BIOCHIM BIOPHYS ACTA, P2497
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rishton GM, 2003, DRUG DISCOV TODAY, V8, P86, DOI 10.1016/S1359644602025722
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saladino R, 2008, CURR MED CHEM, V15, P1500, DOI 10.2174/092986708784638889
   SALARI H, 1984, PROSTA LEUKOTR MED, V13, P53, DOI 10.1016/0262-1746(84)90102-1
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Shang B.-D., 2015, J GEN VIROL, V96, P1264
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sirohi D., 2016, SCIENCE, DOI [10.1126/science.aafS316, DOI 10.1126/SCIENCE.AAFS316]
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stevens AJ, 2009, J MED CHEM, V52, P7911, DOI 10.1021/jm900652e
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Tritsch D, 2015, BIOORG CHEM, V59, P140, DOI 10.1016/j.bioorg.2015.02.008
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Wagstaff K. M., 2012, BIOCHEM J, P443
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Wu YH, 2016, WORLD J GASTROENTERO, V22, P188, DOI 10.3748/wjg.v22.i1.188
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang W, 2013, BIOORGAN MED CHEM, V21, P1050, DOI 10.1016/j.bmc.2013.01.013
   Yokoyama T, 2014, J MED CHEM, V57, P8928, DOI 10.1021/jm500997m
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zavodovskaya M, 2008, J CELL BIOCHEM, V103, P624, DOI 10.1002/jcb.21435
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 172
TC 14
Z9 15
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD NOV
PY 2018
VL 23
IS 11
BP 1833
EP 1847
DI 10.1016/j.drudis.2018.06.014
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HD5NT
UT WOS:000452577900006
PM 29935345
OA Green Published
DA 2020-07-08
ER

PT J
AU Sood, SK
   Mahajan, I
AF Sood, Sandeep K.
   Mahajan, Isha
TI Fog-cloud based cyber-physical system for distinguishing, detecting and
   preventing mosquito borne diseases
SO FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE
LA English
DT Article
DE Cyber-physical system; Fog computing; Cloud computing; Mosquito borne
   diseases; Decision tree; Temporal network analysis
ID ZIKA; CHIKUNGUNYA; INFECTION; TRAVELERS; HEALTH; VIRUS
AB Mosquito-Borne Diseases (MBDs) are deadly infectious diseases those transmit quickly through infected mosquitoes to human or from one infected person to another, resulting in substantial increase in worldwide morbidity and mortality rate. The symptoms of MBDs are almost similar to each other which makes it quite difficult to diagnose the specific disease. However, it is required to diagnose the patient for proper treatment and continuous monitoring of infected patients to control the infection of MBDs. Healthcare services based on fog-cloud assisted cyber-physical system are emerging as a proactive and efficacious solution to provide remote monitoring and early detection of infected users suffering from MBDs. Fog-cloud based cyber-physical system facilitates the alliance of devices in the physical space i.e. smart wearables, IoT sensors and smart cameras with cyber space to generate the required information. Afterwards, it uses cyber space to assimilate, analyze and share medical information amongst users and healthcare service providers. A novel system based on IoT sensors, cloud computing and fog computing is proposed to distinguish, classify and monitor the users infected with MBDs. The objective of this system is to control the outbreak of MBDs at an early stage. In the proposed system, similarity factor is calculated to differentiate among MBDs and then J48 decision tree classifier is used to classify the category of infection for each user. The alerts are instantly generated and sent on user's mobile from fog layer in case of any abnormality. Radio Frequency Identification (RFID) is used to sense the close proximity between users. Temporal Network Analysis (TNA) is applied to monitor and represent the current state of the MBDs outbreak using close proximity data. The experimental evaluations of the proposed system resulted in high accuracy and low error rate to distinguish the MBDs and also provided 94% classification accuracy. The results also reveal that the TNA is an efficient tool to evaluate the state of MBDs outbreak using various statistical parameters. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Sood, Sandeep K.; Mahajan, Isha] GNDU, Dept Comp Sci & Engn, Reg Campus, Gurdaspur, Punjab, India.
RP Mahajan, I (corresponding author), GNDU, Dept Comp Sci & Engn, Reg Campus, Gurdaspur, Punjab, India.
EM sandeep.csegsp@gndu.ac.in; isha_3883@yahoo.co.in
OI Singh, Kiran Deep/0000-0002-8154-0986
CR Ahmad M, 2016, J SUPERCOMPUT, V72, P3677, DOI 10.1007/s11227-016-1634-x
   Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x
   Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Campion M., 2016, FUT TECHN C, DOI [10.1109/FTC.2016.7821628, DOI 10.1109/FTC.2016.7821628]
   Costanzo A., 2016, 13 IEEE ANN CONS COM, DOI [10.1109/CCNC.2016.7444920, DOI 10.1109/CCNC.2016.7444920]
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Fountalis I, 2014, CLIM DYNAM, V42, P879, DOI 10.1007/s00382-013-1729-5
   Fu JC, 2016, PHYSICA A, V444, P428, DOI 10.1016/j.physa.2015.09.091
   Gia T. N., 2015, 2015 IEEE INT C COMP, DOI [10.1109/CITPUCC/DASC/PICOM.2015.51, DOI 10.1109/CITPUCC/DASC/PICOM.2015.51]
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grossman RL, 2009, FUTURE GENER COMP SY, V25, P179, DOI 10.1016/j.future.2008.07.009
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P1, DOI DOI 10.1145/1656274.1656278
   Khan N. A., 2014, 11 INT JOINT C COMP, DOI [10.1109/JCSSE.2014.6841878, DOI 10.1109/JCSSE.2014.6841878]
   Linder N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104855
   Liu XZ, 2015, APPL MATH MODEL, V39, P3194, DOI 10.1016/j.apm.2014.10.035
   Markoff L, 2013, NEW ENGL J MED, V368, P689, DOI 10.1056/NEJMp1300772
   Murugan SB, 2016, ASIAN PAC J TROP MED, V9, P910, DOI 10.1016/j.apjtm.2016.07.020
   Nandyala C., 2016, INT J SMART HOME, V10, P187, DOI DOI 10.14257/IJSH.2016.10.2.18
   Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Rao VSH, 2012, IEEE T INF TECHNOL B, V16, P112, DOI 10.1109/TITB.2011.2171978
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Shah T., 2016, IET CYBER PHYS SYST, V2, P40
   Shu ZG, 2016, MOBILE NETW APPL, V21, P865, DOI 10.1007/s11036-015-0664-6
   Silva S. L. B., 2016, CLIN DIFFERENTIAL DI, DOI [10.1016/J.HGMX.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   Soghaier MA, 2013, J INFECT PUBLIC HEAL, V6, P370, DOI 10.1016/j.jiph.2013.04.007
   Song S. H., 2016, 18 IEEE INT C ADV CO, DOI [10.1109/ICACT.2016.7423430, DOI 10.1109/ICACT.2016.7423430]
   Sood SK, 2018, IEEE INTERNET THINGS, V5, P794, DOI 10.1109/JIOT.2017.2768407
   Sood SK, 2017, COMPUT IND, V91, P33, DOI 10.1016/j.compind.2017.05.006
   Srivastava B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1060-1
   Tang J, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P31
   W.H.O, CHIK
   World Health Organization, YELLOW FEVER
   World Health Organization, MOSQ DIS
   World Health Organization (WHO), ZIK SIT REP
   Yang C. H., 2016, J LIFE SCI TECHNOL, V4, P17
   Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020
NR 38
TC 17
Z9 17
U1 5
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-739X
EI 1872-7115
J9 FUTURE GENER COMP SY
JI Futur. Gener. Comp. Syst.
PD NOV
PY 2018
VL 88
BP 764
EP 775
DI 10.1016/j.future.2018.01.008
PG 12
WC Computer Science, Theory & Methods
SC Computer Science
GA GT2WG
UT WOS:000444360400073
DA 2020-07-08
ER

PT J
AU Mensah, E
   El Zowalaty, ME
AF Mensah, Eric
   El Zowalaty, Mohamed E.
TI Arboviruses in South Africa, known and unknown
SO FUTURE VIROLOGY
LA English
DT Review
DE arboviruses; arthropod-borne viruses; bunyaviruses; encephalitis;
   epidemiology; flaviviruses; human; neurological disease; one-health;
   togaviruses; zoonotic potential
ID WEST-NILE-VIRUS; CONGO HEMORRHAGIC-FEVER; FATAL NEUROLOGIC DISEASE;
   LICENSED DENGUE VACCINE; TICK-BORNE ENCEPHALITIS; ZIKA VIRUS;
   CHIKUNGUNYA VIRUS; LINEAGE 2; GLOBAL PERSPECTIVE; EPIDEMIOLOGY
AB The emergence of novel arboviruses of zoonotic potential in South Africa (SA) threatens human health and animal welfare, and affects economic growth and development. These viruses cause severe infections in animals and humans, including neurological diseases, such as encephalitis, resulting in high morbidities, mortalities and economic losses. With increasing reports of Middelburg, Shuni, Sindbis, West Nile and Wesselsbron virus infections in animals and humans in SA, this article reviews and discusses known and currently emerging arboviruses in the country. These reports underscore the need for increased surveillance, vector control management, public health preparedness, focused research, community awareness programs, and the development of rapid and sensitive diagnostic approaches. Furthermore, appropriate medical personnel training and strengthening initiatives for a one-health approach are required to understand and mitigate the emerging arboviral threat to public health.
C1 [Mensah, Eric; El Zowalaty, Mohamed E.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Hlth Sci, Virol & Microbiol Res Grp, Westville Campus, ZA-4000 Durban, South Africa.
RP El Zowalaty, ME (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Hlth Sci, Virol & Microbiol Res Grp, Westville Campus, ZA-4000 Durban, South Africa.
EM elzow001@gmail.com
OI El Zowalaty, Mohamed/0000-0002-1056-4761
CR Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5
   Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y
   ALEXANDER R. A., 1951, Journal of the South African Veterinary Medical Association, V22, P105
   Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544
   BARNARD BJH, 1986, ONDERSTEPOORT J VET, V53, P181
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006
   Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05
   Burt FJ, 2002, EMERG INFECT DIS, V8, P820, DOI 10.3201/eid0808.020027
   Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687
   Byrd Brian D, 2016, N C Med J, V77, P330, DOI 10.18043/ncm.77.5.330
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CAUSEY OR, 1972, ANN TROP MED PARASIT, V66, P357, DOI 10.1080/00034983.1972.11686835
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Centers for Disease Control and Prevention, 2017, ZIK VIR CLIN EV DIS
   Chua H H, 2010, Med J Malaysia, V65, P83
   Coetzee MJ, 2017, SOUTH AFR J INFECT D, V32, P142, DOI 10.1080/23120053.2017.1345493
   Collins JM, 2011, J CLIMATE, V24, P3649, DOI 10.1175/2011JCLI3753.1
   Cornel AJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2824-6
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006
   Dengue Vaccine Initiative, LIV ATT VACC
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   EDINGTON A. D., 1927, J. Med. Assoc. S. Africa., V1, P446
   Faburay B, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030029
   FISHERHOCH SP, 1992, AM J TROP MED HYG, V47, P337, DOI 10.4269/ajtmh.1992.47.337
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2010, ANTIVIR RES, V87, P111, DOI 10.1016/j.antiviral.2009.07.007
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2016, AM J TROP MED HYG, V95, P741, DOI 10.4269/ajtmh.16-0222
   Hasle G, 2011, TICKS TICK-BORNE DIS, V2, P37, DOI 10.1016/j.ttbdis.2010.10.004
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Human S, 2010, P 9 ANN C SO AFR SOC
   International Relation and Cooperation Republic of South Africa, SUMM YELL FEV POL S
   Ithete NL, 2014, INT J INFECT DIS, V21, P183, DOI 10.1016/j.ijid.2014.03.802
   Jansen van Vuren P, 2012, COMMUN DIS SURVEILL, V10, P1
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09
   Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x
   JUPP PG, 1986, S AFR MED J, V70, P218
   KEMP A, 1991, J AM MOSQUITO CONTR, V7, P574
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   KOKERNOT RH, 1956, J IMMUNOL, V77, P313
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Levinson W., 2010, REV MED MICROBIOLOGY
   Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maes P, 2018, ARCH VIROL, V163, P2295, DOI 10.1007/s00705-018-3843-5
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mai N, 2018, PLOS ONE, V13
   Mapaco Lourenço P., 2012, J. S. Afr. Vet. Assoc., V83, P47
   Mathengtheng L, 2014, VECTOR-BORNE ZOONOT, V14, P261, DOI 10.1089/vbz.2013.1407
   McIntosh B, 1980, THESIS
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mentoor JL, 2016, GENOME ANNOUNC, V4
   Msimang V, 2014, INT J INFECT DIS, V21, P184, DOI 10.1016/j.ijid.2014.03.805
   Msimang V, 2013, NAT I COMMUNIC DIS S, V11, P58
   Msimang V, 2013, COMMUNICABLE DIS SUR, V11, P62
   Muranyi W, 2005, J AM SOC NEPHROL, V16, P3669, DOI 10.1681/ASN.2005050561
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Mutevedzi P, 2015, COMMUN DIS SURVEIL B, V13, P80
   National Department of Health Republic of South Africa., NAT DEP HLTH REP S A
   Neill W., 1985, INT CATALOGUE ARBOVI, P533
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Paweska J.T., 2010, ARBO ZOONET NEWS, V5, P7
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Prinsloo B, 2006, S AFR FAM PRACT, V48, P25, DOI 10.1080/20786204.2006.10873441
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Sam IC, 2010, TROP BIOMED, V27, P343
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   SMITHBURN K. C., 1959, S AFRICAN MED JOUR, V33, P959
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800
   South Africa National Biodiversity Institute, S AFR 5 NAT REP CONV
   Storm N, 2014, EPIDEMIOL INFECT, V142, P234, DOI 10.1017/S0950268813000964
   SWANEPOEL R, 1983, AM J TROP MED HYG, V32, P1407, DOI 10.4269/ajtmh.1983.32.1407
   SWANEPOEL R, 1985, S AFR MED J, V68, P638
   Swanepoel R, 1989, ARBOVIRUSES EPIDEMIO, P32
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Van Eeden C, 2014, J VIROL METHODS, V195, P100, DOI 10.1016/j.jviromet.2013.10.008
   van Eeden C, 2014, ARCH VIROL, V159, P2883, DOI 10.1007/s00705-014-2131-2
   van Eeden C, 2014, EMERG INFECT DIS, V20, P1409, DOI 10.3201/eid2008.131724
   van Eeden C, 2012, EMERG INFECT DIS, V18, P318, DOI 10.3201/eid1802.111403
   van Niekerk S, 2015, EMERG INFECT DIS, V21, P2225, DOI 10.3201/eid2112.150132
   van Vuren PJ, 2017, J GEN VIROL, V98, P935, DOI 10.1099/jgv.0.000753
   van Vuren PJ, 2016, SAMJ S AFR MED J, V106, P232, DOI [10.7196/SAMJ.2016.v106i3.10615, 10.7196/samj.2016.v106i3.10615]
   Vawda S, 2018, EMERG INFECT DIS, V24, P1360, DOI 10.3201/eid2407.172096
   Venter M, 2014, INT J INFECT DIS, V21, P184, DOI 10.1016/j.ijid.2014.03.804
   Venter M, 2010, P 9 ANN C SO AFR SOC
   Venter M, 2017, EMERG INFECT DIS, V23, P2060, DOI 10.3201/eid2312.162078
   Venter M, 2011, EMERG INFECT DIS, V17, P1534, DOI 10.3201/eid1708.101794
   Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230
   Venter M, 2010, EMERG INFECT DIS, V16, P573, DOI 10.3201/eid1603.091042
   Venter M, 2009, EMERG INFECT DIS, V15, P877, DOI 10.3201/eid1506.081515
   Venter M, 2009, NEW ENGL J MED, V360, P1260, DOI 10.1056/NEJMc0808647
   Webster JL, 2017, CURR CLIN MICROBIOL, V4, P159, DOI 10.1007/s40588-017-0068-4
   Weyer J, 2013, VECTOR-BORNE ZOONOT, V13, P330, DOI 10.1089/vbz.2012.1181
   WHO, INT TRAV HLTH TICK B
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Witkowski PT, 2014, VIRUS RES, V187, P34, DOI 10.1016/j.virusres.2013.12.039
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, INT TRAV HLTH YELL F
   World Health Organization, CURR ZIK PROD PIP
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Yi X, 2017, VACCINE, V35, P1227, DOI 10.1016/j.vaccine.2017.01.015
   Zaayman D, 2012, EMERG INFECT DIS, V18, P2051, DOI 10.3201/eid1812.111208
   Zayed H, 2017, FUTURE VIROL, V12, P159, DOI 10.2217/fvl-2016-0139
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 130
TC 1
Z9 1
U1 0
U2 5
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD NOV
PY 2018
VL 13
IS 11
BP 787
EP 802
DI 10.2217/fvl-2018-0090
PG 16
WC Virology
SC Virology
GA HD3EP
UT WOS:000452398000005
DA 2020-07-08
ER

PT J
AU Barik, S
   Das, S
   Vikalo, H
AF Barik, Somsubhra
   Das, Shreepriya
   Vikalo, Haris
TI QSdpR: Viral quasispecies reconstruction via correlation clustering
SO GENOMICS
LA English
DT Article
DE Quasispecies; Clustering; Max K-cut; Next generation sequencing; RNA
   viruses
ID ALGORITHMS; INFERENCE
AB RNA viruses are characterized by high mutation rates that give rise to populations of closely related genomes, known as viral quasispecies. Underlying heterogeneity enables the quasispecies to adapt to changing conditions and proliferate over the course of an infection. Determining genetic diversity of a virus (i.e., inferring haplotypes and their proportions in the population) is essential for understanding its mutation patterns, and for effective drug developments. Here, we present QSdpR, a method and software for the reconstruction of quasispecies from short sequencing reads. The reconstruction is achieved by solving a correlation clustering problem on a read-similarity graph and the results of the clustering are used to estimate frequencies of sub-species; the number of sub-species is determined using pseudo F index. Extensive tests on both synthetic datasets and experimental HIV-1 and Zika virus data demonstrate that QSdpR compares favorably to existing methods in terms of various performance metrics.
C1 [Barik, Somsubhra; Vikalo, Haris] Univ Texas Austin, ECE Dept, Austin, TX 78712 USA.
   [Das, Shreepriya] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
RP Barik, S (corresponding author), Univ Texas Austin, ECE Dept, Austin, TX 78712 USA.
EM sbarik@utexas.edu
FU National Science FoundationNational Science Foundation (NSF)
   [CCF-1618427]
FX This work was funded in part by the National Science Foundation
   CCF-1618427.
CR Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251
   Baaijens J., 2017, BIORXIV
   Bansal N, 2002, ANN IEEE SYMP FOUND, P238, DOI 10.1109/SFCS.2002.1181947
   Boyd Stephen, 2004, CONVEX OPTIMIZATION
   Calinski T., 1974, COMMUN STAT, V3, P1, DOI DOI 10.1080/03610927408827101
   Das S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1408-5
   Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Frieze A, 1997, ALGORITHMICA, V18, P67, DOI 10.1007/BF02523688
   Hong LZ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0517-9
   Huang Austin, 2011, In Silico Biology, V11, P193, DOI 10.3233/ISB-2012-0454
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Jayasundara D., 2014, BIOINFORMATICS, V754
   Lancia G., 2001, Algorithms - ESA 2001. 9th Annual European Symposium. Proceedings (Lecture Notes in Computer Science Vol.2161), P182
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Mangul S, 2014, BIOINFORMATICS, V30, P329, DOI 10.1093/bioinformatics/btu295
   Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856
   NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2
   Pandit A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-56
   Pataki G, 1998, MATH OPER RES, V23, P339, DOI 10.1287/moor.23.2.339
   Prabhakaran S, 2014, IEEE ACM T COMPUT BI, V11, P182, DOI 10.1109/TCBB.2013.145
   Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627
   Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341
   Topfer A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003515
   Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232
   Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119
NR 29
TC 3
Z9 3
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
EI 1089-8646
J9 GENOMICS
JI Genomics
PD NOV
PY 2018
VL 110
IS 6
BP 375
EP 381
DI 10.1016/j.ygeno.2017.12.007
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA HB4WF
UT WOS:000451057100005
PM 29268961
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Mass Gatherings and Zika Virus Infection - Concerns and Facts
SO HEALTH SCOPE
LA English
DT Letter
ID OLYMPICS; PREPAREDNESS; LESSONS
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Hainan, Peoples R China.; Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Al-Tawfiq JA, 2016, ANN AM THORAC SOC, V13, P759, DOI 10.1513/AnnalsATS.201511-772FR
   COOMBES R, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I2899
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Musso D, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0551-8
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Wiwanitkit V, 2016, HEALTH SCOPE, V5
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P329
   Zumla A, 2016, INT J INFECT DIS, V47, P1, DOI 10.1016/j.ijid.2016.06.010
NR 13
TC 0
Z9 0
U1 0
U2 1
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 2251-8959
EI 2251-9513
J9 HEALTH SCOPE
JI Health Scope
PD NOV
PY 2018
VL 7
IS 4
AR e12932
DI 10.5812/jhealthscope.12932
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HD9TP
UT WOS:000452906100004
OA Other Gold
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   de Carvalho, GC
   Marrelli, MT
AF Wilke, Andre Barretto Bruno
   de Carvalho, Gabriela Cristina
   Marrelli, Mauro Toledo
TI Retention of ancestral polymorphism in Culex nigripalpus (Diptera:
   Culicidae) from Sao Paulo, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Microsatellite markers; Urbanization; Microgeographic genetic structure
ID WEST-NILE-VIRUS; MICROSATELLITE LOCI; THEOBALD DIPTERA; MUNICIPAL PARKS;
   URBAN PARKS; ZIKA VIRUS; VECTOR; DENGUE; URBANIZATION; TRANSMISSION
AB Culex nigripalpus Theobald (Diptera: Culicidae) is a native species of Brazil that is well adapted to urban environments and found extensively in the city of Sao Paulo, Brazil. As a native species, it has been present in this region since long before the foundation of the city, but over time Cx. nigripalpus populations have been affected by man-made changes to the environment. We hypothesize that the populations analyzed in this study constituted a large Cx. nigripalpus population that separated into smaller populations as a result of increased levels of urbanization in the city, and that such high levels of urbanization would result in a genetic homogenization effect. We therefore investigated the microgeographic genetic structure and microevolutionary processes in Cx. nigripalpus populations from seven different locations in the city of Sao Paulo using a set of six microsatellite primers originally developed for Culex quinquefasciatus and Culex pipiens. Our results indicate that Cx. nigripalpus did not benefit from urbanization and is currently under selective pressures caused by anthropogenic changes and that populations from areas with higher levels of urbanization exhibited similar genetic patterns and low levels of polymorphism, contrasting with the more sylvatic SHA population. These findings are likely to contribute to a better understanding of how anthropogenic selective pressures are driving population genetics and, to some extent, the dynamics of Cx. nigripalpus populations. They should also help elucidate the effects that urbanization processes have on the ecology and behavior of these mosquito populations.
C1 [Wilke, Andre Barretto Bruno] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [de Carvalho, Gabriela Cristina; Marrelli, Mauro Toledo] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
RP Marrelli, MT (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM mmarelli@usp.br
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/15313-4]; FAPESP
   fellowshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/18965-2]
FX The authors would like to thank the Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) for providing financial support (Grant
   2013/15313-4). GCC is the recipient of a FAPESP fellowship
   (2013/18965-2).
CR Abreu AG, 2012, MOL ECOL RESOUR, V12, P374, DOI 10.1111/j.1755-0998.2011.03109.x
   Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Wilke ABB, 2017, J MED ENTOMOL, V54, P1582, DOI 10.1093/jme/tjx149
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Wilke ABB, 2017, ACTA TROP, V166, P343, DOI 10.1016/j.actatropica.2016.10.025
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003
   Consoli R. A. G. B, 1994, PRINCIPAIS MOSQUITOS, DOI [10.1590/S0102-311X1995000100027, DOI 10.1590/S0102-311X1995000100027]
   Cornuet JM, 1996, GENETICS, V144, P2001
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   DAY JF, 1993, J AM MOSQUITO CONTR, V9, P249
   Day JF, 2000, J MED ENTOMOL, V37, P626, DOI 10.1603/0022-2585-37.4.626
   de Carvalho GC, 2018, J MED ENTOMOL, V55, P1334, DOI 10.1093/jme/tjy075
   de Carvalho GC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2348-5
   de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x
   Dickin SK, 2014, GLOBAL ENVIRON CHANG, V29, P155, DOI 10.1016/j.gloenvcha.2014.09.007
   Edillo FE, 2007, J MED ENTOMOL, V44, P145, DOI 10.1603/0022-2585(2007)44[145:ASOBAM]2.0.CO;2
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   FORATTINI O.P., 2002, CULICIDOLOGIA MED, V2
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693
   Holmes MW, 2016, MOL ECOL, V25, P864, DOI 10.1111/mec.13529
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x
   Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290
   Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   Laporta GZ, 2008, REV BRAS ENTOMOL, V52, P663, DOI 10.1590/S0085-56262008000400019
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2
   Medeiros-Sousa AR, 2015, ACTA TROP, V150, P200, DOI 10.1016/j.actatropica.2015.08.002
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1
   Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110
   Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328
   NAYAR JK, 1968, J MED ENTOMOL, V5, P203, DOI 10.1093/jmedent/5.2.203
   Nielsen AB, 2014, URBAN ECOSYST, V17, P305, DOI 10.1007/s11252-013-0316-1
   Richards SL, 2012, J MED ENTOMOL, V49, P1502, DOI 10.1603/ME12054
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Smith JL, 2005, MOL ECOL NOTES, V5, P697, DOI 10.1111/j.1471-8286.2005.01034.x
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   World Health Organization, 2016, ZIK SIT REP
   Wunderlich J, 2018, EPIDEMIOL INFECT, V146, P236, DOI 10.1017/S0950268817002801
NR 60
TC 4
Z9 4
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD NOV
PY 2018
VL 65
BP 333
EP 339
DI 10.1016/j.meegid.2018.08.017
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GY0JY
UT WOS:000448205100047
PM 30142383
DA 2020-07-08
ER

PT J
AU Arguelles-Nava, VG
   Alvarez-Banuelos, MT
   Cordoba-Suarez, D
   Sampieri, CL
   Ortiz-Leon, MC
   Riande-Juarez, G
   Montero, H
AF Arguelles-Nava, Vianey G.
   Alvarez-Banuelos, Maria T.
   Cordoba-Suarez, Daniel
   Sampieri, Clara L.
   Ortiz-Leon, Maria C.
   Riande-Juarez, Gabriel
   Montero, Hilda
TI Knowledge, Attitudes, and Practices about Zika among a University
   Community Located in an Endemic Zone in Mexico
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Zika virus; disease prevention; knowledge; attitudes and practices
   towards health; health communication; university students; university
   workers; sexual health; infection
AB To assess the knowledge, attitudes, and practices about the Zika virus in both students and workers at the University of Veracruz, an online survey was conducted. The participants were divided into two groups: one according to sex, the other according to whether they were workers or students. Their answers were classified into knowledge, attitudes, and practices and they were rated as low, medium, and high. The results showed that knowledge about Zika prevailing among the university population is considered as medium in 79.4% of the study population. Most respondents know that the mosquito spreads the Zika virus (98.8%) and the clinical characteristics, while sexual transmission by the virus is little known (36.85%). Both the univariate analysis (OR (CI5) 0.227 (0.070-0.735), p = 0.013] and multivariate analysis (OR (CI95) 0.234 (0.071-778), p = 0.018] showed that belonging to the health sciences area is related to having a greater knowledge about Zika. Despite the existing knowledge, a low level of prevention practices prevails in the whole community (55%). A medium level of knowledge about Zika prevailed, while proper implementation of preventive measures for Zika is low, despite the fact that the state of Veracruz-the place where the University is located-is an endemic area.
C1 [Arguelles-Nava, Vianey G.; Alvarez-Banuelos, Maria T.; Sampieri, Clara L.; Ortiz-Leon, Maria C.; Riande-Juarez, Gabriel; Montero, Hilda] Univ Veracruzana, Inst Salud Publ, Xalapa 91190, Veracruz, Mexico.
   [Cordoba-Suarez, Daniel] Univ Veracruzana, Licenciatura Ciencias & Tecn Estadist, Xalapa 91000, Veracruz, Mexico.
RP Montero, H (corresponding author), Univ Veracruzana, Inst Salud Publ, Xalapa 91190, Veracruz, Mexico.
EM varguelles@uv.mx; talvarez@uv.mx; danielcordoba.suarez@gmail.com;
   csampieri@uv.mx; cortiz@uv.mx; griande@uv.mx; hmontero@uv.mx
RI Arguelles-Nava, Vianey Guadalupe/P-1171-2019; Ortiz-Leon, Maria Cristina
   MCOL/G-9569-2019
OI Arguelles-Nava, Vianey Guadalupe/0000-0002-5878-2522; Ortiz-Leon, Maria
   Cristina MCOL/0000-0003-4953-5076; Alvarez-Banuelos, Maria
   T/0000-0003-1922-8673
FU Program for the Professional Development of Teachers (PRODEP)
FX We want to thank the college authorities for facilitating the
   development of this survey, the researchers of the Public Health
   Institute-Maria Lourdes Mota Morales, Dulce Maria Cinta Loaiza and Edit
   Rodriguez Romero-for reviewing the questionnaire, and the Mexican
   Virology Network. We also thank the staff of the college units and
   departments involved in disseminating key messages and the call to
   participate in the survey; in particular, to Luz Elena Najera Jimenez
   for the design and fulfillment of the diffusion program. We thank the
   Program for the Professional Development of Teachers (PRODEP, as it is a
   Spanish acronym) for the funding granted to publish the results of this
   study.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Centers for Disease Control and Prevention, PREV MOSQ BIT
   Centers for Disease Control and Prevention, PREGN
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   DINIZ D, 2017, BMJ SEX REPROD HEAL, V43, DOI DOI 10.1136/jfprhc-2016-101678
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Guerra-Reyes L, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.43, 10.26633/rpsp.2018.43]
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Health Communication Capacity Colaborative, MON RED SOC DEINT RU
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Moreno-Banda GL, 2017, SALUD PUBLICA MEXICO, V59, P41, DOI 10.21149/8414
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Organizacion Mundial de la Salud, ENC CON ACT PRACT EN
   Organizacion Mundial de la Salud, AL EP INF VIR ZIK
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD, P1
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Secretaria de Salud de Mexico, B EP MEX PERT SECR S
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Slenczka W, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0019-2016
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
NR 27
TC 2
Z9 2
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2018
VL 15
IS 11
AR 2548
DI 10.3390/ijerph15112548
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HC2OB
UT WOS:000451640500222
PM 30441747
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Juarbe-Rey, D
   Perez, AO
   Santoni, PCP
   Ramirez, MR
   Vera, M
AF Juarbe-Rey, Deborah
   Perez, Adriana Oben
   Santoni, Papo Christian P.
   Ramirez, Melissa Ramirez
   Vera, Mildred
TI Using Risk Communication Strategies for Zika Virus Prevention and
   Control Driven by Community-Based Participatory Research
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Zika; community-based participatory research; risk communication
ID AFRICAN-AMERICAN; HEALTH WORKERS; DENGUE; TRANSMISSION; PARTNERSHIP;
   CLIMATE
AB Background: In this study, we use community-based participatory processes to engage community and academic partners in a meaningful exchange to identify and pilot test risk communication strategies for Zika virus prevention and control. Methods: Community members were actively involved in planning, developing, and implementing a risk communication initiative. Qualitative and quantitative data gathered through individual interviews, focus groups, and community advisory board input provided information for the identification of relevant risk communication strategies to increase the understanding about Zika virus and to promote behavior change. To examine its impact we obtained baseline and follow-up data from a random sample of 75 community residents. A face-to-face interview was conducted to assess community members' knowledge, attitudes, and behaviors regarding Zika virus infection. Results: Study activities focused on three risk communication strategies: Zika awareness health fair, health education through theater, and community forums and workshops. The risk communication initiative was implemented over a two-month period. Findings from baseline and follow-up data demonstrated significant positive changes in respondents' recognition of personal and community responsibility for the prevention of Zika infection, increased knowledge of prevention strategies, and enhanced engagement in preventive behaviors for mosquito control. Conclusion: Our findings sustain the benefits of community based participatory research for the design and implementation of risk communication strategies that are relevant to enable residents in low-income communities to take informed decisions for the protection against Zika virus and other mosquito-borne diseases.
C1 [Juarbe-Rey, Deborah; Perez, Adriana Oben; Ramirez, Melissa Ramirez] Univ Puerto Rico, Grad Sch Publ Hlth, Ctr Evaluat & Sociomed Res, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
   [Santoni, Papo Christian P.] Manuel A Perez Publ Housing, San Juan, PR 00936 USA.
   [Vera, Mildred] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
RP Vera, M (corresponding author), Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM deborah.juarbe1@upr.edu; adriana.oben@upr.edu; santoni.rp@gmail.com;
   melissa.ramirez2@upr.edu; mildred.vera@upr.edu
FU National Institute on Minority Health and Health Disparities RCMI
   [8G12MD007600]
FX This research was funded by the National Institute on Minority Health
   and Health Disparities RCMI, grant number 8G12MD007600.
CR Ahmed SM, 2010, AM J PUBLIC HEALTH, V100, P1380, DOI 10.2105/AJPH.2009.178137
   Angier H, 2013, J HEALTH CARE POOR U, V24, P840, DOI 10.1353/hpu.2013.0086
   [Anonymous], 2016, VECT CONTR OP FRAM Z
   APHA, 2009, SUPP COMM BAS PART R
   ASTSWMO, 2009, RISK COMM ENV CLEAN
   de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   Dobransky-Fasiska D, 2009, AM J GERIAT PSYCHIAT, V17, P953, DOI 10.1097/JGP.0b013e31818f3a7e
   Dutta M., 2009, HLTH COMMUNICATION N, P59
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Ferreira M.P., 2011, INT J CRITICAL PEDAG, V3, P153
   Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   IBM, 2016, SPSS STAT WIND VERS
   Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173
   Israel BA, 2005, ENVIRON HEALTH PERSP, V113, P1463, DOI 10.1289/ehp.7675
   Jones L, 2010, ETHNIC DIS, V20, P30
   Lopez EDS, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18475
   Lowbridge Chris P, 2011, N S W Public Health Bull, V22, P34, DOI 10.1071/NB10055
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lwin MO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091974
   Minkler M, 2010, AM J PUBLIC HEALTH, V100, pS81, DOI 10.2105/AJPH.2009.165720
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Royce C.R., 2015, INT J COMMUNITY MED, V2, P627
   Smith SA, 2012, J HEALTH CARE POOR U, V23, P77, DOI 10.1353/hpu.2012.0156
   Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P10, DOI 10.1179/2046904712Z.00000000047
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   WHO, 2014, INTR RISK COMM
   WHO, 2016, OUTC EM COMM REG CLU
   WHO, 2012, COMM BEH IMP COMBI
   WHO, 2016, PREGN MAN CONT ZIK V
   Winterbauer NL, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016679211
   Wong LP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121210
   Wright K.B., 2013, HLTH COMMUNICATION 2, P233
   Zhang M, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3549
   Zhang MWB, 2014, TECHNOL HEALTH CARE, V22, P547, DOI 10.3233/THC-140819
NR 43
TC 0
Z9 0
U1 4
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2018
VL 15
IS 11
AR 2505
DI 10.3390/ijerph15112505
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HC2OB
UT WOS:000451640500179
PM 30423904
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cardona-Ospina, JA
   Alvarado-Arnez, LE
   Escalera-Antezana, JP
   Bandeira, AC
   Musso, D
   Rodriguez-Morales, AJ
AF Andres Cardona-Ospina, Jaime
   Elena Alvarado-Arnez, Lucia
   Pablo Escalera-Antezana, Juan
   Bandeira, Antonio C.
   Musso, Didier
   Rodriguez-Morales, Alfonso J.
TI Sexual transmission of arboviruses: More to explore?
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID ZIKA VIRUS; SEMEN; URINE; FEVER
C1 [Andres Cardona-Ospina, Jaime; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Publ Hlth & Infect Grp Res, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Elena Alvarado-Arnez, Lucia; Pablo Escalera-Antezana, Juan; Rodriguez-Morales, Alfonso J.] Univ Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
   [Pablo Escalera-Antezana, Juan] Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan, Hubei, Peoples R China.
   [Pablo Escalera-Antezana, Juan] Huazhong Univ Sci & Technol, Coll Med, Wuhan, Hubei, Peoples R China.
   [Bandeira, Antonio C.] Fac Tecnol & Ciencias, Sch Med, Salvador, BA, Brazil.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Polynesie Franc, France.
   [Musso, Didier] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, IRD,SSA,VITROME, Marseille, France.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Publ Hlth & Infect Grp Res, Fac Hlth Sci, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Univ Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
EM arodriguezm@utp.edu.co
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016;
   Escalera-Antezana, Juan Pablo/Q-6770-2019; Arnez, Lucia Elena
   Alvarado/D-4690-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Escalera-Antezana, Juan Pablo/0000-0003-1235-0019; Arnez, Lucia Elena
   Alvarado/0000-0002-3537-6361; BANDEIRA, ANTONIO/0000-0002-7273-8376
CR Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Kelley Roger E, 2016, J La State Med Soc, V168, P21
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Kumar S, 2018, LANCET GLOB HEALTH, V6, pE618, DOI 10.1016/S2214-109X(18)30214-6
   Lalle E, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.18.18-00197
   Pshenichnaya NY, 2016, INT J INFECT DIS, V45, P109, DOI 10.1016/j.ijid.2016.02.1008
NR 7
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD NOV
PY 2018
VL 76
BP 126
EP 127
DI 10.1016/j.ijid.2018.08.022
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GZ1IJ
UT WOS:000449121300023
PM 30201508
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Munawar, A
   Beelen, S
   Munawar, A
   Lescrinier, E
   Strelkov, SV
AF Munawar, Ali
   Beelen, Steven
   Munawar, Ahmad
   Lescrinier, Eveline
   Strelkov, Sergei V.
TI Discovery of Novel Druggable Sites on Zika Virus NS3 Helicase Using
   X-ray Crystallography-Based Fragment Screening
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; flaviviruses; NS3 helicase; antivirals; structure-based drug
   design; X-ray crystallography; fragment screening; drug discovery;
   protein-protein interaction inhibitor; allosteric inhibitor
ID SMALL-MOLECULE INHIBITORS; DENGUE-VIRUS; CRYSTAL-STRUCTURE; NS2B-NS3
   PROTEASE; TYPE-2; MUTAGENESIS; REFINEMENT; PREDICTION; COMPLEXES;
   PROTEINS
AB The flavivirus family contains several important human pathogens, such as Zika virus (ZIKV), dengue, West Nile, and Yellow Fever viruses, that collectively lead to a large, global disease burden. Currently, there are no approved medicines that can target these viruses. The sudden outbreak of ZIKV infections in 2015-2016 posed a serious threat to global public health. While the epidemic has receded, persistent reservoirs of ZIKV infection can cause reemergence. Here, we have used X-ray crystallography-based screening to discover two novel sites on ZIKV NS3 helicase that can bind drug-like fragments. Both sites are structurally conserved in other flaviviruses, and mechanistically significant. The binding poses of four fragments, two for each of the binding sites, were characterized at atomic precision. Site A is a surface pocket on the NS3 helicase that is vital to its interaction with NS5 polymerase and formation of the flaviviral replication complex. Site B corresponds to a flexible, yet highly conserved, allosteric site at the intersection of the three NS3 helicase domains. Saturation transfer difference nuclear magnetic resonance (NMR) experiments were additionally used to evaluate the binding strength of the fragments, revealing dissociation constants (K-D) in the lower mM range. We conclude that the NS3 helicase of flaviviruses is a viable drug target. The data obtained open opportunities towards structure-based design of first-in-class anti-ZIKV compounds, as well as pan-flaviviral therapeutics.
C1 [Munawar, Ali; Beelen, Steven; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Biocrystallog, B-3000 Leuven, Belgium.
   [Munawar, Ali; Munawar, Ahmad] Orthogon Therapeut LLC, Canton, MA 02021 USA.
   [Lescrinier, Eveline] Katholieke Univ Leuven, Med Chem, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium.
RP Strelkov, SV (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Biocrystallog, B-3000 Leuven, Belgium.
EM ali.munawar@kuleuven.be; steven.beelen@kuleuven.be;
   ahmad@orthogontherapeutics.com; eveline.lescrinier@kuleuven.be;
   sergei.strelkov@kuleuven.be
RI Lescrinier, Eveline/G-9339-2016
OI Lescrinier, Eveline/0000-0001-7066-4329; Strelkov,
   Sergei/0000-0001-7189-4652
FU Orthogon Therapeutics, LLC; Department of Pharmaceutical and
   Pharmacological Sciences, KU Leuven
FX This research was funded in part by a grant from Orthogon Therapeutics,
   LLC, and by the Department of Pharmaceutical and Pharmacological
   Sciences, KU Leuven.
CR Arbuzov A.E., 1952, RUSS CHEM B, V1, P443, DOI [10.1007/BF01171994, DOI 10.1007/BF01171994]
   Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bauman JD, 2013, J MED CHEM, V56, P2738, DOI 10.1021/jm301271j
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerchiaro G, 2006, J BRAZIL CHEM SOC, V17, P1473, DOI 10.1590/S0103-50532006000800003
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109
   Fang JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep34550
   Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107
   Huschmann FU, 2016, ACTA CRYSTALLOGR F, V72, P346, DOI 10.1107/S2053230X16004623
   HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Koh CY, 2015, ACTA CRYSTALLOGR D, V71, P1684, DOI 10.1107/S1399004715007683
   Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853
   Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Matusan AE, 2001, J GEN VIROL, V82, P1647, DOI 10.1099/0022-1317-82-7-1647
   Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q
   Morrow JK, 2012, CURR PHARM DESIGN, V18, P1255
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Pal D, 1998, J BIOMOL STRUCT DYN, V15, P1059, DOI 10.1080/07391102.1998.10509001
   Pierson T.C., 2013, FLAVIVIRUSES, V2
   Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101
   Salam KA, 2013, BIOMED RES INT, DOI 10.1155/2013/467869
   Shadrick WR, 2013, J BIOMOL SCREEN, V18, P761, DOI 10.1177/1087057113482586
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058
   Sondergaard CR, 2009, J MED CHEM, V52, P5673, DOI 10.1021/jm8016464
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Tashiro S, 2018, ACS CHEM BIOL, V13, P2783, DOI 10.1021/acschembio.8b00701
   Tay MYF, 2018, ADV EXP MED BIOL, V1062, P147, DOI 10.1007/978-981-10-8727-1_11
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tonge PJ, 2018, ACS CHEM NEUROSCI, V9, P29, DOI 10.1021/acschemneuro.7b00185
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Webber SE, 1996, J MED CHEM, V39, P5072, DOI 10.1021/jm960603e
   Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006
   Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Zhang WL, 2017, J CHEM INF MODEL, V57, P1453, DOI 10.1021/acs.jcim.7b00163
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y
NR 55
TC 1
Z9 3
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2018
VL 19
IS 11
AR 3664
DI 10.3390/ijms19113664
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HC0ZM
UT WOS:000451528500380
PM 30463319
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Choi, JS
   Kim, KM
AF Choi, Jeong Sil
   Kim, Kyung M.
TI Infection-control knowledge, attitude, practice, and risk perception of
   occupational exposure to Zika virus among nursing students in Korea: A
   cross-sectional survey
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Zika; Nursing student; Knowledge; Attitude; Practice
AB Background: As the number of patients with Zika virus infection increases worldwide, nursing students who conduct clinical practice in hospitals tend to at risk of Zika virus infection. Therefore, this study was conducted to identify nursing students' knowledge, attitudes, practices, and risk perceptions of infection prevention related to occupational exposure to Zika virus infection, and to identify correlations among the related variables.
   Methods: This cross-sectional study included 249 nursing students from 3 nursing colleges located in 3 Korean cities, with experience in hospital clinical practice. A questionnaire to assess the knowledge, attitudes, practices, and risk perceptions of Zika virus infection was developed through a literature review and was subjected to pilot testing and validation.
   Results: The level of infection-control knowledge for Zika virus was 54.5 of 100 points, and that of practice was 4.5 of 5 points. The infection-prevention attitude score was 4.4 of 5 points, and the risk-perception score was 2.3 of 5 points. Significant differences emerged in infection-prevention attitude toward Zika virus based on Zika virus vaccination intention. Additionally, practice and risk-perception scores differed significantly based on gender and Zika virus vaccination intention. Knowledge significantly correlated with attitude and attitude toward preventive behavior.
   Conclusion: Improvement in infection-control knowledge for Zika virus can help improve nurses' related attitudes, which in turn could promote effective practice. Considering the characteristics of nursing students, it is necessary to develop and apply an effective and viable education program related to the prevention of Zika virus infection. (C) 2018 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Choi, Jeong Sil] Gachon Univ, Coll Nursing, Incheon, South Korea.
   [Kim, Kyung M.] Chungbuk Natl Univ, Dept Nursing Sci, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea.
RP Kim, KM (corresponding author), Chungbuk Natl Univ, Dept Nursing Sci, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea.
EM icpkim@chungbuk.ac.kr
OI KIM, KYUNG MI/0000-0001-9799-0677
FU Chungbuk National University; Gachon University [GCU-2017-0174]
FX This study was supported by the research grant from Chungbuk National
   University.; This work was supported by the Gachon University research
   fund of 2017 (GCU-2017-0174).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   [Anonymous], 2017, OCCUPATIONAL SAFETY
   [Anonymous], 2017, PUBLIC HLTH REP, V10, P260
   Centers for Disease Control and Prevention, 2016, CDCS RESP ZIK ZIKA P
   Coyle Amanda L, 2016, Nursing, V46, P22, DOI 10.1097/01.NURSE.0000482279.79660.bb
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   최정실, 2010, [The Journal of Fundamentals of Nursing, 기본간호학회지], V17, P249
   Faul F, 2007, BEHAV RES METH INSTR, P39, DOI DOI 10.3758/BF03193146
   Gebre Y, 2016, ASIAN PAC J TROP BIO, V6, P815, DOI 10.1016/j.apjtb.2016.08.008
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Kim JS, 2016, J CLIN NURS, V25, P2542, DOI 10.1111/jocn.13295
   Kim KM, 2015, ASIAN NURS RES, V9, P109, DOI 10.1016/j.anr.2015.01.002
   Korea Centers for Disease Control and Prevention, 2017, AR RISK ZIK VIR
   Korea Tourism Organization, 2014, SURV REP OV TRAV TRE
   Korean Centers for Disease Control and Prevention, 2016, ZIK VIR PREV GUID
   Korean Nursing Association, 2017, NURS 10 1000 MEN NUR
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Moore KS, 2016, JNP-J NURSE PRACT, V12, P697, DOI 10.1016/j.nurpra.2016.09.012
   National Nurses United, 2017, WHAT EMPL SHOULD DO
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   이창섭, 2008, [The Korean Journal of Medicine, 대한내과학회지], V74, P500
   Park Sun-Nam, 2005, [The Journal of Fundamentals of Nursing, 기본간호학회지], V12, P337
NR 23
TC 2
Z9 2
U1 2
U2 7
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD NOV-DEC
PY 2018
VL 11
IS 6
BP 840
EP 844
DI 10.1016/j.jiph.2018.07.002
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GY6FW
UT WOS:000448683100017
PM 30049612
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baek, YH
   Cheon, HS
   Park, SJ
   Lloren, KKS
   Ahn, SJ
   Jeong, JH
   Choi, WS
   Yu, MA
   Kwon, HI
   Kwon, JJ
   Kim, EH
   Kim, YI
   Antigua, KJC
   Kim, SY
   Jeong, HW
   Choi, YK
   Song, MS
AF Baek, Yun Hee
   Cheon, Hyo-Soon
   Park, Su-Jin
   Lloren, Khristine Kaith S.
   Ahn, Su Jeong
   Jeong, Ju Hwan
   Choi, Won-Suk
   Yu, Min-Ah
   Kwon, Hyeok-il
   Kwon, Jin-Jung
   Kim, Eun-Ha
   Kim, Young-il
   Antigua, Khristine Joy C.
   Kim, Seok-Yong
   Jeong, Hye Won
   Choi, Young Ki
   Song, Min-Suk
TI Simple, Rapid and Sensitive Portable Molecular Diagnosis of SFTS Virus
   Using Reverse Transcriptional Loop-Mediated Isothermal Amplification
   (RT-LAMP)
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE SFTSV; RT-LAMP; colorimetric visualization; pocket warmer
ID THROMBOCYTOPENIA SYNDROME VIRUS; SEVERE FEVER; POCKET-WARMER;
   SOUTH-KOREA; BUNYAVIRUS; TRANSMISSION; INFECTION; ANTIBODIES; ANIMALS;
   MOBILE
AB Recently, human infections caused by severe fever with thrombocytopenia syndrome virus (SFTSV), which can lead to fatality, have dramatically increased in East Asia. With the unavailability of vaccines or antiviral drugs to prevent and/or treat SFTSV infection, early rapid diagnosis is critical for prevention and control of the disease. Here, we report the development of a simple, rapid and sensitive portable detection method for SFTSV infection applying reverse transcription-loop mediated isothermal amplification (RT-LAMP) combined with one-pot colorimetric visualization and electro-free reaction platform. This method utilizes a pocket warmer to facilitate diagnosis in a resource-limited setting. Specific primers were designed to target the highly-conserved region of L gene of SFTSV. The detection limit of the RT-LAMP assay was approximately 10 0 viral genome copies from three different SFTSV strains. This assay exhibited comparable sensitivity to qRT-PCR and 10-fold more sensitivity than conventional RT-PCR, with a rapid detection time of 30 to 60 minutes. The RT-LAMP assay using SFTSV clinical specimens has demonstrated a similar detection rate to qRT-PCR and a higher detection rate compared to conventional RT-PCR. Moreover, there was no observed cross-reactive amplification of other human infectious viruses including Japanese Encephalitis Virus (JEV), Dengue, Enterovirus, Zika, Influenza and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). This highly sensitive, electro- and equipment-free rapid colorimetric visualization method is feasible for resource-limited SFTSV field diagnosis.
C1 [Baek, Yun Hee; Cheon, Hyo-Soon; Park, Su-Jin; Lloren, Khristine Kaith S.; Ahn, Su Jeong; Jeong, Ju Hwan; Choi, Won-Suk; Yu, Min-Ah; Kwon, Hyeok-il; Kwon, Jin-Jung; Kim, Eun-Ha; Kim, Young-il; Antigua, Khristine Joy C.; Kim, Seok-Yong; Choi, Young Ki; Song, Min-Suk] Chungbuk Natl Univ, Coll Med & Med Res Inst, Dept Microbiol, Cheongju 28644, South Korea.
   [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med & Med Res Inst, Dept Internal Med, Cheongju 28644, South Korea.
   [Jeong, Hye Won] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju 28644, South Korea.
RP Choi, YK; Song, MS (corresponding author), Chungbuk Natl Univ, Coll Med & Med Res Inst, Dept Microbiol, Cheongju 28644, South Korea.
EM choiki55@chungbuk.ac.kr; songminsuk@chungbuk.ac.kr
OI Antigua, Khristine Joy/0000-0003-0711-1873
FU Basic Science Research Program of the Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI)
   - Ministry of Health & Welfare, Republic of Korea [HI15C2888,
   HI15C2817]; Chungbuk National University
FX This work was supported by the Basic Science Research Program of the
   Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI), funded by the Ministry of Health &
   Welfare, Republic of Korea [grant number: HI15C2888 to M.-S.S and
   HI15C2817 to Y.K.C] and by a research grant from Chungbuk National
   University in 2014 to M.-S.S.
CR Ablordey A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001590
   Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732
   Fukuta S, 2003, ARCH VIROL, V148, P1713, DOI 10.1007/s00705-003-0134-5
   Hatano B, 2011, J MED VIROL, V83, P568, DOI 10.1002/jmv.22031
   Hatano B, 2010, JPN J INFECT DIS, V63, P36
   Huang XY, 2014, J CLIN MICROBIOL, V52, P531, DOI 10.1128/JCM.01813-13
   Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11
   Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792
   Kim WY, 2015, CLIN INFECT DIS, V60, P1681, DOI 10.1093/cid/civ128
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Li SB, 2011, BIOSCI TRENDS, V5, P273, DOI 10.5582/bst.2011.v5.6.273
   Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020
   Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758
   Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Park JS, 2016, J VIROL METHODS, V228, P21, DOI 10.1016/j.jviromet.2015.10.010
   Park SW, 2016, AM J TROP MED HYG, V95, P1358, DOI 10.4269/ajtmh.16-0251
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031
   Wang SW, 2015, AM J TROP MED HYG, V92, P684, DOI 10.4269/ajtmh.14-0008
   Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369
   Xu HH, 2013, J VIROL METHODS, V194, P21, DOI 10.1016/j.jviromet.2013.07.037
   Yang GL, 2012, ARCH VIROL, V157, P1779, DOI 10.1007/s00705-012-1348-1
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Zhan JB, 2017, VIROL SIN, V32, P51, DOI 10.1007/s12250-016-3931-1
   Zhang YZ, 2016, CURR OPIN VIROL, V16, P126, DOI 10.1016/j.coviro.2016.02.006
   Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470
NR 27
TC 8
Z9 8
U1 6
U2 18
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
EI 1738-8872
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD NOV
PY 2018
VL 28
IS 11
BP 1928
EP 1936
DI 10.4014/jmb.1806.06016
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA HB9TZ
UT WOS:000451437200018
PM 30270605
DA 2020-07-08
ER

PT J
AU Glushakova, LG
   Alto, BW
   Kim, MS
   Wiggins, K
   Eastmond, B
   Moussatche, P
   Burkett-Cadena, ND
   Bennera, SA
AF Glushakova, Lyudmyla G.
   Alto, Barry W.
   Kim, Myong-Sang
   Wiggins, Keenan
   Eastmond, Bradley
   Moussatche, Patricia
   Burkett-Cadena, Nathan D.
   Bennera, Steven A.
TI Optimization of cationic (Q)-paper for detection of arboviruses in
   infected mosquitoes
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Cationic (Q) paper; Arboviruses; Mosquito
ID CHIKUNGUNYA-VIRUS; SYNTHETIC BIOLOGY; FLORIDA MOSQUITOS; QUANTIFICATION;
   TRANSMISSION; INNOVATIONS; SPREAD; FEVER; PAPER; ASSAY
AB Previously (Glushakova et al. 2017), a cellulose-based cationic (Q) paper derivatized with quatenary ammonium groups was shown to be a convenient platform to collect, preserve, and store nucleic acids (NAs) derived from mosquito vectors infected with pathogens for surveillance. NAs bind electrostatically to Q-paper, but the quantity of NA bound depends on the paper's binding capacity. To optimize the original technology for mosquito surveillance, factors that affected NA absorbance on Q-paper were evaluated. Sixteen variations of Q-paper were prepared with modifications of the derivatizing reagents and derivatization temperature. The binding capacities of these variations were determined first with 1,3,5-benzenetricarboxylic (BTCA), then viral RNA (purified or in infected mosquito samples) was used for validation. For this, samples with Zika (ZIKV) and chikungunya (CHIKV) RNA or virus-infected Aedes aegypti mosquito bodies were applied to sixteen Q-paper variants. Washing the paper samples with water versus elution with aqueous salt (1 M) gave samples that were analyzed for viral RNA by a PCR-based direct Luminex hybridization assay. The comparison ranked the Q-paper binding capacities from the lowest to the highest. The Q-paper with the highest RNA binding capability was further validated with ZIKV- and CHIKV-infected mosquito saliva.
C1 [Glushakova, Lyudmyla G.; Kim, Myong-Sang; Moussatche, Patricia; Bennera, Steven A.] Firebird Biomol Sci LLC, 13709 Progress Blvd,Box 17, Alachua, FL 32615 USA.
   [Alto, Barry W.; Wiggins, Keenan; Eastmond, Bradley; Burkett-Cadena, Nathan D.] Univ Florida, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Bennera, SA (corresponding author), Firebird Biomol Sci LLC, 13709 Progress Blvd,Box 17, Alachua, FL 32615 USA.
EM manuscripts@firebirdbio.com
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI128188]; Florida
   Department of Health (FDOH) [7ZK15]; Florida Department of Agriculture
   and Consumer Services (FDACS) [024,376]
FX Research reported in this publication was supported by the National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health (NIH) (R21AI128188), Florida Department of Health (FDOH)
   (7ZK15), and the Florida Department of Agriculture and Consumer Services
   (FDACS) (contract 024,376). The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   NIH, FDOH or FDACS.
CR Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Burkett-Cadena ND, 2016, J MED ENTOMOL, V53, P1449, DOI 10.1093/jme/tjw106
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Glushakova L. G, 2018, J VIROL METHOD UNPUB
   Glushakova LG, 2017, J VIROL METHODS, V246, P104, DOI 10.1016/j.jviromet.2017.04.013
   Glushakova LG, 2015, J VIROL METHODS, V214, P60, DOI 10.1016/j.jviromet.2015.01.003
   Kaur P, 2016, METHODS MOL BIOL, V1426, P93, DOI 10.1007/978-1-4939-3618-2_9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422
   Richards SL, 2010, J VECTOR ECOL, V35, P439, DOI 10.1111/j.1948-7134.2010.00105.x
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176
   Yang F, 2013, WATER SCI TECHNOL, V67, P2560, DOI 10.2166/wst.2013.140
   Yang ZY, 2013, ANAL CHEM, V85, P4705, DOI 10.1021/ac400422r
NR 23
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD NOV
PY 2018
VL 261
BP 71
EP 79
DI 10.1016/j.jviromet.2018.08.004
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA GX5VN
UT WOS:000447819200014
PM 30099053
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Musso, D
   Rodriguez-Morales, AJ
   Levi, JE
   Cao-Lormeau, VM
   Gubler, DJ
AF Musso, Didier
   Rodriguez-Morales, Alfonso J.
   Levi, Jose Eduardo
   Cao-Lormeau, Van-Mai
   Gubler, Duane J.
TI Unexpected outbreaks of arbovirus infections: lessons learned from the
   Pacific and tropical America
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID ROSS RIVER VIRUS; WEST-NILE-VIRUS; ZIKA VIRUS; YELLOW-FEVER; CHANGING
   EPIDEMIOLOGY; AEDES-AEGYPTI; KUNJIN VIRUS; MAYARO VIRUS; DENGUE;
   CHIKUNGUNYA
AB Pandemic arboviruses have emerged as a major global health problem in the past four decades. Predicting where and when the next arbovirus epidemic will occur is a challenge, but history suggests that arboviral black swan events (epidemics that are difficult to predict and that have an extreme effect) will continue to occur as urban growth and globalisation expand. We briefly review unexpected arbovirus epidemics that have occurred in the past 50 years, with emphasis on the American and Pacific regions, to illustrate their unpredictability, and to highlight the need for improved global preparedness, including laboratory-based surveillance, prevention, and control programmes.
C1 [Musso, Didier; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, French Polynesi, France.
   [Musso, Didier; Cao-Lormeau, Van-Mai] Aix Marseille Univ, Unite Mixte Rech Vecteurs Infect Trop & Mediterra, Inst Hosp Univ Mediterranee Infect, AP HP,Inst Rech Dev,Serv Sante Armees, Marseille, France.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Res Zika & Other Arb, Pereira, Colombia.
   [Levi, Jose Eduardo] Univ Sao Paulo, Trop Med Inst, Sao Paulo, Brazil.
   [Levi, Jose Eduardo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Gubler, Duane J.] Duke NUS Med Sch, Programme Emerging Infect, Singapore, Singapore.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, French Polynesi, France.
EM dmusso@ilm.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Arechiga-Ceballos N, 2015, REV SCI TECH OIE, V34, P491, DOI 10.20506/rst.34.2.2374
   Artsob H, 2009, ZOONOSES PUBLIC HLTH, V56, P357, DOI 10.1111/j.1863-2378.2008.01207.x
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Barber B, 2009, AUST FAM PHYSICIAN, V38, P586
   Barboza P, 2008, MED MALADIES INFECT, V38, P513, DOI 10.1016/j.medmal.2008.06.011
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cui SJ, 2017, INT J INFECT DIS, V60, P93, DOI 10.1016/j.ijid.2017.05.001
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DEFIGUEIREDO MLG, 2014, ADV MICROBIOL, V4, P955, DOI DOI 10.4236/aim.2014.413106
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1303, DOI 10.4269/ajtmh.1981.30.1303
   GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Hall RA, 2001, ANN NY ACAD SCI, V951, P153
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Ortiz-Martinez Yeimer, 2017, F1000Res, V6, P398, DOI 10.12688/f1000research.11280.2
   Pan American Health Organization/World Health Organization Regional Office for the Americas, 2017, REG ZIK EP UPD AM
   Prow NA, 2013, INT J ENV RES PUB HE, V10, P6255, DOI 10.3390/ijerph10126255
   Raoult D, 2016, INT J ANTIMICROB AG, V47, P249, DOI 10.1016/j.ijantimicag.2016.01.013
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   ROSEN L, 1981, AM J TROP MED HYG, V30, P1294, DOI 10.4269/ajtmh.1981.30.1294
   ROSEN L, 1954, AM J TROP MED HYG, V3, P878, DOI 10.4269/ajtmh.1954.3.878
   Rossetto EV, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759017, 10.1590/S1678-9946201759017]
   Roth A, 2014, EMERG INFECT DIS, V20
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   World Health Organization, 2018, YELLOW FEVER
   Xavier DR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00186615, 10.1590/0102-311x00186615]
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 78
TC 21
Z9 22
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2018
VL 18
IS 11
BP E355
EP E361
DI 10.1016/S1473-3099(18)30269-X
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GY1WF
UT WOS:000448325300003
PM 29934112
DA 2020-07-08
ER

PT J
AU Coyaud, E
   Ranadheera, C
   Cheng, D
   Goncalves, J
   Dyakov, BJA
   Laurent, EMN
   St-Germain, J
   Pelletier, L
   Gingras, AC
   Brumell, JH
   Kim, PK
   Safronetz, D
   Raught, B
AF Coyaud, Etienne
   Ranadheera, Charlene
   Cheng, Derrick
   Goncalves, Joao
   Dyakov, Boris J. A.
   Laurent, Estelle M. N.
   St-Germain, Jonathan
   Pelletier, Laurence
   Gingras, Anne-Claude
   Brumell, John H.
   Kim, Peter K.
   Safronetz, David
   Raught, Brian
TI Global Interactomics Uncovers Extensive Organellar Targeting by Zika
   Virus
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID NS2B-NS3 PROTEASE; CAPSID PROTEIN; DENGUE; SCREEN; IDENTIFICATION;
   PERSPECTIVES; PEROXISOMES; INFECTION; OUTBREAK; SIGNAL
AB Zika virus (ZIKV) is a membrane enveloped Flavivirus with a positive strand RNA genome, transmitted by Aedes mosquitoes. The geographical range of ZIKV has dramatically expanded in recent decades resulting in increasing numbers of infected individuals, and the spike in ZIKV infections has been linked to significant increases in both Guillain-Barre syndrome and microcephaly. Although a large number of host proteins have been physically and/or functionally linked to other Flaviviruses, very little is known about the virus-host protein interactions established by ZIKV. Here we map host cell protein interaction profiles for each of the ten polypeptides encoded in the ZIKV genome, generating a protein topology network comprising 3033 interactions among 1224 unique human polypeptides. The interactome is enriched in proteins with roles in polypeptide processing and quality control, vesicle trafficking, RNA processing and lipid metabolism. >60% of the network components have been previously implicated in other types of viral infections; the remaining interactors comprise hundreds of new putative ZIKV functional partners. Mining this rich data set, we highlight several examples of how ZIKV may usurp or disrupt the function of host cell organelles, and uncover an important role for peroxisomes in ZIKV infection.
C1 [Coyaud, Etienne; Laurent, Estelle M. N.; St-Germain, Jonathan; Raught, Brian] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.
   [Ranadheera, Charlene; Safronetz, David] Publ Hlth Agcy Canada, Zoonot Dis & Special Pathogens Program, Winnipeg, MB, Canada.
   [Cheng, Derrick; Kim, Peter K.] Hosp Sick Children, Cell Biol Program, Toronto, ON, Canada.
   [Cheng, Derrick; Kim, Peter K.] Univ Toronto, Dept Biochem, Toronto, ON, Canada.
   [Goncalves, Joao; Dyakov, Boris J. A.; Pelletier, Laurence; Gingras, Anne-Claude] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol, Toronto, ON, Canada.
   [Dyakov, Boris J. A.; Pelletier, Laurence; Gingras, Anne-Claude; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.
   [Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada.
   [Brumell, John H.] Hosp Sick Children, Sick Kids IBD Ctr, Toronto, ON, Canada.
   [Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.
RP Raught, B (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.
EM brian.raught@uhnres.utoronto.ca
RI Gingras, Anne-Claude/E-9982-2010
OI Gingras, Anne-Claude/0000-0002-6090-4437; COYAUD,
   Etienne/0000-0002-5893-4557; Dyakov, Boris/0000-0003-3589-1053
FU  [FDN143301]
FX Work in the A.-C.G. lab was supported by FDN143301. J.H.B. holds the
   Pitblado Chair in Cell Biology. B.R. holds the CRC in Proteomics and
   Molecular Medicine.
CR Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barry Michele, 2006, Sci STKE, V2006, ppe21
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Chavali PL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0468
   Chen CH, 2015, J CELL SCI, V128, P3290, DOI 10.1242/jcs.171637
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Cleret-Buhot A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0226-9
   Costello JL, 2017, J CELL BIOL, V216, P331, DOI 10.1083/jcb.201607055
   Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658
   Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065
   Hofer CT, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12679
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Hua R, 2017, J CELL BIOL, V216, P367, DOI 10.1083/jcb.201608128
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lambert JP, 2015, J PROTEOMICS, V118, P81, DOI 10.1016/j.jprot.2014.09.011
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224
   Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Odendall Charlotte, 2013, Subcell Biochem, V69, P67, DOI 10.1007/978-94-007-6889-5_4
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098
   Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15
   South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148
   Tsuchiya Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12567
   Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24534
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 76
TC 25
Z9 25
U1 1
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD NOV
PY 2018
VL 17
IS 11
BP 2242
EP 2255
DI 10.1074/mcp.TIR118.000800
PG 14
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA HC4UI
UT WOS:000451799900012
PM 30037810
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Fernandes, DA
   Souza, MSR
   Teles, YCF
   Oliveira, LHG
   Lima, JB
   Conceicao, AS
   Nunes, FC
   Silva, TMS
   de Souza, MDV
AF Fernandes, Diegina A.
   Souza, Maria S. R.
   Teles, Yanna C. F.
   Oliveira, Louise H. G.
   Lima, Jessica B.
   Conceicao, Adilva S.
   Nunes, Fabiola C.
   Silva, Tania M. S.
   Vanderlei de Souza, Maria de Fatima
TI New Sulphated Flavonoids and Larvicidal Activity of Helicteres velutina
   K. Schum (Sterculiaceae)
SO MOLECULES
LA English
DT Article
DE Helicteres velutina; Sterculiacaeae; sulphated flavonoids; larvicidal
   activity; Aedes aegypti
ID CONSTITUENTS; DERIVATIVES; MALVACEAE; PREGNANE
AB Helicteres velutina K. Schum (Sterculiaceae), commonly known in Brazil as 'pito', is traditionally used by indigenous peoples as insecticides and repellents. The present work reports on the the phytoconstituents from aerial parts of H. velutina and evaluation of the larvicidal potential of its extract. The compounds were isolated using chromatographic techniques and identified by NMR, IR and LC-HRMS. This study led to the isolation of a fatty acid, one aliphatic alcohol, four chlorophyll derivatives, one steroid, triterpenes, a lignan, and flavonoids, highlighting the new compounds in the literature, 5,4' -di-hydroxy-7-methoxy-8-O-sulphate flavone (mariahine) (15a) and 5,3'-di-hydroxy-7,4' -dimethoxy-8-O-sulphate flavone (condadine) (15b). The work presented here contributes to the chemotaxonomic knowledge of the Sterculiaceae family by describing the occurrence of sulphated flavonoids in this family for the first time. The crude ethanolic extract of H. velutina featured robust larvicidal activity against Aedes aegypti larvae, showing that the extract can be useful as a domestic larvicide, just as indicated by traditional use, to combat A. aegypti, a vector insect of severe viral diseases, such as dengue and Zika.
C1 [Fernandes, Diegina A.; Souza, Maria S. R.; Vanderlei de Souza, Maria de Fatima] Univ Fed Paraiba, Post Grad Program Bioact Nat & Synthet Prod, BR-58051900 Joao Pessoa, Paraiba, Brazil.
   [Teles, Yanna C. F.] Univ Fed Paraiba, Dept Chem & Phys, Agr Sci Ctr, BR-58397000 Areia, PB, Brazil.
   [Oliveira, Louise H. G.; Nunes, Fabiola C.] Univ Fed Paraiba, Ctr Biotechnol, BR-58051900 Joao Pessoa, Paraiba, Brazil.
   [Lima, Jessica B.; Conceicao, Adilva S.] Univ Estado Bahia, Dept Educ, Post Graduat Program Plant Biodivers, BR-41150000 Paulo Afonso, BA, Brazil.
   [Silva, Tania M. S.] Rural Fed Univ Pernambuco, Dept Mol Sci, Campus Dois Irmaos, BR-52171900 Recife, PE, Brazil.
   [Vanderlei de Souza, Maria de Fatima] Univ Fed Paraiba, Post Grad Dev & Technol Innovat Med, BR-58051900 Joao Pessoa, Paraiba, Brazil.
RP de Souza, MDV (corresponding author), Univ Fed Paraiba, Post Grad Program Bioact Nat & Synthet Prod, BR-58051900 Joao Pessoa, Paraiba, Brazil.; de Souza, MDV (corresponding author), Univ Fed Paraiba, Post Grad Dev & Technol Innovat Med, BR-58051900 Joao Pessoa, Paraiba, Brazil.
EM diegina@ltf.ufpb.br; sallett@ltf.ufpb.br; yanna@cca.ufpb.br;
   louiseguimaraes@outlook.com; jessica.bl@hotmail.com;
   adilva.souza@gmail.com; fabiola@cbiotec.ufpb.br;
   sarmentosilva@gmail.com; mfvanderlei@ltf.ufpb.br
RI Teles, Yanna Carolina Ferreira/AAH-2135-2019; de Souza Maria de Fatima,
   Vanderlei/Z-1525-2019; Silva, Tania Maria Sarmento/A-6309-2013
OI Teles, Yanna Carolina Ferreira/0000-0001-9409-3727; Silva, Tania Maria
   Sarmento/0000-0003-1887-2598
FU MCT-INSA/National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Universal (CNPq) and Coordination for the Improvement of Higher
   Education Personnel (CAPES)
FX This research was funded by MCT-INSA/National Council for Scientific and
   Technological Development (CNPq); Universal (CNPq) and Coordination for
   the Improvement of Higher Education Personnel (CAPES).
CR Abed R. A., 2007, Revista de Patologia Tropical, V36, P75
   Al Muqarrabun LMR, 2015, EUR J MED CHEM, V92, P514, DOI 10.1016/j.ejmech.2015.01.026
   Amaro N.B., 2007, THESIS
   Barreto MB, 2013, QUIM NOVA, V36, P675, DOI 10.1590/S0100-40422013000500011
   Buchholz H., 2007, U.S. Patent, Patent No. [20,070,134,172A1, 20070134172]
   Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385
   Cabral S.S., 2015, THESIS
   Carvalho GS, 2011, THESIS
   Chaves OS, 2013, MOLECULES, V18, P2769, DOI 10.3390/molecules18032769
   Chen WL, 2006, PHYTOCHEMISTRY, V67, P1041, DOI 10.1016/j.phytochem.2006.03.005
   Chen ZT, 2006, CHEM PHARM BULL, V54, P1605, DOI 10.1248/cpb.54.1605
   Coelho AAM, 2009, BIOASSAY, V4, P1, DOI DOI 10.14295/BA.v4.0.22
   COSTA Vivian Chieregati, 2013, THESIS
   Cruz F.R., 2009, FLORA FANEROGAMICA E, V6, P257
   Cruz F.R., 2007, THESIS
   da Cunha SSL, 2014, REV BIOTEMAS, V27, P79, DOI [10.5007/2175-7925.2014v27n2p79, DOI 10.5007/2175-7925.2014v27n2p79]
   Darmali L., 2015, AFR J PHRAM PHARM, V9, P881, DOI [10.5897/AJPP2015.4420, DOI 10.5897/AJPP2015.4420]
   de Brito SG, 2017, REV BRAS FARMACOGN, V27, P453, DOI 10.1016/j.bjp.2017.06.001
   Fernandes R.S., 2012, THESIS
   Gomes RA, 2015, BRAZ J PHARM SCI, V51, P861, DOI 10.1590/S1984-82502015000400012
   Hossain R., 2016, J SCI RES, V2, P1, DOI [10.3329/jsr.v8i1.23482, DOI 10.3329/JSR.V8I1.23482]
   Huang QF, 2013, ANTIVIR RES, V100, P373, DOI 10.1016/j.antiviral.2013.09.007
   Kamiya K, 2001, PHYTOCHEMISTRY, V57, P297, DOI 10.1016/S0031-9422(01)00005-X
   Kumar Nirmal, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS22, DOI 10.12980/APJTB.4.2014C872
   Monteiro L.C.C.F., 2015, BLUCHER CHEM P, V3, P1, DOI [10.5151/chenpro-5erq-org5, DOI 10.5151/CHENPRO-5ERQ-ORG5]
   Nour A.H., 2012, SCI RES ESSAYS, V7, P2810, DOI DOI 10.5897/SRE12.133
   Oliveira GP, 2014, ENCICLOP BIOSFERA, V10, P442
   Pavia D.L., 2010, INTRO ESPECTROSCOPIA, P169
   Santana H.T., 2012, THESIS
   Santos D, 2015, THESIS
   Santos E.A., 2012, EVID-BASED COMPL ALT, V1, P1, DOI [DOI 10.1155/2012/846583, 10.1155/2012/846583]
   Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214
   Teles YCF, 2018, MOLECULES, V23, DOI 10.3390/molecules23020480
   Teles YCF, 2015, MOLECULES, V20, P20161, DOI 10.3390/molecules201119685
   Varjao RR, 2013, BIOTA NEOTROP, V13, P105, DOI 10.1590/S1676-06032013000200011
   VIEIRAFILHO SA, 2003, HELV CHIM ACTA, V86, P3445, DOI DOI 10.1002/hlca.200390288
   Wang GC, 2012, FITOTERAPIA, V83, P1643, DOI 10.1016/j.fitote.2012.09.016
   Yi B, 2011, MOLECULES, V16, P10157, DOI 10.3390/molecules161210157
NR 38
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2018
VL 23
IS 11
AR 2784
DI 10.3390/molecules23112784
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HC2OO
UT WOS:000451641900056
PM 30373225
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bailey, MJ
   Duehr, J
   Dulin, H
   Broecker, F
   Brown, JA
   Arumemi, FO
   Gonzalez, MCB
   Leyva-Grado, VH
   Evans, MJ
   Simon, V
   Lim, JK
   Krammer, F
   Hai, R
   Palese, P
   Tan, GS
AF Bailey, Mark J.
   Duehr, James
   Dulin, Harrison
   Broecker, Felix
   Brown, Julia A.
   Arumemi, Fortuna O.
   Gonzalez, Maria C. Bermudez
   Leyva-Grado, Victor H.
   Evans, Matthew J.
   Simon, Viviana
   Lim, Jean K.
   Krammer, Florian
   Hai, Rong
   Palese, Peter
   Tan, Gene S.
TI Human antibodies targeting Zika virus NS1 provide protection against
   disease in a mouse model
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; IMMUNE EFFECTOR FUNCTIONS;
   MONOCLONAL-ANTIBODIES; YELLOW-FEVER; DENGUE-2 VIRUS; INFECTED-CELLS;
   IN-VIVO; MICE; VACCINE; ENCEPHALITIS
AB Zika virus is a mosquito-borne flavivirus closely related to dengue virus that can cause severe disease in humans, including microcephaly in newborns and Guillain-Barre syndrome in adults. Specific treatments and vaccines for Zika virus are not currently available. Here, we isolate and characterize four monoclonal antibodies (mAbs) from an infected patient that target the non-structural protein NS1. We show that while these antibodies are non-neutralizing, NS1-specific mAbs can engage Fc gamma R without inducing antibody dependent enhancement (ADE) of infection in vitro. Moreover, we demonstrate that mAb AA12 has protective efficacy against lethal challenges of African and Asian lineage strains of Zika virus in Stat2(-/-) mice. Protection is Fc-dependent, as a mutated antibody unable to activate known Fc effector functions or complement is not protective in vivo. This study highlights the importance of the ZIKV NS1 protein as a potential vaccine antigen.
C1 [Bailey, Mark J.; Duehr, James; Broecker, Felix; Brown, Julia A.; Gonzalez, Maria C. Bermudez; Leyva-Grado, Victor H.; Evans, Matthew J.; Simon, Viviana; Lim, Jean K.; Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Bailey, Mark J.; Duehr, James; Brown, Julia A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Dulin, Harrison; Hai, Rong] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.
   [Arumemi, Fortuna O.; Tan, Gene S.] J Craig Venter Inst, Infect Dis, La Jolla, CA 92037 USA.
   [Gonzalez, Maria C. Bermudez; Simon, Viviana] Icahn Sch Med Mt Sinai, Global Hlth Emerging Pathogens Inst, New York, NY 10029 USA.
   [Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
   [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
   [Tan, Gene S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA.
RP Tan, GS (corresponding author), J Craig Venter Inst, Infect Dis, La Jolla, CA 92037 USA.; Tan, GS (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA.
EM gtan@jcvi.org
RI Leyva-Grado, Victor/AAF-1108-2019; Krammer, Florian/H-3237-2019;
   Broecker, Felix/AAC-5609-2019
OI Leyva-Grado, Victor/0000-0002-9211-6160; Krammer,
   Florian/0000-0003-4121-776X; Duehr, James/0000-0003-2077-6685; Bailey,
   Mark/0000-0003-3874-5334
FU Burroughs Wellcome FundBurroughs Wellcome Fund; J. Craig Venter
   Institute start-up fund;  [1R21AI129477];  [R01AI120998]; 
   [R21AI133649];  [U19A110819]
FX We thank B. Fulton and P. Leon for valuable assistance in plasmablast
   isolation. We also acknowledge the Flow Cytometry Shared Resource
   Facility. This work was supported by 1R21AI129477 (F.K.), R01AI120998
   (V.S), R21AI133649 (M.J.E.). M.J.E. holds an Investigators in
   Pathogenesis of Infectious Disease Award from the Burroughs Wellcome
   Fund. G.S.T. is supported by a J. Craig Venter Institute start-up fund
   and U19A110819. The animal studies performed in this study are in
   accordance with the Institutional Animal Care and Use Committee of the
   Icahn School of Medicine at Mount Sinai and the University of
   California, Riverside.
CR Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   CANE PA, 1988, J GEN VIROL, V69, P1241, DOI 10.1099/0022-1317-69-6-1241
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chu YT, 2017, LAB INVEST, V97, P602, DOI 10.1038/labinvest.2017.10
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428
   DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908
   Duehr J., 2018, MSPHERE, V3
   Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   He WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00928-3
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Petitdemangew C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00209
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   TAN CHC, 1990, J GEN VIROL, V71, P745, DOI 10.1099/0022-1317-71-3-745
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 55
TC 14
Z9 14
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 1
PY 2018
VL 9
AR 4560
DI 10.1038/s41467-018-07008-0
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY9DU
UT WOS:000448940100001
PM 30385750
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zou, J
   Shi, PY
AF Zou, Jing
   Shi, Pei-Yong
TI Targeting vesicle size
SO NATURE MATERIALS
LA English
DT News Item
ID PORE FORMATION; PEPTIDE
AB An amphiphatic peptide has been engineered and is capable of penetrating the blood-brain barrier as well as possessing a potent antiviral activity against Zika and other mosquito-borne viruses.
C1 [Zou, Jing; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
CR Abel S, 2009, ANTIVIR THER, V14, P607
   Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105
   Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105
   Cho NJ, 2007, J AM CHEM SOC, V129, P10050, DOI 10.1021/ja0701412
   Cho NJ, 2009, ACS CHEM BIOL, V4, P1061, DOI 10.1021/cb900149b
   DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012
   Garton M, 2018, P NATL ACAD SCI USA, V115, P1505, DOI 10.1073/pnas.1711837115
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Jackman JA, 2016, J AM CHEM SOC, V138, P1406, DOI 10.1021/jacs.5b12491
   Tabaei SR, 2012, NANO LETT, V12, P5719, DOI 10.1021/nl3029637
NR 10
TC 0
Z9 0
U1 5
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD NOV
PY 2018
VL 17
IS 11
BP 955
EP 956
DI 10.1038/s41563-018-0200-8
PG 2
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA GX8IQ
UT WOS:000448029000008
PM 30353084
OA Green Published
DA 2020-07-08
ER

PT J
AU Richardson, RB
   Ohlson, MB
   Eitson, JL
   Kumar, A
   McDougal, MB
   Boys, IN
   Mar, KB
   De La Cruz-Rivera, PC
   Douglas, C
   Konopka, G
   Xing, C
   Schoggins, JW
AF Richardson, R. Blake
   Ohlson, Maikke B.
   Eitson, Jennifer L.
   Kumar, Ashwani
   McDougal, Matthew B.
   Boys, Ian N.
   Mar, Katrina B.
   De La Cruz-Rivera, Pamela C.
   Douglas, Connor
   Konopka, Genevieve
   Xing, Chao
   Schoggins, John W.
TI A CRISPR screen identifies IFI6 as an ER-resident interferon effector
   that blocks flavivirus replication
SO NATURE MICROBIOLOGY
LA English
DT Article
ID HEPATITIS-C VIRUS; IMMUNOGLOBULIN HEAVY-CHAIN; ENDOPLASMIC-RETICULUM;
   DENGUE VIRUS; BINDING-PROTEIN; GENE 6-16; CELLS; REVEALS; G1P3;
   RESISTANCE
AB The endoplasmic reticulum (ER) is an architecturally diverse organelle that serves as a membrane source for the replication of multiple viruses. Flaviviruses, including yellow fever virus, West Nile virus, dengue virus and Zika virus, induce unique single-membrane ER invaginations that house the viral replication machinery(1). Whether this virus-induced ER remodelling is vulnerable to antiviral pathways is unknown. Here, we show that flavivirus replication at the ER is targeted by the interferon (IFN) response. Through genome-scale CRISPR screening, we uncovered an antiviral mechanism mediated by a functional gene pairing between IFI6 (encoding IFN-alpha-inducible protein 6), an IFN-stimulated gene cloned over 30 years ago(2), and HSPAS, which encodes the ER-resident heat shock protein 70 chaperone BiP. We reveal that IFI6 is an ER-localized integral membrane effector that is stabilized through interactions with BiP. Mechanistically, IFI6 prophylactically protects uninfected cells by preventing the formation of virus-induced ER membrane invaginations. Notably, IFI6 has little effect on other mammalian RNA viruses, including the related Flaviviridae family member hepatitis C virus, which replicates in double-membrane vesicles that protrude outwards from the ER. These findings support a model in which the IFN response is armed with a membrane-targeted effector that discriminately blocks the establishment of virus-specific ER microenvironments that are required for replication.
C1 [Richardson, R. Blake; Ohlson, Maikke B.; Eitson, Jennifer L.; McDougal, Matthew B.; Boys, Ian N.; Mar, Katrina B.; De La Cruz-Rivera, Pamela C.; Schoggins, John W.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
   [Kumar, Ashwani; Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr, Bioinformat Core, Dallas, TX 75390 USA.
   [Douglas, Connor; Konopka, Genevieve] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.
RP Schoggins, JW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
EM john.schoggins@utsouthwestern.edu
OI McDougal, Matthew/0000-0002-3957-8868; Xing, Chao/0000-0002-1838-0502;
   Mar, Katrina/0000-0003-3640-2418
FU NIH T32 Training grants [AI007520, AI005284]; UT Southwestern Endowed
   Scholars program; Rita Allen Foundation; Clayton Foundation for
   Research; National Science Foundation Graduate Research Fellowship
   Program grant [2016217834]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI117922,
   DK095031, UL1TR001105]
FX We thank N. Alto and J. Pfeiffer for critical manuscript feedback, M.
   Diamond and M. Henne for helpful discussions and C. Rice for reagents.
   We acknowledge the technical support of the UT Southwestern Live Cell
   Imaging Core and Electron Microscopy Core. This work was supported in
   part by NIH grants AI117922 and DK095031 (J.W.S.), the UT Southwestern
   Endowed Scholars program (J.W.S.), the Rita Allen Foundation (J.W.S.),
   the Clayton Foundation for Research (J.W.S.) and the National Science
   Foundation Graduate Research Fellowship Program grant 2016217834
   (I.N.B.). C.X. was partially supported by NIH grant UL1TR001105.
   Additional support for R.B.R. and K.B.M. was obtained from NIH T32
   Training grants AI007520 and AI005284, respectively. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the NIH or the other funders.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Cheriyath V, 2012, ONCOGENE, V31, P2222, DOI 10.1038/onc.2011.393
   Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122
   FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97
   Fusco DN, 2013, GASTROENTEROLOGY, V144, P1438, DOI 10.1053/j.gastro.2013.02.026
   GAUT JR, 1993, J BIOL CHEM, V268, P7248
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gjermandsen IM, 2000, CYTOKINE, V12, P233, DOI 10.1006/cyto.1999.0549
   Grigorov B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024135
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x
   Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226
   Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237
   Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550
   Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908
   Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Parker N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-8
   Perelman SS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006102
   Qi HF, 2017, P NATL ACAD SCI USA, V114, P2018, DOI 10.1073/pnas.1614623114
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2
   Vogt D. A, 2015, BIO PROTOC, V5, pe1435
   Wang J, 2017, GENE, V618, P14, DOI 10.1016/j.gene.2017.03.005
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026
NR 40
TC 18
Z9 18
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD NOV
PY 2018
VL 3
IS 11
BP 1214
EP 1223
DI 10.1038/s41564-018-0244-1
PG 10
WC Microbiology
SC Microbiology
GA GY0RK
UT WOS:000448229100008
PM 30224801
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ajamma, YU
   Onchuru, TO
   Ouso, DO
   Omondi, D
   Masiga, DK
   Villinger, J
AF Ajamma, Yvonne Ukamaka
   Onchuru, Thomas Ogao
   Ouso, Daniel O.
   Omondi, David
   Masiga, Daniel K.
   Villinger, Jandouwe
TI Vertical transmission of naturally occurring Bunyamwera and
   insect-specific flavivirus infections in mosquitoes from islands and
   mainland shores of Lakes Victoria and Baringo in Kenya
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; VALLEY FEVER VIRUS; CULEX-PIPIENS DIPTERA;
   AEDES-AEGYPTI; TRANSOVARIAL TRANSMISSION; VECTOR COMPETENCE; DENGUE
   VIRUSES; ZIKA VIRUS; CULICIDAE; ALBOPICTUS
AB Background
   Many arboviruses transmitted by mosquitoes have been implicated as causative agents of both human and animal illnesses in East Africa. Although epidemics of arboviral emerging infectious diseases have risen in frequency in recent years, the extent to which mosquitoes maintain pathogens in circulation during inter-epidemic periods is still poorly understood. This study aimed to investigate whether arboviruses may be maintained by vertical transmission via immature life stages of different mosquito vector species.
   Methodology
   We collected immature mosquitoes (egg, larva, pupa) on the shores and islands of Lake Baringo and Lake Victoria in western Kenya and reared them to adults. Mosquito pools (<= 25 specimens/pool) of each species were screened for mosquito-borne viruses by high-resolution melting analysis and sequencing of multiplex PCR products of genus-specific primers (alphaviruses, flaviviruses, phleboviruses and Bunyamwera-group orthobunya-viruses). We further confirmed positive samples by culturing in baby hamster kidney and Aedes mosquito cell lines and re-sequencing.
   Principal findings
   Culex univittatus (2/31pools) and Anopheles gambiae (1/77 pools) from the Lake Victoria region were positive for Bunyamwera virus, a pathogenic virus that is of public health concern. In addition, Aedes aegypti (3/50), Aedes luteocephalus (3/13), Aedes spp. (2/15), and Culex pipiens (1/140) pools were positive for Aedes flaviviruses at Lake Victoria, whereas at Lake Baringo, three pools of An. gambiae mosquitoes were positive for Anopheles flavivirus. These insect-specific flaviviruses (ISFVs), which are presumably non-pathogenic to vertebrates, were found in known medically important arbovirus and malaria vectors.
   Conclusions
   Our results suggest that not only ISFVs, but also a pathogenic arbovirus, are naturally maintained within mosquito populations by vertical transmission, even in the absence of vertebrate hosts. Therefore, virus and vector surveillance, even during inter-epidemics, and the study of vector-arbovirus-ISFV interactions, may aid in identifying arbovirus transmission risks, with the potential to inform control strategies that lead to disease prevention.
C1 [Ajamma, Yvonne Ukamaka; Onchuru, Thomas Ogao; Ouso, Daniel O.; Omondi, David; Masiga, Daniel K.; Villinger, Jandouwe] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.
   [Onchuru, Thomas Ogao] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Dept Evolutionary Ecol, Mainz, Germany.
   [Omondi, David] Egerton Univ, Biochem & Mol Biol Dept, Egerton, Kenya.
   [Ajamma, Yvonne Ukamaka] Covenant Univ, Covenant Univ Bioinformat Res CUBRe, Dept Comp & Informat Sci, Coll Sci & IT Technol, Ota, Ogun State, Nigeria.
RP Villinger, J (corresponding author), Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.
EM jandouwe@icipe.org
RI onchuru, thomas/AAA-1744-2019
OI Ouso, Daniel/0000-0003-0994-2558; Ajamma, Yvonne/0000-0002-2523-4992;
   Omondi, David/0000-0002-8735-5255; Villinger,
   Jandouwe/0000-0002-5097-6605
FU Swedish International Development Cooperation Agency (Sida) [75000529];
   UK Government; Sida; Swiss Agency for Development and Cooperation (SDC);
   Kenyan Government
FX This work was supported by the Swedish International Development
   Cooperation Agency (Sida) (www.sida.se), grant number 75000529 to YUA as
   an African Regional Postgraduate Programme in Insect Science (ARPPIS)
   scholar; and institutional financial support from UK Aid
   (www.ukaiddirect.org) from the UK Government; Sida; the Swiss Agency for
   Development and Cooperation (SDC) (www.eda.admin.ch/sdc); and the Kenyan
   Government (www.mygov.go.ke).The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. The views expressed herein do not necessarily reflect the
   official opinion of the donors.
CR Ajamma YU, 2016, J MED ENTOMOL, V53, P1348, DOI 10.1093/jme/tjw102
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anderson JF, 2006, J INFECT DIS, V194, P1577, DOI 10.1086/508754
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   Contreras-Gutierrez MA, 2017, AM J TROP MED HYG, V97, P299, DOI 10.4269/ajtmh.16-0987
   Armstrong PM, 2011, JOVE-J VIS EXP, V52, P2889
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   Beckenbach AT, 2011, GENOME, V54, P368, DOI [10.1139/G11-006, 10.1139/g11-006]
   Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Borucki MK, 2002, MICROBES INFECT, V4, P341, DOI 10.1016/S1286-4579(02)01547-2
   Burrell CJ, 2017, FENNER WHITES MED VI, P407, DOI [10.1016/B978-0-12-375156-0.00029-1, DOI 10.1016/B978-0-12-375156-0.00029-1]
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Das Suchismita, 2007, J Vis Exp, P221, DOI 10.3791/221
   Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640
   Edillo FE, 2015, J VECTOR ECOL, V40, P282, DOI 10.1111/jvec.12166
   Edwards F.W., 1941, MOSQUITOES ETHIOPIAN
   Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584
   Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064
   Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9
   Gerberg E., 1994, MANUAL MOSQUITO REAR
   Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004
   Gillies MT, 1987, JOHANNESBURG S AFR I, V55, P1
   Goddard LB, 2003, J MED ENTOMOL, V40, P743, DOI 10.1603/0022-2585-40.6.743
   Grisenti M, 2015, J GEN VIROL, V96, P420, DOI 10.1099/vir.0.069625-0
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Huang YM, 2004, ZOOTAXA, P1
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Jupp P.G., 1996, MOSQUITOES SO AFRICA
   Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   LaBeaud AD, 2011, EMERG INFECT DIS, V17, P233, DOI 10.3201/eid1702.091666
   Lambert AJ, 2009, J CLIN MICROBIOL, V47, P2398, DOI 10.1128/JCM.00182-09
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Lee H. L., 2005, Dengue Bulletin, V29, P106
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434
   LOGAN TM, 1991, J MED ENTOMOL, V28, P293, DOI 10.1093/jmedent/28.2.293
   Lutomiah J, 2014, J MED ENTOMOL, V51, P1091, DOI 10.1603/ME14064
   Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x
   Lutomiah JJL, 2007, J INSECT SCI, V7
   MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P533
   Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371
   Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240
   MILLER BR, 1978, J MED ENTOMOL, V14, P437
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Odhiambo C, 2014, J MED ENTOMOL, V51, P1248, DOI 10.1603/ME14063
   Olanga EA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0860-z
   Omondi CJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1904-y
   Omondi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134375
   Onchuru TO, 2016, INT J TROP INSECT SC, V36, P146, DOI 10.1017/S1742758416000096
   Oncu C, 2018, INFECT GENET EVOL, V57, P36, DOI 10.1016/j.meegid.2017.11.003
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Sang R C, 2001, East Afr Med J, V78, P655
   Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   SHROYER DA, 1986, AM J TROP MED HYG, V35, P408, DOI 10.4269/ajtmh.1986.35.408
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   TESH RB, 1972, SCIENCE, V175, P1477, DOI 10.1126/science.175.4029.1477
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thongrungkiat S, 2011, J VECTOR ECOL, V36, P147, DOI 10.1111/j.1948-7134.2011.00151.x
   TURELL MJ, 1982, AM J TROP MED HYG, V31, P1252, DOI 10.4269/ajtmh.1982.31.1252
   TURELL MJ, 1990, AM J TROP MED HYG, V43, P677, DOI 10.4269/ajtmh.1990.43.677
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Villinger J, 2017, MOL ECOL RESOUR, V17, P466, DOI 10.1111/1755-0998.12584
   WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
NR 84
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006949
DI 10.1371/journal.pntd.0006949
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500053
PM 30452443
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bowman, LR
   Rocklov, J
   Kroeger, A
   Olliaro, P
   Skewes, R
AF Bowman, Leigh R.
   Rocklov, Joacim
   Kroeger, Axel
   Olliaro, Piero
   Skewes, Ronald
TI A comparison of Zika and dengue outbreaks using national surveillance
   data in the Dominican Republic
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS-INFECTION; CROSS-REACTIVITY; ENHANCEMENT; PREVENTION; ANTIBODIES;
   RESPONSES
AB Background
   Aedes-borne arboviruses continue to precipitate epidemics worldwide. In Dominican Republic, the appearance of Zika virus cases that closely followed a large dengue epidemic provided an opportunity to study the different transmission drivers behind these two flaviviruses. Retrospective datasets were used to collect information on the populations at risk and descriptive statistics were used to describe the outbreaks on a national scale.
   Methodology/Principal findings
   Expectedly, box plots showed that 75% of dengue was reported in those aged <20 years while Zika infections were more widely dispersed among the population. Dengue attack rates were marginally higher among males at 25.9 per 10,000 population vs. 21.5 per 10,000 population for females. Zika infections appeared to be highly clustered among females (73.8% (95% CI 72.6%, 75.0%; p<0.05)); age-adjusted Zika attack rates among females were 7.64 per 10,000 population compared with 2.72 per 10,000 population among males. R0 calculations stratified by sex also showed a significantly higher metric among females: 1.84 (1.82, 1.87; p<0.05) when compared to males at 1.72 (1.69, 1.75; p<0.05). However, GBS attack rates stratified by sex revealed slightly higher risk in males vs. females, at 0.62 and 0.57 per 10,000 population respectively.
   Conclusions/Significance
   Evidence suggests little impact of existing dengue immunity on reported attack rates of Zika at the population level. Confounding of R0 and incident risk calculations by sex-specific over-reporting can alter the reliability of epidemiological metrics, which could be addressed using associated proxy syndromes or conditions to explore seemingly sex-skewed incidence. The findings indicate that community awareness campaigns, through influencing short-term health seeking behaviour, remain the most plausible mechanism behind increased reporting among women of reproductive age, although biological susceptibility cannot yet be ruled out. Media campaigns and screening are therefore recommended for women of reproductive age during Zika outbreaks. Future research should focus on clinical Zika outcomes among dengue seropositive individuals.
C1 [Bowman, Leigh R.; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Unit Epidemiol & Global Hlth, Umea, Sweden.
   [Bowman, Leigh R.; Kroeger, Axel; Olliaro, Piero] UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
   [Skewes, Ronald] Minist Hlth, Dept Publ Hlth, Santo Domingo, Dominican Rep.
RP Bowman, LR (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Unit Epidemiol & Global Hlth, Umea, Sweden.; Bowman, LR (corresponding author), UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
EM leigh.bowman@gmail.com
OI Bowman, Leigh/0000-0003-0657-7911; Rocklov, Joacim/0000-0003-4030-0449
FU Umea University; Swedish Research CouncilSwedish Research Council
   [349-2007-8673]; WHO-TDRWorld Health Organization; European Union's
   Horizon 2020 research and innovation programme under ZikaPLAN grant
   [734584]
FX This work was performed as part of the Umea Centre for Microbial
   Research (UCMR) Linnaeus Program supported by Umea University and the
   Swedish Research Council (grant no. 349-2007-8673). LRB received partial
   funding from WHO-TDR. The funders had no influence on the research
   conducted. JR received partial funding from the European Union's Horizon
   2020 research and innovation programme under ZikaPLAN grant agreement No
   734584. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]
   [Anonymous], 2017, ESTR RIESG BROT ENF
   [Anonymous], 2010, MICR EXC MAC 2011 VE
   [Anonymous], RSTUDIO VERS 0 99 90
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bowman LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157971
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Li J., 2011, ADV PHYS CHEM, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0021506
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Olliaro P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005967
   Ooi Eng Eong, 2001, Dengue Bulletin, V25, P40
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Report S, 2017, ZIK VIR MICR GUILL B
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   World Health Organization, 2017, DENG CONTR
   Wunderground, 2017, WEATH CO IBM BUS 201
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 30
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006876
DI 10.1371/journal.pntd.0006876
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500023
PM 30395564
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brustolin, M
   Pujhari, S
   Henderson, CA
   Rasgon, JL
AF Brustolin, Marco
   Pujhari, Sujit
   Henderson, Cory A.
   Rasgon, Jason L.
TI Anopheles mosquitoes may drive invasion and transmission of Mayaro virus
   across geographically diverse regions
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA VIRUS; DENGUE VIRUS; INFECTION; EVOLUTIONARY; OUTBREAK;
   DIPTERA; VECTOR
AB The Togavirus (Alphavirus) Mayaro virus (MAYV) was initially described in 1954 from Mayaro County (Trinidad) and has been responsible for outbreaks in South America and the Caribbean. Imported MAYV cases are on the rise, leading to invasion concerns similar to Chikungunya and Zika viruses. Little is known about the range of mosquito species that are competent MAYV vectors. We tested vector competence of 2 MAYV genotypes in laboratory strains of six mosquito species (Aedes aegypti, Anopheles freeborni, An. gambiae, An. quadrimaculatus, An. stephensi, Culex quinquefasciatus). Ae. aegypti and Cx. quinquefasciatus were poor MAYV vectors, and had either poor or null infection and transmission rates at the tested viral challenge titers. In contrast, all Anopheles species were able to transmit MAYV, and 3 of the 4 species transmitted both genotypes. The Anopheles species tested are divergent and native to widely separated geographic regions (Africa, Asia, North America), suggesting that Anopheles may be important in the invasion and spread of MAYV across diverse regions of the world.
C1 [Brustolin, Marco; Pujhari, Sujit; Henderson, Cory A.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
RP Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
EM jlr54@psu.edu
OI Brustolin, Marco/0000-0002-3594-4488
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI116636,
   R01AI128201, R21AI128918]
FX This research was supported by the National Institutes of Health
   (nih.gov) grants R01AI116636, R01AI128201, and R21AI128918. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   GALINDO P, 1967, AM J TROP MED HYG, V16, P525, DOI 10.4269/ajtmh.1967.16.525
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   KLOWDEN MJ, 1994, J MED ENTOMOL, V31, P618, DOI 10.1093/jmedent/31.4.618
   Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Levine RS, 2004, J MED ENTOMOL, V41, P607, DOI 10.1603/0022-2585-41.4.607
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39
   Rezza G, 2017, PATHOG GLOB HEALTH, V111, P271, DOI 10.1080/20477724.2017.1355431
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Tesh RB, MAYARO VIRUS DIS EME
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   Yadav P, 2003, ACTA VIROL, V47, P45
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 32
TC 10
Z9 10
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006895
DI 10.1371/journal.pntd.0006895
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500028
PM 30403665
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Heffron, AS
   Mohr, EL
   Baker, D
   Haj, AK
   Buechler, CR
   Bailey, A
   Dudley, DM
   Newman, CM
   Mohns, MS
   Koenig, M
   Breitbach, ME
   Rasheed, M
   Stewart, LM
   Eickhoff, J
   Pinapati, RS
   Beckman, E
   Li, HY
   Patel, J
   Tan, JC
   O'Connor, DH
AF Heffron, Anna S.
   Mohr, Emma L.
   Baker, David
   Haj, Amelia K.
   Buechler, Connor R.
   Bailey, Adam
   Dudley, Dawn M.
   Newman, Christina M.
   Mohns, Mariel S.
   Koenig, Michelle
   Breitbach, Meghan E.
   Rasheed, Mustafa
   Stewart, Laurel M.
   Eickhoff, Jens
   Pinapati, Richard S.
   Beckman, Erica
   Li, Hanying
   Patel, Jigar
   Tan, John C.
   O'Connor, David H.
TI Antibody responses to Zika virus proteins in pregnant and non-pregnant
   macaques
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS; DENGUE; INFECTION; IMMUNOASSAY;
   INOCULATION; DIAGNOSIS; RATES; IGM
AB The specificity of the antibody response against Zika virus (ZIKV) is not well-characterized. This is due, in part, to the antigenic similarity between ZIKV and closely related dengue virus (DENV) serotypes. Since these and other similar viruses co-circulate, are spread by the same mosquito species, and can cause similar acute clinical syndromes, it is difficult to disentangle ZIKV-specific antibody responses from responses to closely-related arboviruses in humans. Here we use high-density peptide microarrays to profile anti-ZIKV antibody reactivity in pregnant and non-pregnant macaque monkeys with known exposure histories and compare these results to reactivity following DENV infection. We also compare cross-reactive binding of ZIKV-immune sera to the full proteomes of 28 arboviruses. We independently confirm a purported ZIKV-specific IgG antibody response targeting ZIKV nonstructural protein 2B (NS2B) that was recently reported in ZIKV-infected people and we show that antibody reactivity in pregnant animals can be detected as late as 127 days post-infection (dpi). However, we also show that these responses wane over time, sometimes rapidly, and in one case the response was elicited following DENV infection in a previously ZIKV-exposed animal. These results suggest epidemiologic studies assessing seroprevalence of ZIKV immunity using linear epitope-based strategies will remain challenging to interpret due to susceptibility to false positive results. However, the method used here demonstrates the potential for rapid profiling of proteome-wide antibody responses to a myriad of neglected diseases simultaneously and may be especially useful for distinguishing antibody reactivity among closely related pathogens.
C1 [Heffron, Anna S.; Baker, David; Haj, Amelia K.; Buechler, Connor R.; Bailey, Adam; Dudley, Dawn M.; Newman, Christina M.; Mohns, Mariel S.; Koenig, Michelle; Breitbach, Meghan E.; Rasheed, Mustafa; Stewart, Laurel M.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Mohr, Emma L.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA.
   [Eickhoff, Jens] Univ Wisconsin Madison, Dept Biostat & Med Informat, Madison, WI USA.
   [Pinapati, Richard S.; Beckman, Erica; Li, Hanying; Patel, Jigar; Tan, John C.] Roche Sequencing Solut, Technol Innovat, Madison, WI USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.
EM dhoconno@wisc.edu
RI Pinapati, Richard S/O-1010-2014; amsalu, ribka/G-8780-2019
OI Pinapati, Richard S/0000-0001-7763-4800; Heffron,
   Anna/0000-0001-7555-4137; Haj, Amelia/0000-0002-1453-341X; Baker,
   David/0000-0002-6811-8238
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI116382,
   R24OD017850]; Pediatric Infectious Diseases Society Fellowship Award -
   Sanofi Pasteur (ELM); National Institutes of Health National Research
   Service AwardUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32 AI078985]
FX This study was supported by the National Institutes of Health grants
   R01AI116382 and R24OD017850 (ASH, AKH, CRB, AB, DMD, CMN, MK, MEB, MR,
   LMS, DHO): https://www.nih.gov/.This study was also supported by the
   Pediatric Infectious Diseases Society Fellowship Award funded by Stanley
   A. Plotkin and Sanofi Pasteur (ELM). Finally, this study was also
   supported by the National Institutes of Health National Research Service
   Award T32 AI078985 (ASH). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Azeredo EL, 2018, PLOS CURR, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Bailey AL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006692
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Christiansen A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12913
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Winter J, 2013, PRACT ASSESS RES EVA, V18, P10, DOI DOI 10.7275/E4R6-DJ05
   Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Engmark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36629
   ERTURK M, 1989, MED MICROBIOL IMMUN, V178, P199
   Forsstrom B, 2014, MOL CELL PROTEOMICS, V13, P1585, DOI 10.1074/mcp.M113.033308
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Lyamichev VI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12440-1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pahar B, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0652-x
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Ronnberg B, 2017, MED MICROBIOL IMMUN, V206, P383, DOI 10.1007/s00430-017-0517-y
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Steffen W, 2017, J BIOL CHEM, V292, P15622, DOI 10.1074/jbc.M117.797811
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Tokarz R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21349-2
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu X, 2016, PLOS CURR, V8
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zandian A, 2017, J PROTEOME RES, V16, P1300, DOI 10.1021/acs.jproteome.6b00916
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 57
TC 2
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006903
DI 10.1371/journal.pntd.0006903
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500031
PM 30481182
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moser, LA
   Boylan, BT
   Moreira, FR
   Myers, LJ
   Svenson, EL
   Fedorova, NB
   Pickett, BE
   Bernard, KA
AF Moser, Lindsey A.
   Boylan, Brendan T.
   Moreira, Fernando R.
   Myers, Laurel J.
   Svenson, Emma L.
   Fedorova, Nadia B.
   Pickett, Brett E.
   Bernard, Kristen A.
TI Growth and adaptation of Zika virus in mammalian and mosquito cells
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; SEXUAL TRANSMISSION; BORNE TRANSMISSION; EVOLUTION;
   GLYCOSYLATION; FLAVIVIRUSES; PATHOGENESIS; CHOLESTEROL; INFECTIONS;
   ENVELOPE
AB The recent emergence of Zika virus (ZIKV) in the Americas coincident with increased caseloads of microcephalic infants and Guillain-Barre syndrome has prompted a flurry of research on ZIKV. Much of the research is difficult to compare or repeat because individual laboratories use different virus isolates, growth conditions, and quantitative assays. Here we obtained three readily available contemporary ZIKV isolates and the prototype Ugandan isolate. We generated stocks of each on Vero mammalian cells (ZIKV(mam)) and C6/36 mosquito cells (ZIKV(mos)), determined titers by different assays side-by-side, compared growth characteristics using one-step and multi-step growth curves on Vero and C6/36 cells, and examined plaque phenotype. ZIKV titers consistently peaked earlier on Vero cells than on C6/36 cells. Contemporary ZIKV isolates reached peak titer most quickly in a multi-step growth curve when the amplifying cell line was the same as the titering cell line (e.g., ZIKV(mam) titered on Vero cells). Growth of ZIKV(mam) on mosquito cells was particularly delayed. These data suggest that the ability to infect and/or replicate in insect cells is limited after growth in mammalian cells. In addition, ZIKV(mos) typically had smaller, more homogenous plaques than ZIKV(mam) in a standard plaque assay. We hypothesized that the plaque size difference represented early adaptation to growth in mammalian cells. We plaque purified representative-sized plaques from ZIKV(mos) and ZIKV(mam). ZIKV(mos) isolates maintained the initial phenotype while plaques from ZIKV(mam) isolates became larger with passaging. Our results underscore the importance of the cells used to produce viral stocks and the potential for adaptation with minimal cell passages. In addition, these studies provide a foundation to compare current and emerging ZIKV isolates in vitro and in vivo.
C1 [Moser, Lindsey A.; Boylan, Brendan T.; Moreira, Fernando R.; Myers, Laurel J.; Svenson, Emma L.; Bernard, Kristen A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Fedorova, Nadia B.; Pickett, Brett E.] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA.
RP Bernard, KA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM kristen.bernard@wisc.edu
RI Pickett, Brett/AAE-3582-2020
OI Pickett, Brett/0000-0001-7930-8160
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01-AI099231-01,
   1R21AI137606-01, U19-AI110819, T32AI007414]
FX This work was supported in part by National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health under Award
   Numbers R01-AI099231-01 (KAB), 1R21AI137606-01 (KAB), U19-AI110819
   (BEP), and training grant T32AI007414 (FRM). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Boylan BT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005394
   Brooks SA, 2006, EXPERT REV PROTEOMIC, V3, P345, DOI 10.1586/14789450.3.3.345
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Ciota AT, 2010, VIRUSES-BASEL, V2, P2594, DOI 10.3390/v2122594
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Ebel GD, 2011, J VIROL, V85, P12605, DOI 10.1128/JVI.05637-11
   Fitzpatrick KA, 2010, VIROLOGY, V404, P89, DOI 10.1016/j.virol.2010.04.029
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grubaugh ND, 2016, CURR OPIN VIROL, V21, P132, DOI 10.1016/j.coviro.2016.09.007
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lim PY, 2010, VIROLOGY, V400, P93, DOI 10.1016/j.virol.2010.01.029
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moser LA, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.01528-17, 10.1128/genomea.01528-17]
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528
   WEAVER SC, 1992, CURR TOP MICROBIOL, V176, P99
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 63
TC 10
Z9 10
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006880
DI 10.1371/journal.pntd.0006880
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500024
PM 30418969
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pavia-Ruz, N
   Barrera-Fuentes, GA
   Villanueva-Jorge, S
   Che-Mendoza, A
   Campuzano-Rincon, JC
   Manrique-Saide, P
   Rojas, DP
   Vazquez-Prokopec, GM
   Halloran, ME
   Longini, IM
   Gomez-Dantes, H
AF Pavia-Ruz, Norma
   Abigail Barrera-Fuentes, Gloria
   Villanueva-Jorge, Salha
   Che-Mendoza, Azael
   Cesar Campuzano-Rincon, Julio
   Manrique-Saide, Pablo
   Rojas, Diana Patricia
   Vazquez-Prokopec, Gonzalo M.
   Halloran, M. Elizabeth
   Longini, Ira M.
   Gomez-Dantes, Hector
TI Dengue seroprevalence in a cohort of schoolchildren and their siblings
   in Yucatan, Mexico (2015-2016)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; CHILDREN; TRANSMISSION; ANTIBODIES; EPIDEMIOLOGY; INFECTION;
   THAILAND; AMERICA; AEGYPTI
AB Background
   The implementation of vector control interventions and potential introduction new tools requires baseline data to evaluate their direct and indirect effects. The objective of the study is to present the seroprevalence of dengue infection in a cohort of children 0 to 15 years old followed during 2015 to 2016, the risk factors and the role of enhanced surveillance strategies in three urban sites (Merida, Ticul and Progreso) in Yucatan, Mexico.
   Methods
   A cohort of school children and their family members was randomly selected in three urban areas with different demographic, social conditions and levels of transmission. We included results from 1,844 children aged 0 to 15 years. Serum samples were tested for IgG, NS1 and IgM. Enhanced surveillance strategies were established in schools (absenteeism) and cohort families (toll-free number).
   Results
   Seroprevalence in children 0 to 15 years old was 46.8 (CI 95% 44.1-49.6) with no difference by sex except in Ticul. Prevalence increased with age and was significantly lower in 0 to 5 years old (26.9%, 95% CI: 18.4-35.4) compared with 6 to 8 years old (43.9%, 95% CI: 40.1-47.7) and 9 to 15 years old (61.4%, 95% CI: 58.0-64.8). Sharing the domestic space with other families increased the risk 1.7 times over the individual families that own or rented their house, while risk was significantly higher when kitchen and bathroom were outside. Complete protection with screens in doors and windows decreased risk of infection. Seroprevalence was significantly higher in the medium and high risk areas.
   Conclusions
   The prevalence of antibodies in children 0 to 15 years in three urban settings in the state of Yucatan describe the high exposure and the heterogenous transmission of dengue virus by risk areas and between schools in the study sites. The enhanced surveillance strategy was useful to improve detection of dengue cases with the coincident transmission of chikungunya and Zika viruses.
C1 [Pavia-Ruz, Norma; Abigail Barrera-Fuentes, Gloria; Che-Mendoza, Azael] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Venezuela.
   [Villanueva-Jorge, Salha] Serv Salud Yucatan, Lab Estatal Salud Publ & Referencia Epidemiol, Merida, Yucatan, Venezuela.
   [Cesar Campuzano-Rincon, Julio] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Merida, Yucatan, Venezuela.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Campus Ciencias Biol & Agropecuarias, Merida, Yucatan, Mexico.
   [Rojas, Diana Patricia; Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Rojas, Diana Patricia; Halloran, M. Elizabeth; Longini, Ira M.] Ctr Inference & Dynam Infect Dis, Seattle, WA USA.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Gomez-Dantes, Hector] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Mexico City, DF, Mexico.
RP Gomez-Dantes, H (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Mexico City, DF, Mexico.
EM hector.gomez@insp.mx
RI Rojas, Diana Patricia/AAC-2469-2019
OI Rojas, Diana Patricia/0000-0003-0241-6416; Halloran, M
   Elizabeth/0000-0002-3127-1757; MANRIQUE-SAIDE,
   PABLO/0000-0002-0565-1342; Barrera, Gloria/0000-0001-8491-5803
FU Sanofi-Pasteur Laboratories [DNG25]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R37 AI032042]; National
   Institute of General Medical Sciences from NIH [U54 GM111274]
FX Sanofi-Pasteur Laboratories (DNG25); National Institute of Allergy and
   Infectious Diseases (R37 AI032042) and National Institute of General
   Medical Sciences (U54 GM111274) from NIH financed this Project. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amaya-Larios IY, 2014, AM J TROP MED HYG, V91, P1057, DOI 10.4269/ajtmh.14-0145
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2013, ACTA TROP, V113, P16
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chavez-Arias NP, 2017, STUDYING SOCIOCULTUR
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Endy TP, PLOS NEGL TROP DIS, V5, pe975
   Escobar-Mesa J, 2003, SALUD PUBLICA MEXICO, V45, P43, DOI 10.1590/s0036-36342003000100006
   Farfan-Ale J A, 1991, Bol Med Hosp Infant Mex, V48, P780
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Garg S, 2017, INT J INFECT DIS, V54, P25, DOI 10.1016/j.ijid.2016.10.030
   Gomez-Caro S, 2017, JOURNAL OF EPIDEMIOL, V3, P23
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Instituto Nacional de Estadistica y Geogragia (INEGI), 2010, AN EST ENT FED 2010
   Jeewandara C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144799
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   Lindsay SW, 2017, B WORLD HEALTH ORGAN, V95, P607, DOI 10.2471/BLT.16.189688
   Lorono-Pino MA, 1985, REV LAT AM MICROBIOL, V31, P259
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Manrique-Saide P, 2014, MED VET ENTOMOL, V28, P264, DOI 10.1111/mve.12046
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Perkins TA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0390
   Ratanawong P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161895
   Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656
   Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Sarti E, 2015, INFECT DIS THER, V4, P199, DOI 10.1007/s40121-015-0068-8
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Shen S, 2015, NAT PUBL GR, P1
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Souza Ludmila Sophia, 2012, Rev. bras. epidemiol., V15, P761, DOI 10.1590/S1415-790X2012000400008
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Vazquez-Prokopec GM, 2016, T ROY SOC TROP MED H, V110, P567, DOI 10.1093/trstmh/trw070
   Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996
   Yoksan S, 2009, J CLIN VIROL, V46, pS13, DOI 10.1016/S1386-6532(09)70289-6
   Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357
NR 50
TC 1
Z9 1
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006748
DI 10.1371/journal.pntd.0006748
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500004
PM 30462654
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Rojas, DP
   Barrera-Fuentes, GA
   Pavia-Ruz, N
   Salgado-Rodriguez, M
   Che-Mendoza, A
   Manrique-Saide, P
   Vazquez-Prokopec, GM
   Halloran, ME
   Longini, IM
   Gomez-Dantes, H
AF Rojas, Diana Patricia
   Abigail Barrera-Fuentes, Gloria
   Pavia-Ruz, Norma
   Salgado-Rodriguez, Mariel
   Che-Mendoza, Azael
   Manrique-Saide, Pablo
   Vazquez-Prokopec, Gonzalo M.
   Halloran, M. Elizabeth
   Longini, Ira M.
   Gomez-Dantes, Hector
TI (E)pidemiology of dengue and other arboviruses in a cohort of school
   children and their families in Yucatan, Mexico: Baseline and first year
   follow-up
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; INFECTION; AMERICA; SCHOOLCHILDREN; EPIDEMIOLOGY;
   TRANSMISSION; DIAGNOSIS; DISEASE; BURDEN
AB Dengue is the most prevalent mosquito-borne viral disease of humans and is caused by the four serotypes of dengue virus. To estimate the incidence of dengue and other arboviruses, we analyzed the baseline and first year follow-up of a prospective school-based cohort study and their families in three cities in the state of Yucatan, Mexico. Through enhanced surveillance activities, acute febrile illnesses in the participants were detected and yearly blood samples were collected to evaluate dengue infection incidence. A Cox model was fitted to identify hazard ratios of arboviral infections in the first year of follow-up of the cohort. The incidence of dengue symptomatic infections observed during the first year of follow-up (2015-2016) was 3.5 cases per 1,000 person-years (95% CI: 1.9, 5.9). The incidence of dengue infections was 33.9 infections per 1,000 person-years (95% CI: 31.7, 48.0). The majority of dengue infections and seroconversions were observed in the younger age groups (<= 14 years old). Other arboviruses were circulating in the state of Yucatan during the study period. The incidence of symptomatic chikungunya infections was 8.6 per 1,000 person-years (95% CI: 5.8, 12.3) and the incidence of symptomatic Zika infections was 2.3 per 1,000 person-years (95% CI: 0.9, 4.5). Our model shows that having a dengue infection during the first year of follow-up was significantly associated with being female, living in Ticul or Progreso, and being dengue naive at baseline. Age was not significantly associated with the outcome, it was confounded by prior immunity to dengue that increases with age. This is the first report of a cohort in Latin America that provides incidence estimates of the three arboviruses co-circulating in all age groups. This study provides important information for understanding the epidemiology of dengue and other arboviruses and better informing public health policies.
C1 [Rojas, Diana Patricia; Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA.
   [Rojas, Diana Patricia; Halloran, M. Elizabeth; Longini, Ira M.] Ctr Inference & Dynam Infect Dis, Seattle, WA 98109 USA.
   [Abigail Barrera-Fuentes, Gloria; Pavia-Ruz, Norma; Salgado-Rodriguez, Mariel; Che-Mendoza, Azael] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Mexico.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Gomez-Dantes, Hector] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.
RP Rojas, DP (corresponding author), Univ Florida, Dept Biostat, Gainesville, FL 32611 USA.; Rojas, DP (corresponding author), Ctr Inference & Dynam Infect Dis, Seattle, WA 98109 USA.
EM dprojas@ufl.edu
RI Rojas, Diana Patricia/AAC-2469-2019
OI Rojas, Diana Patricia/0000-0003-0241-6416; Barrera,
   Gloria/0000-0001-8491-5803; Halloran, M Elizabeth/0000-0002-3127-1757
FU Sanofi Pasteur project [DNG25]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R37 AI032042,
   MIDAS U54 GM111274]; Fulbright-Colciencias doctoral scholarship
FX This project was funded by Sanofi Pasteur project DNG25. IML and MEH
   were partially supported by NIH grant R37 AI032042. IML, MEH and DPR
   where partially supported by the NIH grant MIDAS U54 GM111274. DPR had a
   Fulbright-Colciencias doctoral scholarship. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Allison PD, 2014, EVENT HIST SURVIVAL, V46
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, P3, DOI DOI 10.1371/J0URNAL.PNTD.0004551
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Cruz MM, 2017, J IMMUNOL S, V198
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145
   Fleming TR, 2011, COUNTING PROCESSES S
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, P2004, DOI DOI 10.HTTPS://D0I.0RG/10.1371/J0URNAL.PNTD
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Horstick O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003311
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Kalbfleisch JD, 2011, STAT ANAL FAILURE TI, V360
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan-American Health Organization, NUMB REP CAS CHIK FE, P1178, DOI [10.1093/oxfordjournals.aje.a115829, DOI 10.1093/OXFORDJOURNALS.AJE.A115829]
   Pan-American Health Organization Centers for Disease Control, 2011, PREP RESP CHIK VIR I
   Pasteur Sanofi, 2017, DENGUE VACCINE REGIS
   Pavia-Ruz N, 2018, AM J TROP MED HYG, V98, P1202, DOI 10.4269/ajtmh.17-0382
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   R Core Team, 2015, R LANG ENV STAT COMP
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Runge-Ranzinger S, 2008, TROP MED INT HEALTH, V13, P1022, DOI 10.1111/j.1365-3156.2008.02112.x
   Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Secretaria de Salud de Mexico, 2016, EP INF DENG MEX
   Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X
   Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180
   Tissera H, 2014, AM J TROP MED HYG, V91, P132, DOI 10.4269/ajtmh.13-0540
   Toan NT, 2015, TROP MED INT HEALTH, V20, P840, DOI 10.1111/tmi.12498
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 70
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2018
VL 12
IS 11
AR e0006847
DI 10.1371/journal.pntd.0006847
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HC9XZ
UT WOS:000452162500017
PM 30462635
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Grobler, Y
   Yun, CY
   Kahler, DJ
   Bergman, CM
   Lee, H
   Oliver, B
   Lehmann, R
AF Grobler, Yolande
   Yun, Chi Y.
   Kahler, David J.
   Bergman, Casey M.
   Lee, Hangnoh
   Oliver, Brian
   Lehmann, Ruth
TI Whole genome screen reveals a novel relationship between Wolbachia
   levels and Drosophila host translation
SO PLOS PATHOGENS
LA English
DT Article
ID MOSQUITO CELL-LINE; WIDE RNAI SCREEN; DENGUE VIRUS; GENE-EXPRESSION;
   READ ALIGNMENT; BLOCKS DENGUE; ZIKA VIRUS; AEDES; STRAIN; WMEL
AB Wolbachia is an intracellular bacterium that infects a remarkable range of insect hosts. Insects such as mosquitos act as vectors for many devastating human viruses such as Dengue, West Nile, and Zika. Remarkably, Wolbachia infection provides insect hosts with resistance to many arboviruses thereby rendering the insects ineffective as vectors. To utilize Wolbachia effectively as a tool against vector-borne viruses a better understanding of the host-Wolbachia relationship is needed. To investigate Wolbachia-insect interactions we used the Wolbachia/Drosophila model that provides a genetically tractable system for studying host-pathogen interactions. We coupled genome-wide RNAi screening with a novel high-throughput fluorescence in situ hybridization (FISH) assay to detect changes in Wolbachia levels in a Wolbachia-infected Drosophila cell line JW18. 1117 genes altered Wolbachia levels when knocked down by RNAi of which 329 genes increased and 788 genes decreased the level of Wolbachia. Validation of hits included in depth secondary screening using in vitro RNAi, Drosophila mutants, and Wolbachia-detection by DNA qPCR. A diverse set of host gene networks was identified to regulate Wolbachia levels and unexpectedly revealed that perturbations of host translation components such as the ribosome and translation initiation factors results in increased Wolbachia levels both in vitro using RNAi and in vivo using mutants and a chemical-based translation inhibition assay. This work provides evidence for Wolbachia-host translation interaction and strengthens our general understanding of the Wolbachia-host intracellular relationship.
C1 [Grobler, Yolande; Lehmann, Ruth] NYU, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, New York, NY 10016 USA.
   [Grobler, Yolande; Lehmann, Ruth] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10003 USA.
   [Yun, Chi Y.; Kahler, David J.] NYU, Langone Med Ctr, High Throughput Biol Core, Skirball Inst, New York, NY USA.
   [Bergman, Casey M.] Univ Georgia, Dept Genet, Athens, GA 30602 USA.
   [Bergman, Casey M.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA.
   [Lee, Hangnoh; Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, Bethesda, MD 20892 USA.
RP Lehmann, R (corresponding author), NYU, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, New York, NY 10016 USA.; Lehmann, R (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10003 USA.
EM ruth.lehmann@med.nyu.edu
RI Kahler, David J/I-9275-2019; Bergman, Casey/F-7854-2010
OI Kahler, David J/0000-0002-7144-2215; Lee, Hangnoh/0000-0003-0442-8330;
   Lehmann, Ruth/0000-0002-8454-5651; Bergman, Casey/0000-0002-5462-9854
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute; Georgia
   Research Foundation; Intramural Research Programs of the National
   Institutes of Health (NIH), National Institute of Diabetes and Digestive
   and Kidney Diseases (NIDDK); NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [P30CA016087,
   P40OD018537]
FX This research was supported by the Howard Hughes Medical Institute (RL)
   and RL is an investigator of the Howard Hughes Medical Institute. CMB
   received funding from the Georgia Research Foundation. HL and BO
   received funding from the Intramural Research Programs of the National
   Institutes of Health (NIH), National Institute of Diabetes and Digestive
   and Kidney Diseases (NIDDK). The NYU School of Medicine Genome
   Technology Center and High Throughput Core facility are supported by NIH
   P30CA016087. The Bloomington Drosophila Stock Center is supported by NIH
   P40OD018537. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008
   Akimana C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011025
   Albertson R, 2009, J CELL SCI, V122, P4570, DOI 10.1242/jcs.054981
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Baldridge G, 2017, RES MICROBIOL, V168, P609, DOI 10.1016/j.resmic.2017.04.005
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670
   Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Christensen S, 2016, APPL ENVIRON MICROB, V82, P5354, DOI 10.1128/AEM.01255-16
   Chrostek E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002065
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010
   de Abreu LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098966
   Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155
   Fallon AM, 2009, IN VITRO CELL DEV-AN, V45, P460, DOI 10.1007/s11626-009-9193-6
   Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014
   Fontana MF, 2012, INFECT IMMUN, V80, P3570, DOI 10.1128/IAI.00557-12
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gutzwiller F, 2015, G3-GENES GENOM GENET, V5, P2843, DOI 10.1534/g3.115.021931
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hempstead AD, 2015, P NATL ACAD SCI USA, V112, pE6790, DOI 10.1073/pnas.1508716112
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114
   Hu YH, 2013, GENETICS, V195, P37, DOI 10.1534/genetics.113.151340
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Jiggins FM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002780
   Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09
   Kersey PJ, 2014, NUCLEIC ACIDS RES, V42, pD546, DOI 10.1093/nar/gkt979
   Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lee H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-8-r70
   Lemaitre B, 2013, NAT REV MICROBIOL, V11, P365, DOI 10.1038/nrmicro3029
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Newton ILG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004798
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006
   Pietri JE, 2016, MICROBIOLOGYOPEN, V5, P923, DOI 10.1002/mbo3.390
   Prasov L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012315
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rice DW, 2017, GENOME BIOL EVOL, V9, P1925, DOI 10.1093/gbe/evx139
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Sanchez CG, 2016, CELL STEM CELL, V18, P276, DOI 10.1016/j.stem.2015.11.004
   Saucereau Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3985-y
   Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Serbus LR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002922
   Serbus LR, 2011, J CELL SCI, V124, P4299, DOI 10.1242/jcs.092510
   Sheehan KB, 2016, MBIO, V7, DOI 10.1128/mBio.00622-16
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vinayagam A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003629
   Voronin D A, 2004, Dokl Biol Sci, V396, P227, DOI 10.1023/B:DOBS.0000033284.76770.c1
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169
   WRIGHT JD, 1980, J ULTRA MOL STRUCT R, V72, P52, DOI 10.1016/S0022-5320(80)90135-5
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Ye YH, 2016, AM J TROP MED HYG, V94, P812, DOI 10.4269/ajtmh.15-0801
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 88
TC 4
Z9 4
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2018
VL 14
IS 11
AR e1007445
DI 10.1371/journal.ppat.1007445
PG 34
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HC5GP
UT WOS:000451831800040
PM 30422992
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Souza, TMA
   Ribeiro, ED
   Correa, VCE
   Damasco, PV
   Santos, CC
   de Bruycker-Nogueira, F
   Chouin-Carneiro, T
   Faria, NRD
   Nunes, PCG
   Heringer, M
   Lima, MDQ
   Badolato-Correa, J
   Cipitelli, MD
   de Azeredo, EL
   Nogueira, RMR
   dos Santos, FB
AF Alves de Souza, Thiara Manuele
   Ribeiro, Edcelha D'Athaide
   Correa e Correa, Valmir
   Damasco, Paulo Vieira
   Santos, Carla Cunha
   de Bruycker-Nogueira, Fernanda
   Chouin-Carneiro, Thais
   da Costa Faria, Nieli Rodrigues
   Guerra Nunes, Priscila Conrado
   Heringer, Manoela
   Queiroz Lima, Monique da Rocha
   Badolato-Correa, Jessica
   Cipitelli, Marcio da Costa
   de Azeredo, Elzinandes Leal
   Ribeiro Nogueira, Rita Maria
   dos Santos, Flavia Barreto
TI Following in the Footsteps of the Chikungunya Virus in Brazil: The First
   Autochthonous Cases in Amapa in 2014 and Its Emergence in Rio de Janeiro
   during 2016
SO VIRUSES-BASEL
LA English
DT Article
DE chikungunya virus; surveillance; co-infection; ECSA genotype; Asian
   genotype; Brazil
ID PHYLOGENETIC ANALYSES; STRUCTURAL PROTEINS; DENGUE VIRUSES;
   INDIAN-OCEAN; INFECTION; EPIDEMIC; ARTHRALGIA; TRAVELERS; ZIKA;
   TRANSMISSION
AB Currently, Brazil lives a triple arboviruses epidemic (DENV, ZIKV and CHIKV) making the differential diagnosis difficult for health professionals. Here, we aimed to investigate chikungunya cases and the possible occurrence of co-infections during the epidemic in Amapa (AP) that started in 2014 when the first autochthonous cases were reported and in Rio de Janeiro (RJ) in 2016. We further performed molecular characterization and genotyping of representative strains. In AP, 51.4% of the suspected cases were confirmed for CHIKV, 71.0% (76/107). Of those, 24 co-infections by CHIKV/DENV, two by CHIKV/DENV-1, and two by CHIKV/DENV-4 were observed. In RJ, 76.9% of the suspected cases were confirmed for CHIKV and co-infections by CHIKV/DENV (n = 8) and by CHIKV/ZIKV (n = 17) were observed. Overall, fever, arthralgia, myalgia, prostration, edema, exanthema, conjunctival hyperemia, lower back pain, dizziness, nausea, retroorbital pain, and anorexia were the predominating chikungunya clinical symptoms described. All strains analyzed from AP belonged to the Asian genotype and no amino acid changes were observed. In RJ, the East-Central-South-African genotype (ECSA) circulation was demonstrated and no E1-A226V mutation was observed. Despite this, an E1-V156A substitution was characterized in two samples and for the first time, the E1-K211T mutation was reported in all samples analyzed.
C1 [Alves de Souza, Thiara Manuele; de Bruycker-Nogueira, Fernanda; Chouin-Carneiro, Thais; da Costa Faria, Nieli Rodrigues; Guerra Nunes, Priscila Conrado; Heringer, Manoela; Queiroz Lima, Monique da Rocha; Badolato-Correa, Jessica; Cipitelli, Marcio da Costa; de Azeredo, Elzinandes Leal; dos Santos, Flavia Barreto] Oswaldo Cruz Inst, Viral Immunol Lab, BR-21040360 Rio De Janeiro, Brazil.
   [Ribeiro, Edcelha D'Athaide] Lab Cent Amapa LACEN AP, BR-68908530 Macapa, Brazil.
   [Correa e Correa, Valmir] Lab Fronteira LAFRON, BR-69980000 Oiapoque, Amapa, Brazil.
   [Damasco, Paulo Vieira; Santos, Carla Cunha] Rio Laranjeiras Hosp, BR-22240000 Rio De Janeiro, Brazil.
   [Damasco, Paulo Vieira] Fed Univ State Rio de Janeiro, Gaffree Guinle Univ Hosp, BR-20270003 Rio De Janeiro, Brazil.
   [Damasco, Paulo Vieira] Univ Estado Rio De Janeiro, Pedro Ernesto Univ Hosp, BR-20551030 Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Oswaldo Cruz Inst, Flavivirus Lab, BR-21040360 Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Oswaldo Cruz Inst, Viral Immunol Lab, BR-21040360 Rio De Janeiro, Brazil.
EM thiara.biomed@gmail.com; edcelhamanu@hotmail.com;
   paulovieiradamasco@gmail.com; ccih@fblo.com.br; nandanog@ioc.fiocruz.br;
   tatachouin@gmail.com; nielircf@ioc.fiocruz.br; pricgn@ioc.fiocruz.br;
   manoelaheringer@yahoo.com.br; moniqueq@ioc.fiocruz.br;
   jessica.badolato@ioc.fiocruz.br; marcio_cipitelli@ioc.fiocruz.br;
   elzinandes@ioc.fiocruz.br; rita@ioc.fiocruz.br; flaviab@ioc.fiocruz.br
RI /AAD-2097-2020
OI Santos, Flavia/0000-0002-1309-5366; Nunes, Priscila/0000-0002-4841-9308;
   Lima, Monique/0000-0001-9630-8736
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/110.843/2013, E-26/202.003/2016]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [30382202015-5]; Financiadora de Estudos e Projetos FINEPCiencia
   Tecnologia e Inovacao (FINEP) [04.16.0058.00]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro FAPERJ to ELA grant number E-26/110.843/2013 and to FBS
   grant number E-26/202.003/2016, to Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) grant number 30382202015-5 to FBS, to
   Financiadora de Estudos e Projetos FINEP number 04.16.0058.00 to FBS, to
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   CNPq for the students fellowships. The funders had no role in the study
   design, data collection, analysis and decision to publish or preparation
   of the manuscript.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   Alla SAO, 2011, BEST PRACT RES CL RH, V25, P337, DOI 10.1016/j.berh.2011.03.005
   [Anonymous], SVS MS MONITORAMENTO
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Bandyopadhyay D, 2008, INT J DERMATOL, V47, P1148, DOI 10.1111/j.1365-4632.2008.03817.x
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Collao X, 2010, AM J TROP MED HYG, V82, P505, DOI 10.4269/ajtmh.2010.09-0435
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Correia JC, 2012, REV SAUDE PUBL, V46, P935, DOI 10.1590/S0034-89102013005000010
   Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015
   de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   FOURIE ED, 1979, S AFR MED J, V56, P130
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379, DOI 10.1093/oxfordjournals.aje.a120748
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Larrieu S, 2010, J CLIN VIROL, V47, P85, DOI 10.1016/j.jcv.2009.11.014
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   MS (Ministerio da Saude), 2015, FEBRE DE CHIKUNGUNYA
   MS (Ministerio da Saude), 2014, PREP RESP INTR VIR C
   Mulyatno KC, 2012, JPN J INFECT DIS, V65, P92
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Sumathy K, 2012, J MED VIROL, V84, P462, DOI 10.1002/jmv.23187
   SVS/MS Boletim Epidemiologico, 2015, SECR VIGILANCIA EM S, V46
   SVS Secretaria de Vigilancia em SaudeMinisterio da Saude, 2017, MON CAS DENG FEBR CH, P52
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   White SK, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00148-17, 10.1128/genomea.00148-17]
   Yaseen HM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-249
NR 71
TC 1
Z9 1
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 623
DI 10.3390/v10110623
PG 17
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600046
PM 30424530
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alves, MP
   Vielle, NJ
   Thiel, V
   Pfaender, S
AF Alves, Marco P.
   Vielle, Nathalie J.
   Thiel, Volker
   Pfaender, Stephanie
TI Research Models and Tools for the Identification of Antivirals and
   Therapeutics against Zika Virus Infection
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; antivirals; therapeutics; research models and tools
ID HUMAN PLACENTAL TROPHOBLASTS; PLURIPOTENT STEM-CELLS; FDA-APPROVED DRUG;
   BROAD-SPECTRUM; IN-VITRO; CEREBRAL ORGANOIDS; NS2B-NS3 PROTEASE;
   RNA-POLYMERASE; DENGUE VIRUS; GUINEA-PIG
AB Zika virus recently re-emerged and caused global outbreaks mainly in Central Africa, Southeast Asia, the Pacific Islands and in Central and South America. Even though there is a declining trend, the virus continues to spread throughout different geographical regions of the world. Since its re-emergence in 2015, massive advances have been made regarding our understanding of clinical manifestations, epidemiology, genetic diversity, genomic structure and potential therapeutic intervention strategies. Nevertheless, treatment remains a challenge as there is no licensed effective therapy available. This review focuses on the recent advances regarding research models, as well as available experimental tools that can be used for the identification and characterization of potential antiviral targets and therapeutic intervention strategies.
C1 [Alves, Marco P.; Vielle, Nathalie J.; Thiel, Volker; Pfaender, Stephanie] Inst Immunol & Virol, CH-3012 Bern, Switzerland.
   [Alves, Marco P.; Vielle, Nathalie J.; Thiel, Volker; Pfaender, Stephanie] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, CH-3012 Bern, Switzerland.
   [Vielle, Nathalie J.] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland.
RP Alves, MP; Thiel, V; Pfaender, S (corresponding author), Inst Immunol & Virol, CH-3012 Bern, Switzerland.; Alves, MP; Thiel, V; Pfaender, S (corresponding author), Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, CH-3012 Bern, Switzerland.
EM marco.alves@vetsuisse.unibe.ch; nathalie.vielle@vetsuisse.unibe.ch;
   volker.thiel@vetsuisse.unibe.ch; stephanie.pfaender@vetsuisse.unibe.ch
RI Thiel, Volker/AAI-2391-2019
OI Pfaender, Stephanie/0000-0002-3957-5448; Thiel,
   Volker/0000-0002-5783-0887
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Airapetian K V, 1996, Anesteziol Reanimatol, P21
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bierle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187720
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Carvalho CAM, 2017, J GEN VIROL, V98, P1749, DOI 10.1099/jgv.0.000849
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Franca TCC, 2015, J BIOMOL STRUCT DYN, V33, P1780, DOI 10.1080/07391102.2014.971429
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feher M, 2006, DRUG DISCOV TODAY, V11, P421, DOI 10.1016/j.drudis.2006.03.009
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GRIFFITH BP, 1985, J VIROL, V55, P402, DOI 10.1128/JVI.55.2.402-409.1985
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hernandez-Morales I, 2017, ANTIVIR RES, V147, P149, DOI 10.1016/j.antiviral.2017.10.011
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   Izumi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7748
   JAYANTHI CS, 1985, PHYS REV B, V31, P7465, DOI 10.1103/PhysRevB.31.7465
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kota S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032207
   Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877
   Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miller LJ, 2018, AM J TROP MED HYG, V98, P864, DOI 10.4269/ajtmh.17-0686
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Murgueitio Manuela S, 2012, Drug Discov Today Technol, V9, pe219, DOI 10.1016/j.ddtec.2012.07.009
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Onawole AT, 2017, J MOL GRAPH MODEL, V73, P54, DOI 10.1016/j.jmgm.2017.01.018
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324
   Pan T, 2018, J VIROL, V92, DOI [10.1128/JVI.01018-18, 10.1128/jvi.01018-18]
   Papapetrou EP, 2016, SCIENCE, V353, P991, DOI 10.1126/science.aai7626
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Qadir A, 2018, EUR J MED CHEM, V156, P444, DOI 10.1016/j.ejmech.2018.07.014
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quan JY, 2014, METHODS MOL BIOL, V1116, P103, DOI 10.1007/978-1-62703-764-8_8
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Rohini K, 2019, APPL BIOCHEM BIOTECH, V187, P194, DOI 10.1007/s12010-018-2814-3
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tricarico PM, 2019, INFLAMMOPHARMACOLOGY, V27, P621, DOI 10.1007/s10787-018-0517-6
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wetsman N, 2017, NAT MED, V23, P904, DOI 10.1038/nm0817-904
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu JH, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070165
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zitzmann C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01546
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 232
TC 5
Z9 5
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 593
DI 10.3390/v10110593
PG 30
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600016
PM 30380760
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Avila-Perez, G
   Nogales, A
   Martin, V
   Almazan, F
   Martinez-Sobrido, L
AF Avila-Perez, Gines
   Nogales, Aitor
   Martin, Veronica
   Almazan, Fernando
   Martinez-Sobrido, Luis
TI Reverse Genetic Approaches for the Generation of Recombinant Zika Virus
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; Zika virus (ZIKV); reverse genetics; infectious clone;
   full-length molecular clone; bacterial artificial chromosome; replicon;
   infectious RNA
ID ALGA PYLAIELLA-LITTORALIS; INFECTIOUS CDNA-CLONE; REPLICON CELL-LINE;
   DENGUE VIRUS; NUCLEOTIDE-SEQUENCE; MOUSE MODEL; RNA; FLAVIVIRUS;
   CONSTRUCTION; REPLICATION
AB Zika virus (ZIKV) is an emergent mosquito-borne member of the Flaviviridae family that was responsible for a recent epidemic in the Americas. ZIKV has been associated with severe clinical complications, including neurological disorder such as Guillain-Barre syndrome in adults and severe fetal abnormalities and microcephaly in newborn infants. Given the significance of these clinical manifestations, the development of tools and reagents to study the pathogenesis of ZIKV and to develop new therapeutic options are urgently needed. In this respect, the implementation of reverse genetic techniques has allowed the direct manipulation of the viral genome to generate recombinant (r)ZIKVs, which have provided investigators with powerful systems to answer important questions about the biology of ZIKV, including virus-host interactions, the mechanism of transmission and pathogenesis or the function of viral proteins. In this review, we will summarize the different reverse genetic strategies that have been implemented, to date, for the generation of rZIKVs and the applications of these platforms for the development of replicon systems or reporter-expressing viruses.
C1 [Avila-Perez, Gines; Nogales, Aitor; Martinez-Sobrido, Luis] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.
   [Martin, Veronica; Almazan, Fernando] Campus Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, E-28049 Madrid, Spain.
RP Martinez-Sobrido, L (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.; Almazan, F (corresponding author), Campus Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, E-28049 Madrid, Spain.
EM Gines_Perez@urmc.rochester.edu; aitor_nogales@urmc.rochester.edu;
   veronica.martin@inia.es; falmazan@cnb.csic.es;
   luis_martinez@urmc.rochester.edu
RI Martin, Veronica/H-2776-2015; Almazan, Fernando/K-8781-2015
OI Martin, Veronica/0000-0003-1486-1656; NOGALES,
   AITOR/0000-0002-2424-7900; Almazan, Fernando/0000-0002-5752-8469;
   Martinez-Sobrido, Luis/0000-0001-7084-0804
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [BFU2016-79127-R]; National Institute of Allergy and Infectious Diseases
   (NIAID), National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R21
   AI130500]
FX ZIKV research in LMS and FAT laboratories is partially funded by the
   Spanish Ministry of Economy and Competitiveness (MINECO) (grant number
   BFU2016-79127-R) and the National Institute of Allergy and Infectious
   Diseases (NIAID), National Institutes of Health (NIH) (grant number R21
   AI130500).
CR Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516
   Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06
   Almazan F, 2014, VIRUS RES, V189, P262, DOI 10.1016/j.virusres.2014.05.026
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Breen M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070179
   Breen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147723
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Wispelaere M, 2015, J VIROL, V89, P5862, DOI 10.1128/JVI.00358-15
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   Deng CL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070181
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DiPiazza A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11313-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FONTAINE JM, 1995, J MOL BIOL, V251, P378, DOI 10.1006/jmbi.1995.0441
   Fuentes S, 2013, VACCINE, V31, P3987, DOI 10.1016/j.vaccine.2013.05.088
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Ge F, 2007, VIROLOGY, V360, P150, DOI 10.1016/j.virol.2006.10.016
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2887
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hao WD, 2007, ANTIMICROB AGENTS CH, V51, P95, DOI 10.1128/AAC.01008-06
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hu ZY, 2014, ANTIMICROB AGENTS CH, V58, P995, DOI 10.1128/AAC.02094-13
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kato F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050122
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03670-4
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   Li YF, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050127
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   Maguire CA, 2012, MOL IMAGING, V11, P13, DOI 10.2310/7290.2011.00022
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Martinez-Sobrido L, 2017, METHODS MOL BIOL, V1602, P185, DOI 10.1007/978-1-4939-6964-7_13
   Martinez-Sobrido L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070197
   Martinez-Sobrido L, 2016, METHODS MOL BIOL, V1403, P313, DOI 10.1007/978-1-4939-3387-7_17
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Nogales A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010020
   Nogales A, 2016, VIRUS RES, V213, P69, DOI 10.1016/j.virusres.2015.11.014
   Nogales A, 2012, J VIROL, V86, P1261, DOI 10.1128/JVI.06428-11
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pierro DJ, 2006, J GEN VIROL, V87, P2263, DOI 10.1099/vir.0.81958-0
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441
   RACANIELLO VR, 1981, SCIENCE, V214, P916, DOI 10.1126/science.6272391
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   RICE C M, 1989, New Biologist, V1, P285
   RIEDER E, 1993, J VIROL, V67, P5139, DOI 10.1128/JVI.67.9.5139-5145.1993
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, METHODS MOL BIOL, V1602, P47, DOI 10.1007/978-1-4939-6964-7_4
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083
   SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song KY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-44
   Stobart CC, 2014, VIRUSES-BASEL, V6, P2531, DOI 10.3390/v6072531
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Usme-Ciro JA, 2014, VIRUS RES, V180, P12, DOI 10.1016/j.virusres.2013.12.001
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
   Wang K, 1997, BIOTECHNIQUES, V23, P992, DOI 10.2144/97236bm04
   Weger-Lucarelli J, 2017, JOVE-J VIS EXP, DOI 10.3791/55857
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607
   Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
   Zerbato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058263
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 119
TC 0
Z9 0
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 597
DI 10.3390/v10110597
PG 22
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600020
PM 30384426
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Azar, SR
   Rossi, SL
   Haller, SH
   Yun, RM
   Huang, JH
   Plante, JA
   Zhou, JH
   Olano, JP
   Roundy, CM
   Hanley, KA
   Weaver, SC
   Vasilakis, N
AF Azar, Sasha R.
   Rossi, Shannan L.
   Haller, Sherry H.
   Yun, Ruimei
   Huang, Jing H.
   Plante, Jessica A.
   Zhou, Jiehua
   Olano, Juan P.
   Roundy, Christopher M.
   Hanley, Kathryn A.
   Weaver, Scott C.
   Vasilakis, Nikos
TI ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in
   Viremic Cynomolgus Macaques
SO VIRUSES-BASEL
LA English
DT Article
DE Macaca fascicularis; Zika virus; Aedes aegypti; pathogenesis; vector
   competence; Flaviviridae
ID SYLVATIC DENGUE VIRUS; AEDES-AEGYPTI; ANIMAL-MODELS; YELLOW-FEVER;
   CHIKUNGUNYA; TRANSMISSION; EMERGENCE; EPIDEMIC; INOCULATION; PERSISTENCE
AB To evaluate the effects of ZIKV infection on non-human primates (NHPs), as well as to investigate whether these NHPs develop sufficient viremia to infect the major urban vector mosquito, Aedes aegypti, four cynomolgus macaques (Macaca fascicularis) were subcutaneously infected with 5.0 log(10) focus-forming units (FFU) of DNA clone-derived ZIKV strain FSS13025 (Asian lineage, Cambodia, 2010). Following infection, the animals were sampled (blood, urine, tears, and saliva), underwent daily health monitoring, and were exposed to Ae. aegypti at specified time points. All four animals developed viremia, which peaked 3-4 days post-infection at a maximum value of 6.9 log(10) genome copies/mL. No virus was detected in urine, tears, or saliva. Infection by ZIKV caused minimal overt disease: serum biochemistry and CBC values largely fell within the normal ranges, and cytokine elevations were minimal. Strikingly, the minimally colonized population of Ae. aegypti exposed to viremic animals demonstrated a maximum infection rate of 26% during peak viremia, with two of the four macaques failing to infect a single mosquito at any time point. These data indicate that cynomolgus macaques may be an effective model for ZIKV infection of humans and highlights the relative refractoriness of Ae. aegypti for ZIKV infection at the levels of viremia observed.
C1 [Azar, Sasha R.; Rossi, Shannan L.; Huang, Jing H.; Zhou, Jiehua; Olano, Juan P.; Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Rossi, Shannan L.; Haller, Sherry H.; Yun, Ruimei; Plante, Jessica A.; Roundy, Christopher M.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Roundy, Christopher M.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA.
   [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
RP Weaver, SC; Vasilakis, N (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Weaver, SC; Vasilakis, N (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC; Vasilakis, N (corresponding author), Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA.
EM srazar@utmb.edu; slrossi@utmb.edu; shhaller@utmb.edu; ruyun@utmb.edu;
   jinghong2018@yahoo.com; japlante@utmb.edu; jiehzhou@utmb.edu;
   jolano@utmb.edu; cmroundy@utmb.edu; khanley@nmsu.edu; sweaver@utmb.edu;
   nivasila@utmb.edu
OI Haller, Sherry L./0000-0002-4340-721X; Azar, Sasha/0000-0002-9182-216X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942, ICIDR 1U01AI115577-01,
   T32HD055163]; McLaughlin Fellowship Fund
FX This research was funded in part by NIH grants R24AI120942 (SCW), ICIDR
   1U01AI115577-01 (NV), T32HD055163 (SLH), and the McLaughlin Fellowship
   Fund (SRA).
CR Aguiar BS, 2018, INT J INFECT DIS, V70, P20, DOI 10.1016/j.ijid.2018.02.007
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Zanotto PMD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01964
   De Kock M, 2013, CNS NEUROSCI THER, V19, P403, DOI 10.1111/cns.12104
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hanley KA, 2014, AM J TROP MED HYG, V91, P672, DOI 10.4269/ajtmh.13-0492
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Julander JG, 2016, CURR OPIN VIROL, V18, P64, DOI 10.1016/j.coviro.2016.03.010
   Kato F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21582-9
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kong WL, 2018, MICROB PATHOGENESIS, V114, P476, DOI 10.1016/j.micpath.2017.12.031
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matheus S, 2017, EMERG INFECT DIS, V23, P1910, DOI 10.3201/eid2311.170337
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nalca A, 2003, ANTIVIR RES, V60, P153, DOI 10.1016/j.antiviral.2003.08.001
   Ng LFP, 2017, ANNU REV VIROL, V4, P413, DOI 10.1146/annurev-virology-101416-041808
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Park Hyun-Kyu, 2016, Lab Anim Res, V32, P79, DOI 10.5625/lar.2016.32.2.79
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Reynolds ES, 2017, COMPARATIVE MED, V67, P232
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Singh Mandeep S, 2018, Am J Ophthalmol Case Rep, V10, P6, DOI 10.1016/j.ajoc.2018.01.023
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zannoli S., 2017, MICROBIOL MED, V32, DOI [10.4081/mm.2017.7054, DOI 10.4081/MM.2017.7054]
NR 109
TC 2
Z9 2
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 661
DI 10.3390/v10110661
PG 20
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600084
PM 30469417
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caine, EA
   Jagger, BW
   Diamond, MS
AF Caine, Elizabeth A.
   Jagger, Brett W.
   Diamond, Michael S.
TI Animal Models of Zika Virus Infection during Pregnancy
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; vaccines; animal models; pregnancy; non-human primates;
   mice; congenital Zika syndrome; pathogenesis
ID BIRTH-DEFECTS; MOUSE MODEL; VERTICAL TRANSMISSION; HUMAN-ANTIBODIES;
   TERRITORIES; PROTECTS; INFANTS; MONKEYS; VACCINE; STATES
AB Zika virus (ZIKV) emerged suddenly in the Americas in 2015 and was associated with a widespread outbreak of microcephaly and other severe congenital abnormalities in infants born to mothers infected during pregnancy. Vertical transmission of ZIKV in humans was confirmed when viral RNA was detected in fetal and placental tissues, and this outcome has been recapitulated experimentally in animals. Unlike other flaviviruses, ZIKV is both arthropod- and sexually-transmitted, and has a broad tissue tropism in humans, including multiple tissues of the reproductive tract. The threats posed by ZIKV have prompted the development of multiple in vivo models to better understand the pathogenesis of ZIKV, particularly during pregnancy. Here, we review the progress on animal models of ZIKV infection during pregnancy. These studies have generated a foundation of insights into the biology of ZIKV, and provide a means for evaluating vaccines and therapeutics.
C1 [Caine, Elizabeth A.; Jagger, Brett W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM ecaine@wustl.edu; bjagger@wustl.edu; diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI127828, R01 AI073755, T32 AI007172];
   NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01 HD091218]
CR Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McGruder B, 2016, METHODS MOL BIOL, V1435, P61, DOI 10.1007/978-1-4939-3670-0_6
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Poirier MC, 2015, CURR OPIN PEDIATR, V27, P233, DOI 10.1097/MOP.0000000000000193
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SchoondermarkvandeVen EME, 1997, EUR J OBSTET GYN R B, V74, P183, DOI 10.1016/S0301-2115(97)00119-X
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   Slayden OD, 2014, SEMIN REPROD MED, V32, P385, DOI 10.1055/s-0034-1376357
   Smith MA, 2008, INFECT IMMUN, V76, P726, DOI 10.1128/IAI.01366-06
   Stouffer RL, 2017, ILAR J, V58, P281, DOI 10.1093/ilar/ilx027
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Takaki H, 2017, MICROBIOL IMMUNOL, V61, P107, DOI 10.1111/1348-0421.12477
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarantal AF, 1998, J INFECT DIS, V177, P446, DOI 10.1086/514206
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Valentine GC, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.005
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2018, HUM GENE THER, V29, P87, DOI 10.1089/hum.2017.018
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang Z, 2014, VET J, V200, P116, DOI 10.1016/j.tvjl.2013.12.021
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhu XL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0572-7
NR 92
TC 14
Z9 14
U1 0
U2 28
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 598
DI 10.3390/v10110598
PG 21
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600021
PM 30384472
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garg, H
   Mehmetoglu-Gurbuz, T
   Joshi, A
AF Garg, Himanshu
   Mehmetoglu-Gurbuz, Tugba
   Joshi, Anjali
TI Recent Advances in Zika Virus Vaccines
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; flaviviruses; vaccines; virus like particles; clinical
   trials; ZIKV
ID RECOMBINANT SUBVIRAL PARTICLES; NEUTRALIZING IMMUNE-RESPONSES;
   PROTECTIVE EFFICACY; ENCEPHALITIS-VIRUS; MESSENGER-RNA; DNA VACCINE;
   MICE; PROTEINS; IMMUNOGENICITY; IMMUNIZATION
AB The recent outbreaks of Zika virus (ZIKV) infections and associated microcephaly in newborns has resulted in an unprecedented effort by researchers to target this virus. Significant advances have been made in developing vaccine candidates, treatment strategies and diagnostic assays in a relatively short period of time. Being a preventable disease, the first line of defense against ZIKV would be to vaccinate the highly susceptible target population, especially pregnant women. Along those lines, several vaccine candidates including purified inactivated virus (PIV), live attenuated virus (LAV), virus like particles (VLP), DNA, modified RNA, viral vectors and subunit vaccines have been in the pipeline with several advancing to clinical trials. As the primary objective of Zika vaccination is the prevention of vertical transmission of the virus to the unborn fetus, the safety and efficacy requirements for this vaccine remain unique when compared to other diseases. This review will discuss these recent advances in the field of Zika vaccine development.
C1 [Garg, Himanshu; Mehmetoglu-Gurbuz, Tugba; Joshi, Anjali] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Emphasis Infect Dis, El Paso, TX 79905 USA.
RP Garg, H; Joshi, A (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Emphasis Infect Dis, El Paso, TX 79905 USA.
EM himanshu.garg@ttuhsc.edu; tugba.gurbuz@ttuhsc.edu;
   anjali.joshi@ttuhsc.edu
RI Mehmetoglu-Gurbuz, Tugba/M-7452-2016
OI Mehmetoglu-Gurbuz, Tugba/0000-0003-1417-9446
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Basu R, 2018, VACCINE, V36, P1256, DOI 10.1016/j.vaccine.2018.01.056
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duenas-Carrera S, 2000, VACCINE, V19, P992, DOI 10.1016/S0264-410X(00)00209-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durham DP, 2018, ANN INTERN MED, V168, P621, DOI 10.7326/M17-0641
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jarvi SI, 2008, VACCINE, V26, P5338, DOI 10.1016/j.vaccine.2008.08.011
   Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kudchodkar SB, 2018, MICROBES INFECT, V20, P676, DOI 10.1016/j.micinf.2018.03.001
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monath TP, 2002, CURR TOP MICROBIOL, V267, P105
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   PUGACHEV KV, 1995, VIROLOGY, V212, P587, DOI 10.1006/viro.1995.1516
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Suder E, 2018, HUM VACC IMMUNOTHER, V14, P2107, DOI 10.1080/21645515.2018.1473698
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Vantsevich W, 2007, MATH PROBL ENG, V44, P239, DOI DOI 10.1155/2013/686549
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Zhu XL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0572-7
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 74
TC 12
Z9 13
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 631
DI 10.3390/v10110631
PG 13
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600054
PM 30441757
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Harapan, H
   Mudatsir, M
   Yufika, A
   Nawawi, Y
   Wahyuniati, N
   Anwar, S
   Yusri, F
   Haryanti, N
   Wijayanti, NP
   Rizal, R
   Fitriani, D
   Maulida, NF
   Syahriza, M
   Ikram, I
   Fandoko, TP
   Syahadah, M
   Asrizal, FW
   Jamil, KF
   Rajamoorthy, Y
   Wagner, AL
   Groneberg, DA
   Kuch, U
   Muller, R
   Sasmono, RT
   Imrie, A
AF Harapan, Harapan
   Mudatsir, Mudatsir
   Yufika, Amanda
   Nawawi, Yusuf
   Wahyuniati, Nur
   Anwar, Samsul
   Yusri, Fitria
   Haryanti, Novi
   Wijayanti, Nanda Putri
   Rizal, Rizal
   Fitriani, Devi
   Maulida, Nurul Fadhliati
   Syahriza, Muhammad
   Ikram, Ikram
   Fandoko, Try Purwo
   Syahadah, Muniati
   Asrizal, Febrivan Wahyu
   Jamil, Kurnia F.
   Rajamoorthy, Yogambigai
   Wagner, Abram Luther
   Groneberg, David Alexander
   Kuch, Ulrich
   Mueller, Ruth
   Sasmono, R. Tedjo
   Imrie, Allison
TI Willingness to Participate and Associated Factors in a Zika Vaccine
   Trial in Indonesia: A Cross-Sectional Study
SO VIRUSES-BASEL
LA English
DT Article
DE Zika; Zika vaccine; vaccine trial; willingness to participate; vaccine
   acceptance
ID CLINICAL-TRIALS; VIRUS-INFECTION; INFORMED-CONSENT; PARENT ATTITUDES;
   DENGUE VACCINE; RECRUITMENT; ACCEPTANCE; HESITANCY; ALTRUISM; BRAZIL
AB One of the crucial steps during trials for Zika and other vaccines is to recruit participants and to understand how participants' attitudes and sociodemographic characteristics affect willingness to participate (WTP). This study was conducted to assess WTP, its explanatory variables, and the impact of financial compensation on WTP in Indonesia. A health facility-based cross-sectional study was conducted in eleven regencies in the Aceh and West Sumatra provinces of Indonesia. Participants were recruited via a convenience sampling method and were interviewed. The associations between explanatory variables and WTP were assessed using a two-step logistic regression analysis. A total of 1,102 parents were approached, and of these 956 (86.8%) completed the interview and were included in analysis. Of those, 144 (15.1%) were willing to participate in a Zika vaccine trial without a financial compensation. In the multivariate analysis, WTP was tied to an age of more than 50 years old, compared to 20-29 years (odds ratio (OR): 5.0; 95% confidence interval (CI): 2.37-10.53), to being female (OR: 2.20; 95% CI: 1.11-4.37), and to having heard about Zika (OR: 2.41; 95% CI: 1.59-3.65). Participants' WTP increased gradually with higher financial compensation. The rate of WTP increased to 62.3% at the highest offer (US$ 350.4), and those who were still unwilling to participate (37.7%) had a poorer attitude towards childhood vaccination. This study highlights that pre-existing knowledge about Zika and attitudes towards childhood vaccination are important in determining community members being willing to participate in a vaccine trial. Financial incentives are still an important factor to enhance participant recruitment during a vaccine trial.
C1 [Harapan, Harapan; Mudatsir, Mudatsir; Wahyuniati, Nur; Ikram, Ikram; Jamil, Kurnia F.] Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh 23111, Aceh, Indonesia.
   [Harapan, Harapan; Mudatsir, Mudatsir] Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh 23111, Aceh, Indonesia.
   [Harapan, Harapan; Mudatsir, Mudatsir] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh 23111, Aceh, Indonesia.
   [Harapan, Harapan; Imrie, Allison] Univ Western Australia, Sch Biomed Sci, Nedlands, WA 6009, Australia.
   [Yufika, Amanda; Nawawi, Yusuf] Syiah Kuala Univ, Sch Med, Dept Family Med, Banda Aceh 23111, Aceh, Indonesia.
   [Anwar, Samsul] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Stat, Banda Aceh 23111, Aceh, Indonesia.
   [Yusri, Fitria] Malikussaleh Univ, Sch Med, Lhokseumawe 24352, Aceh, Indonesia.
   [Haryanti, Novi] Community Hlth Ctr Meurah Mulia, North Aceh 24372, Aceh, Indonesia.
   [Wijayanti, Nanda Putri] Community Hlth Ctr Tapaktuan, South Aceh 23711, Aceh, Indonesia.
   [Rizal, Rizal] Bunda Hosp, Lhokseumawe 24351, Aceh, Indonesia.
   [Fitriani, Devi] Community Hlth Ctr Teunom, Aceh Jaya 23653, Aceh, Indonesia.
   [Maulida, Nurul Fadhliati] Meuraxa Hosp, Banda Aceh 23231, Aceh, Indonesia.
   [Syahriza, Muhammad] Syiah Kuala Univ, Sch Med, Dept Publ Hlth & Community Med, Banda Aceh 23111, Aceh, Indonesia.
   [Fandoko, Try Purwo] Community Hlth Ctr Gunung, Padang Panjang 27122, West Sumatera, Indonesia.
   [Syahadah, Muniati] Community Hlth Ctr Lima Kaum, Tanah Datar 27211, West Sumatera, Indonesia.
   [Asrizal, Febrivan Wahyu] Community Hlth Ctr Tanjung Paku, Solok 27317, West Sumatera, Indonesia.
   [Jamil, Kurnia F.] Syiah Kuala Univ, Sch Med, Dept Internal Med, Banda Aceh 23111, Aceh, Indonesia.
   [Rajamoorthy, Yogambigai] Univ Tunku Abdul Rahman, Fac Accountancy & Management, Dept Econ, Selangor 43000, Malaysia.
   [Wagner, Abram Luther] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Groneberg, David Alexander; Kuch, Ulrich; Mueller, Ruth] Goethe Univ, Inst Occupat Med Social Med & Environm Med, D-60323 Frankfurt, Germany.
   [Mueller, Ruth] Inst Trop Med, Unit Med Entomol, B-2000 Antwerp, Belgium.
   [Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jakarta 10430, Indonesia.
RP Harapan, H; Mudatsir, M (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh 23111, Aceh, Indonesia.; Harapan, H; Mudatsir, M (corresponding author), Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh 23111, Aceh, Indonesia.; Harapan, H; Mudatsir, M (corresponding author), Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh 23111, Aceh, Indonesia.; Harapan, H (corresponding author), Univ Western Australia, Sch Biomed Sci, Nedlands, WA 6009, Australia.
EM harapan@unsyiah.ac.id; mudatsir@unsyiah.ac.id; amandayufika@gmail.com;
   yusufnawawi@unsyiah.ac.id; nur.wahyuniati@unsyiah.ac.id;
   samsul.anwar@unsyiah.ac.id; fitriayusri1006@gmail.com;
   novi.haryanti1985@gmail.com; puput_sbg@yahoo.com; dr_rizalmz@yahoo.com;
   devifitriani.y@gmail.com; nfmaulidaz@gmail.com; syahriza60@gmail.com;
   ikramkeren@yahoo.co.id; okoex123@gmail.com; muniatisyahadah94@gmail.com;
   febrivanwahyu.asrizal@gmail.com; kurnia_jamil@unsyiah.ac.id;
   yogambigai@utar.edu.my; awag@umich.edu; groneberg@med.uni-frankfurt.de;
   kuch@med.uni-frankfurt.de; ruth.mueller@med.uni-frankfurt.de;
   sasmono@eijkman.go.id; allison.imrie@uwa.edu.au
RI Sasmono, Tedjo/H-5680-2016; Wagner, Abram/X-6379-2019; Imrie,
   Allison/AAH-2421-2019; Mudatsir, Mudatsir/Q-4999-2017; Harapan,
   Harapan/I-8741-2016; Anwar, Samsul/E-9776-2017; Muller, Ruth/D-2551-2009
OI Sasmono, Tedjo/0000-0003-0986-2590; Wagner, Abram/0000-0003-4691-7802;
   Mudatsir, Mudatsir/0000-0002-5643-9384; Harapan,
   Harapan/0000-0001-7630-8413; Anwar, Samsul/0000-0003-3165-2151;
   /0000-0001-8726-0793; Muller, Ruth/0000-0003-3909-3876; Yufika,
   Amanda/0000-0001-8408-9396
FU Scholarships for International Research Fees (SIRF) [F51416]; Australia
   Awards Scholarship [ST000DMX2]; CREID Scholarship [N/A]; Nationales
   Forschungsnetz Zoonotische Infektionskrankheiten [01KI1717]
CR Afshar R, 2012, SAUDI J KIDNEY DIS T, V23, P929, DOI 10.4103/1319-2442.100863
   Azizi FSM, 2017, VACCINE, V35, P2955, DOI 10.1016/j.vaccine.2017.04.010
   Balfour L, 2010, AIDS CARE, V22, P1403, DOI 10.1080/09540121003693522
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bidad N, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1550-7
   Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chu SH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1339-0
   Clark MA, 2007, CANCER EPIDEM BIOMAR, V16, P2605, DOI 10.1158/1055-9965.EPI-07-0157
   Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Detoc M, 2017, EXPERT REV VACCINES, V16, P467, DOI 10.1080/14760584.2017.1297706
   Dong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111321
   Du W, 2008, J THORAC ONCOL, V3, P23, DOI 10.1097/JTO.0b013e31815e8bb2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Evangeli M, 2013, AIDS CARE, V25, P910, DOI 10.1080/09540121.2012.748163
   Frew PM, 2011, VACCINE, V29, P6136, DOI 10.1016/j.vaccine.2011.06.082
   Fry CL, 2005, J MED ETHICS, V31, P542, DOI 10.1136/jme.2004.009290
   Godskesen T, 2015, EUR J CANCER CARE, V24, P133, DOI 10.1111/ecc.12184
   Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Harapan H., 2018, VACCINE UNPUB
   Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Harapan H, 2017, ACTA TROP, V166, P249, DOI 10.1016/j.actatropica.2016.11.035
   Harapan H, 2016, ASIAN PAC J TROP MED, V9, P1092, DOI 10.1016/j.apjtm.2016.07.036
   Harapan H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159139
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198
   Kufa T, 2013, PUBLIC HEALTH ACTION, V3, P31, DOI 10.5588/pha.12.0102
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Limkakeng A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051328
   Lobato L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1156
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marshall PA, 2006, AM J PUBLIC HEALTH, V96, P1989, DOI 10.2105/AJPH.2005.076232
   McCann SK, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-31
   McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9
   Mystakidou K, 2009, SAHARA J-J SOC ASP H, V6, P46, DOI 10.1080/17290376.2009.9724930
   Olowookere SA, 2016, VACCINE, V34, P5758, DOI 10.1016/j.vaccine.2016.10.004
   Opel DJ, 2013, JAMA PEDIATR, V167, P1065, DOI 10.1001/jamapediatrics.2013.2483
   Opel DJ, 2011, VACCINE, V29, P6598, DOI 10.1016/j.vaccine.2011.06.115
   Opel DJ, 2011, HUM VACCINES, V7, P419, DOI 10.4161/hv.7.4.14120
   Pakpahan D., 1996, WOMENS STUDIES J, V6, P7
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Pulley JM, 2008, CELL TISSUE BANK, V9, P55, DOI 10.1007/s10561-007-9051-2
   Raheja D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081743
   Rikin S, 2017, CONT CLIN TRIAL COMM, V7, P122, DOI 10.1016/j.conctc.2017.06.010
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Setyobudihono S, 2016, PROCD SOC BEHV, V222, P160, DOI 10.1016/j.sbspro.2016.05.207
   Singer E, 2008, J EMPIR RES HUM RES, V3, P49, DOI 10.1525/jer.2008.3.3.49
   Strelitz B, 2015, VACCINE, V33, P1802, DOI 10.1016/j.vaccine.2015.02.034
   Suhud U, 2014, J ECO SUSTAIN DEV, V5, P91
   Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360
   Walsh E, 2016, CONT CLIN TRIAL COMM, V3, P23, DOI 10.1016/j.conctc.2016.01.002
   World Health Organization (WHO), 5 M EM COMM INT HLTH
   World Health Organization (WHO), ZIK SIT REP
   World Health Organization (WHO), WHO UNICEF ZIK VIR Z
NR 60
TC 5
Z9 5
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 648
DI 10.3390/v10110648
PG 14
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600071
PM 30453663
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Limonta, D
   Jovel, J
   Kumar, A
   Airo, AM
   Hou, SM
   Saito, L
   Branton, W
   Wong, GKS
   Mason, A
   Power, C
   Hobman, TC
AF Limonta, Daniel
   Jovel, Juan
   Kumar, Anil
   Airo, Adriana M.
   Hou, Shangmei
   Saito, Leina
   Branton, William
   Wong, Gane Ka-Shu
   Mason, Andrew
   Power, Christopher
   Hobman, Tom C.
TI Human Fetal Astrocytes Infected with Zika Virus Exhibit Delayed
   Apoptosis and Resistance to Interferon: Implications for Persistence
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; persistence; astrocytes; interferon; apoptosis
ID I INTERFERON; BRAIN; CELLS; AXL; ORGANOIDS
AB Zika virus (ZIKV) infection and persistence during pregnancy can lead to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome. The immunological and virological events that contribute to the establishment of persistent ZIKV infection in humans are unclear though. Here we show that human fetal astrocytes (HFAs), the most abundant cell type in the central nervous system, become persistently infected with ZIKV resulting in continuous viral shedding for at least one month; a process that is facilitated by TIM/TAM receptors. HFAs are relatively resistant to ZIKV-induced apoptosis, a factor that may be important for chronic infection of these cells. Once infection was established, interferon treatment did not reduce virus replication. Moreover, the fact that the innate immune system was highly activated in persistently infected HFAs indicates that the virus can thrive in the presence of a sustained antiviral response. RNAseq analyses of persistently infected cells revealed that ZIKV alters host gene expression in a manner that could affect developmental processes. Conversely, data from sequencing of ZIKV genomes in persistently infected HFAs suggest that adaptive mutations were not required for establishing chronic infection. Based on these results, we postulate that HFAs are reservoirs for ZIKV in the fetal brain and that moderate apoptosis combined with inefficient antiviral response from these cells may contribute to the establishment of chronic brain infection associated with the ZIKV neurodevelopmental abnormalities.
C1 [Limonta, Daniel; Kumar, Anil; Hou, Shangmei; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.
   [Jovel, Juan; Saito, Leina; Branton, William; Wong, Gane Ka-Shu; Mason, Andrew; Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB T6G 2E1, Canada.
   [Airo, Adriana M.; Mason, Andrew; Power, Christopher; Hobman, Tom C.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.
   [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.
   [Wong, Gane Ka-Shu] Beishan Ind Zone, Beijing Genom Inst, Shenzhen 518083, Peoples R China.
   [Mason, Andrew; Power, Christopher; Hobman, Tom C.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB T6G 1C9, Canada.
   [Hobman, Tom C.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada.
RP Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.; Hobman, TC (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.; Hobman, TC (corresponding author), Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB T6G 1C9, Canada.; Hobman, TC (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada.
EM dlimonta@ualberta.ca; jovel@ualberta.ca; anilkuma@ualberta.ca;
   airo@ualberta.ca; shangmei@ualberta.ca; leina@ualberta.ca;
   wbranton@ualberta.ca; gane@ualberta.ca; am16@ualberta.ca;
   chris.power@ualberta.ca; tom.hobman@ualberta.ca
RI WONG, Gane Ka-Shu/G-5784-2013
OI WONG, Gane Ka-Shu/0000-0001-6108-5560; Kumar, Anil/0000-0002-6179-4516;
   Power, Christopher/0000-0002-5131-9711; Saito, Leina/0000-0001-9443-9775
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [CIHR MOP-125903, PJT-148699, ZV1-149782]; Women &
   Children's Health Research Institute (WCHRI); Li Ka Shing Institute of
   Virology
FX This research was funded by the Canadian Institutes of Health Research
   (CIHR MOP-125903; PJT-148699; ZV1-149782), Women & Children's Health
   Research Institute (WCHRI) and the Li Ka Shing Institute of Virology.
CR Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Callaway JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136708
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grubaugh ND, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv182
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Kari V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063745
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203331
   Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pimentel H., 2016, BIORXIV, DOI [10.1101/058164, DOI 10.1101/058164]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sin C, 2015, J MOL NEUROSCI, V55, P437, DOI 10.1007/s12031-014-0359-7
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674
NR 51
TC 15
Z9 15
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 646
DI 10.3390/v10110646
PG 19
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600069
PM 30453621
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, DBL
   Durigon, GS
   Mendes, EA
   Ladner, JT
   Andreata-Santos, R
   Araujo, DB
   Botosso, VF
   Paola, ND
   Neto, DFL
   Cunha, MP
   Braconi, CT
   Alves, RPS
   Jesus, MR
   Pereira, LR
   Melo, SR
   Mesquita, FS
   Silveira, VB
   Thomazelli, LM
   Favoretto, SR
   Almonfrey, FB
   Abdulkader, RCRM
   Gabrili, JM
   Tambourgi, DV
   Oliveira, SF
   Prieto, K
   Wiley, MR
   Ferreira, LCS
   Silva, MV
   Palacios, GF
   Zanotto, PMA
   Durigon, EL
AF Oliveira, Danielle B. L.
   Durigon, Giuliana S.
   Mendes, Erica A.
   Ladner, Jason T.
   Andreata-Santos, Robert
   Araujo, Danielle B.
   Botosso, Viviane F.
   Paola, Nicholas D.
   Neto, Daniel F. L.
   Cunha, Marielton P.
   Braconi, Carla T.
   Alves, Rubens P. S.
   Jesus, Monica R.
   Pereira, Lennon R.
   Melo, Stella R.
   Mesquita, Flavio S.
   Silveira, Vanessa B.
   Thomazelli, Luciano M.
   Favoretto, Silvana R.
   Almonfrey, Franciane B.
   Abdulkader, Regina C. R. M.
   Gabrili, Joel M.
   Tambourgi, Denise V.
   Oliveira, Sergio F.
   Prieto, Karla
   Wiley, Michael R.
   Ferreira, Luis C. S.
   Silva, Marcos V.
   Palacios, Gustavo F.
   Zanotto, Paolo M. A.
   Durigon, Edison L.
TI Persistence and Intra-Host Genetic Evolution of Zika Virus Infection in
   Symptomatic Adults: A Special View in the Male Reproductive System
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; flavivirus; arbovirus; sexual transmission; host genetic
   variation; immune response
ID DENGUE VIRUS; IDENTIFICATION; BRAZIL
AB We followed the presence of Zika virus (ZIKV) in four healthy adults (two men and two women), for periods ranging from 78 to 298 days post symptom onset. The patients were evaluated regarding the presence of the virus in different body fluids (blood, saliva, urine and semen), development of immune responses (including antibodies, cytokines and chemokines), and virus genetic variation within samples collected from semen and urine during the infection course. The analysis was focused primarily on the two male patients who shed the virus for up to 158 days after the initial symptoms. ZIKV particles were detected in the spermatozoa cytoplasm and flagella, in immature sperm cells and could also be isolated from semen in cell culture, confirming that the virus is able to preserve integrity and infectivity during replication in the male reproductive system (MRS). Despite the damage caused by ZIKV infection within the MRS, our data showed that ZIKV infection did not result in infertility at least in one of the male patients. This patient was able to conceive a child after the infection. We also detected alterations in the male genital cytokine milieu, which could play an important role in the replication and transmission of the virus which could considerably increase the risk of ZIKV sexual spread. In addition, full genome ZIKV sequences were obtained from several samples (mainly semen), which allowed us to monitor the evolution of the virus within a patient during the infection course. We observed genetic changes over time in consensus sequences and lower frequency intra-host single nucleotide variants (iSNV), that suggested independent compartmentalization of ZIKV populations in the reproductive and urinary systems. Altogether, the present observations confirm the risks associated with the long-term replication and shedding of ZIKV in the MRS and help to elucidate patterns of intra-host genetic evolution during long term replication of the virus.
C1 [Oliveira, Danielle B. L.; Mendes, Erica A.; Andreata-Santos, Robert; Araujo, Danielle B.; Paola, Nicholas D.; Neto, Daniel F. L.; Cunha, Marielton P.; Braconi, Carla T.; Alves, Rubens P. S.; Jesus, Monica R.; Pereira, Lennon R.; Melo, Stella R.; Mesquita, Flavio S.; Silveira, Vanessa B.; Thomazelli, Luciano M.; Ferreira, Luis C. S.; Zanotto, Paolo M. A.; Durigon, Edison L.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, BR-05508000 Sao Paulo, SP, Brazil.
   [Durigon, Giuliana S.; Almonfrey, Franciane B.; Abdulkader, Regina C. R. M.] Univ Sao Paulo, Med Sch Clin Hosp, BR-05403000 Sao Paulo, SP, Brazil.
   [Ladner, Jason T.; Prieto, Karla; Wiley, Michael R.; Palacios, Gustavo F.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.
   [Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.
   [Botosso, Viviane F.; Gabrili, Joel M.; Tambourgi, Denise V.] Butantan Inst, Virol Lab, BR-05503900 Sao Paulo, SP, Brazil.
   [Favoretto, Silvana R.] Pasteur Inst, State Hlth Dept, BR-1103000 Sao Paulo, SP, Brazil.
   [Gabrili, Joel M.] Butantan Inst, Immunochem Lab, BR-05503900 Sao Paulo, SP, Brazil.
   [Oliveira, Sergio F.] Univ Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, BR-05508000 Sao Paulo, SP, Brazil.
   [Prieto, Karla; Wiley, Michael R.] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE 68198 USA.
   [Silva, Marcos V.] Inst Infectol Emilio Ribas, BR-01246900 Sao Paulo, SP, Brazil.
   [Silva, Marcos V.] Pontificia Univ Catolica PUC SP, BR-01246900 Sao Paulo, SP, Brazil.
RP Durigon, EL (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, BR-05508000 Sao Paulo, SP, Brazil.
EM danibruna@gmail.com; giuliana.durigon@gmail.com;
   ericaarmendes@gmail.com; jtladner@gmail.com;
   robert_andreata@hotmail.com; daniellebastos@yahoo.com.br;
   viviane.botosso@butantan.gov.br; nicholasdipaola@gmail.com;
   danielviro@gmail.com; marieltondospassos@gmail.com; cabraconi@gmail.com;
   rubens.bmc@gmail.com; modrigues4@gmail.com; lennon_rp@hotmail.com;
   stellmelo@gmail.com; flavio.mesquita@usp.br;
   vanessa.silveirabio@gmail.com; lucmt@usp.br; srfavoretto@usp.br;
   fran_almonfrey@hotmail.com; kader@usp.br; joel.megalegabrili@gmail.com;
   denise.tambourgi@butantan.gov.br; sfolivei@gmail.com;
   karla.prieto.ctr@mail.mil; michael.r.wileyl9.ctr@mail.mil; lcsf@usp.br;
   mvsilva@pucsp.br; gustavo.f.palacios.ctr@mail.mil; pzanotto@usp.br;
   eldurigo@usp.br
RI Tambourgi, Denise/H-7114-2016; Braconi, Carla T./B-3320-2014; Silveira,
   Vanessa/AAJ-9535-2020; Center of Toxins, Immune-response/J-5731-2015;
   Oliveira, Danielle BL/H-8030-2015; Palacios, Gustavo/I-7773-2015;
   Botosso, Viviane/I-5591-2014; Araujo, Danielle B/M-9540-2013; de A.
   Zanotto, Paolo M./B-9286-2019; Ferreira, Luis/M-3954-2014; Thomazelli,
   Luciano Matsumiya/Q-6119-2017
OI Tambourgi, Denise/0000-0003-1896-9074; Braconi, Carla
   T./0000-0002-5370-8980; Oliveira, Danielle BL/0000-0002-3452-1336;
   Palacios, Gustavo/0000-0001-5062-1938; Botosso,
   Viviane/0000-0002-7876-3687; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Ferreira, Luis/0000-0002-4883-1693; Wiley,
   Michael/0000-0001-6688-007X; , Joel/0000-0003-1401-5740; Cunha,
   Marielton/0000-0002-2102-631X; Mesquita, Flavio/0000-0002-4200-7943;
   Oliveira, Danielle/0000-0002-0534-0886; Andreata-Santos,
   Robert/0000-0002-4506-3756; Thomazelli, Luciano
   Matsumiya/0000-0002-9157-6122; Rodrigues de Jesus, Monica
   Josiane/0000-0002-5434-1674; Ladner, Jason/0000-0001-7751-4366
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07467-1,
   2014/16333-1, 2014/17766-9, 2016/08727-5, 2017/50007-2, 2016/20045-7];
   Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq) [303244/2013-5, 440409/2016-0];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [88881.130787/2016-01]; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2014/27228-4, 2014/03911-7, 2015/25643-7,
   2016/08204-2, 2013/26942-2, 2015/02352, 2016/03605-9, 2016/10161-0];
   CAPESCAPES [88887.131387/2016-00, 1522381, 1796450, 1473645];
   CAPES/PRONEX fellowship
FX Funding was granted by Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP), projects No 2013/07467-1 (DVT); 2014/16333-1 (SRF);
   2014/17766-9 (PMAZ); 2016/08727-5 and 2017/50007-2 (DBLO); 2016/20045-7
   (LCSF and ELD) and Conselho Nacional de Pesquisa (CNPq) Project
   303244/2013-5 (DVT); 440409/2016-0 (LCSF) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) project
   88881.130787/2016-01 (LCSF). Received a FAPESP fellowship: 2014/27228-4
   (EAM), 2014/03911-7 (CTB), 2015/25643-7 (FSM), 2016/08204-2 (MPC),
   2013/26942-2 (LRP), 2015/02352 (RPSA), 2016/03605-9 (DFLN), 2016/10161-0
   (VBS). Received a CAPES fellowship: 88887.131387/2016-00 (DBA); 1522381
   (SRM); 1796450 (CTB) and 1473645 (RAS); received CAPES/PRONEX fellowship
   (JMG), respectively.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Garrison E., 2012, ARXIV12073907
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Lisco A, 2012, J INFECT DIS, V205, P97, DOI 10.1093/infdis/jir700
   Lu X, 2012, AM J TROP MED HYG, V87, P947, DOI 10.4269/ajtmh.2012.11-0721
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
NR 31
TC 6
Z9 6
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 615
DI 10.3390/v10110615
PG 16
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600038
PM 30405055
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Viedma, MDM
   Pickett, BE
AF Viedma, Maria del Pilar Martinez
   Pickett, Brett E.
TI Characterizing the Different Effects of Zika Virus Infection in Placenta
   and Microglia Cells
SO VIRUSES-BASEL
LA English
DT Article
DE zika virus; placenta cells; microglia cells; siRNA; TLR7/8
ID SEXUAL TRANSMISSION; AXL
AB Zika virus (ZIKV) is a neuropathic virus that causes serious neurological abnormalities such as Guillain-Barre syndrome in adults and congenital Zika syndrome (CZS) in fetuses, which makes it an important concern for global human health. A catalogue of cells that support ZIKV replication, pathogenesis, and/or the persistence of the virus still remains unknown. Here, we studied the behavior of the virus in human placenta (JEG-3) and human microglia (HMC3) cell lines in order to better understand how different host tissues respond during infection. We quantified the host transcriptional response to ZIKV infection in both types of cells at 24 and 72 h post-infection. A panel of 84 genes that are involved in the innate or adaptive immune responses was used to quantify differential expression in both cell lines. HMC3 cells showed a unique set of significant differentially expressed genes (DEGs) compared with JEG-3 cells at both time points. Subsequent analysis of these data using modern pathway analysis methods revealed that the TLR7/8 pathway was strongly inhibited in HMC3 cells, while it was activated in JEG-3 cells during virus infection. The disruption of these pathways was subsequently confirmed with specific small interfering RNA (siRNA) experiments that characterize their role in the viral life cycle, and may partially explain why ZIKV infection in placental tissue contributes to extreme neurological problems in a developing fetus.
C1 [Viedma, Maria del Pilar Martinez] J Craig Venter Inst, 4120 Capricorn Lane, La Jolla, CA 92037 USA.
   [Pickett, Brett E.] J Craig Venter Inst, 9605 Med Ctr Dr, Rockville, MD 20850 USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, 9605 Med Ctr Dr, Rockville, MD 20850 USA.
EM pviedma@jcvi.org; bpickett@jcvi.org
RI Pickett, Brett/AAE-3582-2020
OI Pickett, Brett/0000-0001-7930-8160; Martinez Viedma, Maria
   Pilar/0000-0002-8885-5008
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pickett BE, 2013, VIROLOGY, V447, P45, DOI 10.1016/j.virol.2013.08.021
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
NR 31
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 649
DI 10.3390/v10110649
PG 16
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600072
PM 30453684
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, LD
   Du, XW
   Chen, CJ
   Chen, ZX
   Zhang, L
   Han, QQ
   Xia, XS
   Song, YZ
   Zhang, JY
AF Zhang, Liding
   Du, Xuewei
   Chen, Congjie
   Chen, Zhixin
   Zhang, Li
   Han, Qinqin
   Xia, Xueshan
   Song, Yuzhu
   Zhang, Jinyang
TI Development and Characterization of Double-Antibody Sandwich ELISA for
   Detection of Zika Virus Infection
SO VIRUSES-BASEL
LA English
DT Article
DE NS1 protein; Zika virus; diagnosis; monoclonal antibodies; ELISA
ID NS1; ASSAY; RNA
AB Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that can cause severe disease, including congenital birth defect and Guillain-Barre syndrome during pregnancy. Although, several molecular diagnostic methods have been developed to detect the ZIKV, these methods pose challenges as they cannot detect early viral infection. Furthermore, these methods require the extraction of RNA, which is easy to contaminate. Nonstructural protein 1 (NS1) is an important biomarker for early diagnosis of the virus, and the detection methods associated with the NS1 protein have recently been reported. The aim of this study was to develop a rapid and sensitive detection method for the detection of the ZIKV based on the NS1 protein. The sensitivity of this method is 120 ng mL(-1) and it detected the ZIKV in the supernatant and lysates of Vero and BHK cells, as well as the sera of tree shrews infected with the ZIKV. Without the isolation of the virus and the extraction of the RNA, our method can be used as a primary screening test as opposed to other diagnosis methods that detect the ZIKV.
C1 [Zhang, Liding; Du, Xuewei; Chen, Congjie; Chen, Zhixin; Zhang, Li; Han, Qinqin; Xia, Xueshan; Song, Yuzhu; Zhang, Jinyang] Kunming Univ Sci & Technol, Fac Life Sci & Technol, 727 Jingming South Rd, Kunming 650500, Yunnan, Peoples R China.
RP Xia, XS; Song, YZ; Zhang, JY (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, 727 Jingming South Rd, Kunming 650500, Yunnan, Peoples R China.
EM lidingzhang@aliyun.com; xueweidu@126.com; kmustccj@163.com;
   arnoldchen1997@gmail.com; lilizhang7102@foxmail.com;
   qqhan10@kmust.edu.cn; oliverxia2000@aliyun.com; syzzam@126.com;
   jyzhang@kmust.edu.cn
RI Zhang, Jinyang/S-9625-2019
OI Zhang, Jinyang/0000-0001-7533-998X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81860625, U1702282]; Applied Basic Research
   Projects of Yunnan Province [2018FB128]
CR Bhavani KG, 2017, J PHARMACEUT BIOMED, V132, P156, DOI 10.1016/j.jpba.2016.09.025
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Jin Z, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.32183
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zhang LD, 2018, JUNDISHAPUR J MICROB, V11, DOI 10.5812/jjm.68858
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 32
TC 4
Z9 5
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD NOV
PY 2018
VL 10
IS 11
AR 634
DI 10.3390/v10110634
PG 12
WC Virology
SC Virology
GA HC2UO
UT WOS:000451657600057
PM 30445676
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Van der Eerden, B
   Mumtaz, N
   Schreuders-Koedam, M
   Koopmans, M
   Rockx, B
   Van Leeuwen, J
AF Van der Eerden, Bram
   Mumtaz, Noreen
   Schreuders-Koedam, Marijke
   Koopmans, Marion
   Rockx, Barry
   Van Leeuwen, Johannes
TI Zika virus infection perturbs osteoblast function
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Bone-and-Mineral-Research
CY SEP 28-OCT 01, 2018
CL Montreal, CANADA
SP Amer Soc Bone & Mineral Res
C1 [Van der Eerden, Bram; Schreuders-Koedam, Marijke; Van Leeuwen, Johannes] Erasmus MC, Internal Med, Rotterdam, Netherlands.
   [Mumtaz, Noreen; Koopmans, Marion; Rockx, Barry] Erasmus MC, Virosci, Rotterdam, Netherlands.
RI van der Eerden, Bram CJ/I-7496-2012; van Leeuwen, Johannes/D-5015-2014
OI van der Eerden, Bram CJ/0000-0003-4403-6497; van Leeuwen,
   Johannes/0000-0002-2282-4006
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD NOV
PY 2018
VL 33
SU 1
MA LB MON - 1
BP 435
EP 435
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA HA7PP
UT WOS:000450475402132
DA 2020-07-08
ER

PT J
AU Silk, BJ
AF Silk, Benjamin J.
TI Infectious Disease Threats and Opportunities for Prevention
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Editorial Material
ID UNITED-STATES; VACCINATION COVERAGE; SURVEILLANCE DATA; ZIKA VIRUS; HIV;
   EPIDEMIOLOGY; TUBERCULOSIS; RESISTANCE; ANIMALS; BURDEN
C1 [Silk, Benjamin J.] CDC, Div TB Eliminat, Mol Epidemiol Act, Atlanta, GA 30333 USA.
   [Silk, Benjamin J.] US PHS, Washington, DC 20416 USA.
RP Silk, BJ (corresponding author), US PHS, Washington, DC 20416 USA.
EM benjaminsilk360@gmail.com
CR Bell BP, 2016, MMWR-MORBID MORTAL W, V65, P4, DOI 10.15585/mmwr.su6503a2
   Caminade C, 2019, ANN NY ACAD SCI, V1436, P157, DOI 10.1111/nyas.13950
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112
   Centers for Disease Control (USA), 1999, Morbidity and Mortality Weekly Report, V48, P621
   Drobnik A, 2014, J PUBLIC HEALTH MAN, V20, P506, DOI 10.1097/PHH.0b013e3182a95607
   Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Garrison LE, 2016, MMWR-MORBID MORTAL W, V65, P576, DOI 10.15585/mmwr.mm6522e1
   Geter A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189973
   Gridley-Smith CL, 2017, J PUBLIC HEALTH MAN, V23, P515, DOI 10.1097/PHH.0000000000000646
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hayes BH, 2018, CHEST, V153, P427, DOI 10.1016/j.chest.2017.09.041
   Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w
   Kaner J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0194-4
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9
   Lee B, 2018, PUBLIC HEALTH REP, V133, P130, DOI 10.1177/0033354917751130
   Lessa FC, 2015, NEW ENGL J MED, V372, P2369, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]
   Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158
   Perlman DC, 2018, CURR HIV-AIDS REP, V15, P96, DOI 10.1007/s11904-018-0390-3
   Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195
   Rebeiro PF, 2017, AIDS PATIENT CARE ST, V31, P129, DOI 10.1089/apc.2016.0178
   Rodriguez-Lainz A, 2018, PUBLIC HEALTH REP, V133, P45, DOI 10.1177/0033354917745503
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Shah NS, 2017, NEW ENGL J MED, V376, P243, DOI 10.1056/NEJMoa1604544
   Silk BJ, 2014, CLIN INFECT DIS, V59, P532, DOI 10.1093/cid/ciu365
   Sims OT, 2017, ANN HEPATOL, V16, P530, DOI 10.5604/01.3001.0010.0282
   Skoff TH, 2017, CLIN INFECT DIS, V65, P1977, DOI 10.1093/cid/cix724
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   The Review on Antimicrobial Resistance Wellcome Trust and the UK Department of Health, 2016, TACKLING DRUG RESIST
   U.S. Centres for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC
   van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X
   Walker TY, 2018, MMWR-MORBID MORTAL W, V67, P909, DOI 10.15585/mmwr.mm6733a1
   Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1
NR 34
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD NOV-DEC
PY 2018
VL 24
IS 6
BP 503
EP 505
DI 10.1097/PHH.0000000000000910
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HB2RH
UT WOS:000450889200005
PM 30273293
DA 2020-07-08
ER

PT J
AU Lee, CT
   Greene, SK
   Baumgartner, J
   Fine, A
AF Lee, Christopher T.
   Greene, Sharon K.
   Baumgartner, Jennifer
   Fine, Anne
TI Disparities in Zika Virus Testing and Incidence Among Women of
   Reproductive Age-New York City, 2016
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE disparities; public health practice; surveillance; Zika virus
ID MALE SEXUAL TRANSMISSION; INFECTIOUS-DISEASES; HEALTH DISPARITIES;
   VISITING FRIENDS; PREPAREDNESS; PERCEPTIONS; TRAVELERS; POVERTY; AREAS;
   RISK
AB Context: The New York City Department of Health and Mental Hygiene (NYC DOHMH) performs surveillance for reportable diseases, including Zika virus (ZIKV) infection and disease, to inform public health responses. Incidence rates of other mosquito-borne diseases related to international travel are associated with census tract poverty level in NYC, suggesting that high poverty areas might be at higher risk for ZIKV infections.
   Objectives: We assessed ZIKV testing rates and incidence of travel-associated infection among reproductive age women in NYC to identify areas with high incidence and low testing rates and assess the effectiveness of public health interventions.
   Design: We analyzed geocoded ZIKV surveillance data collected by NYC DOHMH. Women aged 15 to 44 years tested during January-July 2016 (n = 4733) were assigned to census tracts, which we grouped by poverty level and quartile of the number of persons born in countries or territories with mosquito-borne ZIKV transmission as a proxy for risk of travel to these areas. We calculated crude ZIKV testing rates, incidence rates, and incidence rate ratios (IRRs).
   Setting: New York City.
   Results: Eight percent of patients (n = 376) tested had evidence of ZIKV infection. Cumulative incidence was higher both in areas with higher versus lower poverty levels (IRR = 2.4; 95% confidence interval [CI], 2.0-3.0) and in areas with the largest versus smallest populations of persons born in countries or territories with mosquito-borne ZIKV transmission (IRR = 11.3; 95% CI, 6.2-20.7). Initially, ZIKV testing rates were lowest in higher poverty areas with the largest populations of persons born in countries or territories with mosquito-borne ZIKV transmission (15/100 000), but following targeted interventions, testing rates were highest in these areas (80/100 000).
   Conclusions: Geocoded data enabled us to identify communities with low testing but high ZIKV incidence rates, intervene to promote testing and reduce barriers to testing, and measure changes in testing rates.
C1 [Lee, Christopher T.; Greene, Sharon K.; Baumgartner, Jennifer; Fine, Anne] New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, 42-09 28th St,CN 22A, Long Isl City, NY 11101 USA.
   [Lee, Christopher T.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
RP Fine, A (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, 42-09 28th St,CN 22A, Long Isl City, NY 11101 USA.
EM afine@health.nyc.gov
OI Greene, Sharon/0000-0002-3509-2377
FU US Centers for Disease Control and Prevention Cooperative Agreements for
   Epidemiology and Laboratory Capacity for Infectious Disease (ELC)
   [5U50CK000407]; Public Health Emergency Preparedness (PHEP)
   [NU90TP000546]
FX This work was supported by US Centers for Disease Control and Prevention
   Cooperative Agreements for Epidemiology and Laboratory Capacity for
   Infectious Disease (ELC) grant number 5U50CK000407 and Public Health
   Emergency Preparedness (PHEP) grant number NU90TP000546. The authors
   thank staff in the New York City Department of Health and Mental Hygiene
   (NYC DOHMH) Bureau of Communicable Disease and Public Health Laboratory,
   staff who were activated for the Zika Response as part of the
   Surveillance and Epidemiology Branch of the NYC DOHMH Incident Command
   System, the NYC DOHMH Office of Vital Statistics, and partners at NYC
   Health + Hospitals.
CR Adamson R, 2010, AM J PUBLIC HEALTH, V100, P1249, DOI 10.2105/AJPH.2009.178335
   Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013
   Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856
   Blackstock OJ, 2015, J HEALTH CARE POOR U, V26, P811, DOI 10.1353/hpu.2015.0069
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P700
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Goldstein E, 2017, EPIDEMIOLOGY, V28, P136, DOI 10.1097/EDE.0000000000000571
   Greene SK, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302741
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   KALICHMAN SC, 1992, J CONSULT CLIN PSYCH, V60, P725, DOI 10.1037/0022-006X.60.5.725
   Keystone JS, 2015, CDC HLTH INFORM INT, P573
   Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NYC Department of City Planning, 2016, NEIGHB TAB AR FORM N
   NYC DOHMH, 2016, 2016 DOHMH HLTH AL 4
   NYS DOH Bureau of Communicable Disease Control, 2016, HLTH ADV ZIK VIR TES
   Pan American Health Organization and World Health Organization, 2015, EP AL NEUR SYNDR CON
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richardson LD, 2016, J PUBLIC HEALTH MAN, V22, pS107, DOI 10.1097/PHH.0000000000000372
   Santora M., 2016, NY TIMES
   Sheikh LA, 2009, MATERN CHILD HLTH J, V13, P260, DOI 10.1007/s10995-008-0341-5
   Toprani A, 2013, SELECTING APPL STAND
NR 26
TC 8
Z9 8
U1 2
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD NOV-DEC
PY 2018
VL 24
IS 6
BP 533
EP 541
DI 10.1097/PHH.0000000000000684
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HB2RH
UT WOS:000450889200010
PM 29084118
DA 2020-07-08
ER

PT J
AU Beattie, J
   Parajuli, S
   Sanger, M
   Lee, G
   Pleninger, P
   Crowley, G
   Kwon, S
   Murthy, V
   Manko, JA
   Caplan, A
   Dufort, E
   Pastula, DM
   Nolan, A
AF Beattie, Jason
   Parajuli, Sunita
   Sanger, Matthew
   Lee, Gregory
   Pleninger, Perrin
   Crowley, George
   Kwon, Sophia
   Murthy, Vivek
   Manko, Jeffrey A.
   Caplan, Arthur
   Dufort, Elizabeth
   Pastula, Daniel M.
   Nolan, Anna
TI Zika Virus-Associated Guillain-Barre Syndrome in a Returning US Traveler
SO INFECTIOUS DISEASES IN CLINICAL PRACTICE
LA English
DT Article
DE arbovirus; Guillain-Barre syndrome; Zika virus; Zika virus-associated
   Guillain-Barre syndrome
ID CLINICAL/SCIENTIFIC NOTES; INTERIM GUIDANCE; INFECTION; BRAZIL;
   TRANSMISSION
AB Zika virus (ZIKV) infection has been associated with Guillain-Barre syndrome (GBS). Roughly 60% of people in countries such as the United States live in areas at risk of seasonal spread of ZIKV. Zika virus belongs to a class of diseases that is not typically seen in hospital settings across the United States and Europe. We describe the case presentation, management, and treatment of ZIKV infection complicated by GBS. A 64-year-old woman with recent travel to the Dominican Republic presented with rash followed by an acute, ascending polyneuropathy consistent with GBS. She was confirmed to have an acute ZIKV infection by detection of ZIKV nucleic acid by reverse transcription-polymerase chain reaction. She met Brighton Collaboration criteria level 1 evidence for GBS. She received 2 courses of intravenous immunoglobulin and slowly improved, but still had weakness at discharge. More research is needed to identify the pathophysiology behind ZIKV-associated GBS and its optimal treatment. Prevention is fundamental to limiting infection and spread of ZIKV.
C1 [Beattie, Jason; Crowley, George; Kwon, Sophia; Murthy, Vivek; Nolan, Anna] NYU, Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY 10016 USA.
   [Parajuli, Sunita; Lee, Gregory] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10016 USA.
   [Sanger, Matthew; Pleninger, Perrin] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA.
   [Manko, Jeffrey A.] NYU, Sch Med, Dept Emergency Med, New York, NY 10016 USA.
   [Caplan, Arthur; Nolan, Anna] NYU, Sch Med, Div Eth, Dept Populat Hlth, New York, NY USA.
   [Dufort, Elizabeth] New York State Dept Hlth, Div Epidemiol, Albany, NY 12237 USA.
   [Pastula, Daniel M.] Univ Colorado Denver, Dept Neurol Med & Epidemiol, Aurora, CO USA.
   [Nolan, Anna] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA.
RP Nolan, A (corresponding author), NYU, Sch Med, Div Pulm Crit Care & Sleep, 7N Room 24,462 1st Ave, New York, NY 10016 USA.
EM anna.nolan@med.nyu.edu
RI Nolan, Anna/C-2796-2012; Pastula, Daniel M./M-1325-2019
OI Nolan, Anna/0000-0002-0631-1171; Pastula, Daniel M./0000-0001-9342-4459
FU NIH/NHLBIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01HL119326]
FX NIH/NHLBI R01HL119326.
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gaitanis IN, 2005, EUR SPINE J, V14, P250, DOI 10.1007/s00586-004-0767-4
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Hughes RAC, 1997, LANCET, V349, P225
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sharma Chandra Mohan, 2011, J Indian Med Assoc, V109, P682
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 39
TC 2
Z9 2
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-9103
EI 1536-9943
J9 INFECT DIS CLIN PRAC
JI Infect. Dis. Clin. Pract.
PD NOV
PY 2018
VL 26
IS 6
BP E80
EP E84
DI 10.1097/IPC.0000000000000654
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HA2QH
UT WOS:000450084200013
PM 30923438
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Avelino-Silva, VI
   Kallas, EG
AF Avelino-Silva, Vivian I.
   Kallas, Esper G.
TI Untold stories of the Zika virus epidemic in Brazil
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE congenital Zika syndrome; Guillain-Barre syndrome; microcephaly;
   outbreak; Zika virus
ID GUILLAIN-BARRE-SYNDROME; FDA-APPROVED DRUG; AEDES-AEGYPTI; SEXUAL
   TRANSMISSION; DENGUE VIRUS; CULEX-QUINQUEFASCIATUS; BORNE TRANSMISSION;
   ANTIVIRAL ACTIVITY; CROSS-REACTIVITY; BIRTH-DEFECTS
AB The Zika virus infection outbreak in Brazil in 2014 to 2015 resulted in the identification of previously unknown consequences of the disease, including the notorious microcephaly among many defects in fetuses born to women infected during pregnancy. A number of individuals were involved in this remarkable discovery, from the detection of viral circulation in the country to the studies on the causal link with congenital abnormalities and the provision of awareness and social support to families affected by the disease. In this article, we review the background to this experience, describing aspects of the epidemiology, medical research, and scientific response to the Zika virus outbreak in Brazil.
C1 [Avelino-Silva, Vivian I.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.] Hosp Sirio Libanes, Sao Paulo, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
RP Avelino-Silva, VI (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
EM viviansilva87@gmail.com
RI Avelino-Silva, Vivian I/L-2640-2013
OI Avelino-Silva, Vivian I/0000-0002-6660-3088; Kallas,
   Esper/0000-0003-2026-6925
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   Acosta LJ, 2016, HUFFINGTON POST
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   [Anonymous], MON CAS OB FEBR AM B
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Avelino-Silva A.C, 2017, 53 C SOC BRAS MED TR
   Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2014, EURO SURVEILL, V19
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brasil Ministerio da Saude, PORT N 1 813 11 NOV
   Brasil Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Brito MB, 2016, REV BRAS GINECOL OBS, V38, P583, DOI 10.1055/s-0036-1593411
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darney BG, 2017, OBSTET GYNECOL, V129, P638, DOI [10.1097/AOG.0000000000001914, 10.1097/aog.0000000000001914]
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diaz-Quijano FA, 2017, ANN EPIDEMIOL, V27, P616, DOI 10.1016/j.annepidem.2017.08.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FENTON TR, 2013, BMC PEDIATR, V13
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Freour T., 2016, EURO SURVEILL, V21
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kallas EG, 2016, JAMA PEDIATR, V170, P633, DOI 10.1001/jamapediatrics.2016.0857
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Leite RD, 2015, EMERG INFECT DIS, V21, P1681, DOI 10.3201/eid2109.150391
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Liuzzi G, 2016, NEW MICROBIOL, V39, P83
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio da Saude . Secretaria de Vigilancia em Saude, 2018, B EP, V11
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2016, JAMA PEDIAT
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Muturi EJ, 2017, TROP MED INT HEALTH, V22, P399, DOI 10.1111/tmi.12846
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Partlow J, 2016, WASHINGTON POST
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz-Bailey G, 2017, N ENGL J MED
   Pires de Mello CP, 2017, ANTIMICROB AGENTS CH, V62
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quintero-Gil DC, 2014, J INFECT DEV COUNTR, V8, P876, DOI 10.3855/jidc.3978
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossetto EV, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759017, 10.1590/S1678-9946201759017]
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   SACRAMENTO CQ, 2017, SCI REP UK, V7
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Silveira M., 2015, NAO ENGRAVIDEM AGORA
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas P, 2017, N ENGL J MED
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 131
TC 1
Z9 1
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD NOV
PY 2018
VL 28
IS 6
AR e2000
DI 10.1002/rmv.2000
PG 9
WC Virology
SC Virology
GA HA2NV
UT WOS:000450076600006
PM 30074287
OA Bronze
DA 2020-07-08
ER

PT J
AU Kong, WL
AF Kong, Weili
TI Can semen protect human from ZIKV infection?
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
ID MEN
C1 [Kong, Weili] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14620 USA.
RP Kong, WL (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14620 USA.
EM kongweili345@gmail.com
CR Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Lorusso F, 2010, ANDROLOGIA, V42, P121, DOI 10.1111/j.1439-0272.2009.00970.x
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD NOV
PY 2018
VL 57
BP E30
EP E30
DI 10.1016/j.ejim.2018.08.007
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GZ8DE
UT WOS:000449715900014
PM 30145056
DA 2020-07-08
ER

PT J
AU Lin, KW
   Kraemer, JD
   Piltch-Loeb, R
   Stoto, MA
AF Lin, Kenneth W.
   Kraemer, John D.
   Piltch-Loeb, Rachael
   Stoto, Michael A.
TI The Complex Interpretation and Management of Zika Virus Test Results
SO JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE
LA English
DT Article
DE Centers for Disease Control and Prevention (US); Decision Making;
   Pregnancy; Probability; Public Health; Sensitivity and Specificity;
   Serologic Tests; Zika Virus
ID WHOLE-BLOOD; VIREMIA; INFECTION
AB Zika virus disease provides the latest example of a critical nexus between public health and clinical practice. Interpreting Zika virus test results is complicated by the absence of a single testing approach with superior validity across contexts and populations. Molecular tests are highly specific, variably sensitive, and have a short window period. Serologic tests identify antibodies against Zika virus and are more likely than molecular tests to cross-react with other related viruses, reducing specificity. The type of test performed and timing relative to possible Zika virus exposure depend on public health guidance, testing algorithms, test availability, and capacity. Guidance from the Centers for Disease Control and Prevention and local health departments have changed throughout the course of the US epidemic based on prevalence, geography, and clinical concerns. Women with a low pretest probability of infection should be counseled against testing. Women with a high pretest probability of Zika virus infection should still receive enhanced prenatal monitoring and newborn evaluation, regardless of the test result. An appropriate interpretation of results depends on what tests are used, patient characteristics, and reasons for testing. Clinicians should take these factors into account in shared decision making discussions with pregnant women about Zika virus testing.
C1 [Lin, Kenneth W.] Georgetown Univ, Dept Family Med, Med Ctr, 3900 Reservoir Rd NW Preclin Sci GB-01A, Washington, DC 20007 USA.
   [Kraemer, John D.; Stoto, Michael A.] Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20007 USA.
   [Piltch-Loeb, Rachael] New York Univ, Coll Global Publ Hlth, New York, NY USA.
RP Lin, KW (corresponding author), Georgetown Univ, Dept Family Med, Med Ctr, 3900 Reservoir Rd NW Preclin Sci GB-01A, Washington, DC 20007 USA.
EM Kenneth.Lin@georgetown.edu
CR Abramson D., 2016, US PUBLICS PERCEPTIO
   [Anonymous], 2017, ACTIONS NEEDED ADDRE
   [Anonymous], 2016, NORC ZIKA VIRUS GAPS
   Barzon L, 2018, CLIN INFECT DIS, V67, P1144, DOI 10.1093/cid/ciy262
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Centers for Disease Control and Prevention, 2017, GUIDANCE US LAB TEST
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Flamand C, 2017, EUROSURVEILLANCE, V22
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Goldfarb IT, 2017, JAMA-J AM MED ASSOC, V318, P2075, DOI 10.1001/jama.2017.15680
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Morain SR, 2017, NEW ENGL J MED, V377, P1505, DOI 10.1056/NEJMp1707273
   Paz-Bailey G, N ENGL J MED
   Piltch-Loeb R, 2018, AM J PUBLIC HLTH
   Rabin Roni Caryn, 2016, NY TIMES
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 21
TC 2
Z9 2
U1 0
U2 5
PU AMER BOARD FAMILY MEDICINE
PI LEXINGTON
PA 2228 YOUNG DR, LEXINGTON, KY 40505 USA
SN 1557-2625
EI 1558-7118
J9 J AM BOARD FAM MED
JI J. Am. Board Fam. Med.
PD NOV-DEC
PY 2018
VL 31
IS 6
BP 924
EP 930
DI 10.3122/jabfm.2018.06.180061
PG 7
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA HA0FK
UT WOS:000449883000011
PM 30413548
OA Bronze
DA 2020-07-08
ER

PT J
AU Knaeble, B
   Chan, J
AF Knaeble, Brian
   Chan, Julian
TI Odds are the sign is right
SO BIOMETRICAL JOURNAL
LA English
DT Article
DE association parameters; causal analysis; confounding; sensitivity
   analysis
ID SIMPSONS PARADOX
AB This article introduces a new condition based on odds ratios for sensitivity analysis. The analysis involves the average effect of a treatment or exposure on a response or outcome with estimates adjusted for and conditional on a single, unmeasured, dichotomous covariate. Results of statistical simulations are displayed to show that the odds ratio condition is as reliable as other commonly used conditions for sensitivity analysis. Other conditions utilize quantities reflective of a mediating covariate. The odds ratio condition can be applied when the covariate is a confounding variable. As an example application we use the odds ratio condition to analyze and interpret a positive association observed between Zika virus infection and birth defects.
C1 [Knaeble, Brian] Utah Valley Univ, Dept Math, Orem, UT USA.
   [Chan, Julian] Weber State Univ, Dept Math, 1415 Edvalson St,Dept 2517, Ogden, UT 84404 USA.
RP Chan, J (corresponding author), Weber State Univ, Dept Math, 1415 Edvalson St,Dept 2517, Ogden, UT 84404 USA.
EM julianchan@weber.edu
CR Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1
   BROSS IDJ, 1966, J CHRON DIS, V19, P637, DOI 10.1016/0021-9681(66)90062-2
   BROSS IDJ, 1967, J CHRON DIS, V20, P487, DOI 10.1016/0021-9681(67)90080-X
   Centers for Disease Control and Prevention, 2017, ZIK VIR OUTC COMPL P
   Centers for Disease Control and Prevention, 2017, BIRTH DEF DAT STAT
   Cohen J., 2003, APPL MULTIPLE REGRES
   CORNFIELD J, 1959, J NATL CANCER I, V22, P173
   Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457
   Ding P, 2014, BIOMETRIKA, V101, P971, DOI 10.1093/biomet/asu030
   Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673
   Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658
   Knaeble B, 2017, AM STAT, V71, P97, DOI 10.1080/00031305.2016.1226951
   Lee WC, 2011, STAT MED, V30, P1007, DOI 10.1002/sim.4151
   Malone R. W., 2016, NEGLECTED TROPICAL D, V10, P1582
   Pavlides MG, 2009, AM STAT, V63, P226, DOI 10.1198/tast.2009.09007
   Pearl J, 2014, AM STAT, V68, P8, DOI 10.1080/00031305.2014.876829
   van den Boogaart K. G., 2013, R PACKAGE COMPOSITIO
   VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607
   WAGNER CH, 1982, AM STAT, V36, P46, DOI 10.2307/2684093
   Weinhold B, 2009, ENVIRON HEALTH PERSP, V117, pA440, DOI 10.1289/ehp.117-a440
NR 20
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0323-3847
EI 1521-4036
J9 BIOMETRICAL J
JI Biom. J.
PD NOV
PY 2018
VL 60
IS 6
BP 1164
EP 1171
DI 10.1002/bimj.201700199
PG 8
WC Mathematical & Computational Biology; Statistics & Probability
SC Mathematical & Computational Biology; Mathematics
GA GZ8AS
UT WOS:000449709000024
PM 30259547
DA 2020-07-08
ER

PT J
AU Coelho, KEFA
   Silva, GLCC
   Pinho, SF
   de Carvalho, AL
   Petter, CM
   Brandi, IV
AF Coelho, Katia E. F. A.
   Silva, Grasiele L. C. C.
   Pinho, Suely F.
   de Carvalho, Alessandra L.
   Petter, Cristian M.
   Brandi, Ivar V.
TI Congenital Zika syndrome phenotype in a child born in Brazil in December
   2011
SO CLINICAL CASE REPORTS
LA English
DT Article
DE congenital Zika syndrome; dengue; fetal brain disruption sequence;
   isochromosome X; microcephaly; Zika virus
ID VIRUS
AB We report a case of a Brazilian child born in 2011 with congenital Zika syndrome phenotype. Zika virus (ZIKV) may have been circulating in Brazil more than 4 years before the outbreak. ZIKV infection might be considered in children with this phenotype even without known circulation of ZIKV.
C1 [Coelho, Katia E. F. A.; Petter, Cristian M.] Hosp Sarah Salvador, Genet Dept, Salvador, BA, Brazil.
   [Silva, Grasiele L. C. C.; Pinho, Suely F.; de Carvalho, Alessandra L.] Hosp Sarah Salvador, Pediat Dept, Salvador, BA, Brazil.
   [Brandi, Ivar V.] Hosp Sarah Salvador, Neurol Dept, Salvador, BA, Brazil.
RP Coelho, KEFA (corresponding author), Hosp Sarah Salvador, Salvador, BA, Brazil.
EM katiaedni@sarah.br
OI Petter, Cristian/0000-0001-8103-8235
CR Abdel-Salam GMH, 2015, AM J MED GENET A, V167, P1089, DOI 10.1002/ajmg.a.37010
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hockner M, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2008.05.054
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 13
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2050-0904
J9 CLIN CASE REP
JI Clin. Case Rep.
PD NOV
PY 2018
VL 6
IS 11
BP 2053
EP 2056
DI 10.1002/ccr3.1810
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA GZ7KA
UT WOS:000449656700007
PM 30455890
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Bruycker-Nogueira, F
   Faria, NRD
   Nunes, PCG
   Nogueira, RMR
   de Filippis, AMB
   dos Santos, FB
AF de Bruycker-Nogueira, Fernanda
   da Costa Faria, Nieli Rodrigues
   Guerra Nunes, Priscila Conrado
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   dos Santos, Flavia Barreto
TI First detection and molecular characterization of a DENV-1/DENV-4
   co-infection during an epidemic in Rio de Janeiro, Brazil
SO CLINICAL CASE REPORTS
LA English
DT Article
DE co-infection; dengue virus 1; dengue virus 4; genotype II; genotype V
ID CLINICAL PRESENTATION; DENGUE VIRUSES; ZIKA
AB In the 80s, dengue viruses type 1 and 4 (DENV-1 and 4) were isolated in North region of Brazil. However, it was only after the DENV-1 introduction in the state of Rio de Janeiro (RJ) in mid-1980s, that dengue became a nationwide public health problem. In 2009, this serotype re-emerged causing an explosive epidemic in the country. DENV-4 was first detected in RJ in 2011 and in 2012, and DENV-1 and 4 were co-circulating and responsible for a high number of cases notifications. Here, we describe the detection and molecular characterization of a DENV-1/4 co-infection in sample of 2012 in RJ.
C1 [de Bruycker-Nogueira, Fernanda; Guerra Nunes, Priscila Conrado; dos Santos, Flavia Barreto] Fiocruz MS, Oswaldo Cruz Inst, Viral Immunol Lab, Av Brasil 4365,Pavilhao Helio & Peggy Pereira, BR-21040360 Manguinho, RJ, Brazil.
   [da Costa Faria, Nieli Rodrigues; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fiocruz MS, Oswaldo Cruz Inst, Flavivirus Lab, Rio De Janeiro, Brazil.
RP dos Santos, FB (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Viral Immunol Lab, Av Brasil 4365,Pavilhao Helio & Peggy Pereira, BR-21040360 Manguinho, RJ, Brazil.
EM flaviab@ioc.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPqNational Council for Scientific and Technological
   Development (CNPq) [303822/2015-5]; Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [407690/2012-3]; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.003/2016]; Brazilian Ministry of Health
FX To Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq
   [grant number 303822/2015-5] and Programa Estrategico de Pesquisa em
   Saude/PAPES VI-FIOCRUZ [grant number 407690/2012-3], to Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), to Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ to FBS grant number
   E-26/202.003/2016, to FIOCRUZ, and Brazilian Ministry of Health.
CR Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   [Anonymous], 2016, DENGUE SITUACAO EPID
   [Anonymous], 2018, B EPIDEMIOLOGICO 20, V20
   [Anonymous], 2012, B EPIDEMIOLOGICO DEN
   Azeredo EL, 2018, PLOS CURR, DOI 10. 1371/currents. outbreaks. 0bf6aeb4d30824de63c4d5d745b217f5
   Chaves BA, 2018, J INFECT DIS, V218, P563, DOI 10.1093/infdis/jiy196
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   dos Santos FB, 2013, DENGUE B, V37, P61
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Martins Vdo C, 2014, PLOS ONE, V9
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 19
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2050-0904
J9 CLIN CASE REP
JI Clin. Case Rep.
PD NOV
PY 2018
VL 6
IS 11
BP 2075
EP 2080
DI 10.1002/ccr3.1750
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA GZ7KA
UT WOS:000449656700011
PM 30455894
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carabali, M
   Lim, JK
   Palencia, DC
   Lozano-Parra, A
   Gelvez, RM
   Lee, KS
   Florez, JP
   Herrera, VM
   Kaufman, JS
   Rojas, EM
   Villar, LA
AF Carabali, Mabel
   Lim, Jacqueline K.
   Palencia, Diana C.
   Lozano-Parra, Anyela
   Margarita Gelvez, Rosa
   Lee, Kang Sung
   Florez, Janeth P.
   Mauricio Herrera, Victor
   Kaufman, Jay S.
   Rojas, Elsa M.
   Angel Villar, Luis
TI Burden of dengue among febrile patients at the time of chikungunya
   introduction in Piedecuesta, Colombia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE dengue; chikungunya; Colombia; disease incidence; fever surveillance;
   underreporting; clinical characterisation
ID DIAGNOSTIC-TESTS; VIRUS-INFECTIONS; EPIDEMIOLOGY; SURVEILLANCE;
   CIRCULATION; COUNTRIES; CHILDREN; DISEASE; ZIKA
AB Objective To estimate the age-specific incidence of symptomatic dengue and chikungunya in Colombia. Method Results A passive facility-based fever surveillance study was conducted among individuals with undifferentiated fever. Confirmatory diagnostics included serological and molecular tests in paired samples, and surveillance's underreporting was assessed using capture-recapture methods. Of 839 febrile participants 686 completed the study. There were 33.2% (295/839) dengue infections (51% primary infections), and 35.9% (191/532) of negative dengue cases there were chikungunya cases. On average, dengue cases were younger (median = 18 years) than chikungunya cases (median = 25 years). Thrombocytopaenia and abdominal pain were the main dengue predictors, while presence of rash was the main predictor for chikungunya diagnosis. Underreporting of dengue was 31%; the estimated expansion factors indicate an underreporting rate of dengue cases of threefold for all cases and of almost sixfold for inpatients. Conclusions Objectif These findings highlight the ongoing coexistence of both arboviruses, a distinct clinical profile of each condition in the study area that could be used by clinicians to generate a differential diagnosis, and the presence of underreporting, mostly among hospitalised cases.
C1 [Carabali, Mabel; Lim, Jacqueline K.; Lee, Kang Sung] Int Vaccine Inst, Global Dengue & Aedes Transmitted Dis Consortium, Seoul, South Korea.
   [Carabali, Mabel; Kaufman, Jay S.] McGill Univ, 1020 Pine Ave West,Purvis Hall Room 17A, Montreal, PQ H3A 1A2, Canada.
   [Palencia, Diana C.; Lozano-Parra, Anyela; Margarita Gelvez, Rosa; Florez, Janeth P.; Mauricio Herrera, Victor; Rojas, Elsa M.; Angel Villar, Luis] Univ Ind Santander, Bucaramanga, Colombia.
RP Carabali, M (corresponding author), McGill Univ, 1020 Pine Ave West,Purvis Hall Room 17A, Montreal, PQ H3A 1A2, Canada.
EM mabel.carabali@mail.mcgill.ca
OI Kaufman, Jay/0000-0003-1606-401X
FU Bill & Melinda Gates FoundationGates Foundation [OPP1016669]; Colombian
   Research Funding Agency for Science and Technology- COLCIENCIAS: Fondo
   de Ciencia, Tecnologia e Innovacion del Sistema General de Regalias,
   Santander, Casanare y Valle del Cauca [BPIN 2013000100011]
FX We acknowledge the participation of Piedecuesta's community, medical
   staff and nurses of the study, and of the Public Health and the
   Surveillance office. This study is part of the Dengue Vaccine Initiative
   program, a work supported by the Bill & Melinda Gates Foundation [grant
   number OPP1016669]. Supplemental funding was obtained by the Colombian
   Research Funding Agency for Science and Technology- COLCIENCIAS: Fondo
   de Ciencia, Tecnologia e Innovacion del Sistema General de Regalias,
   Santander, Casanare y Valle del Cauca [grant number BPIN 2013000100011].
CR Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Bartlett JW, 2015, STAT METHODS MED RES, V24, P462, DOI 10.1177/0962280214521348
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   Carter MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003424
   DANE, 2008, PROYECC POBL
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   Diaz-Quijano F A, 2006, An Pediatr (Barc), V64, P523, DOI 10.1157/13089916
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103
   Instituto Nacional de Salud (INS), 2014, INFORM DE EVENTO, P37
   [Instituto Nacional de Salud (INS) Vigilancia y Analisis del Riesgo en Salud Publica], 2016, VIG AN RIESG SAL PUB, VFOR-R02. 4000-001
   [Instituto Nacional de Salud (INS) Publica DdVyAdReS], 2014, B EPIDEMIOLOGICO SEM, V54, P34
   Instuto Nacional de Salud (INS), 2016, INF EV CHIK PER EP 1, P1
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lim JK, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017673
   Martinez-Vega RA, 2006, REV MED CHILE, V134, P1153, DOI 10.4067/S0034-98872006000900010
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Tuan NM, 2017, CLIN INFECT DIS, V64, P656, DOI 10.1093/cid/ciw863
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Toan NT, 2015, TROP MED INT HEALTH, V20, P840, DOI 10.1111/tmi.12498
   Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859
   Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191
   Waggoner JJ, 2017, J INFECT DIS, V215, P1816, DOI 10.1093/infdis/jix195
   Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996
   World Health Organization (WHO), 2012, GLOB STRAT DENG PREV, p[43, vi]
   World Health Organization (WHO), 2015, 68 WORLD HLTH ASS
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 43
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD NOV
PY 2018
VL 23
IS 11
BP 1231
EP 1241
DI 10.1111/tmi.13147
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GZ7UQ
UT WOS:000449690300008
PM 30176107
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Devnarain, N
   Soliman, MES
AF Devnarain, Nikita
   Soliman, Mahmoud E. S.
TI A panoptic uncovering of the dynamical evolution of the Zika Virus NS5
   methyltransferase binding site loops-zeroing in on the molecular
   landscape
SO CHEMICAL BIOLOGY & DRUG DESIGN
LA English
DT Article
DE methyltransferase; molecular dynamics; NS5; Zika virus inhibitors
ID UCSF CHIMERA; DRUG; DISCOVERY; SIMULATIONS; EMERGENCE; DOCKING;
   INHIBITION; ACCURACY; TARGETS; BRAIN
AB The global threat of the Zika virus to humanity is real. Innovative and potent anti-Zika virus drugs are still at large, due to the lack of anti-Zika virus drugs that have passed phase 1 trials. Experimental research has revealed novel inhibitors of Zika virus NS5 methyltransferase enzyme. This study has taken a step further to provide insight into the molecular dynamics of Zika virus and inhibitor binding, which have not been established experimentally. Movements of the methyltransferase binding site loops have a large role to play in the methylation of the viral mRNA cap, which is essential for Zika virus replication. Here, we pinpoint the binding interactions between each potential inhibitor and the methyltransferase, residues that are responsible for binding, as well as which inhibitor-bound complex renders the methyltransferase more stable. We also highlight the conformational changes that occur within the methyltransferase to accommodate binding of inhibitors and consequences of those changes upon the RNA- and cap-binding sites in the methyltransferase. This research will improve the understanding of the Zika virus NS5 methyltransferase enzyme, and will be beneficial in driving the development of anti-Zika virus drugs.
C1 [Devnarain, Nikita; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, ZA-4001 Durban, South Africa.
RP Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, ZA-4001 Durban, South Africa.
EM soliman@ukzn.ac.za
RI Soliman, Mahmoud E S/M-8724-2013
OI Soliman, Mahmoud E S/0000-0002-8711-7783; Devnarain,
   Nikita/0000-0002-9538-4611
FU DAAD-NRF JOINT IN-COUNTRY DOCTORAL SCHOLARSHIP PROGRAMME
   [DAAD170602236415]
FX DAAD-NRF JOINT IN-COUNTRY DOCTORAL SCHOLARSHIP PROGRAMME, Grant/Award
   Number: DAAD170602236415
CR Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   desRuyck J., 2016, ADV APPL BIOINFORMA, V9, P1
   Devnarain N, 2017, RSC ADV, V7, P47416, DOI 10.1039/c7ra05918c
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fauci A. S., 2010, NEW ENGL J MED, V363, P1
   Ganesan A, 2017, DRUG DISCOV TODAY, V22, P249, DOI 10.1016/j.drudis.2016.11.001
   Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936
   HAMILL RL, 1973, J ANTIBIOT, V26, P463, DOI 10.7164/antibiotics.26.463
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Kasahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112419
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Machaba KE, 2016, CELL BIOCHEM BIOPHYS, V74, P473, DOI 10.1007/s12013-016-0764-3
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Munir A, 2016, DRUG DES OPEN ACCESS, V5, P1
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Raabe G, 2017, MOLEC MODEL SIMUL, P83, DOI 10.1007/978-981-10-3545-6_4
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sprenger KG, 2015, J PHYS CHEM B, V119, P5882, DOI 10.1021/acs.jpcb.5b00689
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   WANG JM, 2001, ABSTR PAP AM CHEM 1, V222
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, HIST ZIK VIR
   Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e
   Woods RJ, 2000, J MOL STRUC-THEOCHEM, V527, P149, DOI 10.1016/S0166-1280(00)00487-5
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zhang X., 2015, MOL DYNAMICS SIMULAT, P584
NR 44
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1747-0277
EI 1747-0285
J9 CHEM BIOL DRUG DES
JI Chem. Biol. Drug Des.
PD NOV
PY 2018
VL 92
IS 5
BP 1838
EP 1850
DI 10.1111/cbdd.13353
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA GZ5OW
UT WOS:000449475400003
PM 29923677
OA Bronze
DA 2020-07-08
ER

PT J
AU Potera, C
AF Potera, Carol
TI One in Seven Babies Exposed to Zika Virus In Utero Has Birth Defects
SO AMERICAN JOURNAL OF NURSING
LA English
DT News Item
CR Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
NR 1
TC 0
Z9 0
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD NOV
PY 2018
VL 118
IS 11
BP 12
EP 12
DI 10.1097/01.NAJ.0000547645.00532.dc
PG 1
WC Nursing
SC Nursing
GA GY2RX
UT WOS:000448391800004
PM 30358578
DA 2020-07-08
ER

PT J
AU Aberle, JH
   Koblischke, M
   Stiasny, K
AF Aberle, Judith H.
   Koblischke, Maximilian
   Stiasny, Karin
TI CD4 T cell responses to flaviviruses
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article; Proceedings Paper
CT 20th Annual Meeting of the European-Society-for-Clinical-Virology (ESCV)
CY SEP 13-16, 2017
CL Stresa, ITALY
SP European Soc Clin Virol
DE Flavivirus; CD4 T cell; Epitope; Immunodominance; TBE; Zika; Dengue;
   Flavivirus vaccine
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; TICK-BORNE ENCEPHALITIS;
   TETRAVALENT DENGUE VACCINE; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE;
   ZIKA VIRUS; COMPREHENSIVE ANALYSIS; SECONDARY INFECTION; THAI
   SCHOOLCHILDREN
AB Flaviviruses pose an increasing threat to global health with their potential to cause severe disease in millions of people. Protective and long-lived immunity is closely linked to the generation of CD4 T cells, which provide B cell help and support high affinity neutralizing antibody responses. Research performed during the last years revealed important new insights into the antigen specificities and diverse effector functions of CD4 T cell responses to flaviviruses. Moreover, the identification of mechanisms involved in the regulation of T cell specificity and function provides significant advances in our understanding of how durable protective immunity is established.
   Here, we summarize what is known about human CD4 T cell responses to flaviviruses, with a special emphasis on CD4 T cells that provide direct help to B cells producing neutralizing and protective antibodies. We review recent progress in the identification of epitope sites in the context of the atomic structures of flavivirus proteins and highlight specific influences that shape the human CD4 T cell response in the context of infection or vaccination. Finally, we discuss challenges facing vaccine efforts to generate appropriate CD4 T cell responses, as well as recent strategies to enhance T cell-mediated antibody responses.
C1 [Aberle, Judith H.; Koblischke, Maximilian; Stiasny, Karin] Med Univ Vienna, Ctr Virol, Kinderspitalgasse 15, A-1090 Vienna, Austria.
RP Aberle, JH (corresponding author), Med Univ Vienna, Ctr Virol, Kinderspitalgasse 15, A-1090 Vienna, Austria.
EM judith.aberle@meduniwien.ac.at
OI Stiasny, Karin/0000-0002-1902-8674; Koblischke,
   Maximilian/0000-0003-1223-4990; Aberle, Judith H/0000-0003-1197-3935
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P29881-B30,
   P29928-B30]
FX This work was supported by two research grants from the Austrian Science
   Fund FWF. The two grants have to be mentioned: One to Judith Aberle:
   P29881-B30 and one to Karin Stiasny: P29928-B30.
CR Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001
   Durbin AP, 2016, CELL, V166, P1, DOI 10.1016/j.cell.2016.06.036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gavillet BM, 2015, J IMMUNOL, V194, P4836, DOI 10.4049/jimmunol.1402071
   Goncalves AJS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004277
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gubler D, 2007, FIELDS VIROLOGY, V1
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077
   Hernandez-Triana LM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00271
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003673
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Koblischke M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09331-w
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304
   Landry SJ, 2017, VIRAL IMMUNOL, V30, P479, DOI 10.1089/vim.2017.0008
   Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898
   Lazo L, 2010, ARCH VIROL, V155, P1587, DOI 10.1007/s00705-010-0734-9
   Li JQ, 2013, VACCINE, V31, P4136, DOI 10.1016/j.vaccine.2013.06.099
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Moran E, 2008, EUR J IMMUNOL, V38, P1050, DOI 10.1002/eji.200737699
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pan CH, 2001, J VIROL, V75, P11457, DOI 10.1128/JVI.75.23.11457-11463.2001
   Pierson T. C., 2008, EXPERT REV MOL MED
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Siegrist CA, 2008, VACCINES
   Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   SWAIN SL, 1995, J LEUKOCYTE BIOL, V57, P795
   Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205
   Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 85
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2018
VL 108
BP 126
EP 131
DI 10.1016/j.jcv.2018.09.020
PG 6
WC Virology
SC Virology
GA GY9HD
UT WOS:000448951300022
PM 30312909
DA 2020-07-08
ER

PT J
AU de Sousa, JR
   Azevedo, RSS
   Martins, AJ
   Araujo, MTF
   Moutinho, ERC
   Vasconcelos, BCB
   Cruz, ACR
   Oliveira, CS
   Martins, LC
   Vasconcelos, BHB
   Casseb, LMN
   Chiang, JO
   Quaresma, JAS
   Vasconcelos, PFC
AF de Sousa, Jorge R.
   Azevedo, Raimunda S. S.
   Martins Filho, Arnaldo J.
   Araujo, Marialva T. F.
   Moutinho, Ermelinda R. C.
   Baldez Vasconcelos, Barbara C.
   Cruz, Ana C. R.
   Oliveira, Consuelo S.
   Martins, Livia C.
   Baldez Vasconcelos, Beatriz H.
   Casseb, Livia M. N.
   Chiang, Jannifer O.
   Quaresma, Juarez A. S.
   Vasconcelos, Pedro F. C.
TI Correlation between Apoptosis and in Situ Immune Response in Fatal Cases
   of Microcephaly Caused by Zika Virus
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID INDUCED ENCEPHALITIS; INFECTION; OUTBREAK; DENGUE; CELLS; MECHANISMS;
   EPIDEMIC; FEVER; LIVER
AB Zika virus (ZIKV) is a single-stranded positive-sense RNA flavivirus that possesses a genome approximately 10.7 Kb in length. Although pro-inflammatory and anti-inflammatory cytokines and apoptotic markers belonging to the extrinsic and intrinsic pathways are suggested to be involved in fatal cases of ZIKV-induced microcephaly, their exact roles and associations are unclear. To address this, brain tissue samples were collected from 10 individuals, five of whom were diagnosed as ZIKV positive with microcephaly and a further five were flavivirus-negative controls that died because of other causes. Examination of material from the fatal cases of microcephaly revealed lesions in the cerebral cortex, edema, vascular proliferation, neuronal necrosis, gliosis, neuronophagy, calcifications, apoptosis, and neuron loss. The expression of various apoptosis markers in the neural parenchyma, including FasL, FAS, BAX, BCL2, and caspase 3 differed between ZIKV-positive cases and controls. Further investigation of type 1 and 2 helper T-cell cytokines confirmed a greater anti-inflammatory response in fatal ZIKV-associated microcephaly cases. Finally, an analysis of the linear correlation between tumor necrosis factor-alpha, IL-1 beta, IL-4, IL-10, transforming growth factor-beta, and IL-33 expression and various apoptotic markers suggested that the immune response may be associated with the apoptotic phenomenon observed in ZIKV-induced microcephaly.
C1 [de Sousa, Jorge R.; Azevedo, Raimunda S. S.; Cruz, Ana C. R.; Oliveira, Consuelo S.; Martins, Livia C.; Casseb, Livia M. N.; Chiang, Jannifer O.; Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Rodovia BR-316,Km 07 S-N, BR-67030000 Ananindeua, Brazil.
   [Martins Filho, Arnaldo J.; Araujo, Marialva T. F.; Moutinho, Ermelinda R. C.; Quaresma, Juarez A. S.] Minist Hlth, Evandro Chagas Inst, Dept Pathol, Rodovia BR-316,Km 07 S-N, BR-67030000 Ananindeua, Brazil.
   [Baldez Vasconcelos, Barbara C.; Cruz, Ana C. R.; Quaresma, Juarez A. S.; Vasconcelos, Pedro F. C.] State Univ Para, Ctr Biol & Hlth Sci, Belem, Para, Brazil.
   [Baldez Vasconcelos, Beatriz H.; Quaresma, Juarez A. S.] Fed Univ Para, Trop Med Ctr, Belem, Para, Brazil.
RP Vasconcelos, PFC (corresponding author), Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Rodovia BR-316,Km 07 S-N, BR-67030000 Ananindeua, Brazil.; Quaresma, JAS (corresponding author), Minist Hlth, Evandro Chagas Inst, Dept Pathol, Rodovia BR-316,Km 07 S-N, BR-67030000 Ananindeua, Brazil.
EM juarez@ufpa.br; pedrovasconcelos@iec.gov.br
RI Vasconcelos, Pedro/AAH-3142-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019;
   QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012; Quaresma, Juarez
   AS/M-4190-2014; Filho, Arnaldo Jorge Martins/AAJ-2779-2020; Azevedo,
   Raimunda/T-4656-2019
OI QUARESMA, JUAREZ ANTONIO SIMOES/0000-0002-6267-9966; Quaresma, Juarez
   AS/0000-0002-6267-9966; Filho, Arnaldo Jorge
   Martins/0000-0001-9153-1234; Azevedo, Raimunda/0000-0003-1932-9976
FU Ministry of Science, Technology and Innovation/National Council for
   Scientific and Technological Development CNPQ, Brazil [303999/2016-0,
   439971/2016-0, 440405/2016-5]; Coordination for the Improvement of
   Higher Level Personnel (CAPES), BrazilCAPES
FX Supported by the Ministry of Science, Technology and Innovation/National
   Council for Scientific and Technological Development CNPQ, Brazil grants
   303999/2016-0, 439971/2016-0, and 440405/2016-5 and Coordination for the
   Improvement of Higher Level Personnel (CAPES), Brazil (Zika Fast-Track)
   (P.F.C.V.).
CR Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403
   Ashhurst TM, 2013, INDIAN J MED RES, V138, P632
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Franca RFO, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0628-1
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P1349, DOI 10.1177/29.11.6172466
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Limonta D, 2014, J MED VIROL, V86, P1437, DOI 10.1002/jmv.23832
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131
   Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683
   Okamoto T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090243
   Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231
   Pagliari C, 2014, J MED VIROL, V86, P1193, DOI 10.1002/jmv.23758
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6
   Shrestha B, 2007, J VIROL, V81, P11749, DOI 10.1128/JVI.01136-07
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183
   Sun PF, 2013, SCI WORLD J, DOI 10.1155/2013/843469
   Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5
   Teng Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00327
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Tsao CH, 2008, J GEN VIROL, V89, P1930, DOI 10.1099/vir.0.2008/000182-0
   Wang Y, 2004, IMMUNOL CELL BIOL, V82, P170, DOI 10.1046/j.0818-9641.2004.01227.x
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 52
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 2018
VL 188
IS 11
BP 2644
EP 2652
DI 10.1016/j.ajpath.2018.07.009
PG 9
WC Pathology
SC Pathology
GA GZ0FK
UT WOS:000449036900018
PM 30121258
OA Bronze
DA 2020-07-08
ER

PT J
AU Karkhah, A
   Nouri, HR
   Javanian, M
   Koppolu, V
   Masrour-Roudsari, J
   Kazemi, S
   Ebrahimpour, S
AF Karkhah, Ahmad
   Nouri, Hamid Reza
   Javanian, Mostafa
   Koppolu, Veerendra
   Masrour-Roudsari, Jila
   Kazemi, Sohrab
   Ebrahimpour, Soheil
TI Zika virus: epidemiology, clinical aspects, diagnosis, and control of
   infection
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; Epidemiology; Diagnosis; Treatment; Prevention
ID REGULATORY T-CELLS; NEUROLOGICAL DISORDERS; CHIKUNGUNYA VIRUS;
   TRANSMISSION; DENGUE; ABNORMALITIES; PATHOGENESIS; PERSISTENCE;
   STRATEGIES; PREGNANCY
AB Zika virus (ZIKV) is an emerging pathogen of huge public health significance to human beings. Although majority of infections are benign with self-limiting symptoms, the recent outbreak has established an association with the increased incidence of some congenital anomalies such as microcephaly. In other words, due to the large extent of the virus and mosquito vectors, the infection has become a thoughtful health problem for human societies, though now, there are no antiviral therapies or vaccines against this virus. In spite of extensive research carried out by scientists, not so much information has been gathered about this viral infection. In the current review, we prepared an overview of the remarkable progress made in understanding about the epidemiology, immunology, clinical presentation, and diagnosis methods of ZIKV infection.
C1 [Karkhah, Ahmad; Nouri, Hamid Reza; Kazemi, Sohrab] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Babol Sar, Iran.
   [Karkhah, Ahmad] Babol Univ Med Sci, Student Res Comm, Sch Med, Babol Sar, Iran.
   [Javanian, Mostafa; Masrour-Roudsari, Jila; Ebrahimpour, Soheil] Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol Sar, Iran.
   [Koppolu, Veerendra] Scientist Biopharmaceut Dev Medimmune, Gaithersburg, MD 20878 USA.
RP Ebrahimpour, S (corresponding author), Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol Sar, Iran.
EM drsoheil1503@yahoo.com
RI Karkhah, Ahmad/A-2960-2017; Koppolu, Veerendra/N-1366-2017; Nouri, Hamid
   Reza/AAC-4699-2020
OI Karkhah, Ahmad/0000-0002-9511-7839; Koppolu,
   Veerendra/0000-0001-9141-9058; Nouri, Hamid Reza/0000-0002-8387-0807
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bingham AM, 2016, MMWR MORB MORTAL WKL, V65
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Britt WJ, 2018, SEMINARS PERINATOLOG
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, P1
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen C-H, 2017, IMMUNOLOGY INFECT
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DeSilva M, 2017, VACCINE, V35, P6472, DOI 10.1016/j.vaccine.2017.01.044
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Fellner Chris, 2016, P T, V41, P242
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Frenkel LD, 2018, EUR J CLIN MICROBIOL, V37, P209, DOI 10.1007/s10096-017-3111-8
   Galan-Huerta K, 2016, MED U, V18, P115, DOI DOI 10.1016/J.RMU.2016.05.003
   Gebre Y, 2016, ASIAN PAC J TROP BIO, V6, P815, DOI 10.1016/j.apjtb.2016.08.008
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gulland A., 2016, BMJ, V355, pi5562, DOI 10.1136/bmj.i5562
   Hassan Fatima I., 2017, Infectious Disorders - Drug Targets, V17, P3, DOI 10.2174/1871526516666161018104916
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   Hickman HD, 2017, IMMUNITY, V46, P13, DOI 10.1016/j.immuni.2016.12.020
   Ho HJ, 2017, EMERG INFECT DIS, V23, P2085, DOI 10.3201/eid2312.171224
   Holmes EC, 1998, BIOMED RES REP, P301
   James SH, 2014, J PEDIATR INFECT DIS, V3, pS19, DOI 10.1093/jpids/piu050
   Javanian M, 2018, ROM J INTERN MED
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kalkeri Raj, 2017, F1000Res, V6, P1850, DOI 10.12688/f1000research.12695.1
   Karkhah A, 2018, INFECT GENET EVOL, V59, P32, DOI 10.1016/j.meegid.2018.01.015
   KHANDIA R, 2018, FRONT IMMUNOL, V9
   KMIETOWICZ Z, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/bmj.i649
   Koppolu V, 2018, J NEUROVIROL
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Le Ray C, 2004, ULTRASOUND OBST GYN, V24, P481, DOI 10.1002/uog.1707
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li R, 2017, RADIOL INFECT DIS, V4, P88, DOI [10.1016/j.jrid.2017.01.002, DOI 10.1016/J.JRID.2017.01.002]
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Luksic B, 2017, INT MED CASE REP J, V10, P117, DOI 10.2147/IMCRJ.S130210
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mauk Michael G, 2017, Clin Lab Int, V41, P25
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McCarthy M., 2016, BMJ, V352
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Nejati S, 2018, MICROB PATHOGENESIS, V117, P43, DOI 10.1016/j.micpath.2018.02.016
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1973-5
   Nourollahpour Shiadeh M, 2017, J MATERN-FETAL NEO M, V30, P562, DOI 10.1080/14767058.2016.1177820
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   PAHWA S, 1988, PEDIATR INFECT DIS J, V7, pS61
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen EE, 2016, MMWR MORB MORTAL WKL, V65
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poland GA, 2018, LANCET INFECT DIS
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Saadi M, 2017, INFECT GENET EVOL, V51, P227, DOI 10.1016/j.meegid.2017.04.009
   Sabbagh P, 2018, INFECT GENET EVOL, V62, P270, DOI 10.1016/j.meegid.2018.05.001
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Singh MV, 2017, J NEUROVIROL, V23, P347, DOI 10.1007/s13365-017-0513-4
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Soni N. R., 2016, Asian Pacific Journal of Reproduction, V5, P179, DOI 10.1016/j.apjr.2016.04.014
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Yadav RK, 2014, J SCI INNOVATIVE RES, V3, P258
   Yang KH, 2017, MRS COMMUN, V7, P121, DOI 10.1557/mrc.2017.20
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yi-Pin Lee C, 2018, MICROBES INFECT
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P157, DOI 10.1016/S1473-3099(16)00023-2
NR 111
TC 7
Z9 8
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD NOV
PY 2018
VL 37
IS 11
BP 2035
EP 2043
DI 10.1007/s10096-018-3354-z
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GY4WH
UT WOS:000448567800001
PM 30167886
DA 2020-07-08
ER

PT J
AU Davanzo, R
AF Davanzo, Riccardo
TI Controversies in Breastfeeding
SO FRONTIERS IN PEDIATRICS
LA English
DT Review
DE breastfeeding; contraindication; maternal health conditions;
   reproductive health conditions; maternal infections; cytomegalovirus;
   chemical substances
ID HUMAN-IMMUNODEFICIENCY-VIRUS; MINISTRY-OF-HEALTH; PRETERM INFANTS;
   CYTOMEGALOVIRUS-INFECTION; HUMAN-MILK; ZIKA VIRUS; POSITION STATEMENT;
   PREMATURE-INFANTS; ITALIAN SOCIETY; UNITED-STATES
AB When addressing the compatibility of breastfeeding with certain maternal conditions, we need to differentiate between "contraindication" and "obstacle." Failure to distinguish between the two confuses new mothers and their families, and engenders misconceptions about breastfeeding advice by health professionals. Health conditions that may simply impede the initiation and duration of breastfeeding are often wrongly referred to as true contraindications to breastfeed, under the assumption that they might harm the health of the mother and/or that of the nursing infant. Here, we discuss several topics, including breast surgery, prolactinoma, concurrent new pregnancy, hormonal contraception, and use of medications and contrast agents, that continue to raise controversy. While most conditions appear to be compatible with breastfeeding, the major determinants of a woman's final choice of whether to nurse her infant or not are the attitude of health professionals and the state of mind of being an informed mother.
C1 [Davanzo, Riccardo] Osped Madonna delle Grazie, Div Pediat & Neonatol, Dept Mother & Child Hlth, Matera, Italy.
   [Davanzo, Riccardo] Minist Hlth, Task Force Breastfeeding, Rome, Italy.
RP Davanzo, R (corresponding author), Osped Madonna delle Grazie, Div Pediat & Neonatol, Dept Mother & Child Hlth, Matera, Italy.; Davanzo, R (corresponding author), Minist Hlth, Task Force Breastfeeding, Rome, Italy.
EM riccardo.davanzo@gmail.com
CR Adams WP, 2012, PLAST RECONSTR SURG, V130, p598E, DOI 10.1097/PRS.0b013e318262f607
   American College of Radiology, 2017, COMM DRUGS CONTR MED
   Anderson PO, 2016, CLIN PEDIATR, V55, P236, DOI 10.1177/0009922815594586
   [Anonymous], 2009, ACC MED REAS US BREA
   [Anonymous], 1991, SORANUS GYNECOLOGY
   Antona D, 2017, EPIDEMIOL INFECT, V145, P1471, DOI 10.1017/S0950268817000103
   Arguello B, 2015, BRIT J CLIN PHARMACO, V79, P537, DOI 10.1111/bcp.12515
   Azim HA, 2009, BREAST CANCER RES TR, V114, P7, DOI 10.1007/s10549-008-9983-7
   Balcells C, 2016, J PERINAT MED, V44, P485, DOI 10.1515/jpm-2015-0325
   Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616
   Bartick MC, 2013, OBSTET GYNECOL, V122, P111, DOI 10.1097/AOG.0b013e318297a047
   Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0
   Berardi A, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-52
   Beshyah SA, 2017, PITUITARY, V20, P231, DOI 10.1007/s11102-016-0767-5
   Bispo S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21251
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brown A, 2015, MIDWIFERY, V31, P80, DOI 10.1016/j.midw.2014.06.003
   Brown E, 2014, AUST NZ J OBSTET GYN, V54, P184, DOI 10.1111/ajo.12197
   Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P1010, DOI 10.1079/PHN2005793
   Cattaneo A, 2006, ACTA PAEDIATR, V95, P540, DOI 10.1080/08035250500447936
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Cetin I, 2014, J HUM LACT, V30, P20, DOI 10.1177/0890334413514294
   Chiappini E, 2018, JAIDS-J ACQ IMM DEF, V79, P54, DOI [10.1097/QAI.0000000000001774, 10.1097/qai.0000000000001774]
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cova MA, 2014, EUR RADIOL, V24, P2012, DOI 10.1007/s00330-014-3198-6
   Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1
   Davanzo R, 2016, J HUM LACT, V32, P15, DOI 10.1177/0890334415595513
   Davanzo R, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0191-x
   de Andrade RA, 2010, J PEDIAT-BRAZIL, V86, P239, DOI [10.1590/S0021-75572010000300013, 10.2223/JPED.2002]
   Domingue ME, 2014, CLIN ENDOCRINOL, V80, P642, DOI 10.1111/cen.12370
   Escuder-Vieco D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00926
   Feldman-Winter L, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1229
   Flynn PM, 2018, JAIDS-J ACQ IMM DEF, V77, P383, DOI 10.1097/QAI.0000000000001612
   Flynn PM, 2013, PEDIATRICS, V131, P391, DOI 10.1542/peds.2012-3543
   Fowler MG, 2018, CURR OPIN PEDIATR, V30, P144, DOI 10.1097/MOP.0000000000000579
   Fowler MG, 2012, ADV EXP MED BIOL, V743, P3, DOI 10.1007/978-1-4614-2251-8_1
   Gartner LM, 2005, PEDIATRICS, V115, P496, DOI [10.1542/peds.2011-3552, 10.1542/peds.2004-2491]
   Givens M, 2018, OBSTET GYNECOL SURV, V73, P423, DOI 10.1097/OGX.0000000000000581
   Glezer AN, 2018, MINERVA ENDOCRINOL, V43, P423, DOI 10.23736/S0391-1977.17.02792-4
   Goelz R, 2013, ARCH DIS CHILD-FETAL, V98, pF430, DOI 10.1136/archdischild-2012-303384
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gunkel J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0635
   Halderman LD, 2002, AM J OBSTET GYNECOL, V186, P1250, DOI 10.1067/mob.2002.123738
   Hall-Findlay EJ, 2015, PLAST RECONSTR SURG, V136, p531E, DOI 10.1097/PRS.0000000000001622
   Hamprecht K, 2017, CLIN PERINATOL, V44, P121, DOI 10.1016/j.clp.2016.11.012
   HARMSEN MC, 1995, J INFECT DIS, V172, P380, DOI 10.1093/infdis/172.2.380
   Hauck YL, 2011, MIDWIFERY, V27, pE156, DOI 10.1016/j.midw.2010.02.003
   Hughes Henrietta, 2009, J Fam Health Care, V19, P9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kraut RY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186591
   Kurath S, 2010, PEDIATR INFECT DIS J, V29, P680, DOI 10.1097/INF.0b013e3181dc4d4a
   Lambertini M, 2018, JNCI-J NATL CANCER I, V110, P426, DOI 10.1093/jnci/djx206
   Lanzieri TM, 2013, PEDIATRICS, V131, pE1937, DOI 10.1542/peds.2013-0076
   Maiter D, 2016, ANN ENDOCRINOL-PARIS, V77, P128, DOI 10.1016/j.ando.2016.04.001
   Maschmann J, 2015, NEONATOLOGY, V107, P213, DOI 10.1159/000371753
   MCNEILLY AS, 1983, CLIN ENDOCRINOL, V19, P167, DOI 10.1111/j.1365-2265.1983.tb02978.x
   Mukhopadhyay S, 2016, AM J PERINAT, V33, P894, DOI 10.1055/s-0036-1581080
   Nardone B, 2014, PEDIATR RADIOL, V44, P173, DOI 10.1007/s00247-013-2795-x
   Omarsdottir S, 2015, PEDIATR INFECT DIS J, V34, P482, DOI 10.1097/INF.0000000000000619
   Pagani O, 2011, BREAST CANCER RES TR, V129, P309, DOI 10.1007/s10549-011-1643-7
   Peila C, 2017, J PEDIATR GASTR NUTR, V64, P353, DOI 10.1097/MPG.0000000000001435
   Roberts CL, 2015, MED J AUSTRALIA, V202, P324, DOI 10.5694/mja14.01386
   Rowe H, 2015, CHILD ADOL PSYCH CL, V24, P1, DOI 10.1016/j.chc.2014.09.005
   Saleem Mohamed, 2018, Clin Biochem Rev, V39, P3
   Schiff M, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-17
   Schwarz EB, 2015, AM FAM PHYSICIAN, V91, P602
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Souto Glaucia C, 2003, J Hum Lact, V19, P43, DOI 10.1177/0890334402239733
   Stock K, 2015, BREASTFEED MED, V10, P113, DOI 10.1089/bfm.2014.0108
   Taylor GP, 2011, HIV MED, V12, P389, DOI 10.1111/j.1468-1293.2011.00918.x
   Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012
   WHO/ UNICEF, 2003, GLOB STRAT INF YOUNG
   WHO UNICEF, 2016, GUID UPD HIV INF FEE
   World Health Organization, 2016, WHOZIKVMOC166
NR 74
TC 0
Z9 0
U1 1
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2360
J9 FRONT PEDIATR
JI Front. Pediatr.
PD NOV 1
PY 2018
VL 6
AR 278
DI 10.3389/fped.2018.00278
PG 8
WC Pediatrics
SC Pediatrics
GA GY9XI
UT WOS:000449005600001
PM 30443539
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wong, J
   Soh, A
   Tan, G
   Ng, Y
   Suhardi, H
   Jansen, M
   Rooney, P
   Lye, W
   Luo, R
   Wee, EJ
   Michel, G
   Lee, C
AF Wong, J.
   Soh, A.
   Tan, G.
   Ng, Y.
   Suhardi, H.
   Jansen, M.
   Rooney, P.
   Lye, W.
   Luo, R.
   Wee, E. J.
   Michel, G.
   Lee, C.
TI Triplex Assay for Zika, Dengue, and Chikungunya Viruses by Sentosa SA
   Real-time RT-PCR Assay
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Annual Meeting of the Association-for-Molecular-Pathology (AMP)
CY NOV 01-03, 2018
CL San Antonio, TX
SP Assoc Mol Pathol
C1 [Wong, J.; Soh, A.; Tan, G.; Ng, Y.; Suhardi, H.; Lye, W.; Luo, R.; Wee, E. J.; Lee, C.] Vela Diagnost Singapore Pte Ltd, Singapore, Singapore.
   [Jansen, M.; Rooney, P.] Vela Diagnost USA Inc, Fairfield, NJ USA.
   [Michel, G.] Vela Diagnost GmbH, Hamburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2018
VL 20
IS 6
MA ID018
BP 940
EP 940
PG 1
WC Pathology
SC Pathology
GA GY5RC
UT WOS:000448637200159
DA 2020-07-08
ER

PT J
AU Terefe, YA
   Gaff, H
   Kamga, M
   van der Mescht, L
AF Terefe, Y. A.
   Gaff, H.
   Kamga, M.
   van der Mescht, L.
TI Mathematics of a model for Zika transmission dynamics
SO THEORY IN BIOSCIENCES
LA English
DT Article
DE Zika virus; Disease-free equilibrium; Basic reproduction number
ID VIRUS-INFECTION; STATES; BRAIN
AB Zika is a flavivirus transmitted to humans through either the bite of infected Aedes mosquitoes or sexual intercourse with infected individuals. In this paper, we present a mathematical model based on these two modes of transmission. Using the next-generation matrix method, a threshold parameter called basic reproduction number is determined. Sensitivity analysis of the basic reproduction number in terms of parameters involved in its formulation is discussed. A dynamically consistent nonstandard finite difference scheme is designed to replicate the properties of the continuous model. Numerical simulations of the nonstandard finite difference scheme that we have constructed show the number of infected humans due to sexual intercourse with Zika virus infectious individuals. The numerical simulations also support the theoretical analysis of the model.
C1 [Terefe, Y. A.] Univ Limpopo, Dept Math & Appl Math, Mankweng, South Africa.
   [Gaff, H.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.
   [Kamga, M.] Univ Namibia, Dept Math, Windhoek, Namibia.
   [van der Mescht, L.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa.
RP Terefe, YA (corresponding author), Univ Limpopo, Dept Math & Appl Math, Mankweng, South Africa.
EM yibeltal.terefe@ul.ac.za; holly.gaff@gmail.com; mkamga-pene@unam.na;
   luthervdm@sun.ac.za
RI van der Mescht, Luther/J-8349-2019
OI van der Mescht, Luther/0000-0001-8813-9549
FU DST/NRF SARChI Chair in Mathematical Models and Methods in
   Bioengineering and Biosciences from the University of Pretoria;
   University of South Africa
FX The authors acknowledge the financial support of the DST/NRF SARChI
   Chair in Mathematical Models and Methods in Bioengineering and
   Biosciences from the University of Pretoria and University of South
   Africa. The authors are grateful to the anonymous reviewers, and the
   Handling Editor, for their suggestions that have greatly improved the
   paper.
CR Anguelov R, 2001, NUMER METH PART D E, V17, P518, DOI 10.1002/num.1025
   Blayneh K, 2009, DISCRETE CONT DYN-B, V11, P587, DOI 10.3934/dcdsb.2009.11.587
   Bonyah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185540
   Brauer F, 2012, MATH MODELS COMMUNIC
   Brauer F, 2008, LECT NOTES MATH
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HETHCOTE H W, 1976, Mathematical Biosciences, V28, P335, DOI 10.1016/0025-5564(76)90132-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Kraemer M, 2015, GLOBAL DISTRIBUTION, P1
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Martcheva M, 2015, INTRO MATH EPIDEMIOL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mickens R. E., 1994, NONSTANDARD FINITE D
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI [10.15585/mmwr.mm6508e2, DOI 10.15585/MMWR.MM6508E2]
   Simpson D, 2016, T R SOC TROP MED HYG, V65, P59
   Smith H.L., 1995, MONOTONE DYNAMICAL S
   STUART AM, 1998, DYNAMICAL SYSTEMS NU
   van den Driessche P, 2008, LECT NOTES MATH, V1945, P159
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   World Health Organization, 2016, WHO DIS OUTBREA 0310
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 42
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1431-7613
EI 1611-7530
J9 THEOR BIOSCI
JI Theory Biosci.
PD NOV
PY 2018
VL 137
IS 2
BP 209
EP 218
DI 10.1007/s12064-018-0272-7
PG 10
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA GY9YW
UT WOS:000449011200010
PM 30349980
DA 2020-07-08
ER

PT J
AU Walker, CL
   Merriam, AA
   Gyamfi-Bannerman, C
   Waldorf, KMA
AF Walker, Christie L.
   Merriam, Audrey A.
   Gyamfi-Bannerman, Cynthia
   Waldorf, Kristina M. Adams
TI Femur-sparing pattern of fetal growth after maternal Zika virus
   infection REPLY
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Walker, Christie L.] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA.
   [Merriam, Audrey A.; Gyamfi-Bannerman, Cynthia] Columbia Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Med Ctr, New York, NY USA.
   [Waldorf, Kristina M. Adams] Ctr Innate Immun & Immune Dis, Dept Obstet & Gynecol, Seattle, WA 98109 USA.
RP Waldorf, KMA (corresponding author), Ctr Innate Immun & Immune Dis, Dept Obstet & Gynecol, Seattle, WA 98109 USA.
EM adamsk@u.washington.edu
RI Adams Waldorf, Kristina/F-2608-2013
OI Adams Waldorf, Kristina/0000-0002-6939-7224
CR Anderson M. S., 1999, NEONATOLOGY PATHOPHY, P411
   Chu V, 2017, OPEN FORUM INFECT S1, pS696, DOI [10.1093/ofid/ofx163.1867, DOI 10.1093/OFID/OFX163.1867]
   GHOSH A, 1987, PRENATAL DIAG, V7, P307, DOI 10.1002/pd.1970070503
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
NR 6
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD NOV
PY 2018
VL 219
IS 5
BP 514
EP 515
DI 10.1016/j.ajog.2018.07.008
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GY2TK
UT WOS:000448396200039
PM 30025831
OA Bronze
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Femur-sparing pattern of fetal growth after maternal Zika virus
   infection
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR GHOSH A, 1987, PRENATAL DIAG, V7, P307, DOI 10.1002/pd.1970070503
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 2
Z9 2
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD NOV
PY 2018
VL 219
IS 5
BP 514
EP 514
DI 10.1016/j.ajog.2018.07.009
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GY2TK
UT WOS:000448396200038
PM 30017677
OA Bronze
DA 2020-07-08
ER

EF